PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McCarron, JG; Olson, ML				McCarron, John G.; Olson, Marnie L.			A single luminally continuous sarcoplasmic reticulum with apparently separate Ca2+ stores in smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOID ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; INTRACELLULAR CA2+; CALCIUM-RELEASE; NUCLEAR-ENVELOPE; SEA-URCHIN; CELLS; CHANNEL; WAVES; DISTINCT	Whether or not the sarcoplasmic reticulum ( SR) is a continuous, interconnected network surrounding a single lumen or comprises multiple, separate Ca2+ pools was investigated in voltage-clamped single smooth muscle cells using local photolysis of caged compounds and Ca2+ imaging. The entire SR could be depleted or refilled from one small site via either inositol 1,4,5-trisphosphate receptors ( IP3R) or ryanodine receptors ( RyR) suggesting the SR is luminally continuous and that Ca2+ may diffuse freely throughout. Notwithstanding, regulation of the opening of RyR and IP3R, by the [ Ca2+] within the SR, may create several apparent SR elements with various receptor arrangements. IP3R and RyR may appear to exist entirely on a single store, and there may seem to be additional SR elements that express either only RyR or only IP3R. The various SR receptor arrangements and apparently separate Ca2+ storage elements exist in a single luminally continuous SR entity.	[McCarron, John G.; Olson, Marnie L.] Univ Strathclyde, Strathclyde Inst Phar & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Phar & Biomed Sci, John Arbuthnott Bldg,27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	john.mccarron@strath.ac.uk			British Heart Foundation [pg/06/016] Funding Source: Medline; Wellcome Trust [078054/z/05/z] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; BARO I, 1995, J PHYSIOL-LONDON, V482, P247, DOI 10.1113/jphysiol.1995.sp020514; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 1999, AM J PHYSIOL-CELL PH, V277, pC139, DOI 10.1152/ajpcell.1999.277.1.C139; BOLTON TB, 1989, J PHYSIOL-LONDON, V409, P385, DOI 10.1113/jphysiol.1989.sp017504; BOND M, 1984, J PHYSIOL-LONDON, V355, P677, DOI 10.1113/jphysiol.1984.sp015445; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; CHEEK TR, 1994, BIOCHEM J, V301, P879, DOI 10.1042/bj3010879; Choi YM, 2006, J NEUROSCI, V26, P12127, DOI 10.1523/JNEUROSCI.3158-06.2006; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DEVINE CE, 1972, J CELL BIOL, V52, P690, DOI 10.1083/jcb.52.3.690; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Flynn ERM, 2001, J BIOL CHEM, V276, P36411, DOI 10.1074/jbc.M104308200; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Guerrero-Hernandez A, 2002, FRONT BIOSCI-LANDMRK, V7, pD1676, DOI 10.2741/hernande; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; HENSON JH, 1989, J CELL BIOL, V109, P149, DOI 10.1083/jcb.109.1.149; HIROSE K, 1994, NATURE, V372, P791; IINO M, 1987, BIOCHEM BIOPH RES CO, V142, P47, DOI 10.1016/0006-291X(87)90449-9; IINO M, 1988, BIOCHEM BIOPH RES CO, V152, P417, DOI 10.1016/S0006-291X(88)80730-7; Jabr RI, 1997, BRIT J PHARMACOL, V122, P21, DOI 10.1038/sj.bjp.0701326; Janiak R, 2001, AM J PHYSIOL-CELL PH, V280, pC22, DOI 10.1152/ajpcell.2001.280.1.C22; Kamishima T, 1996, J PHYSIOL-LONDON, V492, P61, DOI 10.1113/jphysiol.1996.sp021289; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KOCH GLE, 1988, J CELL SCI, V91, P511; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; McCarron JG, 2004, J BIOL CHEM, V279, P8417, DOI 10.1074/jbc.M311797200; McCarron JG, 2002, J CELL SCI, V115, P2207; McCarron JG, 1999, J PHYSIOL-LONDON, V516, P149, DOI 10.1111/j.1469-7793.1999.149aa.x; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; MUALLEM S, 1989, J BIOL CHEM, V264, P205; Ohta T, 2002, NEUROSCI LETT, V326, P167, DOI 10.1016/S0304-3940(02)00333-6; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; PACAUD P, 1995, J PHYSIOL-LONDON, V484, P549, DOI 10.1113/jphysiol.1995.sp020685; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; POPESCU LM, 1974, CELL TISSUE RES, V154, P357; POPESCU LM, 1975, J CELL BIOL, V67, P911, DOI 10.1083/jcb.67.3.911; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rooney E, 1996, J BIOL CHEM, V271, P29304, DOI 10.1074/jbc.271.46.29304; Rose HJ, 2006, BIOPHYS J, V91, P4024, DOI 10.1529/biophysj.106.088872; SOMLYO AP, 1989, FASEB J, V3, P2266, DOI 10.1096/fasebj.3.11.2506092; SOMLYO AV, 1985, EXPERIENTIA, V41, P841, DOI 10.1007/BF01970000; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tanimura A, 1996, J CELL BIOL, V132, P607, DOI 10.1083/jcb.132.4.607; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; Venetucci LA, 2007, CIRC RES, V100, P105, DOI 10.1161/01.RES.0000252828.17939.00; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; VOLPE P, 1992, P NATL ACAD SCI USA, V89, P6142, DOI 10.1073/pnas.89.13.6142; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; YAMAZAWA T, 1992, FEBS LETT, V301, P181, DOI 10.1016/0014-5793(92)81243-F	73	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7206	7218		10.1074/jbc.M708923200	http://dx.doi.org/10.1074/jbc.M708923200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18096697	hybrid			2022-12-27	WOS:000253779600066
J	Liu, Y; Vidensky, S; Ruggiero, AM; Maier, S; Sitte, HH; Rothstein, JD				Liu, Yiting; Vidensky, Svetlana; Ruggiero, Alicia M.; Maier, Susanne; Sitte, Harald H.; Rothstein, Jeffrey D.			Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SYNAPTIC STRENGTH; GABA SYNTHESIS; CELL-SURFACE; NOGO-A; EXPRESSION; PROTEIN; NEUROTRANSMITTER; LOCALIZATION; INTERACTS	Excitatory amino acid transporters (EAATs) are the primary regulators of extracellular glutamate concentrations in the central nervous system. Their dysfunction may contribute to several neurological diseases. To date, five distinct mammalian glutamate transporters have been cloned. In brain, EAAC1 (excitatory amino acid carrier 1) is the primary neuronal glutamate transporter, localized on the perisynaptic membranes that are near release sites. Despite its potential importance in synaptic actions, little is known concerning the regulation of EAAC1 trafficking from the endoplasmic reticulum (ER) to the cell surface. Previously, we identified an EAAC1-associated protein, GTRAP3-18, an ER protein that prevents ER exit of EAAC1 when induced. Here we show that RTN2B, a member of the reticulon protein family that mainly localizes in the ER and ER exit sites interacts with EAAC1 and GTRAP3-18. EAAC1 and GTRAP3-18 bind to different regions of RTN2B. Each protein can separately and independently form complexes with EAAC1. RTN2B enhances ER exit and the cell surface composition of EAAC1 in heterologous cells. Expression of short interfering RNA-mediated knockdown of RTN2B decreases the EAAC1 protein level in neurons. Overall, our results suggest that RTN2B functions as a positive regulator in the delivery of EAAC1 from the ER to the cell surface. These studies indicate that transporter exit from the ER controlled by the interaction with its ER binding partner represents a critical regulatory step in glutamate transporter trafficking to the cell surface.	[Liu, Yiting; Vidensky, Svetlana; Ruggiero, Alicia M.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21287 USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21287 USA; [Maier, Susanne; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	Johns Hopkins University; Johns Hopkins University; Medical University of Vienna	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Sch Med, Meyer 6-109,600 N Wolfe St, Baltimore, MD 21287 USA.	jrothstein@jhmi.edu	rothstein, jeffrey d/C-9470-2013; Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958, R01NS052179, U01NS050094, R01NS040151] Funding Source: NIH RePORTER; Austrian Science Fund FWF [P 18706] Funding Source: Medline; NINDS NIH HHS [R01 NS052179-03, U01 NS050094-03, R01 NS040151, R01 NS033958, NS 33958, R01 NS033958-13, U01 NS050094, NS 40151, NS 52179, R01 NS052179] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Butchbach MER, 2003, J NEUROCHEM, V84, P891, DOI 10.1046/j.1471-4159.2003.01588.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Duan SM, 1999, J NEUROSCI, V19, P10193; Eskandari S, 2000, P NATL ACAD SCI USA, V97, P8641, DOI 10.1073/pnas.97.15.8641; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Furuta A, 2003, AM J PATHOL, V163, P779, DOI 10.1016/S0002-9440(10)63705-4; Geisler JG, 1998, MAMM GENOME, V9, P274, DOI 10.1007/s003359900748; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He Y, 2000, J COMP NEUROL, V418, P255; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Iwahashi J, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL467; Iwahashi J, 2002, BIOCHEM BIOPH RES CO, V293, P698, DOI 10.1016/S0006-291X(02)00282-6; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Mathews GC, 2003, J NEUROSCI, V23, P2040; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Roebroek AJM, 1998, GENOMICS, V51, P98, DOI 10.1006/geno.1997.5175; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; SENDEN NHM, 1994, EUR J CELL BIOL, V65, P341; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voutsinos-Porche B, 2006, J CEREBR BLOOD F MET, V26, P1419, DOI 10.1038/sj.jcbfm.9600295; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; WIELAND FT, 1987, CELL, V50, P189; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	55	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6561	6571		10.1074/jbc.M708096200	http://dx.doi.org/10.1074/jbc.M708096200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18096700	hybrid, Green Accepted			2022-12-27	WOS:000253779500062
J	Surinya, KH; Forbes, BE; Occhiodoro, F; Booker, GW; Francis, GL; Siddle, K; Wallace, JC; Cosgrove, LJ				Surinya, Katharina Helen; Forbes, Briony E.; Occhiodoro, Filomena; Booker, Grant W.; Francis, Geoffrey Leonard; Siddle, Kenneth; Wallace, John C.; Cosgrove, Leah J.			An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; ALANINE-SCANNING MUTAGENESIS; HIGH-AFFINITY BINDING; STRUCTURAL BASIS; ALPHA-SUBUNIT; IGF-II; MONOCLONAL-ANTIBODIES; FACTOR (IGF)-II; DOMAIN; SPECIFICITY	To investigate the interaction of the insulin-like growth factor (IGF) ligands with the insulin-like growth factor type 1 receptor (IGF-1R), we have generated two soluble variants of the IGF-1R. We have recombinantly expressed the ectodomain of IGF-1R or fused this domain to the constant domain from the Fc fragment of mouse immunoglobulin. The ligand binding properties of these soluble IGF-1Rs for IGF-I and IGF-II were investigated using conventional ligand competition assays and BIAcore biosensor technology. In ligand competition assays, the soluble IGF-1Rs both bound IGF-I with similar affinities and a 5-fold lower affinity than that seen for the wild type receptor. In addition, both soluble receptors bound IGF-II with similar affinities to the wild type receptor. BIAcore analyses showed that both soluble IGF-1Rs exhibited similar ligand-specific association and dissociation rates for IGF-I and for IGF-II. The soluble IGF-1R proteins both exhibited negative cooperativity for IGF-I, IGF-II, and the 24-60 antibody, which binds to the IGF-1R cysteine-rich domain. We conclude that the addition of the self-associating Fc domain to the IGF-1R ectodomain does not affect ligand binding affinity, which is in contrast to the soluble ectodomain of the IR. This study highlights some significant differences in ligand binding modes between the IGF-1R and the insulin receptor, which may ultimately contribute to the different biological activities conferred by the two receptors.	[Occhiodoro, Filomena; Cosgrove, Leah J.] CSIRO Mol & Hlth Technol, Adelaide, SA 5000, Australia; [Surinya, Katharina Helen; Forbes, Briony E.; Booker, Grant W.; Wallace, John C.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Francis, Geoffrey Leonard] Novozymes GroPep Ltd, Adelaide, SA 5000, Australia; [Siddle, Kenneth] Univ Cambridge, Dept Clin Biochem, Cambridge CB2 2QR, England	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide; Novozymes; University of Cambridge	Cosgrove, LJ (corresponding author), CSIRO Mol & Hlth Technol, PO Box 10041 BC, Adelaide, SA 5000, Australia.	leah.cosgrove@csiro.au	, John/AAP-5150-2020; Cosgrove, Leah J/A-7764-2010; Forbes, Briony/R-1838-2019	Cosgrove, Leah J/0000-0002-8340-4291; Surinya, Kathy/0000-0003-0507-2962; Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; BONISCHNETZLER M, 1987, J BIOL CHEM, V262, P8395; Brandt J, 2001, J BIOL CHEM, V276, P12378, DOI 10.1074/jbc.M009402200; Chakravarty A, 2005, BIOCHEM BIOPH RES CO, V331, P74, DOI 10.1016/j.bbrc.2005.03.122; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CHRISTOFFERSEN CT, 1994, ENDOCRINOLOGY, V135, P472, DOI 10.1210/en.135.1.472; Cosgrove L, 1995, PROTEIN EXPRES PURIF, V6, P789, DOI 10.1006/prep.1995.0010; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, GROWTH HORM IGF RES, V12, P81, DOI 10.1054/ghir.2002.0264; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; FABRY M, 1992, J BIOL CHEM, V267, P8950; FELTZ SM, 1988, BIOCHEMISTRY-US, V27, P3234, DOI 10.1021/bi00409a017; Forbes BE, 2002, EUR J BIOCHEM, V269, P961, DOI 10.1046/j.0014-2956.2001.02735.x; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; GICQUEL C, 1994, J CLIN ENDOCR METAB, V78, P1444, DOI 10.1210/jc.78.6.1444; GUSTAFSON TA, 1990, J BIOL CHEM, V265, P18663; Hao CL, 2006, BIOCHEM BIOPH RES CO, V347, P334, DOI 10.1016/j.bbrc.2006.06.089; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; Jansson M, 1997, J BIOL CHEM, V272, P8189, DOI 10.1074/jbc.272.13.8189; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KJELDSEN T, 1994, J BIOL CHEM, V269, P32942; Kristensen C, 1998, J BIOL CHEM, V273, P17780, DOI 10.1074/jbc.273.28.17780; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; LOETSCHER H, 1991, J BIOL CHEM, V266, P18324; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Molina L, 2000, FEBS LETT, V467, P226, DOI 10.1016/S0014-5793(00)01161-3; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Mynarcik DC, 1997, J BIOL CHEM, V272, P18650, DOI 10.1074/jbc.272.30.18650; PIETRZKOWSKI Z, 1992, CELL GROWTH DIFFER, V3, P199; Quinn KA, 1996, J BIOL CHEM, V271, P11477, DOI 10.1074/jbc.271.19.11477; Renehan AG, 2000, BRIT J CANCER, V83, P1344, DOI 10.1054/bjoc.2000.1462; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SELL C, 1994, MOL CELL BIOL, V14, P3604, DOI 10.1128/MCB.14.6.3604; SOOS MA, 1992, J BIOL CHEM, V267, P12955; Surinya HH, 2002, J BIOL CHEM, V277, P16718, DOI 10.1074/bjc.M112014200; SWEET LJ, 1987, J BIOL CHEM, V262, P6939; TOLLEFSEN SE, 1988, J BIOL CHEM, V263, P16267; TOLLEFSEN SE, 1991, BIOCHEMISTRY-US, V30, P48, DOI 10.1021/bi00215a008; Vella V, 2002, J CLIN ENDOCR METAB, V87, P245, DOI 10.1210/jc.87.1.245; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WHITTAKER J, 1994, MOL ENDOCRINOL, V8, P1521, DOI 10.1210/me.8.11.1521; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Woods KA, 1997, ACTA PAEDIATR, V86, P39; ZHANG B, 1991, P NATL ACAD SCI USA, V88, P9858, DOI 10.1073/pnas.88.21.9858; ZHANG B, 1991, BIOCHEMISTRY-US, V30, P5113, DOI 10.1021/bi00235a001	62	31	35	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5355	5363		10.1074/jbc.M707054200	http://dx.doi.org/10.1074/jbc.M707054200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056713	hybrid			2022-12-27	WOS:000253426700015
J	Guan, B; Pungaliya, P; Li, X; Uquillas, C; Mutton, LN; Rubin, EH; Bieberich, CJ				Guan, Bin; Pungaliya, Pooja; Li, Xiang; Uquillas, Carlos; Mutton, Laura N.; Rubin, Eric H.; Bieberich, Charles J.			Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I-BINDING; HOMEOBOX GENE; SUMO-1 E3-LIGASE; PROTEIN; CANCER; EXPRESSION; P53; CARCINOGENESIS; DELETION; VIVO	The NKX3.1 gene located at 8p21.2 encodes a homeodomain-containing transcription factor that acts as a haploin sufficient tumor suppressor in prostate cancer. Diminished protein expression of NKX3.1 has been observed in prostate cancer precursors and carcinomas. TOPORS is a ubiquitously expressed E3 ubiquitin ligase that can ubiquitinate tumor suppressor p53. Here we report interaction between NKX3.1 and TOPORS. NKX3.1 can be ubiquitinated by TOPORS in vitro and in vivo, and overexpression of TOPORS leads to NKX3.1 proteasomal degradation in prostate cancer cells. Conversely, small interfering RNA-mediated knockdown of TOPORS leads to an increased steady-state level and prolonged half-life of NKX3.1. These data establish TOPORS as a negative regulator of NKX3.1 and implicate TOPORS in prostate cancer progression.	[Guan, Bin; Li, Xiang; Uquillas, Carlos; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA; [Pungaliya, Pooja; Rubin, Eric H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Inst Canc, New Brunswick, NJ 08901 USA; [Pungaliya, Pooja; Rubin, Eric H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Inst Canc, New Brunswick, NJ 08901 USA; [Bieberich, Charles J.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Maryland; University of Maryland Baltimore	Bieberich, CJ (corresponding author), Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Guan, Bin/0000-0001-5986-5189; Bieberich, Charles/0000-0002-9208-5077	NATIONAL CANCER INSTITUTE [R01CA099951] Funding Source: NIH RePORTER; NCI NIH HHS [CA99951] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Gelmann EP, 2002, CANCER RES, V62, P2654; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Ju JH, 2006, J MOL BIOL, V360, P989, DOI 10.1016/j.jmb.2006.05.064; Kim MJ, 2002, CANCER RES, V62, P2999; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ornstein DK, 2001, J UROLOGY, V165, P1329, DOI 10.1016/S0022-5347(01)69894-X; Oyanagi H, 2004, LUNG CANCER, V46, P21, DOI 10.1016/j.lungcan.2004.03.009; Perinchery G, 1999, INT J CANCER, V83, P610, DOI 10.1002/(SICI)1097-0215(19991126)83:5<610::AID-IJC7>3.0.CO;2-2; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Saleem A, 2004, ONCOGENE, V23, P5293, DOI 10.1038/sj.onc.1207700; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Voeller HJ, 1997, CANCER RES, V57, P4455; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	48	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4834	4840		10.1074/jbc.M708630200	http://dx.doi.org/10.1074/jbc.M708630200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077445	hybrid			2022-12-27	WOS:000253426500041
J	Poree, B; Kypriotou, M; Chadjichristos, C; Beauchef, G; Renard, E; Legendre, F; Melin, M; Gueret, S; Hartmann, DJ; Mallein-Gerin, F; Pujol, JP; Boumediene, K; Galera, P				Poree, Benoit; Kypriotou, Magdalini; Chadjichristos, Christos; Beauchef, Gallic; Renard, Emmanuelle; Legendre, Florence; Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean; Mallein-Gerin, Frederic; Pujol, Jean-Pierre; Boumediene, Karim; Galera, Philippe			Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular Chondrocytes requires a decrease of Sp1 center dot Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTORS; SYNOVIAL-FLUID; GROWTH-FACTOR; MATRIX-METALLOPROTEINASE; RHEUMATOID-ARTHRITIS; ESTROGEN REGULATION; UP-REGULATION; ONCOSTATIN M; SP PROTEINS	Type II collagen is composed of alpha 1( II) chains encoded by the COL2A1 gene. Alteration of this cartilage marker is a common feature of osteoarthritis. Interleukin-6 (IL-6) is a pro-inflammatory cytokine that needs a soluble form of receptor called sIL-6R to exert its effects in some cellular models. In that case, sIL-6R exerts agonistic action. This mechanism can make up for the partial or total absence of membrane-anchored IL-6 receptors in some cell types, such as chondrocytes. Our study shows that IL-6, sIL-6R, or both inhibit type II collagen production by rabbit articular chondrocytes through a transcriptional control. The cytokine and/or sIL-6R repress COL2A1 transcription by a -63/-35 sequence that binds Sp1 center dot Sp3. Indeed, IL-6 and/ or sIL-6R inhibit Sp1 and Sp3 expression and their binding activity to the 63-bp promoter. In chromatin immunoprecipitation experiments, IL-6 center dot sIL-6R induced an increase in Sp3 recruitment to the detriment of Sp1. Knockdown of Sp1 center dot Sp3 by small interference RNA and decoy strategies were found to prevent the IL-6- and/ or sIL-6R- induced inhibition of COL2A1 transcription, indicating that each of these Sp proteins is required for down-regulation of the target gene and that a heterotypic Sp1 center dot Sp3 complex is involved. Additionally, Sp1 was shown to interact with Sp3 and HDAC1. Indeed, overexpression of a full-length Sp3 cDNA blocked the Sp1 up-regulation of the 63-bp COL2A1 promoter activity, and by itself, inhibits COL2A1 transcription. We can conclude that IL-6, sIL-6R, or both in combination decrease both the Sp1 center dot Sp3 ratio and DNA-binding activities, thus inhibiting COL2A1 transcription.	[Poree, Benoit; Kypriotou, Magdalini; Chadjichristos, Christos; Beauchef, Gallic; Renard, Emmanuelle; Legendre, Florence; Pujol, Jean-Pierre; Boumediene, Karim; Galera, Philippe] Univ Caen Basse Normandie, Lab Biochim Tissu Conjonctif, IFR ICORE 146, Fac Med,CHU Niveau 3, F-14032 Caen, France; [Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean] Univ Lyon 1, Lab Biomat, F-69373 Lyon 08, France; [Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean] Novatec, F-69007 Lyon, France; [Mallein-Gerin, Frederic] Univ Lyon 1 IFR 128 BioSci Lyon Gerland, CNRS,UMR 5086, Inst Biol & Chim Prot, Lab Biol & Ingn Cartilage, F-69367 Lyon 07, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Galera, P (corresponding author), Univ Caen Basse Normandie, Lab Biochim Tissu Conjonctif, IFR ICORE 146, Fac Med,CHU Niveau 3, Ave Cote Nacre, F-14032 Caen, France.	philippe.galera@unicaen.fr	Chadjichristos, Christos E/J-4871-2016	Chadjichristos, Christos E/0000-0001-6657-7900; legendre, florence/0000-0002-9951-1585; BOUMEDIENE, Karim/0000-0001-6517-8318				Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beauchef G, 2005, BIOCHEM BIOPH RES CO, V333, P1123, DOI 10.1016/j.bbrc.2005.06.020; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Carroll G, 1998, INFLAMM RES, V47, P1, DOI 10.1007/s000110050235; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; de Leon MB, 2005, J BIOL CHEM, V280, P5290, DOI 10.1074/jbc.M411571200; Desgeorges A, 1997, J RHEUMATOL, V24, P1510; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Flannery CR, 2000, MATRIX BIOL, V19, P549, DOI 10.1016/S0945-053X(00)00111-6; FRIELING JTM, 1995, J INFECT DIS, V171, P469, DOI 10.1093/infdis/171.2.469; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; GALERA P, 1992, EXP CELL RES, V200, P21331; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Gierens H, 2000, ARTERIOSCL THROM VAS, V20, P1777, DOI 10.1161/01.ATV.20.7.1777; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Guerne PA, 1999, MATRIX BIOL, V18, P253, DOI 10.1016/S0945-053X(99)00021-9; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Jikko A, 1998, CELL BIOL INT, V22, P615, DOI 10.1006/cbir.1998.0304; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; KANDEL RA, 1990, J RHEUMATOL, V17, P953; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Legendre F, 2005, J RHEUMATOL, V32, P1307; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Li WQ, 2001, J IMMUNOL, V166, P3491, DOI 10.4049/jimmunol.166.5.3491; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MULLBERG J, 1992, BIOCHEM BIOPH RES CO, V189, P794, DOI 10.1016/0006-291X(92)92272-Y; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sandell LJ, 1996, CONNECT TISSUE RES, V35, P1, DOI 10.3109/03008209609029168; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Silacci P, 1998, J BIOL CHEM, V273, P13625, DOI 10.1074/jbc.273.22.13625; Stoner M, 2004, ONCOGENE, V23, P1052, DOI 10.1038/sj.onc.1207201; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; vandeLoo FAJ, 1997, AM J PATHOL, V151, P177; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	67	110	116	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4850	4865		10.1074/jbc.M706387200	http://dx.doi.org/10.1074/jbc.M706387200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18065760	hybrid			2022-12-27	WOS:000253426500043
J	Koutelou, E; Sato, S; Tomomori-Sato, C; Florens, L; Swanson, SK; Washburn, MP; Kokkinaki, M; Conaway, RC; Conaway, JW; Moschonas, NK				Koutelou, Evangelia; Sato, Shigeo; Tomomori-Sato, Chieri; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Kokkinaki, Maria; Conaway, Ronald C.; Conaway, Joan W.; Moschonas, Nicholas K.			Neuralized-like 1 (Neurl1) targeted to the plasma membrane by N-myristoylation regulates the notch ligand Jagged1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; MIND BOMB; CELL FATE; PROTEIN; DELTA; IDENTIFICATION; ENDOCYTOSIS; PROMOTES; HOMOLOG; INTERNALIZATION	Notch signaling constitutes an evolutionarily conserved mechanism that mediates cell-cell interactions in various developmental processes. Numerous regulatory proteins interact with the Notch receptor and its ligands and control signaling at multiple levels. Ubiquitination and endocytosis followed by endosomal sorting of both the receptor and its ligands is essential for Notch-mediated signaling. The E3 ubiquitin ligases, Neuralized (Neur) and Mind Bomb (Mib1), are crucial for regulating the activity and stability of Notch ligands in Drosophila; however, biochemical evidence that the Notch ligands are directly targeted for ubiquitination by Neur and/or Mib1 has been lacking. In this report, we explore the function of Neurl1, a mouse ortholog of Drosophila Neur. We show that Neurl1 can function as an E3 ubiquitin ligase to activate monoubiquitination in vitro of Jagged1, but not other mammalian Notch ligands. Neurl1 expression decreases Jagged1 levels in cells and blocks signaling from Jagged1-expressing cells to neighboring Notch-expressing cells. We demonstrate that Neurl1 is myristoylated at its N terminus, and that myristoylation of Neurl1 targets it to the plasma membrane. Point mutations abolishing either Neurl1 myristoylation and plasma membrane localization or Neurl1 ubiquitin ligase activity impair its ability to down-regulate Jagged1 expression and to block signaling. Taken together, our results argue that Neurl1 at the plasma membrane can affect the signaling activity of Jagged1 by directly enhancing its ubiquitination and subsequent turnover.	[Koutelou, Evangelia; Sato, Shigeo; Tomomori-Sato, Chieri; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Kokkinaki, Maria; Moschonas, Nicholas K.] Univ Patras, Sch Med, Biol Lab, GR-26500 Patras, Greece; [Koutelou, Evangelia] Univ Crete, Dept Biol, Joint Grad Program Mol Biol & Biomed, GR-71409 Iraklion, Greece; [Kokkinaki, Maria; Moschonas, Nicholas K.] Univ Crete, Dept Biol, GR-71409 Iraklion, Greece; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Patras; University of Crete; University of Crete; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers-institute.org; n_moschonas@med.upatras.gr	Koutelou, Evangelia/X-7839-2019	Koutelou, Evangelia/0000-0003-0584-8070; Conaway, Joan/0000-0002-2786-0663; Tomomori-Sato, Chieri/0000-0002-2543-293X; Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650; Moschonas, Nicholas/0000-0002-2556-537X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; GLITTENBERG M, 2006, EMBO J, P1; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pavlopoulos E, 2002, BBA-GENE STRUCT EXPR, V1574, P375, DOI 10.1016/S0167-4781(01)00330-X; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Timmusk T, 2002, MOL CELL NEUROSCI, V20, P649, DOI 10.1006/mcne.2002.1148; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e	46	59	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3846	3853		10.1074/jbc.M706974200	http://dx.doi.org/10.1074/jbc.M706974200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077452	hybrid			2022-12-27	WOS:000253083500019
J	Rush, JS; Gao, N; Lehrman, MA; Waechter, CJ				Rush, Jeffrey S.; Gao, Ningguo; Lehrman, Mark A.; Waechter, Charles J.			Recycling of dolichyl monophosphate to the cytoplasmic leaflet of the endoplasmic reticulum after the cleavage of dolichyl pyrophosphate on the lumenal monolayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER-SOLUBLE ANALOG; GLC-P-DOLICHOL; PHOSPHATE BIOSYNTHESIS; TRANSMEMBRANE MOVEMENT; TRANSBILAYER MOVEMENT; PIG BRAIN; GLYCOSYLATION; MANNOSYLPHOSPHORYLDOLICHOL; DEPHOSPHORYLATION; PHOSPHORYLATION	During protein N-glycosylation, dolichyl pyrophosphate (Dol-P-P) is discharged in the lumenal monolayer of the endoplasmic reticulum (ER). Dol-P-P is then cleaved to Dol-P by Dol-P-P phosphatase (DPPase). Studies with the yeast mutant cwh8 Delta, lacking DPPase activity, indicate that recycling of Dol-P produced by DPPase contributes significantly to the pool of Dol-P utilized for lipid intermediate biosynthesis on the cytoplasmic leaflet. Whether Dol-P formed in the lumen diffuses directly back to the cytoplasmic leaflet or is first dephosphorylated to dolichol has not been determined. Incubation of sealed ER vesicles from calf brain with acetyl-Asn-Tyr-Thr-NH2, an N-glycosylatable peptide, to generate Dol-P-P in the lumenal monolayer produced corresponding increases in the rates of Man-P-Dol, Glc-P-Dol, and GlcNAc-P-P-Dol synthesis in the absence of CTP. No changes in dolichol kinase activity were observed. When streptolysin-O permeabilized CHO cells were incubated with an acceptor peptide, N-glycopeptide synthesis, requiring multiple cycles of the dolichol pathway, occurred in the absence of CTP. The results obtained with sealed microsomes and CHO cells indicate that Dol-P, formed from Dol-P-P, returns to the cytoplasmic leaflet where it can be reutilized for lipid intermediate biosynthesis, and dolichol kinase is not required for recycling. It is possible that the flip-flopping of the carrier lipid is mediated by a flippase, which would provide a mechanism for the recycling of Dol-P derived from Man-P-Dol-mediated reactions in N-, O-, and C-mannosylation of proteins, GPI anchor assembly, and the three Glc-P-Dol-mediated reactions in Glc(3)Man(9)GlcNAc(2)-P-P-Dol (DLO) biosynthesis.	[Rush, Jeffrey S.; Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB 741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102129, R56GM038545, R01GM038545] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038545-20, R01 GM102129, R01 GM038545, GM38545, GM36035] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURTON WA, 1979, J BIOL CHEM, V254, P7129; Buton X, 1996, J BIOL CHEM, V271, P6651, DOI 10.1074/jbc.271.12.6651; DANILOV LL, 1981, FEBS LETT, V131, P310, DOI 10.1016/0014-5793(81)80392-4; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gao NG, 2002, J BIOL CHEM, V277, P39425, DOI 10.1074/jbc.M205195200; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2061, DOI 10.1021/bi00551a009; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; RUSH JS, 1993, J BIOL CHEM, V268, P13110; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Rush JS, 2005, METHODS, V35, P316, DOI 10.1016/j.ymeth.2004.10.002; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; Rush JS, 1998, GLYCOBIOLOGY, V8, P1207, DOI 10.1093/glycob/8.12.1207; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; SCHER MG, 1980, J NEUROCHEM, V35, P844, DOI 10.1111/j.1471-4159.1980.tb07081.x; SCHER MG, 1984, ARCH BIOCHEM BIOPHYS, V231, P293, DOI 10.1016/0003-9861(84)90391-6; SCHER MG, 1984, J BIOL CHEM, V259, P4580; Shridas P, 2006, J BIOL CHEM, V281, P31696, DOI 10.1074/jbc.M604087200; SIEWERT G, 1967, P NATL ACAD SCI USA, V57, P767, DOI 10.1073/pnas.57.3.767; SPIRO MJ, 1986, J BIOL CHEM, V261, P4725; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; WAECHTER CJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P726, DOI 10.1016/0003-9861(76)90403-3; WAECHTER CJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P185, DOI 10.1016/0003-9861(77)90497-0; WELPLY JK, 1983, J BIOL CHEM, V258, P1856	32	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4087	4093		10.1074/jbc.M707067200	http://dx.doi.org/10.1074/jbc.M707067200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077451	hybrid			2022-12-27	WOS:000253083500044
J	Salameh, MA; Soares, AS; Hockla, A; Radisky, ES				Salameh, Moh'd A.; Soares, Alexei S.; Hockla, Alexandra; Radisky, Evette S.			Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SITE PEPTIDE-BOND; REACTIVE-SITE; CRYSTAL-STRUCTURE; HUMAN BRAIN; ALPHA-CHYMOTRYPSIN; PROTEASE-INHIBITOR; ACTIVE-SITE; KINETICS; ZYMOGEN	Human mesotrypsin is an isoform of trypsin that displays unusual resistance to polypeptide trypsin inhibitors and has been observed to cleave several such inhibitors as substrates. Whereas substitution of arginine for the highly conserved glycine 193 in the trypsin active site has been implicated as a critical factor in the inhibitor resistance of mesotrypsin, how this substitution leads to accelerated inhibitor cleavage is not clear. Bovine pancreatic trypsin inhibitor (BPTI) forms an extremely stable and cleavage-resistant complex with trypsin, and thus provides a rigorous challenge of mesotrypsin catalytic activity toward polypeptide inhibitors. Here, we report kinetic constants for mesotrypsin and the highly homologous (but inhibitor sensitive) human cationic trypsin, describing inhibition by, and cleavage of BPTI, as well as crystal structures of the mesotrypsin-BPTI and human cationic trypsin-BPTI complexes. We find that mesotrypsin cleaves BPTI with a rate constant accelerated 350-fold over that of human cationic trypsin and 150,000-fold over that of bovine trypsin. From the crystal structures, we see that small conformational adjustments limited to several side chains enable mesotrypsin-BPTI complex formation, surmounting the predicted steric clash introduced by Arg-193. Our results show that the mesotrypsin-BPTI interface favors catalysis through (a) electrostatic repulsion between the closely spaced mesotrypsin Arg-193 and BPTI Arg-17, and (b) elimination of two hydrogen bonds between the enzyme and the amine leaving group portion of BPTI. Our model predicts that these deleterious interactions accelerate leaving group dissociation and deacylation.	[Salameh, Moh'd A.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Soares, Alexei S/F-4800-2014; Radisky, Evette S/C-8526-2012	Soares, Alexei S/0000-0002-6565-8503; Radisky, Evette S/0000-0003-3121-109X				Afonine P., 2005, CCP4 NEWSLETTER, V42; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Castro MJM, 1996, BIOCHEMISTRY-US, V35, P11435, DOI 10.1021/bi960515w; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; Coligan JE, 1996, CURRENT PROTOCOLS PR; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeLano W.L, PYMOL MOL GRAPHICS S; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI M, 1971, ENZYMES, V3, P375; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; QUAST U, 1978, EUR J BIOCHEM, V86, P353, DOI 10.1111/j.1432-1033.1978.tb12317.x; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Toth J, 2006, J BIOL CHEM, V281, P12596, DOI 10.1074/jbc.M512301200; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; VINCENT JP, 1972, BIOCHEMISTRY-US, V11, P2967, DOI 10.1021/bi00766a007; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zwart PH., 2005, CCP4 NEWSLETTER, V43	54	45	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4115	4123		10.1074/jbc.M708268200	http://dx.doi.org/10.1074/jbc.M708268200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077447	hybrid			2022-12-27	WOS:000253083500047
J	Xie, Y; Xu, K; Linn, DE; Yang, X; Guo, Z; Shimelis, H; Nakanishi, T; Ross, DD; Chen, H; Fazli, L; Gleave, ME; Qiu, Y				Xie, Yingqiu; Xu, Kexin; Linn, Douglas E.; Yang, Xi; Guo, Zhiyong; Shimelis, Hermela; Nakanishi, Takeo; Ross, Douglas D.; Chen, Hegang; Fazli, Ladan; Gleave, Martin E.; Qiu, Yun			The 44-kDa pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; PROTEIN; TRANSPORTER; ANDROGEN; ABCG2; PHOSPHATASE; ACTIVATION; EXPRESSION; RECEPTOR; ETK/BMX	We previously showed that the 44-kDa serine/threonine kinase Pim-1 (Pim-1L) can protect prostate cancer cells from apoptosis induced by chemotherapeutic drugs (Xie, Y., Xu, K., Dai, B., Guo, Z., Jiang, T., Chen, H., and Qiu, Y. (2006) Oncogene 25, 70-78). To further explore the mechanisms of Pim-1L-mediated resistance to chemotherapeutic drugs in prostate cancer cells, we employed a yeast two-hybrid screening to identify cellular proteins that were associated with Pim-1L, and we found the ABC transporter BCRP/ABCG2 as one of the potential interacting partners of Pim-1L. We also showed that the expression level of Pim-1L and BCRP was up-regulated in mitoxantrone and docetaxel-resistant prostate cancer cell lines. Pim-1L was co-localized with BCRP on the plasma membrane and induced phosphorylation of BCRP at threonine 362. Knocking-down Pim-1L expression in the drug-resistant prostate cancer cells abolished multimer formation of endogenous BCRP and resensitized the resistant cells to chemotherapeutic drugs suggesting that BCRP phosphorylation induced by Pim-1L was essential for its functionality. This is further corroborated by our finding that the plasma membrane localization and drug-resistant activity of BCRP were compromised by T362A mutation. Our data suggest that Pim-1L may protect prostate cancer cells from apoptosis, at least in part, through regulation of transmembrane drug efflux pump. These findings may provide a potential therapeutic approach by disrupting Pim-1 signaling to reverse BCRP-mediated multidrug resistance.	[Xie, Yingqiu; Xu, Kexin; Linn, Douglas E.; Yang, Xi; Guo, Zhiyong; Shimelis, Hermela; Ross, Douglas D.; Qiu, Yun] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA; [Nakanishi, Takeo; Ross, Douglas D.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Chen, Hegang] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Nakanishi, Takeo; Ross, Douglas D.; Qiu, Yun] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Ross, Douglas D.; Fazli, Ladan; Gleave, Martin E.] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University System of Maryland; University of Maryland Baltimore; University of British Columbia	Qiu, Y (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St,BRB Rm 4-002, Baltimore, MD 21201 USA.	yqiu@som.umaryland.edu	Nakanishi, Takeo/C-3891-2015	Nakanishi, Takeo/0000-0002-6561-7138; Shimelis, Hermela/0000-0003-1284-8909	NATIONAL CANCER INSTITUTE [R01CA106504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007263] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA106504, CA106504] Funding Source: Medline; NIEHS NIH HHS [T32ES07263] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Allen JD, 2002, MOL CANCER THER, V1, P427; Bachmann M, 2006, INT J BIOCHEM CELL B, V38, P430, DOI 10.1016/j.biocel.2005.10.010; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gregory CW, 2001, CANCER RES, V61, P2892; Henriksen U, 2005, J CELL SCI, V118, P1417, DOI 10.1242/jcs.01729; Huss WJ, 2005, CANCER RES, V65, P6640, DOI 10.1158/0008-5472.CAN-04-2548; Janvilisri T, 2003, J BIOL CHEM, V278, P20645, DOI 10.1074/jbc.M301358200; Jiang TY, 2004, J BIOL CHEM, V279, P50181, DOI 10.1074/jbc.M409108200; Kage K, 2002, INT J CANCER, V97, P626, DOI 10.1002/ijc.10100; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Wakabayashi K, 2006, J EXP THER ONCOL, V5, P205; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Xie XM, 2001, CANCER RES, V61, P6795; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yang HB, 2002, J BIOL CHEM, V277, P30219, DOI 10.1074/jbc.M111933200; Zalcberg J, 2000, PROSTATE CANCER P D, V3, P66, DOI 10.1038/sj.pcan.4500394	26	146	151	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3349	3356		10.1074/jbc.M707773200	http://dx.doi.org/10.1074/jbc.M707773200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056989	hybrid			2022-12-27	WOS:000253083000039
J	Solheim, SA; Torgersen, KM; Tasken, K; Berge, T				Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn			Regulation of FynT function by dual domain docking on PAG/Cbp	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; PROTEIN-TYROSINE KINASE; T-CELL-ACTIVATION; GLYCOSPHINGOLIPID-ENRICHED MICRODOMAINS; SH3 DOMAINS; BINDING-PROTEIN; PHAGE DISPLAY; LIPID RAFTS; PROCESSIVE PHOSPHORYLATION; TRANSMEMBRANE ADAPTER	In resting T-cells, the transmembrane adaptor protein PAG ( phosphoprotein associated with glycosphingolipid-enriched microdomains) is constitutively tyrosine-phosphorylated, a state maintained by the Src family kinase FynT. PAG has a role in negative regulation of Src family kinases in T-cells by recruitment of Csk (C-terminal Src kinase) to the membrane via binding to PAG phosphotyrosine 317. The interaction between FynT and PAG is essential for PAG function; however, so far the FynT binding mode has been unknown. Here, we demonstrate that the FynT-PAG complex formation is a dual domain docking process, involving SH2 domain binding to PAG phosphotyrosines as well as an SH3 domain interaction with the first proline-rich region of PAG. This binding mode affects FynT kinase activity, PAG phosphorylation, and recruitment of FynT and Csk, demonstrated in Jurkat TAg cells after antibody stimulation of the T cell receptor. Furthermore, we show that TCR-induced tyrosine phosphorylation is regulated by SH3 domain modulation of the FynT-PAG interaction in human primary T-cells. Although FynT SH3 domain association is shown to be crucial for efficiently initiating PAG phosphorylation, we suggest that engagement of the SH2 domain on PAG renders FynT insensitive to Csk negative regulation. Thus, in T-cells, PAG is involved in positive as well as negative regulation of FynT activity.	[Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn] Biotechnol Ctr Oslo, NO-0349 Oslo, Norway; [Solheim, Silje Anette; Torgersen, Knut Martin; Tasken, Kjetil; Berge, Torunn] Univ Oslo, Ctr Mol Med Norway, Nord EMBL Partnership, Oslo, Norway	University of Oslo	Solheim, SA (corresponding author), Biotechnol Ctr Oslo, Gaustadalleen 21, NO-0349 Oslo, Norway.	Torunn.Berge@biotek.uio.no		Tasken, Kjetil/0000-0003-2841-4697				Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Brdickova N, 2001, FEBS LETT, V507, P133, DOI 10.1016/S0014-5793(01)02955-6; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Durrheim GA, 2001, CELL BIOL INT, V25, P33, DOI 10.1006/cbir.2000.0675; Feng SB, 1995, P NATL ACAD SCI USA, V92, P12408, DOI 10.1073/pnas.92.26.12408; Guappone AC, 1997, MOL CELL BIOCHEM, V175, P243, DOI 10.1023/A:1006840104666; HIRAI H, 1990, MOL CELL BIOL, V10, P1307, DOI 10.1128/MCB.10.4.1307; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Itoh K, 2002, J IMMUNOL, V168, P541, DOI 10.4049/jimmunol.168.2.541; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kitaura J, 2007, J IMMUNOL, V178, P455, DOI 10.4049/jimmunol.178.1.455; Kramer A, 1998, METH MOL B, V87, P25; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; MarieCardine A, 1997, J BIOL CHEM, V272, P16077, DOI 10.1074/jbc.272.26.16077; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RICHARD S, 1995, MOL CELL BIOL, V15, P186, DOI 10.1128/MCB.15.1.186; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RICKLES RJ, 1994, EMBO J, V13, P5598, DOI 10.1002/j.1460-2075.1994.tb06897.x; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; TAYLOR SJ, 1994, NATURE, V368, P867, DOI 10.1038/368867a0; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Ulmer TS, 2002, STRUCTURE, V10, P901, DOI 10.1016/S0969-2126(02)00781-5; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WENG ZG, 1995, MOL CELL BIOL, V15, P5627; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zozulya S, 1999, NAT BIOTECHNOL, V17, P1193, DOI 10.1038/70736	46	27	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2773	2783		10.1074/jbc.M705215200	http://dx.doi.org/10.1074/jbc.M705215200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056706	hybrid			2022-12-27	WOS:000252622300035
J	Violin, JD; DiPilato, LM; Yildirim, N; Elston, TC; Zhang, J; Lefkowitz, RJ				Violin, Jonathan D.; DiPilato, Lisa M.; Yildirim, Necmettin; Elston, Timothy C.; Zhang, Jin; Lefkowitz, Robert J.			beta(2)-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; DEPENDENT PROTEIN-KINASE; EPAC ACTIVATION; ARRESTIN; PHOSPHORYLATION; INTERNALIZATION; LOCALIZATION; NETWORK; SITES	G protein-coupled receptor signaling is dynamically regulated by multiple feedback mechanisms, which rapidly attenuate signals elicited by ligand stimulation, causing desensitization. The individual contributions of these mechanisms, however, are poorly understood. Here, we use an improved fluorescent biosensor for cAMP to measure second messenger dynamics stimulated by endogenous beta(2)-adrenergic receptor (beta(2)AR) in living cells. beta(2)AR stimulation with isoproterenol results in a transient pulse of cAMP, reaching a maximal concentration of similar to 10 mu M and persisting for less than 5 min. We investigated the contributions of cAMP-dependent kinase, G protein-coupled receptor kinases, and beta-arrestin to the regulation of beta(2)AR signal kinetics by using small molecule inhibitors, small interfering RNAs, and mouse embryonic fibroblasts. We found that the cAMP response is restricted in duration by two distinct mechanisms in HEK-293 cells: G protein-coupled receptor kinase (GRK6)-mediated receptor phosphorylation leading to beta-arrestin mediated receptor inactivation and cAMP-dependent kinase-mediated induction of cAMP metabolism by phosphodiesterases. A mathematical model of beta(2)AR signal kinetics, fit to these data, revealed that direct receptor inactivation by cAMP-dependent kinase is insignificant but that GRK6/beta-arrestin-mediated inactivation is rapid and profound, occurring with a half-time of 70 s. This quantitative system analysis represents an important advance toward quantifying mechanisms contributing to the physiological regulation of receptor signaling.	[Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Violin, Jonathan D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27706 USA; [DiPilato, Lisa M.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA; [Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Biochem, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	telston@amath.unc.edu; jzhang32@jhmi.edu; lefko001@receptor-biol.duke.edu	Lefkowitz, Robert/AAW-2649-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070631, R01HL016037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079271] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 70631, R01 HL 16037] Funding Source: Medline; NIDDK NIH HHS [F31 DK 074831, DK 073368] Funding Source: Medline; NIGMS NIH HHS [GM 079271] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BENOVIC JL, 1986, P NATL ACAD SCI USA, V83, P2797, DOI 10.1073/pnas.83.9.2797; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Cong M, 2001, J BIOL CHEM, V276, P15192, DOI 10.1074/jbc.M009130200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DECHAMPLAIN J, 1976, CIRC RES, V38, P109, DOI 10.1161/01.RES.38.2.109; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lemon G, 2003, J THEOR BIOL, V223, P93, DOI 10.1016/S0022-5193(03)00079-1; Lemon G, 2003, J THEOR BIOL, V223, P113, DOI 10.1016/S0022-5193(03)00080-8; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Penn RB, 1999, J PHARMACOL EXP THER, V288, P428; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zaccolo M, 2002, CURR OPIN CELL BIOL, V14, P160, DOI 10.1016/S0955-0674(02)00316-2; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	38	185	189	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2949	2961		10.1074/jbc.M707009200	http://dx.doi.org/10.1074/jbc.M707009200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045878	hybrid, Green Published			2022-12-27	WOS:000252622300051
J	Reixach, N; Foss, TR; Santelli, E; Pascual, J; Kelly, JW; Buxbaum, JN				Reixach, Natalia; Foss, Ted R.; Santelli, Eugenio; Pascual, Jaime; Kelly, Jeffery W.; Buxbaum, Joel N.			Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic - A lesson in the generation of transgenic models of diseases involving oligomeric proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE CONFORMATIONS; FIBRIL FORMATION; MICE; DENATURATION; GENE; POLYNEUROPATHY; STABILIZATION; REFINEMENT; EXPRESSION; DEPOSITION	The transthyretin amyloidoses appear to be caused by rate-limiting tetramer dissociation and partial monomer unfolding of the human serum protein transthyretin, resulting in aggregation and extracellular deposition of amorphous aggregates and amyloid fibrils. Mice transgenic for few copies of amyloid-prone human transthyretin variants, including the aggressive L55P mutant, failed to develop deposits. Silencing the murine transthyretin gene in the presence of the L55P human gene resulted in enhanced tissue deposition. To test the hypothesis that the murine protein interacted with human transthyretin, preventing the dissociation and partial unfolding required for amyloidogenesis, we produced recombinant murine transthyretin and human/murine transthyretin heterotetramers and compared their structures and biophysical properties to recombinant human transthyretin. We found no significant differences between the crystal structures of murine and human homotetramers. Murine transthyretin is not amyloidogenic because the native homotetramer is kinetically stable under physiologic conditions and cannot dissociate into partially unfolded monomers, the misfolding and aggregation precursor. Heterotetramers composed of murine and human subunits are also kinetically stable. These observations explain the lack of transthyretin deposition in transgenics carrying a low copy number of human transthyretin genes. The incorporation of mouse subunits into tetramers otherwise composed of human amyloidprone transthyretin subunits imposes kinetic stability, preventing dissociation and subsequent amyloidogenesis.	[Reixach, Natalia; Buxbaum, Joel N.] Wm Keck Autoimmune Dis Ctr, Div Rheumatol Res, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Foss, Ted R.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Foss, Ted R.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Santelli, Eugenio; Pascual, Jaime] Burnham Inst Med Res, Inflammat & Infect Dis Ctr, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute	Reixach, N (corresponding author), 10550 N Torrey Pines Rd,MEM-230, La Jolla, CA 92037 USA.	natalia@scripps.edu	pascual, jaime/D-4566-2009	pascual, jaime/0000-0001-8992-7475; Reixach, Natalia/0000-0002-7877-0908	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046335, R01DK046335, R29DK046335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015916] Funding Source: NIH RePORTER; NIA NIH HHS [AG15916] Funding Source: Medline; NIDDK NIH HHS [DK46335] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; ARAKI S, 1994, MOL NEUROBIOL, V8, P15, DOI 10.1007/BF02778004; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUXBAUM JN, 2005, RHEUMATOLOGY, P1669; Coelho Teresa, 1993, Journal of Rheumatology, V20, P179; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Connors LH, 2003, AMYLOID, V10, P160, DOI 10.3109/13506120308998998; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Garzuly F, 1996, NEUROLOGY, V47, P1562, DOI 10.1212/WNL.47.6.1562; Hammarstrom P, 2003, SCIENCE, V299, P713, DOI 10.1126/science.1079589; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; JACOBSON DR, 1992, HUM GENET, V89, P353; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kaplan B, 1997, CLIN EXP IMMUNOL, V110, P472, DOI 10.1046/j.1365-2249.1997.4421454.x; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kohno K, 1997, AM J PATHOL, V150, P1497; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; LIPMAN RD, 1993, LAB ANIM SCI, V43, P439; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1995, J BIOCHEM-TOKYO, V117, P169, DOI 10.1093/oxfordjournals.jbchem.a124705; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Sousa JC, 2004, J NEUROCHEM, V88, P1052, DOI 10.1046/j.1471-4159.2003.02309.x; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Tagoe CE, 2007, AMYLOID, V14, P227, DOI 10.1080/13506120701464396; Teng MH, 2001, LAB INVEST, V81, P385, DOI 10.1038/labinvest.3780246; Teng MH, 1996, AMYLOID, V3, P187, DOI 10.3109/13506129609045521; Ueda M, 2007, BIOCHEM BIOPH RES CO, V352, P299, DOI 10.1016/j.bbrc.2006.11.045; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; YAMAMURA K, 1987, DEV GENET, V8, P195, DOI 10.1002/dvg.1020080404; Zeldenrust S, 1999, AMYLOID AND AMYLOIDOSIS 1998, P255	52	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2098	2107		10.1074/jbc.M708028200	http://dx.doi.org/10.1074/jbc.M708028200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006495	hybrid			2022-12-27	WOS:000252501000037
J	Kaji, N; Muramoto, A; Mizuno, K				Kaji, Noriko; Muramoto, Aya; Mizuno, Kensaku			LIM kinase-mediated cofilin phosphorylation during mitosis is required for precise spindle positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL DIVISIONS; SLINGSHOT PHOSPHATASE; ACTIN REORGANIZATION; PROTEIN-KINASE; ACTIVATION; POLARITY; BINDING; GROWTH; DYNEIN; ROLES	The interaction of astral microtubules with cortical actin networks is essential for the correct orientation of the mitotic spindle; however, little is known about how the cortical actin organization is regulated during mitosis. LIM kinase-1 (LIMK1) regulates actin dynamics by phosphorylating and inactivating cofilin, an actin-depolymerizing protein. LIMK1 activity increases during mitosis. Here we show that mitotic LIMK1 activation is critical for accurate spindle orientation in mammalian cells. Knockdown of LIMK1 suppressed a mitosis-specific increase in cofilin phosphorylation and caused unusual cofilin localization in the cell cortex in metaphase, instability of cortical actin organization and astral microtubules, irregular rotation and misorientation of the spindle, and a delay in anaphase onset. Similar results were obtained by treating the cells with a LIMK1 inhibitor peptide or latrunculin A or by overexpressing a non-phosphorylatable cofilin(S3A) mutant. Furthermore, localization of LGN (a protein containing the repetitive Leu-Gly-Asn tripeptide motifs), an important regulator of spindle orientation, in the crescent-shaped cortical regions was perturbed in LIMK1 knockdown cells. Our results suggest that LIMK1-mediated cofilin phosphorylation is required for accurate spindle orientation by stabilizing cortical actin networks during mitosis.	[Kaji, Noriko; Muramoto, Aya; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015					ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	44	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4983	4992		10.1074/jbc.M708644200	http://dx.doi.org/10.1074/jbc.M708644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079118	hybrid			2022-12-27	WOS:000253426500056
J	Pauff, JM; Zhang, JJ; Bell, CE; Hille, R				Pauff, James M.; Zhang, Jinjin; Bell, Charles E.; Hille, Russ			Substrate orientation in xanthine oxidase - Crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; MOLYBDENUM; MECHANISM; DEHYDROGENASE; CRYSTALLIZATION; SPECIFICITY; REFINEMENT; CATALYSIS; KINETICS; FAMILY	Xanthine oxidoreductase catalyzes the final two steps of purine catabolism and is involved in a variety of pathological states ranging from hyperuricemia to ischemia-reperfusion injury. The human enzyme is expressed primarily in its dehydrogenase form utilizing NAD(+) as the final electron acceptor from the enzyme's flavin site but can exist as an oxidase that utilizes O-2 for this purpose. Central to an understanding of the enzyme's function is knowledge of purine substrate orientation in the enzyme's molybdenum-containing active site. We report here the crystal structure of xanthine oxidase, trapped at the stage of a critical intermediate in the course of reaction with the slow substrate 2-hydroxy-6-methylpurine at 2.3 (A) over circle. This is the first crystal structure of a reaction intermediate with a purine substrate that is hydroxylated at its C8 position as is xanthine and confirms the structure predicted to occur in the course of the presently favored reaction mechanism. The structure also corroborates recent work suggesting that 2-hydroxy6- methylpurine orients in the active site with its C2 carbonyl group interacting with Arg-880 and extends our hypothesis that xanthine binds opposite this orientation, with its C6 carbonyl positioned to interact with Arg-880 in stabilizing the Mo-V transition state.	[Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pauff, James M.; Zhang, Jinjin; Bell, Charles E.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 2466 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 075036] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; BRAY RC, 1985, BIOCHEM SOC T, V13, P560, DOI 10.1042/bst0130560; Canne C, 1999, BIOCHEMISTRY-US, V38, P14077, DOI 10.1021/bi991089s; Choi EY, 2004, J INORG BIOCHEM, V98, P841, DOI 10.1016/j.jinorgbio.2003.11.010; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORIGAN GA, 1994, BBA-BIOENERGETICS, V1185, P284, DOI 10.1016/0005-2728(94)90243-7; Manikandan P, 2001, J AM CHEM SOC, V123, P2658, DOI 10.1021/ja003894w; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rayment I, 2002, STRUCTURE, V10, P147, DOI 10.1016/S0969-2126(02)00711-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tai LA, 2004, BIOCHEMISTRY-US, V43, P4869, DOI 10.1021/bi035467b; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	35	72	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4818	4824		10.1074/jbc.M707918200	http://dx.doi.org/10.1074/jbc.M707918200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063585	hybrid			2022-12-27	WOS:000253426500039
J	Pawluczyk, IZA; Patel, SR; Harris, KPG				Pawluczyk, Izabella Z. A.; Patel, Samita R.; Harris, Kevin P. G.			Perindoprilat modulates the activity of lipoprotein receptor-related protein in human mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; MATRIX-METALLOPROTEINASE; CATABOLISM; MECHANISM; MMP-9; LRP	Low density lipoprotein receptor-related protein (LRP) is a multifunctional endocytic receptor implicated in the modulation of a number of cellular processes, including the turnover of proteases and the degradation of extracellular matrix proteins. As such, it can play a key role in the control of fibrosis. The aim of this investigation was to as certain whether the anti-fibrotic effects exerted by the angiotensin-converting enzyme inhibitor(ACE-I) perindoprilat on macrophage-conditioned medium (MPCM)-injured human mesangial cells can be modulated by this receptor. Addition of receptor-associated protein to MPCM-injured mesangial cells with and without ACE-I increased the amount of tissue plasminogen activator protein detected in mesangial cell culture supernatants without affecting the protein levels of plasminogen activator inhibitor-1. The ability of ACE-I to reduce fibronectin was diminished in the presence of receptor-associated protein. ACE-I induced an increase in mesangial cell MMP9 mRNA, but reduced the MMP9 enzyme activity detected in mesangial cell supernatants. Mesangial cell lysates from ACE-I-treated cells were able to bind immobilized fibronectin at higher dilutions than cell lysates from untreated cells. Flow cytometry showed that MPCM induced an increase in LRP surface expression in mesangial cells over that in control cells and that this expression was further increased by ACE-I treatment. The increase in LRP expression in response to ACE-I was also observed by Western blotting. Northern blot analysis of RNA extracted from cells following a 24-h exposure to MPCM with and without ACE-I demonstrated that there was no change in LRP mRNA expression upon ACE-I treatment. In conclusion, we show that ACE-I treatment is able to modulate mesangial cell-surface expression of LRP, providing an additional mechanism whereby ACE-Is can mediate anti-fibrotic actions independent of their hemodynamic actions.	[Pawluczyk, Izabella Z. A.] Univ Leicester, John Wall Renal Unit, Leicester Gen Hosp, Leicester LE5 4PW, Leics, England; Univ Leicester, Dept Infect Immunity & Inflammat, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Pawluczyk, IZA (corresponding author), Univ Leicester, John Wall Renal Unit, Leicester Gen Hosp, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	izap1@le.ac.uk						FLAVIN MP, 2001, J CEREB BLOOD FLOW M, V21, P631; Guenette SY, 2002, J NEUROCHEM, V82, P755, DOI 10.1046/j.1471-4159.2002.01009.x; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hurst M, 2001, DRUGS, V61, P867, DOI 10.2165/00003495-200161060-00020; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; MARTIN J, 1994, KIDNEY INT, V46, P877, DOI 10.1038/ki.1994.345; Pawluczyk IZA, 2004, KIDNEY INT, V65, P1240, DOI 10.1111/j.1523-1755.2004.00494.x; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Weaver AM, 1996, J BIOL CHEM, V271, P24894, DOI 10.1074/jbc.271.40.24894; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	16	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4588	4594		10.1074/jbc.M709001200	http://dx.doi.org/10.1074/jbc.M709001200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156630	hybrid			2022-12-27	WOS:000253426500015
J	Tsiavaliaris, G; Fujita-Becker, S; Durrwang, U; Diensthuber, RP; Geeves, MA; Manstein, DJ				Tsiavaliaris, Georgios; Fujita-Becker, Setsuko; Duerrwang, Ulrike; Diensthuber, Ralph P.; Geeves, Michael A.; Manstein, Dietmar J.			Mechanism, regulation, and functional properties of Dictyostelium myosin-1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MYOSIN; HEAVY-CHAIN PHOSPHORYLATION; KINETIC MECHANISM; DISCOIDEUM MYOSIN; MOTOR DOMAIN; ADENOSINE-TRIPHOSPHATASE; MOLECULAR MOTOR; ADP RELEASE; ACTIN; MOTILITY	Myosin-1B is one of three long tailed class-1 myosins containing an ATP-insensitive actin-binding site in the tail region that are produced in Dictyostelium discoideum. Myosin-1B localizes to actin-rich structures at the leading edge of migrating cells where it has been implicated in the formation and retraction of membrane projections, the recycling of plasma membrane components, and intracellular particle transport. Here, we have used a combination of molecular engineering approaches to describe the kinetic and motile properties of the myosin-1B motor and its regulation by TEDS site phosphorylation. Our results show that myosin-1B is a low duty ratio motor and displays the fastest nucleotide binding kinetics of any of the Dictyostelium class-1 myosins studied so far. Different from Dictyostelium myosin-1D and myosin-1E, dephosphorylated myosin-1B is not inactivated but moves actin filaments efficiently, albeit at an up to 8-fold slower velocity in the in vitro motility assay. A further difference is that myosin-1B lacks the ability to switch between rapid movement and bearing tension upon physiological changes of free Mg2+ ions. In this respect, its motor properties appear to be more closely related to Dictyostelium myosin-2 and rabbit skeletal muscle myosin.	[Tsiavaliaris, Georgios; Diensthuber, Ralph P.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE 4350, D-30623 Hannover, Germany; [Fujita-Becker, Setsuko; Duerrwang, Ulrike; Manstein, Dietmar J.] Max Planck Inst Med Res, Dept Biophys, D-69120 Heidelberg, Germany; [Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	Hannover Medical School; Max Planck Society; University of Kent	Tsiavaliaris, G (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350, Carl Neuberg Str 1, D-30623 Hannover, Germany.	gtsiaval@bpc.mh-hannover.de	Geeves, Michael/F-7583-2011; Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019	Geeves, Michael/0000-0002-9364-8898; Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147	Wellcome Trust [070021] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BAIN G, 1991, MOL GEN GENET, V226, P59, DOI 10.1007/BF00273587; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Brzeska H, 1999, P NATL ACAD SCI USA, V96, P394, DOI 10.1073/pnas.96.2.394; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; FAULSTICH H, 1983, EXP CELL RES, V144, P73, DOI 10.1016/0014-4827(83)90443-3; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Gliksman NR, 2001, J BIOL CHEM, V276, P5235, DOI 10.1074/jbc.M008319200; Hachikubo Y, 2007, PLANT CELL PHYSIOL, V48, P886, DOI 10.1093/pcp/pcm054; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; JUNG G, 1993, J BIOL CHEM, V268, P14981; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Oberholzer U, 2002, EUKARYOT CELL, V1, P213, DOI 10.1128/EC.1.2.213-228.2002; Ostap EM, 2002, BIOCHEMISTRY-US, V41, P12450, DOI 10.1021/bi0262193; PETERSON MD, 1995, J CELL SCI, V108, P1093; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Schwarz EC, 2000, J CELL SCI, V113, P621; Schwarz Eva C., 1999, Cell Biochemistry and Biophysics, V30, P413, DOI 10.1007/BF02738122; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; TITUS MA, 1993, MOL BIOL CELL, V4, P233, DOI 10.1091/mbc.4.2.233; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang ZY, 1998, P NATL ACAD SCI USA, V95, P15200, DOI 10.1073/pnas.95.26.15200; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; Yazu M, 1999, BIOCHEM BIOPH RES CO, V255, P711, DOI 10.1006/bbrc.1999.0264	58	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4520	4527		10.1074/jbc.M708113200	http://dx.doi.org/10.1074/jbc.M708113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089562	hybrid			2022-12-27	WOS:000253426500008
J	Flashman, E; Bagg, EAL; Chowdhury, R; Mecinovic, J; Loenarz, C; McDonough, MA; Hewitson, KS; Schofield, CJ				Flashman, Emily; Bagg, Eleanor A. L.; Chowdhury, Rasheduzzaman; Mecinovic, Jasmin; Loenarz, Christoph; McDonough, Michael A.; Hewitson, Kirsty S.; Schofield, Christopher J.			Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL FAMILY; CRYSTAL-STRUCTURE; HIF-ALPHA; SYNTHASE; HIF-1-ALPHA; PHD2; PROLYL-HYDROXYLASE-2; 4-HYDROXYLASES; 2-OXOGLUTARATE; DESTRUCTION	Hydroxylation of two conserved prolyl residues in the N- and C-terminal oxygen-dependent degradation domains (NODD and CODD) of the alpha-subunit of hypoxia-inducible factor (HIF) signals for its degradation via the ubiquitin-proteasome pathway. In human cells, three prolyl hydroxylases (PHDs 1-3) belonging to the Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenase family catalyze prolyl hydroxylation with differing selectivity for CODD and NODD. Sequence analysis of the catalytic domains of the PHDs in the light of crystal structures for PHD2, and results for other 2OG oxygenases, suggested that either the C-terminal region or a loop linking two beta-strands (beta 2 and beta 3 in human PHD2) are important in determining substrate selectivity. Mutation analyses on PHD2 revealed that the beta 2 beta 3 loop is a major determinant in conferring selectivity for CODD over NODD peptides. A chimeric PHD in which the beta 2 beta 3 loop of PHD2 was replaced with that of PHD3 displayed an almost complete selectivity for CODD(in competition experiments), as observed for wild-type PHD3. CODD was observed to bind much more tightly to this chimeric protein than the wild type PHD2 catalytic domain.	[Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Oxford OX13TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Mansfield Rd, Oxford OX13TA, England.	christopher.schofield@chem.ox.ac.uk	Mecinovic, Jasmin/F-9694-2015; McDonough, Michael A/G-2744-2013; McDonough, Michael/N-8913-2019; Chowdhury, Rashed/I-7697-2014	Mecinovic, Jasmin/0000-0002-5559-3822; McDonough, Michael A/0000-0003-4664-6942; McDonough, Michael/0000-0003-4664-6942; Chowdhury, Rashed/0000-0002-8058-6149; Bagg, Eleanor/0000-0001-9209-1891; Loenarz, Christoph/0000-0002-8843-2531; Flashman, Emily/0000-0002-4169-4278	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Landazuri MO, 2006, BIOCHEM BIOPH RES CO, V351, P313, DOI 10.1016/j.bbrc.2006.09.170; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lange T, 1997, PHYSIOL PLANTARUM, V100, P543, DOI 10.1034/j.1399-3054.1997.1000316.x; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Sami M, 1997, FEBS LETT, V405, P191, DOI 10.1016/S0014-5793(97)00176-2; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Villar D, 2007, BIOCHEM J, V408, P231, DOI 10.1042/BJ20071052; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	38	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3808	3815		10.1074/jbc.M707411200	http://dx.doi.org/10.1074/jbc.M707411200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063574	hybrid			2022-12-27	WOS:000253083500015
J	Korupolu, RV; Muenster, U; Read, JD; Vale, W; Fischer, WH				Korupolu, Radhika V.; Muenster, Uwe; Read, Jessica D.; Vale, Wylie; Fischer, Wolfgang H.			Activin A/Bone Morphogenetic Protein (BMP) chimeras exhibit BMP-like activity and antagonize activin and myostatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II RECEPTORS; SIGNALING PATHWAYS; CELL-MEMBRANE; BINDING; COMPLEX; CLONING; IDENTIFICATION; PROLIFERATION; ACTIVATION; REGULATORS	Activins and bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta family of growth and differentiation factors that induce signaling in target cells by assembling type II and type I receptors at the cell surface. Ligand residues involved in type II binding are located predominantly in the C-terminal region that forms an extended beta-sheet, whereas residues involved in type I binding are located in the beta-helical and preceding loop central portion of the molecule. To test whether the central residues are sufficient to determine specificity toward type I receptors, activin A/BMP chimeras were constructed in which the central residues (45-79) of activin A were replaced with corresponding residues of BMP2 and BMP7. The chimeras were assessed for activin type II receptor (Act RII) binding, activin-like bioactivity, and BMP-like activity as well as antagonistic properties toward activin A and myostatin. ActA/BMP7 chimera retained Act RII binding affinity comparable with wild type activin A, whereas ActA/BMP2 chimera showed a slightly reduced affinity toward Act RII. Both the chimeras were devoid of significant activin bioactivity in 293T cells in the A3 Lux reporter assay up to concentrations 10-fold higher than the minimal effective activin A concentration (similar to 4 nM). In contrast, these chimeras showed BMP-like activity in a BRE-Luc assay in HepG2 cells as well as induced osteoblast-like phenotype in C2C12 cells expressing alkaline phosphatase. Furthermore, both the chimeras activated Smad1 but not Smad2 in C2C12 cells. Also, both the chimeras antagonized ligands that signal via activin type II receptor, such as activin A and myostatin. These data indicate that activin residues in the central region determine its specificity toward type I receptors. ActA/BMP chimeras can be useful in the study of receptor specificities and modulation of transforming growth factor-beta members, activins, and BMPs.	[Korupolu, Radhika V.; Muenster, Uwe; Read, Jessica D.; Vale, Wylie; Fischer, Wolfgang H.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Fischer, WH (corresponding author), 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	fischer@salk.edu			NICHD NIH HHS [HD-13527] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD013527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Attisano L, 1996, MOL CELL BIOL, V16, P1066; Candia AF, 1997, DEVELOPMENT, V124, P4467; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Duncan SA, 2001, GENE DEV, V15, P1879, DOI 10.1101/gad.920601; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fischer WH, 2003, J ENDOCRINOL, V176, P61, DOI 10.1677/joe.0.1760061; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Harrison CA, 2004, J BIOL CHEM, V279, P28036, DOI 10.1074/jbc.M402782200; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Keller R, 2004, NATURE, V430, P305, DOI 10.1038/430305a; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; Lee WS, 2001, BIOL REPROD, V65, P994, DOI 10.1095/biolreprod65.4.994; LIU VF, 1995, STEM CELLS, V13, P117; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; MATZUK MM, 1996, RECENT PROG HORM RES, V51, P155; Muenster U, 2005, J BIOL CHEM, V280, P36626, DOI 10.1074/jbc.M507236200; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Phillips DJ, 2000, BIOESSAYS, V22, P689, DOI 10.1002/1521-1878(200008)22:8<689::AID-BIES2>3.0.CO;2-5; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; VALE W, 1988, RECENT PROG HORM RES, V44, P1; VALE W, 1983, METHOD ENZYMOL, V103, P565; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wankell M, 2003, ANN NY ACAD SCI, V995, P48, DOI 10.1111/j.1749-6632.2003.tb03209.x; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wuytens G, 1999, J BIOL CHEM, V274, P9821, DOI 10.1074/jbc.274.14.9821; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	46	15	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3782	3790		10.1074/jbc.M704530200	http://dx.doi.org/10.1074/jbc.M704530200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056265	hybrid			2022-12-27	WOS:000253083500012
J	Worby, CA; Gentry, MS; Dixon, JE				Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.			Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; GENOTYPE-PHENOTYPE CORRELATIONS; LAFORA-DISEASE; PHOSPHATASE; METABOLISM; MUTATIONS; GENE; OVEREXPRESSION; SUBUNIT; INSULIN	Lafora disease (LD) is an autosomal recessive neurodegenerative disease that results in progressive myoclonus epilepsy and death. LD is caused by mutations in either the E3 ubiquitin ligase malin or the dual specificity phosphatase laforin. A hallmark of LD is the accumulation of insoluble glycogen in the cytoplasm of cells from most tissues. Glycogen metabolism is regulated by phosphorylation of key metabolic enzymes. One regulator of this phosphorylation is protein targeting to glycogen (PTG/R5), a scaffold protein that binds both glycogen and many of the enzymes involved in glycogen synthesis, including protein phosphatase 1 (PP1), glycogen synthase, phosphorylase, and laforin. Overexpression of PTG markedly increases glycogen accumulation, and decreased PTG expression decreases glycogen stores. To investigate if malin and laforin play a role in glycogen metabolism, we overexpressed PTG, malin, and laforin in tissue culture cells. We found that expression of malin or laforin decreased PTG-stimulated glycogen accumulation by 25%, and co-expression of malin and laforin abolished PTG-stimulated glycogen accumulation. Consistent with this result, we found that malin ubiquitinates PTG in a laforin-dependent manner, both in vivo and in vitro, and targets PTG for proteasome-dependent degradation. These results suggest an additional mechanism, involving laforin and malin, in regulating glycogen metabolism.	[Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Dixon, JE (corresponding author), 9500 Gilman Dr,Leichtag Bldg,RM 284, La Jolla, CA 92093 USA.	jedixon@ucsd.edu			Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R01 DK018849, DK018849-33] Funding Source: Medline; NINDS NIH HHS [1K99NS061803-01, K99 NS061803, R00 NS061803-03, K99 NS061803-02, R00 NS061803] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS061803, R00NS061803] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BERKOVIC SF, 1991, J CLIN NEUROPHYSIOL, V8, P261, DOI 10.1097/00004691-199107010-00003; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; BUSARD HLSM, 1987, ANN NEUROL, V21, P599, DOI 10.1002/ana.410210613; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Ganesh S, 2002, HUM MOL GENET, V11, P1263, DOI 10.1093/hmg/11.11.1263; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Abad C, 2005, NEUROLOGY, V64, P982, DOI 10.1212/01.WNL.0000154519.10805.F7; Greenberg CC, 2006, MOL CELL BIOL, V26, P334, DOI 10.1128/MCB.26.1.334-342.2006; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hodskins MB, 1930, AM J PSYCHIAT, V9, P827; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; Lerin C, 2000, J BIOL CHEM, V275, P39991, DOI 10.1074/jbc.M006251200; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lohi H, 2007, NEUROLOGY, V68, P996, DOI 10.1212/01.wnl.0000258561.02248.2f; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1994, BIOFACTORS, V4, P167; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Munro S, 2002, DIABETES, V51, P591, DOI 10.2337/diabetes.51.3.591; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Raben N, 2001, NEUROLOGY, V56, P1739, DOI 10.1212/WNL.56.12.1739; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 2001, ENDOCRINE PANCREAS R, P609; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHNABEL R, 1968, Pathologia Europaea, V3, P218; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Shen J.-J., 2002, Current Molecular Medicine (Hilversum), V2, P167, DOI 10.2174/1566524024605752; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SOLAZFUSTER MD, 2007, IN PRESS HUM MOL; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TENHAM MWV, 1975, HDB CLIN NEUROLOGY, P647; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	65	117	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4069	4076		10.1074/jbc.M708712200	http://dx.doi.org/10.1074/jbc.M708712200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070875	hybrid, Green Accepted			2022-12-27	WOS:000253083500042
J	Yokouchi, M; Hiramatsu, N; Hayakawa, K; Okamura, M; Du, S; Kasai, A; Takano, Y; Shitamura, A; Shimada, T; Yao, J; Kitamura, M				Yokouchi, Makiko; Hiramatsu, Nobuhiko; Hayakawa, Kunihiro; Okamura, Maro; Du, Shuqi; Kasai, Ayumi; Takano, Yosuke; Shitamura, Akihiro; Shimada, Tsuyoshi; Yao, Jian; Kitamura, Masanori			Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLOMERULAR MESANGIAL CELLS; OXIDATIVE STRESS; SARCOPLASMIC-RETICULUM; INDUCED APOPTOSIS; LLC-PK1 CELLS; UP-REGULATION; KAPPA-B; C-FOS; ACTIVATION	Cadmium triggers apoptosis of LLC-PK1 cells through induction of endoplasmic reticulum (ER) stress. We found that cadmium caused generation of reactive oxygen species (ROS) and that cadmium-induced ER stress was inhibited by antioxidants. In contrast, suppression of ER stress did not attenuate cadmium-triggered oxidative stress, suggesting that ER stress occurs downstream of oxidative stress. Exposure of the cells to either O-2(radical anion), H2O2, or ONOO- caused apoptosis, whereas ER stress was induced only by O-2(radical anion). or ONOO-. Transfection with manganese superoxide dismutase significantly attenuated cadmium-induced ER stress and apoptosis, whereas pharmacological inhibition of ONOO- was ineffective. Interestingly, transfection with catalase attenuated cadmium-induced apoptosis without affecting the level of ER stress. O-2(radical anion). caused activation of the activating transcription factor 6-CCAAT/enhancer-binding protein-homologous protein (CHOP) and the inositol-requiring ER-to-nucleus signal kinase 1-X-box-binding protein 1 (XBP1) proapoptotic cascades, and overexpression of manganese superoxide dismutase attenuated cadmium-triggered induction of both pathways. Furthermore, phosphorylation of proapoptotic c-Jun N-terminal kinase by O-2(radical anion) . or cadmium was suppressed by dominant-negative inhibition of XBP1. These data elucidated 1) cadmium caused ER stress via generation of ROS, 2) O-2(radical anion). was selectively involved in cadmium-triggered, ER stress-mediated apoptosis through activation of the activating transcription factor 6-CHOP and inositol-requiring ER-to-nucleus signal kinase 1-XBP1 pathways, and 3) phosphorylation of JNK was caused by O(radical anion)2-triggered activation of XBP1.	[Yokouchi, Makiko; Hiramatsu, Nobuhiko; Hayakawa, Kunihiro; Okamura, Maro; Kasai, Ayumi; Takano, Yosuke; Shitamura, Akihiro; Shimada, Tsuyoshi; Yao, Jian; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Yamanashi 4093898, Japan; [Du, Shuqi] China Med Univ, Affiliated Hosp 1, Dept Urol, Shenyang 110001, Peoples R China	University of Yamanashi; China Medical University	Kitamura, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Shimokato 1110, Yamanashi 4093898, Japan.	masanori@yamanashi.ac.jp		HAYAKAWA, Kunihiro/0000-0002-8053-746X; Yao, Jian/0000-0003-2622-0215				AMSTAD P, 1990, B CANCER, V77, P501; Brunon J, 2000, NEUROCHIRURGIE, V46, P54; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; FERRARI R, 1991, CARDIOVASC DRUG THER, V5, P277, DOI 10.1007/BF00054749; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kitamura M, 1996, J IMMUNOL, V156, P2964; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; Moreau VH, 1998, FREE RADICAL BIO MED, V25, P554, DOI 10.1016/S0891-5849(98)00084-7; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154	36	171	183	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4252	4260		10.1074/jbc.M705951200	http://dx.doi.org/10.1074/jbc.M705951200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086661	hybrid			2022-12-27	WOS:000253083500060
J	Desmots, F; Russell, HR; Michel, D; McKinnon, PJ				Desmots, Fabienne; Russell, Helen R.; Michel, Denis; McKinnon, Peter J.			Scythe regulates apoptosis-inducing factor stability during endoplasmic reticulum stress-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; FACTOR AIF; UBIQUITIN; REAPER; DEATH; DEGRADATION; CASPASE-3; PATHWAY; ROLES	Scythe (BAT3; HLA-(B) under bar (a) under bar ssociated (t) under bar ranscript (3) under bar, Bag 6) is a protein that has been implicated in apoptosis because it can modulate the Drosophila melanogaster apoptotic regulator, Reaper. Mice lacking Scythe show pronounced defects in organogenesis and in the regulation of apoptosis and proliferation during mammalian development. However, the biochemical pathways important for Scythe function are unknown. We report here multiple levels of interaction between Scythe and the apoptogenic mitochondrial intermembrane protein AIF ((a) under bar poptosis-(i) under bar nducing (f) under bar actor). Scythe physically interacts with AIF and regulates its stability. AIF stability is markedly reduced in Scythe(-/-) cells, which are more resistant to endoplasmic reticulum stress induced by thapsigargin. Reintroduction of Scythe or overexpression of AIF in Scythe(-/-) cells restores their sensitivity to apoptosis. Together, these data implicate Scythe as a regulator of AIF.	[Desmots, Fabienne; Russell, Helen R.; McKinnon, Peter J.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; [Russell, Helen R.; Michel, Denis] Univ Rennes 1, CNRS, UMR 6026, F-35042 Rennes, France	St Jude Children's Research Hospital; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Desmots, F (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA.	fabienne.desmots@univ-rennes1.fr		Michel, Denis/0000-0002-0643-8025				Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Cregan SP, 2004, ONCOGENE, V23, P2785, DOI 10.1038/sj.onc.1207517; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kikukawa Y, 2005, FEBS J, V272, P6373, DOI 10.1111/j.1742-4658.2005.05032.x; Kim JT, 2006, FEBS LETT, V580, P6375, DOI 10.1016/j.febslet.2006.10.049; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kumar R, 2004, BIOCHEM BIOPH RES CO, V323, P1293, DOI 10.1016/j.bbrc.2004.09.006; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Miller J, 2005, FEBS LETT, V579, P3224, DOI 10.1016/j.febslet.2005.03.042; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Porter AG, 2006, BIOESSAYS, V28, P834, DOI 10.1002/bies.20444; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2004, CELL DEATH DIFFER, V11, P800, DOI 10.1038/sj.cdd.4401410; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	28	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3264	3271		10.1074/jbc.M706419200	http://dx.doi.org/10.1074/jbc.M706419200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056262	hybrid			2022-12-27	WOS:000253083000030
J	Dou, H; Theriot, CA; Das, A; Hegde, ML; Matsumoto, Y; Boldogh, I; Hazra, TK; Bhakat, KK; Mitra, S				Dou, Hong; Theriot, Corey A.; Das, Aditi; Hegde, Muralidhar L.; Matsumoto, Yoshihiro; Boldogh, Istvan; Hazra, Tapas K.; Bhakat, Kishor K.; Mitra, Sankar			Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen - The potential for replication-associated repair of oxidized bases in mammaliangenomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFIED HUMAN PROTEINS; EXCISION-REPAIR; ESCHERICHIA-COLI; POLYMERASE-BETA; FLAP ENDONUCLEASE-1; HUMAN NTH1; DAMAGE; PCNA; IDENTIFICATION; COMPLEX	NEIL1 and NEIL2 compose a family of DNA glycosylases that is distinct from that of the other two DNA glycosylases, OGG1 and NTH1, all of which are involved in repair of oxidized bases in mammalian genomes. That the NEIL proteins, unlike OGG1 and NTH1, are able to excise base lesions from single-stranded DNA regions suggests their preferential involvement in repair during replication and/or transcription. Previous studies showing S phase-specific activation of NEIL1, but not NEIL2, suggested NEIL1 involvement in the repair of replicating DNA. Here, we show that human NEIL1 stably interacts both in vivo and in vitro with proliferating cell nuclear antigen ( PCNA), the sliding clamp for DNA replication. PCNA stimulates NEIL1 activity in excising the oxidized base 5-hydroxyuracil from single-stranded DNA sequences including fork structures. PCNA enhances NEIL1 loading on the substrate. In contrast, although present in the NEIL2 immunocomplex, PCNA does not stimulate NEIL2. NEIL1 interacts with PCNA via a domain that is located in a region near the C terminus, dispensable for base excision activity. The interacting sequence in NEIL1, which lacks the canonical PCNA-binding motif, includes a sequence conserved in DNA polymerase delta and implicated in its PCNA binding. Mammalian two-hybrid analysis confirmed PCNA interaction with NEIL1. The G127A mutation in PCNA reduces its stimulatory activity, suggesting that the interdomain connector loop, a common binding interface of PCNA, is involved in NEIL1 binding. These results strongly support in vivo function of NEIL1 in preferential repair of oxidized bases in DNA prior to replication.	[Dou, Hong; Theriot, Corey A.; Das, Aditi; Hegde, Muralidhar L.; Hazra, Tapas K.; Bhakat, Kishor K.; Mitra, Sankar] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Galveston, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Matsumoto, Yoshihiro] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Fox Chase Cancer Center	Mitra, S (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, 6-136 Med Res Bldg, Galveston, TX 77555 USA.	samitra@utmb.edu	Bhakat, Kishor/C-8072-2012; Classen, Scott/AAY-8176-2020	Hegde, Muralidhar/0000-0001-7333-8123; Matsumoto, Yoshihiro/0000-0001-6580-7188	NATIONAL CANCER INSTITUTE [P01CA092584, R01CA102271, R01CA063154, R01CA081063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG021830] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA063154, R01 CA081063, P01 CA092584, R01 CA102271] Funding Source: Medline; NIAID NIH HHS [P01 AI062885] Funding Source: Medline; NIA NIH HHS [P01 AG021830, P01 AG021830-040003] Funding Source: Medline; NIEHS NIH HHS [P30 ES006676-129007, P30 ES006676, P30 ES06676] Funding Source: Medline; PHS HHS [T32-07254] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Das A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703343200; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Guan X, 2007, NUCLEIC ACIDS RES, V35, P2463, DOI 10.1093/nar/gkm075; GUSCHLBAUER W, 1991, NUCLEIC ACIDS RES, V19, P1753, DOI 10.1093/nar/19.8.1753; Harrigan JA, 2006, NUCLEIC ACIDS RES, V34, P745, DOI 10.1093/nar/gkj475; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Helt CE, 2005, CELL CYCLE, V4, P529, DOI 10.4161/cc.4.4.1598; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Lehmann AR, 2006, EXP CELL RES, V312, P2673, DOI 10.1016/j.yexcr.2006.06.010; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Lu AL, 2006, FRONT BIOSCI-LANDMRK, V11, P3062, DOI 10.2741/2033; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Matsumoto Y, 1999, J BIOL CHEM, V274, P33703, DOI 10.1074/jbc.274.47.33703; Matsumoto Y, 2001, PROG NUCLEIC ACID RE, V68, P129; Mitra S, 1997, MOL CELLS, V7, P305; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Oyama M, 2004, BIOCHEM BIOPH RES CO, V321, P183, DOI 10.1016/j.bbrc.2004.06.136; Parlanti E, 2007, NUCLEIC ACIDS RES, V35, P1569, DOI 10.1093/nar/gkl1159; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podlutsky AJ, 2001, EMBO J, V20, P1477, DOI 10.1093/emboj/20.6.1477; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Silvia TA, 2004, DNA REPAIR, V3, P483, DOI 10.1016/j.dnarep.2004.01.003; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Takao M, 2002, J BIOL CHEM, V277, P42205, DOI 10.1074/jbc.M206884200; Tomkinson AE, 2001, PROG NUCLEIC ACID RE, V68, P151; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Zhang P, 1998, J BIOL CHEM, V273, P713, DOI 10.1074/jbc.273.2.713; ZHANG SJ, 1995, J BIOL CHEM, V270, P7988, DOI 10.1074/jbc.270.14.7988; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3	58	119	123	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3130	3140		10.1074/jbc.M709186200	http://dx.doi.org/10.1074/jbc.M709186200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18032376	hybrid			2022-12-27	WOS:000253083000016
J	Skinner, SJ; Deleault, KM; Fecteau, R; Brooks, SA				Skinner, Stephen J.; Deleault, Kristen M.; Fecteau, Ryan; Brooks, Seth A.			Extracellular signal-regulated kinase regulation of tumor necrosis factor-alpha mRNA nucleocytoplasmic transport requires TAP-NxT1 binding and the AU-rich element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; EXON JUNCTION COMPLEX; HUMAN MONOCYTIC CELLS; ZINC-FINGER PROTEINS; TNF-ALPHA; GENE-EXPRESSION; LIPOPOLYSACCHARIDE STIMULATION; POSTTRANSCRIPTIONAL REGULATION; TRISTETRAPROLIN TTP	Tumor necrosis factor-alpha(TNF-alpha) production is regulated by transcriptional and posttranscriptional mechanisms. Lipopolysaccharide activates the NF kappa B pathway increasing TNF-alpha transcription. Lipopolysaccharide also activates the mitogen-activated protein kinase pathways, resulting in stabilization and enhanced translation of the TNF-alpha message. In addition, nuclear export of the TNF-alpha mRNA is a posttranscriptionally regulated process involving the Tpl2-ERK pathway and requiring the presence of the TNF-alpha AU-rich element (ARE). We demonstrate that nuclear export of the TNF-alpha message requires not only the TNF-alpha ARE but also the interaction of the proteins TAP and NxT1, both of which are involved in nucleocytoplasmic transport of mRNA. Through the use of dominant negative ERK1 and ERK2, we establish that control of TNF-alpha mRNA nuclear export operates specifically through ERK1. Finally, we examined the role of two established TNF-alpha ARE-binding proteins, HuR and tristetraprolin, that shuttle between the nucleus and cytoplasm. These data demonstrate that neither tristetraprolin nor HuR is required for TNF-alpha mRNA export. It is unclear at this time if ARE-binding protein(s) directly interact with the TAP-NxT1 complex, if each complex is independently targeted by ERK1, or if only one complex is targeted.	[Skinner, Stephen J.; Brooks, Seth A.] Vet Adm Med Ctr, White River Jct, VT 05009 USA; [Deleault, Kristen M.; Fecteau, Ryan] Dartmouth Coll, Dartmouth Med Sch, Dept Med, Lebanon, NH 03756 USA; [Brooks, Seth A.] Dartmouth Coll, Dept Microbiol & Immunol, Lebanon, NH 03756 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Dartmouth College	Brooks, SA (corresponding author), Vet Adm Med Ctr, Res 151,215 N Main St, White River Jct, VT 05009 USA.	seth.brooks@dartmouth.edu	Fecteau, Ryan/GXI-0446-2022	Fecteau, Ryan/0000-0002-3744-2924				Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Anderson P, 2000, ANN RHEUM DIS, V59, P3; Babu GR, 2006, BBA-MOL CELL RES, V1763, P174, DOI 10.1016/j.bbamcr.2005.12.010; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Baseggio L, 2002, EUR CYTOKINE NETW, V13, P92; Behm-Ansmant I, 2006, GENE DEV, V20, P391, DOI 10.1101/gad.1407606; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Brooks SA, 2004, J IMMUNOL, V172, P7263, DOI 10.4049/jimmunol.172.12.7263; Brooks SA, 2002, ARTHRITIS RHEUM, V46, P1362, DOI 10.1002/art.10235; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Cho J, 2005, J BIOL CHEM, V280, P20442, DOI 10.1074/jbc.M413554200; Cho JH, 2005, P NATL ACAD SCI USA, V102, P2350, DOI 10.1073/pnas.0409856102; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Custodio N, 2004, RNA, V10, P622, DOI 10.1261/rna.5258504; DELEAULT KM, 2007, IN PRESS MOL IMMUNOL; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; FROST JA, 1994, P NATL ACAD SCI USA, V91, P3844, DOI 10.1073/pnas.91.9.3844; GEPPERT TD, 1994, MOL MED, V1, P93; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; HACKER H, 2006, SCI STKE OCT    1017, P2006; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; Kontoyiannis D, 2002, J EXP MED, V196, P1563, DOI 10.1084/jem.20020281; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; KRAMER B, 1994, BBA-GENE STRUCT EXPR, V1219, P413, DOI 10.1016/0167-4781(94)90066-3; KRAMER B, 1995, J BIOL CHEM, V270, P6577; KRUYS V, 1993, J EXP MED, V177, P1383, DOI 10.1084/jem.177.5.1383; Lai WS, 2001, J BIOL CHEM, V276, P23144, DOI 10.1074/jbc.M100680200; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Means TK, 2000, J LEUKOCYTE BIOL, V67, P885, DOI 10.1002/jlb.67.6.885; Medzhitov R, 2000, SEMIN IMMUNOL, V12, P185, DOI 10.1006/smim.2000.0230; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Silverman ES, 2001, AM J RESP CRIT CARE, V163, P778, DOI 10.1164/ajrccm.163.3.2003123; Steer JH, 2000, J BIOL CHEM, V275, P18432, DOI 10.1074/jbc.M906304199; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; TANNENBAUM CS, 1988, J IMMUNOL, V140, P3640; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; TREDE NS, 1995, J IMMUNOL, V155, P902; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsai EY, 2000, MOL CELL BIOL, V20, P6084, DOI 10.1128/MCB.20.16.6084-6094.2000; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; West MA, 2000, J TRAUMA, V49, P298, DOI 10.1097/00005373-200008000-00018; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZUCKERMAN SH, 1989, J IMMUNOL, V143, P1223	70	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3191	3199		10.1074/jbc.M705575200	http://dx.doi.org/10.1074/jbc.M705575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18048358	hybrid			2022-12-27	WOS:000253083000022
J	Diaz, AR; Stephenson, S; Green, JM; Levdikov, VM; Wilkinson, AJ; Perego, M				Diaz, Alejandra R.; Stephenson, Sophie; Green, J. Michael; Levdikov, Vladimir M.; Wilkinson, Anthony J.; Perego, Marta			Functional role for a conserved aspartate in the Spo0E signature motif involved in the dephosphorylation of the Bacillus subtilis sporulation regulator Spo0A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; NEGATIVE REGULATION; PHOSPHATASE; MECHANISM; PROTEINS; INITIATION; CHEY; INHIBITION	Sporulation is a complex developmental system characterizing Gram-positive bacteria of the genus Bacillus and Clostridium. In Bacillus subtilis the phosphorelay signal transduction system regulates the initiation of sporulation by integrating a myriad of positive and negative signals through the action of histidine sensor kinases and aspartyl phosphate phosphatases. The Spo0E family of phosphatases dephosphorylates the Spo0A response regulator and transcription factor of the phosphorelay. In this study we analyzed the role of the Spo0E signature motif in protein activity. This family is characterized by a conserved signature motif centered around the sequence "SQELD." Alanine scanning mutagenesis was carried out on the T-35 IXXSQ ELDCLI46 residues of B. subtilis Spo0E and in vivo and in vitro activities were analyzed. The ability of the mutant proteins to interact with Spo0A similar to P was assayed by fluorescence resonance energy transfer spectroscopy. The results suggested that aspartate 43 has a critical role in Spo0E catalytic activity, whereas the other residues have a role in protein conformation and/or interaction with Spo0A. Residues Thr(35) and Cys(44) did not seem to have any critical functional or structural role. We propose that Asp(43) of Spo0E may function in a manner similar to the one proposed for the catalytic mechanisms of nucleotidase members of the haloacid dehalogenase family. These proteins use an aspartyl nucleophile as their common catalytic strategy and the active site of haloacid dehalogenase proteins shares a common geometry and identity of conserved amino acids with the active site of response regulators (Ridder, I. S., and Dijkstra, B. W. (1999) Biochem. J. 339, 223-226).	[Diaz, Alejandra R.; Stephenson, Sophie; Green, J. Michael; Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, Div Cellular Biol, La Jolla, CA 92037 USA; [Levdikov, Vladimir M.; Wilkinson, Anthony J.] Univ York, Dept Chem, Struct Biol Lab, York YO10 5YW, N Yorkshire, England	Scripps Research Institute; University of York - UK	Perego, M (corresponding author), 10050 N Torrey Pines Rd,MEM-116, La Jolla, CA 92037 USA.	mperego@scripps.edu	Levdikov, Vladimir/AAA-6139-2022	Wilkinson, Anthony/0000-0003-4577-9479; Levdikov, Vladimir/0000-0003-3041-1049	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055594] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 55594] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Bailey MF, 2004, J MOL BIOL, V336, P673, DOI 10.1016/j.jmb.2003.11.023; Bitto E, 2006, J BIOL CHEM, V281, P20521, DOI 10.1074/jbc.M602000200; Bongiorni C, 2005, J BACTERIOL, V187, P4353, DOI 10.1128/JB.187.13.4353-4361.2005; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Grenha R, 2006, J BIOL CHEM, V281, P37993, DOI 10.1074/jbc.M607617200; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Ishikawa S, 2002, J BIOL CHEM, V277, P20483, DOI 10.1074/jbc.M201086200; Jiang M, 2000, MOL MICROBIOL, V38, P535, DOI 10.1046/j.1365-2958.2000.02148.x; KOBAYASHI K, 1995, J BACTERIOL, V177, P176, DOI 10.1128/jb.177.1.176-182.1995; Kumar S, 1998, BIOPHYS J, V75, P1935, DOI 10.1016/S0006-3495(98)77634-9; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; LEDEAUX JR, 1995, J BACTERIOL, V177, P861, DOI 10.1128/jb.177.3.861-863.1995; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lewis RJ, 2000, J MOL BIOL, V297, P757, DOI 10.1006/jmbi.2000.3598; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; PEREGO M, 1994, CELL, V79, P1047, DOI 10.1016/0092-8674(94)90035-3; Perego M, 2001, MOL MICROBIOL, V42, P133, DOI 10.1046/j.1365-2958.2001.02611.x; PEREGO M, 1991, J BACTERIOL, V173, P2514, DOI 10.1128/jb.173.8.2514-2520.1991; PEREGO M, 2002, BACILLUS SUBTILIS IT, P473; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Rinaldo-Matthis A, 2002, NAT STRUCT BIOL, V9, P779, DOI 10.1038/nsb846; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Smits WK, 2007, MOL MICROBIOL, V65, P103, DOI 10.1111/j.1365-2958.2007.05776.x; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Stephenson SJ, 2002, MOL MICROBIOL, V44, P1455, DOI 10.1046/j.1365-2958.2002.02974.x; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Wang L, 1997, GENE DEV, V11, P2569, DOI 10.1101/gad.11.19.2569; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zhao R, 2002, NAT STRUCT BIOL, V9, P570	44	24	25	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2962	2972		10.1074/jbc.M709032200	http://dx.doi.org/10.1074/jbc.M709032200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045868	hybrid			2022-12-27	WOS:000252622300052
J	Harris, SJ; Parry, RV; Westwick, J; Ward, SG				Harris, Stephanie J.; Parry, Richard V.; Westwick, John; Ward, Stephen G.			Phosphoinositide lipid phosphatases: Natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SH2-CONTAINING INOSITOL PHOSPHATASE; TUMOR-SUPPRESSOR PTEN; NEGATIVE REGULATION; 5-PHOSPHATASE SHIP; CELL DEVELOPMENT; MULTIPLE FORMS; CUTTING EDGE; B-CELL; RECEPTOR; ACTIVATION	The phosphoinositide 3-kinase signaling pathway has been implicated in a range of T lymphocyte cellular functions, particularly growth, proliferation, cytokine secretion, and survival. Dysregulation of phosphoinositide 3-kinase-dependent signaling and function in leukocytes, including B and T lymphocytes, has been implicated in many inflammatory and autoimmune diseases. As befits a pivotal signaling cascade, several mechanisms exist to ensure that the pathway is tightly regulated. This minireview focuses on two lipid phosphatases, viz. the 3'-phosphatase PTEN ( phosphatase and tensin homolog deleted on chromosome 10) and SHIP ((S) under bar rc (h) under bar omology 2domain-(c) under bar ontaining (i) under bar nositol-5-(p) under bar hosphatase). We discuss their role in regulating T lymphocyte signaling as well their potential as future therapeutic targets.	[Harris, Stephanie J.; Parry, Richard V.; Ward, Stephen G.] Univ Bath, Dept Pharm & Pharmacol, Inflammatory Cell Biol Lab, Bath BA2 7AY, Avon, England; [Westwick, John] Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England	University of Bath; Novartis	Ward, SG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Inflammatory Cell Biol Lab, Bath BA2 7AY, Avon, England.	s.g.ward@bath.ac.uk	Ward, Stephen/AAE-4341-2020; /AAV-2896-2020	/0000-0002-0821-4498; Ward, Stephen G./0000-0002-6795-6002				Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Avota E, 2004, J VIROL, V78, P9552, DOI 10.1128/JVI.78.17.9552-9559.2004; Avota E, 2006, CELL MICROBIOL, V8, P1826, DOI 10.1111/j.1462-5822.2006.00752.x; Blero D, 2007, PFLUG ARCH EUR J PHY, V455, P31, DOI 10.1007/s00424-007-0304-5; Crabbe T, 2007, TRENDS BIOCHEM SCI, V32, P450, DOI 10.1016/j.tibs.2007.09.001; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Damen JE, 1998, BLOOD, V92, P1199, DOI 10.1182/blood.V92.4.1199.416k16_1199_1205; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Deane JA, 2007, BLOOD, V109, P2894, DOI 10.1182/blood-2006-07-038620; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Edmunds C, 1999, EUR J IMMUNOL, V29, P3507, DOI 10.1002/(SICI)1521-4141(199911)29:11<3507::AID-IMMU3507>3.0.CO;2-9; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao P, 2005, BLOOD, V106, P2619, DOI 10.1182/blood-2004-08-3362; Gloire G, 2006, ONCOGENE, V25, P5485, DOI 10.1038/sj.onc.1209542; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Horn S, 2004, LEUKEMIA, V18, P1839, DOI 10.1038/sj.leu.2403529; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Ji H, 2007, BLOOD, V110, P2940, DOI 10.1182/blood-2007-04-086751; Kashiwada M, 2006, J IMMUNOL, V176, P3958, DOI 10.4049/jimmunol.176.7.3958; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lee KS, 2006, MOL PHARMACOL, V69, P1829, DOI 10.1124/mol.106.022228; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Lucas DM, 1999, BLOOD, V93, P1922, DOI 10.1182/blood.V93.6.1922.406k21_1922_1933; Oak JS, 2006, P NATL ACAD SCI USA, V103, P16882, DOI 10.1073/pnas.0607984103; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Parry RV, 2006, J IMMUNOL, V176, P594, DOI 10.4049/jimmunol.176.1.594; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Rohrschneider LR, 2000, GENE DEV, V14, P505; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Seminario MC, 2004, EUR J IMMUNOL, V34, P3165, DOI 10.1002/eji.200425206; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Smith LD, 2007, CELL SIGNAL, V19, P2528, DOI 10.1016/j.cellsig.2007.08.006; Srivastava S, 2006, MOL CELL BIOL, V26, P5595, DOI 10.1128/MCB.00352-06; Subramanian KK, 2007, BLOOD, V109, P4028, DOI 10.1182/blood-2006-10-055319; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Tomlinson MG, 2004, J BIOL CHEM, V279, P55089, DOI 10.1074/jbc.M408141200; Tu Z, 2001, BLOOD, V98, P2028, DOI 10.1182/blood.V98.7.2028; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wain CM, 2005, CELL SIGNAL, V17, P1194, DOI 10.1016/j.cellsig.2004.12.009; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Ward SG, 2006, TRENDS IMMUNOL, V27, P80, DOI 10.1016/j.it.2005.12.004; Ward SG, 2001, CURR OPIN IMMUNOL, V13, P332, DOI 10.1016/S0952-7915(00)00223-5; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wolf I, 2000, GENOMICS, V69, P104, DOI 10.1006/geno.2000.6324	57	58	59	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2465	2469		10.1074/jbc.R700044200	http://dx.doi.org/10.1074/jbc.R700044200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18073217	hybrid			2022-12-27	WOS:000252622300002
J	Pedersen, M; Carmosino, M; Forbush, B				Pedersen, Meike; Carmosino, Monica; Forbush, Biff			Intramolecular and intermolecular fluorescence resonance energy transfer in fluorescent protein-tagged na-k-cl cotransporter (NKCC1) - Sensitivity to regulatory conformational change and cell volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; CHLORIDE; KINASE; PHOSPHORYLATION; MODULATION; ACTIVATION; TERMINUS; STRESS; ION	To examine the structure and function of the Na-K-Cl cotransporter, NKCC1, we tagged the transporter with cyan (CFP) and yellow (YFP) fluorescent proteins and measured fluorescence resonance energy transfer ( FRET) in stably expressing human embryonic kidney cell lines. Fluorescent protein tags were added at the N-terminal residue between the regulatory domain and the membrane domain and within a poorly conserved region of the C terminus. Both singly and doubly tagged NKCC1s were appropriately trafficked to the cell membrane and were fully functional; regulation was normal except when YFP was inserted near the regulatory domain, in which case activation occurred only upon incubation with calyculin A. Quenching of YFP fluorescence by Cl- provided a ratiometric indicator of intracellular [Cl-]. All of the CFP/YFP NKCC pairs exhibited some level of FRET, demonstrating the presence of dimers or higher multimers in functioning NKCC1. With YFP near the regulatory domain and CFP in the C terminus, we recorded a 6% FRET change signaling the regulatory phosphorylation event. On the other hand, when the probe was placed at the extreme N terminus, such changes were not seen, presumably due to the length and predicted flexibility of the N terminus. Substantial FRET changes were observed cotemporaneous with cell volume changes, possibly reflective of an increase in molecular crowding upon cell shrinkage.	[Pedersen, Meike; Carmosino, Monica; Forbush, Biff] Yale Univ, Dept Cellular & Mol Physiol, Sch Med, New Haven, CT 06520 USA	Yale University	Forbush, B (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, Sch Med, PO 208026, New Haven, CT 06520 USA.	biff.forbush@yale.edu	Carmosino, Monica/O-2594-2014	Carmosino, Monica/0000-0001-7600-8816	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047661] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 47661] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Baker BJ, 2007, J NEUROSCI METH, V161, P32, DOI 10.1016/j.jneumeth.2006.10.005; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; Dempski RE, 2006, J BIOL CHEM, V281, P36338, DOI 10.1074/jbc.M604788200; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; Giraldez T, 2005, J GEN PHYSIOL, V126, P429, DOI 10.1085/jgp.200509368; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Iakoucheva LM, 2003, STRUCTURE, V11, P1316, DOI 10.1016/j.str.2003.10.009; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC1002, DOI 10.1152/ajpcell.1998.274.4.C1002; LYTLE C, 1992, AM J PHYSIOL, V262, pC1009, DOI 10.1152/ajpcell.1992.262.4.C1009; LYTLE C, 1992, J BIOL CHEM, V267, P25428; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; PARKER JC, 1995, J GEN PHYSIOL, V105, P677, DOI 10.1085/jgp.105.6.677; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plata C, 1999, AM J PHYSIOL-RENAL, V276, pF359, DOI 10.1152/ajprenal.1999.276.3.F359; Salahpour A, 2007, NAT METHODS, V4, P599, DOI 10.1038/nmeth0807-599; Salvi A, 2002, AAPS PHARMSCI, V4, DOI 10.1208/ps040421; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Summers JC, 1997, AM J PHYSIOL-CELL PH, V273, pC360, DOI 10.1152/ajpcell.1997.273.2.C360; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Wachter RM, 2000, J MOL BIOL, V301, P157, DOI 10.1006/jmbi.2000.3905; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2003, J NEUROSCI, V23, P8167; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682	54	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2663	2674		10.1074/jbc.M708194200	http://dx.doi.org/10.1074/jbc.M708194200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045874	hybrid			2022-12-27	WOS:000252622300023
J	Evans, ZP; Ellett, JD; Schmidt, MG; Schnellmann, RG; Chavin, KD				Evans, Zachary P.; Ellett, Justin D.; Schmidt, Michael G.; Schnellmann, Rick G.; Chavin, Kenneth D.			Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL DYSFUNCTION; FATTY LIVER; PRIMARY NONFUNCTION; REPERFUSION INJURY; NONALCOHOLIC STEATOHEPATITIS; LIPID-PEROXIDATION; ISCHEMIC-INJURY; DONOR LIVER; PROTON LEAK; UW-SOLUTION	Steatotic livers are not used for transplantation because they have a reduced tolerance for ischemic events with reduced ATP levels and greater levels of cellular necrosis, which ultimately result in total organ failure. Mitochondrial uncoupling protein-2 (UCP2) is highly expressed in steatotic livers and may be responsible for liver sensitivity to ischemia through mitochondrial and ATP regulation. To test this hypothesis, experiments were conducted in lean and steatotic (ob/ob), wild-type, and UCP2 knock-out mice subjected to total warm hepatic ischemia/reperfusion. Although ob/ob UCP2knock-out mice and ob/ob mice have a similar initial phenotype, ob/ob UCP2 knock-out animal survival was 83% when compared with 30% in ob/ob mice 24 h after reperfusion. Serum alanine aminotransferase concentrations and hepatocellular necrosis were decreased in the ob/ob UCP2 knock-out mice when compared with ob/ob mice subjected to ischemia. Liver ATP levels were increased in the ob/ob UCP2 knock-out animals after reperfusion when compared with the ob/ob mice but remained below the concentrations from lean livers. Lipid peroxidation ( thiobarbituric acid-reactive substances) increased after reperfusion most significantly in the steatotic groups, but the increase was not affected by UCP2 deficiency. These results reveal that UCP2 expression is a critical factor, which sensitizes steatotic livers to ischemic injury, regulating liver ATP levels after ischemia and reperfusion.	[Evans, Zachary P.; Ellett, Justin D.; Schmidt, Michael G.; Chavin, Kenneth D.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; [Chavin, Kenneth D.] Med Univ S Carolina, Dept Transplant Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Chavin, KD (corresponding author), Med Univ S Carolina, Div Transplant, Dept Surg, 96 Jonathan Lucas St,CB Suite 404, Charleston, SC 29425 USA.	chavinkd@musc.edu		Schmidt, Michael G/0000-0002-7794-7265	NCRR NIH HHS [5 P20 RR 017677-05] Funding Source: Medline; NIDDK NIH HHS [1 R01 DK 069369] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069369] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Baffy G, 2002, HEPATOLOGY, V35, P753, DOI 10.1053/jhep.2002.32028; Birsner JH, 2004, J SURG RES, V120, P97, DOI 10.1016/j.jss.2003.11.022; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; CALDWELLKENKEL JC, 1991, HEPATOLOGY, V13, P83, DOI 10.1016/0270-9139(91)90219-L; Chavin KD, 2004, AM J TRANSPLANT, V4, P1440, DOI 10.1111/j.1600-6143.2004.00546.x; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024; de Bilbao F, 2004, J NEUROCHEM, V89, P1283, DOI 10.1111/j.1471-4159.2004.02432.x; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; FERGUSON DM, 1991, TRANSPLANT P, V23, P1552; Fernandez-Merino FJ, 2003, TRANSPLANT P, V35, P1793, DOI 10.1016/S0041-1345(03)00722-X; Fiorini RN, 2004, AM J TRANSPLANT, V4, P1567, DOI 10.1111/j.1600-6143.2004.00549.x; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; GAO WS, 1995, TRANSPLANTATION, V59, P674, DOI 10.1097/00007890-199503150-00005; KANNO M, 1993, TRANSPLANT P, V25, P2716; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Li L, 2006, TOXICOL SCI, V93, P136, DOI 10.1093/toxsci/kfl039; Marsman WA, 1996, TRANSPLANTATION, V62, P1246, DOI 10.1097/00007890-199611150-00011; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Neil DAH, 2001, TRANSPLANTATION, V71, P1566, DOI 10.1097/00007890-200106150-00014; OHNO A, 1994, DIGEST DIS SCI, V39, P861, DOI 10.1007/BF02087434; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; SCHNELLMANN RG, 1988, AM J PHYSIOL, V255, pC28, DOI 10.1152/ajpcell.1988.255.1.C28; Seifalian AM, 1999, TRANSPLANTATION, V68, P780, DOI 10.1097/00007890-199909270-00009; Selzner M, 2000, HEPATOLOGY, V32, P1280, DOI 10.1053/jhep.2000.20528; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Uchino S, 2004, J SURG RES, V120, P73, DOI 10.1016/j.jss.2003.10.010; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	44	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8573	8579		10.1074/jbc.M706784200	http://dx.doi.org/10.1074/jbc.M706784200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18086675	Green Published, hybrid			2022-12-27	WOS:000254288000056
J	Hoe, HS; Minami, SS; Makarova, A; Lee, J; Hyman, BT; Matsuoka, Y; Rebeck, GW				Hoe, Hyang-Sook; Minami, S. Sakura; Makarova, Alexandra; Lee, Jiyeon; Hyman, Bradley T.; Matsuoka, Yasuji; Rebeck, G. William			Fyn modulation of dab1 effects on amyloid precursor protein and ApoE receptor 2 processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTORS; ALZHEIMERS-DISEASE; TYROSINE KINASE; BRAIN-DEVELOPMENT; BINDING DOMAIN; LIGAND-BINDING; DISABLED 1; PHOSPHORYLATION; DEGRADATION; ADAPTER	Dab1 is an intracellular adaptor protein that interacts with amyloid precursor protein (APP) and apoE receptor 2 (apoEr2), increases their levels on the cell surface, and increases their cleavage by alpha-secretases. To investigate the mechanism underlying these alterations in processing and trafficking of APP and apoEr2, we examined the effect of Fyn, an Src family-tyrosine kinase known to interact with and phosphorylate Dab1. Co-immunoprecipitation, co-immunostaining, and fluorescence lifetime imaging demonstrated an association between Fyn and APP. Fyn induced phosphorylation of APP at Tyr-757 of the (YENPTY762)-Y-757 motif and increased cell surface expression of APP. Overexpression of Fyn alone did not alter levels of sAPP alpha or cytoplasmic C-terminal fragments, although it significantly decreased production of A beta. However, in the presence of Dab1, Fyn significantly increased sAPP alpha and C-terminal fragments. Fyn-induced APP phosphorylation and cell surface levels of APP were potentiated in the presence of Dab1. Fyn also induced phosphorylation of apoEr2 and increased its cell surface levels and, in the presence of Dab1, affected processing of its C-terminal fragment. In vivo studies showed that sAPP alpha was decreased in the Fyn knock-out, supporting a role for Fyn in APP processing. These data demonstrate that Fyn, due in part to its effects on Dab1, regulates the phosphorylation, trafficking, and processing of APP and apoEr2.	[Hoe, Hyang-Sook; Minami, S. Sakura; Rebeck, G. William] Georgetown Univ, Ctr Med, Dept Neurosci, Washington, DC 20057 USA; [Minami, S. Sakura; Matsuoka, Yasuji] Georgetown Univ, Ctr Med, Dept Neurol, Washington, DC 20057 USA; [Makarova, Alexandra; Hyman, Bradley T.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Disorders, Dept Neurol, Charlestown, MA 02129 USA; [Lee, Jiyeon] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Lee, Jiyeon] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Georgetown University; Georgetown University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL)	Rebeck, GW (corresponding author), Georgetown Univ, Ctr Med, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	NIA NIH HHS [P01 AG030128, AG 14473, AG 022455] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG022455, P01AG030128, R29AG014473, R01AG014473] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bock HH, 2004, J BIOL CHEM, V279, P33471, DOI 10.1074/jbc.M401770200; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Gotoh H, 2006, BIOCHEM BIOPH RES CO, V346, P600, DOI 10.1016/j.bbrc.2006.05.167; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hung CC, 2006, BIOCHEM SOC T, V34, P743, DOI 10.1042/BST0340743; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; MARENGERE LEM, 1994, J CELL SCI, P97; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Parisiadou L, 2007, NEUROBIOL AGING, V28, P377, DOI 10.1016/j.neurobiolaging.2005.12.015; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Wallace TA, 2005, VASC PHARMACOL, V43, P336, DOI 10.1016/j.vph.2005.08.022; Yamada K, 2004, DRUG NEWS PERSPECT, V17, P435, DOI 10.1358/dnp.2004.17.7.863702	36	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6288	6299		10.1074/jbc.M704140200	http://dx.doi.org/10.1074/jbc.M704140200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089558	hybrid			2022-12-27	WOS:000253779500036
J	Mitobe, J; Morita-Ishihara, T; Ishihama, A; Watanabe, H				Mitobe, Jiro; Morita-Ishihara, Tomoko; Ishihama, Akira; Watanabe, Haruo			Involvement of RNA-binding protein Hfq in the post-transcriptional regulation of invE gene expression in Shigella sonnei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORM-I PLASMID; ESCHERICHIA-COLI; H-NS; VIRULENCE GENE; HOST FACTOR; MESSENGER-RNA; CHROMOSOMAL GENES; STATIONARY-PHASE; Q-BETA; FLEXNERI	The temperature-dependent regulation of Shigella virulence genes is believed to be accomplished at the transcriptional stage by the regulators VirF and InvE. Several lines of evidence herein described indicate that post-transcriptional regulation of InvE expression plays a key role in the temperature-dependent regulation of virulence gene expression: (i) a considerable amount of invE mRNA continues to be transcribed under low temperature conditions, where the production of InvE protein is tightly repressed; (ii) the stability of invE mRNA markedly decreases, because its decay rate is significantly increased under the repressing conditions. Strikingly, in the hfq mutant of Shigella sonnei, a considerable amount of InvE protein was produced even at low temperature. This increase in the InvE level was found to be associated with the improved stability of invE mRNA, in agreement with the finding that the RNA chaperon Hfq influences post-transcriptional regulations of various genes. Consistently, overexpression of the Hfq protein decreased the production of InvE protein even under the expressing condition at 37 degrees C. The binding in vitro of purified Hfq protein to invE RNA was shown to be stronger at 30 degrees C than at 37 degrees C in two experiments, gel shift analysis and surface plasmon resonance (Biacore) analysis. These results altogether suggest that Hfq plays an important role in the temperature-dependent regulation of invE expression at the post-transcriptional step.	[Mitobe, Jiro; Morita-Ishihara, Tomoko; Watanabe, Haruo] NIAID, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan; [Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hosei University	Watanabe, H (corresponding author), NIAID, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan.	haruwata@nih.go.jp		Mitobe, Jiro/0000-0003-1424-4594				ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Akabayov B, 2003, IEEE T NANOBIOSCI, V2, P70, DOI 10.1109/TNB.2003.813937; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; DORMAN CJ, 1990, NATURE, V344, P789, DOI 10.1038/344789a0; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; ITO K, 1991, MICROBIOL IMMUNOL, V35, P335, DOI 10.1111/j.1348-0421.1991.tb01563.x; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; KAJITANI M, 1991, NUCLEIC ACIDS RES, V19, P1063, DOI 10.1093/nar/19.5.1063; KATO JI, 1989, INFECT IMMUN, V57, P1391, DOI 10.1128/IAI.57.5.1391-1398.1989; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; MAURELLI AT, 1988, P NATL ACAD SCI USA, V85, P2820, DOI 10.1073/pnas.85.8.2820; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; MILLER PS, 1992, BIOCONJUGATE CHEM, V3, P74, DOI 10.1021/bc00013a012; Mitobe J, 2005, J BACTERIOL, V187, P107, DOI 10.1128/JB.187.1.107-113.2005; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Porter ME, 1997, J BACTERIOL, V179, P6537, DOI 10.1128/jb.179.21.6537-6550.1997; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma AK, 2006, MOL MICROBIOL, V62, P1498, DOI 10.1111/j.1365-2958.2006.05449.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Taniya T, 2003, J BACTERIOL, V185, P5158, DOI 10.1128/JB.185.17.5158-5165.2003; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; TOBE T, 1994, MOL MICROBIOL, V12, P267, DOI 10.1111/j.1365-2958.1994.tb01015.x; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vassilieva IM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1293, DOI 10.1023/A:1021365808520; WATANABE H, 1990, J BACTERIOL, V172, P619, DOI 10.1128/jb.172.2.619-629.1990; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006	53	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5738	5747		10.1074/jbc.M710108200	http://dx.doi.org/10.1074/jbc.M710108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156173	hybrid			2022-12-27	WOS:000253426700055
J	Hebbar, PB; Archer, TK				Hebbar, Pratibha B.; Archer, Trevor K.			Altered histone H1 stoichiometry and an absence of nucleosome positioning on transfected DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR VIRUS PROMOTER; IN-VIVO; LINKER HISTONE; TRANSCRIPTIONAL ACTIVATION; CHROMATIN-STRUCTURE; MMTV PROMOTER; REPLICATION; TEMPLATES; COMPLEXES; MECHANISM	The packaging of DNA with histones to form chromatin represents an important and powerful mechanism to regulate gene expression. Critical aspects of chromatin-specific contributions to gene regulation have been revealed by the comparison of the activities from DNA regulatory elements examined both as transiently transfected reporters and stably integrated reporters organized as chromatin. Using the mouse mammary tumor virus ( MMTV) promoter as a model, we probed the structural differences between transiently transfected and stably integrated DNA templates. We demonstrated that all four core histones and the linker histone (H1) are associated with the transient template. However, whereas the core histones were present at a similar stoichiometry between the transient and the stable templates, we found that linker histone H1 molecules are fewer on the transient template. By using supercoiling assay, we show that the transient template shows intermediate levels of nucleosomal assembly. Overexpression of H1 resulted in repression of MMTV transcriptional activity and reduced accessibility to restriction endonucleases on the transient MMTV promoter. However, the addition of exogenous H1 failed to impose a normal chromatin structure on the transient template as measured by micrococcal nuclease digestion pattern. Thus, our results suggest that while transiently transfected DNA acquires a full complement of core histones, the underrepresentation of H1 on the transient template is indicative of structural differences between the two templates that may underlie the differences in the mechanisms of activation of the two templates.	[Hebbar, Pratibha B.; Archer, Trevor K.] NIEHS, Natl Inst Hlth, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Natl Inst Hlth, Mol Carcinogenesis Lab, 111 Alexander Dr,MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	Intramural NIH HHS [Z01 ES071006-09] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Archer TK, 1997, METHODS, V11, P235, DOI 10.1006/meth.1996.0410; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BAVYKIN S, 1993, P NATL ACAD SCI USA, V90, P3918, DOI 10.1073/pnas.90.9.3918; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; CEREGHINI S, 1984, EMBO J, V3, P1243, DOI 10.1002/j.1460-2075.1984.tb01959.x; Deroo BJ, 2001, MOL BIOL CELL, V12, P3365, DOI 10.1091/mbc.12.11.3365; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; GARNER MM, 1987, P NATL ACAD SCI USA, V84, P2620, DOI 10.1073/pnas.84.9.2620; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Ramachandran A, 2003, J BIOL CHEM, V278, P48590, DOI 10.1074/jbc.M309033200; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Wilson MA, 2002, J BIOL CHEM, V277, P15171, DOI 10.1074/jbc.M200349200; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3	27	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4595	4601		10.1074/jbc.M709121200	http://dx.doi.org/10.1074/jbc.M709121200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156629	Green Accepted, hybrid			2022-12-27	WOS:000253426500016
J	Ohnuma, T; Onaga, S; Murata, K; Taira, T; Katoh, E				Ohnuma, Takayuki; Onaga, Shoko; Murata, Katsuyoshi; Taira, Toki; Katoh, Etsuko			LysM domains from Pteris ryukyuensis Chitinase-A - A stability study and characterization of the chitin-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ENTEROPATHOGENIC ESCHERICHIA-COLI; ISOTHERMAL TITRATION CALORIMETRY; PROTEIN; RECEPTOR; NMR; RECOGNITION; TOOLS; PERCEPTION; BACTERIA	The LysM domain probably binds peptidoglycans, but how it does so has yet to be described. For this report, we measured the thermal stabilities of recombinant LysM domains derived from Pteris ryukyuensis chitinase-A (PrChi-A) and monitored their binding to N-acetylglucosamine oligomers ((GlcNAc)(n)) using differential scanning calorimetry, isothermal titration calorimetry, and NMR spectroscopy. We thereby characterized certain of the domains' functional and structural features. We observed that the domains are very resistant to thermal denaturation and that this resistance depends on the presence of disulfide bonds. We also show that the stoichiometry of (GlcNAc)(n)/LysM domain binding is 1:1. (GlcNAc)(5) titration experiments, monitored by NMR spectroscopy, allowed us to identify the domain residues that are critical for (GlcNAc)(5) binding. The binding site is a shallow groove formed by the N-terminal part of helix 1, the loop between strand 1 and helix 1, the C-terminal part of helix 2, and the loop between helix 2 and strand 2. Furthermore, mutagenesis experiments reiterate the critical involvement of Tyr(72) in (GlcNAc)(n)/LysM domain binding. Ours is the first report describing the physical structure of a LysM oligosaccharide-binding site based on experimental data.	[Ohnuma, Takayuki; Murata, Katsuyoshi; Katoh, Etsuko] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Onaga, Shoko; Taira, Toki] Univ Ryukyus, Fac Agr, Dept Biosci & Biotechnol, Nishihara, Okinawa 9030213, Japan	National Institute of Agrobiological Sciences - Japan; University of the Ryukyus	Katoh, E (corresponding author), Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan.	ekatoh@nias.affrc.go.jp	OHNUMA, Takayuki/T-8839-2019	Taira, Toki/0000-0002-8100-8113				Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; BIRKELAND NK, 1994, CAN J MICROBIOL, V40, P658, DOI 10.1139/m94-104; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frankel G, 1996, J BIOL CHEM, V271, P20359, DOI 10.1074/jbc.271.34.20359; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; GODDARD TD, SPARKY, V3; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; LIVE DH, 1984, J AM CHEM SOC, V106, P1934; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Remmele RL, 2000, BIOPHARM-APPL T BIO, V13, P36; Rudiger H, 2001, GLYCOCONJUGATE J, V18, P589, DOI 10.1023/A:1020687518999; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Topham C M, 1990, Biochem Soc Symp, V57, P1; Waldherr-Teschner M., 1992, Advances in Scientific Visualization, P58; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Yamagami T, 1996, BIOSCI BIOTECH BIOCH, V60, P1081, DOI 10.1271/bbb.60.1081	37	90	94	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5178	5187		10.1074/jbc.M707156200	http://dx.doi.org/10.1074/jbc.M707156200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083709	hybrid			2022-12-27	WOS:000253426500075
J	Saleem, M; Meyer, MC; Breitenstein, D; Galla, HJ				Saleem, Mohammed; Meyer, Michaela C.; Breitenstein, Daniel; Galla, Hans-Joachim			The surfactant peptide KL4 in lipid monolayers - Phase behavior, topography, and chemical distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SP-B; BOVINE PULMONARY SURFACTANT; LUNG SURFACTANT; HYDROPHOBIC PEPTIDE; PHYSICAL-PROPERTIES; SCANNING FORCE; SP-C; PERCOLATION; FILMS; PHOSPHATIDYLCHOLINE	Studies of different fragments and mutants of SP-B suggest that the function related structural and compositional characteristics in SP-B are its positive charges with intermittent hydrophobic domains. KL4 ([lysine-(leucine)(4)](4)-lysine) is a synthetic peptide based on SP-B structure and is the major constituent of Surfaxin(R), a potential therapeutic agent for respiratory distress syndrome in premature infants. There is, however, no clear understanding about the possible lipid-KL4 interactions behind its function, which is an inevitable knowledge to design improved therapeutic agents. To examine the phase behavior, topography, and lipid specificity of KL4/lipid systems, we aimed to study different surfactant model systems containing KL4, neutral dipalmitoylphosphatidylcholine (DPPC) and/or negatively charged dipalmitoylphosphatidylglycerol (DPPG) in the presence of Ca2+ ions. Surface pressure-area isotherms, fluorescence microscopic images, scanning force microscopy as well as time-of-flight secondary ion mass spectrometry suggest (i) that KL4 is not miscible with DPPC and therefore forms peptide aggregates in DPPC/KL4 mixtures; (ii) that KL4 specifically interacts with DPPG via electrostatic interactions and induces percolation of DPPG-rich phases; (iii) that existing DPPG-Ca2+ interactions are too strong to be overcome by KL4, the reason why the peptide remains excluded from condensed DPPG domains and passively colocalizes with DPPC in a demixed fluid phase; and (iv) that the presence of negatively charged lipid is necessary for the formation of bilayer protrusions. These results indicate that the capability of the peptide to induce the formation of a defined surface-confined reservoir depends on the lipid environment, especially on the presence of anionic lipids.	[Saleem, Mohammed; Meyer, Michaela C.; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Breitenstein, Daniel] Tascon GmbH, D-48149 Munster, Germany	University of Munster	Galla, HJ (corresponding author), Univ Munster, Inst Biochem, Wilhelm-Klemm-Str 2, D-48149 Munster, Germany.	gallah@unimuenster.de	Saleem, Mohammed/I-6067-2018; Saleem, Mohammed/AAI-4466-2020	Saleem, Mohammed/0000-0002-1798-1269; 				Alonso C, 2005, BIOPHYS J, V89, P266, DOI 10.1529/biophysj.104.052092; Amrein M, 1997, EUR BIOPHYS J BIOPHY, V26, P349, DOI 10.1007/s002490050089; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Biesinger MC, 2002, ANAL CHEM, V74, P5711, DOI 10.1021/ac020311n; Bourdos N, 2000, LANGMUIR, V16, P1481, DOI 10.1021/la9912693; Bourdos N, 2000, BIOPHYS J, V79, P357, DOI 10.1016/S0006-3495(00)76297-7; Breitenstein D, 2006, BIOPHYS J, V91, P1347, DOI 10.1529/biophysj.105.073247; Cai P, 2003, BIOCHEMISTRY-US, V42, P9446, DOI 10.1021/bi030052b; Cochrane CG, 1996, AM J RESP CRIT CARE, V153, P404, DOI 10.1164/ajrccm.153.1.8542150; COCHRANE CG, 1991, SCIENCE, V254, P566, DOI 10.1126/science.1948032; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P248, DOI 10.1016/0005-2760(91)90101-M; Coelho FP, 1997, BIOPHYS J, V72, P1501, DOI 10.1016/S0006-3495(97)78798-8; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; Curstedt T, 2006, BIOL NEONATE, V89, P336, DOI 10.1159/000092871; Curstedt T, 2006, BIOL NEONATE, V89, P258, DOI 10.1159/000090115; Diemel RV, 2002, J BIOL CHEM, V277, P21179, DOI 10.1074/jbc.M111758200; Ding JQ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.168102; FLEMING BD, 1988, CHEM PHYS LIPIDS, V49, P81, DOI 10.1016/0009-3084(88)90067-9; Garidel P, 2000, BBA-BIOMEMBRANES, V1466, P245, DOI 10.1016/S0005-2736(00)00166-8; GOERKE J, 1974, BIOCHIM BIOPHYS ACTA, V344, P241, DOI 10.1016/0304-4157(74)90009-4; Gustafsson M, 1996, FEBS LETT, V384, P185, DOI 10.1016/0014-5793(96)00290-6; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; Holm BA, 1996, PEDIATR RES, V39, P805, DOI 10.1203/00006450-199605000-00010; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; King DM, 2002, AM J PHYSIOL-LUNG C, V282, pL277, DOI 10.1152/ajplung.00199.2001; Krol S, 2000, BIOPHYS J, V79, P904, DOI 10.1016/S0006-3495(00)76346-6; Lahiri T, 1999, J COLLOID INTERF SCI, V211, P89, DOI 10.1006/jcis.1998.5934; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; Ma JW, 1998, BIOPHYS J, V74, P1899, DOI 10.1016/S0006-3495(98)77899-3; MOHWALD H, 1990, ANNU REV PHYS CHEM, V41, P441, DOI 10.1146/annurev.pc.41.100190.002301; NAG K, 1994, THIN SOLID FILMS, V244, P841; Nakorn PN, 2007, EUR BIOPHYS J BIOPHY, V36, P477, DOI 10.1007/s00249-006-0102-6; NIELSON DW, 1986, J APPL PHYSIOL, V60, P972, DOI 10.1152/jappl.1986.60.3.972; OOSTERLAKENDIJKSTERHUIS MA, 1992, BIOCHIM BIOPHYS ACTA, V1110, P45, DOI 10.1016/0005-2736(92)90292-T; PASTRANARIOS B, 1994, BIOCHEMISTRY-US, V33, P5121, DOI 10.1021/bi00183a016; Piknova B, 1996, BIOPHYS J, V71, P892, DOI 10.1016/S0006-3495(96)79291-3; REVAK SD, 1988, J CLIN INVEST, V81, P826, DOI 10.1172/JCI113391; Robertson B, 1998, BBA-MOL BASIS DIS, V1408, P346, DOI 10.1016/S0925-4439(98)00080-5; Robertson B, 2000, MOL MED TODAY, V6, P119, DOI 10.1016/S1357-4310(99)01656-1; Ross M, 2001, LANGMUIR, V17, P2437, DOI 10.1021/la001617x; Saenz A, 2006, FEBS J, V273, P2515, DOI 10.1111/j.1742-4658.2006.05258.x; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; SCHURCH S, 1995, BIOL NEONATE, V67, P61; Seifert M, 2007, BIOPHYS J, V93, P1192, DOI 10.1529/biophysj.107.106765; TAKAHASHI A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P43, DOI 10.1016/0005-2760(90)90216-K; Takamoto DY, 2001, BIOPHYS J, V81, P153, DOI 10.1016/S0006-3495(01)75688-3; TANAKA Y, 1983, CHEM PHARM BULL, V31, P4100; TANEVA S, 1994, BIOPHYS J, V66, P1137, DOI 10.1016/S0006-3495(94)80895-1; Veldhuizen EJA, 2000, BIOPHYS J, V79, P3164, DOI 10.1016/S0006-3495(00)76550-7; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; VINCENT JS, 1993, BIOCHEMISTRY-US, V32, P8228, DOI 10.1021/bi00083a025; vonNahmen A, 1997, EUR BIOPHYS J BIOPHY, V26, P359, DOI 10.1007/s002490050090; vonNahmen A, 1997, BIOPHYS J, V72, P463, DOI 10.1016/S0006-3495(97)78687-9; WANG ZD, 1995, J LIPID RES, V36, P1283; WARING A, 1989, Peptide Research, V2, P308; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; YU S, 1983, LIPIDS, V18, P522, DOI 10.1007/BF02535391	60	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5195	5207		10.1074/jbc.M705944200	http://dx.doi.org/10.1074/jbc.M705944200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093983	hybrid			2022-12-27	WOS:000253426500077
J	Kim, HS; Hwang, JT; Yun, H; Chi, SG; Lee, SJ; Kang, I; Yoon, KS; Choe, WJ; Kim, SS; Ha, J				Kim, Hak-Su; Hwang, Jin-Taek; Yun, Hee; Chi, Sung-Gil; Lee, Su-Jae; Kang, Insug; Yoon, Kyung-Sik; Choe, Won-Jae; Kim, Sung-Soo; Ha, Joohun			RETRACTED: Inhibition of AMP-activated protein kinase sensitizes cancer cells to cisplatin-induced apoptosis via Hyper-induction of p53 (Retracted article. See vol. 293, pg. 18015, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							SIGNAL-REGULATED KINASE; DAMAGE-INDUCED PHOSPHORYLATION; DNA-DAMAGE; GENE-EXPRESSION; GROWTH-FACTOR; CHECKPOINT; PATHWAYS; HYPOXIA; LKB1; STIMULATION	Cisplatin is one of the most effective and widely used chemotherapeutic agents. However, one of the most salient limitations to the clinical application of cisplatin is the acquired or intrinsic drug resistance exhibited by some tumors. In the present study, we have assessed the potential of an intracellular energy balancing system as a target for augmentation of cisplatin sensitivity in tumors. AMP-activated protein kinase (AMPK) regulates the energy balance system by monitoring intracellular energy status. Here we demonstrate that AMPK is rapidly activated by cisplatin in AGS and HCT116 cancer cells. The inhibition of AMPK in those cells and in xenografts of HCT116 resulted in a remarkable increase in cisplatin-induced apoptosis, which was associated with hyper-induction of the tumor suppressor p53. We further showed that ERK, but not ATM (ataxia telangiectasia mutated) and ATR (ATM- and Rad3-related) kinases, was involved in the hyper-induction of p53 by the inhibition of cisplatin-induced AMPK. By way of contrast, cisplatin did not induce AMPK activation in HeLa cells, which appear to have a relatively high sensitivity to cisplatin-induced cytotoxicity, but expression of the constitutive active form of AMPK in HeLa cells resulted in a significant increase of cell viability after cisplatin treatment. Collectively, our data suggest that AMPK performs a pivotal function for protection against the cytotoxic effect of cisplatin, thereby implying that AMPK is one of the cellular factors determining the cellular sensitivity to cisplatin. On the basis of these observations, we propose that a strategy combining cisplatin and AMPK inhibition could be developed into a novel chemotherapeutic modality.	[Kim, Hak-Su; Yun, Hee; Yoon, Kyung-Sik; Choe, Won-Jae; Kim, Sung-Soo; Ha, Joohun] Kyung Hee Univ, Sch Med, Med Res Ctr Bioreact React Oxygen Species, Dept Biochem & Mol Biol, Seoul 130701, South Korea; [Hwang, Jin-Taek] Korea Food Res Inst, Songnam 463746, South Korea; [Chi, Sung-Gil] Korea Univ, Sch Life Sci, Seoul 136701, South Korea; [Lee, Su-Jae] Hanyang Univ, Dept Chem, Seoul 133791, South Korea	Kyung Hee University; Korea Food Research Institute (KFRI); Korea University; Hanyang University	Ha, J (corresponding author), Kyung Hee Univ, Sch Med, Med Res Ctr Bioreact React Oxygen Species, Dept Biochem & Mol Biol, Tongdaemun-gu,Hoegi-dong 1, Seoul 130701, South Korea.	hajh@khu.ac.kr	Yoon, KyungSik/AAI-2991-2020; Kim, Sung Soo/S-2540-2017	Yoon, KyungSik/0000-0002-2473-4493; Kim, Sung Soo/0000-0002-6817-7668				Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Boulay JL, 2000, CANCER GENE THER, V7, P1215, DOI 10.1038/sj.cgt.7700227; Burkle A, 2005, FEBS J, V272, P4576, DOI 10.1111/j.1742-4658.2005.04864.x; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Choi SL, 2001, BIOCHEM BIOPH RES CO, V287, P92, DOI 10.1006/bbrc.2001.5544; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; Esumi H, 2002, J BIOL CHEM, V277, P32791, DOI 10.1074/jbc.M112270200; Fojo T, 2003, ONCOGENE, V22, P7512, DOI 10.1038/sj.onc.1206951; Galban S, 2003, MOL CELL BIOL, V23, P7083, DOI 10.1128/MCB.23.20.7083-7095.2003; HA J, 1994, J BIOL CHEM, V269, P22162; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hwang JT, 2006, CANCER RES, V66, P10057, DOI 10.1158/0008-5472.CAN-06-1814; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Kim J, 2001, J BIOL CHEM, V276, P19102, DOI 10.1074/jbc.M011579200; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; PRESTAYKO AW, 1979, CANCER TREAT REV, V6, P17, DOI 10.1016/S0305-7372(79)80057-2; Rosenberg B, 1977, Adv Exp Med Biol, V91, P129; Schipper DL, 1996, ANTI-CANCER DRUG, V7, P137, DOI 10.1097/00001813-199602000-00001; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhou N, 2003, J BIOL CHEM, V278, P29532, DOI 10.1074/jbc.M301877200	47	68	71	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3731	3742		10.1074/jbc.M704432200	http://dx.doi.org/10.1074/jbc.M704432200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079115	hybrid			2022-12-27	WOS:000253083500006
J	Martin, MC; Allan, LA; Mancini, EJ; Clarke, PR				Martin, Morag C.; Allan, Lindsey A.; Mancini, Erika J.; Clarke, Paul R.			The docking interaction of caspase-9 with ERK2 provides a mechanism for the selective inhibitory phosphorylation of caspase-9 at threonine 125	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; MAP KINASES; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; IN-VIVO; CYTOCHROME-C; CELL-DEATH; IDENTIFICATION; SPECIFICITY; SUBSTRATE	Caspase-9 plays a critical role in the initiation of apoptosis by the mitochondrial pathway. Activation of caspase-9 is inhibited by phosphorylation at Thr125 by ERK1/2 MAPKs in response to growth factors. Here, we show that phosphorylation of this site is specific for these classical MAPKs and is not strongly induced when JNK and p38 alpha/beta MAPKs are activated by anisomycin. By deletion and mutagenic analysis, we identify domains in caspase-9 and ERK2 that mediate their interaction. Binding of ERK2 to caspase-9 and subsequent phosphorylation of caspase-9 requires a basic docking domain (D domain) in the N-terminal prodomain of the caspase. Mutational analysis of ERK2 reveals a (TTCD160)-T-157 motif required for recognition of caspase-9 that acts independently of the putative common docking domain. Molecular modeling supports the conclusion that Arg(10) in the D domain of caspase-9 interacts with Asp(160) in the TTCD motif of ERK2. Differences in the TTCD motif in other MAPK family members could account for the selective recognition of caspase-9 by ERK1/2. This selectivity may be important for the antiapoptotic role of classical MAPKs in contrast to the proapoptotic roles of stress-activated MAPKs.	[Martin, Morag C.; Allan, Lindsey A.; Clarke, Paul R.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Mancini, Erika J.] Div Struct Biol, Oxford OX37BN, England	University of Dundee	Clarke, PR (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Level 5, Dundee DD1 9SY, Scotland.	p.r.clarke@dundee.ac.uk	Mancini, Erika J/J-9880-2013; Clarke, Paul R./AAA-6803-2020; Clarke, Paul/B-1684-2009	Mancini, Erika J/0000-0001-9591-7898; Clarke, Paul/0000-0003-3525-2622; Martin, Morag/0000-0002-8667-6057	Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim YM, 1999, GENETICS, V153, P763; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tarrega C, 2002, J BIOL CHEM, V277, P2629, DOI 10.1074/jbc.M108874200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	43	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3854	3865		10.1074/jbc.M705647200	http://dx.doi.org/10.1074/jbc.M705647200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18083711	hybrid			2022-12-27	WOS:000253083500020
J	Grubina, R; Basu, S; Tiso, M; Kim-Shapiro, DB; Gladwin, MT				Grubina, Rozalina; Basu, Swati; Tiso, Mauro; Kim-Shapiro, Daniel B.; Gladwin, Mark T.			Nitrite reductase activity of hemoglobin S (sickle) provides insight into contributions of heme redox potential versus ligand affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION; CELL HEMOGLOBIN; OXYGEN-BINDING; OXIDE; DEOXYHEMOGLOBIN; NO; OXIDATION; BLOOD; POLYMERIZATION; KINETICS	Hemoglobin A (HbA) is an allosterically regulated nitrite reductase that reduces nitrite to NO under physiological hypoxia. The efficiency of this reaction is modulated by two intrinsic and opposing properties: availability of unliganded ferrous hemes and R-state character of the hemoglobin tetramer. Nitrite is reduced by deoxygenated ferrous hemes, such that heme deoxygenation increases the rate of NO generation. However, heme reactivity with nitrite, represented by its bimolecular rate constant, is greatest when the tetramer is in the R quaternary state. The mechanism underlying the higher reactivity of R-state hemes remains elusive. It can be due to the lower heme redox potential of R-state ferrous hemes or could reflect the high ligand affinity geometry of R-state tetramers that facilitates nitrite binding. We evaluated the nitrite reductase activity of unpolymerized sickle hemoglobin (HbS), whose oxygen affinity and cooperativity profile are equal to those of HbA, but whose heme iron has a lower redox potential. We now report that HbS exhibits allosteric nitrite reductase activity with competing proton and redox Bohr effects. In addition, we found that solution phase HbS reduces nitrite to NO significantly faster than HbA, supporting the thesis that heme electronics (i.e. redox potential) contributes to the high reactivity of R-state deoxy-hemes with nitrite. From a pathophysiological standpoint, under conditions where HbS polymers form, the rate of nitrite reduction is reduced compared with HbA and solution-phase HbS, indicating that HbS polymers reduce nitrite more slowly.	[Grubina, Rozalina; Tiso, Mauro; Gladwin, Mark T.] NHLBI, Vasc Med Branch, Bethesda, MD 20892 USA; [Gladwin, Mark T.] Natl Inst Hlth, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA; [Grubina, Rozalina] Howard Hughes Med Inst, Natl Inst Res Scholars Program, Bethesda, MD 20814 USA; [Basu, Swati; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Howard Hughes Medical Institute; Wake Forest University	Gladwin, MT (corresponding author), CRC, Bldg 10,Rm 5-5140,10 Ctr Dr, Bethesda, MD 20892 USA.	mgladwin@nih.gov	Kim-Shapiro, Daniel/HGA-2682-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058091, R37HL058091, K02HL078706, R29HL058091] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [HL078706, HL58091, R37 HL058091] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN D W, 1954, Rev Hematol, V9, P155; ANTONINI E, 1964, J BIOL CHEM, V239, P907; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Blankman JI, 2000, BIOCHEMISTRY-US, V39, P14806, DOI 10.1021/bi000731b; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; Bonaventura C, 2002, J BIOL CHEM, V277, P14557, DOI 10.1074/jbc.M107658200; Bonaventura C, 2007, IUBMB LIFE, V59, P498, DOI 10.1080/15216540601188546; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; BRUNORI M, 1965, J BIOL CHEM, V240, P3317; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; DeYoung A, 1981, Methods Enzymol, V76, P792; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; EATON WA, 1987, BLOOD, V70, P1245; FAULKNER KM, 1995, J BIOL CHEM, V270, P13604, DOI 10.1074/jbc.270.23.13604; Gamgee A, 1868, PHILOS T ROY SOC LON, V158, P589, DOI DOI 10.1098/RSTL.1868.0025; GILL SJ, 1979, J MOL BIOL, V130, P175, DOI 10.1016/0022-2836(79)90425-X; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Haldane J, 1901, J Hyg (Lond), V1, P115; Harrington JP, 1998, COMP BIOCHEM PHYS B, V119, P305, DOI 10.1016/S0305-0491(97)00330-1; Hataishi R, 2006, AM J PHYSIOL-HEART C, V291, pH379, DOI 10.1152/ajpheart.01172.2005; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HOFFMAN BM, 1976, P NATL ACAD SCI USA, V73, P800, DOI 10.1073/pnas.73.3.800; HOFRICHTER J, 1976, P NATL ACAD SCI USA, V73, P3035, DOI 10.1073/pnas.73.9.3035; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Hunter CJ, 2004, NAT MED, V10, P1122, DOI 10.1038/nm1109; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Kozlov AV, 2005, ANTIOXID REDOX SIGN, V7, P515, DOI 10.1089/ars.2005.7.515; MIZUKAMI H, 1977, P SOC EXP BIOL MED, V154, P304, DOI 10.3181/00379727-154-39659; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; NOGUCHI CT, 1983, J CLIN INVEST, V72, P846, DOI 10.1172/JCI111055; NOGUCHI CT, 1985, ANNU REV BIOPHYS BIO, V14, P239, DOI 10.1146/annurev.biophys.14.1.239; NOGUCHI CT, 1984, BIOPHYS J, V45, P1153, DOI 10.1016/S0006-3495(84)84263-0; PAPA S, 1986, METHOD ENZYMOL, V126, P331; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PENNELLY RR, 1978, BIOCH CLIN ASPECTS H, P401; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; Rassaf T, 2007, CIRC RES, V100, P1749, DOI 10.1161/CIRCRESAHA.107.152488; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; ROSSIBERNARDI L, 1975, CLIN CHEM, V21, P1747; SEAKINS M, 1973, J CLIN INVEST, V52, P422, DOI 10.1172/JCI107199; SHAPIRO DB, 1994, BIOCHEM BIOPH RES CO, V205, P154, DOI 10.1006/bbrc.1994.2643; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; SINGER K, 1953, BLOOD, V8, P1008, DOI 10.1182/blood.V8.11.1008.1008; SUNSHINE HR, 1979, J MOL BIOL, V133, P435, DOI 10.1016/0022-2836(79)90402-9; SUNSHINE HR, 1982, J MOL BIOL, V158, P251, DOI 10.1016/0022-2836(82)90432-6; Taboy CH, 2000, J BIOL CHEM, V275, P39048, DOI 10.1074/jbc.M004547200; TAYLOR JOHN FULLER, 1939, JOUR BIOL CHEM, V131, P649; Tsuchiya K, 2005, AM J PHYSIOL-HEART C, V288, pH2163, DOI 10.1152/ajpheart.00525.2004; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; WINSLOW RM, 1978, P S CLIN BIOCH ASP H	60	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3628	3638		10.1074/jbc.M705222200	http://dx.doi.org/10.1074/jbc.M705222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056715	hybrid			2022-12-27	WOS:000253083000068
J	Lee, J; Seo, SR; Wonum, J; Park, J; Oh, Y; Chung, KC				Lee, Jung; Seo, Su Ryeon; Wonum, Ji; Park, Joongkyu; Oh, Yohan; Chung, Kwang Chul			NF-kappa B-inducing kinase phosphorylates and blocks the degradation of down syndrome candidate region 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCINEURIN-INTERACTING PROTEIN-1; NEURONAL CELL-DEATH; ALZHEIMERS-DISEASE; DSCR1 ADAPT78; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BETA; INHIBITOR; ALPHA	Down syndrome, the most frequent genetic disorder, is characterized by an extra copy of all or part of chromosome 21. Down syndrome candidate region 1 (DSCR1) gene, which is located on chromosome 21, is highly expressed in the brain of Down syndrome patients. Although its cellular function remains unknown, DSCR1 expression is linked to inflammation, angiogenesis, and cardiac development. To explore the functional role of DSCR1 and the regulation of its expression, we searched for novel DSCR1-interacting proteins using a yeast two-hybrid assay. Using a human fetal brain library, we found that DSCR1 interacts with NF-kappa B-inducing kinase (NIK). Furthermore, we demonstrate that NIK specifically interacts with and phosphorylates the C-terminal region of DSCR1 in immortalized hippocampal cells as well as in primary cortical neurons. This NIK-mediated phosphorylation of DSCR1 increases its protein stability and blocks its proteasomal degradation, the effects of which lead to an increase in soluble and insoluble DSCR1 levels. We show that an increase in insoluble DSCR1 levels results in the formation of cytosolic aggregates. Interestingly, we found that whereas the formation of these inclusions does not significantly alter the viability of neuronal cells, the overexpression of DSCR1 without the formation of aggregates is cytotoxic.	[Lee, Jung; Wonum, Ji; Park, Joongkyu; Oh, Yohan; Chung, Kwang Chul] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; [Seo, Su Ryeon] Kangwon Natl Univ, Sch Biosci & Biotechnol, Dept Mol Biosci, Chunchon 200701, South Korea	Yonsei University; Kangwon National University	Chung, KC (corresponding author), Yonsei Univ, Coll Sci, Dept Biol, Shinchon Dong 134, Seoul 120749, South Korea.	kchung@yonsei.ac.kr	Oh, Yohan/C-9107-2013; Park, Joongkyu/ADZ-1994-2022	Oh, Yohan/0000-0002-9249-8664; Park, Joongkyu/0000-0002-5675-2872				Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Davies KJA, 2001, BIOFACTORS, V15, P91, DOI 10.1002/biof.5520150208; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Epstein C J, 1995, Prog Clin Biol Res, V393, P241; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Kim YS, 2006, J BIOL CHEM, V281, P39051, DOI 10.1074/jbc.M604659200; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lee EJ, 2007, MOL CELL NEUROSCI, V35, P585, DOI 10.1016/j.mcn.2007.05.003; Lilienbaum A, 2003, MOL CELL BIOL, V23, P2680, DOI 10.1128/MCB.23.8.2680-2698.2003; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Lukiw WJ, 2000, NEUROCHEM RES, V25, P1173, DOI 10.1023/A:1007627725251; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; MANN DMA, 1987, J NEUROL SCI, V80, P79, DOI 10.1016/0022-510X(87)90223-1; Min YK, 2003, J NEUROSCI RES, V71, P689, DOI 10.1002/jnr.10520; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Pfister SC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-24; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Ryeom S, 2003, NAT IMMUNOL, V4, P874, DOI 10.1038/ni966; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; Suzuki K, 2001, BIOCHEM BIOPH RES CO, V285, P991, DOI 10.1006/bbrc.2001.5263; Tanzi RE, 1996, NAT MED, V2, P31, DOI 10.1038/nm0196-31; Toyoda A, 2002, GENOME RES, V12, P1323, DOI 10.1101/gr.153702; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; WISNIEWSKI KE, 1984, NEW ENGL J MED, V311, P1187; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Yin L, 2001, SCIENCE, V291, P2162, DOI 10.1126/science.1058453; Zhu J, 2000, CELL MOL LIFE SCI, V57, P411, DOI 10.1007/PL00000703	49	35	35	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3392	3400		10.1074/jbc.M706707200	http://dx.doi.org/10.1074/jbc.M706707200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056702	hybrid			2022-12-27	WOS:000253083000044
J	Ma, J; Yan, RL; Zu, X; Cheng, JM; Rao, K; Liao, DF; Cao, DL				Ma, Jun; Yan, Ruilan; Zu, Xuyu; Cheng, Ji-Ming; Rao, Krishna; Liao, Duan-Fang; Cao, Deliang			Aldo-keto reductase family 1 B10 affects fatty acid synthesis by regulating the stability of acetyl-CoA carboxylase-alpha in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN ALDOSE REDUCTASE; PROSTATE-CANCER; SIGNAL-TRANSDUCTION; GROWTH-INHIBITION; SYNTHASE; OVEREXPRESSION; EXPRESSION; CARCINOMA; GENE	Recent studies have demonstrated that aldo-keto reductase family 1 B10 (AKR1B10), a novel protein overexpressed in human hepatocellular carcinoma and non-small cell lung carcinoma, may facilitate cancer cell growth by detoxifying intracellular reactive carbonyls. This study presents a novel function of AKR1B10 in tumorigenic mammary epithelial cells (RAO-3), regulating fatty acid synthesis. In RAO-3 cells, Sephacryl-S 300 gel filtration and DEAE-Sepharose ion exchange chromatography demonstrated that AKR1B10 exists in two distinct forms, monomers (similar to 40 kDa) bound to DEAE-Sepharose column and protein complexes (similar to 300 kDa) remaining in flow-through. Co-immunoprecipitation with AKR1B10 antibody and protein mass spectrometry analysis identified that AKR1B10 associates with acetyl-CoA carboxylase-alpha (ACCA), arate-limiting enzyme of denovo fatty acid synthesis. This association between AKR1B10 and ACCA proteins was further confirmed by co-immunoprecipitation with ACCA antibody and pulldown assays with recombinant AKR1B10 protein. Intracellular fluorescent studies showed that AKR1B10 and ACCA proteins co-localize in the cytoplasm of RAO-3 cells. More interestingly, small interfering RNA-mediated AKR1B10 knock down increased ACCA degradation through ubiquitination-proteasome pathway and resulted in > 50% decrease of fatty acid synthesis in RAO-3 cells. These data suggest that AKR1B10 is a novel regulator of the biosynthesis of fatty acid, an essential component of the cell membrane, in breast cancer cells.	[Ma, Jun; Yan, Ruilan; Zu, Xuyu; Rao, Krishna] So Illinois Univ, Sch Med, SimmonsCooper Canc Inst, Dept Med Microbiol, Springfield, IL 62702 USA; [Cheng, Ji-Ming] So Illinois Univ, Sch Med, Div Hematol & Oncol, Springfield, IL 62702 USA; [Zu, Xuyu; Liao, Duan-Fang] Nanhua Univ, Sch Life Sci & Technol, Inst Pharm & Pharmacol, Div Pharmacoproteom, Hengyang 421001, Hunan, Peoples R China	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of South China	Cao, DL (corresponding author), So Illinois Univ, Sch Med, SimmonsCooper Canc Inst, Dept Med Microbiol, 913 N Rutledge St, Springfield, IL 62702 USA.	dcao@siumed.edu	高, 雨莉/HGU-8187-2022		NATIONAL CANCER INSTITUTE [R21CA122327] Funding Source: NIH RePORTER; NCI NIH HHS [CA122327] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Cheng JM, 2006, INT J CANCER, V118, P2957, DOI 10.1002/ijc.21739; Crosas B, 2003, BIOCHEM J, V373, P973, DOI 10.1042/BJ20021818; Dragnev K H, 2000, Oncologist, V5, P361, DOI 10.1634/theoncologist.5-5-361; Dyck JRB, 1999, EUR J BIOCHEM, V262, P184, DOI 10.1046/j.1432-1327.1999.00371.x; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Jin J, 2006, FRONT BIOSCI-LANDMRK, V11, P2767, DOI 10.2741/2006; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Lee KWY, 2001, ANTI-CANCER DRUG, V12, P129, DOI 10.1097/00001813-200102000-00005; Magnard C, 2002, ONCOGENE, V21, P6729, DOI 10.1038/sj.onc.1205915; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Moreau K, 2006, J BIOL CHEM, V281, P3172, DOI 10.1074/jbc.M504652200; Neels JG, 2006, SCIENCE, V312, P1756, DOI 10.1126/science.1130476; Penning TM, 2005, CLIN CANCER RES, V11, P1687, DOI 10.1158/1078-0432.CCR-05-0071; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Rossi S, 2003, MOL CANCER RES, V1, P707; Rouquette-Jazdanian AK, 2002, BIOCHEM J, V363, P645, DOI 10.1042/0264-6021:3630645; Shurbaji MS, 1996, HUM PATHOL, V27, P917, DOI 10.1016/S0046-8177(96)90218-X; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077; WITTERS LA, 1994, INT J BIOCHEM, V26, P589, DOI 10.1016/0020-711X(94)90018-3; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933; Zang Y, 2005, OBES RES, V13, P1530, DOI 10.1038/oby.2005.188; Zu XY, 2007, TOXICOL SCI, V97, P562, DOI 10.1093/toxsci/kfm033	35	125	130	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3418	3423		10.1074/jbc.M707650200	http://dx.doi.org/10.1074/jbc.M707650200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056116	hybrid			2022-12-27	WOS:000253083000047
J	Miller, WL; Matewish, MJ; McNally, DJ; Ishiyama, N; Anderson, EM; Brewer, D; Brisson, JR; Berghuis, AM; Lam, JS				Miller, Wayne L.; Matewish, Mauricia J.; McNally, David J.; Ishiyama, Noboru; Anderson, Erin M.; Brewer, Dyanne; Brisson, Jean-Robert; Berghuis, Albert M.; Lam, Joseph S.			Flagellin glycosylation in Pseudomonas aeruginosa PAK requires the O-antigen biosynthesis enzyme WbpO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; GENETIC-CHARACTERIZATION; SEROTYPE O6; BIOCHEMICAL-CHARACTERIZATION; NEISSERIA-MENINGITIDIS; PILIN GLYCOSYLATION; CYSTIC-FIBROSIS; C4 EPIMERASE; LIPOPOLYSACCHARIDE	Pseudomonas aeruginosa PAK (serotype O6) produces a single polar, glycosylated flagellum composed of a-type flagellin. To determine whether or not flagellin glycosylation in this serotype requires O-antigen genes, flagellin was isolated from the wild type, three O-antigen-deficient mutants wbpL, wbpO, and wbpP, and a wbpO mutant complemented with a plasmid containing a wild-type copy of wbpO. Flagellin from the wbpO mutant was smaller (42 kDa) than that of the wild type (45 kDa), or other mutants strains, and exhibited an altered isoelectric point (pI 4.8) when compared with PAK flagellin (pI 4.6). These differences were because of the truncation of the glycan moiety in the wbpO-flagellin. Thus, flagellin glycosylation in P. aeruginosa PAK apparently requires a functional WbpO but not WbpP. Because WbpP was previously proposed to catalyze a metabolic step in the biosynthesis of B-band O-antigen that precedes the action of WbpO, these results prompted us to reevaluate the two-step pathway catalyzed by WbpO and WbpP. Results from WbpO-WbpP-coupled enzymatic assays showed that either WbpO or WbpP is capable of initiating the two-step pathway; however, the kinetic parameters favored the WbpO reaction to occur first, converting UDP-N-acetyl-D-glucosamine to UDP-N-acetyl-D-glucuronic acid prior to the conversion to UDP-N-acetyl-D-galacturonic acid by WbpP. This is the first report to show that a C4 epimerase could utilize UDP-N-acetyl-hexuronic acid as a substrate.	[Miller, Wayne L.; Matewish, Mauricia J.; Anderson, Erin M.; Brewer, Dyanne; Lam, Joseph S.] Univ Guelph, Dept Mol & Cell Biol, Guelph, ON N1G 2W1, Canada; [Ishiyama, Noboru; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A4, Canada; [Ishiyama, Noboru; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 1A4, Canada; [McNally, David J.; Brisson, Jean-Robert] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; McGill University; McGill University; National Research Council Canada	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cell Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca	Berghuis, Albert M/A-6495-2008	Berghuis, Albert/0000-0002-2663-025X	CIHR [48370] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		ALLISON JS, 1985, INFECT IMMUN, V49, P770, DOI 10.1128/IAI.49.3.770-774.1985; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSORG R, 1978, ZBL BAKT-INT J MED M, V242, P228; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; BRISSON JR, 2002, NMR SPECTROSCOPY GLY, P59; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Demendi M, 2005, BIOCHEM J, V389, P173, DOI 10.1042/BJ20050263; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Frirdich E, 2005, J BACTERIOL, V187, P4104, DOI 10.1128/JB.187.12.4104-4115.2005; Frisk A, 2002, J BACTERIOL, V184, P1514, DOI 10.1128/JB.184.6.1514-1521.2002; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Knirel' Iu A, 1994, Biokhimiia, V59, P1784; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM MYC, 1989, J CLIN MICROBIOL, V27, P962, DOI 10.1128/JCM.27.5.962-967.1989; LANYI B, 1970, ACTA MICROBIOL HUNG, V17, P35; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; OSHANNESSY DJ, 1987, ANAL BIOCHEM, V163, P204, DOI 10.1016/0003-2697(87)90114-X; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Rahim R, 2000, MICROBIOL-UK, V146, P2803, DOI 10.1099/00221287-146-11-2803; Rahim R, 2001, MOL MICROBIOL, V40, P708, DOI 10.1046/j.1365-2958.2001.02420.x; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; Uhrin D, 2000, NMR IN MICROBIOLOGY: THEORY AND APPLICATIONS, P165; Wenzel CQ, 2005, MOL MICROBIOL, V57, P1288, DOI 10.1111/j.1365-2958.2004.04767.x; Zhao X, 2000, J BIOL CHEM, V275, P33252, DOI 10.1074/jbc.M004191200	41	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3507	3518		10.1074/jbc.M708894200	http://dx.doi.org/10.1074/jbc.M708894200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065759	hybrid, Green Accepted			2022-12-27	WOS:000253083000056
J	Ochi, H; Hans, S; Westerfield, M				Ochi, Haruki; Hans, Stefan; Westerfield, Monte			Smarcd3 regulates the timing of zebrafish myogenesis onset	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; CHROMATIN REMODELING COMPLEX; MAMMALIAN SWI/SNF COMPLEXES; NO-TAIL; MUSCLE SPECIFICATION; GLI REGULATION; FLOOR PLATE; HEDGEHOG; EMBRYOS; MYF5	A cascade of signaling events triggers myogenesis in vertebrates. Although studies of zebrafish indicate that fibroblast growth factor (Fgf), Hedgehog (Hh), and the T-box transcription factors, No tail (Ntl) and T-box gene 16 (Tbx16), regulate myogenesis, the hierarchy of these factors has not been determined. Recently, another transcriptional cofactor, Smarcd3, a subunit of the SWI/SNF chromatin-remodeling complex, has been shown to be required for heart muscle formation in mouse. In zebrafish, fgf8 and ntl expression commences during blastula stages, whereas myogenesis, as indicated by myod expression, does not begin until much later during mid-gastrula stages. smarcd3b expression, on the other hand, becomes enriched in the marginal zone just prior to the beginning of myod expression. Overexpression of smarcd3 shifts the onset of myod and myf5 expression earlier, and myod and myf5 expression in adaxial cells, the earliest muscle precursors, requires Smarcd3, indicating that Smarcd3 is the limiting factor that regulates the onset of myogenesis. Smarcd3 physically interacts with Ntl, and Smarcd3 overexpression fails to rescue myod expression in ntl mutants, demonstrating that function of Smarcd3 depends on Ntl activity. We propose a model in which cooperative activity of Fgf, Ntl, and Smarcd3 is required for the onset of myogenesis, with Smarcd3b serving as the primary regulator of the timing of myogenesis onset.	[Ochi, Haruki; Hans, Stefan; Westerfield, Monte] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Ochi, H (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	monte@uoneuro.uoregon.edu	Ochi, Haruki/AAR-7235-2020	Ochi, Haruki/0000-0002-0088-581X	NIAMS NIH HHS [AR45575] Funding Source: Medline; NICHD NIH HHS [HD22486] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045575] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amacher SL, 2002, DEVELOPMENT, V129, P3311; Borycki AG, 1999, DEVELOPMENT, V126, P4053; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Eroglu B, 2006, DEV DYNAM, V235, P2722, DOI 10.1002/dvdy.20911; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Goering LM, 2003, P NATL ACAD SCI USA, V100, P9410, DOI 10.1073/pnas.1633548100; Gregg RG, 2003, P NATL ACAD SCI USA, V100, P6535, DOI 10.1073/pnas.0631813100; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Griffin KJP, 2003, DEV BIOL, V264, P456, DOI 10.1016/j.ydbio.2003.09.008; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Groves JA, 2005, DEVELOPMENT, V132, P4211, DOI 10.1242/dev.01958; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Hans S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-5; Hirsinger E, 2004, DEV BIOL, V275, P143, DOI 10.1016/j.ydbio.2004.07.030; Hong WY, 2004, CANCER RES, V64, P7256, DOI 10.1158/0008-5472.CAN-04-0931; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Reifers F, 1998, DEVELOPMENT, V125, P2381; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Teboul L, 2003, GENE DEV, V17, P2870, DOI 10.1101/gad.1117603; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	38	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3529	3536		10.1074/jbc.M708594200	http://dx.doi.org/10.1074/jbc.M708594200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056260	hybrid			2022-12-27	WOS:000253083000058
J	Huang, YH; Lin, Y; Brown, TE; Han, MH; Saal, DB; Neve, RL; Zukin, RS; Sorg, BA; Nestler, EJ; Malenka, RC; Dong, Y				Huang, Yanhua H.; Lin, Ying; Brown, Travis E.; Han, Ming-Hu; Saal, Daniel B.; Neve, Rachael L.; Zukin, R. Suzanne; Sorg, Barbara A.; Nestler, Eric J.; Malenka, Robert C.; Dong, Yan			CREB modulates the functional output of nucleus accumbens neurons - A critical role of N-methyl-D-aspartate glutamate receptor (NMDAR) receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTEX PYRAMIDAL NEURONS; LONG-TERM DEPRESSION; BEHAVIORAL SENSITIZATION; PREFRONTAL CORTEX; IN-VIVO; PROJECTION NEURONS; EMOTIONAL STIMULI; DOPAMINE NEURONS; COCAINE REWARD; EXPRESSION	Nucleusaccumbens(NAc) medium spiny neurons cycle between two states, a functionally inactive downstate and a functionally active upstate. Here, we show that activation of the transcription factor cAMP-response element- binding protein (CREB), a common molecular response to several drugs of abuse, increases both duration of the upstate and action potential firing during the upstate. This effect of CREB is mediated by enhanced N-methyl-D-aspartate glutamate receptor (NMDAR) function: increased CREB activity increases both NMDAR-mediated synaptic currents and surface level of NMDARs, while inhibition of NMDARs abolishes the effect of CREB on upstate duration. Furthermore, mimicking the effect of CREB by pharmacological enhancement of NMDAR function in the NAc in vivo suppressed novelty-and cocaine-elicited locomotor activity. These findings suggest that by enhancing NMDAR-mediated synaptic transmission, CREB activation promotes the proportion of time NAc neurons spend in the upstate. This effect, along with the CREB enhancement of NAc membrane excitability ( Dong, Y.,Green, T., Saal, D., Marie, H., Neve, R., Nestler, E. J., and Malenka, R. C.( 2006) Nat. Neurosci. 9,475 - 477), may counteract drug-induced maladaptations in the NAc and thus ameliorate the addictive state.	[Huang, Yanhua H.; Brown, Travis E.; Saal, Daniel B.; Sorg, Barbara A.; Dong, Yan] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Lin, Ying; Zukin, R. Suzanne] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Neve, Rachael L.] Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA; [Han, Ming-Hu] Univ Texas SW Med Ctr Dallas, Dept Psychiat & Basic Neurosci, Dallas, TX 75390 USA; [Malenka, Robert C.; Dong, Yan] Stanford Univ, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Washington State University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; McLean Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Dong, Y (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, POB 646520-VCAPP,Wegner 205, Pullman, WA 99164 USA.	yandong@vetmed.wsu.edu	Dong, Yan/A-4154-2016; Han, Ming-Hu/G-8836-2012; Huang, Yanhua/P-1583-2015	Dong, Yan/0000-0003-0016-9028; Huang, Yanhua/0000-0003-1770-0196; Sorg, Barbara/0000-0002-4913-4910	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023206] Funding Source: NIH RePORTER; NIDA NIH HHS [R37 DA023206, R01 DA023206-01A2, R01 DA023206] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barrot M, 2002, P NATL ACAD SCI USA, V99, P11435, DOI 10.1073/pnas.172091899; Brady AM, 2005, J NEUROSCI, V25, P6687, DOI 10.1523/JNEUROSCI.0643-05.2005; Brady AM, 2003, ANN NY ACAD SCI, V1003, P358, DOI 10.1196/annals.1300.026; Brebner K, 2005, SCIENCE, V310, P1340, DOI 10.1126/science.1116894; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Cain ME, 2005, EXP CLIN PSYCHOPHARM, V13, P367, DOI 10.1037/1064-1297.13.4.367; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chen BS, 2006, J BIOL CHEM, V281, P16583, DOI 10.1074/jbc.M513029200; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong Y, 2005, J NEUROSCI, V25, P936, DOI 10.1523/JNEUROSCI.4715-04.2005; Dong Y, 2006, NAT NEUROSCI, V9, P475, DOI 10.1038/nn1661; Dong Y, 2004, P NATL ACAD SCI USA, V101, P14282, DOI 10.1073/pnas.0401553101; Dong Y, 2003, J NEUROSCI, V23, P2686; Green TA, 2006, J NEUROSCI, V26, P8235, DOI 10.1523/JNEUROSCI.0880-06.2006; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; LORIAUX MM, 1994, J BIOL CHEM, V269, P28839; Mahon S, 2006, J NEUROSCI, V26, P12587, DOI 10.1523/JNEUROSCI.3987-06.2006; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; Mattson BJ, 2005, J NEUROCHEM, V95, P1481, DOI 10.1111/j.1471-4159.2005.03500.x; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neve RL, 2005, BIOTECHNIQUES, V39, P381, DOI 10.2144/05393PS01; O'Donnell P, 1999, ANN NY ACAD SCI, V877, P157, DOI 10.1111/j.1749-6632.1999.tb09267.x; ODONNELL P, 1995, J NEUROSCI, V15, P3622; ONN SP, 1994, SYNAPSE, V16, P231, DOI 10.1002/syn.890160308; Onn SP, 2000, J NEUROSCI, V20, P2332; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Plenz D, 1998, J NEUROSCI, V18, P266; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Rouaud E, 2003, BRIT J PHARMACOL, V140, P1051, DOI 10.1038/sj.bjp.0705541; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Vergara R, 2003, J PHYSIOL-LONDON, V553, P169, DOI 10.1113/jphysiol.2003.050799; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WILSON CJ, 1986, BRAIN RES, V367, P201, DOI 10.1016/0006-8993(86)91593-3; Wolf JA, 2005, J NEUROSCI, V25, P9080, DOI 10.1523/JNEUROSCI.2220-05.2005	39	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2751	2760		10.1074/jbc.M706578200	http://dx.doi.org/10.1074/jbc.M706578200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055458	Green Accepted, hybrid			2022-12-27	WOS:000252622300033
J	Mayer, G; Hamelin, J; Asselin, MC; Pasquato, A; Marcinkiewicz, E; Tang, M; Tabibzadeh, S; Seidah, NG				Mayer, Gaetan; Hamelin, Josee; Asselin, Marie-Claude; Pasquato, Antonella; Marcinkiewicz, Edwidge; Tang, Meiyi; Tabibzadeh, Siamak; Seidah, Nabil G.			The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL LIPASE; HEPARAN-SULFATE; PROTEOLYTIC ACTIVATION; ENZYME ACTIVATION; GOLGI-APPARATUS; FURIN; CLEAVAGE; ENDOPROTEASE; PROTEINS; MATRIX	The proprotein convertases are synthesized as zymogens that acquire activity upon autocatalytic removal of their NH2-terminal prosegment. Based on the convertase furin, to fold properly and gain activity, the convertases PC5A, PACE4, and PC7 are presumed to undergo two sequential prosegment cleavages in the endoplasmic reticulum and then in the trans-Golgi network. However, biochemical and immunocytochemical experiments revealed that mouse PC5A is complexed to its prosegment at the plasma membrane. This labeling is lost upon treatment with heparin and is increased by overexpressing members of the syndecan family and CD44, suggesting attachment of secreted PC5A-prosegment complex to heparan sulfate proteoglycans. Following stimulation of Y1 cells with adrenocorticotropic hormone or 8-bromo-cyclic AMP, the cell surface labeling of the prosegment of PC5A is greatly diminished, whereas the signal for mature PC5A is increased. Moreover, after stimulation, the protease activity of PC5A is enhanced, as evidenced by the cleavage of the PC5A substrates Lefty, ADAMTS-4, endothelial lipase, and PCSK9. Our data suggest a novel mechanism for PC5A activation and substrate cleavage at the cell surface, through a regulated removal of its prosegment. A similar mechanism may also apply to the convertase PACE4, thereby extending our knowledge of the molecular details of the zymogen activation and functions of these heparan sulfate proteoglycan-bound convertases.	[Mayer, Gaetan; Hamelin, Josee; Asselin, Marie-Claude; Pasquato, Antonella; Marcinkiewicz, Edwidge; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Tang, Meiyi; Tabibzadeh, Siamak] SUNY Stony Brook, Stony Brook, NY 11794 USA	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342; Pasquato, Antonella/0000-0002-9428-0722				Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bergeron E, 2005, BIOCHEM BIOPH RES CO, V326, P554, DOI 10.1016/j.bbrc.2004.11.063; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Broedl UC, 2004, TRENDS CARDIOVAS MED, V14, P202, DOI 10.1016/j.tcm.2004.03.003; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; Cui YZ, 2001, GENE DEV, V15, P2797; DeBie I, 1996, J CELL BIOL, V135, P1261, DOI 10.1083/jcb.135.5.1261; Dubois CM, 2001, AM J PATHOL, V158, P305, DOI 10.1016/S0002-9440(10)63970-3; Essalmani R, 2006, MOL CELL BIOL, V26, P354, DOI 10.1128/MCB.26.1.354-361.2006; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; GARTEN W, 1994, BIOCHIMIE, V76, P217, DOI 10.1016/0300-9084(94)90149-X; Gauster M, 2005, J LIPID RES, V46, P977, DOI 10.1194/jlr.M400500-JLR200; Goldman DC, 2006, DEVELOPMENT, V133, P1933, DOI 10.1242/dev.02368; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lander AD, 1998, MATRIX BIOL, V17, P465, DOI 10.1016/S0945-053X(98)90093-2; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; LUSSON J, 1993, P NATL ACAD SCI USA, V90, P6691, DOI 10.1073/pnas.90.14.6691; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; Mayer G, 2004, CELL TISSUE RES, V316, P55, DOI 10.1007/s00441-004-0866-x; Mayer G, 2004, J HISTOCHEM CYTOCHEM, V52, P567, DOI 10.1177/002215540405200502; Mayer G, 2003, J CELL SCI, V116, P1763, DOI 10.1242/jcs.00394; MOLLOY SS, 1994, EMBO J, V13, P18, DOI 10.1002/j.1460-2075.1994.tb06231.x; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; NAKAGAWA T, 1993, FEBS LETT, V327, P165, DOI 10.1016/0014-5793(93)80163-O; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Pisciotta L, 2006, ATHEROSCLEROSIS, V186, P433, DOI 10.1016/j.atherosclerosis.2005.08.015; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Schimmer BP, 2006, ENDOCRINOLOGY, V147, P2357, DOI 10.1210/en.2005-1526; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2002, ESSAYS BIOCHEM, V38, P79, DOI 10.1042/bse0380079; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Somerville RPT, 2004, J BIOL CHEM, V279, P35159, DOI 10.1074/jbc.M402380200; Sopory S, 2006, J BIOL CHEM, V281, P34021, DOI 10.1074/jbc.M605330200; Stawowy P, 2005, CIRCULATION, V111, P2820, DOI 10.1161/CIRCULATIONAHA.104.502617; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Sucic JF, 1999, BIOCHEM J, V339, P639, DOI 10.1042/0264-6021:3390639; Tang MY, 2005, ENDOCRINOLOGY, V146, P5313, DOI 10.1210/en.2005-0684; Taylor NA, 2003, FASEB J, V17, P1215, DOI 10.1096/fj.02-0831rev; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tsuji A, 1999, J BIOCHEM, V126, P591, DOI 10.1093/oxfordjournals.jbchem.a022491; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Xiang Y, 2000, MOL BIOL CELL, V11, P1257, DOI 10.1091/mbc.11.4.1257; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	63	68	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2373	2384		10.1074/jbc.M708763200	http://dx.doi.org/10.1074/jbc.M708763200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039650	hybrid			2022-12-27	WOS:000252501000064
J	Fu, QH; Figuera-Losada, M; Ploplis, VA; Cnudde, S; Geiger, JH; Prorok, M; Castellino, FJ				Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Cnudde, Sara; Geiger, James H.; Prorok, Mary; Castellino, Francis J.			The lack of binding of VEK-30, an internal peptide from the group a streptococcal m-like protein, PAM, to murine plasminogen is due to two amino acid replacements in the plasminogen kringle-2 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SURFACE PROTEIN; RECOMBINANT KRINGLE-1; S2 CELLS; ACTIVATION; LIGANDS; FIBRIN; GENE; IDENTIFICATION; STREPTOKINASE; ACQUISITION	VEK-30, a 30-amino acid internal peptide present within a streptococcal M-like plasminogen (Pg)-binding protein (PAM) from Gram-positive group-A streptococci (GAS), represents an epitope within PAM that shows high affinity for the lysine binding site (LBS) of the kringle-2 (K2) domain of human (h) Pg. VEK-30 does not interact with this same region of mouse (m) Pg, despite the high conservation of the mK2- and hK2-LBS. To identify the molecular basis for the species specificity of this interaction, hPg and mPg variants were generated, including an hPg chimera with the mK2 sequence and an mPg chimera containing the hK2 sequence. The binding of synthetic VEK-30 to these variants was studied by surface plasmon resonance. The data revealed that, in otherwise intact Pg, the species specificity of VEK-30 binding in these two cases is entirely dictated by two K2 residues that are different between hPg and mPg, namely, Arg-220 of hPg, which is a Gly in mPg, and Leu-222 of hPg, which is a Pro in mPg, neither of which are members of the canonical K2-LBS. Neither the activation of hPg, nor the enzymatic activity of its activated product, plasmin (hPm), are compromised by replacing these two amino acids by their murine counterparts. It is also demonstrated that hPg is more susceptible to activation to hPm after complexation with VEK-30 and that this property is greatly reduced as a result of the R220G and L222P replacements in hPg. These mechanisms for accumulation of protease activity on GAS likely contribute to the virulence of PAM(+)-GAS strains and identify targets for new therapeutic interventions.	[Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Prorok, Mary; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Fu, Qihua; Figuera-Losada, Mariana; Ploplis, Victoria A.; Prorok, Mary; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Cnudde, Sara; Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	University of Notre Dame; University of Notre Dame; Michigan State University	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, 230 Raclin Carmichael Hall, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Fu, Qihua/AAW-9989-2020	Geiger, James/0000-0002-9443-4488	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, P01HL073750, R37HL013423] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 073750, HL 013423] Funding Source: Medline; NIGMS NIH HHS [GM 0638947] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERGE A, 1993, J BIOL CHEM, V268, P25417; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHIBBER BAK, 1986, P NATL ACAD SCI USA, V83, P1237, DOI 10.1073/pnas.83.5.1237; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; DEVRIES C, 1990, J BIOL CHEM, V265, P13547; FLEURY V, 1993, EUR J BIOCHEM, V216, P549, DOI 10.1111/j.1432-1033.1993.tb18173.x; FLEURY V, 1993, FIBRINOLYSIS, V7, P87, DOI 10.1016/0268-9499(93)90028-T; HOOVER GJ, 1993, BIOCHEMISTRY-US, V32, P10936, DOI 10.1021/bi00092a002; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; LOTTENBERG R, 1987, INFECT IMMUN, V55, P1914, DOI 10.1128/IAI.55.8.1914-1918.1987; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; MENHART N, 1991, BIOCHEMISTRY-US, V30, P1948, DOI 10.1021/bi00221a031; MENHART N, 1995, BIOCHEMISTRY-US, V34, P1482, DOI 10.1021/bi00005a003; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1988, J BIOL CHEM, V263, P11928; Monroy V, 2000, INFECT IMMUN, V68, P4327, DOI 10.1128/IAI.68.7.4327-4330.2000; Nilsen SL, 1999, J BIOL CHEM, V274, P22380, DOI 10.1074/jbc.274.32.22380; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Ploplis VA, 2002, THROMB HAEMOSTASIS, V87, P22, DOI 10.1055/s-0037-1612938; Ploplis VA, 2001, FRONT BIOSCI-LANDMRK, V6, pD555, DOI 10.2741/Ploplis; Ploplis VA, 2000, METHODS, V21, P103, DOI 10.1006/meth.2000.0981; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Schenone MM, 2000, J PEPT RES, V56, P438, DOI 10.1034/j.1399-3011.2000.00810.x; Schroeder B, 1999, INFECT IMMUN, V67, P6487; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; URANO T, 1987, P NATL ACAD SCI USA, V84, P4031, DOI 10.1073/pnas.84.12.4031; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	36	17	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1580	1587		10.1074/jbc.M705063200	http://dx.doi.org/10.1074/jbc.M705063200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039665	hybrid			2022-12-27	WOS:000252282700043
J	Hertel, KJ				Hertel, Klemens J.			Combinatorial control of exon recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PRE-MESSENGER-RNA; SPINAL MUSCULAR-ATROPHY; GENOME-WIDE ANALYSIS; SPLICING ENHANCERS; HNRNP A1; IDENTIFICATION; SPLICEOSOME; MECHANISMS; SEQUENCES	Pre-mRNA splicing is a fundamental process required for the expression of most metazoan genes. It is carried out by the spliceosome, which catalyzes the removal of noncoding intronic sequences to assemble exons into mature mRNAs prior to export and translation. Given the complexity of higher eukaryotic genes and the relatively low level of splice site conservation, the precision of the splicing machinery in recognizing and pairing splice sites is impressive. Introns ranging in size from < 100 up to 100,000 bases are removed efficiently. At the same time, a large number of alternative splicing events are observed between different cell types, during development, or during other biological processes. This extensive alternative splicing implies a significant flexibility of the spliceosome to identify and process exons within a given pre-mRNA. To reach this flexibility, splice site selection in higher eukaryotes has evolved to depend on multiple parameters such as splice site strength, the presence or absence of splicing regulators, RNA secondary structures, the exon/intron architecture, and the process of pre-mRNA synthesis itself. The relative contributions of each of these parameters control how efficiently splice sites are recognized and flanking introns are removed.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hertel, KJ (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Med Sci 1,Rm 233, Irvine, CA 92697 USA.	khertel@uci.edu		Hertel, Klemens/0000-0002-7560-9529	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM062287, GM 62287] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boue S, 2003, BIOESSAYS, V25, P1031, DOI 10.1002/bies.10371; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fox-Walsh KL, 2005, P NATL ACAD SCI USA, V102, P16176, DOI 10.1073/pnas.0508489102; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Reed R, 1996, CURR OPIN GENET DEV, V6, P215, DOI 10.1016/S0959-437X(96)80053-0; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Sterner DA, 1996, P NATL ACAD SCI USA, V93, P15081, DOI 10.1073/pnas.93.26.15081; Tange TO, 2001, EMBO J, V20, P5748; Tardiff DF, 2006, MOL CELL, V24, P917, DOI 10.1016/j.molcel.2006.12.002; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	42	150	155	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1211	1215		10.1074/jbc.R700035200	http://dx.doi.org/10.1074/jbc.R700035200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024426	hybrid, Green Published			2022-12-27	WOS:000252282700002
J	Woo, CWH; Siow, YL; Karmin, O				Woo, Connie W. H.; Siow, Yaw L.; Karmin, O.			Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-KAPPA-B; FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; ACUTE CORONARY SYNDROMES; ENDOTHELIAL-CELLS; SYSTEMIC INFLAMMATION; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; VASCULAR-DISEASE; MCP-1 EXPRESSION	Hyperhomocysteinemia is characterized by abnormally high concentrations of homocysteine (Hcy) in the plasma. It is a metabolic disorder associated with dysfunction of several organs such as atherosclerosis, altered lipid metabolism, and liver injury. In this study we investigated the effect of Hcy on transcriptional regulation of monocyte chemoattractant protein-1 (MCP-1), a potent chemokine, expression in hepatocytes. Hyperhomocysteinemia was induced in rats by a high-methionine diet for 4 weeks. MCP-1 mRNA and protein levels were significantly elevated in the liver tissue homogenate and in hepatocytes of hyperhomocysteinemic rats. The role of transcription factors in MCP-1 expression was examined by electrophoretic mobility shift assay. Activation of activator protein (AP)-1 but not nuclear factor kappa B was detected in the liver tissue of those rats. Incubation of rat hepatocytes with Hcy ( 50-200 mu M) caused a significant increase in AP-1 activation followed by an increase in intracellular MCP-1 mRNA expression and an elevation of MCP-1 protein secreted into the culture medium. Hcy markedly increased the DNA binding activity of human recombinant AP-1 (c-Fos and c-Jun proteins). The presence of a sulfhydryl group in Hcy was essential for Hcy-induced AP-1 activation. When hepatocytes were transfected with decoy AP-1 oligodeoxynucleotide to inhibit AP-1 activation, Hcy-induced MCP-1 mRNA expression was abolished. Further analysis revealed that increased hepatic MCP-1 expression was positively correlated with the serum MCP-1 level. These results suggest that Hcy-induced MCP-1 expression in the liver is mediated via AP-1 activation, which may contribute to chronic inflammation associated with hyperhomocysteinemia.	[Woo, Connie W. H.; Siow, Yaw L.; Karmin, O.] Univ Manitoba, Canadian Ctr Agrifood Res Hlth & Med, St Boniface Gen Hosp, Res Ctr,Dept Anim Sci & Physiol, Winnipeg, MB R2H 2A6, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba	Karmin, O (corresponding author), Univ Manitoba, Canadian Ctr Agrifood Res Hlth & Med, St Boniface Gen Hosp, Res Ctr,Dept Anim Sci & Physiol, 351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	karmino@sbrc.ca	Woo, Connie/AAX-2588-2020	Woo, Connie Wai Hong/0000-0002-9574-9828; O, Karmin/0000-0002-2163-9458; Siow, Yaw/0000-0001-6623-2881				ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Au-Yeung KKW, 2004, CIRC RES, V94, P28, DOI 10.1161/01.RES.0000108264.67601.2C; Beauchamp MC, 2002, DIABETES, V51, P1180, DOI 10.2337/diabetes.51.4.1180; Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bukara M, 2000, ALCOHOL, V20, P193, DOI 10.1016/S0741-8329(99)00100-7; CARSON NAJ, 1965, J PEDIATR-US, V66, P565, DOI 10.1016/S0022-3476(65)80121-4; Choudhury JA, 2003, MOL BIOL CELL, V14, P1334, DOI 10.1091/mbc.E02-07-0378; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; de Lemos JA, 2003, CIRCULATION, V107, P690, DOI 10.1161/01.CIR.0000049742.68848.99; Drunat S, 2002, FREE RADICAL BIO MED, V33, P659, DOI 10.1016/S0891-5849(02)00957-7; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Gao CH, 1999, HEPATOLOGY, V30, P1405, DOI 10.1002/hep.510300602; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hung MJ, 2006, AM J CARDIOL, V97, P1429, DOI 10.1016/j.amjcard.2005.12.035; JACOBSEN DW, 2000, HOMOCYSTEINE VASCULA; Ji C, 2003, GASTROENTEROLOGY, V124, P1488, DOI 10.1016/S0016-5085(03)00276-2; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kanno K, 2005, DIGEST DIS SCI, V50, P942, DOI 10.1007/s10620-005-2669-7; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a; Kuboki S, 2007, AM J PHYSIOL-GASTR L, V292, pG201, DOI 10.1152/ajpgi.00186.2006; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; MCCULLY KS, 1969, AM J PATHOL, V56, P111; Mikael LG, 2006, CIRC RES, V98, P564, DOI 10.1161/01.RES.0000204825.66410.0b; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Paxian M, 2002, ANTIOXID REDOX SIGN, V4, P711, DOI 10.1089/152308602760598855; Polytarchou C, 2005, J BIOL CHEM, V280, P40428, DOI 10.1074/jbc.M505120200; RACKER E, 1955, J BIOL CHEM, V217, P867; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Siendones E, 2004, HEPATOLOGY, V40, P1295, DOI 10.1002/hep.20448; Sung FL, 2001, MOL CELL BIOCHEM, V216, P121, DOI 10.1023/A:1017383916068; Suzuki F, 1998, J BIOL CHEM, V273, P29302, DOI 10.1074/jbc.273.45.29302; Suzuki YJ, 2000, FREE RADICAL BIO MED, V28, P39, DOI 10.1016/S0891-5849(99)00200-2; Targher G, 2007, ATHEROSCLEROSIS, V190, P18, DOI 10.1016/j.atherosclerosis.2006.06.004; Wang GP, 2002, ARTERIOSCL THROM VAS, V22, P1777, DOI 10.1161/01.ATV.0000035404.18281.37; Wang GP, 2000, BIOCHEM J, V352, P817, DOI 10.1042/0264-6021:3520817; Wang GP, 2001, AM J PHYSIOL-HEART C, V280, pH2840, DOI 10.1152/ajpheart.2001.280.6.H2840; Wang NP, 1999, ARTERIOSCL THROM VAS, V19, P2078, DOI 10.1161/01.ATV.19.9.2078; Wang YP, 2000, KIDNEY INT, V57, P2011, DOI 10.1046/j.1523-1755.2000.00051.x; WEINSTEIN CL, 1988, J BIOL CHEM, V263, P16568; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Woo CWH, 2006, BBA-MOL BASIS DIS, V1762, P656, DOI 10.1016/j.bbadis.2006.05.012; Woo CWH, 2006, ARTERIOSCL THROM VAS, V26, P1043, DOI 10.1161/01.ATV.0000214981.58499.32; Woo CWH, 2005, AM J PHYSIOL-ENDOC M, V288, pE1002, DOI 10.1152/ajpendo.00518.2004; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3	54	28	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1282	1292		10.1074/jbc.M707886200	http://dx.doi.org/10.1074/jbc.M707886200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024959	hybrid			2022-12-27	WOS:000252282700011
J	Li, XL; Su, V; Kurata, WE; Jin, C; Lau, AF				Li, Xinli; Su, Vivian; Kurata, Wendy E.; Jin, Chengshi; Lau, Alan F.			A novel connexin43-interacting protein, CIP75, which belongs to the UbL-UBA protein family, regulates the turnover of connexin43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; UBIQUITIN-LIKE PROTEIN; PROTEASOME-DEPENDENT DEGRADATION; DAMAGE-INDUCIBLE PROTEINS; EPITHELIAL NA+ CHANNEL; CARDIAC MYOCYTES; INTERCELLULAR COMMUNICATION; LIDDLES-SYNDROME; 26S PROTEASOME; LIGASE NEDD4	The degradation of connexin43 (Cx43) has been reported to involve both lysosomal and proteasomal degradation pathways; however, very little is known about the mechanisms regulating these Cx43 degradation pathways. Using yeast two-hybrid, glutathione S-transferase pull-down, and co-immunoprecipitation approaches, we have identified a novel Cx43-interacting protein of similar to 75 kDa, CIP75. Laser confocal microscopy showed that CIP75 is located primarily at the endoplasmic reticulum, as indicated by the calnexin marker, with Cx43 co-localization in this perinuclear region. CIP75 belongs to the UbL (ubiquitin-like)-UBA (ubiquitin-associated) domain-containing protein family with a N-terminal UbL domain and a C-terminal UBA domain. The UBA domain of CIP75 is the main element mediating the interaction with Cx43, whereas the CIP75-interacting region in Cx43 resides in the PY motif and multiphosphorylation sites located between Lys(264) and Asn(302). Interestingly, the UbL domain interacts with the S2/RPN1 and S5a/RPN10 protein subunits of the regulatory 19 S proteasome cap subunit of the 26 S proteasome complex. Overexpression experiments suggested that CIP75 is involved in the turnover of Cx43 as measured by a significant stimulation of Cx43 degradation and reduction in its half-life with the opposite effects on Cx43 degradation observed in small interference RNA knockdown experiments.	[Li, Xinli; Su, Vivian; Kurata, Wendy E.; Lau, Alan F.] Canc Res Ctr Hawaii, Natl Prod & Canc Biol Program, Honolulu, HI 96813 USA; [Jin, Chengshi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lau, Alan F.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii Manoa	Lau, AF (corresponding author), Canc Res Ctr Hawaii, Natl Prod & Canc Biol Program, 651 Ilalo St,BSB 222L, Honolulu, HI 96813 USA.	aflau@crch.hawaii.edu	LI, XINLI/Q-6808-2019		NATIONAL CANCER INSTITUTE [R01CA052098] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA052098-18, R01 CA052098, CA052098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Girao H, 2003, MOL VIS, V9, P24; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JIN C, 1998, CHARACTERIZATION NOV, P230; Jin CS, 2000, METHODS, V20, P219, DOI 10.1006/meth.1999.0939; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lambertson D, 2003, CURR GENET, V42, P199, DOI 10.1007/s00294-002-0350-7; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Matsuda M, 2001, BIOCHEM BIOPH RES CO, V280, P535, DOI 10.1006/bbrc.2000.4149; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Rutz ML, 2001, EUR J CELL BIOL, V80, P20, DOI 10.1078/0171-9335-00140; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	66	54	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5748	5759		10.1074/jbc.M709288200	http://dx.doi.org/10.1074/jbc.M709288200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18079109	hybrid, Green Accepted			2022-12-27	WOS:000253426700056
J	Kraut-Cohen, J; Muller, WJ; Elson, A				Kraut-Cohen, Judith; Muller, William J.; Elson, Ari			Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner - Increasing coherence in tyrosine phosphatase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PTP-EPSILON; PHOSPHORYLATION SITES; C-SRC; INSULIN SENSITIVITY; CYTOPLASMIC FORMS; ADAPTER PROTEIN; MICE LACKING; HUMAN GENOME; IN-VIVO	Individual protein tyrosine kinases and phosphatases target multiple substrates; this may generate conflicting signals, possibly within a single pathway. Protein-tyrosine phosphatase epsilon (PTP epsilon) performs two potentially opposing roles: in Neu-induced mammary tumors, PTP epsilon activates Src downstream of Neu, whereas in other systems PTP epsilon can indirectly down-regulate MAP kinase signaling. We now show that the latter effect is mediated at least in part via the adaptor protein Shc. PTP epsilon binds and dephosphorylates Shc in vivo, reducing the association of Shc with Grb2 and inhibiting downstream ERK activation. PTP epsilon binds Shc in a phosphotyrosine-independent manner mediated by the Shc PTB domain and aided by a sequence of 10 N-terminal residues in PTP epsilon. Surprisingly, PTP epsilon dephosphorylates Shc in a kinase-dependent manner; PTP epsilon targets Shc in the presence of Src but not in the presence of Neu. Using a series of point mutants of Shc and Neu, we show that Neu protects Shc from dephosphorylation by binding the PTB domain of Shc, most likely competing against PTP epsilon for binding the same domain. In agreement, PTP epsilon dephosphorylates Shc in mouse embryo fibroblasts but not in Neu-induced mammary tumor cells. We conclude that in the context of Neu-induced mammary tumor cells, Neu prevents PTP epsilon from targeting Shc and from reducing its promitogenic signal while phosphorylating PTP epsilon and directing it to activate Src in support of mitogenesis. In so doing, Neu contributes to the coherence of the promitogenic role of PTP epsilon in this system.	[Kraut-Cohen, Judith; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Muller, William J.] McGill Univ, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; [Muller, William J.] McGill Univ, Dept Biochem & Med, Montreal, PQ H3A 1A1, Canada	Weizmann Institute of Science; McGill University; McGill University	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135				AGAMIZRACHI S, 2007, IN PRESS ENDOCRINOLO; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, BIOCHEM J, V354, P581, DOI 10.1042/0264-6021:3540581; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gil-Henn H, 2000, ONCOGENE, V19, P4375, DOI 10.1038/sj.onc.1203790; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kraut J, 2002, EXP CELL RES, V281, P182, DOI 10.1006/excr.2002.5661; Lai KMV, 2000, GENE DEV, V14, P1132; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Nakamura K, 1996, BIOCHEM BIOPH RES CO, V218, P726, DOI 10.1006/bbrc.1996.0129; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Purdom S, 2003, TRENDS MOL MED, V9, P206, DOI 10.1016/S1471-4914(03)00048-0; Rauh MJ, 1999, MOL CELL BIOL, V19, P8169; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; RICCI A, 1995, ONCOGENE, V11, P1519; Sato K, 2005, J BIOCHEM, V137, P61, DOI 10.1093/jb/mvi011; Sato K, 1997, BIOCHEM BIOPH RES CO, V240, P399, DOI 10.1006/bbrc.1997.7667; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tanuma N, 2003, ONCOGENE, V22, P1758, DOI 10.1038/sj.onc.1206267; Thompson LJ, 2001, AM J PHYSIOL-HEART C, V281, pH396, DOI 10.1152/ajpheart.2001.281.1.H396; Toledano-Katchalski H, 1999, ONCOGENE, V18, P5024, DOI 10.1038/sj.onc.1202883; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Toledano-Katchalski H, 2003, MOL CANCER RES, V1, P541; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; van der Wijk T, 2005, METHODS, V35, P73, DOI 10.1016/j.ymeth.2004.07.010; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200	55	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4612	4621		10.1074/jbc.M708822200	http://dx.doi.org/10.1074/jbc.M708822200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093973	hybrid			2022-12-27	WOS:000253426500018
J	Ouellet, H; Podust, LM; de Montellano, PRO				Ouellet, Hugues; Podust, Larissa M.; de Montellano, Paul R. Ortiz			Mycobacterium tuberculosis CYP130 - Crystal structure, biophysical characterization, and interactions with antifungal azole drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 REDUCTASE; ANTIMYCOBACTERIAL ACTIVITY; CATALYTIC-ACTIVITY; LIVER-MICROSOMES; EFFLUX PUMP; SYSTEMS; COMPLEX; BINDING; PURIFICATION; CHOLESTEROL	CYP130 is one of the 20 Mycobacterium tuberculosis cytochrome P450 enzymes, only two of which, CYP51 and CYP121, have so far been studied as individually expressed proteins. Here we characterize a third heterologously expressed M. tuberculosis cytochrome P450, CYP130, by UV-visible spectroscopy, isothermal titration calorimetry, and x-ray crystallography, including determination of the crystal structures of ligand-free and econazole-bound CYP130 at a resolution of 1.46 and 3.0 angstrom, respectively. Ligand-free CYP130 crystallizes in an '' open '' conformation as a monomer, whereas the econazole-bound form crystallizes in a '' closed '' conformation as a dimer. Conformational changes enabling the '' open-closed '' transition involve repositioning of the BC-loop and the F and G helices that envelop the inhibitor in the binding site and reshape the protein surface. Crystal structure analysis shows that the portion of the BC-loop relocates as much as 18 angstrom between the open and closed conformations. Binding of econazole to CYP130 involves a conformational change and is mediated by both a set of hydrophobic interactions with amino acid residues in the active site and coordination of the heme iron. CYP130 also binds miconazole with virtually the same binding affinity as econazole and clotrimazole and ketoconazole with somewhat lower affinities, which makes it a plausible target for this class of therapeutic drugs. Overall, binding of the azole inhibitors is a sequential two-step, entropy-driven endothermic process. Binding of econazole and clotrimazole exhibits positive cooperativity that may reflect a propensity of CYP130 to associate into a dimeric structure.	[Ouellet, Hugues; Podust, Larissa M.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	NIAID NIH HHS [R01 AI74824, R01 AI074824, R01 AI074824-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM025515, R01 GM25515, R01 GM078553, R37 GM025515, R01 GM078553-01, R01 GM025515-26] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078553, R01GM025515, R37GM025515] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Ainsa JA, 1998, J BACTERIOL, V180, P5836; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; BACKES WL, 1989, J BIOL CHEM, V264, P6252; Banfi E, 2006, J ANTIMICROB CHEMOTH, V58, P76, DOI 10.1093/jac/dkl182; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cawley GF, 2001, DRUG METAB DISPOS, V29, P1529; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Hazai E, 2005, J COMPUT AID MOL DES, V19, P271, DOI 10.1007/s10822-005-4995-4; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; Job P, 1928, ANN CHIM FRANCE, V9, P113; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patchkovskii S, 2000, INORG CHEM, V39, P5354, DOI 10.1021/ic0005691; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2003, J BIOL CHEM, V278, P12214, DOI 10.1074/jbc.M212210200; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Xiang H, 2000, J BIOL CHEM, V275, P35999, DOI 10.1074/jbc.M005811200; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120; Yoon MY, 2004, DRUG METAB REV, V36, P219, DOI 10.1081/DMR-120033998; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200	53	72	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5069	5080		10.1074/jbc.M708734200	http://dx.doi.org/10.1074/jbc.M708734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089574	Green Accepted, hybrid			2022-12-27	WOS:000253426500064
J	Connell, CM; Colnaghi, R; Wheatley, SP				Connell, Claire M.; Colnaghi, Rita; Wheatley, Sally P.			Nuclear survivin has reduced stability and is not cytoprotective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICE VARIANTS; SUBCELLULAR-LOCALIZATION; AURORA-B; DEGRADATION; PROTEIN; APOPTOSIS; MITOSIS; EXPORT; PHOSPHORYLATION; EXPRESSION	Survivin is an essential mitotic protein that is overexpressed in many cancers, and its presence is correlated with increased resistance to radiation and chemotherapy. Here we demonstrate that sending survivin into the nucleus accelerates its degradation in a cdh1-dependent manner, abolishes the radio resistance normally conferred to cells by its overexpression, and prevents survivin from inhibiting apoptosis without affecting its mitotic localization. Our data suggest that targeting survivin to the nucleus provides an efficient means of eliminating it from the cell and may prove a novel strategy in cancer treatment, particularly in combination with radiotherapy.	[Connell, Claire M.; Colnaghi, Rita; Wheatley, Sally P.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Wheatley, SP (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	s.p.wheatley@sussex.ac.uk			Medical Research Council [G0300662B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Colnaghi R, 2006, J BIOL CHEM, V281, P33450, DOI 10.1074/jbc.C600164200; Joseph TW, 2003, FASEB J, V17, P1622, DOI 10.1096/fj.02-0931com; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Knauer SK, 2007, FASEB J, V21, P207, DOI 10.1096/fj.06-5741com; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Mahotka C, 1999, CANCER RES, V59, P6097; Mahotka C, 2002, CELL DEATH DIFFER, V9, P1334, DOI 10.1038/sj.cdd.4401091; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; Munoz-Fontela C, 2003, BIOCHEM J, V374, P545, DOI 10.1042/BJ20021890; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Rodriguez JA, 2006, ONCOGENE, V25, P4867, DOI 10.1038/sj.onc.1209499; Rodriguez JA, 2002, EXP CELL RES, V275, P44, DOI 10.1006/excr.2002.5492; Stauber RH, 2006, TRAFFIC, V7, P1461, DOI 10.1111/j.1600-0854.2006.00486.x; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Temme A, 2007, CANCER LETT, V250, P177, DOI 10.1016/j.canlet.2006.09.020; Weinstein J, 1997, J BIOL CHEM, V272, P28501, DOI 10.1074/jbc.272.45.28501; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Zhao J, 2000, J CELL SCI, V113, P4363; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	24	61	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3289	3296		10.1074/jbc.M704461200	http://dx.doi.org/10.1074/jbc.M704461200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057009	hybrid, Green Accepted			2022-12-27	WOS:000253083000033
J	Lehner, I; Basting, D; Meyer, B; Haase, W; Manolikas, T; Kaiser, C; Karas, M; Glaubitz, C				Lehner, Ines; Basting, Daniel; Meyer, Bjoern; Haase, Winfried; Manolikas, Theofanis; Kaiser, Christoph; Karas, Michael; Glaubitz, Clemens			The key residue for substrate transport (Glu(14)) in the EmrE dimer is asymmetric	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL MULTIDRUG TRANSPORTER; CARBON-CARBON CONNECTIVITIES; ANTISEPTIC-RESISTANCE GENES; CELL-FREE EXPRESSION; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; SECONDARY STRUCTURE; LIGAND-BINDING; EFFLUX PUMP; ANTIPORTER	Transport proteins exhibiting broad substrate specificities are major determinants for the phenomenon of multidrug resistance. The Escherichia coli multidrug transporter EmrE, a 4-transmembrane, helical 12-kDa membrane protein, forms a functional dimer to transport a diverse array of aromatic, positively charged substrates in a proton/drug antiport fashion. Here, we report C-13 chemical shifts of the essential residue Glu(14) within the binding pocket. To ensure a native environment, EmrE was reconstituted into E. coli lipids. Experiments were carried out using one- and two-dimensional double quantum filtered C-13 solid state NMR. For an unambiguous assignment of Glu(14), an E25A mutation was introduced to create a single glutamate mutant. Glu(14) was C-13-labeled using cell-free expression. Purity, labeling, homogeneity, and functionality were probed by mass spectrometry, NMR spectroscopy, freeze fracture electron microscopy, and transport assays. For Glu(14), two distinct sets of chemical shifts were observed that indicates structural asymmetry in the binding pocket of homodimeric EmrE. Upon addition of ethidium bromide, chemical shift changes and altered line shapes were observed, demonstrating substrate coordination by both Glu(14) in the dimer.	[Lehner, Ines; Basting, Daniel; Manolikas, Theofanis; Kaiser, Christoph; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Lehner, Ines; Manolikas, Theofanis; Kaiser, Christoph; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Haase, Winfried] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society	Glaubitz, C (corresponding author), Max Von Laue Str 9, D-60438 Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Glaubitz, Clemens/D-5714-2011	Glaubitz, Clemens/0000-0002-3554-6586				Alam MM, 2003, MICROB DRUG RESIST, V9, P109, DOI 10.1089/107662903765826697; Arkin IT, 1996, BIOCHEMISTRY-US, V35, P7233, DOI 10.1021/bi960094i; Basting D, 2008, FASEB J, V22, P365, DOI 10.1096/fj.07-9162com; Betz M, 2004, BIOCHEMISTRY-US, V43, P5820, DOI 10.1021/bi049948m; Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009; Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014; Carravetta M, 2001, J AM CHEM SOC, V123, P10628, DOI 10.1021/ja016027f; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; DROBNY G, 1979, FARADAY DIV CHEM SOC, V13, P49; Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; GRINIUS LL, 1994, J BIOL CHEM, V269, P29998; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Hong M, 2003, BIOPOLYMERS, V70, P158, DOI 10.1002/bip.10431; Jack DL, 2000, J BACTERIOL, V182, P2311, DOI 10.1128/JB.182.8.2311-2313.2000; Kikukawa T, 2006, BBA-BIOMEMBRANES, V1758, P673, DOI 10.1016/j.bbamem.2006.04.004; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Kobayashi M, 2006, J BIOMOL NMR, V36, P279, DOI 10.1007/s10858-006-9094-x; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Krupka RM, 1999, J MEMBRANE BIOL, V167, P35, DOI 10.1007/s002329900469; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; Lesage A, 1999, J AM CHEM SOC, V121, P10987, DOI 10.1021/ja992272b; Lesage A, 1997, J AM CHEM SOC, V119, P7867, DOI 10.1021/ja971089k; Masaoka Y, 2000, J BACTERIOL, V182, P2307, DOI 10.1128/JB.182.8.2307-2310.2000; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Ninio S, 2004, FEBS LETT, V562, P193, DOI 10.1016/S0014-5793(04)00240-6; Ninio S, 2003, J BIOL CHEM, V278, P12000, DOI 10.1074/jbc.M213119200; Noguchi N, 1999, FEMS MICROBIOL LETT, V172, P247, DOI 10.1111/j.1574-6968.1999.tb13475.x; PAULSEN IT, 1995, J BACTERIOL, V177, P2827, DOI 10.1128/jb.177.10.2827-2833.1995; PEROZO E, 1993, BIOCHEMISTRY-US, V32, P10471, DOI 10.1021/bi00090a025; Poget SF, 2007, J AM CHEM SOC, V129, P2432, DOI 10.1021/ja0679836; Poget SF, 2006, J BIOMOL NMR, V36, P10, DOI 10.1007/s10858-005-5346-4; Poole K, 2002, J APPL MICROBIOL, V92, p55S, DOI 10.1046/j.1365-2672.92.5s1.8.x; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Ratnala VRP, 2007, J AM CHEM SOC, V129, P867, DOI 10.1021/ja0652262; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Sachs RK, 2003, J BIOL CHEM, V278, P44222, DOI 10.1074/jbc.M307148200; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Schwaiger M, 1998, EUR J BIOCHEM, V254, P610, DOI 10.1046/j.1432-1327.1998.2540610.x; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sikora CW, 2005, BIOPHYS J, V88, P475, DOI 10.1529/biophysj.104.049247; Soskine M, 2004, J BIOL CHEM, V279, P9951, DOI 10.1074/jbc.M312853200; Soskine M, 2002, P NATL ACAD SCI USA, V99, P12043, DOI 10.1073/pnas.192392899; Soskine M, 2006, J BIOL CHEM, V281, P36205, DOI 10.1074/jbc.M607186200; Straus SK, 1998, J BIOMOL NMR, V12, P39, DOI 10.1023/A:1008280716360; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Tate CG, 2001, EMBO J, V20, P77, DOI 10.1093/emboj/20.1.77; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; VANIWAARDEN PR, 1993, BIOCHEMISTRY-US, V32, P5419, DOI 10.1021/bi00071a017; WANG J, 1994, P NATL ACAD SCI USA, V91, P7242, DOI 10.1073/pnas.91.15.7242; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yerushalmi H, 2001, J BIOL CHEM, V276, P12744, DOI 10.1074/jbc.M010979200; Yerushalmi H, 1996, J BIOL CHEM, V271, P31044, DOI 10.1074/jbc.271.49.31044; Zhang FL, 2005, J MAGN RESON, V174, P219, DOI 10.1016/j.jmr.2005.02.013; Zhang ZG, 2007, BIOCHEMISTRY-US, V46, P5218, DOI 10.1021/bi7001604	65	43	43	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3281	3288		10.1074/jbc.M707899200	http://dx.doi.org/10.1074/jbc.M707899200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18042544	hybrid			2022-12-27	WOS:000253083000032
J	Watanabe, N; Lam, E				Watanabe, Naohide; Lam, Eric			BAX inhibitor-1 modulates endoplasmic reticulum stress-mediated programmed cell death in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; SYSTEMIC ACQUIRED-RESISTANCE; CHEMICAL CHAPERONES; MOLECULAR CHARACTERIZATION; PLANT HOMOLOG; ORYZA-SATIVA; BARLEY ROOTS; SALT STRESS; APOPTOSIS; YEAST	The components and pathways that regulate programmed cell death (PCD) in plants remain poorly understood. Here we describe the impact of drug-induced endoplasmic reticulum ( ER) stress on Arabidopsis seedlings and present evidence for the role of Arabidopsis BAX inhibitor-1 (AtBI1) as a modulator of ER stress-mediated PCD. We found that treatment of Arabidopsis seedlings with tunicamycin (TM), an inhibitor of N-linked glycosylation and an inducer of ER stress by triggering accumulation of unfolded proteins in the ER, results in strong inhibition of root growth and loss of survival accompanied by typical hallmarks of PCD such as accumulation of H2O2, chromatin condensation, and oligonucleosomal fragmentation of nuclear DNA. These phenotypes are alleviated by co-treatment with either of two different chemical chaperones, sodium 4-phenylbutyrate and tauroursodeoxycholic acid, both with chaperone properties that can reduce the load of misfolded protein in the ER. Expression of AtBI1 mRNA and its promoter activity are increased dramatically prior to initiation of TM-induced PCD. Compared with wild-type plants, two AtBI1 mutants (atbi1-1 and atbi1-2) exhibit hypersensitivity to TM with accelerated PCD progression. Conversely, overexpressing AtBI1 markedly reduces the sensitivity of Arabidopsis seedlings to TM. However, alterations in AtBI1 gene expression levels do not cause a significant effect on the expression patterns of typical ER stress-inducible genes (AtBip2, AtPDI, AtCRT1, and AtCNX1). We propose that AtBI1 plays a pivotal role as a highly conserved survival factor during ER stress that acts in parallel to the unfolded protein response pathway.	[Watanabe, Naohide; Lam, Eric] Rutgers State Univ, Biotechnol Ctr Agr & Environm, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lam, E (corresponding author), Rutgers State Univ, Biotechnol Ctr Agr & Environm, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	lam@aesop.rutgers.edu						Baek D, 2004, PLANT MOL BIOL, V56, P15, DOI 10.1007/s11103-004-3096-4; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bolduc N, 2003, PLANTA, V216, P377, DOI 10.1007/s00425-002-0879-1; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; Chae HJ, 2003, GENE, V323, P101, DOI 10.1016/j.gene.2003.09.011; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crosti P, 2001, PROTOPLASMA, V216, P31, DOI 10.1007/BF02680128; Danon A, 2004, J BIOL CHEM, V279, P779, DOI 10.1074/jbc.M304468200; de Almeida SF, 2007, J BIOL CHEM, V282, P27905, DOI 10.1074/jbc.M702672200; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Gallois P, 1997, PLANT J, V11, P1325, DOI 10.1046/j.1365-313X.1997.11061325.x; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huckelhoven R, 2003, P NATL ACAD SCI USA, V100, P5555, DOI 10.1073/pnas.0931464100; Huh GH, 2002, PLANT J, V29, P649, DOI 10.1046/j.0960-7412.2001.01247.x; Ihara-Ohori Y, 2007, PLANT PHYSIOL, V143, P650, DOI 10.1104/pp.106.090878; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Iwata Y, 2005, PLANTA, V220, P804, DOI 10.1007/s00425-004-1479-z; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jelitto-Van Dooren EPWM, 1999, PLANT CELL, V11, P1935, DOI 10.2307/3871088; Jin C, 2002, NAT REV MOL CELL BIO, V3, P453, DOI 10.1038/nrm832; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Katsuhara M, 1997, PLANT CELL PHYSIOL, V38, P1091, DOI 10.1093/oxfordjournals.pcp.a029277; Katsuhara M, 1996, PLANT CELL PHYSIOL, V37, P169, DOI 10.1093/oxfordjournals.pcp.a028928; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kawai M, 1999, FEBS LETT, V464, P143, DOI 10.1016/S0014-5793(99)01695-6; Kawai-Yamada M, 2005, J BIOL CHEM, V280, P39468, DOI 10.1074/jbc.M509632200; Kawai-Yamada M, 2004, PLANT CELL, V16, P21, DOI 10.1105/tpc.014613; Kawai-Yamada M, 2001, P NATL ACAD SCI USA, V98, P12295, DOI 10.1073/pnas.211423998; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Koizumi N, 2001, PLANT PHYSIOL, V127, P949, DOI 10.1104/pp.010636; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329; Lee GH, 2007, J BIOL CHEM, V282, P21618, DOI 10.1074/jbc.M700053200; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okushima Y, 2002, PLANT CELL PHYSIOL, V43, P532, DOI 10.1093/pcp/pcf063; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; PULLEN GR, 1981, J IMMUNOL METHODS, V43, P87, DOI 10.1016/0022-1759(81)90039-9; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Welch WJ, 1996, CELL STRESS CHAPERON, V1, P109, DOI 10.1379/1466-1268(1996)001<0109:IOMACC>2.3.CO;2; Westphalen BC, 2005, CELL DEATH DIFFER, V12, P304, DOI 10.1038/sj.cdd.4401547; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zuppini A, 2004, J CELL SCI, V117, P2591, DOI 10.1242/jcs.01126	60	162	170	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3200	3210		10.1074/jbc.M706659200	http://dx.doi.org/10.1074/jbc.M706659200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039663	hybrid			2022-12-27	WOS:000253083000023
J	Osborne, SL; Wen, PJ; Boucheron, C; Nguyen, HN; Hayakawa, M; Kaizawa, H; Parker, PJ; Vitale, N; Meunier, FA				Osborne, Shona L.; Wen, Peter J.; Boucheron, Christine; Nguyen, Hao N.; Hayakawa, Masahiko; Kaizawa, Hiroyuki; Parker, Peter J.; Vitale, Nicolas; Meunier, Frederic A.			PIKfyve negatively regulates exocytosis in neurosecretory cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE 5-KINASE; PROTEIN-KINASE; PLASMA-MEMBRANE; LOCALIZATION; PHOSPHOINOSITIDES; PHOSPHORYLATION; IDENTIFICATION; METABOLISM; GRANULES; KINETICS	Regulated secretion depends upon a highly coordinated series of protein-protein and protein-lipid interactions. Two phosphoinositides, phosphatidylinositol 4,5- bisphosphate and phosphatidylinositol 3-phosphate, are important for the ATP-dependent priming of the secretory apparatus prior to Ca2+-dependent exocytosis. Mechanisms that control phosphoinositide levels are likely to play an important role in priming fine tuning. Here we have investigated the involvement of PIKfyve, a phosphoinositide 5- kinase that can phosphorylate phosphatidylinositol 3-phosphate to produce phosphatidylinositol 3,5- bisphosphate on large dense core vesicle exocytosis from neuroendocrine cells. PIKfyve localizes to a subpopulation of secretory granules in chromaffin and PC12 cells. Nicotine stimulation promoted recruitment of PIKfyve-EGFP onto secretory vesicles in PC12 cells. YM-201636, a selective inhibitor of PIKfyve activity, and PIKfyve knockdown by small interfering RNA potentiated secretory granule exocytosis. Overexpression of PIKfyve or its yeast orthologue Fab1p inhibited regulated secretion in PC12 cells, whereas a catalytically inactive PIKfyve mutant had no effect. These results demonstrate a novel inhibitory role for PIKfyve catalytic activity in regulated secretion and provide further evidence for a fine tuning of exocytosis by 3-phosphorylated phosphoinositides.	[Osborne, Shona L.; Wen, Peter J.; Nguyen, Hao N.; Meunier, Frederic A.] Univ Queensland, Queensland Brain Inst, Mol Dynam Synapt Funct Lab, Brisbane, Qld 4072, Australia; [Osborne, Shona L.; Wen, Peter J.; Nguyen, Hao N.; Meunier, Frederic A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Boucheron, Christine; Parker, Peter J.] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Hayakawa, Masahiko; Kaizawa, Hiroyuki] Astellas Pharma Inc, Tsukuba, Ibaraki 3058585, Japan; [Vitale, Nicolas] CNRS, UMR 7168 LC2, Inst Neurosci Cellulaires & Integrat, Dept Neurotransmiss & Secret Neuroendocrine, F-67084 Strasbourg, France	University of Queensland; University of Queensland; Cancer Research UK; Astellas Pharmaceuticals; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meunier, FA (corresponding author), Univ Queensland, Queensland Brain Inst, Mol Dynam Synapt Funct Lab, Brisbane, Qld 4072, Australia.	f.meunier@uq.edu.au	Meunier, Frederic A/C-8161-2009; Osborne, Shona/C-8290-2009; Parker, Peter j/D-5192-2013; Vitale, Nicolas/G-5967-2014	Meunier, Frederic A/0000-0001-6400-1107; Vitale, Nicolas/0000-0002-4752-4907; parker, peter/0000-0002-6218-2933; Osborne, Shona/0000-0002-7012-9278				Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; BON S, 1990, EUR J BIOCHEM, V190, P221, DOI 10.1111/j.1432-1033.1990.tb15567.x; BURGOYNE RD, 1992, INVESTIGATION INTRAC; Cabezas A, 2006, GENE, V371, P34, DOI 10.1016/j.gene.2005.11.009; Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x; Cockcroft S, 2001, SEMIN CELL DEV BIOL, V12, P183, DOI 10.1006/scdb.2000.0235; Cooke FT, 2002, ARCH BIOCHEM BIOPHYS, V407, P143, DOI 10.1016/S0003-9861(02)00487-3; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Cremona O, 2001, J CELL SCI, V114, P1041; DITTIE AS, 1995, BIOCHEM J, V310, P777, DOI 10.1042/bj3100777; Evans GJO, 2006, J BIOL CHEM, V281, P1564, DOI 10.1074/jbc.M503628200; Friant S, 2003, DEV CELL, V5, P499, DOI 10.1016/S1534-5807(03)00238-7; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ishiki M, 2005, J BIOL CHEM, V280, P28792, DOI 10.1074/jbc.M500501200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Latham CF, 2007, INT J BIOCHEM CELL B, V39, P1576, DOI 10.1016/j.biocel.2006.11.015; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; McEwen RK, 1999, J BIOL CHEM, V274, P33905, DOI 10.1074/jbc.274.48.33905; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Meunier FA, 2002, EMBO J, V21, P6733, DOI 10.1093/emboj/cdf677; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Osborne SL, 2007, MOL CELL PROTEOMICS, V6, P1158, DOI 10.1074/mcp.M600430-MCP200; Osborne SL, 2006, J NEUROCHEM, V98, P336, DOI 10.1111/j.1471-4159.2006.03892.x; Osborne SL, 2001, NEURON, V32, P9, DOI 10.1016/S0896-6273(01)00455-X; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Shisheva A, 2001, J BIOL CHEM, V276, P11859, DOI 10.1074/jbc.M008437200; Shisheva A, 2001, CELL BIOL INT, V25, P1201, DOI 10.1006/cbir.2001.0803; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sugita S, 2004, METHODS, V33, P267, DOI 10.1016/j.ymeth.2004.01.005; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; Vitale N, 2005, J BIOL CHEM, V280, P29921, DOI 10.1074/jbc.M413748200; Vitale N, 2001, EMBO J, V20, P2424, DOI 10.1093/emboj/20.10.2424; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	50	41	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2804	2813		10.1074/jbc.M704856200	http://dx.doi.org/10.1074/jbc.M704856200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039667	hybrid			2022-12-27	WOS:000252622300038
J	Taylor, PL; Blakely, KM; De Leon, GP; Walker, JR; McArthur, F; Evdokimova, E; Zhang, K; Valvano, MA; Wright, GD; Junop, MS				Taylor, Patricia L.; Blakely, Kim M.; De Leon, Gladys P.; Walker, John R.; McArthur, Fiona; Evdokimova, Elena; Zhang, Kun; Valvano, Miguel A.; Wright, Gerard D.; Junop, Murray S.			Structure and function of sedoheptulose-7-phosphate isomerase, a critical enzyme for lipopolysaccharide biosynthesis and a target for antibiotic adjuvants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-MANNO-HEPTOSE; OUTER-MEMBRANE PERMEABILITY; ESCHERICHIA-COLI; PHOSPHOHEPTOSE ISOMERASE; SALMONELLA-TYPHIMURIUM; PHOSPHOGLUCOSE ISOMERASE; MOLECULAR-BASIS; IN-VIVO; CORE; GENE	The barrier imposed by lipopolysaccharide (LPS) in the outer membrane of Gram-negative bacteria presents a significant challenge in treatment of these organisms with otherwise effective hydrophobic antibiotics. The absence of L-glycero-D-manno-heptose in the LPS molecule is associated with a dramatically increased bacterial susceptibility to hydrophobic antibiotics and thus enzymes in the ADP-heptose biosynthesis pathway are of significant interest. GmhA catalyzes the isomerization of D-sedoheptulose 7-phosphate into D-glycero-Dmannoheptose 7-phosphate, the first committed step in the formation of ADP-heptose. Here we report structures of GmhA from Escherichia coli and Pseudomonas aeruginosa in apo,substrate, and product-bound forms, which together suggest that GmhA adopts two distinct conformations during isomerization through reorganization of quaternary structure. Biochemical characterization of GmhA mutants, combined with in vivo analysis of LPS biosynthesis and novobiocin susceptibility, identifies key catalytic residues. We postulate GmhA acts through an enediol-intermediate isomerase mechanism.	[Taylor, Patricia L.; Blakely, Kim M.; De Leon, Gladys P.; Zhang, Kun; Wright, Gerard D.; Junop, Murray S.] McMaster Univ, Hlth Sci Ctr, Dept Biomed Chem & Biomed Sci, DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada; [Walker, John R.; Evdokimova, Elena] Ontario Ctr Struct Proteom, Best Inst, Toronto, ON M5G 1L6, Canada; [McArthur, Fiona] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [McArthur, Fiona; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6A 5C1, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Structural Genomics Consortium; Western University (University of Western Ontario)	Junop, MS (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Biomed Chem & Biomed Sci, DeGroote Sch Med, 1200 Main St W,Rm 4N20A, Hamilton, ON L8N 3Z5, Canada.	junopm@mcmaster.ca	Junop, Murray S/E-4160-2015; Wright, G/ABB-7666-2021; Valvano, Miguel A/G-8759-2012; Perez-Ponce de Leon, Gerardo/U-3869-2017	Junop, Murray S/0000-0001-6676-5717; Valvano, Miguel A/0000-0001-8229-3641; Wright, Gerard/0000-0002-9129-7131; /0000-0002-5255-895X; Perez-Ponce de Leon, Gerardo/0000-0001-6472-5113				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berrisford JM, 2006, J MOL BIOL, V358, P1353, DOI 10.1016/j.jmb.2006.03.015; Brooke JS, 1996, J BIOL CHEM, V271, P3608; Brooke JS, 1996, J BACTERIOL, V178, P3339, DOI 10.1128/jb.178.11.3339-3341.1996; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Leon GP, 2006, CHEM BIOL, V13, P437, DOI 10.1016/j.chembiol.2006.02.010; EIDELS L, 1971, P NATL ACAD SCI USA, V68, P1673, DOI 10.1073/pnas.68.8.1673; EIDELS L, 1974, J BIOL CHEM, V249, P5642; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; FUKUI K, 1988, BIOCHEMISTRY-US, V27, P6693, DOI 10.1021/bi00418a008; Grossman TH, 1998, GENE, V209, P95, DOI 10.1016/S0378-1119(98)00020-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Kneidinger B, 2001, J BIOL CHEM, V276, P20935, DOI 10.1074/jbc.M100378200; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee S, 1999, J MOL CATAL B-ENZYM, V6, P369, DOI 10.1016/S1381-1177(98)00131-3; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Marolda Cristina L., 2006, V347, P237; McArthur F, 2005, J BACTERIOL, V187, P5292, DOI 10.1128/JB.187.15.5292-5300.2005; Milewski S, 2006, ARCH BIOCHEM BIOPHYS, V450, P39, DOI 10.1016/j.abb.2006.03.019; Morrison JP, 2007, BIOCHEMISTRY-US, V46, P3916, DOI 10.1021/bi602641m; Murshudov GN, 1996, P CCP4 STUDY WEEKEND, P93; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OGara M, 1997, EUR J BIOCHEM, V247, P1009, DOI 10.1111/j.1432-1033.1997.01009.x; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; QORONFLEH MW, 1995, J BIOTECHNOL, V39, P119, DOI 10.1016/0168-1656(94)00149-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Seetharaman J, 2006, PROTEINS, V63, P1092, DOI 10.1002/prot.20908; SIRISENA DM, 1994, J BACTERIOL, V176, P2379, DOI 10.1128/JB.176.8.2379-2385.1994; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Teplyakov A, 1998, STRUCTURE, V6, P1047, DOI 10.1016/S0969-2126(98)00105-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valvano MA, 2000, J BACTERIOL, V182, P488, DOI 10.1128/JB.182.2.488-497.2000; Valvano MA, 2002, MICROBIOL-SGM, V148, P1979, DOI 10.1099/00221287-148-7-1979; Wright GD, 2007, TRENDS MOL MED, V13, P260, DOI 10.1016/j.molmed.2007.04.004; Yethon J. A., 2001, Current Drug Targets - Infectious Disorders, V1, P91, DOI 10.2174/1568005014606143	44	56	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2835	2845		10.1074/jbc.M706163200	http://dx.doi.org/10.1074/jbc.M706163200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056714	hybrid			2022-12-27	WOS:000252622300041
J	Johmura, Y; Osada, S; Nishizuka, M; Imagawa, M				Johmura, Yoshikazu; Osada, Shigehiro; Nishizuka, Makoto; Imagawa, Masayoshi			FAD24 acts in concert with histone acetyltransferase HBO1 to promote adipogenesis by controlling DNA replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; STIMULATES ADIPOCYTE DIFFERENTIATION; ORIGIN RECOGNITION COMPLEX; PREADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; CHROMATIN ASSOCIATION; GENE-EXPRESSION; BUDDING YEAST; 3T3-L1 CELLS; EARLY-STAGE	Preadipocytes differentiate into adipocytes through approximately two rounds of mitosis, referred to as mitotic clonal expansion (MCE), but the events early in the differentiation process are not fully understood. Previously, we identified and characterized a novel gene, fad24 (factor for adipocyte differentiation 24), induced to express at the early stages of adipocyte differentiation. Although fad24 clearly has crucial roles in adipogenesis, its precise functions remain unknown. Here we show that the knockdown of fad24 by RNAi in 3T3-L1 preadipocytes repressed MCE. Moreover, FAD24 interacts with HBO1, a histone acetyltransferase and positive regulator of DNA replication initiation. The knockdown of hbo1 repressed MCE and adipogenesis, indicating that FAD24 acts in concert with HBO1 to promote adipogenesis by controlling DNA replication. Regarding the molecular mechanisms behind the regulation of DNA replication by fad24, we revealed that FAD24 co- localizes with HBO1 to chromatin during late mitosis, which is when the pre-replication initiation complex is assembled. Furthermore, chromatin immunoprecipitation experiments indicated that FAD24 localizes to origins of DNA replication with HBO1. When fad24 expression was inhibited during adipocyte differentiation, the recruitment of HBO1 to origins of DNA replication was reduced. Thus, FAD24 controls DNA replication by recruiting HBO1 to origins of DNA replication and is required for MCE during adipocyte differentiation.	[Johmura, Yoshikazu; Osada, Shigehiro; Nishizuka, Makoto; Imagawa, Masayoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Aichi 4678603, Japan	Nagoya City University	Imagawa, M (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Aichi 4678603, Japan.	imagawa@phar.nagoya-cu.ac.jp						Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77; Burke TW, 2001, J BIOL CHEM, V276, P15397, DOI 10.1074/jbc.M011556200; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hwang CS, 1997, ANNU REV CELL DEV BI, V13, P231, DOI 10.1146/annurev.cellbio.13.1.231; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Imagawa M, 1999, BIOCHEM BIOPH RES CO, V254, P299, DOI 10.1006/bbrc.1998.9937; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nishizuka M, 2002, BIOCHEM J, V361, P629, DOI 10.1042/0264-6021:3610629; Nishizuka M, 2003, J BIOL CHEM, V278, P15279, DOI 10.1074/jbc.M211479200; Nishizuka M, 2001, J BIOL CHEM, V276, P29625, DOI 10.1074/jbc.C100272200; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Patel YM, 2000, J BIOL CHEM, V275, P17653, DOI 10.1074/jbc.M910445199; REBECCA KR, 2006, MOL CELL BIOL, V26, P3707; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tominaga K, 2004, J CELL SCI, V117, P6217, DOI 10.1242/jcs.01546; Tominaga K, 2004, FEBS LETT, V577, P49, DOI 10.1016/j.febslet.2004.09.062; Tominaga K, 2004, J BIOL CHEM, V279, P34840, DOI 10.1074/jbc.M312927200; Tong Q, 2000, SCIENCE, V290, P134, DOI 10.1126/science.290.5489.134; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101; Zhang YX, 2002, CELL, V109, P849, DOI 10.1016/S0092-8674(02)00805-X	54	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2265	2274		10.1074/jbc.M707880200	http://dx.doi.org/10.1074/jbc.M707880200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029353	hybrid			2022-12-27	WOS:000252501000054
J	Soundararajan, R; Wishart, AD; Rupasinghe, HPV; Arcellana-Panlilio, M; Nelson, CM; Mayne, M; Robertson, GS				Soundararajan, Ramani; Wishart, Alexander D.; Rupasinghe, H. P. Vasantha; Arcellana-Panlilio, Mayi; Nelson, Carolanne M.; Mayne, Michael; Robertson, George S.			Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LIPID-PEROXIDATION; LDL-RECEPTOR; ANTIOXIDANT ACTIVITY; INDUCED APOPTOSIS; GENE-EXPRESSION; OXYGEN RADICALS; HEPG2 CELLS; FLAVONOIDS; MEMBRANE	The flavonoid quercetin 3-glucoside (Q3G) protected SH-SY5Y, HEK293, and MCF-7 cells against hydrogen peroxide-induced oxidative stress. cDNA microarray studies suggested that Q3G-pretreated cells subjected to oxidative stress up-regulate the expression of genes associated with lipid and cholesterol biosynthesis. Q3G pretreatment elevated both the expression and activation of sterol regulatory element-binding protein-2 (SREBP-2) only in SH-SY5Y cells subjected to oxidative stress. Inhibition of SREBP-2 expression by small interfering RNA or small molecule inhibitors of 2,3-oxidosqualene: lanosterol cyclase or HMG-CoA reductase blocked Q3G-mediated cytoprotection in SH-SY5Y cells. By contrast, Q3G did not protect either HEK293 or MCF-7 cells via this signaling pathway. Moreover, the addition of isopentenyl pyrophosphate rescued SH-SY5Y cells from the inhibitory effect of HMG-CoA reductase inhibition. Last, Q3G pretreatment enhanced the incorporation of [C-14] acetate into [C-14] cholesterol in SH-SY5Y cells under oxidative stress. Taken together, these studies suggest a novel mechanism for flavonoid-induced cytoprotection in SH-SY5Y cells involving SREBP-2-mediated sterol synthesis that decreases lipid peroxidation by maintaining membrane integrity in the presence of oxidative stress.	[Robertson, George S.] Dalhousie Univ, Dept Pharmacol & Psychiat, Halifax, NS B3H 1X5, Canada; [Soundararajan, Ramani; Wishart, Alexander D.; Robertson, George S.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 1X5, Canada; [Rupasinghe, H. P. Vasantha] Nova Scotia Agr Coll, Dept Environm Sci, Truro, NS B2N 5E3, Canada; [Arcellana-Panlilio, Mayi] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Nelson, Carolanne M.] Univ Prince Edward Isl, Dept Family & Nutr Sci, Charlottetown, PE C1A 4P3, Canada; [Mayne, Michael] Natl Res Council Canada, Inst Nutrisci & Hlth, Charlottetown, PE C1A 5T1, Canada	Dalhousie University; Dalhousie University; Dalhousie University; University of Calgary; University of Prince Edward Island; National Research Council Canada	Robertson, GS (corresponding author), Dalhousie Univ, Dept Pharmacol & Psychiat, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 1X5, Canada.	George.Robertson@dal.ca	Rupasinghe, H.P. Vasantha/B-6049-2013; Arcellana-Panlilio, Mayi/AGZ-0728-2022	Rupasinghe, H.P. Vasantha/0000-0003-3435-0052; Arcellana-Panlilio, Mayi/0000-0003-4829-8873; Robertson, George/0000-0001-8411-7721				AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Angeloni C, 2007, BIOCHIMIE, V89, P73, DOI 10.1016/j.biochi.2006.09.006; Ayala-Grosso C, 2002, BRAIN PATHOL, V12, P430; Beyea MM, 2007, J BIOL CHEM, V282, P5207, DOI 10.1074/jbc.M611063200; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Bursill CA, 2006, J AGR FOOD CHEM, V54, P1621, DOI 10.1021/jf051736o; CATTEL L, 1986, LIPIDS, V21, P31, DOI 10.1007/BF02534300; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Choi YJ, 2005, J NUTR, V135, P707, DOI 10.1093/jn/135.4.707; Chow JM, 2005, BIOCHEM PHARMACOL, V69, P1839, DOI 10.1016/j.bcp.2005.03.017; Dajas F, 2003, BRAZ J MED BIOL RES, V36, P1613, DOI 10.1590/S0100-879X2003001200002; Davalos A, 2006, J NUTR, V136, P1766, DOI 10.1093/jn/136.7.1766; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Endo A, 2004, ATHEROSCLEROSIS SUPP, V5, P67, DOI 10.1016/j.atherosclerosissup.2004.08.026; Fan CL, 2006, PHARMACOL REP, V58, P577; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Girotti AW, 1998, J LIPID RES, V39, P1529; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grand-Perret T, 2001, NAT MED, V7, P1332, DOI 10.1038/nm1201-1332; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; HALLIWELL B, 1993, HAEMOSTASIS, V23, P118; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Higashi Y, 2003, J BIOL CHEM, V278, P21450, DOI 10.1074/jbc.M301376200; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jacob RF, 2005, J BIOL CHEM, V280, P39380, DOI 10.1074/jbc.M507587200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jeong YJ, 2005, BRIT J NUTR, V93, P581, DOI 10.1079/BJN20041397; Kang SS, 2004, BIOORG MED CHEM LETT, V14, P2261, DOI 10.1016/j.bmcl.2004.02.003; Kuhn DJ, 2004, BBA-MOL CELL BIOL L, V1682, P1, DOI 10.1016/j.bbalip.2003.12.006; Lopez-Revuelta A, 2006, CHEM-BIOL INTERACT, V161, P79, DOI 10.1016/j.cbi.2006.03.004; Mandel S, 2006, MOL NUTR FOOD RES, V50, P229, DOI 10.1002/mnfr.200500156; Molina MF, 2003, BIOL PHARM BULL, V26, P1398, DOI 10.1248/bpb.26.1398; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Morand OH, 1997, J LIPID RES, V38, P373; Mullen E, 2004, J NUTR, V134, P2942, DOI 10.1093/jn/134.11.2942; Peng IW, 2003, J NUTR, V133, P2184, DOI 10.1093/jn/133.7.2184; Robichon C, 2007, BIOCHIMIE, V89, P260, DOI 10.1016/j.biochi.2006.09.015; Russo VC, 2004, BRAIN RES, V1009, P40, DOI 10.1016/j.brainres.2004.02.042; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; SAIJA A, 1995, FREE RADICAL BIO MED, V19, P481, DOI 10.1016/0891-5849(94)00240-K; Shin DH, 2006, J NEUROCHEM, V96, P561, DOI 10.1111/j.1471-4159.2005.03582.x; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; Singh DK, 2006, J NUTR, V136, p759S, DOI 10.1093/jn/136.3.759S; Skarits C, 2003, CLIN CHIM ACTA, V336, P27, DOI 10.1016/S0009-8981(03)00295-X; Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Wang H, 1999, FREE RADICAL BIO MED, V27, P683, DOI 10.1016/S0891-5849(99)00119-7; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385; Wolffram S, 2002, J NUTR, V132, P630, DOI 10.1093/jn/132.4.630; Xia M, 2005, J BIOL CHEM, V280, P36792, DOI 10.1074/jbc.M505047200; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; YANG B, FASEB 4, V20, P1501; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; YEAGLE PL, 1991, BIOCHIMIE, V73, P1303, DOI 10.1016/0300-9084(91)90093-G; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Youdim KA, 2002, BIOL CHEM, V383, P503, DOI 10.1515/BC.2002.052; Youdim KA, 2004, FREE RADICAL BIO MED, V37, P1683, DOI 10.1016/j.freeradbiomed.2004.08.002; Zhuang LY, 2005, J CLIN INVEST, V115, P959	67	58	63	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2231	2245		10.1074/jbc.M703583200	http://dx.doi.org/10.1074/jbc.M703583200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032389	hybrid			2022-12-27	WOS:000252501000051
J	Yamashita, T; Bouzhir-Sima, L; Lambry, JC; Liebl, U; Vos, MH				Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.			Ligand dynamics and early signaling events in the heme domain of the sensor protein Dos from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLVED RESONANCE RAMAN; DIRECT OXYGEN SENSOR; GEMINATE-RECOMBINATION; REGULATED PHOSPHODIESTERASE; TRANSCRIPTIONAL ACTIVATOR; CRYSTAL-STRUCTURE; NO RECOMBINATION; EC DOS; BINDING; ABSORPTION	In the heme-based sensor Dos from Escherichia coli, the ferrous heme is coordinated by His-77 and Met-95. The latter residue is replaced upon oxygen binding or oxidation of the heme. Here we investigate the early signaling processes upon dissociation of the distal ligand using ultrafast spectroscopy and site-directed mutagenesis. Geminate CO rebinding to the heme domain DosH appears insensitive to replacement of Met-95, in agreement with the notion that this residue is oriented out of the heme pocket in the presence of external ligands. A uniquely slow 35-ps phase in rebinding of the flexible methionine side chain after dissociation from ferrous DosH is completely abolished in rebinding of the more rigid histidine side chain in the M95H mutant protein, where only the 7-ps phase, common to all 6-coordinate heme proteins, is observed. Temperature-dependence studies indicate that all rebinding of internal and external ligands is essentially barrierless, but that CfigsO escape from the heme pocket is an activated process. Solvent viscosity studies combined with molecular dynamics simulations show that there are two configurations in the ferrous 6-coordinate protein, involving two isomers of the Met-95 side chain, of which the structural changes extend to the solvent-exposed backbone, which is part of the flexible FG loop. One of these configurations has considerable motional freedom in the Met-95-dissociated state. We suggest that this configuration corresponds to an early signaling intermediate state, is responsible for the slow rebinding, and allows small ligands in the protein to efficiently compete for binding with the heme.	[Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Yamashita, Taku; Bouzhir-Sima, Latifa; Lambry, Jean-Christophe; Liebl, Ursula; Vos, Marten H.] INSERM, U696, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu		Lambry, Jean-Christophe/0000-0001-8264-0391; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388				Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Autenrieth F, 2004, J COMPUT CHEM, V25, P1613, DOI 10.1002/jcc.20079; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cianetti S, 2004, J AM CHEM SOC, V126, P13932, DOI 10.1021/ja046442i; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DOSTER W, 1982, BIOCHEMISTRY-US, V21, P4831, DOI 10.1021/bi00263a001; Franzen S, 2001, BIOPHYS J, V80, P2372, DOI 10.1016/S0006-3495(01)76207-8; Franzen S, 2006, J PHYS CHEM B, V110, P14483, DOI 10.1021/jp056790m; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Hirata S, 2003, EUR J BIOCHEM, V270, P4771, DOI 10.1046/j.1432-1033.2003.03879.x; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jasaitis A, 2006, BIOCHEMISTRY-US, V45, P6018, DOI 10.1021/bi060012i; JONGEWARD KA, 1988, J BIOL CHEM, V263, P6027; Key J, 2005, BIOCHEMISTRY-US, V44, P4627, DOI 10.1021/bi047942r; Kriegl JM, 2002, P NATL ACAD SCI USA, V99, P7992, DOI 10.1073/pnas.082244399; Kruglik SG, 2007, P NATL ACAD SCI USA, V104, P7408, DOI 10.1073/pnas.0700445104; Kumazaki S, 2000, J BIOL CHEM, V275, P38378, DOI 10.1074/jbc.M005533200; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; LAMBRIGHT DG, 1991, CHEM PHYS, V158, P249, DOI 10.1016/0301-0104(91)87069-8; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; MARDEN MC, 1986, BIOCHEMISTRY-US, V25, P2786, DOI 10.1021/bi00358a008; MARTIN JL, 1994, METHOD ENZYMOL, V232, P416; Negrerie M, 2006, J PHYS CHEM B, V110, P12766, DOI 10.1021/jp0559377; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; PETRICH JW, 1988, BIOCHEMISTRY-US, V27, P4049, DOI 10.1021/bi00411a022; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Shreve AP, 1999, J PHYS CHEM B, V103, P7969, DOI 10.1021/jp991163g; Silkstone G, 2002, BIOPHYS CHEM, V98, P65, DOI 10.1016/S0301-4622(02)00085-6; Silkstone G, 2007, J BIOL CHEM, V282, P1638, DOI 10.1074/jbc.M605760200; SRAJER V, 1988, J AM CHEM SOC, V110, P6656, DOI 10.1021/ja00228a009; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; Takahashi H, 2006, CHEM LETT, V35, P970, DOI 10.1246/cl.2006.970; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Trent JT, 2002, J BIOL CHEM, V277, P19538, DOI 10.1074/jbc.M201934200; Vos MH, 2008, BBA-BIOENERGETICS, V1777, P15, DOI 10.1016/j.bbabio.2007.10.004; Vos MH, 2000, P NATL ACAD SCI USA, V97, P1554, DOI 10.1073/pnas.030528197; Vos MH, 2000, J CHIN CHEM SOC-TAIP, V47, P765; Wang W, 2000, J PHYS CHEM B, V104, P10789, DOI 10.1021/jp0008602; Ye X, 2005, J AM CHEM SOC, V127, P5854, DOI 10.1021/ja042365f; Ye X, 2002, J AM CHEM SOC, V124, P5914, DOI 10.1021/ja017359n; YOUNG RD, 1984, J CHEM PHYS, V81, P3730, DOI 10.1063/1.448124	47	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2344	2352		10.1074/jbc.M708123200	http://dx.doi.org/10.1074/jbc.M708123200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039668	hybrid			2022-12-27	WOS:000252501000061
J	Amutha, B; Gordon, DM; Gu, YJ; Lyver, ER; Dancis, A; Pain, D				Amutha, Boominathan; Gordon, Donna M.; Gu, Yajuan; Lyver, Elise R.; Dancis, Andrew; Pain, Debkumar			GTP is required for iron-sulfur cluster biogenesis in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FE-S CLUSTER; SACCHAROMYCES-CEREVISIAE; PROTEIN IMPORT; YEAST FRATAXIN; MATURATION; HOMOLOG; ACTIVATION; NFS1P; TRANSLOCATION; TRANSCRIPTION	Iron-sulfur (Fe-S) cluster biogenesis in mitochondria is an essential process and is conserved from yeast to humans. Several proteins with Fe-S cluster cofactors reside in mitochondria, including aconitase [4Fe-4S] and ferredoxin [2Fe-2S]. We found that mitochondria isolated from wild-type yeast contain a pool of apoaconitase and machinery capable of forming new clusters and inserting them into this endogenous apoprotein pool. These observations allowed us to develop assays to assess the role of nucleotides (GTP and ATP) in cluster biogenesis in mitochondria. We show that Fe-S cluster biogenesis in isolated mitochondria is enhanced by the addition of GTP and ATP. Hydrolysis of both GTP and ATP is necessary, and the addition of ATP cannot circumvent processes that require GTP hydrolysis. Both in vivo and in vitro experiments suggest that GTP must enter into the matrix to exert its effects on cluster biogenesis. Upon import into isolated mitochondria, purified apoferredoxin can also be used as a substrate by the Fe-S cluster machinery in a GTP-dependent manner. GTP is likely required for a common step involved in the cluster biogenesis of aconitase and ferredoxin. To our knowledge this is the first report demonstrating a role of GTP in mitochondrial Fe-S cluster biogenesis.	[Amutha, Boominathan; Gordon, Donna M.; Gu, Yajuan; Pain, Debkumar] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, NJ Med Sch, Newark, NJ 07101 USA; [Lyver, Elise R.; Dancis, Andrew] Univ Penn, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Pain, D (corresponding author), Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, NJ Med Sch, 185 S Orange Ave,MSBI-669, Newark, NJ 07101 USA.	painde@umdnj.edu			NIDDK NIH HHS [DK 53953] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053953, R01DK053953] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Amutha B, 2003, BIOCHEM J, V370, P805, DOI 10.1042/BJ20021415; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Blokesch M, 2002, BIOCHEM SOC T, V30, P674, DOI 10.1042/BST0300674; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; FUKUCHI T, 1993, GENE, V129, P141; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gordon DM, 2006, BIOCHEM J, V400, P163, DOI 10.1042/BJ20060904; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENNEDY MC, 1984, J BIOL CHEM, V259, P3145; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kim R, 2001, J BIOL CHEM, V276, P17524, DOI 10.1074/jbc.M010695200; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Lacombe ML, 2000, J BIOENERG BIOMEMBR, V32, P247, DOI 10.1023/A:1005584929050; Lange H, 1999, J BIOL CHEM, V274, P18989, DOI 10.1074/jbc.274.27.18989; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lascu I, 2000, J BIOENERG BIOMEMBR, V32, P237, DOI 10.1023/A:1005532912212; Lesuisse E, 2004, BIOCHEM J, V378, P599, DOI 10.1042/BJ20031387; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schulke N, 1999, J BIOL CHEM, V274, P22847, DOI 10.1074/jbc.274.32.22847; Sepuri NBV, 1998, J BIOL CHEM, V273, P20941, DOI 10.1074/jbc.273.33.20941; Sepuri NBV, 1998, J BIOL CHEM, V273, P1420, DOI 10.1074/jbc.273.3.1420; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; STUART RA, 1994, EUR J BIOCHEM, V220, P9, DOI 10.1111/j.1432-1033.1994.tb18593.x; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Unciuleac MC, 2007, BIOCHEMISTRY-US, V46, P6812, DOI 10.1021/bi6026665; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	51	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1362	1371		10.1074/jbc.M706808200	http://dx.doi.org/10.1074/jbc.M706808200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029354	hybrid			2022-12-27	WOS:000252282700019
J	Lange, Y; Ory, DS; Ye, J; Lanier, MH; Hsu, FF; Steck, TL				Lange, Yvonne; Ory, Daniel S.; Ye, Jin; Lanier, Michael H.; Hsu, Fong-Fu; Steck, Theodore L.			Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; STEROL TRANSPORT; MOVEMENT; LANOSTEROL; COENZYME; 25-HYDROXYCHOLESTEROL; DEGRADATION; BINDING; UBIQUITINATION; BIOSYNTHESIS	The cholesterol content of the endoplasmic reticulum (ER) and the activity of 3-hydroxy- 3-methylglutaryl-CoA reductase (HMGR) imbedded therein respond homeostatically within minutes to changes in the level of plasma membrane cholesterol. We have now examined the roles of sterol regulatory element-binding protein (SREBP)-dependent gene expression, side chain oxysterol biosynthesis, and cholesterol precursors in the short term regulation of ER cholesterol levels and HMGR activity. We found that SREBP-dependent gene expression is not required for the response to changes in cell cholesterol of either the pool of ER cholesterol or the rate of cholesterol esterification. It was also found that the acute proteolytic inactivation of HMGR triggered by cholesterol loading required the conversion of cholesterol to 27-hydroxycholesterol. High levels of exogenous 24,25-dihydrolanosterol drove the inactivation of HMGR; lanosterol did not. However, purging endogenous 24,25-dihydrolanosterol, lanosterol, and other biosynthetic sterol intermediates by treating cells with NB- 598 did not greatly affect either the setting of their ER cholesterol pool or the inactivation of their HMGR. In summary, neither SREBP-regulated genes nor 27-hydroxycholesterol is involved in setting the ER cholesterol pool. On the other hand, 27-hydroxycholesterol, rather than cholesterol itself or biosynthetic precursors of cholesterol, stimulates the rapid inactivation of HMGR in response to high levels of cholesterol.	[Lange, Yvonne; Ye, Jin] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Ory, Daniel S.; Lanier, Michael H.; Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Steck, Theodore L.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Rush University; Washington University (WUSTL); University of Chicago	Lange, Y (corresponding author), Rush Univ, Med Ctr, Dept Pathol, 1653 W Congress Pkwy, Chicago, IL 60612 USA.	ylange@rush.edu	Lange, Yvonne/A-7794-2009; Steck, Theodore/GWM-4373-2022	Steck, Theodore/0000-0002-8391-9244; Hsu, Fong-Fu/0000-0001-5368-0183	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773, R55HL028448, R01HL028448] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 00954] Funding Source: Medline; NHLBI NIH HHS [HL 28448, HL 67773] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRESLOW JL, 1975, BIOCHIM BIOPHYS ACTA, V398, P10, DOI 10.1016/0005-2760(75)90165-4; BROWN MS, 1974, J BIOL CHEM, V249, P7306; BUTTKE TM, 1992, J BIOL CHEM, V267, P8819; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; CHANG TY, 1979, J BIOL CHEM, V254, P1258; Chang TY, 1997, ANNU REV BIOCHEM, V66, P613, DOI 10.1146/annurev.biochem.66.1.613; Du XM, 2004, J BIOL CHEM, V279, P47010, DOI 10.1074/jbc.M408690200; Frolov A, 2003, J BIOL CHEM, V278, P25517, DOI 10.1074/jbc.M302588200; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; HORIE M, 1990, J BIOL CHEM, V265, P18075; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Javitt NB, 2000, BBA-MOL CELL BIOL L, V1529, P136, DOI 10.1016/S1388-1981(00)00143-8; JAVITT NB, 1990, J LIPID RES, V31, P1527; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lange Y, 2005, J BIOL CHEM, V280, P36126, DOI 10.1074/jbc.M507149200; LANGE Y, 1995, J LIPID RES, V36, P1092; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 2002, BIOCHEM BIOPH RES CO, V290, P488, DOI 10.1006/bbrc.2001.6156; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 1996, TRENDS CELL BIOL, V6, P205, DOI 10.1016/0962-8924(96)20016-9; Lange Y, 1997, J BIOL CHEM, V272, P13103, DOI 10.1074/jbc.272.20.13103; Lange Y, 1999, J LIPID RES, V40, P2264; LEITERSDORF E, 1994, AM J HUM GENET, V55, P907; Li YF, 2004, J BIOL CHEM, V279, P45226, DOI 10.1074/jbc.M407600200; Maxfield FR, 2006, CURR OPIN CELL BIOL, V18, P379, DOI 10.1016/j.ceb.2006.06.012; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; PARISH EJ, 1995, LIPIDS, V30, P247, DOI 10.1007/BF02537828; Plemenitas A, 1999, EUR J BIOCHEM, V266, P317, DOI 10.1046/j.1432-1327.1999.00829.x; Prinz WA, 2007, PROG LIPID RES, V46, P297, DOI 10.1016/j.plipres.2007.06.002; Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; REISS AB, 1994, J LIPID RES, V35, P1026; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2004, J BIOL CHEM, V279, P28798, DOI 10.1074/jbc.M402442200; Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; TINT GS, 1982, J LIPID RES, V23, P597	45	87	90	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1445	1455		10.1074/jbc.M706967200	http://dx.doi.org/10.1074/jbc.M706967200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024962	hybrid			2022-12-27	WOS:000252282700028
J	Sakai, H; Sato, A; Masuda, K; Takeoka, S; Tsuchida, E				Sakai, Hiromi; Sato, Atsushi; Masuda, Kaoru; Takeoka, Shinji; Tsuchida, Eishun			Encapsulation of concentrated hemoglobin solution in phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACILITATED OXYGEN-TRANSPORT; HUMAN SERUM-ALBUMIN; NITRIC-OXIDE; CARBON-MONOXIDE; HEMORRHAGIC-SHOCK; HB-VESICLES; BLOOD; ERYTHROCYTES; DERIVATIVES; MEMBRANE	One physiological significance of the red blood cell (RBC) structure is that NO binding of Hb is retarded by encapsulation with the cell membrane. To clarify the mechanism, we analyzed Hb-vesicles (HbVs) with different intracellular Hb concentrations, [Hb] in, and different particle sizes using stopped-flow spectrophotometry. The apparent NO binding rate constant, k(on)'((NO)), of HbV at [Hb](in) = 1 g/dl was 2.6 x 10(7) M-1 s(-1), which was almost equal to k(on)((NO)) of molecular Hb, indicating that the lipid membrane presents no obstacle for NO binding. With increasing [Hb] in to 35 g/dl, k(on)'((NO)) decreased to 0.9 x 10(7) M-1 s(-1), which was further decreased to 0.5 x 10(7) M-1 s(-1) with enlarging particle diameter from 265 to 452 nm. For CO binding, which is intrinsically much slower than NO binding, k(on)'((CO)) did not change greatly with [Hb] in and the particle diameter. Results obtained using diffusion simulations coupled with elementary binding reactions concur with these tendencies and clarify that NO is trapped rapidly by Hb from the interior surface region to the core of HbV at a high [Hb] in, retarding NO diffusion toward the core of HbV. In contrast, slow CO binding allows time for further CO- diffusion to the core. Simulations extrapolated to larger particles (8 mu m) showing retardation even for CO binding. The obtained k(on)'((NO)) and k(on)'((CO)) yield values similar to those reported for RBCs. In summary, the intracellular, not extracellular, diffusion barrier is predominant due to the rapid NO binding that induces a rapid sink of NO from the interior surface to the core, retarding further NO diffusion and binding.	[Sakai, Hiromi; Tsuchida, Eishun] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Sato, Atsushi; Takeoka, Shinji] Waseda Univ, Grad Sch Adv Sci & Engn, Tokyo 1698555, Japan; [Masuda, Kaoru] Kobelco Res Inst Inc, Kobe, Hyogo 6512271, Japan	Waseda University; Waseda University; Kobelco Research Institute Inc.	Tsuchida, E (corresponding author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	eishun@waseda.jp	Sakai, Hiromi/J-2529-2019	Sakai, Hiromi/0000-0002-0681-3032				Azarov I, 2005, J BIOL CHEM, V280, P39024, DOI 10.1074/jbc.M509045200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bouwer ST, 1997, BBA-PROTEIN STRUCT M, V1338, P127, DOI 10.1016/S0167-4838(96)00197-5; Bunn HF, 1995, TRANSFUS CLIN BIOL, V2, P433, DOI 10.1016/S1246-7820(05)80068-0; CARLSEN E, 1958, J GEN PHYSIOL, V42, P83, DOI 10.1085/jgp.42.1.83; Chang TMS, 2006, ARTIF CELL BLOOD SUB, V34, P551, DOI 10.1080/10731190600973808; Chen XS, 1996, B CHEM SOC JPN, V69, P255, DOI 10.1246/bcsj.69.255; COIN JT, 1979, J BIOL CHEM, V254, P1178; DJORDJEVICH L, 1980, EXP HEMATOL, V8, P584; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Goda N, 1998, J CLIN INVEST, V101, P604, DOI 10.1172/JCI1324; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Gulati A, 1999, J LAB CLIN MED, V133, P112, DOI 10.1016/S0022-2143(99)90003-3; Han TH, 2005, BBA-GEN SUBJECTS, V1723, P135, DOI 10.1016/j.bbagen.2005.01.013; Hartridge H, 1927, J PHYSIOL-LONDON, V52, P232, DOI 10.1113/jphysiol.1927.sp002354; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; HESS JR, 1993, J APPL PHYSIOL, V74, P1769, DOI 10.1152/jappl.1993.74.4.1769; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2001, P NATL ACAD SCI USA, V98, P11771, DOI 10.1073/pnas.201276698; Jeffers A, 2006, FREE RADICAL BIO MED, V41, P1557, DOI 10.1016/j.freeradbiomed.2006.08.017; Kavdia M, 2002, AM J PHYSIOL-HEART C, V282, pH2245, DOI 10.1152/ajpheart.00972.2001; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Liu XP, 2002, J BIOL CHEM, V277, P26194, DOI 10.1074/jbc.M201939200; Matheson B, 2002, J APPL PHYSIOL, V93, P1479, DOI 10.1152/japplphysiol.00191.2002; Minneci PC, 2005, J CLIN INVEST, V115, P3409, DOI 10.1172/JCI25040; MINTON AP, 1978, J PHYS CHEM-US, V82, P1934, DOI 10.1021/j100506a016; Nakai K, 1998, J LAB CLIN MED, V132, P313, DOI 10.1016/S0022-2143(98)90045-2; Nakai K, 1996, J CARDIOVASC PHARM, V28, P115, DOI 10.1097/00005344-199607000-00018; Nishide H, 1997, ARTIF CELL BLOOD SUB, V25, P335, DOI 10.3109/10731199709118924; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JS, 2003, METH MOLEC MED, V82, P65; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Page TC, 1998, MICROVASC RES, V55, P54, DOI 10.1006/mvre.1997.2055; Rochon G, 2004, HYPERTENSION, V43, P1110, DOI 10.1161/01.HYP.0000123075.48420.e8; Rohlfs RJ, 1998, J BIOL CHEM, V273, P12128, DOI 10.1074/jbc.273.20.12128; ROSE EJ, 1983, J AM CHEM SOC, V105, P2866, DOI 10.1021/ja00347a056; Rudolph AS, 1997, J APPL PHYSIOL, V82, P1826, DOI 10.1152/jappl.1997.82.6.1826; SAKAI H, 1993, PROTEIN EXPRES PURIF, V4, P563, DOI 10.1006/prep.1993.1074; Sakai H, 1999, AM J PHYSIOL-HEART C, V276, pH553, DOI 10.1152/ajpheart.1999.276.2.H553; Sakai H, 1996, POLYM ADVAN TECHNOL, V7, P639, DOI 10.1002/(SICI)1099-1581(199608)7:8<639::AID-PAT572>3.0.CO;2-2; Sakai H, 2000, AM J PHYSIOL-HEART C, V279, pH908, DOI 10.1152/ajpheart.2000.279.3.H908; Sakai H, 2006, TRANSFUSION, V46, P339, DOI 10.1111/j.1537-2995.2006.00727.x; Sakai H, 1996, BIOTECHNOL PROGR, V12, P119, DOI 10.1021/bp950068w; Sakai H, 2000, BIOCONJUGATE CHEM, V11, P425, DOI 10.1021/bc990173h; Sakai H, 2004, CRIT CARE MED, V32, P539, DOI 10.1097/01.CCM.0000109774.99665.22; Sakai H, 2003, AM J PHYSIOL-HEART C, V285, pH2543, DOI 10.1152/ajpheart.00537.2003; Sakai H, 2003, CLIN CHEM LAB MED, V41, P222, DOI 10.1515/CCLM.2003.036; Sakai H, 2002, J BIOCHEM, V131, P611, DOI 10.1093/oxfordjournals.jbchem.a003141; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; Sou K, 2003, BIOTECHNOL PROGR, V19, P1547, DOI 10.1021/bp0201004; SUEMATSU M, 1995, J CLIN INVEST, V96, P2431, DOI 10.1172/JCI118300; SZEBENI J, 1985, BIOCHEMISTRY-US, V24, P2827, DOI 10.1021/bi00333a003; SZEBENI J, 1984, BIOCHIM BIOPHYS ACTA, V798, P60, DOI 10.1016/0304-4165(84)90010-2; TAKEOKA S, 1994, J MACROMOL SCI PURE, VA31, P97; Takeoka S, 1996, LANGMUIR, V12, P1755, DOI 10.1021/la940936j; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Vandegriff KD, 1997, BIOPHYS CHEM, V69, P23, DOI 10.1016/S0301-4622(97)00079-3; VANDEGRIFF KD, 1984, J BIOL CHEM, V259, P2619; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; WANG L, 1992, POLYM ADVAN TECHNOL, V3, P17; YOKOHAMA H, 1994, ARTIF ORGANS TODAY, V4, P107	62	61	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1508	1517		10.1074/jbc.M707660200	http://dx.doi.org/10.1074/jbc.M707660200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003613	hybrid			2022-12-27	WOS:000252282700035
J	Baumer, AT; ten Freyhaus, H; Sauer, H; Wartenberg, M; Kappert, K; Schnabel, P; Konkol, C; Hescheler, J; Vantler, M; Rosenkranz, S				Baeumer, Anselm T.; ten Freyhaus, Henrik; Sauer, Heinrich; Wartenberg, Maria; Kappert, Kai; Schnabel, Petra; Konkol, Christian; Hescheler, Juergen; Vantler, Marius; Rosenkranz, Stephan			Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47(phox) is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NADPH OXIDASE ACTIVATION; C PDGF-C; ANGIOTENSIN-II; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; NAD(P)H OXIDASE; INHIBITION	Platelet-derived growth factor (PDGF) plays a critical role in the pathogenesis of proliferative diseases. NAD(P) H oxidase (Nox)-derived reactive oxygen species (ROS) are essential for signal transduction by growth factor receptors. Here we investigated the dependence of PDGF-AA-induced ROS production on the cytosolic Nox subunits Rac-1 and p47phox, and we systematically evaluated the signal relay mechanisms by which the alpha PDGF receptor (alpha PDGFR) induces ROS liberation. Stimulation of the alpha PDGFR led to a time-dependent increase of intracellular ROS levels in fibroblasts. Pharmacological inhibitor experiments and enzyme activity assays disclosed Nox as the source of ROS. alpha PDGFR activation is rapidly followed by the translocation of p47phox and Rac-1 from the cytosol to the cell membrane. Experiments performed in p47(phox)(-/-) cells and inhibition of Rac-1 or overexpression of dominant-negative Rac revealed that these Nox subunits are required for PDGF-dependent Nox activation and ROS liberation. To evaluate the signaling pathway mediating PDGF-AA-dependent ROS production, we investigated Ph cells expressing mutant alpha PDGFRs that lack specific binding sites for alpha PDGFR-associated signaling molecules (Src, phosphatidylinositol 3-kinase (PI3K), phospholipase C gamma, and SHP-2). Lack of PI3K signaling (but not Src, phospholipase C gamma, or SHP-2) completely abolished PDGF-dependent p47phox and Rac-1 translocation, increase of Nox activity, and ROS production. Conversely, a mutant alpha PDGFR able to activate only PI3K was sufficient to mediate these subcellular events. Furthermore, the catalytic PI3K subunit p110 alpha(but not p110 beta) was identified as the crucial isoform that elicits alpha PDGFR-mediated production of ROS. Finally, bromodeoxyuridine incorporation and chemotaxis assays revealed that the lack of ROS liberation blunted PDGF-AA-dependent chemotaxis but not cycle progression. We conclude that PI3K/p110 alpha mediates growth factor-dependent ROS production by recruiting p47phox and Rac-1 to the cell membrane, thereby assembling the active Nox complex. ROS are required for PDGF-AA-dependent chemotaxis but not proliferation.	[Baeumer, Anselm T.; ten Freyhaus, Henrik; Kappert, Kai; Schnabel, Petra; Konkol, Christian; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Innere Med Klin 3, Inst Physiol, D-50937 Cologne, Germany; [Sauer, Heinrich] Univ Giessen, D-35392 Giessen, Germany; [Wartenberg, Maria] GKSS Res Inst, Dept Cell Biol, D-14513 Teltow, Germany; [Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, D-50937 Cologne, Germany; [Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany	University of Cologne; Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Cologne; University of Cologne	Rosenkranz, S (corresponding author), Univ Cologne, Innere Med Klin 3, Inst Physiol, Kerpener Str 62, D-50937 Cologne, Germany.	stephan.rosenkranz@uk-koeln.de	Kappert, Kai/H-4116-2017	Kappert, Kai/0000-0001-6976-0428				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bazenet CE, 1996, MOL CELL BIOL, V16, P6926; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Dijkmans J, 2002, INT J BIOCHEM CELL B, V34, P414, DOI 10.1016/S1357-2725(01)00124-8; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Flesch M, 1999, CIRCULATION, V100, P346, DOI 10.1161/01.CIR.100.4.346; FRENKEL K, 1991, FREE RADICAL RES COM, V12-3, P783, DOI 10.3109/10715769109145860; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Godwin SL, 1997, J BIOL CHEM, V272, P11307; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Hart B A, 1992, Biotechnol Ther, V3, P119; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kim KS, 1998, J CLIN INVEST, V101, P1821, DOI 10.1172/JCI1830; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lavigne MC, 2001, CIRCULATION, V104, P79, DOI 10.1161/01.CIR.104.1.79; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Meyer JW, 1999, ENDOTHELIUM-NEW YORK, V7, P11, DOI 10.3109/10623329909165308; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NISHINAKA Y, 1993, BIOCHEM BIOPH RES CO, V193, P554, DOI 10.1006/bbrc.1993.1659; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Rathaus M, 2002, NEPHROL DIAL TRANSPL, V17, P216, DOI 10.1093/ndt/17.2.216; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Rosenkranz S, 1999, J BIOL CHEM, V274, P28335, DOI 10.1074/jbc.274.40.28335; SEIFERT RA, 1993, J BIOL CHEM, V268, P4473; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Viedt C, 2004, J MOL MED, V82, P31, DOI 10.1007/s00109-003-0500-5; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	63	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7864	7876		10.1074/jbc.M704997200	http://dx.doi.org/10.1074/jbc.M704997200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18070887	hybrid			2022-12-27	WOS:000253997900062
J	Fokine, A; Miroshnikov, KA; Shneider, MM; Mesyanzhinov, VV; Rossmann, MG				Fokine, Andrei; Miroshnikov, Konstantin A.; Shneider, Mikhail M.; Mesyanzhinov, Vadim V.; Rossmann, Michael G.			Structure of the bacteriophage phi KZ lytic transglycosylase gp144	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; LYSOZYME; ENDOLYSINS; SOFTWARE; PROGRAM; GENOME; HEN	Lytic transglycosylases are enzymes that act on the peptidoglycan of bacterial cell walls. They cleave the glycosidic linkage between N-acetylmuramoyl and N-acetylglucosaminyl residues with the concomitant formation of a 1,6-anhydromuramoyl product. The x-ray structure of the lytic transglycosylase gp144 from the Pseudomonas bacteriophage phi KZ has been determined to 2.5-angstrom resolution. This protein is probably employed by the bacteriophage in the late stage of the virus reproduction cycle to destroy the bacterial cell wall to release the phage progeny. phi KZgp144 is a 260-residue alpha-helical protein composed of a 70-residue N-terminal cell wall-binding domain and a C-terminal catalytic domain. The fold of the N-terminal domain is similar to the peptidoglycan-binding domain from Streptomyces albus G D-Ala-D-Ala carboxypeptidase and to the N-terminal prodomain of human metalloproteinases that act on extracellular matrices. The C-terminal catalytic domain of gp144 has a structural similarity to the catalytic domain of the transglycosylase Slt70 from Escherichia coli and to lysozymes. The gp144 catalytic domain has an elongated groove that can bind at least five sugar residues at sites A-E. As in other lysozymes, the peptidoglycan cleavage ( catalyzed by Glu(115) in gp144) occurs between sugar-binding subsites D and E. The x-ray structure of the phi KZ transglycosylase complexed with the chitotetraose ( N-acetylglucosamine) 4 has been determined to 2.6-angstrom resolution. The N-acetylglucosamine residues of the chitotetraose bind in sites A-D.	[Fokine, Andrei; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Miroshnikov, Konstantin A.; Shneider, Mikhail M.; Mesyanzhinov, Vadim V.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Miroshnikov, Konstantin A/Q-5515-2016; Miroshnikov, Konstantin/D-5950-2018; Fokine, Andrei/A-1330-2013; Shneider, Mikhail/AAL-6817-2020	Miroshnikov, Konstantin A/0000-0002-4468-4091; Miroshnikov, Konstantin/0000-0002-4468-4091; Shneider, Mikhail/0000-0002-3768-3541				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BLAKE CCF, 2006, INT TABLES CRYSTALLO, VF, P745; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charlier P, 2004, HDB METALLOPROTEINS, V3, P164; DeLano W.L, PYMOL MOL GRAPHICS S; DIDEBERG O, 1982, NATURE, V299, P469, DOI 10.1038/299469a0; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fokine A, 2005, J MOL BIOL, V352, P117, DOI 10.1016/j.jmb.2005.07.018; Fokine A, 2007, STRUCTURE, V15, P1099, DOI 10.1016/j.str.2007.07.008; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GHUYSEN JM, 1994, FEBS LETT, V342, P23, DOI 10.1016/0014-5793(94)80577-6; Giamarellou H, 2000, INT J ANTIMICROB AG, V16, P103, DOI 10.1016/S0924-8579(00)00212-0; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KOHN EC, 1995, CANCER RES, V55, P1856; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRYLOV VN, 1978, VOP VIRUSOL+, P568; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McRee DE, 2004, ACTA CRYSTALLOGR D, V60, P2276, DOI 10.1107/S0907444904025491; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Miroshnikov KA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P300, DOI 10.1134/S0006297906030102; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis-Bleau C, 2007, FEMS MICROBIOL LETT, V266, P201, DOI 10.1111/j.1574-6968.2006.00523.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013	48	46	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7242	7250		10.1074/jbc.M709398200	http://dx.doi.org/10.1074/jbc.M709398200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18160394	hybrid			2022-12-27	WOS:000253779600069
J	Surmann-Schmitt, C; Dietz, U; Kireva, T; Adam, N; Park, J; Tagariello, A; Oennerfjord, P; Heinegard, D; Schlotzer-Schrehardt, U; Deutzmann, R; von der Mark, K; Stock, M				Surmann-Schmitt, Cordula; Dietz, Uwe; Kireva, Trayana; Adam, Nadia; Park, Jung; Tagariello, Andreas; Oennerfjord, Patrik; Heinegard, Dick; Schloetzer-Schrehardt, Ursula; Deutzmann, Rainer; von der Mark, Klaus; Stock, Michael			Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE O-SULFATION; INDIAN HEDGEHOG; CHONDROCYTE DIFFERENTIATION; PROHORMONE CONVERTASES; MASS-SPECTROMETRY; EXPRESSION; IDENTIFICATION; PROPROTEIN; GASTRULATION; MATURATION	Here we report on the structure, expression, and function of a novel cartilage-specific gene coding for a 17-kDa small, highly charged, and secreted protein that we termed Ucma ( unique cartilage matrix-associated protein). The protein is processed by a furin-like protease into an N-terminal peptide of 37 amino acids and a C-terminal fragment ( Ucma-C) of 74 amino acids. Ucma is highly conserved between mouse, rat, human, dog, clawed frog, and zebrafish, but has no homology to other known proteins. Remarkable are 1-2 tyrosine sulfate residues/ molecule and dense clusters of acidic and basic residues in the C-terminal part. In the developing mouse skeleton Ucma mRNA is expressed in resting chondrocytes in the distal and peripheral zones of epiphyseal and vertebral cartilage. Ucma is secreted into the extracellular matrix as an uncleaved precursor and shows the same restricted distribution pattern in cartilage as Ucma mRNA. In contrast, antibodies prepared against the processed C-terminal fragment located Ucma-C in the entire cartilage matrix, indicating that it either diffuses or is retained until chondrocytes reach hypertrophy. During differentiation of an MC615 chondrocyte subclone in vitro, Ucma expression parallels largely the expression of collagen II and decreases with maturation toward hypertrophic cells. Recombinant Ucma-C does not affect expression of chondrocyte-specific genes or proliferation of chondrocytes, but interferes with osteogenic differentiation of primary osteoblasts, mesenchymal stem cells, and MC3T3-E1pre-osteoblasts. These findings suggest that Ucma may be involved in the negative control of osteogenic differentiation of osteochondrogenic precursor cells in peripheral zones of fetal cartilage and at the cartilage-bone interface.	[Surmann-Schmitt, Cordula; Dietz, Uwe; Kireva, Trayana; Adam, Nadia; Park, Jung; von der Mark, Klaus; Stock, Michael] Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Tagariello, Andreas] Univ Hosp, Inst Human Genet, D-91054 Erlangen, Germany; [Oennerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Schloetzer-Schrehardt, Ursula] Univ Hosp, Hosp Eye, D-91054 Erlangen, Germany; [Deutzmann, Rainer] Univ Regensburg, Inst Biochem, D-93053 Regensburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Lund University; University of Erlangen Nuremberg; University of Regensburg	Stock, M (corresponding author), Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.	mstock@molmed.uni-erlangen.de	Stock, Michael/B-9829-2009; Surmann-Schmitt, Cordula/B-9792-2009; von+der+Mark, Klaus/AAJ-1443-2020; Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Stock, Michael/0000-0002-3322-0961				Azizan A, 2001, J BIOL CHEM, V276, P23632, DOI 10.1074/jbc.M009967200; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Farach-Carson MC, 2005, CRIT REV EUKAR GENE, V15, P29, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.30; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; HUANG SC, 1989, PEPTIDES, V10, P785, DOI 10.1016/0196-9781(89)90114-9; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYTE A, 1991, J BIOL CHEM, V266, P740; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schmidl M, 2006, J BIOL CHEM, V281, P31790, DOI 10.1074/jbc.M603419200; Seibert C, 2002, P NATL ACAD SCI USA, V99, P11031, DOI 10.1073/pnas.172380899; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Thomas JT, 2006, J BIOL CHEM, V281, P26725, DOI 10.1074/jbc.M603851200; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; ZHENG M, 1994, J NEUROSCI, V14, P4656	37	59	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7082	7093		10.1074/jbc.M702792200	http://dx.doi.org/10.1074/jbc.M702792200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18156182	hybrid			2022-12-27	WOS:000253779600053
J	Drake, MT; Violin, JD; Whalen, EJ; Wisler, JW; Shenoy, SK; Lefkowitz, RJ				Drake, Matthew T.; Violin, Jonathan D.; Whalen, Erin J.; Wisler, James W.; Shenoy, Sudha K.; Lefkowitz, Robert J.			beta-Arrestin-biased Agonism at the beta 2-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; 7-TRANSMEMBRANE RECEPTORS; ERK1/2 ACTIVATION; INVERSE AGONISTS; TRANSGENIC MICE; KINASE; BETA(2)-ADRENOCEPTOR; PHOSPHORYLATION; EFFICACY	Classically, the beta(2)-adrenergic receptor (beta(2)AR)and other members of the seven-transmembrane receptor (7TMR) superfamily activate G protein-dependent signaling pathways in response to ligand stimulus. It has recently been discovered, however, that a number of 7TMRs, including beta 2AR, can signal via beta-arrestin- dependent pathways independent of G protein activation. It is currently unclear if among beta(2)AR agonists there exist ligands that disproportionately signal via G proteins or beta-arrestins and are hence "biased." Using a variety of approaches that include highly sensitive fluorescence resonance energy transfer-based methodologies, including a novel assay for receptor internalization, we show that the majority of known beta(2)AR agonists exhibit relative efficacies for beta-arrestin- associated activities (beta-arrestin membrane translocation and beta(2)AR internalization) identical to their relative efficacies for G protein dependent signaling ( cyclic AMP generation). However, for three beta AR ligands there is a marked bias toward beta-arrestin signaling; these ligands stimulate beta-arrestin-dependent receptor activities to a much greater extent than would be expected given their efficacy for G protein-dependent activity. Structural comparison of these biased ligands reveals that all three are catecholamines containing an ethyl substitution on the alpha-carbon, a motif absent on all of the other, unbiased ligands tested. Thus, these studies demonstrate the potential for developing a novel class of 7TMR ligands with a distinct bias for beta-arrestin-mediated signaling.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Drake, Matthew T.; Violin, Jonathan D.; Whalen, Erin J.; Wisler, James W.; Shenoy, Sudha K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; soler, martha maricel m gomez/L-6025-2014; Lefkowitz, Robert/AAW-2649-2021	Shenoy, Sudha/0000-0002-2565-4663; soler, martha maricel m gomez/0000-0002-4412-8108; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL16037, R01 HL70631] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P256, DOI 10.1016/S0165-6147(00)89037-9; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; YU SS, 1993, J BIOL CHEM, V268, P337; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	38	201	208	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5669	5676		10.1074/jbc.M708118200	http://dx.doi.org/10.1074/jbc.M708118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086673	hybrid			2022-12-27	WOS:000253426700047
J	Nishihara, T; Nagawa, F; Imai, T; Sakano, H				Nishihara, Tadashi; Nagawa, Fumikiyo; Imai, Takeshi; Sakano, Hitoshi			RAG-heptamer interaction in the synaptic complex is a crucial biochemical checkpoint for the 12/23 recombination rule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIRPIN FORMATION STEP; SINGLE ACTIVE-SITE; C-TERMINAL REGION; V(D)J RECOMBINATION; SIGNAL SEQUENCES; IN-VITRO; STRUCTURE REQUIREMENTS; SOMATIC RECOMBINATION; FOOTPRINT ANALYSIS; IMMUNE-SYSTEM	In V(D) J recombination, the RAG1 and RAG2 protein complex cleaves the recombination signal sequences (RSSs), generating a hairpin structure at the coding end. The cleavage occurs only between two RSSs with different spacer lengths of 12 and 23 bp. Here we report that in the synaptic complex, recombination-activating gene (RAG) proteins interact with the 7-mer and unstack the adjacent base in the coding region. We generated a RAG1 mutant that exhibits reduced RAG-7-mer interaction, unstacking of the coding base, and hairpin formation. Mutation of the 23-RSS at the first position of the 7-mer, which has been reported to impair the cleavage of the partner 12-RSS, demonstrated phenotypes similar to those of the RAG1 mutant; the RAG interaction and base unstacking in the partner 12-RSS are reduced. We propose that the RAG-7-mer interaction is a critical step for coding DNA distortion and hairpin formation in the context of the 12/23 rule.	[Nishihara, Tadashi; Nagawa, Fumikiyo; Imai, Takeshi; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Ciubotaru M, 2004, MOL CELL BIOL, V24, P8727, DOI 10.1128/MCB.24.19.8727-8744.2004; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; Clatworthy AE, 2003, MOL CELL, V12, P489, DOI 10.1016/S1097-2765(03)00305-8; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Eastman QM, 1997, NUCLEIC ACIDS RES, V25, P4370, DOI 10.1093/nar/25.21.4370; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kale SB, 2001, MOL CELL BIOL, V21, P459, DOI 10.1128/MCB.21.2.459-466.2001; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Landree MA, 2001, MOL CELL BIOL, V21, P4256, DOI 10.1128/MCB.21.13.4256-4264.2001; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Mo XM, 1999, J BIOL CHEM, V274, P7025, DOI 10.1074/jbc.274.11.7025; Mo XM, 2001, MOL CELL BIOL, V21, P2038, DOI 10.1128/MCB.21.6.2038-2047.2001; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Nagawa F, 2004, J BIOL CHEM, V279, P38360, DOI 10.1074/jbc.M405485200; Nagawa F, 2002, MOL CELL BIOL, V22, P7217, DOI 10.1128/MCB.22.20.7217-7225.2002; Nagawa F, 1998, MOL CELL BIOL, V18, P655, DOI 10.1128/MCB.18.1.655; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; Nishihara T, 2004, MOL CELL BIOL, V24, P3692, DOI 10.1128/MCB.24.9.3692-3702.2004; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Peak MM, 2003, J BIOL CHEM, V278, P18235, DOI 10.1074/jbc.M302041200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; West RB, 1998, MOL CELL BIOL, V18, P6408, DOI 10.1128/MCB.18.11.6408; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000	62	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4877	4885		10.1074/jbc.M709890200	http://dx.doi.org/10.1074/jbc.M709890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089566	hybrid			2022-12-27	WOS:000253426500045
J	Liu, LB; Pilch, PF				Liu, Libin; Pilch, Paul F.			A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; ADIPOCYTE CAVEOLAE; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; TRANSPORT VESICLES; INSULIN-RESISTANCE; RAT ADIPOCYTES; GOLGI-COMPLEX; ADIPOSE-CELLS; KNOCKOUT MICE	Cavin (PTRF) has been shown to be a highly abundant protein component of caveolae, but its functional role there is unknown. Here, we confirm that cavin co-localizes with caveolin-1 in adipocytes by confocal microscopy and co-distributes with caveolin-1 in lipid raft fractions by sucrose gradient flotation. However, cavin does not directly associate with caveolin-1 as solubilization of caveolae disrupts their interaction. Cholesterol depletion with beta-cyclodextrin causes a significant down-regulation of cavin from plasma membrane lipid raft fractions. Overexpression of cavin in HEK293-Cav-1 cells and knockdown of cavin in 3T3-L1 adipocytes enhances and diminishes caveolin-1 levels, respectively, indicating an important role for cavin in maintaining the level of caveolin-1. A truncated form of cavin, eGFP-cavin-1-322, which lacks 74 amino acids from the C-terminal, reveals a microtubular network localization by confocal microscopy. Disruption of cytoskeletal elements with latrunculin B or nocodazole diminishes cavin expression without affecting the caveolin-1 amount. We propose that the presence of cavin on the inside surface of caveolae stabilizes these structures, probably through interaction with the cytoskeleton, and cavin therefore plays an important role in caveolae formation and organization.	[Liu, Libin; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, 715 Albany St,K402, Boston, MA 02118 USA.	ppilch@bu.edu	Liu, Libin/ABH-6019-2020	Pilch, Paul/0000-0003-1997-0499; Liu, Libin/0000-0001-5056-1517	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030425] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK097708, DK-30425] Funding Source: Medline; PHS HHS [56935] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; CARPENTIER JL, 1976, J LIPID RES, V17, P335; Chamberlain LH, 2002, J BIOL CHEM, V277, P49750, DOI 10.1074/jbc.M206936200; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; DIETZEN DJ, 1995, J BIOL CHEM, V270, P6838, DOI 10.1074/jbc.270.12.6838; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FAN JY, 1983, J CELL SCI, V61, P219; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Hailstones D, 1998, J LIPID RES, V39, P369; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; IZUMI T, 1988, ANAT REC, V220, P225, DOI 10.1002/ar.1092200302; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Kanzaki M, 2002, J BIOL CHEM, V277, P25867, DOI 10.1074/jbc.C200292200; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Liu LB, 2003, J BIOL CHEM, V278, P30157, DOI 10.1074/jbc.M301511200; Liu LB, 2006, MOL BIOL CELL, V17, P4249, DOI 10.1091/mbc.E06-04-0278; MAKITA T, 1978, ARCH HISTOL JAPON, V41, P167, DOI 10.1679/aohc1950.41.167; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Mineo C, 1998, J CELL BIOL, V141, P601, DOI 10.1083/jcb.141.3.601; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101; PALADE GE, 1953, J APPL PHYS, V24, P1424; Park DS, 2002, AM J PATHOL, V160, P2207, DOI 10.1016/S0002-9440(10)61168-6; Parolini I, 1999, J BIOL CHEM, V274, P25718, DOI 10.1074/jbc.274.36.25718; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Razani B, 2001, J BIOL CHEM, V276, P38121; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Souto RP, 2003, J BIOL CHEM, V278, P18321, DOI 10.1074/jbc.M211541200; Sowa G, 2003, P NATL ACAD SCI USA, V100, P6511, DOI 10.1073/pnas.1031672100; Stahlhut M, 2000, MOL BIOL CELL, V11, P325, DOI 10.1091/mbc.11.1.325; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3584, DOI 10.1073/pnas.83.11.3584; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Vinten J, 2001, CELL TISSUE RES, V305, P99, DOI 10.1007/s004410100389; Vinten J, 2005, BBA-BIOMEMBRANES, V1717, P34, DOI 10.1016/j.bbamem.2005.09.013; Voldstedlund M, 2003, ACTA PHYSIOL SCAND, V179, P179, DOI 10.1046/j.1365-201X.2003.01183.x; VOLDSTEDLUND M, 1993, J MEMBRANE BIOL, V136, P63; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Westermann M, 2005, HISTOCHEM CELL BIOL, V123, P613, DOI 10.1007/s00418-004-0750-5; Wharton J, 2005, J BIOL CHEM, V280, P13483, DOI 10.1074/jbc.M413891200; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Zhao YY, 2002, P NATL ACAD SCI USA, V99, P11375, DOI 10.1073/pnas.172360799	63	209	217	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4314	4322		10.1074/jbc.M707890200	http://dx.doi.org/10.1074/jbc.M707890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056712	hybrid			2022-12-27	WOS:000253083500066
J	Wood, RJ; Hulett, MD				Wood, Robert J.; Hulett, Mark D.			Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; GROWTH-FACTOR; GENE-EXPRESSION; SULFATE PROTEOGLYCANS; MAMMALIAN HEPARANASE; MOLECULAR-PROPERTIES; CANCER METASTASIS; LYSOSOMAL-ENZYMES; PANCREATIC ADENOCARCINOMA; REGULATES DEGRADATION	Heparanase is a beta-D-endoglucuronidase that cleaves heparan sulfate, an important structural component of the extracellular matrix (ECM) and vascular basement membrane (BM). The cleavage of heparan sulfate by heparanase-expressing cells, such as activated leukocytes, metastatic tumor cells, and proliferating endothelial cells, facilitates degradation of the ECM/BM to promote cell invasion associated with inflammation, tumor metastasis, and angiogenesis. In addition to its enzymatic function, heparanase has also recently been shown to act as a cell adhesion and/or signaling molecule upon interaction with cell surfaces. Despite the obvious importance of the mechanisms for the binding of heparanase to cell surfaces, the receptor(s) for heparanase remain poorly defined. In this study, we identify the 300-kDa cation-independent mannose 6-phosphate receptor (CIMPR) as a cell surface receptor for heparanase. Purified platelet heparanase was shown to bind the human CIMPR expressed on the surface of a transfected mouse L cell line. Optimal binding was determined to be at a slightly acidic pH (6.5-7.0) with heparanase remaining on the cell surface for up to 10 min at 37 degrees C. In contrast, mouse L cells or Chinese hamster ovary cells expressing the cation-dependent mannose 6-phosphate receptor (CDMPR) showed no binding of heparanase. Interestingly, the binding of heparanase to CIMPR was independent of Man-6-P moieties. Significantly, primary human T cells upon activation were shown to dramatically up-regulate levels of cell surface-expressed CIMPR, which showed a concomitant increase in their capacity to bind heparanase. Furthermore, the tethering of heparanase to the surface of cells via CIMPR was found to increase their capacity to degrade an ECM or a reconstituted BM. These data suggest an important role for CIMPR in the cell surface presentation of enzymatically active heparanase for the efficient passage of T cells into an inflammatory site and have implications for the use of this mechanism by other cell types to enhance cell invasion.	[Wood, Robert J.; Hulett, Mark D.] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canc & Mol Immunol Grp, Acton, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Hulett, MD (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canc & Mol Immunol Grp, Acton, ACT 2601, Australia.	mark.hulett@anu.edu.au	Hulett, Mark D/C-4160-2012	Hulett, Mark/0000-0003-2072-5968				Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; BARTLETT MR, 1995, J LEUKOCYTE BIOL, V57, P207, DOI 10.1002/jlb.57.2.207; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; BRAUKER JH, 1986, EXP CELL RES, V164, P115, DOI 10.1016/0014-4827(86)90459-3; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chen Wen-Tien, 1992, Current Opinion in Cell Biology, V4, P802; CHUNG AE, 1977, CANCER RES, V37, P2072; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P21, DOI 10.1111/j.1432-1033.1985.tb09158.x; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; de Mestre AM, 2007, IMMUNOL CELL BIOL, V85, P205, DOI 10.1038/sj.icb.7100022; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GARMROUDI F, 1994, J BIOL CHEM, V269, P26944; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Haimov-Kochman R, 2002, MOL HUM REPROD, V8, P566, DOI 10.1093/molehr/8.6.566; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hindmarsh EJ, 2001, IMMUNOL CELL BIOL, V79, P436, DOI 10.1046/j.1440-1711.2001.01026.x; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; ISHAIMICHAELI R, 1990, CELL REGUL, V1, P833, DOI 10.1091/mbc.1.11.833; Kang JX, 1997, P NATL ACAD SCI USA, V94, P13671, DOI 10.1073/pnas.94.25.13671; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; Kim AW, 2002, J GASTROINTEST SURG, V6, P167, DOI 10.1016/S1091-255X(01)00087-7; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Koliopanos A, 2001, CANCER RES, V61, P4655; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; KYLE JW, 1988, J BIOL CHEM, V263, P16230; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; LIDER O, 1990, EUR J IMMUNOL, V20, P493, DOI 10.1002/eji.1830200306; LOBEL P, 1988, J BIOL CHEM, V263, P2563; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nadav L, 2002, J CELL SCI, V115, P2179; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; NOVOKHATNY V, 1992, J BIOL CHEM, V267, P3878; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; PARISH CR, 1987, INT J CANCER, V40, P511, DOI 10.1002/ijc.2910400414; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522; ROFF CF, 1983, EXP CELL RES, V144, P333, DOI 10.1016/0014-4827(83)90412-3; ROGERS SA, 1990, J BIOL CHEM, V265, P9722; Rohloff J, 2002, BRIT J CANCER, V86, P1270, DOI 10.1038/sj.bjc.6600232; Sasaki N, 2004, J IMMUNOL, V172, P3830, DOI 10.4049/jimmunol.172.6.3830; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Uno F, 2001, CANCER RES, V61, P7855; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2001, BIOCHIMIE, V83, P831, DOI 10.1016/S0300-9084(01)01318-9; VLODAVSKY I, 1999, CURRENT PROTOCOLS CE, V1; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Warren HS, 2003, J IMMUNOL METHODS, V280, P135, DOI 10.1016/S0022-1759(03)00106-6; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zcharia E, 2001, J MAMMARY GLAND BIOL, V6, P311, DOI 10.1023/A:1011375624902; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	92	41	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4165	4176		10.1074/jbc.M708723200	http://dx.doi.org/10.1074/jbc.M708723200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073203	hybrid			2022-12-27	WOS:000253083500052
J	Fei, Q; McCormack, AL; Di Monte, DA; Ethell, DW				Fei, Qingyan; McCormack, Alison L.; Di Monte, Donato A.; Ethell, Douglas W.			Paraquat neurotoxicity is mediated by a Bak-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVIRONMENTAL RISK-FACTORS; PARKINSONS-DISEASE; CELL-DEATH; OXIDATIVE STRESS; PROAPOPTOTIC BAX; APOPTOSIS; EXPOSURE; BCL-2; PESTICIDES; RESISTANCE	Paraquat (PQ) causes selective degeneration of dopaminergic neurons in the substantia nigra pars compacta, reproducing an important pathological feature of Parkinson disease. Oxidative stress, c-Jun N-terminal kinase activation, and alpha-synuclein aggregation are each induced by PQ, but details of the cell death mechanisms involved remain unclear. We have identified a Bak-dependent cell death mechanism that is required for PQ-induced neurotoxicity. PQ induced morphological and biochemical features that were consistent with apoptosis, including dose-dependent cytochrome c release, with subsequent caspase-3 and poly(ADP-ribose) polymerase cleavage. Changes in nuclear morphology and loss of viability were blocked by cycloheximide, caspase inhibitor, and Bcl-2 overexpression. Evaluation of Bcl-2 family members showed that PQ induced high levels of Bak, Bid, BNip3, and Noxa. Small interfering RNA-mediated knockdown of BNip3, Noxa, and Bak each protected cells from PQ, but Bax knockdown did not. Finally, we tested the sensitivity of Bak-deficient mice and found them to be resistant to PQ treatments that depleted tyrosine hydroxylase immuno-positive neurons in the substantia nigra pars compacta of wild-type mice.	[Fei, Qingyan; Ethell, Douglas W.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [McCormack, Alison L.; Di Monte, Donato A.] Parkinsons Inst, Sunnyvale, CA 94085 USA	University of California System; University of California Riverside	Ethell, DW (corresponding author), B1621 Comp Stats Bldg,UC Riverside,900 Univ Ave, Riverside, CA 92521 USA.	doug.ethell@ucr.edu		Di Monte, Donato/0000-0002-8296-836X				Bharath S, 2002, BIOCHEM PHARMACOL, V64, P1037, DOI 10.1016/S0006-2952(02)01174-7; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Casciano I, 2004, ANN NY ACAD SCI, V1028, P157, DOI 10.1196/annals.1322.017; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Eggert A, 2001, CANCER RES, V61, P1314; ETHELL DW, 2001, APOPTOSIS TECHNIQUES, P21; Filomeni G, 2006, ANTIOXID REDOX SIGN, V8, P2187, DOI 10.1089/ars.2006.8.2187; Gainetdinov RR, 1997, J NEUROCHEM, V69, P1322; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Green DR, 2007, CANCER CELL, V12, P97, DOI 10.1016/j.ccr.2007.07.011; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HERTZMAN C, 1990, AM J IND MED, V17, P349, DOI 10.1002/ajim.4700170307; HUBBLE JP, 1993, NEUROLOGY, V43, P1693, DOI 10.1212/WNL.43.9.1693; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; JIMENEZJIMENEZ FJ, 1992, J NEUROL SCI, V112, P30; Kim DH, 2004, J KOREAN MED SCI, V19, P113, DOI 10.3346/jkms.2004.19.1.113; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; McCormack AL, 2006, NEUROSCIENCE, V141, P929, DOI 10.1016/j.neuroscience.2006.03.069; McCormack AL, 2005, J NEUROCHEM, V93, P1030, DOI 10.1111/j.1471-4159.2005.03088.x; McCormack AL, 2003, J NEUROCHEM, V85, P82, DOI 10.1046/j.1471-4159.2003.01621.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Peng J, 2007, J NEUROSCI, V27, P6914, DOI 10.1523/JNEUROSCI.1569-07.2007; Ramachandiran S, 2007, TOXICOL SCI, V95, P163, DOI 10.1093/toxsci/kfl125; Richardson JR, 2005, TOXICOL SCI, V88, P193, DOI 10.1093/toxsci/kfi304; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; SEMCHUK KM, 1992, NEUROLOGY, V42, P1328, DOI 10.1212/WNL.42.7.1328; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; Sowter HM, 2001, CANCER RES, V61, P6669; Stephenson J, 2000, JAMA-J AM MED ASSOC, V283, P3055, DOI 10.1001/jama.283.23.3055; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Waterhouse NJ, 2001, J CELL BIOL, V153, P319, DOI 10.1083/jcb.153.2.319; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366	49	76	78	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3357	3364		10.1074/jbc.M708451200	http://dx.doi.org/10.1074/jbc.M708451200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056701	hybrid			2022-12-27	WOS:000253083000040
J	Raven, JF; Baltzis, D; Wang, S; Mounir, Z; Papadakis, AI; Gao, HQ; Koromilas, AE				Raven, Jennifer F.; Baltzis, Dionissios; Wang, Shuo; Mounir, Zineb; Papadakis, Andreas I.; Gao, Hong Qing; Koromilas, Antonis E.			PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2 alpha phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-CYCLE PROGRESSION; INITIATION-FACTOR 4E; ELONGATION-FACTOR 1A; TRANSLATIONAL CONTROL; ORNITHINE-DECARBOXYLASE; D1 EXPRESSION; FUNCTIONALLY SUBSTITUTE; MEDIATED DEGRADATION; SELECTIVE INHIBITOR	Cyclin D1 plays a critical role in controlling the G(1)/S transition via the regulation of cyclin-dependent kinase activity. Several studies have indicated that cyclin D1 translation is decreased upon activation of the eukaryotic initiation factor 2 alpha (eIF2 alpha) kinases. We examined the effect of activation of the eIF2 alpha kinases PKR and PKR-like endoplasmic reticulum kinase ( PERK) on cyclin D1 protein levels and translation and determined that cyclin D1 protein levels decrease upon the induction of PKR and PERK catalytic activity but that this decrease is not due to translation. Inhibition of the 26 S proteasome with MG132 rescued cyclin D1 protein levels, indicating that rather than inhibiting translation, PKR and PERK act to increase cyclin D1 degradation. Interestingly, this effect still requires eIF2 alpha phosphorylation at serine 51, as cyclin D1 remains unaffected in cells containing a non-phosphorylatable form of the protein. This proteasome-dependent degradation of cyclin D1 requires an intact ubiquitination pathway, although the ubiquitination of cyclin D1 is not itself affected. Furthermore, this degradation is independent of phosphorylation of cyclin D1 at threonine 286, which is mediated by the glycogen synthase kinase 3 beta and mitogen-activated protein kinase pathways as described in previous studies. Our study reveals a novel functional cross-talk between eIF2 alpha phosphorylation and the proteasomal degradation of cyclin D1 and that this degradation is dependent upon eIF2 alpha phosphorylation during short, but not prolonged, periods of stress.	[Raven, Jennifer F.; Baltzis, Dionissios; Wang, Shuo; Mounir, Zineb; Papadakis, Andreas I.; Gao, Hong Qing; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Raven, Jennifer F.; Baltzis, Dionissios; Mounir, Zineb; Papadakis, Andreas I.; Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ H2W 1S6, Canada	Lady Davis Institute; McGill University; McGill University	Koromilas, AE (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Rm 508,3999 Ch De La Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca						Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Balasubramanyam M, 2005, MOL CELL BIOCHEM, V275, P117, DOI 10.1007/s11010-005-1083-y; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Kronfeld-Kinar Y, 1999, CELL GROWTH DIFFER, V10, P201; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Malki A, 2002, BIOCHEM BIOPH RES CO, V296, P749, DOI 10.1016/S0006-291X(02)00935-X; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nelsen CJ, 2003, J BIOL CHEM, V278, P25853, DOI 10.1074/jbc.M302360200; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Salzberg S, 2000, EXP CELL RES, V254, P45, DOI 10.1006/excr.1999.4721; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sonenberg N, 2001, SCIENCE, V293, P818, DOI 10.1126/science.1062937; Stewart D, 2004, J GEN VIROL, V85, P1419, DOI 10.1099/vir.0.19679-0; Suzui M, 2002, CANCER RES, V62, P3997; Terada Y, 1999, KIDNEY INT, V56, P1258, DOI 10.1046/j.1523-1755.1999.00704.x; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; Yang K, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-33	67	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3097	3108		10.1074/jbc.M709677200	http://dx.doi.org/10.1074/jbc.M709677200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063576	hybrid			2022-12-27	WOS:000253083000013
J	Zhang, DW; Lu, C; Whiteman, M; Chance, B; Armstrong, JS				Zhang, Dawei; Lu, Chao; Whiteman, Matthew; Chance, Britton; Armstrong, Jeffrey S.			The mitochondrial permeability transition regulates cytochrome c release for apoptosis during endoplasmic reticulum stress by remodeling the cristae junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; CELL-DEATH; CYCLOPHILIN-D; OXIDATIVE STRESS; PORE; DNA; BAX; COOPERATE; BCL-2; LIFE	The role of the mitochondrial permeability transition (MPT) in apoptosis and necrosis is controversial. Here we show that the MPT regulates the release of cytochrome c for apoptosis during endoplasmic reticulum (ER) stress by remodeling the cristae junction (CJ). CEM cells, HCT116 colon cancer cells, and murine embryo fibroblast cells were treated with the ER stressor thapsigargin (THG), which led to cyclophilin D-dependent mitochondrial release of the profusion GTPase optic atrophy 1 (OPA1), which controls CJ integrity, and cytochrome c, leading to apoptosis. Interference RNA knockdown of Bax blocked OPA1 and cytochrome c release after THG treatment but did not prevent the MPT, showing that Bax was essential for the release of cytochrome c by MPT. In isolated mitochondria, MPT led to OPA1 and cytochrome c release independently of voltage-dependent anion channel and the outer membrane, indicating that the MPT is an inner membrane phenomenon. Last, the MPT was regulated by the electron transport chain but not mitochondrial reactive oxygen species, since THG-induced cell death was not blocked by antioxidants and did not occur in cells lacking mitochondrial DNA. Our results show that the MPT regulates CJ remodeling for cytochrome c-dependent apoptosis induced by ER stress and that mitochondrial electron transport is indispensable for this process.	[Zhang, Dawei; Lu, Chao; Armstrong, Jeffrey S.] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; [Zhang, Dawei] Inst Biomed Engn & Nanotechnol, Singapore 138669, Singapore; [Whiteman, Matthew] Univ Exeter, Penn Sch Med, Exeter EX1 2LU, Devon, England; [Whiteman, Matthew] Univ Plymouth, Penn Sch Med, Exeter EX1 2LU, Devon, England; [Chance, Britton] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	National University of Singapore; University of Exeter; University of Exeter; University of Plymouth; University of Pennsylvania	Zhang, DW (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	bchjsa@nus.edu.sg	Whiteman, Matthew/C-6079-2009; Lu, Chao/E-8047-2012	Whiteman, Matthew/0000-0002-6583-6779; Lu, Chao/0000-0003-0982-8122; Zhang, Dawei/0000-0001-6613-945X				Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Armstrong JS, 2006, MITOCHONDRION, V6, P225, DOI 10.1016/j.mito.2006.07.006; Armstrong JS, 2002, FASEB J, V16, P1263, DOI 10.1096/fj.02-0097fje; Arnoult D, 2005, J BIOL CHEM, V280, P35742, DOI 10.1074/jbc.M505970200; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chua YL, 2005, BIOCHEM BIOPH RES CO, V337, P375, DOI 10.1016/j.bbrc.2005.09.059; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; DENIAUD A, 2008, IN PRESS ONCOGENE; Fontaine E, 1999, J BIOENERG BIOMEMBR, V31, P335, DOI 10.1023/A:1005475802350; Forte M, 2005, J BIOENERG BIOMEMBR, V37, P121, DOI 10.1007/s10863-005-6565-9; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Gao WH, 2001, J CELL SCI, V114, P2855; Gil J, 2003, FREE RADICAL BIO MED, V35, P1500, DOI 10.1016/j.freeradbiomed.2003.08.022; Gogvadze V, 2004, BIOCHEM J, V378, P213, DOI 10.1042/BJ20031193; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Petit PX, 1996, FEBS LETT, V396, P7, DOI 10.1016/0014-5793(96)00988-X; PON LA, 2001, METHODS CELL BIOL MI, P75; PON LA, 2007, METHODS CELL BIOL MI, P355; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHNEIDER MD, 2005, SCI STKE, V287, P26; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Skulachev VP, 2000, IUBMB LIFE, V49, P365, DOI 10.1080/152165400410209; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Vergani L, 2004, EUR J BIOCHEM, V271, P3646, DOI 10.1111/j.1432-1033.2004.04298.x; Woodfield K, 1998, BIOCHEM J, V336, P287, DOI 10.1042/bj3360287; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamaguchi H, 2003, CANCER RES, V63, P1483; Zhang D, 2007, CELL DEATH DIFFER, V14, P703, DOI 10.1038/sj.cdd.4402072	45	51	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3476	3486		10.1074/jbc.M707528200	http://dx.doi.org/10.1074/jbc.M707528200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056990	hybrid			2022-12-27	WOS:000253083000053
J	Shi, Y; Cui, NR; Shi, WW; Jiang, C				Shi, Yun; Cui, Ningren; Shi, Weiwei; Jiang, Chun			A short motif in Kir6.1 consisting of four phosphorylation repeats underlies the vascular K-ATP channel inhibition by protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; RECTIFYING POTASSIUM CHANNELS; SUBUNIT STOICHIOMETRY; INTRACELLULAR PROTONS; INDUCED ACTIVATION; MESENTERIC-ARTERY; N-TERMINUS; TRAFFICKING; MODULATION; RECEPTOR	Vascular ATP-sensitiveK(+) channels are inhibited by multiple vasoconstricting hormones via the protein kinase C (PKC) pathway. However, the molecular substrates for PKC phosphorylation remain unknown. To identify the PKC sites, Kir6.1/SUR2B and Kir6.2/SUR2B were expressed in HEK293 cells. Following channel activation by pinacidil, the catalytic fragment of PKC inhibited the Kir6.1/SUR2B currents but not the Kir6.2/SUR2B currents. Phorbol 12-myristate 13-acetate (a PKCactivator) had similar effects. Using Kir6.1-Kir6.2 chimeras, two critical protein domains for the PKC-dependent channel inhibition were identified. The proximal N terminus of Kir6.1 was necessary for channel inhibition. Because there was no PKC phosphorylation site in the N-terminal region, our results suggest its potential involvement in channel gating. The distal C terminus of Kir6.1 was crucial where there are several consensus PKC sites. Mutation of Ser-354, Ser-379, Ser-385, Ser-391, or Ser-397 to non-phosphorylatable alanine reduced PKC inhibition moderately but significantly. Combined mutations of these residues had greater effects. The channel inhibition was almost completely abolished when 5 of them were jointly mutated. In vitro phosphorylation assay showed that 4 of the serine residues were necessary for the PKC-dependent P-32 incorporation into the distal C-terminal peptides. Thus, a motif containing four phosphorylation repeats is identified in the Kir6.1 subunit underlying the PKC-dependent inhibition of the Kir6.1/SUR2B channel. The presence of the phosphorylation motif in Kir6.1, but not in its close relative Kir6.2, suggests that the vascular K-ATP channel may have undergone evolutionary optimization, allowing it to be regulated by a variety of vasoconstricting hormones and neurotransmitters.	[Shi, Yun; Cui, Ningren; Shi, Weiwei; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 33 Gilmer St, Atlanta, GA 30302 USA.	cjiang@gsu.edu	SHI, WEIWEI/B-3477-2008; Shi, Yun S/T-8845-2018; Shi, Yun/B-5623-2009	SHI, WEIWEI/0000-0001-6216-712X; Shi, Yun/0000-0002-8842-9818	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067890] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL067890, HL 067890] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babenko AP, 2001, J BIOL CHEM, V276, P49083, DOI 10.1074/jbc.M108763200; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Cole WC, 2000, CIRC RES, V87, P112, DOI 10.1161/01.RES.87.2.112; Cui Y, 2002, AM J RESP CELL MOL, V26, P135, DOI 10.1165/ajrcmb.26.1.4622; Cukras CA, 2002, J GEN PHYSIOL, V120, P437, DOI 10.1085/jgp.20028621; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Hayabuchi Y, 2001, J PHYSIOL-LONDON, V530, P193, DOI 10.1111/j.1469-7793.2001.0193l.x; Hu KL, 2003, NEURON, V38, P417, DOI 10.1016/S0896-6273(03)00256-3; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Kondo C, 1998, RECEPTOR CHANNEL, V6, P129; Kubo M, 1997, J PHYSIOL-LONDON, V503, P489, DOI 10.1111/j.1469-7793.1997.489bg.x; Li L, 2003, J MEMBRANE BIOL, V196, P61, DOI 10.1007/s00232-003-0625-z; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Minami K, 2004, DIABETES, V53, pS176, DOI 10.2337/diabetes.53.suppl_3.S176; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park WS, 2005, J CARDIOVASC PHARM, V45, P99, DOI 10.1097/01.fjc.0000150442.49051.f7; Pearson WL, 2006, J MEMBRANE BIOL, V213, P187, DOI 10.1007/s00232-006-0058-6; Piao HL, 2001, J BIOL CHEM, V276, P36673, DOI 10.1074/jbc.M106123200; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Qu ZQ, 1999, J BIOL CHEM, V274, P13783, DOI 10.1074/jbc.274.20.13783; Quayle JM, 1997, PHYSIOL REV, V77, P1165, DOI 10.1152/physrev.1997.77.4.1165; Quinn KV, 2003, CIRC RES, V93, P646, DOI 10.1161/01.RES.0000095247.81449.8E; Sampson LJ, 2007, CARDIOVASC RES, V76, P61, DOI 10.1016/j.cardiores.2007.05.020; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; STANDEN NB, 1989, SCIENCE, V245, P177, DOI 10.1126/science.2501869; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Wang RP, 2007, MOL PHARMACOL, V71, P1646, DOI 10.1124/mol.106.030528; Wang RP, 2006, J MEMBRANE BIOL, V213, P155, DOI 10.1007/s00232-006-0038-x; Xu HX, 2001, J BIOL CHEM, V276, P38690, DOI 10.1074/jbc.M106595200; Xu HX, 2001, J BIOL CHEM, V276, P12898, DOI 10.1074/jbc.M009631200; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZHANG H, 1995, BRIT J PHARMACOL, V114, P662, DOI 10.1111/j.1476-5381.1995.tb17190.x	40	25	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2488	2494		10.1074/jbc.M708769200	http://dx.doi.org/10.1074/jbc.M708769200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048350	hybrid, Green Accepted			2022-12-27	WOS:000252622300005
J	Ma, XL; Sayed, N; Baskaran, P; Beuve, A; van den Akker, F				Ma, Xiaolei; Sayed, Nazish; Baskaran, Padmamalini; Beuve, Annie; van den Akker, Focco			PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; NITRIC-OXIDE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR GRAPHICS; CATALYTIC DOMAINS; ADENYLYL-CYCLASE; VASCULAR SYSTEM; HEME DOMAIN; NO; SENSOR	Signal transduction histidine kinases (STHK) are key for sensing environmental stresses, crucial for cell survival, and attain their sensing ability using small molecule binding domains. The N-terminal domain in an STHK from Nostoc punctiforme is of unknown function yet is homologous to the central region in soluble guanylyl cyclase (sGC), the main receptor for nitric oxide (NO). This domain is termed H-NOXA (or H-NOBA) because it is often associated with the heme-nitric oxide/oxygen binding (H-NOX) domain. A structure-function approach was taken to investigate the role of H-NOXA in STHK and sGC. We report the 2.1 angstrom resolution crystal structure of the dimerized H-NOXA domain of STHK, which reveals a Per-Arnt-Sim (PAS) fold. The H-NOXA monomers dimerize in a parallel arrangement juxtaposing their N-terminal helices and preceding residues. Such PAS dimerization is similar to that previously observed for EcDOS, AvNifL, and RmFixL. Deletion of 7 N-terminal residues affected dimer organization. Alanine scanning mutagenesis in sGC indicates that the H-NOXA domains of sGC could adopt a similar dimer organization. Although most putative interface mutations did decrease sGC beta 1 H-NOXA homodimerization, heterodimerization of full-length heterodimeric sGC was mostly unaffected, likely due to the additional dimerization contacts of sGC in the coiled-coil and catalytic domains. Exceptions are mutations sGC alpha 1 F285A and sGC beta 1 F217A, which each caused a drastic drop in NO stimulated activity, and mutations sGC alpha 1 Q368A and sGC beta 1 Q309A, which resulted in both a complete lack of activity and heterodimerization. Our structural and mutational results provide new insights into sGC and STHK dimerization and overall architecture.	[Ma, Xiaolei; van den Akker, Focco] Case Western Reserve Univ, Dept Biochem RT500, Cleveland, OH 44106 USA; [Sayed, Nazish; Baskaran, Padmamalini; Beuve, Annie] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pharmacol & Physiol, Newark, NJ 07103 USA	Case Western Reserve University; Rutgers State University New Brunswick; Rutgers State University Medical Center	van den Akker, F (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	focco.vandenakker@case.edu	Ma, Xiaolei/G-2058-2010	Sayed, Nazish/0000-0002-8229-721X; Ma, Xiaolei/0000-0002-5307-827X	NHLBI NIH HHS [R01 HL075329, R01 HL075329-02] Funding Source: Medline; NIGMS NIH HHS [R01 GM067640] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067640] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amezcua CA, 2002, STRUCTURE, V10, P1349, DOI 10.1016/S0969-2126(02)00857-2; Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Behrends S, 2003, CURR MED CHEM, V10, P291, DOI 10.2174/0929867033368286; BIRKTOFT JJ, 1989, BIOCHEMISTRY-US, V28, P6065, DOI 10.1021/bi00440a051; Cary SPL, 2006, TRENDS BIOCHEM SCI, V31, P231, DOI 10.1016/j.tibs.2006.02.003; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hering KW, 2006, BIOORG MED CHEM LETT, V16, P618, DOI 10.1016/j.bmcl.2005.10.093; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Koesling D, 2004, NEUROCHEM INT, V45, P813, DOI 10.1016/j.neuint.2004.03.011; Koglin M, 2001, J BIOL CHEM, V276, P30737, DOI 10.1074/jbc.M102549200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li ZQ, 2005, BIOCHEMISTRY-US, V44, P939, DOI 10.1021/bi0489208; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyatake H, 2000, J MOL BIOL, V301, P415, DOI 10.1006/jmbi.2000.3954; Morton DB, 2003, J EXP BIOL, V206, P937, DOI 10.1242/jeb.00160; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narikawa R, 2004, DNA RES, V11, P69, DOI 10.1093/dnares/11.2.69; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Ohmori M, 2001, DNA RES, V8, P271, DOI 10.1093/dnares/8.6.271; Padayatti PS, 2004, PHARMACOL THERAPEUT, V104, P83, DOI 10.1016/j.pharmthera.2004.08.003; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ponstingl H, 2003, J APPL CRYSTALLOGR, V36, P1116, DOI 10.1107/S0021889803012421; Pyriochou A, 2005, CELL SIGNAL, V17, P407, DOI 10.1016/j.cellsig.2004.09.008; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; Wagner C, 2005, J BIOL CHEM, V280, P17687, DOI 10.1074/jbc.M412099200; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; YUEN PST, 1994, J BIOL CHEM, V269, P791; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhao JM, 2006, P NATL ACAD SCI USA, V103, P11561, DOI 10.1073/pnas.0601567103; Zhou ZM, 2004, J BIOL CHEM, V279, P24935, DOI 10.1074/jbc.M402105200; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	62	78	81	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1167	1178		10.1074/jbc.M706218200	http://dx.doi.org/10.1074/jbc.M706218200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006497	Green Accepted, hybrid			2022-12-27	WOS:000252128100057
J	Bae, B; Ohene-Adjei, S; Kocherginskaya, S; Mackie, RI; Spies, MA; Cann, IKO; Nair, SK				Bae, Brian; Ohene-Adjei, Samuel; Kocherginskaya, Svetlana; Mackie, Roderick I.; Spies, M. Ashley; Cann, Isaac K. O.; Nair, Satish K.			Molecular basis for the selectivity and specificity of ligand recognition by the family 16 carbohydrate-binding modules from Thermoanaerobacterium polysaccharolyticum ManA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; HELIX CONFORMATION; CELLULOMONAS-FIMI; EXPRESSION; DOMAINS; COMPLEX; CLONING; HYDROLYSIS; COMPONENT; CHECKING	Enzymes that hydrolyze complex polysaccharides into simple sugars are modular in architecture and consist of single or multiple catalytic domains fused to targeting modules called carbohydratebinding modules (CBMs). CBMs bind to their ligands with high affinity and increase the efficiency of the catalytic components by targeting the enzymes to its substrate. Here we utilized a multidisciplinary approach to characterize each of the two family 16 carbohydrate-binding domain components of the highly active mannanase from the thermophile Thermoanaerobacterium polysaccharolyticum. These represent the first crystal structures of family 16 CBMs. Calorimetric analysis showed that although these CBMs demonstrate high specificity toward beta-1,4-linked sugars, they can engage both cello- and manno-polysaccharides. To elucidate the molecular basis for this specificity and selectivity, we have determined high resolution crystal structures of each of the two CBMs, as well as of binary complexes of CBM16-1 bound to either mannopentaose or cellopentaose. These results provide detailed molecular insights into ligand recognition and yield a framework for rational engineering experiments designed to expand the natural repertoire of these targeting modules.	[Bae, Brian; Spies, M. Ashley; Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Ohene-Adjei, Samuel; Kocherginskaya, Svetlana; Mackie, Roderick I.; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Mackie, Roderick I.; Spies, M. Ashley; Cann, Isaac K. O.; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 600 S Mathews Ave, Urbana, IL 61801 USA.	snair@uiuc.edu	Nair, Satish/AAY-2510-2021					Ahsan MM, 1996, J BACTERIOL, V178, P5732, DOI 10.1128/jb.178.19.5732-5740.1996; Black GW, 1996, BIOCHEM J, V319, P515, DOI 10.1042/bj3190515; Bolam DN, 2001, BIOCHEMISTRY-US, V40, P2468, DOI 10.1021/bi002564l; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Cann IKO, 1999, J BACTERIOL, V181, P1643, DOI 10.1128/JB.181.5.1643-1651.1999; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P14077, DOI 10.1073/pnas.212516199; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; COUGHLAN MP, 1985, BIOCHEM SOC T, V13, P405, DOI 10.1042/bst0130405; DIN N, 1994, MOL MICROBIOL, V11, P747, DOI 10.1111/j.1365-2958.1994.tb00352.x; Flint J, 2005, J BIOL CHEM, V280, P23718, DOI 10.1074/jbc.M501551200; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Ito Y, 2003, APPL ENVIRON MICROB, V69, P6969, DOI 10.1128/AEM.69.12.6969-6978.2003; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linder M, 1996, J BIOL CHEM, V271, P21268, DOI 10.1074/jbc.271.35.21268; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mizushima T, 2004, NAT STRUCT MOL BIOL, V11, P365, DOI 10.1038/nsmb732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SAITO H, 1991, CARBOHYD RES, V217, P181, DOI 10.1016/0008-6215(91)84128-2; Southall SM, 1999, FEBS LETT, V447, P58, DOI 10.1016/S0014-5793(99)00263-X; Sunna A, 2001, BIOCHEM J, V356, P791, DOI 10.1042/0264-6021:3560791; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; TOMME P, 1991, BIOCHEMISTRY-US, V35, P13885; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; Young SH, 2000, J BIOL CHEM, V275, P11874, DOI 10.1074/jbc.275.16.11874	36	39	42	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12415	12425		10.1074/jbc.M706513200	http://dx.doi.org/10.1074/jbc.M706513200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18025086	hybrid			2022-12-27	WOS:000255340000058
J	Metcalfe, C; Macdonald, IK; Murphy, EJ; Brown, KA; Raven, EL; Moody, PCE				Metcalfe, Clive; Macdonald, Isabel K.; Murphy, Emma J.; Brown, Katherine A.; Raven, Emma Lloyd; Moody, Peter C. E.			The tuberculosis prodrug isoniazid bound to activating peroxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; ARTHROMYCES-RAMOSUS PEROXIDASE; CYTOCHROME-C PEROXIDASE; MYCOBACTERIUM-TUBERCULOSIS; CATALASE-PEROXIDASE; CRYSTAL-STRUCTURE; ASCORBATE PEROXIDASE; SALICYLHYDROXAMIC ACID; BENZHYDROXAMIC ACID; ACTIVE-SITE	Isoniazid (INH, isonicotinic acid hydrazine) is one of only two therapeutic agents effective in treating tuberculosis. This prodrug is activated by the heme enzyme catalase peroxidase (KatG) endogenous to Mycobacterium tuberculosis but the mechanism of activation is poorly understood, in part because the binding interaction has not been properly established. The class I peroxidases ascorbate peroxidase (APX) and cytochrome c peroxidase (CcP) have active site structures very similar to KatG and are also capable of activating isoniazid. We report here the first crystal structures of complexes of isoniazid bound to APX and CcP. These are the first structures of isoniazid bound to any activating enzymes. The structures show that isoniazid binds close to the delta-heme edge in both APX and CcP, although the precise binding orientation varies slightly in the two cases. A second binding site for INH is found in APX at the gamma-heme edge close to the established ascorbate binding site, indicating that the gamma-heme edge can also support the binding of aromatic substrates. We also show that in an active site mutant of soybean APX (W41A) INH can bind directly to the heme iron to become an inhibitor and in a different mode when the distal histidine is replaced by alanine (H42A). These structures provide the first unambiguous evidence for the location of the isoniazid binding site in the class I peroxidases and provide rationalization of isoniazid resistance in naturally occurring KatG mutant strains of M. tuberculosis.	[Moody, Peter C. E.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Metcalfe, Clive; Macdonald, Isabel K.; Murphy, Emma J.; Raven, Emma Lloyd] Univ Leicester, Dept Chem, Leicester LE1 9HN, Leics, England; [Brown, Katherine A.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, Dept Life Sci, London SW7 2AZ, England	University of Leicester; University of Leicester; Imperial College London	Moody, PCE (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	peter.moody@le.ac.uk	Moody, Peter/A-6832-2008	Moody, Peter/0000-0003-1762-9238; Murphy, Emma/0000-0003-4551-8068; Raven, Emma/0000-0002-1643-8694; Metcalfe, Clive/0000-0002-7856-8574	Biotechnology and Biological Sciences Research Council [BB/C001184/1, B19083] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Badyal SK, 2006, J BIOL CHEM, V281, P24512, DOI 10.1074/jbc.M602602200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Bodiguel J, 2001, J AM CHEM SOC, V123, P3832, DOI 10.1021/ja002674f; COCKERILL FR, 1995, J INFECT DIS, V171, P240, DOI 10.1093/infdis/171.1.240; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINZEL BC, 1984, J BIOL CHEM, V259, P3027; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; FISHEL LA, 1987, BIOCHEMISTRY-US, V26, P351, DOI 10.1021/bi00376a004; Haas WH, 1997, ANTIMICROB AGENTS CH, V41, P1601, DOI 10.1128/AAC.41.7.1601; Henriksen A, 1998, BIOCHEMISTRY-US, V37, P8054, DOI 10.1021/bi980234j; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Itakura H, 1997, FEBS LETT, V412, P107, DOI 10.1016/S0014-5793(97)00751-5; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Lad L, 2002, EUR J BIOCHEM, V269, P3182, DOI 10.1046/j.1432-1033.2002.02998.x; Lad L, 2002, BIOCHEMISTRY-US, V41, P13774, DOI 10.1021/bi0261591; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Marttila HJ, 1998, ANTIMICROB AGENTS CH, V42, P2443, DOI 10.1128/AAC.42.9.2443; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musser JM, 1996, J INFECT DIS, V173, P196, DOI 10.1093/infdis/173.1.196; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Pierattelli R, 2004, J BIOL CHEM, V279, P39000, DOI 10.1074/jbc.M402384200; Poulos TL, 2007, NAT PROD REP, V24, P504, DOI 10.1039/b604195g; POULOS TL, 1980, J BIOL CHEM, V255, P575; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; ROUSE DA, 1995, ANTIMICROB AGENTS CH, V39, P2472, DOI 10.1128/AAC.39.11.2472; ROUSE DA, 1995, INFECT IMMUN, V63, P1427, DOI 10.1128/IAI.63.4.1427-1433.1995; Sharp KH, 2004, BIOCHEMISTRY-US, V43, P8644, DOI 10.1021/bi049343q; Sharp KH, 2003, NAT STRUCT BIOL, V10, P303, DOI 10.1038/nsb913; SUNDARAMOORTHY M, 1994, J BIOL CHEM, V269, P32759; Tsukamoto K, 1999, BIOCHEMISTRY-US, V38, P12558, DOI 10.1021/bi982925l; Welinder KG., 1992, CURR OPIN STRUC BIOL, V2, P388, DOI [10.1016/0959-440x(92)90230-5, DOI 10.1016/0959-440X(92)90230-5]; *WHO, 2002, REP INF DIS; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0	38	67	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6193	6200		10.1074/jbc.M707412200	http://dx.doi.org/10.1074/jbc.M707412200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18056997	Green Published, hybrid			2022-12-27	WOS:000253779500026
J	Cerpa, W; Godoy, JA; Alfaro, I; Farlas, GG; Metcalfe, MJ; Fuentealba, R; Bonansco, C; Inestrosa, NC				Cerpa, Waldo; Godoy, Juan A.; Alfaro, Ivan; Farlas, Ginny G.; Metcalfe, Maria J.; Fuentealba, Rodrigo; Bonansco, Christian; Inestrosa, Nibaldo C.			Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PEPTIDE NEUROTOXICITY; LONG-TERM POTENTIATION; EXCITATORY POSTSYNAPTIC CURRENTS; PAIRED-PULSE FACILITATION; SIGNALING PATHWAY; DROSOPHILA WNT; SYNAPSIN-I; PROTEIN; CATENIN; RELEASE	Wnt signaling is essential for neuronal development and the maintenance of the developing nervous system. Recent studies indicated that Wnt signaling modulates long term potentiation in adult hippocampal slices. We report here that different Wnt ligands are present in hippocampal neurons of rat embryo and adult rat, including Wnt-4, -5a, -7a, and -11. Wnt-7a acts as a canonical Wnt ligand in rat hippocampal neurons, stimulates clustering of presynaptic proteins, and induces recycling and exocytosis of synaptic vesicles as studied by FM dyes. Wnt-3a has a moderate effect on recycling of synaptic vesicles, and no effect of Wnt-1 and Wnt-5a was detected. Electrophysiological analysis on adult rat hippocampal slices indicates that Wnt-7a, but not Wnt-5a, increases neurotransmitter release in CA3-CA1 synapses by decreasing paired pulse facilitation and increasing the miniature excitatory post-synaptic currents frequency. These results indicate that the presynaptic function of rat hippocampal neurons is modulated by the canonical Wnt signaling.	[Cerpa, Waldo; Godoy, Juan A.; Alfaro, Ivan; Farlas, Ginny G.; Metcalfe, Maria J.; Fuentealba, Rodrigo; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regul Celular & Patol Joaquin V Luco, Dept Biol Celular & Mol, Santiago 8331010, Chile; [Bonansco, Christian] Univ Valparaiso, Fac Ciencias, Dept Fisiol, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Valparaiso	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Biomed Ctr, CRCP, Almeda 340, Santiago 8331010, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018; Cerpa, Waldo/GSI-5204-2022	Godoy, Juan A/0000-0001-9920-6698; Cerpa, Waldo/0000-0001-7344-0144; Metcalfe, Mariajose/0000-0002-5016-8739; Fuentealba, Rodrigo/0000-0001-8724-091X				Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bonansco C, 2003, HIPPOCAMPUS, V13, P150, DOI 10.1002/hipo.10067; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CLARK KA, 1994, EXP BRAIN RES, V101, P272, DOI 10.1007/BF00228747; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Fradkin LG, 2005, J NEUROSCI, V25, P10376, DOI 10.1523/JNEUROSCI.3429-05.2005; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Inestrosa NC, 2002, NEUROCHEM INT, V41, P341, DOI 10.1016/S0197-0186(02)00056-6; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; KUHNT U, 1994, NEUROSCIENCE, V62, P391, DOI 10.1016/0306-4522(94)90374-3; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	47	166	172	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5918	5927		10.1074/jbc.M705943200	http://dx.doi.org/10.1074/jbc.M705943200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096705	hybrid			2022-12-27	WOS:000253426700070
J	Long, J; Gallagher, TRA; Cavey, JR; Sheppard, PW; Ralston, SH; Layfield, R; Searle, MS				Long, Jed; Gallagher, Thomas R. A.; Cavey, James R.; Sheppard, Paul W.; Ralston, Stuart H.; Layfield, Robert; Searle, Mark S.			Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; REPAIR PROTEIN HHR23A; LYS48-LINKED POLYUBIQUITIN CHAIN; FAMILIAL EXPANSILE OSTEOLYSIS; CAUSE PAGETS-DISEASE; UBA DOMAIN; 3-DIMENSIONAL STRUCTURES; BIOMOLECULAR STRUCTURE; MULTIUBIQUITIN CHAINS; NMR-SPECTROSCOPY	The p62 protein functions as a scaffold in signaling pathways that lead to activation of NF-kappa B and is an important regulator of osteoclastogenesis. Mutations affecting the receptor activator of NF-kappa B signaling axis can result in human skeletal disorders, including those identified in the C-terminal ubiquitin-associated (UBA) domain of p62 in patients with Paget disease of bone. These observations suggest that the disease may involve a common mechanism related to alterations in the ubiquitin-binding properties of p62. The structural basis for ubiquitin recognition by the UBA domain of p62 has been investigated using NMR and reveals a novel binding mechanism involving a slow exchange structural reorganization of the UBA domain to a "bound" non-canonical UBA conformation that is not significantly populated in the absence of ubiquitin. The repacking of the three-helix bundle generates a binding surface localized around the conserved Xaa-Gly-Phe-Xaa loop that appears to optimize both hydrophobic and electrostatic surface complementarity with ubiquitin. NMR titration analysis shows that the p62-UBA binds to Lys(48)-linked di-ubiquitin with similar to 4-fold lower affinity than to mono-ubiquitin, suggesting preferential binding of the p62-UBA to single ubiquitin units, consistent with the apparent in vivo preference of the p62 protein for Lys(63)-linked polyubiquitin chains (which adopt a more open and extended structure). The conformational switch observed on binding may represent a novel mechanism that underlies specificity in regulating signal-induced protein recognition events.	[Long, Jed; Gallagher, Thomas R. A.; Searle, Mark S.] Univ Nottingham, Ctr Biomol Sci, Sch Chem, Nottingham NG7 2RD, England; [Cavey, James R.; Layfield, Robert] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; [Sheppard, Paul W.] Palatine House, BIOMOL Int, Exeter EX2 8NL, Devon, England; [Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Rheumat Dis Unit, Edinburgh EH2 2XU, Midlothian, Scotland	University of Nottingham; University of Nottingham; University of Edinburgh	Layfield, R (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Chem, Nottingham NG7 2RD, England.	robert.layfield@nottingham.ac.uk; mark.searle@nottingham.uk		Layfield, Robert/0000-0003-0702-3259; Searle, Mark/0000-0001-8387-9978; Cavey, James/0000-0003-4515-0515	Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cavey JR, 2006, CALCIFIED TISSUE INT, V78, P271, DOI 10.1007/s00223-005-1299-6; Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; EVANS CL, 2008, IN PRESS PROTEINS ST; Falchetti A, 2004, J BONE MINER RES, V19, P1013, DOI 10.1359/JBMR.040203; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hocking LJ, 2004, J BONE MINER RES, V19, P1122, DOI 10.1359/JBMR.0403015; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Ishii Y, 2001, J BIOMOL NMR, V21, P141, DOI 10.1023/A:1012417721455; Johnson-Pais TL, 2003, J BONE MINER RES, V18, P1748, DOI 10.1359/jbmr.2003.18.10.1748; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kanis J., 1998, PATHOPHYSIOLOGY TREA, VSecond; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Mesleh MF, 2003, J AM CHEM SOC, V125, P8928, DOI 10.1021/ja034211q; Mittag T, 2006, J AM CHEM SOC, V128, P9844, DOI 10.1021/ja0616128; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh JD, 2005, J MAGN RESON, V174, P152, DOI 10.1016/j.jmr.2005.01.018; Walsh JP, 2004, MED J AUSTRALIA, V181, P262, DOI 10.5694/j.1326-5377.2004.tb06265.x; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Whyte MP, 2002, J BONE MINER RES, V17, P26, DOI 10.1359/jbmr.2002.17.1.26; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152	67	115	117	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5427	5440		10.1074/jbc.M704973200	http://dx.doi.org/10.1074/jbc.M704973200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18083707	hybrid			2022-12-27	WOS:000253426700023
J	Gamsjaeger, R; Swanton, MK; Kobus, FJ; Lehtomaki, E; Lowry, JA; Kwan, AH; Matthews, JM; Mackay, JP				Gamsjaeger, Roland; Swanton, Michael K.; Kobus, Felix J.; Lehtomaki, Eija; Lowry, Jason A.; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.			Structural and biophysical analysis of the DNA binding properties of myelin transcription factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; ZINC-FINGER; OLIGODENDROCYTE LINEAGE; PROTEIN STRUCTURES; ESCHERICHIA-COLI; HISTONE H3K4ME3; NERVOUS-SYSTEM; RECOGNITION; FAMILY; DOCKING	Zinc binding domains, or zinc fingers (ZnFs), form one of the most numerous and most diverse superclasses of protein structural motifs in eukaryotes. Although our understanding of the functions of several classes of these domains is relatively well developed, we know much less about the molecular mechanisms of action of many others. Myelin transcription factor 1 (MyT1) type ZnFs are found in organisms as diverse as nematodes and mammals and are found in a range of sequence contexts. MyT1, one of the early transcription factors expressed in the developing central nervous system, contains seven MyT1 ZnFs that are very highly conserved both within the protein and between species. We have used a range of biophysical techniques, including NMR spectroscopy and data-driven macromolecular docking, to investigate the structural basis for the interaction between MyT1 ZnFs and DNA. Our data indicate that MyT1 ZnFs recognize the major groove of DNA in a way that appears to differ from other known zinc binding domains.	[Gamsjaeger, Roland; Swanton, Michael K.; Kobus, Felix J.; Lehtomaki, Eija; Lowry, Jason A.; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney	Mackay, JP (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	j.mackay@mmb.usyd.edu.au	Matthews, Jacqueline/A-7322-2013; Mackay, Joel/D-6834-2011	Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Matthews, Jacqueline/0000-0001-8518-3472; Mackay, Joel/0000-0001-7508-8033				Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Berkovits-Cymet HJ, 2004, BIOCHEMISTRY-US, V43, P898, DOI 10.1021/bi035159d; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EDISON AS, 1994, J BIOMOL NMR, V4, P543, DOI 10.1007/BF00156619; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Macke T., 1998, MODELING UNUSUAL NUC; Matsushita F, 2002, MECH DEVELOP, V118, P209, DOI 10.1016/S0925-4773(02)00250-2; NEUHAUS D, 1992, J MOL BIOL, V228, P637, DOI 10.1016/0022-2836(92)90846-C; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; PELTON JG, 1993, PROTEIN SCI, V2, P543; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Simpson RJY, 2003, J BIOL CHEM, V278, P28011, DOI 10.1074/jbc.M211146200; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zhang XX, 2006, J BIOL CHEM, V281, P8296, DOI 10.1074/jbc.M512015200	50	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5158	5167		10.1074/jbc.M703772200	http://dx.doi.org/10.1074/jbc.M703772200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073212	hybrid			2022-12-27	WOS:000253426500073
J	Perez, TD; Tamada, M; Sheetz, MP; Nelson, WJ				Perez, Tomas D.; Tamada, Masako; Sheetz, Michael P.; Nelson, W. James			Immediate-early signaling induced by E-cadherin engagement and adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; SINGLE-PARTICLE TRACKING; RHO-FAMILY GTPASES; PHOSPHATIDYLINOSITOL 3-KINASE; CONTACT FORMATION; BETA-CATENIN; FLUORESCENT PROTEIN; MEMBRANE ADHESION; EPITHELIAL-CELLS; RAC	Epithelial cell-cell interactions require localized adhesive interactions between E-cadherin on opposing membranes and the activation of downstream signaling pathways that affect membrane and actin dynamics. However, it is not known whether E-cadherin engagement and activation of these signaling pathways are locally coordinated or whether signaling is sustained or locally down-regulated like other receptor-mediated pathways. To obtain high spatiotemporal resolution of immediate early signaling events upon E-cadherin engagement, we used laser tweezers to place beads coated with functional E-cadherin extracellular domain on cells. We show that cellular E-cadherin accumulated rapidly around beads, reaching a sustained plateau level in 1-3 min. Phosphoinositides and Rac1 co-accumulated with E-cadherin, reached peak levels with E-cadherin, but then rapidly dispersed. Both E-cadherin and Rac1 accumulated independently of Rac1 GTP binding/hydrolysis, but these activities were required for Rac1 dispersal. E-cadherin accumulation was dependent on membrane dynamics and actin polymerization, but actin did not stably co-accumulate with E-cadherin; mathematical modeling showed that diffusion-mediated trapping could account for the initial E-cadherin accumulation. We propose that initial E-cadherin accumulation requires active membrane dynamics and involves diffusion-mediated trapping at contact sites; to propagate further contacts, phosphatidylinositol 3-kinase and Rac1 are transiently activated by E-cadherin engagement and initiate a new round of membrane dynamics, but they are subsequently suppressed at that site to allow maintenance of weak E-cadherin mediated adhesion.	[Perez, Tomas D.; Nelson, W. James] Stanford Univ, James H Clark Ctr, Bio X Program, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Tamada, Masako; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Stanford University; Stanford University; Columbia University	Nelson, WJ (corresponding author), Stanford Univ, James H Clark Ctr, Bio X Program, Dept Mol & Cellular Physiol, 318 Campus Dr,E200-B, Stanford, CA 94305 USA.	wjnelson@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM035527, GM35527, R01 GM035527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Betson M, 2002, J BIOL CHEM, V277, P36962, DOI 10.1074/jbc.M207358200; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Drees Frauke, 2004, V294, P303; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Lambert M, 2000, J CELL SCI, V113, P2207; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nakagawa M, 2001, J CELL SCI, V114, P1829; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Singh S., 1976, Sugarcane Pathologists' Newsletter, P1; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thoumine O, 2005, BIOPHYS J, V89, pL40, DOI 10.1529/biophysj.105.071688; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	41	78	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5014	5022		10.1074/jbc.M705209200	http://dx.doi.org/10.1074/jbc.M705209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089563	hybrid, Green Accepted			2022-12-27	WOS:000253426500059
J	Tanimoto, A; Murata, Y; Wang, KY; Tsutsui, M; Kohno, K; Sasaguri, Y				Tanimoto, Akihide; Murata, Yoshitaka; Wang, Ke-Yong; Tsutsui, Masato; Kohno, Kimitoshi; Sasaguri, Yasuyuki			Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via jak2-stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CHEMOKINE RECEPTOR EXPRESSION; MESSENGER-RNA STABILITY; GM-CSF; GENE-EXPRESSION; GROWTH-FACTOR; BINDING PROTEIN; FLOW CONDITIONS; RHO GTPASE; IN-VITRO	The proinflammatory cytokine granulocyte-macrophage colonystimulating factor (GM-CSF) is expressed in inflammatory and atherosclerotic lesions. GM-CSF is known to enhance monocytic expression of monocyte chemoattractant protein-1 (MCP-1). However, the molecular mechanism(s) by which GMCSF up-regulates the MCP-1 expression remains to be clarified. Thus, in this study, we examined our hypothesis that GM-CSF up-regulates the MCP-1 expression via Jak2-Stat5 signaling pathway. In human monocytic cell line U937, GM-CSF increased MCP-1 expression in protein and mRNA levels. Furthermore, analysis of the GM-CSF promoter element revealed that the STAT5 (signal transducer and activator of transcription5) transcription factor binding site, located between-152 and -144 upstream of the transcription start site, as well as Janus kinase-2-mediated Stat5 activation were necessary for the GM-CSF-induced transcriptional up-regulation of the MCP-1 gene. This GM-CSF-induced MCP-1 expression, measured as both protein and mRNA levels, was down-regulated by atorvastatin, a 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor. However, this decrease in MCP-1 expression was not at the transcriptional level of MCP-1 gene but rather at the level of the stability of MCP-1 mRNA. These results indicate that GM-CSF regulates MCP-1 expression via Janus kinase-2-Stat5 pathway and by a novel regulatory mechanism of statins to reduce inflammatory reactions by down-regulating the expression of monocytic MCP-1, which promotes atherogenesis.	[Tanimoto, Akihide; Wang, Ke-Yong; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Tsutsui, Masato] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Murata, Yoshitaka] Kyurin Corp, Kyurin Omtest Lab Dept, Yahatanishi Ku, Kitakyushu, Fukuoka 8060046, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Tanimoto, A (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	aki@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229				Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Biswas P, 1998, BLOOD, V91, P258, DOI 10.1182/blood.V91.1.258.258_258_265; Bogdanov VY, 1998, J BIOL CHEM, V273, P24932, DOI 10.1074/jbc.273.38.24932; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf; Chen YM, 2004, J PHARMACOL EXP THER, V309, P978, DOI 10.1124/jpet.103.062620; Choi EK, 2004, FEBS LETT, V559, P141, DOI 10.1016/S0014-5793(04)00058-4; EIERMAN DF, 1989, J IMMUNOL, V142, P1970; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hansson GK, 1997, CURR OPIN LIPIDOL, V8, P301, DOI 10.1097/00041433-199710000-00009; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Jarmin DI, 1999, EXP HEMATOL, V27, P1735, DOI 10.1016/S0301-472X(99)00115-0; Jost MM, 2003, FASEB J, V17, P2281, DOI 10.1096/fj.03-0071fje; Kao CY, 1999, J BIOL CHEM, V274, P23043, DOI 10.1074/jbc.274.33.23043; Kawakami A, 2002, CIRC RES, V91, P263, DOI 10.1161/01.RES.0000028454.42385.8B; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kohno Y, 2004, PATHOL INT, V54, P693, DOI 10.1111/j.1440-1827.2004.01682.x; Kwon EM, 2000, BLOOD, V95, P2552, DOI 10.1182/blood.V95.8.2552.008k30_2552_2558; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; Murata Y, 2005, ARTERIOSCL THROM VAS, V25, P430, DOI 10.1161/01.ATV.0000148705.13411.65; Ni WH, 2001, CIRCULATION, V103, P2096; Plenz G, 1997, ARTERIOSCL THROM VAS, V17, P2489, DOI 10.1161/01.ATV.17.11.2489; Poon M, 1999, MOL CELL BIOL, V19, P6471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Takahashi M, 1996, CIRCULATION, V93, P1185, DOI 10.1161/01.CIR.93.6.1185; TAKAHASHI M, 1995, CIRC RES, V76, P750, DOI 10.1161/01.RES.76.5.750; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; TAUBMAN MB, 1992, CIRC RES, V70, P314, DOI 10.1161/01.RES.70.2.314; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Veillard NR, 2006, ATHEROSCLEROSIS, V188, P51, DOI 10.1016/j.atherosclerosis.2005.10.015; Warby TJ, 2003, J VIROL, V77, P12630, DOI 10.1128/JVI.77.23.12630-12638.2003; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Wu LH, 2001, BIOCHEM BIOPH RES CO, V285, P300, DOI 10.1006/bbrc.2001.5161; YAMADA M, 2001, ARTERIOSCLER THROMB, V23, P1996; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143	45	41	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4643	4651		10.1074/jbc.M708853200	http://dx.doi.org/10.1074/jbc.M708853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089573	hybrid			2022-12-27	WOS:000253426500021
J	Kiss, AZ; Ruban, AV; Horton, P				Kiss, Anett Z.; Ruban, Alexander V.; Horton, Peter			The PsbS protein controls the organization of the photosystem II antenna in higher plant thylakoid membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; GREEN PLANTS; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; CIRCULAR-DICHROISM; EXCITATION-ENERGY; CHLOROPLASTS; PHOTOPROTECTION; SUBUNIT; PHOTOSYNTHESIS	The PsbS subunit of photosystem II (PSII) plays a key role in nonphotochemical quenching (NPQ), the major photoprotective regulatory mechanism in higher plant thylakoid membranes, but its mechanism of action is unknown. Here we describe direct evidence that PsbS controls the organization of PSII and its light harvesting system (LHCII). The changes in chlorophyll fluorescence amplitude associated with the Mg2+-dependent restacking of thylakoid membranes were measured in thylakoids prepared from wild-type plants, a PsbS-deficient mutant and a PsbS overexpresser. The Mg2+ requirement and sigmoidicity of the titration curves for the fluorescence rise were negatively correlated with the level of PsbS. Using a range of PsbS mutants, this effect of PsbS was shown not to depend upon its efficacy in controlling NPQ, but to be related only to protein concentration. Electron microscopy and fluorescence spectroscopy showed that this effect was because of enhancement of the Mg2+-dependent re-association of PSII and LHCII by PsbS, rather than an effect on stacking per se. In the presence of PsbS the LHCII.PSII complex was also more readily removed from thylakoid membranes by detergent, and the level of PsbS protein correlated with the amplitude of the psi-type CD signal originating from features of LHCII.PSII organization. It is proposed that PsbS regulates the interaction between LHCII and PSII in the grana membranes, explaining how it acts as a pH-dependent trigger of the conformational changes within the PSII light harvesting system that result in NPQ.	[Ruban, Alexander V.] Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England; [Kiss, Anett Z.; Horton, Peter] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; Queen Mary University London; University of Sheffield	Kiss, AZ (corresponding author), Univ London Queen Mary Coll, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	a.ruban@qmul.ac.uk; p.horton@sheffield.ac.uk	Horton, Peter/A-3958-2012	Horton, Peter/0000-0002-6095-1460; Kiss, Anett/0000-0001-5720-3325	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARNTZEN CJ, 1976, BIOCHIM BIOPHYS ACTA, V449, P259, DOI 10.1016/0005-2728(76)90138-9; BARBER J, 1982, ANNU REV PLANT PHYS, V33, P261, DOI 10.1146/annurev.pp.33.060182.001401; BARZDA V, 1994, BIOCHEMISTRY-US, V33, P10837, DOI 10.1021/bi00201a034; Bergantino E, 2003, P NATL ACAD SCI USA, V100, P15265, DOI 10.1073/pnas.2533072100; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; BRIANTAIS JM, 1979, BIOCHIM BIOPHYS ACTA, V548, P128, DOI 10.1016/0005-2728(79)90193-2; BUTLER WL, 1975, BIOCHIM BIOPHYS ACTA, V396, P72, DOI 10.1016/0005-2728(75)90190-5; Crouchman S, 2006, FEBS LETT, V580, P2053, DOI 10.1016/j.febslet.2006.03.005; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; GARAB G, 1988, BIOCHEMISTRY-US, V27, P2425, DOI 10.1021/bi00407a027; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; Horton P, 2005, FEBS LETT, V579, P4201, DOI 10.1016/j.febslet.2005.07.003; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Jansson S, 1997, BBA-BIOENERGETICS, V1320, P297, DOI 10.1016/S0005-2728(97)00033-9; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JANSSON S, 1994, BBA-BIOENERGETICS, V1184, P1, DOI 10.1016/0005-2728(94)90148-1; KELLER D, 1986, J CHEM PHYS, V84, P2972, DOI 10.1063/1.450278; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, P NATL ACAD SCI USA, V99, P15222, DOI 10.1073/pnas.232447699; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V189, P171, DOI 10.1016/0005-2728(69)90045-0; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peterson RB, 2001, PLANTA, V214, P142, DOI 10.1007/s004250100601; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2006, J BIOL CHEM, V281, P14981, DOI 10.1074/jbc.M511415200; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBIN BT, 1981, BIOCHIM BIOPHYS ACTA, V634, P174, DOI 10.1016/0005-2728(81)90137-7; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; van Amerongen H, 2001, J PHYS CHEM B, V105, P604, DOI 10.1021/jp0028406; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	37	144	151	2	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3972	3978		10.1074/jbc.M707410200	http://dx.doi.org/10.1074/jbc.M707410200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055452	hybrid			2022-12-27	WOS:000253083500031
J	Anelli, V; Gault, CR; Cheng, AB; Obeid, LM				Anelli, Viviana; Gault, Christopher R.; Cheng, Amy B.; Obeid, Lina M.			Sphingosine kinase 1 is up-regulated during hypoxia in U87MG glioma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; FACTOR-INDUCED ACTIVATION; INDUCIBLE FACTOR-ALPHA; SPHINGOSINE-1-PHOSPHATE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; EXTRACELLULAR RELEASE; MOLECULAR-CLONING; KINASE EXPRESSION; GRANULE CELLS; PROTEIN	Sphingosine 1-phosphate (S1P), a sphingolipid metabolite that plays an important role in the regulation of cell survival, growth, migration, and angiogenesis, acts both inside the cells and as an extracellular mediator through binding to five G protein-coupled receptors (S1P(1-5)). Sphingosine kinase 1 (SK1), the enzyme responsible for S1P production, is overexpressed in many solid tumors, including gliomas. One common feature of these tumors is the presence of "hypoxic regions," characterized by cells expressing high levels of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha, two transcription regulators that modulate the levels of proteins with crucial roles in tumor progression. So far, nothing is known about the role and the regulation of SK1 during tumor-induced hypoxia or about SK1 regulation and HIFs. Here we investigated the role of HIF-1 alpha and HIF-2 alpha in the regulation of SK1 during hypoxic stress in glioma-derived U87MG cells. We report that hypoxia increases SK1 mRNA levels, protein expression, and enzyme activity, followed by intracellular S1P production and S1P release. Interestingly, knockdown of HIF-2 alpha by small interfering RNA abolished the induction of SK1 and the production of extracellular S1P after CoCl2 treatment, whereas HIF-1 alpha small interfering RNA resulted in an increase of HIF-2 alpha and of SK1 protein levels. Moreover, using chromatin immunoprecipitation analysis, we demonstrate that HIF-2 alpha binds the SK1 promoter. Functionally, we demonstrate that conditioned medium from hypoxia-treated tumor cells results in neoangiogenesis in human umbilical vein endothelial cells in a S1P receptor-dependent manner. These studies provide evidence of a link between S1P production as a potent angiogenic agent and the hypoxic phenotype observed in many tumors.	[Obeid, Lina M.] Ralph H Johnson Affairs Med Ctr, Charleston, SC 29401 USA; [Gault, Christopher R.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Anelli, Viviana; Cheng, Amy B.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Anelli, Viviana] Univ Milan, Dept Med Chem Biochem & Biotechnol, I-20090 Milan, Italy	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; University of Milan	Obeid, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med Geriatr, POB 250779, Charleston, SC 29403 USA.	obeid@musc.edu		ANELLI, Viviana Vittoria/0000-0003-1964-3252; obeid, lina/0000-0002-0734-0847	NCI NIH HHS [P01 CA097132] Funding Source: Medline; NIGMS NIH HHS [R01 GM062887] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad M, 2006, PROSTAG OTH LIPID M, V79, P278, DOI 10.1016/j.prostaglandins.2006.03.001; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Fieber CB, 2006, EXP CELL RES, V312, P1164, DOI 10.1016/j.yexcr.2006.01.022; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2003, CANCER RES, V63, P5962; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Heringdorf DM, 1999, FEBS LETT, V461, P217, DOI 10.1016/S0014-5793(99)01463-5; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Igarashi J, 2003, P NATL ACAD SCI USA, V100, P10664, DOI 10.1073/pnas.1934494100; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2005, J HISTOCHEM CYTOCHEM, V53, P1159, DOI 10.1369/jhc.4A6606.2005; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Khatua S, 2003, CANCER RES, V63, P1865; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Leek RD, 2002, CANCER RES, V62, P1326; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Nava VE, 2000, FEBS LETT, V473, P81, DOI 10.1016/S0014-5793(00)01510-6; O'Rourke JF, 1997, ONCOL RES, V9, P327; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Riboni L, 2000, J NEUROCHEM, V75, P503, DOI 10.1046/j.1471-4159.2000.0750503.x; Rius RA, 1997, FEBS LETT, V417, P173, DOI 10.1016/S0014-5793(97)01277-5; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Srinivas V, 1999, BIOCHEM BIOPH RES CO, V260, P557, DOI 10.1006/bbrc.1999.0878; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Tao R, 2007, CARDIOVASC RES, V74, P56, DOI 10.1016/j.cardiores.2007.01.015; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wykoff CC, 2004, BRIT J CANCER, V90, P1235, DOI 10.1038/sj.bjc.6601657; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Young N, 2006, THESCIENTIFICWORLDJO, V6, P946, DOI 10.1100/tsw.2006.182; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Yun JK, 2002, ARCH BIOCHEM BIOPHYS, V408, P78, DOI 10.1016/S0003-9861(02)00526-X	62	108	119	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3365	3375		10.1074/jbc.M708241200	http://dx.doi.org/10.1074/jbc.M708241200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055454	hybrid			2022-12-27	WOS:000253083000041
J	Connors, EC; Ballif, BA; Morielli, AD				Connors, Emilee C.; Ballif, Bryan A.; Morielli, Anthony D.			Homeostatic regulation of kv1.2 potassium channel trafficking by cyclic AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-DEPENDENT SUPPRESSION; ROOT GANGLION NEURONS; GENE-EXPRESSION; MESSENGER-RNA; CELL LINE; PHOSPHORYLATION; ENDOCYTOSIS; CAMP; CORTACTIN; STIMULATION	The Shaker family potassium channel, Kv1.2, is a key determinant of membrane excitability in neurons and cardiovascular tissue. Kv1.2 is subject to multiple forms of regulation and therefore integrates cellular signals involved in the homeostasis of excitability. The cyclic AMP/protein kinase A (PKA) pathway enhances Kv1.2 ionic current; however, the mechanisms for this are not fully known. Here we show that cAMP maintains Kv1.2 homeostasis through opposing effects on channel trafficking. We found that Kv1.2 is regulated by two distinct cAMP pathways, one PKA-dependent and the other PKA-independent. PKA inhibitors elevate Kv1.2 surface levels, suggesting that basal levels of cAMP control steady-state turnover of the channel. Elevation of cAMP above basal levels also increases the amount of Kv1.2 at the cell surface. This effect is not blocked by PKA inhibitors, but is blocked by inhibition of Kv1.2 endocytosis. We conclude that Kv1.2 levels at the cell surface are kept in dynamic balance by opposing effects of cAMP.	[Connors, Emilee C.; Morielli, Anthony D.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Morielli, AD (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Rm E-317,89 Beamout Ave, Burlington, VT 05405 USA.	anthony.morielli@uvm.edu			NCRR NIH HHS [5 P20 RR016435-07, P20 RR16462] Funding Source: Medline; NINDS NIH HHS [R0NS050623] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435, P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050623] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Chang SY, 2002, J CELL SCI, V115, P783; Chen L, 2006, ACTA BIOCH BIOPH SIN, V38, P95, DOI 10.1111/j.1745-7270.2006.00141.x; Chen ZX, 2007, INT J PARASITOL, V37, P743, DOI 10.1016/j.ijpara.2006.12.018; Cox RH, 2002, VASC PHARMACOL, V38, P13, DOI 10.1016/S1537-1891(02)00122-2; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Hattan D, 2002, J BIOL CHEM, V277, P38596, DOI 10.1074/jbc.M205005200; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Hong ZG, 2004, AM J RESP CELL MOL, V31, P337, DOI 10.1165/rcmb.2003-0386OC; HOSODA K, 1994, J NEUROCHEM, V63, P1635; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; HUANG XY, 1993, CELL, V75, P1145, DOI 10.1016/0092-8674(93)90324-J; HUANG XY, 1994, P NATL ACAD SCI USA, V91, P624, DOI 10.1073/pnas.91.2.624; Ishikawa K, 1999, MUSCLE NERVE, V22, P502, DOI 10.1002/(SICI)1097-4598(199904)22:4<502::AID-MUS12>3.0.CO;2-K; Kim DS, 2002, MOL BRAIN RES, V105, P146, DOI 10.1016/S0169-328X(02)00388-1; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; Lambe EK, 2001, J NEUROSCI, V21, P9955, DOI 10.1523/JNEUROSCI.21-24-09955.2001; Lu H, 2004, AM J PHYSIOL-RENAL, V286, pF233, DOI 10.1152/ajprenal.00179.2003; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Nesti E, 2004, MOL BIOL CELL, V15, P4073, DOI 10.1091/mbc.E03-11-0788; Pereira MMC, 2007, BIOCHEM J, V405, P181, DOI 10.1042/BJ20061879; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Valenti G, 2000, J CELL SCI, V113, P1985; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Yang EK, 2004, NEUROSCIENCE, V123, P867, DOI 10.1016/j.neuroscience.2003.11.014; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200	32	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3445	3453		10.1074/jbc.M708875200	http://dx.doi.org/10.1074/jbc.M708875200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18003609	hybrid			2022-12-27	WOS:000253083000050
J	Jamieson, KV; Wu, J; Hubbard, SR; Meruelo, D				Jamieson, Kelly V.; Wu, Jinhua; Hubbard, Stevan R.; Meruelo, Daniel			Crystal structure of the human laminin receptor precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; VIRUS; ANGIOGENESIS; DOMAINS; CELLS; GENE; TEA	The human laminin receptor (LamR) interacts with many ligands, including laminin, prions, Sindbis virus, and the polyphenol (-)-epigallocatechin-3-gallate (EGCG), and has been implicated in a number of diseases. LamR is overexpressed on tumor cells, and targeting LamR elicits anti-cancer effects. Here, we report the crystal structure of human LamR, which provides insights into its function and should facilitate the design of novel therapeutics targeting LamR.	[Jamieson, Kelly V.; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Jamieson, Kelly V.; Meruelo, Daniel] NYU, Sch Med, Gene Therapy Ctr, New York, NY 10016 USA; [Wu, Jinhua; Hubbard, Stevan R.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Wu, Jinhua; Hubbard, Stevan R.] NYU, Sch Med, Struct Biol Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Meruelo, D (corresponding author), NYU, Sch Med, Dept Pathol, 550 1St Ave, New York, NY 10016 USA.	daniel.meruelo@med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383	NCI NIH HHS [CA100687, CA68498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068498, R01CA100687] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford CL, 1999, CANCER RES, V59, P704; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Jackers P, 1996, ONCOGENE, V13, P495; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; McNichol BA, 2007, INFECT IMMUN, V75, P5095, DOI 10.1128/IAI.00075-07; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	26	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3002	3005		10.1074/jbc.C700206200	http://dx.doi.org/10.1074/jbc.C700206200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063583	hybrid			2022-12-27	WOS:000253083000002
J	Rott, R; Szargel, R; Haskin, J; Shani, V; Shainskaya, A; Manov, I; Liani, E; Avraham, E; Engelender, S				Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Shainskaya, Alla; Manov, Irena; Liani, Esti; Avraham, Eyal; Engelender, Simone			Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY-BODY FORMATION; UBIQUITIN-BINDING PROTEINS; INCLUSION FORMATION; PROTEASOME IMPAIRMENT; DROSOPHILA MODEL; FIBRIL FORMATION; TRANSGENIC MICE; SYNPHILIN-1; MUTATION	alpha-Synuclein plays a major role in Parkinson disease. Unraveling the mechanisms of alpha-synuclein aggregation is essential to understand the formation of Lewy bodies and their involvement in dopaminergic cell death. alpha-Synuclein is ubiquitylated in Lewy bodies, but the role of alpha-synuclein ubiquitylation has been mysterious. We now report that the ubiquitin-protein isopeptide ligase seven in absentia homolog (SIAH) directly interacts with and monoubiquitylates alpha-synuclein and promotes its aggregation in vitro and in vivo, which is toxic to cells. Mass spectrometry analysis demonstrates that SIAH monoubiquitylates alpha-synuclein at lysines 12, 21, and 23, which were previously shown to be ubiquitylated in Lewy bodies. SIAH ubiquitylates lysines 10, 34, 43, and 96 as well. Suppression of SIAH expression by short hairpin RNA to SIAH-1 and SIAH-2 abolished alpha-synuclein monoubiquitylation in dopaminergic cells, indicating that endogenous SIAH ubiquitylates alpha-synuclein. Moreover, SIAH co-immunoprecipitated with alpha-synuclein from brain extracts. Inhibition of proteasomal, lysosomal, and autophagic pathways, as well as overexpression of a ubiquitin mutant less prone to deubiquitylation, G76A, increased monoubiquitylation of alpha-synuclein by SIAH. Monoubiquitylation increased the aggregation of alpha-synuclein in vitro. At the electron microscopy level, monoubiquitylated alpha-synuclein promoted the formation of massive amounts of amorphous aggregates. Monoubiquitylation also increased alpha-synuclein aggregation in vivo as observed by increased formation of alpha-synuclein inclusion bodies within dopaminergic cells. These inclusions are toxic to cells, and their formation was prevented when endogenous SIAH expression was suppressed. Our data suggest that monoubiquitylation represents a possible trigger event for alpha-synuclein aggregation and Lewy body formation.	[Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Liani, Esti; Avraham, Eyal; Engelender, Simone] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel; [Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Liani, Esti; Avraham, Eyal; Engelender, Simone] Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel; [Shainskaya, Alla] Weizmann Inst Sci, Dept Biol Serv, Biol Mass Spectrometry Facil, IL-76100 Rehovot, Israel; [Manov, Irena] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Pediat Res & Electron Microscopy Unit, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Engelender, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel.	simone@tx.technion.ac.il		Engelender, Simone/0000-0001-7401-6855; Manov, Irena/0000-0001-8523-0849				Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Baba M, 1998, AM J PATHOL, V152, P879; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, P NATL ACAD SCI USA, V103, P5917, DOI 10.1073/pnas.0509707103; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kussmann M, 1997, J MASS SPECTROM, V32, P483; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilm M, 1996, ANAL CHEM, V68, P527, DOI 10.1021/ac950875+; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	126	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3316	3328		10.1074/jbc.M704809200	http://dx.doi.org/10.1074/jbc.M704809200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070888	hybrid			2022-12-27	WOS:000253083000036
J	Cocolakis, E; Dai, M; Drevet, L; Ho, J; Haines, E; Ali, S; Lebrun, JJ				Cocolakis, Eftihia; Dai, Meiou; Drevet, Loren; Ho, Joanne; Haines, Eric; Ali, Suhad; Lebrun, Jean-Jacques			Smad signaling antagonizes STAT5-mediated gene transcription and mammary epithelial cell differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; CASEIN GENE; PROLACTIN RECEPTOR; FUNCTIONAL-DIFFERENTIATION; TYROSINE PHOSPHORYLATION; TARGETED DISRUPTION; STAT5-LIKE FACTOR; INTERFERON-GAMMA; PROLINE-RICH	Both the transforming growth factor-beta(TGF beta)/Smad and the prolactin/JAK/STAT pathway are critical to the proper development, maintenance, and function of the mammary epithelial tissue. Interestingly, opposing physiological effects between these two signaling pathways are prominent in the regulation of mammary gland development. However, the exact nature of the biological network existing between the Smad and STAT signal transduction pathways has remained elusive. We identified a novel regulatory cross-talk mechanism by which TGF beta-induced Smad signaling acts to antagonize prolactin-mediated JAK/STAT signaling and expression of target genes. Furthermore, we found activin, another member of the TGF beta family, to also efficiently block STAT5 signaling and beta-casein expression in mammary epithelial cells. Our results indicate that ligand-induced activation of Smad2, -3, and -4 by activin and TGF beta leads to a direct inhibition of STAT5 transactivation and STAT5-mediated transcription of the downstream target genes, beta-casein and cyclin D1, thereby blocking vital processes for mammary gland growth and differentiation. Finally, we unveiled the mechanism by which these two signaling cascades antagonize their effects, and we found that activated Smads inhibit STAT5 association with its co-activator CREB-binding protein, thus blocking STAT5 transactivation of its target genes and leading to inhibition of mammary gland differentiation and lactation.	[Cocolakis, Eftihia; Dai, Meiou; Drevet, Loren; Ho, Joanne; Haines, Eric; Ali, Suhad; Lebrun, Jean-Jacques] McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada	McGill University; Royal Victoria Hospital	Lebrun, JJ (corresponding author), McGill Univ, Royal Victoria Hosp, Dept Med, Hormones & Canc Res Unit, 687 Pine Ave, Montreal, PQ H3A 1A1, Canada.	JJ.Lebrun@mcgill.ca	Lebrun, Jean-Jacques/GNP-5222-2022					Bailey JP, 2004, MOL ENDOCRINOL, V18, P1171, DOI 10.1210/me.2003-0345; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; Bright JJ, 1998, J IMMUNOL, V161, P1772; Bright JJ, 1997, J IMMUNOL, V159, P175; Brockman JL, 2005, MOL CELL ENDOCRINOL, V239, P45, DOI 10.1016/j.mce.2005.04.006; Callus BA, 2000, J BIOL CHEM, V275, P16954, DOI 10.1074/jbc.M909976199; Cella N, 1998, MOL CELL BIOL, V18, P1783, DOI 10.1128/MCB.18.4.1783; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chacko BM, 2001, NAT STRUCT BIOL, V8, P248, DOI 10.1038/84995; Choi KM, 2004, MOL ENDOCRINOL, V18, P1670, DOI 10.1210/me.2003-0483; Cocolakis E, 2001, J BIOL CHEM, V276, P18430, DOI 10.1074/jbc.M010768200; Daniel CW, 2001, ADV EXP MED BIOL, V501, P61; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; de Guise C, 2006, ENDOCRINOLOGY, V147, P4351, DOI 10.1210/en.2006-0444; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DOPPLER W, 1990, MOL ENDOCRINOL, V4, P912, DOI 10.1210/mend-4-6-912; DOPPLER W, 1995, J BIOL CHEM, V270, P17962, DOI 10.1074/jbc.270.30.17962; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; DUSANTERFOURT I, 1994, EMBO J, V13, P2583, DOI 10.1002/j.1460-2075.1994.tb06548.x; EBERT KM, 1991, BIO-TECHNOL, V9, P835, DOI 10.1038/nbt0991-835; Faure E, 2000, CELL TISSUE RES, V300, P89, DOI 10.1007/s004410000183; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; GUYETTE WA, 1979, CELL, V17, P1013, DOI 10.1016/0092-8674(79)90340-4; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jayaraman L, 2000, J BIOL CHEM, V275, P40710, DOI 10.1074/jbc.M005799200; JHAPPAN C, 1993, EMBO J, V12, P1835, DOI 10.1002/j.1460-2075.1993.tb05832.x; Kabotyanski EB, 2006, MOL ENDOCRINOL, V20, P2355, DOI 10.1210/me.2006-0160; Kirch HC, 1997, EUR J BIOCHEM, V246, P736, DOI 10.1111/j.1432-1033.1997.00736.x; LEBRUN JJ, 1995, P NATL ACAD SCI USA, V92, P4031, DOI 10.1073/pnas.92.9.4031; LEBRUN JJ, 1995, J BIOL CHEM, V270, P10664, DOI 10.1074/jbc.270.18.10664; LEBRUN JJ, 1997, INHIBIN ACTIVIN FOLL, P1; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Mieth M, 1990, GROWTH FACTORS, V4, DOI 10.3109/08977199009011005; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; PALLARD C, 1995, J BIOL CHEM, V270, P15942, DOI 10.1074/jbc.270.27.15942; PALLARD C, 1995, EMBO J, V14, P2847, DOI 10.1002/j.1460-2075.1995.tb07284.x; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; PIERCE DF, 1993, GENE DEV, V7, P2308, DOI 10.1101/gad.7.12a.2308; Ripperger JA, 1995, ANN NY ACAD SCI, V762, P459; RIPPERGER JA, 1995, J BIOL CHEM, V270, P29998, DOI 10.1074/jbc.270.50.29998; Robinson GW, 1997, DEVELOPMENT, V124, P2701; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; ROBINSON SD, 1993, J CELL BIOL, V120, P245, DOI 10.1083/jcb.120.1.245; RUFFJAMISON S, 1995, P NATL ACAD SCI USA, V92, P4215, DOI 10.1073/pnas.92.10.4215; RUI H, 1994, J BIOL CHEM, V269, P5364; RUI H, 1994, ENDOCRINOLOGY, V135, P1299, DOI 10.1210/en.135.4.1299; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Senyuk V, 2002, ONCOGENE, V21, P3232, DOI 10.1038/sj.onc.1205436; Sicinski P, 1997, J MAMMARY GLAND BIOL, V2, P335, DOI 10.1023/A:1026391128117; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Sovak MA, 1999, CELL GROWTH DIFFER, V10, P537; STRANGE R, 1992, DEVELOPMENT, V115, P49; Sudarshan C, 1999, J IMMUNOL, V162, P2974; SUDLOW AW, 1994, BIOCHEM J, V304, P333, DOI 10.1042/bj3040333; TOPPER YJ, 1980, PHYSIOL REV, V60, P1049, DOI 10.1152/physrev.1980.60.4.1049; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Valderrama-Carvajal H, 2002, NAT CELL BIOL, V4, P963, DOI 10.1038/ncb885; WAKAO H, 1994, EMBO J, V13, P2182, DOI 10.1002/j.1460-2075.1994.tb06495.x; Wang GN, 2005, BIOCHEM J, V386, P29, DOI 10.1042/BJ20041820; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	72	49	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1293	1307		10.1074/jbc.M707492200	http://dx.doi.org/10.1074/jbc.M707492200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024957	hybrid			2022-12-27	WOS:000252282700012
J	Fan, YX; Wong, LL; Ding, JH; Spiridonov, NA; Johnson, RC; Johnson, GR				Fan, Ying-Xin; Wong, Lily; Ding, Jinhui; Spiridonov, Nikolay A.; Johnson, Richard C.; Johnson, Gibbes R.			Mutational activation of ErbB2 reveals a new protein kinase autoinhibition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; EXTRACELLULAR REGION; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; CATALYTIC-ACTIVITY; LUNG-CANCER; DOMAIN; EGF; PHOSPHORYLATION	Autoinhibition plays a key role in the control of protein kinase activity. ErbB2 is a unique receptor-tyrosine kinase that does not bind ligand but possesses an extracellular domain poised to engage other ErbBs. Little is known about the molecular mechanism for ErbB2 catalytic regulation. Here we show that ErbB2 kinase is strongly autoinhibited, and a loop connecting the alpha C helix and beta 4 sheet within the kinase domain plays a major role in the control of kinase activity. Mutations of two Gly residues at positions 776 and 778 in this loop dramatically increase ErbB2 catalytic activity. Kinetic analysis demonstrates that mutational activation is due to similar to 10- and similar to 7-fold increases in ATP binding affinity and turnover number, respectively. Expression of the activated ErbB2 mutants in cells resulted in elevated ligand- independent ErbB2 autophosphorylation, ErbB3 phosphorylation, and stimulation of mitogen-activated protein kinase. Molecular modeling suggests that the ErbB2 kinase domain is stabilized in an inactive state via a hydrophobic interaction between the alpha C-beta 4 and activation loops. Importantly, many ErbB2 human cancer mutations have been identified in the alpha C-beta 4 loop, including the activating G776S mutation studied here. Our findings reveal a new kinase regulatory mechanism in which the alpha C-beta 4 loop functions as an intramolecular switch that controls ErbB2 activity and suggests that loss of alpha C-beta 4 loop-mediated autoinhibition is involved in oncogenic activation of ErbB2.	[Fan, Ying-Xin; Wong, Lily; Spiridonov, Nikolay A.; Johnson, Gibbes R.] US FDA, Ctr Drug Evaluat & Res, Div Therapeut Prot, Bethesda, MD 20892 USA; [Ding, Jinhui] NIH, NIA, Neurogenet Lab, Bioinformat Sect, Bethesda, MD 20892 USA; [Johnson, Richard C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Fan, YX (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Therapeut Prot, Bldg 29A,Rm 3B-20,8800 Rockville Pike, Bethesda, MD 20892 USA.	ying-xin.fan@fda.hhs.gov; gibbes.johnson@fda.hhs.gov	Spiridonov, Nikolay/B-6287-2014					Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Alimandi M, 1997, EMBO J, V16, P5608, DOI 10.1093/emboj/16.18.5608; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brignola PS, 2002, J BIOL CHEM, V277, P1576, DOI 10.1074/jbc.M105907200; Chan R, 2002, MOL CELL BIOL, V22, P1073, DOI 10.1128/MCB.22.4.1073-1078.2002; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen BM, 1996, J BIOL CHEM, V271, P4813; Deb TB, 1998, J BIOL CHEM, V273, P16643, DOI 10.1074/jbc.273.27.16643; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; Fan YX, 2005, BIOCHEM J, V392, P417, DOI 10.1042/BJ20051122; Fan YX, 2004, J BIOL CHEM, V279, P38143, DOI 10.1074/jbc.M405760200; Fan YX, 1996, BIOCHEM J, V315, P97, DOI 10.1042/bj3150097; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1992, J BIOL CHEM, V267, P13851; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ishizawar RC, 2007, ONCOGENE, V26, P3503, DOI 10.1038/sj.onc.1210138; Jan AY, 2000, BIOCHEMISTRY-US, V39, P9786, DOI 10.1021/bi9924922; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Lee JW, 2006, CLIN CANCER RES, V12, P57, DOI 10.1158/1078-0432.CCR-05-0976; LENTERINK AE, 1998, EMBO J, V17, P3385; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1990, New Biologist, V2, P187; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tikhomirov O, 2003, CANCER RES, V63, P39; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Wang SZE, 2006, CANCER CELL, V10, P25, DOI 10.1016/j.ccr.2006.05.023; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1588	1596		10.1074/jbc.M708116200	http://dx.doi.org/10.1074/jbc.M708116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039657	hybrid			2022-12-27	WOS:000252282700044
J	Jung, YS; Kim, HY; Kim, J; Lee, MG; Pouyssegur, J; Kim, E				Jung, Yong-Sam; Kim, Hye-Young; Kim, Juno; Lee, Min-Goo; Pouyssegur, Jacques; Kim, Eunhee			Physical interactions and functional coupling between Daxx and sodium hydrogen exchanger 1 in ischemic cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-H EXCHANGE; PML ONCOGENIC DOMAINS; NHE1 NA+/H+ EXCHANGER; FAS-INDUCED APOPTOSIS; ADAPTER PROTEIN DAXX; BINDING-PROTEIN; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVATION; INTRACELLULAR PH; ERM PROTEINS	Daxx, a death domain-associated protein, is implicated in ischemic cell death. To clarify the mechanism of cell death mediated by Daxx, a yeast two-hybrid assay was performed. Sodium hydrogen exchanger isoform 1 (NHE1) was identified as a Daxx-interacting protein. During ischemic stress, Daxx translocates from the nucleus to the cytoplasm, where it colocalizes with NHE1. Daxx binds to the ezrin/radixin/moesin-interacting domain of NHE1, in competition with ezrin. Consistent with this finding, transfection of the constitutively cytoplasmic mutant, Daxx(W621A), inhibited ezrin-mediated Akt-1 activation. Moreover, transfection of Daxx(W621A), but not the Daxx(S667A) mutant that is confined to the nucleus, accelerated pH(i) recovery from an acid load, indicating that the cytoplasmic protein activates NHE1. Based on the results, we propose that ischemic insult triggers the nucleocytoplasmic translocation of Daxx, following which cytoplasmic Daxx stimulates the NHE1 transporter activity and suppresses activation of the NHE1-ezrin-Akt-1 pathway. Our data support a novel molecular function of Daxx as an upstream regulator of NHE1 in ischemic cell death.	[Jung, Yong-Sam; Kim, Hye-Young; Kim, Eunhee] Chungnam Natl Univ, Sch Biosci & Biotechnol, Taejon 305764, South Korea; [Kim, Juno; Lee, Min-Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Kim, Juno; Lee, Min-Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Pouyssegur, Jacques] Univ Nice, Inst Signaling Dev Biol & Canc Res, CNRS, UMR 6543,Ctr A Lacassagne, F-06189 Nice, France	Chungnam National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Kim, E (corresponding author), Chungnam Natl Univ, Sch Biosci & Biotechnol, 220 Gung Dong, Taejon 305764, South Korea.	eunhee@cnu.ac.kr	Lee, Min Goo/D-5635-2012; Lee, Min Goo/AAS-4636-2020	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X				Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Bianchini L, 1997, J BIOL CHEM, V272, P271; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Charette SJ, 2000, ANN NY ACAD SCI, V926, P126; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Ding D, 2000, EXP NEUROL, V162, P1, DOI 10.1006/exnr.2000.7226; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; FLIEGEL L, 1993, BIOCHEM J, V296, P273, DOI 10.1042/bj2960273; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Gautreau A, 1999, P NATL ACAD SCI USA, V96, P7300, DOI 10.1073/pnas.96.13.7300; Gottlieb RA, 1996, J CLIN INVEST, V97, P2391, DOI 10.1172/JCI118683; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Hooley R, 1996, J BIOL CHEM, V271, P6152, DOI 10.1074/jbc.271.11.6152; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jang MS, 2002, BIOCHEM BIOPH RES CO, V295, P495, DOI 10.1016/S0006-291X(02)00699-X; Jorgensen NK, 1999, J NEUROSCI RES, V56, P358; Jung YS, 2007, FEBS LETT, V581, P843, DOI 10.1016/j.febslet.2007.01.055; Karmazyn M, 2001, EXPERT OPIN INV DRUG, V10, P835, DOI 10.1517/13543784.10.5.835; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Khaled AR, 2001, MOL CELL BIOL, V21, P7545, DOI 10.1128/MCB.21.22.7545-7557.2001; Kim EJ, 2003, NUCLEIC ACIDS RES, V31, P5356, DOI 10.1093/nar/gkg741; Kim J, 2007, EUR J PHARMACOL, V567, P131, DOI 10.1016/j.ejphar.2007.03.056; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li RZ, 2000, ONCOGENE, V19, P745, DOI 10.1038/sj.onc.1203385; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Liu H, 1997, J MOL CELL CARDIOL, V29, P2077, DOI 10.1006/jmcc.1997.0442; Luo J, 2005, J NEUROSCI, V25, P11256, DOI 10.1523/JNEUROSCI.3271-05.2005; Mentzer RM, 2003, ANN THORAC SURG, V75, pS700, DOI 10.1016/S0003-4975(02)04700-8; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Muromoto R, 2006, ONCOGENE, V25, P2131, DOI 10.1038/sj.onc.1209235; MURPHY E, 1991, CIRC RES, V68, P1250, DOI 10.1161/01.RES.68.5.1250; Nefkens I, 2003, J CELL SCI, V116, P513, DOI 10.1242/jcs.00253; ORLOWSKI J, 2003, THE NA PLUS H PLUS E, P17; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Perlman R, 2001, NAT CELL BIOL, V3, P708, DOI 10.1038/35087019; Piper HM, 1996, BASIC RES CARDIOL, V91, P191, DOI 10.1007/BF00788905; POLLENZ RS, 1992, CELL, V69, P951, DOI 10.1016/0092-8674(92)90614-I; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; SARDET C, 1990, SCIENCE, V247, P723, DOI 10.1126/science.2154036; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SIESJO BK, 1993, PROG BRAIN RES, V96, P23; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Song JJ, 2003, J CELL BIOCHEM, V90, P304, DOI 10.1002/jcb.10619; Song JJ, 2004, J BIOL CHEM, V279, P30573, DOI 10.1074/jbc.M404512200; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tominaga T, 1998, EMBO J, V17, P4712, DOI 10.1093/emboj/17.16.4712; Torii S, 1999, EMBO J, V18, P6037, DOI 10.1093/emboj/18.21.6037; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631	70	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1018	1025		10.1074/jbc.M707722200	http://dx.doi.org/10.1074/jbc.M707722200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003619	hybrid			2022-12-27	WOS:000252128100041
J	Davey, AM; Krise, KM; Sheets, ED; Heikal, AA				Davey, Angel M.; Krise, Keith M.; Sheets, Erin D.; Heikal, Ahmed A.			Molecular perspective of antigen-mediated mast cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; GPI-ANCHORED PROTEINS; FLUID/FLUID PHASE-SEPARATION; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; PLASMA-MEMBRANE VESICLES; LIPID RAFTS; IMMUNOGLOBULIN-E; MODEL MEMBRANES; LIVING CELLS	Antigen-mediated cross-linking of the high affinity receptor for IgE (Fc epsilon RI), in the plasma membrane of mast cells, is the first step in the allergic immune response. This event triggers the phosphorylation of specific tyrosines in the cytoplasmic segments of the beta and gamma subunits of Fc epsilon RI by the Src tyrosine kinase Lyn, which is anchored to the inner leaflet of the plasma membrane. Lyn-induced phosphorylation of Fc epsilon RI occurs in a cholesterol-dependent manner, leading to the hypothesis that cholesterol-rich domains, or "lipid rafts," may act as functional platforms for IgE receptor signaling. Testing this hypothesis under physiological conditions remains challenging because of the notion that these functional domains are likely transient and much smaller than the diffraction limit of optical microscopy. Here we use ultrafast fluorescence dynamics to investigate the correlation between nanostructural changes in the plasma membrane ( labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine (diI-C-18)) and IgE-Fc epsilon RI cross-linking in adherent RBL mast cells stimulated with multivalent antigen. Time-dependent two-photon fluorescence lifetime imaging microscopy of diI-C18 shows changes in lifetime that agree with the kinetics of stimulated tyrosine phosphorylation of Fc epsilon RI, the first identifiable biochemical step of the allergic response, under the same conditions. In addition, two-photon fluorescence lifetime imaging microscopy of Alexa Fluor 488-labeled IgE indicates that Forster resonance energy transfer occurs with diI-C-18 in the plasma membrane. Our live cell studies provide direct evidence for the association of IgE-Fc epsilon RI with specialized cholesterol-rich domains within similar to 4-nm proximity and with an energy transfer efficiency of 0.22 +/- 0.01 at maximal association during IgE receptor signaling.	[Davey, Angel M.; Krise, Keith M.; Sheets, Erin D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Heikal, Ahmed A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Sheets, Erin D.; Heikal, Ahmed A.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sheets, ED (corresponding author), Penn State Univ, Dept Chem, 104 Chem Bldg, University Pk, PA 16802 USA.	eds11@psu.edu; aah12@psu.edu		Sheets, Erin/0000-0002-5980-3225	NIA NIH HHS [AG030949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG030949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Ariola FS, 2006, PHYS CHEM CHEM PHYS, V8, P4517, DOI 10.1039/b608629b; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; BAIRD B, 1985, BIOCHEMISTRY-US, V24, P6252, DOI 10.1021/bi00343a032; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Davey AM, 2007, BIOPHYS J, V92, P343, DOI 10.1529/biophysj.106.088815; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Frigeri L, 1999, J IMMUNOL, V162, P2243; FURUICHI K, 1984, J IMMUNOL, V133, P1513; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Ge MT, 1999, BIOPHYS J, V76, P264, DOI 10.1016/S0006-3495(99)77195-X; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Hess ST, 2003, BIOPHYS J, V85, P2566, DOI 10.1016/S0006-3495(03)74679-7; Holowka D, 2000, J CELL SCI, V113, P1009; HOLOWKA D, 2005, BIOCHIM BIOPHYS ACTA, V1743, P252; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Hullin-Matsuda F, 2007, CELL MOL LIFE SCI, V64, P2492, DOI 10.1007/s00018-007-7281-x; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Navratil M, 2006, ANAL CHEM, V78, P4005, DOI 10.1021/ac0606756; Ortega E, 1999, J IMMUNOL, V162, P176; Owen DM, 2007, SEMIN CELL DEV BIOL, V18, P591, DOI 10.1016/j.semcdb.2007.07.011; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Rivera J, 2007, IMMUNOL REV, V217, P255, DOI 10.1111/j.1600-065X.2007.00505.x; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Sheets ED, 1999, CURR OPIN CHEM BIOL, V3, P95, DOI 10.1016/S1367-5931(99)80017-9; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Sinha M, 2003, EUR BIOPHYS J BIOPHY, V32, P381, DOI 10.1007/s00249-003-0281-3; Stottrup BL, 2004, BIOPHYS J, V86, P2942, DOI 10.1016/S0006-3495(04)74345-3; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Xu K, 1998, J CELL SCI, V111, P2385; Xu KL, 1998, J IMMUNOL, V160, P3225; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zewail AH, 2001, ANGEW CHEM INT EDIT, V40, P4371, DOI 10.1002/1521-3773(20011203)40:23<4371::AID-ANIE4371>3.0.CO;2-I	57	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7117	7127		10.1074/jbc.M708879200	http://dx.doi.org/10.1074/jbc.M708879200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18093971	hybrid			2022-12-27	WOS:000253779600057
J	Bernstein, J; Patterson, DN; Wilson, GM; Toth, EA				Bernstein, Jade; Patterson, Dimeka N.; Wilson, Gerald M.; Toth, Eric A.			Characterization of the essential activities of Saccharomyces cerevisiae Mtr4p, a 3 '-> 5 ' helicase partner of the nuclear exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4A; BOX RNA HELICASES; TRANSLATION-INITIATION; CRYSTAL-STRUCTURE; POLY(A) POLYMERASE; KINETIC-ANALYSIS; STRUCTURAL BASIS; RIBOSOMAL-RNA; IN-VIVO; PROTEIN	Mtr4p belongs to the Ski2p family of DEVH-box containing proteins and is required for processing and degradation of a variety of RNA substrates in the nucleus. In particular, Mtr4p is required for creating the 5.8 S ribosomal RNA from its 7 S precursor, proper 3'-end processing of the U4 small nuclear RNA and some small nucleolar RNAs, and degradation of aberrant mRNAs and tRNAs. In these studies we have shown that Mtr4p has RNA-dependent ATPase (or dATPase) activity that is stimulated effectively by likely substrates (e. g. tRNA) but surprisingly weakly by poly(A). Using an RNA strand-displacement assay, we have demonstrated that Mtr4p can, in the presence of ATP or dATP, unwind the duplex region of a partial duplex RNA substrate in the 3' -> 5' direction. We have examined the ability of Mtr4p to bind model RNA substrates in the presence of nucleotides that mimic the stages (i.e. ATP-bound, ADP-bound, and nucleotide-free) of the unwinding reaction. Our results demonstrate that the presence of a non-hydrolyzable ATP analog allows Mtr4p to discriminate between partial duplex RNA substrates, binding a 3'-tailed substrate with 5-fold higher affinity than a 5'-tailed substrate. In addition, Mtr4p displays a marked preference for binding to poly(A) RNA relative to an oligoribo nucleotide of the same length and a random sequence. This binding exhibits apparent cooperativity and different dynamic behavior from binding to the random single-stranded RNA. This unique binding mode might be employed primarily for degradation.	[Bernstein, Jade; Patterson, Dimeka N.; Wilson, Gerald M.; Toth, Eric A.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wilson, Gerald M.; Toth, Eric A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Toth, EA (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	etoth001@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507	NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102428] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bernstein KA, 2006, MOL CELL BIOL, V26, P1195, DOI 10.1128/MCB.26.4.1195-1208.2006; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Dandliker W B, 1981, Methods Enzymol, V74 Pt C, P3; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Du MX, 2002, BIOCHEM J, V363, P147, DOI 10.1042/0264-6021:3630147; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Haracska L, 2005, MOL CELL BIOL, V25, P10183, DOI 10.1128/MCB.25.22.10183-10189.2005; Heilman-Miller SL, 2001, J MOL BIOL, V306, P1157, DOI 10.1006/jmbi.2001.4437; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; SEAL SN, 1983, P NATL ACAD SCI-BIOL, V80, P6562, DOI 10.1073/pnas.80.21.6562; SEIFRIED SE, 1988, J BIOL CHEM, V263, P13511; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; XU FF, 1993, P NATL ACAD SCI USA, V90, P6756, DOI 10.1073/pnas.90.14.6756; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006	55	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4930	4942		10.1074/jbc.M706677200	http://dx.doi.org/10.1074/jbc.M706677200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096702	hybrid			2022-12-27	WOS:000253426500051
J	Kang, DW; Park, MH; Lee, YJ; Kim, HS; Kwon, TK; Park, WS; Min, DS				Kang, Dong Woo; Park, Mi Hee; Lee, Young Jun; Kim, Hyung Sik; Kwon, Taeg Kyu; Park, Won-Sang; Min, Do Sik			Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NF kappa B-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN FIBROSARCOMA CELLS; MEDIATED APOPTOSIS; RAS; TUMOR; TRANSFORMATION; INDUCTION; DOMAIN; METALLOPROTEINASE; PROLIFERATION	Despite its importance in cell proliferation and tumorigenesis, very little is known about the molecular mechanism underlying the regulation of phospholipase D (PLD) expression. PLD isozymes are significantly co-overexpressed with cancer marker genes in colorectal carcinoma. Phorbol 12-myristate 13-acetate (PMA) treatment, as a mitogenic signal in colon cancer cells, selectively increases PLD1 expression in transcription and post-transcription. Moreover, experiments using intraperitoneal injection of PMA into mice showed selective PLD1 induction in the intestine and lung tissues, which suggests its physiological relevance in vivo. Therefore, we have undertaken a detailed analysis of the effects of PMA on the promoter activity of PLD genes. Protein kinase C inhibitors, but not a protein kinase A inhibitor, were found to suppress the up-regulation of PLD1 but not PLD2. Dominant-negative mutants of Ras, Raf, and MEK suppressed the induction and activity of PLD1. Moreover, depletion of the supposedly involved proteins reduced the endogenous PLD1 protein level. An important role for NF kappa B as a downstream target of ERK in PMA-induced PLD1 induction was also demonstrated using the inhibitor, small interfering RNA, chromatin immunoprecipitation assay, and site-specific mutagenesis. Furthermore, inhibitors of these signaling proteins and depletion of PLD1 suppressed PMA-induced matrix metalloproteinase-9 secretion and PLD1 induction. In conclusion, we demonstrate for the first time that induction of PLD1 through a protein kinase C/Ras/ERK/NF kappa B-dependent pathway is involved in the secretion of matrix metalloproteinase-9 in colorectal cancer cells.	[Kang, Dong Woo; Park, Mi Hee; Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea; [Lee, Young Jun; Kim, Hyung Sik] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; [Kwon, Taeg Kyu] Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea; [Park, Won-Sang] Catholic Univ, Coll Med, Dept Pathol, Seoul 137701, South Korea	Pusan National University; Pusan National University; Keimyung University; Catholic University of Korea	Min, DS (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr						Abbas T, 2004, J BIOL CHEM, V279, P9970, DOI 10.1074/jbc.M306979200; Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; BOS JL, 1989, CANCER RES, V49, P4682; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Foster DA, 2003, MOL CANCER RES, V1, P789; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gustin DM, 2002, CANCER METAST REV, V21, P323, DOI 10.1023/A:1021271229476; Herrant M, 2002, ONCOGENE, V21, P4957, DOI 10.1038/sj.onc.1205689; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurland JF, 2003, J BIOL CHEM, V278, P32465, DOI 10.1074/jbc.M212919200; LIOTTA LA, 1979, P NATL ACAD SCI USA, V76, P2268, DOI 10.1073/pnas.76.5.2268; LIOTTA LA, 1981, BIOCHEMISTRY-US, V20, P100, DOI 10.1021/bi00504a017; MACKAY AR, 1992, INVAS METAST, V12, P168; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; MOERKERK P, 1994, CANCER RES, V54, P3376; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Pospisilova S, 2004, BIOCHEM J, V378, P939, DOI 10.1042/BJ20030662; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Thomas RP, 2002, SURGERY, V132, P127, DOI 10.1067/msy.2002.124930; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wakelam MJO, 1997, ADV ENZYME REGUL, V37, P29, DOI 10.1016/S0065-2571(96)00023-4; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Williger BT, 1999, J BIOL CHEM, V274, P735, DOI 10.1074/jbc.274.2.735	37	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4094	4104		10.1074/jbc.M707416200	http://dx.doi.org/10.1074/jbc.M707416200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18084005	hybrid, Green Published			2022-12-27	WOS:000253083500045
J	Ohgaki, R; Fukura, N; Matsushita, M; Mitsui, K; Kanazawa, H				Ohgaki, Ryuichi; Fukura, Naomi; Matsushita, Masafumi; Mitsui, Keiji; Kanazawa, Hiroshi			Cell surface levels of organellar Na+/H+ exchanger isoform 6 are regulated by interaction with RACK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; MOLECULAR-CLONING; FUNCTIONAL EXPRESSION; SECRETORY PATHWAY; TOPOLOGY MODEL; PH REGULATION; RECEPTOR; MEMBRANE; GOLGI; TRANSPORT	In mammalian cells, four Na+/H+ exchangers (NHE6-NHE9) are localized to intracellular compartments. NHE6 and NHE9 are predominantly localized to sorting and recycling endosomes, NHE7 to the trans-Golgi network, and NHE8 to the mid-trans-Golgi stacks. The unique localization of NHEs may contribute to establishing organelle-specific pH values and ion homeostasis in cells. Mechanisms underlying the regulation and targeting of organellar NHEs are largely unknown. We identified an interaction between NHE9 and RACK1 (receptor for activated C kinase 1), a cytoplasmic scaffold protein, by yeast two-hybrid screening using the NHE9 C terminus as bait. The NHE9 C terminus is exposed to the cytoplasm, verifying that the interaction is topologically possible. The binding region was further delineated to the central region of the NHE9 C terminus. RACK1 also bound NHE6 and NHE7, but not NHE8, in vitro. Endogenous association between NHE6 and RACK1 was confirmed by co-immunoprecipitation and co-localization in HeLa cells. The luminal pH of the recycling endosome was elevated in RACK1 knockdown cells, accompanied by a decrease in the amount of NHE6 on the cell surface, although the total level of NHE6 was not significantly altered. These results indicate that RACK1 plays a role in regulating the distribution of NHE6 between endosomes and the plasma membrane and contributes to maintaining luminal pH of the endocytic recycling compartments.	[Ohgaki, Ryuichi; Fukura, Naomi; Matsushita, Masafumi; Mitsui, Keiji; Kanazawa, Hiroshi] Osaka Univ, Grad Sch Med, Dept Biol Sci, Osaka 5600043, Japan	Osaka University	Kanazawa, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Biol Sci, Osaka 5600043, Japan.	kanazawa@bio.sci.osaka-u.ac.jp		Ohgaki, Ryuichi/0000-0002-6894-7239				Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; CARNELL L, 1994, J CELL BIOL, V127, P693, DOI 10.1083/jcb.127.3.693; COSSON P, 1989, J CELL BIOL, V108, P377, DOI 10.1083/jcb.108.2.377; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Futai M, 2000, J EXP BIOL, V203, P107; Gallina A, 2001, VIROLOGY, V283, P7, DOI 10.1006/viro.2001.0855; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Lehoux S, 2001, J BIOL CHEM, V276, P15794, DOI 10.1074/jbc.M100410200; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Miyazaki E, 2001, J BIOL CHEM, V276, P49221, DOI 10.1074/jbc.M106267200; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nieland TJF, 2004, TRAFFIC, V5, P478, DOI 10.1111/j.1398-9219.2004.00193.x; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Smith PR, 2000, J VIROL, V74, P3082, DOI 10.1128/JVI.74.7.3082-3092.2000; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; TSE CM, 1993, J BIOL CHEM, V268, P11917; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Wells KM, 2001, J BIOL CHEM, V276, P3401, DOI 10.1074/jbc.M001688200; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yan WH, 2001, J BIOL CHEM, V276, P31349, DOI 10.1074/jbc.M102679200; Yedovitzky M, 1997, J BIOL CHEM, V272, P1417, DOI 10.1074/jbc.272.3.1417; ZEN K, 1992, J CELL BIOL, V119, P99, DOI 10.1083/jcb.119.1.99	45	53	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4417	4429		10.1074/jbc.M705146200	http://dx.doi.org/10.1074/jbc.M705146200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057008	hybrid			2022-12-27	WOS:000253083500076
J	Aguiar, RS; Lovsin, N; Tanuri, A; Peterlin, BM				Aguiar, Renato S.; Lovsin, Nika; Tanuri, Amilcar; Peterlin, B. Matija			Vpr.A3A chimera inhibits HIV replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL RESTRICTION; POTENT INHIBITORS; ENZYME APOBEC3G; PROTEINS; VPR; RETROTRANSPOSITION; INFECTION; DNA; HYPERMUTATION	Several APOBEC3 proteins (A3F and A3G), that are cytidine deaminases restrict human immunodeficiency virus (HIV) replication in the absence of the viral infectivity factor (Vif) protein. However, Vif leads to their degradation and counteracts their effects. Another member, A3A, restricts some retrotransposons and another virus but not HIV. Wereasoned that this failure was due to the lack of appropriate targeting. Thus, we fused A3A to another viral protein, Vpr, which binds p6 in Gag and is incorporated into viral cores. Indeed, the Vpr. A3A chimera but not A3A was found abundantly in the viral core. It also restricted potently the replication of HIV and simian immunodeficiency virus in the presence and absence of Vif. Because we identified a high frequency of G to Amutations in viral cDNAs, this antiviral activity was mediated by DNA editing. Interestingly, our fusion protein did not restrict murine leukemia virus, which does not incorporate Vpr. Thus, by targeting appropriately a potent single domain cytidine deaminase, we rendered HIV and simian immunodeficiency virus restriction resistant to Vif.	[Aguiar, Renato S.; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med Microbiol & Immunol, San Francisco, CA 94143 USA; [Lovsin, Nika] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21944970 Rio De Janeiro, Brazil	University of California System; University of California San Francisco; University of Ljubljana; Universidade Federal do Rio de Janeiro	Peterlin, BM (corresponding author), Univ Calif San Francisco, Dept Med Microbiol & Immunol, 533 Parnassus Ave,U422, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	Aguiar, Renato S/G-3542-2015; Tanuri, Amilcar/AAM-8601-2021	Aguiar, Renato S/0000-0001-5180-3717; 	NIGMS NIH HHS [P50 GM082250, P50 GM082250-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fletcher TM, 1997, EMBO J, V16, P5123, DOI 10.1093/emboj/16.16.5123; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kieffer TL, 2005, J VIROL, V79, P1975, DOI 10.1128/JVI.79.3.1975-1980.2005; KONDO E, 1995, J VIROL, V69, P2759, DOI 10.1128/JVI.69.5.2759-2764.1995; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Lee YN, 2007, PLOS PATHOG, V3, P119, DOI 10.1371/journal.ppat.0030010; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Morner A, 1999, J VIROL, V73, P2343; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113; WU XY, 1995, J VIROL, V69, P3389, DOI 10.1128/JVI.69.6.3389-3398.1995; Yao XJ, 1999, GENE THER, V6, P1590, DOI 10.1038/sj.gt.3300988; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou V, 2006, VIROLOGY, V349, P31, DOI 10.1016/j.virol.2005.12.035; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	47	54	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2518	2525		10.1074/jbc.M706436200	http://dx.doi.org/10.1074/jbc.M706436200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18057006	hybrid			2022-12-27	WOS:000252622300008
J	Harwood, FC; Shu, L; Houghton, PJ				Harwood, Franklin C.; Shu, Lili; Houghton, Peter J.			mTORC1 signaling can regulate growth factor activation of p44/42 mitogen-activated protein kinases through protein phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-1; SARCOMA-CELL-LINES; P70 S6 KINASE; MAP KINASE; MAMMALIAN TARGET; GENE-PRODUCTS; CATALYTIC SUBUNIT; MULTIPLE ROLES; MESSENGER-RNA; OKADAIC ACID	The mTORC1 complex ( mammalian target of rapamycin (mTOR)-raptor) is modulated by mitogen-activated protein (p44/42 MAP) kinases (p44/42) through phosphorylation and inactivation of the tuberous sclerosis complex. However, a role for mTORC1 signaling in modulating activation of p44/42 has not been reported. We show that in two cancer cell lines regulation of the p44/42 MAPKs is mTORC1-dependent. In Rh1 cells rapamycin inhibited insulin-like growth factor-I (IGF-I)-stimulated phosphorylation of Thr(202) but not Tyr(204) and suppressed activation of p44/42 kinase activity. Down-regulation of raptor, which inhibits mTORC1 signaling, had a similar effect to rapamycin in blocking IGF-I- stimulated Tyr204 phosphorylation. Rapamycin did not block maximal phosphorylation of Tyr204 but retarded the rate of dephosphorylation of Tyr204 following IGF-I stimulation. IGF-I stimulation of MEK1 phosphorylation (Ser(217/221)) was not inhibited by rapamycin. Higher concentrations of rapamycin (>= 100 ng/ml) were required to inhibit epidermal growth factor (EGF)induced phosphorylation of p44/42 ( Thr202). Rapamycin-induced inhibition of p44/42 ( Thr202) phosphorylation by IGF-I was reversed by low concentrations of okadaic acid, suggesting involvement of protein phosphatase 2A(PP2A). Both IGF-I and EGF caused dissociation of PP2A catalytic subunit (PP2Ac) from p42. Whereas low concentrations of rapamycin ( 1 ng/ml) inhibited dissociation of PP2Ac after IGF-I stimulation, it required higher concentrations (> 100 ng/ ml) to block EGF-induced dissociation, consistent with the ability for rapamycin to attenuate growth factor-induced activation of p44/42. The effect of rapamycin on IGF-I or insulin activation of p44/42 was recapitulated by amino acid deprivation. Rapamycin effects altering the kinetics of p44/42 phosphorylation were completely abrogated in Rh1mTORrr cells that express a rapamycin-resistant mTOR, whereas the effects of amino acid deprivation were similar in Rh1 and Rh1mTORrr cells. These results indicate complex regulation of p44/42 by phosphatases downstream of mTORC1. This suggests a model in which mTORC1 modulates the phosphorylation of Thr202 on p44/42 MAPKs through direct or indirect regulation of PP2Ac.	[Harwood, Franklin C.; Shu, Lili; Houghton, Peter J.] St Jude Childrens Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Houghton, PJ (corresponding author), St Jude Childrens Hosp, Dept Mol Pharmacol, 332 N Lauderdale St, Memphis, TN 38105 USA.	peter.houghton@stjude.org	Houghton, Peter/E-3265-2011		NATIONAL CANCER INSTITUTE [P01CA023099, R01CA077776] Funding Source: NIH RePORTER; NCI NIH HHS [CA 21675, CA 77776, CA 23099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; ALESSI DR, 1995, CURR BIOL, V5, P283, DOI 10.1016/S0960-9822(95)00059-5; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Begum N, 1996, J BIOL CHEM, V271, P31166, DOI 10.1074/jbc.271.49.31166; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Braczkowski R, 2002, CANCER-AM CANCER SOC, V95, P1735, DOI 10.1002/cncr.10865; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Chung HY, 1999, CELL SIGNAL, V11, P575, DOI 10.1016/S0898-6568(99)00033-9; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; DILLING MB, 1994, CANCER RES, V54, P903; Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4; ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; GOTOH Y, 1990, EUR J BIOCHEM, V193, P671, DOI 10.1111/j.1432-1033.1990.tb19385.x; GRESSNER AM, 1974, BIOCHEM BIOPH RES CO, V60, P1482, DOI 10.1016/0006-291X(74)90365-9; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Iiboshi Y, 1999, J BIOL CHEM, V274, P1092, DOI 10.1074/jbc.274.2.1092; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Kloeker S, 2003, PROTEIN EXPRES PURIF, V31, P19, DOI 10.1016/S1046-5928(03)00141-4; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; NIELSEN FC, 1995, NATURE, V377, P358, DOI 10.1038/377358a0; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Prickett TD, 2004, J BIOL CHEM, V279, P38912, DOI 10.1074/jbc.M401444200; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Remmelink M, 1998, J CANCER RES CLIN, V124, P155, DOI 10.1007/s004320050149; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sekulic A, 2000, CANCER RES, V60, P3504; SHAPIRO DN, 1994, J CLIN INVEST, V94, P1235, DOI 10.1172/JCI117441; SMITH MA, 2007, IN PRESS PEDIAT BLOO; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thimmaiah KN, 2003, CANCER RES, V63, P364; Toretsky JA, 2001, CANCER-AM CANCER SOC, V92, P2941, DOI 10.1002/1097-0142(20011201)92:11<2941::AID-CNCR10072>3.0.CO;2-C; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	66	22	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2575	2585		10.1074/jbc.M706173200	http://dx.doi.org/10.1074/jbc.M706173200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056704	hybrid			2022-12-27	WOS:000252622300014
J	Freeman, SN; Ma, YH; Cress, WD				Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas			RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR GENES; DNA-BINDING DOMAINS; CHROMOSOME ARM 8P; S-PHASE ENTRY; FAMILY-MEMBER; TRANSCRIPTION FACTORS; UBIQUITIN-LIGASE; MICROARRAY ANALYSIS; RB/E2F PATHWAY	We have identified the RhoBTB2 putative tumor suppressor gene as a direct target of the E2F1 transcription factor. Overexpression of E2F1 led to up- regulation of RhoBTB2 at the level of mRNA and protein. This also occurred during the induction of E2F1 activity in the presence of cycloheximide, thus indicating that RhoBTB2 is a direct target. RNAi- mediated knockdown of E2F1 resulted in decreased RhoBTB2 protein expression, demonstrating that RhoBTB2 is a physiological target of E2F1. Because E2F1 primarily serves to transcribe genes involved in cell cycle progression and apoptosis, we explored whether RhoBTB2 played roles in either of these processes. We found RhoBTB2 expression highly up- regulated during mitosis, which was partially dependent on the presence of E2F1. Furthermore, overexpression of RhoBTB2 induced a short term increase in cell cycle progression and proliferation, while long term expression had a negative effect on these processes. We similarly found RhoBTB2 up- regulated during drug- induced apoptosis, with this being primarily dependent on E2F1. Finally, we observed that knockdown of RhoBTB2 levels via siRNA delayed the onset of drug- induced apoptosis. Collectively, we describe RhoBTB2 as a novel direct target of E2F1 with roles in cell cycle and apoptosis.	[Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas] Univ S Florida, Mol Oncol Program, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Freeman, Scott N.; Ma, Yihong; Cress, W. Douglas] Univ S Florida, Dept Interdisciplinary Oncol, Tampa, FL 33612 USA; [Freeman, Scott N.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Cress, WD (corresponding author), 12902 Magnolia Dr, Tampa, FL 33612 USA.	douglas.cress@moffitt.org			NATIONAL CANCER INSTITUTE [R01CA090489] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090489-05, R01 CA090489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; BOVA GS, 1993, CANCER RES, V53, P3869; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Brown MR, 1999, GYNECOL ONCOL, V74, P98, DOI 10.1006/gyno.1999.5439; BUCK V, 1995, ONCOGENE, V11, P31; Cam H, 2003, CANCER CELL, V3, P311, DOI 10.1016/S1535-6108(03)00080-1; Carrassa L, 2003, CELL CYCLE, V2, P604, DOI 10.4161/cc.2.6.503; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; CRESS WD, 1994, J VIROL, V68, P4212, DOI 10.1128/JVI.68.7.4213-4219.1994; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; DeGregori J, 2006, CURR MOL MED, V6, P739; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; EMI M, 1992, CANCER RES, V52, P5368; Frame FM, 2006, ONCOGENE, V25, P3258, DOI 10.1038/sj.onc.1209352; FUJIWARA Y, 1993, CANCER RES, V53, P1172; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; He YW, 2000, ONCOGENE, V19, P3422, DOI 10.1038/sj.onc.1203682; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001; ITOH A, 1995, CELL MOL BIOL RES, V41, P147; IVEYHOYLE M, 1993, MOL CELL BIOL, V13, P7802, DOI 10.1128/MCB.13.12.7802; Johnson DG, 2006, CURR MOL MED, V6, P731; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; KOWALIK TF, 1995, J VIROL, V69, P2491, DOI 10.1128/JVI.69.4.2491-2500.1995; LEES JA, 1993, MOL CELL BIOL, V13, P7813, DOI 10.1128/MCB.13.12.7813; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; LUNDGREN R, 1992, GENE CHROMOSOME CANC, V4, P16, DOI 10.1002/gcc.2870040103; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Ma YH, 2003, MOL CANCER THER, V2, P73; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Siripurapu V, 2005, J MOL BIOL, V346, P83, DOI 10.1016/j.jmb.2004.11.043; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Sunwoo JB, 1996, GENE CHROMOSOME CANC, V16, P164, DOI 10.1002/(SICI)1098-2264(199607)16:3<164::AID-GCC2>3.0.CO;2-X; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Wilkins A, 2004, GENE DEV, V18, P856, DOI 10.1101/gad.1177904; Wistuba II, 1999, CANCER RES, V59, P1973; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; YEE AS, 1987, EMBO J, V6, P2061, DOI 10.1002/j.1460-2075.1987.tb02471.x; Yoshihara T, 2007, BIOCHEM BIOPH RES CO, V358, P1076, DOI 10.1016/j.bbrc.2007.05.037; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	61	24	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2353	2362		10.1074/jbc.M705986200	http://dx.doi.org/10.1074/jbc.M705986200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039672	Green Accepted, hybrid			2022-12-27	WOS:000252501000062
J	Zhao, W; Liu, M; Kirkwood, KL				Zhao, Wenpu; Liu, Min; Kirkwood, Keith L.			p38 alpha stabilizes interleukin-6 mRNA via multiple AU-rich elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GENE-EXPRESSION; POSTTRANSCRIPTIONAL REGULATION; SECONDARY STRUCTURES; BINDING PROTEINS; GROWTH; CLONING; PATHWAY; BIOSYNTHESIS; DEGRADATION	AU-rich elements (AREs) in the 3'- untranslated region (UTR) of unstable mRNA dictate their degradation or mediate translational repression. Cell signaling through p38 alpha MAPK is necessary for post-transcriptional regulation of many pro-inflammatory cytokines. Here, the cis-acting elements of interleukin-6 (IL-6) 3'-UTR mRNA that required p38 alpha signaling for mRNA stability and translation were identified. Using mouse embryonic fibroblasts (MEFs) derived from p38 alpha(+/+) and p38 alpha(-/-) mice, we observed that p38 alpha is obligatory for the IL-1-induced IL-6 biosynthesis. IL-6 mRNA stability is promoted by p38 alpha via 3'-UTR. To understand the mechanism of cis-elements regulated by p38 alpha at post-transcriptional level, truncation of 3'-UTR and the full-length 3'-UTR with individual AUUUA motif mutation placed in gene reporter system was employed. Mutation-based screen performed in p38 alpha(+/+) and p38 alpha(-/-) mouse embryonic fibroblast cells revealed that ARE1, ARE2, and ARE5 in IL-6 3'-UTR were targeted by p38 alpha, and truncation-based screen showed that IL-6 3'- UTR-(56-173) was targeted by p38 alpha to stable mRNA. RNA secondary structure analysis indicated that modulated reporter gene expression was consistent with predicted secondary structure changes.	[Zhao, Wenpu; Liu, Min; Kirkwood, Keith L.] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kirkwood, KL (corresponding author), Univ Michigan, Dept Periodont & Oral Med, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	klkirk@umich.edu	Kirkwood, Keith L/L-4728-2018	Kirkwood, Keith/0000-0003-4519-8973	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018290] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE018290, R01 DE018290-01] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Clark A, 2000, ARTHRITIS RES, V2, P172, DOI 10.1186/ar83; Derrigo M, 2000, INT J MOL MED, V5, P111; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fu J, 1998, CHINESE MED J-PEKING, V111, P265; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hackermuller J, 2005, GENE, V345, P3, DOI 10.1016/j.gene.2004.11.043; Hiller M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl544; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Huang QJ, 2004, NAT IMMUNOL, V5, P98, DOI 10.1038/ni1014; ISSHIKI H, 1990, MOL CELL BIOL, V10, P2757, DOI 10.1128/MCB.10.6.2757; Jiang Y, 1996, J BIOL CHEM, V271, P17920, DOI 10.1074/jbc.271.30.17920; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Okamoto M, 1997, CANCER RES, V57, P141; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Patil C, 2004, IMMUNOL INVEST, V33, P213, DOI 10.1081/IMM-120034231; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; RAY A, 1989, ANN NY ACAD SCI, V557, P353; Ray A, 1989, ANN NY ACAD SCI, V557, P361; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Stoecklin G, 2001, RNA, V7, P1578; Tachibana M, 2000, CELL TISSUE RES, V301, P353, DOI 10.1007/s004410000235; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	44	59	61	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1778	1785		10.1074/jbc.M707573200	http://dx.doi.org/10.1074/jbc.M707573200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042545	Green Accepted, hybrid			2022-12-27	WOS:000252501000003
J	Haince, JF; McDonald, D; Rodrigue, A; Dery, U; Masson, JY; Hendzel, MJ; Poirier, GG				Haince, Jean-Francois; McDonald, Darin; Rodrigue, Amelie; Dery, Ugo; Masson, Jean-Yves; Hendzel, Michael J.; Poirier, Guy G.			PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; POSTTRANSLATIONAL MODIFICATION; HOMOLOGOUS RECOMBINATION; CHROMATIN-STRUCTURE; ATM ACTIVATION; EARLY RESPONSE; POLY(ADP-RIBOSE); REPAIR; PARP-1; CELLS	Poly(ADP-ribose) polymerase 1 (PARP1) is a nuclear enzyme that is rapidly activated by DNA strand breaks and signals the presence of DNA lesions by attaching ADP-ribose units to chromatin-associated proteins. The therapeutic applications of PARP inhibitors in potentiating the killing action of ionizing radiation have been well documented and are attracting increasing interest as a cancer treatment. However, the initial kinetics underlying the recognition of multiple DNA lesions by PARP1 and how inhibition of PARP potentiates the activity of DNA-damaging agents are unknown. Here we report the spatiotemporal dynamics of PARP1 recruitment to DNA damage induced by laser microirradiation in single living cells. We provide direct evidence that PARP1 is able to accumulate at a locally induced DNA double strand break. Most importantly, we observed that the rapid accumulation of MRE11 and NBS1 at sites of DNA damage requires PARP1. By determining the kinetics of protein assembly following DNA damage, our study reveals the cooperation between PARP1 and the double strand break sensors MRE11 and NBS1 in the close vicinity of a DNA lesion. This may explain the sensitivity of cancer cells to PARP inhibitors.	[Haince, Jean-Francois; Poirier, Guy G.] Univ Laval, Ctr Hosp Univ Quebec, Fac Med, Hlth & Environm Unit,Laval Univ Hosp Res Ctr, Quebec City, PQ G1V 4G2, Canada; [McDonald, Darin; Hendzel, Michael J.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [McDonald, Darin; Hendzel, Michael J.] Univ Alberta, Fac Med, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Rodrigue, Amelie; Dery, Ugo; Masson, Jean-Yves] CHUQ, Hotel Dieu, Genome Stabil Lab, Laval Univ Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada	Laval University; University of Alberta; University of Alberta; Laval University	Poirier, GG (corresponding author), CHUL Rm RC-9700,2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada.	guy.poirier@crchul.ulaval.ca	Hendzel, Michael/C-3391-2009	Hendzel, Michael/0000-0002-9603-7945; Masson, Jean Yves/0000-0002-4403-7169; Rodrigue, Amelie/0000-0001-9883-7084; Poirier, Guy/0000-0002-4869-1424				Aguilar-Quesada R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-29; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Bradshaw PS, 2005, NAT GENET, V37, P193, DOI 10.1038/ng1506; Brown ML, 2002, P NATL ACAD SCI USA, V99, P4532, DOI 10.1073/pnas.072495299; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Dong ZW, 1999, J BIOL CHEM, V274, P19513, DOI 10.1074/jbc.274.28.19513; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Huber A, 2004, DNA REPAIR, V3, P1103, DOI 10.1016/j.dnarep.2004.06.002; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Meldrum RA, 2003, EMBO REP, V4, P1144, DOI 10.1038/sj.embor.7400028; Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Tartier L, 2003, MUTAGENESIS, V18, P411, DOI 10.1093/mutage/geg015; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200	39	396	412	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1197	1208		10.1074/jbc.M706734200	http://dx.doi.org/10.1074/jbc.M706734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18025084	hybrid			2022-12-27	WOS:000252128100060
J	Hoeberichts, FA; Vaeck, E; Kiddle, G; Coppens, E; van de Cotte, B; Adamantidis, A; Ormenese, S; Foyer, CH; Zabeau, M; Inze, D; Perilleux, C; Van Breusegem, F; Vuylsteke, M				Hoeberichts, Frank A.; Vaeck, Elke; Kiddle, Guy; Coppens, Emmy; van de Cotte, Brigitte; Adamantidis, Antoine; Ormenese, Sandra; Foyer, Christine H.; Zabeau, Marc; Inze, Dirk; Perilleux, Claire; Van Breusegem, Frank; Vuylsteke, Marnik			A temperature-sensitive mutation in the Arabidopsis thaliana phosphomannomutase gene disrupts protein glycosylation and triggers cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASCORBIC-ACID; CELLULOSE BIOSYNTHESIS; DISULFIDE-ISOMERASE; GLUCOSIDASE-I; HIGHER-PLANTS; GDP-MANNOSE; VITAMIN-C; DEFICIENT; MUTANTS; OLIGOSACCHARYLTRANSFERASE	Eukaryotic phosphomannomutases (PMMs) catalyze the interconversion of mannose 6-phosphate to mannose 1-phosphate and are essential to the biosynthesis of GDP-mannose. As such, plant PMMs are involved in ascorbic acid (AsA) biosynthesis and N-glycosylation. We report on the conditional phenotype of the temperature-sensitive Arabidopsis thaliana pmm- 12 mutant. Mutant seedlings were phenotypically similar to wild type seedlings when grown at 16 - 18 degrees C but died within several days after transfer to 28 degrees C. This phenotype was observed throughout both vegetative and reproductive development. Protein extracts derived from pmm-12 plants had lower PMM protein and enzyme activity levels. In vitro biochemical analysis of recombinant proteins showed that the mutant PMM protein was compromised in its catalytic efficiency (K-cat/K-m). Despite significantly decreased AsA levels in pmm-12 plants, AsA deficiency could not account for the observed phenotype. Since, at restrictive temperature, total glycoprotein patterns were altered and glycosylation of protein-disulfide isomerase was perturbed, we propose that a deficiency in protein glycosylation is responsible for the observed cell death phenotype.	[Hoeberichts, Frank A.; Vaeck, Elke; Coppens, Emmy; van de Cotte, Brigitte; Inze, Dirk; Van Breusegem, Frank; Vuylsteke, Marnik] Univ Ghent VIB, Dept Plant Syst Biol, Vrije Univ Brussel VIB, B-9052 Ghent, Belgium; [Kiddle, Guy; Foyer, Christine H.] Crop Performance & Improvement Div, Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Adamantidis, Antoine; Ormenese, Sandra; Perilleux, Claire] Univ Liege, Dept Plant Physiol, B-4000 Liege, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Liege	Van Breusegem, F (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technologiepark 927, B-9052 Ghent, Belgium.	frank.vanbreusegem@psb.ugent.be	Inzé, Dirk/AAW-6381-2021; Foyer, Christine/K-2143-2012; Van Breusegem, Frank/AAJ-2647-2020; Van Breusegem, Frank/Y-2999-2019	Inzé, Dirk/0000-0002-3217-8407; Van Breusegem, Frank/0000-0002-3147-0860; Adamantidis, Antoine/0000-0003-2531-5175; Foyer, Christine/0000-0001-5989-6989; Perilleux, Claire/0000-0001-7653-2431				BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BERNSTEIN M, 1985, J CELL BIOL, V101, P2374, DOI 10.1083/jcb.101.6.2374; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Gillmor CS, 2005, PLANT CELL, V17, P1128, DOI 10.1105/tpc.105.031815; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Hancock Robert D., 2003, BMC Plant Biology, V3, P7, DOI 10.1186/1471-2229-3-7; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KEPES F, 1988, J BIOL CHEM, V263, P9155; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kukuruzinska MA, 1999, BBA-GEN SUBJECTS, V1426, P359, DOI 10.1016/S0304-4165(98)00136-6; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Peters JL, 2004, THEOR APPL GENET, V108, P321, DOI 10.1007/s00122-003-1427-5; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rozen S, 2000, Methods Mol Biol, V132, P365; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; SHIMONI Y, 1995, PLANT PHYSIOL, V108, P327, DOI 10.1104/pp.108.1.327; SHORROSH BS, 1993, PLANT PHYSIOL, V103, P719, DOI 10.1104/pp.103.3.719; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VAECK E, 2006, THESIS GHENT U GENT; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; VERNON LP, 1960, ANAL CHEM, V32, P1144, DOI 10.1021/ac60165a029; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034	49	51	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5708	5718		10.1074/jbc.M704991200	http://dx.doi.org/10.1074/jbc.M704991200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086684	Green Published, hybrid			2022-12-27	WOS:000253426700052
J	Balannik, V; Lamb, RA; Pinto, LH				Balannik, Victoria; Lamb, Robert A.; Pinto, Lawrence H.			The oligomeric state of the active BM2 ion channel protein of influenza B virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; RESONANCE ENERGY-TRANSFER; TRANSFER FRET MEASUREMENT; M-2 PROTON CHANNEL; A VIRUS; POTASSIUM CHANNEL; M2 PROTEIN; CONFOCAL MICROSCOPY; CELL-SURFACE; SELECTIVITY	Influenza A virus and influenza B virus particles both contain small integral membrane proteins (A/M2 and BM2, respectively) that function as a pH-sensitive proton channel and are essential for virus replication. The mechanism of action of the M2 channels is a subject of scientific interest particularly as A/M2 channel was shown to be a target for the action of the antiviral drug amantadine. Unfortunately, an inhibitor of the BM2 channel activity is not known. Thus, knowledge of the structural and functional properties of the BM2 channel is essential for the development of potent antiviral drugs. The characterization of the oligomeric state of the BM2 channel is an essential first step in the understanding of channel function. Here we describe determination of the stoichiometry of the BM2 proton channel by utilizing three different approaches. 1) We demonstrated that BM2 monomers can be chemically cross-linked to yield species consistent with dimers, trimers, and tetramers. 2) We studied electrophysiological and biochemical properties of mixed oligomers consisting of wild-type and mutated BM2 subunits and related these data to predicted binomial distribution models. 3) We used fluorescence resonance energy transfer (FRET) in combination with biochemical measurements to estimate the relationships between BM2 channel subunits expressed in the plasma membrane. Our experimental data are consistent with a tetrameric structure of the BM2 channel. Finally, we demonstrated that BM2 transmembrane domain is responsible for the channel oligomerization.	[Balannik, Victoria; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Pinto, LH (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Hogan Hall,2205 Tech Dr, Evanston, IL 60208 USA.	larry-pinto@northwestern.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057363] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI-57363] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Clegg R.M., 1996, FLUORESCENCE IMAGING, V137, P179; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P369, DOI DOI 10.1007/978-1-4757-3061-6; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Mould JA, 2003, DEV CELL, V5, P175, DOI 10.1016/S1534-5807(03)00190-4; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Odagiri T, 1999, J GEN VIROL, V80, P2573, DOI 10.1099/0022-1317-80-10-2573; PANAYOTOV PP, 1992, VIROLOGY, V186, P352, DOI 10.1016/0042-6822(92)90096-8; Paterson RG, 2003, VIROLOGY, V306, P7, DOI 10.1016/S0042-6822(02)00083-1; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Sakaguchi T, 1997, P NATL ACAD SCI USA, V94, P5000, DOI 10.1073/pnas.94.10.5000; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Shuck K, 2000, J VIROL, V74, P7755, DOI 10.1128/JVI.74.17.7755-7761.2000; STOUFFER AL, 2007, IN PRESS NATURE; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	41	33	33	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4895	4904		10.1074/jbc.M709433200	http://dx.doi.org/10.1074/jbc.M709433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073201	hybrid			2022-12-27	WOS:000253426500047
J	Hebbachi, AM; Knight, BL; Wiggins, D; Patel, DD; Gibbons, GF				Hebbachi, Abdel M.; Knight, Brian L.; Wiggins, David; Patel, Dilip D.; Gibbons, Geoffrey F.			Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; LIVER-X-RECEPTOR; PPAR-ALPHA; INSULIN-RESISTANCE; LIPID-METABOLISM; MICE; GLUCOSE; CHOLESTEROL; SREBP-1C	The mRNA expression of lipogenic genes Scd-1 and Fas is regulated partly by the insulin-sensitive transcription factor SREBP-1c and liver X receptor alpha (LXR alpha). Compared with normal mice, the increase in the mRNA expression of hepatic Scd-1, Fas, and Srebp-1c was severely attenuated in peroxisome proliferator-activated receptor alpha(PPAR alpha)-deficient mice during the transition from the starved to the re-fed states. The concentration of the membrane-bound form of SREBP-1c was also lower in the livers of the PPAR alpha-deficient mice during re-feeding but there was little difference in the concentration of the active, nuclear form, or in the abundance of Insig-2a mRNA. The response of plasma insulin to starvation and re-feeding was normal in the PPAR alpha-deficient mice. Rat hepatocytes transfected with an adenovirus encoding a dominant negative form of PPAR alpha were resistant to the stimulatory effects of insulin on Fas and Scd-1 mRNA expression in vitro. When LXR alpha was activated in vivo by inclusion of a non-steroidal ligand in the diet, the expression of the mRNA for hepatic Srebp-1c, Fas, and Scd-1 was increased severalfold in mice of both genotypes and resistance associated with PPAR alpha deficiency was abolished during re-feeding. However, although re-feeding the LXR alpha ligand induced the immature form of SREBP-1c equally in the livers of both genotypes, the concentration of the nuclear form remained relatively low in the livers of the PPAR alpha-deficient mice. We conclude that intact PPAR alpha is required to mediate the response of Scd-1 and Fas gene expression to insulin and that this is normally achieved directly by activation of LXR alpha.	[Hebbachi, Abdel M.; Wiggins, David; Gibbons, Geoffrey F.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Met Res Lab, Oxford OX3 7LJ, England; [Knight, Brian L.; Patel, Dilip D.] Univ London Imperial Coll Sci Technol & Med, Sch Med, Med Res Council Ctr Clin Sci, London W12 0NN, England	University of Oxford; Imperial College London	Gibbons, GF (corresponding author), Churchill Hosp, OCDEM, Old Rd, Oxford OX3 7LJ, England.	geoff.gibbons@mrl.ox.ac.uk			Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; BARTLETT SM, 1988, BIOCHEM J, V249, P37, DOI 10.1042/bj2490037; BOURGEOIS CS, 1995, AM J PHYSIOL-ENDOC M, V269, pE208, DOI 10.1152/ajpendo.1995.269.2.E208; Bulow J, 1999, J LIPID RES, V40, P2034; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gibbons G, 2005, NAT MED, V11, P722, DOI 10.1038/nm0705-722; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim HJ, 2002, J LIPID RES, V43, P1750, DOI 10.1194/jlr.M100433-JLR200; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Li Y, 2005, J LIPID RES, V46, P2432, DOI 10.1194/jlr.M500237-JLR200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Mziaut H, 2000, P NATL ACAD SCI USA, V97, P8883, DOI 10.1073/pnas.97.16.8883; Patel DD, 2001, J LIPID RES, V42, P328; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Semple RK, 2005, ENDOCRINOLOGY, V146, P1871, DOI 10.1210/en.2004-1405; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Trickett JI, 2001, J BIOL CHEM, V276, P39522, DOI 10.1074/jbc.M101764200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100	45	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4866	4876		10.1074/jbc.M709471200	http://dx.doi.org/10.1074/jbc.M709471200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079124	hybrid			2022-12-27	WOS:000253426500044
J	Macoritto, M; Nguyen-Yamamoto, L; Huang, DC; Samuel, S; Yang, XF; Wang, TT; White, JH; Kremer, R				Macoritto, Michael; Nguyen-Yamamoto, Loan; Huang, Dao Chao; Samuel, Sara; Yang, Xian Fang; Wang, Tian Tian; White, John H.; Kremer, Richard			Phosphorylation of the human retinoid X receptor alpha at serine 260 impairs coactivator(s) recruitment and induces hormone resistance to multiple ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN-PAPILLOMAVIRUS TYPE-16; GENE PROMOTER; ACTIVATION; PROTEIN; EXPRESSION; BINDING; TRANSACTIVATION; IDENTIFICATION; KERATINOCYTES	The retinoid X receptor alpha(RXR alpha) is a member of the nuclear receptor superfamily that regulates transcription of target genes through heterodimerization with several partners, including peroxisome proliferator-activated receptor, retinoic acid receptor, thyroid receptor, and vitamin D receptor (VDR). We have shown previously that signaling through VDR center dot RXR alpha heterodimers was attenuated in ras-transformed keratinocytes due to phosphorylation of serine 260 of the RXR alpha via the activated Ras-Raf-MAPK cascade in these cells. In this study we demonstrate that phosphorylation at serine 260, a site located in the omega loop-AF-2 interacting domain of RXR alpha, inhibits signaling through several heterodimeric partners of the RXR alpha. The inhibition of signaling results in reduced transactivational response to ligand presentation and the reduced physiological response of growth inhibition not only of 1,25-dihydroxyvitamin D-3 but also of retinoic acid receptor alpha ligands and LG1069 (an RXR alpha ligand). This partial resistance to ligands could be reversed by inhibition of MAPK activity or by overexpression of a non-phosphorylable RXR alpha mutant at serine 260 (RXR alpha Ser-260 -> Ala). Importantly, phosphorylation of RXR alpha at serine 260 impaired the recruitment of DRIP205 and other coactivators to the VDR center dot RXR alpha complex. Chromatin immunoprecipitation and pulldown assays further demonstrated that coactivator recruitment to the VDR center dot RXR complex could be restored by treatment with a MAPK inhibitor. Our data suggest that phosphorylation at serine 260 plays a critical role in inducing hormone resistance of RXR alpha-mediated signaling likely through structural changes in the H-1-H-3 omega loop-AF2 coactivator(s) interacting domain.	[Macoritto, Michael; Nguyen-Yamamoto, Loan; Huang, Dao Chao; Samuel, Sara; Yang, Xian Fang; Wang, Tian Tian; White, John H.; Kremer, Richard] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada	McGill University	Kremer, R (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W,Rm H4-67, Montreal, PQ H3A 1A1, Canada.	Richard.kremer@mcgill.ca	white, john h/N-9782-2013	white, john h/0000-0002-4785-2687; Kremer, Richard/0000-0002-7053-2139				BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; Bruck N, 2005, CELL SIGNAL, V17, P1229, DOI 10.1016/j.cellsig.2004.12.006; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; DURST M, 1987, ONCOGENE, V1, P251; DURST M, 1989, VIROLOGY, V173, P767, DOI 10.1016/0042-6822(89)90595-3; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Horiuchi H, 2004, J EXP CLIN CANC RES, V23, P599; JIANG HP, 1994, ONCOGENE, V9, P3397; Li D, 2002, J BIOL CHEM, V277, P31416, DOI 10.1074/jbc.M204818200; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; MCKENNA NJ, 1995, NATURE, V375, P359; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Narvaez CJ, 1996, ENDOCRINOLOGY, V137, P400, DOI 10.1210/en.137.2.400; Oda Y, 2003, MOL ENDOCRINOL, V17, P2329, DOI 10.1210/me.2003-0063; ONATE SA, 1995, SCIENCE, V270, P1354; Pandey PK, 2005, MOL CELL BIOL, V25, P10695, DOI 10.1128/MCB.25.24.10695-10710.2005; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Saramaki A, 2006, NUCLEIC ACIDS RES, V34, P543, DOI 10.1093/nar/gkj460; SEBAG M, 1992, J BIOL CHEM, V267, P12162; Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502; Solomon C, 1999, J CLIN INVEST, V103, P1729, DOI 10.1172/JCI6871; Solomon C, 2001, RADIAT RES, V155, P156, DOI 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; Takeshita A, 1997, J BIOL CHEM, V272, P27629, DOI 10.1074/jbc.272.44.27629; TASSET D, 1990, CELL, V62, P1177, DOI 10.1016/0092-8674(90)90394-T; Thompson PD, 2001, J MOL ENDOCRINOL, V27, P211, DOI 10.1677/jme.0.0270211; TRAMONTANO D, 1986, J BIOL CHEM, V261, P3919; Tran NQ, 2004, BIOCHEM J, V381, P267, DOI 10.1042/BJ20031653; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.bi.63.070194.002315; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; WEIGEL NL, 1995, J STEROID BIOCHEM, V53, P509, DOI 10.1016/0960-0760(95)00098-K; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; WHITFIELD GK, 2005, VITAMIN D, P220; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P206; Zachos G, 1997, CRIT REV ONCOL HEMAT, V26, P65, DOI 10.1016/S1040-8428(97)00013-9; Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/mend.15.4.0624; Zugmaier G, 1996, BRIT J CANCER, V73, P1341, DOI 10.1038/bjc.1996.256	47	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4943	4956		10.1074/jbc.M707517200	http://dx.doi.org/10.1074/jbc.M707517200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18003614	hybrid			2022-12-27	WOS:000253426500052
J	Niles, BJ; Clegg, MS; Hanna, LA; Chou, SS; Momma, TY; Hong, H; Keen, CL				Niles, Brad J.; Clegg, Michael S.; Hanna, Lynn A.; Chou, Susan S.; Momma, Tony Y.; Hong, Heeok; Keen, Carl L.			Zinc deficiency-induced iron accumulation, a consequence of alterations in iron regulatory protein-binding activity, iron transporters, and iron storage proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; NITRIC-OXIDE; OXIDATIVE STRESS; TRANSLATIONAL REGULATION; RESPONSIVE ELEMENTS; RNA-BINDING; FERRITIN; IRP2; DEGRADATION; MODULATION	One consequence of zinc deficiency is an elevation in cell and tissue iron concentrations. To examine the mechanism(s) underlying this phenomenon, Swiss 3T3 cells were cultured in zinc-deficient (D, 0.5 mu M zinc), zinc-supplemented (S, 50 mu M zinc), or control (C, 4 mu M zinc) media. After 24 h of culture, cells in the D group were characterized by a 50% decrease in intracellular zinc and a 35% increase in intracellular iron relative to cells in the S and C groups. The increase in cellular iron was associated with increased transferrin receptor 1 protein and mRNA levels and increased ferritin light chain expression. The divalent metal transporter 1(+) iron-responsive element isoform mRNA was decreased during zinc deficiency-induced iron accumulation. Examination of zinc-deficient cells revealed increased binding of iron regulatory protein 2 (IRP2) and decreased binding of IRP1 to a consensus iron-responsive element. The increased IRP2-binding activity in zinc-deficient cells coincided with an increased level of IRP2 protein. The accumulation of IRP2 protein was independent of zinc deficiency-induced intracellular nitric oxide production but was attenuated by the addition of the antioxidant N-acetylcysteine or ascorbate to the D medium. These data support the concept that zinc deficiency can result in alterations in iron transporter, storage, and regulatory proteins, which facilitate iron accumulation.	[Niles, Brad J.; Clegg, Michael S.; Hanna, Lynn A.; Chou, Susan S.; Momma, Tony Y.; Keen, Carl L.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keen, Carl L.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Hong, Heeok] Sangmyung Univ, Dept Food Serv Management & Nutr, Seoul 110743, South Korea	University of California System; University of California Davis; University of California System; University of California Davis; Sang Myung University	Keen, CL (corresponding author), Univ Calif Davis, Dept Nutr, 1 Shields Ave, Davis, CA 95616 USA.	clkeen@ucdavis.edu		Hong, Heeok/0000-0001-6533-6064	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD001743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007355] Funding Source: NIH RePORTER; NICHD NIH HHS [HD01743] Funding Source: Medline; NIDDK NIH HHS [DK07355] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Bouton C, 1998, J BIOL CHEM, V273, P9403, DOI 10.1074/jbc.273.16.9403; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chou SS, 2004, BIOCHEM J, V383, P63, DOI 10.1042/BJ20040074; Clegg MS, 2005, IUBMB LIFE, V57, P661, DOI 10.1080/15216540500264554; Cui L, 1997, J NUTR, V127, P1729, DOI 10.1093/jn/127.9.1729; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Gariboldi MB, 2000, FREE RADICAL BIO MED, V29, P633, DOI 10.1016/S0891-5849(00)00347-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; KEEN CL, 1988, AM J CLIN NUTR, V47, P1041, DOI 10.1093/ajcn/47.6.1041; KEEN CL, 1985, BIOL TRACE ELEM RES, V8, P123, DOI 10.1007/BF02917466; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Oliveira L, 1999, J BIOL CHEM, V274, P516, DOI 10.1074/jbc.274.1.516; Oteiza PI, 2000, FREE RADICAL BIO MED, V28, P1091, DOI 10.1016/S0891-5849(00)00200-8; OTEIZA PI, 1995, J NUTR, V125, P823; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Phillips JD, 1996, BLOOD, V87, P2983, DOI 10.1182/blood.V87.7.2983.bloodjournal8772983; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; ROGERS JM, 1985, TERATOLOGY, V31, P89, DOI 10.1002/tera.1420310111; ROGERS JM, 1987, J NUTR, V117, P1875, DOI 10.1093/jn/117.11.1875; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; VanOrden HE, 2006, ANN PHARMACOTHER, V40, P1110, DOI 10.1345/aph.1G566; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2006, MOL CELL BIOL, V26, P1948, DOI 10.1128/MCB.26.5.1948-1954.2006; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; Whitington PF, 2006, HEPATOLOGY, V43, P654, DOI 10.1002/hep.21129; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024	50	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5168	5177		10.1074/jbc.M709043200	http://dx.doi.org/10.1074/jbc.M709043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073202	hybrid			2022-12-27	WOS:000253426500074
J	Kramer, DL; Diegelman, P; Jell, J; Vujcic, S; Merali, S; Porter, CW				Kramer, Debora L.; Diegelman, Paula; Jell, Jason; Vujcic, Slavoljub; Merali, Salim; Porter, Carl W.			Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE; S-ADENOSYLMETHIONINE DECARBOXYLASE; ORNITHINE-DECARBOXYLASE; RELATIVE ABILITIES; FAT-METABOLISM; ADIPOSE-TISSUE; CANCER-THERAPY; GROWTH; CATABOLISM; MICE	Recent studies suggest that overexpression of the polyamine-acetylating enzyme spermidine/spermine N-1-acetyltransferase (SSAT) significantly increases metabolic flux through the polyamine pathway. The concept derives from the observation that SSAT-induced acetylation of polyamines gives rise to a compensatory increase in biosynthesis and presumably to increased flow through the pathway. Despite the strength of this deduction, the existence of heightened polyamine flux has not yet been experimentally demonstrated. Here, we use the artificial polyamine precursor 4-fluoro-ornithine to measure polyamine flux by tracking fluorine unit permeation of polyamine pools in human prostate carcinoma LNCaP cells. Conditional overexpression of SSAT was accompanied by a massive increase in intracellular and extracellular acetylated spermidine and by a 6-20-fold increase in biosynthetic enzyme activities. In the presence of 300 mu M 4-fluoro-ornithine, SSAT overexpression led to the sequential appearance of fluorinated putrescine, spermidine, acetylated spermidine, and spermine. As fluorinated polyamines increased, endogenous polyamines decreased, so that the total polyamine pool size remained relatively constant. At 24 h, 56% of the spermine pool in the induced SSAT cells was fluorine-labeled compared with only 12% in uninduced cells. Thus, SSAT induction increased metabolic flux by similar to 5-fold. Flux could be interrupted by inhibition of polyamine biosynthesis but not by inhibition of polyamine oxidation. Overall, the findings are consistent with a paradigm whereby flux is initiated by SSAT acetylation of spermine and particularly spermidine followed by a marked increase in key biosynthetic enzymes. The latter sustains the flux cycle by providing a constant supply of polyamines for subsequent acetylation by SSAT. The broader metabolic implications of this futile metabolic cycling are discussed in detail.	[Kramer, Debora L.; Diegelman, Paula; Jell, Jason; Vujcic, Slavoljub; Porter, Carl W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Merali, Salim] Temple Univ, Sch Med, Fels Inst, Philadelphia, PA 19140 USA; [Merali, Salim] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Porter, CW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	carl.porter@roswellpark.org			NCI NIH HHS [CA-76428, CA 109619, CA-09072, CA-22153] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022153, R01CA076428, R01CA109619] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Alhonen L, 1998, J BIOL CHEM, V273, P1964, DOI 10.1074/jbc.273.4.1964; ASK A, 1992, CANCER LETT, V66, P29, DOI 10.1016/0304-3835(92)90276-2; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BYERS TL, 1990, J CELL PHYSIOL, V143, P460, DOI 10.1002/jcp.1041430309; CASERO RA, 1989, CANCER RES, V49, P3829; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen Y, 2003, MOL PHARMACOL, V64, P1153, DOI 10.1124/mol.64.5.1153; Chen Y, 2001, CANCER RES, V61, P6437; CLARK JL, 1975, BIOCHEMISTRY-US, V14, P4403, DOI 10.1021/bi00691a010; DEZEURE F, 1988, INT J BIOCHEM, V20, P1299, DOI 10.1016/0020-711X(88)90235-2; FogelPetrovic M, 1996, FEBS LETT, V391, P89, DOI 10.1016/0014-5793(96)00710-7; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Gschwend JE, 1997, PROSTATE, V33, P166; Hector S, 2004, MOL CANCER THER, V3, P813; Janne J, 2006, J BIOCHEM, V139, P155, DOI 10.1093/jb/mvj035; JANNE J, 1978, BIOCHIM BIOPHYS ACTA, V473, P241, DOI 10.1016/0304-419X(78)90015-X; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; KRAMER D, 1995, BIOCHEM PHARMACOL, V50, P1433, DOI 10.1016/0006-2952(95)02037-3; KRAMER D, 1995, J BIOL CHEM, V270, P2124, DOI 10.1074/jbc.270.5.2124; KRAMER DL, 1993, J CELL PHYSIOL, V155, P399, DOI 10.1002/jcp.1041550222; KRAMER DL, 1989, BIOCHEM J, V259, P325, DOI 10.1042/bj2590325; KRAMER DL, 2004, CANC DRUG DISC DEV, P339; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; MADHUBALA R, 1988, BIOCHEM J, V254, P45, DOI 10.1042/bj2540045; McCloskey DE, 1999, J BIOL CHEM, V274, P6175, DOI 10.1074/jbc.274.10.6175; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MOULINOUX JP, 1991, J UROLOGY, V146, P1408, DOI 10.1016/S0022-5347(17)38125-9; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; PEGG AE, 1988, CANCER RES, V48, P759; PERSSON L, 1988, CANCER RES, V48, P4807; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; Porter C W, 1988, Adv Exp Med Biol, V250, P677; PORTER CW, 1987, BIOCHEM J, V242, P433, DOI 10.1042/bj2420433; PORTER CW, 1985, CANCER RES, V45, P2050; PORTER CW, 1991, CANCER RES, V51, P3715; PORTER CW, 1988, ADV ENZYME REGUL, V27, P57; PORTER CW, 1987, CANCER RES, V47, P2821; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; SARHAN S, 1989, ANTICANCER RES, V9, P215; SEILER N, 1980, J CHROMATOGR, V221, P227, DOI 10.1016/S0378-4347(00)84307-8; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Seiler N, 2003, CURR DRUG TARGETS, V4, P565, DOI 10.2174/1389450033490876; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Seiler Nikolaus, 2002, Prog Drug Res, V59, P1; SHAPPELL NW, 1993, FEBS LETT, V321, P179, DOI 10.1016/0014-5793(93)80103-2; Tucker JM, 2005, CANCER RES, V65, P5390, DOI 10.1158/0008-5472.CAN-05-0229; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Wallace H M, 1988, Adv Exp Med Biol, V250, P331; WALLACE HM, 1985, BIOCHEM SOC T, V13, P329, DOI 10.1042/bst0130329; Wang XJ, 2007, CARCINOGENESIS, V28, P2404, DOI 10.1093/carcin/bgm162	59	60	64	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4241	4251		10.1074/jbc.M706806200	http://dx.doi.org/10.1074/jbc.M706806200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18089555	hybrid			2022-12-27	WOS:000253083500059
J	Lajoie-Mazenc, I; Tovar, D; Penary, M; Lortal, B; Allart, S; Favard, C; Brihoum, M; Pradines, A; Favre, G				Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Allart, Sophie; Favard, Cyril; Brihoum, Meryem; Pradines, Anne; Favre, Gilles			MAP1A light chain-2 interacts with GTP-RhoB to control epidermal growth factor (EGF)-dependent EGF receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-1A; BINDING-PROTEIN; RAS TRANSFORMATION; FACTOR-BETA; EXPRESSION; CELLS; ACTIN; GTPASES; FAMILY; LOCALIZATION	Rho GTPases have been implicated in the control of several cellular functions, including regulation of the actin cytoskeleton, cell proliferation, and oncogenesis. Unlike RhoA and RhoC, RhoB localizes in part to endosomes and controls endocytic trafficking. Using a yeast two-hybrid screen and a glutathione S-transferase pulldown assay, we identified LC2, the light chain of the microtubule-associated protein MAP1A, as a novel binding partner for RhoB. GTP binding and the 18-amino acid C-terminal hypervariable domain of RhoB are critical for its binding to MAP1A/LC2. Coimmunoprecipitation and immunofluorescence experiments showed that this interaction occurs in U87 cells. Down-regulation of MAP1A/LC2 expression decreased epidermal growth factor (EGF) receptor expression and modified the signaling response to EGF treatment. We concluded that MAP1A/LC2 is critical for RhoB function in EGF-induced EGF receptor regulation. Because MAP1A/LC2 is thought to function as an adaptor between microtubules and other molecules, we postulate that the RhoB and MAP1A/LC2 interactions facilitate endocytic vesicle trafficking and regulate the trafficking of signaling molecules.	[Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Pradines, Anne] Inst Claudius Regaud, INSERM, U 563, F-31052 Toulouse, France; [Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Pradines, Anne; Favre, Gilles] Dept Oncogenese Signalisat & Innovat Therapeut, INSERM, U 563, F-31059 Toulouse, France; [Lajoie-Mazenc, Isabelle; Tovar, Daniel; Penary, Marie; Lortal, Barbara; Brihoum, Meryem; Pradines, Anne; Favre, Gilles] Univ Toulouse 3, Fac Pharmaceut Sci, F-31059 Toulouse, France; [Allart, Sophie] INSERM, IFR 30, F-31024 Toulouse, France; [Favard, Cyril] IPBS, CNRS, UMR 5089, F-31077 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lajoie-Mazenc, I (corresponding author), Inst Claudius Regaud, INSERM, U 563, F-31052 Toulouse, France.	lajoie.isabelle@claudiusregaud.fr	Lajoie-Mazenc, Isabelle/M-4636-2014; Pradines, Anne/M-3935-2014; Favard, Cyril/P-6392-2016; FAVRE, Gilles/K-9189-2014	Pradines, Anne/0000-0002-2449-678X; Favard, Cyril/0000-0002-8304-2980; FAVRE, Gilles/0000-0002-2344-1883				ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617; Ader I, 2002, ONCOGENE, V21, P5998, DOI 10.1038/sj.onc.1205746; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, J BIOL CHEM, V277, P8500, DOI 10.1074/jbc.M104367200; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; BLOOM GS, 1984, J CELL BIOL, V98, P331, DOI 10.1083/jcb.98.1.331; Brenman JE, 1998, J NEUROSCI, V18, P8805; Canguilhem B, 2005, J BIOL CHEM, V280, P43257, DOI 10.1074/jbc.M508650200; Chien CL, 2005, EXP CELL RES, V308, P446, DOI 10.1016/j.yexcr.2005.05.007; DeFranco C, 1998, MOL BIOL CELL, V9, P1695, DOI 10.1091/mbc.9.7.1695; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; Fritz G, 1997, J BIOL CHEM, V272, P30637, DOI 10.1074/jbc.272.49.30637; Fritz G, 2000, BIOCHEM BIOPH RES CO, V268, P784, DOI 10.1006/bbrc.2000.2211; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Huang M, 2006, HISTOL HISTOPATHOL, V21, P213, DOI 10.14670/HH-21.213; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; LEBOWITZ PF, 1995, MOL CELL BIOL, V15, P6613; Lebowitz PF, 1998, CELL ADHES COMMUN, V6, P277, DOI 10.3109/15419069809010787; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Magiera MM, 2004, BIOCHEM J, V382, P803, DOI 10.1042/BJ20040122; Malcolm T, 2003, ONCOGENE, V22, P6142, DOI 10.1038/sj.onc.1206638; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Mellor H, 1998, J BIOL CHEM, V273, P4811, DOI 10.1074/jbc.273.9.4811; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Milia J, 2005, CELL DEATH DIFFER, V12, P492, DOI 10.1038/sj.cdd.4401586; Mircescu H, 2002, EUR J BIOCHEM, V269, P6241, DOI 10.1046/j.1432-1033.2002.03343.x; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Neel NF, 2007, J CELL SCI, V120, P1559, DOI 10.1242/jcs.03437; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Park SM, 2004, FEBS LETT, V570, P143, DOI 10.1016/j.febslet.2004.06.037; PEDROTTI B, 1994, CELL MOTIL CYTOSKEL, V29, P110, DOI 10.1002/cm.970290203; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Rondanino C, 2007, TRAFFIC, V8, P932, DOI 10.1111/j.1600-0854.2007.00575.x; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Skuli N, 2006, CANCER RES, V66, P482, DOI 10.1158/0008-5472.CAN-05-2299; Stamatakis K, 2002, J BIOL CHEM, V277, P49389, DOI 10.1074/jbc.M204049200; Steuve S, 2006, EXP CELL RES, V312, P3981, DOI 10.1016/j.yexcr.2006.08.028; Togel M, 1999, FEBS LETT, V451, P15, DOI 10.1016/S0014-5793(99)00523-2; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; WANG S, 2004, NOVART FDN SYMP, V259, P285; Wang Shaowen, 2004, Novartis Found Symp, V259, P238; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westmark CJ, 2005, ONCOGENE, V24, P502, DOI 10.1038/sj.onc.1208224; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; ZALCMAN G, 1995, ONCOGENE, V10, P1935	69	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4155	4164		10.1074/jbc.M709639200	http://dx.doi.org/10.1074/jbc.M709639200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056259	hybrid			2022-12-27	WOS:000253083500051
J	Thakran, S; Li, HF; Lavine, CL; Miller, MA; Bina, JE; Bina, XWR; Re, F				Thakran, Shalini; Li, Hanfen; Lavine, Christy L.; Miller, Mark A.; Bina, James E.; Bina, Xiaowen R.; Re, Fabio			Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR)2/TLR1 heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE-VACCINE STRAIN; NF-KAPPA-B; MEMBRANE-PROTEINS; INFLAMMATORY RESPONSES; MEDIATED-IMMUNITY; CELL ACTIVATION; TLR2; LVS; INNATE; LIPOPOLYSACCHARIDE	The innate immune response to Francisella tularensis is primarily mediated by TLR2, though the bacterial products that stimulate this receptor remain unknown. Here we report the identification of two Francisella lipoproteins, TUL4 and FTT1103, which activate TLR2. We demonstrate that TUL4 and FTT1103 stimulate chemokine production in human and mouse cells in a TLR2-dependent way. Using an assay that relies on chimeric TLR proteins, we show that TUL4 and FTT1103 stimulate exclusively the TLR2/TLR1 heterodimer. Our results also show that yet unidentified Francisella proteins, possibly unlipidated, have the ability to stimulate the TLR2/TLR6 heterodimer. Through domain-exchange analysis, we determined that an extended region that comprises LRR9-17 in the extracellular portion of TLR1 mediates response to Francisella lipoproteins and triacylated lipopeptide. Substitution of the corresponding LRR of TLR6 with the LRR derived from TLR1 enables TLR6 to recognize TUL4, FTT1103, and triacylated lipopeptide. This study identifies for the first time specific Francisella products capable of stimulating a proinflammatory response and the cellular receptors they trigger.	[Thakran, Shalini; Li, Hanfen; Lavine, Christy L.; Miller, Mark A.; Bina, James E.; Bina, Xiaowen R.; Re, Fabio] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Re, F (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, 858 Madison Ave, Memphis, TN 38163 USA.	fre@utmem.edu	Bina, Xiaowen/AAE-9100-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061260, R21AI074582] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI074582, AI061260, AI-05466501, AI074582] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; Argueta JGM, 2006, ORAL MICROBIOL IMMUN, V21, P245, DOI 10.1111/j.1399-302X.2006.00286.x; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bina XWR, 2006, ARCH MICROBIOL, V186, P219, DOI 10.1007/s00203-006-0140-6; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRAUN V, 1993, BACTERIAL CELL WALL, V27, P319; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Ray A, 2004, MOL IMMUNOL, V41, P1167, DOI 10.1016/j.molimm.2004.06.007; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; SJOSTEDT A, 1991, INFECT IMMUN, V59, P3163; SJOSTEDT A, 1989, MICROB PATHOGENESIS, V6, P403, DOI 10.1016/0882-4010(89)90082-X; SJOSTEDT A, 1992, INFECT IMMUN, V60, P2855; Takenaka R, 2004, MICROBIOL-SGM, V150, P3913, DOI 10.1099/mic.0.27527-0; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008	40	84	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3751	3760		10.1074/jbc.M706854200	http://dx.doi.org/10.1074/jbc.M706854200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079113	hybrid			2022-12-27	WOS:000253083500008
J	Tiruppathi, C; Shimizu, J; Miyawaki-Shimizu, K; Vogel, SM; Bair, AM; Minshall, RD; Predescu, D; Malik, AB				Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.			Role of NF-kappa B-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL LIPOPOLYSACCHARIDE; MICROVASCULAR PERMEABILITY; DIFFERENTIAL EXPRESSION; PROTEIN EXPRESSION; UP-REGULATION; ACTIVATION; CELLS; RECEPTOR; TRANSCYTOSIS; TRANSPORT	We investigated the role of NF-kappa B activation by the bacterial product lipopolysaccharide (LPS) in inducing caveolin-1 (Cav-1) expression and its consequence in contributing to the leakiness of the endothelial barrier. We observed that LPS challenge of human lung microvascular endothelial cells induced concentration-and time-dependent increases in expression of Cav-1 mRNA and protein. The NEMO (NF-kappa B essential modifier binding domain)-binding domain peptide (IkB kinase (IKK)-NEMO-binding domain (NBD) peptide), which prevents NF-kappa B activation by inhibiting the interaction of IKK gamma with the IKK complex, blocked LPS-induced Cav-1 mRNA and protein expression. Knockdown of NF-kappa B subunit p65/RelA expression with small interfering RNA also prevented LPS-induced Cav-1 expression. Caveolae open to the apical and basal plasmalemma of endothelial cells increased 2-4-fold within 4 h of LPS exposure. IKK-NBD peptide markedly reduced the LPS-induced increase in the number of caveolae as well as transendothelial albumin permeability. These observations were recapitulated in mouse studies in which IKK-NBD peptide prevented Cav-1 expression and interfered with the increase in lung microvessel permeability induced by LPS. Thus, LPS mediates NF-kappa B-dependent Cav-1 expression that results in increased caveolae number and thereby contributes to the mechanism of increased transendothelial albumin permeability.	[Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Malik, AB (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, M-C 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	abmalik@uic.edu		Malik, Asrar/0000-0002-8205-7128	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, P01HL060678, R01HL045638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL045638, P01HL060678, P01 HL077806, P01 HL060678-09, P01 HL077806-03, R01 HL045638-19, P01 HL060678, P01HL077806, R01 HL045638] Funding Source: Medline; NIGMS NIH HHS [R01 GM058531-10, R01 GM58531, R01 GM058531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; LANTZ RC, 1991, AM REV RESPIR DIS, V144, P167, DOI 10.1164/ajrccm/144.1.167; Lei MG, 2000, INFECT IMMUN, V68, P5084, DOI 10.1128/IAI.68.9.5084-5089.2000; Lei MG, 2005, INFECT IMMUN, V73, P8136, DOI 10.1128/IAI.73.12.8136-8143.2005; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Pascariu M, 2004, J HISTOCHEM CYTOCHEM, V52, P65, DOI 10.1177/002215540405200107; Rahman A, 1998, AM J PHYSIOL-LUNG C, V275, pL533, DOI 10.1152/ajplung.1998.275.3.L533; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587	37	88	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4210	4218		10.1074/jbc.M703153200	http://dx.doi.org/10.1074/jbc.M703153200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077459	Green Accepted, hybrid			2022-12-27	WOS:000253083500056
J	Bogenhagen, DF; Rousseau, D; Burke, S				Bogenhagen, Daniel F.; Rousseau, Denis; Burke, Stephanie			The layered structure of human mitochondrial DNA nucleoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMALDEHYDE CROSS-LINKING; INNER MEMBRANE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LON PROTEASE; IN-VIVO; POLYMERASE-DELTA; TOPOISOMERASE-I; MESSENGER-RNA; LIGASE-III	Mitochondrial DNA (mtDNA) occurs in cells in nucleoids containing several copies of the genome. Previous studies have identified proteins associated with these large DNA structures when they are biochemically purified by sedimentation and immunoaffinity chromatography. In this study, formaldehyde cross-linking was performed to determine which nucleoid proteins are in close contact with the mtDNA. A set of core nucleoid proteins is found in both native and cross-linked nucleoids, including 13 proteins with known roles in mtDNA transactions. Several other metabolic proteins and chaperones identified in native nucleoids, including ATAD3, were not observed to cross-link to mtDNA. Additional immunofluorescence and protease susceptibility studies showed that an N-terminal domain of ATAD3 previously proposed to bind to the mtDNA D-loop is directed away from the mitochondrial matrix, so it is unlikely to interact with mtDNA in vivo. These results are discussed in relation to a model for a layered structure of mtDNA nucleoids in which replication and transcription occur in the central core, whereas translation and complex assembly may occur in the peripheral region.	[Bogenhagen, Daniel F.; Burke, Stephanie] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Rousseau, Denis] UJF, CNRS,CEA, Lab Biochim & Biophys Syst Integres P438B, Inst Rec Technol & Sci, F-38054 Grenoble 09, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	dan@pharm.sunysb.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012039] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES12039] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Arakaki N, 2006, BBA-GEN SUBJECTS, V1760, P1364, DOI 10.1016/j.bbagen.2006.05.012; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bryan AC, 2002, GENETICS, V160, P75; CANTATORE P, 1987, FEBS LETT, V213, P144, DOI 10.1016/0014-5793(87)81480-1; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Cheng XL, 2005, J BIOCHEM, V138, P673, DOI 10.1093/jb/mvi169; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NASS MMK, 1969, SCIENCE, V165, P25, DOI 10.1126/science.165.3888.25; Neuwald AF, 2005, NUCLEIC ACIDS RES, V33, P3614, DOI 10.1093/nar/gki674; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Perez-Jannotti RM, 2001, J BIOL CHEM, V276, P48978, DOI 10.1074/jbc.M107177200; Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shen EL, 2001, NUCLEIC ACIDS RES, V29, P2822, DOI 10.1093/nar/29.13.2822; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; TZAGOLOFF A, 1982, MITOCHONDRIA, P211; Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WHITFORD TA, 1993, THESIS STATE U NEW Y; Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; ZELENAYATROITSKAYA O, 1995, EMBO J, V14, P3268, DOI 10.1002/j.1460-2075.1995.tb07330.x; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998	72	318	335	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3665	3675		10.1074/jbc.M708444200	http://dx.doi.org/10.1074/jbc.M708444200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063578	hybrid			2022-12-27	WOS:000253083000071
J	Kweon, SM; Cho, YJ; Minoo, P; Groffen, J; Heisterkamp, N				Kweon, Soo-Mi; Cho, Young Jin; Minoo, Parviz; Groffen, John; Heisterkamp, Nora			Activity of the Bcr GTPase-activating domain is regulated through direct protein protein interaction with the rho guanine nucleotide dissociation inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ENCODES; LACKING ABR; BINDING; PHOSPHORYLATION; COMPLEX; FAMILY; GDI; SUPEROXIDE; MOLECULES	The cycling of Rac GTPases, alternating between an active GTP-and an inactive GDP-bound state, is controlled by guanine nucleotide exchange factors, GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs). Little is known about how these controlling activities are coordinated. Studies using null mutant mice have demonstrated that Bcr and Abr are two physiologically important GAPs for Rac. Here, we report that in the presence of RhoGDI alpha, Bcr is unable to convert Rac-GTP to Rac-GDP because RhoGDI forms a direct protein complex with Bcr. Interestingly, RhoGDI alpha binds to the GAP domain in Bcr and Abr, a domain that also binds to Rac-GTP and catalyzes conversion of the bound GTP to GDP on Rac. The presence of activated Rac diminished the Bcr/RhoGDI alpha interaction. Moreover, a Bcr mutant that lacks the ability to promote hydrolysis of Rac-GTP bound to its GAP domain did not bind to RhoGDI alpha in cell lysates, indicating that binding of RhoGDI alpha and Rac-GTP to the Bcr GAP domain is mutually exclusive. Our results provide the first identification of a protein that regulates BcrGAP activity.	[Kweon, Soo-Mi; Cho, Young Jin; Groffen, John; Heisterkamp, Nora] Childrens Hosp, Div Hematol Oncol, Sect Mol Carcinogenesis, Saban Res Inst, Los Angeles, CA 90027 USA; [Minoo, Parviz] Univ Calif Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Groffen, John; Heisterkamp, Nora] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Heisterkamp, N (corresponding author), Childrens Hosp, Div Hematol Oncol, Sect Mol Carcinogenesis, Saban Res Inst, Ms 54,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	NHLBI NIH HHS [HL71945, HL060231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071945, P01HL060231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; CHUANG TH, 1993, J BIOL CHEM, V268, P775; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Guillemot JC, 1996, BLOOD, V88, P2722, DOI 10.1182/blood.V88.7.2722.bloodjournal8872722; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Heisterkamp N, 2002, ONCOGENE, V21, P8536, DOI 10.1038/sj.onc.1206080; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kuribayashi K, 2007, J CELL BIOL, V176, P1049, DOI 10.1083/jcb.200607019; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lian LY, 2000, STRUCT FOLD DES, V8, P47, DOI 10.1016/S0969-2126(00)00080-0; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Newcombe AR, 1999, BIOCHEMISTRY-US, V38, P6879, DOI 10.1021/bi9829837; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Olabisi OO, 2006, CANCER RES, V66, P6250, DOI 10.1158/0008-5472.CAN-06-0536; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAN EC, 1993, J BIOL CHEM, V268, P27291; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	35	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3023	3030		10.1074/jbc.M705513200	http://dx.doi.org/10.1074/jbc.M705513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070886	hybrid			2022-12-27	WOS:000253083000005
J	Leclerc, D; Rozen, R				Leclerc, Daniel; Rozen, Rima			Endoplasmic reticulum stress increases the expression of methylenetetrahydrofolate reductase through the IRE1 transducer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; UNFOLDED PROTEIN RESPONSE; N-TERMINAL KINASE; GENE-EXPRESSION; MICE DEFICIENT; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; METHIONINE SYNTHASE; KAPPA-B	Methylenetetrahydrofolate reductase ( MTHFR), an enzyme in folate and homocysteine metabolism, influences many cellular processes including methionine and nucleotide synthesis, methylation reactions, and maintenance of homocysteine at nontoxic levels. Mild deficiency of MTHFR is common in many populations and modifies risk for several complex traits including vascular disease, birth defects, and cancer. We recently demonstrated that MTHFR can be up-regulated by NF-kappa B, an important mediator of cell survival that is activated by endoplasmic reticulum ( ER) stress. This observation, coupled with the reports that homocysteine can induce ER stress, prompted us to examine the possible regulation of MTHFR by ER stress. We found that several well characterized stress inducers ( tunicamycin, thapsigargin, and A23187) as well as homocysteine could increase Mthfr mRNA and protein in Neuro-2a cells. The induction of MTHFR was also observed after overexpression of inositol-requiring enzyme-1 (IRE1) and was inhibited by a dominant-negative mutant of IRE1. Because IRE1 triggers c-Jun signaling, we examined the possible involvement of c-Jun in up-regulation of MTHFR. Transfection of c-Jun and two activators of c-Jun (LiCl and sodium valproate) increased MTHFR expression, whereas a reported inhibitor of c-Jun (SP600125) and a dominant-negative derivative of c-Jun N-terminal kinase-1 reduced MTHFR activation. We conclude that ER stress increases MTHFR expression and that IRE1 and c-Jun mediate this activation. These findings provide a novel mechanism by which the ER can regulate homeostasis and allude to an important role for MTHFR in cell survival.	[Leclerc, Daniel; Rozen, Rima] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Leclerc, Daniel; Rozen, Rima] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada	McGill University; McGill University	Rozen, R (corresponding author), 4060 Ste Catherine W,Rm 200, Montreal, PQ H3Z 2Z3, Canada.	rima.rozen@mcgill.ca	Leclerc, Daniel/B-6375-2012; Longo, Kenneth A/A-5631-2010; Leclerc, Daniel/AAB-4524-2021; Rozen, Rima/AAE-9294-2020	Leclerc, Daniel/0000-0002-9766-8941; 				Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Althausen S, 2000, MOL BRAIN RES, V84, P32, DOI 10.1016/S0169-328X(00)00208-4; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen G, 1999, MOL BRAIN RES, V64, P52, DOI 10.1016/S0169-328X(98)00303-9; Chen Zhoutao, 2002, Brain Res Gene Expr Patterns, V1, P89; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Jacobsen DW, 2005, CLIN CHEM LAB MED, V43, P1076, DOI 10.1515/CCLM.2005.188; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaneko M, 2004, BIOL PHARM BULL, V27, P1202, DOI 10.1248/bpb.27.1202; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; LECLERC D, 2005, MTHFR POLYMORPHISMS, P1; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LENTZ SR, 1991, J CLIN INVEST, V88, P1906, DOI 10.1172/JCI115514; Lenz B, 2006, EXP CELL RES, V312, P4049, DOI 10.1016/j.yexcr.2006.09.004; Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Oltean S, 2005, J BIOL CHEM, V280, P32662, DOI 10.1074/jbc.M501964200; Ortiou S, 2004, CELL PHYSIOL BIOCHEM, V14, P407, DOI 10.1159/000080350; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pickell L, 2005, BBA-GENE STRUCT EXPR, V1731, P104, DOI 10.1016/j.bbaexp.2005.09.002; Ramaswami G, 2004, J VASC SURG, V40, P1216, DOI 10.1016/j.jvs.2004.09.021; Robert K, 2004, J NEUROCHEM, V89, P33, DOI 10.1046/j.1471-4159.2003.02297.x; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Tran P, 2002, MAMM GENOME, V13, P483, DOI 10.1007/s00335-002-2167-6; UELAND PM, 2005, MTHFR POLYMORPHISM D; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yuan PX, 1999, J NEUROCHEM, V73, P2299, DOI 10.1046/j.1471-4159.1999.0732299.x; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	51	17	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3151	3160		10.1074/jbc.M708598200	http://dx.doi.org/10.1074/jbc.M708598200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065414	hybrid			2022-12-27	WOS:000253083000018
J	Tibrewal, N; Wu, Y; D'mello, V; Akakura, R; George, TC; Varnum, B; Birge, RB				Tibrewal, Nitu; Wu, Yi; D'mello, Veera; Akakura, Reiko; George, Thaddeus C.; Varnum, Brian; Birge, Raymond B.			Autophosphorylation docking site tyr-867 in mer receptor tyrosine kinase allows for dissociation of multiple signaling pathways for phagocytosis of apoptotic cells and down-modulation of lipopolysaccharide-inducible NF-kappa B transcriptional activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER SEGMENT PHAGOCYTOSIS; PIGMENT EPITHELIAL-CELLS; C-MER; PROTEIN-S; PHOSPHATIDYLSERINE RECEPTOR; EXPRESSION ANALYSIS; RETINAL DYSTROPHY; DENDRITIC CELLS; KNOCKOUT MICE; V-RYK	Efficient clearance of apoptotic cells is essential for tissue homeostasis, allowing for cellular turnover without inflammatory consequences. The Mer (Nyk and c-Eyk) receptor tyrosine kinase (Mertk) is involved in two aspects of apoptotic cell clearance by acting as a receptor for Gas6, a gamma-carboxylated phosphatidylserine-binding protein that bridges apoptotic and viable cells. First, Mertk acts in a bona fide engulfment pathway in concert with alpha v beta 5 integrin by regulating cytoskeletal assemblages, and second, it acts as a negative regulator for inflammation by down-modulating pro-inflammatory signals mediated from bacterial lipopolysaccharide-Toll-like receptor 4 (TLR4) signaling, and hence recapitulating anti-inflammatory immune modulation by apoptotic cells. Here we describe Mertk postreceptor events that govern phagocytosis and cytoskeletal signaling are principally mediated by autophosphorylation site Tyr-867. Using the Mertk Y867F mutant and pharmacological inhibitors, we show that Tyr-867 is required for phosphatidylinositol 3-kinase and phospholipase C gamma 2 activation; their activation in turn elicits protein kinase C-dependent signals that act on the actin cytoskeleton. Although Mertk(Y867F) blocked the tyrosine phosphorylation of FAK on Tyr-861 and p130(cas) and also abrogated the phagocytosis of apoptotic cells, this mutant did not suppress lipopolysaccharide-inducible NF-kappa B transcription, nor was NF-kappa B activation dependent on the protein kinase C inhibitor, calphostin C. Finally, unlike the cytoskeletal events associated with Tyr-867 autophosphorylation, the trans-inhibition of NF kappa B occurred in a postnuclear-dependent fashion independent of cytosolic I kappa B phosphorylation and p65/RelA sequestration. Taken together, these data suggest that Mertk has distinct and separable effects for phagocytosis and for resolving inflammation, providing a molecular rationale for how immune licensing and inflammation can be dissociated from phagocytosis in a single phagocytic receptor.	[Tibrewal, Nitu; Wu, Yi; D'mello, Veera; Akakura, Reiko; Birge, Raymond B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [George, Thaddeus C.] Amnis Corp, Seattle, WA 98121 USA; [Varnum, Brian] Amgen Inc, Amgen Pharmaceut, Inflammat Dept, Newbury Pk, CA 91320 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Amgen	Birge, RB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, 185 S Orange Ave, Newark, NJ 07103 USA.	birgera@umdnj.edu	D'Mello, Veera/GNM-5247-2022					Camenisch TD, 1999, J IMMUNOL, V162, P3498; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; Duncan JL, 2003, ADV EXP MED BIOL, V533, P165; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Ek S, 2002, CANCER RES, V62, P4398; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Finnemann SC, 1999, J EXP MED, V190, P861, DOI 10.1084/jem.190.6.861; Fraser DA, 2007, J BIOL CHEM, V282, P7360, DOI 10.1074/jbc.M605741200; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Georgescu MM, 1999, MOL CELL BIOL, V19, P1171; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Hall MO, 2003, ADV EXP MED BIOL, V533, P331; Hall MO, 2001, EXP EYE RES, V73, P509, DOI 10.1006/exer.2001.1062; JIA R, 1992, J VIROL, V66, P5975, DOI 10.1128/JVI.66.10.5975-5987.1992; JIA R, 1994, J BIOL CHEM, V269, P1839; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Khaled AR, 1998, CELL IMMUNOL, V185, P49, DOI 10.1006/cimm.1998.1272; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Ling L, 1996, J BIOL CHEM, V271, P18355, DOI 10.1074/jbc.271.31.18355; LING L, 1995, MOL CELL BIOL, V15, P6582; Liu YQ, 2005, J PHARMACOL SCI, V98, P361, DOI 10.1254/jphs.FPJ05005X; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Lucas M, 2003, J IMMUNOL, V171, P2610, DOI 10.4049/jimmunol.171.5.2610; Lucas M, 2006, J IMMUNOL, V177, P4047, DOI 10.4049/jimmunol.177.6.4047; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Mitchell JE, 2006, J BIOL CHEM, V281, P5718, DOI 10.1074/jbc.M509775200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nandrot EF, 2006, AM J PHYSIOL-CELL PH, V290, pC1256, DOI 10.1152/ajpcell.00480.2005; Neznanov N, 2004, DNA CELL BIOL, V23, P175, DOI 10.1089/104454904322964779; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; RESCIGNO J, 1991, ONCOGENE, V6, P1909; Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Todt JC, 2004, J LEUKOCYTE BIOL, V75, P705, DOI 10.1189/jlb.0903439; Todt JC, 2002, J BIOL CHEM, V277, P35906, DOI 10.1074/jbc.M202967200; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; Vely F, 1997, J IMMUNOL, V159, P2075; Wu Y, 2006, TRENDS CELL BIOL, V16, P189, DOI 10.1016/j.tcb.2006.02.003; Wu Y, 2005, J CELL SCI, V118, P539, DOI 10.1242/jcs.01632	52	99	106	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3618	3627		10.1074/jbc.M706906200	http://dx.doi.org/10.1074/jbc.M706906200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039660	hybrid			2022-12-27	WOS:000253083000067
J	Ashish; Juncadella, IJ; Garg, R; Boone, CD; Anguita, J; Krueger, JK				Ashish; Juncadella, Ignacio J.; Garg, Renu; Boone, Christopher D.; Anguita, Juan; Krueger, Joanna K.			Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CRYSTAL-STRUCTURE; HIV; ANTIBODIES; RESOLUTION; FRAGMENT; TYPE-1	Ligand binding induces shape changes within the four modular ectodomains (D1-D4) of the CD4 receptor, an important receptor in immune signaling. Small angle x-ray scattering (SAXS) on both a two-domain and a four-domain construct of the soluble CD4 (sCD4) is consistent with known crystal structures demonstrating a bilobal and a semi-extended tetralobal Z conformation in solution, respectively. Detection of conformational changes within sCD4 as a result of ligand binding was followed by SAXS on sCD4 bound to two different glycoprotein ligands: the tick saliva immunosuppressor Salp15 and the HIV-1 envelope protein gp120. Ab initio modeling of these data showed that both Salp15 and gp120 bind to the D1 domain of sCD4 and yet induce drastically different structural rearrangements. Upon binding, Salp15 primarily distorts the characteristic lobal architecture of the sCD4 without significantly altering the semi-extended shape of the sCD4 receptor. In sharp contrast, the interaction of gp120 with sCD4 induces a shape change within sCD4 that can be described as a Z-to-U bi-fold closure of the four domains across its flexible D2-D3 linker. Placement of known crystal structures within the boundaries of the SAXS-derived models suggests that the ligand induced shape changes could be a result of conformational changes within this D2 - D3 linker. Functionally, the observed shape changes in CD4 receptor causes dissociation of lymphocyte kinase from the cytoplasmic domain of Salp15-bound CD4 and facilitates an interaction between the exposed V3 loops of CD4-bound gp120 molecule to the extracellular loops of its co-receptor, a step essential for HIV-1 viral entry.	[Ashish; Boone, Christopher D.; Krueger, Joanna K.] Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA; [Garg, Renu] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Juncadella, Ignacio J.; Anguita, Juan] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte; University of Massachusetts System; University of Massachusetts Amherst	Krueger, JK (corresponding author), Univ N Carolina, Dept Chem, Charlotte, NC 28223 USA.	jkkruege@uncc.edu	Anguita, Juan/D-5432-2011; Krueger, Joanna/A-3110-2011	Anguita, Juan/0000-0003-2061-7182; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053064] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 053064, R01 AI053064-05, R01 AI053064] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Ashish, 2006, BIOPHYS J, V91, pL69, DOI 10.1529/biophysj.106.090381; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADY RL, 1993, SCIENCE, V260, P979, DOI 10.1126/science.8493535; Garg R, 2006, J IMMUNOL, V177, P6579, DOI 10.4049/jimmunol.177.10.6579; GARLICK RL, 1990, AIDS RES HUM RETROV, V6, P465, DOI 10.1089/aid.1990.6.465; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hager-Braun C, 2002, BIOCHEMISTRY-US, V41, P1759, DOI 10.1021/bi011626k; HARRISON SC, 1992, COLD SPRING HARB SYM, V57, P541, DOI 10.1101/SQB.1992.057.01.059; Hartley O, 2005, AIDS RES HUM RETROV, V21, P171, DOI 10.1089/aid.2005.21.171; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Huang B, 1997, J IMMUNOL, V158, P216; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KWONG PD, 1990, P NATL ACAD SCI USA, V87, P6423, DOI 10.1073/pnas.87.16.6423; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LIFSON JD, 1989, IMMUNOL REV, V109, P93, DOI 10.1111/j.1600-065X.1989.tb00021.x; Moir S, 1996, J VIROL, V70, P8019, DOI 10.1128/JVI.70.11.8019-8028.1996; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; RYU SE, 1994, STRUCTURE, V2, P59, DOI 10.1016/S0969-2126(00)00008-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWEET RW, 1991, CURR OPIN BIOTECH, V2, P622, DOI 10.1016/0958-1669(91)90089-N; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WANG JH, 1990, NATURE, V348, P411, DOI 10.1038/348411a0; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Wu H, 1996, P NATL ACAD SCI USA, V93, P15030, DOI 10.1073/pnas.93.26.15030; Wu H, 1997, NATURE, V387, P527, DOI 10.1038/387527a0; Zhou TQ, 2005, P NATL ACAD SCI USA, V102, P14575, DOI 10.1073/pnas.0507267102	34	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2761	2772		10.1074/jbc.M708325200	http://dx.doi.org/10.1074/jbc.M708325200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045872	hybrid			2022-12-27	WOS:000252622300034
J	Li, J; Chen, LA; Townsend, CM; Evers, BM				Li, Jing; Chen, L. Andy; Townsend, Courtney M., Jr.; Evers, B. Mark			PKD1, PKD2, and their substrate Kidins220 regulate neurotensin secretion in the BON human endocrine cell line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-D; ENDOPLASMIC-RETICULUM STRESS; MEMBRANE-SPANNING PROTEIN; GOLGI COMPARTMENT; D ACTIVATION; PKC-ALPHA; C-MU; GROWTH; PHOSPHORYLATION; NEUROTROPHIN	Neurotensin (NT) is a gut peptide that plays an important role in gastrointestinal secretion, motility, and growth as well as the proliferation of NT receptor-positive cancers. Protein kinase D (PKD) family members (PKD1, 2, and 3) have been identified as important regulators of secretory transport at the trans-Golgi network. Previously, we showed that PKD1 contributes to stimulated NT secretion; however, the mechanisms are not entirely clear. Here, we show that Kidins220, which is a substrate of PKD proteins in neuroendocrine cells, is localized in the ends of the processes of BON cells, similar to the expression pattern of NT vesicles, and translocates to the membrane and large vesicle-like structures formed in response to phorbol 12-myristate 13-acetate treatment. The short hairpin RNA targeting Kidins220 inhibits NT secretion in parental BON cells or BON cells stably expressing the gastrin-releasing peptide receptor treated with either phorbol 12-myristate 13-acetate or bombesin, respectively. Furthermore, we demonstrate that endogenous PKD1, PKD2, and Kidins220 co-exist with NT-containing vesicles. Overexpression of the kinase-dead PKD1 abrogates Kidins220 expression and NT vesicle formation. Our data establish a physiological link between the PKD/Kidins220 pathway and NT-containing vesicles and suggest the role of this pathway in the regulation of hormone secretion. Because NT is an important gut hormone that affects secretion, inflammation, and both normal and tumor cell growth, our findings identify a novel signaling pathway that may be amenable to drug targeting for clinical applications.	[Li, Jing; Chen, L. Andy; Townsend, Courtney M., Jr.; Evers, B. Mark] Univ Texas Galveston, Med Branch, Dept Surg, Galveston, TX 77555 USA; [Li, Jing; Chen, L. Andy; Evers, B. Mark] Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Evers, BM (corresponding author), Univ Texas Galveston, Med Branch, Dept Surg, 301 Univ Blvd, Galveston, TX 77555 USA.	mevers@utmb.edu	Li, Jing/B-7206-2011		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048498, P01DK035608, U01DK048489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG010885] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG 10885, R37 AG010885-16, R37 AG010885] Funding Source: Medline; NIDDK NIH HHS [P01 DK035608-220001, P01 DK035608-22, P01 DK035608, R01 DK 48489, P01 DK 35608, R01 DK048498, R01 DK048498-13, U01 DK048489] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Arevolo JC, 2006, J BIOL CHEM, V281, P1001, DOI 10.1074/jbc.M504163200; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; CARRAWAY R, 1975, J BIOL CHEM, V250, P1907; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; CARY N, 2004, SAS STAT 9 1 USERS G; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Chang HW, 2007, J CLIN ENDOCR METAB, V92, P1863, DOI 10.1210/jc.2006-2338; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; EVERS BM, 1994, ANN NY ACAD SCI, V733, P393, DOI 10.1111/j.1749-6632.1994.tb17289.x; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Li J, 2005, J BIOL CHEM, V280, P8351, DOI 10.1074/jbc.M409431200; Li J, 2002, AM J PHYSIOL-GASTR L, V283, pG1197, DOI 10.1152/ajpgi.00177.2002; Li J, 2004, J BIOL CHEM, V279, P28466, DOI 10.1074/jbc.M314307200; Li J, 2007, MOL ENDOCRINOL, V21, P159, DOI 10.1210/me.2006-0340; Maier D, 2006, GENE EXPR PATTERNS, V6, P849, DOI 10.1016/j.modgep.2006.03.007; MARGIORIS AN, 1992, ENDOCRINOLOGY, V131, P703, DOI 10.1210/en.131.2.703; Moore EDW, 1999, J BIOL CHEM, V274, P22493, DOI 10.1074/jbc.274.32.22493; Pothoulakis C, 2000, CURR OPIN GASTROEN, V16, P536, DOI 10.1097/00001574-200011000-00013; Prestle J, 1996, J CELL BIOL, V134, P1401, DOI 10.1083/jcb.134.6.1401; Renna M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703778200; Riol-Blanco L, 2004, EUR J IMMUNOL, V34, P108, DOI 10.1002/eji.200324640; Romero DG, 2006, ENDOCRINOLOGY, V147, P6046, DOI 10.1210/en.2006-0794; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Van Lint J, 2002, TRENDS CELL BIOL, V12, P193, DOI 10.1016/S0962-8924(02)02262-6; Yaney GC, 2002, AM J PHYSIOL-ENDOC M, V283, pE880, DOI 10.1152/ajpendo.00474.2001; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yeaman C, 2004, NAT CELL BIOL, V6, P106, DOI 10.1038/ncb1090	36	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2614	2621		10.1074/jbc.M707513200	http://dx.doi.org/10.1074/jbc.M707513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048355	hybrid, Green Accepted			2022-12-27	WOS:000252622300018
J	Girard, C; Verheggen, C; Neel, H; Cammas, A; Vagner, S; Soret, J; Bertrand, E; Bordonne, R				Girard, Cyrille; Verheggen, Celine; Neel, Henry; Cammas, Anne; Vagner, Stephan; Soret, Johann; Bertrand, Edouard; Bordonne, Remy			Characterization of a short isoform of human Tgs1 hypermethylase associating with small nucleolar ribonucleoprotein core proteins and produced by limited proteolytic processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME ENTRY SITE; NF-KAPPA-B; SMALL-NUCLEAR; ALTERNATIVE TRANSLATION; CAP HYPERMETHYLASE; BINDING-SITE; RNASE III; PROTEASOME; YEAST; METHYLTRANSFERASE	Tgs1 is the hypermethylase responsible for m(3)G cap formation of U small nuclear RNAs (U snRNAs) and small nucleolar RNAs (snoRNAs). In vertebrates, hypermethylation of snRNAs occurs in the cytoplasm, whereas this process takes place in the nucleus for snoRNAs. Accordingly, the hypermethylase is found in both compartments with a diffuse localization in the cytoplasm and a concentration in Cajal bodies in the nucleoplasm. In this study, we report that the Tgs1 hypermethylase exists as two species, a full-length cytoplasmic isoform and a shorter nuclear isoform of 65-70 kDa. The short isoform exhibits methyltransferase activity and associates with components of box C/D and H/ACA snoRNPs, pointing to a role of this isoform in hypermethylation of snoRNAs. We also show that production of the short Tgs1 isoform is inhibited by MG132, suggesting that it results from proteasomal limited processing of the full-length Tgs1 protein. Together, our results suggest that proteasome maturation constitutes a mechanism regulating Tgs1 function by generating Tgs1 species with different substrate specificities, subcellular localizations, and functions.	[Girard, Cyrille; Verheggen, Celine; Neel, Henry; Soret, Johann; Bertrand, Edouard; Bordonne, Remy] Univ Montpellier, CNRS, IFR 122, Inst Genet Mol,UMR 5535, Montpellier 5, France; [Cammas, Anne; Vagner, Stephan] Univ Toulouse 2, INSERM U653, F-31052 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Bordonne, R (corresponding author), Univ Montpellier, CNRS, IFR 122, Inst Genet Mol,UMR 5535, 1919 Route Mende, Montpellier 5, France.	remy.bordonne@igmm.cnrs.fr	Vagner, Stephan/G-3664-2013; CAMMAS, Anne/M-7238-2014; Girard, Cyrille/ABA-2180-2020	CAMMAS, Anne/0000-0002-3240-9172; Verheggen, Celine/0000-0003-2459-9700; bertrand, edouard/0000-0002-9642-7994; vagner, stephan/0000-0003-1452-7164				AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, P491; Baker SP, 2005, CELL, V123, P361, DOI 10.1016/j.cell.2005.10.013; Bertrand E, 2004, PROG MOL SUBCELL BIO, V35, P79; Bharti AK, 1996, J BIOL CHEM, V271, P1993, DOI 10.1074/jbc.271.4.1993; Bonnal S, 2005, J BIOL CHEM, V280, P4144, DOI 10.1074/jbc.M411492200; Bonnal S, 2003, J BIOL CHEM, V278, P39330, DOI 10.1074/jbc.M305580200; Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Enunlu I, 2003, BIOCHEM BIOPH RES CO, V309, P44, DOI 10.1016/S0006-291X(03)01514-6; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Hausmann S, 2005, J BIOL CHEM, V280, P4021, DOI 10.1074/jbc.C400554200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Komonyi O, 2005, J BIOL CHEM, V280, P12397, DOI 10.1074/jbc.M409251200; Kufel J, 2000, MOL CELL BIOL, V20, P5415, DOI 10.1128/MCB.20.15.5415-5424.2000; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Maraia RJ, 2002, GENE EXPRESSION, V10, P41; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Mouaikel J, 2003, NUCLEIC ACIDS RES, V31, P4899, DOI 10.1093/nar/gkg656; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Mouaikel J, 2002, MOL CELL, V9, P891, DOI 10.1016/S1097-2765(02)00484-7; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; ORIAN A, 1995, J BIOL CHEM, V270, P21707, DOI 10.1074/jbc.270.37.21707; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PLESSEL G, 1994, MOL CELL BIOL, V14, P4160, DOI 10.1128/MCB.14.6.4160; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Seipelt RL, 1999, NUCLEIC ACIDS RES, V27, P587, DOI 10.1093/nar/27.2.587; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; TERNS MP, 1994, SCIENCE, V264, P959, DOI 10.1126/science.8178154; Terns MP, 2001, CURR BIOL, V11, pR862, DOI 10.1016/S0960-9822(01)00517-6; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Xue DH, 2000, EMBO J, V19, P1650, DOI 10.1093/emboj/19.7.1650	42	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2060	2069		10.1074/jbc.M704209200	http://dx.doi.org/10.1074/jbc.M704209200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039666	hybrid			2022-12-27	WOS:000252501000033
J	Suzuki, T; Kelly, VP; Motohashi, H; Nakajima, O; Takahashi, S; Nishimura, S; Yamamoto, M				Suzuki, Takafumi; Kelly, Vincent P.; Motohashi, Hozumi; Nakajima, Osamu; Takahashi, Satoru; Nishimura, Susumu; Yamamoto, Masayuki			Deletion of the selenocysteine tRNA gene in macrophages and liver results in compensatory gene induction of cytoprotective enzymes by Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; SELENOPROTEIN SYNTHESIS; SELENIUM DEFICIENCY; SELECTIVE-INHIBITION; NRF2-KEAP1 PATHWAY; HEME OXYGENASE-1; EXPRESSION; MICE; PROTECTION; GROWTH	The selenocysteine tRNA (tRNA(Sec)) molecule is the sight of synthesis for the amino acid selenocysteine and the adaptor for its translational insertion into selenoprotein enzymes, the majority of which contribute to cellular redox homeostasis. To examine the consequences of selenoprotein depletion on the oxidative environment of the cell, we generated a conditional knock-out mouse for the tRNASec gene (Trsp). Deletion of Trsp in either macrophages or liver elevated oxidative stress and activated the transcriptional induction of cytoprotective antioxidant and detoxification enzyme genes, including glutathione S-transferase P1 and NAD( P)H:quinone oxidoreductase 1, and other well known target genes of the transcription factor Nrf2 ((N) under barF-E2-(r) under bar elated (f) under bar actor 2). Simultaneous disruption of Trsp and Nrf2 severely compromised the cytoprotective response. Double knock-out macrophages displayed reduced viability, elevated oxidative stress, and increased susceptible to hydrogen peroxide treatment compared with deletion of either gene alone. Mice carrying a liver-specific deletion of Trsp on an Nrf2-null background experienced hepatocellular apoptosis and displayed a severely reduced survival rate compared with loss of Trsp alone. Our results thus demonstrate that reduced selenoprotein activity is counterbalanced by an Nrf2-mediated cytoprotective response, which is essential for maintaining cellular redox homeostasis and viability.	[Motohashi, Hozumi; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Suzuki, Takafumi; Kelly, Vincent P.; Nishimura, Susumu; Yamamoto, Masayuki] Univ Tsukuba, Exploratory Res Adv Technol Environm Response Pro, Tsukuba, Ibaraki 3058577, Japan; [Suzuki, Takafumi; Kelly, Vincent P.; Nishimura, Susumu; Yamamoto, Masayuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Motohashi, Hozumi; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Nakajima, Osamu] Yamagata Univ, Res Lab Mol Genet, Yamagata 9909585, Japan	Tohoku University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Yamagata University	Yamamoto, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	masi@mail.tains.tohoku.ac.jp	Suzuki, Takafumi/ABC-6582-2020; Yamamoto, Masayuki/A-4873-2010; Motohashi, Hozumi/AAZ-2628-2020; Kelly, Vincent P/I-2151-2017	Suzuki, Takafumi/0000-0002-3425-8208; Yamamoto, Masayuki/0000-0002-9073-9436; Kelly, Vincent P/0000-0001-7067-5407				Aoki Y, 2001, TOXICOL APPL PHARM, V173, P154, DOI 10.1006/taap.2001.9176; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Behne D, 2001, ANNU REV NUTR, V21, P453, DOI 10.1146/annurev.nutr.21.1.453; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; BOYNE R, 1986, J COMP PATHOL, V96, P379, DOI 10.1016/0021-9975(86)90033-2; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; CHANG M, 1990, J BIOL CHEM, V265, P5418; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; CHRISTENSEN MJ, 1994, BIOCHEM BIOPH RES CO, V202, P271, DOI 10.1006/bbrc.1994.1923; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; Dinkova-Kostova AT, 2001, P NATL ACAD SCI USA, V98, P3404, DOI 10.1073/pnas.051632198; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Enomoto A, 2001, TOXICOL SCI, V59, P169, DOI 10.1093/toxsci/59.1.169; Faust N, 2000, BLOOD, V96, P719; Fuhrman B, 2004, FREE RADICAL BIO MED, V37, P259, DOI 10.1016/j.freeradbiomed.2004.04.026; GAIROLA C, 1985, BIOCHEM BIOPH RES CO, V132, P397, DOI 10.1016/0006-291X(85)91035-6; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3; Ishii T, 1999, FREE RADICAL RES, V31, P351, DOI 10.1080/10715769900300921; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jameson RR, 2002, J NUTR, V132, P1830, DOI 10.1093/jn/132.7.1830; Jeong DW, 2002, J BIOL CHEM, V277, P17871, DOI 10.1074/jbc.M200808200; Katsuoka F, 2005, J BIOL CHEM, V280, P4483, DOI 10.1074/jbc.M411451200; Kelly VP, 2005, MOL CELL BIOL, V25, P3658, DOI 10.1128/MCB.25.9.3658-3669.2005; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; MCKEEHAN WL, 1976, P NATL ACAD SCI USA, V73, P2023, DOI 10.1073/pnas.73.6.2023; McMahon M, 2001, CANCER RES, V61, P3299; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Moosmann B, 2004, LANCET, V363, P892, DOI 10.1016/S0140-6736(04)15739-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mostert V, 2003, BIOL CHEM, V384, P681, DOI 10.1515/BC.2003.076; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; OLSSON U, 1993, INT J VITAM NUTR RES, V63, P31; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2003, J BIOL CHEM, V278, P39428, DOI 10.1074/jbc.M305542200; Sakurai A, 2005, J CELL PHYSIOL, V203, P529, DOI 10.1002/jcp.20246; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Shibahara S, 2002, ANTIOXID REDOX SIGN, V4, P593, DOI 10.1089/15230860260220094; Sinzinger H, 2001, J CLIN PHARM THER, V26, P303, DOI 10.1046/j.1365-2710.2001.00360.x; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Warner GJ, 2000, J BIOL CHEM, V275, P28110; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324	60	70	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2021	2030		10.1074/jbc.M708352200	http://dx.doi.org/10.1074/jbc.M708352200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039655	hybrid			2022-12-27	WOS:000252501000029
J	House, AE; Lynch, KW				House, Amy E.; Lynch, Kristen W.			Regulation of alternative splicing: More than just the ABCs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SR PROTEINS; SITE; EXON; SPLICEOSOME; SNRNP; YEAST; MECHANISM; ELEMENTS; ENHANCER; BINDING	Alternative pre-mRNA splicing, the differential inclusion or exclusion of portions of a nascent transcript into the final protein-coding mRNA, is widely recognized to be a ubiquitous mechanism for controlling protein expression. Thus, understanding the molecular basis of alternative splicing is essential for deciphering post-transcriptional control of the genome. Pre-mRNA splicing in general is catalyzed by a large dynamic macromolecular machine known as the spliceosome. Notably, the recognition of the intron substrate by spliceosomal components and the assembly of these components to form a catalytic spliceosome occur through a network of highly combinatorial molecular interactions. Many, if not all, of these interactions are subject to regulation, forming the basis of alternative splicing. This minireview focuses on recent advances in our understanding of the diversity of mechanisms by which the spliceosome can be regulated so as to achieve precise control of alternative splicing under a range of cellular conditions.	[House, Amy E.; Lynch, Kristen W.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Lynch, KW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	kristen.lynch@utsouthwestern.edu						BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 1999, EMBO J, V18, P1939, DOI 10.1093/emboj/18.7.1939; Buratti E, 2004, NUCLEIC ACIDS RES, V32, P4224, DOI 10.1093/nar/gkh752; Buratti E, 2004, MOL CELL BIOL, V24, P1387, DOI 10.1128/MCB.24.3.1387-1400.2004; CHIARA MD, 1995, NATURE, V375, P510, DOI 10.1038/375510a0; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Giles KE, 2005, MOL CELL BIOL, V25, P4397, DOI 10.1128/MCB.25.11.4397-4405.2005; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hilliker AK, 2007, GENE DEV, V21, P821, DOI 10.1101/gad.1536107; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kan JLC, 1999, GENE DEV, V13, P462, DOI 10.1101/gad.13.4.462; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Lallena MJ, 2002, CELL, V109, P285, DOI 10.1016/S0092-8674(02)00730-4; Lim SR, 2004, MOL CELL, V15, P477, DOI 10.1016/j.molcel.2004.06.025; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mayas RM, 2006, NAT STRUCT MOL BIOL, V13, P482, DOI 10.1038/nsmb1093; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Nasim FUH, 2002, RNA, V8, P1078, DOI 10.1017/S1355838202024056; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Perriman RJ, 2007, GENE DEV, V21, P811, DOI 10.1101/gad.1524307; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Query CC, 2006, NAT STRUCT MOL BIOL, V13, P472, DOI 10.1038/nsmb0606-472; ROSCIGNO RF, 1995, RNA, V1, P692; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Shen HH, 2007, NAT STRUCT MOL BIOL, V14, P597, DOI 10.1038/nsmb1263; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; SIEBEL CW, 1992, GENE DEV, V6, P1386, DOI 10.1101/gad.6.8.1386; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tardiff DF, 2006, RNA, V12, P968, DOI 10.1261/rna.50506; Valadkhan S, 2007, CURR OPIN STRUC BIOL, V17, P310, DOI 10.1016/j.sbi.2007.05.001; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	43	108	111	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1217	1221		10.1074/jbc.R700031200	http://dx.doi.org/10.1074/jbc.R700031200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024429	hybrid			2022-12-27	WOS:000252282700003
J	Kondo, A; Hirayama, N; Sugito, Y; Shono, M; Tanaka, T; Kitamura, N				Kondo, Asuka; Hirayama, Naoki; Sugito, Yasuko; Shono, Michihiro; Tanaka, Toshiaki; Kitamura, Naomi			Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; MET RECEPTOR; SCATTER FACTOR; CYCLE ARREST; TRANSCRIPTION FACTORS; REGULATED KINASE; BINDING-SITE; MAP-KINASE; LINE HEPG2; C-MET	Activation of the extracellular signal-regulated kinase (ERK) pathway is a key factor in the regulation of cell proliferation by growth factors. Hepatocyte growth factor (HGF)-induced cell cycle arrest in the human hepatocellular carcinoma cell line HepG2 requires strong activation of the ERK pathway. In this study, we investigated the molecular mechanism of the activation. We constructed a chimeric receptor composed of the extracellular domain of the NGF receptor and the cytoplasmic domain of the HGF receptor (c-Met) and introduced a point mutation (N1358H) into the chimeric receptor, which specifically abrogates the direct binding of Grb2 to c-Met. The mutant chimeric receptor failed to mediate the strong activation of ERK, up-regulation of the expression of a Cdk inhibitor p16(INK4a) and inhibition of HepG2 cell proliferation by ligand stimulation. Moreover, the mutant receptor did not induce tyrosine phosphorylation of the docking protein Gab1. Knockdown of Gab1 using siRNA suppressed the HGF-induced strong activation of ERK and inhibition of HepG2 cell proliferation. These results suggest that coupling of Grb2 to Gab1 mediates the HGF-induced strong activation of the ERK pathway, which is required for the inhibition of HepG2 cell proliferation.	[Kondo, Asuka; Hirayama, Naoki; Sugito, Yasuko; Shono, Michihiro; Tanaka, Toshiaki; Kitamura, Naomi] Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Tokyo Institute of Technology	Kitamura, N (corresponding author), Tokyo Inst Technol, Dept Biol Sci, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268501, Japan.	nkitamur@bio.titech.ac.jp	Tanaka, Toshiaki/C-5567-2013	Tanaka, Toshiaki/0000-0002-9448-1452				BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; FATEUR V, 1997, CELL GROWTH DIFFER, V8, P655; Fenig E, 1997, CLIN CANCER RES, V3, P135; Fourier TM, 1996, J BIOL CHEM, V271, P22211, DOI 10.1074/jbc.271.36.22211; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Han JH, 2005, J BIOL CHEM, V280, P31548, DOI 10.1074/jbc.M503431200; Kimura A, 1999, CANCER RES, V59, P5133; KOMADA M, 1992, EUR J BIOCHEM, V204, P857, DOI 10.1111/j.1432-1033.1992.tb16705.x; Lahlou H, 2003, J BIOL CHEM, V278, P39356, DOI 10.1074/jbc.M304524200; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Montagner A, 2005, J BIOL CHEM, V280, P5350, DOI 10.1074/jbc.M410012200; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; PELICCI G, 1995, ONCOGENE, V10, P1631; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Ponzetto C, 1996, J BIOL CHEM, V271, P14119, DOI 10.1074/jbc.271.24.14119; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Potempa S, 1998, MOL BIOL CELL, V9, P2185, DOI 10.1091/mbc.9.8.2185; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schaeper U, 2000, J CELL BIOL, V149, P1419, DOI 10.1083/jcb.149.7.1419; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SKOLNIK EY, 1993, EMBO J, V12, P1929, DOI 10.1002/j.1460-2075.1993.tb05842.x; Terauchi R, 2000, EXP CELL RES, V256, P411, DOI 10.1006/excr.2000.4850; Tsukada Y, 2004, J BIOCHEM, V136, P701, DOI 10.1093/jb/mvh177; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WEIDNER KM, 1993, J CELL BIOL, V121, P145, DOI 10.1083/jcb.121.1.145	30	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1428	1436		10.1074/jbc.M704999200	http://dx.doi.org/10.1074/jbc.M704999200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003605	hybrid			2022-12-27	WOS:000252282700026
J	Jia, SH; Parodo, J; Kapus, A; Rotstein, OD; Marshall, JC				Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.			Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS FOLLOWING INGESTION; COLONY-STIMULATING FACTOR; NF-KAPPA-B; CELL-DEATH; KINASE; INFLAMMATION; INHIBITION; SEPSIS; RESOLUTION; FAMILY	Efficient expression of innate immunity is critically dependent upon the capacity of the neutrophil to be activated rapidly in the face of an acute threat and to involute once that threat has been eliminated. Here we report a novel mechanism regulating neutrophil survival dynamically through the tyrosine phosphorylation or dephosphorylation of caspase-8. Caspase-8 is tyrosine-phosphorylated in freshly isolated neutrophils but spontaneously dephosphorylates in culture, in association with the progression of constitutive apoptosis. Phosphorylation of caspase-8 on Tyr-310 facilitates its interaction with the Src-homology domain 2 containing tyrosine phosphatase-1 (SHP-1) and enables SHP-1 to dephosphorylate caspase-8, permitting apoptosis to proceed. The non-receptor tyrosine kinase, Lyn, can phosphorylate caspase-8 on Tyr- 397 and Tyr-465, rendering it resistant to activational cleavage and inhibiting apoptosis. Exposure to lipopolysaccharide reduces SHP-1 activity and binding to caspase-8, caspase-8 activity, and rates of spontaneous apoptosis. SHP-1 activity is reduced and Lyn increased in neutrophils from patients with sepsis, in association with profoundly delayed apoptosis; inhibition of Lyn can partially reverse this delay. Thus the phosphorylation and dephosphorylation of caspase-8, mediated by Lyn and SHP-1, respectively, represents a novel, dynamic post-translational mechanism for the regulation of neutrophil apoptosis whose dysregulation contributes to persistent neutrophil survival in sepsis.	[Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Marshall, John C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Sepsis Res Lab, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marshall, JC (corresponding author), St Michaels Hosp, 4th Floor Bond Wing,Rm 4-007,30 Bond St, Toronto, ON M5B 1W8, Canada.	marshallj@smh.toronto.on.ca						Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; El Kebir D, 2006, CELL SIGNAL, V18, P2302, DOI 10.1016/j.cellsig.2006.05.013; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Himeji D, 2002, BLOOD, V99, P4070, DOI 10.1182/blood.V99.11.4070; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hu ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC1171, DOI 10.1152/ajpcell.00312.2004; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Kupfner JG, 2001, J IMMUNOL, V167, P7044, DOI 10.4049/jimmunol.167.12.7044; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; MARSHALL J, 1990, ARCH SURG-CHICAGO, V125, P17; Marshall John C, 2007, Novartis Found Symp, V280, P53; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rotstein D, 2000, SHOCK, V14, P278, DOI 10.1097/00024382-200014030-00006; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Vlahos R, 2006, PHARMACOL THERAPEUT, V112, P106, DOI 10.1016/j.pharmthera.2006.03.007; Watson RWG, 1997, FEBS LETT, V412, P603, DOI 10.1016/S0014-5793(97)00779-5; Watson RWG, 1996, J IMMUNOL, V156, P3986; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei S, 1996, J IMMUNOL, V157, P5155; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; William R, 1998, J IMMUNOL, V161, P957; Yamamoto A, 2002, CLIN EXP IMMUNOL, V129, P479, DOI 10.1046/j.1365-2249.2002.01930.x; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	57	65	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5402	5413		10.1074/jbc.M706462200	http://dx.doi.org/10.1074/jbc.M706462200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086677	hybrid			2022-12-27	WOS:000253426700020
J	Lim, D; Fedrizzi, L; Tartari, M; Zuccato, C; Cattaneo, E; Brini, M; Carafoli, E				Lim, Dmitry; Fedrizzi, Laura; Tartari, Marzia; Zuccato, Chiara; Cattaneo, Elena; Brini, Marisa; Carafoli, Ernesto			Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; WILD-TYPE HUNTINGTIN; MUTANT HUNTINGTIN; 3-NITROPROPIONIC ACID; CELL-DEATH; OXIDATIVE STRESS; MOUSE MODEL; DNA DAMAGE; TRANSCRIPTIONAL REPRESSION; SELECTIVE VULNERABILITY	Dysfunctions of Ca2+ homeostasis and of mitochondria have been studied in immortalized striatal cells from a commonly used Huntington disease mouse model. Transcriptional changes in the components of the phosphatidylinositol cycle and in the receptors for myo-inositol trisphosphate-linked agonists have been found in the cells and in the striatum of the parent Huntington disease mouse. The overall result of the changes is to delay myo-inositol trisphosphate production and to decrease basal Ca2+ in mutant cells. When tested directly, mitochondria in mutant cells behave nearly normally, but are unable to handle large Ca2+ loads. This appears to be due to the increased Ca2+ sensitivity of the permeability transition pore, which dissipates the membrane potential, prompting the release of accumulated Ca2+. Harmful reactive oxygen species, which are produced by defective mitochondria and may in turn stress them, increase in mutant cells, particularly if the damage to mitochondria is artificially exacerbated, for instance with complex II inhibitors. Mitochondria in mutant cells are thus peculiarly vulnerable to stresses induced by Ca2+ and reactive oxygen species. The observed decrease of cell Ca2+ could be a compensatory attempt to prevent the Ca2+ stress that would irreversibly damage mitochondria and eventually lead to cell death.	Venetian Inst Mol Med, I-35129 Padua, Italy; [Lim, Dmitry; Fedrizzi, Laura; Carafoli, Ernesto] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Fedrizzi, Laura; Brini, Marisa] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Tartari, Marzia; Zuccato, Chiara; Cattaneo, Elena; Carafoli, Ernesto] Univ Milan, Dept Pharmacol Sci, Milan, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Milan	Carafoli, E (corresponding author), Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.	ernesto.carafoli@unipd.it	Brini, Marisa/K-5189-2016; Carafoli, Ernesto/K-5192-2016; Lim, Dmitry/H-9101-2012	Carafoli, Ernesto/0000-0002-7826-0094; Brini, Marisa/0000-0001-5141-0243; CATTANEO, ELENA/0000-0002-0755-4917; ZUCCATO, CHIARA/0000-0003-1771-3392	Telethon [GGP04169] Funding Source: Medline	Telethon(Fondazione Telethon)		Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BEAL MF, 1993, J NEUROSCI, V13, P4181; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bowyer JF, 1996, BRAIN RES, V712, P221, DOI 10.1016/0006-8993(95)01417-9; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; GREENE JG, 1995, J NEUROCHEM, V64, P430; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorenc-Koci E, 2005, BRAIN RES, V1051, P145, DOI 10.1016/j.brainres.2005.06.007; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Maragos WF, 2004, NEUROCHEM RES, V29, P741, DOI 10.1023/B:NERE.0000018845.82808.45; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Scemes E, 2003, J NEUROSCI, V23, P11444; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	57	148	150	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5780	5789		10.1074/jbc.M704704200	http://dx.doi.org/10.1074/jbc.M704704200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156184	hybrid			2022-12-27	WOS:000253426700059
J	Lu, XH; Huang, LJS; Lodish, HF				Lu, Xiaohui; Huang, Lily Jun-Shen; Lodish, Harvey F.			Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK2 V617F MUTATION; CHRONIC-MYELOMONOCYTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; ERYTHROPOIETIN RECEPTOR; MEGAKARYOBLASTIC LEUKEMIA; JANUS KINASES; FERM DOMAIN	The majority of the BCR-ABL-negative myeloproliferative disorders express the mutant JAK2, JAK2V617F. Previously we showed that constitutive activation of this oncogenic JAK2 mutant in Ba/F3 or 32D cells requires coexpression of a cognate homodimeric cytokine receptor, such as the EpoR. However, overexpression of JAK2V617F in Ba/F3 cells renders them cytokine-independent for growth in the absence of an exogenous cytokine receptor. Here, we demonstrated that JAK2V617F domains required for receptor association are essential for cytokine-independent growth by overexpressed JAK2V617F, suggesting JAK2V617F is binding to an unknown endogenous cytokine receptor(s) for its activation. We further showed that disruption of EpoR dimerization by coexpressing a truncated EpoR disrupted JAK2V617F-mediated transformation, indicating that EpoR dimerization plays an essential role in the activation of JAK2V617F. Interestingly, coexpression of JAK2V617F with EpoR mutants that retain JAK2 binding but are defective in mediating Epo-dependent JAK2 activation due to mutations in a conserved juxtamembrane motif does lead to cytokine-independent activation of JAK2V617F. Overall, these findings confirm that JAK2V617F requires binding to a dimerized cytokine receptor for its activation, and that the key EpoR juxtamembrane regulatory motif essential for Epo-dependent JAK2 activation is not essential for the activation of JAK2V617F. The structure of the activated JAK2V617F is thus likely to be different from that of the activated wild-type JAK2, raising the possibility of developing a specifically targeted therapy for myeloproliferative disorders.	[Lu, Xiaohui; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Huang, Lily Jun-Shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu			NATIONAL CANCER INSTITUTE [K01CA095150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA95150] Funding Source: Medline; NHLBI NIH HHS [P01 HL 32262] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johan MF, 2005, BRIT J HAEMATOL, V130, P968, DOI 10.1111/j.1365-2141.2005.05719.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Naoe T, 2004, CELL MOL LIFE SCI, V61, P2932, DOI 10.1007/s00018-004-4274-x; Ohyashiki K, 2005, LEUKEMIA, V19, P2359, DOI 10.1038/sj.leu.2403989; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	34	100	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5258	5266		10.1074/jbc.M707125200	http://dx.doi.org/10.1074/jbc.M707125200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158285	hybrid			2022-12-27	WOS:000253426700005
J	De Rosa, MF; Ackerley, C; Wang, B; Ito, S; Clarke, DM; Lingwood, C				De Rosa, Maria Fabiana; Ackerley, Cameron; Wang, Bernice; Ito, Shinya; Clarke, David M.; Lingwood, Clifford			Inhibition of multidrug resistance by AdamantylGb(3), a globotriaosylceramide analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P-GLYCOPROTEIN; SHIGA-LIKE TOXIN; LIPID RAFTS; CANCER-CELLS; B-SUBUNIT; GLYCOSPHINGOLIPID GLOBOTRIAOSYLCERAMIDE; DRUG-RESISTANCE; CROSS-LINKING; BINDING; GLUCOSYLCERAMIDE	Multidrug resistance (MDR) via the ABC drug transporter (ABCB1), P-glycoprotein (P-gp/MDR1) overexpression, is a major obstacle in cancer chemotherapy. Many inhibitors reverse MDR but, like cyclosporin A (CsA), have significant toxicities. MDR1 is also a translocase that flips glucosylceramide inside the Golgi to enhance neutral glycosphingolipid (GSL) synthesis. We observed partial MDR1/globotriaosylceramide (Gb(3)) cell surface co-localization, and GSL removal depleted cell surface MDR1. MDR1 may therefore interact with GSLs. AdamantylGb(3), a water-soluble Gb(3) mimic, but not other GSL analogs, reversed MDR1-MDCK cell drug resistance. Cell surface MDR1 was up-regulated 1 h after treatment with CsA or adaGb(3), but at 72 h, cell surface expression was lost. Intracellular MDR1 accumulated throughout, suggesting long term defects in plasma membrane MDR1 trafficking. AdaGb(3) or CsA rapidly reduced rhodamine 123 cellular efflux. MDR1 also mediates gastrointestinal epithelial drug efflux, restricting oral bioavailability. Vinblastine apical-to-basal transport in polarized human intestinal C2BBe1 cells was significantly increased when adaGb3 was added to both sides, or to the apical side only, comparable with verapamil, a standard MDR1 inhibitor. Disulfide cross-linking of mutant MDR1s showed no binding of adaGb3 to the MDR1 verapamil/cyclosporin-binding site between surface proximal helices of transmembrane segments (TM)6 and TM7, but rather to an adjacent site nearer the center of TM6 and the TM7 extracellular face, i.e. close to the bilayer leaflet interface. Verotoxin-mediated Gb(3) endocytosis also upregulated total MDR1 and inhibited drug efflux. Thus, a functional interplay between membrane Gb(3) and MDR1 provides a more physiologically based approach to MDR1 regulation to increase the bioavailability of chemotherapeutic drugs.	[De Rosa, Maria Fabiana; Lingwood, Clifford] Hosp Sick Children, Div Mol Struct & Func, Toronto, ON M5G 1X8, Canada; [De Rosa, Maria Fabiana; Ackerley, Cameron; Lingwood, Clifford] Hosp Sick Children, Dept Pediat, Lab Med, Toronto, ON M5G 1X8, Canada; [Wang, Bernice; Ito, Shinya] Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; [De Rosa, Maria Fabiana; Lingwood, Clifford] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Wang, Bernice; Ito, Shinya] Univ Toronto, Dept Pediat & Pharmacol, Toronto, ON M5S 1A8, Canada; [De Rosa, Maria Fabiana; Clarke, David M.] Univ Toronto, Dept Med Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto	Lingwood, C (corresponding author), Hosp Sick Children, Div Mol Struct & Func, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cling@sickkids.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184				ABE A, 1992, J BIOCHEM-TOKYO, V111, P191, DOI 10.1093/oxfordjournals.jbchem.a123736; Arab S, 1997, ONCOL RES, V9, P553; Barakat S, 2005, BIOCHEM J, V388, P563, DOI 10.1042/BJ20041999; Bast DJ, 1997, INFECT IMMUN, V65, P2019, DOI 10.1128/IAI.65.6.2019-2028.1997; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BOULANGER J, 1994, ANAL BIOCHEM, V217, P1, DOI 10.1006/abio.1994.1075; BOYD B, 1991, INFECT IMMUN, V59, P750, DOI 10.1128/IAI.59.3.750-757.1991; BRADLEY G, 1989, CANCER RES, V49, P2790; Dantzig AH, 1996, CANCER RES, V56, P4171; De Rosa MF, 2004, J BIOL CHEM, V279, P7867, DOI 10.1074/jbc.M305645200; Demeule M, 2000, FEBS LETT, V466, P219, DOI 10.1016/S0014-5793(00)01087-5; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Falguieres T, 2006, FEBS J, V273, P5205, DOI 10.1111/j.1742-4658.2006.05516.x; Fisher GA, 1996, EUR J CANCER, V32A, P1082, DOI 10.1016/0959-8049(96)00111-6; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Ford J M, 1996, Cancer Treat Res, V87, P3; Gayet L, 2005, BIOCHEMISTRY-US, V44, P4499, DOI 10.1021/bi048669w; Germann UA, 1996, EUR J CANCER, V32A, P927, DOI 10.1016/0959-8049(96)00057-3; Ghetie MA, 2004, BLOOD, V104, P178, DOI 10.1182/blood-2003-12-4255; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hammerle SP, 2000, EUR J PHARM SCI, V12, P69, DOI 10.1016/S0928-0987(00)00142-1; HERZOG CE, 1993, J BIOL CHEM, V268, P2946; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; HYAFIL F, 1993, CANCER RES, V53, P4595; Jarvis RM, 2007, BIOCHEM BIOPH RES CO, V355, P944, DOI 10.1016/j.bbrc.2007.02.053; Jette L, 1996, AM J PHYSIOL-RENAL, V270, pF756, DOI 10.1152/ajprenal.1996.270.5.F756; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; KHINE AA, 1994, J CELL PHYSIOL, V161, P319, DOI 10.1002/jcp.1041610217; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Kovbasnjuk O, 2005, P NATL ACAD SCI USA, V102, P19087, DOI 10.1073/pnas.0506474102; Kovbasnjuk O, 2001, J CELL SCI, V114, P4025; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lala P, 2000, J BIOL CHEM, V275, P6246, DOI 10.1074/jbc.275.9.6246; Lavie Y, 1998, J BIOL CHEM, V273, P32380, DOI 10.1074/jbc.273.49.32380; Lavie Y, 1996, J BIOL CHEM, V271, P19530, DOI 10.1074/jbc.271.32.19530; Le Goff W, 2006, J LIPID RES, V47, P51, DOI 10.1194/jlr.M500255-JLR200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; LOO TW, 1994, J BIOL CHEM, V269, P28683; Lucci A, 1998, ANTICANCER RES, V18, P475; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Luker GD, 2001, J LIPID RES, V42, P1389; Lund N, 2006, AIDS, V20, P333, DOI 10.1097/01.aids.0000206499.78664.58; Mahfoud R, 2002, J LIPID RES, V43, P1670, DOI 10.1194/jlr.M200165-JLR200; Mattocks M, 2006, FEBS J, V273, P2064, DOI 10.1111/j.1742-4658.2006.05223.x; Morjani H, 2001, INT J CANCER, V94, P157, DOI 10.1002/ijc.1449; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mylvaganam M, 1999, BIOCHEM BIOPH RES CO, V257, P391, DOI 10.1006/bbrc.1999.0474; MYLVAGANAM M, 2003, CARBOHYDRATE BASED D, P761; Nicholson KM, 1999, BRIT J CANCER, V81, P423, DOI 10.1038/sj.bjc.6690711; Norris-Cervetto E, 2004, J BIOL CHEM, V279, P40412, DOI 10.1074/jbc.M404466200; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Oswald S, 2006, CLIN PHARMACOL THER, V79, P206, DOI 10.1016/j.clpt.2005.11.004; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; Plo I, 2002, MOL PHARMACOL, V62, P304, DOI 10.1124/mol.62.2.304; Puri A, 1998, P NATL ACAD SCI USA, V95, P14435, DOI 10.1073/pnas.95.24.14435; RAMOTAR K, 1990, BIOCHEM J, V272, P805, DOI 10.1042/bj2720805; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; Rothnie A, 2005, FEBS LETT, V579, P3984, DOI 10.1016/j.febslet.2005.06.030; Rowinsky EK, 1998, J CLIN ONCOL, V16, P2964, DOI 10.1200/JCO.1998.16.9.2964; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; Sikic BI, 1997, CANCER CHEMOTH PHARM, V40, pS13, DOI 10.1007/s002800051055; Sillence DJ, 2002, J LIPID RES, V43, P1837, DOI 10.1194/jlr.M200232-JLR200; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Sugawara S, 2005, BIOL PHARM BULL, V28, P434, DOI 10.1248/bpb.28.434; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Veldman RJ, 1999, BIOCHEM BIOPH RES CO, V266, P492, DOI 10.1006/bbrc.1999.1850; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Zhao YL, 2002, BRAIN RES, V956, P246, DOI 10.1016/S0006-8993(02)03546-1	78	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4501	4511		10.1074/jbc.M705473200	http://dx.doi.org/10.1074/jbc.M705473200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18003606	hybrid			2022-12-27	WOS:000253426500006
J	Bundgaard, JR; Rehfeld, JF				Bundgaard, Jens R.; Rehfeld, Jens F.			Distinct linkage between post-translational processing and differential secretion of progastrin derivatives in endocrine cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-O-SULFATION; TRANS-GOLGI NETWORK; GRANULE BIOGENESIS; MUTATIONAL ANALYSIS; BETA-CELL; PATHWAY; PROTEINS; SEQUENCE; RADIOIMMUNOASSAY; NEUROENDOCRINE	Prohormones often undergo extensive cellular processing prior to secretion. These post-translational processing events occur in organelles of the constitutive or regulated secretory pathway. The aim of this study was to examine the relationship between post-translational modifications and the secretory pathways taken by peptides derived from progastrin, the prohormone of gastrin, which in vivo is secreted by cells of the pyloric glands and stimulates the release of gastric acid. Targeting progastrin to compartments of the early secretory pathway shows that endoproteolytic processing is initiated in a pre-trans-Golgi network compartment of endocrine but not non-endocrine cells. The resulting N-terminal fragments of progastrin are secreted via the constitutive pathway, whereas endoproteolytically processed C-terminal fragments are secreted via the regulated or constitutive-like pathways. C-terminal fragments derived from progastrin differ in characteristic manners in levels and patterns of carboxyamidation and tyrosine sulfation in accordance with the secretory pathway taken. Point mutations introduced into a sorting motif disrupt these patterns, suggesting that differences in post-translational modifications are attributable to differential intracellular sorting of precursors. The results suggest a two-step sorting mechanism for progastrin leading to differential secretion of processed fragments via different secretory pathways.	[Bundgaard, Jens R.; Rehfeld, Jens F.] Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Bundgaard, JR (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Rigshosp, Dept Clin Biochem, KB 3014,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	jrb@rh.dk		Bundgaard, Jens Rene/0000-0001-9600-1224				Arvan P, 2004, TRAFFIC, V5, P53, DOI 10.1111/j.1600-0854.2004.00152.x; Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; BARDRAM L, 1989, SCAND J CLIN LAB INV, V49, P173, DOI 10.3109/00365518909105418; Bundgaard Jens R, 2002, Methods Mol Biol, V194, P223; BUNDGAARD JR, 1995, EMBO J, V14, P3073, DOI 10.1002/j.1460-2075.1995.tb07310.x; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; Bundgaard JR, 1996, DNA CELL BIOL, V15, P147, DOI 10.1089/dna.1996.15.147; Bundgaard JR, 2004, J BIOL CHEM, V279, P5488, DOI 10.1074/jbc.M310547200; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024; Dockray GJ, 2001, ANNU REV PHYSIOL, V63, P119, DOI 10.1146/annurev.physiol.63.1.119; Ferraro F, 2007, MOL BIOL CELL, V18, P4813, DOI 10.1091/mbc.E07-05-0503; Glombik MM, 2000, BIOCHIMIE, V82, P315, DOI 10.1016/S0300-9084(00)00195-4; Goetze JP, 2006, REGUL PEPTIDES, V133, P47, DOI 10.1016/j.regpep.2005.09.016; Hauri HP, 2000, J CELL SCI, V113, P587; HILSTED L, 1987, J BIOL CHEM, V262, P16953; HILSTED L, 1986, ANAL BIOCHEM, V152, P119, DOI 10.1016/0003-2697(86)90129-6; HILSTED L, 1988, AM J PHYSIOL, V255, pG665, DOI 10.1152/ajpgi.1988.255.5.G665; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Kuiper RP, 2000, BIOCHEM CELL BIOL, V78, P289, DOI 10.1139/bcb-78-3-289; Lahtinen U, 1996, J BIOL CHEM, V271, P4031; Molinete M, 2000, SEMIN CELL DEV BIOL, V11, P243, DOI 10.1006/scdb.2000.0173; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; REHFELD JF, 1978, J BIOL CHEM, V253, P4016; Rehfeld JF, 2004, REGUL PEPTIDES, V120, P177, DOI 10.1016/j.regpep.2004.03.006; Rehfeld JF, 2002, FEBS LETT, V510, P89, DOI 10.1016/S0014-5793(01)03234-3; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SEVA C, 1994, SCIENCE, V265, P410, DOI 10.1126/science.8023165; Smith KA, 2006, GASTROENTEROLOGY, V131, P1463, DOI 10.1053/j.gastro.2006.08.040; TAMBURINI PP, 1990, INT J PEPT PROT RES, V35, P153; TOOZE J, 1987, J CELL BIOL, V105, P1215, DOI 10.1083/jcb.105.3.1215; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; VANSOLINGE WW, 1990, CLIN CHIM ACTA, V192, P35, DOI 10.1016/0009-8981(90)90269-X; VARRO A, 1990, J BIOL CHEM, V265, P21476	39	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4014	4021		10.1074/jbc.M707908200	http://dx.doi.org/10.1074/jbc.M707908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057001	hybrid			2022-12-27	WOS:000253083500036
J	Chen, HJ; Levine, YC; Golan, DE; Michel, T; Lin, AJ				Chen, Hongjie; Levine, Yehoshua C.; Golan, David E.; Michel, Thomas; Lin, Alison J.			Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLYL CYCLASE; SMOOTH-MUSCLE FUNCTION; ENA/VASP PROTEINS; EXTRACELLULAR-MATRIX; MEDIATED ANGIOGENESIS; ACTIN CYTOSKELETON; BASEMENT-MEMBRANE; MAMMALIAN-CELLS	Nitric oxide (NO)- and atrial natriuretic peptide (ANP)-initiated cGMP signaling cascades are important in the maintenance of cardiovascular homeostasis. The molecular signaling mechanisms downstream of cGMP are not well understood, however. We have used small interfering RNA (siRNA) approaches to specifically knock down a series of signaling proteins in bovine aortic endothelial cells, and we have combined biochemical analyses with physiological assays to investigate cGMP-mediated signal transduction pathways. Activation of particulate guanylate cyclase (GC-A) by ANP leads to a substantial, dose-dependent, rapid, and sustained increase in intracellular cGMP. In contrast, stimulation of soluble guanylate cyclase by NO yields only a weak and transient increase in cGMP. ANP-induced cGMP production is selectively suppressed by siRNA-mediated knockdown of GC-A. ANP greatly enhances the phosphorylation at Ser-239 of the vasodilator-stimulated phosphoprotein (VASP), a major substrate of cGMP-dependent protein kinase (PKG) that significantly influences actin dynamics. Moreover, the ANP-induced phosphorylation of VASP at Ser-239 is accompanied by increased actin stress fiber formation and enhanced endothelial tube formation. siRNA-mediated knockdown of GC-A, VASP, or PKG abolishes ANP-induced VASP Ser-239 phosphorylation, stress fiber formation, and endothelial tube formation. We have demonstrated similar findings in human umbilical vein endothelial cells, where ANP substantially enhances intracellular cGMP content, phosphorylation of VASP at Ser-239, and endothelial tube formation. Taken together, our findings suggest that ANP-mediated cGMP signal transduction pathways regulate PKG phosphorylation of VASP Ser-239 in endothelial cells, resulting in reorganization of the actin cytoskeleton and enhancement of angiogenesis.	[Chen, Hongjie; Levine, Yehoshua C.; Michel, Thomas; Lin, Alison J.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Cardiovasc,Med Sch, Boston, MA 02115 USA; [Golan, David E.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA; [Golan, David E.; Michel, Thomas; Lin, Alison J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Golan, DE (corresponding author), 250 Longwood Ave,SGMB 304, Boston, MA 02115 USA.	dgolan@hms.harvard.edu; tmichel@rics.bwh.harvard.edu; alison_lin@hms.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032854, R01HL032854, U54HL070819, P01HL048743, R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32854, HL70819, HL48743, HL46457] Funding Source: Medline; NIGMS NIH HHS [GM36259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Al-Ani B, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000025; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cea Luis Bolanos, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P87, DOI 10.2174/1568016053544309; Chen LH, 2004, ARTERIOSCL THROM VAS, V24, P1403, DOI 10.1161/01.ATV.0000134705.39654.53; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Galler AB, 2006, HISTOCHEM CELL BIOL, V125, P457, DOI 10.1007/s00418-005-0091-z; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; GRANT DS, 1994, PATHOL RES PRACT, V190, P854; Hamad AM, 2003, AM J PHYSIOL-LUNG C, V285, pL973, DOI 10.1152/ajplung.00033.2003; Han B, 2003, CARDIOVASC DRUG THER, V17, P41, DOI 10.1023/A:1024255808831; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hohenstein B, 2005, J AM SOC NEPHROL, V16, P986, DOI 10.1681/ASN.2004070591; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; ISHII K, 1989, AM J PHYSIOL, V256, pC495, DOI 10.1152/ajpcell.1989.256.3.C495; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kiemer Alexandra K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P11; KISHI Y, 1994, J CARDIOVASC PHARM, V24, P351, DOI 10.1097/00005344-199409000-00001; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kook H, 2003, AM J PHYSIOL-HEART C, V284, pH1388, DOI 10.1152/ajpheart.00414.2002; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; KUZUYA M, 1994, J CELL PHYSIOL, V161, P267, DOI 10.1002/jcp.1041610211; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moncada S., 2006, V176, P213; Morbidelli L, 2003, CURR PHARM DESIGN, V9, P521, DOI 10.2174/1381612033391405; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Pedram A, 2001, ENDOCRINOLOGY, V142, P1578, DOI 10.1210/en.142.4.1578; Price CJ, 2000, ARTERIOSCL THROM VAS, V20, P2051, DOI 10.1161/01.ATV.20.9.2051; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; Rivero-Vilches FJ, 2003, AM J PHYSIOL-CELL PH, V285, pC891, DOI 10.1152/ajpcell.00590.2002; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; Salazar R, 1999, EXP CELL RES, V249, P22, DOI 10.1006/excr.1999.4460; Shen WG, 2007, CELL BIOL INT, V31, P126, DOI 10.1016/j.cellbi.2006.09.017; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Sporbert A, 1999, MOL BRAIN RES, V67, P258, DOI 10.1016/S0169-328X(99)00067-4; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Zhu B, 2005, AM J PHYSIOL-LUNG C, V289, pL196, DOI 10.1152/ajplung.00433.2004	70	65	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4439	4447		10.1074/jbc.M709439200	http://dx.doi.org/10.1074/jbc.M709439200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079117	hybrid			2022-12-27	WOS:000253083500078
J	Gomes, DA; Rodrigues, MA; Leite, MF; Gomez, MV; Varnai, P; Balla, T; Bennett, AM; Nathanson, MH				Gomes, Dawidson A.; Rodrigues, Michele A.; Leite, M. Fatima; Gomez, Marcus V.; Varnai, Peter; Balla, Tamas; Bennett, Anton M.; Nathanson, Michael H.			C-met must translocate to the nucleus to initiate calcium signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; PERFUSED-RAT-LIVER; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; DOWN-REGULATION; FACTOR RECEPTOR; BILE SECRETION; CA2+; LOCALIZATION; RELEASE	Hepatocyte growth factor (HGF) is important for cell proliferation, differentiation, and related activities. HGF acts through its receptor c-Met, which activates downstream signaling pathways. HGF binds to c-Met at the plasma membrane, where it is generally believed that c-Met signaling is initiated. Here we report that c-Met rapidly translocates to the nucleus upon stimulation with HGF. Ca2+ signals that are induced by HGF result from phosphatidylinositol 4,5-bisphosphate hydrolysis and inositol 1,4,5-trisphosphate formation within the nucleus rather than within the cytoplasm. Translocation of c-Met to the nucleus depends upon the adaptor protein Gab1 and importin beta 1, and formation of Ca2+ signals in turn depends upon this translocation. HGF may exert its particular effects on cells because it bypasses signaling pathways in the cytoplasm to directly activate signaling pathways in the nucleus.	[Gomes, Dawidson A.; Rodrigues, Michele A.; Nathanson, Michael H.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gomez, Marcus V.] Univ Fed Minas Gerais, Dept Pharmacol, BR-31270901 Belo Horizonte, MG, Brazil; [Gomes, Dawidson A.; Rodrigues, Michele A.; Leite, M. Fatima] Univ Fed Minas Gerais, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil; [Varnai, Peter; Balla, Tamas] NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA	Yale University; Yale University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nathanson, MH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rm TAC S241D, New Haven, CT 06520 USA.	michael.nathanson@yale.edu	de Fatima Leite, Maria/AAK-2555-2021; Gomes, Dawidson Assis/O-1372-2013; Gomez, Marcus Vinicius/I-4081-2012	Gomes, Dawidson Assis/0000-0001-7714-991X; Gomez, Marcus Vinicius/0000-0002-6082-930X; Bennett, Anton/0000-0001-5187-7599; Balla, Tamas/0000-0002-9077-3335	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK37989, P01 DK057751, R01 DK045710-06A2, DK57751, P01 DK057751-01A1, P30 DK034989, P30 DK034989-169004, R01 DK045710, DK45710] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK045710, R01DK037989, P01DK057751, R29DK045710] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hernandez E, 2007, J BIOL CHEM, V282, P10057, DOI 10.1074/jbc.M700746200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; KIM SJ, 1993, J CELL PHYSIOL, V157, P217, DOI 10.1002/jcp.1041570203; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; Leite MF, 2002, J BIOL CHEM, V277, P16313, DOI 10.1074/jbc.M109207200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; Martelli AM, 2000, FEBS LETT, V486, P230, DOI 10.1016/S0014-5793(00)02313-9; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nagata J, 2007, GASTROENTEROLOGY, V133, P256, DOI 10.1053/j.gastro.2007.03.115; NATHANSON MH, 1992, AM J PHYSIOL, V262, pG1079, DOI 10.1152/ajpgi.1992.262.6.G1079; Nathanson MH, 1999, GASTROENTEROLOGY, V116, P1176, DOI 10.1016/S0016-5085(99)70021-1; NATHANSON MH, 1992, HEPATOLOGY, V15, P107, DOI 10.1002/hep.1840150119; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; OKANO Y, 1993, BIOCHEM BIOPH RES CO, V190, P842, DOI 10.1006/bbrc.1993.1125; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SHANKAR G, 1993, J CELL SCI, V105, P61; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8	49	116	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4344	4351		10.1074/jbc.M706550200	http://dx.doi.org/10.1074/jbc.M706550200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073207	hybrid, Green Accepted			2022-12-27	WOS:000253083500069
J	Heras, B; Kurz, M; Jarrott, R; Shouldice, SR; Frei, P; Robin, G; Cemazar, M; Thony-Meyer, L; Glockshuber, R; Martin, JL				Heras, Begona; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Frei, Patrick; Robin, Gautier; Cemazar, Masa; Thoeny-Meyer, Linda; Glockshuber, Rudi; Martin, Jennifer L.			Staphylococcus aureus DsbA does not have a destabilizing disulfide - A new paradigm for bacterial oxidative folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; BOND FORMATION INVIVO; III SECRETION SYSTEM; FORMATION IN-VIVO; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ACTIVE-SITE; ANOMALOUS DIFFRACTION; VIRULENCE FACTORS; CRYSTAL-STRUCTURE	In Gram-negative bacteria, the introduction of disulfide bonds into folding proteins occurs in the periplasm and is catalyzed by donation of an energetically unstable disulfide from DsbA, which is subsequently re-oxidized through interaction with DsbB. Gram-positive bacteria lack a classic periplasm but nonetheless encode Dsb-like proteins. Staphylococcus aureus encodes just one Dsb protein, a DsbA, and no DsbB. Here we report the crystal structure of S. aureus DsbA (SaDsbA), which incorporates a thioredoxin fold with an inserted helical domain, like its Escherichia coli counterpart EcDsbA, but it lacks the characteristic hydrophobic patch and has a truncated binding groove near the active site. These findings suggest that SaDsbA has a different substrate specificity than EcDsbA. Thermodynamic studies indicate that the oxidized and reduced forms of SaDsbA are energetically equivalent, in contrast to the energetically unstable disulfide form of EcDsbA. Further, the partial complementation of EcDsbA by SaDsbA is independent of EcDsbB and biochemical assays show that SaDsbA does not interact with EcDsbB. The identical stabilities of oxidized and reduced SaDsbA may facilitate direct re-oxidation of the protein by extracellular oxidants, without the need for DsbB.	[Heras, Begona; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Robin, Gautier; Cemazar, Masa; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Frei, Patrick; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Thoeny-Meyer, Linda] EMPA, Lab Biomat, CH-9014 St Gallen, Switzerland	University of Queensland; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Heras, B (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct,Bldg 80 Carmody Rd, Brisbane, Qld 4072, Australia.	bheras@imb.uq.edu.au	Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Martin, Jennifer L./0000-0002-9225-8863; Jarrott, Russell/0000-0003-4326-1203				Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Delano W.L., 2002, DELANO SCI; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Dziewanowska K, 1996, ARCH BIOCHEM BIOPHYS, V335, P102, DOI 10.1006/abbi.1996.0486; Ellermeier CD, 2004, J BACTERIOL, V186, P68, DOI 10.1128/JB.186.1.68-79.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Heras B, 2007, ACTA CRYSTALLOGR F, V63, P953, DOI 10.1107/S174430910704821X; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOVDE CJ, 1994, MOL MICROBIOL, V13, P897, DOI 10.1111/j.1365-2958.1994.tb00481.x; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; ISHIHARA T, 1995, J BACTERIOL, V177, P745, DOI 10.1128/jb.177.3.745-749.1995; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krupka HI, 2002, PROTEIN SCI, V11, P642, DOI 10.1110/ps.39702; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OKAMOTO K, 1995, J BACTERIOL, V177, P4579, DOI 10.1128/jb.177.16.4579-4586.1995; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pooley HM, 1996, MICROB DRUG RESIST, V2, P9, DOI 10.1089/mdr.1996.2.9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	60	56	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4261	4271		10.1074/jbc.M707838200	http://dx.doi.org/10.1074/jbc.M707838200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077463	Green Published, hybrid			2022-12-27	WOS:000253083500061
J	Hess, CR; McGuirl, MM; Klinman, JP				Hess, Corinna R.; McGuirl, Michele M.; Klinman, Judith P.			Mechanism of the insect enzyme, tyramine beta-monooxygenase, reveals differences from the mammalian enzyme, dopamine beta-monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HYDROXYLATING MONOOXYGENASE; ELECTRON-TRANSFER; KINETIC MECHANISM; FINE-STRUCTURE; COPPER; OCTOPAMINE; DROSOPHILA; DEFICIENCY; ACTIVATION; AMIDATION	Tyramine beta-monooxygenase (T beta M) catalyzes the synthesis of the neurotransmitter, octopamine, in insects. Kinetic and isotope effect studies have been carried out to determine the kinetic mechanism of T beta M for comparison with the homologous mammalian enzymes, dopamine beta-monooxygenase and peptidylglycine alpha-hydroxylating monooxygenase. A new and distinctive feature of T beta M is very strong substrate inhibition that is dependent on the level of the co-substrate, O-2, and reductant as well as substrate deuteration. This has led to a model in which tyramine can bind to either the Cu(I) or Cu(II) forms of T beta M, with substrate inhibition ameliorated at very high ascorbate levels. The rate of ascorbate reduction of the E-Cu(II) form of T beta M is also reduced at high tyramine, leading us to propose the existence of a binding site for ascorbate to this class of enzymes. These findings may be relevant to the control of octopamine production in insect cells.	[Hess, Corinna R.; Klinman, Judith P.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hess, Corinna R.; Klinman, Judith P.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McGuirl, Michele M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [McGuirl, Michele M.] Univ Montana, Biomol Struct & Dynam Program, Missoula, MT 59812 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Montana System; University of Montana; University of Montana System; University of Montana	Klinman, JP (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	klinman@berkeley.edu	McGuirl, Michele/N-2311-2014; Hess, Corinna/J-1504-2012	Hess, Corinna/0000-0002-9607-9184	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025765, F32GM067351, R01GM025765] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM25765, GM067351] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN N, 1983, BIOCHEMISTRY-US, V22, P3096, DOI 10.1021/bi00282a012; Blackburn NJ, 2000, J BIOL INORG CHEM, V5, P341, DOI 10.1007/PL00010663; BLACKBURN NJ, 1991, J BIOL CHEM, V266, P23120; BLACKBURN NJ, 1990, J BIOL CHEM, V265, P15383; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Cubells JF, 2004, PSYCHOPHARMACOLOGY, V174, P463, DOI 10.1007/s00213-004-1840-8; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; EVANS PD, 1976, J PHYSIOL-LONDON, V262, P51, DOI 10.1113/jphysiol.1976.sp011585; Francisco WA, 2004, J AM CHEM SOC, V126, P13168, DOI 10.1021/ja046888z; Francisco WA, 1998, BIOCHEMISTRY-US, V37, P8244, DOI 10.1021/bi973004y; Gray EE, 2006, PROTEIN EXPRES PURIF, V47, P162, DOI 10.1016/j.pep.2005.11.008; HOYLE G, 1980, J NEUROBIOL, V11, P103, DOI 10.1002/neu.480110109; HOYLE G, 1975, J EXP ZOOL, V193, P425, DOI 10.1002/jez.1401930321; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; KLINMAN JP, 1980, J BIOL CHEM, V255, P1648; Lehman HK, 2006, J EXP BIOL, V209, P2774, DOI 10.1242/jeb.02296; LJONES T, 1978, FEBS LETT, V92, P81, DOI 10.1016/0014-5793(78)80726-1; MILLER SM, 1982, METHOD ENZYMOL, V87, P711; MILLER SM, 1985, BIOCHEMISTRY-US, V24, P2114, DOI 10.1021/bi00330a004; MILLER SM, 1983, BIOCHEMISTRY-US, V22, P3091, DOI 10.1021/bi00282a011; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Monastirioti M, 2003, DEV BIOL, V264, P38, DOI 10.1016/j.ydbio.2003.07.019; Prigge ST, 1999, NAT STRUCT BIOL, V6, P976; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Segel I. H., 1993, ENZYME KINETICS BEHA, p[273, 626, 660]; STEWART LC, 1987, BIOCHEMISTRY-US, V26, P5302, DOI 10.1021/bi00391a013; STEWART LC, 1991, J BIOL CHEM, V266, P11537; Timmers HJLM, 2004, ANN NY ACAD SCI, V1018, P520, DOI 10.1196/annals.1296.064	32	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3042	3049		10.1074/jbc.M705911200	http://dx.doi.org/10.1074/jbc.M705911200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18032384	hybrid			2022-12-27	WOS:000253083000007
J	Xu, L; Han, C; Lim, K; Wu, T				Xu, Lihong; Han, Chang; Lim, Kyu; Wu, Tong			Activation of cytosolic phospholipase A(2)alpha through nitric oxide-induced S-nitrosylation - Involvement of inducible nitric-oxide synthase and cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); FATTY-ACID TRANSDUCTION; NITROLINOLEIC ACID; SIGNALING PATHWAYS; BONE-RESORPTION; MICE DEFICIENT; MAST-CELLS; INJURY; BIOSYNTHESIS; INFLAMMATION	Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) is the rate-limiting key enzyme that cleaves arachidonic acid (AA) from membrane phospholipids for the biosynthesis of eicosanoids, including prostaglandin E-2 (PGE(2)), a key lipid mediator involved in inflammation and carcinogenesis. Here we show that cPLA(2)alpha protein is S-nitrosylated, and its activity is enhanced by nitric oxide ( NO). Forced expression of inducible nitric-oxide synthase ( iNOS) in human epithelial cells induced cPLA(2)alpha S-nitrosylation, enhanced its catalytic activity, and increased AA release. The iNOS-induced cPLA(2)alpha activation is blocked by the specific iNOS inhibitor, 1400W. The addition of the NO donor, S-nitrosoglutathione, to isolated cell lysates or purified recombinant human cPLA(2)alpha protein induced S-nitrosylation of cPLA(2)alpha in vitro. Incubation of cultured cells with the iNOS substrate L-arginine and NO donor significantly increased cPLA(2)alpha activity and AA release. These findings demonstrate that iNOS-derived NO S-nitrosylates and activates cPLA(2)alpha in human cells. Site-directed mutagenesis revealed that Cys-152 of cPLA(2)alpha is critical for S-nitrosylation. Furthermore, COX-2 induction or expression markedly enhanced iNOS-induced cPLA(2)alpha S-nitrosylation and activation, leading to 9-, 23-, and 20-fold increase of AA release and 100-, 38-, and 88-fold of PGE(2) production in A549, SG231, and HEK293 cells, respectively, whereas COX-2 alone leads to less than 2-fold change. These results indicate that COX-2 has the ability to enhance iNOS-induced cPLA(2)alpha S-nitrosylation and that maximal PG synthesis is achieved by the synergistic interaction among iNOS, cPLA(2)alpha, and COX-2. Since COX-2 enhances the formation of cPLA(2)alpha-iNOS binding complex, it appears that COX-2-induced augmentation of cPLA(2)alpha S-nitrosylation is mediated at least in part through increased association between iNOS and cPLA(2)alpha. These findings disclose a novel link among cPLA(2)alpha, iNOS, and COX-2, which form a multiprotein complex leading to cPLA(2)alpha S-nitrosylation and activation. Therefore, therapy aimed at disrupting this interplay may represent a promising strategy to effectively inhibit PGE(2) production and prevent inflammation and carcinogenesis.	[Xu, Lihong; Han, Chang; Lim, Kyu; Wu, Tong] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, T (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, MUH E-740,200 Lothrop St, Pittsburgh, PA 15213 USA.	wut@upmc.edu			NATIONAL CANCER INSTITUTE [R01CA102325, R01CA106280] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102325, R01 CA106280] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bonventre JV, 2004, TRENDS IMMUNOL, V25, P116, DOI 10.1016/j.it.2004.01.006; BRAUGHLER JM, 1979, J BIOL CHEM, V254, P2450; Capper EA, 2001, PROG LIPID RES, V40, P167, DOI 10.1016/S0163-7827(01)00002-9; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Foster MW, 2006, NAT CHEM BIOL, V2, P570, DOI 10.1038/nchembio1106-570; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Han C, 2004, J BIOL CHEM, V279, P44344, DOI 10.1074/jbc.M404852200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Laye JP, 2003, DRUG DISCOV TODAY, V8, P710, DOI 10.1016/S1359-6446(03)02754-5; Marusic S, 2005, J EXP MED, V202, P841, DOI 10.1084/jem.20050665; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Mustafa AK, 2007, P NATL ACAD SCI USA, V104, P2950, DOI 10.1073/pnas.0611620104; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Nakanishi M, 2006, BBA-MOL CELL BIOL L, V1761, P1335, DOI 10.1016/j.bbalip.2006.09.005; Nakatani N, 2000, BIOCHEM J, V352, P311, DOI 10.1042/0264-6021:3520311; Oikawa Y, 2005, FEBS LETT, V579, P3975, DOI 10.1016/j.febslet.2005.06.024; Riccio A, 2006, MOL CELL, V21, P283, DOI 10.1016/j.molcel.2005.12.006; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Schade S, 2002, BIOCHEM PHARMACOL, V64, P1227, DOI 10.1016/S0006-2952(02)01290-X; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schopfer FJ, 2005, J BIOL CHEM, V280, P19289, DOI 10.1074/jbc.M414689200; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Tabuchi S, 2003, ACT NEUR S, V86, P169; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu LH, 2006, J BIOL CHEM, V281, P33982, DOI 10.1074/jbc.M600135200	46	57	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3077	3087		10.1074/jbc.M705709200	http://dx.doi.org/10.1074/jbc.M705709200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18029351	hybrid			2022-12-27	WOS:000253083000011
J	Watatani, Y; Ichikawa, K; Nakanishi, N; Fujimoto, M; Takeda, H; Kimura, N; Hirose, H; Takahashi, S; Takahashi, Y				Watatani, Yujiro; Ichikawa, Kenji; Nakanishi, Noriko; Fujimoto, Maki; Takeda, Hitoshi; Kimura, Natsumi; Hirose, Hidenori; Takahashi, Shigeru; Takahashi, Yuji			Stress-induced translation of ATF5 mRNA is regulated by the 5 '-untranslated region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN READING FRAME; TRANSCRIPTION FACTORS; MAMMALIAN-CELLS; GENE-EXPRESSION; INITIATION; PROTEIN; KINASE; PHOSPHORYLATION; INHIBITION; ELEMENT	Activating transcription factor (ATF) 5 is a transcription factor belonging to the ATF/cAMP-response element-binding protein gene family. We previously reported that ATF5 mRNA expression increased in response to amino acid limitation. The ATF5 gene allows transcription of mRNAs with at least two alternative 5 '-untranslated regions (5 '-UTRs), 5 '-UTR alpha and 5 '-UTR beta, derived from exon1 alpha and exon1 beta. 5 '-UTR alpha contains highly conserved sequences, in which the upstream open reading frames (uORFs) uORF1 and uORF2 are found in many species. This study was designed to investigate the potential role of 5 '-UTRs in translational control. These 5 '-UTRs differentially determined translation efficiency from mRNA. The presence of 5 '-UTR alpha or 5 '-UTR beta represses translation from the downstream ATF5 ORF. Moreover, 5 '-UTR alpha-regulated translational repression is released by amino acid limitation or NaAsO2 exposure. This release was not seen for 5 '-UTR beta. Mutation of uAUG2 in the uORF2 of 5 '-UTR alpha restored the basal expression and abolished the positive regulation by amino acid limitation or arsenite exposure. Wedemonstrated that phosphorylation of eukaryotic initiation factor 2 alpha was required for amino acid limitation-induced translational regulation of ATF5. Furthermore, arsenite exposure activated the exogenously expressed heme-regulated inhibitor kinase and induced the phosphorylation of eukaryotic initiation factor 2 alpha in nonerythroid cells. These results suggest that translation of ATF5 is regulated by the alternative 5 '-UTR region of its mRNA, and ATF5 may play a role in protecting cells from amino acid limitation or arsenite-induced oxidative stress.	[Watatani, Yujiro; Ichikawa, Kenji; Nakanishi, Noriko; Fujimoto, Maki; Takeda, Hitoshi; Kimura, Natsumi; Hirose, Hidenori; Takahashi, Shigeru; Takahashi, Yuji] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Environm Mol Physiol, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences	Takahashi, S (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Environm Mol Physiol, 1432-1 Horinouchi, Tokyo 1920392, Japan.	shigeru@ls.toyaku.ac.jp	Ichikawa, Kenji/AAW-1613-2021					Angelastro JM, 2003, J NEUROSCI, V23, P4590; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; CARTER MS, 1995, J BIOL CHEM, V270, P28995, DOI 10.1074/jbc.270.48.28995; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Fernandez J, 2002, J BIOL CHEM, V277, P2050, DOI 10.1074/jbc.M109199200; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HOPLICK M, 2005, NAT REV MOL CELL BIO, V6, P318; Hughes TA, 2005, J BIOL CHEM, V280, P8581, DOI 10.1074/jbc.M410806200; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2001, NUCLEIC ACIDS RES, V29, P4341, DOI 10.1093/nar/29.21.4341; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Muller EA, 2004, J BIOL CHEM, V279, P44645, DOI 10.1074/jbc.M406550200; NISHIZAWA M, 1992, FEBS LETT, V299, P36, DOI 10.1016/0014-5793(92)80094-W; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pati D, 1999, MOL CELL BIOL, V19, P5001; PERRY FS, 2002, BIOL CHEM, V277, P24120; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Rohwedel J, 2003, CELL MOL LIFE SCI, V60, P1705, DOI 10.1007/s00018-003-3134-4; Ruan HJ, 1996, J BIOL CHEM, V271, P29576, DOI 10.1074/jbc.271.47.29576; SARRAJ JA, 2005, BIOL CHEM, V386, P873; Shinomura T, 2006, BIOCHEM BIOPH RES CO, V341, P167, DOI 10.1016/j.bbrc.2005.12.169; Tonelli DD, 2004, NUCLEIC ACIDS RES, V32, P1808, DOI 10.1093/nar/gkh348; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Watatani Y, 2007, LIFE SCI, V80, P879, DOI 10.1016/j.lfs.2006.11.013; Wilusz CJ, 2001, GENE DEV, V15, P2781; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443	39	98	103	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2543	2553		10.1074/jbc.M707781200	http://dx.doi.org/10.1074/jbc.M707781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055463	hybrid			2022-12-27	WOS:000252622300011
J	Ueda, H; Nagae, R; Kozawa, M; Morishita, R; Kimura, S; Nagase, T; Ohara, O; Yoshida, S; Asano, T				Ueda, Hiroshi; Nagae, Rika; Kozawa, Mika; Morishita, Rika; Kimura, Shinji; Nagase, Takahiro; Ohara, Osamu; Yoshida, Satoshi; Asano, Tomiko			Heterotrimeric G protein beta gamma subunits stimulate FLJ00018, a guanine nucleotide exchange factor for Rac1 and Cdc42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-GTPASES; P115 RHOGEF; CELL; DBL; REORGANIZATION; PURIFICATION; ACTIVATION; NUCLEATION; MECHANISM; ADHESION	We previously reported that G beta gamma signaling regulates cell spreading or cell shape change through activation of a Rho family small GTPase, suggesting the existence of a G beta gamma-regulated Rho guanine-nucleotide exchange factor ( RhoGEF). In this study we examined various RhoGEF clones, found FLJ00018 to be a G beta gamma-activated RhoGEF, and investigated the molecular mechanism of G beta gamma-induced activation of Rho family GTPases. Co-expression of the genes for FLJ00018 and G beta gamma enhanced serum response element-mediated gene transcription in HEK-293 cells. Combined expression of G beta gamma and FLJ00018 significantly induced activation of Rac and Cdc42 but not RhoA. FLJ00018 also enhanced gene transcription induced by carbachol-stimulated m2 muscarinic acetylcholine receptor, and this enhancement was blocked by pertussis toxin. Furthermore, we demonstrated G beta gamma to interact directly with the N-terminal region of FLJ00018 and the N-terminal fragment of this molecule to inhibit serum response element-dependent transcription induced by G beta gamma/FLJ00018 and carbachol. In NIH3T3 cells, FLJ00018 enhanced lysophosphatidic acid-induced cell spreading, which was also blocked by the N-terminal fragment of FLJ00018. These results provide evidence for a signaling pathway by which G(i)-coupled receptor specifically induces Rac and Cdc42 activation through direct interaction of G beta gamma with FLJ00018.	[Ueda, Hiroshi; Nagae, Rika; Kozawa, Mika; Kimura, Shinji; Yoshida, Satoshi] Gifu Univ, Fac Engn, Dept Biomol Sci, Gifu 5011193, Japan; [Morishita, Rika; Asano, Tomiko] Aichi Human Serv Ctr, Inst Dev Res, Aichi 4800392, Japan; [Nagase, Takahiro; Ohara, Osamu] Kazusa DNA Res Inst, Kisarazu 2920818, Japan; [Ohara, Osamu] RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Kanagawa 2300045, Japan	Gifu University; Kazusa DNA Research Institute; RIKEN	Ueda, H (corresponding author), Gifu Univ, Fac Engn, Dept Biomol Sci, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp	Ohara, Osamu/A-9119-2012; Yoshida, Satoshi/B-6779-2012; Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571				ASANO T, 1993, J BIOL CHEM, V268, P20512; Belisle B, 2000, J BIOL CHEM, V275, P26225, DOI 10.1074/jbc.M002743200; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Himmel KL, 2002, J BIOL CHEM, V277, P13463, DOI 10.1074/jbc.M110981200; Kato J, 2000, BIOCHEM BIOPH RES CO, V268, P141, DOI 10.1006/bbrc.2000.2106; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kiyono M, 1999, P NATL ACAD SCI USA, V96, P4826, DOI 10.1073/pnas.96.9.4826; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ma AD, 1998, MOL CELL BIOL, V18, P4744, DOI 10.1128/MCB.18.8.4744; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1913, DOI 10.1074/jbc.M506034200; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; Nakajima D, 2002, DNA RES, V9, P99, DOI 10.1093/dnares/9.3.99; Nishida K, 1999, FEBS LETT, V459, P186, DOI 10.1016/S0014-5793(99)01244-2; Niu JX, 2003, CIRC RES, V93, P848, DOI 10.1161/01.RES.0000097607.14733.0C; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Ueda H, 2001, J BIOL CHEM, V276, P6846, DOI 10.1074/jbc.M007541200; Ueda H, 2000, J BIOL CHEM, V275, P2098, DOI 10.1074/jbc.275.3.2098; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	42	45	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1946	1953		10.1074/jbc.M707037200	http://dx.doi.org/10.1074/jbc.M707037200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045877	hybrid			2022-12-27	WOS:000252501000021
J	Cozzolino, M; Amori, I; Pesaresi, MG; Ferri, A; Nencini, M; Carri, MT				Cozzolino, Mauro; Amori, Ilaria; Pesaresi, Maria Grazia; Ferri, Alberto; Nencini, Monica; Carri, Maria Teresa			Cysteine 111 affects aggregation and cytotoxicity of mutant Cu,Zn-superoxide dismutase associated with familial amyotrophic lateral sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT COMPLEXES; CEREBELLAR GRANULE NEURONS; DOPAMINE-INDUCED APOPTOSIS; ZN-SUPEROXIDE-DISMUTASE; ALS-LINKED SOD1; OXIDATIVE STRESS; TRANSGENIC MICE; DISULFIDE; GLUTAREDOXIN; MITOCHONDRIA	Converging evidence indicates that aberrant aggregation of mutant Cu,Zn-superoxide dismutase ( mutSOD1) is strongly implicated in familial amyotrophic lateral sclerosis ( FALS). MutSOD1 forms high molecular weight oligomers, which disappear under reducing conditions, both in neural tissues of FALS transgenic mice and in transfected cultured cells, indicating a role for aberrant intermolecular disulfide cross-linking in the oligomerization and aggregation process. To study the contribution of specific cysteines in the mechanism of aggregation, we mutated human SOD1 in each of its four cysteine residues and, using a cell transfection assay, analyzed the solubility and aggregation of those SOD1s. Our results suggest that the formation of mutSOD1 aggregates are the consequence of covalent disulfide cross-linking and non-covalent interactions. In particular, we found that the removal of Cys-111 strongly reduces the ability of a range of different FALS-associated mutSOD1s to form aggregates and impair cell viability in cultured NSC-34 cells. Moreover, the removal of Cys-111 impairs the ability of mutSOD1s to form disulfide cross-linking. Treatments that deplete the cellular pool of GSH exacerbate mutSOD1s insolubility, whereas an overload of intracellular GSH or overexpression of glutare-doxin-1, which specifically catalyzes the reduction of protein-SSG-mixed disulfides, significantly rescues mutSOD1s solubility. These data are consistent with the view that the redox environment influences the oligomerization/aggregation pathway of mutSOD1 and point to Cys-111 as a key mediator of this process.	[Cozzolino, Mauro; Amori, Ilaria; Pesaresi, Maria Grazia; Ferri, Alberto; Nencini, Monica; Carri, Maria Teresa] Fdn S Lucia Ist Ric & Cura Carattere Sci, Neurochem Lab, I-00179 Rome, Italy; [Ferri, Alberto] CNR, Inst Neurosci, Dept Psychobiol & Psychopharmacol, I-00100 Rome, Italy; [Carri, Maria Teresa] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Rome Tor Vergata	Carri, MT (corresponding author), Fdn S Lucia Ist Ric & Cura Carattere Sci, Neurochem Lab, I-00179 Rome, Italy.	carri@bio.uniroma2.it	FERRI, ALBERTO/B-7660-2015; cozzolino, mauro/AAY-2244-2020; Nencini, Monica/ABI-6619-2020; Carri, Maria Teresa/K-5480-2016	FERRI, ALBERTO/0000-0002-4097-0605; Carri, Maria Teresa/0000-0002-1789-1546; COZZOLINO, MAURO/0000-0003-0342-8961; Nencini, Monica/0000-0001-9602-1954	Telethon [GGP07018] Funding Source: Medline	Telethon(Fondazione Telethon)		Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Carri MT, 2006, TRENDS PHARMACOL SCI, V27, P267, DOI 10.1016/j.tips.2006.03.009; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Ciriolo MR, 1997, J BIOL CHEM, V272, P2700, DOI 10.1074/jbc.272.5.2700; Daily D, 2001, J BIOL CHEM, V276, P21618, DOI 10.1074/jbc.M101400200; Daily D, 2001, J BIOL CHEM, V276, P1335, DOI 10.1074/jbc.M008121200; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hashemy SI, 2007, J BIOL CHEM, V282, P14428, DOI 10.1074/jbc.M700927200; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Welker E, 2001, P NATL ACAD SCI USA, V98, P4334, DOI 10.1073/pnas.071066598; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200	30	100	104	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					866	874		10.1074/jbc.M705657200	http://dx.doi.org/10.1074/jbc.M705657200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006498	hybrid, Green Accepted			2022-12-27	WOS:000252128100027
J	Yagishita, S; Morishima-Kawashima, M; Ishiura, S; Ihara, Y				Yagishita, Sosuke; Morishima-Kawashima, Maho; Ishiura, Shoichi; Ihara, Yasuo			A beta 46 is processed to A beta 40 and A beta 43, but not to A beta 42, in the low density membrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE ACTIVITY; C-TERMINAL FRAGMENT; BETA-PROTEIN; INTRAMEMBRANE CLEAVAGE; LIPID RAFTS; PRESENILIN; BETA-PROTEIN-42; INHIBITOR; MECHANISM	gamma-Secretase cleaves the transmembrane domain of beta-amyloid precursor protein at multiple sites referred to as gamma-, epsilon-, and zeta-cleavage sites. We previously showed that N-[N-( 3,5-difluoro-phenacetyl)-L- alanyl]-S-phenylglycine t-butyl ester (DAPT), a potent dipeptide gamma- secretase inhibitor, causes differential accumulation of longer amyloid beta-proteins (A beta s) within Chinese hamster ovary cells co-expressing beta C-terminal fragment and wild-type presenilin 1(C99/wtPS1 cells). In this study, we used sucrose density gradient centrifugation to fractionate the membranes from C99/wtPS1 cells that had been pretreated with DAPT. We found that accumulating A beta 46 localized exclusively to low density membrane (LDM) domains. Incubating the A beta 46-accumulating LDM domains at 37 degrees C produced A beta 40, A beta 42, A beta 43, and beta-amyloid precursor protein intracellular domain. The addition of L685,458 completely prevented beta-amyloid precursor protein intracellular domain generation and resulted in a large decrease in the level of A beta 46 and the concomitant appearance of A beta 40 and A beta 43 but not A beta 42. Further addition of DAPT suppressed the production of A beta 40/43 and abolished the decrease in the amount of A beta 46. These data indicate that preaccumulated A beta 46 is processed by gamma-secretase to A beta 40/43 but not to A beta 42 in the LDM domains. The amount of newly produced A beta 40 and A beta 43 was roughly equivalent to the decrease in the amount of A beta 46. Temporal profiles did not show a maximal concentration for A beta 43, suggesting that A beta 46 is processed to A beta 40 and A beta 43 through a nonsuccessive process.	[Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Planning Off, Kizugawa Shi, Kyoto 6190225, Japan; [Yagishita, Sosuke; Morishima-Kawashima, Maho; Ihara, Yasuo] Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; [Yagishita, Sosuke; Ishiura, Shoichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Morishima-Kawashima, Maho] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600812, Japan	Doshisha University; University of Tokyo; University of Tokyo; Hokkaido University	Ihara, Y (corresponding author), Doshisha Univ, Fac Life & Med Sci, Planning Off, 4-1-1 Kizugawadai, Kizugawa Shi, Kyoto 6190225, Japan.	yihara@mail.doshisha.ac.jp						Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Funamoto S, 2004, BIOCHEMISTRY-US, V43, P13532, DOI 10.1021/bi049399k; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2001, J BIOL CHEM, V276, P5413, DOI 10.1074/jbc.R000026200; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200; Zhao GJ, 2007, J NEUROCHEM, V100, P1234, DOI 10.1111/j.1471-4159.2006.04302.x	26	41	41	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					733	738		10.1074/jbc.M707103200	http://dx.doi.org/10.1074/jbc.M707103200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18024430	hybrid			2022-12-27	WOS:000252128100011
J	Fitzgerald, JB; Jin, M; Chai, DH; Siparsky, P; Fanning, P; Grodzinsky, AJ				Fitzgerald, Jonathan B.; Jin, Moonsoo; Chai, Diana H.; Siparsky, Patrick; Fanning, Paul; Grodzinsky, Alan J.			Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; FACTOR-KAPPA-B; GENE-EXPRESSION; PROTEIN-KINASE; MECHANICAL STIMULATION; GROWTH-FACTOR; BIOSYNTHETIC RESPONSE; SIGNALING PATHWAYS; TERMINAL KINASE; P38	Chondrocytes regulate the composition of cartilage extracellular matrix in response to mechanical signals, but the intracellular pathways involved in mechanotransduction are still being defined. Mitogen-activated protein kinase ( MAPK) pathways are activated by static and dynamic compression of cartilage, which simultaneously induce intratissue fluid flow, pressure gradients, cell, and matrix deformation. First, to determine whether cell and matrix deformation alone could induce MAPK activation, we applied dynamic shear to bovine cartilage explants. Using Western blotting, we measured ERK1/2 and p38 activation at multiple time points over 24 h. Distinct activation time courses were observed for different MAPKs: a sustained 50% increase for ERK1/2 and a delayed increase in p38 of 180%. We then investigated the role of MAPK activation in mechano-induced chondrocyte gene expression. Cartilage explants were preincubated with inhibitors of ERK1/2 and p38 activation before application of 1-24 h of three distinct mechanical stimuli relevant to in vivo loading ( 50% static compression, 3% dynamic compression at 0.1 Hz, or 3% dynamic shear at 0.1 Hz). mRNA levels of selected genes involved in matrix homeostasis were measured using real-time PCR and analyzed by k-means clustering to characterize the time- and load-dependent effects of the inhibitors. Most genes examined required ERK1/2 and p38 activation to be regulated by these loading regimens, including matrix proteins aggrecan and type II collagen, matrix metalloproteinases MMP13, and ADAMTS5, and transcription factors downstream of the MAPK pathway, c-Fos, and c-Jun. Thus, we demonstrated that the MAPK pathway is a central conduit for transducing mechanical forces into biological responses in cartilage.	[Jin, Moonsoo; Grodzinsky, Alan J.] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Fitzgerald, Jonathan B.; Chai, Diana H.; Siparsky, Patrick; Grodzinsky, Alan J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Fanning, Paul] Univ Massachusetts, Sch Med, Dept Orthoped, Boston, MA 02215 USA; [Fanning, Paul] Univ Massachusetts, Sch Med, Dept Cell Biol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Grodzinsky, AJ (corresponding author), MIT, Ctr Biomed Engn, NE 47-377,77 Massachusetts Ave, Cambridge, MA 02139 USA.	alg@mit.edu	Jin, Moonsoo/D-6128-2011		NIAMS NIH HHS [AR33236] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR033236, R01AR033236] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; AUTDERHEIDE AC, 2006, ANN BIOMED ENG, V34, P1463; Badger AM, 1998, J IMMUNOL, V161, P467; Borden P, 1996, J BIOL CHEM, V271, P33706, DOI 10.1074/jbc.271.52.33706; De Croos JNA, 2006, MATRIX BIOL, V25, P323, DOI 10.1016/j.matbio.2006.03.005; Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; GRAY ML, 1989, BIOCHIM BIOPHYS ACTA, V991, P415, DOI 10.1016/0304-4165(89)90067-6; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Guilak F, 1994, Osteoarthritis Cartilage, V2, P91, DOI 10.1016/S1063-4584(05)80059-7; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Hui A, 1998, ARTHRITIS RHEUM, V41, P869, DOI 10.1002/1529-0131(199805)41:5<869::AID-ART15>3.0.CO;2-3; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Jin M, 2001, ARCH BIOCHEM BIOPHYS, V395, P41, DOI 10.1006/abbi.2001.2543; Kim YJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P331, DOI 10.1006/abbi.1996.0181; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li KW, 2003, ARTHRITIS RHEUM-US, V48, P689, DOI 10.1002/art.10849; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; Ridley SH, 1997, J IMMUNOL, V158, P3165; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; Salter DM, 2002, BIORHEOLOGY, V39, P97; Scherle PA, 1997, BIOCHEM BIOPH RES CO, V230, P573, DOI 10.1006/bbrc.1996.5985; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Steinmeyer J, 1997, OSTEOARTHR CARTILAGE, V5, P331, DOI 10.1016/S1063-4584(97)80037-4; Studer RK, 2005, J ORTHOP RES, V23, P454, DOI 10.1016/j.orthres.2004.08.012; Studer RK, 2004, ARTHRITIS RES THER, V6, pR56, DOI 10.1186/ar1022; Szafranski JD, 2004, OSTEOARTHR CARTILAGE, V12, P937, DOI 10.1016/j.joca.2004.08.004; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Valhmu WB, 1998, ARCH BIOCHEM BIOPHYS, V353, P29, DOI 10.1006/abbi.1998.0633; Vincent T, 2006, BIOCHEM SOC T, V34, P456, DOI 10.1042/BST0340456; VINCENTI MP, 1994, NUCLEIC ACIDS RES, V22, P4818, DOI 10.1093/nar/22.22.4818; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; vonKempis J, 1997, OSTEOARTHR CARTILAGE, V5, P394, DOI 10.1016/S1063-4584(97)80044-1; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Wong M, 1999, MATRIX BIOL, V18, P391, DOI 10.1016/S0945-053X(99)00029-3; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	52	74	75	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6735	6743		10.1074/jbc.M708670200	http://dx.doi.org/10.1074/jbc.M708670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18086670	hybrid			2022-12-27	WOS:000253779600015
J	Sun, S; Yu, JP; Chen, F; Zhao, TJ; Fang, XH; Li, YQ; Sui, SF				Sun, Shan; Yu, Jun-Ping; Chen, Feng; Zhao, Tong-Jin; Fang, Xiao-Hong; Li, Yi-Qin; Sui, Sen-Fang			TINY, a dehydration-responsive element (DRE)-binding protein-like transcription factor connecting the DRE- and ethylene-responsive element-mediated signaling pathways in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GENE-EXPRESSION; LOW-TEMPERATURE; GCC-BOX; FREEZING TOLERANCE; OSMOTIC-STRESS; ERF/AP2 DOMAIN; HIGH-SALT; IN-VITRO; DROUGHT	Dehydration-responsive element-binding proteins (DREBs) and ethylene-responsive element (ERE) binding factors are two major subfamilies of the AP2/ethylene-responsive element-binding protein family and play crucial roles in the regulation of abiotic-and biotic-stress responses, respectively. In the present work, we have reported a previously identified DREB-like factor, TINY, that was involved in both abiotic- and biotic-stress signaling pathways. TINY was capable of binding to both DRE and ERE with similar affinity and could activate the expression of reporter genes driven by either of these two elements in tobacco cells. The 15th amino acid in the APETALA2 (AP2)/ethylene-responsive element-binding factor domain was demonstrated to be essential for its specific binding to ERE, whereas the 14th and 19th amino acids were responsible for the binding to DRE. The expression of TINY was greatly activated by drought, cold, ethylene, and slightly by methyl jasmonate. Additionally, overexpression of TINY in Arabidopsis resulted in elevated expressions of both the DRE- and the ERE-containing genes. Moreover, the expression of DRE- regulated genes, such as COR6.6 and ERD10, was up-regulated upon ethylene treatment, and the expression of ERE-regulated genes, such as HLS1, was also increased by cold stress, when the expression of TINY was being induced. These results strongly suggested that TINY might play a role in the cross-talk between abiotic- and biotic-stress-responsive gene expressions by connecting the DRE- and ERE-mediated signaling pathways. The results herein might promote the understanding of the mechanisms of specific DNA recognition and gene expression regulation by DREBs.	[Sun, Shan; Chen, Feng; Zhao, Tong-Jin; Li, Yi-Qin; Sui, Sen-Fang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Shan; Chen, Feng; Zhao, Tong-Jin; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yu, Jun-Ping; Fang, Xiao-Hong] Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Sui, SF (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Zhao, Tong-Jin/AFH-2915-2022; Yu, Junping/O-9887-2018	Yu, Junping/0000-0001-9024-0793				ABELES FB, 1992, ETHYLENE PLANT BIOL, P196; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Cao ZF, 2001, BIOCHEMISTRY-MOSCOW+, V66, P623, DOI 10.1023/A:1010251129429; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hao DY, 2002, BIOCHEMISTRY-US, V41, P4202, DOI 10.1021/bi015979v; Huang ZJ, 2004, FEBS LETT, V573, P110, DOI 10.1016/j.febslet.2004.07.064; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Lee JH, 2004, PLANT MOL BIOL, V55, P61, DOI 10.1007/s11103-004-0417-6; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu Y, 2006, FEBS LETT, V580, P1303, DOI 10.1016/j.febslet.2006.01.048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Manners JM, 1998, PLANT MOL BIOL, V38, P1071, DOI 10.1023/A:1006070413843; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki K, 2007, PLANT J, V50, P1079, DOI 10.1111/j.1365-313X.2007.03111.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Souter MA, 2004, PLANTA, V219, P773, DOI 10.1007/s00425-004-1280-z; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Wang H, 2004, PLANT MOL BIOL, V55, P183, DOI 10.1007/s11103-004-0113-6; Wei G, 2005, J BIOCHEM MOL BIOL, V38, P440; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yi SY, 2004, PLANT PHYSIOL, V136, P2862, DOI 10.1104/pp.104.042903; Yu JP, 2006, POLYMER, V47, P2533, DOI 10.1016/j.polymer.2005.12.087; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; ZHIFANG C, 2001, TSINGHUA SCI TECHNOL, V6, P432	47	112	125	4	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6261	6271		10.1074/jbc.M706800200	http://dx.doi.org/10.1074/jbc.M706800200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089556	hybrid			2022-12-27	WOS:000253779500033
J	Allagnat, F; Alonso, F; Martin, D; Abderrahmani, A; Waeber, G; Haefliger, JA				Allagnat, Florent; Alonso, Florian; Martin, David; Abderrahmani, Amar; Waeber, Gerard; Haefliger, Jacques-Antoine			ICER-1 gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; LONG-TERM EXPOSURE; FREE FATTY-ACIDS; CARBOXYLASE GENE-EXPRESSION; BASAL INSULIN; GLUCOSE-CONCENTRATIONS; CA2+ OSCILLATIONS; RAT ISLETS; RELEASE; STIMULATION	Channels formed by the gap junction protein connexin36 (Cx36) contribute to the proper control of insulin secretion. We investigated the impact of chronic hyperlipidemia on Cx36 expression in pancreatic beta-cells. Prolonged exposure to the saturated free fatty acid palmitate reduced the expression of Cx36 in several insulin-secreting cell lines and isolated mouse islets. The effect of palmitate was fully blocked upon protein kinase A (PKA) inhibition by H89 and (Rp)-cAMP, indicating that the cAMP/PKA pathway is involved in the control of Cx36 expression. Palmitate treatment led to overexpression of the inducible cAMP early repressor (ICER-1 gamma), which bound to a functional cAMP-response element located in the promoter of the CX36 gene. Inhibition of ICER-1 gamma overexpression prevented the Cx36 decrease, as well as the palmitate-induced beta-cell secretory dysfunction. Finally, freshly isolated islets from mice undergoing a long term high fat diet expressed reduced Cx36 levels and increased ICER-1 gamma levels. Taken together, these data demonstrate that chronic exposure to palmitate inhibits the Cx36 expression through PKA-mediated ICER-1 gamma overexpression. This Cx36 down-regulation may contribute to the reduced glucose sensitivity and altered insulin secretion observed during the pre-diabetic stage and in the metabolic syndrome.	[Allagnat, Florent; Alonso, Florian; Martin, David; Waeber, Gerard; Haefliger, Jacques-Antoine] CHU Vaudois, Univ Hosp, Dept Med, CH-1011 Lausanne, Switzerland; [Abderrahmani, Amar] Univ Lausanne, Dept Cellular Biol & Morphol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Haefliger, JA (corresponding author), CHU Vaudois, Univ Hosp, Dept Med, Mol Med Lab, 19-135S, CH-1011 Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Abderrahmani, Amar/O-3124-2017; Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017; Allagnat, Florent/AAY-7188-2021; Alonso, Florian/AAA-2776-2020	Abderrahmani, Amar/0000-0003-0752-0343; Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; Alonso, Florian/0000-0002-6794-1513; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Waeber, Gerard/0000-0003-4193-788X				Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Andreolas C, 2002, DIABETES, V51, P2536, DOI 10.2337/diabetes.51.8.2536; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Boden Guenther, 2005, Curr Diab Rep, V5, P167, DOI 10.1007/s11892-005-0004-5; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Briaud I, 1999, METABOLISM, V48, P319, DOI 10.1016/S0026-0495(99)90079-3; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Caton D, 2003, J CELL SCI, V116, P2285, DOI 10.1242/jcs.00442; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Gumbiner B, 1996, J CLIN ENDOCR METAB, V81, P2061, DOI 10.1210/jc.81.6.2061; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Inada A, 1998, BIOCHEM BIOPH RES CO, V253, P712, DOI 10.1006/bbrc.1998.9833; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Le Gurun S, 2003, J BIOL CHEM, V278, P37690, DOI 10.1074/jbc.M212382200; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Okajima F, 2005, BBA-MOL CELL BIOL L, V1687, P173, DOI 10.1016/j.bbalip.2004.11.018; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Parker SM, 2003, METABOLISM, V52, P1367, DOI 10.1016/S0026-0495(03)00279-8; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Thams P, 2001, DIABETOLOGIA, V44, P738, DOI 10.1007/s001250051683; Theis M, 2004, EXP CELL RES, V294, P18, DOI 10.1016/j.yexcr.2003.09.031; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; WARNOTTE C, 1994, DIABETES, V43, P703, DOI 10.2337/diabetes.43.5.703; WELSH M, 1986, J BIOL CHEM, V261, P2915; Wyne KL, 2003, AM J MED, V115, P29, DOI 10.1016/j.amjmed.2003.09.004; Yuan L., 2004, J HUAZHONG U SCI TEC, V24, P364; Yuan Li, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P358; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200; ZHOU YP, 1995, DIABETES, V44, P394, DOI 10.2337/diabetes.44.4.394	60	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5226	5234		10.1074/jbc.M708181200	http://dx.doi.org/10.1074/jbc.M708181200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18073214	hybrid			2022-12-27	WOS:000253426700002
J	Ho, KK; Anderson, AA; Rosivatz, E; Lam, EWF; Woscholski, R; Mann, DJ				Ho, Ka-Kei; Anderson, Alexandra A.; Rosivatz, Erika; Lam, Eric W. -F.; Woscholski, Rudiger; Mann, David J.			Identification of cyclin A(2) as the downstream effector of the nuclear phosphatidylinositol 4,5-bisphosphate signaling network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SWISS 3T3 CELLS; GROWTH-FACTOR-I; PHOSPHOLIPASE-C; INDUCED MITOGENESIS; PHORBOL ESTERS; D1; PHOSPHORYLATION; TRANSLOCATION; LOCALIZATION	In addition to the well characterized phosphoinositide second messengers derived from the plasma membrane, increasing evidence supports the existence of a nuclear phosphoinositide signaling network. The aim of this investigation was to dissect the role played by nuclear phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5) P-2) in cell cycle progression and to determine the cell cycle regulatory component(s) that are involved. A number of cytosolic/nuclear PtdIns(4,5) P-2-deficient Swiss 3T3 cell lines were established, and their G(0)/G(1)/S cell cycle phase transitions induced by defined mitogens were examined. Our results demonstrate that nuclear PtdIns(4,5) P-2 down-regulation caused a delay in phorbol ester-induced S phase entry and that this was at least in part channeled through cyclin A(2) at the transcriptional level. In summary, these data identify cyclin A(2) as a downstream effector of the nuclear PtdIns(4,5) P-2 signaling network and highlight the importance of nuclear PtdIns(4,5) P-2 in the regulation of mammalian mitogenesis.	[Ho, Ka-Kei; Anderson, Alexandra A.; Rosivatz, Erika; Woscholski, Rudiger; Mann, David J.] Univ London Imperial Coll Sci & Technol, Div Cell & Mol Biol, London SW7 2AZ, England; [Ho, Ka-Kei; Lam, Eric W. -F.] Univ London Imperial Coll Sci & Technol, Dept Oncol, Canc Res UK, London W12 0NN, England	Imperial College London; Cancer Research UK; Imperial College London	Mann, DJ (corresponding author), Univ London Imperial Coll Sci & Technol, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	d.mann@imperial.ac.uk	Lam, Eric W-F/AAW-8566-2020; Rosivatz, Erika/K-4341-2012	Lam, Eric W-F/0000-0003-1274-3576; Rosivatz, Erika/0000-0002-7111-1416	MRC [G0000138] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C508134/1] Funding Source: Medline; Medical Research Council [G0000138] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERT DA, 1992, P NATL ACAD SCI USA, V89, P1597, DOI 10.1073/pnas.89.5.1597; Backers K, 2003, ADV ENZYME REGUL, V43, P15, DOI 10.1016/S0065-2571(02)00043-2; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; COCCO L, 1995, ADV ENZYME REGUL, V35, P23, DOI 10.1016/0065-2571(94)00004-M; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; FILMUS J, 1994, ONCOGENE, V9, P3627; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Haller H, 1998, CIRC RES, V82, P157; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Irvine RF, 2006, BBA-MOL CELL BIOL L, V1761, P505, DOI 10.1016/j.bbalip.2006.02.008; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li C, 2002, ACTA PHYSIOL SCAND, V174, P237, DOI 10.1046/j.1365-201x.2002.00945.x; LOVEC H, 1994, ONCOGENE, V9, P323; Mann DJ, 1997, ONCOGENE, V14, P1759, DOI 10.1038/sj.onc.1201134; Mann DJ, 2006, SIGNAL TRANSDUCTION, V6, P92; Manzoli L, 1997, CANCER RES, V57, P2137; Martelli AM, 1999, J CELL BIOCHEM, V72, P339, DOI 10.1002/(SICI)1097-4644(19990301)72:3<339::AID-JCB3>3.0.CO;2-L; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Neri LM, 1997, CELL SIGNAL, V9, P353, DOI 10.1016/S0898-6568(96)00178-7; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okada M, 2005, FEBS LETT, V579, P4949, DOI 10.1016/j.febslet.2005.07.082; Ramakrishnan M, 1998, AM J RESP CELL MOL, V18, P736, DOI 10.1165/ajrcmb.18.6.3152; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shears SB, 2000, BIOESSAYS, V22, P786, DOI 10.1002/1521-1878(200009)22:9<786::AID-BIES3>3.3.CO;2-S; Singh AT, 2003, J BONE MINER RES, V18, P1453, DOI 10.1359/jbmr.2003.18.8.1453; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Xu AM, 2001, MOL CELL BIOL, V21, P2981, DOI 10.1128/MCB.21.9.2981-2990.2001; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 1994, J BIOL CHEM, V269, P7847; ZACHARY I, 1987, BIOCHEM BIOPH RES CO, V146, P456, DOI 10.1016/0006-291X(87)90551-1	46	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5477	5485		10.1074/jbc.M706623200	http://dx.doi.org/10.1074/jbc.M706623200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18077453	hybrid			2022-12-27	WOS:000253426700028
J	Chopra, S; Dooling, RM; Horner, CG; Howell, EE				Chopra, Shaileja; Dooling, Russell M.; Horner, Caroline Glyn; Howell, Elizabeth E.			A balancing act between net uptake of water during dihydrofolate binding and net release of water upon NADPH binding in R67 dihydrofolate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DNA INTERACTIONS; ESCHERICHIA-COLI; OSMOTIC-STRESS; LIGAND-BINDING; PREFERENTIAL HYDRATION; TERNARY COMPLEX; BOUND WATER; PYRIDINE-NUCLEOTIDES; PEPTIDE BINDING; EXCLUDED-VOLUME	R67 dihydrofolate reductase (DHFR) catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate using NADPH as a cofactor. This enzyme is a homotetramer possessing 222 symmetry, and a single active site pore traverses the length of the protein. A promiscuous binding surface can accommodate either DHF or NADPH, thus two nonproductive complexes can form (2NADPH or 2DHF) as well as a productive complex (NADPH center dot DHF). The role of water in binding was monitored using a number of different osmolytes. From isothermal titration calorimetry (ITC) studies, binding of NADPH is accompanied by the net release of 38 water molecules. In contrast, from both steady state kinetics and ITC studies, binding of DHF is accompanied by the net uptake of water. Although different osmolytes have similar effects on NADPH binding, variable results are observed when DHF binding is probed. Sensitivity to water activity can also be probed by an in vivo selection using the antibacterial drug, trimethoprim, where the water content of the media is decreased by increasing concentrations of sorbitol. The ability of wild type and mutant clones of R67 DHFR to allow host Escherichia coli to grow in the presence of trimethoprim plus added sorbitol parallels the catalytic efficiency of the DHFR clones, indicating water content strongly correlates with the in vivo function of R67 DHFR.	[Chopra, Shaileja; Dooling, Russell M.; Horner, Caroline Glyn; Howell, Elizabeth E.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Howell, EE (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	lzh@utk.edu		Howell, Elizabeth/0000-0001-6157-433X				AMYES SGB, 1976, EUR J BIOCHEM, V61, P597, DOI 10.1111/j.1432-1033.1976.tb10055.x; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; Beck DAC, 2007, METHOD ENZYMOL, V428, P373, DOI 10.1016/S0076-6879(07)28022-X; BENNAIM A, 1975, BIOPOLYMERS, V14, P1337, DOI 10.1002/bip.1975.360140704; Bennion BJ, 2004, P NATL ACAD SCI USA, V101, P6433, DOI 10.1073/pnas.0308633101; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Bradrick TD, 1996, BIOCHEMISTRY-US, V35, P11414, DOI 10.1021/bi960205d; BRITO RMM, 1991, BIOCHEMISTRY-US, V30, P1461, DOI 10.1021/bi00220a003; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CHERVENAK MC, 1994, J AM CHEM SOC, V116, P10533, DOI 10.1021/ja00102a021; Chik J, 2005, J PHYS CHEM B, V109, P9111, DOI 10.1021/jp046999k; Chopra S, 2006, BIOCHEMISTRY-US, V45, P6596, DOI 10.1021/bi052504l; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; Csonka L N, 1981, Basic Life Sci, V18, P533; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dashnau JL, 2005, J PHYS CHEM B, V109, P24152, DOI 10.1021/jp0543072; Davis-Searles PR, 1998, BIOCHEMISTRY-US, V37, P17048, DOI 10.1021/bi981364v; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; DZINGELESKI GD, 1993, BIOCHEMISTRY-US, V32, P9143, DOI 10.1021/bi00086a020; Edsall J., 1943, PROTEINS AMINO ACIDS, P140; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FIERKE CA, 1987, COLD SPRING HARB SYM, V52, P631, DOI 10.1101/SQB.1987.052.01.072; Fried MG, 2002, J BIOL CHEM, V277, P50676, DOI 10.1074/jbc.M208540200; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Furukawa Y, 2001, J BIOL CHEM, V276, P12983, DOI 10.1074/jbc.M010217200; GARNER MM, 1995, EMBO J, V14, P1257, DOI 10.1002/j.1460-2075.1995.tb07109.x; GARNER MM, 1994, AM J PHYSIOL, V266, pC877, DOI 10.1152/ajpcell.1994.266.4.C877; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gulotta M, 2007, BIOCHEMISTRY-US, V46, P10055, DOI 10.1021/bi700990d; HAMMALVAREZ SF, 1990, J BIOL CHEM, V265, P9850; Harries D, 2005, J AM CHEM SOC, V127, P2184, DOI 10.1021/ja045541t; Hicks SN, 2004, J BIOL CHEM, V279, P46995, DOI 10.1074/jbc.M404484200; Hicks SN, 2003, BIOCHEMISTRY-US, V42, P10569, DOI 10.1021/bi034643d; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Howell EE, 2005, CHEMBIOCHEM, V6, P591, DOI 10.1002/cbic.200400237; Howell EE, 2001, J COMPUT AID MOL DES, V15, P1035, DOI 10.1023/A:1014824725891; HOWELL EE, 1987, BIOCHEMISTRY-US, V26, P8591, DOI 10.1021/bi00400a015; Hultgren A, 2004, BIOCHEMISTRY-US, V43, P8272, DOI 10.1021/bi049559s; Isbister BD, 1995, J AM CHEM SOC, V117, P12877, DOI 10.1021/ja00156a033; Jackson M, 2005, BIOCHEMISTRY-US, V44, P12420, DOI 10.1021/bi050881s; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; Kiser JR, 2005, BIOCHEMISTRY-US, V44, P16988, DOI 10.1021/bi051769x; KORNBLATT JA, 1993, BIOPHYS J, V65, P1059, DOI 10.1016/S0006-3495(93)81168-8; Kornblatt JA, 2002, BBA-PROTEIN STRUCT M, V1595, P30, DOI 10.1016/S0167-4838(01)00333-8; Krahn JM, 2007, BIOCHEMISTRY-US, V46, P14878, DOI 10.1021/bi701532r; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Larsen J, 1996, TOXICOL APPL PHARM, V140, P296, DOI 10.1006/taap.1996.0225; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Li DW, 2001, BIOCHEMISTRY-US, V40, P4242, DOI 10.1021/bi0026425; LiCata VJ, 1997, BIOCHEMISTRY-US, V36, P10161, DOI 10.1021/bi970669r; LiCata VJ, 1998, METHOD ENZYMOL, V295, P42; MCLAGGAN D, 1990, J BACTERIOL, V172, P3631, DOI 10.1128/jb.172.7.3631-3636.1990; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Modig K, 2003, J MOL BIOL, V332, P965, DOI 10.1016/S0022-2836(03)00968-9; NARAYANA N, 1995, NAT STRUCT BIOL, V2, P1018, DOI 10.1038/nsb1195-1018; Park H, 1997, PROTEIN ENG, V10, P1415, DOI 10.1093/protein/10.12.1415; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Pitcher WH, 2003, BIOCHEMISTRY-US, V42, P11150, DOI 10.1021/bi0349874; QUIOCHO FA, 1989, NATURE, V340, P404, DOI 10.1038/340404a0; REECE LJ, 1991, BIOCHEMISTRY-US, V30, P10895, DOI 10.1021/bi00109a013; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Robinson CR, 1995, METHOD ENZYMOL, V259, P395; Sambrook J., 1989, MOL CLONING LAB MANU; Saunders AJ, 2000, BIOPOLYMERS, V53, P293, DOI 10.1002/(SICI)1097-0282(20000405)53:4<293::AID-BIP2>3.3.CO;2-K; Schellman JA, 2003, BIOPHYS J, V85, P108, DOI 10.1016/S0006-3495(03)74459-2; Schurr JM, 2005, BIOPHYS J, V89, P2258, DOI 10.1529/biophysj.104.057331; Sidorova N, 2004, NUCL ACID M, V14, P319; Sidorova NY, 2006, J BIOL CHEM, V281, P35656, DOI 10.1074/jbc.M608018200; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Smiley RD, 2004, ANAL BIOCHEM, V334, P204, DOI 10.1016/j.ab.2004.06.040; Smiley RD, 2002, BIOCHEMISTRY-US, V41, P15664, DOI 10.1021/bi026676j; SMITH SL, 1983, P NATL ACAD SCI-BIOL, V80, P4619, DOI 10.1073/pnas.80.15.4619; Stanley C, 2006, BIOPHYS J, V91, P912, DOI 10.1529/biophysj.106.086579; Stinnett LG, 2004, J BIOL CHEM, V279, P47003, DOI 10.1074/jbc.M404485200; STONE SR, 1986, BIOCHIM BIOPHYS ACTA, V869, P275, DOI 10.1016/0167-4838(86)90067-1; Strader MB, 2001, BIOCHEMISTRY-US, V40, P11344, DOI 10.1021/bi0110544; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; SWEENEY TE, 1993, AM J PHYSIOL, V264, pR469, DOI 10.1152/ajpregu.1993.264.3.R469; TAYLOR IW, 1982, CANCER RES, V42, P5159; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Vippagunta SR, 2007, J PHARM SCI-US, V96, P294, DOI 10.1002/jps.20754; Vossen KM, 1997, BIOCHEMISTRY-US, V36, P11640, DOI 10.1021/bi971193e; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WILLENBROCK F, 1995, BIOCHEMISTRY-US, V34, P12012, DOI 10.1021/bi00037a044; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xavier KA, 1997, BIOPHYS J, V73, P2116, DOI 10.1016/S0006-3495(97)78242-0; YU HA, 1988, J CHEM PHYS, V89, P2366, DOI 10.1063/1.455080	99	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4690	4698		10.1074/jbc.M709443200	http://dx.doi.org/10.1074/jbc.M709443200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086667	hybrid			2022-12-27	WOS:000253426500027
J	Querin, L; Sanvito, R; Magni, F; Busti, S; Van Dorsselaer, A; Alberghina, L; Vanoni, M				Querin, Lorenzo; Sanvito, Rossella; Magni, Fulvio; Busti, Stefano; Van Dorsselaer, Alain; Alberghina, Lilia; Vanoni, Marco			Proteomic analysis of a nutritional shift-up in Saccharomyces cerevisiae identifies Gvp36 as a BAR-containing protein involved in vesicular traffic and nutritional adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN CYTOSKELETON; CELL-CYCLE PROGRESSION; BUDDING YEAST; GENE-EXPRESSION; MESSENGER-RNAS; BUD EMERGENCE; REVEALS ROLES; GROWTH; LOCALIZATION; TRANSITION	Yeast cells undergoing a nutritional shift-up from a poor to a rich carbon source take several hours to adapt to the novel, richer carbon source. The budding index is a physiologically relevant "global" parameter that reflects the complex links between cell growth and division that are both coordinately and deeply affected by nutritional conditions. We used changes in budding index as a guide to choose appropriate, relevant time points during an ethanol to glucose nutritional shift-up for preparation of samples for the analysis of proteome by two-dimensional electro-phoresis/mass spectrometry. About 600 spots were detected. 90 spots, mostly comprising proteins involved in intermediary metabolism, protein synthesis, and response to stress, showed differential expression after glucose addition. Among modulated proteins we identified a protein of previously unknown function, Gvp36, showing a transitory increase corresponding to the drop of the fraction of budded cells. A gvp36 Delta strain shares several phenotypes( including general growth defects, heat shock, and high salt sensitivity, defects in polarization of the actin cytoskeleton, in endocytosis and in vacuolar biogenesis, defects in entering stationary phase upon nutrient starvation) with secretory pathway mutants and with mutants in genes encoding the two previously known yeast BAR proteins (RSV161 and RSV167). We thus propose that Gvp36 represents a novel yeast BAR protein involved in vesicular traffic and in nutritional adaptation.	[Querin, Lorenzo; Busti, Stefano; Alberghina, Lilia] Univ Milan, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Sanvito, Rossella; Magni, Fulvio] Univ Milan, DIMESAB, I-20052 Monza, Italy; [Van Dorsselaer, Alain] Univ Strasbourg, CNRS, LSMBO, F-67070 Strasbourg, France	University of Milan; University of Milan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vanoni, M (corresponding author), Piazza Sci 2, I-20126 Milan, Italy.	marco.vanoni@unimib.it	Vanoni, Marco/AAA-3699-2021; Magni, Fulvio/A-7340-2014	Vanoni, Marco/0000-0002-8690-2587; Alberghina, Lilia/0000-0003-1694-931X; Magni, Fulvio/0000-0002-8663-0374				Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; Alberghina L, 1998, J BACTERIOL, V180, P3864, DOI 10.1128/JB.180.15.3864-3872.1998; Alberghina L, 2005, TOP CURR GENET, V13, P325, DOI 10.1007/b138746; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Basmaji F, 2006, MOL GENET GENOMICS, V275, P217, DOI 10.1007/s00438-005-0082-8; BATAILLE N, 1988, ELECTROPHORESIS, V9, P774, DOI 10.1002/elps.1150091113; BATAILLE N, 1991, YEAST, V7, P367, DOI 10.1002/yea.320070407; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; BOLES E, 1993, ARCH MICROBIOL, V160, P324, DOI 10.1007/BF00292085; BOUCHERIE H, 1985, J BACTERIOL, V161, P385, DOI 10.1128/JB.161.1.385-392.1985; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Brown AJP, 2001, EMBO J, V20, P3177, DOI 10.1093/emboj/20.12.3177; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ENTIAN KD, 1997, YEAST SUGAR METABOLI, P409; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLLEAU A, 1996, SCIENCE, V274, P563; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Hughes TR, 2004, CURR OPIN MICROBIOL, V7, P546, DOI 10.1016/j.mib.2004.08.015; IIDA H, 1984, J CELL BIOL, V98, P1185, DOI 10.1083/jcb.98.4.1185; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; JOHNSTON M, 1992, MOL BIOL YEAST SACCH; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LOMBARDO A, 1992, MOL CELL BIOL, V12, P2941, DOI 10.1128/MCB.12.7.2941; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Martin-Yken H, 2002, CURR GENET, V41, P323, DOI 10.1007/s00294-002-0299-6; MERCADO JJ, 1994, EUR J BIOCHEM, V224, P473, DOI 10.1111/j.1432-1033.1994.00473.x; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; STURANI E, 1976, EXP CELL RES, V99, P245, DOI 10.1016/0014-4827(76)90580-2; SUROSKY RT, 1994, MOL CELL BIOL, V14, P3446, DOI 10.1128/MCB.14.5.3446; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; VANONI M, 1991, EUR J CELL BIOL, V55, P179; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; WINDERICKX J, 2003, YEAST STRESS RESPONS, P307; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11721, DOI 10.1073/pnas.95.20.11721	68	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4730	4743		10.1074/jbc.M707787200	http://dx.doi.org/10.1074/jbc.M707787200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156177	hybrid			2022-12-27	WOS:000253426500031
J	Samways, DSK; Migita, K; Li, Z; Egan, TM				Samways, Damien S. K.; Migita, Keisuke; Li, Zhiyuan; Egan, Terrance M.			On the role of the first transmembrane domain in cation permeability and flux of the ATP-gated P2X(2) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE ACCESSIBILITY METHOD; TRANSMEMBRANE SEGMENTS; CHANNEL PERMEABILITY; ION-CHANNEL; DOMAIN; RESIDUES; CALCIUM; NEURONS; IDENTIFICATION; SELECTIVITY	P2X receptors are a family of seven ligand-gated ion channels (P2X(1)-P2X(7)) that open in the presence of ATP. We used ala-nine-scanning mutagenesis and patch clamp photometry to study the role of the first transmembrane domain of the rat P2X(2) receptor in cation permeability and flux. Three alanine-substituted mutants did not respond to ATP, and 19 of the 22 functional receptors resembled the wild-type receptor with regard to the fraction of the total ATP-gated current carried by calcium or the permeability of calcium relative to cesium. The remaining three mutants showed modest changes in calcium dynamics. Two of these occurred at sites (Gly(30) and Phe(44)) that are unlikely to interact with permeating cations in a meaningful way. The third was a conserved tyrosine (Tyr(43)) that may form an inter-pore binding site for calcium. The data suggest that, with the possible exception of Tyr(43), the first transmembrane domain contributes little to the permeation properties of the P2X(2) receptor.	[Samways, Damien S. K.; Migita, Keisuke; Li, Zhiyuan; Egan, Terrance M.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	Saint Louis University	Egan, TM (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 S Grand Blvd, St Louis, MO 63104 USA.	egantm@slu.edu	Migita, Keisuke/E-8274-2013	Egan, Terrance/0000-0002-7249-3161				Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; CHAUMONT S, 2006, BIOPHYS ASPECTS LIGA, P445; CHOTHIA C, 1975, NATURE, V254, P304, DOI 10.1038/254304a0; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DeLano WL, 2002, PYMOL USERS MANUAL; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dutton JL, 2000, NEUROPHARMACOLOGY, V39, P2054, DOI 10.1016/S0028-3908(00)00058-7; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fisher JA, 2004, J NEUROSCI, V24, P10475, DOI 10.1523/JNEUROSCI.3250-04.2004; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Frings S, 2000, METHOD ENZYMOL, V315, P797; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; HILLE B, 2004, IONIC CHANNELS EXCIT, P441; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2005, J BIOL CHEM, V280, P6118, DOI 10.1074/jbc.M411324200; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Li ZY, 2004, J NEUROSCI, V24, P7378, DOI 10.1523/JNEUROSCI.1423-04.2004; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nakazawa K, 1998, EUR J PHARMACOL, V347, P141, DOI 10.1016/S0014-2999(98)00207-6; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Petsko G. A., 2004, PROTEIN STRUCTURE FU, P50; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Samways DSK, 2007, J GEN PHYSIOL, V129, P245, DOI 10.1085/jgp.200609677; SAMWAYS DS, 2006, BIOPHYSICAL ASPECTS, P419; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; Silberberg SD, 2005, J GEN PHYSIOL, V125, P347, DOI 10.1085/jgp.200409221; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Wollmuth LP, 1998, J GEN PHYSIOL, V112, P623, DOI 10.1085/jgp.112.5.623	41	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5110	5117		10.1074/jbc.M708713200	http://dx.doi.org/10.1074/jbc.M708713200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18048351	hybrid			2022-12-27	WOS:000253426500068
J	Cook, PD; Holden, HM				Cook, Paul D.; Holden, Hazel M.			GDP-4-keto-6-deoxy-D-mannose 3-dehydratase, accommodating a sugar substrate in the active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; MOLECULAR ARCHITECTURE; PSEUDAMINIC ACID; BIOSYNTHESIS; ENZYME; AMINOTRANSFERASE; HELICOBACTER; DESOSAMINE	Colitose is a dideoxysugar found in the O-antigen of the lipopolysaccharide that coats the outer membrane of some Gram-negative bacteria. Four enzymes are required for its production starting from D-mannose-1-phosphate and GTP. The focus of this investigation is GDP-4-keto-6-deoxy-D-mannose 3-dehydratase or ColD, which catalyzes the removal of the C3'-hydroxyl group from GDP-4-keto-6-deoxymannose. The enzyme is pyridoxal 5'-phosphate-dependent, but unlike most of these proteins, the conserved lysine residue that covalently holds the cofactor in the active site is replaced with a histidine residue. Here we describe the three-dimensional structure of ColD, determined to 1.7 angstrom resolution, whereby the active site histidine has been replaced with an asparagine residue. For this investigation, crystals of the site-directed mutant protein were grown in the presence of GDP-4-amino-4,6-dideoxy-D-mannose (GDP-perosamine). The electron density map clearly reveals the presence of the sugar analog trapped in the active site as an external aldimine. The active site is positioned between the two subunits of the dimer. Whereas the pyrophosphoryl groups of the ligand are anchored to the protein via Arg-219 and Arg-331, the hydroxyl groups of the hexose only lie within hydrogen bonding distance to ordered water molecules. Interestingly, the hexose moiety of the ligand adopts a boat rather than the typically observed chair conformation. Activity assays demonstrate that this mutant protein cannot catalyze the dehydration step. Additionally, we report data revealing that wild-type ColD is able to catalyze the production of GDP-4-keto-3,6-dideoxymannose using GDP-perosamine instead of GDP-4-keto-6-deoxymannose as a substrate.	[Cook, Paul D.; Holden, Hazel M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Holden, HM (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Hazel_Holden@biochem.wisc.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047814, R56DK047814] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK47814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam J, 2004, BIOCHEMISTRY-US, V43, P16450, DOI 10.1021/bi0483763; Burgie ES, 2007, BIOCHEMISTRY-US, V46, P8999, DOI 10.1021/bi700751d; Burgie ES, 2007, PROTEIN SCI, V16, P887, DOI 10.1110/ps.062711007; Cook PD, 2007, BIOCHEMISTRY-US, V46, P14215, DOI 10.1021/bi701686s; Cook PD, 2006, PROTEIN SCI, V15, P2093, DOI 10.1110/ps.062328306; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; Noland BW, 2002, STRUCTURE, V10, P1569, DOI 10.1016/S0969-2126(02)00879-1; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Schoenhofen IC, 2006, J BIOL CHEM, V281, P8907, DOI 10.1074/jbc.M512987200; Schoenhofen IC, 2006, J BIOL CHEM, V281, P723, DOI 10.1074/jbc.M511021200; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124	14	8	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4295	4303		10.1074/jbc.M708893200	http://dx.doi.org/10.1074/jbc.M708893200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045869	hybrid			2022-12-27	WOS:000253083500064
J	Chen, SJ; Lin, G; Chang, KJ; Yeh, LS; Wang, CC				Chen, Shun-Jia; Lin, Grace; Chang, Kuang-Jung; Yeh, Lu-Shu; Wang, Chien-Chia			Translational efficiency of a non-AUG initiation codon is significantly affected by its sequence context in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; RIBOSOMAL-SUBUNIT; GENE ENCODES; MITOCHONDRIAL; SELECTION; PROTEIN; NUCLEOTIDES; MECHANISM	Previous studies have shown that translation of mRNA for yeast glycyl-tRNA synthetase is alternatively initiated from UUG and a downstream AUG initiation codon. Evidence presented here shows that unlike an AUG initiation codon, efficiency of this non-AUG initiation codon is significantly affected by its sequence context, in particular the nucleotides at positions -3 to -1 relative to the initiation codon. A/A/R (R represents A or G) and C/G/C appear to be the most and least favorable sequences at these positions, respectively. Mutation of the native context sequence -3 to -1 from AAA to CGC reduced translation initiation from the UUG codon up to 32-fold and resulted in loss of mitochondrial respiration. Although an AUG initiation codon is, in general, unresponsive to context changes in yeast, an AAA (-3 to -1) to CGC mutation still reduced its initiating activity up to 8-fold under similar conditions. These results suggest that sequence context is more important for translation initiation in yeast than previously appreciated.	[Chen, Shun-Jia; Lin, Grace; Chang, Kuang-Jung; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jungli 32001, Taiwan; [Yeh, Lu-Shu] Tzu Chi Univ, Dept Life Sci, Hualin 97041, Taiwan	National Central University; Tzu Chi University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jungli 32001, Taiwan.	dukewang@cc.ncu.edu.tw	Chang, Kuang-Jung/J-2193-2012	Chen, Shun-Jia/0000-0002-5489-4930				Abramczyk D, 2003, YEAST, V20, P1045, DOI 10.1002/yea.1020; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; CIGAN AM, 1987, GENE, V59, P1; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; Huang CL, 2006, MATER LETT, V60, P198, DOI 10.1016/j.matlet.2005.08.016; Huang HY, 2006, J BIOL CHEM, V281, P31430, DOI 10.1074/jbc.M601869200; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; SIKORSKI RS, 1989, GENETICS, V122, P19; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	42	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3173	3180		10.1074/jbc.M706968200	http://dx.doi.org/10.1074/jbc.M706968200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065417	hybrid			2022-12-27	WOS:000253083000020
J	Kainov, DE; Mancini, EJ; Telenius, J; Lisai, J; Grimes, JM; Bamford, DH; Stuart, DI; Tuma, R				Kainov, Denis E.; Mancini, Erika J.; Telenius, Jelena; Lisai, Jiri; Grimes, Jonathan M.; Bamford, Dennis H.; Stuart, David I.; Tuma, Roman			Structural basis of mechanochemical coupling in a hexameric molecular motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; AMINO-ACID-RESIDUES; STRANDED-RNA BACTERIOPHAGES; TERMINATION FACTOR-RHO; ATP HYDROLYSIS; CRYSTAL-STRUCTURE; PACKAGING MOTOR; PCRA HELICASE; DNA HELICASE; CONFORMATIONAL-CHANGES	The P4 protein of bacteriophage phi 12 is a hexameric molecular motor closely related to superfamily 4 helicases. P4 converts chemical energy from ATP hydrolysis into mechanical work, to translocate single-stranded RNA into a viral capsid. The molecular basis of mechanochemical coupling, i.e. how small similar to 1 angstrom changes in the ATP-binding site are amplified into nanometer scale motion along the nucleic acid, is not understood at the atomic level. Here we study in atomic detail the mechanochemical coupling using structural and biochemical analyses of P4 mutants. We show that a conserved region, consisting of superfamily 4 helicase motifs H3 and H4 and loop L2, constitutes the moving lever of the motor. The lever tip encompasses an RNA-binding site that moves along the mechanical reaction coordinate. The lever is flanked by gamma-phosphate sensors (Asn-234 and Ser-252) that report the nucleotide state of neighboring subunits and control the lever position. Insertion of an arginine finger (Arg-279) into the neighboring catalytic site is concomitant with lever movement and commences ATP hydrolysis. This ensures cooperative sequential hydrolysis that is tightly coupled to mechanical motion. Given the structural conservation, the mutated residues may play similar roles in other hexameric helicases and related molecular motors.	[Tuma, Roman] Univ Leeds, Inst Cell & Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Kainov, Denis E.; Telenius, Jelena; Lisai, Jiri; Bamford, Dennis H.; Tuma, Roman] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kainov, Denis E.; Telenius, Jelena; Lisai, Jiri; Bamford, Dennis H.; Tuma, Roman] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Mancini, Erika J.; Grimes, Jonathan M.; Stuart, David I.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England	University of Leeds; University of Helsinki; University of Helsinki; University of Oxford	Tuma, R (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	r.tuma@leeds.ac.uk	Tuma, Roman/AAL-4436-2020; kainov, denis/I-5526-2019; Mancini, Erika J/J-9880-2013	Tuma, Roman/0000-0003-0047-0013; kainov, denis/0000-0001-7716-6955; Mancini, Erika J/0000-0001-9591-7898; Grimes, Jonathan Mark/0000-0001-9698-0389; Bamford, Dennis/0000-0002-6438-8118; Telenius, Jelena/0000-0003-4353-3854; Stuart, David/0000-0002-3426-4210	Medical Research Council [G0500367, G0500365] Funding Source: Medline; MRC [G0500367, G0500365] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ADMIRAAL SJ, 1995, CHEM BIOL, V2, P729, DOI 10.1016/1074-5521(95)90101-9; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Datta S, 2003, PROTEINS, V50, P474, DOI 10.1002/prot.10315; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Dillingham MS, 2001, P NATL ACAD SCI USA, V98, P8381, DOI 10.1073/pnas.131009598; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Dittrich M, 2003, BIOPHYS J, V85, P2253, DOI 10.1016/S0006-3495(03)74650-5; Dittrich M, 2006, STRUCTURE, V14, P1345, DOI 10.1016/j.str.2006.06.017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GOTTLIEB P, 1992, J VIROL, V66, P6220, DOI 10.1128/JVI.66.10.6220-6222.1992; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; LAKOWICZ J, 1999, PRINCIPLES FLUORESCE, P45; Levin M.K., 2003, MOL MOTORS, P179; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lisal J, 2005, J BIOL CHEM, V280, P23157, DOI 10.1074/jbc.M502658200; Lisal J, 2005, NAT STRUCT MOL BIOL, V12, P460, DOI 10.1038/nsmb927; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; MIWA Y, 1995, J MOL BIOL, V254, P815, DOI 10.1006/jmbi.1995.0658; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pirttimaa MJT, 2000, RNA, V6, P880, DOI 10.1017/S1355838200992598; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; SOGA S, 1989, ARCH BIOCHEM BIOPHYS, V268, P643, DOI 10.1016/0003-9861(89)90332-9; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P4051, DOI 10.1093/nar/gkf527; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sun S, 2003, EUR BIOPHYS J BIOPHY, V32, P676, DOI 10.1007/s00249-003-0335-6; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Ziegelin G, 2003, NUCLEIC ACIDS RES, V31, P5917, DOI 10.1093/nar/gkg790	53	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3607	3617		10.1074/jbc.M706366200	http://dx.doi.org/10.1074/jbc.M706366200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057007	hybrid			2022-12-27	WOS:000253083000066
J	Mittra, B; Zamudio, JR; Bujnicki, JM; Stepinski, J; Darzynkiewicz, E; Campbell, DA; Sturm, NR				Mittra, Bidyottam; Zamudio, Jesse R.; Bujnicki, Janusz M.; Stepinski, Janusz; Darzynkiewicz, Edward; Campbell, David A.; Sturm, Nancy R.			The TbMTr1 spliced leader RNA cap 1 2 '-O-Ribose methyltransferase from trypanosoma brucei acts with substrate specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEAR-RNA; MESSENGER-RNA; VACCINIA VIRUS; CRYSTAL-STRUCTURE; GUANINE N-7; PROTEIN; METHYLATION; VP39; TRIPHOSPHATASE; RECOGNITION	In metazoa cap 1 (m(7)GpppNmp-RNA) is linked to higher levels of translation; however, the enzyme responsible remains unidentified. We have validated the first eukaryotic encoded cap 1 2 '-O-ribose methyltransferase, TbMTr1, a member of a conserved family that modifies the first transcribed nucleotide of spliced leader and U1 small nuclear RNAs in the kinetoplastid protozoan Trypanosoma brucei. In addition to cap 0 (m(7)GpppNp-RNA), mRNA in these parasites has ribose methylations on the first four nucleotides with base methylations on the first and fourth (m(7)Gpppm(6,6)AmpAmpCmpm(3)Ump-SL RNA) conveyed via transsplicing of a universal spliced leader. The function of this cap 4 is unclear. Spliced leader is the majority RNA polymerase II transcript; the RNA polymerase III-transcribed U1 small nuclear RNA has the same first four nucleotides as spliced leader, but it receives an m(2,2,7)G cap with hypermethylation at position one only (m(2,2,7)Gpppm(6,6)AmpApCpUp-U1 snRNA). Here we examine the biochemical properties of recombinant TbMTr1. Active over a pH range of 6.0 to 9.5, TbMTr1 is sensitive to Mg2+. Positions Lys(95)-Asp(204)- Lys(259)-Glu(285) constitute the conserved catalytic core. A guanosine cap on RNA independent of its N-7 methylation status is required for substrate recognition, but an m(2,2,7G)-cap is not recognized. TbMTr1 favors the spliced leader 5 ' sequence, as reflected by a preference for A at position 1 and modulation of activity for substrates with base changes at positions 2 and 3. With similarities to human cap 1 methyltransferase activity, TbMTr1 is an excellent model for higher eukaryotic cap 1 methyltransferases and the consequences of cap 1 modification.	[Mittra, Bidyottam; Zamudio, Jesse R.; Campbell, David A.; Sturm, Nancy R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Peotein Engn, PL-02109 Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, PL-61614 Poznan, Poland; [Darzynkiewicz, Edward] Univ Warsaw, Inst Expt Phys, Dept Biophys, PL-02089 Warsaw, Poland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University; University of Warsaw	Campbell, DA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, 609 Charles E Young Dr, Los Angeles, CA 90095 USA.	dc@ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056034] Funding Source: NIH RePORTER; NIAID NIH HHS [AI056034] Funding Source: Medline; NIGMS NIH HHS [GM07104] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arhin GK, 2006, MOL BIOCHEM PARASIT, V147, P137, DOI 10.1016/j.molbiopara.2006.01.011; Arhin GK, 2006, RNA, V12, P53, DOI 10.1261/rna.2223406; BANERJEE AK, 1980, MICROBIOL REV, V44, P175, DOI 10.1128/MMBR.44.2.175-205.1980; BANGS JD, 1992, J BIOL CHEM, V267, P9805; BARBOSA E, 1978, J BIOL CHEM, V253, P7698; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Bujnicki JM, 2001, GENOME BIOL, V2; Bujnicki Janusz M., 1999, In Silico Biology, V1, P175; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FAURNAN EB, 1999, S ADENOSYL METHIONIN, P1; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Hager J, 2002, J BIOL CHEM, V277, P41978, DOI 10.1074/jbc.M205423200; Hall MP, 2006, NUCLEIC ACIDS RES, V34, P5594, DOI 10.1093/nar/gkl573; Hall MP, 2006, RNA, V12, P488, DOI 10.1261/rna.2250606; Ho CK, 2001, J BIOL CHEM, V276, P46182, DOI 10.1074/jbc.M108706200; Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; LABAHN J, 1994, P NATL ACAD SCI USA, V91, P10957, DOI 10.1073/pnas.91.23.10957; LANGBERG SR, 1981, J BIOL CHEM, V256, P54; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Li JR, 2006, P NATL ACAD SCI USA, V103, P8493, DOI 10.1073/pnas.0509821103; Li JR, 2005, J VIROL, V79, P13373, DOI 10.1128/JVI.79.21.13373-13384.2005; Lockless SW, 1998, BIOCHEMISTRY-US, V37, P8564, DOI 10.1021/bi980178m; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Mandelboim M, 2002, J BIOL CHEM, V277, P35210, DOI 10.1074/jbc.M201910200; MARONEY PA, 1990, EMBO J, V9, P3667, DOI 10.1002/j.1460-2075.1990.tb07578.x; MARONEY PA, 1995, RNA, V1, P714; MATTHEWS KR, 1994, GENE DEV, V8, P491, DOI 10.1101/gad.8.4.491; PERRY RP, 1976, CELL, V8, P433, DOI 10.1016/0092-8674(76)90156-2; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Ruan JP, 2007, MOL BIOCHEM PARASIT, V155, P66, DOI 10.1016/j.molbiopara.2007.05.008; Schnare MN, 1999, J BIOL CHEM, V274, P23691, DOI 10.1074/jbc.274.34.23691; Shuman S, 2007, MOL CELL, V27, P517, DOI 10.1016/j.molcel.2007.08.001; Sturm NR, 1998, J BIOL CHEM, V273, P18689, DOI 10.1074/jbc.273.30.18689; Takagi Y, 2007, J BIOL CHEM, V282, P15995, DOI 10.1074/jbc.M701569200; ULLU E, 1991, P NATL ACAD SCI USA, V88, P10074, DOI 10.1073/pnas.88.22.10074; ULLU E, 1995, J BIOL CHEM, V270, P20365, DOI 10.1074/jbc.270.35.20365; Wu XF, 2003, J VIROL, V77, P3430, DOI 10.1128/JVI.77.6.3430-3440.2003; Zamudio JR, 2007, MOL CELL BIOL, V27, P6084, DOI 10.1128/MCB.00647-07; Zamudio JR, 2006, EUKARYOT CELL, V5, P905, DOI 10.1128/EC.00080-06; Zeiner GM, 2003, J BIOL CHEM, V278, P38269, DOI 10.1074/jbc.M304295200; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	53	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3161	3172		10.1074/jbc.M707367200	http://dx.doi.org/10.1074/jbc.M707367200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18048356	hybrid			2022-12-27	WOS:000253083000019
J	Piao, W; Song, C; Chen, H; Wahl, LM; Fitzgerald, KA; O'Neill, LA; Medvedev, AE				Piao, Wenji; Song, Chang; Chen, Haiyan; Wahl, Larry M.; Fitzgerald, Katherine A.; O'Neill, Luke A.; Medvedev, Andrei E.			Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; DOUBLE-STRANDED-RNA; CUTTING EDGE; TIR-DOMAIN; DOWN-REGULATION; KINASE; INNATE; ACTIVATION	Toll-like receptor 4 (TLR4) recognition of lipopolysaccharide triggers signalosome assembly among TLR4, sorting ( e. g. MyD88 adapter-like (Mal)) and signaling (e.g. MyD88) adapters, initiating recruitment and activation of kinases, activation of transcription factors, and production of inflammatory mediators. In this study we examined whether tyrosine phosphorylation of Mal regulates its interactions with TLR4, MyD88, interleukin-1 (IL-1) receptor-associated kinase (IRAK)-2, and tumor necrosis factor receptor-associated factor (TRAF)-6 and is important for signaling. Overexpression of wild-type Mal in human embryonic kidney 293T cells induced its constitutive tyrosine phosphorylation and led to activation of p38, NF-kappa B, and IL-8 gene expression. Mutagenesis of Tyr-86, Tyr-106, and Tyr-159 residues within the Toll-IL-1 receptor domain impaired Mal tyrosine phosphorylation, interactions with Bruton tyrosine kinase, phosphorylation of p38, and NF-kappa B activation. Lipopolysaccharide triggered tyrosine phosphorylation of endogenous Mal and initiated Mal-Bruton-tyrosine kinase interactions in 293/TLR4/MD-2 cells and human monocytes that were suppressed in endotoxin-tolerant cells. Compared with wild-type Mal, Y86A-,Y06A-, and Y159A-Mal variants exhibited higher interactions with TLR4 and MyD88, whereas associations with IRAK-2 and TRAF-6 were not affected. Overexpression of Y86A- and Y106A-Mal in 293/TLR4/MD-2 cells exerted dominant-negative effects on TLR4-inducible p38 phosphorylation and NF-kappa B reporter activation to the extent comparable with P125H-Mal-mediated suppression. In contrast, tyrosine-deficient Mal species did not affect NF-kappa B activation when signaling was initiated at the post-receptor level by overexpression of MyD88, IRAK-2, or TRAF-6. Thus, tyrosine phosphorylation of Mal is required for adapter signaling, regulates Mal interactions with TLR4 and receptor signaling, and is inhibited in endotoxin tolerance.	[Piao, Wenji; Song, Chang; Chen, Haiyan; Medvedev, Andrei E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wahl, Larry M.] NIDCR, NIH, Bethesda, MD 20892 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [O'Neill, Luke A.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin	Medvedev, AE (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 660 W Red Wood St,Howard Hall Bldg,Rm HH 324, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu	Chen, Haiyan/HGB-6216-2022; Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; O'Neill, Luke/0000-0002-4333-2748	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000456] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI059524-04, R01 AI-059524, R01 AI059524-05, R01 AI059524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	62	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3109	3119		10.1074/jbc.M707400200	http://dx.doi.org/10.1074/jbc.M707400200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070880	Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000253083000014
J	Yang, PC; Yang, CH; Huang, CC; Hsu, KS				Yang, Ping-Chun; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen			Phosphatidylinositol 3-kinase activation is required for stress protocol-induced modification of hippocampal synaptic plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; NMDA RECEPTOR; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; DEPENDENT MECHANISMS; RETROGRADE-AMNESIA; SIGNALING PATHWAY; NEURONAL SURVIVAL; PROTEIN-SYNTHESIS	Stress dramatically affects the induction of hippocampal synaptic plasticity; however, the molecular details of how it does so remain unclear. Phosphatidylinositol 3-kinase (PI3K) signaling plays a crucial role in promoting neuronal survival and neuroplasticity, but its role, if any, in stress-induced alterations of long term potentiation (LTP) and long term depression (LTD) is unknown. We found here that inhibitors of PI3K signaling blocked the effects of acute restraint-tail shock stress protocol on LTP and LTD. Therefore, the purpose of the present study is to explore the signaling events involving PI3K in terms of its role in mediating stress protocol-induced alterations of LTP and LTD. We found that stress protocol- induced PI3K activation can be blocked by various inhibitors, including RU38486 for glucocorticoid receptors, LY294002 for PI3K, and DL-2-amino5- phosphonopentanoic acid for N-methyl-D-aspartate receptors or brain-derived neurotrophic factor antisense oligonucleotides. Also, immunoblotting analyses revealed that stress protocol induced a profound and prolonged phosphorylation of numbers of PI3K downstream effectors, including 3-phosphoinositide-dependent protein kinase-1, protein kinase B, mammalian target of rapamycin ( mTOR), p70 S6 kinase, and eukaryotic initiation factor 4B in hippocampal CA1 homogenate, which was prevented by the PI3K inhibitor pretreatment. More importantly, we found that stress protocol significantly increased the protein expression of dendritic scaffolding protein PSD-95 ( postsynaptic density-95), which is known to be involved in LTP and LTD, in an mTOR-dependent manner. These results identify a key role of PI3K signaling in mediating the stress protocol- induced modification of hippocampal synaptic plasticity and further suggest that PI3K may do so by invoking the protein expression of PSD-95.	[Yang, Ping-Chun; Yang, Chih-Hao; Huang, Chiung-Chun; Hsu, Kuei-Sen] Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, Tainan 701, Taiwan; [Hsu, Kuei-Sen] Natl Cheng Kung Univ, Ctr Gene Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Hsu, KS (corresponding author), Natl Cheng Kung Univ, Dept Pharmacol, Coll Med, 1 Univ Rd, Tainan 701, Taiwan.	richard@mail.ncku.edu.tw	Hsu, Kuei-Sen/AAV-8386-2021					ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Akama KT, 2003, J NEUROSCI, V23, P2333; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Barros DM, 2001, BEHAV PHARMACOL, V12, P629, DOI 10.1097/00008877-200112000-00007; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; DIAMOND DM, 1990, PSYCHOBIOLOGY, V18, P273; Diamond DM, 2004, HIPPOCAMPUS, V14, P281, DOI 10.1002/hipo.10186; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; DUNCAN R, 1985, J BIOL CHEM, V260, P5486; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FAVARON M, 1993, NEUROREPORT, V4, P1171; FOY MR, 1987, BEHAV NEURAL BIOL, V48, P138, DOI 10.1016/S0163-1047(87)90664-9; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Garcia R, 2001, SYNAPSE, V40, P180, DOI 10.1002/syn.1040; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang CC, 2006, J NEUROCHEM, V96, P179, DOI 10.1111/j.1471-4159.2005.03527.x; Huang CC, 2005, MOL NEUROBIOL, V32, P223, DOI 10.1385/MN:32:3:223; Izquierdo I, 1999, EUR J NEUROSCI, V11, P3323, DOI 10.1046/j.1460-9568.1999.00742.x; Kalia LV, 2006, EMBO J, V25, P4971, DOI 10.1038/sj.emboj.7601342; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; KERR DS, 1994, PSYCHOBIOLOGY, V22, P123; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kim JJ, 1996, P NATL ACAD SCI USA, V93, P4750, DOI 10.1073/pnas.93.10.4750; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Leemhuis J, 2004, N-S ARCH PHARMACOL, V370, P211, DOI 10.1007/s00210-004-0965-y; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mizuno M, 2003, MOL PSYCHIATR, V8, P217, DOI 10.1038/sj.mp.4001215; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Okragly AJ, 1997, EXP NEUROL, V145, P592, DOI 10.1006/exnr.1997.6500; Opazo P, 2003, J NEUROSCI, V23, P3679; PAVLIDES C, 1993, HIPPOCAMPUS, V3, P183, DOI 10.1002/hipo.450030210; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; PETROS AM, 1992, J BIOMOL NMR, V2, P11, DOI 10.1007/BF02192797; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Raymond CR, 2002, NEUROSCIENCE, V109, P531, DOI 10.1016/S0306-4522(01)00500-0; Rolls ET, 2002, P ROY SOC B-BIOL SCI, V269, P1087, DOI 10.1098/rspb.2002.2009; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sanna PP, 2002, J NEUROSCI, V22, P3359; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; SHORS TJ, 1995, NEUROREPORT, V6, P677, DOI 10.1097/00001756-199503000-00023; SHORS TJ, 1989, SCIENCE, V244, P224, DOI 10.1126/science.2704997; SHORS TJ, 1992, SYNAPSE, V11, P262, DOI 10.1002/syn.890110311; Stein V, 2003, J NEUROSCI, V23, P5503; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Takahashi T, 2002, J NEUROCHEM, V83, P1441, DOI 10.1046/j.1471-4159.2002.01251.x; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; TAOKA T, 1990, BIOCHEM BIOPH RES CO, V170, P1151, DOI 10.1016/0006-291X(90)90513-M; TRACHSEL H, 1977, J MOL BIOL, V116, P755, DOI 10.1016/0022-2836(77)90269-8; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yang CH, 2006, J PHYSIOL-LONDON, V577, P601, DOI 10.1113/jphysiol.2006.120386; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903	83	69	73	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2631	2643		10.1074/jbc.M706954200	http://dx.doi.org/10.1074/jbc.M706954200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18057005	hybrid			2022-12-27	WOS:000252622300020
J	Yin, QY; Wang, X; McBride, J; Fewell, C; Flemington, E				Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik			B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INDUCED LYMPHOMAS; NF-KAPPA-B; GENE; MIR-155; TRANSCRIPTION; MICRORNA-155; HODGKIN; FOSB; RNA	microRNA-155 is an oncogenic microRNA that has been shown to be critical for B-cell maturation and immunoglobulin production in response to antigen. In line with its function in B-cell activation, miR-155, and its primary transcript, B-cell integration cluster (BIC), is induced by B-cell receptor (BCR) cross-linking. Using pharmacological inhibitors in the human B-cell line, Ramos, we show that activation of BIC and miR-155 expression by BCR signaling occurs through the extracellular signaling-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) pathways but not the p38 pathway. BCR activation results in the induction of c-Fos, FosB, and JunB, and expression of these are suppressed by ERK and JNK inhibitors. Reporter analysis established a key role for a conserved AP-1 site similar to 40 bp upstream from the site of initiation but not an upstream NF-kappa B site or a putative c-Ets located at the site of initiation. Lastly, chromatin immunoprecipitation analysis demonstrated the recruitment of FosB and JunB to the miR-155 promoter following BCR activation. These results identify key determinants of BCR-mediated induction of BIC/miR-155.	[Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik] Tulane Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA 70112 USA; [Yin, Qinyan; Wang, Xia; McBride, Jane; Fewell, Claire; Flemington, Erik] Tulane Canc Ctr, New Orleans, LA 70112 USA	Tulane University; Tulane University	Flemington, E (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pathol, SL79, New Orleans, LA 70112 USA.	eflemin@tulane.edu			NATIONAL CANCER INSTITUTE [R01CA130752, R01CA124311] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE017008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048045, R29GM048045] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA130752-02, R01 CA124311-03, R01 CA124311, R01 CA130752, R01 CA 124311, R01 CA130752-01A1] Funding Source: Medline; NCRR NIH HHS [P20 RR020152, P20 RR 020152] Funding Source: Medline; NIDCR NIH HHS [DE 017008, R21 DE017008] Funding Source: Medline; NIGMS NIH HHS [GM 48045, R01 GM048045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cahir-McFarland ED, 2004, J VIROL, V78, P4108, DOI 10.1128/JVI.78.8.4108-4119.2004; CAMERON J, 2007, IN PRESS J VIROL; Carrozza ML, 1997, ONCOGENE, V14, P1083, DOI 10.1038/sj.onc.1200921; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2006, GENE CHROMOSOME CANC, V45, P103, DOI 10.1002/gcc.20264; Joseph AM, 2000, J VIROL, V74, P9964, DOI 10.1128/JVI.74.21.9964-9971.2000; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; LAZO PS, 1992, NUCLEIC ACIDS RES, V20, P343, DOI 10.1093/nar/20.2.343; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rosenberger SF, 1999, J BIOL CHEM, V274, P1124, DOI 10.1074/jbc.274.2.1124; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; van den Berg A, 2003, GENE CHROMOSOME CANC, V37, P20, DOI 10.1002/gcc.10186; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	30	181	187	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2654	2662		10.1074/jbc.M708218200	http://dx.doi.org/10.1074/jbc.M708218200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048365	hybrid, Green Accepted			2022-12-27	WOS:000252622300022
J	Masip, L; Klein-Marcuschamer, D; Quan, S; Bardwell, JCA; Georgiou, G				Masip, Lluis; Klein-Marcuschamer, Daniel; Quan, Shu; Bardwell, James C. A.; Georgiou, George			Laboratory evolution of Escherichia coli thioredoxin for enhanced catalysis of protein oxidation in the periplasm reveals a phylogenetically conserved substrate specificity determinant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; IN-VIVO; DSBA; PATHWAY; MECHANISM; EFFICIENT; VARIANTS; EXPORT; OXIDOREDUCTASES; SUPERFAMILY	Thioredoxin exported into the Escherichia coli periplasm catalyzes the oxidation of protein thiols in a DsbB-dependent function. However, the oxidative activity of periplasmic thioredoxin is insufficient to render dsbA(-) cells susceptible to infection by M13, a phenotype that is critically dependent on disulfide bond formation in the cell envelope. We sought to examine the molecular determinants that are required in order to convert thioredoxin from a reductant into an efficient periplasmic oxidant. A genetic screen for mutations in thioredoxin that render dsbA(-) cells sensitive to infection by M13 led to the isolation of a single amino acid substitution, G74S. In vivo the TrxA(G74S) mutant exhibited enhanced catalytic activity in the oxidation of alkaline phosphatase but was unable to oxidize FlgI and restore cell motility. In vitro studies revealed that the G74S substitution does not affect the redox potential of the thioredoxin-active site or its kinetics of oxidation by DsbB. Thus, the gain of function afforded by G74S stems in part from its altered substrate specificity, which also rendered the protein more resistant to reduction by DsbD/DsbC in the periplasm.	[Masip, Lluis; Klein-Marcuschamer, Daniel; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Genet & Microbiol, Austin, TX 78712 USA; [Georgiou, George] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA; [Quan, Shu; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Michigan System; University of Michigan	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu	Masip, Lluis/F-9919-2015; Quan, Shu/O-4562-2015	Masip, Lluis/0000-0002-3938-4633; Quan, Shu/0000-0002-6672-4947	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055090, R01GM069872] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM069872, GM55090] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1996, ESCHERICHIA COLI SAL; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 2001, J BACTERIOL, V183, P980, DOI 10.1128/JB.183.3.980-988.2001; CHATRENET B, 1992, J BIOL CHEM, V267, P3038; DAILEY FE, 1993, P NATL ACAD SCI USA, V90, P1043, DOI 10.1073/pnas.90.3.1043; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Debarbieux L, 2000, J BACTERIOL, V182, P723, DOI 10.1128/JB.182.3.723-727.2000; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; Elton TC, 2005, J BACTERIOL, V187, P8267, DOI 10.1128/JB.187.24.8267-8277.2005; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Himawan JS, 1996, J BIOL CHEM, V271, P19999, DOI 10.1074/jbc.271.33.19999; Hizukuri Y, 2006, J BACTERIOL, V188, P4190, DOI 10.1128/JB.01896-05; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Jonda S, 1999, EMBO J, V18, P3271, DOI 10.1093/emboj/18.12.3271; Karlsson F, 2003, J BACTERIOL, V185, P2628, DOI 10.1128/JB.185.8.2628-2634.2003; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mossner E, 1998, PROTEIN SCI, V7, P1233; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Pille S, 1996, EUR J BIOCHEM, V235, P713, DOI 10.1111/j.1432-1033.1996.00713.x; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; RUSSEL M, 1988, J BACTERIOL, V170, P5312, DOI 10.1128/jb.170.11.5312-5316.1988; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; SAMBROOK J, 2000, MOL CLONING LAB MANU; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; WUNDERLICH M, 1995, J MOL BIOL, V247, P28, DOI 10.1006/jmbi.1995.0119	44	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					840	848		10.1074/jbc.M705147200	http://dx.doi.org/10.1074/jbc.M705147200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003618	hybrid			2022-12-27	WOS:000252128100024
J	Boath, A; Graf, C; Lidome, E; Ullrich, T; Nussbaumer, P; Bornancin, F				Boath, Alistair; Graf, Christine; Lidome, Emilie; Ullrich, Thomas; Nussbaumer, Peter; Bornancin, Frederic			Regulation and traffic of ceramide 1-phosphate produced by ceramide kinase - Comparative analysis to glucosylceramide and sphingomyelin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; CROSS-METATHESIS REACTION; LEUKEMIA HL-60 CELLS; GOLGI-APPARATUS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; CULTURED FIBROBLASTS; PHOSPHATASE-ACTIVITY	Ceramide 1-phosphate (C1P) has been characterized as a sphingolipid that participates in cell signaling. Although C1P synthesis is thought to occur via phosphorylation of ceramide by ceramide kinase (CerK), the processes that regulate C1P formation and fate remain largely unknown. In this study we analyzed bone marrow-derived macrophages (BMDM) from CerK-null mice (Cerk(-/-)) and found significant levels of C1P, suggesting that previously unrecognized pathways may also lead to C1P formation. After these experiments we used an overexpression system, BMDMfrom Cerk(-/)-mice, and short-chain fluorescent ceramides to trace CerK-dependent formation of C1P. Because the ceramide analogs can also be converted to glucosylceramide (GlcCer) and sphingomyelin (SM), they allowed us to directly compare all three metabolites. We found that C1P produced by CerK is turned over rapidly when serum is removed or upon calcium chelation, whereas GlcCer and SM are stable under these conditions. We further demonstrated that ceramide must be transported to the Golgi complex to be phosphorylated by CerK. Inhibition of the ceramide transfer protein slowed down SM formation without decreasing C1P, suggesting an alternate route of ceramide transport. Other experiments indicated that, like GlcCer and SM, C1P traffics along the secretory pathway to reach the plasma membrane. Furthermore, in BMDM C1P was secreted more readily than was GlcCer or SM. Altogether, our results indicate that CerK is essential to C1P formation via phosphorylation of Cer, providing the first insights into mechanisms underlying ceramide access to CerK and C1P trafficking as well as clarifying C1P as a signaling entity.	[Boath, Alistair; Graf, Christine; Lidome, Emilie; Ullrich, Thomas; Nussbaumer, Peter; Bornancin, Frederic] Novartis Inst BioMed Res, A-1235 Vienna, Austria	Novartis	Bornancin, F (corresponding author), Novartis Inst BioMed Res, Brunnerstr 59, A-1235 Vienna, Austria.	frederic.bornancin@novartis.com	Bornancin, Frederic/AAA-2888-2021	Bornancin, Frederic/0000-0002-0152-6720				Ardail D, 2003, BIOCHEM J, V371, P1013, DOI 10.1042/BJ20021834; Bajjalieh S, 2000, METHOD ENZYMOL, V311, P207; BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; Baumruker T, 2005, IMMUNOL LETT, V96, P175, DOI 10.1016/j.imlet.2004.09.001; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; BOUDKER O, 1993, J BIOL CHEM, V268, P22150; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Colina C, 2005, BIOCHEM BIOPH RES CO, V336, P54, DOI 10.1016/j.bbrc.2005.08.039; DRESSLER KA, 1990, J BIOL CHEM, V265, P14917; Ettmayer P, 2004, BIOORG MED CHEM LETT, V14, P1555, DOI 10.1016/j.bmcl.2003.12.099; Fukasawa M, 1999, J CELL BIOL, V144, P673, DOI 10.1083/jcb.144.4.673; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Gomez-Munoz A, 2005, FEBS LETT, V579, P3744, DOI 10.1016/j.febslet.2005.05.067; Gomez-Munoz A, 2004, J LIPID RES, V45, P99, DOI 10.1194/jlr.M300158-JLR200; GOMEZMUNOZ A, 1995, MOL PHARMACOL, V47, P883; Graf C, 2007, BIOCHEM BIOPH RES CO, V354, P309, DOI 10.1016/j.bbrc.2006.12.208; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; HELMS JB, 1990, J BIOL CHEM, V265, P20027; Hinkovska-Galcheva VT, 1998, J BIOL CHEM, V273, P33203, DOI 10.1074/jbc.273.50.33203; Huitema K, 2004, EMBO J, V23, P33, DOI 10.1038/sj.emboj.7600034; JECKEL D, 1992, J CELL BIOL, V117, P259, DOI 10.1083/jcb.117.2.259; Jeon HJ, 2005, J NEUROCHEM, V95, P811, DOI 10.1111/j.1471-4159.2005.03403.x; Kim TJ, 2006, BIOCHEM BIOPH RES CO, V342, P611, DOI 10.1016/j.bbrc.2006.01.170; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; KOLESNICK RN, 1990, J BIOL CHEM, V265, P18803; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; LIPSKY NG, 1983, P NATL ACAD SCI-BIOL, V80, P2608, DOI 10.1073/pnas.80.9.2608; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Mitsutake S, 2005, J BIOL CHEM, V280, P40436, DOI 10.1074/jbc.M501962200; Mitsutake S, 2004, J BIOL CHEM, V279, P17570, DOI 10.1074/jbc.M312885200; Nussbaumer P, 2005, CHEM COMMUN, P5086, DOI 10.1039/b508132g; NUSSBAUMER P, 2008, IN PRESS CHEMMEDCHEM; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Peters C, 2007, J ORG CHEM, V72, P1842, DOI 10.1021/jo062347b; Pettus BJ, 2003, J BIOL CHEM, V278, P38206, DOI 10.1074/jbc.M304816200; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Rovina P, 2006, BIOCHEM J, V400, P255, DOI 10.1042/BJ20060316; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; SHINGHAL R, 1993, J NEUROCHEM, V61, P2279, DOI 10.1111/j.1471-4159.1993.tb07470.x; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tornquist K, 2004, BIOCHEM J, V380, P661, DOI 10.1042/BJ20031637; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002	54	87	89	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8517	8526		10.1074/jbc.M707107200	http://dx.doi.org/10.1074/jbc.M707107200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18086664	hybrid			2022-12-27	WOS:000254288000050
J	Kienesberger, PC; Lass, A; Preiss-Landl, K; Wolinski, H; Kohlwein, SD; Zimmermann, R; Zechner, R				Kienesberger, Petra C.; Lass, Achim; Preiss-Landl, Karina; Wolinski, Heimo; Kohlwein, Sepp D.; Zimmermann, Robert; Zechner, Rudolf			Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; EXPRESSION; PROTEIN; CELLS; DOMAIN; GLYCEROPHOSPHOCHOLINE; PHOSPHATIDYLCHOLINE; NEURODEGENERATION; PROLIFERATION; TRANSACYLASE	Neuropathy target esterase (NTE) is a member of the family of patatin domain-containing proteins and exhibits phospholipase activity in brain and cultured cells. NTE was originally identified as target enzyme for organophosphorus compounds that cause a delayed paralyzing syndrome with degeneration of nerve axons. Here we show that the structurally related murine protein NTE-related esterase (NRE) is a potent lysophospholipase. The enzyme efficiently hydrolyzes sn-1 esters in lysophosphatidylcholine and lysophosphatidic acid. No lipase activity was observed when triacylglycerols, cholesteryl esters, retinyl esters, phosphatidylcholine, or monoacylglycerol were used as substrates. Although NTE is predominantly expressed in the nervous system, we found the highest NRE mRNA levels in testes, skeletal muscle, cardiac muscle, and adipose tissue. Induction of NRE mRNA concentrations in these tissues during fasting suggested a nutritional regulation of enzyme expression and, in accordance with this observation, insulin reduced NRE mRNA levels in a dose-dependent manner in 3T3-L1 adipocytes. A green fluorescent protein-NRE fusion protein colocalized to the endoplasmic reticulum and lipid droplets. Thus, NRE is a previously unrecognized ER- and lipid droplet-associated lysophospholipase. Regulation of enzyme expression by the nutritional status and insulin suggests a role of NRE in the catabolism of lipid precursors and/or mediators that affect energy metabolism in mammals.	[Kienesberger, Petra C.; Lass, Achim; Preiss-Landl, Karina; Wolinski, Heimo; Kohlwein, Sepp D.; Zimmermann, Robert; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Wolinski, Heimo/0000-0002-1583-6092; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Zechner, Rudolf/0000-0001-5483-1182; Kienesberger, Petra/0000-0001-9643-8338; Zimmermann, Robert/0000-0002-7354-870X	Austrian Science Fund FWF [F 3002, F 3005, W 901] Funding Source: Medline; Austrian Science Fund (FWF) [Z 136, F 3002, F 3005, W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Atkins J, 2000, J BIOL CHEM, V275, P24477, DOI 10.1074/jbc.M002921200; Bajpai M, 1998, ANDROLOGIA, V30, P311; Boechzelt H, 1998, J LIPID RES, V39, P1503; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; ESTIVILLTORRUS G, 2007, IN PRESS CEREB CORTE; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gao J, 2005, J INVEST DERMATOL, V124, P1259, DOI 10.1111/j.0022-202X.2005.23761.x; Glynn P, 1999, BIOCHEM J, V344, P625, DOI 10.1042/0264-6021:3440625; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1975, ARCH TOXICOL, V34, P259, DOI 10.1007/BF00353848; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Li Y, 2003, J BIOL CHEM, V278, P8820, DOI 10.1074/jbc.M210743200; Lush MJ, 1998, BIOCHEM J, V332, P1; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Quistad GB, 2003, P NATL ACAD SCI USA, V100, P7983, DOI 10.1073/pnas.1232473100; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; YAMAMOTO N, 1987, CANCER RES, V47, P2008; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	48	45	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5908	5917		10.1074/jbc.M709598200	http://dx.doi.org/10.1074/jbc.M709598200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086666	hybrid			2022-12-27	WOS:000253426700069
J	Rouget, R; Auclair, Y; Loignon, M; Affar, EB; Drobetsky, EA				Rouget, Raphael; Auclair, Yannick; Loignon, Martin; Affar, El Bachir; Drobetsky, Elliot A.			A sensitive flow Cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; XERODERMA-PIGMENTOSUM; C-JUN; INDUCED PHOSPHORYLATION; MAPKAP KINASE-2; JNK ACTIVATION; P53 PROTEIN; EXPRESSION; APOPTOSIS; PATHWAY	In response to diverse genotoxic stimuli ( e. g. UV and cisplatin), the mitogen-activated protein kinases ERK1/2, JNK1/2, and p38 alpha/beta become rapidly phosphorylated and in turn activate multiple downstream effectors that modulate apoptosis and/or growth arrest. Furthermore, previous lines of evidence have strongly suggested that ERK1/2 and JNK1/2 participate in global-genomic nucleotide excision repair, a critical antineoplastic pathway that removes helix-distorting DNA adducts induced by a variety of mutagenic agents, including UV. To rigorously evaluate the potential role of mitogen-activated protein kinases in global-genomic nucleotide excision repair, various human cell strains ( primary skin fibroblasts, primary lung fibroblasts, and HCT116 colon carcinoma cells) were treated with highly specific chemical inhibitors, which, following UV exposure, (i) abrogated the capacities of ERK1/2, JNK1/2, or p38 alpha/beta to phosphorylate specific downstream effectors and (ii) characteristically modulated cellular proliferation, clonogenic survival, and/or apoptosis. A highly sensitive flow cytometry-based nucleotide excision repair assay recently optimized and validated in our laboratory was then employed to directly demonstrate that the kinetics of UV DNA photoadduct repair are highly similar in mock-treated versus mitogen-activated protein kinase inhibitor-treated cells. These data on primary and tumor cells treated with pharmacological inhibitors were fully corroborated by repair studies using ( i) short hairpin RNA-mediated knockdown of ERK1/2 or JNK1/2 in human U2OS osteosarcoma cells and ( ii) expression of a dominant negative p38 alpha mutant in human primary lung fibroblasts. Our results provide solid evidence for the first time, in disaccord with a burgeoning perception, that mitogen-activated protein kinase signaling does not influence the efficiency of human global-genomic nucleotide excision repair.	[Rouget, Raphael; Auclair, Yannick; Loignon, Martin; Affar, El Bachir; Drobetsky, Elliot A.] Univ Montreal, Hop Maison Neuve Rosemont, Res Ctr, Fac Med,Dept Immunol & Oncol, Montreal, PQ H1T 2M4, Canada	Universite de Montreal	Drobetsky, EA (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, 5415 Boul Assomption, Montreal, PQ H1T 2M4, Canada.	elliot.drobetsky@umontreal.ca						ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERG RJW, 1993, CARCINOGENESIS, V14, P103, DOI 10.1093/carcin/14.1.103; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Gjerset RA, 1999, CELL GROWTH DIFFER, V10, P545; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hanawalt PC, 2001, ENVIRON MOL MUTAGEN, V38, P89, DOI 10.1002/em.1057; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200	43	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5533	5541		10.1074/jbc.M706257200	http://dx.doi.org/10.1074/jbc.M706257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093981	hybrid			2022-12-27	WOS:000253426700034
J	Petropoulos, AD; Kouvela, EC; Dinos, GP; Kalpaxis, DL				Petropoulos, Alexandros D.; Kouvela, Ekaterini C.; Dinos, George P.; Kalpaxis, Dimitrios L.			Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL TRANSFERASE CENTER; MACROLIDE ANTIBIOTICS; RESISTANCE MUTATION; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; BOND FORMATION; BLASTICIDIN-S; RNA; SITE; SUBUNIT	Erythromycin and tylosin are 14- and 16-membered lactone ring macrolides, respectively. The current work shows by means of kinetic and chemical footprinting analysis that both antibiotics bind to Escherichia coli ribosomes in a two-step process. The first step established rapidly, involves a low-affinity binding site placed at the entrance of the exit tunnel in the large ribosomal subunit, where macrolides bind primarily through their hydrophobic portions. Subsequently, slow conformational changes mediated by the antibiotic hydrophilic portion push the drugs deeper into the tunnel, in a high-affinity site. Compared with erythromycin, tylosin shifts to the high-affinity site more rapidly, due to the interaction of the mycinose sugar of the drug with the loop of H35 in domain II of 23 S rRNA. Consistently, mutations of nucleosides U2609 and U754 implicated in the high-affinity site reduce the shift of tylosin to this site and destabilize, respectively, the final drug-ribosome complex. The weak interaction between tylosin and the ribosome is Mg2+ independent, unlike the tight binding. In contrast, both interactions between erythromycin and the ribosome are reduced by increasing concentrations of Mg2+ ions. Polyamines attenuate erythromycin affinity for the ribosome at both sequential steps of binding. In contrast, polyamines facilitate the initial binding of tylosin, but exert a detrimental, more pronounced, effect on the drug accommodation at its final position. Our results emphasize the role of the particular interactions that side chains of tylosin and erythromycin establish with 23 S rRNA, which govern the exact binding process of each drug and its response to the ionic environment.	[Petropoulos, Alexandros D.; Kouvela, Ekaterini C.; Dinos, George P.; Kalpaxis, Dimitrios L.] Univ Patras, Sch Med, Biochem Lab, Patras 26500, Greece	University of Patras	Kalpaxis, DL (corresponding author), Univ Patras, Sch Med, Biochem Lab, Patras 26500, Greece.	dimkal@med.upatras.gr	Dinos, George/AAR-8444-2020	Dinos, George/0000-0003-3914-7408				Amarantos I, 2001, BIOCHEMISTRY-US, V40, P7641, DOI 10.1021/bi010010s; Berisio R, 2006, ANTIMICROB AGENTS CH, V50, P3816, DOI 10.1128/AAC.00767-06; Bertho G, 1998, BIOORGAN MED CHEM, V6, P209, DOI 10.1016/S0968-0896(97)10028-1; Braga PC, 2004, INT J ANTIMICROB AG, V24, P254, DOI 10.1016/j.ijantimicag.2004.02.031; Champney W. S., 2001, Current Drug Targets - Infectious Disorders, V1, P19, DOI 10.2174/1568005013343281; Davydova N, 2002, J MOL BIOL, V322, P635, DOI 10.1016/S0022-2836(02)00772-6; DIGIAMBATTISTA M, 1987, J BIOL CHEM, V262, P8591; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Dinos GP, 2000, BIOCHEMISTRY-US, V39, P11621, DOI 10.1021/bi000811f; DOUTHWAITE S, 1993, J MOL BIOL, V232, P725, DOI 10.1006/jmbi.1993.1426; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; FERNANDEZMUNOZ R, 1973, J ANTIBIOT, V26, P107, DOI 10.7164/antibiotics.26.107; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; GOLDMAN RC, 1990, ANTIMICROB AGENTS CH, V34, P426, DOI 10.1128/AAC.34.3.426; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Hennelly SP, 2005, J MOL BIOL, V346, P1243, DOI 10.1016/j.jmb.2004.12.054; KALPAXIS DL, 1986, EUR J BIOCHEM, V154, P267, DOI 10.1111/j.1432-1033.1986.tb09392.x; Katz L, 2005, CHEM REV, V105, P499, DOI 10.1021/cr030107f; Kirillov SV, 1999, RNA, V5, P1003, DOI 10.1017/S1355838299990568; Liu MF, 2002, P NATL ACAD SCI USA, V99, P14658, DOI 10.1073/pnas.232580599; Lovmar M, 2004, J BIOL CHEM, V279, P53506, DOI 10.1074/jbc.M401625200; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nanavaty J, 1998, CURR MICROBIOL, V36, P212; Petropoulos AD, 2004, J BIOL CHEM, V279, P26518, DOI 10.1074/jbc.M313634200; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5180, DOI 10.1073/pnas.0501598102; Pfister P, 2004, J MOL BIOL, V342, P1569, DOI 10.1016/j.jmb.2004.07.095; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; STERN S, 1988, METHOD ENZYMOL, V164, P481; TEJEDOR F, 1986, BIOCHEMISTRY-US, V25, P7725, DOI 10.1021/bi00371a066; TERAOKA H, 1973, EUR J BIOCHEM, V33, P578, DOI 10.1111/j.1432-1033.1973.tb02718.x; Thompson J, 2004, ANTIMICROB AGENTS CH, V48, P4889, DOI 10.1128/AAC.48.12.4889-4891.2004; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Vazquez D., 1979, MOL BIOL BIOCH BIOPH, Vi-x, P1, DOI [10.1007/978-3-642-81309-2, DOI 10.1007/978-3-642-81309-2]; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VOGEL Z, 1971, J MOL BIOL, V60, P339, DOI 10.1016/0022-2836(71)90298-1; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Wilson DN, 2005, BIOL CHEM, V386, P1239, DOI 10.1515/BC.2005.141; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557; Zhong P, 1999, MICROB DRUG RESIST, V5, P183, DOI 10.1089/mdr.1999.5.183	44	21	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4756	4765		10.1074/jbc.M708371200	http://dx.doi.org/10.1074/jbc.M708371200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079110	hybrid			2022-12-27	WOS:000253426500033
J	Seino, Y; Miki, T; Kiyonari, H; Abe, T; Fujimoto, W; Kimura, K; Takeuchi, A; Takahashi, Y; Oiso, Y; Iwanaga, T; Seino, S				Seino, Yusuke; Miki, Takashi; Kiyonari, Hiroshi; Abe, Takaya; Fujimoto, Wakako; Kimura, Keita; Takeuchi, Ayako; Takahashi, Yoshihisa; Oiso, Yutaka; Iwanaga, Toshihiko; Seino, Susumu			Isx participates in the maintenance of vitamin A metabolism by regulation of beta-carotene 15,15 '-Monooxygenase (Bcmo1) expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B SCAVENGER RECEPTOR; I SR-BI; CDX2 MUTANT MICE; BETA,BETA-CAROTENE 15,15'-MONOOXYGENASE; STEM-CELLS; IDENTIFICATION; INTESTINE; GENE; DIFFERENTIATION; ABSORPTION	Isx (intestine specific homeobox) is an intestine-specific transcription factor. To elucidate its physiological function, we generated Isx-deficient mice by knocking in the beta-galactosidase gene (LacZ) in the Isx locus (Isx(LacZ/ LacZ) mice). LacZ staining of heterozygous (Isx(LacZ/+)) mice revealed that Isx was expressed abundantly in intestinal epithelial cells from duodenum to proximal colon. Quantitative mRNA expression profiling of duodenum and jejunum showed that beta-carotene 15,15 '-monooxygenase (EC1.14.99.36 Bcmo1) and the class B type I scavenger receptor, which are involved in vitamin A synthesis and carotenoid uptake, respectively, were drastically increased in Isx(LacZ/LacZ) mice. Although mild vitamin A deficiency decreased Isx expression in duodenum of wild-type (Isx(+/+)) mice, severe vitamin A deficiency decreased Isx mRNA expression in both duodenum and jejunum of Isx(+/+) mice. On the other hand, vitamin A deficiency increased Bcmo1 expression in both duodenum and jejunum of Isx(+/+) mice. However, Bcmo1 expression was not increased in duodenum of Isx(LacZ/LacZ) mice by mild vitamin A deficiency. These data suggest that Isx participates in the maintenance of vitamin A metabolism by regulating Bcmo1 expression in the intestine.	[Seino, Yusuke; Miki, Takashi; Fujimoto, Wakako; Kimura, Keita; Takahashi, Yoshihisa; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan; [Seino, Yusuke; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Div Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Aichi 6500047, Japan; [Fujimoto, Wakako] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Kobe, Hyogo 6500017, Japan	Kobe University; Nagoya University; RIKEN; Hokkaido University	Seino, S (corresponding author), 7-5-1 Kusunoki,Chuo Ku, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626				ACTON SL, 1994, J BIOL CHEM, V269, P21003; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Cai SF, 2001, J LIPID RES, V42, P902; CALVO D, 1993, J BIOL CHEM, V268, P18929; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Fujimoto W, 2007, P NATL ACAD SCI USA, V104, P15514, DOI 10.1073/pnas.0707328104; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; HERMISTON ML, 1995, AM J PHYSIOL-GASTR L, V268, pG813, DOI 10.1152/ajpgi.1995.268.5.G813; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Mardones P, 2002, J NUTR, V132, P443, DOI 10.1093/jn/132.3.443; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S; YAGI T, 1993, ANAL BIOCHEM, V214, P68; Zhang Y, 2002, J BIOL CHEM, V277, P28065, DOI 10.1074/jbc.C100767200	35	60	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4905	4911		10.1074/jbc.M707928200	http://dx.doi.org/10.1074/jbc.M707928200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093975	hybrid			2022-12-27	WOS:000253426500048
J	Pietrement, C; Da Silva, N; Silberstein, C; James, M; Marsolais, M; Van Hoek, A; Brown, D; Pastor-Soler, N; Ameen, N; Laprade, R; Ramesh, V; Breton, S				Pietrement, Christine; Da Silva, Nicolas; Silberstein, Claudia; James, Marianne; Marsolais, Mireille; Van Hoek, Alfred; Brown, Dennis; Pastor-Soler, Nuria; Ameen, Nadia; Laprade, Raynald; Ramesh, Vijaya; Breton, Sylvie			Role of NHERF1, cystic fibrosis transmembrane conductance regulator, and cAMP in the regulation of aquaporin 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL BILATERAL ABSENCE; VAS-DEFERENS; MOLECULAR CHARACTERIZATION; WATER REABSORPTION; INITIAL SEGMENT; RAT EPIDIDYMIS; ION-TRANSPORT; CFTR; PROTEIN; CHANNEL	Water and solute transport across the plasma membrane of cells is a crucial biological function that is mediated mainly by aquaporins and aquaglyceroporins. The regulation of these membrane proteins is still incompletely understood. Using the male reproductive tract as a model system in which water and glycerol transport are critical for the establishment of fertility, we now report a novel pathway for the regulation of aquaporin 9 (AQP9) permeability. AQP9 is the major aquaglyceroporin of the epididymis, liver, and peripheral leukocytes, and its COOH-terminal portion contains a putative PDZ binding motif (SVIM). Here we show that NHERF1, cystic fibrosis transmembrane conductance regulator (CFTR), and AQP9 co-localize in the apical membrane of principal cells of the epididymis and the vas deferens, and that both NHERF1 and CFTR co-immunoprecipitate with AQP9. Overlay assays revealed that AQP9 binds to both the PDZ1 and PDZ2 domains of NHERF1, with an apparently higher affinity for PDZ1 versus PDZ2. Pull-down assays showed that the AQP9 COOH-terminal SVIM motif is essential for interaction with NHERF1. Functional assays on isolated tubules perfused in vitro showed a high permeability of the apical membrane to glycerol, which is inhibited by the AQP9 inhibitor, phloretin, and is markedly activated by cAMP. The CFTR inhibitors DPC, GlyH-101 and CFTRinh-172 all significantly reduced the cAMP-activated glycerol-induced cell swelling. We propose that CFTR is an important regulator of AQP9 and that the interaction between AQP9, NHERF1, and CFTR may facilitate the activation of AQP9 by cAMP.	[Pietrement, Christine; Da Silva, Nicolas; Silberstein, Claudia; Van Hoek, Alfred; Brown, Dennis; Breton, Sylvie] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Div Nephrol, Boston, MA 02114 USA; [James, Marianne; Ramesh, Vijaya] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Van Hoek, Alfred; Brown, Dennis; Ramesh, Vijaya; Breton, Sylvie] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Marsolais, Mireille; Laprade, Raynald] Univ Montreal, Grp Proteins Membranaires, Montreal, PQ, Canada; [Ameen, Nadia] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Universite de Montreal; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Breton, S (corresponding author), Massachusetts Gen Hosp, Simches Res Ctr, Program Membrane Biol, 185 Cambridge St,Suite 8204, Boston, MA 02114 USA.	sbreton@partners.org	Da Silva, Nicolas/T-3528-2019	Van Hoek, Alfred/0000-0003-2724-6855	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 045821] Funding Source: Medline; NIDDK NIH HHS [DK 57521, DK 43351] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGUIANO A, 1992, JAMA-J AM MED ASSOC, V267, P1794, DOI 10.1001/jama.267.13.1794; Badran HH, 2002, J ANDROL, V23, P358; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF426, DOI 10.1152/ajprenal.2001.280.3.F426; Blau H, 2002, ARCH DIS CHILD, V87, P135, DOI 10.1136/adc.87.2.135; Breton S, 2000, J BIOL CHEM, V275, P18219, DOI 10.1074/jbc.M909857199; BRETON S, 1992, AM J PHYSIOL, V263, pF656, DOI 10.1152/ajprenal.1992.263.4.F656; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Brone B, 2005, AM J PHYSIOL-CELL PH, V288, pC20, DOI 10.1152/ajpcell.00368.2004; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; BROWN D, 1995, HISTOCHEM CELL BIOL, V104, P1, DOI 10.1007/BF01464780; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Cheung KH, 2003, BIOL REPROD, V68, P1505, DOI 10.1095/biolreprod.102.010017; CLULOW J, 1994, EXP PHYSIOL, V79, P915, DOI 10.1113/expphysiol.1994.sp003817; Clulow J, 1998, J REPROD FERTIL, P1; COOPER TG, 1981, J REPROD FERTIL, V61, P163, DOI 10.1530/jrf.0.0610163; CRABO B, 1965, ACTA VET SCAND, VS  6, P1; Cuppens H, 2004, INT J ANDROL, V27, P251, DOI 10.1111/j.1365-2605.2004.00485.x; Da Silva N, 2006, BIOL REPROD, V74, P427, DOI 10.1095/biolreprod.105.044735; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Gaillard DA, 1997, J UROLOGY, V158, P1549, DOI 10.1016/S0022-5347(01)64278-2; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hansen LA, 1999, EXP PHYSIOL, V84, P521, DOI 10.1111/j.1469-445X.1999.01788.x; HINTON BT, 1995, MICROSC RES TECHNIQ, V30, P67, DOI 10.1002/jemt.1070300106; HOHLBRUGGER G, 1983, ARCH ANDROLOGY, V11, P265, DOI 10.3109/01485018308987492; James MF, 2004, J CELL SCI, V117, P2951, DOI 10.1242/jcs.01156; JOHNSON AL, 1977, SCIENCE, V195, P492, DOI 10.1126/science.835008; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Nicchia GP, 2001, J HISTOCHEM CYTOCHEM, V49, P1547, DOI 10.1177/002215540104901208; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; OATES RD, 1994, J ANDROL, V15, P1; Oliveira CA, 2005, BIOL CELL, V97, P385, DOI 10.1042/BC20040078; Pastor-Soler L, 2002, BIOL REPROD, V66, P1716, DOI 10.1095/biolreprod66.6.1716; Pastor-Soler N, 2001, BIOL REPROD, V65, P384, DOI 10.1095/biolreprod65.2.384; Raghuram V, 2003, P NATL ACAD SCI USA, V100, P9620, DOI 10.1073/pnas.1633250100; Robaire B., 1988, P999; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Ruz R, 2004, J ANDROL, V25, P265; Sedlacek RL, 2001, AM J PHYSIOL-RENAL, V281, pF557, DOI 10.1152/ajprenal.2001.281.3.F557; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; TURNER TT, 1984, J REPROD FERTIL, V72, P509, DOI 10.1530/jrf.0.0720509; TURNER TT, 1995, J ANDROL, V16, P292; TURNER TT, 1983, J ANDROL, V4, P197; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2005, J PHYSIOL-LONDON, V567, P27, DOI 10.1113/jphysiol.2005.086777; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174; Wong PYD, 1998, MOL HUM REPROD, V4, P107, DOI 10.1093/molehr/4.2.107; WONG YC, 1978, EXPERIENTIA, V34, P485, DOI 10.1007/BF01935943; YEUNG CH, 1993, BIOL REPROD, V49, P274, DOI 10.1095/biolreprod49.2.274; Yoo D, 2004, J BIOL CHEM, V279, P6863, DOI 10.1074/jbc.M311599200; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	67	57	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2986	2996		10.1074/jbc.M704678200	http://dx.doi.org/10.1074/jbc.M704678200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055461	hybrid			2022-12-27	WOS:000252622300054
J	Qian, YJ; Zhang, J; Yan, BF; Chen, XB				Qian, Yingjuan; Zhang, Jin; Yan, Bingfang; Chen, Xinbin			DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; TUMOR-CELLS; IN-VIVO; FUNCTIONAL DOMAINS; INDUCED APOPTOSIS; ONCOGENIC RAS; EXPRESSION; ACTIVATION; PATHWAY	Cellular senescence plays an important role in tumor suppression. p53 tumor suppressor has been reported to be crucial in cellular senescence. However, the underlying mechanism is poorly understood. In this regard, a cDNA microarray assay was performed to identify p53 targets involved in senescence. Among the many candidates is DEC1, a basic helix-loop-helix transcription factor that has been recently shown to be up- regulated in K-ras-induced premature senescence. However, it is not clear whether DEC1 is capable of inducing senescence. Here, we found that DEC1 is a novel target gene of the p53 family and mediates p53-dependent premature senescence. Specifically, we showed that DEC1 is induced by the p53 family and DNA damage in a p53-dependent manner. We also found that the p53 family proteins bind to, and activate, the promoter of the DEC1 gene. In addition, we showed that overexpression of DEC1 induces G(1) arrest and promotes senescence. Moreover, we found that targeting endogenous DEC1 attenuates p53-mediated premature senescence in response to DNA damage. Furthermore, overexpression of DEC1 induces cellular senescence in p53-knockdown cells, albeit to a lesser extent. Finally, we showed that DEC1-induced senescence is p21-independent. Taken together, our data provided strong evidence that DEC1 is one of the effectors downstream of p53 to promote premature senescence.	[Qian, Yingjuan; Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Ctr Comparat Oncol, Davis, CA 95616 USA; [Qian, Yingjuan] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Yan, Bingfang] Univ Rhode Isl, Kingston, RI 02881 USA	University of California System; University of California Davis; University of Alabama System; University of Alabama Birmingham; University of Rhode Island	Chen, XB (corresponding author), Univ Calif Davis, Ctr Comparat Oncol, 2128 Tupper Hall, Davis, CA 95616 USA.	xbchen@ucdavis.edu			NATIONAL CANCER INSTITUTE [R01CA076069, R01CA102188, R01CA081237, R29CA076069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061988] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA076069, R01 CA076069, CA 076009, CA 081237, R01 CA081237, R01 CA102188, CA 102188] Funding Source: Medline; NIEHS NIH HHS [R01 ES 007965, R01 ES007965] Funding Source: Medline; NIGMS NIH HHS [R01 GM061988, R01 GM 061988] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Chang BD, 1999, CANCER RES, V59, P3761; CHEN XB, 1995, CANCER RES, V55, P4257; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HU QJ, 1991, MOL CELL BIOL, V11, P5792, DOI 10.1128/MCB.11.11.5792; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Jin SK, 2001, J CELL SCI, V114, P4139; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; Kapic A, 2006, CELL DEATH DIFFER, V13, P324, DOI 10.1038/sj.cdd.4401756; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Nozell S, 2003, ONCOGENE, V22, P4333, DOI 10.1038/sj.onc.1206470; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; PARRY D, 1995, EMBO J, V14, P503, DOI 10.1002/j.1460-2075.1995.tb07026.x; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Prives C, 1999, J PATHOL, V187, P112; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; te Poele RH, 2002, CANCER RES, V62, P1876; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	49	96	100	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2896	2905		10.1074/jbc.M708624200	http://dx.doi.org/10.1074/jbc.M708624200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18025081	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000252622300046
J	Christoffersen, C; Jauhiainen, M; Moser, M; Porse, B; Ehnholm, C; Boesl, M; Dahlback, B; Nielsen, LB				Christoffersen, Christina; Jauhiainen, Matti; Moser, Markus; Porse, Bo; Ehnholm, Christian; Boesl, Michael; Dahlback, Bjorn; Nielsen, Lars Bo			Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; APO A-I; HUMAN-PLASMA; CELLULAR CHOLESTEROL; TRANSGENIC MICE; HDL CONVERSION; EFFLUX; BINDING; DISEASE	To investigate the role of apoM in high density lipoprotein (HDL) metabolism and atherogenesis, we generated human apoM transgenic (apoM-Tg) and apoM-deficient ( apoM(-/-)) mice. Plasma apoM was predominantly associated with 10-12-nm alpha-migrating HDL particles. Human apoM overexpression (11-fold) increased plasma cholesterol concentration by 13-22%, whereas apoM deficiency decreased it by 17-21%. The size and charge of apoA-I-containing HDL in plasma were not changed in apoM-Tg or apoM(-/-) mice. However, in plasma incubated at 37 C, lecithin: cholesterol acyltransferase-dependent conversion of alpha- to pre-alpha-migrating HDL was delayed in apoM-Tg mice. Moreover, lecithin: cholesterol acyltransferase-independent generation of pre-beta-migrating apoA-I-containing particles in plasma was increased in apoM-Tg mice (4.2 +/- 1.1%, p = 0.06) and decreased in apoM(-/-) mice (0.5 +/- 0.3%, p = 0.03) versus controls ( 1.8 +/- 0.05%). In the setting of low density lipoprotein receptor deficiency, apoM-Tg mice with similar to 2-fold increased plasma apoM concentrations developed smaller atherosclerotic lesions than controls. The effect of apoM on atherosclerosis may be facilitated by enzymatic modulation of plasma HDL particles, increased cholesterol efflux from foam cells, and an antioxidative effect of apoM-containing HDL.	[Christoffersen, Christina; Porse, Bo; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, DK-2100 Copenhagen, Denmark; [Ehnholm, Christian] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Moser, Markus; Boesl, Michael] Max Planck Inst Biochem, Dept Mol Med, D-82152 Matinsried, Germany; [Dahlback, Bjorn] Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem, S-20502 Malmo, Sweden	Rigshospitalet; University of Copenhagen; University of Copenhagen; Finland National Institute for Health & Welfare; Max Planck Society; Lund University; Skane University Hospital	Nielsen, LB (corresponding author), Rigshosp, Dept Clin Biochem, KB3011,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Porse, Bo/B-1332-2012	Porse, Bo/0000-0001-6043-0844; Christoffersen, Christina/0000-0003-3751-5203; Dahlback, Bjorn/0000-0003-1546-0328				Ahnstrom J, 2007, J LIPID RES, V48, P1754, DOI 10.1194/jlr.M700103-JLR200; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Alexander ET, 2005, BIOCHEMISTRY-US, V44, P5409, DOI 10.1021/bi047412v; Axler O, 2007, J LIPID RES, V48, P1772, DOI 10.1194/jlr.M700113-JLR200; BARRANS A, 1994, J BIOL CHEM, V269, P11572; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bro S, 2003, J AM SOC NEPHROL, V14, P2466, DOI 10.1097/01.ASN.0000088024.72216.2E; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; Christoffersen C, 2006, J LIPID RES, V47, P1833, DOI 10.1194/jlr.M600055-JLR200; CLAY MA, 1992, BIOCHIM BIOPHYS ACTA, V1124, P52, DOI 10.1016/0005-2760(92)90125-F; Costet P, 2000, J BIOL CHEM, V275, P28240; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Deakin JE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-281; Duan JX, 2001, FEBS LETT, V499, P127, DOI 10.1016/S0014-5793(01)02544-3; Ehnholm C, 1986, Methods Enzymol, V129, P716; Faber K, 2006, MOL ENDOCRINOL, V20, P212, DOI 10.1210/me.2005-0209; Faber K, 2004, J LIPID RES, V45, P1272, DOI 10.1194/jlr.M300451-JLR200; FLOWER DR, 1994, FEBS LETT, V354, P7, DOI 10.1016/0014-5793(94)01078-1; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; GLOMSET JA, 1968, J LIPID RES, V9, P155; GLOMSET JA, 1962, BIOCHIM BIOPHYS ACTA, V65, P128, DOI 10.1016/0006-3002(62)90156-7; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P459, DOI 10.1161/01.ATV.20.2.459; Huuskonen J, 2000, BIOCHEMISTRY-US, V39, P16092, DOI 10.1021/bi0019287; ISHIDA BY, 1990, J LIPID RES, V31, P227; JAUHIAINEN M, 1993, J BIOL CHEM, V268, P4032; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jiang XC, 1996, J CLIN INVEST, V98, P2373, DOI 10.1172/JCI119050; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; Korhonen A, 1998, BIOCHEM BIOPH RES CO, V249, P910, DOI 10.1006/bbrc.1998.9162; KUNITAKE ST, 1985, J LIPID RES, V26, P549; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; LIU M, 1993, BIOCHIM BIOPHYS ACTA, V1168, P144, DOI 10.1016/0005-2760(93)90118-S; Lund-Katz S, 2003, FRONT BIOSCI-LANDMRK, V8, pD1044, DOI 10.2741/1077; MIIDA T, 1992, BIOCHEMISTRY-US, V31, P11112, DOI 10.1021/bi00160a022; NISHIDA HI, 1986, J BIOL CHEM, V261, P2028; Nobecourt E, 2007, DIABETOLOGIA, V50, P643, DOI 10.1007/s00125-006-0574-z; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Pussinen PJ, 2001, ATHEROSCLEROSIS, V155, P297, DOI 10.1016/S0021-9150(00)00568-2; Rader DJ, 2007, NAT CLIN PRACT CARD, V4, P102, DOI 10.1038/ncpcardio0768; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; Sviridov D, 2002, ARTERIOSCL THROM VAS, V22, P1482, DOI 10.1161/01.ATV.0000029120.44088.FE; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; van Haperen R, 2000, ARTERIOSCL THROM VAS, V20, P1082, DOI 10.1161/01.ATV.20.4.1082; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; von Eckardstein A, 1998, ATHEROSCLEROSIS, V138, P25, DOI 10.1016/S0021-9150(97)00280-3; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286	54	148	159	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1839	1847		10.1074/jbc.M704576200	http://dx.doi.org/10.1074/jbc.M704576200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006500	hybrid			2022-12-27	WOS:000252501000009
J	Liden, A; van Wieringen, T; Lannergard, J; Kassner, A; Heinegard, D; Reed, RK; Guss, B; Rubin, K				Liden, Asa; van Wieringen, Tijs; Lannergard, Jonas; Kassner, Anja; Heinegard, Dick; Reed, Rolf K.; Guss, Bengt; Rubin, Kristofer			A secreted collagen- and fibronectin-binding streptococcal protein modulates cell-mediated collagen gel contraction and interstitial fluid pressure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BB; MOLECULAR-BASIS; EQUI; INTEGRIN; EDEMA; ALPHA(11)BETA(1); ALPHA(1)BETA(1); IDENTIFICATION; ADHERENCE; RECEPTOR	Fibroblast-mediated collagen gel contraction depends on collagen-binding beta 1 integrins. Perturbation of these integrins reveals an alternative contraction process that is integrin alpha V beta 3-dependent and platelet-derived growth factor ( PDGF) BB-stimulated. Connective tissue cells actively control interstitial fluid pressure (IFP), and inflammation-induced lowering of IFP provides a driving force for edema formation. PDGF-BB normalizes a lowered IFP by an alpha V beta 3-dependent process. A potential modulation of IFP by extracellular matrix-binding bacterial proteins has previously not been addressed. The fibronectin (FN)-binding protein FNE is specifically secreted by the highly virulent Streptococcus equi subspecies equi. FNE bound FN and native collagen type I with K-d values of similar to 20 and similar to 50 nM determined by solid-phase binding assays. Rotary shadowing revealed a single FNE binding site located at on average 122 nm from the C terminus of procollagen type I. FNE induced alpha V beta 3-mediated contraction by C2C12 cells in a concentration-dependent manner having a maximal effect at similar to 100 nM. This activity of FNE required cellular FN, and FNE acted synergistically to added plasma FN or PDGF-BB. FNE enhanced binding of soluble FN to immobilized collagen, and conversely the binding of collagen to immobilized FN. Marked bell-shaped concentration dependences for these interactions suggest that FNE forms a bridge between FN and collagen. Finally, FNE normalized dermal IFP lowered by anaphylaxis. Our data suggest that secreted FNE normalized lowering of IFP by stimulating connective tissue cell contraction.	[Liden, Asa; van Wieringen, Tijs; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Liden, Asa; Reed, Rolf K.] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway; [Lannergard, Jonas; Guss, Bengt] Swedish Univ Agr Sci, Dept Microbiol, SE-75007 Uppsala, Sweden; [Kassner, Anja; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Uppsala University; University of Bergen; Swedish University of Agricultural Sciences; Lund University	Rubin, K (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC,Box 582, SE-75123 Uppsala, Sweden.	Kristofer.Rubin@imbim.uu.se	Reed, Rolf K./B-9422-2017; Lannergård, Jonas/L-6513-2013; Rubin, Kristofer/AAC-1810-2020	Reed, Rolf K./0000-0002-2633-6595; Rubin, Kristofer/0000-0003-2789-6276; Lannergard, Jonas/0000-0001-9072-6486; Guss, Bengt/0000-0002-7044-0701				Ahlen K, 1998, CELL ADHES COMMUN, V5, P461, DOI 10.3109/15419069809005604; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Berg A, 1998, AM J PHYSIOL-HEART C, V274, pH663, DOI 10.1152/ajpheart.1998.274.2.H663; Berg A, 2001, AM J PHYSIOL-HEART C, V281, pH7, DOI 10.1152/ajpheart.2001.281.1.H7; Cooke ME, 2000, J CELL SCI, V113, P2375; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; Grundstrom G, 2003, EXP CELL RES, V291, P463, DOI 10.1016/j.yexcr.2003.07.010; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hong KS, 2005, FEMS IMMUNOL MED MIC, V45, P231, DOI 10.1016/j.femsim.2005.04.006; KADLER KE, 1987, J BIOL CHEM, V262, P15696; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lannergard J, 2005, INFECT IMMUN, V73, P7243, DOI 10.1128/IAI.73.11.7243-7251.2005; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Liden A, 2006, BIOCHEM BIOPH RES CO, V340, P604, DOI 10.1016/j.bbrc.2005.12.043; Lindmark H, 1999, INFECT IMMUN, V67, P2383, DOI 10.1128/IAI.67.5.2383-2388.1999; Lindmark H, 2001, INFECT IMMUN, V69, P3159, DOI 10.1128/IAI.69.5.3159-3163.2001; Lindmark H, 1996, INFECT IMMUN, V64, P3993, DOI 10.1128/IAI.64.10.3993-3999.1996; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; MILLER EJ, 1982, METHOD ENZYMOL, V82, P33; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; REED RK, 1992, CIRC RES, V71, P978, DOI 10.1161/01.RES.71.4.978; RODT SA, 1994, CIRC RES, V75, P942, DOI 10.1161/01.RES.75.5.942; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; RUBIN K, 1981, CELL, V24, P463, DOI 10.1016/0092-8674(81)90337-8; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x; Xu Y, 2000, J BIOL CHEM, V275, P38981, DOI 10.1074/jbc.M007668200; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200	34	14	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1234	1242		10.1074/jbc.M704827200	http://dx.doi.org/10.1074/jbc.M704827200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003607	hybrid			2022-12-27	WOS:000252282700006
J	Zhu, CH; Sato, M; Yanagisawa, T; Fujimoto, M; Tsubata, T				Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Fujimoto, Manabu; Tsubata, Takeshi			Novel binding site for src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED SIGNALS; NEGATIVE REGULATOR; CELL ACTIVATION; CD22-DEFICIENT MICE; SHP-1; PHOSPHORYLATION; LYN; DOMAINS; PATHWAY; REQUIREMENT	CD22, a B lymphocyte membrane glycoprotein, contains immunoreceptor tyrosine-based inhibition motifs (ITIMs) in the cytoplasmic region and recruits Src homology 2-containing protein-tyrosine phosphatase-1 (SHP-1) to the phosphorylated ITIMs upon ligation of B lymphocyte antigen receptor (BCR), thereby negatively regulating BCR signaling. Among the three previously identified ITIMs, both ITIMs containing tyrosine residues at position 843 (Tyr(843)) and 863 (Tyr(863)), respectively, are shown to be required for CD22 to recruit SHP-1 and regulate BCR signaling upon BCR ligation by anti-Ig antibody ( Ab), indicating that CD22 has the SHP-1-binding domain at the region containing Tyr(843) and Tyr(863). Here we address the requirement of CD22 for SHP-1 recruitment and BCR regulation upon BCR ligation by antigen, which induces much stronger CD22 phosphorylation than anti-Ig Ab does. We demonstrate that the CD22 mutant in which both Tyr(843) and Tyr(863) are replaced by phenylalanine (CD22F5/6) recruits SHP-1 and regulates BCR signaling upon stimulation with antigen but not anti-Ig Ab. This result strongly suggests that CD22 contains another SHP-1 binding domain that is specifically activated upon stimulation with antigen. Both of the flanking sequences of Tyr(783) and Tyr(817) fit the consensus sequence of ITIM, and the CD22F5/6 mutant requires these tyrosine residues for SHP-1 binding and BCR regulation. Thus, these ITIMs constitute a novel conditional SHP-1-binding site of CD22 that is activated upon BCR ligation by antigen but not by anti-Ig Ab.	[Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Tsubata, Takeshi] Tokyo Med & Dent Univ, Immunol Lab, Sch Biomed Sci, Bunkyo Ku, Tokyo 1138510, Japan; [Zhu, Chenghua; Sato, Motohiko; Yanagisawa, Teruhiko; Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Tokyo 1138510, Japan; [Fujimoto, Manabu] Kanazawa Univ, Dept Dermatol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Zhu, Chenghua; Tsubata, Takeshi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Kanazawa University; Japan Science & Technology Agency (JST)	Tsubata, T (corresponding author), Tokyo Med & Dent Univ, Immunol Lab, Sch Biomed Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258; Fujimoto, Manabu/0000-0002-3062-4872				Blasioli J, 1999, J BIOL CHEM, V274, P2303, DOI 10.1074/jbc.274.4.2303; Chan VWF, 1998, CURR BIOL, V8, P545, DOI 10.1016/S0960-9822(98)70223-4; Chen J, 2004, NAT IMMUNOL, V5, P651, DOI 10.1038/ni1072; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Fujimoto M, 2006, J IMMUNOL, V176, P873, DOI 10.4049/jimmunol.176.2.873; Grignani F, 1998, CANCER RES, V58, P14; Hokazono Y, 2003, J IMMUNOL, V171, P1835, DOI 10.4049/jimmunol.171.4.1835; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; Nitschke L, 2005, CURR OPIN IMMUNOL, V17, P290, DOI 10.1016/j.coi.2005.03.005; Nitschke L, 2004, TRENDS IMMUNOL, V25, P543, DOI 10.1016/j.it.2004.08.002; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Onishi M, 1996, EXP HEMATOL, V24, P324; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Otipoby KL, 2001, J BIOL CHEM, V276, P44315, DOI 10.1074/jbc.M105446200; Poe JC, 2000, J BIOL CHEM, V275, P17420, DOI 10.1074/jbc.M001892200; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Smith KGC, 1998, J EXP MED, V187, P807, DOI 10.1084/jem.187.5.807; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; THOMAS ML, 1995, J EXP MED, V181, P1953, DOI 10.1084/jem.181.6.1953; Tooze RM, 1997, IMMUNITY, V7, P59, DOI 10.1016/S1074-7613(00)80510-5; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Yamanashi Y, 1997, J EXP MED, V185, P1387, DOI 10.1084/jem.185.7.1387; Yang J, 2003, J BIOL CHEM, V278, P6516, DOI 10.1074/jbc.M210430200; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769; Yu J, 2007, BIOCHEM BIOPH RES CO, V360, P759, DOI 10.1016/j.bbrc.2007.06.110; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	33	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1653	1659		10.1074/jbc.M706584200	http://dx.doi.org/10.1074/jbc.M706584200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024433	hybrid			2022-12-27	WOS:000252282700052
J	Thorn, A; Egerer-Sieber, C; Jager, CM; Herl, V; Muller-Uri, F; Kreis, W; Muller, YA				Thorn, Andrea; Egerer-Sieber, Claudia; Jaeger, Christof M.; Herl, Vanessa; Mueller-Uri, Frieder; Kreis, Wolfgang; Muller, Yves A.			The crystal structure of progesterone 5 beta-reductase from Digitalis lanata defines a novel class of short chain dehydrogenases/reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL ASSIGNMENTS; ALCOHOL DEHYDROGENASES; BIOSYNTHETIC-PATHWAY; LIGAND INTERACTIONS; ACTIVE-SITE; REDUCTASE; PROTEINS; ENZYME; REFINEMENT; FAMILY	Progesterone 5 beta-reductase (5 beta-POR) catalyzes the stereospecific reduction of progesterone to 5 beta-pregnane-3,20-dione and is a key enzyme in the biosynthetic pathway of cardenolides in Digitalis (foxglove) plants. Sequence considerations suggested that 5 beta-POR is a member of the short chain dehydrogenase/reductase (SDR) family of proteins but at the same time revealed that the sequence motifs that in standard SDRs contain the catalytically important residues are missing. Here we present crystal structures of 5 beta-POR from Digitalis lanata in complex with NADP(+) at 2.3 angstrom and without cofactor bound at 2.4 angstrom resolution together with a model of a ternary complex consisting of 5 beta-POR, NADP(+), and progesterone. Indeed, 5 beta-POR displays the fold of an extended SDR. The architecture of the active site is, however, unprecedented because none of the standard catalytic residues are structurally conserved. A tyrosine (Tyr-179) and a lysine residue (Lys-147) are present in the active site, but they are displayed from novel positions and are part of novel sequence motifs. Mutating Tyr-179 to either alanine or phenylalanine completely abolishes the enzymatic activity. We propose that the distinct topology reflects the fact that 5 beta-POR reduces a conjugated double bond in a steroid substrate via a 1-4 addition mechanism and that this requires a repositioning of the catalytically important residues. Our observation that the sequence motifs that line the active site are conserved in a number of bacterial and plant enzymes of yet unknown function leads us to the proposition that 5 beta-POR defines a novel class of SDRs.	[Thorn, Andrea; Egerer-Sieber, Claudia; Jaeger, Christof M.; Muller, Yves A.] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, D-91052 Erlangen, Germany; [Herl, Vanessa; Mueller-Uri, Frieder; Kreis, Wolfgang] Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Pharmazeut Biol, D-91058 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Lehrstuhl Biotech, Henkestr 91, D-91052 Erlangen, Germany.	ymuller@biologie.uni-erlangen.de	Muller, Yves A/R-5397-2016; Thorn, Andrea/HHC-2296-2022; Thorn, Andrea/Q-3142-2017; Jäger, Christof/N-1740-2014	Muller, Yves A/0000-0003-0519-8928; Thorn, Andrea/0000-0003-4503-4258; Jäger, Christof/0000-0002-1802-1892				Alphey MS, 2005, J BIOL CHEM, V280, P3068, DOI 10.1074/jbc.M411069200; ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; ANTMAN EM, 1985, ANNU REV MED, V36, P357; Bennett MJ, 1996, BIOCHEMISTRY-US, V35, P10702, DOI 10.1021/bi9604688; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BJORKHEM I, 1992, J BIOL CHEM, V267, P19872; Bottoms CA, 2002, PROTEIN SCI, V11, P2125, DOI 10.1110/ps.0213502; Breton R, 1996, STRUCTURE, V4, P905, DOI 10.1016/S0969-2126(96)00098-6; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; CASPI E, 1967, SCIENCE, V156, P519, DOI 10.1126/science.156.3774.519; Chayen NE, 1996, PROTEIN ENG, V9, P927, DOI 10.1093/protein/9.10.927; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Edwards KJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P173, DOI 10.1006/abbi.1996.0158; Egerer-Sieber C, 2006, ACTA CRYSTALLOGR F, V62, P186, DOI 10.1107/S1744309106001916; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; GARTNER DE, 1990, FEBS LETT, V271, P239, DOI 10.1016/0014-5793(90)80415-F; Gavidia I, 2007, PHYTOCHEMISTRY, V68, P853, DOI 10.1016/j.phytochem.2006.11.019; Gheorghiade M, 2004, CIRCULATION, V109, P2959, DOI 10.1161/01.CIR.0000132482.95686.87; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Grimm C, 2000, J BIOL CHEM, V275, P41333, DOI 10.1074/jbc.M007559200; Herl V, 2006, PHYTOCHEMISTRY, V67, P225, DOI 10.1016/j.phytochem.2005.11.013; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 2001, CHEM-BIOL INTERACT, V130, P499, DOI 10.1016/S0009-2797(00)00295-7; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Jornvall H, 1999, FEBS LETT, V445, P261, DOI 10.1016/S0014-5793(99)00130-1; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kallberg Y, 2002, EUR J BIOCHEM, V269, P4409, DOI 10.1046/j.1432-1033.2002.03130.x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; LEACH AR, 1994, J MOL BIOL, V235, P345, DOI 10.1016/S0022-2836(05)80038-5; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; MATHEWS CK, 2000, BIOCHEMISTRY-US, P340; Michael G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Penning TM, 2001, CHEM-BIOL INTERACT, V130, P659, DOI 10.1016/S0009-2797(00)00257-X; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; RAFFERTY JB, 1995, STRUCTURE, V3, P927, DOI 10.1016/S0969-2126(01)00227-1; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; ROSSMANN MG, 1976, J MOL BIOL, V105, P75, DOI 10.1016/0022-2836(76)90195-9; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Stuhlemmer U, 1996, PLANT PHYSIOL BIOCH, V34, P85; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb NA, 2004, PROTEIN SCI, V13, P529, DOI 10.1110/ps.03393904; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WITHERING W, 1941, CLASSICS CARDIOLOGY, V1, P231	52	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2008	283	25					17260	17269		10.1074/jbc.M706185200	http://dx.doi.org/10.1074/jbc.M706185200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	313DF	18032383	hybrid			2022-12-27	WOS:000256720600035
J	D'Costa, SM; Bainbridge, TW; Condit, RC				D'Costa, Susan M.; Bainbridge, Travis W.; Condit, Richard C.			Purification and properties of the vaccinia virus mRNA processing factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPHOSPHATE PHOSPHOHYDROLASE I; TRANSCRIPTION ELONGATION-FACTOR; TEMPERATURE-SENSITIVE MUTANTS; A18R DNA HELICASE; EXONUCLEASE XRN2; J3 PROTEIN; GENE G2R; H5R GENE; POLYMERASE; TERMINATION	The mRNAs encoding the vaccinia virus F17 protein and the cowpox A-type inclusion protein are known to possess sequence-homogeneous 3' ends, generated by a post-transcriptional cleavage event. By using partially purified extracts, we have previously shown that the same factor probably cleaves both the F17 and A-type inclusion protein transcripts and that the cleavage factor is either virus-coded or virus-induced during the post-replicative phase of virus replication. In this study, we have purified the cleavage factor from vaccinia-infected HeLa cells using column chromatography and gel filtration. The factor eluted from the gel filtration column with an apparent molecular mass of similar to 440 kDa. Mass spectrometric analyses of the proteins present in the peak active fractions revealed the presence of at least one vaccinia protein with a high degree of certainty, the H5R gene product. To extend this finding, extracts were prepared from HeLa cells infected with vaccinia virus over-expressing His-tagged H5, chromatographed on a nickel affinity column, and eluted using an imidazole gradient. Cleavage activity eluted with the peak of His-tagged H5. Gel filtration of the affinity-purified material further demonstrated that cleavage activity and His-tagged H5 co-chromatographed with an apparent molecular mass of 463 kDa. We therefore conclude that H5 is specifically associated with post-transcriptional cleavage of F17R transcripts. In addition, we show that dephosphorylation of a cleavage competent extract with a nonspecific phosphatase abolishes cleavage activity implying a role for phosphorylation in cleavage activity.	[D'Costa, Susan M.; Bainbridge, Travis W.; Condit, Richard C.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	D'Costa, SM (corresponding author), Univ Florida, J Hillis Miller Hlth Ctr, PO Box 100266, Gainesville, FL 32610 USA.	ihssd@ufl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018094] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI18094] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; BEAUD G, 1995, J VIROL, V69, P1819, DOI 10.1128/JVI.69.3.1819-1826.1995; Beaud G, 1997, J GEN VIROL, V78, P3297, DOI 10.1099/0022-1317-78-12-3297; Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Brown N G, 2000, BMC Biochem, V1, P2, DOI 10.1186/1471-2091-1-2; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Condit RC, 1996, VIROLOGY, V220, P10, DOI 10.1006/viro.1996.0280; CONDIT RC, 1991, VIROLOGY, V185, P857, DOI 10.1016/0042-6822(91)90559-T; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cresawn SG, 2007, VIROLOGY, V363, P319, DOI 10.1016/j.virol.2007.02.005; Cresawn SG, 2007, VIROLOGY, V363, P333, DOI 10.1016/j.virol.2007.02.016; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; Dellis S, 2004, VIROLOGY, V329, P328, DOI 10.1016/j.virol.2004.08.017; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GORDON J, 1991, VIROLOGY, V181, P671, DOI 10.1016/0042-6822(91)90901-M; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; Lackner CA, 2000, J BIOL CHEM, V275, P1485, DOI 10.1074/jbc.275.2.1485; Lackner CA, 2003, VIROLOGY, V305, P240, DOI 10.1006/viro.2002.1745; Latner DR, 2000, VIROLOGY, V269, P345, DOI 10.1006/viro.2000.0243; Latner DR, 2002, VIROLOGY, V301, P64, DOI 10.1006/viro.2002.1538; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; MEIS RJ, 1991, VIROLOGY, V182, P442, DOI 10.1016/0042-6822(91)90585-Y; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; Moss B, 2001, FIELDS VIROLOGY, P2849; NOWAKOWSKI M, 1978, VIROLOGY, V86, P217, DOI 10.1016/0042-6822(78)90022-3; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; Rodgers ND, 2002, J BIOL CHEM, V277, P2597, DOI 10.1074/jbc.M108330200; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Turner PC, 1999, J VIROL, V73, P6394, DOI 10.1128/JVI.73.8.6394-6404.1999; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Xiang Y, 2000, VIROLOGY, V269, P356, DOI 10.1006/viro.2000.0242; Xiang Y, 1998, J VIROL, V72, P7012, DOI 10.1128/JVI.72.9.7012-7023.1998; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	54	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5267	5275		10.1074/jbc.M709258200	http://dx.doi.org/10.1074/jbc.M709258200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089571	hybrid			2022-12-27	WOS:000253426700006
J	Zhang, HM; Hamdane, D; Im, SC; Waskell, L				Zhang, Haoming; Hamdane, Djemel; Im, Sang-Choul; Waskell, Lucy			Cytochrome b(5) inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P4502B4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; P450 REDUCTASE; PROTEIN INTERACTIONS; P-450 REDUCTASE; ENZYME-SYSTEM; BINDING-SITE; B(5); NADPH; OXIDATION; 2B4	Experiments demonstrating that cytochrome (cyt) b(5) inhibits the activity of cytochrome P450 2B4 ( cyt P450 2B4) at higher concentrations suggested that cyt b(5) was occupying the cyt P450 reductase-binding site on cyt P450 2B4 and preventing the reduction of ferric cyt P450 (Zhang, H., Im, S.-C., and Waskell, L. (2007) J. Biol. Chem. 282, 29766-29776). In this work experiments were undertaken with manganese-containing cyt b(5) (Mn-cyt b(5)) to test this hypothesis. Because Mn-cyt b(5) does not undergo oxidation state changes under our experimental conditions, interpretation of the experimental results was unambiguous. The rate of electron transfer from cyt P450 reductase to ferric cyt P450 2B4 was decreased by Mn-cyt b(5) in a concentration-dependent manner. Moreover, reduction of cyt P450 2B4 by cyt P450 reductase was incomplete in the presence of Mn-cyt b5. At a Mn-cyt b5: cyt P450 2B4: cyt P450 reductase molar ratio of 5: 1: 1, the rate of reduction of ferric cyt P450 was decreased by 10-fold, and only 30% of the cyt P450 was reduced, whereas 70% remained oxidized. It could be demonstrated that Mn-cyt b(5) had its effect by acting on cyt P450, not the reductase, because the reduction of cyt c by cyt P450 reductase in the presence of Mn-cyt b(5) was not effected. Furthermore, under steady-state conditions in the cyt P450 reconstituted system, Mn-cyt b(5), which lacks the ability to reduce oxyferrous cyt P450 2B4, was unable to stimulate the activity of cyt P450. Mn-cyt b(5) only inhibited the cyt P450 2B4 activity. In conjunction with site-directed mutagenesis studies and experiments that strongly suggested that cyt b(5) competed with cyt P450 reductase for binding to cyt P450, the current investigation demonstrates unequivocally that cyt b(5) inhibits the activity of cyt P450 2B4 by preventing cyt P450 reductase from binding to cyt P450, a prerequisite for electron transfer from cyt P450 reductase to cyt P450 and catalysis.	[Zhang, Haoming; Hamdane, Djemel; Im, Sang-Choul; Waskell, Lucy] Univ Michigan, Sch Med, Vet Affairs Med Ctr, Dept Anesthesiol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Waskell, L (corresponding author), Univ Michigan, Dept Anesthesiol, Res Serv, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	waskell@umich.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKES WL, 1989, J BIOL CHEM, V264, P6252; BACKES WL, 1988, J BIOL CHEM, V263, P247; BONFILS C, 1981, J BIOL CHEM, V256, P9457; BOSTERLING B, 1982, J BIOL CHEM, V257, P4375; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CANOVADAVIS E, 1984, J BIOL CHEM, V259, P2541; Davydov DR, 2000, BIOCHEMISTRY-US, V39, P6489, DOI 10.1021/bi992936u; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Estabrook R W, 1978, Methods Enzymol, V52, P212; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; GRAY RD, 1978, J BIOL CHEM, V253, P4364; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Gruenke LD, 1997, BIOCHEMISTRY-US, V36, P7114, DOI 10.1021/bi970407p; GUENGERICH FP, 1975, J BIOL CHEM, V250, P7405; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Guryev OL, 2001, BIOCHEMISTRY-US, V40, P5018, DOI 10.1021/bi002305w; Ivanov YD, 1999, ARCH BIOCHEM BIOPHYS, V362, P87, DOI 10.1006/abbi.1998.0981; Locuson CW, 2007, DRUG METAB DISPOS, V35, P1174, DOI 10.1124/dmd.107.014910; MAYUZUMI H, 1994, ARCH BIOCHEM BIOPHYS, V310, P367, DOI 10.1006/abbi.1994.1180; MIWA GT, 1979, J BIOL CHEM, V254, P5695; Mokashi V, 2003, ARCH BIOCHEM BIOPHYS, V412, P147, DOI 10.1016/S0003-9861(03)00040-7; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; PETERSON JA, 1977, J BIOL CHEM, V252, P4431; POMPON D, 1984, J BIOL CHEM, V259, P5377; Reed JR, 2003, J INORG BIOCHEM, V97, P265, DOI 10.1016/S0162-0134(03)00275-7; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SPATZ L, 1971, P NATL ACAD SCI USA, V68, P1042, DOI 10.1073/pnas.68.5.1042; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; TAMBURINI PP, 1987, P NATL ACAD SCI USA, V84, P11, DOI 10.1073/pnas.84.1.11; TAMBURINI PP, 1985, J BIOL CHEM, V260, P4007; VAN GB, 1962, BIOCHIM BIOPHYS ACTA, V58, P593; VATSIS KP, 1979, ACTA BIOL MED GER, V38, P459; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; WU FF, 1994, ARCH BIOCHEM BIOPHYS, V308, P380, DOI 10.1006/abbi.1994.1054; Yamaori S, 2003, BIOCHEM PHARMACOL, V66, P2333, DOI 10.1016/j.bcp.2003.08.004; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhang HM, 2005, BIOCHEM BIOPH RES CO, V338, P499, DOI 10.1016/j.bbrc.2005.09.022	49	44	44	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5217	5225		10.1074/jbc.M709094200	http://dx.doi.org/10.1074/jbc.M709094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086668	hybrid			2022-12-27	WOS:000253426700001
J	Choi, DW; Seo, YM; Kim, EA; Sung, KS; Ahn, JW; Park, SJ; Lee, SR; Choi, CY				Choi, Dong Wook; Seo, Yu-Mi; Kim, Eun-A; Sung, Ki Sa; Ahn, Jang Won; Park, Sang-Joon; Lee, Seung-Rock; Choi, Cheol Yong			Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SOCS-BOX; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; P53 PHOSPHORYLATION; WD-REPEAT; HIPK2; KINASE-2; APOPTOSIS; LIGASE	Homeodomain-interacting protein kinase 2 (HIPK2) is a member of the nuclear protein kinase family, which induces both p53- and CtBP-mediated apoptosis. Levels of HIPK2 were increased by UV irradiation and cisplatin treatment, thereby implying the degradation of HIPK2 in cells under normal conditions. Here, we indicate that HIPK2 is ubiquitinated and degraded by the WD40-repeat/SOCS box protein WSB-1, a process that is blocked under DNA damage conditions. Yeast two-hybrid screening was conducted to identify the proteins that interact with HIPK2. WSB-1, an E3 ubiquitin ligase, was characterized as an HIPK2-interacting protein. The coexpression of WSB-1 resulted in the degradation of HIPK2 via its C-terminal region. Domain analysis of WSB-1 showed that WD40-repeats and the SOCS box were required for its interaction with and degradation of HIPK2, respectively. In support of the degradation of HIPK2 by WSB-1, HIPK2 was polyubiquitinated by WSB-1 in vitro and in vivo. The knockdown of endogenous WSB-1 with the expression of short hairpin RNA against WSB-1 increases the stability of endogenous HIPK2 and resulted in the accumulation of HIPK2. The ubiquitination and degradation of HIPK2 by WSB-1 was inhibited completely via the administration of DNA damage reagents, including Adriamycin and cisplatin. These findings effectively illustrate the regulatory mechanisms by which HIPK2 is maintained at a low level, by WSB-1 in cells under normal conditions, and stabilized by genotoxic stresses.	[Choi, Dong Wook; Seo, Yu-Mi; Kim, Eun-A; Sung, Ki Sa; Ahn, Jang Won; Choi, Cheol Yong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Park, Sang-Joon] Korea Res Inst Chem Technol, Korea Inst Toxicol, Taejon 305600, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med, Ctr Aging & Geriatr, Dept Biochem, Kwangju 501746, South Korea	Sungkyunkwan University (SKKU); Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Chonnam National University	Choi, CY (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, 300 Chunchundong, Suwon 440746, South Korea.	choicy@skku.ac.kr		Choi, Dong Wook/0000-0002-5729-2273				Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Erkeland SJ, 2007, ONCOGENE, V26, P1985, DOI 10.1038/sj.onc.1210004; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Moller A, 2003, ONCOGENE, V22, P8731, DOI 10.1038/sj.onc.1207079; Moller A, 2003, CANCER RES, V63, P4310; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang Y, 2001, BBA-GENE STRUCT EXPR, V1518, P168, DOI 10.1016/S0167-4781(00)00308-0; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Zeold A, 2006, J BIOL CHEM, V281, P31538, DOI 10.1074/jbc.M604728200; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102	52	87	93	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4682	4689		10.1074/jbc.M708873200	http://dx.doi.org/10.1074/jbc.M708873200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093972	hybrid			2022-12-27	WOS:000253426500026
J	Nakamura, T; de Vega, S; Fukumoto, S; Jimenez, L; Unda, F; Yamada, Y				Nakamura, Takashi; de Vega, Susana; Fukumoto, Satoshi; Jimenez, Lucia; Unda, Fernando; Yamada, Yoshihiko			Transcription factor epiprofin is essential for tooth morphogenesis by regulating epithelial cell fate and tooth number	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING MOUSE TOOTH; EPIDERMAL MORPHOGENESIS; MICE; LIMB; PROLIFERATION; EXPRESSION; GROWTH; GENE; ABNORMALITIES; AMELOBLASTIN	In tooth morphogenesis, the dental epithelium and mesenchyme interact reciprocally for growth and differentiation to form the proper number and shapes of teeth. We previously identified epiprofin (Epfn), a gene preferentially expressed in dental epithelia, differentiated ameloblasts, and certain ectodermal organs. To identify the role of Epfn in tooth development, we created Epfn-deficient mice (Epfn(-/-)). Epfn(-/-) mice developed an excess number of teeth, enamel deficiency, defects in cusp and root formation, and abnormal dentin structure. Mutant tooth germs formed multiple dental epithelial buds into the mesenchyme. In Epfn(-/-) molars, rapid proliferation and differentiation of the inner dental epithelium were inhibited, and the dental epithelium retained the progenitor phenotype. Formation of the enamel knot, a signaling center for cusps, whose cells differentiate from the dental epithelium, was also inhibited. However, multiple premature nonproliferating enamel knot-like structures were formed ectopically. These dental epithelial abnormalities were accompanied by dysregulation of Lef-1, which is required for the normal transition from the bud to cap stage. Transfection of an Epfn vector promoted dental epithelial cell differentiation into ameloblasts and activated promoter activity of the enamel matrix ameloblastin gene. Our results suggest that in Epfn-deficient teeth, ectopic nonproliferating regions likely bud off from the self-renewable dental epithelium, form multiple branches, and eventually develop into supernumerary teeth. Thus, Epfn has multiple functions for cell fate determination of the dental epithelium by regulating both proliferation and differentiation, preventing continuous tooth budding and generation.	[Nakamura, Takashi; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, Bethesda, MD 20892 USA; [Fukumoto, Satoshi] Kyushu Univ, Fac Dent Sci, Dept Pediat Dent, Fukuoka 8128582, Japan; [Jimenez, Lucia; Unda, Fernando] Univ Basque Country, Fac Med & Dent, Dept Cell Biol & Histol, Vizcaya 48940, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; University of Basque Country	Yamada, Y (corresponding author), NIDCR, Lab Cell & Dev Biol, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	de Vega, Susana/AAH-4775-2020; Unda, Fernando/AAF-9128-2019; Nakamura, Takashi/A-8931-2012; Jimenez, Lucia/AAG-1367-2019; Nakamura, Takashi/P-7796-2016; Jimenez, Lucia/K-3377-2012	Nakamura, Takashi/0000-0001-9904-1037; Jimenez, Lucia/0000-0003-1699-8437; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Fjeld K, 2005, DEV DYNAM, V233, P161, DOI 10.1002/dvdy.20285; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; JARVINEN E, 2006, P NATL ACAD SCI US; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawano S, 2002, CONNECT TISSUE RES, V43, P409, DOI 10.1080/03008200290000637; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Li FQ, 2000, MOL CELL BIOL, V20, P5129, DOI 10.1128/MCB.20.14.5129-5139.2000; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	32	86	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4825	4833		10.1074/jbc.M708388200	http://dx.doi.org/10.1074/jbc.M708388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156176	hybrid			2022-12-27	WOS:000253426500040
J	Hu, Z; Shanker, S; MacLean, JA; Ackerman, SL; Wilkinson, MF				Hu, Zhiying; Shanker, Sreenath; MacLean, James A., II; Ackerman, Susan L.; Wilkinson, Miles F.			The RHOX5 homeodomain protein mediates transcriptional repression of the netrin-1 receptor gene Unc5c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SERTOLI-CELLS; HOMEOBOX GENES; RAT TESTIS; SEX DETERMINATION; DEFICIENT MICE; MUTANT MICE; DNA COMPLEX; C-ELEGANS; HOX; CLUSTER	The X-linked mouse Rhox gene cluster contains more than 30 homeobox genes that are candidates to regulate multiple steps in male and female gametogenesis. The founding member of the Rhox gene cluster, Rhox5, is an androgen-dependent gene expressed in Sertoli cells that promotes the survival and differentiation of the adjacent male germ cells. Here, we report the first identification and characterization of a Rhox5-regulated gene. This gene, Unc5c, encodes a pro-apoptotic receptor with tumor suppressor activity that we found is negatively regulated by Rhox5 in the testis in vivo. Transfection analyses in cell lines of different origin indicated that Rhox5-dependent down-regulation of Unc5c requires another Sertoli cell-specific cofactor. Examination of other mouse Rhox family members revealed that mouse RHOX2 and RHOX3 also have the ability to down-regulate Unc5c expression. The human RHOX protein PEPP2 (RHOXF2) also had this ability, indicating that Unc5c repression is a conserved RHOX-dependent response. Deletion analysis identified a Rhox5-responsive element in the Unc5c 5'-untranslated region. Although 5'-untranslated regions typically house post-transcriptional elements, several lines of evidence indicated that Rhox5 down-regulates Unc5c at the transcriptional level. The repression of Unc5c expression by Rhox5 may, in part, mediate the pro-survival function of Rhox5 in the testis, as we found that Unc5c mutant mice have decreased germ cell apoptosis in the testis. Along with our other data, these findings led us to propose a model in which Rhox5 is a negative regulator upstream of Unc5c in a Sertoli-cell pathway that promotes germ-cell survival.	[Hu, Zhiying; Shanker, Sreenath; MacLean, James A., II; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hu, Zhiying] Univ Texas Houston, Grad Sch Biomed Sci, Grad Training Program Genes & Dev, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; Jackson Laboratory; University of Texas System; University of Texas Health Science Center Houston	Wilkinson, MF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mwilkins@mdanderson.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; NICHD NIH HHS [HD45595, R01 HD045595] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ackerman SL, 1998, GENOMICS, V52, P205, DOI 10.1006/geno.1998.5425; ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Benson GV, 1996, DEVELOPMENT, V122, P2687; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chiba S, 1998, INT J HEMATOL, V68, P343; Darbinian N, 2006, J CELL BIOCHEM, V99, P1052, DOI 10.1002/jcb.20872; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Ebner A, 2005, DEVELOPMENT, V132, P1591, DOI 10.1242/dev.01721; Fohn LE, 2001, GENOMICS, V74, P105, DOI 10.1006/geno.2001.6532; GEHRING WJ, 1993, GENE, V135, P215, DOI 10.1016/0378-1119(93)90068-E; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Guo F, 2005, ACTA BIOCH BIOPH SIN, V37, P784, DOI 10.1111/j.1745-7270.2005.00102.x; Guo Fen, 2007, Journal of Genetics and Genomics, V34, P392, DOI 10.1016/S1673-8527(07)60042-3; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Jahnukainen K, 2004, BIOL REPROD, V70, P290, DOI 10.1095/biolreprod.103.018390; Kappen C, 2000, P NATL ACAD SCI USA, V97, P4481, DOI 10.1073/pnas.97.9.4481; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Lee CS, 2004, BEST PRACT RES CL EN, V18, P453, DOI 10.1016/j.beem.2004.08.008; Lemmens IH, 2001, BIOCHEM BIOPH RES CO, V286, P426, DOI 10.1006/bbrc.2001.5405; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEPESANT JA, 1990, REPROD NUTR DEV, pS9, DOI 10.1051/rnd:19900702; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Lin CJ, 2001, J IMMUNOL, V166, P6134, DOI 10.4049/jimmunol.166.10.6134; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; Lindsey JS, 1996, BIOL REPROD, V55, P975, DOI 10.1095/biolreprod55.5.975; Lindsey S, 1996, J ASSIST REPROD GEN, V13, P182, DOI 10.1007/BF02072542; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Luo Zhi-Wen, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P125; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; MACLEOD CL, 1990, CELL GROWTH DIFFER, V1, P271; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Porter AG, 2004, BIOESSAYS, V26, P656, DOI 10.1002/bies.20037; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Rao M, 2002, EPIDIDYMIS MOL CLIN, P269, DOI 10.1007/978-1-4615-0679-9_15; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; STEINBERGER A, 1971, BIOL REPROD, V4, P84, DOI 10.1093/biolreprod/4.1.84; Sutton KA, 1998, J ANDROL, V19, P21; Suzuki M, 2003, J BIOL CHEM, V278, P30148, DOI 10.1074/jbc.M303932200; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WAGLE JR, 1986, IN VITRO CELL DEV B, V22, P325; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; WILKINSON M, 1991, ESSENTIAL MOL BIOL, V1, P69; WILKINSON MF, 1990, DEV BIOL, V141, P451, DOI 10.1016/0012-1606(90)90400-D; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759	72	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3866	3876		10.1074/jbc.M706717200	http://dx.doi.org/10.1074/jbc.M706717200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077458	hybrid			2022-12-27	WOS:000253083500021
J	Kim, EJ; Kim, JS; Lee, IH; Rhee, HJ; Lee, JK				Kim, Eui-Jin; Kim, Ju-Sim; Lee, Il-Han; Rhee, Hae J.; Lee, Jeong K.			Superoxide generation by chlorophyllide a reductase of Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE REDUCTASE; IRON-SULFUR PROTEINS; ESCHERICHIA-COLI; BACTERIOCHLOROPHYLL BIOSYNTHESIS; GENETIC-ANALYSIS; RHODOPSEUDOMONAS-SPHAEROIDES; OXIDATIVE STRESS; CAPSULATUS; EXPRESSION; NITROGENASE	Chlorophyllide a reductase of Rhodobacter sphaeroides, which were reconstituted with the purified subunits of BchX, BchY, and BchZ, reduced ring B of chlorophyllide a using NADH under anaerobic conditions. Interestingly, suppressor mutations rescuing the inability of R. sphaeroides Fe-SOD mutant to grow in succinate-based minimal medium were predominantly mapped to BchZ subunit of chlorophyllide a reductase. The enzyme is labile in the presence of O-2. However, it generates superoxide at low O-2. The enzymes reconstituted with BchX, BchY, and the mutein subunit of BchZ from suppressor mutants showed less activity not only for chlorophyllide a reduction but also for superoxide generation compared with the enzyme reconstituted with the wild-type subunits. BchX, which contains FMN, and BchY are iron-sulfur proteins, whereas BchZ is a hemoprotein containing b-type heme. Neither chlorophyllide a reduction nor superoxide generation was observed with the enzyme reconstituted with the wild-type subunits of BchX and BchY, and the apo-subunit of BchZ that had been refolded without heme, in which FMN of BchX was fully reduced. Thus, superoxide is generated not from FMN of BchX but from heme of BchZ. Consistently, the heme of BchZ muteins was half-reduced in its redox state compared with that of wild-type BchZ.	[Kim, Eui-Jin; Kim, Ju-Sim; Lee, Il-Han; Rhee, Hae J.; Lee, Jeong K.] Sogang Univ, Dept Life Sci, Interdisciplinary Program Integrated Biol, Seoul 121742, South Korea	Sogang University	Lee, JK (corresponding author), Sogang Univ, Dept Life Sci, Interdisciplinary Program Integrated Biol, Seoul 121742, South Korea.	jgklee@sogang.ac.kr	lee, jeong/HGD-9839-2022					Abada EM, 2002, MOL GENET GENOMICS, V267, P202, DOI 10.1007/s00438-002-0652-y; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; ARMSTRONG GA, 1993, J GEN MICROBIOL, V139, P897, DOI 10.1099/00221287-139-5-897; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benov L, 1999, J BIOL CHEM, V274, P4202, DOI 10.1074/jbc.274.7.4202; Benov L, 1996, J BIOL CHEM, V271, P21037, DOI 10.1074/jbc.271.35.21037; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Cortez N, 1998, J BACTERIOL, V180, P5413, DOI 10.1128/JB.180.20.5413-5420.1998; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; DAILEY HA, 1982, J BIOL CHEM, V257, P4714; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; Des Marais DJ, 2000, SCIENCE, V289, P1703; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; DONOHUE TJ, 1986, J BACTERIOL, V168, P962, DOI 10.1128/jb.168.2.962-972.1986; DRYDEN SC, 1990, NUCLEIC ACIDS RES, V18, P7267, DOI 10.1093/nar/18.24.7267; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096; FUHRHOP JH, 1975, LAB METHODS, P804; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; GAUDU P, 1994, J BIOL CHEM, V269, P8182; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; GOMELSKY M, 1995, J BACTERIOL, V177, P1634, DOI 10.1128/jb.177.6.1634-1637.1995; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Goodwin PJ, 1998, BIOCHEMISTRY-US, V37, P10420, DOI 10.1021/bi980435n; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; JOHNSON MK, 1988, J BIOL CHEM, V263, P14732; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Kho DH, 2004, FEMS MICROBIOL LETT, V234, P261, DOI 10.1111/j.1574-6968.2004.tb09542.x; Kim JS, 2003, J BIOL CHEM, V278, P18455, DOI 10.1074/jbc.M211740200; Kim JS, 2006, J BACTERIOL, V188, P8586, DOI 10.1128/JB.01084-06; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kroliczewski J, 2005, BIOCHEMISTRY-US, V44, P7570, DOI 10.1021/bi047422w; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; Lee IH, 2002, APPL MICROBIOL BIOT, V60, P147, DOI 10.1007/s00253-002-1097-2; LEE JK, 1992, J BACTERIOL, V174, P1146, DOI 10.1128/jb.174.4.1146-1157.1992; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCGLYNN P, 1993, MOL GEN GENET, V236, P227, DOI 10.1007/BF00277117; MEINHARDT SW, 1985, ARCH BIOCHEM BIOPHYS, V236, P130, DOI 10.1016/0003-9861(85)90612-5; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Oh JI, 2001, MOL MICROBIOL, V39, P1116, DOI 10.1046/j.1365-2958.2001.02299.x; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Pasternak C, 1999, J BACTERIOL, V181, P100, DOI 10.1128/JB.181.1.100-106.1999; Ponnampalam SN, 1998, J BIOL CHEM, V273, P30757, DOI 10.1074/jbc.273.46.30757; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Roubaud V, 1998, ANAL BIOCHEM, V257, P210, DOI 10.1006/abio.1997.2542; Sambrook J., 2001, MOL CLONING LAB MANU; SIMON R, 1986, METHOD ENZYMOL, V118, P640; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; Tabares LC, 2003, J BACTERIOL, V185, P3223, DOI 10.1128/JB.185.10.3223-3227.2003; TAI TN, 1988, PLASMID, V19, P175, DOI 10.1016/0147-619X(88)90037-6; Tehrani A, 2003, BIOCHEMISTRY-US, V42, P8919, DOI 10.1021/bi0346650; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Willett J, 2007, J BACTERIOL, V189, P7765, DOI 10.1128/JB.00853-07	74	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3718	3730		10.1074/jbc.M707774200	http://dx.doi.org/10.1074/jbc.M707774200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079120	hybrid			2022-12-27	WOS:000253083500005
J	Badugu, R; Garcia, M; Bondada, V; Joshi, A; Geddes, JW				Badugu, RamaKrishna; Garcia, Matthew; Bondada, Vimala; Joshi, Aashish; Geddes, James W.			N terminus of calpain 1 is a mitochondrial targeting sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; SMALL-SUBUNIT GENE; MU-CALPAIN; CALPAIN/CALPASTATIN NETWORK; EMBRYONIC-DEVELOPMENT; INTERMEMBRANE SPACE; BINDING PROTEIN; CALPASTATIN; ASSOCIATION; IMPORT	The ubiquitous m- and mu-calpains are thought to be localized in the cytosolic compartment, as is their endogenous inhibitor calpastatin. Previously, mu-calpain was found to be enriched in mitochondrial fractions isolated from rat cerebral cortex and SH-SY5Y neuroblastoma cells, but the submitochondrial localization of mu-calpain was not determined. In the present study, submitochondrial fractionation and digitonin permeabilization studies indicated that both calpain 1 and calpain small subunit 1, which together form mu-calpain, are present in the mitochondrial intermembrane space. The N terminus of calpain 1 contains an amphipathic alpha-helical domain, and is distinct from the N terminus of calpain 2. Calpain 1, but not calpain 2, was imported into mitochondria. Removal of the N-terminal 22 amino acids of calpain 1 blocked the mitochondrial calpain import, while addition of this N-terminal region to calpain 2 or green fluorescent protein enabled mitochondrial import. The N terminus of calpain 1 was not processed following mitochondrial import, but was removed by autolysis following calpain activation. Calpain small subunit 1 was not directly imported into mitochondria, but was imported in the presence of calpain 1. The presence of a mitochondrial targeting sequence in the N-terminal region of calpain 1 is consistent with the localization of mu-calpain to the mitochondrial intermembrane space and provides new insight into the possible functions of this cysteine protease.	[Badugu, RamaKrishna; Bondada, Vimala] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Garcia, Matthew; Joshi, Aashish; Geddes, James W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B477 BBSRB, Lexington, KY 40536 USA.	jgeddes@uky.edu	Badugu, RamaKrishna/A-8572-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045726, P01NS058484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010836] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG010836] Funding Source: Medline; NINDS NIH HHS [R01NS045726, P01NS058484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI Y, 1991, J BIOL CHEM, V266, P3968; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; BAUDRY M, 1987, SYNAPSE, V1, P506, DOI 10.1002/syn.890010603; BEER DG, 1982, BIOCHEM BIOPH RES CO, V109, P1276, DOI 10.1016/0006-291X(82)91915-5; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; CHAKRABARTI AK, 1988, J NEUROSCI RES, V20, P351, DOI 10.1002/jnr.490200309; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CONG JY, 1989, J BIOL CHEM, V264, P10096; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; Duret L, 1996, COMPUT APPL BIOSCI, V12, P507; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Elce JS, 1997, BIOCHEM J, V326, P31, DOI 10.1042/bj3260031; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; Friedrich P, 2004, EUR J NEUROSCI, V19, P1819, DOI 10.1111/j.1460-9568.2004.03313.x; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOPALAKRISHNA R, 1986, J BIOL CHEM, V261, P13936; GRAHAMSIEGENTHALER K, 1994, J BIOL CHEM, V269, P30457; Griparic L, 2005, METHOD ENZYMOL, V404, P620, DOI 10.1016/S0076-6879(05)04054-1; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Kar P, 2007, ARCH BIOCHEM BIOPHYS, V466, P290, DOI 10.1016/j.abb.2007.07.022; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kumar M, 2006, J BIOL CHEM, V281, P5357, DOI 10.1074/jbc.M511061200; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; MURAKAMI T, 1981, J BIOCHEM-TOKYO, V90, P1809, DOI 10.1093/oxfordjournals.jbchem.a133659; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Saga Kenji, 2005, Medical Molecular Morphology, V38, P155, DOI 10.1007/s00795-005-0287-2; Shulga N, 2006, J BIOL CHEM, V281, P30824, DOI 10.1074/jbc.M602503200; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; TAKANO E, 1982, J BIOCHEM-TOKYO, V92, P2021, DOI 10.1093/oxfordjournals.jbchem.a134134; TAVARES A, 1991, BIOMED BIOCHIM ACTA, V50, P523; TAYLOR RG, 1991, BIOMED BIOCHIM ACTA, V50, P491; Thompson VF, 2000, METH MOL B, V144, P3; TULLIO RD, 1999, BIOCHEM J, V343, P467; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Weil R, 1999, MOL CELL BIOL, V19, P6345; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63; ZIMMERMAN UJP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P192, DOI 10.1016/0167-4838(91)99009-H	72	55	56	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3409	3417		10.1074/jbc.M706851200	http://dx.doi.org/10.1074/jbc.M706851200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070881	hybrid			2022-12-27	WOS:000253083000046
J	van der Merwe, M; Bjornsti, MA				van der Merwe, Marie; Bjornsti, Mary-Ann			Mutation of Gly(721) alters DNA topoisomerase I active site architecture and sensitivity to camptothecin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; YEAST; CLEAVAGE; MECHANISMS; RESISTANCE; DOMAIN; COVALENT; LINKER; DRUGS; FLEXIBILITY	DNA topoisomerase I (Top1p) catalyzes the relaxation of supercoiled DNA via a concerted mechanism of DNA strand cleavage and religation. Top1p is the cellular target of the anticancer drug camptothecin (CPT), which reversibly stabilizes a covalent enzyme-DNA intermediate. Top1p clamps around duplex DNA, wherein the core and C-terminal domains are connected by extended alpha-helices (linker domain), which position the active site Tyr of the C-terminal domain within the catalytic pocket. The physical connection of the linker with the Top1p clamp as well as linker flexibility affect enzyme sensitivity to CPT. Crystallographic data reveal that a conserved Gly residue (located at the juncture between the linker and C-terminal domains) is at one end of a short alpha-helix, which extends to the active site Tyr covalently linked to the DNA. In the presence of drug, the linker is rigid and this alpha-helix extends to include Gly and the preceding Leu. We report that mutation of this conserved Gly in yeast Top1p alters enzyme sensitivity to CPT. Mutating Gly to Asp, Glu, Asn, Gln, Leu, or Ala enhanced enzyme CPT sensitivity, with the acidic residues inducing the greatest increase in drug sensitivity in vivo and in vitro. By contrast, Val or Phe substituents rendered the enzyme CPT-resistant. Mutation-induced alterations in enzyme architecture preceding the active site Tyr suggest these structural transitions modulate enzyme sensitivity to CPT, while enhancing the rate of DNA cleavage. We postulate that this conserved Gly residue provides a flexible hinge within the Top1p catalytic pocket to facilitate linker dynamics and the structural alterations that accompany drug binding of the covalent enzyme-DNA intermediate.	[van der Merwe, Marie; Bjornsti, Mary-Ann] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Bjornsti, MA (corresponding author), St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA.	mary-ann.bjornsti@stjude.org			NCI NIH HHS [R01 CA058755, CA58755, P30 CA021765, CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA058755] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BJORNSTI MA, 1987, P NATL ACAD SCI USA, V84, P8971, DOI 10.1073/pnas.84.24.8971; Bjornsti MA, 2002, CANCER CELL, V2, P267, DOI 10.1016/S1535-6108(02)00160-5; BURGIN AB, 1995, NUCLEIC ACIDS RES, V23, P2973, DOI 10.1093/nar/23.15.2973; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chillemi G, 2003, NUCLEIC ACIDS RES, V31, P1525, DOI 10.1093/nar/gkg242; Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007; Colley WC, 2004, J BIOL CHEM, V279, P54069, DOI 10.1074/jbc.M409764200; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Fertala J, 2000, J BIOL CHEM, V275, P15246, DOI 10.1074/jbc.275.20.15246; Fiorani P, 1999, MOL PHARMACOL, V56, P1105, DOI 10.1124/mol.56.6.1105; Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200; Fiorani P, 2006, NUCLEIC ACIDS RES, V34, P5093, DOI 10.1093/nar/gkl670; Kaiser C., 1994, METHODS YEAST GENETI; KAUH EA, 1995, P NATL ACAD SCI USA, V92, P6299, DOI 10.1073/pnas.92.14.6299; KNAB AM, 1993, J BIOL CHEM, V268, P22322; Koster DA, 2007, NATURE, V448, P213, DOI 10.1038/nature05938; LEVIN NA, 1993, GENETICS, V133, P799; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Lisby M, 2001, J BIOL CHEM, V276, P20220, DOI 10.1074/jbc.M010991200; Losasso C, 2007, J BIOL CHEM, V282, P9855, DOI 10.1074/jbc.M608200200; Megonigal MD, 1997, J BIOL CHEM, V272, P12801, DOI 10.1074/jbc.272.19.12801; Montaudon D, 2007, J BIOL CHEM, V282, P14403, DOI 10.1074/jbc.M611673200; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 1997, J BIOL CHEM, V272, P26441, DOI 10.1074/jbc.272.42.26441; Pourquier P, 1999, J BIOL CHEM, V274, P8516, DOI 10.1074/jbc.274.13.8516; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reid RJD, 1998, BBA-GENE STRUCT EXPR, V1400, P289, DOI 10.1016/S0167-4781(98)00142-0; Staker BL, 2005, J MED CHEM, V48, P2336, DOI 10.1021/jm049146p; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Stewart L, 1999, J BIOL CHEM, V274, P32950, DOI 10.1074/jbc.274.46.32950; Stewart L, 1997, J MOL BIOL, V269, P355, DOI 10.1006/jmbi.1997.1056; Stewart L, 1998, SCIENCE, V279, P1534, DOI 10.1126/science.279.5356.1534; Stewart L, 1996, J BIOL CHEM, V271, P7602, DOI 10.1074/jbc.271.13.7602; STIVERS JT, 1994, BIOCHEMISTRY-US, V33, P327, DOI 10.1021/bi00167a043; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Woo MH, 2003, P NATL ACAD SCI USA, V100, P13767, DOI 10.1073/pnas.2235886100; Woo MH, 2002, J BIOL CHEM, V277, P3813, DOI 10.1074/jbc.M110484200	40	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3305	3315		10.1074/jbc.M705781200	http://dx.doi.org/10.1074/jbc.M705781200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056711	Green Accepted, hybrid			2022-12-27	WOS:000253083000035
J	Irarrazabal, CE; Williams, CK; Ely, MA; Birrer, MJ; Garcia-Perez, A; Burg, MB; Ferraris, JD				Irarrazabal, Carlos E.; Williams, Chester K.; Ely, Megan A.; Birrer, Michael J.; Garcia-Perez, Arlyn; Burg, Maurice B.; Ferraris, Joan D.			Activator protein-1 contributes to high NaCl-induced increase in tonicity-responsive enhancer/osmotic response element-binding protein transactivating activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALDOSE REDUCTASE GENE; INOSITOL COTRANSPORTER GENE; OSMOTIC RESPONSE; DNA-BINDING; C-JUN; STIMULATES TRANSCRIPTION; STRUCTURAL ORGANIZATION; HYPEROSMOTIC STRESS; EXPRESSION	Tonicity-responsive enhancer/osmotic response element-binding protein (TonEBP/OREBP) is a Rel protein that activates transcription of osmoprotective genes at high extracellular NaCl. Other Rel proteins NFAT1-4 and NF-kappa B complex with activator protein-1 (AP-1) to transactivate target genes through interaction at composite NFAT/NF-kappa B center dot AP-1 sites. TonEBP/OREBP target genes commonly have one or more conserved AP-1 binding sites near TonEBP/OREBPcognateelements(OREs). Also, TonEBP/OREBP and the AP-1 proteins c-Fos and c-Jun are all activated by high NaCl. We now find, using an ORE center dot AP-1 reporter from the target aldose reductase gene or the same reporter with a mutated AP-1 site, that upon stimulation by high extracellular NaCl, 1) the presence of a wild type, but not a mutated, AP-1 site contributes to TonEBP/OREBP-dependent transcription and 2) AP-1 dominant negative constructs inhibit TonEBP/OREBP-dependent transcription provided the AP-1 site is not mutated. Using supershifts and an ORE center dot AP-1 probe, we find c-Fos and c-Jun present in combination with TonEBP/ OREBP. Also, c-Fos and c-Jun coimmunoprecipitate with TonEBP/ OREBP, indicating physical association. Small interfering RNA knockdown of either c-Fos or c-Jun inhibits high NaCl-induced increase of mRNA abundance of the TonEBP/ OREBP target genes AR and BGT1. Furthermore, a dominant negative AP-1 also reduces high NaCl-induced increase of TonEBP/ OREBP transactivating activity. Inhibition of p38, which is known to stimulate TonEBP/OREBP transcriptional activity, reduces high NaCl-dependent transcription of anORE center dot AP-1 reporter only if the AP-1 site is intact. Thus, AP-1 is part of the TonEBP/ OREBP enhanceosome, and its role in high NaCl-induced activation of TonEBP/ OREBP may require p38 activity.	[Irarrazabal, Carlos E.; Williams, Chester K.; Ely, Megan A.; Garcia-Perez, Arlyn; Burg, Maurice B.; Ferraris, Joan D.] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Birrer, Michael J.] NCI, Cell & Canc Biol Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ferraris, JD (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, Dept Hlth & Human Serv, 10 Ctr Dr,MSC 1603, Bethesda, MD 20892 USA.	ferraris@nhlbi.nih.gov		Irarrazabal, Carlos Ernesto/0000-0002-6538-5314	NATIONAL CANCER INSTITUTE [Z01SC000165, ZIASC000165] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001283, Z01HL001283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aida K, 1999, ENDOCRINOLOGY, V140, P609, DOI 10.1210/en.140.2.609; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; BORSOOK D, 1994, MOL ENDOCRINOL, V8, P240, DOI 10.1210/me.8.2.240; BROWN PH, 1994, ONCOGENE, V9, P791; Burg MB, 1997, ANNU REV PHYSIOL, V59, P437, DOI 10.1146/annurev.physiol.59.1.437; Cai Q, 2005, AM J PHYSIOL-RENAL, V289, pF803, DOI 10.1152/ajprenal.00448.2004; Cai Q, 2004, AM J PHYSIOL-RENAL, V286, pF58, DOI 10.1152/ajprenal.00037.2003; Chen Y, 2007, AM J PHYSIOL-RENAL, V292, pP981, DOI 10.1152/ajprenal.00493.2005; CHOWDHURY M, 1993, ONCOGENE, V8, P887; Clerk A, 1997, BIOCHEM J, V325, P801, DOI 10.1042/bj3250801; COHEN DM, 1991, AM J PHYSIOL, V261, pC594, DOI 10.1152/ajpcell.1991.261.4.C594; COLLA E, 2003, BIOCHEM J, V393, P411; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; Daoudal S, 1997, J BIOL CHEM, V272, P2615, DOI 10.1074/jbc.272.5.2615; Esensten JH, 2005, NUCLEIC ACIDS RES, V33, P3845, DOI 10.1093/nar/gki701; FERRARIS JD, 1994, P NATL ACAD SCI USA, V91, P10742, DOI 10.1073/pnas.91.22.10742; Ferraris JD, 1999, AM J PHYSIOL-CELL PH, V276, pC667, DOI 10.1152/ajpcell.1999.276.3.C667; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P16800, DOI 10.1073/pnas.222659799; Ferraris JD, 2001, AM ZOOL, V41, P734, DOI 10.1668/0003-1569(2001)041[0734:ORGTMO]2.0.CO;2; Ferraris JD, 1996, J BIOL CHEM, V271, P18318, DOI 10.1074/jbc.271.31.18318; Ferraris JD, 2002, P NATL ACAD SCI USA, V99, P739, DOI 10.1073/pnas.241637298; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Irarrazabal CE, 2006, P NATL ACAD SCI USA, V103, P8882, DOI 10.1073/pnas.0602911103; Irarrazabal CE, 2004, P NATL ACAD SCI USA, V101, P8809, DOI 10.1073/pnas.0403062101; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Ko BCB, 2000, BIOCHEM BIOPH RES CO, V270, P52, DOI 10.1006/bbrc.2000.2376; Ko BCB, 2002, J BIOL CHEM, V277, P46085, DOI 10.1074/jbc.M208138200; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lee SD, 2002, BIOCHEM BIOPH RES CO, V294, P968, DOI 10.1016/S0006-291X(02)00572-7; Liu GM, 2006, MOL CARCINOGEN, V45, P582, DOI 10.1002/mc.20189; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallee JJ, 1997, GENOMICS, V46, P459, DOI 10.1006/geno.1997.5055; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Miyakawa H, 1999, BBA-GENE STRUCT EXPR, V1446, P359, DOI 10.1016/S0167-4781(99)00122-0; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; Rauchman MI, 1997, AM J PHYSIOL-RENAL, V273, pF9, DOI 10.1152/ajprenal.1997.273.1.F9; Rim JS, 1997, ARCH BIOCHEM BIOPHYS, V341, P193, DOI 10.1006/abbi.1997.9950; SMARDO FL, 1992, AM J PHYSIOL, V262, pC776, DOI 10.1152/ajpcell.1992.262.3.C776; Stroud JC, 2002, NAT STRUCT BIOL, V9, P90, DOI 10.1038/nsb749; TAKENAKA M, 1994, J BIOL CHEM, V269, P29379; Tanaka M, 1996, P NATL ACAD SCI USA, V93, P4311, DOI 10.1073/pnas.93.9.4311; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Thomas RS, 1997, ONCOGENE, V14, P2845, DOI 10.1038/sj.onc.1201125; Trama J, 2000, J IMMUNOL, V165, P4884, DOI 10.4049/jimmunol.165.9.4884; UCHIDA S, 1987, AM J PHYSIOL, V253, pC230, DOI 10.1152/ajpcell.1987.253.2.C230; Westermarck J, 2002, EMBO J, V21, P451, DOI 10.1093/emboj/21.3.451; Wiese S, 1998, BIOL CHEM, V379, P667, DOI 10.1515/bchm.1998.379.6.667; WOLLNIK B, 1993, BIOCHEM BIOPH RES CO, V194, P642, DOI 10.1006/bbrc.1993.1869; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Ying Z, 1996, MOL BRAIN RES, V39, P109, DOI 10.1016/0169-328X(96)00015-0; Zhang Z, 2005, AM J PHYSIOL-RENAL, V289, pF506, DOI 10.1152/ajprenal.00417.2004; Zhou C, 1997, EXP EYE RES, V65, P349, DOI 10.1006/exer.1997.0335	61	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2554	2563		10.1074/jbc.M703490200	http://dx.doi.org/10.1074/jbc.M703490200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056707	hybrid			2022-12-27	WOS:000252622300012
J	Klewpatinond, M; Davies, P; Bowen, S; Brown, DR; Viles, JH				Klewpatinond, Mark; Davies, Paul; Bowen, Suzanne; Brown, David R.; Viles, John H.			Deconvoluting the Cu2+ binding modes of full-length prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRP KNOCKOUT MICE; COPPER-BINDING; CIRCULAR-DICHROISM; OCTAREPEAT DOMAIN; REPEAT REGION; METAL-BINDING; N-TERMINUS; AFFINITY; DISEASE; RECOMBINANT	The prion protein (PrP) is a cell-surface Cu2+-binding glycoprotein that when misfolded is responsible for a number of transmissible spongiform encephalopathies. Full-length PrP(23-231) and constructs in which the octarepeat region has been removed, or His(95) and His(110) is replaced by alanine residues, have been used to elucidate the order and mode of Cu2+ coordination to PrP-(23-231). We have built on our understanding of the appearance of visible CD spectra and EPR for various PrP fragments to characterize Cu2+ coordination to full-length PrP. At physiological pH, Cu2+ initially binds to full-length PrP in the amyloidogenic region between the octarepeats and the structured domain at His(95) and His(110). Only subsequent Cu2+ ions bind to single histidine residues within the octarepeat region. Ni2+ ions are used to further probe metal binding and, like Cu2+, Ni2+ will bind individually to His(95) and His(110), involving preceding main chain amides. Competitive chelators are used to determine the affinity of the first mole equivalent of Cu2+ bound to full-length PrP; this approach places the affinity in the nanomolar range. The affinity and number of Cu2+ binding sites support the suggestion that PrP could act as a sacrificial quencher of free radicals generated by copper redox cycling.	[Klewpatinond, Mark; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Davies, Paul; Bowen, Suzanne; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of London; University of Bath	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, Mile End Rd, London E1 4NS, England.	j.viles@qmul.ac.uk		Davies, Paul/0000-0001-8022-2719	BBSRC [BB/D005027/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005027/1] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdelraheim SR, 2006, INT J BIOCHEM CELL B, V38, P1429, DOI 10.1016/j.biocel.2006.02.007; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 2004, DALTON T, P1907, DOI 10.1039/b401985g; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; Burns CS, 2002, BIOCHEMISTRY-US, V41, P3991, DOI 10.1021/bi011922x; Burns CS, 2003, BIOCHEMISTRY-US, V42, P6794, DOI 10.1021/bi027138+; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Florio T, 2003, J NEUROCHEM, V85, P62, DOI 10.1046/j.1471-4159.2003.01664.x; Garnett AP, 2003, J BIOL CHEM, V278, P6795, DOI 10.1074/jbc.M209280200; Garnett AP, 2006, DALTON T, P509, DOI 10.1039/b511553a; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Joergstuerenburg H, 1999, J NEUROL NEUROSUR PS, V67, P252, DOI 10.1136/jnnp.67.2.252; Jones CE, 2005, J MOL BIOL, V346, P1393, DOI 10.1016/j.jmb.2004.12.043; Jones CE, 2004, J BIOL CHEM, V279, P32018, DOI 10.1074/jbc.M403467200; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Klewpatinond M, 2007, BIOCHEM J, V404, P393, DOI 10.1042/BJ20061893; Kramer ML, 2001, J BIOL CHEM, V276, P16711, DOI 10.1074/jbc.M006554200; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MASUOKA J, 1993, J BIOL CHEM, V268, P21533; Millhauser GL, 2004, ACCOUNTS CHEM RES, V37, P79, DOI 10.1021/ar0301678; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nadal RC, 2007, FREE RADICAL BIO MED, V42, P79, DOI 10.1016/j.freeradbiomed.2006.09.019; Osz K, 2002, POLYHEDRON, V21, P2149, DOI 10.1016/S0277-5387(02)01151-8; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PELSACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Rachidi W, 2003, J BIOL CHEM, V278, P14595, DOI 10.1074/jbc.C300092200; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; Requena JR, 2001, P NATL ACAD SCI USA, V98, P7170, DOI 10.1073/pnas.121190898; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Sigurdsson EM, 2003, J BIOL CHEM, V278, P46199, DOI 10.1074/jbc.C300303200; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Wadsworth JDF, 1999, NAT CELL BIOL, V1, P55, DOI 10.1038/9030; Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; Watt NT, 2005, J BIOL CHEM, V280, P35914, DOI 10.1074/jbc.M507327200; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x	61	94	95	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1870	1881		10.1074/jbc.M708472200	http://dx.doi.org/10.1074/jbc.M708472200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042548	hybrid			2022-12-27	WOS:000252501000013
J	Adhikari, S; Uren, A; Roy, R				Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra			Dipole-dipole interaction stabilizes the transition state of apurinic/apyrimidinic endonuclease - Abasic site interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; DNA-POLYMERASE-BETA; HUMAN APURINIC ENDONUCLEASE; ESCHERICHIA-COLI; SUBSTRATE-BINDING; MECHANISM; DAMAGE; GLYCOSYLASE; KINETICS; IDENTIFICATION	Human apurinic/apyrimidinic (AP) endonuclease (hAPE) initiates the repair of an abasic site AP site). To gain insight into the mechanisms of damage recognition of hAPE, we conducted surface plasmon resonance spectroscopy to study the thermodynamics and kinetics of its interaction with substrate DNA containing an abasic site AP DNA). The affinity of hAPE binding toward DNA increased as much as 6-fold after replacing a single adenine equilibrium dissociation constant, K-D, 5.3 nM) with an AP site K-D, 0.87 nM). The enzyme-substrate complex formation appears to be thermodynamically stabilized and favored by a large change in Gibbs free energy, Delta G degrees -50 kJ/mol). The latter is supported by a high negative change in enthalpy, Delta H degrees -43 kJ/ mol) and also positive change in entropy, Delta S degrees 24 J/ K mol)), and thus the binding process is spontaneous at all temperatures. Analysis of kinetic parameters reveals small enthalpy of activation for association, Delta H-ass degrees double dagger -17 kJ/ mol), and activation energy for association E-a, -14 kJ/ mol) when compared with the enthalpy of activation for dissociation, Delta H-diss degrees double dagger 26 kJ/ mol), and activation energy in the reverse direction E-d, 28 kJ/ mol). Furthermore, varying concentration of KCl showed an increase in binding affinity at low concentration but complete abrogation of the binding at higher concentration, implying the importance of hydrophobic, but predominately ionic, forces in the Michaelis-Menten complex formation. Thus, low activation energy and the enthalpy of activation, which are perhaps a result of dipole-dipole interactions, play critical roles in AP site binding of APE.	[Adhikari, Sanjay; Uren, Aykut; Roy, Rabindra] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA	Georgetown University	Adhikari, S (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, LL Level,S-120,3800 Reservoir Rd, Washington, DC 20057 USA.	sa354@georgetown.edu; rr228@georgetown.edu			NCI NIH HHS [R01 CA 108641, R01 CA092306, R01 CA 92306] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA108641, R01CA092306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikari S, 2008, DNA REPAIR, V7, P31, DOI 10.1016/j.dnarep.2007.07.012; Adhikari S, 2007, J BIOL CHEM, V282, P30078, DOI 10.1074/jbc.M704051200; Adhikari S, 2006, J BIOL CHEM, V281, P29525, DOI 10.1074/jbc.M602673200; Beard WA, 2004, J BIOL CHEM, V279, P31921, DOI 10.1074/jbc.M404016200; Bennett RAO, 1997, P NATL ACAD SCI USA, V94, P7166, DOI 10.1073/pnas.94.14.7166; Berg BJV, 2001, J BIOL CHEM, V276, P3408, DOI 10.1074/jbc.M002884200; Boniface JJ, 1999, P NATL ACAD SCI USA, V96, P11446, DOI 10.1073/pnas.96.20.11446; Chou KM, 2002, NATURE, V415, P655, DOI 10.1038/415655a; DAY YSN, 2007, PROTEIN SCI, V2002, P1017; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Donny W, 2004, J BIOL CHEM, V279, P25268, DOI 10.1074/jbc.M400804200; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P59; Fung H, 2005, MOL CELL, V17, P463, DOI 10.1016/j.molcel.2004.12.029; Hadd AG, 1996, J ORG CHEM, V61, P2657, DOI 10.1021/jo951627g; LARSON K, 1985, MUTAT RES, V233, P211; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Madhusudan Srinivasan, 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P1237; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, P81, DOI 10.1093/nar/gki148; Mitra S, 2001, ENVIRON MOL MUTAGEN, V38, P180, DOI 10.1002/em.1070; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; MOSBAUGH DW, 1994, PROG NUCLEIC ACID RE, V48, P315, DOI 10.1016/S0079-6603(08)60859-4; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Ohkubo K, 2005, J PHYS CHEM A, V109, P1105, DOI 10.1021/jp0453008; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pischel U, 2001, J AM CHEM SOC, V123, P9727, DOI 10.1021/ja011212e; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; Roy R, 1998, BIOCHEMISTRY-US, V37, P580, DOI 10.1021/bi972313l; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Strauss PR, 1997, J BIOL CHEM, V272, P1302, DOI 10.1074/jbc.272.2.1302; Suetake I, 2006, J BIOCHEM, V140, P553, DOI 10.1093/jb/mvj185; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Zou Y, 1998, J MOL BIOL, V281, P107, DOI 10.1006/jmbi.1998.1903	44	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1334	1339		10.1074/jbc.M704594200	http://dx.doi.org/10.1074/jbc.M704594200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18025089	hybrid			2022-12-27	WOS:000252282700016
J	Moriuchi, H; Koda, N; Okuda-Ashitaka, E; Daiyasu, H; Ogasawara, K; Toh, H; Ito, S; Woodward, DF; Watanabe, K				Moriuchi, Hiroshi; Koda, Noriko; Okuda-Ashitaka, Emiko; Daiyasu, Hiromi; Ogasawara, Kensuke; Toh, Hiroyuki; Ito, Seiji; Woodward, David F.; Watanabe, Kikuko			Molecular characterization of a novel type of prostamide/prostaglandin F synthase, belonging to the thioredoxin-like superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE LUNG; PROSTAGLANDIN-ETHANOLAMIDES; CANNABINOID RECEPTOR; PHYSIOLOGICAL FUNCTIONS; GLYCEROL ESTERS; CDNA CLONING; IN-VITRO; ANANDAMIDE; BIMATOPROST; EXPRESSION	Prostaglandin F (PGF) ethanolamide (prostamide F) synthase, which catalyzed the reduction of prostamide H-2 to prostamide F-2 alpha,F-, was found in mouse and swine brain. The enzyme was purified from swine brain, and its amino acid sequence was defined. The mouse enzyme consisted of a 603-bp open reading frame coding for a 201-amino acid polypeptide with a molecular weight of 21,669. The amino acid sequence placed the enzyme in the thioredoxin-like superfamily with Cys(44) being the active site. The enzyme expressed in Escherichia coli as well as the native enzyme catalyzed not only the reduction of prostamide H-2 to prostamide F-2 alpha but also that of PGH(2) to PGF(2 alpha). The V-max and Km values for prostamide H-2 were about 0.25 mu mol/min center dot mg of protein and 7.6 mu M, respectively, and those for PGH(2) were about 0.69 mu mol/min center dot mg of protein and 6.9 mu M, respectively. Neither PGE(2) nor PGD(2) served as a substrate for this synthase. Based on these data, we named the enzyme prostamide/PGF synthase. Although the enzyme showed a broad specificity for reductants, reduced thioredoxin preferentially served as a reducing equivalent donor for this enzyme. Moreover, Northern and Western blot analyses in addition to the prostamide F synthase activity showed that the enzyme was mainly distributed in the brain and spinal cord, and the immunohistochemical study in the spinal cord showed that the enzyme was found mainly in the cytosol. These results suggest that prostamide/PGF synthase may play an important functional role in the central nervous system.	[Moriuchi, Hiroshi; Koda, Noriko; Ogasawara, Kensuke; Watanabe, Kikuko] Univ E Asia, Grad Sch Integrated Sci & Art, Div Life Sci, Yamaguchi 7518503, Japan; [Okuda-Ashitaka, Emiko; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Osaka 5708506, Japan; [Daiyasu, Hiromi] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka 5608531, Japan; [Toh, Hiroyuki] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Woodward, David F.] Allergan Pharmaceut Inc, Dept Biol Sci, Irvine, CA 92612 USA	Kansai Medical University; Osaka University; Kyushu University; AbbVie; Allergan	Watanabe, K (corresponding author), Univ E Asia, Grad Sch Integrated Sci & Art, Div Life Sci, 2-1 Ichinomiyagakuen, Yamaguchi 7518503, Japan.	watanabe@toua-u.ac.jp		ito, Seiji/0000-0002-0942-1624				Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; CHEN LY, 1992, ARCH BIOCHEM BIOPHYS, V296, P17, DOI 10.1016/0003-9861(92)90539-9; Ciceri P, 2002, J PHARMACOL EXP THER, V302, P846, DOI 10.1124/jpet.302.3.846; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P91, DOI 10.1054/plef.2001.0339; FELDER CC, 1993, P NATL ACAD SCI USA, V90, P7656, DOI 10.1073/pnas.90.16.7656; Gandolfi SA, 2003, OPHTHALMOLOGY, V110, P609, DOI 10.1016/S0161-6420(02)01891-2; GRIPPO JF, 1985, J BIOL CHEM, V260, P93; Koda N, 2004, ARCH BIOCHEM BIOPHYS, V424, P128, DOI 10.1016/j.abb.2004.02.009; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kozak KR, 2001, J BIOL CHEM, V276, P36993, DOI 10.1074/jbc.M105854200; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; LEVINE L, 1975, PROSTAGLANDINS, V9, P531, DOI 10.1016/0090-6980(75)90059-3; Li S, 2005, J MOL BIOL, V346, P1035, DOI 10.1016/j.jmb.2004.12.046; Liang YB, 2003, J BIOL CHEM, V278, P27267, DOI 10.1074/jbc.M301009200; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; Matias I, 2004, J PHARMACOL EXP THER, V309, P745, DOI 10.1124/jpet.103.061705; Moon S, 2005, INVEST OPHTH VIS SCI, V46, P3783, DOI 10.1167/iovs.05-0237; Muratani T, 2003, J NEUROCHEM, V86, P374, DOI 10.1046/j.1471-4159.2003.01840.x; Okuda K, 2002, DOMEST ANIM ENDOCRIN, V23, P255, DOI 10.1016/S0739-7240(02)00161-3; Pekkari K, 2004, ANTIOXID REDOX SIGN, V6, P53, DOI 10.1089/152308604771978345; Shima S, 1998, EUR J BIOCHEM, V258, P85, DOI 10.1046/j.1432-1327.1998.2580085.x; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Suzuki T, 1999, J BIOL CHEM, V274, P241, DOI 10.1074/jbc.274.1.241; Suzuki-Yamamoto T, 1999, FEBS LETT, V462, P335, DOI 10.1016/S0014-5793(99)01551-3; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; URADE Y, 1995, J LIPID MEDIAT CELL, V12, P257, DOI 10.1016/0929-7855(95)00032-L; Wan Z, 2007, INVEST OPHTH VIS SCI, V48, P4107, DOI 10.1167/iovs.07-0080; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1991, BIOCHEM BIOPH RES CO, V181, P272, DOI 10.1016/S0006-291X(05)81413-5; WATANABE K, 1981, BIOCHEM INT, V2, P603; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2007, BRIT J PHARMACOL, V150, P342, DOI 10.1038/sj.bjp.0706989; Woodward DF, 2003, J PHARMACOL EXP THER, V305, P772, DOI 10.1124/jpet.102.047837; Yoshikawa K, 2006, J BIOL CHEM, V281, P14663, DOI 10.1074/jbc.M511089200; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	40	36	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					792	801		10.1074/jbc.M705638200	http://dx.doi.org/10.1074/jbc.M705638200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18006499	hybrid			2022-12-27	WOS:000252128100018
J	Shibata, H; Yoshioka, Y; Ohkawa, A; Minowa, K; Mukai, Y; Abe, Y; Taniai, M; Nomura, T; Kayamuro, H; Nabeshi, H; Sugita, T; Imai, S; Nagano, K; Yoshikawa, T; Fujita, T; Nakagawa, S; Yamamoto, A; Ohta, T; Hayakawa, T; Mayumi, T; Vandenabeele, P; Aggarwal, BB; Nakamura, T; Yamagata, Y; Tsunoda, S; Kamada, H; Tsutsumi, Y				Shibata, Hiroko; Yoshioka, Yasuo; Ohkawa, Akiko; Minowa, Kyoko; Mukai, Yohei; Abe, Yasuhiro; Taniai, Madoka; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Yoshikawa, Tomoaki; Fujita, Takuya; Nakagawa, Shinsaku; Yamamoto, Akira; Ohta, Tsunetaka; Hayakawa, Takao; Mayumi, Tadanori; Vandenabeele, Peter; Aggarwal, Bharat B.; Nakamura, Teruya; Yamagata, Yuriko; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo			Creation and x-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF RECEPTOR-TYPE; RHEUMATOID-ARTHRITIS; MEDIATED APOPTOSIS; TRANSMEMBRANE TNF; SECRETED TNF; INFECTION; THERAPY; MICE; BINDING; PROLIFERATION	Tumor necrosis factor-alpha (TNF) induces inflammatory response predominantly through the TNF receptor-1 (TNFR1). Thus, blocking the binding of TNF to TNFR1 is an important strategy for the treatment of many inflammatory diseases, such as hepatitis and rheumatoid arthritis. In this study, we identified a TNFR1-selective antagonistic mutant TNF from a phage library displaying structural human TNF variants in which each one of the six amino acid residues at the receptor-binding site ( amino acids at positions 84-89) was replaced with other amino acids. Consequently, a TNFR1-selective antagonistic mutant TNF (R1antTNF), containing mutations A84S, V85T, S86T, Y87H, Q88N, and T89Q, was isolated from the library. The R1antTNF did not activate TNFR1-mediated responses, although its affinity for the TNFR1 was almost similar to that of the human wild-type TNF (wtTNF). Additionally, the R1antTNF neutralized the TNFR1-mediated bioactivity of wtTNF without influencing its TNFR2-mediated bioactivity and inhibited hepatic injury in an experimental hepatitis model. To understand the mechanism underlying the antagonistic activity of R1antTNF, we analyzed this mutant using the surface plasmon resonance spectroscopy and x-ray crystallography. Kinetic association/dissociation parameters of the R1antTNF were higher than those of the wtTNF, indicating very fast bond dissociation. Furthermore, x-ray crystallographic analysis of R1antTNF suggested that the mutation Y87H changed the binding mode from the hydrophobic to the electrostatic interaction, which may be one of the reasons why R1antTNF behaved as an antagonist. Our studies demonstrate the feasibility of generating TNF receptor subtype-specific antagonist by extensive substitution of amino acids of the wild-type ligand protein.	[Shibata, Hiroko; Yoshioka, Yasuo; Ohkawa, Akiko; Minowa, Kyoko; Mukai, Yohei; Abe, Yasuhiro; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Yoshikawa, Tomoaki; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo] Natl Inst Biomed Innovat, Lab Pharmaceut Prote, Osaka 5670085, Japan; [Shibata, Hiroko; Hayakawa, Takao] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan; [Yoshioka, Yasuo; Nakagawa, Shinsaku; Tsunoda, Shin-ichi; Kamada, Haruhiko; Tsutsumi, Yasuo] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan; [Minowa, Kyoko; Fujita, Takuya; Yamamoto, Akira] Kyoto Pharmaceut Univ, Yamashina Ku, Kyoto 6078414, Japan; [Mukai, Yohei; Abe, Yasuhiro; Nomura, Tetsuya; Kayamuro, Hiroyuki; Nabeshi, Hiromi; Sugita, Toshiki; Imai, Sunao; Nagano, Kazuya; Nakagawa, Shinsaku; Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Taniai, Madoka; Ohta, Tsunetaka] Hayashibara Biochem Labs Inc, Okayama 7028006, Japan; [Mayumi, Tadanori] Kobe Gakuin Univ, Grad Sch Pharmaceut Sci, Nishi Ku, Kobe, Hyogo 6512180, Japan; [Vandenabeele, Peter] Univ Ghent VIB, Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Mol Biol, B-9052 Ghent, Belgium; [Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Fac Med & Pharmaceut Sci, Kumamoto 8620973, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; Osaka University; Kyoto Pharmaceutical University; Osaka University; Hayashibara Biochemical Laboratories, Inc.; Kobe Gakuin University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of Texas System; UTMD Anderson Cancer Center; Kumamoto University	Kamada, H (corresponding author), Natl Inst Biomed Innovat, Lab Pharmaceut Prote, 7-6-8 Saito Asagi, Osaka 5670085, Japan.	kamada@nibio.go.jp	Vandenabeele, Peter/AAD-5793-2022; Abe, Yasuhiro/F-5206-2016; Vandenabeele, Peter/C-8597-2009; Fujita, Takuya/AAC-3442-2022; Yamamoto, Akira/AAC-1635-2022; Aggarwal, Bharat B/G-3388-2013	Vandenabeele, Peter/0000-0002-6669-8822; Abe, Yasuhiro/0000-0002-5931-6590; Fujita, Takuya/0000-0002-7724-6522; Kamada, Haruhiko/0000-0002-2478-3818; Nakamura, Teruya/0000-0003-2013-3057; Tsunoda, Shin-ichi/0000-0003-3299-2182				ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; AGGARWAL BB, 1985, NATURE, V318, P665, DOI 10.1038/318665a0; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; BARBARA JAJ, 1994, EMBO J, V13, P843, DOI 10.1002/j.1460-2075.1994.tb06327.x; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Brunetti CR, 2003, P NATL ACAD SCI USA, V100, P4831, DOI 10.1073/pnas.0737244100; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carter PH, 2001, P NATL ACAD SCI USA, V98, P11879, DOI 10.1073/pnas.211178398; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; ECK MJ, 1989, J BIOL CHEM, V264, P17595; ENGELMANN H, 1990, J BIOL CHEM, V265, P14497; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Fremond C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-136; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Grell M, 1998, EUR J IMMUNOL, V28, P257, DOI 10.1002/(SICI)1521-4141(199801)28:01<257::AID-IMMU257>3.0.CO;2-G; Harrop JA, 1998, J BIOL CHEM, V273, P27548, DOI 10.1074/jbc.273.42.27548; HISHINUMA I, 1990, HEPATOLOGY, V12, P1187, DOI 10.1002/hep.1840120518; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kafrouni MI, 2003, J LEUKOCYTE BIOL, V74, P564, DOI 10.1189/jlb.0103035; Kamada H, 2003, NAT BIOTECHNOL, V21, P399, DOI 10.1038/nbt798; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Krippner-Heidenreich A, 2002, J BIOL CHEM, V277, P44155, DOI 10.1074/jbc.M207399200; LEIST M, 1995, J IMMUNOL, V154, P1307; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; MACKAY F, 1993, J EXP MED, V177, P1277, DOI 10.1084/jem.177.5.1277; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mori L, 1996, J IMMUNOL, V157, P3178; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; MUTO Y, 1988, LANCET, V2, P72; Nagaki M, 1999, J HEPATOL, V31, P997, DOI 10.1016/S0168-8278(99)80311-0; Nathan DM, 2006, J GASTROEN HEPATOL, V21, P1366, DOI 10.1111/j.1440-1746.2006.04559.x; Olleros ML, 2002, J IMMUNOL, V168, P3394, DOI 10.4049/jimmunol.168.7.3394; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Saunders BM, 2005, J IMMUNOL, V174, P4852, DOI 10.4049/jimmunol.174.8.4852; Shakoor N, 2002, LANCET, V359, P579, DOI 10.1016/S0140-6736(02)07714-0; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; TSUTSUMI Y, 1995, BRIT J CANCER, V71, P963, DOI 10.1038/bjc.1995.186; VANDENABEELE P, 1992, J EXP MED, V176, P1015, DOI 10.1084/jem.176.4.1015; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; ZHANG XM, 1992, J BIOL CHEM, V267, P24069; Zhou A, 2003, ONCOGENE, V22, P2054, DOI 10.1038/sj.onc.1206262	49	78	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					998	1007		10.1074/jbc.M707933200	http://dx.doi.org/10.1074/jbc.M707933200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003610	hybrid			2022-12-27	WOS:000252128100039
J	Oxley, CL; Anthis, NJ; Lowe, ED; Vakonakis, I; Campbell, ID; Wegener, KL				Oxley, Camilla L.; Anthis, Nicholas J.; Lowe, Edward D.; Vakonakis, Ioannis; Campbell, Iain D.; Wegener, Kate L.			An integrin phosphorylation switch - The effect of beta 3 integrin tail phosphorylation on Dok1 and talin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; BETA(3) TYROSINE PHOSPHORYLATION; STRUCTURAL BASIS; PTB DOMAINS; PROTEIN; ACTIVATION; ADHESION; RECEPTOR; INSULIN; RECOGNITION	Integrins play a fundamental role in cell migration and adhesion; knowledge of how they are regulated and controlled is vital for understanding these processes. Recent work showed that Dok1 negatively regulates integrin activation, presumably by competition with talin. To understand how this occurs, we used NMR spectroscopy and x-ray crystallography to investigate the molecular details of interactions with integrins. The binding affinities of beta 3 integrin tails for the Dok1 and talin phosphotyrosine binding domains were quantified using N-15-H-1 heteronuclear single quantum correlation titrations, revealing that the unphosphorylated integrin tail binds more strongly to talin than Dok1. Chemical shift mapping showed that unlike talin, Dok1 exclusively interacts with the canonical NPXY motif of the beta 3 integrin tail. Upon phosphorylation of Tyr(747) in the beta 3 integrin tail, however, Dok1 then binds much more strongly than talin. Thus, we show that phosphorylation of Tyr(747) provides a switch for integrin ligand binding. This switch may represent an in vivo mechanism for control of integrin receptor activation. These results have implications for the control of integrin signaling by proteins containing phosphotyrosine binding domains.	[Oxley, Camilla L.; Anthis, Nicholas J.; Lowe, Edward D.; Vakonakis, Ioannis; Campbell, Iain D.; Wegener, Kate L.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Wegener, KL (corresponding author), Univ Oxford, Dept Biochem, S Pk Rd, Oxford OX1 3QU, England.	kate.wegener@bioch.ox.ac.uk	Wegener, Kate/E-5077-2010; Lowe, Edward/AAP-5381-2021	Wegener, Kate/0000-0002-1562-6060; Lowe, Edward/0000-0002-1757-0208; Anthis, Nicholas/0000-0002-1881-450X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Liu SC, 2000, J CELL SCI, V113, P3563; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi N, 2004, J BIOL CHEM, V279, P4962, DOI 10.1074/jbc.M311030200; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAPLEY P, 1989, ONCOGENE, V4, P325; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015	39	88	91	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5420	5426		10.1074/jbc.M709435200	http://dx.doi.org/10.1074/jbc.M709435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156175	hybrid			2022-12-27	WOS:000253426700022
J	Beck, EJ; Yang, Y; Yaemsiri, S; Raghuram, V				Beck, Edward J.; Yang, Yu; Yaemsiri, Sirin; Raghuram, Viswanathan			Conformational changes in a pore-lining helix coupled to cystic fibrosis transmembrane conductance regulator channel gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CFTR CHLORIDE CHANNEL; ACETYLCHOLINE-RECEPTOR CHANNEL; NUCLEOTIDE-BINDING DOMAIN; ABC TRANSPORTER; P-GLYCOPROTEIN; ANION-BINDING; CL-CHANNELS; CYSTEINE; MECHANISM; SITE	Cystic fibrosis transmembrane conductance regulator (CFTR), the protein dysfunctional in cystic fibrosis, is unique among ATP-binding cassette transporters in that it functions as an ion channel. In CFTR, ATP binding opens the channel, and its subsequent hydrolysis causes channel closure. We studied the conformational changes in the pore-lining sixth transmembrane segment upon ATP binding by measuring state-dependent changes in accessibility of substituted cysteines to methanethiosulfonate reagents. Modification rates of three residues (resides 331, 333, and 335) near the extracellular side were 10-1000-fold slower in the open state than in the closed state. Introduction of a charged residue by chemical modification at two of these positions (resides 331 and 333) affected CFTR single-channel gating. In contrast, modifications of pore-lining residues 334 and 338 were not state-dependent. Our results suggest that ATP binding induces a modest conformational change in the sixth transmembrane segment, and this conformational change is coupled to the gating mechanism that regulates ion conduction. These results may establish a structural basis of gating involving the dynamic rearrangement of transmembrane domains necessary for vectorial transport of substrates in ATP-binding cassette transporters.	[Beck, Edward J.; Yang, Yu; Yaemsiri, Sirin; Raghuram, Viswanathan] NHLBI, Kidney & Electrolyte Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Raghuram, V (corresponding author), NHLBI, Kidney & Electrolyte Metab Lab, NIH, 9000 Rockville Pike,Bldg 10,Rm 7D13, Bethesda, MD 20892 USA.	raghuramv@mail.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001286, ZIAHL001286] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Al-Nakkash L, 1999, PFLUG ARCH EUR J PHY, V437, P553, DOI 10.1007/s004240050817; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Csanady L, 2006, J GEN PHYSIOL, V128, P523, DOI 10.1085/jgp.200609558; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Dawson David C., 1999, Physiological Reviews, V79, pS47; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gupta J, 2003, MOL MEMBR BIOL, V20, P45, DOI 10.1080/0968031000045824; HASEGAWA H, 1992, SCIENCE, V258, P1477, DOI 10.1126/science.1279809; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; LINTON KJ, 2007, PFLUG ARCH EUR J PHY, V453, P355; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; Liu XH, 2001, J GEN PHYSIOL, V118, P433, DOI 10.1085/jgp.118.4.433; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mansoura MK, 1998, BIOPHYS J, V74, P1320, DOI 10.1016/S0006-3495(98)77845-2; McCarty NA, 2000, J EXP BIOL, V203, P1947; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wilkinson DJ, 1996, J GEN PHYSIOL, V107, P103, DOI 10.1085/jgp.107.1.103; Wilson GG, 2000, J GEN PHYSIOL, V115, P93, DOI 10.1085/jgp.115.2.93; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200	38	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4957	4966		10.1074/jbc.M702235200	http://dx.doi.org/10.1074/jbc.M702235200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056267	hybrid			2022-12-27	WOS:000253426500053
J	Hellman, NE; SpectorO, J; Robinson, J; Zuo, XF; Saunier, S; Antignac, C; Tobias, JW; Lipschutz, JH				Hellman, Nathan E.; SpectorO, June; Robinson, Jonathan; Zuo, Xiaofeng; Saunier, Sophie; Antignac, Corinne; Tobias, John W.; Lipschutz, Joshua H.			Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; POLARIZED EPITHELIAL-CELLS; MATRIX METALLOPROTEINASES; IN-VITRO; BRANCHING MORPHOGENESIS; COLLAGEN ACCUMULATION; RNA INTERFERENCE; MOUSE KIDNEY; MDCK CELLS; LINE MDCK	A classic model of tubulogenesis utilizes Madin-Darby canine kidney (MDCK) cells. MDCK cells form monoclonal cysts in three-dimensional collagen and tubulate in response to hepatocyte growth factor, which activates multiple signaling pathways, including the mitogen-activated protein kinase (MAPK) pathway. It was shown previously that MAPK activation is necessary and sufficient to induce the first stage of tubulogenesis, the partial epithelial to mesenchymal transition (p-EMT), whereas matrix metalloproteinases (MMPs) are necessary for the second redifferentiation stage. To identify specific MMP genes, their regulators, tissue inhibitors of matrix metalloproteinases (TIMPs), and the molecular pathways by which they are activated, we used two distinct MAPK inhibitors and a technique we have termed subtraction pathway microarray analysis. Of the 19 MMPs and 3 TIMPs present on the Canine Genome 2.0 Array, MMP13 and TIMP1 were up-regulated 198- and 169-fold, respectively, via the MAPK pathway. This was confirmed by two-dimensional and three-dimensional real time PCR, as well as in MDCK cells inducible for the MAPK gene Raf. Knockdown of MMP13 using short hairpin RNA prevented progression past the initial phase of p-EMT. Knockdown of TIMP1 prevented normal cystogenesis, although the initial phase of p-EMT did occasionally occur. The MMP13 knockdown phenotype is likely because of decreased collagenase activity, whereas the TIMP1 knockdown phenotype appears due to increased apoptosis. These data suggest a model, which may also be important for development of other branched organs, whereby the MAPK pathway controls both MDCK p-EMT and redifferentiation, in part by activating MMP13 and TIMP1.	[Hellman, Nathan E.; SpectorO, June; Robinson, Jonathan; Zuo, Xiaofeng; Lipschutz, Joshua H.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Lipschutz, Joshua H.] Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; [Saunier, Sophie; Antignac, Corinne] Univ Paris 05, Hop Necker Enfants Malades, INSERM, U 574, F-75015 Paris, France; [Tobias, John W.] Univ Penn, Genom Inst Bioinformat Core, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Lipschutz, JH (corresponding author), 431 Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	jhlipsch@mail.med.upenn.edu	ANTIGNAC, Corinne/H-8945-2017; Saunier, Sophie/G-6044-2015	ANTIGNAC, Corinne/0000-0002-9934-4940; Saunier, Sophie/0000-0002-1069-0047	NIDDK NIH HHS [DK069909, DK070980] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070980, R01DK069909] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balkovetz DF, 2004, AM J PHYSIOL-RENAL, V286, pF702, DOI 10.1152/ajprenal.00270.2003; Balkovetz DF, 1999, INT REV CYTOL, V186, P225; Balkovetz DF, 1997, J BIOL CHEM, V272, P3471, DOI 10.1074/jbc.272.6.3471; Balkovetz DF, 1999, KIDNEY INT, V56, P910, DOI 10.1046/j.1523-1755.1999.00623.x; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chaillan FA, 2006, BEHAV BRAIN RES, V173, P191, DOI 10.1016/j.bbr.2006.06.020; CREPALDI T, 1994, J CELL BIOL, V125, P313, DOI 10.1083/jcb.125.2.313; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; EKBLOM P, 1992, KIDNEY PHYSL PATHOPH, P475; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gabay L, 1997, DEVELOPMENT, V124, P3535; GUMBINER BM, 1992, CELL, V69, P385, DOI 10.1016/0092-8674(92)90440-N; Hansen SH, 2000, MOL CELL BIOL, V20, P9364, DOI 10.1128/MCB.20.24.9364-9375.2000; Hellman NE, 2005, AM J PHYSIOL-RENAL, V289, pF777, DOI 10.1152/ajprenal.00429.2004; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kanwar YS, 1999, AM J PHYSIOL-RENAL, V277, pF934, DOI 10.1152/ajprenal.1999.277.6.F934; Lee MM, 2005, INFECT IMMUN, V73, P661, DOI 10.1128/IAI.73.1.661-665.2005; Legallicier B, 2001, J AM SOC NEPHROL, V12, P2358, DOI 10.1681/ASN.V12112358; LEIGHTON J, 1970, CANCER-AM CANCER SOC, V26, P1022, DOI 10.1002/1097-0142(197011)26:5<1022::AID-CNCR2820260509>3.0.CO;2-M; Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Lipschutz JH, 2007, AM J PHYSIOL-RENAL, V293, pF985, DOI 10.1152/ajprenal.00292.2007; Liu XW, 2005, CANCER RES, V65, P898; Liu Z, 2007, BIOCHEM BIOPH RES CO, V353, P793, DOI 10.1016/j.bbrc.2006.12.106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MADIN SH, 1957, AM J VET RES, V18, P932; McAteer J A, 1986, Scan Electron Microsc, P1135; MCATEER JA, 1987, ANAT REC, V217, P229, DOI 10.1002/ar.1092170303; MCATEER JA, 1988, SCANNING MICROSCOPY, V2, P1739; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; Nakopoulou L, 2007, NEPHROL DIAL TRANSPL, V22, P109, DOI 10.1093/ndt/gfl618; O'Brien LE, 2004, DEV CELL, V7, P21, DOI 10.1016/j.devcel.2004.06.001; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; RudolphOwen LA, 1997, ENDOCRINOLOGY, V138, P4902, DOI 10.1210/en.138.11.4902; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakurai H, 1997, AM J PHYSIOL-RENAL, V273, pF463, DOI 10.1152/ajprenal.1997.273.3.F463; Sakurai H, 1997, P NATL ACAD SCI USA, V94, P6279, DOI 10.1073/pnas.94.12.6279; SAXEN L, 1987, ORGANOGENESIS KIDNEY, P1; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Vainio S, 1997, CELL, V90, P975, DOI 10.1016/S0092-8674(00)80363-3; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; Zeng F, 2007, MOL BIOL CELL, V18, P4446, DOI 10.1091/mbc.E07-03-0223; Zhou HE, 2004, BIOL REPROD, V71, P534, DOI 10.1095/biolreprod.104.029181	58	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4272	4282		10.1074/jbc.M708027200	http://dx.doi.org/10.1074/jbc.M708027200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18039671	hybrid			2022-12-27	WOS:000253083500062
J	Kimura, I; Nakayama, Y; Yamauchi, H; Konishi, M; Miyake, A; Mori, M; Ohta, M; Itoh, N; Fujimoto, M				Kimura, Ikuo; Nakayama, Yoshiaki; Yamauchi, Hajime; Konishi, Morichika; Miyake, Ayumi; Mori, Masahiro; Ohta, Mitsuhiro; Itoh, Nobuyuki; Fujimoto, Masafumi			Neurotrophic activity of neudesin, a novel extracellular heme-binding protein, is dependent on the binding of heme to its cytochrome b(5)-like heme/steroid-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RAT; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; MECHANISMS; EXPRESSION; OXIDATION; RECEPTOR	Neudesin is a secreted protein with neurotrophic activity in neurons and undifferentiated neural cells. We report here that neudesin is an extracellular heme-binding protein and that its neurotrophic activity is dependent on the binding of heme to its cytochrome b(5)-like heme/steroid-binding domain. At first, we found that at least a portion of the purified recombinant neudesin appeared to bind hemin because the purified neudesin solution was tinged with green and had a sharp absorbance peak at 402 nm. The addition of exogenous hemin extensively increased the amount of hemin-bound neudesin. In contrast, neudesin Delta HBD, a mutant lacking the heme-binding domain, could not bind hemin. The neurotrophic activity of the recombinant neudesin that bound exogenous hemin (neudesin-hemin) was significantly greater than that of the recombinant neudesin in either primary cultured neurons or Neuro2a cells, suggesting that the activity of neudesin depends on hemin. The neurotrophic activity of neudesin was enhanced by the binding of Fe(III)-protoporphyrin IX, but neither Fe(II)-protoporphyrin IX nor protoporphyrin IX alone. The inhibition of endogenous neudesin by RNA interference significantly decreased cell survival in Neuro2a cells. This indicates that endogenous neudesin possibly contains hemin. The experiment with anti-neudesin antibody suggested that the endogenous neudesin detected in the culture medium of Neuro2a cells was associated with hemin because it was not retained on a heme-affinity column at all. Neudesin is the first extracellular heme-binding protein that shows signal transducing activity by itself. The present findings may shed new light on the function of extracellular heme-binding proteins.	[Kimura, Ikuo; Mori, Masahiro; Fujimoto, Masafumi] Chiba Inst Sci, Fac Pharm, Lab Appl Pharmacol, Chiba 2880025, Japan; [Nakayama, Yoshiaki; Yamauchi, Hajime; Konishi, Morichika; Miyake, Ayumi; Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biochem Genet, Sakyo Ku, Kyoto 6068501, Japan; [Ohta, Mitsuhiro] Kobe Pharmaceut Univ, Dept Med Biochem, Kobe, Hyogo 6588558, Japan	Kyoto University; Kobe Pharmaceutical University	Kimura, I (corresponding author), Chiba Inst Sci, Fac Pharm, Lab Appl Pharmacol, Shiomi Choshi, Chiba 2880025, Japan.	ikimura@cis.ac.jp	Kimura, Ikuo/B-4193-2015	Nakayama, Yoshiaki/0000-0003-2187-3292				BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; BALLA G, 1992, J BIOL CHEM, V267, P18148; BLACK SM, 1994, P NATL ACAD SCI USA, V91, P7247, DOI 10.1073/pnas.91.15.7247; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Camejo G, 1998, J LIPID RES, V39, P755; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hoshikawa M, 2002, MOL BRAIN RES, V105, P60, DOI 10.1016/S0169-328X(02)00393-5; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; Kimura I, 2005, J NEUROSCI RES, V79, P287, DOI 10.1002/jnr.20356; Kimura I, 2006, J NEUROSCI RES, V83, P1415, DOI 10.1002/jnr.20849; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Min L, 2004, MOL CELL ENDOCRINOL, V215, P143, DOI 10.1016/j.mce.2003.11.025; MITSUD W, 2002, GENOME BIOL, V3, P12; Nakanishi N, 2006, J BIOCHEM, V140, P561, DOI 10.1093/jb/mvj189; Sawada H, 1996, J NEUROSCI RES, V43, P503, DOI 10.1002/(SICI)1097-4547(19960215)43:4<503::AID-JNR12>3.0.CO;2-2; Selmin O, 1996, CARCINOGENESIS, V17, P2609, DOI 10.1093/carcin/17.12.2609; SEO HG, 1995, BIOCHEM BIOPH RES CO, V208, P10, DOI 10.1006/bbrc.1995.1298; Shinohara H, 2004, J BIOL CHEM, V279, P41141, DOI 10.1074/jbc.M406721200; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SONO M, 1995, J BIOL CHEM, V270, P19943, DOI 10.1074/jbc.270.34.19943; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; THOMAS PE, 1976, ANAL BIOCHEM, V75, P168, DOI 10.1016/0003-2697(76)90067-1; Yamashita T, 2002, J BIOL CHEM, V277, P28265, DOI 10.1074/jbc.M202527200; Zhu LJ, 2005, ANAL BIOCHEM, V345, P102, DOI 10.1016/j.ab.2005.07.028	33	43	47	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4323	4331		10.1074/jbc.M706679200	http://dx.doi.org/10.1074/jbc.M706679200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056703	hybrid			2022-12-27	WOS:000253083500067
J	Moncoq, K; Kemp, G; Li, XJ; Fliegel, L; Young, HS				Moncoq, Karine; Kemp, Grant; Li, Xiuju; Fliegel, Larry; Young, Howard S.			Dimeric structure of human Na+/H+ exchanger isoform 1 overproduced in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS EXPRESSION; FUNCTIONAL-CHARACTERIZATION; PROTEIN; NHE1; PURIFICATION; ANTIPORTER; TRANSPORT; YEAST; CRYSTALLIZATION; IDENTIFICATION	The Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates intracellular pH by extruding an intracellular H+ in exchange for one extracellular Na+. The human NHE1 isoform is involved in heart disease and cell growth and proliferation. Although details of NHE1 regulation and transport are being revealed, there is little information available on the structure of the intact protein. In this report, we demonstrate overexpression, purification, and characterization of the human NHE1 (hNHE1) protein in Saccharomyces cerevisiae. Overproduction of the His-tagged protein followed by purification via nickel-nitrilotriacetic acid-agarose chromatography yielded 0.2 mg of pure protein/liter of cell culture. Reconstitution of hNHE1 in proteoliposomes demonstrated that the protein was active and responsive to an NHE1-specific inhibitor. Circular dichroism spectroscopy of purified hNHE1 revealed that the protein contains 41% alpha-helix, 23% beta-sheet, and 36% random coil. Size exclusion chromatography indicated that the protein-detergent micelle was in excess of 200 kDa, consistent with an hNHE1 dimer. Electron microscopy and single particle reconstruction of negatively stained hNHE1 confirmed that the protein was a dimer, with a compact globular domain assigned to the transmembrane region and an apical ridge assigned to the cytoplasmic domain. The transmembrane domain of the hNHE1 reconstruction was clearly dimeric, where each monomer had a size and shape consistent with the predicted 12 membrane-spanning segments for hNHE1.	[Moncoq, Karine; Kemp, Grant; Li, Xiuju; Fliegel, Larry; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca	Kemp, Grant/AAF-6735-2019	Kemp, Grant/0000-0001-5125-2740; Young, Howard/0000-0002-5990-8422				Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; Dibrov P, 1998, MOL CELL BIOCHEM, V183, P125, DOI 10.1023/A:1006801104502; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Flegelova H, 2006, BBA-GEN SUBJECTS, V1760, P504, DOI 10.1016/j.bbagen.2006.01.014; Flegelova H, 2005, FEBS LETT, V579, P4733, DOI 10.1016/j.febslet.2005.07.046; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; FLIEGEL L, 1993, BIOCHEM J, V289, P101, DOI 10.1042/bj2890101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gebreselassie D, 1998, BIOCHEM CELL BIOL, V76, P837, DOI 10.1139/bcb-76-5-837; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hisamitsu T, 2004, BIOCHEMISTRY-US, V43, P11135, DOI 10.1021/bi049367x; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jahn T, 2001, J MOL BIOL, V309, P465, DOI 10.1006/jmbi.2001.4688; JEAN T, 1985, J BIOL CHEM, V260, P9678; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; KLEINMAN JG, 1988, AM J PHYSIOL, V255, pG206, DOI 10.1152/ajpgi.1988.255.2.G206; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mentzer RM, 2003, CIRCULATION, V108; Montero-Lomeli M, 1999, BIOCHEM CELL BIOL, V77, P25, DOI 10.1139/bcb-77-1-25; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Parcej DN, 2003, J MOL BIOL, V333, P103, DOI 10.1016/j.jmb.2003.07.009; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Rieder CV, 2002, AM J PHYSIOL-HEART C, V283, pH273, DOI 10.1152/ajpheart.00042.2002; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SEKLER I, 1995, J BIOL CHEM, V270, P21028, DOI 10.1074/jbc.270.36.21028; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; VENEMA K, 1993, BIOCHIM BIOPHYS ACTA, V1146, P87, DOI 10.1016/0005-2736(93)90342-W; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	54	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4145	4154		10.1074/jbc.M704844200	http://dx.doi.org/10.1074/jbc.M704844200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077454	hybrid			2022-12-27	WOS:000253083500050
J	Roose, JL; Pakrasi, HB				Roose, Johnna L.; Pakrasi, Himadri B.			The Psb27 protein facilitates manganese cluster assembly in photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; ARABIDOPSIS-THALIANA; STABILIZING PROTEIN; CRYSTAL-STRUCTURE; IN-VIVO; RESOLUTION; COMPLEXES; BINDING; PHOTOINACTIVATION; BIOGENESIS	Photosystem II (PSII) is a large membrane protein complex that uses light energy to convert water to molecular oxygen. This enzyme undergoes an intricate assembly process to ensure accurate and efficient positioning of its many components. It has been proposed that the Psb27 protein, a lumenal extrinsic subunit, serves as a PSII assembly factor. Using a psb27 genetic deletion strain (Delta psb27) of the cyanobacterium Synechocystis sp. PCC 6803, we have defined the role of the Psb27 protein in PSII biogenesis. While the Psb27 protein was not essential for photosynthetic activity, various PSII assembly assays revealed that the Delta psb27 mutant was defective in integration of the Mn4Ca1Clx cluster, the catalytic core of the oxygen-evolving machinery within the PSII complex. The other lumenal extrinsic proteins (PsbO, PsbU, PsbV, and PsbQ) are key components of the fully assembled PSII complex and are important for the water oxidation reaction, but we propose that the Psb27 protein has a distinct function separate from these subunits. We show that the Psb27 protein facilitates Mn4Ca1Clx cluster assembly in PSII at least in part by preventing the premature association of the other extrinsic proteins. Thus, we propose an exchange of lumenal subunits and cofactors during PSII assembly, in that the Psb27 protein is replaced by the other extrinsic proteins upon assembly of the Mn4Ca1Clx cluster. Furthermore, we show that the Psb27 protein provides a selective advantage for cyanobacterial cells under conditions such as nutrient deprivation where Mn4Ca1Clx cluster assembly efficiency is critical for survival.	[Roose, Johnna L.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu						ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Burnap RL, 1996, BIOCHEMISTRY-US, V35, P874, DOI 10.1021/bi951964j; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; Chandler LE, 2003, BIOCHEMISTRY-US, V42, P5508, DOI 10.1021/bi027113a; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6150, DOI 10.1021/bi00186a014; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Ivleva NB, 2000, PLANT PHYSIOL, V124, P1403, DOI 10.1104/pp.124.3.1403; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; KLIMOV VV, 1990, PHOTOSYNTH RES, V23, P59, DOI 10.1007/BF00030063; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qian M, 1997, BIOCHEMISTRY-US, V36, P15244, DOI 10.1021/bi9713198; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; THEG SM, 1986, BIOCHIM BIOPHYS ACTA, V849, P104, DOI 10.1016/0005-2728(86)90101-5; Wang HL, 2002, BIOTECHNIQUES, V33, P26, DOI 10.2144/02331bm02; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	87	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4044	4050		10.1074/jbc.M708960200	http://dx.doi.org/10.1074/jbc.M708960200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18089572	Green Published, hybrid			2022-12-27	WOS:000253083500039
J	Whorton, MR; Jastrzebska, B; Park, PSH; Fotiadis, D; Engel, A; Palczewski, K; Sunahara, RK				Whorton, Matthew R.; Jastrzebska, Beata; Park, Paul S. -H.; Fotiadis, Dimitrios; Engel, Andreas; Palczewski, Krzysztof; Sunahara, Roger K.			Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; G-PROTEIN ACTIVATION; CRYSTAL-STRUCTURE; GPCR FUNCTION; RECEPTOR; HETERODIMERIZATION; LIGHT; ARRESTIN; BINDING; DIMERS	G protein-coupled receptors (GPCRs) are seven transmembrane domain proteins that transduce extracellular signals across the plasma membrane and couple to the heterotrimeric family of G proteins. Like most intrinsic membrane proteins, GPCRs are capable of oligomerization, the function of which has only been established for a few different receptor systems. One challenge in understanding the function of oligomers relates to the inability to separate monomeric and oligomeric receptor complexes in membrane environments. Here we report the reconstitution of bovine rhodopsin, a GPCR expressed in the retina, into an apolipoprotein A-I phospholipid particle, derived from high density lipoprotein (HDL). We demonstrate that rhodopsin, when incorporated into these 10 nm reconstituted HDL (rHDL) particles, is monomeric and functional. Rhodopsin . rHDL maintains the appropriate spectral properties with respect to photoactivation and formation of the active form, metarhodopsin II. Additionally, the kinetics of metarhodopsin II decay is similar between rhodopsin in native membranes and rhodopsin in rHDL particles. Photoactivation of monomeric rhodopsin . rHDL also results in the rapid activation of transducin, at a rate that is comparable with that found in native rod outer segments and 20-fold faster than rhodopsin in detergent micelles. These data suggest that monomeric rhodopsin is the minimal functional unit in G protein activation and that oligomerization is not absolutely required for this process.	[Whorton, Matthew R.; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Jastrzebska, Beata; Park, Paul S. -H.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Fotiadis, Dimitrios; Engel, Andreas] Univ Basel, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland	University of Michigan System; University of Michigan; Case Western Reserve University; University of Basel	Sunahara, RK (corresponding author), 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	sunahara@umich.edu	Sunahara, Roger/AAJ-8667-2020		NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079191, R01GM068603] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BALDWIN PA, 1985, BIOCHEMISTRY-US, V24, P2633, DOI 10.1021/bi00332a007; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; Baneres JL, 2003, J MOL BIOL, V329, P801, DOI 10.1016/S0022-2836(03)00438-8; Bayburt TH, 2003, PROTEIN SCI, V12, P2476, DOI 10.1110/ps.03267503; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; CERIONE RA, 1991, METHOD ENZYMOL, V195, P329; Cha KW, 2000, P NATL ACAD SCI USA, V97, P3016, DOI 10.1073/pnas.97.7.3016; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; DEGRIP WJ, 1982, METHOD ENZYMOL, V81, P197; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; FORTE TM, 1986, METHOD ENZYMOL, V128, P442; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goudet C, 2005, J BIOL CHEM, V280, P24380, DOI 10.1074/jbc.M502642200; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; JONAS A, 1990, J BIOL CHEM, V265, P22123; JONAS A, 1986, METHOD ENZYMOL, V128, P553; JONES AL, 1968, J HISTOCHEM CYTOCHEM, V16, P366, DOI 10.1177/16.5.366; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kisselev OG, 2006, BIOCHEMISTRY-US, V45, P9386, DOI 10.1021/bi060806x; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Lewis GF, 2006, CURR OPIN CARDIOL, V21, P345, DOI 10.1097/01.hco.0000231405.76930.a0; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; OBRIEN DF, 1977, BIOCHEMISTRY-US, V16, P1295, DOI 10.1021/bi00626a009; OKADA T, 2005, PROTEIN COUPLED RECE, P245; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; POWNALL HJ, 1986, METHOD ENZYMOL, V128, P515; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Segrest JP, 2000, CURR OPIN LIPIDOL, V11, P105, DOI 10.1097/00041433-200004000-00002; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vogel R, 2003, BIOCHEMISTRY-US, V42, P9863, DOI 10.1021/bi034684+; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104	62	209	209	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4387	4394		10.1074/jbc.M703346200	http://dx.doi.org/10.1074/jbc.M703346200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18033822	Green Accepted, hybrid			2022-12-27	WOS:000253083500073
J	Datta, K; von Hippel, PH				Datta, Kausiki; von Hippel, Peter H.			Direct spectroscopic study of reconstituted transcription complexes reveals that intrinsic termination is driven primarily by thermodynamic destabilization of the nucleic acid framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; LOW-ENERGY CD; ELONGATION COMPLEXES; ESCHERICHIA-COLI; NASCENT RNA; 3 END; DNA; HAIRPIN; CONFORMATION; BUBBLE	Changes in near UV circular dichroism (CD) and fluorescence spectra of site-specifically placed pairs of 2-aminopurine residues have been used to probe the roles of the RNA hairpin and the RNA-DNA hybrid in controlling intrinsic termination of transcription. Functional transcription complexes were assembled directly by mixing preformed nucleic acid scaffolds of defined sequence with T7 RNA polymerase (RNAP). Scaffolds containing RNA hairpins immediately upstream of a GC-rich hybrid formed complexes of reduced stability, whereas the same hairpins adjacent to a hybrid of rU-dA base pairs triggered complex dissociation and transcript release. 2-Aminopurine probes at the upstream ends of the hairpin stems show that the hairpins open on RNAP binding and that stem re-formation begins after one or two RNA bases on the downstream side of the stem have emerged from the RNAP exit tunnel. Hairpins directly adjacent to the RNA-DNA hybrid weaken RNAP binding, decrease elongation efficiency, and disrupt the upstream end of the hybrid as well as interfere with the movement of the template base at the RNAP active site. Probing the edges of the DNA transcription bubble demonstrates that termination hairpins prevent translocation of the RNAP, suggesting that they transiently "lock" the polymerase to the nucleic acid scaffold and, thus, hold the RNA-DNA hybrid "in frame." At intrinsic terminators the weak rU-dA hybrid and the adjacent termination hairpin combine to destabilize the elongation complex sufficiently to permit significant transcript release, whereas hairpin-dependent pausing provides time for the process to go to completion.	[Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	NIGMS NIH HHS [R01 GM029158, GM-29158, GM-15792, R01 GM015792, R01 GM015792-42] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015792, R01GM015792, R01GM029158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Datta K, 2006, J MOL BIOL, V360, P800, DOI 10.1016/j.jmb.2006.05.053; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; DORVAL BC, 1991, J MOL BIOL, V221, P837, DOI 10.1016/0022-2836(91)80179-X; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; FENG GH, 1994, J BIOL CHEM, V269, P22282; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; JENG ST, 1992, J BIOL CHEM, V267, P19306; Johnson NP, 2005, J BIOL CHEM, V280, P32177, DOI 10.1074/jbc.M504619200; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Ma KY, 2005, P NATL ACAD SCI USA, V102, P17612, DOI 10.1073/pnas.0508865102; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Wilson KS, 1999, J MOL BIOL, V289, P1179, DOI 10.1006/jmbi.1999.2814; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104	31	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3537	3549		10.1074/jbc.M707998200	http://dx.doi.org/10.1074/jbc.M707998200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070878	Green Accepted, hybrid			2022-12-27	WOS:000253083000059
J	Kainu, V; Hermansson, M; Somerharju, P				Kainu, Ville; Hermansson, Martin; Somerharju, Pentti			Electrospray lonization mass spectrometry and exogenous heavy isotope-labeled lipid species provide detailed information on aminophospholipid acyl chain remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVEN FRAGMENTATION PROCESSES; ENERGY COLLISIONAL ACTIVATION; RAT-LIVER MICROSOMES; CDP-CHOLINE PATHWAY; MAMMALIAN-CELLS; PLASMA-MEMBRANE; MOLECULAR HYDROPHOBICITY; MECHANISTIC PROPOSAL; CULTURED-CELLS; FATTY-ACIDS	Mammalian cells maintain the phospholipid compositions of their different membranes remarkably constant. Beside de novo synthesis, degradation, and intracellular trafficking, acyl chain remodeling plays an important role in phospholipid homeostasis. However, many key details of this process remain unresolved, largely because of limitations of existing methodologies. Here we describe a novel approach that allows one to study metabolism of individual phospholipid species in unprecedented detail. Forty different phosphatidylethanolamine (PE) or-serine (PS) species with a deuterium-labeled head group were synthesized and introduced to BHK21 or HeLa cells using cyclodextrin-mediated transfer. Their metabolism was then monitored in detail by electrospray ionization mass spectrometry. Atypical PE and PS species were rapidly remodeled at both sn1 and sn2 position, yielding a molecular species profile similar to that the endogenous PE and PS. In contrast, remodeling of exogenous species identical or similar to major endogenous ones was more limited and much slower. Major differences in remodeling pathways and kinetics were observed between species within a class, as well as between corresponding PE and PS species. These data along with those obtained with pharmacological inhibitors strongly suggest that multiple lipid class-specific A-type phospholipases and acyl transferases are involved in aminophospholipid remodeling. In conclusion, the approach described here provides highly detailed information on remodeling of exogenously added (amino) glycerophospholipids and should thus be very helpful when elucidating the proteins and processes maintaining molecular species homeostasis.	[Kainu, Ville; Hermansson, Martin; Somerharju, Pentti] Univ Helsinki, Dept Biochem, Inst Biomed, FIN-00014 Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki	Hermansson, M (corresponding author), Univ Helsinki, Dept Biochem, Inst Biomed, PL 63, FIN-00014 Helsinki, Finland.	martin.hermansson@helsinki.fi	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365				Asai K, 2003, J BIOL CHEM, V278, P8809, DOI 10.1074/jbc.M212117200; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Bao SZ, 2006, J BIOL CHEM, V281, P187, DOI 10.1074/jbc.M509105200; BARTLETT EM, 1970, ANAL BIOCHEM, V36, P159, DOI 10.1016/0003-2697(70)90343-X; Binder M, 2006, J BIOL CHEM, V281, P21869, DOI 10.1074/jbc.M603025200; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; CAESAR PA, 1991, AM J RESP CELL MOL, V5, P363, DOI 10.1165/ajrcmb/5.4.363; Chambers K, 2004, BIOCHEM BIOPH RES CO, V313, P681, DOI 10.1016/j.bbrc.2003.12.016; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DOI O, 1978, BIOCHIM BIOPHYS ACTA, V509, P239, DOI 10.1016/0005-2736(78)90044-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAMBLE W, 1978, J LIPID RES, V19, P1068; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Heikinheimo L, 2002, BBA-MOL CELL RES, V1591, P75, DOI 10.1016/S0167-4889(02)00253-7; Heikinheimo L, 1998, J BIOL CHEM, V273, P3327, DOI 10.1074/jbc.273.6.3327; Hermansson M, 2005, ANAL CHEM, V77, P2166, DOI 10.1021/ac048489s; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3; Hunt AN, 2006, METHODS, V39, P104, DOI 10.1016/j.ymeth.2006.05.005; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Hvattum E, 1998, RAPID COMMUN MASS SP, V12, P1405, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1405::AID-RCM338>3.0.CO;2-B; Ivanova PT, 2001, P NATL ACAD SCI USA, V98, P7152, DOI 10.1073/pnas.131195098; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Kakela R, 2003, J NEUROCHEM, V84, P1051, DOI 10.1046/j.1471-4159.2003.01602.x; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kinsey GR, 2005, BIOCHEM BIOPH RES CO, V327, P287, DOI 10.1016/j.bbrc.2004.12.016; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Koivusalo M, 2001, J LIPID RES, V42, P663; Kol MA, 2004, BBA-MOL CELL BIOL L, V1636, P205, DOI 10.1016/j.bbalip.2004.01.002; KRAMER RM, 1984, J BIOL CHEM, V259, P2403; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; MACDONALD JIS, 1991, BIOCHIM BIOPHYS ACTA, V1084, P105, DOI 10.1016/0005-2760(91)90209-Z; Maxfield FR, 2006, BIOCHEM SOC T, V34, P335, DOI 10.1042/BST0340335; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Nixon AB, 1996, BBA-LIPID LIPID MET, V1300, P187, DOI 10.1016/0005-2760(96)00011-2; OUSLEY AH, 1992, J BIOL CHEM, V267, P10362; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Perez R, 2006, J LIPID RES, V47, P484, DOI 10.1194/jlr.M500397-JLR200; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Postle AD, 2007, PROG LIPID RES, V46, P200, DOI 10.1016/j.plipres.2007.04.001; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; REDDY PV, 1987, BIOCHIM BIOPHYS ACTA, V922, P379, DOI 10.1016/0005-2760(87)90062-2; Rouzer CA, 2007, BIOCHEMISTRY-US, V46, P6026, DOI 10.1021/bi0621617; SAMBORSKI RW, 1990, J BIOL CHEM, V265, P18322; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; SCHMID PC, 1991, J BIOL CHEM, V266, P13690; SCHMID PC, 1995, ARCH BIOCHEM BIOPHYS, V319, P168, DOI 10.1006/abbi.1995.1279; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Silversand C, 1997, J CHROMATOGR B, V703, P7, DOI 10.1016/S0378-4347(97)00385-X; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; SOMERHARJU PJ, 1987, BIOCHEMISTRY-US, V26, P7193, DOI 10.1021/bi00396a048; STORRIE B, 1990, METHOD ENZYMOL, V182, P203; Tanhuanpaa K, 1999, J BIOL CHEM, V274, P35359, DOI 10.1074/jbc.274.50.35359; Tanhuanpaa K, 2000, BBA-MOL CELL RES, V1497, P308, DOI 10.1016/S0167-4889(00)00068-9; Tanhuanpaa K, 2001, BIOPHYS J, V81, P1501, DOI 10.1016/S0006-3495(01)75804-3; THOMPSON W, 1986, BIOCHIM BIOPHYS ACTA, V876, P379, DOI 10.1016/0005-2760(86)90023-8; TIJBURG LBM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P184, DOI 10.1016/0005-2760(91)90093-W; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1; Yang YZ, 2004, J BIOL CHEM, V279, P55866, DOI 10.1074/jbc.M406710200	71	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3676	3687		10.1074/jbc.M709176200	http://dx.doi.org/10.1074/jbc.M709176200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056998	hybrid			2022-12-27	WOS:000253083000072
J	Li, Z; Nardi, MA; Wu, J; Pan, R; Zhang, W; Karpatkin, S				Li, Zongdong; Nardi, Michael A.; Wu, Jing; Pan, Ruimin; Zhang, Wei; Karpatkin, Simon			Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta 3 integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; PHAGE DISPLAY; GLYCOPROTEIN IIIA; IMMUNIZED DONORS; POLYMORPHISM; INTEGRINS; INTEGRIN-ALPHA(IIB)BETA(3); LIBRARIES; SELECTION; THERAPY	We have described an autoantibody against beta 3 (GPIIIa49-66), a region of platelet integrin alpha IIb beta 3 that is unique. It induces platelet fragmentation in the absence of complement via antibody activation of platelet NADPH oxidase and 12-lipoxygenase to release reactive oxygen species, which destroy platelets. To study the mechanism of anti-GPIIIa antibody-induced platelet fragmentation, we screened a human single chain Fv antibody library with the GPIIIa49-66 peptide. Nine monoclonal antibodies were identified that were capable of binding to GPIIIa49-66. Surprisingly, binding avidity for GPIIIa49-66 did not correlate with activity of induction of platelet fragmentation. We therefore investigated the requirements for platelet fragmentation. Mutations were introduced into the heavy chain complementary-determining region-3 of clones 11, 43, and 54 by site-directed mutagenesis. The capability of these clones to induce platelet fragmentation or bind to GPIIIa49-66 subsequently changed. Molecular modeling of these clones with their mutants revealed that the ability to induce platelet fragmentation is affected by the side chain orientation of positively charged amino acids in the heavy chain of residues 99-102. Thus, a structural change in the conformation of anti-GPIIIa49-66 antibody contributes to its binding to the beta 3 integrin and subsequent antibody-induced platelet fragmentation and aggregate dissolution.	[Li, Zongdong; Wu, Jing; Pan, Ruimin; Zhang, Wei; Karpatkin, Simon] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Nardi, Michael A.] NYU, Sch Med, Dept Pediat, New York, NY 10016 USA	New York University; New York University	Li, Z (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	liz04@med.nyu.edu		Nardi, Michael/0000-0002-3276-3198	NHLBI NIH HHS [HL13336] Funding Source: Medline; NIDA NIH HHS [K01 DA020816] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA020816] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andrioli G, 2000, BRIT J HAEMATOL, V110, P911, DOI 10.1046/j.1365-2141.2000.02300.x; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Bhatt DL, 2003, NAT REV DRUG DISCOV, V2, P15, DOI 10.1038/nrd985; CLACKSON T, 1991, NATURE, V352, P624, DOI 10.1038/352624a0; Davoren A, 2004, TRANSFUSION, V44, P1220, DOI 10.1111/j.1537-2995.2004.04026.x; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Jacobin MJ, 2002, J IMMUNOL, V168, P2035, DOI 10.4049/jimmunol.168.4.2035; Jacobin MJ, 2003, CLIN IMMUNOL, V108, P199, DOI 10.1016/S1521-6616(03)00143-8; Li ZD, 2005, BLOOD, V106, P572, DOI 10.1182/blood-2005-01-0243; Michelson AD, 2000, CIRCULATION, V101, P1013, DOI 10.1161/01.CIR.101.9.1013; MORRIS L, 1982, ANN INTERN MED, V96, P714, DOI 10.7326/0003-4819-96-6-714; NAJEAN Y, 1994, J LAB CLIN MED, V123, P415; Nardi M, 2004, J CLIN INVEST, V113, P973, DOI 10.1172/JCI200420726; Nardi M, 2001, CELL, V106, P551, DOI 10.1016/S0092-8674(01)00477-9; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Schwarz M, 2004, FASEB J, V18, P1704, DOI 10.1096/fj.04-1513fje; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Szczeklik A, 2000, BRIT J HAEMATOL, V110, P965, DOI 10.1046/j.1365-2141.2000.02267.x; Undas A, 2001, CIRCULATION, V104, P2666, DOI 10.1161/hc4701.099787; Winters JL, 1998, VOX SANG, V74, P256, DOI 10.1046/j.1423-0410.1998.7440256.x; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976	22	18	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3224	3230		10.1074/jbc.M705902200	http://dx.doi.org/10.1074/jbc.M705902200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056258	hybrid			2022-12-27	WOS:000253083000026
J	Xu, C; Prasad, AM; Inesi, G; Toyoshima, C				Xu, Cheng; Prasad, Anand Mohan; Inesi, Giuseppe; Toyoshima, Chikashi			Critical role of Val-304 in conformational transitions that allow Ca2+ occlusion and phosphoenzyme turnover in the Ca2+ transport ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; CALCIUM-PUMP; CRYSTAL-STRUCTURE; PHOSPHORYLATION; DOMAIN; ANALOG; CA(2+)-ATPASE; INTERMEDIATE; INHIBITION; MECHANISM	Site-directed mutations were produced in the distal segments of the Ca2+-ATPase (SERCA) transmembrane region. Mutations of Arg-290 (M3-M4 loop), Lys-958, and Thr-960 (M9-M10 loop) had minor effects on ATPase activity and Ca2+ transport. On the other hand, Val-304 (M4) mutations to Ile, Thr, Lys, Ala, or Glu inhibited transport by 90-95% while reducing ATP hydrolysis by 83% (Ile, Thr, and Lys), 56% (Ala), or 45% (Glu). Val-304 participates in Ca2+ coordination with its main-chain carbonyl oxygen, and this function is not expected to be altered by mutations of its side chain. In fact, despite turnover inhibition, the Ca2+ concentration dependence of residual ATPase activity remained unchanged in Val-304 mutants. However, the rates (but not the final levels) of phosphoenzyme formation, as well the rates of its hydrolytic cleavage, were reduced in proportion to the ATPase activity. Furthermore, with the Val-304 -> Glu mutant, which retained the highest residual ATPase activity, it was possible to show that occlusion of bound Ca2+ was also impaired, thereby explaining the stronger inhibition of Ca2+ transport relative to ATPase activity. The effects of Val-304 mutations on phosphoenzyme turnover are attributed to interference with mechanical links that couple movements of transmembrane segments and headpiece domains. The effects of thermal activation energy on reaction rates are thereby reduced. Furthermore, inadequate occlusion of bound Ca2+ following utilization of ATP in Val-304 side-chain mutations is attributed to inadequate stabilization of the Glu-309 side chain and consequent defect of its gating function.	[Xu, Cheng; Prasad, Anand Mohan; Inesi, Giuseppe] Calif Pacific Med Ctr, Res Inst, San Francisco, CA 94107 USA; [Toyoshima, Chikashi] Univ Tokyo, Inst Mol & Cellular Biol, Bunkyo Ku, Tokyo 113, Japan	California Pacific Medical Center; California Pacific Medical Center Research Institute; University of Tokyo	Inesi, G (corresponding author), Calif Pacific Med Ctr, Res Inst, 475 Brannan St, San Francisco, CA 94107 USA.	ginesi@CPMCRI.com	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778	PHS HHS [R01-69830] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andersen JP, 1998, ACTA PHYSIOL SCAND, V163, P45; ANDERSEN JP, 1992, J BIOL CHEM, V267, P19383; BIGELOW DJ, 1992, J BIOL CHEM, V267, P6952; Chen L, 1996, J BIOL CHEM, V271, P10745, DOI 10.1074/jbc.271.18.10745; CLARKE DM, 1993, J BIOL CHEM, V268, P18359; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1982, ANN NY ACAD SCI, V402, P535; Einholm AP, 2004, J BIOL CHEM, V279, P15888, DOI 10.1074/jbc.M400158200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; INESI G, 1980, J BIOL CHEM, V255, P3025; KARIN NJ, 1989, MOL CELL BIOL, V9, P1978, DOI 10.1128/MCB.9.5.1978; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MOLLER JV, 1986, BIOCHIM BIOPHYS ACTA, V1286, P1; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Picard M, 2005, J BIOL CHEM, V280, P18745, DOI 10.1074/jbc.M501596200; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104; SUMBILLA C, 1993, J BIOL CHEM, V268, P21185; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; ZHANG Z, 1995, J BIOL CHEM, V270, P16283	32	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3297	3304		10.1074/jbc.M706315200	http://dx.doi.org/10.1074/jbc.M706315200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056991	hybrid			2022-12-27	WOS:000253083000034
J	Radjabi, AR; Sawada, K; Jagadeeswaran, S; Eichbichler, A; Kenny, HA; Montag, A; Bruno, K; Lengyel, E				Radjabi, A. Reza; Sawada, Kenjiro; Jagadeeswaran, Sujatha; Eichbichler, Alfred; Kenny, Hilary A.; Montag, Anthony; Bruno, Katharina; Lengyel, Ernst			Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta 1-integrin on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV COLLAGENASE EXPRESSION; C-MET OVEREXPRESSION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; MATRIX METALLOPROTEINASE-9; PROMOTER ACTIVITY; TISSUE INHIBITOR; INTEGRIN; UROKINASE; RECEPTOR	The procoagulatory serine protease, thrombin, is known to induce invasion and metastasis in various cancers, but the mechanisms by which it promotes tumorigenesis are poorly understood. Because the 92-kDa gelatinase (MMP-9) is a known mediator of tumor cell invasion, we sought to determine whether and how thrombin regulates MMP-9. The thrombin receptor, PAR-1, and MMP-9 are expressed in osteosarcomas, as determined by immunohistochemistry. Stimulation of U2-OS osteosarcoma cells with thrombin and a thrombin receptor-activating peptide induced pro-MMP-9 secretion as well as cell surface-associated pro-MMP-9 expression and proteolytic activity. This was paralleled by an increase in MMP-9 mRNA and MMP-9 promoter activity. Thrombin-induced invasion of U2-OS cells through Matrigel was mediated by the phosphatidylinositol 3-kinase signaling pathway and could be inhibited with an MMP-9 antibody. The stimulation of MMP-9 by thrombin was paralleled by an increase in beta 1-integrin mRNA and beta 1-integrin expression on the cell surface, which was also mediated by phosphatidylinositol 3-kinase and was required for invasion. Thrombin activation induced and co-localized both beta 1-integrin and proMMP-9 on the cell membrane, as evidenced by co-immunoprecipitation, confocal microscopy, and a protein binding assay. The thrombin-mediated association of these two proteins, as well as thrombin-mediated invasion of U2-OS cells, could be blocked with a cyclic peptide and with an antibody preventing binding of the MMP-9 hemopexin domain to beta 1-integrin. These results suggest that thrombin induces expression and association of beta 1-integrin with MMP-9 and that the cell surface localization of the protease by the integrin promotes tumor cell invasion.	[Radjabi, A. Reza; Sawada, Kenjiro; Jagadeeswaran, Sujatha; Kenny, Hilary A.; Lengyel, Ernst] Univ Chicago, Dept Obstet & Gynecol, Gynecol Oncol Sect, Ctr Integrat Sci, Chicago, IL 60637 USA; [Montag, Anthony] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Bruno, Katharina] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Lengyel, Ernst] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Eichbichler, Alfred] Bogenhausen Med Ctr, Dept Orthoped Surg, D-81925 Munich, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Lengyel, E (corresponding author), MC 20650,5841 S Maryland Ave, Chicago, IL 60637 USA.	elengyel@uchicago.edu	Lengyel, Ernst/D-9220-2014	Lengyel, Ernst/0000-0001-8624-1507	NCI NIH HHS [R01 CA111882, R01 CA 111882, R01 CA111882-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA111882] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannikov GA, 2002, J BIOL CHEM, V277, P16022, DOI 10.1074/jbc.M110931200; Bjorklund M, 2004, J BIOL CHEM, V279, P29589, DOI 10.1074/jbc.M401601200; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chapman HA, 2001, THROMB HAEMOSTASIS, V86, P124; Coe APF, 2001, J BIOL CHEM, V276, P35854, DOI 10.1074/jbc.M103639200; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Even-Ram SC, 2001, J BIOL CHEM, V276, P10952, DOI 10.1074/jbc.M007027200; Falanga A, 2005, CURR OPIN PULM MED, V11, P403, DOI 10.1097/01.mcp.0000174247.23009.06; Ferrari C, 2004, ACTA ORTHOP SCAND, V75, P487, DOI 10.1080/00016470410001295-1; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Grisaru-Granovsky S, 2005, INT J CANCER, V113, P372, DOI 10.1002/ijc.20607; Gum R, 1996, J BIOL CHEM, V271, P10672, DOI 10.1074/jbc.271.18.10672; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Henrikson KP, 1999, BRIT J CANCER, V79, P401, DOI 10.1038/sj.bjc.6690063; Hernandez-Rodriguez NA, 2002, INT J BIOL MARKER, V17, P189, DOI 10.1177/172460080201700308; Hu L, 2004, BLOOD, V104, P2746, DOI 10.1182/blood-2004-03-1047; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; JONES L, 2002, THEORY PRACTICE HIST, P152; KANTHOU C, 1995, THROMB HAEMOSTASIS, V74, P1340; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; KRAMER RM, 1995, J BIOL CHEM, V270, P27395, DOI 10.1074/jbc.270.46.27395; LAMORTE VJ, 1993, J BIOL CHEM, V268, P19411; Lengyel E, 2005, INT J CANCER, V113, P678, DOI 10.1002/ijc.20598; LENGYEL E, 1995, CANCER RES, V55, P963; LENGYEL E, 1995, J BIOL CHEM, V270, P23007, DOI 10.1074/jbc.270.39.23007; Maragoudakis ME, 2001, ENDOTHELIUM-J ENDOTH, V8, P195; Mira E, 1999, ENDOCRINOLOGY, V140, P1657, DOI 10.1210/en.140.4.1657; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Mylona E, 2007, HISTOPATHOLOGY, V50, P338, DOI 10.1111/j.1365-2559.2007.02615.x; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RAMOSDESIMONE N, 1993, HYBRIDOMA, V12, P349, DOI 10.1089/hyb.1993.12.349; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Shi XL, 2004, MOL CANCER RES, V2, P395; Su G, 2007, AM J RESP CELL MOL, V36, P377, DOI 10.1165/rcmb.2006-0238OC; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Toth M, 2003, BIOCHEM BIOPH RES CO, V308, P386, DOI 10.1016/S0006-291X(03)01405-0; Toth M, 1997, CANCER RES, V57, P3159; TROUSSEAU A, 1965, CLIN MED HOTEL DIEU; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9; Wei Y, 2005, J CELL BIOL, V168, P501, DOI 10.1083/jcb.200404112; WOJTUKIEWICZ MZ, 1993, INT J CANCER, V54, P793, DOI 10.1002/ijc.2910540514; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; YOSHIDA E, 1994, CANCER RES, V54, P3300; ZUCKER S, 1995, J BIOL CHEM, V270, P23730, DOI 10.1074/jbc.270.40.23730	58	61	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2822	2834		10.1074/jbc.M704855200	http://dx.doi.org/10.1074/jbc.M704855200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048360	Green Accepted, hybrid			2022-12-27	WOS:000252622300040
J	Wen, YF; Golubkov, VS; Strongin, AY; Jiang, W; Reed, JC				Wen, Yunfei; Golubkov, Vladislav S.; Strongin, Alex Y.; Jiang, Wei; Reed, John C.			Interaction of hepatitis B viral oncoprotein with cellular target HBXIP dysregulates centrosome dynamics and mitotic spindle formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X-PROTEIN; TRANSCRIPTIONAL TRANSACTIVATION; CYCLE PROGRESSION; EPITHELIAL-CELLS; CYTOKINESIS; APOPTOSIS; REPLICATION; EXPRESSION; CENTRIOLE; DIFFERENTIATION	Hepatitis B virus infection is associated with hepatocellular carcinoma, claiming 1 million lives annually worldwide. To understand the carcinogenic mechanism of hepatitis B virus-encoded oncoprotein HBx, we explored the function of HBx interaction with its cellular target HBXIP. Previously, we demonstrated that viral HBx and cellular HBXIP control mitotic spindle formation, regulating centrosome splitting. By using various fragments of HBx, we determined that residues (CRHK140)-C-137 within HBx are necessary for binding HBXIP. Mutation of the 137CRHK140 motif in HBx abolished its ability to bind HBXIP and to dysregulate centrosome dynamics in HeLa and immortal diploid RPE-1 cells. Unlike wild-type HBx, which targets to centrosomes as determined by subcellular fractionation and immunofluorescence microscopy, HBx mutants failed to localize to centrosomes. Overexpression of viral HBx wildtype protein and knockdown of endogenous HBXIP altered centrosome assembly and induced modifications of pericentrin and centrin-2, two essential proteins required for centrosome formation and function, whereas HBXIP nonbinding mutants of HBx did not. Overexpression of HBXIP or fragments of HBXIP that bind HBx neutralized the effects of viral HBx on centrosome dynamics and spindle formation. These results suggest that HBXIP is a critical target of viral HBx for promoting genetic instability through formation of defective spindles and subsequent aberrant chromosome segregation.	[Wen, Yunfei; Reed, John C.] Burnham Inst Med Res, Program Apoptosis & Cell Death Res, La Jolla, CA 92037 USA; [Golubkov, Vladislav S.; Strongin, Alex Y.] Burnham Inst Med Res, Program Cell Adhes & Extracellular Matrix Biol, La Jolla, CA 92037 USA; [Jiang, Wei] Burnham Inst Med Res, Program Canc Genet & Epigenet, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Reed, JC (corresponding author), 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	reedoffice@burnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; Jiang, Wei/0000-0002-2309-9571	NCI NIH HHS [CA 12053] Funding Source: Medline; NIA NIH HHS [AG 15402] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; Birrer RB, 2003, ANN CLIN LAB SCI, V33, P39; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Christodoulou A, 2006, J CELL SCI, V119, P2035, DOI 10.1242/jcs.02922; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Deryugina EI, 2002, CANCER RES, V62, P580; Forgues M, 2003, MOL CELL BIOL, V23, P5282, DOI 10.1128/MCB.23.15.5282-5292.2003; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; HOPPESEYLER F, 1995, J MOL MED, V73, P529; JOHNS RH, 1996, NATL WEA DIG, V20, P2; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kanda T, 2004, SCAND J GASTROENTERO, V39, P478, DOI 10.1080/00365520310008719; Kang SG, 2001, CURR EYE RES, V22, P174, DOI 10.1076/ceyr.22.3.174.5513; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim SY, 2005, IUBMB LIFE, V57, P651, DOI 10.1080/15216540500239697; Laoukili J, 2000, J CELL SCI, V113, P1355; Lok ASF, 2000, J HEPATOL, V32, P89, DOI 10.1016/S0168-8278(00)80418-3; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McArthur GA, 1998, COLD SPRING HARB SYM, V63, P423, DOI 10.1101/sqb.1998.63.423; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Mohammad RM, 1999, INT J ONCOL, V14, P945; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073; Warner AK, 2006, TRAFFIC, V7, P205, DOI 10.1111/j.1600-0854.2005.00377.x; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	41	64	66	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2793	2803		10.1074/jbc.M708419200	http://dx.doi.org/10.1074/jbc.M708419200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032378	hybrid			2022-12-27	WOS:000252622300037
J	Altman, JK; Yoon, P; Katsoulidis, E; Kroczynska, B; Sassano, A; Redig, AJ; Glaser, H; Jordan, A; Tallman, MS; Hay, N; Platanias, LC				Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Hay, Nissim; Platanias, Leonidas C.			Regulatory effects of mammalian target of rapamycin-mediated signals in the generation of arsenic trioxide responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; MESSENGER-RNA TRANSLATION; MYELOID-LEUKEMIA; INDUCED APOPTOSIS; DOWN-REGULATION; CELL APOPTOSIS; IN-VITRO; PATHWAY	Arsenic trioxide (As2O3) is a potent inducer of apoptosis of leukemic cells in vitro and in vivo, but the mechanisms that mediate such effects are not well understood. We provide evidence that the Akt kinase is phosphorylated/activated during treatment of leukemia cells with As2O3, to regulate downstream engagement of mammalian target of rapamycin (mTOR) and its effectors. Using cells with targeted disruption of both the Akt1 and Akt2 genes, we found that induction of arsenic trioxide-dependent apoptosis is strongly enhanced in the absence of these kinases, suggesting that Akt1/Akt2 are activated in a negative feedback regulatory manner, to control generation of As2O3 responses. Consistent with this, As2O3-dependent pro-apoptotic effects are enhanced in double knock-out cells for both isoforms of the p70 S6 kinase (S6k1/S6k2), a downstream effector of Akt and mTOR. On the other hand, As2O3-dependent induction of apoptosis is diminished in cells with targeted disruption of TSC2, a negative upstream effector of mTOR. In studies using primary hematopoietic progenitors from patients with acute myeloid leukemia, we found that pharmacological inhibition of mTOR enhances the suppressive effects of arsenic trioxide on leukemic progenitor colony formation. Moreover, short interfering RNA-mediated inhibition of expression of the negative downstream effector, translational repressor 4E-BP1, partially reverses the effects of As2O3. Altogether, these data provide evidence for a key regulatory role of the Akt/mTOR pathway in the generation of the effects of As2O3, and suggest that targeting this signaling cascade may provide a novel therapeutic approach to enhance the anti-leukemic properties of As2O3.	[Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Altman, Jessica K.; Yoon, Patrick; Katsoulidis, Efstratios; Kroczynska, Barbara; Sassano, Antonella; Redig, Amanda J.; Glaser, Heather; Jordan, Alison; Tallman, Martin S.; Platanias, Leonidas C.] Lakeside Vet Adm Med Ctr, Chicago, IL 60611 USA; [Hay, Nissim] Univ Illinois, Dept Mol Genet, Chicago, IL 60607 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu			NCI NIH HHS [CA121192, CA77816, T32 CA079447, CA100579] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA079447, R01CA100579, R01CA077816, R01CA121192] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; ANDERSON KC, 2002, CANCER J, V28, P12; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; BIORNSTI MAM, 2004, NAT REV CANCER, V4, P335; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chen GQ, 1996, BLOOD, V88, P1052; Chen Z, 2002, SEMIN HEMATOL, V39, P22, DOI 10.1053/shem.2002.33611; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Davison K, 2003, LEUKEMIA, V17, P931, DOI 10.1038/sj.leu.2402876; Davison K, 2002, SEMIN HEMATOL, V39, P3, DOI 10.1053/shem.2002.33610; DEL PL, 1997, SCIENCE, V278, P687; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Gingras AC, 2001, GENE DEV, V15, P2852; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Mahieux R, 2001, BLOOD, V98, P3762, DOI 10.1182/blood.V98.13.3762; METHOT N, 1994, MOL CELL BIOL, V14, P2307, DOI 10.1128/MCB.14.4.2307; Methot N, 1996, RNA, V2, P38; Miller WH, 2002, CANCER RES, V62, P3893; Murgo AJ, 2001, ONCOLOGIST, V6, P22, DOI 10.1634/theoncologist.6-suppl_2-22; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; O'Dwyer ME, 2002, SEMIN HEMATOL, V39, P18, DOI 10.1053/shem.2002.33612; Ozpolat B, 2007, MOL CANCER RES, V5, P95, DOI 10.1158/1541-7786.MCR-06-0125; Parmar S, 2005, BLOOD, V106, P2436, DOI 10.1182/blood-2004-10-4003; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SMALL EJ, 2003, CANCER, V15, P2090; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Tallman MS, 2001, BLOOD REV, V15, P133, DOI 10.1054/blre.2001.0160; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Verstovsek S, 2006, HEMATOL ONCOL, V24, P181, DOI 10.1002/hon.787; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Wang ZG, 1998, BLOOD, V92, P1497, DOI 10.1182/blood.V92.5.1497.417k41_1497_1504; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263; Yoshida C, 2004, INT J HEMATOL, V79, P420, DOI 10.1532/IJH97.04032; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222	58	35	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1992	2001		10.1074/jbc.M705227200	http://dx.doi.org/10.1074/jbc.M705227200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048359	hybrid			2022-12-27	WOS:000252501000026
J	Finetti, F; Solito, R; Morbidelli, L; Giachetti, A; Ziche, M; Donnini, S				Finetti, Federica; Solito, Raffaella; Morbidelli, Lucia; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra			Prostaglandin E-2 regulates angiogenesis via activation of fibroblast growth factor receptor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; BREAST-CANCER; MATRIX-METALLOPROTEINASE; SELECTIVE-INHIBITION; ENDOTHELIAL-CELLS; EGF RECEPTOR; CYCLOOXYGENASE-2; EXPRESSION; CARCINOMA; ADHESION	Prostaglandin E-2 (PGE(2)) behaves as a mitogen in epithelial tumor cells as well as in many other cell types. We investigated the actions of PGE(2) on microvascular endothelial cells ( capillary venular endothelial cells) with the purpose of delineating the signaling pathway leading to the acquisition of the angiogenic phenotype and to new vessel formation. PGE(2) (100 nM) produced activation of the fibroblast growth factor receptor 1 (FGFR-1), as measured by its phosphorylation, but not of vascular endothelial growth factor receptor 2. PGE(2) stimulated the EP3 subtype receptor, as deduced by abrogation of EP3G alpha(i) subunit activity through pertussis toxin. Consistent with this result, in human umbilical venular endothelial cells missing the EP3 receptor, PGE(2) did not phosphorylate FGFR-1. Upon binding to its receptor, PGE2 initiated an autocrine/paracrine signaling cascade involving the intracellular activation of c-Src, activation of matrix metalloproteinase (predominantly MMP2), which in turn caused the mobilization of membrane-anchored fibroblast growth factor-2 (FGF-2). In fact, in cells unable to release FGF-2 the transfection with both FGFR-1 and EP3 did not result in FGFR-1 phosphorylation in response to PGE(2). Relevance for the FGF2-FGFR-1 system was highlighted by confocal analysis, showing receptor internalization after cell exposure to the prostanoid. ERK1/2 appeared to be the distal signal involved, its phosphorylation being sensitive to either cSrc inhibitor or FGFR-1 blocker. Finally, PGE(2) stimulated cell migration and capillary formation in aortic rings, which were severely reduced by inhibitors of signaling molecules or by receptor antagonist. In conclusion, this study provides evidence for the involvement of FGFR-1 through FGF2 in eliciting PGE(2) angiogenic responses. This signaling pattern is similar to the autocrine-paracrine mechanism which operates in endothelial cells to support neovascular growth.	[Finetti, Federica; Solito, Raffaella; Morbidelli, Lucia; Giachetti, Antonio; Ziche, Marina; Donnini, Sandra] Univ Siena, Dept Mol Biol, Pharmacol Angiogenesis Lab, I-53100 Siena, Italy	University of Siena	Donnini, S (corresponding author), Univ Siena, Dept Mol Biol, Pharmacol Angiogenesis Lab, Via Aldo Moro, I-53100 Siena, Italy.	donnini4@unisi.it	Finetti, Federica/J-9089-2016; Morbidelli, Lucia/AAC-7858-2020; Morbidelli, Lucia/K-4053-2016; Donnini, Sandra/K-9252-2019	Morbidelli, Lucia/0000-0001-8148-7049; Donnini, Sandra/0000-0001-6617-1644				Abdelrahim M, 2005, MOL PHARMACOL, V68, P317, DOI 10.1124/mol.105.011825; Backlund MG, 2005, ONCOLOGY-BASEL, V69, P28, DOI 10.1159/000086629; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Casu B, 2002, BIOCHEMISTRY-US, V41, P10519, DOI 10.1021/bi020118n; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Donnini S, 2006, CELL DEATH DIFFER, V13, P1088, DOI 10.1038/sj.cdd.4401803; Donnini S, 2004, LIFE SCI, V74, P2975, DOI 10.1016/j.lfs.2003.09.075; Donnini S, 2007, FASEB J, V21, P2418, DOI 10.1096/fj.06-7581com; Dormond O, 2002, J BIOL CHEM, V277, P45838, DOI 10.1074/jbc.M209213200; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Han S, 2005, INT J CANCER, V116, P536, DOI 10.1002/ijc.21125; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Huang SP, 2005, J BIOMED SCI, V12, P229, DOI 10.1007/s11373-004-8177-5; Kamiyama M, 2006, ONCOGENE, V25, P7019, DOI 10.1038/sj.onc.1209694; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Larkins TL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-181; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Mehrotra S, 2006, J PATHOL, V208, P356, DOI 10.1002/path.1907; Mohammed SI, 2002, CANCER RES, V62, P356; Morbidelli L, 2003, CLIN CANCER RES, V9, P5358; Mutoh M, 2006, CURR PHARM DESIGN, V12, P2375, DOI 10.2174/138161206777698972; Namkoong S, 2005, EXP MOL MED, V37, P588, DOI 10.1038/emm.2005.72; Nyalendo C, 2007, J BIOL CHEM, V282, P15690, DOI 10.1074/jbc.M608045200; Pai R, 2002, NAT MED, V8, P289, DOI 10.1038/nm0302-289; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Salcedo R, 2003, BLOOD, V102, P1966, DOI 10.1182/blood-2002-11-3400; SCHELLING ME, 1988, AM J PHYSIOL, V254, pH1211, DOI 10.1152/ajpheart.1988.254.6.H1211; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Wang DZ, 2004, P NATL ACAD SCI USA, V101, P415, DOI 10.1073/pnas.0307640100; Yazawa K, 2005, CANCER SCI, V96, P93, DOI 10.1111/j.1349-7006.2005.00022.x; ZICHE M, 1982, JNCI-J NATL CANCER I, V69, P475	36	95	98	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2139	2146		10.1074/jbc.M703090200	http://dx.doi.org/10.1074/jbc.M703090200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042549	hybrid			2022-12-27	WOS:000252501000041
J	Hostetler, HA; Huang, H; Kier, AB; Schroeder, F				Hostetler, Heather A.; Huang, Huan; Kier, Ann B.; Schroeder, Friedhelm			Glucose directly links to lipid metabolism through high affinity interaction with peroxisome proliferator-activated receptor alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID-BINDING; PPAR-ALPHA; LIGAND SELECTIVITY; LONG-CHAIN; PROTEIN; GAMMA; EXPRESSION; DOMAIN; J(2)	The pathophysiology of diabetes is characterized not only by elevated glucose but also elevated long chain fatty acid levels. We show for the first time that the peroxisome proliferator-activated receptor-alpha(PPAR alpha) binds glucose and glucose metabolites with high affinity, resulting in significantly altered PPAR alpha secondary structure. Glucose decreased PPAR alpha interaction with fatty acid metabolites and steroid receptor coactivator-1 while increasing PPAR alpha interaction with DNA. Concomitantly, glucose increased PPAR alpha interaction with steroid receptor coactivator-1, DNA binding, and transactivation of beta-oxidation pathways in the presence of activating ligands. Heterodimerization of PPAR alpha to the retinoid X receptor-alpha resulted in even larger increases in transactivation with the addition of glucose. These data suggest that PPAR alpha is responsible for maintaining energy homeostasis through a concentration- dependent regulation of both lipids and sugars and that hyperglycemic injury mediated by PPAR alpha occurs not only indirectly through elevated long chain fatty acid levels but also through direct action of glucose on PPAR alpha.	[Hostetler, Heather A.; Huang, Huan; Schroeder, Friedhelm] Texas A&M Univ, Dept Physiol & Pharmacol, TVMC, College Stn, TX 77843 USA; [Kier, Ann B.] Texas A&M Univ, Dept Pathobiol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Schroeder, F (corresponding author), Texas A&M Univ, Dept Physiol & Pharmacol, TVMC, College Stn, TX 77843 USA.	fschroeder@cvm.tamu.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077573, R01DK041402, F32DK066732] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32 DK066732-03, DK066732, F32 DK066732, K99 DK077573, K99 DK077573-01, DK41402, K99 DK77573] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANNER CD, 1993, J LIPID RES, V34, P1583; Bonilla S, 2000, BRIT J NUTR, V83, P665, DOI 10.1017/S0007114500000842; Buira I, 2004, J CELL PHYSIOL, V198, P12, DOI 10.1002/jcp.10402; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Corkey BE, 2000, J NUTR, V130, p299S, DOI 10.1093/jn/130.2.299S; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; DROCHMANS P, 1975, J CELL BIOL, V66, P1, DOI 10.1083/jcb.66.1.1; Elholm M, 2001, J BIOL CHEM, V276, P21410, DOI 10.1074/jbc.M101073200; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Finck BN, 2004, CURR OPIN CLIN NUTR, V7, P391, DOI 10.1097/01.mco.0000134371.70815.32; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frederiksen KS, 2003, J MOL ENDOCRINOL, V30, P317, DOI 10.1677/jme.0.0300317; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hi R, 1999, J BIOL CHEM, V274, P35152, DOI 10.1074/jbc.274.49.35152; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Hostetler HA, 2006, BIOCHEMISTRY-US, V45, P7669, DOI 10.1021/bi060198l; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kiec-Wilk B, 2005, J PHYSIOL PHARMACOL, V56, P149; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; Li TL, 1998, J BIOMAT SCI-POLYM E, V9, P327, DOI 10.1080/09205063.1998.9753059; Lin QO, 1999, BIOCHEMISTRY-US, V38, P185, DOI 10.1021/bi9816094; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Murakami K, 2001, BIOCHEM J, V353, P231, DOI 10.1042/0264-6021:3530231; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; SPECTOR AA, 1969, ANAL BIOCHEM, V32, P297, DOI 10.1016/0003-2697(69)90089-X; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stewart JM, 1998, BBA-LIPID LIPID MET, V1391, P1, DOI 10.1016/S0005-2760(97)00202-6; Voet D VJ, 1990, BIOCHEMISTRY; Wasserman DH, 1998, ADV EXP MED BIOL, V441, P1; Wolfrum C, 1999, J LIPID RES, V40, P708; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yao TP, 1996, P NATL ACAD SCI USA, V93, P10626, DOI 10.1073/pnas.93.20.10626; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	42	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2246	2254		10.1074/jbc.M705138200	http://dx.doi.org/10.1074/jbc.M705138200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055466	hybrid			2022-12-27	WOS:000252501000052
J	Krzysiak, TC; Grabe, M; Gilbert, SP				Krzysiak, Troy C.; Grabe, Michael; Gilbert, Susan P.			Getting in sync with dimeric Eg5 - Initiation and regulation of the processive run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC KINESIN EG5; CROSS-LINKS MICROTUBULES; SMALL-MOLECULE INHIBITOR; ATP HYDROLYSIS; MOTOR PROTEIN; SACCHAROMYCES-CEREVISIAE; DROSOPHILA EMBRYOS; MECHANISTIC MODEL; MEIOTIC SPINDLES; BIPOLAR KINESIN	Eg5/KSP is the kinesin-related motor protein that generates the major plus-end directed force for mitotic spindle assembly and dynamics. Recent work using a dimeric form of Eg5 has found it to be a processive motor; however, its mechanochemical cycle is different from that of conventional Kinesin-1. Dimeric Eg5 appears to undergo a conformational change shortly after collision with the microtubule that primes the motor for its characteristically short processive runs. To better understand this conformational change as well as head-head communication during processive stepping, equilibrium and transient kinetic approaches have been used. By contrast to the mechanism of Kinesin-1, microtubule association triggers ADP release from both motor domains of Eg5. One motor domain releases ADP rapidly, whereas ADP release from the other occurs after a slow conformational change at similar to 1 s(-1). Therefore, dimeric Eg5 begins its processive run with both motor domains associated with the microtubule and in the nucleotide-free state. During processive stepping however, ATP binding and potentially ATP hydrolysis signals rearward head advancement 16nm forward to the next microtubule-binding site. This alternating cycle of processive stepping is proposed to terminate after a few steps because the head-head communication does not sufficiently control the timing to prevent both motor domains from entering the ADP-bound state simultaneously.	[Krzysiak, Troy C.; Grabe, Michael; Gilbert, Susan P.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.	sgilbert@rpi.edu	Grabe, Michael/B-3705-2009		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141] Funding Source: NIH RePORTER; NIAMS NIH HHS [K02 AR047841-05, K02 AR047841-03, K02 AR047841, K02-AR47841, K02 AR047841-04] Funding Source: Medline; NIGMS NIH HHS [R01 GM054141-08, R01 GM054141-13, R01 GM054141-09, R01 GM054141-11, R01 GM054141-10, R01-GM54141, R01 GM054141-12, R01 GM054141] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; COLE DG, 1994, J BIOL CHEM, V269, P22913; Cox CD, 2005, BIOORG MED CHEM LETT, V15, P2041, DOI 10.1016/j.bmcl.2005.02.055; Cytrynbaum EN, 2003, BIOPHYS J, V84, P757, DOI 10.1016/S0006-3495(03)74895-4; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Duhl DM, 2005, CURR OPIN DRUG DISC, V8, P431; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Gaglio T, 1996, J CELL BIOL, V135, P399, DOI 10.1083/jcb.135.2.399; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gordon DM, 1999, J BIOL CHEM, V274, P28779, DOI 10.1074/jbc.274.40.28779; Goshima G, 2005, MOL BIOL CELL, V16, P3896, DOI 10.1091/mbc.E05-02-0118; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; HECK MMS, 1993, J CELL BIOL, V123, P665, DOI 10.1083/jcb.123.3.665; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HOYT MA, 1992, J CELL BIOL, V118, P109, DOI 10.1083/jcb.118.1.109; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Kwok BH, 2004, CURR BIOL, V14, P1783, DOI 10.1016/j.cub.2004.09.052; Kwon M, 2004, TRENDS CELL BIOL, V14, P194, DOI 10.1016/j.tcb.2004.03.003; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Patel SS, 2003, METHOD ENZYMOL, V370, P668; Press W. H., 1997, NUMERICAL RECIPES; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Sakowicz R, 2004, CANCER RES, V64, P3276, DOI 10.1158/0008-5472.CAN-03-3839; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sharp DJ, 1999, J CELL BIOL, V144, P125, DOI 10.1083/jcb.144.1.125; Shirasu-Hiza M, 2004, CURR BIOL, V14, P1941, DOI 10.1016/j.cub.2004.10.029; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Tao L, 2006, CURR BIOL, V16, P2293, DOI 10.1016/j.cub.2006.09.064; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Valentine MT, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-31; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	58	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2078	2087		10.1074/jbc.M708354200	http://dx.doi.org/10.1074/jbc.M708354200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18037705	Green Accepted, hybrid			2022-12-27	WOS:000252501000035
J	Zhou, XY; He, W; Huang, ZP; Gotto, AM; Hajjar, DP; Han, JH				Zhou, Xiaoye; He, Wei; Huang, Zhiping; Gotto, Antonio M., Jr.; Hajjar, David P.; Han, Jihong			Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression - A new SREBP1-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASSETTE TRANSPORTER A1; VASCULAR ENDOTHELIAL-CELLS; B SCAVENGER RECEPTOR; X-RECEPTOR; CHOLESTEROL EFFLUX; FAMILIAL HYPERCHOLESTEROLEMIA; TANGIER-DISEASE; KNOCKOUT MICE; LDL RECEPTOR; ATHEROSCLEROSIS	Lowdensity lipoprotein receptor (LDLR) mutations cause familial hypercholesterolemia and early atherosclerosis. ABCA1 facilitates free cholesterol efflux from peripheral tissues. We investigated the effects of LDLR deletion (LDLR-/-) on ABCA1 expression. LDLR-/- macrophages had reduced basal levels of ABCA1, ABCG1, and cholesterol efflux. A high fat diet increased cholesterol in LDLR-/- macrophages but not wild type cells. A liver X receptor (LXR) agonist induced expression of ABCA1, ABCG1, and cholesterol efflux in both LDLR-/- and wild type macrophages, whereas expression of LXR alpha or LXR beta was similar. Interestingly, oxidized LDL induced more ABCA1 in wild type macrophages than LDLR-/- cells. LDL induced ABCA1 expression in wild type cells but inhibited it in LDLR-/- macrophages in a concentration-dependent manner. However, lipoproteins regulated ABCG1 expression similarly in LDLR-/- and wild type macrophages. Cholesterol or oxysterols induced ABCA1 expression in wild type macrophages but had little or inhibitory effects on ABCA1 expression in LDLR-/- macrophages. Active sterol regulatory element-binding protein 1a (SREBP1a) inhibited ABCA1 promoter activity in an LXRE-dependent manner and decreased both macrophage ABCA1 expression and cholesterol efflux. Expression of ABCA1 in animal tissues was inversely correlated to active SREBP1. Oxysterols inactivated SREBP1 in wild type macrophages but not in LDLR-/- cells. Oxysterol synergized with nonsteroid LXR ligand induced ABCA1 expression in wild type macrophages but blocked induction in LDLR-/- cells. Taken together, our studies suggest that LDLR is critical in the regulation of cholesterol efflux and ABCA1 expression in macrophage. Lack of the LDLR impairs sterol-induced macrophage ABCA1 expression by a sterol regulatory element-binding protein 1-dependent mechanism that can result in reduced cholesterol efflux and lipid accumulation in macrophages under hypercholesterolemic conditions.	[Zhou, Xiaoye; He, Wei; Huang, Zhiping; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, New York, NY 10065 USA; [Zhou, Xiaoye; He, Wei; Huang, Zhiping; Hajjar, David P.; Han, Jihong] Cornell Univ, Weill Cornell Med Coll, Dept Pathol, New York, NY 10065 USA; [Gotto, Antonio M., Jr.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Han, Jihong] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Cornell University; Cornell University; Cornell University; Nankai University	Han, JH (corresponding author), Cornell Univ, Weill Cornell Med Coll, Ctr Vasc Biol, 1300 York Ave, New York, NY 10065 USA.	Jhan@med.cornell.edu			NHLBI NIH HHS [P01 HL-072942] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL072942] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Basso F, 2006, BIOCHEM BIOPH RES CO, V351, P398, DOI 10.1016/j.bbrc.2006.10.044; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BRINTON EA, 1989, J CLIN INVEST, V84, P262, DOI 10.1172/JCI114149; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CALVERT GD, 1994, AUST NZ J MED, V24, P89, DOI 10.1111/j.1445-5994.1994.tb04442.x; Cavelier LB, 2001, J BIOL CHEM, V276, P18046, DOI 10.1074/jbc.M100565200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Claudel T, 2001, P NATL ACAD SCI USA, V98, P2610, DOI 10.1073/pnas.041609298; Costet P, 2000, J BIOL CHEM, V275, P28240; Defesche Joep C, 2004, Semin Vasc Med, V4, P5; Descamps OS, 2001, ATHEROSCLEROSIS, V157, P514, DOI 10.1016/S0021-9150(01)00533-0; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Edwards PA, 2000, BBA-MOL CELL BIOL L, V1529, P103, DOI 10.1016/S1388-1981(00)00140-2; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gan XD, 2001, J BIOL CHEM, V276, P48702, DOI 10.1074/jbc.M109402200; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Han JH, 2004, CIRCULATION, V110, P3472, DOI 10.1161/01.CIR.0000148368.79202.F1; Han JH, 1999, J LIPID RES, V40, P830; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Joseph SB, 2002, P NATL ACAD SCI USA, V99, P7604, DOI 10.1073/pnas.112059299; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lala DS, 1997, P NATL ACAD SCI USA, V94, P4895, DOI 10.1073/pnas.94.10.4895; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liao HL, 2002, ARTERIOSCL THROM VAS, V22, P127, DOI 10.1161/hq1201.101772; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Ose L, 1999, ANN MED, V31, P13, DOI 10.1080/07853890.1999.11904394; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Sone H, 2004, BIOCHEM BIOPH RES CO, V316, P790, DOI 10.1016/j.bbrc.2004.02.121; Takahashi Kei, 2005, Medical Molecular Morphology, V38, P2, DOI 10.1007/s00795-004-0278-8; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; van Aalst-Cohen Emily S, 2004, Semin Vasc Med, V4, P31; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang CD, 2006, J BIOL CHEM, V281, P27816, DOI 10.1074/jbc.M603781200; Yang XP, 2002, J LIPID RES, V43, P297; Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200	52	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2129	2138		10.1074/jbc.M706636200	http://dx.doi.org/10.1074/jbc.M706636200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029360	hybrid			2022-12-27	WOS:000252501000040
J	van Grinsven, KWA; Rosnowsky, S; van Weelden, SWH; Putz, S; van der Giezen, M; Martin, W; van Hellemond, JJ; Tielens, AGM; Henze, K				van Grinsven, Koen W. A.; Rosnowsky, Silke; van Weelden, Susanne W. H.; Puetz, Simone; van der Giezen, Mark; Martin, William; van Hellemond, Jaap J.; Tielens, Aloysius G. M.; Henze, Katrin			Acetate : succinate CoA-transferase in the hydrogenosomes of Trichomonas vaginalis - Identification and characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITRICHOMONAS-FETUS; COENZYME-A; MITOCHONDRIAL; SEQUENCE; PROTEIN; ENZYME; LOCALIZATION; METABOLISM; HYDROLASE; PURIFICATION	Acetate: succinate CoA-transferases ( ASCT) are acetate-producing enzymes in hydrogenosomes, anaerobically functioning mitochondria and in the aerobically functioning mitochondria of trypanosomatids. Although acetate is produced in the hydrogenosomes of a number of anaerobic microbial eukaryotes such as Trichomonas vaginalis, no acetate producing enzyme has ever been identified in these organelles. Acetate production is the last unidentified enzymatic reaction of hydrogenosomal carbohydrate metabolism. We identified a gene encoding an enzyme for acetate production in the genome of the hydrogenosome-containing protozoan parasite T. vaginalis. This gene shows high similarity to Saccharomyces cerevisiae acetyl-CoA hydrolase and Clostridium kluyveri succinyl-CoA:CoA-transferase. Here we demonstrate that this protein is expressed and is present in the hydrogenosomes where it functions as the T. vaginalis acetate: succinate CoA-transferase (TvASCT). Heterologous expression of TvASCT in CHO cells resulted in the expression of an active ASCT. Furthermore, homologous overexpression of the TvASCT gene in T. vaginalis resulted in an equivalent increase in ASCT activity. It was shown that the CoA transferase activity is succinate-dependent. These results demonstrate that this acetyl-CoA hydrolase/transferase homolog functions as the hydrogenosomal ASCT of T. vaginalis. This is the first hydrogenosomal acetate-producing enzyme to be identified. Interestingly, TvASCT does not share any similarity with the mitochondrial ASCT from Trypanosoma brucei, the only other eukaryotic succinate-dependent acetyl-CoA-transferase identified so far. The trichomonad enzyme clearly belongs to a distinct class of acetate: succinate CoA-transferases. Apparently, two completely different enzymes for succinate-dependent acetate production have evolved independently in ATP-generating organelles.	[Rosnowsky, Silke; Puetz, Simone; Martin, William; Henze, Katrin] Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany; [van Grinsven, Koen W. A.; van Weelden, Susanne W. H.; van Hellemond, Jaap J.; Tielens, Aloysius G. M.] Univ Utrecht, Fac Vet Med, Dept Biochem & Cell Biol, NL-3584 CM Utrecht, Netherlands; [van der Giezen, Mark] Univ Exeter, Sch Biosci, Ctr Eukaryot Evolutionary Microbiol, Exeter EX4 4QD, Devon, England; [van Hellemond, Jaap J.; Tielens, Aloysius G. M.] ErasmusMC Univ, Med Ctr, Dept Med Microbiol & Infect Dis, NL-3015 GD Rotterdam, Netherlands	Heinrich Heine University Dusseldorf; Utrecht University; University of Exeter; Erasmus University Rotterdam; Erasmus MC	Henze, K (corresponding author), Univ Dusseldorf, Inst Bot 3, Univ Str 1, D-40225 Dusseldorf, Germany.	katrin.henze@uni-duesseldorf.de	van Hellemond, Jaap/T-7555-2019; Martin, William/C-5680-2008; van der Giezen, Mark/J-9550-2019; Martin, William F./O-5446-2015	van Hellemond, Jaap/0000-0003-4862-7796; van der Giezen, Mark/0000-0002-1033-1335; Martin, William F./0000-0003-1478-6449; Tielens, Aloysius/0000-0002-5485-1105				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENCHIMOL M, 1983, J PROTOZOOL, V30, P422, DOI 10.1111/j.1550-7408.1983.tb02942.x; Bradley PJ, 1997, EMBO J, V16, P3484, DOI 10.1093/emboj/16.12.3484; BROWN TDK, 1977, J GEN MICROBIOL, V102, P327, DOI 10.1099/00221287-102-2-327; Bryant D, 2002, LECT NOTES COMPUT SC, V2452, P375; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; Buu LM, 2003, J BIOL CHEM, V278, P17203, DOI 10.1074/jbc.M213268200; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Embley TM, 2003, PHILOS T R SOC B, V358, P191, DOI 10.1098/rstb.2002.1190; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Guda C, 2004, NUCLEIC ACIDS RES, V32, pW372, DOI 10.1093/nar/gkh374; Hausler T, 1997, EUR J CELL BIOL, V73, P240; HONIGBERG BM, 1984, J PROTOZOOL, V31, P116, DOI 10.1111/j.1550-7408.1984.tb04300.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; LEE FJS, 1990, J BIOL CHEM, V265, P7413; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; MARVINSIKKEMA FD, 1993, ARCH MICROBIOL, V160, P388; MCLAUGHLIN GL, 1986, COMP BIOCHEM PHYS B, V83, P523, DOI 10.1016/0305-0491(86)90290-7; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; MULLER M, 1982, PARASITES THEIR WORL; Oulton MM, 2003, EUR J BIOCHEM, V270, P4962, DOI 10.1046/j.1432-1033.2003.03898.x; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; Putz S, 2005, MOL BIOCHEM PARASIT, V142, P212, DOI 10.1016/j.molbiopara.2005.04.003; REEVES RE, 1977, J BIOL CHEM, V252, P726; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Sanchez LB, 1996, FEBS LETT, V378, P240, DOI 10.1016/0014-5793(95)01463-2; Saz HJ, 1996, J PARASITOL, V82, P694, DOI 10.2307/3283876; Sohling B, 1996, J BACTERIOL, V178, P871; STEINBUCHEL A, 1986, MOL BIOCHEM PARASIT, V20, P57, DOI 10.1016/0166-6851(86)90142-8; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Thollesson M, 2004, BIOINFORMATICS, V20, P416, DOI 10.1093/bioinformatics/btg422; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tielens AGM, 1998, BBA-BIOENERGETICS, V1365, P71, DOI 10.1016/S0005-2728(98)00045-0; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Van Hellemond JJ, 1998, P NATL ACAD SCI USA, V95, P3036, DOI 10.1073/pnas.95.6.3036; van Hellemond JJ, 2003, PHILOS T ROY SOC B, V358, P205, DOI 10.1098/rstb.2002.1182; van Hoek AHAM, 2000, MOL BIOL EVOL, V17, P251, DOI 10.1093/oxfordjournals.molbev.a026304; vanderGiezen M, 1997, MOL MICROBIOL, V23, P11, DOI 10.1046/j.1365-2958.1997.1891553.x; WITKOWSKI A, 1994, J BIOL CHEM, V269, P379	45	46	89	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1411	1418		10.1074/jbc.M702528200	http://dx.doi.org/10.1074/jbc.M702528200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024431	hybrid			2022-12-27	WOS:000252282700024
J	Bansal, PS; Torres, AM; Crossett, B; Wong, KKY; Koh, JMS; Geraghty, DP; Vandenberg, JI; Kuchel, PW				Bansal, Paramjit S.; Torres, Allan M.; Crossett, Ben; Wong, Karen K. Y.; Koh, Jennifer M. S.; Geraghty, Dominic P.; Vandenberg, Jamie I.; Kuchel, Philip W.			Substrate specificity of platypus venom L-to-D-peptide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO-ACID; ENZYME-CATALYZED REACTIONS; CARBON ACIDS; RESIDUE; SKIN; ISOMERIZATION; DERMORPHIN	The L-to-D-peptide isomerase from the venom of the platypus ( Ornithorhyncus anatinus) is the first such enzyme to be reported for a mammal. In delineating its catalytic mechanism and broader roles in the animal, its substrate specificity was explored. We used N-terminal segments of defensin-like peptides DLP-2 and DLP-4 and natriuretic peptide OvCNP from the venom as substrates. The DLP analogues IMFsrs and ImFsrs ( srs is a solubilizing chain; lowercase letters denote D-amino acid) were effective substrates for the isomerase; it appears to recognize the N-terminal tripeptide sequence Ile-Xaa-Phe-.Asuite of 26 mutants of these hexapeptides was synthesized by replacing the second residue ( Met) with another amino acid, viz. Ala, alpha-aminobutyric acid, Ile, Leu, Lys, norleucine, Phe, Tyr, and Val. It was shown that mutant peptides incorporating norleucine and Phe are substrates and exhibit L-or D-amino acid isomerization, but mutant peptides that contain residues with shorter, beta-branched or long side chains with polar terminal groups, viz. Ala, alpha-aminobutyric acid, Ile, Val, Leu, Lys, and Tyr, respectively, are not substrates. It was demonstrated that at least three N-terminal amino acid residues are absolutely essential for L-to D-isomerization; furthermore, the third amino acid must be a Phe residue. None of the hexapeptides based on LLH, the first three residues of OvCNP, were substrates. A consistent 2-base mechanism is proposed for the isomerization; abstraction of a proton by 1 base is concomitant with delivery of a proton by the conjugate acid of a second base.	[Bansal, Paramjit S.; Crossett, Ben; Wong, Karen K. Y.; Koh, Jennifer M. S.; Kuchel, Philip W.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Torres, Allan M.] Univ Western Sydney, Coll Hlth & Sci, Nanoscale Org & Dynam Grp, Penrith, NSW 1797, Australia; [Geraghty, Dominic P.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia; [Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Cardiac Electrophysiol & Biop, Darlinghurst, NSW 2010, Australia	University of Sydney; Western Sydney University; University of Tasmania; Victor Chang Cardiac Research Institute	Kuchel, PW (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	p.kuchel@mmb.usyd.edu.au	Vandenberg, Jamie I/B-6608-2013; Geraghty, Dominic P/A-4362-2013; Torres, Allan/GSN-4624-2022; Crossett, Ben/G-2316-2011	Vandenberg, Jamie I/0000-0002-3859-3716; Koh, Jennifer/0000-0003-2140-3151; Geraghty, Dominic (Dom)/0000-0001-8968-5912; Kuchel, Philip/0000-0003-4100-7332				CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; DOOLEY CT, 1994, SCIENCE, V266, P2019, DOI 10.1126/science.7801131; GERLT JA, 1991, J AM CHEM SOC, V113, P9667, DOI 10.1021/ja00025a039; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jilek A, 2005, P NATL ACAD SCI USA, V102, P4235, DOI 10.1073/pnas.0500789102; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; RICHTER K, 1987, SCIENCE, V238, P200, DOI 10.1126/science.3659910; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Torres AM, 2007, AMINO ACIDS, V32, P63, DOI 10.1007/s00726-006-0346-6; Torres AM, 2006, FEBS LETT, V580, P1587, DOI 10.1016/j.febslet.2006.01.089; Torres AM, 2005, BIOCHEM J, V391, P215, DOI 10.1042/BJ20050900; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; VOLKMANN RA, 1998, D AMINOACIDS INSEQUE, P57	19	42	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8969	8975		10.1074/jbc.M709762200	http://dx.doi.org/10.1074/jbc.M709762200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18158286	hybrid			2022-12-27	WOS:000254465800026
J	Giorgini, F; Moller, T; Kwan, W; Zwilling, D; Wacker, JL; Hong, S; Tsai, LCL; Cheah, CS; Schwarcz, R; Guidetti, P; Muchowski, PJ				Giorgini, Flaviano; Moller, Thomas; Kwan, Wanda; Zwilling, Daniel; Wacker, Jennifer L.; Hong, Soyon; Tsai, Li-Chun L.; Cheah, Christine S.; Schwarcz, Robert; Guidetti, Paolo; Muchowski, Paul J.			Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; MOUSE MODEL; QUINOLINIC ACID; DISEASE GENE; DEPENDENT NEURODEGENERATION; POLYGLUTAMINE; BRAIN; HD; 3-HYDROXYKYNURENINE; DYSREGULATION	The kynurenine pathway of tryptophan degradation is hypothesized to play an important role in Huntington disease, a neurodegenerative disorder caused by a polyglutamine expansion in the protein huntingtin. Neurotoxic metabolites of the kynurenine pathway, generated in microglia and macrophages, are present at increased levels in the brains of patients and mouse models during early stages of disease, but the mechanism by which kynurenine pathway up-regulation occurs in Huntington disease is unknown. Here we report that expression of a mutant huntingtin fragment was sufficient to induce transcription of the kynurenine pathway in yeast and that this induction was abrogated by impairing the activity of the histone deacetylase Rpd3. Moreover, numerous genetic suppressors of mutant huntingtin toxicity that are functionally unrelated converged unexpectedly on the kynurenine pathway, supporting a critical role for the kynurenine pathway in mediating mutant huntingtin toxicity in yeast. Histone deacetylase-dependent regulation of the kynurenine pathway was also observed in a mouse model of Huntington disease, in which treatment with a neuroprotective histone deacetylase inhibitor blocked activation of the kynurenine pathway in microglia expressing a mutant huntingtin fragment in vitro and in vivo. These findings suggest that a mutant huntingtin fragment can perturb transcriptional programs in microglia, and thus implicate these cells as potential modulators of neurodegeneration in Huntington disease that are worthy of further investigation.	[Giorgini, Flaviano; Wacker, Jennifer L.; Tsai, Li-Chun L.; Cheah, Christine S.; Muchowski, Paul J.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Giorgini, Flaviano; Wacker, Jennifer L.; Tsai, Li-Chun L.; Cheah, Christine S.; Muchowski, Paul J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Kwan, Wanda; Zwilling, Daniel; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Schwarcz, Robert; Guidetti, Paolo] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Muchowski, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	pmuchowski@gladstone.ucsf.edu	Schwarcz, Robert/P-3134-2018; Hong, Soyon/AAE-9662-2021	Hong, Soyon/0000-0002-5744-4871; Giorgini, Flaviano/0000-0001-7881-9508	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NINDS NIH HHS [R01 NS057715] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BURACZYNSKA MJ, 1995, CYTOGENET CELL GENET, V71, P197, DOI 10.1159/000134106; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; DAVIES SW, 1988, SCIENCE, V241, P474, DOI 10.1126/science.2969147; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Guillemin GJ, 1999, ADV EXP MED BIOL, V467, P125; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; PEARSON SJ, 1992, NEUROSCI LETT, V144, P199, DOI 10.1016/0304-3940(92)90749-W; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SAITO K, 1992, NEUROSCIENCE, V51, P25, DOI 10.1016/0306-4522(92)90467-G; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schuettengruber B, 2003, J BIOL CHEM, V278, P1784, DOI 10.1074/jbc.M204843200; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; TOPPER R, 1993, EXP NEUROL, V123, P271, DOI 10.1006/exnr.1993.1159; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yu ZX, 2003, J NEUROSCI, V23, P2193	59	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7390	7400		10.1074/jbc.M708192200	http://dx.doi.org/10.1074/jbc.M708192200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18079112	hybrid			2022-12-27	WOS:000253997900013
J	Bai, S; Kopan, R; Zou, W; Hilton, MJ; Ong, CT; Long, FX; Ross, FP; Teitelbaum, SL				Bai, Shuting; Kopan, Raphael; Zou, Wei; Hilton, Matthew J.; Ong, Chin-tong; Long, Fanxin; Ross, F. Patrick; Teitelbaum, Steven L.			NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC LETHALITY; MUTANT MICE; LIGAND; DIFFERENTIATION; GENE; ACTIVATION; DEFECTS; EXPRESSION; SKELETAL; HOMOLOG	NOTCH signaling is a key regulator of cell fate decisions in prenatal skeletal development and is active during adult tissue renewal. In addition, its association with neoplasia suggests that it is a candidate therapeutic target. We find that attenuated NOTCH signaling enhances osteoclastogenesis and bone resorption in vitro and in vivo by a combination of molecular mechanisms. First, deletion of Notch1-3 in bone marrow macrophages directly promotes their commitment to the osteoclast phenotype. These osteoclast precursors proliferate more rapidly than the wild type in response to macrophage colony-stimulating factor and are sensitized to RANKL and macrophage colony-stimulating factor, undergoing enhanced differentiation in response to low doses of either cytokine. Conforming with a role for NOTCH in this process, presentation of the NOTCH ligand JAGGED1 blunts the capacity of wild-type bone marrow macrophages to become osteoclasts. Combined, these data establish that NOTCH suppresses osteoclastogenesis via ligand-mediated receptor activation. Although NOTCH1 and NOTCH3 collaborate in regulating osteoclast formation, NOTCH1 is the dominant paralog. In addition, NOTCH1 deficiency promotes osteoclastogenesis indirectly by enhancing the ability of osteoblast lineage cells to stimulate osteoclastogenesis. This is achieved by decreasing the osteoprotegerin/RANKL expression ratio. Thus, NOTCH1 acts as a net inhibitor of bone resorption, exerting its effect both directly in osteoclast precursors and indirectly via osteoblast lineage cells. These observations raise caution that therapeutic inhibition of NOTCH signaling may adversely accelerate bone loss in humans.	[Bai, Shuting; Zou, Wei; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kopan, Raphael; Ong, Chin-tong] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Hilton, Matthew J.; Long, Fanxin] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Hilton, Matthew/0000-0003-3165-267X; Zou, Wei/0000-0001-8081-268X; Teitelbaum, Steven/0000-0002-4054-6679; Kopan, Raphael/0000-0002-0350-2730; Ong, Chin-Tong/0000-0002-5450-4760	NIAMS NIH HHS [AR 32788, AR 46523, AR 48812, AR 46852, AR 48853] Funding Source: Medline; NICHD NIH HHS [HD 044056] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-07, DK 065789, P30 DK056341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788, R01AR048853, R37AR046523, R01AR048812, R01AR046852, R01AR046523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789, P30DK056341] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Ball Douglas W, 2003, Cancer Treat Res, V115, P95; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; ILAGAN MX, 2007, CELL, V128, pE2; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maillard I, 2003, IMMUNITY, V18, P587, DOI 10.1016/S1074-7613(03)00119-5; Maillard I, 2007, SCIENCE, V316, P840, DOI 10.1126/science.1143336; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nam Y, 2002, CURR OPIN CHEM BIOL, V6, P501, DOI 10.1016/S1367-5931(02)00346-0; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Parks AL, 2000, DEVELOPMENT, V127, P1373; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang MWH, 2004, J CLIN INVEST, V114, P206, DOI 10.1172/JCI200415797; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	47	164	186	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6509	6518		10.1074/jbc.M707000200	http://dx.doi.org/10.1074/jbc.M707000200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156632	hybrid			2022-12-27	WOS:000253779500058
J	Ricotta, D; Hansen, J; Preiss, C; Teichert, D; Honing, S				Ricotta, Doris; Hansen, Jens; Preiss, Carolin; Teichert, Dominic; Hoening, Stefan			Characterization of a protein phosphatase 2A holoenzyme that dephosphorylates the clathrin adaptors AP-1 and AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-ASSOCIATED KINASE; COATED VESICLES; MEDIATED ENDOCYTOSIS; SORTING SIGNALS; PHOSPHORYLATION; SUBUNIT; COMPLEX; BINDING; AAK1; AP2	The AP-2 complex is a key factor in the formation of endocytic clathrin-coated vesicles (CCVs). AP-2 sorts and packages cargo membrane proteins into CCVs, binds the coat protein clathrin, and recruits numerous other factors to the site of vesicle formation. Structural information on the AP-2 complex and biochemical work have allowed understanding its function on the molecular level, and recent studies showed that cycles of phosphorylation are key steps in the regulation of AP-2 function. The complex is phosphorylated on both large subunits (alpha- and beta 2- adaptins) as well as at a single threonine residue (Thr-156) of the medium subunit mu 2. Phosphorylation of mu 2 is necessary for efficient cargo recruitment, whereas the functional context of the large subunit phosphorylation is unknown. Here, we show that the subunit phosphorylation of AP-2 exhibits striking differences, with calculated half-lives of < 1 min for mu 2, similar to 25 min for beta 2, and similar to 70 min for alpha. We were also able to purify a phosphatase that dephosphorylates the mu 2 subunit. The enzyme is a member of the protein phosphatase 2A family and composed of a catalytic C beta subunit, a scaffolding A beta subunit, and a regulatory B alpha subunit. RNA interference knock down of the latter subunit in HeLa cells resulted in increased levels of phosphorylated adaptors and altered endocytosis, showing that a specific PP2A holoenzyme is an important regulatory enzyme in CCV-mediated transport.	[Teichert, Dominic] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Ricotta, Doris] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25100 Brescia, Italy; [Hansen, Jens; Preiss, Carolin; Hoening, Stefan] Univ Gottingen, Inst Biochem 2, D-37073 Gottingen, Germany	University of Cologne; University of Brescia; University of Gottingen	Honing, S (corresponding author), Univ Cologne, Inst Biochem 1, Joseph Stelzman Str 52, D-50931 Cologne, Germany.	shoening@unikoeln.de						AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200; Flett A, 2005, BIOCHEM SOC SYMP, V72, P65, DOI 10.1042/bss0720065; Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Korolchuk V, 2003, BIOCHEM SOC T, V31, P857, DOI 10.1042/BST0310857; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; PAULOIN A, 1984, BIOCHIM BIOPHYS ACTA, V799, P238, DOI 10.1016/0304-4165(84)90266-6; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang CX, 2005, TRAFFIC, V6, P1103, DOI 10.1111/j.1600-0854.2005.00346.x; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5510	5517		10.1074/jbc.M707166200	http://dx.doi.org/10.1074/jbc.M707166200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158287	hybrid			2022-12-27	WOS:000253426700031
J	Werther, T; Spinka, M; Tittmann, K; Schutz, A; Golbik, R; Mrestani-Klaus, C; Hubner, G; Konig, S				Werther, Tobias; Spinka, Michael; Tittmann, Kai; Schuetz, Anja; Golbik, Ralph; Mrestani-Klaus, Carmen; Huebner, Gerhard; Koenig, Stephan			Amino acids allosterically regulate the thiamine diphosphate-dependent alpha-keto acid decarboxylase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-DECARBOXYLASE; SUBSTRATE ACTIVATION BEHAVIOR; SACCHAROMYCES-CEREVISIAE; INDOLE-3-ACETIC-ACID BIOSYNTHESIS; INDOLEPYRUVATE DECARBOXYLASE; KLUYVEROMYCES-LACTIS; KEY ENZYME; PHENYLPYRUVATE DECARBOXYLASE; AZOSPIRILLUM-BRASILENSE; ENTEROBACTER-CLOACAE	The gene rv0853c from Mycobacterium tuberculosis strain H37Rv codes for a thiamine diphosphate-dependent alpha-keto acid decarboxylase (MtKDC), an enzyme involved in the amino acid degradation via the Ehrlich pathway. Steady state kinetic experiments were performed to determine the substrate specificity of MtKDC. The mycobacterial enzyme was found to convert a broad spectrum of branched-chain and aromatic alpha-keto acids. Stopped-flow kinetics showed that MtKDC is allosterically activated by alpha-keto acids. Even more, we demonstrate that also amino acids are potent activators of this thiamine diphosphate-dependent enzyme. Thus, metabolic flow through the Ehrlich pathway can be directly regulated at the decarboxylation step. The influence of amino acids on MtKDC catalysis was investigated, and implications for other thiamine diphosphate-dependent enzymes are discussed.	[Werther, Tobias; Spinka, Michael; Tittmann, Kai; Schuetz, Anja; Golbik, Ralph; Mrestani-Klaus, Carmen; Huebner, Gerhard; Koenig, Stephan] Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Konig, S (corresponding author), Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Germany.	stephan.koenig@biochemtech.uni-halle.de	Koenig, Stephan/GRX-2480-2022	Schutz, Anja/0000-0002-0606-2574				Acar S, 2007, ENZYME MICROB TECH, V40, P675, DOI 10.1016/j.enzmictec.2006.05.028; ALVAREZ FJ, 1991, J AM CHEM SOC, V113, P8402, DOI 10.1021/ja00022a030; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1245, DOI 10.1021/bi9709912; Baburina I, 1996, BIOCHEMISTRY-US, V35, P10249, DOI 10.1021/bi961141+; BABURINA I, 1994, BIOCHEMISTRY-US, V33, P5630, DOI 10.1021/bi00184a035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; BRINGERMEYER S, 1986, ARCH MICROBIOL, V146, P105, DOI 10.1007/BF00402334; CROSBY J, 1970, J AM CHEM SOC, V92, P5707, DOI 10.1021/ja00722a027; DAVIES DD, 1967, P BIOCH SOC, V104; Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200; Dietrich A, 1997, FEBS LETT, V400, P42, DOI 10.1016/S0014-5793(96)01326-9; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; FISCHER G, 1971, INVESTIGATIONS STRUC; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Furey W, 1998, BBA-PROTEIN STRUCT M, V1385, P253, DOI 10.1016/S0167-4838(98)00073-9; HEGEMAN GD, 1966, J BACTERIOL, V91, P1140, DOI 10.1128/JB.91.3.1140-1154.1966; HOLZER H, 1956, BIOCHEM Z, V327, P331; HUBNER G, 1978, EUR J BIOCHEM, V92, P175, DOI 10.1111/j.1432-1033.1978.tb12735.x; HUBNER G, 1986, BIOCHEM INT, V13, P767; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 1999, BIOCHEMISTRY-US, V38, P6369, DOI 10.1021/bi990373g; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kiers J, 1998, YEAST, V14, P459, DOI 10.1002/(SICI)1097-0061(19980330)14:5<459::AID-YEA248>3.0.CO;2-O; KOGA J, 1992, J BIOL CHEM, V267, P15823; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; LEHMANN H, 1973, EUR J BIOCHEM, V32, P83, DOI 10.1111/j.1432-1033.1973.tb02582.x; Li H, 1999, BIOCHEMISTRY-US, V38, P10004, DOI 10.1021/bi9902440; Li HJ, 1999, BIOCHEMISTRY-US, V38, P9992, DOI 10.1021/bi9902438; Lu GG, 1997, FEBS LETT, V403, P249, DOI 10.1016/S0014-5793(97)00057-4; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; Neuberg C, 1911, BIOCHEM Z, V36, P68; Neuser F, 2000, BIOL CHEM, V381, P349, DOI 10.1515/BC.2000.046; RUDOLPH R, 1997, PROTEIN FUNCTION PRA, P55; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schellenberger A, 1998, BBA-PROTEIN STRUCT M, V1385, P177, DOI 10.1016/S0167-4838(98)00067-3; Schowen RL, 2007, ISOT ENVIRON HEALT S, V43, P1, DOI 10.1080/10256010600990393; Schutz A, 2003, EUR J BIOCHEM, V270, P2322, DOI 10.1046/j.1432-1033.2003.03602.x; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7382, DOI 10.1021/bi002857e; Smit BA, 2005, APPL ENVIRON MICROB, V71, P303, DOI 10.1128/AEM.71.1.303-311.2005; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Versees W, 2007, J BIOL CHEM, V282, P35269, DOI 10.1074/jbc.M706048200; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Vuralhan Z, 2005, APPL ENVIRON MICROB, V71, P3276, DOI 10.1128/AEM.71.6.3276-3284.2005; Vuralhan Z, 2003, APPL ENVIRON MICROB, V69, P4534, DOI 10.1128/AEM.69.8.4534-4541.2003; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WEISS PM, 1988, BIOCHEMISTRY-US, V27, P2197, DOI 10.1021/bi00406a058; WERTHER T, 2006, HASYLAB ANN REPORT, P361; Yep A, 2006, BIOORG CHEM, V34, P325, DOI 10.1016/j.bioorg.2006.08.005; ZEHENDER H, 1987, EUR J BIOCHEM, V167, P149, DOI 10.1111/j.1432-1033.1987.tb13316.x; Zhang S, 2005, BIOCHEMISTRY-US, V44, P2237, DOI 10.1021/bi047696j	57	12	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5344	5354		10.1074/jbc.M706569200	http://dx.doi.org/10.1074/jbc.M706569200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086676	hybrid			2022-12-27	WOS:000253426700014
J	Hochbaum, D; Hong, K; Barila, G; Ribeiro-Neto, F; Altschuler, DL				Hochbaum, Daniel; Hong, Kyoungja; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR EPAC; DOG THYROID-CELLS; CYCLIC-AMP; SIGNALING PATHWAYS; DEP DOMAIN; RAP1; PROLIFERATION; ACTIVATION; FAMILY	cAMP stimulates proliferation in many cell types. For many years, cAMP-dependent protein kinase (PKA) represented the only known cAMP effector. PKA, however, does not fully mimic the action of cAMP, indicating the existence of a PKA-independent component. Since cAMP-mediated activation of the G-protein Rap1 and its phosphorylation by PKA are strictly required for the effects of cAMP on mitogenesis, we hypothesized that the Rap1 activator Epac might represent the PKA-independent factor. Here we report that Epac acts synergistically with PKA in cAMP-mediated mitogenesis. We have generated a new dominant negative Epac mutant that revealed that activation of Epac is required for thyroid-stimulating hormone or cAMP stimulation of DNA synthesis. We demonstrate that Epac's action on cAMP-mediated activation of Rap1 and cAMP-mediated mitogenesis depends on the subcellular localization of Epac via its DEP domain. Disruption of the DEP-dependent subcellular targeting of Epac abolished cAMP-Epac-mediated Rap1 activation and thyroid-stimulating hormone-mediated cell proliferation, indicating that an Epac-Rap-PKA signaling unit is critical for the mitogenic action of cAMP.	[Hochbaum, Daniel; Hong, Kyoungja; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Dept Pharmacol, Sch Med, 200 Lothrop St,W1316 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Hochbaum, Daniel/0000-0001-6387-7529	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCI NIH HHS [CA071649] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071649, R29CA071649] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Civera C, 2005, PROTEINS, V58, P354, DOI 10.1002/prot.20320; De Falco V, 2007, CANCER RES, V67, P381, DOI 10.1158/0008-5472.CAN-06-0981; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dremier S, 1997, MOL CELL BIOL, V17, P6717, DOI 10.1128/MCB.17.11.6717; Dremier S, 2000, BIOCHEM BIOPH RES CO, V267, P7, DOI 10.1006/bbrc.1999.1919; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178	36	67	68	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4464	4468		10.1074/jbc.C700171200	http://dx.doi.org/10.1074/jbc.C700171200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063584	hybrid			2022-12-27	WOS:000253426500002
J	Nelson, LD; Johnson, AE; London, E				Nelson, Lindsay D.; Johnson, Arthur E.; London, Erwin			How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH - Insights into the origin of perfringolysin O-lipid raft interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; TRANSMEMBRANE BETA-HAIRPINS; STREPTOLYSIN-O; PORE FORMATION; BINDING CYTOLYSIN; DIPHTHERIA-TOXIN; DOMAIN FORMATION; LISTERIOLYSIN-O; CLOSTRIDIUM-PERFRINGENS; ACTIVATED TOXIN	Perfringolysin O (PFO) is a sterol-dependent, pore-forming cytolysin. To understand the molecular basis of PFO membrane interaction, we studied its dependence upon sterol and lipid structure and aqueous environment. PFO interacted with diverse sterols, although binding was affected by double bond location in the sterol rings, sterol side chain structure, and sterol polar group structure. Importantly, a sterol structure promoting formation of ordered membrane domains ( lipid rafts) was not critical for interaction. PFO membrane interaction was also affected by phospholipid acyl chain structure, being inversely related to tight acyl chain packing with cholesterol. Experiments using the pre-pore Y181A mutant demonstrated that sterol binding strength and specificity was not affected by whether PFO forms a transmembrane beta-barrel. Combined, these observations are consistent with a model in which the strength and specificity of sterol interaction arises from both sterol interactions with domain 4 and sterol chemical activity within membranes. The lipid raft-binding portions of sterol bound to PFO may remain largely exposed to the lipid bilayer. These results place important constraints upon the origin of PFO raft affinity. Additional experiments demonstrated that the structure of membrane-inserted PFO at low and neutral pH was similar as judged by the effect of phospholipid and sterol structure upon PFO properties and membrane interaction. However, low pH enhanced PFO membrane binding, oligomerization, and pore formation. In lipid vesicles mimicking the exofacial ( outer) membrane leaflet, PFO-membrane binding was maximal at pH 5.5-6. This is consistent with the hypothesis that PFO function involves acidic vacuoles.	[Nelson, Lindsay D.; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Mol & Cellular Biol, College Stn, TX 77843 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	erwin.london@stonybrook.edu	Johnson, Arthur E/G-3457-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007539, R01AI037657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048596] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007539, AI 37657] Funding Source: Medline; NIGMS NIH HHS [GM 48596] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALOUF JE, 1984, EUR J BIOCHEM, V141, P205, DOI 10.1111/j.1432-1033.1984.tb08176.x; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; CHUNG LA, 1988, BIOCHEMISTRY-US, V27, P1245, DOI 10.1021/bi00404a026; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; EMANS N, 1995, BIOPHYS J, V69, P716, DOI 10.1016/S0006-3495(95)79947-7; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; GEOFFROY C, 1983, J BIOL CHEM, V258, P9968; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; JOHNSON MK, 1980, INFECT IMMUN, V27, P97, DOI 10.1128/IAI.27.1.97-101.1980; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; LONDON E, 1992, MOL MICROBIOL, V6, P3277, DOI 10.1111/j.1365-2958.1992.tb02195.x; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; PINKNEY M, 1989, INFECT IMMUN, V57, P2553, DOI 10.1128/IAI.57.8.2553-2558.1989; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; PRIGENT D, 1976, BIOCHIM BIOPHYS ACTA, V443, P288, DOI 10.1016/0005-2736(76)90511-3; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rebolj K, 2006, BBA-BIOMEMBRANES, V1758, P1662, DOI 10.1016/j.bbamem.2006.06.003; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; WATSON KC, 1974, BIOCHEM J, V140, P95, DOI 10.1042/bj1400095; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; ZHAO JM, 1986, P NATL ACAD SCI USA, V83, P2002, DOI 10.1073/pnas.83.7.2002; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	53	93	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4632	4642		10.1074/jbc.M709483200	http://dx.doi.org/10.1074/jbc.M709483200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089559	hybrid			2022-12-27	WOS:000253426500020
J	Fan, J; Ren, HG; Jia, NL; Fei, E; Zhou, T; Jiang, P; Wu, M; Wang, GH				Fan, Jun; Ren, Haigang; Jia, Nali; Fei, Erkang; Zhou, Tian; Jiang, Peng; Wu, Mian; Wang, Guanghui			DJ-1 decreases Bax expression through repressing p53 transcriptional activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; CELL-DEATH; ALPHA-SYNUCLEIN; NEURONAL APOPTOSIS; PROTEASOME INHIBITION; TYROSINE-HYDROXYLASE; DOPAMINERGIC-NEURONS; NEGATIVE REGULATOR; ANDROGEN RECEPTOR; OXIDATIVE STRESS	DJ-1, originally identified as an oncogene product, is a protein with various functions in cellular transformation, oxidative stress response, and transcriptional regulation. Although previous studies suggest that DJ-1 is cytoprotective, the mechanism by which DJ-1 exerts its survival functions remains largely unknown. Here we show that DJ-1 exerts its cytoprotection through inhibiting p53-Bax-caspase pathway. DJ-1 interacts with p53 in vitro and in vivo. Overexpression of DJ-1 decreases the expression of Bax and inhibits caspase activation, whereas knock- down of DJ-1 increases Bax protein levels and accelerates caspase-3 activation and cell death induced by UV exposure. Our data provide evidence that the protective effects of DJ-1 on apoptosis are associated with its ability of decreasing Bax level through inhibiting p53 transcriptional activity.	[Fan, Jun; Ren, Haigang; Jia, Nali; Fei, Erkang; Zhou, Tian; Jiang, Peng; Wu, Mian; Wang, Guanghui] Univ Sci & Technol China, Lab Mol Neuropathol, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wang, GH (corresponding author), Univ Sci & Technol China, Lab Mol Neuropathol, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wghui@ustc.edu.cn	Wang, Guanghui/U-3979-2017; Jiang, Peng/A-1946-2013; Fan, Jun/F-8224-2012; FEI, Erkang/AAI-9825-2021; Ren, Haigang/U-6034-2017	Wang, Guanghui/0000-0001-8551-6468; Ren, Haigang/0000-0001-8844-4754; Wu, Mian/0000-0002-2714-0500; FEI, Erkang/0000-0002-3581-9521				Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; de la Monte SM, 1998, LAB INVEST, V78, P401; Dornan D, 2004, CANCER RES, V64, P7226, DOI 10.1158/0008-5472.CAN-04-2601; Duan WZ, 2002, ANN NEUROL, V52, P597, DOI 10.1002/ana.10350; Eberhardt O, 2003, TOXICOL LETT, V139, P135, DOI 10.1016/S0378-4274(02)00428-9; Grzmil M, 2004, INT J ONCOL, V24, P97; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hague S, 2003, ANN NEUROL, V54, P271, DOI 10.1002/ana.10663; Hartmann A, 2000, P NATL ACAD SCI USA, V97, P2875, DOI 10.1073/pnas.040556597; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hod Y, 2004, J CELL BIOCHEM, V92, P1221, DOI 10.1002/jcb.20159; Jeong H, 2006, NEUROSCI LETT, V396, P57, DOI 10.1016/j.neulet.2005.11.011; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; McNeill-Blue C, 2006, BRAIN RES, V1112, P1, DOI 10.1016/j.brainres.2006.07.024; Miura K, 2002, CANCER RES, V62, P3244; Morrison RS, 2003, NEUROCHEM RES, V28, P15, DOI 10.1023/A:1021687810103; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; Niki T, 2003, MOL CANCER RES, V1, P247; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Olzmann JA, 2007, J COMP NEUROL, V500, P585, DOI 10.1002/cne.21191; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Shinbo YM, 2005, INT J ONCOL, V26, P641; Spillare EA, 1999, GENE DEV, V13, P1355, DOI 10.1101/gad.13.11.1355; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Thornborrow EC, 2001, J BIOL CHEM, V276, P15598, DOI 10.1074/jbc.M011643200; Vaghefi H, 2004, ONCOGENE, V23, P8078, DOI 10.1038/sj.onc.1207953; Vila M, 2001, P NATL ACAD SCI USA, V98, P2837, DOI 10.1073/pnas.051633998; Viswanath V, 2001, J NEUROSCI, V21, P9519, DOI 10.1523/JNEUROSCI.21-24-09519.2001; Wagenfeld A, 1998, BIOCHEM BIOPH RES CO, V251, P545, DOI 10.1006/bbrc.1998.9512; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yokota T, 2003, BIOCHEM BIOPH RES CO, V312, P1342, DOI 10.1016/j.bbrc.2003.11.056; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	56	190	198	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4022	4030		10.1074/jbc.M707176200	http://dx.doi.org/10.1074/jbc.M707176200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18042550	hybrid			2022-12-27	WOS:000253083500037
J	Maiti, SN; Balasubramanian, K; Ramoth, JA; Schroit, AJ				Maiti, Sourindra N.; Balasubramanian, Krishnakumar; Ramoth, Johanna A.; Schroit, Alan J.			beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells - Binding to lipoprotein receptor-related protein receptor family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ADP-INDUCED AGGREGATION; BETA(2)-GLYCOPROTEIN I; APOLIPOPROTEIN-H; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; PHOSPHOLIPID-VESICLES; SURFACE CALRETICULIN; IMMUNE CLEARANCE; HUMAN-PLATELETS	The recognition and removal of apoptotic cells is critical to development, tissue homeostasis, and the resolution of inflammation. Many studies have shown that phagocytosis is regulated by signaling mechanisms that involve distinct ligand-receptor interactions that drive the engulfment of apoptotic cells. Studies from our laboratory have shown that the plasma protein beta-2glycoprotein 1 (beta 2GP1), a member of the short consensus repeat superfamily, binds phosphatidylserine-containing vesicles and apoptotic cells and promotes their bridging and subsequent engulfment by phagocytes. The phagocyte receptor for the protein/apoptotic cell complex, however, is unknown. Here we report that a member of the low density lipoprotein receptor-related protein family on phagocytes binds and facilitates engulfment of beta 2GP1-phosphatidylserine and beta 2GP1-apoptotic cell complexes. Using recombinant beta 2GP1, we also show that beta 2GP1-dependent uptake is mediated by bridging of the target cell to the phagocyte through the protein C- and N-terminal domains, respectively.	[Maiti, Sourindra N.; Balasubramanian, Krishnakumar; Ramoth, Johanna A.; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			NIGMS NIH HHS [GM70964] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Atsumi T, 2005, AUTOIMMUNITY, V38, P377, DOI 10.1080/08916930500124312; Balasubramanian K, 2005, APOPTOSIS, V10, P439, DOI 10.1007/s10495-005-0817-3; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845; DELPAPA N, 1995, CLIN EXP RHEUMATOL, V13, P179; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GOLDSMITH GH, 1994, BRIT J HAEMATOL, V87, P548, DOI 10.1111/j.1365-2141.1994.tb08311.x; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; HAGIHARA Y, 1995, J BIOCHEM-TOKYO, V118, P129, DOI 10.1093/oxfordjournals.jbchem.a124867; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hong DP, 2001, BIOCHEMISTRY-US, V40, P8092, DOI 10.1021/bi010196v; HUNT J, 1994, J IMMUNOL, V152, P653; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; KRISTENSEN T, 1986, J IMMUNOL, V136, P3407; KRISTENSEN T, 1991, FEBS LETT, V289, P183, DOI 10.1016/0014-5793(91)81065-G; Lee AT, 2000, BBA-BIOMEMBRANES, V1509, P475, DOI 10.1016/S0005-2736(00)00329-1; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luster TA, 2006, J BIOL CHEM, V281, P29863, DOI 10.1074/jbc.M605252200; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Matsuura E, 2006, PROG LIPID RES, V45, P466, DOI 10.1016/j.plipres.2006.05.001; Matsuura Eiji, 2004, Clin Dev Immunol, V11, P103, DOI 10.1080/10446670410001722186; Moestrup SK, 1998, J CLIN INVEST, V102, P902, DOI 10.1172/JCI3772; NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Patel M, 2003, J BIOL CHEM, V278, P44799, DOI 10.1074/jbc.M308982200; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SHI W, 1993, BLOOD, V81, P1255; Shoenfeld Y, 2000, J AUTOIMMUN, V15, P199, DOI 10.1006/jaut.2000.0393; Wang SX, 1999, BIOCHEMISTRY-US, V38, P9477, DOI 10.1021/bi990084s; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X	51	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3761	3766		10.1074/jbc.M704990200	http://dx.doi.org/10.1074/jbc.M704990200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073216	hybrid			2022-12-27	WOS:000253083500009
J	Noriega, VM; Tortorella, D				Noriega, Vanessa M.; Tortorella, Domenico			A bipartite trigger for dislocation directs the proteasomal degradation of an endoplasmic reticulum membrane glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; CELL RECEPTOR-CD3 COMPLEX; MHC CLASS-I; HEAVY-CHAINS; ANTIGEN PRESENTATION; CHARGED RESIDUES; SIGNAL PEPTIDE; PROTEIN; US2; ER	Polypeptides are organized into distinct substructures, termed protein domains, that are often associated with diverse functions. These modular units can act as binding sites, areas of post-translational modification, and sites of complex multimerization. The human cytomegalovirus US2 gene product is organized into discrete domains that together catalyze the proteasome-dependent degradation of class I major histocompatibility complex heavy chains. US2 co-opts the endogenous ER quality control pathway in order to dispose of class I. The US2 endoplasmic reticulum (ER)-lumenal region is the class I binding domain, whereas the carboxyl terminus can be referred to as the degradation domain. In the present study, we examined the role of the US2 transmembrane domain in virus-mediated class I degradation. Replacement of the US2 transmembrane domain with that of the CD4 glycoprotein completely blocked the ability of US2 to induce class I destruction. A more precise mutagenesis revealed that subregions of the US2 transmembrane domain differ in their ability to trigger class I degradation. Collectively, the data support a model in which US2-mediated class I degradation occurs as a highly regulated process where the US2 transmembrane domain and cytoplasmic tail work in concert to eliminate class I molecules. Host factors, including a signal peptidase complex, probably associate with the US2 molecule in a coordinated fashion to create a predislocation complex to promote the extraction of class I out of the ER. The results imply that the ER quality control machinery may recognize and eliminate misfolded proteins using a similar multistep regulated process.	[Noriega, Vanessa M.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Domenico.Tortorella@mssm.edu		Tortorella, Domenico/0000-0003-0961-3535	NIAID NIH HHS [T32 AI007647, R01 AI060905-03S1, R01 AI060905, AI07647, AI060905, AI060905-S1, T32 AI007647-03, R01 AI060905-04, R01 AI060905-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060905, T32AI007647] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boppana SB, 1996, VIROLOGY, V222, P293, DOI 10.1006/viro.1996.0424; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Chevalier MS, 2002, J VIROL, V76, P8265, DOI 10.1128/JVI.76.16.8265-8275.2002; Ciczora Y, 2005, J GEN VIROL, V86, P2793, DOI 10.1099/vir.0.81140-0; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hendrickson WA, 2005, Q REV BIOPHYS, V38, P321, DOI 10.1017/S0033583506004136; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jones TR, 1997, J VIROL, V71, P2970, DOI 10.1128/JVI.71.4.2970-2979.1997; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mocarski E, 1996, FIELDS VIROLOGY, P2447; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PARHAM P, 1979, J IMMUNOL, V123, P342; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Reddehase MJ, 2000, CURR OPIN IMMUNOL, V12, P390, DOI 10.1016/S0952-7915(00)00106-0; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	39	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4031	4043		10.1074/jbc.M706283200	http://dx.doi.org/10.1074/jbc.M706283200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086679	Green Accepted, hybrid			2022-12-27	WOS:000253083500038
J	Rutkowska, A; Mayer, MP; Hoffmann, A; Merz, F; Zachmann-Brand, B; Schaffitzel, C; Ban, N; Deuerling, E; Bukau, B				Rutkowska, Anna; Mayer, Matthias P.; Hoffmann, Anja; Merz, Frieder; Zachmann-Brand, Beate; Schaffitzel, Christiane; Ban, Nenad; Deuerling, Elke; Bukau, Bernd			Dynamics of trigger factor interaction with translating ribosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEWLY SYNTHESIZED PROTEINS; NASCENT CHAIN COMPLEXES; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROLYL ISOMERASE; RNA-POLYMERASE; IN-VIVO; DNAK; BINDING; DOMAIN	In all organisms ribosome-associated chaperones assist early steps of protein folding. To elucidate the mechanism of their action, we determined the kinetics of individual steps of the ribosome binding/release cycle of bacterial trigger factor (TF), using fluorescently labeled chaperone and ribosome-nascent chain complexes. Both the association and dissociation rates of TF-ribosome complexes are modulated by nascent chains, whereby their length, sequence, and folding status are influencing parameters. However, the effect of the folding status is modest, indicating that TF can bind small globular domains and accommodate them within its substrate binding cavity. In general, the presence of a nascent chain causes an up to 9-fold increase in the rate of TF association, which provides a kinetic explanation for the observed ability of TF to efficiently compete with other cytosolic chaperones for binding to nascent chains. Furthermore, a subset of longer nascent polypeptides promotes the stabilization of TF-ribosome complexes, which increases the half-life of these complexes from 15 to 50 s. Nascent chains thus regulate their folding environment generated by ribosome-associated chaperones.	[Rutkowska, Anna; Mayer, Matthias P.; Hoffmann, Anja; Merz, Frieder; Zachmann-Brand, Beate; Deuerling, Elke; Bukau, Bernd] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Schaffitzel, Christiane; Ban, Nenad] ETH, Inst Mol & Biophys, CH-8093 Zurich, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Deuerling, E (corresponding author), Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany.	e.deuerling@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Bukau, Bernd/0000-0003-0521-7199; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Blanco FJ, 1999, J MOL BIOL, V285, P741, DOI 10.1006/jmbi.1998.2333; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Campbell EA, 2005, EMBO J, V24, P674, DOI 10.1038/sj.emboj.7600499; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Evans MS, 2005, NAT METHODS, V2, P757, DOI 10.1038/NMETH790; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Hesterkamp T, 1996, FEBS LETT, V385, P67, DOI 10.1016/0014-5793(96)00351-1; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Ludlam AV, 2004, P NATL ACAD SCI USA, V101, P13436, DOI 10.1073/pnas.0405868101; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; MAUGUEN Y, 1982, NATURE, V297, P162, DOI 10.1038/297162a0; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; MOSSAKOWSKA DE, 1989, BIOCHEMISTRY-US, V28, P3843, DOI 10.1021/bi00435a033; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Neira JL, 1999, J MOL BIOL, V285, P1309, DOI 10.1006/jmbi.1998.2249; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2004, BIOCHIMIE, V86, P495, DOI 10.1016/j.biochi.2004.05.004; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Schaffitzel C, 2007, J STRUCT BIOL, V158, P463, DOI 10.1016/j.jsb.2007.01.005; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	39	72	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4124	4132		10.1074/jbc.M708294200	http://dx.doi.org/10.1074/jbc.M708294200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045873	Green Submitted, hybrid			2022-12-27	WOS:000253083500048
J	van de Graaf, SFJ; Rescher, U; Hoenderop, JGJ; Verkaart, S; Bindels, RJM; Gerke, V				van de Graaf, Stan F. J.; Rescher, Ursula; Hoenderop, Joost G. J.; Verkaart, Sjoerd; Bindels, Rene J. M.; Gerke, Volker			TRPV5 is internalized via clathrin-dependent endocytosis to enter a Ca2+-controlled recycling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS TRPV5; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; TRAFFICKING; EXPRESSION; RECEPTORS; INSERTION; TRANSLOCATION; CONTRIBUTES; INCREASES	The epithelial Ca2+ channel TRPV5 plays an essential role in transcellular Ca2+ transport and is one of the most Ca2+-selective members of the transient receptor potential superfamily. Regulation of the abundance of TRPV5 at the cell surface is critical in body Ca2+ homeostasis. However, little is known about the mechanisms underlying TRPV5 endo- and exocytosis. Here, we show that TRPV5 is constitutively internalized in a dynamin and clathrin-dependent manner. Internalized TRPV5 first appears in small vesicular structures and then localizes to perinuclear structures positive for Rab11a. TRPV5 has a half-life of more than 8 h and is stable even after internalization from the cell surface for more than 3 h. Disruption of cell surface delivery of newly synthesized TRPV5 by brefeldin A does not reduce TRPV5-mediated Ca2+ influx in cells, suggesting the presence of a stable intracellular pool of the channel capable of recycling back to the surface. Furthermore, the endocytic recycling kinetics is decreased upon treatment with Ca2+ chelator BAPTA-AM, indicating that the channel's trafficking pathways are dynamically controlled by Ca2+.	[van de Graaf, Stan F. J.; Rescher, Ursula; Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Hoenderop, Joost G. J.; Verkaart, Sjoerd; Bindels, Rene J. M.] Radboud Univ Nijmegen, Nijmegan Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	University of Munster; Radboud University Nijmegen	van de Graaf, SFJ (corresponding author), UMC Utrecht, Wilhelmina Childrens Hosp, Dept Metab & Endocrine Dis, Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	S.vandeGraaf-4@umcutrecht.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; van de Graaf, Stan/0000-0003-4238-4359				Ambudkar I. S., 2007, V179, P541; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; den Dekker E, 2005, PFLUG ARCH EUR J PHY, V450, P236, DOI 10.1007/s00424-005-1409-3; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Knight DE, 2002, TRAFFIC, V3, P298, DOI 10.1034/j.1600-0854.2002.030407.x; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Sainte-Marie J, 1997, EUR J BIOCHEM, V250, P689, DOI 10.1111/j.1432-1033.1997.00689.x; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	43	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4077	4086		10.1074/jbc.M706959200	http://dx.doi.org/10.1074/jbc.M706959200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077461	hybrid, Green Published			2022-12-27	WOS:000253083500043
J	Edwin, F; Patel, TB				Edwin, Francis; Patel, Tarun B.			A novel role of sprouty 2 in regulating cellular apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; C-CBL; BIOLOGICAL ACTIONS; KIDNEY DEVELOPMENT; LIGASE ACTIVITY; DOWN-REGULATION; PROTEIN-KINASE; ACTIVATION; MIGRATION	Sprouty (SPRY) proteins modulate receptor-tyrosine kinase signaling and, thereby, regulate cell migration and proliferation. Here, we have examined the role of endogenous human SPRY2 (hSPRY2) in the regulation of cellular apoptosis. Small inhibitory RNA-mediated silencing of hSPRY2 abolished the anti-apoptotic action of serum in adrenal cortex adenocarcinoma (SW13) cells. Silencing of hSPRY2 decreased serum- or epidermal growth factor (EGF)-elicited activation of AKT and ERK1/2 and reduced the levels of EGF receptor. Silencing of hSPRY2 also inhibited serum- induced activation of p90RSK and decreased phosphorylation of pro-apoptotic protein BAD (BCL2-antagonist of cell death) by p90RSK. Inhibiting both the ERK1/2 and AKT pathways abolished the ability of serum to protect against apoptosis, mimicking the effects of silencing hSPRY2. Serum transactivated the EGF receptor ( EGFR), and inhibition of the EGFR by a neutralizing antibody attenuated the anti-apoptotic actions of serum. Consistent with the role of EGFR and perhaps other growth factor receptors in the antiapoptotic actions of serum, the tyrosine kinase binding domain of c-Cbl (Cbl-TKB) protected against down-regulation of the growth factor receptors such as EGFR and preserved the antiapoptotic actions of serum when hSpry2 was silenced. Additionally, silencing of Spry2 in c-Cbl null cells did not alter the ability of serum to promote cell survival. Moreover, reintroduction of wild type hSPRY2, but not its mutants that do not bind c-Cbl or CIN85 into SW13 cells after endogenous hSPRY2 had been silenced, restored the anti-apoptotic actions of serum. Overall, we conclude that endogenous hSPRY2-mediated regulation of apoptosis requires c-Cbl and is manifested by the ability of hSPRY2 to sequester c-Cbl and thereby augment signaling via growth factor receptors.	[Edwin, Francis; Patel, Tarun B.] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu			NIGMS NIH HHS [GM073181, R01 GM073181-03S1, R01 GM073181] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073181] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng WL, 2004, J BIOL CHEM, V279, P47871, DOI 10.1074/jbc.M405443200; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li X, 2003, BIOCHEM SOC T, V31, P1445; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Minowada G, 1999, DEVELOPMENT, V126, P4465; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; Perl AKT, 2003, DEV BIOL, V258, P154, DOI 10.1016/S0012-1606(03)00106-4; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Reich A, 1999, DEVELOPMENT, V126, P4139; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	50	27	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3181	3190		10.1074/jbc.M706567200	http://dx.doi.org/10.1074/jbc.M706567200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070883	Green Accepted, hybrid			2022-12-27	WOS:000253083000021
J	Li, L; Kobayashi, M; Kaneko, H; Nakajima-Takagi, Y; Nakayama, Y; Yamamoto, M				Li, Li; Kobayashi, Makoto; Kaneko, Hiroshi; Nakajima-Takagi, Yaeko; Nakayama, Yuko; Yamamoto, Masayuki			Molecular evolution of Keap1 - Two Keap1 molecules with distinctive intervening region structures are conserved among fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; RECOGNITION MODEL; PHASE-2 RESPONSE; DLG MOTIFS; NRF2; ZEBRAFISH; PROTEIN; DOMAIN; GENES; ELECTROPHILES	Keap1 is a BTB-Kelch-type substrate adaptor protein of the Cul3-dependent ubiquitin ligase complex. Keap1 facilitates the degradation of Nrf2, a transcription factor regulating the inducible expression of many cytoprotective genes. Through comparative genome analyses, we found that amino acid residues composing the pocket of Keap1 that interacts with Nrf2 are highly conserved among Keap1 orthologs and related proteins in all vertebrates and in certain invertebrates, including flies and mosquitoes. The interaction between Nrf2 and Keap1 appears to be widely preserved in vertebrates. Similarly, cysteine residues corresponding to Cys-273 and Cys-288 in the intervening region of mouse Keap1, which are essential for the repression of Nrf2 activity in cultured cells, are conserved among Keap1 orthologs in vertebrates and invertebrates, except fish. We found that fish have two types of Keap1, Keap1a and Keap1b. To our surprise, Keap1a and Keap1b contain the cysteine residue corresponding to Cys-288 and Cys-273, respectively. In our analysis of zebrafish Keap1a and Keap1b activities, both Keap1a and Keap1b were able to facilitate the degradation of Nrf2 protein and repress Nrf2-mediated target gene activation. Individual mutation of either residual cysteine residue in Keap1a and Keap1b disrupted the ability of Keap1 to repress Nrf2, indicating that the presence of either Cys-273 or Cys-288 is sufficient for fish Keap1 molecules to fully function. These results provide an important insight into the means by which Keap1 cysteines act as sensors of electrophiles and oxidants.	[Li, Li; Kobayashi, Makoto; Nakayama, Yuko; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Environm Response Project, Tsukuba, Ibaraki 3058575, Japan; [Kobayashi, Makoto; Kaneko, Hiroshi; Nakajima-Takagi, Yaeko; Yamamoto, Masayuki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 9808575, Japan	University of Tsukuba; University of Tsukuba; Tohoku University	Kobayashi, M (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Environm Response Project, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	makobayash@md.tsukuba.ac.jp	Kobayashi, Makoto/B-2537-2008; Yamamoto, Masayuki/A-4873-2010	Kobayashi, Makoto/0000-0001-6660-450X; Yamamoto, Masayuki/0000-0002-9073-9436				Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Appel B, 1998, DEVELOPMENT, V125, P371; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2002, GENES CELLS, V7, P807, DOI 10.1046/j.1365-2443.2002.00561.x; Kobayashi M, 2001, DEVELOPMENT, V128, P2341; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Suzuki T, 2005, BIOCHEM J, V388, P65, DOI 10.1042/BJ20041860; Takagi Y, 2004, BIOCHEM BIOPH RES CO, V320, P62, DOI 10.1016/j.bbrc.2004.05.131; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	35	88	92	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3248	3255		10.1074/jbc.M708702200	http://dx.doi.org/10.1074/jbc.M708702200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057000	Green Submitted, hybrid			2022-12-27	WOS:000253083000028
J	Barnett, JP; Eijlander, RT; Kuipers, OP; Robinson, C				Barnett, James P.; Eijlander, Robyn T.; Kuipers, Oscar P.; Robinson, Colin			A minimal tat system from a gram-positive organism - A bifunctional TatA subunit participates in discrete TatAC and TatA complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TWIN-ARGININE TRANSLOCASE; SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; SIGNAL PEPTIDE; STREPTOMYCES-LIVIDANS; EXPORT PATHWAY; TRANSPORT; COMPONENT; BACTERIAL; BACILLUS	The Tat system transports folded proteins across bacterial and thylakoid membranes. In Gram-negative organisms, a TatABC substrate-binding complex and separate TatA complex are believed to coalesce to form an active translocon, with all three subunits essential for translocation. Most Gram-positive organisms lack a tatB gene, indicating major differences in organization and possible differences in mode of action. Here, we have studied Tat complexes encoded by the tatAdCd genes of Bacillus subtilis. Expression of tatAdCd in an Escherichia coli tat null mutant results in efficient export of a large, cofactor-containing E. coli Tat substrate, TorA. We show that the tatAd gene complements E. coli mutants lacking either tatAE or tatB, indicating a bifunctional role for this subunit in B. subtilis. Second, we have identified and characterized two distinct Tat complexes that are novel in key respects: a TatAdCd complex of similar to 230 kDa that is significantly smaller than the analogous E. coli TatABC complex (similar to 370 kDa on BN gels) and a separate TatAd complex. The latter is a discrete entity of similar to 270 kDa as judged by gel filtration chromatography, very different from the highly heterogeneous E. coli TatA complex that ranges in size from similar to 50 kDa to over 600 kDa. TatA heterogeneity has been linked to the varying size of Tat substrates being translocated, but the singular nature of the B. subtilis TatAd complex suggests that discrete TatAC and TatA complexes may form a single form of translocon.	[Barnett, James P.; Robinson, Colin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Eijlander, Robyn T.; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, NL-9751 NN Haren, Netherlands	University of Warwick; University of Groningen	Robinson, C (corresponding author), Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England.	colin.robinson@warwick.ac.uk	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Barnett, James/0000-0003-1827-036X	Biotechnology and Biological Sciences Research Council [BB/E010245/1] Funding Source: Medline; BBSRC [BB/E010245/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Barrett CML, 2005, J MOL BIOL, V347, P453, DOI 10.1016/j.jmb.2005.01.026; Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; CHADDOCK AM, 1995, EMBO J, V14, P2715, DOI 10.1002/j.1460-2075.1995.tb07272.x; CLINE K, 1992, J BIOL CHEM, V267, P2688; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Dalbey RE, 2000, ANNU REV CELL DEV BI, V16, P51, DOI 10.1146/annurev.cellbio.16.1.51; De Keersmaeker S, 2007, MICROBIOL-SGM, V153, P1087, DOI 10.1099/mic.0.2006/003053-0; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2000, J BIOL CHEM, V275, P41350, DOI 10.1074/jbc.M004887200; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Oates J, 2005, J MOL BIOL, V346, P295, DOI 10.1016/j.jmb.2004.11.047; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Pop O, 2002, J BIOL CHEM, V277, P3268, DOI 10.1074/jbc.M110829200; Robinson C, 2004, BBA-MOL CELL RES, V1694, P135, DOI 10.1016/j.bbamcr.2004.03.010; Rodrigue A, 1999, J BIOL CHEM, V274, P13223, DOI 10.1074/jbc.274.19.13223; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santini CL, 1998, EMBO J, V17, P101, DOI 10.1093/emboj/17.1.101; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; Schreiber S, 2006, J BIOL CHEM, V281, P19977, DOI 10.1074/jbc.M513900200; SILVESTRO A, 1989, BIOCHIM BIOPHYS ACTA, V999, P208, DOI 10.1016/0167-4838(89)90220-3; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; Westermann M, 2006, BBA-BIOMEMBRANES, V1758, P443, DOI 10.1016/j.bbamem.2006.03.018	40	61	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2534	2542		10.1074/jbc.M708134200	http://dx.doi.org/10.1074/jbc.M708134200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18029357	hybrid, Green Published			2022-12-27	WOS:000252622300010
J	Woodall, BP; Nystrom, A; Iozzo, RA; Eble, JA; Niland, S; Krieg, T; Eckes, B; Pozzi, A; Iozzo, RV				Woodall, Benjamin P.; Nystrom, Alexander; Iozzo, Rex A.; Eble, Johannes A.; Niland, Stephan; Krieg, Thomas; Eckes, Beate; Pozzi, Ambra; Iozzo, Renato V.			Integrin alpha 2 beta 1 is the required receptor for endorepellin angiostatic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; EXTRACELLULAR-MATRIX; ALPHA-DYSTROGLYCAN; CRYSTAL-STRUCTURE; HEPARAN-SULFATE; CELL-ADHESION; PROTEIN CORE; TUMOR-GROWTH; I DOMAIN; PERLECAN	Endorepellin, the C- terminal module of perlecan, has angiostatic activity. Here we provide definitive genetic and biochemical evidence that the functional endorepellin receptor is the alpha 2 beta 1 integrin. Notably, the specific endorepellin binding to the receptor was cation- independent and was mediated by the alpha 2 I domain. We show that the anti- angiogenic effects of endorepellin cannot occur in the absence of alpha 2 beta 1. Microvascular endothelial cells from alpha 2 beta 1(-/-) mice, but not those isolated from either wild- type or alpha 1 beta 1(-/-) mice, did not respond to endorepellin. Moreover, syngeneic Lewis lung carcinoma xenografts in alpha 2 beta 1(-/-) mice failed to respond to systemic delivery of endorepellin. In contrast, endorepellin inhibited tumor growth and angiogenesis in the wild- type mice expressing integrin alpha 2 beta 1. We conclude that the angiostatic effects of endorepellin in vivo are mediated by a specific interaction of endorepellin with the alpha 2 beta 1 integrin receptor.	[Woodall, Benjamin P.; Nystrom, Alexander; Iozzo, Rex A.; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Eble, Johannes A.; Niland, Stephan] Muenster Univ Hosp, Inst Physiol Chem, D-48149 Munster, Germany; [Krieg, Thomas; Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Pozzi, Ambra] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA	Jefferson University; University of Munster; University of Cologne; Vanderbilt University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Rm 249 JAH, Philadelphia, PA 19107 USA.	iozzo@mail.jci.tju.edu	Iozzo, Renato/AAS-1980-2020	Iozzo, Renato/0000-0002-5908-5112; Nystrom, Alexander/0000-0002-4666-2240	NCI NIH HHS [R01 CA47282, R01 CA39481, R01 CA120975] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA039481, R01CA047282, R01CA120975] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adatia R, 1997, ANN ONCOL, V8, P1257, DOI 10.1023/A:1008243115385; Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2007, BLOOD, V109, P3745, DOI 10.1182/blood-2006-08-039925; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Datta MW, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-9; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2003, BIOCHEM J, V376, P77, DOI 10.1042/BJ20030373; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Funahashi Y, 2002, CANCER RES, V62, P6116; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Grenache DG, 2007, J INVEST DERMATOL, V127, P455, DOI 10.1038/sj.jid.5700611; HASSELL JR, 2003, GLYCOCONJ J, V19, P263; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3; Holtkotter O, 2002, J BIOL CHEM, V277, P10789, DOI 10.1074/jbc.M112307200; Horii K, 2004, J MOL BIOL, V341, P519, DOI 10.1016/j.jmb.2004.06.036; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; IOZZO RV, 1994, MATRIX BIOL, V14, P203, DOI 10.1016/0945-053X(94)90183-X; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; KERN A, 1993, EUR J BIOCHEM, V215, P151, DOI 10.1111/j.1432-1033.1993.tb18017.x; King SL, 1997, J BIOL CHEM, V272, P28518, DOI 10.1074/jbc.272.45.28518; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Mathiak M, 1997, CANCER RES, V57, P2130; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Pozzi A, 2000, P NATL ACAD SCI USA, V97, P2202, DOI 10.1073/pnas.040378497; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1; Savore C, 2005, CLIN EXP METASTAS, V22, P377, DOI 10.1007/s10585-005-2339-3; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Stricker TP, 2001, J BIOL CHEM, V276, P29375, DOI 10.1074/jbc.M102217200; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	60	90	93	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2335	2343		10.1074/jbc.M708364200	http://dx.doi.org/10.1074/jbc.M708364200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18024432	hybrid			2022-12-27	WOS:000252501000060
J	Laval, F; Haites, R; Movahedzadeh, F; Lemassu, A; Wong, CY; Stoker, N; Billman-Jacobe, H; Daffe, M				Laval, Francoise; Haites, Ruth; Movahedzadeh, Farahnaz; Lemassu, Anne; Wong, Chinn Yi; Stoker, Neil; Billman-Jacobe, Helen; Daffe, Mamadou			Investigating the function of the putative mycolic acid methyltransferase UmaA - Divergence between the Mycobacterium smegmatis and Mycobacterium tuberculosis proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPROPANE SYNTHETASE; FATTY-ACIDS; BIOSYNTHESIS; GENE; VIRULENCE; MUTANT; IDENTIFICATION; FORTUITUM; ENVELOPE; ENCODES	Mycolic acids are major and specific lipid components of the cell envelope of mycobacteria that include the causative agents of tuberculosis and leprosy, Mycobacterium tuberculosis and Mycobacterium leprae, respectively. Subtle structural variations that are known to be crucial for both their virulence and the permeability of their cell envelope occur in mycolic acids. Among these are the introduction of cyclopropyl groups and methyl branches by mycolic acid S-adenosylmethionine-dependent methyltransferases (MA-MTs). While the functions of seven of the M. tuberculosis MA-MTs have been either established or strongly presumed nothing is known of the roles of the remaining umaA gene product and those of M. smegmatis MA-MTs. Mutants of the M. tuberculosis umaA gene and its putative M. smegmatis orthologue, MSMEG0913, were created. The lipid extracts of the resulting mutants were analyzed in detail using a combination of analytical techniques such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and proton nuclear magnetic resonance spectroscopy, and chemical degradation methods. The M. smegmatis mutants no longer synthesized subtypes of mycolates containing a methyl branch adjacent to either trans cyclopropyl group or trans double bond at the "proximal" position of both alpha- and epoxy-mycolates. Complementation with MSMEG0913, but not with umaA, fully restored the wild-type phenotype in M. smegmatis.	[Laval, Francoise; Lemassu, Anne; Daffe, Mamadou] Univ Toulouse 3, IPBS, F-31077 Toulouse, France; [Laval, Francoise; Lemassu, Anne; Daffe, Mamadou] CNRS, Unite Mixte Rech 5089, IPBS, F-31077 Toulouse, France; [Haites, Ruth; Wong, Chinn Yi; Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Movahedzadeh, Farahnaz; Stoker, Neil] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London NW1 0TU, England	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Melbourne; University of London; University of London Royal Veterinary College	Daffe, M (corresponding author), Univ Toulouse 3, IPBS, 205 Route Narbonne, F-31077 Toulouse, France.	daffe@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019; Stoker, Neil G/L-8812-2016	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Stoker, Neil G/0000-0001-7055-6184; Billman-Jacobe, Helen/0000-0001-5713-4657	Wellcome Trust [073237, 051880] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; ASSELINEAU C, 1981, ANN INST PASTEUR MIC, VA132, P19; Asselineau C, 2002, PROG LIPID RES, V41, P501, DOI 10.1016/S0163-7827(02)00008-5; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAFFE M, 1981, TETRAHEDRON LETT, V22, P4515, DOI 10.1016/S0040-4039(01)93029-1; DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; DRAPER P, 1982, ANN INST PASTEUR MIC, VB133, P39; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; ETEMADI AH, 1965, THESIS U PARIS; Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; GRAY G R, 1982, Progress in Lipid Research, V21, P91, DOI 10.1016/0163-7827(82)90001-7; GUILHOT C, 1994, J BACTERIOL, V176, P535, DOI 10.1128/JB.176.2.535-539.1994; Jeevarajah D, 2004, J BACTERIOL, V186, P6792, DOI 10.1128/JB.186.20.6792-6799.2004; LACAVE C, 1987, EUR J BIOCHEM, V163, P369, DOI 10.1111/j.1432-1033.1987.tb10809.x; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; McAdam RA, 2002, MICROBIOL-SGM, V148, P2975, DOI 10.1099/00221287-148-10-2975; MINNIKIN DE, 1982, BIOCHIM BIOPHYS ACTA, V712, P616, DOI 10.1016/0005-2760(82)90290-9; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Puech V, 2002, MOL MICROBIOL, V44, P1109, DOI 10.1046/j.1365-2958.2002.02953.x; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Schroeder BG, 2001, BIOORG CHEM, V29, P164, DOI 10.1006/bioo.2001.1207; Shin SJ, 2006, INFECT IMMUN, V74, P3825, DOI 10.1128/IAI.01742-05; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; VONRUDLOFF E, 1956, CAN J CHEM, V34, P1413; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828	37	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1419	1427		10.1074/jbc.M708859200	http://dx.doi.org/10.1074/jbc.M708859200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006503	hybrid			2022-12-27	WOS:000252282700025
J	Massengo-Tiasse, RP; Cronan, JE				Massengo-Tiasse, R. Prisca; Cronan, John E.			Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; ANTIBACTERIAL DRUG DISCOVERY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; STREPTOCOCCUS-PNEUMONIAE; TRICLOSAN; INHIBITION; SINGLE; GENE; COLLECTION	Enoyl-acyl carrier protein (ACP) reductase catalyzes the last step of the fatty acid elongation cycle. The paradigm enoyl-ACP reductase is the FabI protein of Escherichia coli that is the target of the antibacterial compound, triclosan. However, some Gram-positive bacteria are naturally resistant to triclosan due to the presence of the triclosan-resistant enoyl-ACP reductase isoforms, FabK and FabL. The genome of the Gram-negative bacterium, Vibrio cholerae lacks a gene encoding a homologue of any of the three known enoyl-ACP reductase isozymes suggesting that this organism encodes a novel fourth enoyl-ACP reductase isoform. We report that this is the case. The gene encoding the new isoform, called FabV, was isolated by complementation of a conditionally lethal E. coli fabI mutant strain and was shown to restore fatty acid synthesis to the mutant strain both in vivo and in vitro. Like FabI and FabL, FabV is a member of the short chain dehydrogenase reductase superfamily, although it is considerably larger ( 402 residues) than either FabI ( 262 residues) or FabL ( 250 residues). The FabV, FabI and FabL sequences can be aligned, but only poorly. Alignment requires many gaps and yields only 15% identical residues. Thus, FabV defines a new class of enoyl-ACP reductase. The native FabV protein has been purified to homogeneity and is active with both crotonyl-ACP and the model substrate, crotonyl-CoA. In contrast to FabI and FabL, FabV shows a very strong preference for NADH over NADPH. Expression of FabV in E. coli results in markedly increased resistance to triclosan and the purified enzyme is much more resistant to triclosan than is E. coli FabI.	[Massengo-Tiasse, R. Prisca; Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019	Yoder, Prisca/0000-0003-0845-152X				Bergler H, 1996, EUR J BIOCHEM, V242, P689, DOI 10.1111/j.1432-1033.1996.0689r.x; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; BERGLER H, 1994, J BIOL CHEM, V269, P5493; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cronan JE, 2006, NAT CHEM BIOL, V2, P232, DOI 10.1038/nchembio0506-232; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2006, CELL, V126, P641, DOI 10.1016/j.cell.2006.08.001; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; Duax WL, 1996, CURR OPIN STRUC BIOL, V6, P813, DOI 10.1016/S0959-440X(96)80012-1; Escalada MG, 2005, LETT APPL MICROBIOL, V41, P476, DOI 10.1111/j.1472-765X.2005.01790.x; GELMANN EP, 1972, J BACTERIOL, V112, P381, DOI 10.1128/JB.112.1.381-387.1972; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; Kim KH, 2007, ACTA CRYSTALLOGR F, V63, P246, DOI 10.1107/S1744309107008469; Kouzminova EA, 2004, MOL MICROBIOL, V51, P1279, DOI 10.1111/j.1365-2958.2003.03924.x; Lai CY, 2004, J BACTERIOL, V186, P1869, DOI 10.1128/JB.186.6.1869-1878.2004; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147, DOI 10.1128/CMR.12.1.147; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; Nichols BP, 1998, J BACTERIOL, V180, P6408; Payne DJ, 2001, DRUG DISCOV TODAY, V6, P537, DOI 10.1016/S1359-6446(01)01774-3; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SINGER M, 1989, MICROBIOL REV, V53, P1; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; STELLWAGEN E, 1977, ACCOUNTS CHEM RES, V10, P92, DOI 10.1021/ar50111a004; Thomas J, 2005, J BIOL CHEM, V280, P34675, DOI 10.1074/jbc.M505736200; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200; Zheng CJ, 2007, BIOCHEM BIOPH RES CO, V362, P1107, DOI 10.1016/j.bbrc.2007.08.144; Zheng CJ, 2006, J ANTIBIOT, V59, P808, DOI 10.1038/ja.2006.108	40	89	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1308	1316		10.1074/jbc.M708171200	http://dx.doi.org/10.1074/jbc.M708171200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18032386	hybrid			2022-12-27	WOS:000252282700013
J	Pugh, RA; Honda, M; Leesley, H; Thomas, A; Lin, YY; Nilges, MJ; Cann, IKO; Spies, M				Pugh, Robert A.; Honda, Masayoshi; Leesley, Haley; Thomas, Alvin; Lin, Yuyen; Nilges, Mark J.; Cann, Isaac K. O.; Spies, Maria			The iron-containing domain is essential in Rad3 helicases for coupling of ATP hydrolysis to DNA translocation and for targeting the helicase to the single-stranded DNA-double-stranded DNA junction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; GENE ENCODES; REPAIR; PROTEIN; TFIIH; CORE; FANCJ; BACH1	Helicases often achieve functional specificity through utilization of unique structural features incorporated into an otherwise conserved core. The archaeal Rad3 (xeroderma pigmentosum group D protein (XPD)) helicase is a prototypical member of the Rad3 family, distinct from other related ( superfamily II) SF2 enzymes because of a unique insertion containing an iron-sulfur (FeS) cluster. This insertion may represent an auxiliary domain responsible for modifying helicase activity or for conferring specificity for selected DNA repair intermediates. The importance of the FeS cluster for the fine-tuning of Rad3-DNA interactions is illustrated by several clinically relevant point mutations in the FeS domain of human Bach1 (FancJ) and XPD helicases that result in distinct disease phenotypes. Here we analyzed the substrate specificity of the Rad3 (XPD) helicase from Ferroplasma acidarmanus (FacRad3) and probed the importance of the FeS cluster for Rad3-DNA interactions. We found that the FeS cluster stabilizes secondary structure of the auxiliary domain important for coupling of single-stranded (ss) DNA-dependent ATP hydrolysis to ssDNA translocation. Additionally, we observed specific quenching of the Cy5 fluorescent dye when the FeS cluster of a bound helicase is positioned in close proximity to a Cy5 fluorophore incorporated into the DNA molecule. Taking advantage of this Cy5 quenching, we developed an equilibrium assay for analysis of the Rad3 interactions with various DNA substrates. We determined that the FeS cluster-containing domain recognizes the ssDNA-double-stranded DNA junction and positions the helicase in an orientation consistent with duplex unwinding. Although it interacts specifically with the junction, the enzyme binds tightly to ssDNA, and the single-stranded regions of the substrate are the major contributors to the energetics of FacRad3-substrate interactions.	[Pugh, Robert A.; Honda, Masayoshi; Leesley, Haley; Spies, Maria] Univ Illinois, Dept Biochem, Roger Adams Lab 493 MC 712, Urbana, IL 61801 USA; [Thomas, Alvin; Lin, Yuyen; Cann, Isaac K. O.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Thomas, Alvin; Cann, Isaac K. O.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Nilges, Mark J.] Univ Illinois, Illinois EPR Res Ctr, Urbana, IL 61801 USA; [Cann, Isaac K. O.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Spies, M (corresponding author), Univ Illinois, Dept Biochem, Roger Adams Lab 493 MC 712, Urbana, IL 61801 USA.	mspies@life.uiuc.edu		Honda, Masayoshi/0000-0001-8920-6301; Spies, Maria/0000-0002-7375-8037				Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang WH, 2000, CELL, V102, P609, DOI 10.1016/S0092-8674(00)00083-0; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Dopson M, 2004, APPL ENVIRON MICROB, V70, P2079, DOI 10.1128/AEM.70.4.2079-2088.2004; Egly JM, 2001, FEBS LETT, V498, P124, DOI 10.1016/S0014-5793(01)02458-9; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guan Y, 1998, NAT STRUCT BIOL, V5, P1058, DOI 10.1038/4168; Gupta R, 2006, NUCLEIC ACIDS RES, V34, P6673, DOI 10.1093/nar/gkl964; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Kaplan DL, 2002, MOL CELL, V10, P647, DOI 10.1016/S1097-2765(02)00642-1; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1993, NUCLEIC ACIDS RES, V21, P1497, DOI 10.1093/nar/21.6.1497; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Liu ZR, 2003, PLANT PHYSIOL, V132, P1405, DOI 10.1104/pp.103.021808; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Salerno V, 2003, NUCLEIC ACIDS RES, V31, P6127, DOI 10.1093/nar/gkg831; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; Schultz P, 2000, CELL, V102, P599, DOI 10.1016/S0092-8674(00)00082-9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Soultanas P, 2001, TRENDS BIOCHEM SCI, V26, P47, DOI 10.1016/S0968-0004(00)01734-5; Sung P, 1996, J BIOL CHEM, V271, P10821, DOI 10.1074/jbc.271.18.10821; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; Takagi Y, 2003, J BIOL CHEM, V278, P43897, DOI 10.1074/jbc.C300417200; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; Voloshin ON, 2007, J BIOL CHEM, V282, P18437, DOI 10.1074/jbc.M700376200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	34	77	80	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1732	1743		10.1074/jbc.M707064200	http://dx.doi.org/10.1074/jbc.M707064200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029358	hybrid			2022-12-27	WOS:000252282700060
J	Romney, SJ; Thacker, C; Leibold, EA				Romney, S. Joshua; Thacker, Colin; Leibold, Elizabeth A.			An iron enhancer element in the FTN-1 gene directs iron-dependent expression in Caenorhabditis elegans intestine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-1; FERRITIN MESSENGER-RNA; RESPONSIVE ELEMENT; C-ELEGANS; SCHIZOSACCHAROMYCES-POMBE; SIDEROPHORE BIOSYNTHESIS; REGULATORY PROTEIN-2; ARABIDOPSIS-THALIANA; CELLULAR-REGULATION; MUTATION	Ferritin is a ubiquitous protein that sequesters iron and protects cells from iron toxicity. Caenorhabditis elegans express two ferritins, FTN-1 and FTN-2, which are transcriptionally regulated by iron. To identify the cis-acting sequences and proteins required for iron-dependent regulation of ftn-1 and ftn-2 expression, we generated transcriptional GFP reporters corresponding to 5'-upstream sequences of the ftn-1 and ftn-2 genes. We identified a conserved 63-bp sequence, the iron-dependent element (IDE), that is required for iron-dependent regulation of a ftn-1 GFP reporter in intestine. The IDE contains two GATA-binding motifs and three octameric direct repeats. Site-directed mutagenesis of the GATA sequences, singly or in combination, reduces ftn-1 GFP reporter expression in the intestine. In vitro DNA mobility shift assays show that the intestine-specific GATA protein ELT-2 binds to both GATA sequences. Inhibition of ELT-2 function by RNA interference blocks ftn-1 GFP reporter expression in vivo. Insertion of the IDE into the promoter region of a heterologous reporter activates iron-dependent transcription in intestine. These data demonstrate that the activation of ftn-1 and ftn-2 transcription by iron requires ELT-2 and that the IDE functions as an iron-dependent enhancer in intestine.	[Romney, S. Joshua; Leibold, Elizabeth A.] Univ Utah, Eccles Program Human Mol Biol & Genet, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Thacker, Colin] Univ Utah, Hlth Sci Ctr Core Res Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Leibold, EA (corresponding author), Univ Utah, Eccles Program Human Mol Biol & Genet, 2030 E,Rm 3240, Salt Lake City, UT 84112 USA.	betty.leibold@hmbg.utah.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068602, P30DK072437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK068602, 1P30DK072437, R01DK068602] Funding Source: Medline; NIGMS NIH HHS [R01 GM045201] Funding Source: Medline; PHS HHS [R01GMS45201] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Arnaud N, 2007, BIOCHEM J, V405, P523, DOI 10.1042/BJ20061874; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; BEAUMONT C, 1995, NAT GENET, V11, P444, DOI 10.1038/ng1295-444; Britton C, 1998, J MOL BIOL, V283, P15, DOI 10.1006/jmbi.1998.2093; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; EGAN CR, 1995, DEV BIOL, V170, P397, DOI 10.1006/dbio.1995.1225; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 2005, DEV BIOL, V279, P446, DOI 10.1016/j.ydbio.2004.12.012; Georgieva T, 1999, P NATL ACAD SCI USA, V96, P2716, DOI 10.1073/pnas.96.6.2716; GIRELLI D, 1995, BLOOD, V86, P4050, DOI 10.1182/blood.V86.11.4050.bloodjournal86114050; Gourley BL, 2003, J BIOL CHEM, V278, P3227, DOI 10.1074/jbc.M210333200; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Harrison KA, 2002, BIOCHEMISTRY-US, V41, P15288, DOI 10.1021/bi0204995; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato J, 2001, AM J HUM GENET, V69, P191, DOI 10.1086/321261; Kim YI, 2004, J MOL BIOL, V342, P421, DOI 10.1016/j.jmb.2004.07.036; Koh K, 2001, DEVELOPMENT, V128, P2867; LEGGETT BA, 1993, J GASTROEN HEPATOL, V8, P21, DOI 10.1111/j.1440-1746.1993.tb01170.x; LESCURE AM, 1991, P NATL ACAD SCI USA, V88, P8222, DOI 10.1073/pnas.88.18.8222; Lind MI, 2006, J BIOL CHEM, V281, P18707, DOI 10.1074/jbc.M603354200; Ling HQ, 2002, P NATL ACAD SCI USA, V99, P13938, DOI 10.1073/pnas.212448699; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; OMICHINSKI JG, 1993, P NATL ACAD SCI USA, V90, P1676, DOI 10.1073/pnas.90.5.1676; Oskouian B, 2005, J BIOL CHEM, V280, P18403, DOI 10.1074/jbc.M410928200; Page BD, 1997, GENE DEV, V11, P1651, DOI 10.1101/gad.11.13.1651; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Pelletier B, 2005, J BIOL CHEM, V280, P25146, DOI 10.1074/jbc.M502947200; Pelletier B, 2003, NUCLEIC ACIDS RES, V31, P4332, DOI 10.1093/nar/gkg647; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Pham DQD, 1999, EUR J BIOCHEM, V266, P236, DOI 10.1046/j.1432-1327.1999.00849.x; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shimizu R, 2007, J BIOL CHEM, V282, P15862, DOI 10.1074/jbc.M701936200; Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; VOISARD C, 1993, MOL CELL BIOL, V13, P7091, DOI 10.1128/MCB.13.11.7091; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wei JZ, 2000, J BIOL CHEM, V275, P17488, DOI 10.1074/jbc.M910334199; Welch KD, 2002, FREE RADICAL BIO MED, V32, P577, DOI 10.1016/S0891-5849(02)00760-8; WHITE K, 1988, J BIOL CHEM, V263, P8938; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zhao J, 2007, MECH DEVELOP, V124, P377, DOI 10.1016/j.mod.2007.01.005	60	35	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					716	725		10.1074/jbc.M707043200	http://dx.doi.org/10.1074/jbc.M707043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18024960	hybrid			2022-12-27	WOS:000252128100009
J	Hernandez-Deviez, DJ; Howes, MT; Laval, SH; Bushby, K; Hancock, JF; Parton, RG				Hernandez-Deviez, Delia J.; Howes, Mark T.; Laval, Steven H.; Bushby, Kate; Hancock, John F.; Parton, Robert G.			Caveolin regulates endocytosis of the muscle repair protein, dysferlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; TRANS-GOLGI-NETWORK; MIYOSHI MYOPATHY; PLASMA-MEMBRANE; SKELETAL-MUSCLE; LIPID RAFTS; PHENOTYPIC BEHAVIOR; FER-1-LIKE PROTEIN; TARGETING DOMAIN; DISTAL MYOPATHY	Dysferlin and Caveolin-3 are plasma membrane proteins associated with muscular dystrophy. Patients with mutations in the CAV3 gene show dysferlin mislocalization in muscle cells. By utilizing caveolin-null cells, expression of caveolin mutants, and different mutants of dysferlin, we have dissected the site of action of caveolin with respect to dysferlin trafficking pathways. We now show that Caveolin-1 or -3 can facilitate exit of a dysferlin mutant that accumulates in the Golgi complex of Cav1(-/-) cells. In contrast, wild type dysferlin reaches the plasma membrane but is rapidly endocytosed in Cav1(-/-) cells. We demonstrate that the primary effect of caveolin is to cause surface retention of dysferlin. Caveolin-1 or Caveolin-3, but not specific caveolin mutants, inhibit endocytosis of dysferlin through a clathrin-independent pathway colocalizing with internalized glycosylphosphatidylinositol-anchored proteins. Our results provide new insights into the role of this endocytic pathway in surface remodeling of specific surface components. In addition, they highlight a novel mechanism of action of caveolins relevant to the pathogenic mechanisms underlying caveolin-associated disease.	[Hernandez-Deviez, Delia J.; Howes, Mark T.; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Laval, Steven H.; Bushby, Kate] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Queensland; University of Queensland; Newcastle University - UK	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	R.Parton@imb.uq.edu.au	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; Hancock, John/0000-0003-0542-4710; Howes, Mark/0000-0002-9666-3364	MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Betz RC, 2001, NAT GENET, V28, P218, DOI 10.1038/90050; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Capanni C, 2003, EXP MOL MED, V35, P538, DOI 10.1038/emm.2003.70; Carbone I, 2000, NEUROLOGY, V54, P1373, DOI 10.1212/WNL.54.6.1373; Carozzi AJ, 2002, J BIOL CHEM, V277, P17944, DOI 10.1074/jbc.M110879200; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cocucci E, 2004, MOL BIOL CELL, V15, P5356, DOI 10.1091/mbc.E04-07-0577; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; de Paula F, 2001, AM J MED GENET, V99, P303, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1168>3.0.CO;2-O; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doyle DD, 2003, BIOCHEM BIOPH RES CO, V304, P22, DOI 10.1016/S0006-291X(03)00528-X; Draviam RA, 2006, TRAFFIC, V7, P793, DOI 10.1111/j.1600-0854.2006.00433.x; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fanin M, 1997, J MED GENET, V34, P973, DOI 10.1136/jmg.34.12.973; Figarella-Branger D, 2003, NEUROLOGY, V61, P562, DOI 10.1212/01.WNL.0000076486.57572.5C; Fischer D, 2003, ANN NEUROL, V53, P233, DOI 10.1002/ana.10442; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Kubisch C, 2003, ANN NEUROL, V53, P512, DOI 10.1002/ana.10501; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Merlini L, 2002, J NEUROL NEUROSUR PS, V73, P65, DOI 10.1136/jnnp.73.1.65; Mikoshiba K, 1999, CHEM PHYS LIPIDS, V98, P59, DOI 10.1016/S0009-3084(99)00018-3; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Pallanck L, 2003, TRENDS NEUROSCI, V26, P2, DOI 10.1016/S0166-2236(02)00007-3; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2000, J CELL SCI, V113, P2103; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Sotgia F, 2003, AM J PHYSIOL-CELL PH, V285, pC1150, DOI 10.1152/ajpcell.00166.2003; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tateyama M, 2002, NEUROLOGY, V58, P323, DOI 10.1212/WNL.58.2.323; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Vorgerd M, 2001, NEUROLOGY, V57, P2273, DOI 10.1212/WNL.57.12.2273; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Yabe I, 2003, ACTA NEUROL SCAND, V108, P47, DOI 10.1034/j.1600-0404.2003.00083.x; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	80	70	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6476	6488		10.1074/jbc.M708776200	http://dx.doi.org/10.1074/jbc.M708776200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18096699	hybrid			2022-12-27	WOS:000253779500055
J	Catlow, KR; Deakin, JA; Wei, Z; Delehedde, M; Fernig, DG; Gherardi, E; Gallagher, JT; Pavao, MSG; Lyon, M				Catlow, Krista R.; Deakin, Jon A.; Wei, Zheng; Delehedde, Maryse; Fernig, David G.; Gherardi, Ermanno; Gallagher, John T.; Pavao, Mauro S. G.; Lyon, Malcolm			Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; HEPARIN-DERIVED OLIGOSACCHARIDES; DERMATAN SULFATE; C-MET; CRYSTAL-STRUCTURE; SUSTAINED PHOSPHORYLATION; ANTICOAGULANT ACTIVITY; STRUCTURAL FEATURES; MITOGENIC ACTIVITY; RECEPTOR-BINDING	Hepatocyte growth factor/scatter factor (HGF/SF) has a cofactor requirement for heparan sulfate (HS) and dermatan sulfate (DS) in the optimal activation of its signaling receptor MET. However, these two glycosaminoglycans (GAGs) have different sugar backbones and sulfation patterns, with only the presence of iduronate in common. The structural basis for GAG recognition and activation is thus very unclear. We have clarified this by testing a wide array of natural and modified GAGs for both protein binding and activation. Comparisons between Ascidia nigra (2,6-O-sulfated) and mammalian (mainly 4-O-sulfated) DS species, as well as between a panel of specifically desulfated heparins, revealed that no specific sulfate isomer, in either GAG, is vital for interaction and activity. Moreover, different GAGs of similar sulfate density had comparable properties, although affinity and potency notably increase with increasing sulfate density. The weaker interaction with CS-E, compared with DS, shows that GlcA-containing polymers can bind, if highly sulfated, but emphasizes the importance of the flexible IdoA ring. Our data indicate that the preferred binding sites in DS in vivo will be comprised of disulfated, IdoA(2S)-containing motifs. In HS, clustering of N-/2-O-/6-O-sulfation in S-domains will lead to strong reactivity, although binding can also be mediated by the transition zones where sulfates are mainly at the N- and 6-O- positions. GAG recognition of HGF/SF thus appears to be primarily driven by electrostatic interactions and exhibits an interesting interplay between requirements for iduronate and sulfate density that may reflect in part a preference for particular sugar chain conformations.	[Catlow, Krista R.; Deakin, Jon A.; Wei, Zheng; Gallagher, John T.; Lyon, Malcolm] Univ Manchester, Paterson Inst Canc Res, Sch Canc & Imaging Sci, Canc Res UK Glyco Oncol Grp, Manchester M20 4BX, Lancs, England; [Delehedde, Maryse; Fernig, David G.] Univ Liverpool, Biosci Bldg, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Gherardi, Ermanno] MRC Ctr, Growth Factors Grp, Cambridge CB2 2QH, England; [Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Program Glicobiol, Hosp Univ Clementino Fraga, Cambridge CB2 2QH, England	Paterson Institute for Cancer Research; University of Manchester; University of Liverpool; MRC Laboratory Molecular Biology	Lyon, M (corresponding author), Univ Manchester, Paterson Inst Canc Res, Glyco Oncol Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	MLyon@picr.man.ac.uk	Fernig, David G/A-3590-2008; Gherardi, Ermanno/AAB-9608-2022; Pavao, Mauro Sergio Goncalves/B-1979-2010	Fernig, David G/0000-0003-4875-4293; Pavao, Mauro Sergio Goncalves/0000-0002-1336-4271; DELEHEDDE, Maryse/0000-0003-2724-143X; Lyon, Malcolm/0000-0001-9575-6879; GHERARDI, ERMANNO/0000-0002-0016-2945	FOGARTY INTERNATIONAL CENTER [R03TW005775] Funding Source: NIH RePORTER; MRC [G0800025] Funding Source: UKRI; Cancer Research UK Funding Source: Medline; FIC NIH HHS [R03TW05775] Funding Source: Medline; Medical Research Council [G0800025] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ASHIKARI S, 1995, J BIOL CHEM, V270, P29586, DOI 10.1074/jbc.270.49.29586; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BAME KJ, 1991, J BIOL CHEM, V266, P10287; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; Baumann H, 1998, CARBOHYD RES, V308, P381, DOI 10.1016/S0008-6215(98)00097-4; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; CASU B, 1988, TRENDS BIOCHEM SCI, V13, P221, DOI 10.1016/0968-0004(88)90088-6; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; DANISHEFSKY I, 1960, ARCH BIOCHEM BIOPHYS, V90, P114, DOI 10.1016/0003-9861(60)90621-4; Deakin JA, 1999, J CELL SCI, V112, P1999; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Delehedde M, 2002, BIOCHEM J, V366, P235, DOI 10.1042/BJ20011718; Delehedde M, 2002, J BIOL CHEM, V277, P12456, DOI 10.1074/jbc.M111345200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hartmann G, 1998, CURR BIOL, V8, P125, DOI 10.1016/S0960-9822(98)70059-4; Holmes O, 2007, J MOL BIOL, V367, P395, DOI 10.1016/j.jmb.2006.12.061; HOUNSELL EF, 1986, EUR J BIOCHEM, V157, P375, DOI 10.1111/j.1432-1033.1986.tb09679.x; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P451, DOI 10.1093/glycob/4.4.451; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Kinoshita A, 1997, J BIOL CHEM, V272, P19656, DOI 10.1074/jbc.272.32.19656; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lai JP, 2004, ONCOGENE, V23, P1439, DOI 10.1038/sj.onc.1207258; Leali D, 2001, J BIOL CHEM, V276, P37900; Li FC, 2007, J BIOL CHEM, V282, P2956, DOI 10.1074/jbc.M609296200; Lietha D, 2001, EMBO J, V20, P5543, DOI 10.1093/emboj/20.20.5543; Lyon M, 2004, J BIOL CHEM, V279, P43560, DOI 10.1074/jbc.M408510200; LYON M, 1994, J BIOL CHEM, V269, P11216; Lyon M, 2000, J BIOL CHEM, V275, P4599, DOI 10.1074/jbc.275.7.4599; Lyon M, 1998, J BIOL CHEM, V273, P271, DOI 10.1074/jbc.273.1.271; Lyon M, 2002, J BIOL CHEM, V277, P1040, DOI 10.1074/jbc.M107506200; MARK MR, 1992, J BIOL CHEM, V267, P26166; Matsumoto K, 2001, KIDNEY INT, V59, P2023, DOI 10.1046/j.1523-1755.2001.00717.x; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Pavao MSG, 1995, J BIOL CHEM, V270, P31027, DOI 10.1074/jbc.270.52.31027; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116; Plaas AHK, 2001, GLYCOBIOLOGY, V11, P779, DOI 10.1093/glycob/11.10.779; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; Rahmoune H, 1998, BIOCHEMISTRY-US, V37, P6003, DOI 10.1021/bi972468t; Raiber EA, 2007, BIOORG MED CHEM LETT, V17, P6321, DOI 10.1016/j.bmcl.2007.08.074; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Rubin JS, 2001, J BIOL CHEM, V276, P32977, DOI 10.1074/jbc.M105486200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sergeant N, 2000, J BIOL CHEM, V275, P17094, DOI 10.1074/jbc.M000237200; van der Voort R, 1999, J BIOL CHEM, V274, P6499, DOI 10.1074/jbc.274.10.6499; Wei Z, 2005, J BIOL CHEM, V280, P15742, DOI 10.1074/jbc.M501102200; Yates EA, 2000, CARBOHYD RES, V329, P239, DOI 10.1016/S0008-6215(00)00144-0; Zhou HJ, 1999, BIOCHEMISTRY-US, V38, P14793, DOI 10.1021/bi9908641; ZIONCHECK TF, 1995, J BIOL CHEM, V270, P16871, DOI 10.1074/jbc.270.28.16871	62	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5235	5248		10.1074/jbc.M706589200	http://dx.doi.org/10.1074/jbc.M706589200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156180	hybrid			2022-12-27	WOS:000253426700003
J	't Hoen, PAC; de Meijer, EJ; Boer, JM; Vossen, RHAM; Turk, R; Maatman, RGHJ; Davies, KE; van Ommen, GJB; van Deutekom, JCT; den Dunnen, JT				't Hoen, Peter A. C.; de Meijer, Emile J.; Boer, Judith M.; Vossen, Rolf H. A. M.; Turk, Rolf; Maatman, Ronald G. H. J.; Davies, Kay E.; van Ommen, Gert-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johan T.			Generation and characterization of transgenic mice with the full-length human DMD gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DEFICIENT MDX MICE; GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; SYSTEMIC DELIVERY; MOUSE MUSCLE; IN-VITRO; EXPRESSION; UTROPHIN; PROTEIN	We report the generation of mice with an intact and functional copy of the 2.3-megabase human dystrophin gene (hDMD), the largest functional stretch of human DNA thus far integrated into a mouse chromosome. Yeast spheroplasts containing an artificial chromosome with the full-length hDMD gene were fused with mouse embryonic stem cells and were subsequently injected into mouse blastocysts to produce transgenic hDMD mice. Human-specific PCR, Southern blotting, and fluorescent in situ hybridization techniques demonstrated the intactness and stable chromosomal integration of the hDMD gene on mouse chromosome 5. Expression of the transgene was confirmed by RT-PCR and Western blotting. The tissue-specific expression pattern of the different DMD transcripts was maintained. However, the human Dp427p and Dp427m transcripts were expressed at 2-fold higher levels and human Dp427c and Dp260 transcripts were expressed at 2- and 4-fold lower levels than their endogenous counterparts. Ultimate functional proof of the hDMD transgene was obtained by crossing of hDMD mice with dystrophin-deficient mdx mice and dystrophin and utrophin-deficient mdx x Utrn(-/-) mice. The hDMD transgene rescued the lethal dystrophic phenotype of the mdx x Utrn(-/-) mice. All signs of muscular dystrophy disappeared in the rescued mice, as demonstrated by histological staining of muscle sections and gene expression profiling experiments. Currently, hDMD mice are extensively used for preclinical testing of sequence-specific therapeutics for the treatment of Duchenne muscular dystrophy. In addition, the hDMD mouse can be used to study the influence of the genomic context on deletion and recombination frequencies, genome stability, and gene expression regulation.	['t Hoen, Peter A. C.; de Meijer, Emile J.; Boer, Judith M.; Vossen, Rolf H. A. M.; Turk, Rolf; Maatman, Ronald G. H. J.; van Ommen, Gert-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johan T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Davies, Kay E.] MRC, Dept Physiol Anat & Genet, Funct Genet Unit, Oxford OX1 3QX, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	't Hoen, PAC (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Postal Zone S4-P, NL-2300 RC Leiden, Netherlands.	p.a.c.hoen@lumc.nl	Hoen, Peter A 't/D-3950-2018; 't Hoen, Peter/A-4857-2012; dunnen, johan den/ABH-4228-2020; Boer, Judith/A-7546-2010; Turk, Rolf/E-7832-2010	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; Turk, Rolf/0000-0003-1283-9594; Boer, Judith/0000-0003-4848-7789	Medical Research Council [MC_U137761449] Funding Source: Medline; MRC [MC_U137761449] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Bertoni C, 2002, HUM GENE THER, V13, P707, DOI 10.1089/104303402317322276; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Clemens PR, 1996, GENE THER, V3, P965; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; DENDUNNEN IT, 1989, BR MED B, V45, P644; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Ferrer A, 2004, GENE THER, V11, P884, DOI 10.1038/sj.gt.3302242; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GUTH L, 1969, EXP NEUROL, V25, P138, DOI 10.1016/0014-4886(69)90077-6; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LOVE DR, 1991, GENOMICS, V10, P57, DOI 10.1016/0888-7543(91)90484-V; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Taylor SS, 1996, CHROMOSOMA, V105, P70, DOI 10.1007/BF02509516; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180	42	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5899	5907		10.1074/jbc.M709410200	http://dx.doi.org/10.1074/jbc.M709410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18083704	hybrid			2022-12-27	WOS:000253426700068
J	Zhao, Z; Mckee, CJ; Kessl, JJ; Santos, WL; Daigle, JE; Engelman, A; Verdine, G; Kvaratskhelia, M				Zhao, Zhuojun; McKee, Christopher J.; Kessl, Jacques J.; Santos, Webster L.; Daigle, Janet E.; Engelman, Alan; Verdine, Gregory; Kvaratskhelia, Mamuka			Subunit-specific protein footprinting reveals significant structural Rearrangements and a role for N-terminal Lys-14 of HIV-1 integrase during viral DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHOTO-CROSS-LINKING; INDUCED CONFORMATIONAL-CHANGE; REVERSE-TRANSCRIPTASE; STRAND TRANSFER; RETROVIRAL DNA; NUCLEOCAPSID PROTEIN; CRYSTAL-STRUCTURE; CATALYTIC CORE; ACTIVE-SITE	To identify functional contacts between HIV-1 integrase ( IN) and its viral DNA substrate, we devised a new experimental strategy combining the following two methodologies. First, disulfide-mediated cross-linking was used to site-specifically link select core and C-terminal domain amino acids to respective positions in viral DNA. Next, surface topologies of free IN and IN-DNA complexes were compared using Lys-and Arg-selective small chemical modifiers and mass spectrometric analysis. This approach enabled us to dissect specific contacts made by different monomers within the multimeric complex. The footprinting studies for the first time revealed the importance of a specific N-terminal domain residue, Lys-14, in viral DNA binding. In addition, a DNA-induced conformational change involving the connection between the core and C-terminal domains was observed. Site-directed mutagenesis experiments confirmed the importance of the identified contacts for recombinant IN activities and virus infection. These new findings provided major constraints, enabling us to identify the viral DNA binding channel in the active full-length IN multimer. The experimental approach described here has general application to mapping interactions within functional nucleoprotein complexes.	[Zhao, Zhuojun; McKee, Christopher J.; Kessl, Jacques J.; Verdine, Gregory; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Santos, Webster L.; Verdine, Gregory] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Daigle, Janet E.; Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Div AIDS, Boston, MA 02115 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Ctr Comprehens Canc, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/AAV-2526-2021; Kessl, Jacques/J-6073-2015	Santos, Webster/0000-0002-4731-8548	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520, R37AI039394, R01AI039394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067380, R01GM044853] Funding Source: NIH RePORTER; NIAID NIH HHS [AI062520, R01 AI039394, AI039394, R37 AI039394, R01 AI062520] Funding Source: Medline; NIGMS NIH HHS [R01 GM044853-15, R01 GM044853, F32 GM067380, F32 GM067380-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Brown P. O., 1997, P161; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; Di Santo R, 2006, J MED CHEM, V49, P1939, DOI 10.1021/jm0511583; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; ENGELMAN A, 2007, FUTURE HIV THER, V1, P415; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mazumder A, 1996, J BIOL CHEM, V271, P27330, DOI 10.1074/jbc.271.44.27330; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Puglia J, 2006, J VIROL, V80, P9497, DOI 10.1128/JVI.00856-06; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; van den Ent FMI, 1999, J VIROL, V73, P3176, DOI 10.1128/JVI.73.4.3176-3183.1999; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2	61	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5632	5641		10.1074/jbc.M705241200	http://dx.doi.org/10.1074/jbc.M705241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093980	Green Accepted, hybrid, Green Published			2022-12-27	WOS:000253426700043
J	Grechez-Cassiau, A; Rayet, B; Guillaumond, F; Teboul, M; Delaunay, F				Grechez-Cassiau, Aline; Rayet, Beatrice; Guillaumond, Fabienne; Teboul, Michele; Delaunay, Franck			The circadian clock component BMAL1 is a critical regulator of p21(WAF1/CIP1) expression and hepatocyte proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; BONE-MARROW; GENE; RHYTHMS; P21; DIFFERENTIATION; INHIBITORS; PACEMAKER; MUCOSA; PLAYS	Most living organisms show circadian (similar to 24 h) rhythms in physiology and behavior. These oscillations are generated by endogenous circadian clocks, present in virtually all cells where they control key biological processes. Although circadian gating of mitosis has been reported for many years in some peripheral tissues, the underlying molecular mechanisms have remained poorly understood. Here we show that the cell cycle inhibitor p21(WAF1/CIP1) is rhythmically expressed in mouse peripheral organs. This rhythmic pattern of mRNA and protein expression was recapitulated in vitro in serum-shocked differentiated skeletal muscle cells. p21(WAF1/CIP1) circadian expression is dramatically increased and no longer rhythmic in clock-deficient Bmal1(-/-) knock-out mice. Biochemical and genetic data show that oscillation of p21(WAF1/CIP1) gene transcription is regulated by the antagonistic activities of the orphan nuclear receptors REV-ERB alpha/beta and ROR alpha 4/gamma, which are core clock regulators. Importantly, p21(WAF1/CIP1) overexpressing Bmal1(-/-) primary hepatocytes exhibit a decreased proliferation rate. This phenotype could be reversed using small interfering RNA-mediated knockdown of p21(WAF1/CIP1). These data establish a novel molecular link between clock and cell cycle genes and suggest that the G(1) progression phase is a target of the circadian clock during liver cell proliferation.	[Grechez-Cassiau, Aline; Rayet, Beatrice; Guillaumond, Fabienne; Teboul, Michele; Delaunay, Franck] Univ Nice Sophia Antipolis, CNRS, FRE 3094, Lab Biol & Physiopathol Syst Integres, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Delaunay, F (corresponding author), Univ Nice Sophia Antipolis, CNRS, FRE 3094, Lab Biol & Physiopathol Syst Integres, 28 Ave Valrose, F-06108 Nice 2, France.	delaunay@unice.fr	Guillaumond, Fabienne/E-8265-2017	Guillaumond, Fabienne/0000-0001-7456-7315; Delaunay, Franck/0000-0003-4927-1701; Teboul, Michele/0000-0002-3418-4384				Biederbick A, 1998, CELL TISSUE RES, V291, P277, DOI 10.1007/s004410050997; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Burke L, 1996, NUCLEIC ACIDS RES, V24, P3481, DOI 10.1093/nar/24.18.3481; Delaunay F, 2002, TRENDS GENET, V18, P595, DOI 10.1016/S0168-9525(02)02794-4; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Diehl AM, 2002, FRONT BIOSCI-LANDMRK, V7, pE301, DOI 10.2741/diehl; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; EDMUNDS LN, 1969, SCIENCE, V165, P500, DOI 10.1126/science.165.3892.500; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Granda TG, 2004, FASEB J, V18, P304, DOI 10.1096/fj.04-2665fje; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; GUO K, 1995, MOL CELL BIOL, V15, P3823; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Ilyin GP, 2003, AM J PHYSIOL-GASTR L, V285, pG115, DOI 10.1152/ajpgi.00309.2002; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SCHEVING LE, 1972, AM J ANAT, V135, P311, DOI 10.1002/aja.1001350302; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	44	220	232	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4535	4542		10.1074/jbc.M705576200	http://dx.doi.org/10.1074/jbc.M705576200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086663	hybrid			2022-12-27	WOS:000253426500010
J	Umekawa, M; Huang, W; Li, B; Fujita, K; Ashida, H; Wang, LX; Yamamoto, K				Umekawa, Midori; Huang, Wei; Li, Bing; Fujita, Kiyotaka; Ashida, Hisashi; Wang, Lai-Xi; Yamamoto, Kenji			Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SUBSTRATE; COMPLEX; OLIGOSACCHARIDES; GLYCOPEPTIDES; ENDOGLYCOSIDASE; IDENTIFICATION; GLYCOSYLATION	Endo-beta-N-acetylglucosaminidase from Mucor hiemalis(Endo-M), a family 85 glycoside hydrolase, acts on the beta 1,4 linkage of N,N'-diacetylchitobiose moiety in the N-linked glycans of glycoproteins and catalyzes not only the hydrolysis reaction but also the transglycosylation reaction that transfers the releasing sugar chain to an acceptor other than water to form a new glycosidic linkage. The transglycosylation activity of Endo-M holds a great promise for the chemo-enzymatic synthesis and glyco-engineering of glycoproteins, but the inherent hydrolytic activity for product hydrolysis and low transglycosylation have hampered its broad applications. This paper describes the site-directed mutagenesis on residues in the putative catalytic region of Endo-M to generate mutants with superior transglycosylation activity. Two interesting mutants were discovered. The Y217F mutant was found to possess much enhanced transglycosylation activity and yet much diminished hydrolytic activity in comparison with the wild-type Endo-M. Kinetic analyses revealed that the K-m value of Y217F for an acceptor substrate 4-methylumbel-liferyl-beta-D-N-acetylglucosaminide was only one-tenth of that of the wild-type, implicating a much higher affinity of Y217F for the acceptor substrate than the wild-type. The other mutant, N175A, acts like a glycosynthase. It was found that mutation at Asn175"knocked out" the hydrolytic activity, but the mutant was able to take the highly active sugar oxazolines ( the transition state mimics) as donor substrates for transglycosylation. This is the first glycosynthase derived from endo-beta-N-acetylglucosaminidases that proceed via a substrate-assisted mechanism. Our findings provide further insights on the substrate-assisted mechanism of GH85. The usefulness of the novel glycosynthase was exemplified by the efficient synthesis of a human immunodeficiency deficiency virus, type 1 (HIV-1) glycopeptide with potent anti-HIV activity.	[Huang, Wei; Li, Bing; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Huang, Wei; Li, Bing; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Umekawa, Midori; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Fujita, Kiyotaka] Kagoshima Univ, Dept Biochem Sci & Technol, Fac Agr, Kagoshima 8900065, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Kyoto University; Kagoshima University	Wang, LX (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	lwang3@ihv.umaryland.edu	Huang, Wei/A-2167-2011; Wang, Lai-Xi/E-8790-2019; wang, xl/Y-8251-2019; Ashida, Hisashi/HCI-0293-2022; Wang, Lai-Xi/E-8755-2019; Huang, Wei/P-9631-2017	Wang, Lai-Xi/0000-0003-4293-5819; Huang, Wei/0000-0001-6432-1848; Fujita, Kiyotaka/0000-0002-3780-3750; Umekawa, Midori/0000-0002-8071-3902; Ashida, Hisashi/0000-0001-5844-4075	NIGMS NIH HHS [R01 GM 073717, R01 GM080374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374, R01GM073717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akaike E, 2004, CARBOHYD RES, V339, P719, DOI 10.1016/j.carres.2003.12.007; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita K, 2006, BBA-GEN SUBJECTS, V1760, P1631, DOI 10.1016/j.bbagen.2006.09.003; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Haneda K, 1996, CARBOHYD RES, V292, P61; Hauser S, 2005, BIOCHEM BIOPH RES CO, V328, P580, DOI 10.1016/j.bbrc.2005.01.012; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Li HG, 2005, J ORG CHEM, V70, P9990, DOI 10.1021/jo051729z; Li HG, 2005, BIOORG MED CHEM LETT, V15, P895, DOI 10.1016/j.bmcl.2004.12.066; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Rising TWDF, 2006, CARBOHYD RES, V341, P1574, DOI 10.1016/j.carres.2006.03.007; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2005, CHEMBIOCHEM, V6, P1068, DOI 10.1002/cbic.200400440; Wang LX, 2004, ACS SYM SER, V873, P73; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yamamoto K, 1997, CARBOHYD RES, V305, P415, DOI 10.1016/S0008-6215(97)10018-0; Yamamoto K, 1997, TRENDS GLYCOSCI GLYC, V9, P339, DOI 10.4052/tigg.9.339; Yamamoto K, 2006, ENDOGLYCOSIDASES BIO, P129; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Zeng Y, 2006, CHEM-EUR J, V12, P3355, DOI 10.1002/chem.200501196	38	188	198	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4469	4479		10.1074/jbc.M707137200	http://dx.doi.org/10.1074/jbc.M707137200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096701	hybrid			2022-12-27	WOS:000253426500003
J	Perez-Garcia, MJ; Gou-Fabregas, M; de Pablo, Y; Llovera, M; Comella, JX; Soler, RM				Perez-Garcia, M. Jose; Gou-Fabregas, Myriam; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.; Soler, Rosa M.			Neuroprotection by neurotrophic factors and membrane depolarization is regulated by calmodulin kinase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; AUTONOMOUS ACTIVITY; NEURONAL SURVIVAL; CELL-SURVIVAL; ACTIVATION; CALCIUM/CALMODULIN; GROWTH; MECHANISM; DEATH	Neurotrophic factors promote motoneuron (MN) survival through increased intracellular calcium (Ca2+) and regulation of the phosphatidylinositol (PI) 3-kinase/protein kinase B(PKB) pathway by calmodulin (CaM). Activation of the PI 3-kinase/PKB pathway is one of the well established mechanisms involved in MN survival. The Ca2+/CaM complex interacts with and modulates the functionality of a large number of proteins, including serine/threonine protein kinases such as Ca2+/CaM-dependent protein kinases (CaMKs). Using a primary culture of embryonic chicken spinal cord MNs, we investigated the role of CaMKIV in mediating this process. We cloned chicken CaMKIV and demonstrated its expression in purified MNs by means of reverse transcription-PCR, Western blot, and immunofluorescence. Using RNA interference, we show that endogenous CaMKIV mediates cell survival induced by neurotrophic factors or membrane depolarization. The survival effect is independent of CaMKIV kinase activity; however, CaMKIV functionality depends on the presence of Ca2+/CaM. Finally, CaMKIV associates to the p85 subunit of PI 3- kinase in a Ca2+-dependent manner, suggesting a role in regulating PI 3-kinase/PKB activation.	[Perez-Garcia, M. Jose; Gou-Fabregas, Myriam; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.; Soler, Rosa M.] Univ Lleida, Cell Signaling & Apoptosis Grp, Dept Ciencies Med Bas, Fac Med, Lleida 25008, Spain; [Perez-Garcia, M. Jose; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.] Univ Lleida, Hosp Univ Arnau Vilanova, Lab Recerca, Inst Recerca Biomed, Lleida 25008, Spain	Universitat de Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova	Soler, RM (corresponding author), Univ Lleida, Cell Signaling & Apoptosis Grp, Dept Ciencies Med Bas, Fac Med, Montserrat Roig 2, Lleida 25008, Spain.	rosa.soler@cmb.udl.es	Gou-Fabregas, Myriam/G-6803-2012; de Pablo, Yolanda/AAD-1642-2019; Llovera, Marta/B-5585-2009; Tatche, Rosa M Soler/AAJ-6721-2021; Gou-Fabregas, Myriam/K-1899-2016; Comella, Joan/GQA-4279-2022; Llovera, Marta/AAE-4230-2021; Soler, Rosa M/A-7361-2010; Comella, Joan X/D-7333-2012	Gou-Fabregas, Myriam/0000-0002-5329-7640; de Pablo, Yolanda/0000-0001-5208-2114; Llovera, Marta/0000-0001-8399-6867; Tatche, Rosa M Soler/0000-0003-0528-3102; Gou-Fabregas, Myriam/0000-0002-5329-7640; Soler, Rosa M/0000-0003-0528-3102; Comella, Joan X/0000-0002-6218-0786				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anderson KA, 1998, BIOMETALS, V11, P331, DOI 10.1023/A:1009276932076; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; COMELLA JX, 1994, J NEUROSCI, V14, P2674; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DeBernardi MA, 1996, J BIOL CHEM, V271, P6092, DOI 10.1074/jbc.271.11.6092; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1987, J NEUROSCI, V7, P2203; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hansen MR, 2003, J NEUROSCI RES, V72, P169, DOI 10.1002/jnr.10551; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Johnson K, 2005, J NEUROSCI RES, V79, P809, DOI 10.1002/jnr.20415; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Llovera M, 2004, J NEUROCHEM, V88, P422, DOI 10.1046/j.1471-4159.2003.02178.x; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Perez-Garcia MJ, 2004, J BIOL CHEM, V279, P6132, DOI 10.1074/jbc.M308367200; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Soler RM, 1999, J NEUROSCI, V19, P9160; Soler RM, 1998, J NEUROSCI, V18, P1230; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4133	4144		10.1074/jbc.M705477200	http://dx.doi.org/10.1074/jbc.M705477200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079114	hybrid, Green Published			2022-12-27	WOS:000253083500049
J	Mao, G; Pan, X; Gu, L				Mao, Guogen; Pan, Xiaoyu; Gu, Liya			Evidence that a mutation in the MLH1 3 '-untranslated region confers a mutator phenotype and mismatch repair deficiency in patients with relapsed leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; UNTRANSLATED REGION; CANCER; IDENTIFICATION	Defects in DNA mismatch repair (MMR) are the molecular basis of certain cancers, including hematological malignancies. The defects are often caused by mutations in coding regions of MMR genes or promoter methylation of the genes. However, in many cases, despite that a hypermutable phenotype is detected in a patient, no mutations/hypermethylations of MMR genes can be detected. We report here a novel mechanism that a mutation in the MLH1 3 '-untranslated region (3 '-UTR) leads to MMR deficiency. A relapsed leukemia patient displayed micro-satellite instability, but no genetic and epigenetic alterations in key MMR genes were identifiable. Instead, a 3-nucleotide (TTC) deletion in the MLH1 3 '-UTR was found in the patient's blood sample. The mutant MLH1 3 '-UTR was found to significantly reduce the expressions of both a firefly luciferase reporter gene and an ectopic MLH1 gene in model cell lines. Consistent with these observations, a significant reduction in the steady-state level of MLH1 mRNA was observed in white blood cells of the patient. These findings suggest that the mutant MLH1 3 '-UTR can cause a severely reduced/defective MMR activity conferring leukemia relapse, likely by down-regulating MLH1 expression at the mRNA level. Although the exact mechanism by which the mutant 3 '-UTR down-regulates the MLH1 mRNA is not known, our findings provide a novel marker for cancers with MMR defects.	[Mao, Guogen; Pan, Xiaoyu; Gu, Liya] Univ Kentucky, Coll Med, Dept Toxicol, Lexington, KY 40536 USA; [Gu, Liya] Univ Kentucky, Coll Med, Dept Pathol, Lexington, KY 40536 USA; [Gu, Liya] Univ Kentucky, Coll Med, Media Lab, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Gu, L (corresponding author), 136 Hlth Sci Res Bldg,1095 VA Dr, Lexington, KY 40536 USA.	lgu0@email.uky.edu			NATIONAL CANCER INSTITUTE [R01CA104333] Funding Source: NIH RePORTER; NCI NIH HHS [CA104333] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Boland CR, 1998, CANCER RES, V58, P5248; Buermeyer AB, 1999, ANNU REV GENET, V33, P533, DOI 10.1146/annurev.genet.33.1.533; Cejka P, 2003, EMBO J, V22, P2245, DOI 10.1093/emboj/cdg216; Chung DC, 2003, ANN INTERN MED, V138, P560, DOI 10.7326/0003-4819-138-7-200304010-00012; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Gu LY, 2002, ONCOGENE, V21, P5758, DOI 10.1038/sj.onc.1205695; Hew Y, 2000, J BIOL CHEM, V275, P24857, DOI 10.1074/jbc.M002776200; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li GM, 2003, FRONT BIOSCI-LANDMRK, V8, pD997, DOI 10.2741/1121; Li XL, 2007, J BIOL CHEM, V282, P7950, DOI 10.1074/jbc.M607939200; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MAO G, 2008, IN PRESS CELL RES; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Murata H, 2002, ONCOGENE, V21, P5696, DOI 10.1038/sj.onc.1205683; Offman J, 2005, MOL CANCER RES, V3, P251, DOI 10.1158/1541-7786.MCR-04-0182; Rustgi AK, 2006, GENE DEV, V20, P3049, DOI 10.1101/gad.1501106; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3211	3216		10.1074/jbc.M709276200	http://dx.doi.org/10.1074/jbc.M709276200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056700	hybrid			2022-12-27	WOS:000253083000024
J	Tian, L; McClafferty, H; Chen, L; Shipston, MJ				Tian, Lijun; McClafferty, Heather; Chen, Lie; Shipston, Michael J.			Reversible tyrosine protein phosphorylation regulates large conductance voltage- and calcium-activated potassium channels via cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MAXI-K CHANNELS; GROWTH-FACTOR; BKCA CHANNEL; STIMULATION; MODULATION; PHOSPHATASES; INHIBITION; DYNAMICS; SUBUNIT	Large conductance calcium- and voltage-activated potassium (BK) channels assemble as macromolecular signaling complexes and are potently regulated by reversible protein phosphorylation. However, although numerous studies have revealed regulation of BK channels through changes in direct phosphorylation of the pore-forming alpha-subunits the functional role of changes in phosphorylation of defined adapter/signaling proteins within the complex on channel function are essentially not known. Here, we demonstrate that mammalian BK channels are potently regulated by endogenous protein-tyrosine kinase and protein-tyrosine phosphatase activity closely associated with the channel. BK channel regulation was not dependent upon direct phosphorylation of the BK alpha-subunit, rather channel function was controlled by the tyrosine phosphorylation status of the adapter protein cortactin that assembles directly with the BK channel. Our data thus reveal a novel mode for BK channel regulation by reversible tyrosine phosphorylation and strongly support the hypothesis that phosphorylation-dependent regulation of accessory proteins within the BK channel signaling complex represents an important target for control of BK channel function.	[Tian, Lijun; McClafferty, Heather; Chen, Lie; Shipston, Michael J.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X; Chen, Lie/0000-0001-9764-4299	Wellcome Trust [082407, 067683] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abedi H, 1998, BIOCHEM BIOPH RES CO, V245, P646, DOI 10.1006/bbrc.1998.8284; Alioua A, 2002, P NATL ACAD SCI USA, V99, P14560, DOI 10.1073/pnas.222348099; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Cowan-Jacob SW, 2006, CELL MOL LIFE SCI, V63, P2608, DOI 10.1007/s00018-006-6202-8; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Fan LZ, 2004, BIOCHEM J, V380, P581, DOI 10.1042/BJ20040178; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Holm NR, 1997, P NATL ACAD SCI USA, V94, P1002, DOI 10.1073/pnas.94.3.1002; HSU CYJ, 1991, J BIOL CHEM, V266, P21105; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Jin P, 2002, J BIOL CHEM, V277, P10014, DOI 10.1074/jbc.M107682200; Ling SZ, 2004, AM J PHYSIOL-CELL PH, V287, pC698, DOI 10.1152/ajpcell.00030.2004; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Ma XY, 2006, FASEB J, V20, pA1208; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; Nara M, 1998, J BIOL CHEM, V273, P14920, DOI 10.1074/jbc.273.24.14920; Olsen ML, 2005, J NEUROSCI RES, V81, P179, DOI 10.1002/jnr.20543; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Rezzonico R, 2002, J BONE MINER RES, V17, P869, DOI 10.1359/jbmr.2002.17.5.869; Stumpff F, 1999, INVEST OPHTH VIS SCI, V40, P1404; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2003, J BIOL CHEM, V278, P8669, DOI 10.1074/jbc.M211661200; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Wang H, 1999, J NEUROSCI, V19, pU1; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; XIONG ZG, 1995, EUR J PHARM-MOLEC PH, V290, P117, DOI 10.1016/0922-4106(95)90023-3; Zhou R, 2005, CARDIOVASC RES, V68, P327, DOI 10.1016/j.cardiores.2005.06.005; Zhou XB, 2001, J BIOL CHEM, V276, P43239, DOI 10.1074/jbc.M104202200; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	34	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3067	3076		10.1074/jbc.M706826200	http://dx.doi.org/10.1074/jbc.M706826200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039661	hybrid			2022-12-27	WOS:000253083000010
J	Zhao, B; Yu, M; Neitzel, M; Marugg, J; Jagodzinski, J; Lee, M; Hu, K; Schenk, D; Yednock, T; Basi, G				Zhao, Byron; Yu, Mei; Neitzel, Martin; Marugg, Jennifer; Jagodzinski, Jacek; Lee, Mike; Hu, Kang; Schenk, Dale; Yednock, Ted; Basi, Guriqbal			Identification of gamma-secretase inhibitor potency determinants on presenilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; TRANSGENIC MICE; CELL DIFFERENTIATION; SYNAPTIC PLASTICITY; MISSENSE MUTATIONS; PEPTIDE PRODUCTION; KNOCKOUT MICE; IN-VIVO; NOTCH	Production of amyloid beta peptides (A beta), followed by their deposition in the brain as amyloid plaques, contributes to the hallmark pathology of Alzheimer disease. The enzymes responsible for production of A beta, BACE1 and gamma-secretase, are therapeutic targets for treatment of Alzheimer disease. Two presenilin (PS) homologues, referred to as PS1 and PS2, comprise the catalytic core of gamma-secretase. In comparing presenilin selectivity of several classes of gamma-secretase inhibitors, we observed that sulfonamides in general tend to be more selective for inhibition of PS1-comprising gamma-secretase, as exemplified by ELN318463 and BMS299897. We employed a combination of chimeric constructs and point mutants to identify structural determinants for PS1-selective inhibition by ELN318463. Our studies identified amino acid residues Leu(172), Thr(281), and Leu(282) in PS1 as necessary for PS1-selective inhibition by ELN318463. These residues also contributed in part to the PS1-selective inhibition by BMS299897. Alanine scanning mutagenesis of areas flanking Leu(172), Thr(281), and Leu(282) identified additional amino acids that affect inhibitor potency of not only these sulfonamides but also nonsulfonamide inhibitors, without affecting A beta production and presenilin endoproteolysis. Interestingly, many of these same residues have been identified previously to be important for gamma-secretase function. These findings implicate TM3 and a second region near the carboxyl terminus of PS1 amino-terminal fragment in mediating the activity of gamma-secretase inhibitors. Our observations demonstrate that PS-selective inhibitors of gamma-secretase are feasible, and such inhibitors may allow differential inhibition of A beta peptide production and Notch signaling.	[Zhao, Byron; Yu, Mei; Neitzel, Martin; Marugg, Jennifer; Jagodzinski, Jacek; Lee, Mike; Hu, Kang; Schenk, Dale; Yednock, Ted; Basi, Guriqbal] Elan Pharmaceut Inc, San Francisco, CA 94080 USA		Basi, G (corresponding author), Elan Pharmaceut Inc, 700 Gateway Blvd, San Francisco, CA 94080 USA.	guriq.basi@elan.com						Anderson JJ, 2005, BIOCHEM PHARMACOL, V69, P689, DOI 10.1016/j.bcp.2004.11.015; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; BERKNER KL, 1987, J VIROL, V61, P1213, DOI 10.1128/JVI.61.4.1213-1220.1987; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; Ikeuchi T, 2003, J BIOL CHEM, V278, P7010, DOI 10.1074/jbc.M209252200; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Kulic L, 2000, P NATL ACAD SCI USA, V97, P5913, DOI 10.1073/pnas.100049897; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Kwok JBJ, 2003, J BIOL CHEM, V278, P6748, DOI 10.1074/jbc.M211827200; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J BIOL CHEM, V279, P23925, DOI 10.1074/jbc.M401277200; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li T, 2007, J NEUROSCI, V27, P10849, DOI 10.1523/JNEUROSCI.2152-07.2007; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Mastrangelo P, 2005, P NATL ACAD SCI USA, V102, P8972, DOI 10.1073/pnas.0500940102; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nakaya Y, 2005, J BIOL CHEM, V280, P19070, DOI 10.1074/jbc.M501130200; NEITZEL M, 2005, Patent No. 2005042489; Oh YS, 2005, AM J PHYSIOL-CELL PH, V289, pC576, DOI 10.1152/ajpcell.00636.2004; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Qyang YB, 2004, BIOCHEMISTRY-US, V43, P5352, DOI 10.1021/bi049826u; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SMITH DW, 2000, Patent No. 6967196; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tournoy J, 2004, HUM MOL GENET, V13, P1321, DOI 10.1093/hmg/ddh151; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wolfe MS, 2006, BIOCHEMISTRY-US, V45, P7931, DOI 10.1021/bi060799c; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia WM, 2000, NEUROBIOL DIS, V7, P673, DOI 10.1006/nbdi.2000.0322; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhao GJ, 2005, J BIOL CHEM, V280, P37689, DOI 10.1074/jbc.M507993200	63	50	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2927	2938		10.1074/jbc.M708870200	http://dx.doi.org/10.1074/jbc.M708870200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032377	hybrid			2022-12-27	WOS:000252622300049
J	Fujioka, Y; Noda, NN; Fujii, K; Yoshimoto, K; Ohsumi, Y; Inagaki, F				Fujioka, Yuko; Noda, Nobuo N.; Fujii, Kiyonaga; Yoshimoto, Kohki; Ohsumi, Yoshinori; Inagaki, Fuyuhiko			In vitro reconstitution of plant ATG8 and ATG12 conjugation systems essential for autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS-THALIANA; YEAST; ENZYME; GENES; LC3; SENESCENCE; HOMOLOG; GABARAP; MAP-LC3; GATE-16	Genetic and biochemical analyses using yeast Saccharomyces cerevisiae showed that two ubiquitin-like conjugation systems, the Atg8 and Atg12 systems, exist and play essential roles in autophagy, the bulk degradation system conserved in yeast and mammals. These conjugation systems are also conserved in Arabidopsis thaliana; however, further detailed study of plant ATG (autophagy-related) conjugation systems in relation to those in yeast and mammals is needed. Here, we describe the in vitro reconstitution of Arabidopsis thaliana ATG8 and ATG12 (AtATG8 and AtATG12) conjugation systems using purified recombinant proteins. AtATG12b was conjugated to AtATG5 in a manner dependent on AtATG7, AtATG10, and ATP, whereas AtATG8a was conjugated to phosphatidylethanolamine (PE) in a manner dependent on AtATG7, AtATG3, and ATP. Other AtATG8 homologs (AtATG8b-8i) were similarly conjugated to PE. The AtATG8 conjugates were deconjugated by AtATG4a and AtATG4b. These results support the hypothesis that the ATG conjugation systems in Arabidopsis are very similar to those in yeast and mammals. Intriguingly, in vitro analyses showed that AtATG12-AtATG5 conjugates accelerated the formation of AtATG8-PE, whereas AtATG3 inhibited the formation of AtATG12-AtATG5 conjugates. The in vitro conjugation systems reported here will afford a tool with which to investigate the cross-talk mechanism between two conjugation systems.	[Fujioka, Yuko; Noda, Nobuo N.; Fujii, Kiyonaga; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Dept Biol Struct, Sapporo, Hokkaido 0010021, Japan; [Yoshimoto, Kohki; Ohsumi, Yoshinori] Natl Inst Basic Biol, Dept Mol Cell Biol, Okazaki, Aichi 4448585, Japan	Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Dept Biol Struct, N-21,W-11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Yoshimoto, Kohki/C-6322-2011; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Yoshimoto, Kohki/0000-0003-3948-3751; Noda, Nobuo/0000-0002-6940-8069; Fujioka, Yuko/0000-0002-6905-0669				Bassham DC, 2006, AUTOPHAGY, V2, P2, DOI 10.4161/auto.2092; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hashida S, 2004, J BIOL CHEM, V279, P26378, DOI 10.1074/jbc.M309724200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509; Shao W, 2007, AUTOPHAGY, V3, P10, DOI 10.4161/auto.3270; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Slavikova S, 2005, J EXP BOT, V56, P2839, DOI 10.1093/jxb/eri276; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395	27	91	96	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1921	1928		10.1074/jbc.M706214200	http://dx.doi.org/10.1074/jbc.M706214200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039664	hybrid			2022-12-27	WOS:000252501000018
J	Jacobs, RL; Lingrell, S; Zhao, Y; Francis, GA; Vance, DE				Jacobs, Rene L.; Lingrell, Susanne; Zhao, Yang; Francis, Gordon A.; Vance, Dennis E.			Hepatic CTP : phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY HEART-DISEASE; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; BINDING CASSETTE TRANSPORTERS; FATTY-ACIDS PHOSPHORYLATE; CDP-CHOLINE PATHWAY; APOLIPOPROTEIN-A-I; RAT-LIVER CTP; PHOSPHATIDYLCHOLINE SYNTHESIS; CELLULAR CHOLESTEROL; TARGETED DELETION	CTP:phosphocholine cytidylyltransferase (CT) is the key regulatory enzyme in the CDP-choline pathway for the biosynthesis of phosphatidylcholine (PC). We previously generated a mouse in which the hepatic CT alpha gene was specifically inactivated by the cre/loxP procedure. In CT alpha knock-out mice, plasma high density lipoprotein (HDL) and very low density lipoprotein (VLDL) levels were markedly lower than in wild type mice (Jacobs, R.L., Devlin, C., Tabas, I., and Vance, D. E. (2004) J. Biol. Chem. 279, 47402-47410.) To investigate the mechanism(s) responsible for the decrease in plasma lipoprotein levels, we isolated primary hepatocytes from knock-out and wild type mice. ABCA1 expression was reduced in knock-out hepatocytes and apoAI-dependent cholesterol, and PC efflux was impaired. When knock-out hepatocytes were infected with an adenovirus expressing CT alpha, apoAI-dependent PC efflux returned partially, whereas cholesterol efflux and ABCA1 levels were not restored to normal levels. Adenoviral expression of CT alpha did not increase VLDL secretion in knock-out hepatocytes, even though cellular PC levels returned to normal. However, in vivo adenoviral delivery of CT alpha normalized plasma HDL and VLDL levels in knock-out mice. The observations demonstrate that hepatic PC biosynthesis is a key player in maintaining plasma VLDL and HDL, and further underscores the importance of the liver in HDL formation.	[Jacobs, Rene L.; Lingrell, Susanne; Zhao, Yang; Vance, Dennis E.] Univ Alberta, Dept Biochem, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Francis, Gordon A.] Univ Alberta, Dept Med, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada	University of Alberta; University of Alberta	Vance, DE (corresponding author), Univ Alberta, Dept Biochem, Canadian Inst, Hlth Res Grp Mol & Cell Biol Lipids, 328 HMRC, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Jacobs, Rene/0000-0002-5525-1355				Abe-Dohmae S, 2006, FEBS LETT, V580, P1178, DOI 10.1016/j.febslet.2005.12.029; Best CH, 1932, J PHYSIOL-LONDON, V75, P405, DOI 10.1113/jphysiol.1932.sp002899; BOJANOVSKI D, 1987, J CLIN INVEST, V80, P1742, DOI 10.1172/JCI113266; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Choi JY, 2004, J BIOL CHEM, V279, P42321, DOI 10.1074/jbc.M405074200; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; FAST DG, 1995, BBA-LIPID LIPID MET, V1258, P159, DOI 10.1016/0005-2760(95)00116-T; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gotto AM, 2001, CIRCULATION, V103, P2213, DOI 10.1161/01.CIR.103.17.2213; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kiss RS, 2003, J BIOL CHEM, V278, P10119, DOI 10.1074/jbc.M300137200; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; Lawn RM, 2001, ARTERIOSCL THROM VAS, V21, P378, DOI 10.1161/01.ATV.21.3.378; Li ZY, 2007, BBA-MOL CELL BIOL L, V1771, P486, DOI 10.1016/j.bbalip.2007.01.003; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; MYHER JJ, 1989, LIPIDS, V24, P408, DOI 10.1007/BF02535148; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; ROBINSON BS, 1989, BIOCHEM J, V260, P207, DOI 10.1042/bj2600207; Sahoo D, 2004, J LIPID RES, V45, P1122, DOI 10.1194/jlr.M300529-JLR200; Schmitz G, 2001, FRONT BIOSCI, V6, pD505, DOI 10.2741/Schmitz; Selzner N, 2006, J HEPATOL, V44, P694, DOI 10.1016/j.jhep.2005.07.032; Singaraja RR, 2006, CIRCULATION, V114, P1301, DOI 10.1161/CIRCULATIONAHA.106.621433; Singaraja RR, 2006, ARTERIOSCL THROM VAS, V26, P1821, DOI 10.1161/01.ATV.0000229219.13757.a2; Storey MK, 2001, J BIOL CHEM, V276, P48539, DOI 10.1074/jbc.M109043200; SWEITZER TD, 1994, ARCH BIOCHEM BIOPHYS, V311, P107, DOI 10.1006/abbi.1994.1215; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Van Eck M, 2005, CURR OPIN LIPIDOL, V16, P307; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; Waite KA, 2002, J NUTR, V132, P68, DOI 10.1093/jn/132.1.68; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2003, J BIOL CHEM, V278, P42906, DOI 10.1074/jbc.M307831200; Wang YT, 2005, J BIOL CHEM, V280, P35896, DOI 10.1074/jbc.M506210200; Wang YT, 2007, J LIPID RES, V48, P1062, DOI 10.1194/jlr.M600437-JLR200; Wellington CL, 2003, J LIPID RES, V44, P1470, DOI 10.1194/jlr.M300110-JLR200; YAO Z, 1990, BIOCHEM CELL BIOL, V68, P552, DOI 10.1139/o90-079; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YAO ZM, 1989, J BIOL CHEM, V264, P11373; ZEISEL SH, 1991, FASEB J, V5, P2093, DOI 10.1096/fasebj.5.7.2010061; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200; Zheng H, 2005, J BIOL CHEM, V280, P21612, DOI 10.1074/jbc.m502200200; Zhou JM, 2004, J LIPID RES, V45, P1758, DOI 10.1194/jlr.M400179-JLR200; ZHOU X, 1992, J LIPID RES, V33, P1233	63	60	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2147	2155		10.1074/jbc.M706628200	http://dx.doi.org/10.1074/jbc.M706628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042552	hybrid			2022-12-27	WOS:000252501000042
J	Thompson, C; Cloutier, A; Bosse, Y; Poisson, C; Larivee, P; McDonald, PP; Stankova, J; Rola-Pleszczynski, M				Thompson, Charles; Cloutier, Alexandre; Bosse, Ynuk; Poisson, Caroline; Larivee, Pierre; McDonald, Patrick P.; Stankova, Jana; Rola-Pleszczynski, Marek			Signaling by the cysteinyl-leukotriene receptor 2 - Involvement in chemokine gene transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-8 GENE; ENDOTHELIAL-CELLS; MOLECULAR-CLONING; EXPRESSION; ACTIVATION; PATHWAY; PHOSPHORYLATION	Cysteinyl-leukotrienes are involved in inflammation and act on at least two G-protein-coupled receptors, CysLT1 and CysLT2. However, the role of the CysLT2 receptor as well as its signaling remain poorly understood. Here we show that leukotriene (LT)C-4 induced the production of the chemokine interleukin (IL)-8 in endothelial cells. To further study the signaling cascade involved, HEK293 cells were stably transfected with CysLT2 and used to study the transcriptional regulation of the IL-8 promoter. Stimulation of the cells with increasing concentrations of LTC4 resulted in a time- and concentration-dependent induction of IL-8 transcription and protein synthesis. Use of IL-8 promoter mutants with substitutions in their NF-kappa B, AP-1, or NF-IL-6 binding elements revealed an almost total requirement for NF-kappa B and AP-1 elements, and a lesser requirement for the NF-IL-6 element. Overexpression of dominant-negative I kappa B alpha prevented the IL-8 transactivation induced by LTC4. LTC4 stimulation induced NF-kappa B and AP-1 DNA binding, which involved the formation of a p50/p65 and a c-JUN.c-FOS complex, respectively. Transfection of the cells with a dominant negative (dn) form of PKC epsilon prevented p65 phosphorylation, whereas dnPKC delta prevented AP-1 binding. Moreover, dnPKC delta, dnPKC epsilon, and dnPKC delta prevented LTC4-induced IL-8 transcription in response to LTC4. Our data show for the first time that LTC4 can act via the CysLT2 receptor to transcriptionally activate chemokine production through induction of NF-kappa B and AP-1 transcription factors. These findings suggest the potential implication of CysLT2 in the inflammatory response through the modulation of chemokine gene transcription.	[Thompson, Charles; Bosse, Ynuk; Poisson, Caroline; Stankova, Jana; Rola-Pleszczynski, Marek] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med, Sherbrooke, PQ J1H 5N4, Canada; [Cloutier, Alexandre; Larivee, Pierre; McDonald, Patrick P.] Univ Sherbrooke, Fac Med, Div Pulm, Dept Med, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; University of Sherbrooke	Rola-Pleszczynski, M (corresponding author), 3001 N 12th Ave, Sherbrooke, PQ J1H 5N4, Canada.	marek.rola-pleszczynski@usherbrooke.ca						ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; Barnes PJ, 1998, EUR RESPIR J, V12, P221, DOI 10.1183/09031936.98.12010221; Beller TC, 2004, J BIOL CHEM, V279, P46129, DOI 10.1074/jbc.M407057200; BRACH MA, 1992, EUR J IMMUNOL, V22, P2705, DOI 10.1002/eji.1830221034; Chen LC, 2004, BBA-MOL CELL BIOL L, V1683, P38, DOI 10.1016/j.bbalip.2004.04.003; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen LY, 2005, J BIOL CHEM, V280, P22497, DOI 10.1074/jbc.M413033200; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Devillier P, 1999, PHARMACOL RES, V40, P15, DOI 10.1006/phrs.1998.0461; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; Drazen JM, 1998, AM J RESP CRIT CARE, V158, pS193, DOI 10.1164/ajrccm.158.supplement_2.13tac180; Dupre DJ, 2007, CELL SIGNAL, V19, P2068, DOI 10.1016/j.cellsig.2007.05.015; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Figueroa DJ, 2003, CLIN EXP ALLERGY, V33, P1380, DOI 10.1046/j.1365-2222.2003.01786.x; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Guo BC, 2007, J IMMUNOL, V178, P4726, DOI 10.4049/jimmunol.178.8.4726; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Kaminska B, 2000, ACTA NEUROBIOL EXP, V60, P395; Koon HW, 2005, J PHARMACOL EXP THER, V314, P1393, DOI 10.1124/jpet.105.088013; Kuriyama M, 2004, BIOCHEM BIOPH RES CO, V325, P843, DOI 10.1016/j.bbrc.2004.10.102; LABAT C, 1992, J PHARMACOL EXP THER, V263, P800; Lallena MJ, 1999, MOL CELL BIOL, V19, P2180; LAM S, 1988, J ALLERGY CLIN IMMUN, V81, P711, DOI 10.1016/0091-6749(88)91043-3; LeHoux JG, 2001, J BIOL CHEM, V276, P8021, DOI 10.1074/jbc.M009495200; LEWIS RA, 1990, NEW ENGL J MED, V323, P645; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotzer K, 2003, ARTERIOSCL THROM VAS, V23, pE32, DOI 10.1161/01.ATV.0000082690.23131.CB; Lynch KR, 1999, NATURE, V399, P789; Macfarlane AJ, 2000, AM J RESP CRIT CARE, V161, P1553, DOI 10.1164/ajrccm.161.5.9906068; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Norzila MZ, 2000, AM J RESP CRIT CARE, V161, P769, DOI 10.1164/ajrccm.161.3.9809071; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pavord ID, 1999, AM J RESP CRIT CARE, V160, P1905, DOI 10.1164/ajrccm.160.6.9903114; Pillai SG, 2004, PHARMACOGENETICS, V14, P627, DOI 10.1097/00008571-200409000-00007; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Sjostrom M, 2003, ARTERIOSCL THROM VAS, V23, pE37, DOI 10.1161/01.ATV.0000082689.46538.DF; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Stankova J, 1996, AM J PHYSIOL-CELL PH, V271, pC1073, DOI 10.1152/ajpcell.1996.271.4.C1073; STEIN B, 1993, MOL CELL BIOL, V13, P7191, DOI 10.1128/MCB.13.11.7191; Takasaki J, 2000, BIOCHEM BIOPH RES CO, V274, P316, DOI 10.1006/bbrc.2000.3140; Tan SL, 2003, BIOCHEM J, V376, P545, DOI 10.1042/BJ20031406; Thodeti CK, 2001, EXP CELL RES, V262, P95, DOI 10.1006/excr.2000.5077; Thompson C, 2006, AM J RESP CELL MOL, V35, P697, DOI 10.1165/rcmb.2005-0407OC; Thompson MD, 2003, PHARMACOGENETICS, V13, P641, DOI 10.1097/00008571-200310000-00008; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; WENZEL SE, 1990, AM REV RESPIR DIS, V142, P112, DOI 10.1164/ajrccm/142.1.112; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	63	26	27	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1974	1984		10.1074/jbc.M608197200	http://dx.doi.org/10.1074/jbc.M608197200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048362	hybrid			2022-12-27	WOS:000252501000024
J	Dai, JQ; Zhu, XJ; Liu, FQ; Xiang, JH; Nagasawa, H; Yang, WJ				Dai, Jie-Qiong; Zhu, Xiao-Jing; Liu, Feng-Qi; Xiang, Jian-Hai; Nagasawa, Hiromichi; Yang, Wei-Jun			Involvement of p90 ribosomal S6 kinase in termination of cell cycle arrest during development of Artemia-encysted embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; RSK; PHOSPHORYLATION; P90(RSK); IDENTIFICATION; REPLICATION; DOMAINS; SALINA; GENES	Artemia has evolved a unique developmental pattern of encysted embryos to cope with various environmental threats. Cell divisions totally cease during the preemergence developmental stage from gastrula to prenauplius. The molecular mechanism of this, however, remains unknown. Our study focuses on the involvement of p90 ribosomal S6 kinase (RSK), a family of serine/threonine kinase-mediating signal transduction downstream of mitogen-activated protein kinase cascades, in the termination of cell cycle arrest during the post-embryonic development of Artemia-encysted gastrula. With immunochemistry, morphology, and cell cycle analysis, the identified Artemia RSK was established to be specifically activated during the post-embryonic and early larval developmental stages when arrested cells of encysted embryos resumed mitoses. In vivo knockdown of RSK activity by RNA interference, kinase inhibition, and antibody neutralization consistently induced defective larvae with distinct gaps between the exoskeleton and internal tissues. In these abnormal individuals, mitoses were detected to be largely inhibited in the affected regions. These results display the requirement of RSK activity during Artemia development and suggest its role in termination of cell cycle (G(2)/M phase) arrest and promotion of mitogenesis. Our findings may, thus, provide insights into the regulation of cell division during Artemia post-embryonic development and reveal further aspects of RSK functions.	[Dai, Jie-Qiong; Zhu, Xiao-Jing; Yang, Wei-Jun] Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Feng-Qi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Xiang, Jian-Hai] Chinese Acad Sci, Inst Oceanol, Qingdao 266071, Shandong, Peoples R China; [Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Zhejiang University; Nankai University; Chinese Academy of Sciences; Institute of Oceanology, CAS; University of Tokyo	Yang, WJ (corresponding author), Zhejiang Univ, Inst Cell Biol & Genet, Coll Life Sci, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn	xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787; Yang, Wei-Jun/0000-0002-4591-8830				Benesch R., 1969, Zoologische Jahrbuecher (Anatomie), V86, P307; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; BJORBAEK C, 1995, J BIOL CHEM, V270, P18848, DOI 10.1074/jbc.270.32.18848; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clegg J.S., 1978, P117; Clegg James S., 2002, P129; Copf T, 2004, P NATL ACAD SCI USA, V101, P17711, DOI 10.1073/pnas.0407327102; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; Criel Godelieve R.J., 2002, P39; Dai ZM, 2007, J BIOTECHNOL, V128, P435, DOI 10.1016/j.jbiotec.2006.10.018; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Drinkwater L.E., 1991, P93; FINAMORE FJ, 1969, CELL CYCLE GENE ENZY, P249; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; FREEMAN JA, 1992, DEV BIOL, V152, P279, DOI 10.1016/0012-1606(92)90135-4; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Gajardo Gonzalo, 2002, P225; Godeny MD, 2006, AM J PHYSIOL-CELL PH, V291, pC1308, DOI 10.1152/ajpcell.00618.2005; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Gross SD, 2001, J BIOL CHEM, V276, P46099, DOI 10.1074/jbc.C100496200; Hans A, 2001, J BIOL CHEM, V276, P7258, DOI 10.1074/jbc.M005107200; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HENTSCHEL CC, 1976, TRENDS BIOCHEM SCI, V1, P97, DOI 10.1016/0968-0004(76)90317-0; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majka M, 2000, BLOOD, V96, P4142, DOI 10.1182/blood.V96.13.4142.h8004142_4142_4151; Mori M, 2006, DEVELOPMENT, V133, P1823, DOI 10.1242/dev.02348; NAKANISHI YHT, 1963, P JPN ACAD, V39, P306, DOI 10.2183/pjab1945.39.306; NAKANISHI Yu.H., 1962, ANNOT ZOOL JAPON, V35, P223; OLSON C, 1976, EXPERIENTIA, V32, P864, DOI 10.1007/BF02003733; OLSON CS, 1978, ROUX ARCH DEV BIOL, V184, P1, DOI 10.1007/BF00848665; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Slegers H., 1991, P37; Smith JA, 2005, CANCER RES, V65, P1027; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186	40	32	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1705	1712		10.1074/jbc.M707853200	http://dx.doi.org/10.1074/jbc.M707853200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	17999958	hybrid			2022-12-27	WOS:000252282700057
J	Ramachandran, B; Yu, GS; Li, SG; Zhu, B; Gulick, T				Ramachandran, Bindu; Yu, Gengsheng; Li, Shiguang; Zhu, Bangmin; Gulick, Tod			Myocyte enhancer factor 2A is transcriptionally autoregulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SIGNAL-REGULATED KINASE-5; MEF2 PROTEIN FAMILY; GENE-EXPRESSION; MADS-BOX; HISTONE DEACETYLASES; MOUSE EMBRYOGENESIS; NEURONAL SURVIVAL; STRIATED-MUSCLE; NERVOUS-SYSTEM	MEF2 (myocyte enhancer factor 2) proteins are a small family of transcription factors that play pivotal roles in striated muscle differentiation, development, and metabolism, in neuron survival and synaptic formation, and in lymphocyte selection and activation. Products of the four mammalian MEF2 genes, MEF2A, MEF2B, MEF2C, and MEF2D, are expressed with overlapping but distinct temporospatial patterns. Toward analysis of MEF2A functions and the determinants of its regulated expression, we have mapped and begun studies of the transcriptional control regions of this gene. Heterogeneous 5'-untranslated regions of MEF2A mRNAs result from use of alternative promoters and splicing patterns. The two closely approximated TATA-less promoters are similar to 65 kb upstream of the exon containing the sole initiation codon. Ribonuclease protection and primer extension assays show that each promoter is active in various adult tissues. A canonical MEF2 site overlies the major promoter 1 transcription start site. This element specifically binds MEF2 factors, including endogenous nuclear MEF2A according to chromatin immunoprecipitation studies, and is critical to MEF2A transcription in myocytes. The site exerts reciprocal control of the alternative promoters, silencing promoter 1 and activating promoter 2 under some conditions. Erk5 and p38 MAPK signaling stimulate MEF2A expression by activating both promoters from the MEF2 element. MEF2A transcription is therefore subject to positive or negative regulation by its protein products, depending on signaling activities that influence MEF2 factor trans-activity. The sole MEF2 gene of the cephalochordate amphioxus has a similar regulatory region structure, suggesting that this mode of autoregulatory control is conserved among higher metazoan MEF2 genes.	[Ramachandran, Bindu; Yu, Gengsheng; Li, Shiguang; Zhu, Bangmin; Gulick, Tod] Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, Charlestown, MA 02129 USA; [Yu, Gengsheng; Zhu, Bangmin; Gulick, Tod] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gulick, T (corresponding author), Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, CNY 149 8219, Charlestown, MA 02129 USA.	gulick@helix.mgh.harvard.edu			NHLBI NIH HHS [HL72713] Funding Source: Medline; NIDDK NIH HHS [DK55875, DK02461, P30-DK40561] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K02DK002461, R01DK055875] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1997, MOL CELL BIOL, V17, P2756, DOI 10.1128/MCB.17.5.2756; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; BLACK BL, 1995, J BIOL CHEM, V270, P2889, DOI 10.1074/jbc.270.7.2889; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; Cavanaugh JE, 2004, EUR J BIOCHEM, V271, P2056, DOI 10.1111/j.1432-1033.2004.04131.x; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Grayson J, 1998, J CELL BIOCHEM, V70, P366, DOI 10.1002/(SICI)1097-4644(19980901)70:3<366::AID-JCB10>3.3.CO;2-T; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junion G, 2005, P NATL ACAD SCI USA, V102, P18479, DOI 10.1073/pnas.0507030102; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Liu Y., 2005, J MUSCLE RES CELL M, P1; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puri PL, 2000, GENE DEV, V14, P574; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sharp PA, 2005, TRENDS BIOCHEM SCI, V30, P279, DOI 10.1016/j.tibs.2005.04.002; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; Sugahara Y, 2001, GENE, V263, P93, DOI 10.1016/S0378-1119(00)00557-6; Suzuki E, 1996, CYTOGENET CELL GENET, V73, P244, DOI 10.1159/000134348; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Wang DZ, 2001, DEVELOPMENT, V128, P4623; WONG MW, 1994, DEV BIOL, V166, P683, DOI 10.1006/dbio.1994.1347; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Yu GS, 2007, MODERN PATHOL, V20, p310A; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 2002, ARCH BIOCHEM BIOPHYS, V400, P199, DOI 10.1016/S0003-9861(02)00028-0; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	83	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10318	10329		10.1074/jbc.M707623200	http://dx.doi.org/10.1074/jbc.M707623200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18073218	Green Published, hybrid			2022-12-27	WOS:000254894700012
J	Madsen, L; Pedersen, LM; Liaset, B; Ma, T; Petersen, RK; van den Berg, S; Pan, J; Muller-Decker, K; Dulsner, ED; Kleemann, R; Kooistra, T; Doskeland, SO; Kristiansen, K				Madsen, Lise; Pedersen, Lone Moller; Liaset, Bjorn; Ma, Tao; Petersen, Rasmus Koefoed; van den Berg, Sjoerd; Pan, Jie; Mueller-Decker, Karin; Duelsner, Erik D.; Kleemann, Robert; Kooistra, Teake; Doskeland, Stein Ove; Kristiansen, Karsten			cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; ADIPOCYTE DIFFERENTIATION; HEPATIC GLUCONEOGENESIS; ARACHIDONIC-ACID; COACTIVATOR PGC-1; RATS; DIET; INSULIN; LIVER; GENE	The effect of n-6 polyunsaturated fatty acids ( n-6 PUFAs) on adipogenesis and obesity is controversial. Using in vitro cell culture models, we show that n-6 PUFAs was pro-adipogenic under conditions with base-line levels of cAMP, but anti-adipogenic when the levels of cAMP were elevated. The anti-adipogenic action of n-6 PUFAs was dependent on a cAMP-dependent protein kinase-mediated induction of cyclooxygenase expression and activity. We show that n-6 PUFAs were pro-adipogenic when combined with a high carbohydrate diet, but non-adipogenic when combined with a high protein diet in mice. The high protein diet increased the glucagon/ insulin ratio, leading to elevated cAMP-dependent signaling and induction of cyclooxygenase-mediated prostaglandin synthesis. Mice fed the high protein diet had a markedly lower feed efficiency than mice fed the high carbohydrate diet. Yet, oxygen consumption and apparent heat production were similar. Mice on a high protein diet had increased hepatic expression of PGC-1 alpha(peroxisome proliferator-activated receptor gamma coactivator 1 alpha) and genes involved in energy-demanding processes like urea synthesis and gluconeogenesis. We conclude that cAMP signaling is pivotal in regulating the adipogenic effect of n-6 PUFAs and that diet-induced differences in cAMP levels may explain the ability of n-6 PUFAs to either enhance or counteract adipogenesis and obesity.	[Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Madsen, Lise; Pedersen, Lone Moller; Ma, Tao; Petersen, Rasmus Koefoed; Kristiansen, Karsten] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [van den Berg, Sjoerd] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Pan, Jie] Shandong Normal Univ, Coll Life Sci, Key Lab Anti Morbid Anim Biol, Jinan 250014, Peoples R China; [Mueller-Decker, Karin; Duelsner, Erik D.] Deutsch Krebsforschungszentrum, Core Facil Tumor Models, D-69120 Heidelberg, Germany; [Kleemann, Robert; Kooistra, Teake] TNO, Dept Biosci, NL-2301 CE Leiden, Netherlands; [Doskeland, Stein Ove] Univ Bergen, Dept Biomed, N-5097 Bergen, Norway	University of Southern Denmark; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shandong Normal University; Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Organization Applied Science Research; University of Bergen	Madsen, L (corresponding author), Natl Inst Nutr & Seafood Res, Postboks 2029, N-5817 Bergen, Norway.	lise.madsen@bmb.sdu.dk; kak@bmb.sdu.dk	Kristiansen, Karsten/J-5148-2014; van den Berg, Sjoerd A/R-9541-2018; Madsen, Lise/C-6246-2012; van den Berg, Sjoerd AA/B-1994-2009	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; van den Berg, Sjoerd/0000-0001-8967-376X; Doskeland, Stein Ove/0000-0002-4009-4756; van den Berg, Sjoerd/0000-0001-5937-7505; Liaset, Bjorn/0000-0002-8652-7801				Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Arslan G, 2002, LIPIDS, V37, P935, DOI 10.1007/s11745-006-0983-2; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cleary MP, 1999, P SOC EXP BIOL MED, V220, P153, DOI 10.1046/j.1525-1373.1999.d01-23.x; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; CRAWFORD M, 1968, LANCET, V291, P1329; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fine Eugene J, 2004, Nutr Metab (Lond), V1, P15, DOI 10.1186/1743-7075-1-15; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; HAHN P, 1980, J NUTR, V110, P330, DOI 10.1093/jn/110.2.330; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HYMAN BT, 1982, BIOCHIM BIOPHYS ACTA, V713, P375, DOI 10.1016/0005-2760(82)90256-9; ILLIANO G, 1972, SCIENCE, V175, P906, DOI 10.1126/science.175.4024.906; IP MM, 1977, J NUTR, V107, P746, DOI 10.1093/jn/107.5.746; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; LACEY JH, 1981, BIOCHEM J, V194, P29, DOI 10.1042/bj1940029; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; MANGANIELLO VC, 1971, J BIOL CHEM, V246, P2195; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Matsuo T, 2002, ASIA PAC J CLIN NUTR, V11, P302, DOI 10.1046/j.1440-6047.2002.00299.x; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; MULLERDECKER K, 1994, TOXICOL APPL PHARM, V127, P99, DOI 10.1006/taap.1994.1144; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Prentice AM, 2001, OBES RES, V9, p234S, DOI 10.1038/oby.2001.124; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; SERRERO G, 1992, ENDOCRINOLOGY, V131, P2545, DOI 10.1210/en.131.6.2545; SERRERO G, 1992, BIOCHEM BIOPH RES CO, V183, P438, DOI 10.1016/0006-291X(92)90500-K; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; SPITZER JA, 1990, AGENTS ACTIONS, V31, P341, DOI 10.1007/BF01997629; van den Hoek AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE238, DOI 10.1152/ajpendo.00239.2006; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Watson PM, 2000, AM J PHYSIOL-ENDOC M, V279, pE356, DOI 10.1152/ajpendo.2000.279.2.E356; Westerterp-Plantenga MS, 2005, APPETITE, V45, P187, DOI 10.1016/j.appet.2005.02.005; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou L, 2001, J LIPID RES, V42, P1521	40	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7196	7205		10.1074/jbc.M707775200	http://dx.doi.org/10.1074/jbc.M707775200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18070879	hybrid, Green Published			2022-12-27	WOS:000253779600065
J	Alioua, A; Lu, R; Kumar, Y; Eghbali, M; Kundu, P; Toro, L; Stefani, E				Alioua, Abderrahmane; Lu, Rong; Kumar, Yogesh; Eghbali, Mansoureh; Kundu, Pallob; Toro, Ligia; Stefani, Enrico			Slo1 caveolin-binding motif, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CA2+-ACTIVATED K+ CHANNEL; C-TERMINUS; SCAFFOLDING DOMAIN; PLASMA-MEMBRANE; BK CHANNELS; RECEPTOR; PROTEINS; VOLTAGE; ALPHA	The large conductance, voltage- and Ca2+- activated potassium (MaxiK, BK) channel and caveolin-1 play important roles in regulating vascular contractility. Here, we hypothesized that the MaxiK alpha-subunit (Slo1) and caveolin-1 may interact with each other. Slo1 and caveolin-1 physiological association in native vascular tissue is strongly supported by (i) detergent-free purification of caveolin-1-rich domains demonstrating a pool of aortic Slo1 co-migrating with caveolin-1 to light density sucrose fractions, (ii) reverse co-immunoprecipitation, and (iii) double immunolabeling of freshly isolated myocytes revealing caveolin-1 and Slo1 proximity at the plasmalemma. In HEK293T cells, Slo1-caveolin-1 association was unaffected by the smooth muscle MaxiK beta 1-subunit. Sequence analysis revealed two potential caveolin-binding motifs along the Slo1 C terminus, one equivalent, (1007)YNMLCFGIY(1015), and another mirror image, (537)YTEYLSSAF(545), to the consensus sequence, phi XXXX phi XX phi. Deletion of 1007YNMLCFGIY1015 caused similar to 80% loss of Slo1-caveolin-1 association while preserving channel normal folding and overall Slo1 and caveolin-1 intracellular distribution patterns. (537)YTEYLSSAF(545) deletion had an insignificant dissociative effect. Interestingly, caveolin-1 coexpression reduced Slo1 surface and functional expression near 70% without affecting channel voltage sensitivity, and deletion of (1007)YNMLCFGIY(1015) motif obliterated channel surface expression. The results suggest (1007)YNMLCFGIY(1015) possible participation in Slo1 plasmalemmal targeting and demonstrate its role as a main mechanism for caveolin-1 association with Slo1 potentially serving a dual role: (i) maintaining channels in intracellular compartments down sizing their surface expression and/or (ii) serving as anchor of plasma membrane resident channels to caveolin-1-rich membranes. Because the caveolin-1 scaffolding domain is juxtamembrane, it is tempting to suggest that Slo1-caveolin-1 interaction facilitates the tethering of the Slo1 C-terminal end to the membrane.	[Alioua, Abderrahmane; Lu, Rong; Kumar, Yogesh; Eghbali, Mansoureh; Kundu, Pallob; Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Alioua, A (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, BH-509A CHS, Los Angeles, CA 90095 USA.	aalioua@ucla.edu	KUMAR, YOGESH/GXN-1220-2022		NHLBI NIH HHS [HL54970, HL77705, P01-HL080111] Funding Source: Medline; NICHD NIH HHS [HD046510] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046510] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080111, R01HL054970, R01HL077705] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Daniel EE, 2001, AM J PHYSIOL-GASTR L, V281, pG1101, DOI 10.1152/ajpgi.2001.281.4.G1101; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; LAU YH, 1979, J GEN PHYSIOL, V74, P335, DOI 10.1085/jgp.74.3.335; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schmalhofer WA, 2005, BIOCHEMISTRY-US, V44, P10135, DOI 10.1021/bi050527u; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Taggart MJ, 2000, EXP CELL RES, V258, P72, DOI 10.1006/excr.2000.4891; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thyberg J, 2002, J HISTOCHEM CYTOCHEM, V50, P185, DOI 10.1177/002215540205000206; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; VILLASCHI S, 1994, IN VITRO CELL DEV-AN, V30A, P589; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wood LS, 1997, BIOCHEM BIOPH RES CO, V240, P623, DOI 10.1006/bbrc.1997.7714; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101	40	58	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4808	4817		10.1074/jbc.M709802200	http://dx.doi.org/10.1074/jbc.M709802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079116	hybrid			2022-12-27	WOS:000253426500038
J	Knierim, B; Hofmann, KP; Gartner, W; Hubbell, WL; Ernst, OP				Knierim, Bernhard; Hofmann, Klaus Peter; Gaertner, Wolfgang; Hubbell, Wayne L.; Ernst, Oliver P.			Rhodopsin and 9-demethyl-retinal analog - Effect of a partial agonist on displacement of transmembrane helix 6 in class A G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METARHODOPSIN-II; TRANSDUCIN ACTIVATION; BOVINE RHODOPSIN; 9-METHYL GROUP; PROTON UPTAKE; STATE; PHOTOINTERMEDIATE; DYNAMICS; LINKING; REGION	Rhodopsin is the visual pigment of rod cells and a prototypical G protein-coupled receptor. It is activated by cis -> trans photoisomerization of the covalently bound chromophore 11-cis-retinal, which acts in the cis configuration as an inverse agonist. Light-induced formation of the full agonist all-trans-retinal in situ triggers conformational changes in the protein moiety. Partial agonists of rhodopsin include a retinal analog lacking the methyl group at C-9, termed 9-demethyl-retinal (9-dm-retinal). Rhodopsin reconstituted with this retinal (9-dm-rhodopsin) activates G protein poorly. Here we investigated the molecular nature of the partial agonism in 9-dm-rhodopsin using site-directed spin labeling. Earlier site-directed spin labeling studies of rhodopsin identified a rigid-body tilt of the cytoplasmic segment of helix transmembrane helix 6 (TM6) by similar to 6 angstrom as a central event in rhodopsin activation. Data presented here provide additional evidence for this mechanism. Only a small fraction of photoexcited 9-dm pigments reaches the TM6-tilted conformation. This fraction can be increased by increasing proton concentration by anticipation of the activating protonation step by the mutation E134Q in 9-dm-rhodopsin. These results on protein conformation are in complete accord with previous findings regarding the biological activity of the 9-dm pigments. When the proton concentration is further increased, a new state arises in 9-dm pigments that is linked to direct proton uptake at the retinal Schiff base. This state apparently has a conformation distinguishable from the active state.	[Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Knierim, Bernhard; Hofmann, Klaus Peter; Ernst, Oliver P.] Charite Univ Med Berlin, Inst Med Phys & Biophys CCM, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10015 Berlin, Germany; [Gaertner, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society	Hubbell, WL (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	hubbellw@jsei.ucla.edu; oliver.ernst@charite.de		Gartner, Wolfgang/0000-0002-6898-7011	NATIONAL EYE INSTITUTE [R01EY005216, R37EY005216] Funding Source: NIH RePORTER; NEI NIH HHS [EY05216] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Bartl FJ, 2005, J BIOL CHEM, V280, P34259, DOI 10.1074/jbc.M505260200; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fahmy K, 2000, BIOCHEMISTRY-US, V39, P10607, DOI 10.1021/bi000912d; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Hofmann K. P., 2000, HDB BIOL PHYSICS, P91, DOI 10.1016/s1383-8121(00)80006-8; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Morizumi T, 2003, J BIOCHEM, V134, P259, DOI 10.1093/jb/mvg139; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Vogel R, 2006, BIOCHEMISTRY-US, V45, P1640, DOI 10.1021/bi052196r; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; ZVYAGA TA, 1994, BIOCHEMISTRY-US, V33, P9753, DOI 10.1021/bi00198a046	34	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4967	4974		10.1074/jbc.M703059200	http://dx.doi.org/10.1074/jbc.M703059200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063586	hybrid			2022-12-27	WOS:000253426500054
J	Wang, YJ; Singh, R; Massey, AC; Kane, SS; Kaushik, S; Grant, T; Xiang, YQ; Cuervo, AM; Czaja, MJ				Wang, Yongjun; Singh, Rajat; Massey, Ashish C.; Kane, Saul S.; Kaushik, Susmita; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.			Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM STRESS; CHAPERONE-MEDIATED AUTOPHAGY; BCL-2 FAMILY PROTEINS; TUMOR-NECROSIS; CELL-DEATH; LIPID-PEROXIDATION; C-MYC; KINASE; DEGRADATION	Macroautophagy has been implicated as a mechanism of cell death. However, the relationship between this degradative pathway and cell death is unclear as macroautophagy has been shown recently to protect against apoptosis. To better define the interplay between these two critical cellular processes, we determined whether inhibition of macroautophagy could have both pro-apoptotic and anti-apoptotic effects in the same cell. Embryonic fibroblasts from mice with a knock-out of the essential macroautophagy gene atg5 were treated with activators of the extrinsic and intrinsic death pathways. Loss of macroautophagy sensitized these cells to caspase-dependent apoptosis from the death receptor ligands Fas and tumor necrosis factor-alpha (TNF-alpha). Atg5(-/-) mouse embryonic fibroblasts had increased activation of the mitochondrial death pathway in response to Fas/TNF-alpha in concert with decreased ATP levels. Fas/TNF-alpha treatment failed to up-regulate macroautophagy, and in fact, decreased activity at late time points. In contrast to their sensitization to Fas/TNF-alpha, Atg5(-/-) cells were resistant to death from menadione and UV light. In the absence of macroautophagy, an up-regulation of chaperone-mediated autophagy induced resistance to these stressors. These results demonstrate that inhibition of macroautophagy can promote or prevent apoptosis in the same cell and that the response is governed by the nature of the death stimulus and compensatory changes in other forms of autophagy. Experimental findings that an inhibition of macroautophagy blocks apoptosis do not prove that autophagy mediates cell death as this effect may result from the protective up-regulation of other autophagic pathways such as chaperone-mediated autophagy.	[Wang, Yongjun; Singh, Rajat; Massey, Ashish C.; Kane, Saul S.; Kaushik, Susmita; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; [Wang, Yongjun; Singh, Rajat; Kane, Saul S.; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Massey, Ashish C.; Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Czaja, MJ (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	czaja@aecom.yu.edu	Kaushik, Susmita/GVS-3186-2022	Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	NIA NIH HHS [R01 AG021904-06, R01 AG021904-07, R37 AG021904, AG021904, T32 AG023475, T32AG023475, R01 AG021904] Funding Source: Medline; NIDDK NIH HHS [R01 DK044234-15, P01 DK041918-16, DK041918, R01 DK044234, R01 DK044234-16, P01 DK041918, P01 DK041918-17, DK044234] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918, R01DK044234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, T32AG023475, R37AG021904] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Duke RC, 1992, CURR PROT IMMUNOL S3, V17, P1; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jia L, 1997, BRIT J HAEMATOL, V98, P673, DOI 10.1046/j.1365-2141.1997.2623081.x; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu HL, 2000, J BIOL CHEM, V275, P40155, DOI 10.1074/jbc.M001565200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; MORLIERE P, 1995, FREE RADICAL BIO MED, V19, P365, DOI 10.1016/0891-5849(95)00043-W; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Paglin S, 2001, CANCER RES, V61, P439; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Przybyszewski WM, 2002, TERATOGEN CARCIN MUT, V22, P93, DOI 10.1002/tcm.10006; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shinoura N, 2000, HUM GENE THER, V11, P1123, DOI 10.1089/10430340050015185; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4; THOR H, 1982, J BIOL CHEM, V257, P2419; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	67	112	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4766	4777		10.1074/jbc.M706666200	http://dx.doi.org/10.1074/jbc.M706666200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073215	hybrid, Green Accepted			2022-12-27	WOS:000253426500034
J	Johnson, AC; Li, XX; Pearlman, E				Johnson, Angela C.; Li, Xiaoxia; Pearlman, Eric			MyD88 functions as a negative regulator of TLR3/TRIF-induced corneal inflammation by inhibiting activation of c-Jun N-terminal kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTOR; DOUBLE-STRANDED-RNA; PROINFLAMMATORY GENE-EXPRESSION; KAPPA-B ACTIVATION; IFN-BETA PROMOTER; EPITHELIAL-CELLS; MOLECULAR-CLONING; CUTTING EDGE; RECOGNITION; RESPONSES	The adaptor molecule MyD88 is necessary for responses to all Toll-like receptors except TLR3 and a subset of TLR4 signaling events, which are mediated by the adaptor molecule TRIF. To determine the role of TRIF in host inflammatory responses, corneal epithelium of C57BL/6, TLR3(-/-), TRIF-/-, and MyD88(-/-) mice was abraded and stimulated with the synthetic TLR3 ligand poly(I: C). We found that poly(I:C) induced a pronounced cellular infiltration into the corneal stroma, which was TLR3- and TRIF-dependent. Unexpectedly, the inflammatory response was exacerbated in MyD88(-/-) mice, with enhanced neutrophil and F4/80(+) cell infiltration into the corneal stroma and elevated corneal haze, which is an indicator of loss of corneal transparency. To determine whether MyD88-dependent inhibition of TLR3/TRIF responses is a general phenomenon, we examined cytokine production by MyD88(-/-) bone marrow-derived macrophages; however, no significant difference was observed between MyD88(+/+) or MyD88(-/-) macrophages. In contrast, human corneal epithelial cells (HCECs) transfected with MyD88 small interfering RNA had significantly increased (2.5-fold) CCL5/RANTES production compared with control HCECs, demonstrating a negative regulatory role for MyD88 in TLR3/TRIF responses in these cells. Finally, knockdown of MyD88 in HCECs resulted in increased phosphorylation of c-Jun N-terminal kinase (JNK), but not p38, IRF-3, or NF-kappa B. Consistent with this finding, the JNK inhibitor SP600125, but not p38 inhibitor SB203580, ablated this response. Taken together, these findings demonstrate a novel JNK-dependent inhibitory role for MyD88 in the TLR3/TRIF activation pathway.	[Johnson, Angela C.; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Li, Xiaoxia] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Case Western Reserve University; Cleveland Clinic Foundation	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	eric.pearlman@case.edu			NEI NIH HHS [R01EY14362, P30EY11373, P30 EY011373] Funding Source: Medline; NIGMS NIH HHS [R01GM060020] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014362, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060020] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; ADHIKARY G, 2008, IN PRESS J LEUKOCYTE; Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Aksoy E, 2005, EUR J IMMUNOL, V35, P2200, DOI 10.1002/eji.200425801; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barton GM, 2007, SEMIN IMMUNOL, V19, P33, DOI 10.1016/j.smim.2007.01.003; Bjorkbacka H, 2004, PHYSIOL GENOMICS, V19, P319, DOI 10.1152/physiolgenomics.00128.2004; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brissette-Storkus CS, 2002, INVEST OPHTH VIS SCI, V43, P2264; Caminschi I, 2001, J IMMUNOL, V167, P3570, DOI 10.4049/jimmunol.167.7.3570; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Cenni V, 2003, BIOCHEM J, V376, P303, DOI 10.1042/BJ20030028; Chang JH, 2006, BRIT J OPHTHALMOL, V90, P103, DOI 10.1136/bjo.2005.072686; Edelmann KH, 2004, VIROLOGY, V322, P231, DOI 10.1016/j.virol.2004.01.033; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Hayashi K, 2006, J GEN VIROL, V87, P2161, DOI 10.1099/vir.0.81772-0; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Johnson A, 2005, OCUL SURF, V3, pS187; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kaye S, 2006, PROG RETIN EYE RES, V25, P355, DOI 10.1016/j.preteyeres.2006.05.001; Khatri S, 2002, INVEST OPHTH VIS SCI, V43, P2278; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Kumar A, 2006, CURR MOL MED, V6, P327, DOI 10.2174/156652406776894572; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; LOPEZ AF, 1984, MOL IMMUNOL, V21, P371, DOI 10.1016/0161-5890(84)90033-6; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Ueta M, 2004, J IMMUNOL, V173, P3337, DOI 10.4049/jimmunol.173.5.3337; Visintin A, 2006, J LEUKOCYTE BIOL, V80, P1584, DOI 10.1189/jlb.0606388; Weighardt H, 2006, INFECT IMMUN, V74, P3618, DOI 10.1128/IAI.01681-05; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	55	59	62	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3988	3996		10.1074/jbc.M707264200	http://dx.doi.org/10.1074/jbc.M707264200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057004	hybrid			2022-12-27	WOS:000253083500033
J	Tian, W; Wijewickrama, GT; Kim, JH; Das, S; Tun, MP; Gokhale, N; Jung, JW; Kim, KP; Cho, W				Tian, Wen; Wijewickrama, Gihani T.; Kim, Jung Hwan; Das, Sudipto; Tun, Moe P.; Gokhale, Nikhil; Jung, Jin Woo; Kim, Kwang Pyo; Cho, Wonhwa			Mechanism of regulation of group IVA phospholipase A(2) activity by Ser(727) phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; ARACHIDONIC-ACID RELEASE; LIPID-BINDING DOMAIN; C2 DOMAIN; GROWTH-FACTOR; PROSTAGLANDIN GENERATION; LEUKOTRIENE BIOSYNTHESIS; CERAMIDE 1-PHOSPHATE; HUMAN NEUTROPHILS; CRYSTAL-STRUCTURE	Although group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) has been reported to be phosphorylated at multiple Ser residues, the mechanisms by which phosphorylation at different sites regulates cPLA(2)alpha activities are not fully understood. To explore the possibility that phosphorylation of Ser(727) modulates cellular protein-protein interactions, we measured the effect of Ser(727) mutations on the interaction of cPLA(2)alpha with a reported cPLA(2)alpha-binding protein, p11. In vitro activity assays and membrane binding measurements by surface plasmon resonance analysis showed that a heterotetramer (A2t) of p11 and annexin A2, but not p11 or annexin A2 alone, directly binds cPLA(2)alpha via Ser(727), which keeps the enzyme from binding the membrane and catalyzing the phospholipid hydrolysis. Phosphorylation of Ser(727) disrupts this inhibitory cPLA(2)alpha-A2t interaction, thereby activating cPLA(2)alpha. Subcellular translocation and activity measurements in HEK293 cells cotransfected with cPLA(2)alpha and p11 also showed that p11, in the form of A2t, inhibits cPLA(2)alpha by the same mechanism and that phosphorylation of Ser(727) activates cPLA(2)alpha by interfering with the inhibitory cPLA(2)alpha-A2t interaction. Collectively, these studies provide new insight into the regulatory mechanism of cPLA(2)alpha through Ser(727) phosphorylation.	[Tian, Wen; Wijewickrama, Gihani T.; Kim, Jung Hwan; Das, Sudipto; Tun, Moe P.; Gokhale, Nikhil; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Kim, Kwang Pyo] Konkuk Univ, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Jung, Jin Woo; Kim, Kwang Pyo] Konkuk Univ, Dept Mol Biotechnol, Seoul 143701, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Konkuk University; Konkuk University	Cho, W (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	Kim, Kwang Pyo/AAG-1815-2020	Kim, Jung Hwan/0000-0001-8548-4435	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52598] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiba S, 2000, BRIT J PHARMACOL, V131, P1004, DOI 10.1038/sj.bjp.0703637; Akiba S, 2001, J BIOL CHEM, V276, P21854, DOI 10.1074/jbc.M010201200; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; BERS DM, 1982, AM J PHYSIOL, V242, P404; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 2000, BBA-MOL CELL BIOL L, V1488, P124, DOI 10.1016/S1388-1981(00)00115-3; Huang XL, 2002, J BIOL CHEM, V277, P38431, DOI 10.1074/jbc.M207406200; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Muthalif MM, 2001, J BIOL CHEM, V276, P39653, DOI 10.1074/jbc.M103136200; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; Nakatani Y, 2002, ADV EXP MED BIOL, V507, P21; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Rety S, 1999, NAT STRUCT BIOL, V6, P89; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	51	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3960	3971		10.1074/jbc.M707345200	http://dx.doi.org/10.1074/jbc.M707345200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065419	hybrid			2022-12-27	WOS:000253083500030
J	Molina-Cruz, A; Dejong, RJ; Charles, B; Gupta, L; Kumar, S; Jaramillo-Gutierrez, G; Barillas-Mury, C				Molina-Cruz, Alvaro; Dejong, Randall J.; Charles, Bradley; Gupta, Lalita; Kumar, Sanjeev; Jaramillo-Gutierrez, Giovanna; Barillas-Mury, Carolina			Reactive oxygen species modulate anopheles gambiae immunity against bacteria and plasmodium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; GENE-EXPRESSION; INNATE IMMUNITY; MIDGUT CELLS; MOSQUITO; VECTOR; PROTEIN; BERGHEI; DETERMINANT; NITRATION	The involvement of reactive oxygen species (ROS) in mosquito immunity against bacteria and Plasmodium was investigated in the malaria vector Anopheles gambiae. Strains of An. gambiae with higher systemic levels of ROS survive a bacterial challenge better, whereas reduction of ROS by dietary administration of antioxidants significantly decreases survival, indicating that ROS are required to mount effective antibacterial responses. Expression of several ROS detoxification enzymes increases in the midgut and fat body after a blood meal. Furthermore, expression of several of these enzymes increases to even higher levels when mosquitoes are fed a Plasmodium berghei-infected meal, indicating that the oxidative stress after a blood meal is exacerbated by Plasmodium infection. Paradoxically, a complete lack of induction of catalase mRNA and lower catalase activity were observed in P. berghei-infected midguts. This suppression of midgut catalase expression is a specific response to ookinete midgut invasion and is expected to lead to higher local levels of hydrogen peroxide. Further reduction of catalase expression by double-stranded RNA-mediated gene silencing promoted parasite clearance by a lytic mechanism and reduced infection significantly. High mosquito mortality is often observed after P. berghei infection. Death appears to result in part from excess production of ROS, as mortality can be decreased by oral administration of uric acid, a strong antioxidant. We conclude that ROS modulate An. gambiae immunity and that the mosquito response to P. berghei involves a local reduction of detoxification of hydrogen peroxide in the midgut that contributes to limit Plasmodium infection through a lytic mechanism.	[Molina-Cruz, Alvaro; Dejong, Randall J.; Gupta, Lalita; Kumar, Sanjeev; Jaramillo-Gutierrez, Giovanna; Barillas-Mury, Carolina] NIAID, NIH, LMVR, Bethesda, MD 20892 USA; [Charles, Bradley] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Colorado State University	Molina-Cruz, A (corresponding author), NIAID, NIH, LMVR, Twinbrook 3,MSC 8130,12735 Twinbrook Pkwy,Rm 2E-2, Bethesda, MD 20892 USA.	amolina-cruz@niaid.nih.gov	Gupta, Lalita/R-1111-2019	Kumar, Sanjeev/0000-0003-3866-4593; GUPTA, LALITA/0000-0002-0712-8512	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947, Z01AI000947] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; BRIEGEL H, 1975, J INSECT PHYSIOL, V21, P1597, DOI 10.1016/0022-1910(75)90197-3; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; de Munoz FGG, 2007, ARCH INSECT BIOCHEM, V65, P20, DOI 10.1002/arch.20174; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Peterson TML, 2006, FREE RADICAL BIO MED, V40, P1067, DOI 10.1016/j.freeradbiomed.2005.10.059; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Whitten MMA, 1999, J INSECT PHYSIOL, V45, P667, DOI 10.1016/S0022-1910(99)00039-6; *WHO, 2005, GLOB MAL REP 2005; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	34	199	205	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3217	3223		10.1074/jbc.M705873200	http://dx.doi.org/10.1074/jbc.M705873200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065421	hybrid			2022-12-27	WOS:000253083000025
J	Milstein, ML; McFarland, TP; Marsh, JD; Cala, SE				Milstein, Michelle L.; McFarland, Timothy P.; Marsh, James D.; Cala, Steven E.			Inefficient glycosylation leads to high steady-state levels of actively degrading cardiac triadin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL SARCOPLASMIC-RETICULUM; RYANODINE RECEPTOR; MOLECULAR-CLONING; SKELETAL-MUSCLE; IMPORTANT DETERMINANT; N-GLYCOSYLATION; RELEASE CHANNEL; AMINO-ACID; CALSEQUESTRIN; PROTEIN	In junctional sarcoplasmic reticulum, binding to cardiac triadin-1 provides a mechanism by which the Ca2+-release channel/ryanodine receptor may link with calsequestrin to regulate Ca2+ release. Calsequestrin and triadin-1 both contain N-linked glycans, but about half of triadin-1 in the heart remains unglycosylated. To investigate mechanisms for this incomplete glycosylation, we overexpressed triadin-1 as a series of glycoform variants in non-muscle cell lines and neonatal heart cells using plasmid and adenoviral vectors. We showed that the characteristic incomplete glycosylation stemmed from properties of the glycosylation sequence that are conserved among triadin splice variants, including the close proximity of Asn(75) to the sarcoplasmic reticulum inner membrane. Although triadin-1 appeared by SDS-PAGE analysis as a 35/40-kDa doublet in all cells, variations occurred in the relative levels of the two glycoforms depending on the cell type and whether overexpression involved a plasmid or adenoviral vector. Treatment of triadin-1 with the proteasome inhibitor MG-132 led to striking changes in the relative levels of triadin-1 that indicated active breakdown of unglycosylated, but not glycosylated, triadin-1. Besides substantial increases in the relative levels of unglycosylated triadin-1, proteasome inhibition led to an accumulation of two new modified forms of triadin-1 that were seen with triadin-1 only when it is not glycosylated on Asn(75). Effects of tunicamycin and endoglycosidase H confirmed that these novel isoforms represent two alternative N-linked glycosylation sites, indicating that an alternative topology occurs infrequently leading to yet other glycoforms with short half-lives.	[McFarland, Timothy P.; Cala, Steven E.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Milstein, Michelle L.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Marsh, James D.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA	Wayne State University; Wayne State University; University of Arkansas System; University of Arkansas Medical Sciences	Cala, SE (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, Elliman Bldg 421 E Canfield Ave, Detroit, MI 48201 USA.	s.cala@wayne.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062586] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62586] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Guo W, 1996, J BIOL CHEM, V271, P458, DOI 10.1074/jbc.271.1.458; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holscher C, 2001, J BIOL CHEM, V276, P13388, DOI 10.1074/jbc.M007331200; Hong CS, 2001, GENE, V278, P193, DOI 10.1016/S0378-1119(01)00718-1; Houle TD, 2006, EXP CELL RES, V312, P4150, DOI 10.1016/j.yexcr.2006.09.010; INUI M, 1987, J BIOL CHEM, V262, P15637; Jones LR, 1995, J BIOL CHEM, V270, P30787, DOI 10.1074/jbc.270.51.30787; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; Kirchhof P, 2007, J MOL CELL CARDIOL, V42, P962, DOI 10.1016/j.yjmcc.2007.02.012; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JM, 2004, J BIOL CHEM, V279, P6994, DOI 10.1074/jbc.M312446200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maki T, 1996, J CLIN INVEST, V97, P656, DOI 10.1172/JCI118462; Mellquist JL, 1998, BIOCHEMISTRY-US, V37, P6833, DOI 10.1021/bi972217k; NAKAI J, 1990, FEBS LETT, V271, P169, DOI 10.1016/0014-5793(90)80399-4; O'Brian JJ, 2002, J BIOL CHEM, V277, P37154, DOI 10.1074/jbc.M204370200; OTSU K, 1990, J BIOL CHEM, V265, P13472; Popov M, 1997, J BIOL CHEM, V272, P18325, DOI 10.1074/jbc.272.29.18325; Ram ML, 2004, MOL CELL BIOCHEM, V266, P209, DOI 10.1023/B:MCBI.0000049164.28580.56; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Terentyev D, 2005, CIRC RES, V96, P651, DOI 10.1161/01.RES.0000160609.98948.25; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389	30	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1929	1935		10.1074/jbc.M704623200	http://dx.doi.org/10.1074/jbc.M704623200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025088	hybrid			2022-12-27	WOS:000252501000019
J	Stamm, S				Stamm, Stefan			Regulation of alternative splicing by reversible protein phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-BINDING PROTEINS; SR PROTEINS; RS DOMAIN; INTRANUCLEAR LOCALIZATION; TYROSINE PHOSPHORYLATION; PHOSPHATASE PP2C-GAMMA; MESSENGER-RNAS; TAU EXON-10; CELL-CYCLE; HNRNP A1	The vast majority of human protein-coding genes are subject to alternative splicing, which allows the generation of more than one protein isoform from a single gene. Cells can change alternative splicing patterns in response to a signal, which creates protein variants with different biological properties. The selection of alternative splice sites is governed by the dynamic formation of protein complexes on the processed pre-mRNA. A unique set of these splicing regulatory proteins assembles on different pre-mRNAs, generating a "splicing" or "messenger ribonucleoprotein code" that determines exon recognition. By influencing protein/protein and protein/RNA interactions, reversible protein phosphorylation modulates the assembly of regulatory proteins on pre-mRNA and therefore contributes to the splicing code. Studies of the serine/arginine-rich protein class of regulators identified different kinases and protein phosphatase 1 as the molecules that control reversible phosphorylation, which controls not only splice site selection, but also the localization of serine/ arginine-rich proteins and mRNA export. The involvement of protein phosphatase 1 explains why second messengers like cAMP and ceramide that control the activity of this phosphatase influence alternative splicing. The emerging mechanistic links between splicing regulatory proteins and known signal transduction pathways now allow in detail the understanding how cellular signals modulate gene expression by influencing alternative splicing. This knowledge can be applied to human diseases that are caused by the selection of wrong splice sites.	Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Kentucky	Stamm, S (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, 741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net						Allemand E, 2005, P NATL ACAD SCI USA, V102, P3605, DOI 10.1073/pnas.0409889102; Allemand E, 2007, NAT STRUCT MOL BIOL, V14, P630, DOI 10.1038/nsmb1257; Aubol BE, 2003, P NATL ACAD SCI USA, V100, P12601, DOI 10.1073/pnas.1635129100; Beullens M, 2002, J BIOL CHEM, V277, P19855, DOI 10.1074/jbc.M200847200; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Blaustein M, 2007, INT J BIOCHEM CELL B, V39, P2031, DOI 10.1016/j.biocel.2007.04.004; Brady MJ, 2001, RECENT PROG HORM RES, V56, P157, DOI 10.1210/rp.56.1.157; Cao WH, 1997, RNA, V3, P1456; CARDINALI B, 1994, FEBS LETT, V352, P276, DOI 10.1016/0014-5793(94)00973-2; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Daoud R, 2002, J NEUROSCI, V22, P5889; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fukuhara T, 2006, P NATL ACAD SCI USA, V103, P11329, DOI 10.1073/pnas.0604616103; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Hanamura A, 1998, RNA, V4, P430; Hanks SK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-111; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hernandez F, 2004, J BIOL CHEM, V279, P3801, DOI 10.1074/jbc.M311512200; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; JEANTEUR P, 2006, PROGR MOL SUBCELLULA, V44; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lukong KE, 2005, J BIOL CHEM, V280, P38639, DOI 10.1074/jbc.M505802200; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Murray MV, 1999, GENE DEV, V13, P87, DOI 10.1101/gad.13.1.87; Nayler O, 1998, J BIOL CHEM, V273, P34341, DOI 10.1074/jbc.273.51.34341; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Rafalska I, 2004, HUM MOL GENET, V13, P1535, DOI 10.1093/hmg/ddh167; Rho J, 2007, ARCH BIOCHEM BIOPHYS, V466, P49, DOI 10.1016/j.abb.2007.07.017; Roberts GC, 2002, CURR OPIN CHEM BIOL, V6, P375, DOI 10.1016/S1367-5931(02)00320-4; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Sanford JR, 2005, BIOCHEM SOC T, V33, P443, DOI 10.1042/BST0330443; Sanford JR, 2005, P NATL ACAD SCI USA, V102, P15042, DOI 10.1073/pnas.0507827102; Shen HH, 2006, GENE DEV, V20, P1755, DOI 10.1101/gad.1422106; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Soret J, 2003, CANCER RES, V63, P8203; SOULARD M, 1993, NUCLEIC ACIDS RES, V21, P4210, DOI 10.1093/nar/21.18.4210; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2002, HUM MOL GENET, V11, P2409, DOI 10.1093/hmg/11.20.2409; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200	69	182	194	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1223	1227		10.1074/jbc.R700034200	http://dx.doi.org/10.1074/jbc.R700034200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024427	hybrid			2022-12-27	WOS:000252282700004
J	Abdulhussein, R; Koo, DHH; Vogel, WF				Abdulhussein, Rahim; Koo, Diana H. H.; Vogel, Wolfgang F.			Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISCOIDIN DOMAIN RECEPTOR-1; GROWTH-FACTOR RECEPTOR; HUMAN INSULIN-RECEPTOR; COLLAGEN-BINDING; ACTIVATION; DIMERIZATION; EXPRESSION; CANCER; CELLS; MIGRATION	Discoidin domain receptor 1 (DDR1) is a transmembrane receptor tyrosine kinase activated by triple-helical collagen. So far six different isoforms of DDR1 have been described. Aberrant expression and signaling of DDR1 have been implicated in several human diseases linked to accelerated matrix degradation and remodeling, including tumor invasion, atherosclerosis, and lung fibrosis. Here we show that DDR1 exists as a disulfide-linked dimer in transfected as well as endogenously expressing cells. This dimer formation occurred irrespective of its kinase domain, as dimers were also found for the truncated DDR1d isoform. A deletion analysis of the extracellular domain showed that DDR1 mutants lacking the stalk region failed to form dimers, whereas deletion of the discoidin domain did not prevent dimerization. Point mutagenesis within the stalk region suggested that cysteines 303 and 348 are necessary for dimerization, collagen binding, and activation of kinase function. The identification of DDR1 dimers provides new insights into the molecular structure of receptor tyrosine kinases and suggests distinct signaling mechanisms of each receptor subfamily.	[Abdulhussein, Rahim; Koo, Diana H. H.; Vogel, Wolfgang F.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Abdulhussein, R (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Banting Inst, 100 Coll St,Rm 110, Toronto, ON M5G 1L5, Canada.	rahim.abdulhussein@utoronto.ca						Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; ALVES F, 1995, ONCOGENE, V10, P609; Alves F, 2001, FASEB J, V15, P1321, DOI 10.1096/fj.00-0626fje; Avivi-Green C, 2006, AM J RESP CRIT CARE, V174, P420, DOI 10.1164/rccm.200603-333OC; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Faraci-Orf E, 2006, J CELL BIOCHEM, V97, P109, DOI 10.1002/jcb.20618; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Franco-Pons N, 2006, NEUROSCIENCE, V140, P463, DOI 10.1016/j.neuroscience.2006.02.033; Fruehauf J, 2006, J EXP THER ONCOL, V5, P231; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gross O, 2004, KIDNEY INT, V66, P102, DOI 10.1111/j.1523-1755.2004.00712.x; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Koo DHH, 2006, FEBS LETT, V580, P15, DOI 10.1016/j.febslet.2005.11.035; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Lu KH, 1996, MOL BIOL CELL, V7, P679, DOI 10.1091/mbc.7.5.679; Mullenbach E, 2006, GENE, V372, P53, DOI 10.1016/j.gene.2005.12.004; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Playford MP, 1996, GENOME RES, V6, P620, DOI 10.1101/gr.6.7.620; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wu JJP, 2004, J BIOL CHEM, V279, P25765, DOI 10.1074/jbc.M314281200; Wu JJP, 2002, J BIOL CHEM, V277, P27809, DOI 10.1074/jbc.M200367200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12026	12033		10.1074/jbc.M704592200	http://dx.doi.org/10.1074/jbc.M704592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18065762	Green Published, hybrid			2022-12-27	WOS:000255340000018
J	Watanabe, S; Watanabe, TM; Sato, O; Awata, J; Homma, K; Umeki, N; Higuchi, H; Ikebe, R; Ikebe, M				Watanabe, Shinya; Watanabe, Tomonobu M.; Sato, Osamu; Awata, Junya; Homma, Kazuaki; Umeki, Nobuhisa; Higuchi, Hideo; Ikebe, Reiko; Ikebe, Mitsuo			Human myosin Vc is a low duty ratio nonprocessive motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; KINETIC MECHANISM; LIGHT-CHAIN; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE; ATPASE MECHANISMS; MESSENGER-RNA; ACTIN; ACTOMYOSIN; YEAST	There are three distinct members of the myosin V family in vertebrates, and each isoform is involved in different membrane trafficking pathways. Both myosin Va and Vb have demonstrated that they are high duty ratio motors that are consistent with the processive nature of these motors. Here we report that the ATPase cycle mechanism of the single-headed construct of myosin Vc is quite different from those of other vertebrate myosin Visoforms. K-ATPase of the actin-activated ATPase was 62 mu M, which is much higher than that of myosin Va (similar to 1 mu M). The rate of ADP release from actomyosin Vc was 12.7 s(-1), which was 2 times greater than the entire ATPase cycle rate, 6.5 s(-1). Pi burst size was 0.31, indicating that the equilibrium of the ATP hydrolysis step is shifted to the prehydrolysis form. Our kinetic model, based on all kinetic data we determined in this study, suggests that myosin Vc spends the majority of the ATPase cycle time in the weak actin binding state in contrast to myosin Va and Vb. Consistently, the two-headed myosin Vc construct did not show processive movement in total internal reflection fluorescence microscope analysis, demonstrating that myosin Vc is a non-processive motor. Our findings suggest that myosin Vc fulfills its function as a cargo transporter by different mechanisms from other myosin V isoforms.	[Watanabe, Shinya; Watanabe, Tomonobu M.; Sato, Osamu; Awata, Junya; Homma, Kazuaki; Umeki, Nobuhisa; Ikebe, Reiko; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [Higuchi, Hideo] Tohoku Univ, Biomed Res Org, Sendai, Miyagi 981, Japan	University of Massachusetts System; University of Massachusetts Worcester; Tohoku University	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.	Mitsuo.lkebe@umassmed.edu	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230	NIAMS NIH HHS [AR41653, AR048898, AR048526] Funding Source: Medline; NIDCD NIH HHS [DC006103] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR041653, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ajtai K, 2004, J BIOL CHEM, V279, P23415, DOI 10.1074/jbc.M310775200; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Kambara T, 1999, J BIOL CHEM, V274, P16400, DOI 10.1074/jbc.274.23.16400; KODAMA T, 1985, PHYSIOL REV, V65, P467, DOI 10.1152/physrev.1985.65.2.467; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Munchow S, 1999, J CELL SCI, V112, P1511; Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 1997, J CELL SCI, V110, P847; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	47	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10581	10592		10.1074/jbc.M707657200	http://dx.doi.org/10.1074/jbc.M707657200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18079121	hybrid, Green Published			2022-12-27	WOS:000254894700040
J	Ganichkin, OM; Xu, XM; Carlson, BA; Mix, H; Hatfield, DL; Gladyshev, VN; Wahl, MC				Ganichkin, Oleg M.; Xu, Xue-Ming; Carlson, Bradley A.; Mix, Heiko; Hatfield, Dolph L.; Gladyshev, Vadim N.; Wahl, Markus C.			Structure and catalytic mechanism of eukaryotic selenocysteine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SELENOPROTEIN SYNTHESIS; SECONDARY-STRUCTURE; TARGET ANTIGEN; PROTEIN; IDENTIFICATION; HOMOLOG; LYASE	In eukaryotes and Archaea, selenocysteine synthase (SecS) converts O-phospho-L-seryl-tRNA([Ser]Sec) into selenocysteyl-tRNA([Ser]Sec) using selenophosphate as the selenium donor compound. The molecular mechanisms underlying SecS activity are presently unknown. We have delineated a 450-residue core of mouse SecS, which retained full selenocysteyl-tRNA([Ser]Sec) synthesis activity, and determined its crystal structure at 1.65 angstrom resolution. SecS exhibits three domains that place it in the fold type I family of pyridoxal phosphate (PLP)-dependent enzymes. Two SecS monomers interact intimately and together build up two identical active sites around PLP in a Schiff-base linkage with lysine 284. Two SecS dimers further associate to form a homotetramer. The N terminus, which mediates tetramer formation, and a large insertion that remodels the active site set SecS aside from other members of the family. The active site insertion contributes to PLP binding and positions a glutamate next to the PLP, where it could repel substrates with a free alpha-carboxyl group, suggesting why SecS does not act on free O-phospho-L-serine. Upon soaking crystals in phosphate buffer, a previously disordered loop within the active site insertion contracted to form a phosphate binding site. Residues that are strictly conserved in SecS orthologs but variant in related enzymes coordinate the phosphate and upon mutation corrupt SecS activity. Modeling suggested that the phosphate loop accommodates the gamma-phosphate moiety of O-phospho-L-seryl-tRNA([Ser]Sec) and, after phosphate elimination, binds selenophosphate to initiate attack on the proposed aminoacrylyl-tRNA([Ser]Sec) intermediate. Based on these results and on the activity profiles of mechanism-based inhibitors, we offer a detailed reaction mechanism for the enzyme.	[Ganichkin, Oleg M.; Wahl, Markus C.] Max Planck Inst Biophys Chem, Zellulare Biochem Makromol Rontgenkristallog, D-37077 Gottingen, Germany; [Xu, Xue-Ming; Carlson, Bradley A.; Hatfield, Dolph L.] NIH, NCI, Canc Res Ctr, Lab Canc Prevent Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Mix, Heiko; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Zellulare Biochem Makromol Rontgenkristallog, Am Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Gladyshev, Vadim N/A-9894-2013; Wahl, Markus C./D-6365-2017; Gladyshev, Vadim N/J-6187-2013	Wahl, Markus C./0000-0002-2811-5307; Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010767, Z01BC010767] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; BARON C, 1991, J BIOL CHEM, V266, P20375; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; DWIVEDI CM, 1982, BIOCHEMISTRY-US, V21, P3064, DOI 10.1021/bi00256a005; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; Hendrickson TL, 2007, NAT STRUCT MOL BIOL, V14, P100, DOI 10.1038/nsmb0207-100; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hubert N, 1998, RNA, V4, P1029, DOI 10.1017/S1355838298980888; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kernebeck T, 2001, HEPATOLOGY, V34, P230, DOI 10.1053/jhep.2001.26632; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rother M, 2001, BIOFACTORS, V14, P75, DOI 10.1002/biof.5520140111; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; YUAN J, 2006, P NATL ACAD SCI USA, V103, P1893	59	42	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5849	5865		10.1074/jbc.M709342200	http://dx.doi.org/10.1074/jbc.M709342200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093968	hybrid, Green Submitted			2022-12-27	WOS:000253426700064
J	Lee, JY; Urbatsch, IL; Senior, AE; Wilkens, S				Lee, Jyh-Yeuan; Urbatsch, Ina L.; Senior, Alan E.; Wilkens, Stephan			Nucleotide-induced structural changes in P-glycoprotein observed by electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; ABC TRANSPORTER; ATP-BINDING; PROJECTION STRUCTURE; CATALYTIC CYCLE; ESCHERICHIA-COLI; CONFORMATION; PURIFICATION; MECHANISM; AFFINITY	P-glycoprotein (Pgp) is an ATP hydrolysis driven multidrug efflux pump, which, when overexpressed in the plasma membrane of certain cancers, can lead to the failure of chemotherapy. Previously, we have presented a projection structure of nucleotide-free mouse Pgp from electron microscopic images of lipid monolayer-generated two-dimensional crystals (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2002) J. Biol. Chem. 277, 40125-40131). Here we have analyzed the structure of cysteine-free human Pgp from two-dimensional crystals that were generated with the same lipid-monolayer technique in the absence and presence of various nucleotides. The images show that human Pgp has a similar structure to the mouse protein. Furthermore, the analysis of projection structures obtained under different nucleotide conditions suggests that Pgp can exist in at least two major conformations, one of which shows a central cavity between the N-and C-terminal halves of the molecule and another in which the two halves have moved sideways, thereby closing the central cavity. Intermediate conformations were observed for some nucleotide/vanadate combinations. A low-resolution, three-dimensional model of human Pgp was calculated from tilted specimen crystallized in the presence of the non-hydrolyzable nucleotide analog, adenosine 5'-O-(thiotriphosphate). The structural analysis presented here adds to the emerging picture that multidrug ABC transporters function by switching between two major conformations in a nucleotide-dependent manner.	[Lee, Jyh-Yeuan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Senior, Alan E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, New York, NY 14642 USA; [Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of California System; University of California Riverside; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Lee, Jyh-Yeuan/ACA-2717-2022	Lee, Jyh-Yeuan/0000-0003-1799-2416	NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050156] Funding Source: NIH RePORTER; NCI NIH HHS [CA100246] Funding Source: Medline; NIGMS NIH HHS [GM50156] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell JD, 2005, FEBS LETT, V579, P4193, DOI 10.1016/j.febslet.2005.06.027; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; KESSEL M, 1985, J MICROSC-OXFORD, V139, P63, DOI 10.1111/j.1365-2818.1985.tb04662.x; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Sherman MB, 1998, ULTRAMICROSCOPY, V74, P179, DOI 10.1016/S0304-3991(98)00041-2; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Unger VM, 2000, ACTA CRYSTALLOGR D, V56, P1259, DOI 10.1107/S0907444900011252; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; van Veen HW, 2001, SEMIN CELL DEV BIOL, V12, P239, DOI 10.1006/scdb.2000.0249; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558	47	64	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5769	5779		10.1074/jbc.M707028200	http://dx.doi.org/10.1074/jbc.M707028200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093977	hybrid			2022-12-27	WOS:000253426700058
J	Yuan, C; O'Connell, RJ; Wilson, A; Pietrzykowski, AZ; Treistman, SN				Yuan, Chunbo; O'Connell, Robert J.; Wilson, Andrew; Pietrzykowski, Andrzej Z.; Treistman, Steven N.			Acute alcohol tolerance is intrinsic to the BKCa protein, but is modulated by the lipid environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; PHOSPHOLIPID SURFACE-CHARGE; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; SMOOTH-MUSCLE; ETHANOL POTENTIATION; BILAYER THICKNESS; NEUROHYPOPHYSEAL TERMINALS; ANESTHETIC ACTION; BINDING-SITE	Ethanol tolerance, in which exposure leads to reduced sensitivity, is an important component of alcohol abuse and addiction. The molecular mechanisms underlying this process remain poorly understood. The BKCa channel plays a central role in the behavioral response to ethanol in Caenorhabditis elegans (Davies, A. G., Pierce-Shimomura, J.T., Kim, H., VanHoven, M. K., Thiele, T. R., Bonci, A., Bargmann, C.I., and McIntire, S. L. (2003) Cell 115, 655 666) and Drosophila (Cowmeadow, R. B., Krishnan, H.R., and Atkinson, N.S. (2005) Alcohol. Clin. Exp. Res. 29, 1777-1786). In neurons, ethanol tolerance in BKCa channels has two components: a reduced number of membrane channels and decreased potentiation of the remaining channels (Pietrzykowski, A.Z., Martin, G.E., Puig, S.I., Knott, T.K., Lemos, J.R., and Treistman, S.N. (2004) J. Neurosci. 24, 8322-8332). Here, heterologous expression coupled with planar bilayer techniques examines two additional aspects of tolerance in human BKCa channels. 1) Is acute tolerance observed in a single channel protein complex within a lipid environment reduced to only two lipids? 2) Does lipid bilayer composition affect the appearance of acute tolerance? We found that tolerance was observable in BKCa channels in membrane patches pulled from HEK cells and when they are placed into reconstituted1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine/1palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine membranes. Furthermore, altering bilayer thickness by incorporating the channel into lipid mixtures of 1,2-dioleoyl-3-phosphatidylethanolamine with phosphatidylcholines of increasing chain length, or with sphingomyelin, strongly affected the sensitivity of the channel, as well as the time course of the acute response. Ethanol sensitivity changed from a strong potentiation in thin bilayers to inhibition in thick sphingomyelin/1,2-dioleoyl-3-phosphatidylethanolamine bilayers. Thus, tolerance can be an intrinsic property of the channel protein-lipid complex, and bilayer thickness plays an important role in shaping the pattern of response to ethanol. As a consequence of these findings the protein-lipid complex should be treated as a unit when studying ethanol action.	[Yuan, Chunbo; O'Connell, Robert J.; Wilson, Andrew; Pietrzykowski, Andrzej Z.; Treistman, Steven N.] Univ Massachusetts, Sch Med, Brudnic Neuropsychiat Res Inst, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester	Treistman, SN (corresponding author), Univ Massachusetts, Sch Med, Brudnic Neuropsychiat Res Inst, Worcester, MA 01604 USA.		Yuan, Chunbo/E-9627-2011		NIAAA NIH HHS [R37 AA012054-10, R37 AA012054, AA12054, R01 AA018038, R01 AA018038-02] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012054, R01AA018038] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Alvarez O., 1986, ION CHANNEL RECONSTI, P115; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BARRY JA, 1995, BIOCHEMISTRY-US, V34, P8852, DOI 10.1021/bi00027a037; BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; Blevins T, 1997, J NEUROCHEM, V69, P2345; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Brodie MS, 2007, ALCOHOL CLIN EXP RES, V31, P1625, DOI 10.1111/j.1530-0277.2007.00469.x; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; Ghezzi A, 2004, P NATL ACAD SCI USA, V101, P17276, DOI 10.1073/pnas.0405584101; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gribkoff V K, 1997, Adv Pharmacol, V37, P319; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris T, 2000, J BIOL CHEM, V275, P4928, DOI 10.1074/jbc.275.7.4928; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hering H, 2003, J NEUROSCI, V23, P3262; Jakab M, 2006, ACTA PHYSIOL, V187, P51, DOI 10.1111/j.1748-1716.2006.01544.x; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Knott TK, 2002, MOL PHARMACOL, V62, P135, DOI 10.1124/mol.62.1.135; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Liu PC, 2004, P NATL ACAD SCI USA, V101, P18217, DOI 10.1073/pnas.0406096102; Liu PC, 2003, ALCOHOL CLIN EXP RES, V27, P1640, DOI 10.1097/01.ALC.0000094756.41638.5D; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pietrzykowski AZ, 2004, J NEUROSCI, V24, P8322, DOI 10.1523/JNEUROSCI.1536-04.2004; REINHART PH, 1991, J NEUROSCI, V11, P1627; Sansom MSP, 2002, BBA-BIOMEMBRANES, V1565, P294, DOI 10.1016/S0005-2736(02)00576-X; Schuckit M A, 1993, Alcohol Alcohol Suppl, V2, P91; Shahidullah M, 2003, BIOCHEMISTRY-US, V42, P11243, DOI 10.1021/bi034738f; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002	58	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5090	5098		10.1074/jbc.M708214200	http://dx.doi.org/10.1074/jbc.M708214200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18084004	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000253426500066
J	Bergamaschi, C; Rosati, M; Jalah, R; Valentin, A; Kulkarni, V; Alicea, C; Zhang, GM; Patel, V; Felber, BK; Pavlakis, GN				Bergamaschi, Cristina; Rosati, Margherita; Jalah, Rashmi; Valentin, Antonio; Kulkarni, Viraj; Alicea, Candido; Zhang, Gen-Mu; Patel, Vainav; Felber, Barbara K.; Pavlakis, George N.			Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; NATURAL-KILLER-CELLS; CD8(+) T-CELLS; IL-15 ACTIVITY; CUTTING EDGE; BETA-CHAIN; EXPRESSION; CYTOKINE; REV; PROLIFERATION	We show that co-expression of interleukin 15 (IL-15) and IL-15 receptor alpha(IL-15R alpha) in the same cell allows for the intracellular interaction of the two proteins early after translation, resulting in increased stability and secretion of both molecules as a complex. In the absence of co-expressed IL-15R alpha, a large portion of the produced IL-15 is rapidly degraded immediately after synthesis. Co-injection into mice of IL-15 and IL-15R alpha expression plasmids led to significantly increased levels of the cytokine in serum as well as increased biological activity of IL-15. Examination of natural killer cells and T lymphocytes in mouse organs showed a great expansion of both cell types in the lung, liver, and spleen. The presence of IL-15R alpha also increased the number of CD44(high) memory cells with effector phenotype (CD44(high)CD62L-). Thus, mutual stabilization of IL-15 and IL-15R alpha leads to remarkable increases in production, stability, and tissue availability of bioactive IL-15 in vivo. The in vivo data show that the most potent form of IL-15 is as part of a complex with its receptor alpha either on the surface of the producing cells or as a soluble extracellular complex. These results explain the reason for coordinate expression of IL-15 and IL-15R alpha in the same cell and suggest that the IL-15R alpha is part of the active IL-15 cytokine rather than part of the receptor.	[Bergamaschi, Cristina; Rosati, Margherita; Valentin, Antonio; Zhang, Gen-Mu; Patel, Vainav; Pavlakis, George N.] NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Sect,NIH, Frederick, MD 21702 USA; [Jalah, Rashmi; Kulkarni, Viraj; Alicea, Candido; Zhang, Gen-Mu; Felber, Barbara K.] NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Pathogenesis Sect,NIH, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Canc Res Ctr, Vaccine Branch, Human Retrovirus Sect,NIH, Bldg 535,Rm 210, Frederick, MD 21702 USA.	pavlakis@ncifcrf.gov			NATIONAL CANCER INSTITUTE [ZIABC010334, ZIABC010750, Z01BC010334, ZIABC010350, Z01BC010350, Z01BC010750] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Azimi N, 2001, P NATL ACAD SCI USA, V98, P14559, DOI 10.1073/pnas.251540598; Bamford RN, 1998, J IMMUNOL, V160, P4418; Becker TC, 2002, J EXP MED, V195, P1541, DOI 10.1084/jem.20020369; Budagian V, 2004, J BIOL CHEM, V279, P40368, DOI 10.1074/jbc.M404125200; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Burkett PR, 2003, P NATL ACAD SCI USA, V100, P4724, DOI 10.1073/pnas.0737048100; BURTON JD, 1994, P NATL ACAD SCI USA, V91, P4935, DOI 10.1073/pnas.91.11.4935; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; GRABSTEIN KH, 1994, SCIENCE, V264, P965, DOI 10.1126/science.8178155; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Jiang JJ, 2001, BIOCHEM BIOPH RES CO, V289, P1088, DOI 10.1006/bbrc.2001.6100; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; Lodolce JP, 2001, J EXP MED, V194, P1187, DOI 10.1084/jem.194.8.1187; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Mariner JM, 2002, J IMMUNOL, V168, P5667, DOI 10.4049/jimmunol.168.11.5667; Mortier E, 2006, J BIOL CHEM, V281, P1612, DOI 10.1074/jbc.M508624200; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Onu A, 1997, J IMMUNOL, V158, P255; Ortaldo JR, 2005, J IMMUNOL, V175, P693, DOI 10.4049/jimmunol.175.2.693; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Rosati M, 2005, J VIROL, V79, P8480, DOI 10.1128/JVI.79.13.8480-8492.2005; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Ruchatz H, 1998, J IMMUNOL, V160, P5654; Ruckert R, 2003, EUR J IMMUNOL, V33, P3493, DOI 10.1002/eji.200324545; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Sato N, 2007, P NATL ACAD SCI USA, V104, P588, DOI 10.1073/pnas.0610115104; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Schluns KS, 2004, BLOOD, V103, P988, DOI 10.1182/blood-2003-08-2814; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P150, DOI 10.1128/JVI.66.1.150-159.1992; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Smith XG, 2000, J IMMUNOL, V165, P3444, DOI 10.4049/jimmunol.165.6.3444; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; VARKI A, 1991, FASEB J, V5, P226, DOI 10.1096/fasebj.5.2.2004668; Villinger F, 2004, VACCINE, V22, P3510, DOI 10.1016/j.vaccine.2003.07.022; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9	56	125	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4189	4199		10.1074/jbc.M705725200	http://dx.doi.org/10.1074/jbc.M705725200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055460	hybrid			2022-12-27	WOS:000253083500054
J	Bierings, R; Beato, M; Edel, MJ				Bierings, Ruben; Beato, Miguel; Edel, Michael J.			An endothelial cell genetic screen identifies the GTPase Rem2 as a suppressor of p19(ARF) expression that promotes endothelial cell proliferation and angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-CHANNEL ACTIVITY; TUMOR-SUPPRESSOR; MOUSE EYE; SENESCENCE; CANCER; P53; 14-3-3-GAMMA; INHIBITORS; FAMILY; SHAPE	Angiogenesis requires an increase in endothelial cell proliferation to support an increase in mass of blood vessels. We designed an in vitro endothelial cell model to functionally screen for genes that regulate endothelial cell proliferation. A gain of function screen for genes that bypass p53 endothelial cell arrest identified Rem2, a Ras-like GTPase. We show that ectopic Rem2 suppresses p14(ARF) (human) or p19(ARF) (mouse) expression that leads to increased endothelial cell proliferation. Conversely, loss of ectopic Rem2 by RNA interference restores p19ARF expression in endothelial cells. We further show that Rem2-interacting 14-3-3 proteins are involved in the cell localization of Rem2, regulation of p19ARF expression, and endothelial cell proliferation. Finally, we demonstrate using the RIP1 tag2 mouse model of pancreatic disease that Rem2 is up-regulated in endothelial cells of stage IV disease. The data unravel a possible molecular mechanism for Rem2-induced angiogenesis and suggests Rem2 as a potential novel target for treating pathological angiogenesis.	[Bierings, Ruben] Sanquin Res & Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands; [Beato, Miguel; Edel, Michael J.] Univ Pompeu Fabra, CRG, Barcelona, Spain	University of Amsterdam; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bierings, R (corresponding author), Sanquin Res & Landsteiner Lab, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands.		Bierings, Ruben/AAQ-8854-2020; Edel, Michael J/L-1954-2014; Beato, Miguel/B-5564-2015	Bierings, Ruben/0000-0002-1205-9689; Edel, Michael J/0000-0002-5619-8680; Beato, Miguel/0000-0002-2878-2222				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; DelVillar K, 1996, BIOCHEM SOC T, V24, P709; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Esteller M, 2001, CANCER RES, V61, P3225; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; FOLKMAN J, 1989, NEW ENGL J MED, V320, P1211, DOI 10.1056/NEJM198905043201811; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kanda S, 1996, CELL GROWTH DIFFER, V7, P383; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; McKeller RN, 2002, P NATL ACAD SCI USA, V99, P3848, DOI 10.1073/pnas.052484199; Pan JY, 2000, J CELL BIOL, V149, P1107, DOI 10.1083/jcb.149.5.1107; Piddini E, 2001, EMBO J, V20, P4076, DOI 10.1093/emboj/20.15.4076; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva RLA, 2005, EMBO J, V24, P2803, DOI 10.1038/sj.emboj.7600751; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Towbin H, 2003, J BIOL CHEM, V278, P52964, DOI 10.1074/jbc.M309039200; Weidner Noel, 1996, P167	26	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4408	4416		10.1074/jbc.M707438200	http://dx.doi.org/10.1074/jbc.M707438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056257	hybrid			2022-12-27	WOS:000253083500075
J	Fischer, A; Garcia-Rodriguez, C; Geren, I; Lou, JL; Marks, JD; Nakagawa, T; Montal, M				Fischer, Audrey; Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.; Nakagawa, Terunaga; Montal, Mauricio			Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN PROTEASE; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; TETANUS NEUROTOXIN; SEROTYPE-A; CLOSTRIDIAL NEUROTOXINS; SUBSTRATE RECOGNITION; ANGSTROM RESOLUTION; CATALYTIC DOMAIN; SYNAPTOTAGMIN-I	Clostridial botulinum neurotoxin (BoNT) causes a neuroparalytic condition recognized as botulism by arresting synaptic vesicle exocytosis. Although the crystal structures of full-length BoNT/A and BoNT/B holotoxins are known, the molecular architecture of the five other serotypes remains elusive. Here, we present the structures of BoNT/A and BoNT/E using single particle electron microscopy. Labeling of the particles with three different monoclonal antibodies raised against BoNT/E revealed the positions of their epitopes in the electron microscopy structure, thereby identifying the three hallmark domains of BoNT (protease, translocation, and receptor binding). Correspondingly, these antibodies selectively inhibit BoNT translocation activity as detected using a single molecule assay. The global structure of BoNT/E is strikingly different from that of BoNT/A despite strong sequence similarity. We postulate that the unique architecture of functionally conserved modules underlies the distinguishing attributes of BoNT/E and contributes to differences with BoNT/A.	[Fischer, Audrey; Montal, Mauricio] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Nakagawa, Terunaga] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Garcia-Rodriguez, Consuelo; Geren, Isin; Lou, Jianlong; Marks, James D.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nakagawa, T (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	nakagawa@ucsd.edu; mmontal@ucsd.edu	Taylor, Graham/A-4027-2012; Pacific-Southwest, RCE/B-6155-2009; Geren, Isin/AAG-7281-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056493, U54AI065359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033050, R37GM033050] Funding Source: NIH RePORTER; NCRR NIH HHS [1S10RR20016] Funding Source: Medline; NIAID NIH HHS [U01 AI056493, AI065359] Funding Source: Medline; NIGMS NIH HHS [GM033050] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal R, 2005, BIOCHEMISTRY-US, V44, P11758, DOI 10.1021/bi0510072; Agarwal R, 2004, BIOCHEMISTRY-US, V43, P6637, DOI 10.1021/bi036278w; Arndt JW, 2006, BIOCHEMISTRY-US, V45, P3255, DOI 10.1021/bi052518r; Arndt JW, 2005, BIOCHEMISTRY-US, V44, P9574, DOI 10.1021/bi0505924; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bade S, 2004, J NEUROCHEM, V91, P1461, DOI 10.1111/j.1471-4159.2004.02844.x; Bajohrs M, 2004, EMBO REP, V5, P1090, DOI 10.1038/sj.embor.7400278; Breidenbach MA, 2005, BIOCHEMISTRY-US, V44, P7450, DOI 10.1021/bi050262j; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; Ferrer-Montiel AV, 1998, FEBS LETT, V435, P84, DOI 10.1016/S0014-5793(98)01012-6; FerrerMontiel AV, 1996, J BIOL CHEM, V271, P18322, DOI 10.1074/jbc.271.31.18322; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fotinou C, 2001, J BIOL CHEM, V276, P32274, DOI 10.1074/jbc.M103285200; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; HOCH DH, 1985, P NATL ACAD SCI USA, V82, P1692, DOI 10.1073/pnas.82.6.1692; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jayaraman S, 2005, PROTEINS, V61, P288, DOI 10.1002/prot.20595; Jin RS, 2007, BIOCHEMISTRY-US, V46, P10685, DOI 10.1021/bi701162d; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Keller JE, 2001, J BIOL CHEM, V276, P13476, DOI 10.1074/jbc.M010992200; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Nishiki T, 1996, NEUROSCI LETT, V208, P105, DOI 10.1016/0304-3940(96)12557-X; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Rao KN, 2005, TOXICON, V45, P929, DOI 10.1016/j.toxicon.2005.02.032; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; ROBINSON JP, 1988, J MOL BIOL, V200, P367, DOI 10.1016/0022-2836(88)90247-1; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; SATHYAMOORTHY V, 1985, J BIOL CHEM, V260, P461; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Vaidyanathan VV, 1999, J NEUROCHEM, V72, P327, DOI 10.1046/j.1471-4159.1999.0720327.x; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	49	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3997	4003		10.1074/jbc.M707917200	http://dx.doi.org/10.1074/jbc.M707917200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18032388	hybrid			2022-12-27	WOS:000253083500034
J	Flock, U; Thorndycroft, FH; Matorin, AD; Richardson, DJ; Watmough, NJ; Ardelroth, P				Flock, Ulrika; Thorndycroft, Faye H.; Matorin, Andrey D.; Richardson, David J.; Watmough, Nicholas J.; Ardelroth, Pia			Defining the proton entry point in the bacterial respiratory nitric-oxide reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-COPPER OXIDASE; CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; PATHWAY; ENZYME; EXISTENCE; CHANNEL; OXYGEN; SITE	The bacterial respiratory nitric-oxide reductase (NOR) is a member of the superfamily of O-2-reducing, proton-pumping, heme-copper oxidases. Even although nitric oxide reduction is a highly exergonic reaction, NOR is not a proton pump and rather than taking up protons from the cytoplasmic (membrane potential-negative) side of the membrane, like the heme-copper oxidases, NOR derives its substrate protons from the periplasmic (membrane potential-positive) side of the membrane. The molecular details of this non-electrogenic proton transfer are not yet resolved, so in this study we have explored a role in a proposed proton pathway for a conserved surface glutamate (Glu-122) in the catalytic subunit (NorB). The effect of substituting Glu-122 with Ala, Gln, or Asp on a single turnover of the reduced NOR variants with O-2, an alternative and experimentally tractable substrate for NOR, was determined. Electron transfer coupled to proton uptake to the bound O-2 is severely and specifically inhibited in both the E122A and E122Q variants, establishing the importance of a protonatable side chain at this position. In the E122D mutant, proton uptake is retained but it is associated with a significant increase in the observed pK(a) of the group donating protons to the active site. This suggests that Glu-122 is important in defining this proton donor. A second nearby glutamate (Glu-125) is also required for the electron transfer coupled to proton uptake, further emphasizing the importance of this region of NorB in proton transfer. Because Glu-122 is predicted to lie near the periplasmic surface of NOR, the results provide strong experimental evidence that this residue contributes to defining the aperture of a non-electrogenic "E-pathway" that serves to deliver protons from the periplasm to the buried active site in NOR.	[Flock, Ulrika; Ardelroth, Pia] Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden; [Thorndycroft, Faye H.; Matorin, Andrey D.; Richardson, David J.; Watmough, Nicholas J.] Univ E Anglia, Ctr Mol Struct & Biochem, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Stockholm University; University of East Anglia	Ardelroth, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Arrhenius Labs Nat Sci, S-10691 Stockholm, Sweden.	piaa@dbb.su.se	Watmough, Nicholas J/A-6643-2010; Richardson, David J/E-2275-2011	Watmough, Nicholas J/0000-0001-5901-6750; 	Biotechnology and Biological Sciences Research Council [B19851, BB/C007719/1, BBC0077191] Funding Source: Medline; Medical Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; BELL LC, 1992, J GEN MICROBIOL, V138, P437, DOI 10.1099/00221287-138-3-437; Blomberg LM, 2006, BBA-BIOENERGETICS, V1757, P31, DOI 10.1016/j.bbabio.2005.11.004; BLOMBERG LM, 2006, THESIS STOCKHOLM U S; Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398; Butland G, 2001, J BACTERIOL, V183, P189, DOI 10.1128/JB.183.1.189-199.2001; Cheesman MR, 1998, BIOCHEMISTRY-US, V37, P3994, DOI 10.1021/bi972437y; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Flock U, 2005, BIOCHEMISTRY-US, V44, P10711, DOI 10.1021/bi050524h; Flock U, 2006, BIOCHEM SOC T, V34, P188, DOI 10.1042/BST0340188; Fujiwara T, 1996, J BACTERIOL, V178, P1866, DOI 10.1128/jb.178.7.1866-1871.1996; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Girsch P, 1997, BBA-BIOENERGETICS, V1318, P202, DOI 10.1016/S0005-2728(96)00138-7; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hendriks J, 1998, BIOCHEMISTRY-US, V37, P13102, DOI 10.1021/bi980943x; Hendriks JHM, 2002, BIOCHEMISTRY-US, V41, P2331, DOI 10.1021/bi0121050; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lancaster CRD, 2002, BBA-BIOMEMBRANES, V1565, P215, DOI 10.1016/S0005-2736(02)00571-0; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; SARASTE M, 1994, FEBS LETT, V341, P1, DOI 10.1016/0014-5793(94)80228-9; SHAPLEIGH JP, 1985, J BACTERIOL, V163, P837, DOI 10.1128/JB.163.3.837-840.1985; Silverman DN, 2000, BBA-BIOENERGETICS, V1458, P88, DOI 10.1016/S0005-2728(00)00061-X; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; Thorndycroft FH, 2007, BIOCHEM J, V401, P111, DOI 10.1042/BJ20060856; Toledo-Cuevas M, 1998, BBA-BIOENERGETICS, V1365, P421, DOI 10.1016/S0005-2728(98)00095-4; VANDEROOST J, 1994, FEMS MICROBIOL LETT, V121, P1, DOI 10.1016/0378-1097(94)90137-6; Vijgenboom G.W.E., 1998, BIOL ELECT TRANSFER, P279; Watmough NJ, 1999, BBA-BIOENERGETICS, V1411, P456, DOI 10.1016/S0005-2728(99)00032-8; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	30	48	48	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3839	3845		10.1074/jbc.M704615200	http://dx.doi.org/10.1074/jbc.M704615200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056717	hybrid			2022-12-27	WOS:000253083500018
J	Sadikovic, B; Andrews, J; Carter, D; Robinson, J; Rodenhiser, DI				Sadikovic, Bekim; Andrews, Joseph; Carter, David; Robinson, John; Rodenhiser, David I.			Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; GENE-EXPRESSION; DIOL EPOXIDE; EPIGENETICS; EXPOSURE; IMPACT; SITES; LUNG; HYPERMETHYLATION; HYPOMETHYLATION	Current toxicogenomic approaches generate transcriptional profiles that can identify functional gene expression signatures of environmental toxicants. However, the intricate processes governing transcription are overlaid with a complex set of molecular instructions involving epigenetic modifications. These commands regulate both gene expression and chromatin organization through coordinated sets of histone modifications and heritable DNA methylation patterns. Although the effects of specific environmental toxicants on gene expression are the subject of much study, the epigenetic effects of such compounds are poorly understood. Here we have used human promoter tiling arrays along with chromatin immunoprecipitation to identify changes in histone acetylation profiles because of chemical exposure. Chromatin from cells exposed to the polyaromatic hydrocarbon benzo(a) pyrene was immunoprecipitated with antibodies against acetylated histones. Affymetrix promoter tiling microarrays were probed to generate epigenomic profiles of hypo-and hyperacetylated chromatin localized to gene promoter regions. Statistical analyses, data mining, and expression studies revealed that treated cells possessed differentially acetylated gene promoter regions and gene-specific expression changes. This chromatin immunoprecipitation-on-chip approach permits genome-wide profiling of histone acetylation patterns that can identify chromatin-related signatures of environmental toxicants and potentially determine the molecular pathways these changes target. This approach also has potential applications for profiling histone modifications and DNA methylation changes during embryonic development, in cancer biology, and in the development and assessment of cancer therapeutics.	[Sadikovic, Bekim; Andrews, Joseph; Rodenhiser, David I.] London Hlth Sci Ctr, London Reg Canc Program, London, ON N6A 4L6, Canada; [Carter, David; Robinson, John; Rodenhiser, David I.] Univ Western Ontario, Childrens Hlth Res Inst, EpiGenWestern Res Grp, London, ON N6A 4L6, Canada; [Carter, David; Robinson, John] Univ Western Ontario, Robarts Res Inst, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Oncol, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Paediat, London, ON N6A 4L6, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Rodenhiser, DI (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, A4-134 Victroria Res Labs,790 Commiss Rd E, London, ON N6A 4L6, Canada.	drodenhi@uwo.ca						Baskunov VB, 2005, BIOCHEMISTRY-US, V44, P1054, DOI 10.1021/bi048130y; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIPPLE A, 1991, MUTAT RES, V259, P263, DOI 10.1016/0165-1218(91)90122-3; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fahrner JA, 2002, CANCER RES, V62, P7213; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; Hu WW, 2003, BIOCHEMISTRY-US, V42, P10012, DOI 10.1021/bi034631s; Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irwin Richard D, 2004, Toxicol Pathol, V32 Suppl 1, P72, DOI 10.1080/01926230490424752; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Mahadevan B, 2005, CANCER RES, V65, P1251, DOI 10.1158/0008-5472.CAN-04-2357; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Neumann NF, 2002, BIOTECHNOL ADV, V20, P391, DOI 10.1016/S0734-9750(02)00025-3; Revel A, 2003, J APPL TOXICOL, V23, P255, DOI 10.1002/jat.916; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sadikovic B, 2004, BREAST CANCER RES, V6, pR329, DOI 10.1186/bcr799; Sadikovic B, 2006, TOXICOL APPL PHARM, V216, P458, DOI 10.1016/j.taap.2006.06.012; Scherer G, 2000, CANCER EPIDEM BIOMAR, V9, P373; Schmidt CW, 2002, ENVIRON HEALTH PERSP, V110, pA750, DOI 10.1289/ehp.110-a750; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisenberger DJ, 1999, J BIOL CHEM, V274, P23948, DOI 10.1074/jbc.274.34.23948; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; WILSON VL, 1984, CARCINOGENESIS, V5, P1027, DOI 10.1093/carcin/5.8.1027; Yoon JH, 2001, CANCER RES, V61, P7110; Zhang N, 2005, J MOL BIOL, V346, P951, DOI 10.1016/j.jmb.2004.12.027	41	60	63	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4051	4060		10.1074/jbc.M707506200	http://dx.doi.org/10.1074/jbc.M707506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065415	hybrid			2022-12-27	WOS:000253083500040
J	Tan, K; Duquette, M; Liu, JH; Shanmugasundaram, K; Joachimiak, A; Gallagher, JT; Rigby, AC; Wang, JH; Lawler, J				Tan, Kemin; Duquette, Mark; Liu, Jin-huan; Shanmugasundaram, Kumaran; Joachimiak, Andrzej; Gallagher, John T.; Rigby, Alan C.; Wang, Jia-huai; Lawler, Jack			Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR DIPOLE; TERNARY COMPLEX; BINDING; RECOGNITION; PROTEINS; REVEALS; GLYCOSAMINOGLYCANS; ANTITHROMBIN; INTEGRIN	Through its interactions with proteins and proteoglycans, thrombospondin-1 (TSP-1) functions at the interface of the cell membrane and the extracellular matrix to regulate matrix structure and cellular phenotype. We have previously determined the structure of the high affinity heparin-binding domain of TSP-1, designated TSPN-1, in association with the synthetic heparin, Arixtra. To establish that the binding of TSPN-1 to Arixtra is representative of the association with naturally occurring heparins, we have determined the structures of TSPN-1 in complex with heparin oligosaccharides containing eight (dp8) and ten (dp10) subunits, by x-ray crystallography. We have found that dp8 and dp10 bind to TSPN-1 in a manner similar to Arixtra and that dp8 and dp10 induce the formation of trans and cis TSPN-1 dimers, respectively. In silico docking calculations partnered with our crystal structures support the importance of arginine residues in positions 29, 42, and 77 in binding sulfate groups of the dp8 and dp10 forms of heparin. The ability of several TSPN-1 domains to bind to glycosaminoglycans simultaneously probably increases the affinity of binding through multivalent interactions. The formation of cis and trans dimers of the TSPN-1 domain with relatively short segments of heparin further enhances the ability of TSP-1 to participate in high affinity binding to glycosaminoglycans. Dimer formation may also involve TSPN-1 domains from two separate TSP-1 molecules. This association would enable glycosaminoglycans to cluster TSP-1.	[Wang, Jia-huai] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; [Tan, Kemin; Liu, Jin-huan; Wang, Jia-huai] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Duquette, Mark; Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA; [Tan, Kemin; Liu, Jin-huan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lawler, Jack] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Gem & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Gallagher, John T.] Univ Manchester, Christie Hosp NHS Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Christie NHS Foundation Trust; Christie Hospital; University of Manchester	Rigby, AC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Med,Div Mol & Vasc Med, 330 Brookline Ave, Boston, MA 02215 USA.	arigby@bidmc.harvard.edu; jwang@red.dfci.harvard.edu; jlawler@bidmc.harvard.edu	Lawler, Jack/AAJ-1379-2020		NHLBI NIH HHS [R01 HL049081, HL48675, P01 HL048675, HL68003, HL49081, R01 HL068003, R01 HL049081-10] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081, P01HL048675, R01HL068003] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer KA, 2003, CHEST, V124, p364S, DOI 10.1378/chest.124.6_suppl.364S; Bitomsky W, 1999, J AM CHEM SOC, V121, P3004, DOI 10.1021/ja983319g; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzada MJ, 2004, CIRC RES, V94, P462, DOI 10.1161/01.RES.0000115555.05668.93; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; do Outeiro-Bernstein MAF, 2002, MATRIX BIOL, V21, P311, DOI 10.1016/S0945-053X(02)00010-0; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 1998, CURR OPIN STRUC BIOL, V8, P578, DOI 10.1016/S0959-440X(98)80147-4; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Herndon ME, 1999, GLYCOBIOLOGY, V9, P143, DOI 10.1093/glycob/9.2.143; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOPPENOL WH, 1980, BIOPHYS J, V29, P493, DOI 10.1016/S0006-3495(80)85148-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krieger E, 2004, PROTEINS, V54, P768, DOI 10.1002/prot.10590; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; MULATERO C, 2003, P AM ASSOC CANC RES, V44, P1430; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; SANANTONIO JD, 1993, BIOCHEMISTRY-US, V32, P4746, DOI 10.1021/bi00069a008; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Sargiannidou I, 2004, SEMIN THROMB HEMOST, V30, P127; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sergeev YV, 2000, BIOCHEMISTRY-US, V39, P15799, DOI 10.1021/bi001882h; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Sinha D, 2005, BIOCHEMISTRY-US, V44, P10416, DOI 10.1021/bi050361x; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Taraboletti G, 2000, FASEB J, V14, P1674; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Voland C, 2000, J BONE MINER RES, V15, P361, DOI 10.1359/jbmr.2000.15.2.361; Wang SX, 2004, J CELL BIOCHEM, V91, P766, DOI 10.1002/jcb.10781; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	51	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3932	3941		10.1074/jbc.M705203200	http://dx.doi.org/10.1074/jbc.M705203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065761	Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000253083500027
J	Van Dijk, J; Miro, J; Strub, JM; Lacroix, B; Van Dorsselaer, A; Edde, B; Janke, C				Van Dijk, Juliette; Miro, Julie; Strub, Jean-Marc; Lacroix, Benjamin; Van Dorsselaer, Alain; Edde, Bernard; Janke, Carsten			Polyglutamylation is a post-translational modification with a broad range of substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; BETA-TUBULIN; STRUCTURAL INSIGHTS; PROTEIN; CELLS; PURIFICATION; DOMAIN; ACID; TAU	Polyglutamylation is a post-translational modification that generates lateral acidic side chains on proteins by sequential addition of glutamate amino acids. This modification was first discovered on tubulins, and it is important for several microtubule functions. Besides tubulins, only the nucleosome assembly proteins NAP1 and NAP2 have been shown to be polyglutamylated. Here, using a proteomic approach, we identify a large number of putative substrates for polyglutamylation in HeLa cells. By analyzing a selection of these putative substrates, we show that several of them can serve as in vitro substrates for two of the recently discovered polyglutamylases, TTLL4 and TTLL5. We further show that TTLL4 is the main polyglutamylase enzyme present in HeLa cells and that new substrates of polyglutamylation are indeed modified by TTLL4 in a cellular context. No clear consensus polyglutamylation site could be defined from the primary sequence of the here-identified new substrates of polyglutamylation. However, we demonstrate that glutamate-rich stretches are important for a protein to become polyglutamylated. Most of the newly identified substrates of polyglutamylation are nucleocytoplasmic shuttling proteins, including many chromatin-binding proteins. Our work reveals that polyglutamylation is a much more widespread post-translational modification than initially thought and thus that it might be a regulator of many cellular processes.	[Van Dijk, Juliette; Miro, Julie; Lacroix, Benjamin; Edde, Bernard; Janke, Carsten] Univ Montpellier 2 & 1, CNRS, CRBM, F-34293 Montpellier, France; [Strub, Jean-Marc; Van Dorsselaer, Alain] CNRS, Lab Spectometrie Masse BioOrgan, F-67087 Strasbourg, France; [Edde, Bernard] Univ Paris 06, F-75252 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite	Janke, C (corresponding author), Univ Montpellier 2 & 1, CNRS, CRBM, 1919 Route De Mende, F-34293 Montpellier, France.	carsten.janke@crbm.cnrs.fr	Lacroix, Benjamin/AAL-8428-2020; Janke, Carsten/A-7279-2011	Lacroix, Benjamin/0000-0003-2533-9150; Janke, Carsten/0000-0001-7053-2000; Miro, Julie/0000-0003-0913-6126; Strub, Jean-Marc/0000-0001-6224-3428				AUDEBERT S, 1993, MOL BIOL CELL, V4, P615, DOI 10.1091/mbc.4.6.615; Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575; Bonnet C, 2001, J BIOL CHEM, V276, P12839, DOI 10.1074/jbc.M011380200; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; EDDE B, 1990, SCIENCE, V247, P83, DOI 10.1126/science.1967194; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Gagnon C, 1996, J CELL SCI, V109, P1545; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; JUHASZ P, 1994, P NATL ACAD SCI USA, V91, P4333, DOI 10.1073/pnas.91.10.4333; Kjellstrom S, 2004, ANAL CHEM, V76, P5109, DOI 10.1021/ac0400257; Larcher JC, 1996, J BIOL CHEM, V271, P22117, DOI 10.1074/jbc.271.36.22117; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Million K, 1999, J CELL SCI, V112, P4357; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Regnard C, 2000, J BIOL CHEM, V275, P15969, DOI 10.1074/jbc.M000045200; Regnard C, 1999, J CELL SCI, V112, P4281; RUDIGER M, 1992, FEBS LETT, V308, P101, DOI 10.1016/0014-5793(92)81061-P; Santa-Coloma TA, 2003, CEREBELLUM, V2, P310, DOI 10.1080/14734220310017212; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wilson CL, 2006, J PEPT SCI, V12, P721, DOI 10.1002/psc.784; WOLFF A, 1992, EUR J CELL BIOL, V59, P425	27	72	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3915	3922		10.1074/jbc.M705813200	http://dx.doi.org/10.1074/jbc.M705813200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18045879	Green Submitted, hybrid			2022-12-27	WOS:000253083500025
J	Yu, PB; Deng, DY; Beppu, H; Hong, CC; Lai, C; Hoyng, SA; Kawai, N; Bloch, KD				Yu, Paul B.; Deng, Donna Y.; Beppu, Hideyuki; Hong, Charles C.; Lai, Carol; Hoyng, Stefan A.; Kawai, Noriko; Bloch, Kenneth D.			Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; VASCULAR CALCIFICATION; INHIBITS PROLIFERATION; GERMLINE MUTATIONS; SIGNALING PATHWAYS; EXPRESSION; ACTIVATION; HYPERTENSION; NOTCH; APOPTOSIS	Bone morphogenetic protein (BMP) signals regulate the growth and differentiation of diverse lineages. The association of mutations in the BMP type II receptor (BMPRII) with idiopathic pulmonary arterial hypertension suggests an important role of this receptor in vascular remodeling. Pulmonary artery smooth muscle cells lacking BMPRII can transduce BMP signals using ActRIIa (Activin type II receptor). We investigated whether or not BMP signaling via the two receptors leads to differential effects on vascular smooth muscle cells. BMP4, but not BMP7, inhibited platelet-derived growth factor-activated proliferation in wild-type pulmonary artery smooth muscle cells, whereas neither ligand inhibited the growth of BMPRII-deficient cells. Adenoviral gene transfer of BMPRII enabled BMP4, as well as BMP7, to inhibit proliferation in BMPRII-deficient cells. BMP-mediated growth inhibition was also reconstituted by the BMPRII short isoform, lacking the C-terminal domain present in the long form. BMP4, but not BMP7, induced the expression of osteoblast markers in wild-type cells, whereas neither ligand induced these markers in BMPRII-deficient cells. Overexpression of short or long forms of BMPRII in BMPRII-deficient cells enabled BMP4 and BMP7 to induce osteogenic differentiation. Although signaling via BMPRII or ActRIIa transiently activated SMAD1/5/8, only BMPRII signaling led to persistent SMAD1/5/8 activation and sustained increases in Id1 mRNA and protein expression. Pharmacologic blockade of BMPtype I receptor function within 24 h after BMP stimulation abrogated differentiation. These data suggest that sustained BMP pathway activation, such as that mediated by BMPRII, is necessary for growth and differentiation control in vascular smooth muscle.	[Yu, Paul B.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Harvard Med Sch, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Yu, PB (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Anesthesia Ctr Crit Care Res, Harvard Med Sch, Boston, MA 02114 USA.	pbyu@partners.org	Yu, Paul B./J-7540-2019; Hong, Charles/C-9989-2010	Yu, Paul B./0000-0003-2145-4944; Hoyng, Stefan/0000-0001-8371-3871	NHLBI NIH HHS [R01 HL074352, 1K08HL079943, K08 HL079943, K08 HL079943-02, 5R01HL074352] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, R01HL074352] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Baba Y, 2005, MICROBIOL IMMUNOL, V49, P559, DOI 10.1111/j.1348-0421.2005.tb03753.x; Bennett BJ, 2006, ARTERIOSCL THROM VAS, V26, P2117, DOI 10.1161/01.ATV.0000236428.91125.e6; Beppu H, 2005, GENESIS, V41, P133, DOI 10.1002/gene.20099; Beppu H, 1997, BIOCHEM BIOPH RES CO, V235, P499, DOI 10.1006/bbrc.1997.6816; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Cogan JD, 2005, GENET MED, V7, P169, DOI 10.1097/01.GIM.0000156525.09595.E9; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; de Jong DS, 2004, BIOCHEM BIOPH RES CO, V320, P100, DOI 10.1016/j.bbrc.2004.05.150; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dorai H, 2000, J CELL PHYSIOL, V184, P37, DOI 10.1002/(SICI)1097-4652(200007)184:1<37::AID-JCP4>3.0.CO;2-M; Dorai H, 2001, J BONE JOINT SURG AM, V83A, pS70; Duan XY, 2006, J BIOL CHEM, V281, P36526, DOI 10.1074/jbc.M605169200; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Forrest S, 2004, ARTERIOSCL THROM VAS, V24, P2014, DOI 10.1161/01.ATV.0000143932.03151.ad; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Gallea S, 2001, BONE, V28, P491, DOI 10.1016/S8756-3282(01)00415-X; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Goumans MJ, 2000, INT J DEV BIOL, V44, P253; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Hassel S, 2004, PROTEOMICS, V4, P1346, DOI 10.1002/pmic.200300770; Hayashi Y, 2006, MOL BIOL CELL, V17; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; Izumi M, 2001, J BIOL CHEM, V276, P31133, DOI 10.1074/jbc.M101463200; Jeffery TK, 2005, AM J PHYSIOL-LUNG C, V288, pL370, DOI 10.1152/ajplung.00242.2004; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kim IY, 2000, CANCER RES, V60, P2840; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Kim IY, 2003, CLIN CANCER RES, V9, P6046; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Kluppel M, 2005, BIOESSAYS, V27, P115, DOI 10.1002/bies.20187; Lagna G, 2006, AM J PHYSIOL-LUNG C, V291, pL1059, DOI 10.1152/ajplung.00180.2006; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Li IWS, 1996, J CELL PHYSIOL, V169, P115, DOI 10.1002/(SICI)1097-4652(199610)169:1<115::AID-JCP12>3.0.CO;2-C; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; LIU F, 1995, MOL CELL BIOL, V15, P3479; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Moser M, 2005, THROMB HAEMOSTASIS, V94, P713, DOI 10.1160/TH05-05-0312; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063; Nohe A, 2005, J CELL SCI, V118, P643, DOI 10.1242/jcs.01402; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; Takizawa T, 2003, NUCLEIC ACIDS RES, V31, P5723, DOI 10.1093/nar/gkg778; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tintut Y, 2005, J MOL CELL CARDIOL, V39, P389, DOI 10.1016/j.yjmcc.2005.03.019; Tintut Y, 2003, CIRCULATION, V108, P2505, DOI 10.1161/01.CIR.0000096485.64373.C5; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Wong GA, 2003, AM J PHYSIOL-ENDOC M, V284, pE972, DOI 10.1152/ajpendo.00385.2002; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; YANG X, 2005, CIRC RES; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; YU PB, 2007, IN PRESS NAT CHEM BI; Zakrzewicz A, 2007, CIRCULATION, V115, P2957, DOI 10.1161/CIRCULATIONAHA.106.670026; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	79	80	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3877	3888		10.1074/jbc.M706797200	http://dx.doi.org/10.1074/jbc.M706797200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18042551	hybrid			2022-12-27	WOS:000253083500022
J	Dhar, SS; Ongwijitwat, S; Wong-Riley, MTT				Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.			Nuclear respiratory factor 1 regulates all ten nuclear-encoded Subunits of cytochrome c oxidase in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; ACTIVITY-DEPENDENT REGULATION; TISSUE-SPECIFIC EXPRESSION; SPECIFYING 2 ISOFORMS; RESPIRATORY FACTOR-I; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ALZHEIMERS-DISEASE; PROMOTER ANALYSIS; FACTOR-2	Cytochrome c oxidase (COX) is one of only four bigenomic proteins in mammalian cells, having ten subunits encoded in the nuclear genome and three in the mitochondrial DNA. The mechanism of its bigenomic control is not well understood. The ten nuclear subunits are on different chromosomes, and the possibility of their coordinate regulation by the same transcription factor(s) deserves serious consideration. The present study tested our hypothesis that nuclear respiratory factor 1 (NRF-1) serves such a role in subunit coordination. Following in silico analysis of murine nuclear-encoded COX subunit promoters, electrophoretic mobility shift and supershift assays indicated NRF-1 binding to all ten promoters. In vivo chromatin immuno-precipitation assays also showed NRF-1 binding to all ten promoters in murine neuroblastoma cells. Site-directed mutagenesis of putative NRF-1 binding sites confirmed the functionality of NRF-1 binding on all ten COX promoters. These sites are highly conserved among mice, rats, and humans. Silencing of NRF-1 with RNA interference reduced all ten COX subunit mRNAs and mRNAs of other genes involved in mitochondrial biogenesis. We conclude that NRF-1 plays a significant role in coordinating the transcriptional regulation of all ten nuclear-encoded COX subunits in neurons. Moreover, NRF-1 is known to activate mitochondrial transcription factors A and B, thereby indirectly regulating the expressions of the three mitochondrial-encoded COX subunits. Thus, NRF-1 and our previously described NRF-2 prove to be the two key bigenomic coordinators for transcriptional regulation of all cytochrome c oxidase subunits in neurons. Possible interactions between the NRFs will be investigated in the future.	[Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Wong-Riley, Margaret/AGM-6202-2022		NATIONAL EYE INSTITUTE [R01EY005439, R01EY018441] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05439, R01 EY018441-02, R01 EY018441, R01 EY005439] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARNAUDO E, 1992, GENE, V119, P299, DOI 10.1016/0378-1119(92)90287-Y; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Bachman NJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P152, DOI 10.1006/abbi.1996.0376; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FABRIZI GM, 1992, GENE, V119, P307, DOI 10.1016/0378-1119(92)90288-Z; Frank V, 1996, FEBS LETT, V382, P121, DOI 10.1016/0014-5793(96)00096-8; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Guo AL, 2000, J COMP NEUROL, V417, P221, DOI 10.1002/(SICI)1096-9861(20000207)417:2<221::AID-CNE7>3.0.CO;2-4; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Jaradat SA, 1998, GENOMICS, V49, P363, DOI 10.1006/geno.1998.5279; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lee I, 2001, EUR J BIOCHEM, V268, P6329, DOI 10.1046/j.0014-2956.2001.02602.x; Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liang HL, 2006, NEUROSCIENCE, V140, P177, DOI 10.1016/j.neuroscience.2006.01.056; Liang HL, 2006, NEUROREPORT, V17, P401, DOI 10.1097/01.wnr.0000204980.98876.11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Nie F, 1999, J COMP NEUROL, V404, P310, DOI 10.1002/(SICI)1096-9861(19990215)404:3<310::AID-CNE3>3.0.CO;2-4; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schmidt TR, 1997, MOL BIOL EVOL, V14, P595, DOI 10.1093/oxfordjournals.molbev.a025798; Seelan RS, 1997, J BIOL CHEM, V272, P10175, DOI 10.1074/jbc.272.15.10175; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Wong-Riley M, 2000, GENE, V247, P63, DOI 10.1016/S0378-1119(00)00121-9; Wong-Riley M, 1997, VISION RES, V37, P3593, DOI 10.1016/S0042-6989(96)00210-6; Wong-Riley MTT, 2005, VISUAL NEUROSCI, V22, P1, DOI 10.1017/S0952523805221016; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yang SJ, 2004, EUR J NEUROSCI, V19, P1153, DOI 10.1111/j.1460-9568.2004.03250.x; Yu M, 2002, BBA-GENE STRUCT EXPR, V1574, P345, DOI 10.1016/S0167-4781(02)00228-2; Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x	55	124	131	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3120	3129		10.1074/jbc.M707587200	http://dx.doi.org/10.1074/jbc.M707587200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18077450	Green Accepted, hybrid			2022-12-27	WOS:000253083000015
J	Jones, NG; Nietlispach, D; Sharma, R; Burke, DF; Eyres, I; Mues, M; Mott, HR; Carrington, M				Jones, Nicola G.; Nietlispach, Daniel; Sharma, Reuben; Burke, David F.; Eyres, Isobel; Mues, Marsilius; Mott, Helen R.; Carrington, Mark			Structure of a glycosylphosphatidylinositol-anchored domain from a trypanosome variant surface glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BONDS; BRUCEI; GLYCAN; FORMS; COAT	The cell surface of African trypanosomes is covered by a densely packed monolayer of a single protein, the variant surface glycoprotein (VSG). The VSG protects the trypanosome cell surface from effector molecules of the host immune system and is the mediator of antigenic variation. The sequence divergence between VSGs that is necessary for antigenic variation can only occur within the constraints imposed by the structural features necessary to form the monolayer barrier. Here, the structures of the two domains that together comprise the C-terminal di-domain of VSG IL Tat 1.24 have been determined. The first domain has a structure similar to the single C-terminal domain of VSG MIT at 1.2 and provides proof of structural conservation in VSG C-terminal domains complementing the conservation of structure present in the N-terminal domain. The second domain, although based on the same fold, is a minimized version missing several structural features. The structure of the second domain contains the C-terminal residue that in the native VSG is attached to a glycosylphosphatidylinositol (GPI) anchor that retains the VSG on the external face of the plasma membrane. The solution structures of this domain and a VSG GPI glycan have been combined to produce the first structure-based model of a GPI-anchored protein. The model suggests that the core glycan of the GPI anchor lies in a groove on the surface of the domain and that there is a close association between the GPI glycan and protein. More widely, the GPI glycan may be an integral part of the structure of other GPI-anchored proteins.	[Jones, Nicola G.; Nietlispach, Daniel; Sharma, Reuben; Burke, David F.; Eyres, Isobel; Mues, Marsilius; Mott, Helen R.; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Jones, NG (corresponding author), Tech Univ Darmstadt, Dept Genet & Microbiol, Schnittspahnstr 10, D-64287 Darmstadt, Germany.	jones@bio.tu-darmstadt.de	Carrington, Mark/N-3653-2019; Mott, Helen/AAV-3873-2020; Jones, Nicola/AAP-5835-2021; Sharma, Reuben/AAI-6444-2020; Burke, David F/C-2091-2013; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Mott, Helen/0000-0002-7890-7097; Jones, Nicola/0000-0003-3384-0156; Burke, David F/0000-0001-8830-3951; Carrington, Mark/0000-0002-6435-7266; Nietlispach, Daniel/0000-0003-4364-9291	Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN G, 1983, BIOCHEM J, V209, P481, DOI 10.1042/bj2090481; BARBONI E, 1995, J CELL SCI, V108, P487; Barry David, 2004, P25, DOI 10.1079/9780851994758.0025; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULOW R, 1988, BIOCHEMISTRY-US, V27, P2384; Bussler H, 1998, J BIOL CHEM, V273, P32582, DOI 10.1074/jbc.273.49.32582; Butikofer P, 2001, FASEB J, V15, P545, DOI 10.1096/fj.00-0415hyp; CARRINGTON M, 1991, J MOL BIOL, V221, P823, DOI 10.1016/0022-2836(91)80178-W; Chattopadhyay A, 2005, J BIOL CHEM, V280, P7228, DOI 10.1074/jbc.M410787200; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; GARMAN SC, 1994, THESIS HARVARD U; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; HOMANS SW, 1989, BIOCHEMISTRY-US, V28, P2881, DOI 10.1021/bi00433a020; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; JACKSON DG, 1985, BIOCHEM J, V230, P195, DOI 10.1042/bj2300195; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P868; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; MCCONVILLE MJ, 1993, BIOCHEM J, V294, P305, DOI 10.1042/bj2940305; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; RADEMACHER T W, 1991, Current Biology, V1, P41, DOI 10.1016/0960-9822(91)90123-E; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; ZAMZE SE, 1990, EUR J BIOCHEM, V187, P657, DOI 10.1111/j.1432-1033.1990.tb15350.x; Zhou JL, 2004, ACTA TROP, V90, P271, DOI 10.1016/j.actatropica.2004.02.002; ZIEGELBAUER K, 1993, INFECT IMMUN, V61, P4540, DOI 10.1128/IAI.61.11.4540-4545.1993	34	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3584	3593		10.1074/jbc.M706207200	http://dx.doi.org/10.1074/jbc.M706207200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18003615	Green Accepted, hybrid			2022-12-27	WOS:000253083000064
J	Kwofie, MA; Skowronski, J				Kwofie, Michael A.; Skowronski, Jacek			Specific recognition of Rac2 and Cdc42 by DOCK2 and DOCK9 guanine nucleotide exchange factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; T-LYMPHOCYTE; ACTIVATION; GEF; COMPLEX; DOMAIN; PROTEINS; PHAGOCYTOSIS; MULTIPLE; SCAFFOLD	Recognition of cognate Rho GTPases by guanine-nucleotide exchange factors (GEF) is fundamental to Rho GTPase signaling specificity. Two main GEF families use either the Dbl homology (DH) or the DOCK homology region 2 (DHR-2) catalytic domain. How DHR-2-containing GEFs distinguish between the GTPases Rac and Cdc42 is not known. To determine how these GEFs specifically recognize the two Rho GTPases, we studied the amino acid sequences in Rac2 and Cdc42 that are crucial for activation by DOCK2, a Rac-specific GEF, and DOCK9, a distantly related Cdc42-specific GEF. Two elements in the N-terminal regions of Rac2 and Cdc42 were found to be essential for specific interactions with DOCK2 and DOCK9. One element consists of divergent amino acid residues in the switch 1 regions of the GTPases. Significantly, these residues were also found to be important for GTPase recognition by Rac-specific DOCK180, DOCK3, and DOCK4 GEFs. These findings were unexpected because the same residues were shown previously to interact with GTPase effectors rather than GEFs. The other element comprises divergent residues in the beta 3 strand that are known to mediate specific recognition by DH domain containing GEFs. Remarkably, Rac2-to-Cdc42 substitutions of four of these residues were sufficient for Rac2 to be specifically activated by DOCK9. Thus, DOCK2 and DOCK9 specifically recognize Rac2 and Cdc42 through their switch 1 as well as beta 2-beta 3 regions and the mode of recognition via switch 1 appears to be conserved among diverse Rac-specific DHR-2 GEFs.	[Kwofie, Michael A.; Skowronski, Jacek] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kwofie, Michael A.] SUNY Stony Brook, Genet Program, Stony Brook, NY 11790 USA; [Kwofie, Michael A.] SUNY Stony Brook, Med Sci Training Program, Stony Brook, NY 11790 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Skowronski, J (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	skowrons@cshl.edu		Kwofie, Michael/0000-0003-4632-5436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042561] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-42561] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aghazadeh B, 1998, NAT STRUCT BIOL, V5, P1098, DOI 10.1038/4209; Aktories K, 2000, BIOL CHEM, V381, P421, DOI 10.1515/BC.2000.054; Albert ML, 2000, NAT CELL BIOL, V2, P899, DOI 10.1038/35046549; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cote JF, 2006, METHOD ENZYMOL, V406, P41, DOI 10.1016/S0076-6879(06)06004-6; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gao Y, 2001, J BIOL CHEM, V276, P47530, DOI 10.1074/jbc.M108865200; Garcia-Bernal D, 2006, J IMMUNOL, V177, P5215, DOI 10.4049/jimmunol.177.8.5215; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Horiguchi Y, 2001, TOXICON, V39, P1619, DOI 10.1016/S0041-0101(01)00149-0; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Karnoub AE, 2001, NAT STRUCT BIOL, V8, P1037, DOI 10.1038/nsb719; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; KWONG CH, 1995, J BIOL CHEM, V270, P19868, DOI 10.1074/jbc.270.34.19868; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Li R, 1997, J BIOL CHEM, V272, P4671, DOI 10.1074/jbc.272.8.4671; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Nishihara H, 2002, BIOCHEM BIOPH RES CO, V296, P716, DOI 10.1016/S0006-291X(02)00931-2; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Swigut T, 2003, J VIROL, V77, P8116, DOI 10.1128/JVI.77.14.8116-8126.2003; VAN AL, 1997, GENE DEV, V11, P2295; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; Williams DA, 2000, BLOOD, V96, P1646; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	51	25	26	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3088	3096		10.1074/jbc.M705170200	http://dx.doi.org/10.1074/jbc.M705170200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056264	hybrid			2022-12-27	WOS:000253083000012
J	Tu, CL; Chang, WH; Xie, ZJ; Bikle, DD				Tu, Chia-Ling; Chang, Wenhan; Xie, Zhongjian; Bikle, Daniel D.			Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR-FREE CALCIUM; FYN TYROSINE KINASE; EXTRACELLULAR CALCIUM; CA2+-SENSING RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; ADHERENS JUNCTIONS; FILAMIN-A; ACTIVATION; CA2+; ACTIN	Extracellular Ca2+ (Ca-o(2+)) is a critical regulator that promotes differentiation in epidermal keratinocytes. The calcium sensing receptor (CaR) is essential for mediating Ca2+ signaling during Ca-o(2+)-induced differentiation. Inactivation of the endogenous CaR-encoding gene CASR by adenoviral expression of a CaR antisense cDNA inhibited the Ca-o(2+)-induced increase in intracellular free calcium (Ca-i(2+)) and expression of terminal differentiation genes, while promoting apoptosis. Ca-o(2+) also instigates E-cadherin-mediated cell-cell adhesion, which plays a critical role in orchestrating cellular signals mediating cell survival and differentiation. Raising Ca-o(2+) concentration ([ Ca2+](o)) from 0.03 to 2 mM rapidly induced the co-localization of alpha-, beta-, and p120-catenin with E-cadherin in the intercellular adherens junctions (AJs). To assess whether CaR is required for the Ca-o(2+)-induced activation of E-cadherin signaling, we examined the impact of CaR inactivation on AJ formation. Decreased CaR expression suppressed the Ca-o(2+)-induced AJ formation, membrane translocation, and the complex formation of E-cadherin, catenins, and the phosphatidylinositol 3-kinase (PI3K), although the expression of these proteins was not affected. The assembly of the E-cadherin-catenin-PI3K complex was sensitive to the pharmacologic inhibition of Src family tyrosine kinases but was not affected by inhibition of Ca-o(2+)-induced rise in Ca-i(2+). Inhibition of CaR expression blocked the Ca-o(2+)-induced tyrosine phosphorylation of beta-, gamma-, and p120-catenin, PI3K, and the tyrosine kinase Fyn and the association of Fyn with E-cadherin and PI3K. Our results indicate that the CaR regulates cell survival and Ca-o(2+)-induced differentiation in keratinocytes at least in part by activating the E-cadherin/PI3K pathway through a Src family tyrosine kinase-mediated signaling.	[Tu, Chia-Ling; Chang, Wenhan; Xie, Zhongjian; Bikle, Daniel D.] Vet Adm Med Ctr, Endocrine Unit 111N, San Francisco, CA 94121 USA; [Tu, Chia-Ling; Chang, Wenhan; Bikle, Daniel D.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Xie, Zhongjian] No Calif Inst Res & Educ, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Northern California Institute for Research & Education	Tu, CL (corresponding author), Vet Adm Med Ctr, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	chia-ling.tu@ucsf.edu		Tu, Chia-Ling/0000-0002-7323-7733	NIAMS NIH HHS [R01-AR38386, P01-AR39448] Funding Source: Medline; NIA NIH HHS [R01-AG21353] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448, R01AR038386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021353] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CALAUTTI E, 1995, GENE DEV, V9, P2279, DOI 10.1101/gad.9.18.2279; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Ferreira MCD, 1998, J BIOL CHEM, V273, P15192, DOI 10.1074/jbc.273.24.15192; FILVAROFF E, 1994, J BIOL CHEM, V269, P21735; Furukawa F, 1997, MICROSC RES TECHNIQ, V38, P343; FURUKAWA F, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P802, DOI 10.1111/j.1346-8138.1994.tb03294.x; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang WT, 2004, J RARE EARTH, V22, P30; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Komuves L, 2002, J CELL PHYSIOL, V192, P45, DOI 10.1002/jcp.10107; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; LI LW, 1995, CELL GROWTH DIFFER, V6, P1171; Liu KP, 2003, J NEUROSCI, V23, P2049; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; PILLAI S, 1991, J CELL PHYSIOL, V146, P94, DOI 10.1002/jcp.1041460113; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; SHARPE GR, 1993, ARCH DERMATOL RES, V284, P445, DOI 10.1007/BF00373354; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2001, J BIOL CHEM, V276, P41079, DOI 10.1074/jbc.M107122200; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109; Xie ZJ, 1999, J BIOL CHEM, V274, P20421, DOI 10.1074/jbc.274.29.20421; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	41	100	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3519	3528		10.1074/jbc.M708318200	http://dx.doi.org/10.1074/jbc.M708318200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065418	Green Submitted, hybrid			2022-12-27	WOS:000253083000057
J	Yoshizaki, K; Yamamoto, S; Yamada, A; Yuasa, K; Iwamoto, T; Fukumoto, E; Harada, H; Saito, M; Nakasima, A; Nonaka, K; Yamada, Y; Fukumoto, S				Yoshizaki, Keigo; Yamamoto, Shinya; Yamada, Aya; Yuasa, Kenji; Iwamoto, Tsutomu; Fukumoto, Emiko; Harada, Hidemitsu; Saito, Masahiro; Nakasima, Akihiko; Nonaka, Kazuaki; Yamada, Yoshihiko; Fukumoto, Satoshi			Neurotrophic factor neurotrophin-4 regulates ameloblastin expression via full-length TrkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SP3; GROWTH-FACTOR RECEPTOR; MICE LACKING; TOOTH DEVELOPMENT; EXTRACELLULAR-MATRIX; RAT TRKC; DIFFERENTIATION; CELLS; MORPHOGENESIS; DEFICITS	Neurotrophic factors play an important role in the development and maintenance of not only neural but also nonneural tissues. Several neurotrophic factors are expressed in dental tissues, but their role in tooth development is not clear. Here, we report that neurotrophic factor neurotrophin (NT)-4 promotes differentiation of dental epithelial cells and enhances the expression of enamel matrix genes. Dental epithelial cells from 3-day-old mice expressed NT-4 and three variants of TrkB receptors for neurotrophins (full-length TrkB-FL and truncated TrkB-T1 and -T2). Dental epithelial cell line HAT-7 expressed these genes, similar to those in dental epithelial cells. We found that NT-4 reduced HAT-7 cell proliferation and induced the expression of enamel matrix genes, such as ameloblastin (Ambn). Transfection of HAT-7 cells with the TrkB-FL expression construct enhanced the NT-4-mediated induction of Ambn expression. This enhancement was blocked by K252a, an inhibitor for Trk tyrosine kinases. Phosphorylation of ERK1/2, a downstream molecule of TrkB, was induced in HAT-7 cells upon NT-4 treatment. TrkB-FL but not TrkB-T1 transfection increased the phosphorylation level of ERK1/2 in NT-4-treated HAT-7 cells. These results suggest that NT-4 induced Ambn expression via the TrkB-MAPK pathway. The p75 inhibitor TAT-pep5 decreased NT-4-mediated induction of the expression of Ambn, TrkB-FL, and TrkB-T1, suggesting that both high affinity and low affinity neurotrophin receptors were required for NT-4 activity. We found that NT-4-null mice developed a thin enamel layer and had a decrease in Ambn expression. Our results suggest that NT-4 regulates proliferation and differentiation of the dental epithelium and promotes production of the enamel matrix.	[Yoshizaki, Keigo; Yamamoto, Shinya; Yamada, Aya; Yuasa, Kenji; Iwamoto, Tsutomu; Nonaka, Kazuaki; Fukumoto, Satoshi] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Pediat Dent, Fukuoka 8128582, Japan; [Fukumoto, Emiko] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Harada, Hidemitsu] Iwate Med Coll, Sch Dent, Dept Oral Anat 2, Morioka, Iwate 0208505, Japan; [Saito, Masahiro] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, Suita, Osaka 5650871, Japan; [Yamada, Yoshihiko] NIH, NIDCR, Craniofacial Dev Biol & Regenerat Biol Branch, Bethesda, MD 20892 USA; [Fukumoto, Satoshi] Tohoku Univ, Grad Sch Dent, Dept Oral Hlth & Dev Sci, Div Pediat, Sendai, Miyagi 9808575, Japan	Kyushu University; Nagasaki University; Iwate Medical University; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tohoku University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev, Div Pediat Detn, Sendai, Miyagi 9808575, Japan.	fukumoto@mail.tains.tohoku.ac.jp	Harada, Hidemitsu/P-5692-2017; Iwamoto, Tsutomu/AAI-8952-2021; Iwamoto, Tsutomu/AAA-6597-2019	Harada, Hidemitsu/0000-0002-9724-8568; Iwamoto, Tsutomu/0000-0001-8472-605X; Yoshizaki, Keigo/0000-0002-0598-5879; Fukumoto, Satoshi/0000-0002-5046-6891	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; BARRETT GL, 1994, P NATL ACAD SCI USA, V91, P6501, DOI 10.1073/pnas.91.14.6501; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; CONOVER JC, 1995, NATURE, V375, P235, DOI 10.1038/375235a0; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; DIMARCO E, 1993, J BIOL CHEM, V268, P22838; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eide FF, 1996, J NEUROSCI, V16, P3123; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Frank RN, 2003, INVEST OPHTH VIS SCI, V44, P1; Fukumoto S, 2005, CONNECT TISSUE RES, V46, P220, DOI 10.1080/03008200500344017; Fukumoto S, 2006, J BIOL CHEM, V281, P5008, DOI 10.1074/jbc.M509295200; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Luukko K, 1997, DEV DYNAM, V210, P117, DOI 10.1002/(SICI)1097-0177(199710)210:2<117::AID-AJA5>3.0.CO;2-J; Luukko K, 1996, DEV DYNAM, V206, P87, DOI 10.1002/(SICI)1097-0177(199605)206:1<87::AID-AJA8>3.0.CO;2-X; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Nosrat CA, 1997, CELL TISSUE RES, V290, P569, DOI 10.1007/s004410050962; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; SARIOLA H, 1991, SCIENCE, V254, P571, DOI 10.1126/science.1658930; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; THESLEFF I, 1995, INT J DEV BIOL, V39, P35; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Yuasa K, 2004, J BIOL CHEM, V279, P10286, DOI 10.1074/jbc.M310013200; ZEICHNERDAVID M, 1995, INT J DEV BIOL, V39, P69	40	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3385	3391		10.1074/jbc.M704913200	http://dx.doi.org/10.1074/jbc.M704913200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045880	hybrid			2022-12-27	WOS:000253083000043
J	Kojima, K; Tsuzuki, S; Fushiki, T; Inouye, K				Kojima, Kenji; Tsuzuki, Satoshi; Fushiki, Tohru; Inouye, Kuniyo			Roles of functional and structural domains of hepatocyte growth factor activator inhibitor type 1 in the inhibition of matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE 1/MATRIPTASE; FACTOR-XA INHIBITION; PLASMINOGEN-ACTIVATOR; SLOW-BINDING; EXPRESSION; CANCER; RECEPTOR; KINETICS; HAI-1; LOCALIZATION	Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is a membrane-bound, Kunitz-type serine protease inhibitor. HAI-1 inhibits serine proteases that have potent pro-hepatocyte growth factor-converting activity, such as the membrane-type serine protease, matriptase. HAI-1 comprises an N-terminaldomain, followed by an internal domain, first protease inhibitory domain (Kunitz domain I), low-density lipoprotein receptor A module (LDLRA) domain, and a second Kunitz domain (Kunitz domain II) in the extracellular region. Our aim was to assess the roles of these domains in the inhibition of matriptase. Soluble forms of recombinant rat HAI-1 mutants made up with various combinations of domains were produced, and their inhibitory activities toward the hydrolysis of a chromogenic substrate were analyzed using a soluble recombinant rat matriptase. Kunitz domain I exhibited inhibitory activity against matriptase, but Kunitz domain II did not. The N-terminal domain and Kunitz domain II decreased the association rate between Kunitz domain I and matriptase, whereas the internal domain increased this rate. The LDLRA domain suppressed the dissociation of the Kunitz domain I-matriptase complex. Surprisingly, an HAI-1 mutant lacking the N- terminal domain and Kunitz domain II showed an inhibitor constant of 1.6 pM, and the inhibitory activity was 400 times higher in this HAI-1 mutant than in the mutant with all domains. These findings, together with the known occurrence of an HAI-1 species lacking the N- terminal domain and Kunitz domain II in vivo, suggest that the domain structure of HAI-1 is organized in a way that allows HAI-1 to flexibly control matriptase activity.	[Kojima, Kenji; Inouye, Kuniyo] Kyoto Univ, Div Food Sci & Biotechnol, Lab Enzyme Chem, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan; [Tsuzuki, Satoshi; Fushiki, Tohru] Kyoto Univ, Div Food Sci & Biotechnol, Nutr Chem Lab, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan	Kyoto University; Kyoto University	Inouye, K (corresponding author), Kyoto Univ, Div Food Sci & Biotechnol, Lab Enzyme Chem, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan.	inouye@kais.kyoto-u.ac.jp		Tsuzuki, Satoshi/0000-0003-4385-0075				Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Brown MS, 1997, NATURE, V388, P629, DOI 10.1038/41672; COPELAND RA, 2005, EVALUATION ENZYME IN, P141; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Dharmasena SP, 2002, BIOCHEMISTRY-US, V41, P12414, DOI 10.1021/bi0262606; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kirchhofer D, 2003, J BIOL CHEM, V278, P36341, DOI 10.1074/jbc.M304643200; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lu DS, 1997, J BIOL CHEM, V272, P31293, DOI 10.1074/jbc.272.50.31293; Mazzone M, 2006, FASEB J, V20, P1611, DOI 10.1096/fj.06-5947rev; MIYAZAWA K, 1993, J BIOL CHEM, V268, P10024; MOESTRUP SK, 1994, BBA-REV BIOMEMBRANES, V1197, P197, DOI 10.1016/0304-4157(94)90005-1; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nozaki S, 2006, ANTI-CANCER DRUG, V17, P1109, DOI 10.1097/01.cad.0000231483.09439.3a; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Oberst MD, 2002, CLIN CANCER RES, V8, P1101; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P3368, DOI 10.1021/bi036177y; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Scandura JM, 1997, BIOCHEMISTRY-US, V36, P412, DOI 10.1021/bi9612576; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Vogel LK, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-176; Yamasaki Y, 2003, J NUTR SCI VITAMINOL, V49, P27, DOI 10.3177/jnsv.49.27	37	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2478	2487		10.1074/jbc.M709073200	http://dx.doi.org/10.1074/jbc.M709073200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048349	hybrid			2022-12-27	WOS:000252622300004
J	Bissonnette, SA; Glazier, CM; Stewart, MQ; Brown, GE; Ellson, CD; Yaffe, MB				Bissonnette, Sarah A.; Glazier, Christina M.; Stewart, Mary Q.; Brown, Glenn E.; Ellson, Chris D.; Yaffe, Michael B.			Phosphatidylinositol 3-phosphate-dependent and -independent functions of p40(phox) in activation of the neutrophil NADPH oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; ADENINE-DINUCLEOTIDE PHOSPHATE; PX DOMAIN; PROTEIN P40(PHOX); CYTOSOLIC SUBUNIT; MOLECULAR-BASIS; PC MOTIF; P67(PHOX); BINDING; P47(PHOX)	In response to bacterial infection, the neutrophil NADPH oxidase assembles on phagolysosomes to catalyze the transfer of electrons from NADPH to oxygen, forming superoxide and downstream reactive oxygen species (ROS). The active oxidase is composed of a membrane-bound cytochrome together with three cytosolic phox proteins, p40(phox), p47(phox), and p67(phox), and the small GTPase Rac2, and is regulated through a process involving protein kinase C, MAPK, and phosphatidylinositol 3-kinase. The role of p40(phox) remains less well defined than those of p47(phox) and p67(phox). We investigated the biological role of p40(phox) in differentiated PLB-985 neutrophils, and we show that depletion of endogenous p40(phox) using lentiviral short hairpin RNA reduces ROS production and impairs bacterial killing under conditions where p67(phox) levels remain constant. Biochemical studies using a cytosol-reconstituted permeabilized human neutrophil cores system that recapitulates intracellular oxidase activation revealed that depletion of p40(phox) reduces both the maximal rate and total amount of ROS produced without altering the K-M value of the oxidase for NADPH. Using a series of mutants, p47PX-p40(phox) chimeras, and deletion constructs, we found that the p40(phox) PX domain has phosphatidylinositol 3-phosphate(PtdIns(3) P)-dependentand - independent functions. Translocation of p67(phox) requires the PX domain but not 3- phosphoinositide binding. Activation of the oxidase by p40(phox), however, requires both PtdIns(3) P binding and an Src homology 3 (SH3) domain competent to bind to poly-Pro ligands. Mutations that disrupt the closed auto-inhibited form of full-length p40(phox) can increase oxidase activity similar to 2.5-fold above that of wild-type p40(phox) but maintain the requirement for PX and SH3 domain function. We present a model where p40(phox) translocates p67(phox) to the region of the cytochrome and subsequently switches the oxidase to an activated state dependent upon PtdIns(3) P and SH3 domain engagement.	[Bissonnette, Sarah A.; Glazier, Christina M.; Stewart, Mary Q.; Ellson, Chris D.; Yaffe, Michael B.] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA; [Yaffe, Michael B.] MIT, Ctr Canc Res, Div Biol Engn, Cambridge, MA 02139 USA; [Brown, Glenn E.; Yaffe, Michael B.] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02130 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center	Yaffe, MB (corresponding author), MIT, Ctr Canc Res, Dept Biol, 77 Massachusetts Ave,E18-580, Cambridge, MA 02139 USA.	myaffe@mit.edu		Stewart, Mary Q/0000-0001-6924-0123	NIGMS NIH HHS [GM59281, R01 GM059281-09, R01 GM059281] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059281] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Bravo J, 2001, MOL CELL, V8, P829, DOI 10.1016/S1097-2765(01)00372-0; Brown GE, 2004, J BIOL CHEM, V279, P27059, DOI 10.1074/jbc.M314258200; Brown GE, 2003, MOL CELL, V11, P35, DOI 10.1016/S1097-2765(03)00005-4; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; Cross AR, 1999, BIOCHEM J, V341, P251, DOI 10.1042/0264-6021:3410251; Cross AR, 2000, BIOCHEM J, V349, P113, DOI 10.1042/0264-6021:3490113; CURNUTTE JT, 1987, J BIOL CHEM, V262, P5563; Dagher MC, 2007, BIOCHIMIE, V89, P1123, DOI 10.1016/j.biochi.2007.03.002; Dang PMC, 1999, BIOCHEMISTRY-US, V38, P5746, DOI 10.1021/bi982750f; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Ellson CD, 2001, NAT CELL BIOL, V3, P679, DOI 10.1038/35083076; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Fuchs A, 1996, BBA-MOL CELL RES, V1312, P39, DOI 10.1016/0167-4889(96)00020-1; Grogan A, 1997, J CELL SCI, V110, P3071; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heyworth PG, 2003, CURR OPIN IMMUNOL, V15, P578, DOI 10.1016/S0952-7915(03)00109-2; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; Hiroaki H, 2001, NAT STRUCT BIOL, V8, P526, DOI 10.1038/88591; Honbou K, 2007, EMBO J, V26, P1176, DOI 10.1038/sj.emboj.7601561; Ito T, 2001, EMBO J, V20, P3938, DOI 10.1093/emboj/20.15.3938; Kanai F, 2001, NAT CELL BIOL, V3, P675, DOI 10.1038/35083070; Karathanassis D, 2002, EMBO J, V21, P5057, DOI 10.1093/emboj/cdf519; Karlsson A, 2000, J LEUKOCYTE BIOL, V67, P396, DOI 10.1002/jlb.67.3.396; Kobayashi T, 1998, J CELL SCI, V111, P81; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Li YM, 2002, P NATL ACAD SCI USA, V99, P8289, DOI 10.1073/pnas.122244799; Massenet C, 2005, J BIOL CHEM, V280, P13752, DOI 10.1074/jbc.M412897200; Meischl C, 1998, SPRINGER SEMIN IMMUN, V19, P417, DOI 10.1007/BF00792600; Nakamura R, 1998, EUR J BIOCHEM, V251, P583, DOI 10.1046/j.1432-1327.1998.2510583.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Park JW, 1997, J BIOL CHEM, V272, P11035; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; QUINN MT, 1993, J BIOL CHEM, V268, P20983; ROTROSEN D, 1990, J BIOL CHEM, V265, P19910; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sathyamoorthy M, 1997, J BIOL CHEM, V272, P9141; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Smith RM, 1996, J CLIN INVEST, V98, P977, DOI 10.1172/JCI118882; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Tu YZ, 2001, BIOCHEM J, V354, P315, DOI 10.1042/0264-6021:3540315; Ueyama T, 2007, MOL BIOL CELL, V18, P441, DOI 10.1091/mbc.E06-08-0731; Vaissiere C, 1999, J LEUKOCYTE BIOL, V65, P629, DOI 10.1002/jlb.65.5.629; van Bruggen R, 2004, J BIOL CHEM, V279, P9097, DOI 10.1074/jbc.M309284200; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wientjes FB, 2001, BIOCHEM BIOPH RES CO, V289, P382, DOI 10.1006/bbrc.2001.5982	50	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2108	2119		10.1074/jbc.M706639200	http://dx.doi.org/10.1074/jbc.M706639200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029359	Green Accepted, hybrid			2022-12-27	WOS:000252501000038
J	Hoffmeister, M; Riha, P; Neumueller, O; Danielewski, O; Schultess, J; Smolenski, AP				Hoffmeister, Meike; Riha, Pavel; Neumueller, Olga; Danielewski, Oliver; Schultess, Jan; Smolenski, Albert P.			Cyclic nucleotide-dependent protein kinases inhibit binding of 14-3-3 to the GTPase-activating protein Rap1GAP2 in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CELL; SPECIFICITY; ISOFORMS; MICE; ADHESION; PATHWAY; RAP	GTPase-activating proteins are required to terminate signaling by Rap1, a small guanine nucleotide-binding protein that controls integrin activity and cell adhesion. Recently, we identified Rap1GAP2, a GTPase-activating protein of Rap1 in platelets. Here we show that 14-3-3 proteins interact with phosphorylated serine 9 at the N terminus of Rap1GAP2. Platelet activation by ADP and thrombin enhances serine 9 phosphorylation and increases 14-3-3 binding to endogenous Rap1GAP2. Conversely, inhibition of platelets by endothelium-derived factors nitric oxide and prostacyclin disrupts 14-3-3 binding. These effects are mediated by cGMP-and cAMP-dependent protein kinases that phosphorylate Rap1GAP2 at serine 7, adjacent to the 14-3-3 binding site. 14-3-3 binding does not change the GTPase-activating function of Rap1GAP2 in vitro. However, 14-3-3 binding attenuates Rap1GAP2 mediated inhibition of cell adhesion. Our findings define a novel crossover point of activatory and inhibitory signaling pathways in platelets.	[Hoffmeister, Meike; Riha, Pavel; Neumueller, Olga; Danielewski, Oliver; Schultess, Jan; Smolenski, Albert P.] Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Riha, Pavel] Charles Univ Prague, Fac Med 1, Prague 12108, Czech Republic	Goethe University Frankfurt; Charles University Prague	Smolenski, AP (corresponding author), Univ Frankfurt, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	smolenski@biochem2.de	Riha, Pavel/C-3309-2009	Smolenski, Albert/0000-0001-9210-9406				Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Aitken A, 2002, PLANT MOL BIOL, V50, P993, DOI 10.1023/A:1021261931561; Andrews RK, 1998, BIOCHEMISTRY-US, V37, P638, DOI 10.1021/bi970893g; Barry FA, 2003, FEBS LETT, V553, P173, DOI 10.1016/S0014-5793(03)01015-9; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Danielewski O, 2005, THROMB HAEMOSTASIS, V93, P319, DOI 10.1160/TH04-09-0582; Daumke O, 2004, NATURE, V429, P197, DOI 10.1038/nature02505; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Hattori M, 2003, J BIOCHEM, V134, P479, DOI 10.1093/jb/mvg180; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kjarland E, 2006, CURR PHARM BIOTECHNO, V7, P217, DOI 10.2174/138920106777549777; Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stafford MJ, 2003, BLOOD, V101, P1392, DOI 10.1182/blood-2002-08-2384; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yacoub D, 2006, J BIOL CHEM, V281, P30024, DOI 10.1074/jbc.M604504200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	41	34	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2297	2306		10.1074/jbc.M706825200	http://dx.doi.org/10.1074/jbc.M706825200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039662	Green Submitted, hybrid			2022-12-27	WOS:000252501000057
J	Watkins, PA				Watkins, Paul A.			Very-long-chain Acyl-CoA synthetases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FATTY-ACID TRANSPORT; SACCHAROMYCES-CEREVISIAE; PROTEIN-1 GENE; ADIPOSE-TISSUE; METABOLISM; EXPRESSION; CLONING; FAMILY; COENZYME; MOUSE		[Watkins, Paul A.] Kennedy Krieger Inst, Baltimore, MD 21205 USA; [Watkins, Paul A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA	Kennedy Krieger Institute; Johns Hopkins University	Watkins, PA (corresponding author), Kennedy Krieger Inst, 707 N Broadway, Baltimore, MD 21205 USA.	watkins@kennedykrieger.org		Watkins, Paul A./0000-0002-3246-1405				Binnert C, 2000, AM J PHYSIOL-ENDOC M, V279, pE1072, DOI 10.1152/ajpendo.2000.279.5.E1072; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, GASTROENTEROLOGY, V130, P1245, DOI 10.1053/j.gastro.2006.02.006; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Gertow K, 2004, J CLIN ENDOCR METAB, V89, P392, DOI 10.1210/jc.2003-030682; Gertow K, 2003, ATHEROSCLEROSIS, V167, P265, DOI 10.1016/S0021-9150(02)00454-9; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Gimeno RE, 2007, CURR OPIN LIPIDOL, V18, P271, DOI 10.1097/MOL.0b013e3281338558; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hubbard B, 2006, GASTROENTEROLOGY, V130, P1259, DOI 10.1053/j.gastro.2006.02.012; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; Jia ZZ, 2004, MOL GENET METAB, V83, P117, DOI 10.1016/j.ymgme.2004.06.015; Lewis SE, 2001, J BIOL CHEM, V276, P37042, DOI 10.1074/jbc.M105556200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Man MZ, 1996, MOL ENDOCRINOL, V10, P1021, DOI 10.1210/me.10.8.1021; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Meirhaeghe A, 2000, ARTERIOSCL THROM VAS, V20, P1330, DOI 10.1161/01.ATV.20.5.1330; Mihalik SJ, 2002, J BIOL CHEM, V277, P24771, DOI 10.1074/jbc.M203295200; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; Pei ZT, 2006, J BIOL CHEM, V281, P6632, DOI 10.1074/jbc.M511558200; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Pownall HJ, 2003, ACTA PHYSIOL SCAND, V178, P357, DOI 10.1046/j.1365-201X.2003.01154.x; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Richards MR, 2003, J BIOL CHEM, V278, P10477, DOI 10.1074/jbc.M212469200; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Schmuth M, 2005, J INVEST DERMATOL, V125, P1174, DOI 10.1111/j.0022-202X.2005.23934.x; SINGH I, 1982, FED PROC, V41, P1192; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Steinberg SJ, 2000, J BIOL CHEM, V275, P35162, DOI 10.1074/jbc.M006403200; Steinberg SJ, 1999, MOL GENET METAB, V68, P32, DOI 10.1006/mgme.1999.2883; Steinberg SJ, 1999, BIOCHEM BIOPH RES CO, V257, P615, DOI 10.1006/bbrc.1999.0510; Uchida Y, 1996, J BIOCHEM, V119, P565; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 1997, PROG LIPID RES, V36, P55, DOI 10.1016/S0163-7827(97)00004-0; Watkins PA, 1999, PROSTAG LEUKOTR ESS, V60, P323, DOI 10.1016/S0952-3278(99)80007-6; Watkins PA, 1998, J BIOL CHEM, V273, P18210, DOI 10.1074/jbc.273.29.18210; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zou ZY, 2003, J BIOL CHEM, V278, P16414, DOI 10.1074/jbc.M210557200	55	113	117	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1773	1777		10.1074/jbc.R700037200	http://dx.doi.org/10.1074/jbc.R700037200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18024425	hybrid			2022-12-27	WOS:000252501000002
J	Hale, BG; Batty, IH; Downes, CP; Randall, RE				Hale, Benjamin G.; Batty, Ian H.; Downes, C. Peter; Randall, Richard E.			Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 beta suggests a novel mechanism for phosphoinositide 3-kinase activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P85 REGULATORY SUBUNIT; RNA-BINDING; PHOSPHATIDYLINOSITOL 3-KINASE; CATALYTIC SUBUNIT; EFFECTOR DOMAIN; INFECTED-CELLS; PI 3-KINASE; SH2 DOMAINS; PATHWAY; KINASE	Influenza A virus NS1 protein stimulates host-cell phosphoinositide 3-kinase (PI3K) signaling by binding to the p85 beta regulatory subunit of PI3K. Here, in an attempt to establish a mechanism for this activation, we report further on the functional interaction between NS1 and p85 beta. Complex formation was found to be independent of NS1 RNA binding activity and is mediated by the C-terminal effector domain of NS1. Intriguingly, the primary direct binding site for NS1 on p85 beta is the inter-SH2 domain, a coiled-coil structure that acts as a scaffold for the p110 catalytic subunit of PI3K. In vitro kinase activity assays, together with protein binding competition studies, reveal that NS1 does not displace p110 from the inter-SH2 domain, and indicate that NS1 can form an active heterotrimeric complex with PI3K. In addition, it was established that residues at the C terminus of the inter-SH2 domain are essential for mediating the interaction between p85 beta and NS1. Equivalent residues in p85 alpha have previously been implicated in the basal inhibition of p110. However, such p85 alpha residues were unable to substitute for those in p85 alpha with regards NS1 binding. Overall, these data suggest a model by which NS1 activates PI3K catalytic activity by masking a normal regulatory element specific to the p85 beta inter-SH2 domain.	[Hale, Benjamin G.; Randall, Richard E.] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland; [Batty, Ian H.; Downes, C. Peter] Univ Dundee, Fac Life Sci, Div Mol Physiol, Dundee DD1 5EH, Scotland	University of St Andrews; University of Dundee	Hale, BG (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland.	bgh1@st-andrews.ac.uk	Hale, Benjamin G./D-4958-2015	Hale, Benjamin G./0000-0002-3891-9480	Medical Research Council [G9403619, G0601126] Funding Source: Medline; MRC [G0601126, G9403619] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batty IH, 2004, BIOCHEM J, V379, P641, DOI 10.1042/BJ20031700; Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARPENTER CL, 1993, J BIOL CHEM, V268, P9478; CARPENTER CL, 1993, MOL CELL BIOL, V13, P1657, DOI 10.1128/MCB.13.3.1657; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Foukas LC, 2004, MOL CELL BIOL, V24, P966, DOI 10.1128/MCB.24.3.966-975.2004; Fu Z, 2004, ARCH BIOCHEM BIOPHYS, V432, P244, DOI 10.1016/j.abb.2004.09.032; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Garcia-Sastre A, 2005, MODULATION OF HOST GENE EXPRESSION AND INNATE IMMUNITY BY VIRUSES, P95, DOI 10.1007/1-4020-3242-0_5; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Gout I, 2000, EMBO J, V19, P4015, DOI 10.1093/emboj/19.15.4015; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Ichaso N, 2001, ONCOGENE, V20, P7908, DOI 10.1038/sj.onc.1204859; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Qian XY, 1995, RNA, V1, P948; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Shekar SC, 2005, J BIOL CHEM, V280, P27850, DOI 10.1074/jbc.M506005200; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zhu ZQ, 2007, BIOCHEM BIOPH RES CO, V358, P66, DOI 10.1016/j.bbrc.2007.04.096	53	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1372	1380		10.1074/jbc.M708862200	http://dx.doi.org/10.1074/jbc.M708862200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029356	hybrid			2022-12-27	WOS:000252282700020
J	Spassova, MA; Hewavitharana, T; Fandino, RA; Kaya, A; Tanaka, J; Gill, DL				Spassova, Maria A.; Hewavitharana, Tharnara; Fandino, Richard A.; Kaya, Asli; Tanaka, Jacqueline; Gill, Donald L.			Voltage gating at the selectivity filter of the Ca2+ release-activated Ca2+ channel induced by mutation of the orai1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; CURRENT I-CRAC; CA2+-SELECTIVE ARC CHANNELS; BASOPHILIC LEUKEMIA-CELLS; OPERATED CALCIUM-CHANNEL; RECTIFIER K+ CHANNEL; PLASMA-MEMBRANE; STORE DEPLETION; STIM1; ENTRY	The Ca2+ release-activated Ca2+ (CRAC) channel is a plasma membrane (PM) channel that is uniquely activated when free Ca2+ level in the endoplasmic reticulum (ER) is substantially reduced. Several small interfering RNA screens identified two membrane proteins, Orai1 and STIM1, to be essential for the CRAC channel function. STIM1 appears to function in the PM and as the Ca2+ sensor in the ER. Orai1 is forming the pore of the CRAC channel. Despite the recent breakthroughs, a mechanistic understanding of the CRAC channel gating is still lacking. Here we reveal new insights on the structure-function relationship of STIM1 and Orai1. Our data suggest that the cytoplasmic coiled-coil region of STIM1 provides structural means for coupling of the ER membrane to the PM to activate the CRAC channel. We mutated two hydrophobic residues in this region to proline (L286P/L292P) to introduce a kink in the first a-helix of the coiled-coil domain. This STIM1 mutant caused a dramatic inhibition of the CRAC channel gating compared with the wild type. Structure-function analysis of the Orai1 protein revealed the presence of intrinsic voltage gating of the CRAC channel. A mutation of Orai1 (V102I) close to the selectivity filter modified CRAC channel voltage sensitivity. Expression of the Orai1(VI02I) mutant resulted in slow voltage gating of the CRAC channel by negative potentials. The results revealed that the alteration of Val(102) develops voltage gating in the CRAC channel. Our data strongly suggest the presence of a novel voltage gating mechanism at the selectivity filter of the CRAC channel.	[Spassova, Maria A.; Fandino, Richard A.; Kaya, Asli; Tanaka, Jacqueline] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Hewavitharana, Tharnara; Gill, Donald L.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Maryland; University of Maryland Baltimore	Spassova, MA (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, 1900 N 12th St, Philadelphia, PA 19122 USA.	spassova@temple.edu		Fandino, Richard A./0000-0003-2442-2681	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 058173] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bakowski D, 2000, J PHYSIOL-LONDON, V529, P295, DOI 10.1111/j.1469-7793.2000.00295.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	41	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					14938	14945		10.1074/jbc.M702208200	http://dx.doi.org/10.1074/jbc.M702208200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18096706	Green Published, hybrid			2022-12-27	WOS:000256232000005
J	Kruit, JK; Drayer, AL; Bloks, VW; Blom, N; Olthof, SG; Sauer, PJJ; De Haan, G; Kema, IP; Vellenga, E; Kuipers, F				Kruit, Janine K.; Drayer, A. Lyndsay; Bloks, Vincent W.; Blom, Nel; Olthof, Sandra G.; Sauer, Pieter J. J.; De Haan, Gerald; Kema, Ido P.; Vellenga, Edo; Kuipers, Folkert			Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; CHOLESTEROL ABSORPTION; DIETARY-CHOLESTEROL; BETA-SITOSTEROLEMIA; ABCG5; MICE; ACTIVATION; XANTHOMATOSIS; TRANSPORTER; EZETIMIBE	Mutations in either ABCG5 or ABCG8 cause sitosterolemia, an inborn error of metabolism characterized by high plasma plant sterol concentrations. Recently, macrothrombocytopenia was described in a number of sitosterolemia patients, linking hematological dysfunction to disturbed sterol metabolism. Here, we demonstrate that macrothrombocytopenia is an intrinsic feature of murine sitosterolemia. Abcg5-deficient (Abcg5(-/-)) mice showed a 68% reduction in platelet count, and platelets were enlarged compared with wild-type controls. Macrothrombocytopenia was not due to decreased numbers of megakaryocytes or their progenitors, but defective megakaryocyte development with deterioration of the demarcation membrane system was evident. Lethally irradiated wild-type mice transplanted with bone marrow from Abcg5(-/-) mice displayed normal platelets, whereas Abcg5(-/-) mice transplanted with wild-type bone marrow still showed macrothrombocytopenia. Treatment with the sterol absorption inhibitor ezetimibe rapidly reversed macrothrombocytopenia in Abcg5(-/-) mice concomitant with a strong decrease in plasma plant sterols. Thus, accumulation of plant sterols is responsible for development of macrothrombocytopenia in sitosterolemia, and blocking intestinal plant sterol absorption provides an effective means of treatment.	[Kruit, Janine K.; Bloks, Vincent W.; Sauer, Pieter J. J.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Drayer, A. Lyndsay] Sanquin Blood Bank, NL-9713 GZ Groningen, Netherlands; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands; [De Haan, Gerald] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Stem Cell Biol, NL-9713 GZ Groningen, Netherlands; [Blom, Nel; Olthof, Sandra G.; Vellenga, Edo] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 GZ Groningen, Netherlands; [Blom, Nel] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Elect Microscopy, NL-9713 GZ Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands.	kuipers@med.umcg.nl	Bloks, Vincent/A-7609-2012; de Haan, Gerald/D-2081-2015; de Haan, Gerald/AAF-8963-2019; Kruit, Janine/AGI-8582-2022	Bloks, Vincent/0000-0001-6493-7482; de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138; Kruit, Janine/0000-0002-5414-0485; Kuipers, Folkert/0000-0003-2518-737X				Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BERGER GMB, 1994, POSTGRAD MED J, V70, P631, DOI 10.1136/pgmj.70.827.631; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; CLAYTON PT, 1993, GASTROENTEROLOGY, V105, P1806, DOI 10.1016/0016-5085(93)91079-W; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dieter MZ, 2004, COMP BIOCHEM PHYS C, V139, P209, DOI 10.1016/j.cca.2004.11.002; GOULET O, 1986, JPEN-PARENTER ENTER, V10, P284, DOI 10.1177/0148607186010003284; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Igel M, 2003, J LIPID RES, V44, P533, DOI 10.1194/jlr.M200393-JLR200; ISCOVE NN, 1975, EXP HEMATOL, V3, P32; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; KUKSIS A, 1976, LIPIDS, V11, P581, DOI 10.1007/BF02532869; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; LEIKIN AI, 1989, BIOCHIM BIOPHYS ACTA, V1005, P187, DOI 10.1016/0005-2760(89)90186-0; Louwes H, 1999, AM J MED, V106, P430, DOI 10.1016/S0002-9343(99)00054-6; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Mahaut-Smith MP, 2003, BIOPHYS J, V84, P2646, DOI 10.1016/S0006-3495(03)75070-X; Manning KL, 1996, LAB ANIM SCI, V46, P545; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; MIETTINEN TA, 1980, EUR J CLIN INVEST, V10, P27, DOI 10.1111/j.1365-2362.1980.tb00006.x; ORCUTT RH, 1995, J PHARMACOL TOXICOL, V34, P169, DOI 10.1016/1056-8719(95)00081-5; Plat J, 2005, J LIPID RES, V46, P68, DOI 10.1194/jlr.M400210-JLR200; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Plosch T, 2006, J NUTR, V136, P2135, DOI 10.1093/jn/136.8.2135; Rees DC, 2005, BRIT J HAEMATOL, V130, P297, DOI 10.1111/j.1365-2141.2005.05599.x; Salen G, 2006, GASTROENTEROLOGY, V130, P1853, DOI 10.1053/j.gastro.2006.02.027; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; SALEN G, 1992, J LIPID RES, V33, P945; Saubion JL, 1998, NUTRITION, V14, P477, DOI 10.1016/S0899-9007(98)00025-2; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; SHULMAN RS, 1976, NEW ENGL J MED, V294, P482, DOI 10.1056/NEJM197602262940907; Su YH, 2006, HAEMATOLOGICA, V91, P1392; Temel RE, 2003, J BIOL CHEM, V278, P47594, DOI 10.1074/jbc.M308235200; VANDERMEER R, 1991, AM J PHYSIOL, V260, pG142, DOI 10.1152/ajpgi.1991.260.1.G142; WANG C, 1981, AM J MED, V71, P313, DOI 10.1016/0002-9343(81)90134-0; WEIHRAUCH JL, 1978, J AM DIET ASSOC, V73, P39; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J LIPID RES, V46, P1739, DOI 10.1194/jlr.M500124-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	47	30	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6281	6287		10.1074/jbc.M706689200	http://dx.doi.org/10.1074/jbc.M706689200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156627	Green Published, hybrid			2022-12-27	WOS:000253779500035
J	Peter, C; Waibel, M; Radu, CG; Yang, LV; Witte, ON; Schulze-Osthoff, K; Wesselborg, S; Lauber, K				Peter, Christoph; Waibel, Michaela; Radu, Caius G.; Yang, Li V.; Witte, Owen N.; Schulze-Osthoff, Klaus; Wesselborg, Sebastian; Lauber, Kirsten			Migration to apoptotic "Find-me" signals is mediated via the phagocyte receptor G2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; LYSOPHOSPHATIDYLCHOLINE; CELLS; CLEARANCE; COMPLEMENT; ACID; IDENTIFICATION; CALRETICULIN; CHEMOTAXIS; LIGANDS	Phagocytosis of apoptotic cells is fundamentally important throughout life, because non-cleared cells become secondarily necrotic and release intracellular contents, thus instigating inflammatory and autoimmune responses. Secreted "find-me" and exposed "eat-me" signals displayed by the dying cell in concert with the phagocyte receptors comprise the phagocytic synapse of apoptotic cell clearance. In this scenario, lysophospholipids (lysoPLs) are assumed to act as find-me signals for the attraction of phagocytes. However, both the identity of the lysoPLs released from apoptotic cells and the nature of the phagocyte receptor are largely unknown. By a detailed analysis of the structural requirements we show here that lysophosphatidylcholine (lysoPC), but none of the lysoPC metabolites or other lysoPLs, represents the essential apoptotic attraction signal able to trigger a phagocyte chemotactic response. Furthermore, using RNA interference and expression studies, we demonstrate that the G-protein-coupled receptor G2A, unlike its relative GPR4, is involved in the chemotaxis of monocytic cells. Thus, our study identifies lysoPC and G2A as the crucial receptor/ligand system for the attraction of phagocytes to apoptotic cells and the prevention of autoimmunity.	[Peter, Christoph; Waibel, Michaela; Wesselborg, Sebastian; Lauber, Kirsten] Univ Tubingen, Dept Internal Med, D-72076 Tubingen, Germany; [Radu, Caius G.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Yang, Li V.; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Schulze-Osthoff, Klaus] Univ Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Heinrich Heine University Dusseldorf	Wesselborg, S (corresponding author), Univ Tubingen, Dept Internal Med, Otfried-Muller-Str 10, D-72076 Tubingen, Germany.	sebastian.wesselborg@uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013; Peter, Christoph/ABB-4684-2020; Radu, Caius/D-3936-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Peter, Christoph/0000-0002-0048-2279; Radu, Caius/0000-0002-9338-5397; Wesselborg, Sebastian/0000-0002-5236-942X; Yang, Li/0000-0002-8654-4927				Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Gaipl Udo S, 2004, Curr Rheumatol Rep, V6, P401, DOI 10.1007/s11926-004-0016-1; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HENRICKS PAJ, 1991, PROSTAGLANDINS, V41, P21, DOI 10.1016/0090-6980(91)90101-K; Horino K, 1998, LAB INVEST, V78, P603; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Witte Owen N, 2005, Science, V307, P206; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Zhu K, 2005, J BIOL CHEM, V280, P43280; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	32	165	171	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5296	5305		10.1074/jbc.M706586200	http://dx.doi.org/10.1074/jbc.M706586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089568	hybrid			2022-12-27	WOS:000253426700009
J	Di Matteo, A; Scandurra, FM; Testa, F; Forte, E; Sarti, P; Brunori, M; Giuffre, A				Di Matteo, Adele; Scandurra, Francesca Maria; Testa, Fabrizio; Forte, Elena; Sarti, Paolo; Brunori, Maurizio; Giuffre, Alessandro			The O-2-scavenging flavodiiron protein in the human parasite Giardia intestinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE REDUCTASE; ESCHERICHIA-COLI; DESULFOVIBRIO-GIGAS; MOORELLA-THERMOACETICA; ELECTRON-TRANSFER; IN-VIVO; FLAVORUBREDOXIN; DETOXIFICATION; DUODENALIS; LAMBLIA	The flavodiiron proteins (FDP) are widespread among strict or facultative anaerobic prokaryotes, where they are involved in the response to nitrosative and/or oxidative stress. Unexpectedly, FDPs were fairly recently identified in a restricted group of microaerobic protozoa, including Giardia intestinalis, the causative agent of the human infectious disease giardiasis. The FDP from Giardia was expressed, purified, and extensively characterized by x-ray crystallography, stopped-flow spectroscopy, respirometry, and NO amperometry. Contrary to flavorubredoxin, the FDP from Escherichia coli, the enzyme from Giardia has high O-2-reductase activity (>40 s(-1)), but very low NO-reductase activity (similar to 0.2 s(-1)); O-2 reacts with the reduced protein quite rapidly (milliseconds) and with high affinity (K-m <= 2 mu M), producing H2O. The three-dimensional structure of the oxidized protein determined at 1.9 angstrom resolution shows remarkable similarities with prokaryotic FDPs. Consistent with HPLC analysis, the enzyme is a dimer of dimers with FMN and the non-heme di-iron site topologically close at the monomer-monomer interface. Unlike the FDP from Desulfovibrio gigas, the residue His-90 is a ligand of the di-iron site, in contrast with the proposal that ligation of this histidine is crucial for a preferential specificity for NO. We propose that in G. intestinalis the primary function of FDP is to efficiently scavenge O-2, allowing this microaerobic parasite to survive in the human small intestine, thus promoting its pathogenicity.	Univ Roma La Sapienza, Dept Biochem Sci, CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Giuffre, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Biol & Patol Mol, CNR, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alessandro.giuffre@uniroma1.it	Forte, Elena/K-6015-2015; Giuffrè, Alessandro/K-4341-2015; Di Matteo, Adele/AAC-8338-2019; Sarti, Paolo/D-2946-2009	Giuffrè, Alessandro/0000-0001-5301-0681; Di Matteo, Adele/0000-0002-5921-7365; FORTE, Elena/0000-0001-9049-6916; Brunori, Maurizio/0000-0002-7795-1635; Sarti, Paolo/0000-0002-8219-4827				Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; BROWN DM, 1995, MOL BIOCHEM PARASIT, V72, P47, DOI 10.1016/0166-6851(95)00065-9; Brown DM, 1996, EUR J BIOCHEM, V241, P155, DOI 10.1111/j.1432-1033.1996.0155t.x; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; ELLIS JE, 1993, INT J PARASITOL, V23, P35, DOI 10.1016/0020-7519(93)90095-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gomes CM, 1997, J BIOL CHEM, V272, P22502, DOI 10.1074/jbc.272.36.22502; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; Li L, 2006, MOL MICROBIOL, V59, P202, DOI 10.1111/j.1365-2958.2005.04896.x; Lloyd D, 2000, MICROBIOL-UK, V146, P3109, DOI 10.1099/00221287-146-12-3109; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGET TA, 1989, J GEN MICROBIOL, V135, P145; Rodrigues R, 2006, J BACTERIOL, V188, P2745, DOI 10.1128/JB.188.8.2745-2751.2006; Roxstrom-Lindquist K, 2006, TRENDS PARASITOL, V22, P26, DOI 10.1016/j.pt.2005.11.005; Saraiva LM, 2004, ADV MICROB PHYSIOL, V49, P77, DOI 10.1016/S0065-2911(04)49002-X; Sarti P, 2004, CELL MOL LIFE SCI, V61, P618, DOI 10.1007/s00018-003-3413-8; Seedorf H, 2004, ARCH MICROBIOL, V182, P126, DOI 10.1007/s00203-004-0675-3; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P3572, DOI 10.1021/bi0477337; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SUSIN S, 1993, J BIOL CHEM, V268, P20958; Townson SM, 1996, MOL BIOCHEM PARASIT, V79, P183, DOI 10.1016/0166-6851(96)02661-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; Vicente JB, 2007, FEBS J, V274, P677, DOI 10.1111/j.1742-4658.2006.05612.x; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x	47	84	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4061	4068		10.1074/jbc.M705605200	http://dx.doi.org/10.1074/jbc.M705605200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077462	hybrid			2022-12-27	WOS:000253083500041
J	Fekete, Z; Ellis, TP; Schonauer, MS; Dieckmann, CL				Fekete, Zsuzsanna; Ellis, Timothy P.; Schonauer, Melissa S.; Dieckmann, Carol L.			Pet127 Governs a 5 ' -> 3 '-exonuclease important in maturation of apocytochrome b mRNA in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYTOCHROME-B; YEAST MITOCHONDRIA; 5'-UNTRANSLATED REGION; ESCHERICHIA-COLI; MEMBRANE SYSTEM; CBP1; GENE; DEGRADOSOME; DECAY; EXORIBONUCLEASE	The details of mRNA maturation in Saccharomyces mitochondria are not well understood. All seven mRNAs are transcribed as part of multigenic units. The mRNAs are processed at a common 3'-dodecamer sequence, but the 5'-ends have seven different sequences. To investigate whether apocytochrome b (COB) mRNA is processed at the 5'-end from a longer precursor by an endonuclease or an exonuclease, a 64-nucleotide sequence, which is required for the protection of COB mRNA by the Cbp1 protein and is found at the 5'-end of the processed COB mRNA, was duplicated in tandem. The wild-type 64-nucleotide element functioned in either the upstream or downstream position when paired with a mutant element. In the tandem wild-type strain, the 5'-end of the mRNA was at the 5'-end of the upstream unit, demonstrating that the mRNA is processed by an exonuclease. Accumulation of precursor COB RNA in single and double element strains with a deletion of PET127 demonstrated that the encoded protein governs the 5'-exonuclease responsible for processing the precursor to the mature form.	[Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Biophys, Tucson, AZ 85721 USA; [Fekete, Zsuzsanna] Univ Pecs, Sch Med, Dept Med Biol, H-7624 Pecs, Hungary; [Fekete, Zsuzsanna; Ellis, Timothy P.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biol, Tucson, AZ 85721 USA	University of Arizona; University of Pecs; University of Arizona	Dieckmann, CL (corresponding author), Univ Arizona, Dept Biochem & Biophys, PO Box 210106, Tucson, AZ 85721 USA.	dieckman@u.arizona.edu		Fekete, Zsuzsanna/0000-0002-4264-2365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034893] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34893] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS A, 1997, METHODS YEAST GENETI, P145; BONITZ SG, 1982, J BIOL CHEM, V257, P6268; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CHEN JY, 1988, J BIOL CHEM, V263, P13677; CHEN W, 1994, J BIOL CHEM, V269, P16574; Chen W, 1999, GENETICS, V151, P1315; Chen W, 1997, MOL CELL BIOL, V17, P6203, DOI 10.1128/MCB.17.11.6203; CHRISTIANSON T, 1983, P NATL ACAD SCI-BIOL, V80, P5564, DOI 10.1073/pnas.80.18.5564; DIECKMANN CL, 1984, J BIOL CHEM, V259, P4722; DIECKMANN CL, 1982, P NATL ACAD SCI-BIOL, V79, P1805, DOI 10.1073/pnas.79.6.1805; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 2001, METHOD ENZYMOL, V342, P367, DOI 10.1016/S0076-6879(01)42559-6; Ellis TP, 2005, GENETICS, V171, P949, DOI 10.1534/genetics.104.036467; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; HEYER WD, 1995, MOL CELL BIOL, V15, P2728; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; Houalla R, 2006, YEAST, V23, P439, DOI 10.1002/yea.1369; Islas-Osuna MA, 2002, J BIOL CHEM, V277, P37987, DOI 10.1074/jbc.M206132200; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maniatis T, 1982, MOL CLONING LABORATO, P68; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; MAYER SA, 1989, MOL CELL BIOL, V9, P4161, DOI 10.1128/MCB.9.10.4161; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; MITTELMEIER TM, 1993, MOL CELL BIOL, V13, P4203, DOI 10.1128/MCB.13.7.4203; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Poole T L, 1995, Nucleic Acids Symp Ser, P79; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; STAPLES RR, 1993, GENETICS, V135, P981; Wegierski T, 1998, ACTA BIOCHIM POL, V45, P935, DOI 10.18388/abp.1998_4352; Wiesenberger G, 1997, MOL CELL BIOL, V17, P2816, DOI 10.1128/MCB.17.5.2816; Wiesenberger G, 2007, J MOL BIOL, V367, P681, DOI 10.1016/j.jmb.2007.01.014; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	37	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3767	3772		10.1074/jbc.M709617200	http://dx.doi.org/10.1074/jbc.M709617200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086665	hybrid			2022-12-27	WOS:000253083500010
J	Vigetti, D; Viola, M; Karousou, E; Rizzi, M; Moretto, P; Genasetti, A; Clerici, M; Hascall, VC; De Luca, G; Passi, A				Vigetti, Davide; Viola, Manuela; Karousou, Eugenia; Rizzi, Manuela; Moretto, Paola; Genasetti, Anna; Clerici, Moira; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; HYALURONAN RECEPTOR; IN-VITRO; GEL-ELECTROPHORESIS; CHONDROITIN SULFATE; ENDOCYTOSIS HARE; MIGRATION; CD44; BINDING; ACID	The glycosaminoglycan hyaluronan (HA) modulates cell proliferation and migration, and it is involved in several human vascular pathologies including atherosclerosis and vascular restenosis. During intima layer thickening, HA increases dramatically in the neointima extracellular matrix. Aging is one of the major risk factors for the insurgence of vascular diseases, in which smooth muscle cells (SMCs) play a role by determining neointima formation through their migration and proliferation. Therefore, we established an in vitro aging model consisting of sequential passages of human aortic smooth muscle cells (AoSMCs). Comparing young and aged cells, we found that, during the aging process in vitro, HA synthesis significantly increases, as do HA synthetic enzymes (i.e. HAS2 and HAS3), the precursor synthetic enzyme (UDP-glucose dehydrogenase), and the HA receptor CD44. In aged cells, we also observed increased CD44 signaling that consisted of higher levels of phosphorylated MAP kinase ERK1/2. Further, aged AoSMCs migrated faster than young cells, and such migration could be modulated by HA, which alters the ERK1/2 phosphorylation. HA oligosaccharides of 6.8 kDa and an anti-CD44 blocking antibody prevented ERK1/2 phosphorylation and inhibited AoSMCs migration. These results indicate that, during aging, HA can modulate cell migration involving CD44-mediated signaling through ERK1/2. These data suggest that age-related HA accumulation could promote SMC migration and intima thickening during vascular neointima formation.	[Vigetti, Davide; Viola, Manuela; Karousou, Eugenia; Rizzi, Manuela; Moretto, Paola; Genasetti, Anna; Clerici, Moira; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; [Hascall, Vincent C.] Cleveland Clin Fdn, Orthopaed Res Ctr ND20, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Rizzi, Manuela/AAE-9202-2021; Vigetti, Davide/C-9861-2010; Viola, Manuela/B-7120-2011; passi, alberto g/A-1752-2018	Rizzi, Manuela/0000-0002-6174-7111; Vigetti, Davide/0000-0002-6339-8453; Viola, Manuela/0000-0002-0634-6390; passi, alberto g/0000-0003-3328-3089				Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chajara A, 1998, ATHEROSCLEROSIS, V138, P53, DOI 10.1016/S0021-9150(98)00004-5; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARIRI RJ, 1986, J EXP MED, V164, P1171, DOI 10.1084/jem.164.4.1171; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heldin P, 2003, BRAZ J MED BIOL RES, V36, P967, DOI 10.1590/S0100-879X2003000800002; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang J, 2005, EMERG INFECT DIS, V11, P1473, DOI 10.3201/eid1109.050011; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; KITAYAMA J, 1993, J IMMUNOL, V151, P1663; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li ZH, 1997, EXP MOL PATHOL, V64, P1, DOI 10.1006/exmp.1997.2204; LIAO HX, 1995, J IMMUNOL, V155, P3938; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; Lundberg MS, 1999, EXP GERONTOL, V34, P549, DOI 10.1016/S0531-5565(99)00036-4; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; MARTIN GM, 1983, AM J PATHOL, V110, P236; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; MURATA K, 1989, ATHEROSCLEROSIS, V78, P69, DOI 10.1016/0021-9150(89)90160-3; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Raio L, 2005, MATRIX BIOL, V24, P166, DOI 10.1016/j.matbio.2005.01.006; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ruiz-Torres A, 2003, J GERONTOL A-BIOL, V58, P1074; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; STUHLSATZ HW, 1982, J CLIN CHEM CLIN BIO, V20, P713; Tawada A, 2002, GLYCOBIOLOGY, V12, P421, DOI 10.1093/glycob/cwf048; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tovar AMF, 1998, ARTERIOSCL THROM VAS, V18, P604, DOI 10.1161/01.ATV.18.4.604; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	55	79	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4448	4458		10.1074/jbc.M709051200	http://dx.doi.org/10.1074/jbc.M709051200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077444	Green Published, hybrid			2022-12-27	WOS:000253083500079
J	Wang, JR; Yen, A				Wang, Jianrong; Yen, Andrew			A MAPK-positive feedback mechanism for BLR1 signaling propels retinoic acid-triggered differentiation and cell cycle arrest	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; HL-60 CELLS; MONOCYTIC DIFFERENTIATION; NUCLEAR TRANSLOCATION; LEUKEMIA-CELLS; GROWTH-FACTOR; RAR-ALPHA; G0 ARREST; EXPRESSION; ACTIVATION	MAPK signaling is required for retinoic acid (RA)-triggered G(0) cell cycle arrest and cell differentiation, but the mechanism is not well defined. In this study, RA is found to cause MAPK activation with sustained association of RAF to MEK or ERK, leading to a MAPK-dependent accumulation of p21(Waf1/Cip1) and binding to CDK2 blocking G(1)/S transition. BLR1, a chemokine receptor, was found to function as a critical component of RA-triggered MAPK signaling. Unlike wild-type parental cells, RA-treated BLR1 knockout cells failed to show RAF and consequential MEK and ERK phosphorylation, failed to accumulate CDK inhibitors that control G(1)/S transition, and failed to differentiate and arrest in response to RA, whereas ectopically overexpressing BLR1 enhanced MAPK signaling and caused accelerated RA-induced differentiation and arrest. Ectopic overexpression of RAF enhanced BLR1 expression in response to RA, whereas inhibition of RAF or MEK by inhibitors or knockdown of RAF by short interfering RNA diminished RA-induced BLR1 expression and attenuated differentiation and growth arrest. Ectopic expression of the RAF CR3, the catalytically active domain, in the BLR1 knock-out restored RA-induced MAPK activation and the ability to differentiate and arrest, indicating that RAF effects MAPK signaling by BLR1 to propel differentiation/arrest. Taken together, RA induces cell differentiation and growth arrest through activation of a novel MAPK pathway with BLR1 as a critical component in a positive feedback mechanism that may contribute to the prolonged MAPK signaling propelling RA-induced cell cycle arrest and differentiation.	[Wang, Jianrong; Yen, Andrew] Cornell Univ, Dept Biomed Sci, VRT, Ithaca, NY 14853 USA	Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, VRT, TB013, Ithaca, NY 14853 USA.	ay13@cornell.edu						Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; COLCH W, 2000, BIOCHEM J, V351, P289; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; DOBNER T, 1992, EUR J IMMUNOL, V22, P2795, DOI 10.1002/eji.1830221107; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; FORSTER R, 1994, BLOOD, V84, P830; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; KAISER E, 1993, EUR J IMMUNOL, V23, P2532, DOI 10.1002/eji.1830231023; KATAGIRI K, 1994, BLOOD, V84, P1780; Lamkin TJ, 2006, AM J HEMATOL, V81, P603, DOI 10.1002/ajh.20667; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Schmidt M, 2000, J BIOL CHEM, V275, P41011, DOI 10.1074/jbc.M003716200; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Tanaka T, 2007, J BIOL CHEM, V282, P29987, DOI 10.1074/jbc.M701700200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Wang JR, 2004, MOL CELL BIOL, V24, P2423, DOI 10.1128/MCB.24.6.2423-2443.2004; YEN A, 1984, J CELL PHYSIOL, V118, P277, DOI 10.1002/jcp.1041180310; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1994, EUR J CELL BIOL, V65, P103; YEN A, 1986, LEUKEMIA RES, V10, P619, DOI 10.1016/0145-2126(86)90264-X; Yen A, 1998, CANCER RES, V58, P3163	34	42	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4375	4386		10.1074/jbc.M708471200	http://dx.doi.org/10.1074/jbc.M708471200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18006504	hybrid			2022-12-27	WOS:000253083500072
J	Anil, VS; Rajkumar, P; Kumar, P; Mathew, MK				Anil, Veena S.; Rajkumar, Premraj; Kumar, Pavan; Mathew, M. K.			A plant Ca2+ pump, ACA2, relieves salt hypersensitivity in yeast - Modulation of cytosolic calcium signature and activation of adaptive Na+ homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL AUTOINHIBITORY DOMAIN; DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; ION HOMEOSTASIS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSE; HYPERTONIC SHOCK	Stress responses in both plants and yeast utilize calcium-mediated signaling. A yeast strain, K616, which lacks Ca2+ pumps, requires micromolar Ca(2+)for growth. In medium containing 100 mu M Ca2+, K616 can withstand osmotic stress (750 mM sorbitol) and ionic stress (300 mM KCl) but not hypersodic stress (300 mM NaCl). Heterologous expression of the endoplasmic reticulum-located Arabidopsis thaliana Ca2+-ATPase, ACA2, permits K616 to grow under NaCl stress even in Ca2+-depleted medium. All stresses tested generated transient elevation of cytosolic Ca2+ in wild type yeast, K601, whereas NaCl alone induced prolonged elevation of cytosolic Ca2+ in K616. Both the Ca2+ transient and survival of cultures subjected to NaCl stress was similar for the ACA2 transformant and K601. However, whereas K601 maintained low cytosolic Na+ predominantly by pumping it out across the plasma membrane, the transformant sequestered Na+ in internal organelles. This sequestration requires the presence of an endomembrane Na+/H+-antiporter, NHX1, which does not play a significant role in salt tolerance of wild type yeast except at acidic pH. Transcript levels of the plasma membrane Na+-ATPase, ENA1, were strongly induced only in K601, whereas NHX1 was strongly induced in both K601 and the ACA2 transformant. The calmodulin kinase inhibitor KN62 significantly reduced the salt tolerance of the ACA2 transformant and the transcriptional induction of NHX1. Thus, the heterologous expression of a plant endomembrane Ca2+ pump results in the rapid depletion of cytosolic Ca2+ and the activation of an alternate mechanism for surviving saline stress.	[Anil, Veena S.; Rajkumar, Premraj; Kumar, Pavan; Mathew, M. K.] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mathew, MK (corresponding author), Natl Ctr Biol Sci, UAS GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mathew@ncbs.res.in	Anil, Veena/ABI-3683-2020	Mathew, M K/0000-0002-5932-3598; Anil, Veena/0000-0002-7404-7683				ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Anil Veena S., 2007, Proceedings of the Indian National Science Academy, V73, P43; Anil VS, 2007, PHYSIOL PLANTARUM, V129, P607, DOI 10.1111/j.1399-3054.2006.00854.x; Anil VS, 2005, PHYSIOL PLANTARUM, V124, P451, DOI 10.1111/j.1399-3054.2005.00529.x; Anil VS, 2001, J PLANT PHYSIOL, V158, P1237, DOI 10.1078/0176-1617-00550; Anil VS, 2000, PLANT PHYSIOL, V123, P1301, DOI 10.1104/pp.123.4.1301; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cessna SG, 1998, J BIOL CHEM, V273, P27286, DOI 10.1074/jbc.273.42.27286; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cui JJ, 2006, CELL CALCIUM, V39, P337, DOI 10.1016/j.ceca.2005.12.001; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Elbe R, 1992, BIOTECHNIQUES, V13, P18; Epstein E, 1998, SCIENCE, V280, P1906, DOI 10.1126/science.280.5371.1906; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Halperin SJ, 2003, J EXP BOT, V54, P2035, DOI 10.1093/jxb/erg219; Haro R, 2002, BBA-BIOMEMBRANES, V1564, P114, DOI 10.1016/S0005-2736(02)00408-X; Harper JF, 1998, J BIOL CHEM, V273, P1099, DOI 10.1074/jbc.273.2.1099; HARTENECK C, 2007, DRUG REV, V25, P61; HIRATA D, 1995, MOL GEN GENET, V249, P257, DOI 10.1007/BF00290525; Hirschi K, 2001, TRENDS PLANT SCI, V6, P100, DOI 10.1016/S1360-1385(00)01863-X; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KLUSENER B, 1995, EMBO J, V14, P2708, DOI 10.1002/j.1460-2075.1995.tb07271.x; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Maas E.V., 1990, ASCE MANUALS REPORTS, P262; Malho R, 1996, PLANT CELL, V8, P1935, DOI 10.1105/tpc.8.11.1935; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Melcher ML, 1996, J BIOL CHEM, V271, P29958, DOI 10.1074/jbc.271.47.29958; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; PEREZPRAT E, 1992, PLANT PHYSIOL, V100, P1471, DOI 10.1104/pp.100.3.1471; Phean-O-pas S, 2005, J BIOCHEM MOL BIOL, V38, P432; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Serrano R, 1999, J EXP BOT, V50, P1023, DOI 10.1093/jexbot/50.suppl_1.1023; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	60	42	46	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3497	3506		10.1074/jbc.M700766200	http://dx.doi.org/10.1074/jbc.M700766200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073213	hybrid			2022-12-27	WOS:000253083000055
J	Esser, L; Elberry, M; Zhou, F; Yu, CA; Yu, L; Xia, D				Esser, Lothar; Elberry, Maria; Zhou, Fei; Yu, Chang-An; Yu, Linda; Xia, Di			Inhibitor-complexed structures of the cytochrome bc(1) from the photosynthetic bacterium Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; MITOCHONDRIAL RESPIRATORY-CHAIN; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; EXTRA FRAGMENT; B(6)F COMPLEX; C REDUCTASE; SUBUNIT; BINDING; SITE	The cytochrome bc(1) complex (bc(1)) is a major contributor to the proton motive force across the membrane by coupling electron transfer to proton translocation. The crystal structures of wild type and mutant bc(1) complexes from the photosynthetic purple bacterium Rhodobacter sphaeroides(Rsbc(1)), stabilized with the quinol oxidation (Q(P)) site inhibitor stigmatellin alone or in combination with the quinone reduction (Q(N)) site inhibitor antimycin, were determined. The high quality electron density permitted assignments of a new metal-binding site to the cytochrome c(1) subunit and a number of lipid and detergent molecules. Structural differences between Rsbc(1) and its mitochondrial counterparts are mostly extra membranous and provide a basis for understanding the function of the predominantly longer sequences in the bacterial subunits. Functional implications for the bc(1) complex are derived from analyses of 10 independent molecules in various crystal forms and from comparisons with mitochondrial complexes.	[Esser, Lothar; Xia, Di] NCI, Natl Inst Hlth, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA; [Elberry, Maria; Zhou, Fei; Yu, Chang-An; Yu, Linda] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oklahoma State University System; Oklahoma State University - Stillwater	Xia, D (corresponding author), NCI, Natl Inst Hlth, Cell Biol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	dixia@helix.nih.gov			Intramural NIH HHS Funding Source: Medline; NIGMS NIH HHS [GM 30721] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030721, R01GM030721] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; BROWN MD, 1992, GENETICS, V130, P163; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen YR, 1996, J BIOL CHEM, V271, P2057, DOI 10.1074/jbc.271.4.2057; Covian R, 2002, J BIOL CHEM, V277, P48449, DOI 10.1074/jbc.M208060200; CROFTS AR, 2004, ANN REV PHYSL, V66; Darrouzet E, 2000, BIOCHEMISTRY-US, V39, P15475, DOI 10.1021/bi000750l; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Elberry M, 2006, BIOCHEMISTRY-US, V45, P4991, DOI 10.1021/bi0522246; Elberry M, 2006, BBA-BIOENERGETICS, V1757, P835, DOI 10.1016/j.bbabio.2006.05.031; ESNOUSF BM, 1997, J MOL GRAPHICS, V15, P138; Esser L, 2004, J MOL BIOL, V341, P281, DOI 10.1016/j.jmb.2004.05.065; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; GENNIS RB, 1993, J BIOENERG BIOMEMBR, V25, P195, DOI 10.1007/BF00762582; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; Huang BS, 2005, CEMENT CONCRETE RES, V35, P2008, DOI 10.1016/j.cemconres.2005.05.002; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2003, FEBS LETT, V545, P39, DOI 10.1016/S0014-5793(03)00391-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jordan DB, 1999, PESTIC SCI, V55, P105, DOI 10.1002/(SICI)1096-9063(199902)55:2&lt;105::AID-PS879&gt;3.0.CO;2-D; Kessl JJ, 2003, J BIOL CHEM, V278, P31312, DOI 10.1074/jbc.M304042200; Kim H, 1999, J AM CHEM SOC, V121, P4902, DOI 10.1021/ja990190h; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; Kolling DRJ, 2003, J BIOL CHEM, V278, P39747, DOI 10.1074/jbc.M305913200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Liu XY, 2004, J BIOL CHEM, V279, P47363, DOI 10.1074/jbc.M406497200; MIYOSHI H, 1995, BBA-BIOENERGETICS, V1229, P149, DOI 10.1016/0005-2728(94)00185-8; Nett JH, 2000, EUR J BIOCHEM, V267, P5777, DOI 10.1046/j.1432-1327.2000.01650.x; OHNISHI T, 1988, EUR J BIOCHEM, V176, P385, DOI 10.1111/j.1432-1033.1988.tb14293.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rodgers S, 2000, EUR J BIOCHEM, V267, P3753, DOI 10.1046/j.1432-1327.2000.01411.x; Sauter H, 1999, ANGEW CHEM INT EDIT, V38, P1329, DOI 10.1002/(SICI)1521-3773(19990517)38:10<1328::AID-ANIE1328>3.0.CO;2-1; Schnaufer A, 2000, CURR GENET, V37, P234, DOI 10.1007/s002940050525; Staniek K, 2002, FREE RADICAL RES, V36, P381, DOI 10.1080/10715760290021225; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; TRUMPOWER BL, 1980, J BIOENERG BIOMEMBR, V12, P151, DOI 10.1007/BF00744680; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; VONJAGOW G, 1986, BIOCHEMISTRY-US, V25, P775, DOI 10.1021/bi00352a006; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Yamashita E, 2007, J MOL BIOL, V370, P39, DOI 10.1016/j.jmb.2007.04.011; Yu L, 1999, J BIOENERG BIOMEMBR, V31, P251, DOI 10.1023/A:1005423913639; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	58	118	119	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2846	2857		10.1074/jbc.M708608200	http://dx.doi.org/10.1074/jbc.M708608200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039651	hybrid			2022-12-27	WOS:000252622300042
J	Sciara, G; Blangy, S; Siponen, M; Mc Grath, S; van Sinderen, D; Tegoni, M; Cambillau, C; Campanacci, V				Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Mc Grath, Stephen; van Sinderen, Douwe; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie			A topological model of the baseplate of lactococcal phage Tuc2009	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING PROTEIN; BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN; CELL-WALL; BACTERIOPHAGE TP901-1; CRYSTAL-STRUCTURE; IDENTIFICATION; LACTIS; TAIL; SPECIFICITY	Phages infecting Lactococcus lactis, a Gram-positive bacterium, are a recurrent problem in the dairy industry. Despite their economical importance, the knowledge on these phages, belonging mostly to Siphoviridae, lags behind that accumulated for members of Myoviridae. The three-dimensional structures of the receptor-binding proteins (RBP) of three lactococcal phages have been determined recently, illustrating their modular assembly and assigning the nature of their bacterial receptor. These RBPs are attached to the baseplate, a large phage organelle, located at the tip of the tail. Tuc2009 baseplate is formed by the products of 6 open read frames, including the RBP. Because phage binding to its receptor induces DNA release, it has been postulated that the baseplate might be the trigger for DNA injection. We embarked on a structural study of the lactococcal phages baseplate, ultimately to gain insight into the triggering mechanism following receptor binding. Structural features of the Tuc2009 baseplate were established using size exclusion chromatography coupled to on-line UV-visible absorbance, light scattering, and refractive index detection (MALS/UV/RI). Combining the results of this approach with literature data led us to propose a "low resolution" model of Tuc2009 baseplate. This model will serve as a knowledge base to submit relevant complexes to crystallization trials.	[Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] CNRS, Architecture & Fonct Macromol Biol, UMR 6098, F-13288 Marseille, France; [Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] Univ Aix Marseille 1, F-13288 Marseille, France; [Sciara, Giuliano; Blangy, Stephanie; Siponen, Marina; Tegoni, Mariella; Cambillau, Christian; Campanacci, Valerie] Univ Aix Marseille 2, F-13288 Marseille, France; [Mc Grath, Stephen; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University College Cork; University College Cork	Cambillau, C (corresponding author), CNRS, Architecture & Fonct Macromol Biol, UMR 6098, F-13288 Marseille, France.	cambillau@afmb.univ-mrs.fr; valerie.campanacci@afmb.univ-mrs.fr	Van Sinderen, Douwe/A-6778-2015; sciara, giuliano/AAL-4478-2020	Van Sinderen, Douwe/0000-0003-1823-7957; Campanacci, Valerie/0000-0001-6407-6395				BOURNE Y, 1990, PROTEINS, V8, P365, DOI 10.1002/prot.340080410; BOURNE Y, 1994, STRUCTURE, V2, P209, DOI 10.1016/S0969-2126(00)00022-8; Deveau H, 2006, APPL ENVIRON MICROB, V72, P4338, DOI 10.1128/AEM.02517-05; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; Geller BL, 2005, J DAIRY SCI, V88, P900, DOI 10.3168/jds.S0022-0302(05)72756-9; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Leiman PG, 2004, CELL, V118, P419, DOI 10.1016/j.cell.2004.07.022; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; MONTEVILLE MR, 1994, APPL ENVIRON MICROB, V60, P3204, DOI 10.1128/AEM.60.9.3204-3211.1994; Olia AS, 2007, BIOCHEMISTRY-US, V46, P8776, DOI 10.1021/bi700186e; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Plancon L, 2002, J MOL BIOL, V318, P557, DOI 10.1016/S0022-2836(02)00089-X; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Rabsch W, 2007, J BACTERIOL, V189, P5658, DOI 10.1128/JB.00437-07; Ricagno S, 2006, J VIROL, V80, P9331, DOI 10.1128/JVI.01160-06; Sao-Jose C, 2006, J BIOL CHEM, V281, P11464, DOI 10.1074/jbc.M513625200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; VALYASEVI R, 1994, J DAIRY SCI, V77, P1, DOI 10.3168/jds.S0022-0302(94)76921-6; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Vincentelli R, 2005, ANAL BIOCHEM, V346, P77, DOI 10.1016/j.ab.2005.07.039; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; Ye HP, 2006, ANAL BIOCHEM, V356, P76, DOI 10.1016/j.ab.2006.05.025	30	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2716	2723		10.1074/jbc.M707533200	http://dx.doi.org/10.1074/jbc.M707533200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045876	hybrid			2022-12-27	WOS:000252622300029
J	Cocheme, HM; Murphy, MP				Cocheme, Helena M.; Murphy, Michael P.			Complex I is the major site of mitochondrial superoxide production by paraquat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; OXIDATIVE STRESS; UBIQUINONE OXIDOREDUCTASE; GLUTATHIONE-PEROXIDASE; LIPID-PEROXIDATION; RESPIRATORY-CHAIN; RADICAL FORMATION; NULL MUTANTS; NITRIC-OXIDE; YEAST-CELLS	Paraquat (1,1'-dimethyl-4,4'-bipyridinium dichloride) is widely used as a redox cycler to stimulate superoxide production in organisms, cells, and mitochondria. This superoxide production causes extensive mitochondrial oxidative damage, however, there is considerable uncertainty over the mitochondrial sites of paraquat reduction and superoxide formation. Here we show that in yeast and mammalian mitochondria, superoxide production by paraquat occurs in the mitochondrial matrix, as inferred from manganese superoxide dismutase-sensitive mitochondrial DNA damage, as well as from superoxide assays in isolated mitochondria, which were unaffected by exogenous superoxide dismutase. This paraquat-induced superoxide production in the mitochondrial matrix required a membrane potential that was essential for paraquat uptake into mitochondria. This uptake was of the paraquat dication, not the radical monocation, and was carrier-mediated. Experiments with disrupted mitochondria showed that once in the matrix paraquat was principally reduced by complex I (mammals) or by NADPH dehydrogenases (yeast) to form the paraquat radical cation that then reacted with oxygen to form superoxide. Together this membrane potential-dependent uptake across the mitochondrial inner membrane and the subsequent rapid reduction to the paraquat radical cation explain the toxicity of paraquat to mitochondria.	[Cocheme, Helena M.; Murphy, Michael P.] Wellcome Trust Res Labs, Med Res Council Diunn Human Nutr Unit, Cambridge CB2 0XY, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Wellcome Trust Sanger Institute	Murphy, MP (corresponding author), Wellcome Trust Res Labs, Med Res Council Diunn Human Nutr Unit, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	mpm@mrc-dunn.cam.ac.uk	Murphy, Michael P/C-2120-2009	Murphy, Michael P/0000-0003-1115-9618; Cocheme, Helena/0000-0001-8637-0042	MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSEN OS, 1978, BIOPHYS J, V21, P35, DOI 10.1016/S0006-3495(78)85507-6; BLASZCZYNSKI M, 1985, ACTA MICROBIOL POL, V34, P243; Brand M. D., 1995, BIOENERGETICS, V154, P62; BUS JS, 1974, BIOCHEM BIOPH RES CO, V58, P749, DOI 10.1016/S0006-291X(74)80481-X; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; DAVEY GP, 1992, BIOCHEM J, V288, P439, DOI 10.1042/bj2880439; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Esteves TC, 2004, BIOCHEM J, V379, P309, DOI 10.1042/BJ20031682; FOURY F, 1992, EMBO J, V11, P2717, DOI 10.1002/j.1460-2075.1992.tb05337.x; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; FUKUSHIMA T, 1993, EXP TOXICOL PATHOL, V45, P345, DOI 10.1016/S0940-2993(11)80424-0; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; GAGE JC, 1968, BIOCHEM J, V109, P757, DOI 10.1042/bj1090757; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; GORNALL AG, 1949, J BIOL CHEM, V177, P751; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; HASSAN HM, 1984, METHOD ENZYMOL, V105, P523; HAUSLADEN A, 1994, J BIOL CHEM, V269, P29405; HIRAI KI, 1992, TOXICOLOGY, V72, P1, DOI 10.1016/0300-483X(92)90081-O; Hsu AY, 2000, BBA-MOL CELL BIOL L, V1484, P287, DOI 10.1016/S1388-1981(00)00019-6; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kervinen M, 2004, ANAL BIOCHEM, V324, P45, DOI 10.1016/j.ab.2003.09.004; Kirby K, 2002, P NATL ACAD SCI USA, V99, P16162, DOI 10.1073/pnas.252342899; KRALL J, 1988, J BIOL CHEM, V263, P1910; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; LANOUE KF, 1979, ARCH BIOCHEM BIOPHYS, V195, P578, DOI 10.1016/0003-9861(79)90384-9; LIU XF, 1992, J BIOL CHEM, V267, P18298; LUCAS M, 1992, ANAL BIOCHEM, V206, P273, DOI 10.1016/0003-2697(92)90366-F; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Margolis AS, 2000, BBA-GEN SUBJECTS, V1524, P253, DOI 10.1016/S0304-4165(00)00167-7; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; Mollace V, 2003, NEUROSCI LETT, V335, P163, DOI 10.1016/S0304-3940(02)01168-0; Murakami K, 1997, BIOCHEM MOL BIOL INT, V41, P481; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2003, J BIOL CHEM, V278, P48534, DOI 10.1074/jbc.M308529200; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; NICHOLLS DG, 2002, BIOENERGITICS, V3; O'Brien KM, 2004, J BIOL CHEM, V279, P51817, DOI 10.1074/jbc.M405958200; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Peixoto F, 2004, TOXICOL IN VITRO, V18, P733, DOI 10.1016/j.tiv.2004.02.009; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Rees JF, 1998, J EXP BIOL, V201, P1211; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rodriguez-Juarez F, 2007, BIOCHEM J, V405, P223, DOI 10.1042/BJ20070033; Ross MF, 2006, BIOCHEM J, V400, P199, DOI 10.1042/BJ20060919; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Sampayo JN, 2003, AGING CELL, V2, P319, DOI 10.1046/j.1474-9728.2003.00063.x; Shimada H, 1998, ARCH BIOCHEM BIOPHYS, V351, P75, DOI 10.1006/abbi.1997.0557; Shimizu K, 2001, BRAIN RES, V906, P135, DOI 10.1016/S0006-8993(01)02577-X; SMITH LL, 1981, BIOCHEM PHARMACOL, V30, P1053, DOI 10.1016/0006-2952(81)90441-X; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sturtz LA, 2002, METHOD ENZYMOL, V349, P167, DOI 10.1016/S0076-6879(02)49332-9; Tampo Y, 1999, FREE RADICAL BIO MED, V27, P588, DOI 10.1016/S0891-5849(99)00110-0; Thiruchelvam M, 2005, J BIOL CHEM, V280, P22530, DOI 10.1074/jbc.M500417200; Thiruchelvam M, 2000, J NEUROSCI, V20, P9207; Tsukamoto M, 2002, TOXICOL APPL PHARM, V178, P82, DOI 10.1006/taap.2001.9325; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; WANG GY, 1992, J ELECTRON MICROSC, V41, P181; WATANABE K, 1992, JPN J TOX ENV HEALTH, V38, P142	74	399	418	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1786	1798		10.1074/jbc.M708597200	http://dx.doi.org/10.1074/jbc.M708597200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039652	hybrid			2022-12-27	WOS:000252501000004
J	Greenberg, ME; Li, XM; Gugiu, BG; Gu, XD; Qin, J; Salomon, RG; Hazen, SL				Greenberg, Michael E.; Li, Xin-Min; Gugiu, Bogdan G.; Gu, Xiaodong; Qin, Jun; Salomon, Robert G.; Hazen, Stanley L.			The lipid whisker model of the structure of oxidized cell membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; PLATELET-ACTIVATING-FACTOR; SCAVENGER RECEPTOR CD36; MOUSE PERITONEAL-MACROPHAGES; APOPTOTIC CELLS; ETHANOLAMINE PHOSPHOLIPIDS; FACTOR ACETYLHYDROLASE; PROTEIN MOIETIES; OXIDANT STRESS; VESICLE FUSION	An essential feature of the innate immune system is maintaining cellular homeostasis by identifying and removing senescent and apoptotic cells and modified lipoproteins. Identification is achieved through the recognition of molecular patterns, including structurally distinct oxidized phospholipids, on target cells by macrophage receptors. Both the structural nature of the molecular patterns recognized and their orientation within membranes has remained elusive. We recently described the membrane conformation of an endogenous oxidized phospholipid ligand for macrophage scavenger receptor CD36, where the truncated oxidized sn-2 fatty acid moiety protrudes into the aqueous phase, rendering it accessible for recognition. Herein we examine the generality of this conformational motif for peroxidized glycerophospholipids within membranes. Our data reveal that the addition of a polar oxygen atom on numerous peroxidized fatty acids reorients the acyl chain, whereby it no longer remains buried within the membrane interior but rather protrudes into the aqueous compartment. Moreover, we show that neither a conformational change in the head group relative to the membrane surface nor the presence of a polar head group is essential for CD36 recognition of free oxidized phospholipid ligands within membranes. Rather, our results suggest the following global phenomenon. As cellular membranes undergo lipid peroxidation, such as during senescence or apoptosis, previously hydrophobic portions of fatty acids will move from the interior of the lipid bilayer to the aqueous exterior. This enables physical contact between pattern recognition receptor and molecular pattern ligand. Cell membranes thus " grow whiskers" as phospholipids undergo peroxidation, and many of their oxidized fatty acids protrude at the surface.	[Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin, Dept Cell Biol, Cleveland, OH 44195 USA; [Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Greenberg, Michael E.; Li, Xin-Min; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Hazen, SL (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Gu, Xiaodong/N-9017-2013; Salomon, Robert G/C-3463-2008; Hazen, Stanley L/ABD-5845-2021	Salomon, Robert/0000-0001-9456-3557; Qin, Jun/0000-0002-2647-9270	NEI NIH HHS [R01 EY016813, EY016813] Funding Source: Medline; NHLBI NIH HHS [HL70621, HL53315, R01 HL053315, P01 HL076491, P01 HL077107] Funding Source: Medline; NIGMS NIH HHS [GM21249, R01 GM021249] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY016813] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491, P50HL077107, R01HL070621, R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adachi H, 2006, PROG LIPID RES, V45, P379, DOI 10.1016/j.plipres.2006.03.002; BABER J, 1995, BIOCHEMISTRY-US, V34, P6533, DOI 10.1021/bi00019a035; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Bird DA, 1999, P NATL ACAD SCI USA, V96, P6347, DOI 10.1073/pnas.96.11.6347; Bjorkbacka H, 2006, CURR OPIN LIPIDOL, V17, P527; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Boullier A, 2000, J BIOL CHEM, V275, P9163, DOI 10.1074/jbc.275.13.9163; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; ELLENA JF, 1987, BIOCHEMISTRY-US, V26, P4584, DOI 10.1021/bi00388a062; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 1998, J IMMUNOL, V161, P6250; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Greenberg ME, 2006, J EXP MED, V203, P2613, DOI 10.1084/jem.20060370; Gugiu BG, 2006, CHEM RES TOXICOL, V19, P262, DOI 10.1021/tx050247f; Gugiu BG, 2003, ORG LETT, V5, P2797, DOI 10.1021/ol034729z; HAN XL, 1990, BIOCHEMISTRY-US, V29, P4992, DOI 10.1021/bi00472a032; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Knecht V, 2007, BIOPHYS J, V92, P4254, DOI 10.1529/biophysj.106.103572; KOURODA Y, 1984, J AM CHEM SOC, V106, P1; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li XM, 2007, BIOCHEMISTRY-US, V46, P5009, DOI 10.1021/bi700163y; Marathe GK, 2001, TRENDS CARDIOVAS MED, V11, P139, DOI 10.1016/S1050-1738(01)00100-1; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; PACE RJ, 1982, J CHEM PHYS, V76, P4241, DOI 10.1063/1.443501; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shimada H, 1998, BIOCHEMISTRY-US, V37, P854, DOI 10.1021/bi972348l; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smeijers AF, 2006, J PHYS CHEM B, V110, P13212, DOI 10.1021/jp060824o; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Terpstra V, 1998, P NATL ACAD SCI USA, V95, P1806, DOI 10.1073/pnas.95.4.1806; WAGNER G, 1979, J MAGN RESON, V26, P629	52	218	225	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2385	2396		10.1074/jbc.M707348200	http://dx.doi.org/10.1074/jbc.M707348200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045864	hybrid			2022-12-27	WOS:000252501000065
J	Kang, YH; Zhang, XZ; Dobie, F; Wu, HY; Craig, AM				Kang, Yunhee; Zhang, XueZhao; Dobie, Frederick; Wu, Huaiyang; Craig, Ann Marie			Induction of GABAergic postsynaptic differentiation by alpha-neurexins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA1 PYRAMIDAL NEURONS; INHIBITORY SYNAPSES; BETA-NEUREXINS; CELL-ADHESION; SYNAPTIC-TRANSMISSION; EXCITATORY SYNAPSES; HIPPOCAMPAL-NEURONS; RECEPTOR SUBTYPES; EPHB RECEPTORS; CA2+ CHANNELS	beta-Neurexin and neuroligin cell adhesion molecules contribute to synapse development in the brain. The longer beta-neurexins function at both glutamate and gamma-aminobutyric acid (GABA) synapses in coupling to presynaptic calcium channels. Binding of alpha-neurexins to neuroligins was recently reported, but the role of the alpha-neurexins in synapse development has not been well studied. Here we report that in COS cell neuron coculture assays, all three alpha-neurexins induce clustering of the GABAergic postsynaptic scaffolding protein gephyrin and neuroligin 2 but not of the glutamatergic postsynaptic scaffolding protein PSD-95 or neuroligin 1/ 3/ 4. alpha-Neurexins also induce clustering of the GABAA receptor gamma 2 subunit. This synapse promoting activity of alpha-neurexins is mediated by the sixth LNS (laminin neurexin sex hormone-binding protein) domain and negatively modulated by upstream sequences. Although inserts at splice site 4 (S4) in beta-neurexins promote greater clustering activity for GABA than glutamate proteins in coculture assay, alpha-neurexinspecific sequences confer complete specificity for GABA proteins. We further report a developmental increase in the ratio of -S4 to + S4 forms of neurexins correlating with an increase in glutamate relative to GABA synaptogenesis and activity regulation of splicing at S4. Thus, + S4 beta-neurexins and, even more selectively, alpha-neurexins may be mediators of GABAergic synaptic protein recruitment and stabilization.	[Kang, Yunhee; Dobie, Frederick; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Kang, Yunhee; Dobie, Frederick; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; [Kang, Yunhee; Zhang, XueZhao; Wu, Huaiyang; Craig, Ann Marie] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of British Columbia; University of British Columbia; Washington University (WUSTL)	Craig, AM (corresponding author), Univ British Columbia, Brain Res Ctr, Rm F149,2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	amcraig@interchange.ubc.ca	Craig, Ann Marie/M-2054-2014	Dobie, Frederick/0000-0002-0550-8095	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070860] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH-070860, R01 MH070860-03, R01 MH070860-02, R01 MH070860-01A1, R01 MH070860] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Conroy WG, 2007, DEV BIOL, V307, P79, DOI 10.1016/j.ydbio.2007.04.017; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Goslin K., 1998, CULTURING NERVE CELL, P339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Grootjans JJ, 2000, J BIOL CHEM, V275, P19933, DOI 10.1074/jbc.M002459200; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; KIM S, 2006, FEBS LETT, V9, P1294; Knuesel I, 1999, EUR J NEUROSCI, V11, P4457, DOI 10.1046/j.1460-9568.1999.00887.x; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Patzke H, 2000, MOL CELL NEUROSCI, V15, P561, DOI 10.1006/mcne.2000.0853; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sons MS, 2006, NEUROSCIENCE, V138, P433, DOI 10.1016/j.neuroscience.2005.11.040; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2002, GENOMICS, V79, P849, DOI 10.1006/geno.2002.6780; Tyzio R, 1999, J NEUROSCI, V19, P10372; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; USHKARYOV YA, 1993, P NATL ACAD SCI USA, V90, P6410, DOI 10.1073/pnas.90.14.6410; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Zeng ZH, 2006, INT J DEV BIOL, V50, P39, DOI 10.1387/ijdb.052068zz; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	59	99	100	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2323	2334		10.1074/jbc.M703957200	http://dx.doi.org/10.1074/jbc.M703957200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006501	Green Accepted, hybrid			2022-12-27	WOS:000252501000059
J	Lunn, FA; MacDonnell, JE; Bearne, SL				Lunn, Faylene A.; MacDonnell, Jennifer E.; Bearne, Stephen L.			Structural requirements for the activation of Escherichia coli CTP synthase by the allosteric effector GTP are stringent, but requirements for inhibition are lax	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE TRIPHOSPHATE SYNTHETASE; PROTEIN-KINASE-A; GLUTAMINE AMIDOTRANSFERASE DOMAIN; AFRICAN SLEEPING SICKNESS; SACCHAROMYCES-CEREVISIAE; CYCLOPENTENYL CYTOSINE; LACTOCOCCUS-LACTIS; DRUG-RESISTANCE; PHOSPHORYLATION; IDENTIFICATION	Cytidine 5 '-triphosphate synthase catalyzes the ATP-dependent formation of CTP from UTP using either NH3 or L-glutamine (Gln) as the source of nitrogen. GTP acts as an allosteric effector promoting Gln hydrolysis but inhibiting Gln-dependent CTP formation at concentrations of > 0.15 mM and NH3-dependent CTP formation at all concentrations. A structure-activity study using a variety of GTP and guanosine analogues revealed that only a few GTP analogues were capable of activating Gln-dependent CTP formation to varying degrees: GTP approximate to 6-thio-GTP > ITP approximate to guanosine 5 '-tetraphosphate > O-6-methyl-GTP > 2 '-deoxy-GTP. No activation was observed with guanosine, GMP, GDP, 2 ', 3 '-dideoxy- GTP, acycloguanosine, and acycloguanosine monophosphate, indicating that the 5 '-triphosphate, 2 '-OH, and 3 '-OH are required for full activation. The 2-NH2 group plays an important role in binding recognition, whereas substituents at the 6-position play an important role in activation. The presence of a 6-NH2 group obviates activation, consistent with the inability of ATP to substitute for GTP. Nucleotide and nucleoside analogues of GTP and guanosine, respectively, all inhibited NH3- and Gln-dependent CTP formation ( often in a cooperative manner) to a similar extent ( IC50 approximate to 0.2-0.5 mM). This inhibition appeared to be due solely to the purine base and was relatively insensitive to the identity of the purine with the exception of inosine, ITP, and adenosine ( IC50 approximate to 4-12 mM). 8-Oxoguanosine was the best inhibitor identified ( IC50 = 80 mu M). Our findings suggest that modifying 2-aminopurine or 2-aminopurine riboside may serve as an effective strategy for developing cytidine 5 '-triphosphate synthase inhibitors.	[Lunn, Faylene A.; MacDonnell, Jennifer E.; Bearne, Stephen L.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada	Dalhousie University	Bearne, SL (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.	sbearne@dal.ca	Bearne, Stephen/ABF-8338-2021					Aronow B, 1986, Adv Exp Med Biol, V195 Pt B, P263; Bearne SL, 2001, BIOCHEM J, V356, P223, DOI 10.1042/0264-6021:3560223; Chang YF, 2007, J BIOL CHEM, V282, P17613, DOI 10.1074/jbc.M702799200; Choi MG, 2007, J BIOL CHEM, V282, P5367, DOI 10.1074/jbc.M610993200; De Clercq E, 2001, CLIN MICROBIOL REV, V14, P382, DOI 10.1128/CMR.14.2.382-397.2001; DECLERCQ E, 1993, ADV VIRUS RES, V42, P1, DOI 10.1016/S0065-3527(08)60082-2; Endrizzi JA, 2005, BIOCHEMISTRY-US, V44, P13491, DOI 10.1021/bi051282o; Endrizzi JA, 2004, BIOCHEMISTRY-US, V43, P6447, DOI 10.1021/bi0496945; Fijolek A, 2007, J BIOL CHEM, V282, P11858, DOI 10.1074/jbc.M611580200; Gao WY, 2000, NUCLEOS NUCLEOT NUCL, V19, P371, DOI 10.1080/15257770008033015; Goto M, 2004, STRUCTURE, V12, P1413, DOI 10.1016/j.str.2004.05.013; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Hatse S, 1999, BIOCHEM PHARMACOL, V58, P539, DOI 10.1016/S0006-2952(99)00035-0; Higgins MJ, 2007, J BIOL CHEM, V282, P29493, DOI 10.1074/jbc.M703948200; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Iyengar A, 2003, BIOCHEM J, V369, P497, DOI 10.1042/BJ20021110; Iyengar A, 2002, ANAL BIOCHEM, V308, P396, DOI 10.1016/S0003-2697(02)00240-3; JENCKS WP, 1968, HDB BIOCH, pJ165; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; KENSLER TW, 1989, DESIGN ENZYME INHIBI, P379; Koshland DE., 1974, ENZYMES, P539; Kursula P, 2006, ACTA CRYSTALLOGR F, V62, P613, DOI 10.1107/S1744309106018136; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P247, DOI 10.1021/bi00752a016; LEVITZKI A, 1972, BIOCHEMISTRY-US, V11, P241, DOI 10.1021/bi00752a015; Lim RLH, 1996, MOL BIOCHEM PARASIT, V78, P249, DOI 10.1016/S0166-6851(96)02635-7; LOFTFIELD RB, 1969, SCIENCE, V164, P305, DOI 10.1126/science.164.3877.305; Long C, 1978, Methods Enzymol, V51, P79; LONG CW, 1967, J BIOL CHEM, V242, P4715; Lunn FA, 2004, EUR J BIOCHEM, V271, P4204, DOI 10.1111/j.1432-1033.2004.04360.x; MacDonnell JE, 2004, BBA-PROTEINS PROTEOM, V1699, P213, DOI 10.1016/j.bbapap.2004.03.002; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Park TS, 1999, BIOCHEMISTRY-US, V38, P8839, DOI 10.1021/bi990784x; Seela F, 2007, ORG BIOMOL CHEM, V5, P3034, DOI 10.1039/b708736e; SEGEL IH, 1975, ENZYME KINETICS, P470; Simard D, 2003, EUR J BIOCHEM, V270, P2195, DOI 10.1046/j.1432-1033.2003.03588.x; Stoychev G, 2002, EUR J BIOCHEM, V269, P4048, DOI 10.1046/j.1432-1033.2002.03097.x; Verschuur AC, 2004, NUCLEOS NUCLEOT NUCL, V23, P1517, DOI 10.1081/NCN-200027733; Verschuur AC, 2000, EUR J CANCER, V36, P627, DOI 10.1016/S0959-8049(00)00021-6; Verschuur AC, 2001, LEUKEMIA RES, V25, P891, DOI 10.1016/S0145-2126(01)00047-9; VONDERSAAL W, 1985, J AM CHEM SOC, V107, P703, DOI 10.1021/ja00289a031; VONDERSAAL W, 1985, J BIOL CHEM, V260, P4993; WENG M, 1987, J BACTERIOL, V169, P3023, DOI 10.1128/jb.169.7.3023-3028.1987; WENG M, 1986, J BIOL CHEM, V261, P5568; WHELAN J, 1994, LEUKEMIA, V8, P264; WHELAN J, 1993, NAT GENET, V3, P317, DOI 10.1038/ng0493-317; Willemoes M, 2005, FEBS J, V272, P856, DOI 10.1111/j.1742-4658.2004.04525.x; Willemoes M, 2003, J BIOL CHEM, V278, P9407, DOI 10.1074/jbc.M212995200; Willemoes M, 2002, EUR J BIOCHEM, V269, P4772, DOI 10.1046/j.1432-1033.2002.03175.x; Wylie JL, 1996, J BIOL CHEM, V271, P15393, DOI 10.1074/jbc.271.26.15393; Yuan P, 2005, MOL BIOCHEM PARASIT, V143, P200, DOI 10.1016/j.molbiopara.2005.06.004; ZALKIN H, 1985, METHOD ENZYMOL, V113, P282; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203	55	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2010	2020		10.1074/jbc.M707803200	http://dx.doi.org/10.1074/jbc.M707803200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18003612	hybrid			2022-12-27	WOS:000252501000028
J	Pinto, JR; Parvatiyar, MS; Jones, MA; Liang, JS; Potter, JD				Pinto, Jose R.; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.			A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC-MUSCLE CONTRACTION; THIN FILAMENT REGULATION; ATPASE ACTIVITY; DILATED CARDIOMYOPATHY; TROPOMYOSIN-BINDING; VENTRICULAR MUSCLE; FUNCTIONAL REGIONS; ISOFORMS AFFECT; HEART-FAILURE	Restrictive cardiomyopathy (RCM) is a rare disorder characterized by impaired ventricular filling with decreased diastolic volume. We are reporting the functional effects of the first cardiac troponin T (CTnT) mutation linked to infantile RCM resulting from a de novo deletion mutation of glutamic acid 96. The mutation was introduced into adult and fetal isoforms of human cardiac TnT (HCTnT3-Delta E96 and HCTnT1-Delta E106, respectively) and studied with either cardiac troponin I (CTnI) or slow skeletal troponin I (SSTnI). Skinned cardiac fiber measurements showed a large leftward shift in the Ca2+ sensitivity of force development with no differences in the maximal force. HCTnT1-Delta E106 showed a significant increase in the activation of actomyosin ATPase with either CTnI or SSTnI, whereas HCTnT3-Delta E96 was only able to increase the ATPase activity with CTnI. Both mutants showed an impaired ability to inhibit the ATPase activity. The capacity of the CTnI center dot CTnC and SSTnI center dot CTnC complexes to fully relax the fibers after TnT displacement was also compromised. Experiments performed using fetal troponin isoforms showed a less severe impact compared with the adult isoforms, which is consistent with the cardioprotective role of SSTnI and the rapid onset of RCM after birth following the isoform switch. These data indicate that troponin mutations related to RCM may have specific functional phenotypes, including large leftward shifts in the Ca2+ sensitivity and impaired abilities to inhibit ATPase and to relax skinned fibers. All of this would account for and contribute to the severe diastolic dysfunction seen in RCM.	[Pinto, Jose R.; Parvatiyar, Michelle S.; Jones, Michelle A.; Liang, Jingsheng; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Potter, JD (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave, Miami, FL 33136 USA.	jdpotter@miami.edu	parvatiyar, michelle/ABH-7542-2020; Pinto, Jose Renato/H-2631-2017	Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042325, R37HL042325] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-42325, HL-674154] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abusamhadneh E, 2001, FEBS LETT, V506, P51, DOI 10.1016/S0014-5793(01)02790-9; Ammash NM, 2000, CIRCULATION, V101, P2490, DOI 10.1161/01.CIR.101.21.2490; ANDERSON PAW, 1995, CIRC RES, V76, P681, DOI 10.1161/01.RES.76.4.681; Belin RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2344, DOI 10.1152/ajpheart.00541.2006; Biesiadecki BJ, 2007, BIOCHEMISTRY-US, V46, P1368, DOI 10.1021/bi061949m; Chandra M, 2005, AM J PHYSIOL-HEART C, V289, pH2112, DOI 10.1152/ajpheart.00571.2005; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; CHANDRA M, 2001, AM J PHYSIOL, V280, pH706; Chen SC, 2001, J HEART LUNG TRANSPL, V20, P90, DOI 10.1016/S1053-2498(00)00162-5; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiske CH, 1925, J BIOL CHEM, V66, P375; FRYER MW, 1988, J PHYSIOL-LONDON, V407, P53, DOI 10.1113/jphysiol.1988.sp017403; GODT RE, 1989, J PHYSIOL-LONDON, V412, P155, DOI 10.1113/jphysiol.1989.sp017609; Gomes AV, 2005, J BIOL CHEM, V280, P30909, DOI 10.1074/jbc.M500287200; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gomes AV, 2004, J BIOL CHEM, V279, P49579, DOI 10.1074/jbc.M407340200; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; GUTH K, 1987, J BIOL CHEM, V262, P13627; Harada K, 2004, J BIOL CHEM, V279, P14488, DOI 10.1074/jbc.M309355200; HEALD RW, 1988, J BIOL CHEM, V263, P5254; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Hernandez OM, 2001, J APPL PHYSIOL, V90, P1125, DOI 10.1152/jappl.2001.90.3.1125; HILL LE, 1992, J BIOL CHEM, V267, P16106; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; HITCHCOCKDEGREGORI SE, 1985, BIOCHEMISTRY-US, V24, P3305, DOI 10.1021/bi00334a035; Huang XP, 2004, ACTA PHARMACOL SIN, V25, P1569; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimberlin MT, 2002, J HEART LUNG TRANSPL, V21, P455, DOI 10.1016/S1053-2498(01)00400-4; Kleerekoper Q, 1998, J BIOL CHEM, V273, P8153, DOI 10.1074/jbc.273.14.8153; Kubo T, 2007, J AM COLL CARDIOL, V49, P2419, DOI 10.1016/j.jacc.2007.02.061; Kushwaha SS, 1997, NEW ENGL J MED, V336, P267, DOI 10.1056/NEJM199701233360407; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Li Y, 2000, P NATL ACAD SCI USA, V97, P5140, DOI 10.1073/pnas.090098997; Marian AJ, 2003, J AM COLL CARDIOL, V41, P994, DOI 10.1016/S0735-1097(02)03003-6; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; Peddy SB, 2006, PEDIATRICS, V117, P1830, DOI 10.1542/peds.2005-2301; Perry SV, 1999, MOL CELL BIOCHEM, V190, P9, DOI 10.1023/A:1006939307715; POTTER JD, 1995, J BIOL CHEM, V270, P2557, DOI 10.1074/jbc.270.6.2557; Regnier M, 1995, AM J PHYSIOL-CELL PH, V269, pC1532, DOI 10.1152/ajpcell.1995.269.6.C1532; Rivenes SM, 2000, CIRCULATION, V102, P876; SASSE S, 1993, CIRC RES, V72, P932, DOI 10.1161/01.RES.72.5.932; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; SOLARO RJ, 1986, J PHARMACOL EXP THER, V238, P502; SOLARO RJ, 1988, CIRC RES, V63, P779, DOI 10.1161/01.RES.63.4.779; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Venkatraman G, 2005, J BIOL CHEM, V280, P17584, DOI 10.1074/jbc.M409337200; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; Wahr PA, 1999, BIOPHYS J, V76, P2166, DOI 10.1016/S0006-3495(99)77371-6; Wang YC, 2007, FASEB J, V21, P2205, DOI 10.1096/fj.06-7538com; WILLADSEN KA, 1992, J BIOL CHEM, V267, P23746; Yumoto F, 2005, BIOCHEM BIOPH RES CO, V338, P1519, DOI 10.1016/j.bbrc.2005.10.116; Zhang J, 2001, CLIN GENET, V59, P248, DOI 10.1034/j.1399-0004.2001.590406.x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535; ZOT AS, 1989, BIOCHEMISTRY-US, V28, P6751, DOI 10.1021/bi00442a031	59	40	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2156	2166		10.1074/jbc.M707066200	http://dx.doi.org/10.1074/jbc.M707066200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032382	hybrid			2022-12-27	WOS:000252501000043
J	Reinehr, R; Sommerfeld, A; Keitel, V; Grether-Beck, S; Haussinger, D				Reinehr, Roland; Sommerfeld, Annika; Keitel, Verena; Grether-Beck, Susanne; Haeussinger, Dieter			Amplification of CD95 activation by caspase 8-induced endosomal acidification in rat hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NADPH OXIDASE ISOFORMS; FAMILY KINASE YES; TYROSINE PHOSPHORYLATION; MEMBRANE TRAFFICKING; CHLORIDE CHANNELS; INDUCED APOPTOSIS; CELL-MEMBRANE; CL-CHANNELS; SPHINGOMYELINASE	Although in rat hepatocytes CD95 is predominantly located inside the cell with almost undetectable immunostaining at the plasma membrane, the addition of CD95-ligand (CD95L) induces hepatocyte apoptosis, which is preceded by a targeting and activation of intracellularly localized CD95 to the plasma membrane including formation of the death-inducing signaling complex. This process involves an NADPH oxidase-dependent generation of reactive oxygen species (ROS) through a ceramide- and protein kinase C zeta-dependent pathway, which leads to an activating phosphorylation of p47(phox). The mechanisms underlying CD95L-induced ceramide formation were addressed in the present study. It was found that CD95L lowered within seconds the apparent vesicular pH from 6.0 to 5.7 in a fluorescein isothiocyanate-dextran-accessible endosomal compartment, which was previously shown to contain acidic sphingomyelinase, and decreased N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bromide fluorescence, suggestive for an increase of cytosolic [Cl-]. Bafilomycin or 4,4 '-diisothiocyanostilbene-2,2 '-disulfonic acid disodium salt largely abolished the CD95L-induced endosomal acidification, ceramide formation, and downstream events, such as p47phox phosphorylation, ROS formation, CD95 activation, and apoptosis. These responses were also abolished after knock-down of acidic sphingomyelinase in rat hepatocytes. Interestingly, caspase 8 inhibitors abolished these CD95L-induced signaling events, including the increase in cytosolic [Cl-], endosomal acidification, ceramide formation, and ROS generation as well as CD95 targeting to the plasma membrane and CD95 activation. The data suggest that CD95L initiates a rapid caspase 8-dependent endosomal acidification, which triggers ceramide- dependent ROS formation as an upstream event of trafficking of intracellularly stored CD95 to the plasma membrane. It is concluded that a rapid caspase 8 activation in response to CD95L signals to intracellularly stored CD95, which becomes activated and targeted to the plasma membrane. This autoamplification of CD95-activation is required for apoptosis induction.	[Reinehr, Roland; Sommerfeld, Annika; Keitel, Verena; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect, D-40225 Dusseldorf, Germany; [Grether-Beck, Susanne] Inst Umweltmed Forsch, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Klinikum Dusseldorf, Klin Gastroeneterol Hepetol & Infektol, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de	Reinehr, Roland/G-6118-2016; Keitel, Verena/AAF-3471-2019; Keitel, Verena/AAH-9016-2021	Keitel, Verena/0000-0003-1383-7662				Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Becker S, 2007, BIOL CHEM, V388, P185, DOI 10.1515/BC.2007.021; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; CHEN JQ, 1995, J BIOL CHEM, V270, P25233, DOI 10.1074/jbc.270.42.25233; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; Eberle A, 2005, HEPATOLOGY, V41, P315, DOI 10.1002/hep.20564; Eberle A, 2007, APOPTOSIS, V12, P719, DOI 10.1007/s10495-006-0003-2; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Faundez Victor, 2004, Sci STKE, V2004, pre8, DOI 10.1126/stke.2332004re8; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOWLER S, 1969, BIOCHIM BIOPHYS ACTA, V191, P481, DOI 10.1016/0005-2744(69)90271-X; GRAF J, 1987, J MEMBRANE BIOL, V95, P241, DOI 10.1007/BF01869486; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grether-Beck S, 2000, EMBO J, V19, P5793, DOI 10.1093/emboj/19.21.5793; Grullich C, 2000, J BIOL CHEM, V275, P8650, DOI 10.1074/jbc.275.12.8650; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Higuchi H, 2001, J BIOL CHEM, V276, P38610, DOI 10.1074/jbc.M105300200; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; Li XH, 2002, ANNU REV PHYSIOL, V64, P609, DOI 10.1146/annurev.physiol.64.090501.145429; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; Mauricio AC, 1999, EXP PHYSIOL, V84, P489; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; MUALLEM S, 1988, J BIOL CHEM, V263, P14703; Nakashima S, 2003, J BIOCHEM, V134, P359, DOI 10.1093/jb/mvg153; NISHIHARA T, 1995, BIOCHEM BIOPH RES CO, V212, P255, DOI 10.1006/bbrc.1995.1964; Nolte F, 2004, FEBS LETT, V578, P85, DOI 10.1016/j.febslet.2004.10.075; Pazoles C J, 1980, Ann N Y Acad Sci, V358, P354, DOI 10.1111/j.1749-6632.1980.tb15417.x; Piiper A, 2003, J BIOL CHEM, V278, P7065, DOI 10.1074/jbc.M211234200; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Reinehr R, 2004, GASTROENTEROLOGY, V127, P1540, DOI 10.1053/j.gastro.2004.08.056; Reinehr R, 2004, J BIOL CHEM, V279, P23977, DOI 10.1074/jbc.M401519200; Reinehr R, 2004, J BIOL CHEM, V279, P10364, DOI 10.1074/jbc.M311997200; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2002, HEPATOLOGY, V36, P602, DOI 10.1053/jhep.2002.35447; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Sawada M, 2002, EXP CELL RES, V273, P157, DOI 10.1006/excr.2001.5437; SCHREIBER R, 1994, BIOCHEM J, V303, P113, DOI 10.1042/bj3030113; Schreiber R, 1996, BIOCHEM J, V315, P385, DOI 10.1042/bj3150385; SCHREIBER R, 1995, BIOCHEM J, V309, P19, DOI 10.1042/bj3090019; Seki Shuichi, 1999, Medical Electron Microscopy, V32, P199; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Talanian RV, 1997, J BIOL CHEM, V272, P9677; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; TIMMER A, 2004, PLANAR CHROMATOGR, V93, P2; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wang KW, 2005, J BIOL CHEM, V280, P23490, DOI 10.1074/jbc.M411607200; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; WEHNER F, 1993, PFLUG ARCH EUR J PHY, V424, P145, DOI 10.1007/BF00374605; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; YOSHIDA Y, 1985, J BIOCHEM-TOKYO, V98, P1669, DOI 10.1093/oxfordjournals.jbchem.a135438; Zsembery A, 2000, FASEB J, V14, P2345, DOI 10.1096/fj.99-0509com	59	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2211	2222		10.1074/jbc.M706853200	http://dx.doi.org/10.1074/jbc.M706853200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045865	hybrid			2022-12-27	WOS:000252501000049
J	Ben-Dov, C; Hartmann, B; Lundgren, J; Valcarcel, J				Ben-Dov, Claudia; Hartmann, Britta; Lundgren, Josefin; Valcarcel, Juan			Genome-wide analysis of alternative Pre-mRNA splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLOBAL ANALYSIS; PROSTATE-CANCER; GENE-EXPRESSION; EXONS; IDENTIFICATION; REGULATORS; VARIANTS; TRANSCRIPTOME; SPECIFICITY; MECHANISMS	Alternative splicing of mRNA precursors allows the synthesis of multiple mRNAs from a single primary transcript, significantly expanding the information content and regulatory possibilities of higher eukaryotic genomes. High-throughput enabling technologies, particularly large-scale sequencing and splicing-sensitive microarrays, are providing unprecedented opportunities to address key questions in this field. The picture emerging from these pioneering studies is that alternative splicing affects most human genes and a significant fraction of the genes in other multicellular organisms, with the potential to greatly influence the evolution of complex genomes. A combinatorial code of regulatory signals and factors can deploy physiologically coherent programs of alternative splicing that are distinct from those regulated at other steps of gene expression. Pre-mRNA splicing and its regulation play important roles in human pathologies, and genome-wide analyses in this area are paving the way for improved diagnostic tools and for the identification of novel and more specific pharmaceutical targets.	[Ben-Dov, Claudia; Hartmann, Britta; Lundgren, Josefin; Valcarcel, Juan] Ctr Regulacio Genom, Barcelona 08003, Spain; [Valcarcel, Juan] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain; [Valcarcel, Juan] Univ Pompeu Fabra, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Pompeu Fabra University	Valcarcel, J (corresponding author), Ctr Regulacio Genom, Dr Aiguader 88, Barcelona 08003, Spain.	juan.valcarcel@crg.es	Valcarcel, Juan/O-9814-2014	Valcarcel, Juan/0000-0001-5398-3571	ICREA Funding Source: Custom	ICREA(ICREA)		Alekseyenko AV, 2007, RNA, V13, P661, DOI 10.1261/rna.325107; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blanchette M, 2005, GENE DEV, V19, P1306, DOI 10.1101/gad.1314205; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; CALARCO JA, 2007, IN PRESS ALTERNATIVE, P65; Chasin LA, 2007, ADV EXP MED BIOL, V623, P85, DOI 10.1007/978-0-387-77374-2_6; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; Hiller M, 2006, PLOS GENET, V2, P1944, DOI 10.1371/journal.pgen.0020207; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Le K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh173; Li CX, 2006, CANCER RES, V66, P1990, DOI 10.1158/0008-5472.CAN-05-2593; Li HR, 2006, CANCER RES, V66, P4079, DOI 10.1158/0008-5472.CAN-05-4264; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; McIntyre LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r79; Milani L, 2006, CLIN CHEM, V52, P202, DOI 10.1373/clinchem.2005.062042; Nagao K, 2005, GENOMICS, V85, P462, DOI 10.1016/j.ygeno.2004.11.014; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Relogio A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/jbc.M411976200; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Roy M, 2005, NUCLEIC ACIDS RES, V33, P5026, DOI 10.1093/nar/gki792; Sorek R, 2007, RNA, V13, P1603, DOI 10.1261/rna.682507; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Tress ML, 2007, P NATL ACAD SCI USA, V104, P5495, DOI 10.1073/pnas.0700800104; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang P, 2005, P NATL ACAD SCI USA, V102, P18920, DOI 10.1073/pnas.0506770102; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wang ZN, 2003, CANCER RES, V63, P655; Watahiki A, 2004, NAT METHODS, V1, P233, DOI 10.1038/NMETH719; Xu Q, 2003, NUCLEIC ACIDS RES, V31, P5635, DOI 10.1093/nar/gkg786; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Zavolan M, 2006, CURR OPIN STRUC BIOL, V16, P362, DOI 10.1016/j.sbi.2006.05.002; Zhang CL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-202; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	71	103	117	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1229	1233		10.1074/jbc.R700033200	http://dx.doi.org/10.1074/jbc.R700033200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024428	hybrid			2022-12-27	WOS:000252282700005
J	Ing, NH; Massuto, DA; Jaeger, LA				Ing, Nancy H.; Massuto, Dana A.; Jaeger, Laurie A.			Estradiol up-regulates AUF1p45 binding to stabilizing regions within the 3 '-untranslated region of estrogen receptor alpha mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; AU-RICH ELEMENT; BREAST-CANCER CELLS; GENE-EXPRESSION; RIBONUCLEIC-ACID; RAT UTERUS; HNRNP-D; MEDIATED TRANSCRIPTION; PROTEIN INTERACTIONS; SHEEP ENDOMETRIUM	Estradiol up-regulates expression of the estrogen receptor alpha gene in the uterus by stabilizing estrogen receptor alpha mRNA. Previously, we defined two discrete minimal estradiol-modulated stability sequences (MEMSS) within the extensive 3'-untranslated region of estrogen receptor alpha mRNA with an in vitro stability assay using cytosolic extracts from sheep uterus. We report here that excess MEMSS RNA inhibited the enhanced stability of estrogen receptor alpha mRNA in extracts from estradiol-treated ewes compared with those from control ewes. Several estradiol-induced MEMSS-binding proteins were characterized by UV cross-linking in uterine extracts from ewes in a time course study ( 0, 8, 16, and 24 h after estradiol injection). The pattern of binding proteins changed at 16 h post-injection, concurrent with enhanced estrogen receptor alpha mRNA stability and the highest rate of accumulation of estrogen receptor alpha mRNA. The predominant MEMSS-binding protein induced by estradiol treatment was identified as AUF1 (A+U-rich RNA-binding factor 1) protein isoform p45 (a product of the heterogeneous nuclear ribonucleoprotein D gene). Immunoblot analysis indicated that only two of four AUF1 protein isoforms were present in the uterine cytosolic extracts and that estradiol treatment strongly increased the ratio of AUF1 isoforms p45 to p37. Non-phosphorylated recombinant AUF1p45 protected estrogen receptor alpha mRNA in vitro in a dose-dependent manner. These studies describe estrogenic induction of AUF1p45 binding to the estrogen receptor alpha mRNA as a molecular mechanism for post-transcriptional up-regulation of gene expression.	[Ing, Nancy H.] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA; [Ing, Nancy H.; Massuto, Dana A.; Jaeger, Laurie A.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Ing, NH (corresponding author), Texas A&M Univ, Dept Anim Sci, 2471 TAMU, College Stn, TX 77843 USA.	ning@cvm.tamu.edu	Ing, Nancy/AAC-9927-2020					Arao Y, 2004, MOL ENDOCRINOL, V18, P2255, DOI 10.1210/me.2004-0103; Arao Y, 2002, BIOCHEM J, V361, P125, DOI 10.1042/0264-6021:3610125; Bell O, 2005, MOL ENDOCRINOL, V19, P516, DOI 10.1210/me.2004-0108; Bhattacharya S, 1999, NUCLEIC ACIDS RES, V27, P1464, DOI 10.1093/nar/27.6.1464; Blaxall BC, 2000, MOL CARCINOGEN, V28, P76; Blum JL, 2005, AM J PHYSIOL-HEART C, V289, pH2543, DOI 10.1152/ajpheart.00545.2005; Buzby JS, 1996, BLOOD, V88, P2889, DOI 10.1182/blood.V88.8.2889.bloodjournal8882889; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Cunningham KS, 2000, P NATL ACAD SCI USA, V97, P12498, DOI 10.1073/pnas.220425497; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dodson RE, 2002, PROG NUCLEIC ACID RE, V72, P129, DOI 10.1016/S0079-6603(02)72069-2; Fan J, 2005, EUR RESPIR J, V26, P933, DOI 10.1183/09031936.05.00120204; Farhana L, 2000, CELL GROWTH DIFFER, V11, P541; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Ford LP, 1999, METHODS, V17, P21, DOI 10.1006/meth.1998.0703; Friend KE, 1997, MOL CELL ENDOCRINOL, V131, P147, DOI 10.1016/S0303-7207(97)00098-1; FRITZ DT, 2000, SCI STKE 2000; Fritzemeier KH, 2004, E SCHERING RES FDN W, V46, P127; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Gouble A, 2002, CANCER RES, V62, P1489; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Hu YL, 2000, ARCH BIOCHEM BIOPHYS, V383, P215, DOI 10.1006/abbi.2000.2063; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Ing NH, 1999, BIOL REPROD, V60, P134, DOI 10.1095/biolreprod60.1.134; Ing NH, 2005, BIOL REPROD, V72, P1290, DOI 10.1095/biolreprod.105.040014; Ing NH, 1997, BIOL REPROD, V56, P1205, DOI 10.1095/biolreprod56.5.1205; Ing NH, 1996, BIOL REPROD, V54, P591, DOI 10.1095/biolreprod54.3.591; ING NH, 1999, EMBRYO IMPLANTATION, P287; Inoue A, 2003, BIOCHEM J, V372, P775, DOI 10.1042/BJ20021719; INOUE A, 1986, J BIOCHEM-TOKYO, V100, P747, DOI 10.1093/oxfordjournals.jbchem.a121767; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Keen JC, 2005, J BIOL CHEM, V280, P29519, DOI 10.1074/jbc.M505317200; Kenealy MR, 2000, ENDOCRINOLOGY, V141, P2805, DOI 10.1210/en.141.8.2805; Kiledjian M, 1997, MOL CELL BIOL, V17, P4870, DOI 10.1128/MCB.17.8.4870; KRAUS WL, 1993, ENDOCRINOLOGY, V132, P2371, DOI 10.1210/en.132.6.2371; Lafon I, 1998, ONCOGENE, V16, P3413, DOI 10.1038/sj.onc.1201895; Lal A, 2006, MOL CELL, V22, P117, DOI 10.1016/j.molcel.2006.03.016; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Lu JY, 2006, RNA, V12, P883, DOI 10.1261/rna.2308106; Lu Q, 2003, J BIOL CHEM, V278, P4639, DOI 10.1074/jbc.M210949200; Medunjanin S, 2005, J BIOL CHEM, V280, P33006, DOI 10.1074/jbc.M506758200; Mitchell DC, 2003, MOL ENDOCRINOL, V17, P562, DOI 10.1210/me.2002-0313; Moraes KCM, 2003, BIOL CHEM, V384, P25, DOI 10.1515/BC.2003.004; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; NARDULLI AM, 1986, ENDOCRINOLOGY, V119, P2038, DOI 10.1210/endo-119-5-2038; Pan YX, 2005, J BIOL CHEM, V280, P34609, DOI 10.1074/jbc.M507802200; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Proia DA, 2006, J BIOL CHEM, V281, P7089, DOI 10.1074/jbc.M511839200; Rodriguez-Pinon M, 2005, DOMEST ANIM ENDOCRIN, V28, P442, DOI 10.1016/j.domaniend.2005.02.011; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; ROSS J, 1993, CONTROL MESSENGER RN, P417; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Sarkar B, 2003, J BIOL CHEM, V278, P20700, DOI 10.1074/jbc.M301176200; Sela-Brown A, 2000, J BIOL CHEM, V275, P7424, DOI 10.1074/jbc.275.10.7424; Sheflin LG, 2001, ENDOCRINOLOGY, V142, P2361, DOI 10.1210/en.142.6.2361; SMITH DB, 2000, CURRENT PROTOCOLS MO; Sommer S, 2005, J STEROID BIOCHEM, V97, P219, DOI 10.1016/j.jsbmb.2005.09.002; *STAT AN SYST I IN, 1982, SAS US GUID BAS; Staton JM, 2000, J MOL ENDOCRINOL, V25, P17, DOI 10.1677/jme.0.0250017; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Thomson AM, 1999, BIOTECHNIQUES, V27, P1032, DOI 10.2144/99275rr03; Tolnay M, 2000, BIOCHEM J, V348, P151, DOI 10.1042/0264-6021:3480151; Tolnay M, 1999, BIOCHEM J, V338, P417, DOI 10.1042/0264-6021:3380417; Tsai M-J, 1998, WILLIAMS TXB ENDOCRI, P55; VOKAER A, 1974, P NATL ACAD SCI USA, V71, P4482, DOI 10.1073/pnas.71.11.4482; Wagner BJ, 1998, GENOMICS, V48, P195, DOI 10.1006/geno.1997.5142; Wang H, 1999, BIOL REPROD, V61, P955, DOI 10.1095/biolreprod61.4.955; Watson CS, 1999, P SOC EXP BIOL MED, V220, P9, DOI 10.1046/j.1525-1373.1999.d01-2.x; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2003, J BIOL CHEM, V278, P33029, DOI 10.1074/jbc.M305772200; Wilson GM, 2003, J BIOL CHEM, V278, P33039, DOI 10.1074/jbc.M305775200; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Xu NH, 2001, MOL CELL BIOL, V21, P6960, DOI 10.1128/MCB.21.20.6960-6971.2001; Yeap BB, 2004, BIOESSAYS, V26, P672, DOI 10.1002/bies.20051; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	85	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1764	1772		10.1074/jbc.M704745200	http://dx.doi.org/10.1074/jbc.M704745200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029355	hybrid			2022-12-27	WOS:000252282700063
J	Germain, M; Milburn, J; Duronio, V				Germain, Marc; Milburn, Jocelyn; Duronio, Vincent			MCL-1 inhibits BAX in the absence of MCL-1/BAX interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; INITIATION; FISSION	The BCL-2 family of proteins plays a major role in the control of apoptosis as the primary regulator of mitochondrial permeability. The pro-apoptotic BCL-2 homologues BAX and BAK are activated following the induction of apoptosis and induce cytochrome c release from mitochondria. A second class of BCL-2 homologues, the BH3-only proteins, is required for the activation of BAX and BAK. The activity of both BAX/BAK and BH3-only proteins is opposed by anti-apoptotic BCL-2 homologues such as BCL-2 and MCL-1. Here we show that anti-apoptotic MCL-1 inhibits the function of BAX downstream of its initial activation and translocation to mitochondria. Although MCL-1 interacted with BAK and inhibited its activation, the activity of MCL-1 against BAX was independent of an interaction between the two proteins. However, the anti-apoptotic function of MCL-1 required the presence of BAX. These results suggest that the pro-survival activity of MCL-1 proceeds via inhibition of BAX function at mitochondria, downstream of its activation and translocation to this organelle.	Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada; Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Germain, M (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada.							Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	26	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6384	6392		10.1074/jbc.M707762200	http://dx.doi.org/10.1074/jbc.M707762200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089567	hybrid			2022-12-27	WOS:000253779500046
J	Hao, YW; Chun, A; Cheung, K; Rashidi, B; Yang, XL				Hao, Yawei; Chun, Alex; Cheung, Kevin; Rashidi, Babak; Yang, Xiaolong			Tumor suppressor LATS1 is a negative regulator of oncogene YAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; CELL-PROLIFERATION; HUMAN HOMOLOG; SIGNALING PATHWAY; DROSOPHILA LATS; HIPPO PATHWAY; GROWTH; APOPTOSIS; KINASE; PROMOTES	LATS ((la) under bar rge (t) under bar umor (s) under bar uppressor) or warts is a Ser/Thr kinase that belongs to the Ndr/LATS subfamily of AGC ( protein kinase (A) under bar /PK (G) under bar /PK (C) under bar) kinases. It is a tumor suppressor gene originally isolated from Drosophila and recently isolated from mice and humans. Drosophila or mice mutant for LATS develop tumors in various tissues. Recent studies in Drosophila demonstrate that LATS is a central player of an emerging tumor suppressor pathway called the Hippo-LATS/Warts pathway that suppresses tumor growth by regulating cell proliferation, cell growth, and cell death. Although tremendous progress has been made toward understanding the roles of LATS in tumorigenesis, the kinase substrates of LATS or downstream target proteins mediating LATS function remain largely unknown. In this study, we have provided convincing evidence that the LATS1 tumor suppressor can bind to and phosphorylate transcription regulator and oncogene YAP in vitro and in vivo. We have also identified HX(R/H/K)XX(S/T) as the consensus phosphorylation sequence for LATS/Ndr kinase substrates. Significantly, we have discovered that LATS1 inactivates YAP oncogenic function by suppressing its transcription regulation of cellular genes via sequestration of YAP in the cytoplasm after phosphorylation of YAP. Finally, by using microarray analysis, we have also identified many oncogenes or tumor suppressor genes up-regulated or down-regulated by YAP. These research findings will have profound impacts on our understanding of the molecular mechanism of the LATS tumor suppressor and the emerging Hippo-LATS/Warts pathway.	[Hao, Yawei; Chun, Alex; Cheung, Kevin; Rashidi, Babak; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Richard Lab 201,88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@cliff.path.queensu.ca		Rashidi, Babak/0000-0001-7273-8686				Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; HERGOVICH A, 2007, BIOCH BIOPHYS ACTA; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Virdee K, 2007, FEBS LETT, V581, P2657, DOI 10.1016/j.febslet.2007.05.009; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	54	594	620	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5496	5509		10.1074/jbc.M709037200	http://dx.doi.org/10.1074/jbc.M709037200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158288	hybrid			2022-12-27	WOS:000253426700030
J	Kim, YK; Wassef, L; Hamberger, L; Piantedosi, R; Palczewski, K; Blaner, WS; Quadro, L				Kim, Youn-Kyung; Wassef, Lesley; Hamberger, Leora; Piantedosi, Roseann; Palczewski, Krzysztof; Blaner, William S.; Quadro, Loredana			Retinyl ester formation by lecithin: Retinol acyltransferase is a key regulator of retinoid Homeostasis in mouse embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A-DEFICIENCY; BINDING-PROTEIN; EMBRYONIC-DEVELOPMENT; DIFFERENTIAL EXPRESSION; HUMAN CYTOCHROME-P450; MEMBRANE-RECEPTOR; ZEBRAFISH EMBRYO; CELLULAR UPTAKE; RAT-LIVER; ACID	The developing mammalian embryo is entirely dependent on the maternal circulation for its supply of retinoids ( vitamin A and its metabolites). The mechanisms through which mammalian developing tissues maintain adequate retinoid levels in the face of suboptimal or excessive maternal dietary vitamin A intake have not been established. We investigated the role of retinyl ester formation catalyzed by lecithin: retinol acyltransferase (LRAT) in regulating retinoid homeostasis during embryogenesis. Dams lacking both LRAT and retinol-binding protein (RBP), the sole specific carrier for retinol in serum, were maintained on diets containing different amounts of vitamin A during pregnancy. We hypothesized that the lack of both proteins would make the embryo more vulnerable to changes in maternal dietary vitamin A intake. Our data demonstrate that maternal dietary vitamin A deprivation during pregnancy generates a severe retinoid-deficient phenotype of the embryo due to the severe retinoid- deficient status of the double mutant dams rather than to the lack of LRAT in the developing tissues. Moreover, in the case of excessive maternal dietary vitamin A intake, LRAT acts together with Cyp26A1, one of the enzymes that catalyze the degradation of retinoic acid, and possibly with STRA6, the recently identified cell surface receptor for retinol-RBP, in maintaining adequate levels of retinoids in embryonic and extraembryonic tissues. In contrast, the pathway of retinoic acid synthesis does not contribute significantly to regulating retinoid homeostasis during mammalian development except under conditions of severe maternal retinoid deficiency.	[Kim, Youn-Kyung; Wassef, Lesley; Hamberger, Leora; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Piantedosi, Roseann; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Columbia University; Case Western Reserve University	Quadro, L (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	quadro@aesop.rutgers.edu			NEI NIH HHS [R01 EY009339, EY09339] Funding Source: Medline; NICHD NIH HHS [R01 HD057493] Funding Source: Medline; NIDDK NIH HHS [DK068437, R01 DK079221, DK079221, R56 DK068437, R01 DK061310, R01 DK068437, DK061310] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068437, R01DK079221, R01DK061310, R01DK068437] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1994, J BIOL CHEM, V269, P16559; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; DELIGDISH L, 1992, HORMONES FETAL PATHO; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Guo XJ, 2002, CANCER RES, V62, P1654; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; Marceau G, 2007, VITAM HORM, V75, P97, DOI 10.1016/S0083-6729(06)75004-X; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OSMOND MK, 1991, DEVELOPMENT, V113, P1405; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; ROSS AC, 2003, J NUTR, V133, P291; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Sapin V, 2000, MECH DEVELOP, V92, P295, DOI 10.1016/S0925-4773(00)00241-0; SATRE MA, 1992, BIOL REPROD, V46, P802, DOI 10.1095/biolreprod46.5.802; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; VOGEL S, 1999, HANDB EXP PHARM, V139, P31; Wang XS, 2001, GENOMICS, V74, P245, DOI 10.1006/geno.2001.6546; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; *WHO, 1998, MICR SER WHO; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; WOLBACH SB, 1947, J BONE JOINT SURG, V29, P171; Wolf G, 2007, NUTR REV, V65, P385, DOI 10.1301/nr.2007.aug.385-388; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705; Zolfaghari R, 2000, J LIPID RES, V41, P2024	54	59	61	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5611	5621		10.1074/jbc.M708885200	http://dx.doi.org/10.1074/jbc.M708885200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093970	Green Accepted, hybrid			2022-12-27	WOS:000253426700041
J	Chang, WC; Di Capite, J; Singaravelu, K; Nelson, C; Halse, V; Parekh, AB				Chang, Wei-Chiao; Di Capite, Joseph; Singaravelu, Karthika; Nelson, Charmaine; Halse, Victoria; Parekh, Anant B.			Local Ca2+ influx through Ca2+ release-activated Ca2+ (CRAC) channels stimulates production of an intracellular messenger and an intercellular pro-inflammatory signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT ACTIVATION; LEUKOTRIENE C-4 SECRETION; MAST-CELLS; PLASMA-MEMBRANE; TRPC3 CHANNELS; RBL-1 CELLS; T-CELLS; ENTRY; MICRODOMAINS; DEPLETION	Ca2+ entry through store-operated Ca2+ channels drives the production of the pro-inflammatory molecule leukotriene C-4 (LTC4) from mast cells through a pathway involving Ca2+-dependent protein kinase C, mitogen-activated protein kinases ERK1/2, phospholipase A(2), and 5-lipoxygenase. Here we examine whether local Ca2+ influx through store-operated Ca2+ release-activated Ca2+ (CRAC) channels in the plasma membrane stimulates this signaling pathway. Manipulating the amplitude and spatial extent of Ca2+ entry by altering chemical and electrical gradients for Ca2+ influx or changing the Ca2+ buffering of the cytoplasm all impacted on protein kinase C and ERK activation, generation of arachidonic acid and LTC4 secretion, with little change in the bulk cytoplasmic Ca2+ rise. Similar bulk cytoplasmic Ca2+ concentrations were achieved when CRAC channels were activated in 0.25 mM external Ca2+ versus 2 mM Ca2+ and 100 nM La3+, an inhibitor of CRAC channels. However, despite similar bulk cytoplasmic Ca2+, protein kinase C activation and LTC4 secretion were larger in 2 mM Ca2+ and La3+ than in 0.25 mM Ca2+, consistent with the central involvement of a subplasmalemmal Ca2+ rise. The nonreceptor tyrosine kinase Syk coupled CRAC channel opening to protein kinase C and ERK activation. Recombinant TRPC3 channels also activated protein kinase C, suggesting that subplasmalemmal Ca2+ rather than a microdomain exclusive to CRAC channels is the trigger. Hence a subplasmalemmal Ca2+ increase in mast cells is highly versatile in that it triggers cytoplasmic responses through generation of intracellular messengers as well as long distance changes through increased secretion of paracrine signals.	[Chang, Wei-Chiao; Di Capite, Joseph; Singaravelu, Karthika; Nelson, Charmaine; Halse, Victoria; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Pk Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Chang, Wei-Chiao/0000-0002-8573-5924	Medical Research Council [G0200218] Funding Source: Medline; MRC [G0200218] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2007, J IMMUNOL, V179, P5255, DOI 10.4049/jimmunol.179.8.5255; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fierro L, 2000, J PHYSIOL-LONDON, V522, P247, DOI 10.1111/j.1469-7793.2000.t01-1-00247.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; MCCLOSKEY MA, 1990, J GEN PHYSIOL, V95, P205, DOI 10.1085/jgp.95.2.205; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peters-Golden M, 2006, CLIN EXP ALLERGY, V36, P689, DOI 10.1111/j.1365-2222.2006.02498.x; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; PREMACK BA, 1994, J IMMUNOL, V152, P5226; Reeves JP, 2003, AM J PHYSIOL-CELL PH, V285, pC763, DOI 10.1152/ajpcell.00168.2003; Rezaul K, 1997, BIOCHEM BIOPH RES CO, V239, P23, DOI 10.1006/bbrc.1997.7419; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; Straube S, 2002, PFLUG ARCH EUR J PHY, V444, P389, DOI 10.1007/s00424-002-0812-2; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	40	72	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4622	4631		10.1074/jbc.M705002200	http://dx.doi.org/10.1074/jbc.M705002200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156181	hybrid			2022-12-27	WOS:000253426500019
J	Donnelly, PS; Caragounis, A; Du, T; Laughton, KM; Volitakis, I; Cherny, RA; Sharples, RA; Hill, AF; Li, QX; Masters, CL; Barnham, KJ; White, AR				Donnelly, Paul S.; Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.			Selective intracellular release of copper and zinc ions from bis( thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIS(THIOSEMICARBAZONE) COMPLEXES; TRANSGENIC MICE; METAL-COMPLEXES; BINDING; BRAIN; NEURODEGENERATION; ACCUMULATION; CU(II); AGENTS; CELLS	Copper and zinc play important roles in Alzheimer disease pathology with recent reports describing potential therapeutics based on modulation of metal bioavailability. We examined the ability of a range of metal bis( thiosemicarbazonato) complexes (M-II(btsc), where M = Cu-II or Zn-II) to increase intracellular metal levels in Chinese hamster ovary cells overexpressing amyloid precursor protein (APP-CHO) and the subsequent effect on extracellular levels of amyloid-beta peptide (A beta). The Cu-II( btsc) complexes were engineered to be either stable to both a change in oxidation state and dissociation of metal or susceptible to intracellular reduction and dissociation of metal. Treatment of APP-CHO cells with stable complexes resulted in elevated levels of intracellular copper with no effect on the detected levels of A beta. Treatment with complexes susceptible to intracellular reduction increased intracellular copper levels but also resulted in a dose-dependent reduction in the levels of monomeric A beta. Treatment with less stable Zn-II( btsc) complexes increased intracellular zinc levels with a subsequent dose-dependent depletion of monomeric A beta levels. The increased levels of intracellular bioavailable copper and zinc initiated a signaling cascade involving activation of phosphoinositol 3-kinase and c-Jun N-terminal kinase. Inhibition of these enzymes prevented A beta depletion induced by the M-II( btsc) complexes. Inhibition of metalloproteases also partially restored A beta levels, implicating metal-driven metalloprotease activation in the extracellular monomeric A beta depletion. However, a role for alternative metal-induced A beta metabolism has not been ruled out. These studies demonstrate that MII( btsc) complexes have potential for Alzheimer disease therapy.	[Donnelly, Paul S.; Sharples, Robyn A.; Barnham, Kevin J.] Univ Melbourne, Sch Chem, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Caragounis, Aphrodite; Du, Tai; Masters, Colin L.; White, Anthony R.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Sharples, Robyn A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Donnelly, PS (corresponding author), Univ Melbourne, Sch Chem, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.	pauld@unimelb.edu.au; arwhite@unimelb.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009; White, Anthony/P-5596-2016	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; White, Anthony/0000-0003-1802-9891; Volitakis, Irene/0000-0003-0766-817X				Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Ali FEA, 2004, AUST J CHEM, V57, P511, DOI 10.1071/CH04026; Alsop L, 2005, INORG CHIM ACTA, V358, P2770, DOI 10.1016/j.ica.2005.03.027; Anderson CJ, 1999, CHEM REV, V99, P2219, DOI 10.1021/cr980451q; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Barnham K.J., 2004, DRUG DES REV ONLINE, V1, P75, DOI DOI 10.2174/1567269043480690; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; Brown DR, 2004, DALTON T, P1907, DOI 10.1039/b401985g; Burdette SC, 2003, P NATL ACAD SCI USA, V100, P3605, DOI 10.1073/pnas.0637711100; Caragounis A, 2007, BIOCHEM J, V407, P435, DOI 10.1042/BJ20070579; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Ciuculescu ED, 2005, CHEM-EUR J, V11, P903, DOI 10.1002/chem.200400786; Cowley AR, 2002, J AM CHEM SOC, V124, P5270, DOI 10.1021/ja012668z; Cowley AR, 2005, CHEM COMMUN, P845, DOI 10.1039/b417206j; Curtain Cyril C., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P309, DOI 10.2174/1568013033483276; Dearling JLJ, 1998, CHEM COMMUN, P2531, DOI 10.1039/a805957h; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Donnelly PS, 2007, CURR OPIN CHEM BIOL, V11, P128, DOI 10.1016/j.cbpa.2007.01.678; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; GREEN MA, 1988, J NUCL MED, V29, P1549; KRAKER A, 1985, J BIOL CHEM, V260, P3710; Lewis JS, 2001, P NATL ACAD SCI USA, V98, P1206, DOI 10.1073/pnas.98.3.1206; Lewis JS, 2001, J NUCL MED, V42, P655; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Pajonk FG, 2005, J ALZHEIMERS DIS, V8, P23; PETERING DH, 1974, BIOCHEM PHARMACOL, V23, P567, DOI 10.1016/0006-2952(74)90621-2; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P1, DOI 10.1006/abbi.1994.1132; WEST DX, 1993, COORDIN CHEM REV, V123, P49, DOI 10.1016/0010-8545(93)85052-6; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wu WD, 2004, AM J RESP CELL MOL, V30, P540, DOI 10.1165/rcmb.2003-0233OC	37	157	157	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4568	4577		10.1074/jbc.M705957200	http://dx.doi.org/10.1074/jbc.M705957200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086681	hybrid			2022-12-27	WOS:000253426500013
J	Kelber, JA; Shani, G; Booker, EC; Vale, WW; Gray, PC				Kelber, Jonathan A.; Shani, Gidi; Booker, Evan C.; Vale, Wylie W.; Gray, Peter C.			Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EMBRYONIC STEM-CELLS; TGF-BETA; VERTEBRATE DEVELOPMENT; MESODERM INDUCTION; XENOPUS EMBRYOS; BINDING-SITE; I RECEPTORS; MECHANISMS; PATHWAY	Cripto plays critical roles during embryogenesis and has been implicated in promoting the growth and spread of tumors. Cripto is required for signaling by certain transforming growth factor-beta superfamily members, such as Nodal, but also antagonizes others, such as activin. The opposing effects of Cripto on Nodal and activin signaling seem contradictory, however, because these closely related ligands utilize the same type I (ALK4) and type II (ActRII/IIB) receptors. Here, we have addressed this apparent paradox by demonstrating that Cripto forms analogous receptor complexes with Nodal and activin and functions as a noncompetitive activin antagonist. Our results show that activin-A and Nodal elicit similar maximal signaling responses in the presence of Cripto that are substantially lower than that of activin-A in the absence of Cripto. In addition, we provide biochemical evidence for complexes containing activin-A, Cripto, and both receptor types and show that the assembly of such complexes is competitively inhibited by Nodal. We further demonstrate that Nodal and activin-A share the same binding site on ActRII and that ALK4 has distinct and separable binding sites for activin-A and Cripto. Finally, we show that ALK4 mutants with disrupted activin-A binding retain Cripto binding and prevent the effects of Cripto on both activin-A and Nodal signaling. Together, our data indicate that Cripto facilitates Nodal signaling and inhibits activin signaling by forming receptor complexes with these ligands that are structurally and functionally similar.	[Kelber, Jonathan A.; Shani, Gidi; Booker, Evan C.; Vale, Wylie W.; Gray, Peter C.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Kelber, Jonathan A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Booker, Evan C.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Gray, PC (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA.	gray@salk.edu		Kelber, Jonathan/0000-0002-4606-1445	NCI NIH HHS [R01CA107420] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107420] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Parish CL, 2005, STEM CELLS, V23, P471, DOI 10.1634/stemcells.2004-0294; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 2003, J CLIN INVEST, V112, P500, DOI 10.1172/JCI200319546; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; TSUCHIDA K, 1995, ENDOCRINOLOGY, V136, P5493, DOI 10.1210/en.136.12.5493; VAUGHAN JM, 1993, ENDOCRINOLOGY, V132, P2038, DOI 10.1210/en.132.5.2038; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	44	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4490	4500		10.1074/jbc.M704960200	http://dx.doi.org/10.1074/jbc.M704960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089557	hybrid			2022-12-27	WOS:000253426500005
J	Relini, A; De Stefano, S; Torrassa, S; Cavalleri, O; Rolandi, R; Gliozzi, A; Giorgetti, S; Raimondi, S; Marchese, L; Verga, L; Rossi, A; Stoppini, M; Bellotti, V				Relini, Annalisa; De Stefano, Silvia; Torrassa, Silvia; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra; Giorgetti, Sofia; Raimondi, Sara; Marchese, Loredana; Verga, Laura; Rossi, Antonio; Stoppini, Monica; Bellotti, Vittorio			Heparin strongly enhances the formation of beta(2)-microglobulin amyloid fibrils in the presence of type I collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIALYSIS-RELATED AMYLOIDOSIS; HUMAN BETA-2-MICROGLOBULIN; ALZHEIMERS-DISEASE; NEUTRAL PH; GLYCOSAMINOGLYCANS; AGGREGATION; SULFATE; HEMODIALYSIS; AFFINITY; AMYLOIDOGENESIS	The tissue specificity of fibrillar deposition in dialysis-related amyloidosis is most likely associated with the peculiar interaction of beta(2)-microglobulin (beta(2)-m) with collagen fibers. However, other co-factors such as glycosaminoglycans might facilitate amyloid formation. In this study we have investigated the role of heparin in the process of collagen-driven amyloidogenesis. In fact, heparin is a well known positive effector of fibrillogenesis, and the elucidation of its potential effect in this type of amyloidosis is particularly relevant because heparin is regularly given to patients subject to hemodialysis to prevent blood clotting. We have monitored by atomic force microscopy the formation of beta(2)-m amyloid fibrils in the presence of collagen fibers, and we have discovered that heparin strongly accelerates amyloid deposition. The mechanism of this effect is still largely unexplained. Using dynamic light scattering, we have found that heparin promotes beta(2)-m aggregation in solution at pH 6.4. Morphology and structure of fibrils obtained in the presence of collagen and heparin are highly similar to those of natural fibrils. The fibril surface topology, investigated by limited proteolysis, suggests that the general assembly of amyloid fibrils grown under these conditions and in vitro at low pH is similar. The exposure of these fibrils to trypsin generates a cleavage at the C-terminal of lysine 6 and creates the 7-99 truncated form of beta(2)-m (Delta N6 beta(2)-m) that is a ubiquitous constituent of the natural beta(2)-m fibrils. The formation of this beta(2)-m species, which has a strong propensity to aggregate, might play an important role in the acceleration of local amyloid deposition.	[Giorgetti, Sofia; Raimondi, Sara; Marchese, Loredana; Rossi, Antonio; Bellotti, Vittorio] Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy; [Relini, Annalisa; De Stefano, Silvia; Torrassa, Silvia; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Relini, Annalisa; Cavalleri, Ornella; Rolandi, Ranieri; Gliozzi, Alessandra] CNISM, I-16146 Genoa, Italy; [Giorgetti, Sofia; Verga, Laura; Stoppini, Monica; Bellotti, Vittorio] Policlin San Matteo, IRCCS, Biotechnol Lab, I-27100 Pavia, Italy; [Stoppini, Monica; Bellotti, Vittorio] INBB, Consorzio Interuniv Ist Nazl Biostrutture & Biosi, I-00136 Rome, Italy	University of Pavia; University of Genoa; IRCCS Fondazione San Matteo; University of Pavia	Bellotti, V (corresponding author), Univ Pavia, Dipartimento Biochim, Via Taramelli,3B-27100, I-27100 Pavia, Italy.	vbellot@unipv.it	Giorgetti, Sofia/AAD-4341-2019; Verga, Laura/AAG-5105-2020; Rolandi, Ranieri/C-4765-2012; Bellotti, Vittorio/A-6201-2014; Rossi, Antonio/E-9935-2012; Relini, Annalisa/AHC-3105-2022	Giorgetti, Sofia/0000-0001-9438-6511; Rolandi, Ranieri/0000-0002-0580-1611; Bellotti, Vittorio/0000-0001-8678-662X; RELINI, ANNALISA/0000-0002-4040-9279				Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; Borysik AJ, 2007, KIDNEY INT, V72, P174, DOI 10.1038/sj.ki.5002270; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; Fareed J, 2004, CURR PHARM DESIGN, V10, P983, DOI 10.2174/1381612043452811; Giorgetti S, 2005, PROTEIN SCI, V14, P696, DOI 10.1110/ps.041194005; Giorgetti S, 2007, PROTEIN SCI, V16, P343, DOI 10.1110/ps.062563507; HOMMA N, 1989, NEPHRON, V53, P37, DOI 10.1159/000185699; HUSZAR G, 1980, ANAL BIOCHEM, V105, P424, DOI 10.1016/0003-2697(80)90481-9; Ikizler TA, 2005, AM J KIDNEY DIS, V46, P976, DOI 10.1053/j.ajkd.2005.07.037; Khlebtsov NG, 2003, COLLOID J+, V65, P652, DOI 10.1023/A:1026148512418; Kielty Cay M., 1993, P103; KISILEVSKY R, 1995, NAT MED, V1, P143, DOI 10.1038/nm0295-143; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Lindahl U, 2007, THROMB HAEMOSTASIS, V98, P109, DOI 10.1160/Th07-04-0310; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; MINTON AP, 1995, BIOPHYS J, V68, P1311, DOI 10.1016/S0006-3495(95)80304-8; Miyata T, 2005, J DERMATOL, V32, P410, DOI 10.1111/j.1346-8138.2005.tb00918.x; Monti M, 2002, PROTEIN SCI, V11, P2362, DOI 10.1110/ps.0206902; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Ohashi K, 2002, NEPHRON, V90, P158, DOI 10.1159/000049037; OKON M, 1992, BIOCHEMISTRY-US, V31, P8906, DOI 10.1021/bi00152a030; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; SNOW AD, 1985, LAB INVEST, V53, P37; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7	36	95	99	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4912	4920		10.1074/jbc.M702712200	http://dx.doi.org/10.1074/jbc.M702712200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056266	hybrid			2022-12-27	WOS:000253426500049
J	Taguchi, H; Planque, S; Nishiyama, Y; Symersky, J; Boivin, S; Szabo, P; Friedland, RP; Ramsland, PA; Edmundson, AB; Weksler, ME; Paul, S				Taguchi, Hiroaki; Planque, Stephanie; Nishiyama, Yasuhiro; Symersky, Jindrich; Boivin, Stephane; Szabo, Paul; Friedland, Robert P.; Ramsland, Paul A.; Edmundson, Allen B.; Weksler, Marc E.; Paul, Sudhir			Autoantibody-catalyzed hydrolysis of amyloid beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; VASOACTIVE-INTESTINAL-PEPTIDE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; IMMUNE-RESPONSE; ANTIBODY; PROTEIN; CLEARANCE; IMMUNOTHERAPY	We describe IgM class human autoantibodies that hydrolyze amyloid beta peptide 1-40 (A beta 40). A monoclonal IgM from a patient with Waldenstrom's macroglobulinemia hydrolyzed A beta 40 at the Lys-28 -Gly-29 bond and Lys-16 - Ala-17 bonds. The catalytic activity was inhibited stoichiometrically by an electrophilic serine protease inhibitor. Treatment with the catalytic IgM blocked the aggregation and toxicity of A beta 40 in neuronal cell cultures. IgMs purified from the sera of patients with Alzheimer disease (AD) hydrolyzed A beta 40 at rates superior to IgMs from age-matched humans without dementia. IgMs from non-elderly humans expressed the least catalytic activity. The reaction rate was sufficient to afford appreciable degradation at physiological A beta and IgM concentrations found in peripheral circulation. Increased A beta concentrations in the AD brain are thought to induce neurodegenerative effects. Peripheral administration of A beta binding antibodies has been suggested as a potential treatment of AD. Our results suggest that catalytic IgM autoantibodies can help clear A beta, and they open the possibility of using catalytic Abs for AD immunotherapy.	[Taguchi, Hiroaki; Planque, Stephanie; Nishiyama, Yasuhiro; Symersky, Jindrich; Boivin, Stephane; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Szabo, Paul; Weksler, Marc E.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Friedland, Robert P.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Ramsland, Paul A.] Macfarlane Burnet Inst Med Res Fdn, Struct Immunol Lab, Heidelberg, Vic 3084, Australia; [Edmundson, Allen B.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Health Science Center Houston; Cornell University; Case Western Reserve University; Burnet Institute; Oklahoma Medical Research Foundation	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Friedland, Robert/A-2834-2010; Boivin, Stephane/K-4018-2012	Friedland, Robert/0000-0001-5721-1843; Boivin, Stephane/0000-0003-1460-326X; Ramsland, Paul/0000-0002-2107-2738	NIA NIH HHS [1R01AG025304, R01AG017173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG025304, R01AG017173] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berisha HI, 2002, PULM PHARMACOL THER, V15, P121, DOI 10.1006/pupt.2001.0337; BLACK RS, 2006, 9 INT GEN SPR S ADV, P21; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burbach GJ, 2007, NEUROBIOL AGING, V28, P202, DOI 10.1016/j.neurobiolaging.2005.12.003; Chander H, 2006, BRAIN RES, V1082, P173, DOI 10.1016/j.brainres.2006.01.079; Chauhan V, 2005, J ALZHEIMERS DIS, V7, P37; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; ELOVAARA I, 1985, J NEUROL SCI, V70, P73, DOI 10.1016/0022-510X(85)90189-3; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Geylis V, 2006, AUTOIMMUN REV, V5, P33, DOI 10.1016/j.autrev.2005.06.007; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Howe CL, 2006, NEUROBIOL DIS, V23, P731, DOI 10.1016/j.nbd.2006.06.012; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu R, 2004, BIOCHEMISTRY-US, V43, P9999, DOI 10.1021/bi0492354; Lue LF, 2002, J NEUROSCI RES, V70, P599, DOI 10.1002/jnr.10422; Matsuoka Y, 2003, J NEUROSCI, V23, P29; MEI S, 1991, J BIOL CHEM, V266, P15571; Mirshahi M, 2006, IMMUNOL LETT, V106, P57, DOI 10.1016/j.imlet.2006.04.008; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Paul S, 2005, SPRINGER SEMIN IMMUN, V26, P485, DOI 10.1007/s00281-004-0191-1; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rangan SK, 2003, BIOCHEMISTRY-US, V42, P14328, DOI 10.1021/bi035038d; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; SAXON A, 1989, B LYMPHOCYTE SYSTEM; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Vos Q, 2000, IMMUNOL REV, V176, P154; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wolfe Michael S., 2002, Current Topics in Medicinal Chemistry, V2, P371, DOI 10.2174/1568026024607535; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	66	64	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4714	4722		10.1074/jbc.M707983200	http://dx.doi.org/10.1074/jbc.M707983200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086674	hybrid			2022-12-27	WOS:000253426500029
J	Zheng, YX; Boeglin, WE; Schneider, C; Brash, AR				Zheng, Yuxiang; Boeglin, William E.; Schneider, Claus; Brash, Alan R.			A 49-kDa mini-lipoxygenase from Anabaena sp PCC 7120 retains catalytically complete functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORAL PLEXAURA-HOMOMALLA; FATTY-ACID-COMPOSITION; N-TERMINAL DOMAIN; BLUE-GREEN-ALGAE; SOYBEAN LIPOXYGENASE-1; FUSION PROTEIN; CYCLOOXYGENASE CATALYSIS; NOSTOC-PUNCTIFORME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE	Anabaena sp. PCC 7120 is one of the few prokaryotes harboring a lipoxygenase (LOX) gene. The sequence resides in an open reading frame encoding a fusion protein of a catalase-like hemoprotein with an unusually short LOX (similar to 49 kDa) at the C terminus. The recombinant mini-LOX contains a non-heme iron in the active site and is highly active with linoleic and alpha-linolenic acids (which occur naturally in Anabaena) giving the respective 9R-hydroperoxides, the mirror image of the 9S-LOX products of plants. Using stereospecifically labeled [11-H-3] linoleic acids we show that reaction is catalyzed via a typical antarafacial relationship of initial hydrogen abstraction and oxygenation. The mini-LOX oxygenated C-16/C-18:2-phosphatidylcholine with 9R specificity, suggesting a '' tail first '' mode of fatty acid binding. Site-directed mutagenesis of an active site Ala (Ala(215)), typically conserved as Gly in R-LOX, revealed that substitution with Gly retained 9R specificity, whereas the larger Val substitution switched oxygenation to 13S, implying that Ala(215) represents the functional equivalent of the Gly in other R-LOX. Metabolism studies using a synthetic fatty acid with extended double bond conjugation, 9E, 11Z, 14Z-20:3 omega 6, showed that the mini-LOX can control oxygenation two positions further along the fatty acid carbon chain. We conclude that the mini-LOX, despite lacking the beta-barrel domain and much additional sequence, is catalytically complete. Interestingly, animal and plant LOX, which undoubtedly share a common ancestor, are related in sequence only in the catalytic domain; it is possible that the prokaryotic LOX represents a common link and that the beta-barrel domain was then acquired independently in the animal and plant kingdoms.	[Zheng, Yuxiang; Boeglin, William E.; Schneider, Claus; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S, Nashville, TN 37232 USA.	brash@vanderbilt.edu			NIGMS NIH HHS [GM-074888] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BILD GS, 1977, LIPIDS, V12, P732, DOI 10.1007/BF02570904; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; BOEYNAEMS JM, 1980, ANAL BIOCHEM, V104, P259, DOI 10.1016/0003-2697(80)90073-1; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coffa G, 2005, J BIOL CHEM, V280, P38756, DOI 10.1074/jbc.M504870200; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; COREY EJ, 1987, TETRAHEDRON LETT, V28, P5391, DOI 10.1016/S0040-4039(00)96736-4; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; GREELEY RH, 1974, J CHROMATOGR, V88, P229; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; LABELLE M, 1990, TETRAHEDRON, V46, P6301, DOI 10.1016/S0040-4020(01)96002-8; Lang I, 2007, PHYTOCHEMISTRY, V68, P1120, DOI 10.1016/j.phytochem.2007.02.028; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Li RH, 2004, CURR MICROBIOL, V49, P376, DOI 10.1007/s00284-004-4380-x; Maccarrone M, 2001, BIOCHEMISTRY-US, V40, P6819, DOI 10.1021/bi010187m; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MURAKAMI N, 1992, LIPIDS, V27, P776, DOI 10.1007/BF02535848; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; PARKER PL, 1967, SCIENCE, V155, P707, DOI 10.1126/science.155.3763.707; PERCIVAL MD, 1991, J BIOL CHEM, V266, P10058; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; Rector CL, 2007, CHEM RES TOXICOL, V20, P1582, DOI 10.1021/tx700120r; SATO N, 1979, BIOCHIM BIOPHYS ACTA, V572, P19; Schneider C, 1997, CHIRALITY, V9, P563, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<563::AID-CHIR25>3.0.CO;2-L; Schneider C, 2000, ANAL BIOCHEM, V284, P125, DOI 10.1006/abio.2000.4670; Schneider C, 2002, PROSTAG OTH LIPID M, V68-9, P291, DOI 10.1016/S0090-6980(02)00041-2; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; TSUZUKI M, 1990, PLANT PHYSIOL, V93, P851, DOI 10.1104/pp.93.3.851; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200	50	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5138	5147		10.1074/jbc.M705780200	http://dx.doi.org/10.1074/jbc.M705780200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18070874	hybrid			2022-12-27	WOS:000253426500071
J	Prieto, J; Epinat, JC; Redondo, P; Ramos, E; Padro, D; Cedrone, F; Montoya, G; Paques, F; Blanco, FJ				Prieto, Jesus; Epinat, Jean-Charles; Redondo, Pilar; Ramos, Elena; Padro, Daniel; Cedrone, Frederic; Montoya, Guillermo; Paques, Frederic; Blanco, Francisco J.			Generation and analysis of mesophilic variants of the thermostable archaeal I-DmoI homing endonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENTIAL RANDOM MUTAGENESIS; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; PROTEIN STABILITY; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; SUBSTRATE-SPECIFICITY; CLEAVAGE SPECIFICITY	The hyperthermophilic archaeon Desulfurococcus mobilis I-DmoI protein belongs to the family of proteins known as homing endonucleases (HEs). HEs are highly specific DNA-cleaving enzymes that recognize long stretches of DNA and are powerful tools for genome engineering. Because of its monomeric nature, I-DmoI is an ideal scaffold for generating mutant enzymes with novel DNA specificities, similarly reported for homodimeric HEs, but providing single chain endonucleases instead of dimers. However, this would require the use of a mesophilic variant cleaving its substrate at temperatures of 37 C and below. We have generated mesophilic mutants of I-DmoI, using a single round of directed evolution that relies on a functional assay in yeast. The effect of mutations identified in the novel proteins has been investigated. These mutations are located distant to the DNA-binding site and cause changes in the size and polarity of buried residues, suggesting that they act by destabilizing the protein. Two of the novel proteins have been produced and analyzed in vitro. Their overall structures are similar to that of the parent protein, but they are destabilized against thermal and chemical denaturation. The temperature-dependent activity profiles for the mutants shifted toward lower temperatures with respect to the wild-type activity profile. However, the most destabilized mutant was not the most active at low temperatures, suggesting that other effects, like local structural distortions and/or changes in the protein dynamics, also influence their activity. These mesophilic I-DmoI mutants form the basis for generating new variants with tailored DNA specificities.	[Epinat, Jean-Charles; Cedrone, Frederic; Paques, Frederic] Cellectis SA, F-93235 Romainville, France; [Prieto, Jesus; Ramos, Elena; Padro, Daniel] Spanish Natl Canc Ctr, NMR Grp, Struct Biol & Biocomp Programme, Madrid, Spain; [Redondo, Pilar; Montoya, Guillermo] Spanish Natl Canc Ctr, Macromol Crystallog Grp, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Paques, F (corresponding author), Cellectis SA, 102 Route Noisy, F-93235 Romainville, France.	paques@cellectis.com; fblanco@cicbiogune.es	Redondo, Pilar/L-7612-2014; Padro, Daniel/L-4091-2015; Blanco, Francisco J/D-4401-2009; Padro, Daniel/AAG-3529-2021; biomaGUNE, CIC/J-9136-2014	Redondo, Pilar/0000-0002-6723-0818; Padro, Daniel/0000-0002-3932-9351; Blanco, Francisco J/0000-0003-2545-4319; Padro, Daniel/0000-0002-3932-9351; biomaGUNE, CIC/0000-0001-7690-0660				Aagaard C, 1997, NUCLEIC ACIDS RES, V25, P1523, DOI 10.1093/nar/25.8.1523; Adekoya OA, 2006, PROTEINS, V62, P435, DOI 10.1002/prot.20773; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bibikova M, 2002, GENETICS, V161, P1169; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; CADWELL RC, 1994, PCR METH APPL, V3, pS136; Chames P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni175; CHEN KQ, 1993, P NATL ACAD SCI USA, V90, P5618, DOI 10.1073/pnas.90.12.5618; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; Chodorge M, 2005, ADV SYNTH CATAL, V347, P1022, DOI 10.1002/adsc.200505055; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Dalgaard JZ, 1998, ACTA CRYSTALLOGR D, V54, P1435, DOI 10.1107/S0907444998006222; DALGAARD JZ, 1993, P NATL ACAD SCI USA, V90, P5414, DOI 10.1073/pnas.90.12.5414; DALGAARD JZ, 1994, J BIOL CHEM, V269, P28885; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Duan XQ, 1997, CELL, V89, P555, DOI 10.1016/S0092-8674(00)80237-8; Epinat JC, 2003, NUCLEIC ACIDS RES, V31, P2952, DOI 10.1093/nar/gkg375; Flick KE, 1997, PROTEIN SCI, V6, P2677; Gimble FS, 2003, J MOL BIOL, V334, P993, DOI 10.1016/j.jmb.2003.10.013; HICKS JB, 1979, COLD SPRING HARB SYM, V43, P1305, DOI 10.1101/SQB.1979.043.01.149; Ichiyanagi K, 2000, J MOL BIOL, V300, P889, DOI 10.1006/jmbi.2000.3873; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Lebbink JHG, 2000, BIOCHEMISTRY-US, V39, P3656, DOI 10.1021/bi991483q; Lehmann M, 2002, PROTEIN ENG, V15, P403, DOI 10.1093/protein/15.5.403; Lehmann M, 2000, PROTEIN ENG, V13, P49, DOI 10.1093/protein/13.1.49; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; LYKKEANDERSEN J, 1994, NUCLEIC ACIDS RES, V22, P4583, DOI 10.1093/nar/22.22.4583; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MARSHALL P, 1994, EUR J BIOCHEM, V220, P855, DOI 10.1111/j.1432-1033.1994.tb18688.x; Moure CM, 2003, J MOL BIOL, V334, P685, DOI 10.1016/j.jmb.2003.09.068; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nakayama H, 2007, J MOL BIOL, V365, P362, DOI 10.1016/j.jmb.2006.09.066; Pace CN, 2000, PROTEINS, P1; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; Perl D, 2002, CHEMBIOCHEM, V3, P39, DOI 10.1002/1439-7633(20020104)3:1<39::AID-CBIC39>3.0.CO;2-D; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Poland BW, 2000, J BIOL CHEM, V275, P16408, DOI 10.1074/jbc.275.22.16408; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Rubin-Pitel SB, 2006, COMB CHEM HIGH T SCR, V9, P247, DOI 10.2174/138620706776843183; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; SERRANO L, 1993, J MOL BIOL, V233, P305, DOI 10.1006/jmbi.1993.1508; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Spiegel PC, 2006, STRUCTURE, V14, P869, DOI 10.1016/j.str.2006.03.009; Sriprapundh D, 2003, PROTEIN ENG, V16, P683, DOI 10.1093/protein/gzg082; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Steuer S, 2004, CHEMBIOCHEM, V5, P206, DOI 10.1002/cbic.200300718; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Taguchi S, 1998, APPL ENVIRON MICROB, V64, P492; Tindbaek N, 2004, PROTEIN ENG DES SEL, V17, P149, DOI 10.1093/protein/gzh019; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P2142, DOI 10.1021/bi00174a022; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767; WELLS JA, 1986, J BIOL CHEM, V261, P6564; Werner E, 2002, NUCLEIC ACIDS RES, V30, P3962, DOI 10.1093/nar/gkf523; Wintrode PL, 2000, J BIOL CHEM, V275, P31635, DOI 10.1074/jbc.M004503200; Wintrode PL, 2001, ADV PROTEIN CHEM, V55, P161, DOI 10.1016/S0065-3233(01)55004-4	70	15	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4364	4374		10.1074/jbc.M706323200	http://dx.doi.org/10.1074/jbc.M706323200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	17999959	hybrid, Green Published			2022-12-27	WOS:000253083500071
J	Chernyavsky, AI; Arredondo, J; Piser, T; Karlsson, E; Grando, SA				Chernyavsky, Alex I.; Arredondo, Juan; Piser, Timothy; Karlsson, Evert; Grando, Sergei A.			Differential coupling of M-1 muscarinic and alpha 7 nicotinic receptors to inhibition of pemphigus acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATINOCYTE ACETYLCHOLINE-RECEPTORS; TYROSINE PHOSPHORYLATION; BETA-CATENIN; E-CADHERIN; VULGARIS-IGG; PROTEIN-PHOSPHORYLATION; PATHWAYS DOWNSTREAM; CHOLINERGIC CONTROL; CELLS; MECHANISMS	The mechanisms mediating and regulating assembly and disassembly of intercellular junctions is a subject of intensive research. The IgG autoantibodies produced in patients with the immunoblistering skin disease pemphigus vulgaris (PV) can induce keratinocyte (KC) dyshesion (acantholysis) via mechanisms that involve signaling kinases targeting intercellular adhesion molecules, thus providing a useful model to study the physiologic regulation of KC cohesion. Previous studies showed that activation of Src and protein kinase C are the earliest events in the PV IgG-induced intracellular phosphorylation cascades and that cholinergic agonists are effective for treating patients with pemphigus. In this study, we sought to elucidate the molecular mechanisms allowing cholinergic agonists to inhibit PV IgG-induced acantholysis and phosphorylation of KC adhesion molecules. The extent of acantholysis in KC monolayers correlated closely with the degree of PV IgG-induced phosphorylation of p120- and beta-catenins, with classic isoforms of protein kinase C mediating serine phosphorylation of beta-catenin and Src-tyrosine phosphorylation of p120-catenin. The M-1 muscarinic agonist pilocarpine blocked phosphorylation of both catenins, which could be abolised by the M-1 antagonist MT7. The alpha 7 nicotinic agonist AR-R17779 inhibited phosphorylation of P120-cateinin. The alpha 7 antagonist methyllycaconitine abolished the effect of AR-R17779. Okadaic acid abrogated protective effects of agonists on phosphorylation of alpha-catenin, and pervanadate, on that of p120-catenin. Stimulation of KCs with pilocarpine significantly (p < 0.05) elevated both serine/threonine and tyrosine phosphatase activities in KCs. AR-R17779 both stimulated tyrosine phosphatase and decreased PV IgG-induced Src activity. Methyllycaconitine released Src activity in intact KCs and caused acantholysis. Thus, downstream signaling from M-1 abolished PV IgG-dependent catenin phosphorylation due to activation of both serine/threonine and tyrosine phosphatases, whereas alpha 7 action involved both activation of tyrosine phosphatase and inhibition of Src. These findings identified novel paradigm of regulation of signaling kinases associated with cholinergic receptors and provided mechanistic explanation of therapeutic activity of cholinomimetics in PV patients.	[Chernyavsky, Alex I.; Arredondo, Juan; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Piser, Timothy] AstraZeneca, Wilmington, DE 19850 USA; [Karlsson, Evert] Karolinska Inst, S-75240 Uppsala, Sweden	University of California System; University of California Irvine; AstraZeneca; Karolinska Institutet	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, C340 Med Sci 1, Irvine, CA 92697 USA.	sgrando@uci.edu			NIGMS NIH HHS [GM62136] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Amar LS, 1999, CELL ADHES COMMUN, V7, P125, DOI 10.3109/15419069909034396; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CHAFFINS ML, 1993, J AM ACAD DERMATOL, V28, P998, DOI 10.1016/S0190-9622(08)80651-2; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Chilton M, 2004, LIFE SCI, V74, P3133, DOI 10.1016/j.lfs.2003.11.012; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 2004, J INVEST DERM SYMP P, V9, P84, DOI 10.1111/j.1087-0024.2004.00826.x; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grishin AA, 2005, NEUROPHARMACOLOGY, V49, P328, DOI 10.1016/j.neuropharm.2005.03.019; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Iraji F, 2006, INT J DERMATOL, V45, P743, DOI 10.1111/j.1365-4632.2006.02766.x; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KARLSSON E, 1994, ANN NY ACAD SCI, V710, P153, DOI 10.1111/j.1749-6632.1994.tb26623.x; Karlsson E, 2000, BIOCHIMIE, V82, P793, DOI 10.1016/S0300-9084(00)01176-7; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Kebabian J.W., 1994, RBI HDB RECEPTOR CLA; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Kitajima Y, 1995, EPITHELIAL CELL BIOL, V4, P70; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; Kurzen H, 2006, J INVEST DERMATOL, V126, P2458, DOI 10.1038/sj.jid.5700443; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Matsuoka Y, 2001, J DERMATOL SCI, V27, P206, DOI 10.1016/S0923-1811(01)00137-2; Mehta JN, 2000, ARCH DERMATOL, V136, P15, DOI 10.1001/archderm.136.1.15; Moon HS, 2001, GYNECOL ONCOL, V81, P355, DOI 10.1006/gyno.2001.6163; MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X; Namazi M R, 2004, J Drugs Dermatol, V3, P484; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Nguyen VT, 2003, LIFE SCI, V72, P2081, DOI 10.1016/S0024-3205(03)00087-0; Pasdar M, 1997, CELL GROWTH DIFFER, V8, P451; PASDAR M, 1995, CELL MOTIL CYTOSKEL, V30, P108, DOI 10.1002/cm.970300203; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; ROMANENKO AV, 1987, FIZIOL ZH SSSR, V33, P51; Rubenstein DS, 2006, AUTOIMMUNITY, V39, P577, DOI 10.1080/08916930600971885; Sanchez-Carpintero I, 2004, BRIT J DERMATOL, V151, P565, DOI 10.1111/j.1365-2133.2004.06147.x; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Shelden E, 1996, CELL MOTIL CYTOSKEL, V35, P24, DOI 10.1002/(SICI)1097-0169(1996)35:1<24::AID-CM2>3.0.CO;2-I; Stoytcheva M, 1996, ELECTROANAL, V8, P676, DOI 10.1002/elan.1140080714; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; VANDERMEERS A, 1995, TOXICON, V33, P1171, DOI 10.1016/0041-0101(95)00057-S; vanHoek ML, 1997, BIOCHEM J, V326, P271, DOI 10.1042/bj3260271; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Wakita H, 1997, INT J CANCER, V73, P432, DOI 10.1002/(SICI)1097-0215(19971104)73:3<432::AID-IJC19>3.0.CO;2-E; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200	71	32	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3401	3408		10.1074/jbc.M704956200	http://dx.doi.org/10.1074/jbc.M704956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073210	hybrid			2022-12-27	WOS:000253083000045
J	Iberg, AN; Espejo, A; Cheng, D; Kim, D; Michaud-Levesque, J; Richard, S; Bedford, MT				Iberg, Aimee N.; Espejo, Alexsandra; Cheng, Donghang; Kim, Daehoon; Michaud-Levesque, Jonathan; Richard, Stephane; Bedford, Mark T.			Arginine methylation of the histone H3 tail impedes effector binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE-4 TRIMETHYLATION; DYNAMIC REGULATION; PLANT HOMEODOMAIN; RECOGNITION; COMPLEX; WDR5; TRANSCRIPTION; H3K4ME3; DOMAIN	Histone tail post-translational modification results in changes in cellular processes, either by generating or blocking docking sites for histone code readers or by altering the higher order chromatin structure. H3K4me3 is known to mark the promoter regions of active transcription. Proteins bind H3K4 in a methyl-dependent manner and aid in the recruitment of histone-remodeling enzymes and transcriptional cofactors. The H3K4me3 binders harbor methyl-specific chromatin binding domains, including plant homeodomain, Chromo, and tudor domains. Structural analysis of the plant homeodomains present in effector proteins, as well as the WD40 repeats of WDR5, reveals critical contacts between residues in these domains and H3R2. The intimate contact between H3R2 and these domain types leads to the hypothesis that methylation of this arginine residue antagonizes the binding of effector proteins to the N-terminal tail of H3. Here we show that H3 tail binding effector proteins are indeed sensitive to H3R2 methylation and that PRMT6, not CARM1/PRMT4, is the primary methyltransferase acting on this site. We have tested the expression of a select group of H3K4 effector-regulated genes in PRMT6 knockdown cells and found that their levels are altered. Thus, PRMT6 methylates H3R2 and is a negative regulator of N-terminal H3 tail binding.	[Iberg, Aimee N.; Espejo, Alexsandra; Cheng, Donghang; Kim, Daehoon; Bedford, Mark T.] Univ Texas Dallas, MD Anderson Canc Ctr, Div Res, Smithville, TX 78957 USA; [Michaud-Levesque, Jonathan; Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada	University of Texas System; University of Texas Dallas; UTMD Anderson Cancer Center; McGill University	Bedford, MT (corresponding author), Univ Texas Dallas, MD Anderson Canc Ctr, Div Res, Sci Pk,POB 389, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Bedford, Mark T/E-7856-2011	Espejo, Alexsandra/0000-0002-8841-7219	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062248, R56DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023449] Funding Source: NIH RePORTER; NIDA NIH HHS [DA023449] Funding Source: Medline; NIDDK NIH HHS [DK62248] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dormann HL, 2006, CELL CYCLE, V5, P2842, DOI 10.4161/cc.5.24.3540; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	24	146	152	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3006	3010		10.1074/jbc.C700192200	http://dx.doi.org/10.1074/jbc.C700192200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18077460	hybrid			2022-12-27	WOS:000253083000003
J	Cuthbertson, BJ; Liao, Y; Birnbaumer, L; Blackshear, PJ				Cuthbertson, Brandon J.; Liao, Yanhong; Birnbaumer, Lutz; Blackshear, Perry J.			Characterization of zfs1 as an mRNA-binding and -destabilizing protein in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; ZINC-FINGER PROTEINS; GENE-EXPRESSION; CONFORMATIONAL-CHANGES; IRON-DEFICIENCY; GLOBAL ANALYSIS; HUMAN HOMOLOG; SWISS-MODEL; TRISTETRAPROLIN; DEADENYLATION	Tristetraprolin is a vertebrate CCCH tandem zinc finger protein that can bind to and destabilize certain mRNAs containing AU-rich element binding sites. zfs1 is the single gene in the fission yeast, Schizosaccharomyces pombe, that encodes a protein containing the critical features of the tristetraprolin zinc finger domain. zfs1 has been linked to pheromone signal transduction control and to the coordination of mitosis, but no biological function has been ascribed to the zfs1 protein. Through a functional genomics approach we compared transcript levels in wild-type and zfs1-deficient S. pombe strains; those elevated in the zfs1-deficient strain were examined for the presence of potential tristetraprolin-like binding sites. One such potential target transcript was encoded by arz1, a gene encoding a protein of unknown function that contains armadillo repeats. arz1 mRNA decay was inhibited in the zfs1-deficient strain when it was expressed under the control of a thiamine-repressible promoter. Mutations within one AU-rich element present in the arz1 3 '- untranslated region protected this transcript from zfs1-promoted decay, whereas mutating another potential binding site had no effect. Binding assays confirmed a direct interaction between zfs1 and arz1 mRNA-based probes; this interaction was eliminated when key residues were mutated in either zfs1 zinc finger. zfs1 and its targets in S. pombe represent a useful model system for studies of zinc finger protein/AU-rich element interactions that result in mRNA decay.	[Cuthbertson, Brandon J.; Blackshear, Perry J.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Liao, Yanhong; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] NIEHS, Clin Res Program, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, Lab Signal Transduct, NIH, 111 TW Alexander Dr,MD A2-05, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684, Z01ES101643, ZIAES090080] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 ES999999, Z01 ES101684-05, Z01 ES101643-05] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARNARD RC, 1993, NUCLEIC ACIDS RES, V21, P3580, DOI 10.1093/nar/21.15.3580; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Beltraminelli N, 1999, J CELL SCI, V112, P3103; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2006, BIOCHEMISTRY-US, V45, P13807, DOI 10.1021/bi061320j; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Carballo E, 2000, BLOOD, V95, P1891, DOI 10.1182/blood.V95.6.1891; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Labbe S, 2007, BIOMETALS, V20, P523, DOI 10.1007/s10534-006-9056-5; Lai WS, 2006, MOL CELL BIOL, V26, P9196, DOI 10.1128/MCB.00945-06; Lai WS, 2003, MOL CELL BIOL, V23, P3798, DOI 10.1128/MCB.23.11.3798-3812.2003; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lo PCH, 1998, MECH DEVELOP, V72, P65, DOI 10.1016/S0925-4773(98)00016-1; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; NIE XF, 1995, GENE, V152, P285, DOI 10.1016/0378-1119(94)00696-P; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Thompson MJ, 1996, GENE, V174, P225, DOI 10.1016/0378-1119(96)00084-4; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	25	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2586	2594		10.1074/jbc.M707154200	http://dx.doi.org/10.1074/jbc.M707154200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18042546	Green Accepted, hybrid			2022-12-27	WOS:000252622300015
J	Bagamasbad, P; Howdeshell, KL; Sachs, LM; Demeneix, BA; Denver, RJ				Bagamasbad, Pia; Howdeshell, Kembra L.; Sachs, Laurent M.; Demeneix, Barbara A.; Denver, Robert J.			A role for basic transcription element-binding protein 1 (BTEB1) in the autoinduction of thyroid hormone receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS METAMORPHOSIS; ENDOMETRIAL EPITHELIAL-CELLS; GENE-EXPRESSION PROGRAM; BREAST-CANCER CELLS; KRUPPEL-LIKE FAMILY; AMPHIBIAN METAMORPHOSIS; ESTROGEN-RECEPTOR; NUCLEAR-LOCALIZATION; FUNCTIONAL-ANALYSIS; PROMOTER ACTIVITY	Thyroid hormone (T-3) induces gene regulation programs necessary for tadpole metamorphosis. Among the earliest responses to T3 are the up-regulation of T3 receptor beta (TR beta; autoinduction) and BTEB1 (basic transcription element-binding protein 1). BTEB1 is a member of the Kruppel family of transcription factors that bind to GC-rich regions in gene promoters. The proximal promoter of the Xenopus laevis Tr beta A gene has seven GC-rich sequences, which led us to hypothesize that BTEB1 binds to and regulates Tr beta A. In tadpoles and the frog fibroblast-derived cell line XTC-2, T3 up-regulated Bteb1 mRNA with faster kinetics than Tr beta A, and Bteb1 mRNA correlated with increased BTEB1 protein expression. BTEB1 bound to GC-rich sequences in the proximal Tr beta A promoter in vitro. By using chromatin immunoprecipitation assay, we show that BTEB1 associates with the Tr beta A promoter in vivo in a T3 and developmental stage-dependent manner. Induced expression of BTEB1 in XTC-2 cells caused accelerated and enhanced autoinduction of the Tr beta A gene. This enhancement was lost in N-terminal truncated mutants of BTEB1. However, point mutations in the zinc fingers of BTEB1 that destroyed DNA binding did not alter the activity of the protein on Tr beta A autoinduction, suggesting that BTEB1 can function in this regard through protein-protein interactions. Our findings support the hypothesis that BTEB1 associates with the Tr beta A promoter in vivo and enhances autoinduction, but this action does not depend on its DNA binding activity. Cooperation among the protein products of immediate early genes may be a common mechanism for driving developmental signaling pathways.	[Bagamasbad, Pia; Howdeshell, Kembra L.; Denver, Robert J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Sachs, Laurent M.; Demeneix, Barbara A.] USM 501 Museum Natl Hist Nat, Dept Regulat Dev & Divers Mol, F-75231 Paris 05, France	University of Michigan System; University of Michigan; Museum National d'Histoire Naturelle (MNHN)	Denver, RJ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	rdenver@umich.edu	Sachs, Laurent/AAE-1504-2020; Denver, Robert/AAT-7481-2021	Bagamasbad, Pia/0000-0001-9751-7521	NINDS NIH HHS [1 R01 NS046690] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046690] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown DD, 1996, P NATL ACAD SCI USA, V93, P1924, DOI 10.1073/pnas.93.5.1924; BROWN DD, 1995, RECENT PROG HORM RES, V50, P309; BUCKBINDER L, 1992, J BIOL CHEM, V262, P11221; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chen AP, 2000, MOL CELL BIOL, V20, P2818, DOI 10.1128/MCB.20.8.2818-2826.2000; Dang DT, 2000, INT J BIOCHEM CELL B, V32, P1103, DOI 10.1016/S1357-2725(00)00059-5; Das B, 2006, DEV BIOL, V291, P342, DOI 10.1016/j.ydbio.2005.12.032; Denver RJ, 1999, J BIOL CHEM, V274, P23128, DOI 10.1074/jbc.274.33.23128; Denver RJ, 1997, J BIOL CHEM, V272, P8179, DOI 10.1074/jbc.272.13.8179; Duan R, 1998, ENDOCRINOLOGY, V139, P1981, DOI 10.1210/en.139.4.1981; Foti D, 1998, BIOCHEM BIOPH RES CO, V253, P109, DOI 10.1006/bbrc.1998.9759; Furlow JD, 1999, MOL ENDOCRINOL, V13, P2076, DOI 10.1210/me.13.12.2076; Furlow JD, 2002, ENDOCRINOLOGY, V143, P3295, DOI 10.1210/en.2002-220126; Helbing CC, 2003, MOL ENDOCRINOL, V17, P1395, DOI 10.1210/me.2002-0274; Hoopfer ED, 2002, DEV GROWTH DIFFER, V44, P365; Hsiang CH, 2002, ONCOGENE, V21, P2212, DOI 10.1038/sj.onc.1205293; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; IMATAKA H, 1993, AIDS RES HUM RETROV, V9, P825, DOI 10.1089/aid.1993.9.825; Imhof A, 1999, MOL CELL BIOL, V19, P194; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; KANAMORI A, 1993, P NATL ACAD SCI USA, V90, P6013, DOI 10.1073/pnas.90.13.6013; KOBAYASHI A, 1995, J BIOCHEM-TOKYO, V117, P91, DOI 10.1093/oxfordjournals.jbchem.a124727; MACHUCA I, 1995, MOL ENDOCRINOL, V9, P96, DOI 10.1210/me.9.1.96; Manzon RG, 2004, J ENDOCRINOL, V182, P273, DOI 10.1677/joe.0.1820273; Martin KM, 2000, BIOCHEM J, V345, P529, DOI 10.1042/0264-6021:3450529; MeunierDurmort C, 1997, GENE THER, V4, P808, DOI 10.1038/sj.gt.3300450; Morita M, 2003, MOL CELL BIOL, V23, P2489, DOI 10.1128/MCB.23.7.2489-2500.2003; NIEWKOOP PD, 1956, NORMAL TABLE XENOPUS; Pandya K, 2002, J BIOL CHEM, V277, P16304, DOI 10.1074/jbc.M200866200; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Sachs LM, 2000, P NATL ACAD SCI USA, V97, P13138, DOI 10.1073/pnas.260141297; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Shi Y.B., 2000, AMPHIBIAN METAMORPHO; SHI YB, 1992, J BIOL CHEM, V267, P733; SHI YB, 1994, DEV BIOL, V161, P48, DOI 10.1006/dbio.1994.1006; SHI YB, 1993, J BIOL CHEM, V268, P20312; Simmen RCM, 1999, ENDOCRINOLOGY, V140, P2517, DOI 10.1210/en.140.6.2517; Simmen RCM, 2002, DNA CELL BIOL, V21, P115, DOI 10.1089/104454902753604998; Simmen RCM, 2000, MOL CELL ENDOCRINOL, V159, P159, DOI 10.1016/S0303-7207(99)00191-4; Sjottem E, 1996, J VIROL, V70, P188; SOGAWA K, 1993, J BIOCHEM, V114, P605, DOI 10.1093/oxfordjournals.jbchem.a124224; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tata JR, 2000, INSECT BIOCHEM MOLEC, V30, P645, DOI 10.1016/S0965-1748(00)00035-7; Veldhoen N, 2002, DEV DYNAM, V225, P457, DOI 10.1002/dvdy.10175; WANG Z, 1991, P NATL ACAD SCI USA, V88, P11505, DOI 10.1073/pnas.88.24.11505; WANG Z, 1993, J BIOL CHEM, V268, P16270; Wong JM, 1998, J BIOL CHEM, V273, P14186, DOI 10.1074/jbc.273.23.14186; YANAGIDA A, 1990, MOL CELL BIOL, V10, P1470, DOI 10.1128/MCB.10.4.1470; Yang ML, 1999, J BIOL CHEM, V274, P27399, DOI 10.1074/jbc.274.39.27399; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; YAOITA Y, 1990, P NATL ACAD SCI USA, V87, P7090, DOI 10.1073/pnas.87.18.7090; Zhang DY, 2002, ENDOCRINOLOGY, V143, P62, DOI 10.1210/en.143.1.62	57	48	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2275	2285		10.1074/jbc.M709306200	http://dx.doi.org/10.1074/jbc.M709306200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045867	hybrid			2022-12-27	WOS:000252501000055
J	Sidera, K; Gaitanou, M; Stellas, D; Matsas, R; Patsavoudi, E				Sidera, Katerina; Gaitanou, Maria; Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia			A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; DEVELOPING NERVOUS-SYSTEM; MONOCLONAL-ANTIBODY 4C5; ERBB SIGNALING NETWORK; BREAST-CANCER; RECEPTOR INTERACTIONS; ACTIN CYTOSKELETON; TYROSINE KINASES; SURFACE-ANTIGEN; PROTEIN	HSP90 is a ubiquitously expressed molecular chaperone that controls the folding, assembly, intracellular disposition, and proteolytic turnover of many proteins, most of which are involved in signal transduction processes. Recently, a surface form of HSP90 has been identified and associated with cell migration events. In this paper, we explore the interaction of surface HSP90 with HER-2, a receptor-like glycoprotein and member of the ErbB family of receptor tyrosine kinases that play central roles in cellular proliferation, differentiation, and migration as well as in cancer progress. The involvement of HSP90 in the regulation of HER-2 has been attributed so far to receptor stabilization via interaction with its cytoplasmic kinase domain. Here we present evidence, using glutathione S-transferase pull-down and transfection assays, for a novel interaction between surface HSP90 and the extracellular domain of HER-2. Specific disruption of this interaction using mAb 4C5, a function-blocking monoclonal antibody against HSP90, inhibits cell invasion accompanied by altered actin dynamics in human breast cancer cells under ligand stimulation conditions with heregulin. Additionally, disruption of surface HSP90/HER-2 interaction leads to inhibition of heregulin-induced HER-2-HER-3 heterodimer formation, reduced HER-2 phosphorylation, and impaired downstream kinase signaling. Interestingly, this disruption does not affect HER-2 internalization. Our data suggest that surface HSP90 is involved in heregulin-induced HER-2 activation and signaling, leading to cytoskeletal rearrangement, essential for cell invasion.	[Sidera, Katerina; Gaitanou, Maria; Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia] Helen Pasteur Inst, Dept Biochem, Athens 11521, Greece; [Stellas, Dimitris; Matsas, Rebecca; Patsavoudi, Evangelia] Technol Educat Inst Athens, Dept Med Instrumentat, Athens 12210, Greece	University of West Attica	Patsavoudi, E (corresponding author), Helen Pasteur Inst, Dept Biochem, 127 Vasilissis Sofias Ave, Athens 11521, Greece.	epatsavoudi@pasteur.gr	Stellas, Dimitris/AAP-8958-2021; Stellas, Dimitris/AAG-2473-2021	Stellas, Dimitris/0000-0002-7787-3921; Stellas, Dimitris/0000-0002-9587-6288				Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Alroy I, 1997, FEBS LETT, V410, P83, DOI 10.1016/S0014-5793(97)00412-2; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Berven LA, 2004, EXP CELL RES, V296, P183, DOI 10.1016/j.yexer.2003.12.032; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Citri A, 2004, CELL CYCLE, V3, P51; Eustace BK, 2004, CELL CYCLE, V3, P1098; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hijazi MM, 2000, INT J ONCOL, V17, P629; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Jackson JG, 2004, CANCER RES, V64, P2601, DOI 10.1158/0008-5472.CAN-03-3106; Johannessen LE, 2001, BIOCHEM J, V356, P87, DOI 10.1042/0264-6021:3560087; KANG KI, 1994, P NATL ACAD SCI USA, V91, P340, DOI 10.1073/pnas.91.1.340; Lavdas AA, 2006, GLIA, V53, P868, DOI 10.1002/glia.20340; Lee KJ, 2006, EXP MOL MED, V38, P364, DOI 10.1038/emm.2006.43; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Meintanis S, 2001, GLIA, V34, P39, DOI 10.1002/glia.1038; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; Neckers Len, 2003, Current Opinion in Oncology, V15, P419, DOI 10.1097/00001622-200311000-00003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nollen EAA, 2002, J CELL SCI, V115, P2809; PATSAVOUDI E, 1991, J NEUROCHEM, V56, P782, DOI 10.1111/j.1471-4159.1991.tb01992.x; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Qian Y, 2004, AM J PHYSIOL-CELL PH, V286, pC153, DOI 10.1152/ajpcell.00142.2003; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V319, P1, DOI 10.1016/j.bbrc.2004.04.150; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Sidera K, 2004, J BIOL CHEM, V279, P45379, DOI 10.1074/jbc.M405486200; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Stellas D, 2007, CLIN CANCER RES, V13, P1831, DOI 10.1158/1078-0432.CCR-06-1585; Tago K, 2004, MOL CELL ENDOCRINOL, V213, P131, DOI 10.1016/j.mce.2003.10.057; THOMAIDOU D, 1995, J NEUROCHEM, V64, P1937; THOMAIDOU D, 1993, NEUROSCIENCE, V53, P813, DOI 10.1016/0306-4522(93)90626-Q; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vadlamudi RK, 2002, J CELL PHYSIOL, V190, P189, DOI 10.1002/JCP.10054; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yfanti E, 1998, J NEUROCHEM, V71, P1381; Yfanti E, 2004, GLIA, V45, P39, DOI 10.1002/glia.10307; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zeigler ME, 1999, J CELL PHYSIOL, V180, P271; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	58	124	136	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2031	2041		10.1074/jbc.M701803200	http://dx.doi.org/10.1074/jbc.M701803200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18056992	hybrid			2022-12-27	WOS:000252501000030
J	Kono, N; Inoue, T; Yoshida, Y; Sato, H; Matsusue, T; Itabe, H; Niki, E; Aoki, J; Arai, H				Kono, Nozomu; Inoue, Takao; Yoshida, Yasukazu; Sato, Hiroyuki; Matsusue, Tomokazu; Itabe, Hiroyuki; Niki, Etsuo; Aoki, Junken; Arai, Hiroyuki			Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRACHLORIDE-INDUCED HEPATOTOXICITY; CARBON-TETRACHLORIDE; HUMAN-PLASMA; PAF-ACETYLHYDROLASE; LIPID-PEROXIDATION; CAENORHABDITIS-ELEGANS; MISSENSE MUTATION; RECEPTOR-GAMMA; LIVER-INJURY; RISK-FACTOR	Membrane phospholipids are susceptible to oxidation, which is involved in various pathological processes such as inflammation, atherogenesis, neurodegeneration, and aging. One enzyme that may help to remove oxidized phospholipids from cells is intracellular type II platelet-activating factor acetylhydrolase (PAF-AH (II)), which hydrolyzes oxidatively fragmented fatty acyl chains attached to phospholipids. Overexpression of PAF-AH (II) in cells or tissues was previously shown to suppress oxidative stress-induced cell death. In this study we investigated the functions of PAF-AH (II) by generating PAF-AH (II)-deficient (Pafah2(-/-)) mice. PAF-AH (II) was predominantly expressed in epithelial cells such as kidney proximal and distal tubules, intestinal column epithelium, and hepatocytes. Although PAF- AH activity was almost abolished in the liver and kidney of Pafah2(-/-) mice, Pafah2(-/-) mice developed normally and were phenotypically indistinguishable from wild- type mice. However, mouse embryonic fibroblasts derived from Pafah2(-/-) mice were more sensitive to tert- butylhydroperoxide treatment than those derived from wild- type mice. When carbon tetrachloride (CCl4) was injected into mice, Pafah2(-/-) mice showed a delay in hepatic injury recovery. Moreover, after CCl4 administration, liver levels of the esterified form of 8-iso-PGF(2 alpha), a known in vitro substrate of PAF-AH (II), were higher in Pafah2(-/-) mice than in wild-type mice. These results indicate that PAF-AH (II) is involved in the metabolism of esterified 8-isoprostaglandin F-2 alpha and protects tissue from oxidative stress-induced injury.	[Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Yoshida, Yasukazu; Niki, Etsuo] Natl Inst Adv Ind Sci & Technol, Human Stress Signal Res Ctr, Osaka 5638577, Japan; [Sato, Hiroyuki; Matsusue, Tomokazu] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Shizuoka 4128524, Japan; [Itabe, Hiroyuki] Showa Univ, Sch Pharmaceut Sci, Dept Biol Chem, Shinagawa Ku, Tokyo 1428555, Japan; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kono, Nozomu; Inoue, Takao; Arai, Hiroyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Mochida Pharmaceutical Co Ltd; Showa University; Tohoku University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Arai, H (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	harai@mol.f.u-tokyo.ac.jp	板部板部, 洋之/ABC-7746-2020; KONO, nozomu/AAM-3178-2020; YOSHIDA, YASUKAZU/H-8510-2016	YOSHIDA, YASUKAZU/0000-0001-6034-2502; Aoki, Junken/0000-0001-9435-1896				AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; Bae KA, 2000, J BIOL CHEM, V275, P26704; BIASI F, 1991, CELL BIOCHEM FUNCT, V9, P111, DOI 10.1002/cbf.290090208; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Campo GM, 2001, FREE RADICAL RES, V34, P379, DOI 10.1080/10715760100300321; Chen R, 2007, J BIOL CHEM, V282, P24842, DOI 10.1074/jbc.M702865200; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Fruhwirth GO, 2007, BBA-MOL BASIS DIS, V1772, P718, DOI 10.1016/j.bbadis.2007.04.009; Fukuda Y, 2000, EUR J PHARMACOL, V390, P203, DOI 10.1016/S0014-2999(99)00920-6; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HATTORI M, 1993, J BIOL CHEM, V268, P18748; Henderson WR, 2000, J IMMUNOL, V164, P3360, DOI 10.4049/jimmunol.164.6.3360; Hiramoto M, 1997, STROKE, V28, P2417, DOI 10.1161/01.STR.28.12.2417; Hofbauer B, 1998, GASTROENTEROLOGY, V115, P1238, DOI 10.1016/S0016-5085(98)70096-4; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Inoue T, 2004, P NATL ACAD SCI USA, V101, P13233, DOI 10.1073/pnas.0405507101; ITABE H, 1988, BIOCHIM BIOPHYS ACTA, V962, P8; Karabina SA, 2006, BBA-MOL CELL BIOL L, V1761, P1351, DOI 10.1016/j.bbalip.2006.05.008; Karasawa K, 2006, BBA-MOL CELL BIOL L, V1761, P1359, DOI 10.1016/j.bbalip.2006.06.017; KAYGANICHHARRISON KA, 1993, J LIPID RES, V34, P1229; KINNUNEN PKJ, 1991, CHEM PHYS LIPIDS, V57, P375, DOI 10.1016/0009-3084(91)90087-R; Kriska T, 2007, J BIOL CHEM, V282, P100, DOI 10.1074/jbc.M608135200; Kruse S, 2000, AM J HUM GENET, V66, P1522, DOI 10.1086/302901; Lawson JA, 1999, J BIOL CHEM, V274, P24441, DOI 10.1074/jbc.274.35.24441; Liu P, 2001, LIVER, V21, P384, DOI 10.1034/j.1600-0676.2001.210604.x; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Matsuzawa A, 1997, J BIOL CHEM, V272, P32315, DOI 10.1074/jbc.272.51.32315; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Min JH, 2001, BIOCHEMISTRY-US, V40, P4539, DOI 10.1021/bi002600g; MIWA M, 1988, J CLIN INVEST, V82, P1983, DOI 10.1172/JCI113818; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; MORROW JD, 1994, BBA-LIPID LIPID MET, V1210, P244, DOI 10.1016/0005-2760(94)90128-7; MORROW JD, 1992, P NATL ACAD SCI USA, V89, P10721, DOI 10.1073/pnas.89.22.10721; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Nigam S, 2000, BBA-MOL CELL BIOL L, V1488, P167, DOI 10.1016/S1388-1981(00)00119-0; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Ohshima N, 2002, J BIOL CHEM, V277, P9722, DOI 10.1074/jbc.M112406200; Prescott SM, 2000, ANNU REV BIOCHEM, V69, P419, DOI 10.1146/annurev.biochem.69.1.419; Quarck R, 2001, CIRCULATION, V103, P2495; Satoh N, 1999, AM J RESP CRIT CARE, V159, P974, DOI 10.1164/ajrccm.159.3.9807093; SATOUCHI K, 1993, LIPIDS, V28, P837, DOI 10.1007/BF02536239; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Sotelo-Felix JI, 2002, EUR J GASTROEN HEPAT, V14, P1001, DOI 10.1097/00042737-200209000-00011; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; Stafforini DM, 1996, J CLIN INVEST, V97, P2784, DOI 10.1172/JCI118733; Stafforini DM, 1997, J BIOL CHEM, V272, P17895, DOI 10.1074/jbc.272.29.17895; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4223; Stafforini DM, 1996, BBA-LIPID LIPID MET, V1301, P161, DOI 10.1016/0005-2760(96)00040-9; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; STREMLER KE, 1989, J BIOL CHEM, V264, P5331; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; TAKAHASHI K, 1992, J CLIN INVEST, V90, P136, DOI 10.1172/JCI115826; Tanaka M, 2004, FEBS LETT, V571, P197, DOI 10.1016/j.febslet.2004.06.083; Theilmeier G, 2000, FASEB J, V14, P2032, DOI 10.1096/fj.99-1029com; Tjoelker LW, 2000, BBA-MOL CELL BIOL L, V1488, P102, DOI 10.1016/S1388-1981(00)00114-1; TJOELKER LW, 1995, NATURE, V374, P549, DOI 10.1038/374549a0; TSELEPIS AD, 1995, ARTERIOSCL THROM VAS, V15, P1764, DOI 10.1161/01.ATV.15.10.1764; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Umemura K, 2007, STROKE, V38, P1063, DOI 10.1161/01.STR.0000257981.09329.d2; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Wong FWY, 1998, TOXICOL APPL PHARM, V153, P109, DOI 10.1006/taap.1998.8547; Wu Y, 2007, TOXICOLOGY, V232, P50, DOI 10.1016/j.tox.2006.12.013; Yamada Y, 1997, BIOCHEM BIOPH RES CO, V236, P772, DOI 10.1006/bbrc.1997.7047; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Yoshida Y, 2005, TOXICOL APPL PHARM, V208, P87, DOI 10.1016/j.taap.2005.01.015; Zhang QW, 2005, J BIOL CHEM, V280, P73, DOI 10.1074/jbc.M409795200	71	59	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1628	1636		10.1074/jbc.M708622200	http://dx.doi.org/10.1074/jbc.M708622200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024956	hybrid			2022-12-27	WOS:000252282700049
J	Tavares-Carreon, F; Camacho-Villasana, Y; Zamudio-Ochoa, A; Shingu-Vazquez, M; Torres-Larios, A; Perez-Martinez, X				Tavares-Carreon, Faviola; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Shingu-Vazquez, Miguel; Torres-Larios, Alfredo; Perez-Martinez, Xochitl			The pentatricopeptide repeats present in pet309 are necessary for translation but not for stability of the mitochondrial COX1 mRNA in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; INNER MEMBRANE; CYTOCHROME-OXIDASE; REVEALS SIMILARITY; SHUTTLE VECTORS; IN-VIVO; PROTEIN; ARABIDOPSIS; ACTIVATOR	Pet309 is a protein essential for respiratory growth. It is involved in translation of the yeast mitochondrial COX1 gene, which encodes subunit I of the cytochrome c oxidase. Pet309 is also involved in stabilization of the COX1 mRNA. Mutations in a similar human protein, Lrp130, are associated with Leigh syndrome, where cytochrome c oxidase activity is affected. The sequence of Pet309 reveals the presence of at least seven pentatricopeptide repeats (PPRs) located in tandem in the central portion of the protein. Proteins containing PPR motifs are present in mitochondria and chloroplasts and are in general involved in RNA metabolism. Despite the increasing number of proteins from this family found to play essential roles in mitochondria and chloroplasts, little is understood about the mechanism of action of the PPR domains present in these proteins. In a series of in vivo analyses we constructed a pet309 mutant lacking the PPR motifs. Although the stability of the COX1 mRNA was not affected, synthesis of Cox1 was abolished. The deletion of one PPR motif at a time showed that all the PPR motifs are required for COX1 mRNA translation and respiratory growth. Mutations of basic residues in PPR3 caused reduced respiratory growth. According to a molecular model, these residues are facing a central cavity that could be involved in mRNA-binding activity, forming a possible path for this molecule on Pet309. Our results show that the RNA metabolism function of Pet309 is found in at least two separate domains of the protein.	[Tavares-Carreon, Faviola; Camacho-Villasana, Yolanda; Zamudio-Ochoa, Angelica; Shingu-Vazquez, Miguel; Torres-Larios, Alfredo; Perez-Martinez, Xochitl] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Martinez, X (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioquim, Circuito Exterior S-N,Ciudad Univ,Apartado Postal, Mexico City 04510, DF, Mexico.	xperez@ifc.unam.mx	Zamudio-Ochoa, Angelica/AAC-3684-2020	Zamudio-Ochoa, Angelica/0000-0002-6347-5789; Torres-Larios, Alfredo/0000-0002-0702-350X; Tavares-Carreon, Faviola/0000-0002-5914-6640				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Bentolila S, 2002, P NATL ACAD SCI USA, V99, P10887, DOI 10.1073/pnas.102301599; Bonnefoy N, 2001, MOL CELL BIOL, V21, P2359, DOI 10.1128/MCB.21.7.2359-2372.2001; BROWN NG, 1994, MOL CELL BIOL, V14, P1045, DOI 10.1128/MCB.14.2.1045; Coffin JW, 1997, CURR GENET, V32, P273, DOI 10.1007/s002940050277; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; DIECKMANN CL, 1994, INT REV CYTOL, V152, P145, DOI 10.1016/S0074-7696(08)62556-5; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Fiori A, 2005, MOL MICROBIOL, V56, P1689, DOI 10.1111/j.1365-2958.2005.04658.x; Fisk DG, 1999, EMBO J, V18, P2621, DOI 10.1093/emboj/18.9.2621; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gillman JD, 2007, PLANT J, V49, P217, DOI 10.1111/j.1365-313X.2006.02953.x; Glick BS, 1995, METHOD ENZYMOL, V260, P224, DOI 10.1016/0076-6879(95)60140-6; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Green-Willms NS, 2001, J BIOL CHEM, V276, P6392, DOI 10.1074/jbc.M009856200; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hattori M, 2007, J BIOL CHEM, V282, P10773, DOI 10.1074/jbc.M608034200; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahmy S, 2000, FEBS LETT, V480, P255, DOI 10.1016/S0014-5793(00)01935-9; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Manthey GM, 1998, EUR J BIOCHEM, V255, P156, DOI 10.1046/j.1432-1327.1998.2550156.x; Maslov DA, 2007, MOL BIOCHEM PARASIT, V152, P203, DOI 10.1016/j.molbiopara.2007.01.012; Meierhoff K, 2003, PLANT CELL, V15, P1480, DOI 10.1105/tpc.010397; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nakamura T, 2003, EUR J BIOCHEM, V270, P4070, DOI 10.1046/j.1432-1033.2003.03796.x; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; ROSE MD, 1988, METHODS YEAST GENETI; Sanchirico ME, 1998, EMBO J, V17, P5796, DOI 10.1093/emboj/17.19.5796; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P2791, DOI 10.1105/tpc.105.034454; Schmitz-Linneweber C, 2006, PLANT CELL, V18, P2650, DOI 10.1105/tpc.106.046110; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SHEN ZH, 1989, NUCLEIC ACIDS RES, V17, P4535, DOI 10.1093/nar/17.12.4535; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; SIKORSKI RS, 1989, GENETICS, V122, P19; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steele DF, 1996, P NATL ACAD SCI USA, V93, P5253, DOI 10.1073/pnas.93.11.5253; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Tzschoppe K, 2000, BIOL CHEM, V381, P1175, DOI 10.1515/BC.2000.145; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Williams EH, 2003, RNA, V9, P419, DOI 10.1261/rna.2182903; Williams PM, 2003, PLANT J, V36, P675, DOI 10.1046/j.1365-313X.2003.01915.x; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; YAFFE MP, 1991, METHOD ENZYMOL, V194, P627; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	63	68	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1472	1479		10.1074/jbc.M708437200	http://dx.doi.org/10.1074/jbc.M708437200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18039654	hybrid			2022-12-27	WOS:000252282700031
J	Mac, TT; von Hacht, A; Hung, KC; Dutton, RJ; Boyd, D; Bardwell, JCA; Ulmer, TS				Mac, Thien-Thi; von Hacht, Annekathrin; Hung, Kuo-Chan; Dutton, Rachel J.; Boyd, Dana; Bardwell, James C. A.; Ulmer, Tobias S.			Insight into disulfide bond catalysis in Chlamydia from the structure and function of DsbH, a novel oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; HUMAN THIOREDOXIN; CHEMICAL-SHIFT; NMR STRUCTURES; PROTEIN; ISOMERASE; DYNAMICS; REVEALS; PEPTIDE	The Chlamydia family of human pathogens uses outer envelope proteins that are highly cross-linked by disulfide bonds but nevertheless keeps an unusually high number of unpaired cysteines in its secreted proteins. To gain insight into chlamydial disulfide bond catalysis, the structure, function, and substrate interaction of a novel periplasmic oxidoreductase, termed DsbH, were determined. The structure of DsbH, its redox potential of -269 mV, and its functional properties are similar to thioredoxin and the C-terminal domain of DsbD, i.e.characteristic of a disulfide reductase. As compared with these proteins, the two central residues of the DsbH catalytic motif (CMWC) shield the catalytic disulfide bond and are selectively perturbed by a peptide ligand. This shows that these oxidoreductase family characteristic residues are not only important in determining the redox potential of the catalytic disulfide bond but also in influencing substrate interactions. For DsbH, three functional roles are conceivable; that is, reducing intermolecular disulfides between proteins and small molecules, keeping a specific subset of exported proteins reduced, or maintaining the periplasm of Chlamydia in a generally reducing state.	[Mac, Thien-Thi; Hung, Kuo-Chan; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Mac, Thien-Thi; Hung, Kuo-Chan; Ulmer, Tobias S.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [von Hacht, Annekathrin; Bardwell, James C. A.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [von Hacht, Annekathrin; Bardwell, James C. A.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Dutton, Rachel J.; Boyd, Dana] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	University of Southern California; University of Southern California; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School	Ulmer, TS (corresponding author), 1501 San Pablo St,ZNI 111, Los Angeles, CA 90033 USA.	tulmer@usc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM041883] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bessette PH, 1999, J BIOL CHEM, V274, P7784, DOI 10.1074/jbc.274.12.7784; Chou JJ, 2000, J BIOMOL NMR, V18, P101, DOI 10.1023/A:1008358318863; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Collet JF, 2002, J BIOL CHEM, V277, P26886, DOI 10.1074/jbc.M203028200; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n; EVERETT KDE, 1995, J BACTERIOL, V177, P877, DOI 10.1128/jb.177.4.877-882.1995; Fabianek RA, 2000, FEMS MICROBIOL REV, V24, P303, DOI 10.1111/j.1574-6976.2000.tb00544.x; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gehring K, 1998, J MAGN RESON, V135, P185, DOI 10.1006/jmre.1998.1543; Glockshuber R, 1999, NATURE, V401, P30, DOI 10.1038/43344; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Grayston JT, 2000, J INFECT DIS, V181, pS402, DOI 10.1086/315596; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Grove J, 1996, MOL GEN GENET, V252, P332; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hatch TP, 1996, J BACTERIOL, V178, P1; Hu JS, 1997, J AM CHEM SOC, V119, P1803, DOI 10.1021/ja963625z; Inaba K, 2006, P NATL ACAD SCI USA, V103, P287, DOI 10.1073/pnas.0507570103; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jaroniec CP, 2004, J BIOMOL NMR, V30, P181, DOI 10.1023/B:JNMR.0000048946.71249.2f; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; Kuszewski J, 1999, J AM CHEM SOC, V121, P2337, DOI 10.1021/ja9843730; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; MISSIAKAS D, 1993, P NATL ACAD SCI USA, V90, P7084, DOI 10.1073/pnas.90.15.7084; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; OWENS RA, 1986, J BACTERIOL, V168, P109, DOI 10.1128/jb.168.1.109-114.1986; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pan JL, 2006, PROTEIN SCI, V15, P2217, DOI 10.1110/ps.062268106; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Pittman MS, 2002, J BIOL CHEM, V277, P49841, DOI 10.1074/jbc.M205615200; QIN J, 1995, STRUCTURE, V3, P289, DOI 10.1016/S0969-2126(01)00159-9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Rietsch A, 1997, J BACTERIOL, V179, P6602, DOI 10.1128/jb.179.21.6602-6608.1997; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; Sako T, 2002, ATHEROSCLEROSIS, V162, P253, DOI 10.1016/S0021-9150(01)00710-9; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Segatori L, 2006, J BIOL CHEM, V281, P4911, DOI 10.1074/jbc.M505453200; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	57	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					824	832		10.1074/jbc.M707863200	http://dx.doi.org/10.1074/jbc.M707863200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003611	hybrid			2022-12-27	WOS:000252128100022
J	Sundaram, S; Rathinasabapathi, B; Ma, LQ; Rosen, BP				Sundaram, Sabarinath; Rathinasabapathi, Bala; Ma, Lena Q.; Rosen, Barry P.			An arsenate-activated glutaredoxin from the arsenic hyperaccumulator fern Pteris vittata L. regulates intracellular arsenite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; TRANSPORT; THIOREDOXIN; PROTECTION; STRESS	To elucidate the mechanisms of arsenic resistance in the arsenic hyperaccumulator fern Pteris vittata L., a cDNA for a glutaredoxin (Grx) Pv5-6 was isolated from a frond expression cDNA library based on the ability of the cDNA to increase arsenic resistance in Escherichia coli. The deduced amino acid sequence of Pv5-6 showed high homology with an Arabidopsis chloroplastic Grx and contained two CXXS putative catalytic motifs. Purified recombinant Pv5-6 exhibited glutaredoxin activity that was increased 1.6-fold by 10mM arsenate. Site-specific mutation of Cys(67) to Ala(67) resulted in the loss of both GRX activity and arsenic resistance. PvGrx5 was expressed in E. coli mutants in which the arsenic resistance genes of the ars operon were deleted (strain AW3110), a deletion of the gene for the ArsC arsenate reductase (strain WC3110), and a strain in which the ars operon was deleted and the gene for the GlpF aquaglyceroporin was disrupted (strain OSBR1). Expression of PvGrx5 increased arsenic tolerance in strains AW3110 and WC3110, but not in OSBR1, suggesting that PvGrx5 had a role in cellular arsenic resistance independent of the ars operon genes but dependent on GlpF. AW3110 cells expressing PvGrx5 had significantly lower levels of arsenite when compared with vector controls when cultured in medium containing 2.5 mM arsenate. Our results are consistent with PvGrx5 having a role in regulating intracellular arsenite levels, by either directly or indirectly modulating the aquaglyceroporin. To our knowledge, PvGrx5 is the first plant Grx implicated in arsenic metabolism.	[Sundaram, Sabarinath; Rathinasabapathi, Bala] Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; [Ma, Lena Q.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Wayne State University	Rathinasabapathi, B (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA.	brath@ufl.edu	Rathinasabapathi, Bala/I-5811-2019; Ma, Lena Q/E-5854-2010; sundaram, sabarinath/E-2405-2011; sundaram, sabarinath/A-8806-2012	Rathinasabapathi, Bala/0000-0002-7867-465X; Ma, Lena Q/0000-0002-8463-9957; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052216] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 52216] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caille N, 2004, ENVIRON POLLUT, V132, P113, DOI 10.1016/j.envpol.2004.03.018; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Chen M, 1998, J ENVIRON QUAL, V27, P1294, DOI 10.2134/jeq1998.00472425002700060004x; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, J BIOL CHEM, V278, P6503, DOI 10.1074/jbc.M210883200; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Elless MP, 2005, WATER RES, V39, P3863, DOI 10.1016/j.watres.2005.07.029; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fouad WM, 2006, PLANT MOL BIOL, V60, P495, DOI 10.1007/s11103-005-4844-9; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Johanson U, 2002, MOL BIOL EVOL, V19, P456, DOI 10.1093/oxfordjournals.molbev.a004101; Kertulis GM, 2005, ENVIRON EXP BOT, V54, P239, DOI 10.1016/j.envexpbot.2004.09.001; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Liu ZJ, 2006, ENVIRON HEALTH PERSP, V114, P527, DOI 10.1289/ehp.8600; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Ma LQ, 2001, NATURE, V409, P579, DOI 10.1038/35054664; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Pickering IJ, 2006, ENVIRON SCI TECHNOL, V40, P5010, DOI 10.1021/es052559a; Poynton CY, 2004, PLANTA, V219, P1080, DOI 10.1007/s00425-004-1304-8; Rathinasabapathi B, 2006, PLANT MOL BIOL, V62, P845, DOI 10.1007/s11103-006-9060-8; Rathinasabapathi B, 2006, NEW PHYTOL, V172, P385, DOI 10.1111/j.1469-8137.2006.01889.x; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Shi HL, 2004, MOL CELL BIOCHEM, V255, P67, DOI 10.1023/B:MCBI.0000007262.26044.e8; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Singh N, 2006, PLANT SCI, V170, P274, DOI 10.1016/j.plantsci.2005.08.013; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Srivastava M, 2005, J EXP BOT, V56, P1335, DOI 10.1093/jxb/eri134; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tu C, 2002, J ENVIRON QUAL, V31, P1671, DOI 10.2134/jeq2002.1671; Tu S, 2004, INT J PHYTOREMEDIAT, V6, P35, DOI 10.1080/16226510490439972; WANG J, 2002, PLANT PHYSIOL, V130, P1; Xing SP, 2005, DEVELOPMENT, V132, P1555, DOI 10.1242/dev.01725; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005	47	66	72	3	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6095	6101		10.1074/jbc.M704149200	http://dx.doi.org/10.1074/jbc.M704149200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156657	hybrid			2022-12-27	WOS:000253779500015
J	Urs, NM; Kowalczyk, AP; Radhakrishna, H				Urs, Nikhil M.; Kowalczyk, Andrew P.; Radhakrishna, Harish			Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA(1) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN-MEDIATED ENDOCYTOSIS; KINASE-C; BETA-ARRESTIN; ACTIVATED RECEPTOR-1; CARBOXYL-TERMINUS; TRAFFICKING; CELLS; PHOSPHORYLATION; DESENSITIZATION	Lysophosphatidic acid (LPA) stimulates cells by activation of five G-protein-coupled receptors, termed LPA(1-5). The LPA(1) receptor is the most widely expressed and is a major regulator of cell migration. In this study, we show that phorbol ester (PMA)-induced internalization of the LPA(1) receptor requires clathrin AP-2 complexes, protein kinase C, and a distal dileucine motif (amino acids 352 and 353) in the cytoplasmic tail but not beta-arrestin. Agonist-dependent internalization of LPA(1), however, requires a cluster of serine residues (amino acids 341-347) located proximal to the dileucine motif, beta-arrestin, and to a lesser extent clathrin AP-2. The serine cluster of LPA(1) is required for beta-arrestin2-GFP translocation to the plasma membrane and signal desensitization. In contrast, the dileucine motif (IL) is required for both basal and PMA-induced internalization. Evidence for the beta-arrestin independence of PMA-induced internalization of LPA(1) comes from the observations that beta-arrestin2-GFP is not recruited to the plasma membrane upon PMA treatment and that LPA(1) is readily internalized in beta-arrestin1/2 knock-out mouse embryonic fibroblasts. These results indicate that distinct molecular mechanisms regulate agonist-dependent and PMA-dependent internalization of the LPA(1) receptor.	[Urs, Nikhil M.; Radhakrishna, Harish] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kowalczyk, Andrew P.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Radhakrishna, H (corresponding author), Coca Cola Co, One Coca-Cola Plaza,TEC-437, Atlanta, GA 30301 USA.	hradha@earthlink.net			NHLBI NIH HHS [HL 67314] Funding Source: Medline; NIAMS NIH HHS [AR 050501] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050501] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ally RA, 2003, MOL PHARMACOL, V64, P890, DOI 10.1124/mol.64.4.890; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Avendano-Vazquez SEA, 2005, BIOCHEM J, V385, P677, DOI 10.1042/BJ20040891; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Droese J, 2004, BIOCHEM BIOPH RES CO, V322, P42, DOI 10.1016/j.bbrc.2004.07.076; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	45	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5249	5257		10.1074/jbc.M710003200	http://dx.doi.org/10.1074/jbc.M710003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089565	hybrid			2022-12-27	WOS:000253426700004
J	Campo, N; Marquis, KA; Rudner, DZ				Campo, Nathalie; Marquis, Kathleen A.; Rudner, David Z.			SpoIIQ anchors membrane proteins on both sides of the sporulation septum in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; CELL-SPECIFIC TRANSCRIPTION; SUBCELLULAR-LOCALIZATION; ASYMMETRIC DIVISION; GENE-EXPRESSION; ACTIVATION; FTSZ; PHOSPHATASE; ENGULFMENT; FORESPORE	During the process of spore formation in Bacillus subtilis, many membrane proteins localize to the polar septum where they participate in morphogenesis and signal transduction. The forespore membrane protein SpoIIQ plays a central role in anchoring several mother-cell membrane proteins in the septal membrane. Here, we report that SpoIIQ is also responsible for anchoring a membrane protein on the forespore side of the sporulation septum. Co-immunoprecipitation experiments reveal that SpoIIQ resides in a complex with the polytopic membrane protein SpoIIE. During the early stages of sporulation, SpoIIE participates in the switch from medial to polar division and co-localizes with FtsZ at the polar septum. We show that after cytokinesis, SpoIIE is released from the septum and transiently localizes to all membranes in the forespore compartment. Upon the initiation of engulfment, it specifically re-localizes to the septal membrane on the forespore side. Importantly, the re-localization of SpoIIE to the engulfing septum requires SpoIIQ. These results indicate that SpoIIQ is required to anchor membrane proteins on both sides of the division septum. Moreover, our data suggest that forespore membrane proteins can localize to the septal membrane by diffusion-and-capture as has been described for membrane proteins in the mother cell. Finally, our results raise the intriguing possibility that SpoIIE has an uncharacterized function at a late stage of sporulation.	[Campo, Nathalie; Marquis, Kathleen A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rudner, DZ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	rudner@hms.harvard.edu	Campo, Nathalie/GYU-6339-2022		NIGMS NIH HHS [GM073831-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Campo N, 2007, J BACTERIOL, V189, P6021, DOI 10.1128/JB.00399-07; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; Doan T, 2007, MOL MICROBIOL, V64, P500, DOI 10.1111/j.1365-2958.2007.05677.x; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Harwood C.R., 1990, MOL BIOL METHODS BAC; Jiang X, 2005, MOL MICROBIOL, V58, P102, DOI 10.1111/j.1365-2958.2005.04811.x; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Khvorova A, 1998, J BACTERIOL, V180, P1256, DOI 10.1128/JB.180.5.1256-1260.1998; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lewis PJ, 1998, J BACTERIOL, V180, P3276, DOI 10.1128/JB.180.13.3276-3284.1998; Resnekov O, 1998, P NATL ACAD SCI USA, V95, P3162, DOI 10.1073/pnas.95.6.3162; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Wu LJ, 1998, GENE DEV, V12, P1371, DOI 10.1101/gad.12.9.1371; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	41	33	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4975	4982		10.1074/jbc.M708024200	http://dx.doi.org/10.1074/jbc.M708024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077456	hybrid			2022-12-27	WOS:000253426500055
J	Jarboe, LR; Hyduke, DR; Tran, LM; Chou, KJY; Liao, JC				Jarboe, Laura R.; Hyduke, Daniel R.; Tran, Linh M.; Chou, Katherine J. Y.; Liao, James C.			Determination of the Escherichia coli S-nitrosoglutathione response network using integrated biochemical and systems analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL NETWORKS; METHIONINE BIOSYNTHESIS; REGULATORY ACTIVITIES; COMPONENT ANALYSIS; GROWTH-CONDITIONS; NITROGEN-OXIDES; GENE-EXPRESSION; IN-VIVO	During infection or denitrification, bacteria encounter reactive nitrogen species. Although the molecular targets of and defensive response against nitric oxide (NO) in Escherichia coli are well studied, the response elements specific to S-nitrosothiols are less clear. Previously, we employed an integrated systems biology approach to unravel the E. coli NO-response network. Here we use a similar approach to confirm that S-nitrosoglutathione (GSNO) primarily impacts the metabolic and regulatory programs of E. coli in minimal medium by reaction with homocysteine and cysteine and subsequent disruption of the methionine biosynthesis pathway. Targeting of homocysteine and cysteine results in altered regulatory activity of MetJ, MetR, and CysB, activation of the stringent response and growth inhibition. Deletion of metJ or supplementation with methionine strongly attenuated the effect of GSNO on growth and gene expression. Furthermore, GSNO inhibited the ArcAB two-component system. Consistent with the underlying nitrosative and thiol-oxidative chemistry, growth inhibition and the majority of the regulatory perturbations were dependent upon GSNO internalization by the Dpp dipeptide transporter. Contrastingly, perturbation of NsrR appeared to be a result of the submicromolar levels of NO released from GSNO and did not require GSNO internalization.	[Jarboe, Laura R.; Hyduke, Daniel R.; Tran, Linh M.; Chou, Katherine J. Y.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Liao, JC (corresponding author), 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076143] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM076143] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; COTTER PA, 1992, FEMS MICROBIOL LETT, V91, P31; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; da Costa PN, 2003, FEMS MICROBIOL LETT, V218, P385, DOI 10.1016/S0378-1097(02)01186-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Dicks A.P., 1996, J CHEM SOC PERK T, V4, P481; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Galbraith SJ, 2006, BIOINFORMATICS, V22, P1886, DOI 10.1093/bioinformatics/btl279; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gow AJ, 1997, J BIOL CHEM, V272, P2841, DOI 10.1074/jbc.272.5.2841; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; LEE LW, 1966, J BIOL CHEM, V241, P5479; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MALOY S, 1989, EXPT TECHNIQUES BACT; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Mancardi D, 2004, CURR MOL MED, V4, P723, DOI 10.2174/1566524043359854; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; SHOEMAN R, 1985, P NATL ACAD SCI USA, V82, P3601, DOI 10.1073/pnas.82.11.3601; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Stamler JS, 1999, CORONARY ARTERY DIS, V10, P273, DOI 10.1097/00019501-199907000-00001; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; TAUXE RV, 1991, LAB MED, V22, P55; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tsikas D, 1999, ANAL BIOCHEM, V270, P231, DOI 10.1006/abio.1999.4084; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Wanner B.L., 1994, METH MOL G, V3, P291; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6	53	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5148	5157		10.1074/jbc.M706018200	http://dx.doi.org/10.1074/jbc.M706018200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18070885	hybrid			2022-12-27	WOS:000253426500072
J	Noor, S; Goldfine, H; Tucker, DE; Suram, S; Lenz, LL; Akira, S; Uematsu, S; Girotti, M; Bonventre, JV; Breuel, K; Williams, DL; Leslie, CC				Noor, Shahid; Goldfine, Howard; Tucker, Dawn E.; Suram, Saritha; Lenz, Laurel L.; Akira, Shizuo; Uematsu, Satoshi; Girotti, Milena; Bonventre, Joseph V.; Breuel, Kevin; Williams, David L.; Leslie, Christina C.			Activation of cytosolic phospholipase A(2)alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-A; TNF-ALPHA; PHOSPHOINOSITIDE 3-KINASE; INTRACELLULAR GROWTH; DIFFERENTIAL ROLES; CYTOKINE RELEASE; GENE-EXPRESSION; CELL ACTIVATION	Eicosanoid production by macrophages is an early response to microbial infection that promotes acute inflammation. The intracellular pathogen Listeria monocytogenes stimulates arachidonic acid release and eicosanoid production from resident mouse peritoneal macrophages through activation of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha). The ability of wild type L. monocytogenes (WTLM) to stimulate arachidonic acid release is partially dependent on the virulence factor listeriolysin O; however, WTLM and L. monocytogenes lacking listeriolysin O (Delta hlyLM) induce similar levels of cyclooxygenase 2. Arachidonic acid release requires activation of MAPKs by WTLM and Delta hlyLM. The attenuated release of arachidonic acid that is observed in TLR2(-/-) and MyD88(-/-) macrophages infected with WTLM and Delta hlyLM correlates with diminished MAPK activation. WTLM but not Delta hlyLM increases intracellular calcium, which is implicated in regulation of cPLA(2)alpha. Prostaglandin E-2, prostaglandin I-2, and leukotriene C-4 are produced by cPLA(2)alpha(+/+) but not cPLA(2)alpha(-/-) macrophages in response to WTLM and Delta hlyLM. Tumor necrosis factor (TNF)-alpha production is significantly lower in cPLA(2)alpha(+/+) than in cPLA(2)alpha(-/-) macrophages infected with WTLM and Delta hlyLM. Treatment of infected cPLA(2)alpha(+/+) macrophages with the cyclooxygenase inhibitor indomethacin increases TNF alpha production to the level produced by cPLA(2)alpha(-/-) macrophages implicating prostaglandins in TNF alpha down-regulation. Therefore activation of cPLA(2)alpha in macrophages may impact immune responses to L. monocytogenes.	[Noor, Shahid; Tucker, Dawn E.; Suram, Saritha; Leslie, Christina C.] Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA; [Lenz, Laurel L.] Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; [Goldfine, Howard] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Girotti, Milena] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Breuel, Kevin] ETSU Phys & Assoc, ETSU Clin Labs, Johnson City, TN 37604 USA; [Williams, David L.] James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Leslie, Christina C.] Univ Colorado, Sch Med, Dept Pathol & Pharmacol, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; University of Pennsylvania; Osaka University; University of Colorado System; University of Colorado Boulder; Harvard University; Brigham & Women's Hospital; East Tennessee State University; East Tennessee State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njc.org	Akira, Shizuo/C-3134-2009; Goldfine, Howard/AAB-8097-2020	Lenz, Laurel/0000-0002-4933-8913	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065638, R56AI065638] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34303, P01 HL034303] Funding Source: Medline; NIAID NIH HHS [AI065638, R56 AI065638, R01 AI065638, R01 AI065638-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; DREVETS DA, 1994, INFECT IMMUN, V62, P2222, DOI 10.1128/IAI.62.6.2222-2228.1994; DUSSURGET O, 2004, ANNU REV MICROBIOL, V58, P611; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fennekohl A, 2002, J HEPATOL, V36, P328, DOI 10.1016/S0168-8278(01)00277-X; FIEREN MWJA, 1992, IMMUNOL LETT, V31, P85, DOI 10.1016/0165-2478(92)90015-G; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Goldfine H, 2002, MICROBES INFECT, V4, P1335, DOI 10.1016/S1286-4579(02)00011-4; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Humann J, 2007, J IMMUNOL, V178, P2407, DOI 10.4049/jimmunol.178.4.2407; HUTCHISON DL, 1987, CELL IMMUNOL, V110, P68, DOI 10.1016/0008-8749(87)90102-X; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mansell A, 2001, J BIOL CHEM, V276, P43597, DOI 10.1074/jbc.M105202200; MARCINKIEWICZ J, 1991, CYTOKINE, V3, P327, DOI 10.1016/1043-4666(91)90501-4; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; PETIT JC, 1985, INFECT IMMUN, V49, P383, DOI 10.1128/IAI.49.2.383-388.1985; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; ROLAND CR, 1994, ANN SURG, V219, P389, DOI 10.1097/00000658-199404000-00010; Rose F, 2001, INFECT IMMUN, V69, P897, DOI 10.1128/IAI.69.2.897-905.2001; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Sawyer RT, 1996, J LEUKOCYTE BIOL, V60, P603, DOI 10.1002/jlb.60.5.603; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Sibelius U, 1999, INFECT IMMUN, V67, P1125, DOI 10.1128/IAI.67.3.1125-1130.1999; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang P, 1996, INFECT IMMUN, V64, P2359, DOI 10.1128/IAI.64.6.2359-2361.1996; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; TRIPP CS, 1987, J CLIN INVEST, V79, P399, DOI 10.1172/JCI112825; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Weiglein I, 1997, FEMS MICROBIOL LETT, V148, P189, DOI 10.1016/S0378-1097(97)00032-3; Wing MG, 1999, J NEUROIMMUNOL, V94, P74, DOI 10.1016/S0165-5728(98)00227-6; ZHONG WW, 1995, IMMUNOLOGY, V84, P446	86	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4744	4755		10.1074/jbc.M709956200	http://dx.doi.org/10.1074/jbc.M709956200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083708	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000253426500032
J	Pham, LV; Zhou, HJ; Lin-Lee, YC; Tamayo, AT; Yoshimura, LC; Fu, LC; Darnay, BG; Ford, RJ				Pham, Lan V.; Zhou, Hai-Jun; Lin-Lee, Yen-Chiu; Tamayo, Archito T.; Yoshimura, Linda C.; Fu, Lingchen; Darnay, Bryant G.; Ford, Richard J.			Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-myb-mediated transactivation through small ubiquitin-related modifier-1 modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SUMO MODIFICATION; EXPORT SIGNAL; LOCALIZATION; PROTEIN; TRAF6; ACTIVATION; TRANSCRIPTION; STIMULATION; MECHANISMS	Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an adaptor/scaffold protein that mediates several important signaling pathways, including the tumor necrosis factor-R:NF-kappa B pathway, involved in immune surveillance, inflammation, etc. Because most studies of TRAF6 function have focused primarily on its role as an adaptor molecule in signaling pathways in the cytoplasm, the potential functions of TRAF6 in other cellular compartments has not been previously investigated. Here, we demonstrate that TRAF6 resides not only in the cellular cytoplasm but is also found in the nuclei of both normal and malignant B lymphocytes. TRAF6 does not possess a nuclear localization signal but enters the nucleus through the nuclear pore complex containing RanGap1. Chromatin immunoprecipitation cloning experiments demonstrated that nuclear TRAF6 associates with c-Myb within the 5'-end of the c-Myb promoter. Further analysis showed that nuclear TRAF6 is modified by small ubiquitin-related modifier-1, interacts with histone deacetylase 1, and represses c-Myb-mediated transactivation. Thus, TRAF6negatively regulates c-Myb through a novel repressor function in the nuclei of both normal and malignant B-lymphocytes that could represent a novel control mechanism that maintains cell homeostasis and immune surveillance.	[Pham, Lan V.; Zhou, Hai-Jun; Lin-Lee, Yen-Chiu; Tamayo, Archito T.; Yoshimura, Linda C.; Fu, Lingchen; Ford, Richard J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematol, Houston, TX 77030 USA; [Darnay, Bryant G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Ford, RJ (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematol, Box 54,1515 Holcombe Blvd, Houston, TX 77030 USA.	rford@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA100836, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16672-26, CA-R01-100836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Fu SL, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-54; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Glauner H, 2002, EUR J BIOCHEM, V269, P4819, DOI 10.1046/j.1432-1033.2002.03180.x; Gonda TJ, 1996, CURR TOP MICROBIOL, V211, P99; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lauder A, 2001, MOL CELL BIOL, V21, P5797, DOI 10.1128/MCB.21.17.5797-5805.2001; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; Liu BH, 2007, BIOCHEM BIOPH RES CO, V358, P136, DOI 10.1016/j.bbrc.2007.04.097; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Min W, 1998, J IMMUNOL, V161, P319; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Pham LV, 2003, J IMMUNOL, V171, P88, DOI 10.4049/jimmunol.171.1.88; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weston K, 1999, ONCOGENE, V18, P3034, DOI 10.1038/sj.onc.1202728; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	44	22	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5081	5089		10.1074/jbc.M706307200	http://dx.doi.org/10.1074/jbc.M706307200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093978	hybrid			2022-12-27	WOS:000253426500065
J	Richards, JD; Johnson, KA; Liu, H; McRobbie, AM; McMahon, S; Oke, M; Carter, L; Naismith, JH; White, MF				Richards, Jodi D.; Johnson, Kenneth A.; Liu, Huanting; McRobbie, Anne-Marie; McMahon, Stephen; Oke, Muse; Carter, Lester; Naismith, James H.; White, Malcolm F.			Structure of the DNA repair helicase Hel308 reveals DNA binding and autoinhibitory domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; SULFOLOBUS-SOLFATARICUS; FLUORESCENCE POLARIZATION; ESCHERICHIA-COLI; PROTEIN; POLYMERASE; OLIGONUCLEOTIDES; ENDONUCLEASE; DISPLACEMENT	Hel308 is a superfamily 2 helicase conserved in eukaryotes and archaea. It is thought to function in the early stages of recombination following replication fork arrest and has a specificity for removal of the lagging strand in model replication forks. A homologous helicase constitutes the N-terminal domain of human DNA polymerase Q. The Drosophila homologue mus301 is implicated in double strand break repair and meiotic recombination. We have solved the high resolution crystal structure of Hel308 from the cre-narchaeon Sulfolobus solfataricus, revealing a five-domain structure with a central pore lined with essential DNA binding residues. The fifth domain is shown to act as an autoinhibitory domain or molecular brake, clamping the single-stranded DNA extruded through the central pore of the helicase structure to limit the helicase activity of the enzyme. This provides an elegant mechanism to tune the processivity of the enzyme to its functional role. Hel308 can displace streptavidin from a biotinylated DNA molecule, and this activity is only partially inhibited when the DNA is pre-bound with abundant DNA-binding proteins RPA or Alba1, whereas pre-binding with the recombinase RadA has no effect on activity. These data suggest that one function of the enzyme may be in the removal of bound proteins at stalled replication forks and recombination intermediates.	[Richards, Jodi D.; Johnson, Kenneth A.; Liu, Huanting; McRobbie, Anne-Marie; McMahon, Stephen; Oke, Muse; Carter, Lester; Naismith, James H.; White, Malcolm F.] Univ St Andrews, Ctr Biomed Sci, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Naismith, JH (corresponding author), Univ St Andrews, Ctr Biomed Sci, St Andrews KY16 9ST, Fife, Scotland.	jhn@st-and.ac.uk; mfw2@st-and.ac.uk	White, Malcolm F/A-6055-2010; Naismith, James Henderson/AAB-8614-2020; Carter, Lester/G-6561-2014; Naismith, James Henderson/H-3408-2012	White, Malcolm F/0000-0003-1543-9342; Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Oke, Muse/0000-0002-0169-752X	Biotechnology and Biological Sciences Research Council [BBS/B/14426] Funding Source: Medline; Medical Research Council [G0500367] Funding Source: Medline; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ariza A, 2005, NUCLEIC ACIDS RES, V33, P1465, DOI 10.1093/nar/gki288; BOYD JB, 1976, GENETICS, V84, P485; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2006, NUCLEIC ACIDS RES, V34, P3020, DOI 10.1093/nar/gkl369; Cowtan K, 2001, ACTA CRYSTALLOGR D, V57, P1435, DOI 10.1107/S0907444901010812; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Fujikane R, 2006, GENES CELLS, V11, P99, DOI 10.1111/j.1365-2443.2006.00925.x; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hanada K, 2007, CELL MOL LIFE SCI, V64, P2306, DOI 10.1007/s00018-007-7121-z; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Jelinska C, 2005, STRUCTURE, V13, P963, DOI 10.1016/j.str.2005.04.016; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvaratskhelia M, 2000, J MOL BIOL, V295, P193, DOI 10.1006/jmbi.1999.3363; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Marini F, 2002, J BIOL CHEM, V277, P8716, DOI 10.1074/jbc.M110271200; Marsh VL, 2006, J MOL BIOL, V357, P1345, DOI 10.1016/j.jmb.2006.01.074; McCaffrey R, 2006, GENETICS, V174, P1273, DOI 10.1534/genetics.106.058289; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Morris PD, 1999, BIOCHEMISTRY-US, V38, P5164, DOI 10.1021/bi9822269; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Roberts JA, 2005, J BIOL CHEM, V280, P5924, DOI 10.1074/jbc.M412766200; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seki M, 2003, NUCLEIC ACIDS RES, V31, P6117, DOI 10.1093/nar/gkg814; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Wang H, 2006, J BIOL CHEM, V281, P15227, DOI 10.1074/jbc.M601476200; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	46	69	83	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5118	5126		10.1074/jbc.M707548200	http://dx.doi.org/10.1074/jbc.M707548200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18056710	Green Accepted, hybrid			2022-12-27	WOS:000253426500069
J	Bessiere, D; Lacroix, C; Campagne, S; Ecochard, V; Guillet, V; Mourey, L; Lopez, F; Czaplicki, J; Demange, P; Milon, A; Girard, JP; Gervais, V				Bessiere, Damien; Lacroix, Chrystelle; Campagne, Sebastien; Ecochard, Vincent; Guillet, Valerie; Mourey, Lionel; Lopez, Frederic; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Girard, Jean-Philippe; Gervais, Virginie			Structure-function analysis of the THAP zinc finger of THAP1, a large C2CH DNA-binding module linked to Rb/E2F pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-ELEMENT TRANSPOSASE; SYNTHETIC MULTIVULVA GENES; CAENORHABDITIS-ELEGANS; C-ELEGANS; CLASS-B; CELL-PROLIFERATION; CHEMICAL-SHIFT; TARGET GENES; PROTEIN; DOMAIN	THAP1, the founding member of a previously uncharacterized large family of cellular proteins (THAP proteins), is a sequence-specific DNA-binding factor that has recently been shown to regulate cell proliferation through modulation of pRb/ E2F cell cycle target genes. THAP1 shares its DNA-binding THAP zinc finger domain with Drosophila P element transposase, zebrafish E2F6, and several nematode proteins interacting genetically with the retinoblastoma protein pRb. In this study, we report the three-dimensional structure and structure-function relationships of the THAP zinc finger of human THAP1. Deletion mutagenesis and multidimensional NMR spectroscopy revealed that the THAP domain of THAP1 is an atypical zinc finger of similar to 80 residues, distinguished by the presence between the C2CH zinc coordinating residues of a short antiparallel beta-sheet interspersed by a long loop-helix-loop insertion. Alanine scanning mutagenesis of this loop-helix-loop motif resulted in the identification of a number of critical residues for DNA recognition. NMR chemical shift perturbation analysis was used to further characterize the residues involved in DNA binding. The combination of the mutagenesis and NMR data allowed the mapping of the DNA binding interface of the THAP zinc finger to a highly positively charged area harboring multiple lysine and arginine residues. Together, these data represent the first structure-function analysis of a functional THAP domain, with demonstrated sequence-specific DNA binding activity. They also provide a structural framework for understanding DNA recognition by this atypical zinc finger, which defines a novel family of cellular factors linked to cell proliferation and pRb/E2F cell cycle pathways in humans, fish, and nematodes.	[Bessiere, Damien; Lacroix, Chrystelle; Campagne, Sebastien; Ecochard, Vincent; Guillet, Valerie; Mourey, Lionel; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Girard, Jean-Philippe; Gervais, Virginie] Univ Toulouse, Inst Pharmacol & Struct Biol, CNRS, F-31077 Toulouse, France; [Bessiere, Damien; Campagne, Sebastien; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Gervais, Virginie] IPBS CNRS UPS, Lab NMR & Prot Membrane Interact, F-31077 Toulouse, France; [Lacroix, Chrystelle; Ecochard, Vincent; Girard, Jean-Philippe] IPBS CNRS UPS, Lab Vasc Biol, F-31077 Toulouse, France; [Guillet, Valerie; Mourey, Lionel] IPBS CNRS UPS, Lab Struct Biophys, F-31077 Toulouse, France; [Lopez, Frederic] CHU Rangueil, INSERM, IFR 31, F-31059 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Girard, JP (corresponding author), Univ Toulouse, Inst Pharmacol & Struct Biol, CNRS, F-31077 Toulouse, France.	jean-philippe.girard@ipbs.fr; virginie.gervais@ipbs.fr	MILON, Alain/B-3767-2010; GIRARD, Jean-Philippe/F-5229-2010; Czaplicki, Georges/ABC-7047-2020; demange, pascal JP/U-3561-2018; Mourey, Lionel/B-5662-2009; Guillet, Valérie/C-6058-2011	MILON, Alain/0000-0001-5692-8201; GIRARD, Jean-Philippe/0000-0002-9154-1691; Czaplicki, Georges/0000-0001-5348-4107; demange, pascal JP/0000-0002-9572-9990; Mourey, Lionel/0000-0002-8259-1259; Sebastien, Campagne/0000-0002-0094-4760; Gervais, Virginie/0000-0002-1144-6185				Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Billeter M, 1995, J BIOMOL NMR, V5, P1; Boxem M, 2002, CURR BIOL, V12, P906, DOI 10.1016/S0960-9822(02)00844-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Chesney MA, 2006, GENETICS, V172, P915, DOI 10.1534/genetics.105.048751; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAIKUN GP, 1986, NATURE, V324, P688; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; FERGUSON EL, 1989, GENETICS, V123, P109; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Hammer SE, 2005, MOL BIOL EVOL, V22, P833, DOI 10.1093/molbev/msi068; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Jauch R, 2003, STRUCTURE, V11, P1393, DOI 10.1016/j.str.2003.09.015; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAUFMAN PD, 1989, CELL, V59, P359, DOI 10.1016/0092-8674(89)90297-3; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Koreth J, 2005, ONCOGENE, V24, P2756, DOI 10.1038/sj.onc.1208607; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CC, 1998, EMBO J, V17, P4166, DOI 10.1093/emboj/17.14.4166; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Liew CK, 2007, J MOL BIOL, V366, P382, DOI 10.1016/j.jmb.2006.11.058; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Ponstingl H, 1998, J BIOMOL NMR, V12, P319, DOI 10.1023/A:1008293016073; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; Thomas JH, 1999, DEVELOPMENT, V126, P3449; WUTHRICH K, 1986, NMR PROTEINS NUCLEIC, P122	45	62	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4352	4363		10.1074/jbc.M707537200	http://dx.doi.org/10.1074/jbc.M707537200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073205	Green Published, hybrid			2022-12-27	WOS:000253083500070
J	Sampath, V; Balakrishnan, B; Verma-Gaur, J; Onesti, S; Sadhale, PP				Sampath, Vinaya; Balakrishnan, Bindu; Verma-Gaur, Jiyoti; Onesti, Silvia; Sadhale, Parag P.			Unstructured N terminus of the RNA polymerase II subunit Rpb4 contributes to the interaction of Rpb4 center dot Rpb7 subcomplex with the core RNA polymerase II of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2 DISSOCIABLE SUBUNITS; FUNCTIONAL CONSERVATION; NONESSENTIAL SUBUNIT; STRESS SURVIVAL; IN-VITRO; YEAST; TRANSCRIPTION; INITIATION; ORGANIZATION; TEMPERATURE	Two subunits of eukaryotic RNA polymerase II, Rpb7 and Rpb4, form a subcomplex that has counterparts in RNA polymerases I and III. Although a medium resolution structure has been solved for the 12-subunit RNA polymerase II, the relative contributions of the contact regions between the subcomplex and the core polymerase and the consequences of disrupting them have not been studied in detail. We have identified mutations in the N-terminal ribonucleoprotein-like domain of Saccharomyces cerevisiae Rpb7 that affect its role in certain stress responses, such as growth at high temperature and sporulation. These mutations increase the dependence of Rpb7 on Rpb4 for interaction with the rest of the polymerase. Complementation analysis and RNA polymerase pulldown assays reveal that the Rpb4 center dot Rbp7 subcomplex associates with the rest of the core RNA polymerase II through two crucial interaction points: one at the N-terminal ribonucleoprotein-like domain of Rpb7 and the other at the partially ordered N-terminal region of Rpb4. These findings are in agreement with the crystal structure of the 12-subunit polymerase. We show here that the weak interaction predicted for the N-terminal region of Rpb4 with Rpb2 in the crystal structure actually plays a significant role in interaction of the subcomplex with the core in vivo. Our mutant analysis also suggests that Rpb7 plays an essential role in the cell through its ability to interact with the rest of the polymerase.	[Sampath, Vinaya; Balakrishnan, Bindu; Verma-Gaur, Jiyoti; Sadhale, Parag P.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Onesti, Silvia] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Cell & Mol Biol, London SW7 2AZ, England	Indian Institute of Science (IISC) - Bangalore; Imperial College London	Sadhale, PP (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	pps@mcbl.iisc.ernet.in	Sadhale, PArag/A-7799-2009	Onesti, Silvia/0000-0002-0612-7948				Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Farago M, 2003, MOL BIOL CELL, V14, P2744, DOI 10.1091/mbc.E02-11-0740; FINLEY RL, 1997, YEAST 2 HYBRID SYSTE, P197; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Kanemaki M, 2003, NATURE, V423, P720, DOI 10.1038/nature01692; KHAZAK V, 1995, MOL BIOL CELL, V6, P759, DOI 10.1091/mbc.6.7.759; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; Lotan R, 2005, GENE DEV, V19, P3004, DOI 10.1101/gad.353205; MCKUNE K, 1993, YEAST, V9, P295, DOI 10.1002/yea.320090309; Meka H, 2005, NUCLEIC ACIDS RES, V33, P6435, DOI 10.1093/nar/gki945; Orlicky SM, 2001, J BIOL CHEM, V276, P10097, DOI 10.1074/jbc.M003165200; Pillai B, 2003, J BIOL CHEM, V278, P3339, DOI 10.1074/jbc.M112180200; Pillai B, 2001, J BIOL CHEM, V276, P30641, DOI 10.1074/jbc.M010952200; Rosenheck S, 1998, J BACTERIOL, V180, P6187; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Sampath V, 2005, IUBMB LIFE, V57, P93, DOI 10.1080/15216540500078905; Sampath V, 2003, J BIOL CHEM, V278, P51566, DOI 10.1074/jbc.M305863200; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sharma N, 1999, J GENET, V78, P149, DOI 10.1007/BF02934460; Sheffer A, 1999, MOL CELL BIOL, V19, P2672; Sherman F., 1983, METHODS YEAST GENETI; Shpakovski GV, 2000, J MOL BIOL, V295, P1119, DOI 10.1006/jmbi.1999.3399; Singh SR, 2004, NUCLEIC ACIDS RES, V32, P201, DOI 10.1093/nar/gkh163; Singh SR, 2007, BIOCHEM BIOPH RES CO, V356, P266, DOI 10.1016/j.bbrc.2007.02.120; Tan Q, 2003, MOL CELL BIOL, V23, P3329, DOI 10.1128/MCB.23.9.3329-3338.2003; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854	33	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3923	3931		10.1074/jbc.M708746200	http://dx.doi.org/10.1074/jbc.M708746200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056993	hybrid			2022-12-27	WOS:000253083500026
J	Zhang, LZ; Zambon, AC; Vranizan, K; Pothula, K; Conklin, BR; Insel, PA				Zhang, Lingzhi; Zambon, Alexander C.; Vranizan, Karen; Pothula, Kanishka; Conklin, Bruce R.; Insel, Paul A.			Gene expression signatures of cAMP/protein kinase A (PKA)-promoted, mitochondrial-dependent apoptosis - Comparative analysis of wild-type and camp-deathless S49 lymphoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY REPRESSOR ICER; AGONISTS INDUCE APOPTOSIS; CYCLIC-AMP; UP-REGULATION; PROTEIN; INHIBITION; PATHWAY; BCL-2; ACTIVATION; CREM	The second messenger cAMP acts via protein kinase A (PKA) to induce apoptosis by mechanisms that are poorly understood. Here, we assessed a role for mitochondria and analyzed gene expression in cAMP/PKA-promoted apoptosis by comparing wild-type (WT) S49 lymphoma cells and the S49 variant, D- (cAMP-deathless), which lacks cAMP-promoted apoptosis but has wild-type levels of PKA activity and cAMP-promoted G(1) growth arrest. Treatment of WT, but not D-, S49 cells with 8-CPT-cAMP (8-(4-chlorophenylthio)-adenosine-3':5'-cyclic monophosphate) for 24 h induced loss of mitochondrial membrane potential, mitochondrial release of cytochrome c and SMAC, and increase in caspase-3 activity. Gene expression analysis (using Affymetrix 430 2.0 arrays) revealed that WT and D- cells incubated with 8-CPT-cAMP have similar, but non-identical, extents of cAMP-regulated gene expression at 2 h (similar to 800 transcripts) and 6 h (similar to 1000 transcripts) (vertical bar Fold vertical bar > 2, p < 0.06); by contrast, at 24 h, similar to 2500 and similar to 1100 transcripts were changed in WT and D- cells, respectively. Using an approach that combined regression analysis, clustering, and functional annotation to identify transcripts that showed differential expression between WT and D- cells, we found differences in cAMP-mediated regulation of mRNAs involved in transcriptional repression, apoptosis, the cell cycle, RNA splicing, Golgi, and lysosomes. The two cell lines differed in cAMP-response element-binding protein (CREB) phosphorylation and expression of the transcriptional inhibitor ICER (inducible cAMP early repressor) and in cAMP-regulated expression of genes in the inhibitor of apoptosis (IAP) and Bcl families. The findings indicate that cAMP/PKA-promoted apoptosis of lymphoid cells occurs via mitochondrial-mediated events and imply that such apoptosis involves gene networks in multiple biochemical pathways.	[Zhang, Lingzhi; Zambon, Alexander C.; Pothula, Kanishka; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94141 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94141 USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94141 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,BSB 3073 UCSD 0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	Conklin, Bruce/E-4738-2019	Conklin, Bruce/0000-0003-1463-6061	NIGMS NIH HHS [GM06852, R01 GM061774-04, GM61774, R01 GM061774] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061774] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT DA, 1995, J CLIN INVEST, V95, P1490, DOI 10.1172/JCI117820; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Baell JB, 2002, BIOCHEM PHARMACOL, V64, P851, DOI 10.1016/S0006-2952(02)01148-6; Conran N, 2007, BRIT J HAEMATOL, V139, P148, DOI 10.1111/j.1365-2141.2007.06748.x; Ding B, 2005, P NATL ACAD SCI USA, V102, P14771, DOI 10.1073/pnas.0506489102; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fuld S, 2005, EXP CELL RES, V309, P161, DOI 10.1016/j.yexcr.2005.05.016; Halgren RG, 1998, BLOOD, V92, P2893, DOI 10.1182/blood.V92.8.2893.420k01_2893_2898; Harris SG, 2002, IMMUNOLOGY, V105, P23, DOI 10.1046/j.0019-2805.2001.01340.x; Harris SG, 2001, EUR J IMMUNOL, V31, P1098, DOI 10.1002/1521-4141(200104)31:4<1098::AID-IMMU1098>3.0.CO;2-I; He J, 2005, GENES CELLS, V10, P23, DOI 10.1111/j.1365-2443.2004.00811.x; IGAZ LM, 2002, BIOCHIM BIOPHYS ACTA, V1542, P139; Jaworski J, 2003, J NEUROSCI, V23, P4519; Ji ZY, 2007, J BIOL CHEM, V282, P37370, DOI 10.1074/jbc.M703697200; Joza N, 2002, TRENDS GENET, V18, P142, DOI 10.1016/S0168-9525(01)02618-X; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2491, DOI 10.1002/cncr.20696; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Krett NL, 1997, CLIN CANCER RES, V3, P1781; Lamas M, 1996, PHILOS T R SOC B, V351, P561, DOI 10.1098/rstb.1996.0055; LEMAIRE I, 1977, CELL, V11, P149, DOI 10.1016/0092-8674(77)90325-7; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Machamer CE, 2003, TRENDS CELL BIOL, V13, P279, DOI 10.1016/S0962-8924(03)00101-6; Martinez-Velazquez M, 2007, CELL SIGNAL, V19, P1212, DOI 10.1016/j.cellsig.2007.01.001; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Monaco L, 1997, ONCOGENE, V15, P2493, DOI 10.1038/sj.onc.1201636; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Tiwari S, 2004, BLOOD, V103, P2661, DOI 10.1182/blood-2003-06-2154; Tomita H, 2003, CIRC RES, V93, P12, DOI 10.1161/01.RES.0000079794.57578.F1; VANDERLAAN MJ, 2001, 93 U CAL DIV BIOST; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Wang XM, 2005, J BIOL CHEM, V280, P16705, DOI 10.1074/jbc.M501819200; Wang Y, 2006, APOPTOSIS, V11, P441, DOI 10.1007/s10495-005-4293-6; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yan LZ, 2000, AM J PHYSIOL-CELL PH, V279, pC1665, DOI 10.1152/ajpcell.2000.279.5.C1665; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang LZ, 2001, AM J PHYSIOL-CELL PH, V281, pC1642, DOI 10.1152/ajpcell.2001.281.5.C1642; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200	48	47	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4304	4313		10.1074/jbc.M708673200	http://dx.doi.org/10.1074/jbc.M708673200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18048352	Green Accepted, hybrid			2022-12-27	WOS:000253083500065
J	Bhardwaj, K; Palaninathan, S; Alcantara, JMO; Yi, LL; Guarino, L; Sacchettini, JC; Kao, CC				Bhardwaj, Kanchan; Palaninathan, Satheesh; Alcantara, Joanna Maria Ortiz; Yi, Lillian Li; Guarino, Linda; Sacchettini, James C.; Kao, C. Cheng			Structural and functional analyses of the severe acute respiratory syndrome coronavirus endoribonuclease Nsp15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-CORONAVIRUS; VIRUS; GENOME; IDENTIFICATION; TRANSCRIPTION; REPLICATION; DOCKING; PROTEIN	The severe acute respiratory syndrome (SARS) coronavirus encodes several RNA-processing enzymes that are unusual for RNA viruses, including Nsp15 (nonstructural protein 15), a hexameric endoribonuclease that preferentially cleaves 3' of uridines. We solved the structure of a catalytically inactive mutant version of Nsp15, which was crystallized as a hexamer. The structure contains unreported flexibility in the active site of each subunit. Substitutions in the active site residues serine 293 and proline 343 allowed Nsp15 to cleave at cytidylate, whereas mutation of leucine 345 rendered Nsp15 able to cleave at purines as well as pyrimidines. Mutations that targeted the residues involved in subunit interactions generally resulted in the formation of catalytically inactive monomers. The RNA-binding residues were mapped by a method linking reversible cross-linking, RNA affinity purification, and peptide fingerprinting. Alanine substitution of several residues in the RNA-contacting portion of Nsp15 did not affect hexamer formation but decreased the affinity of RNA binding and reduced endonuclease activity. This suggests a model for Nsp15 hexamer interaction with RNA.	[Bhardwaj, Kanchan; Palaninathan, Satheesh; Alcantara, Joanna Maria Ortiz; Yi, Lillian Li; Guarino, Linda; Sacchettini, James C.; Kao, C. Cheng] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Yi, Lillian Li; Guarino, Linda] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kao, CC (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	ckao@tamu.edu	Bhardwaj, Kanchan/CAH-2291-2022	Bhardwaj, Kanchan/0000-0002-7331-7717; Ortiz-Alcantara, Joanna Maria/0000-0003-2894-3652	NIAID NIH HHS [1R45AI06164] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		An SW, 1998, J VIROL, V72, P8517, DOI 10.1128/JVI.72.11.8517-8524.1998; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhardwaj K, 2004, J VIROL, V78, P12218, DOI 10.1128/JVI.78.22.12218-12224.2004; Bhardwaj K, 2006, J MOL BIOL, V361, P243, DOI 10.1016/j.jmb.2006.06.021; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Deshpande RA, 2002, CRIT REV MICROBIOL, V28, P79, DOI 10.1080/1040-840291046704; Eckerle LD, 2007, J VIROL, V81, P12135, DOI 10.1128/JVI.01296-07; FERRIN TE, 1988, J MOL GRAPHICS, V6, P13, DOI 10.1016/0263-7855(88)80054-7; Gioia U, 2005, J BIOL CHEM, V280, P18996, DOI 10.1074/jbc.M501160200; Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017; Guarino LA, 2005, J MOL BIOL, V353, P1106, DOI 10.1016/j.jmb.2005.09.007; Ivanov KA, 2004, P NATL ACAD SCI USA, V101, P12694, DOI 10.1073/pnas.0403127101; Kang H, 2007, J VIROL, V81, P13587, DOI 10.1128/JVI.00547-07; Kim YC, 2005, J BIOL CHEM, V280, P38011, DOI 10.1074/jbc.M508145200; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; LAI MMC, 1990, ANNU REV MICROBIOL, V44, P303, DOI 10.1146/annurev.mi.44.100190.001511; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posthuma CC, 2006, J VIROL, V80, P1653, DOI 10.1128/JVI.80.4.1653-1661.2006; Ricagno S, 2006, P NATL ACAD SCI USA, V103, P11892, DOI 10.1073/pnas.0601708103; Saida F, 2003, NUCLEIC ACIDS RES, V31, P2751, DOI 10.1093/nar/gkg377; Sawicki S G, 1995, Adv Exp Med Biol, V380, P499; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Xu XL, 2006, J VIROL, V80, P7909, DOI 10.1128/JVI.00525-06	34	74	76	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3655	3664		10.1074/jbc.M708375200	http://dx.doi.org/10.1074/jbc.M708375200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045871	hybrid, Green Published			2022-12-27	WOS:000253083000070
J	Emami, N; Diamandis, EP				Emami, Nashmil; Diamandis, Eleftherios P.			Human kallikrein-related peptidase 14 (KLK14) is a new activator component of the KLK proteolytic cascade - Possible function in seminal plasma and skin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN TISSUE KALLIKREINS; PROTEIN-C INHIBITOR; FACTOR PATHWAY INHIBITOR; STRATUM-CORNEUM; SERINE-PROTEASES; HUMAN SEMEN; SUBSTRATE-SPECIFICITY; CANCER BIOMARKER; ENZYMATIC ACTION	Human kallikrein-related peptidases (KLKs) are a family of 15 serine proteases mainly known for their biomarker utility in various neoplastic and non-neoplastic diseases. Despite significant progress in understanding their clinical application, little is known about the activation mechanism(s) of this important family of enzymes. Emerging evidence indicates that KLKs are activated in a stepwise manner, which is a characteristic of proteolytic cascades. Thus far, KLK cascades have been implicated in semen liquefaction and skin desquamation. Many members of the KLK family have been reported to be active in seminal plasma and/or skin, suggesting their involvement in common proteolytic cascades. KLK14, in particular, is highly active and has recently been proposed as one of the key trypsin-like proteases involved in skin desquamation. This study aims to elucidate a probable cascade-mediated role of KLK14 by 1) examining KLK14-mediated cleavage of a heptapeptide library encompassing activation sites of the 15 KLKs and 2) verifying activation of certain candidate downstream targets of KLK14 (i.e. pro-KLK1, -KLK3, and -KLK11). Heptapeptides encompassing activation motifs of KLK2, -3, -5, and -11 were cleaved with a high (>= 85%) cleavage efficiency. Activation of these candidates was confirmed using full-length recombinant proteins. Pro-KLK11, -KLK3, and -KLK1 were rapidly activated in a concentration-dependent manner. Pro-KLK3 regulation was bidirectional because activation was followed by inactivation via internal cleavage of active KLK3. We are proposing a putative cascade model, operating through multiple KLKs. Identification of novel members of such proteolytic cascades will aid in further defining mechanisms involved in seminal/skin homeostasis.	[Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Mt Sinai Hosp, Lab Med, Toronto, ON M5G 1X5, Canada; [Emami, Nashmil; Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto	Diamandis, EP (corresponding author), Mt Sinai Hosp, Dept Pathol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Amour A, 2004, BIOCHEM SOC T, V32, P15, DOI 10.1042/BST0320015; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Borg TK, 2004, AM J PATHOL, V164, P1141, DOI 10.1016/S0002-9440(10)63201-4; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2003, CANCER RES, V63, P9032; BORGONO CA, 2006, J BIOL CHEM; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Campbell DJ, 2001, CLIN EXP PHARMACOL P, V28, P1060, DOI 10.1046/j.1440-1681.2001.03564.x; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; CHRISTENSSON A, 1990, EUR J BIOCHEM, V194, P755, DOI 10.1111/j.1432-1033.1990.tb19466.x; Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; de Lamirande E, 2007, SEMIN THROMB HEMOST, V33, P60, DOI 10.1055/s-2006-958463; Denmeade SR, 2001, PROSTATE, V48, P122, DOI 10.1002/pros.1088; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; ESPANA F, 1995, EUR J BIOCHEM, V234, P641, DOI 10.1111/j.1432-1033.1995.641_b.x; Espana F, 2007, SEMIN THROMB HEMOST, V33, P41, DOI 10.1055/s-2006-958460; Felber LM, 2005, BIOL CHEM, V386, P291, DOI 10.1515/BC.2005.035; Fernandez JA, 2007, SEMIN THROMB HEMOST, V33, P13, DOI 10.1055/s-2006-958457; FINK E, 1985, BIOL CHEM H-S, V366, P917, DOI 10.1515/bchm3.1985.366.2.917; Giusti B, 2005, ARTHRITIS RHEUM-US, V52, P3618, DOI 10.1002/art.21383; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jonsson M, 2005, BIOCHEM J, V387, P447, DOI 10.1042/BJ20041424; Kim R, 2005, ONCOL REP, V14, P595; Komatsu N, 2005, J INVEST DERMATOL, V125, P1182, DOI 10.1111/j.0022-202X.2005.23933.x; Komatsu N, 2006, J INVEST DERMATOL, V126, P2338, DOI 10.1038/sj.jid.5700379; Kumar A, 1997, CANCER RES, V57, P3111; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; LILJA H, 1985, SCAND J CLIN LAB INV, V45, P635, DOI 10.3109/00365518509155271; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lovgren J, 1999, EUR J BIOCHEM, V262, P781, DOI 10.1046/j.1432-1327.1999.00433.x; Lovgren J, 1997, BIOCHEM BIOPH RES CO, V238, P549, DOI 10.1006/bbrc.1997.7333; Luo LY, 2006, CLIN CANCER RES, V12, P742, DOI 10.1158/1078-0432.CCR-05-1696; Lwaleed BA, 2005, THROMB HAEMOSTASIS, V93, P847, DOI 10.1160/TH04-09-0600; Lwaleed BA, 2004, THROMB HAEMOSTASIS, V92, P752, DOI 10.1160/TH04-03-0142; Lwaleed BA, 2007, SEMIN THROMB HEMOST, V33, P3, DOI 10.1055/s-2006-958456; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Malm J, 2000, PROSTATE, V45, P132, DOI 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3; MANDAL A, 1988, ARCH ANDROLOGY, V20, P141, DOI 10.3109/01485018808987065; Matsuda Y, 2002, ARCH ANDROLOGY, V48, P295, DOI 10.1080/01485010290031600; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; Mikhailichenko VV, 2005, FERTIL STERIL, V84, P256, DOI 10.1016/j.fertnstert.2004.11.086; MISKA W, 1994, ARCH ANDROLOGY, V33, P1; MISKA W, 1990, ARCH ANDROLOGY, V25, P63, DOI 10.3109/01485019008987595; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; POLAK B, 1990, EUR J OBSTET GYN R B, V35, P223, DOI 10.1016/0028-2243(90)90166-X; POLAK B, 1989, INT J ANDROL, V12, P187, DOI 10.1111/j.1365-2605.1989.tb01303.x; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Robert M, 1997, BIOCHEMISTRY-US, V36, P3811, DOI 10.1021/bi9626158; Schechter NM, 2005, BIOL CHEM, V386, P1173, DOI 10.1515/BC.2005.134; SCHILL WB, 1992, ANDROLOGIA, V24, P69; SENSABAUGH GF, 1990, J UROLOGY, V144, P1523, DOI 10.1016/S0022-5347(17)39790-2; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Sidera C, 2004, BIOCHEM SOC T, V32, P33, DOI 10.1042/BST0320033; Siems WE, 2003, ANDROLOGIA, V35, P44, DOI 10.1046/j.1439-0272.2003.00536.x; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Suzuki K, 2007, SEMIN THROMB HEMOST, V33, P46, DOI 10.1055/s-2006-958461; Takayama TK, 2001, BIOCHEMISTRY-US, V40, P15341, DOI 10.1021/bi015775e; Thyzel E, 2003, THROMB RES, V109, P329, DOI 10.1016/S0049-3848(03)00210-X; Vaisanen V, 1999, PROSTATE CANCER P D, V2, P91, DOI 10.1038/sj.pcan.4500289; Van Dreden P, 2007, SEMIN THROMB HEMOST, V33, P21, DOI 10.1055/s-2006-958458; WATT KWK, 1986, P NATL ACAD SCI USA, V83, P3166, DOI 10.1073/pnas.83.10.3166; Wennemuth G, 2003, BRIT J PHARMACOL, V138, P351, DOI 10.1038/sj.bjp.0705039; WILSON VB, 1975, J UROLOGY, V113, P509, DOI 10.1016/S0022-5347(17)59513-0; Woessner JF, 2004, HDB PROTEOLYTIC ENZY; Yamakoshi Y, 2006, EUR J ORAL SCI, V114, P45, DOI 10.1111/j.1600-0722.2006.00281.x; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Yousef GM, 2002, BIOL CHEM, V383, P1045, DOI 10.1515/BC.2002.113; Yousef GM, 2001, ENDOCR REV, V22, P184, DOI 10.1210/er.22.2.184; ZHANG WM, 1995, CLIN CHEM, V41, P1567	76	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3031	3041		10.1074/jbc.M707253200	http://dx.doi.org/10.1074/jbc.M707253200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056261	hybrid			2022-12-27	WOS:000253083000006
J	Esteban, O; Bernal, RA; Donohoe, M; Videler, H; Sharon, M; Robinson, CV; Stock, D				Esteban, Olga; Bernal, Ricardo A.; Donohoe, Mhairi; Videler, Hortense; Sharon, Michal; Robinson, Carol V.; Stock, Daniela			Stoichiometry and localization of the stator subunits E and G in Thermus thermophilus H+-ATPase/synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROSPRAY MASS-SPECTROMETRY; MITOCHONDRIAL ATP SYNTHASE; YEAST V-ATPASE; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; VACUOLAR ATPASE; MACROMOLECULAR ASSEMBLIES; 3-DIMENSIONAL STRUCTURE; PERIPHERAL STALK; PHAGE DISPLAY	Proton-translocating ATPases are central to biological energy conversion. Although eukaryotes contain specialized F-ATPases for ATP synthesis and V-ATPases for proton pumping, eubacteria and archaea typically contain only one enzyme for both tasks. Although many eubacteria contain ATPases of the F-type, some eubacteria and all known archaea contain ATPases of the A-type. A-ATPases are closely related to V-ATPases but simpler in design. Although the nucleotide-binding and transmembrane rotor subunits share sequence homology between A-, V-, and F-ATPases, the peripheral stalk is strikingly different in sequence, composition, and stoichiometry. We have analyzed the peripheral stalk of Thermus thermophilus A- ATPase by using phage display-derived single-domain antibody fragments in combination with electron microscopy and tandem mass spectrometry. Our data provide the first direct evidence for the existence of two peripheral stalks in the A- ATPase, each one composed of heterodimers of subunits E and G arranged symmetrically around the soluble A(1) domain. To our knowledge, this is the first description of phage display-derived antibody selection against a multi-subunit membrane protein used for purification and single particle analysis by electron microscopy. It is also the first instance of the derivation of subunit stoichiometry by tandem mass spectrometry to an intact membrane protein complex. Both approaches could be applicable to the structural analysis of other membrane protein complexes.	[Donohoe, Mhairi; Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Esteban, Olga; Bernal, Ricardo A.; Donohoe, Mhairi; Stock, Daniela] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Videler, Hortense; Sharon, Michal; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	Victor Chang Cardiac Research Institute; MRC Laboratory Molecular Biology; University of Texas System; University of Texas El Paso; University of New South Wales Sydney; University of Cambridge	Stock, D (corresponding author), Victor Chang Cardiac Res Inst, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	d.stock@victorchang.edu.au	Bernal, Ricardo A/B-2124-2010	Videler, Hortense/0000-0002-6369-5984; Sharon, Michal/0000-0003-3933-0595; robinson, carol/0000-0001-7829-5505; Bernal, Ricardo A./0000-0001-5849-8647	MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Betts S, 1999, METHOD ENZYMOL, V309, P333; Biukovic G, 2007, BIOCHEMISTRY-US, V46, P2070, DOI 10.1021/bi062123n; Boekema EJ, 1999, NATURE, V401, P37, DOI 10.1038/43369; Bottcher B, 1998, J MOL BIOL, V281, P757, DOI 10.1006/jmbi.1998.1957; Carbajo RJ, 2007, J MOL BIOL, V368, P310, DOI 10.1016/j.jmb.2007.02.059; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Coskun U, 2004, J BIOL CHEM, V279, P38644, DOI 10.1074/jbc.M406196200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Gruber G, 2001, J EXP BIOL, V204, P2597; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; Karrasch S, 1999, J MOL BIOL, V290, P379, DOI 10.1006/jmbi.1999.2897; KIBAK H, 1992, J BIOENERG BIOMEMBR, V24, P415, DOI 10.1007/BF00762534; KOHLER G, 1975, NATURE, V256, P497; Lokanath NK, 2007, J MOL BIOL, V366, P933, DOI 10.1016/j.jmb.2006.11.088; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Norgett EE, 2007, J BIOL CHEM, V282, P14421, DOI 10.1074/jbc.M701226200; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Rothlisberger D, 2004, FEBS LETT, V564, P340, DOI 10.1016/S0014-5793(04)00359-X; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Rubinstein JL, 2003, ANAL BIOCHEM, V314, P294, DOI 10.1016/S0003-2697(02)00649-8; Schafer IB, 2006, J MOL BIOL, V358, P725, DOI 10.1016/j.jmb.2006.02.057; Sharon M, 2006, PLOS BIOL, V4, P1314, DOI 10.1371/journal.pbio.0040267; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Speed MA, 1997, PROTEIN SCI, V6, P99; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Wilkens S, 2000, J MOL BIOL, V295, P387, DOI 10.1006/jmbi.1999.3381; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 1998, BBA-BIOENERGETICS, V1365, P93, DOI 10.1016/S0005-2728(98)00048-6; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001	44	47	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2595	2603		10.1074/jbc.M704941200	http://dx.doi.org/10.1074/jbc.M704941200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055467	hybrid			2022-12-27	WOS:000252622300016
J	Gore, Y; Starlets, D; Maharshak, N; Becker-Herman, S; Kaneyuki, U; Leng, L; Bucala, R; Shachar, I				Gore, Yael; Starlets, Diana; Maharshak, Nitsan; Becker-Herman, Shirly; Kaneyuki, Utako; Leng, Lin; Bucala, Richard; Shachar, Idit			Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVARIANT CHAIN; FACTOR MIF; LEISHMANIA-MAJOR; REGULATORY ROLE; EXPRESSION; CD44; MATURATION; GROWTH; CD74; PROLIFERATION	Macrophage migration inhibitory factor (MIF) is an upstream activator of innate immunity that regulates subsequent adaptive responses. It was previously shown that in macrophages, MIF binds to a complex of CD74 and CD44, resulting in initiation of a signaling pathway. In the current study, we investigated the role of MIF in B cell survival. We show that in B lymphocytes, MIF initiates a signaling cascade that involves Syk and Akt, leading to NF-kappa B activation, proliferation, and survival in a CD74-and CD44-dependent manner. Thus, MIF regulates the adaptive immune response by maintaining the mature B cell population.	[Gore, Yael; Starlets, Diana; Maharshak, Nitsan; Becker-Herman, Shirly; Shachar, Idit] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA	Weizmann Institute of Science; Yale University	Shachar, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	idit.shachar@weizmann.ac.il		Leng, Lin/0000-0002-0605-358X	NIAID NIH HHS [AI 042310] Funding Source: Medline; NIAMS NIH HHS [AR 049610, AR 050498] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI042310, R01AI042310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050498, R01AR049610] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; BERNHAGEN J, 1994, BIOCHEMISTRY-US, V33, P14144, DOI 10.1021/bi00251a025; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Cantrell D, 2002, SEMIN IMMUNOL, V14, P19, DOI 10.1006/smim.2001.0338; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; Datta MW, 2000, APPL IMMUNOHISTO M M, V8, P210, DOI 10.1097/00022744-200009000-00007; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Dios A, 2002, J MED CHEM, V45, P2410, DOI 10.1021/jm010534q; Donnelly SC, 1997, MOL MED TODAY, V3, P502, DOI 10.1016/S1357-4310(97)01133-7; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; ERICKSON AH, 1979, J BIOL CHEM, V254, P1771; Fruman DA, 2004, CURR OPIN IMMUNOL, V16, P314, DOI 10.1016/j.coi.2004.03.014; GEORGE M, 1962, P SOC EXP BIOL MED, V111, P514; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Ioachim HL, 1996, AM J SURG PATHOL, V20, P64, DOI 10.1097/00000478-199601000-00007; Ishigami S, 2001, CANCER LETT, V168, P87, DOI 10.1016/S0304-3835(01)00503-1; Jones RG, 2000, J EXP MED, V191, P1721, DOI 10.1084/jem.191.10.1721; Juttner S, 1998, J IMMUNOL, V161, P2383; Kane LP, 2001, NAT IMMUNOL, V2, P37, DOI 10.1038/83144; Lazova R, 1997, CANCER-AM CANCER SOC, V79, P2115, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Matza D, 2002, IMMUNITY, V17, P549, DOI 10.1016/S1074-7613(02)00455-7; Matza D, 2002, P NATL ACAD SCI USA, V99, P3018, DOI 10.1073/pnas.052703299; Matza D, 2001, J BIOL CHEM, V276, P27203, DOI 10.1074/jbc.M104684200; Meyer-Siegler KL, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-34; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2000, INT J MOL MED, V5, P397; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; NATHAN CF, 1973, J EXP MED, V137, P275, DOI 10.1084/jem.137.2.275; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Nebreda AR, 2006, CURR OPIN CELL BIOL, V18, P192, DOI 10.1016/j.ceb.2006.01.001; Nishihira J, 2000, J INTERF CYTOK RES, V20, P751, DOI 10.1089/10799900050151012; Nishihira J, 2003, ANN NY ACAD SCI, V995, P171, DOI 10.1111/j.1749-6632.2003.tb03220.x; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SHACHAR I, 1995, IMMUNITY, V3, P373, DOI 10.1016/1074-7613(95)90121-3; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Stein R, 2004, BLOOD, V104, P3705, DOI 10.1182/blood-2004-03-0890; Stumptner-Cuvelette P, 2002, BBA-MOL CELL RES, V1542, P1, DOI 10.1016/S0167-4889(01)00166-5; Takano T, 2002, ANTIOXID REDOX SIGN, V4, P533, DOI 10.1089/15230860260196335; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X	54	180	196	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2784	2792		10.1074/jbc.M703265200	http://dx.doi.org/10.1074/jbc.M703265200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18056708	hybrid			2022-12-27	WOS:000252622300036
J	Li, YC; Chiang, CW; Yeh, HC; Hsu, PY; Whitby, FG; Wang, LH; Chan, NL				Li, Yi-Ching; Chiang, Chia-Wang; Yeh, Hui-Chun; Hsu, Pei-Yung; Whitby, Frank G.; Wang, Lee-Ho; Chan, Nei-Li			Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; CYTOCHROME P450S; CAMPHOR; HYDROXYLATION; ENVIRONMENT; SYNTHETASE; PORPHYRINS; MECHANISMS; CATALYSIS; CLEAVAGE	Prostacyclin synthase (PGIS) is a cytochrome P450 ( P450) enzyme that catalyzes production of prostacyclin from prostaglandin H-2. PGIS is unusual in that it catalyzes an isomerization rather than a monooxygenation, which is typical of P450 enzymes. To understand the structural basis for prostacyclin biosynthesis in greater detail, we have determined the crystal structures of ligand-free, inhibitor ( minoxidil)-bound and substrate analog U51605-bound PGIS. These structures demonstrate a stereo-specific substrate binding and suggest features of the enzyme that facilitate isomerization. Unlike most microsomal P450s, where large substrate-induced conformational changes take place at the distal side of the heme, conformational changes in PGIS are observed at the proximal side and in the heme itself. The conserved and extensive heme propionate-protein interactions seen in all other P450s, which are largely absent in the ligand-free PGIS, are recovered upon U51605 binding accompanied by water exclusion from the active site. In contrast, when minoxidil binds, the propionate-protein interactions are not recovered and water molecules are largely retained. These findings suggest that PGIS represents a divergent evolution of the P450 family, in which a heme barrier has evolved to ensure strict binding specificity for prostaglandin H-2, leading to a radical-mediated isomerization with high product fidelity. The U51605-bound structure also provides a view of the substrate entrance and product exit channels.	[Chan, Nei-Li] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Yeh, Hui-Chun; Hsu, Pei-Yung; Wang, Lee-Ho] Univ Texas Houston, Hlth Sci Ctr, Div Hematol, Dept Internal Med, Houston, TX 77030 USA; [Li, Yi-Ching; Chiang, Chia-Wang; Chan, Nei-Li] Natl Chung Hsing Univ, Coll Life Sci, Inst Biochem, Taichung 40227, Taiwan; [Whitby, Frank G.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	National Taiwan University; University of Texas System; University of Texas Health Science Center Houston; National Chung Hsing University; Utah System of Higher Education; University of Utah	Wang, LH (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Div Hematol, Dept Internal Med, 6431 Fannin, Houston, TX 77030 USA.	lee-ho.wang@uth.tmc.edu; nlchan@ntu.edu.tw		CHAN, NEI-LI/0000-0003-0139-6513	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060625] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL060625, R01 HL060625-08, HL 60625] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altun A, 2006, J AM CHEM SOC, V128, P3924, DOI 10.1021/ja058196w; Altun A, 2007, J AM CHEM SOC, V129, P8978, DOI 10.1021/ja066847y; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; CHO MJ, 1978, PROSTAGLANDINS, V15, P943, DOI 10.1016/0090-6980(78)90037-0; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; *COLL COMP PROJ, 1994, ACTA CRYSTALLOGR D, V50, P764; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Guallar V, 2006, J INORG BIOCHEM, V100, P755, DOI 10.1016/j.jinorgbio.2006.01.019; HARA S, 1994, J BIOL CHEM, V269, P19897; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; He YA, 1997, BIOCHEMISTRY-US, V36, P8831, DOI 10.1021/bi970182i; HECKER M, 1988, BIOCHEM PHARMACOL, V37, P3363, DOI 10.1016/0006-2952(88)90652-1; HECKER M, 1989, J BIOL CHEM, V264, P141; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KADISH KM, 1995, INORG CHEM, V34, P2984, DOI 10.1021/ic00115a028; KOGA H, 1993, FEBS LETT, V331, P109, DOI 10.1016/0014-5793(93)80307-G; Li HY, 2004, CURR TOP MED CHEM, V4, P1789, DOI 10.2174/1568026043387205; Lounnas V, 1997, BIOCHEMISTRY-US, V36, P5402, DOI 10.1021/bi9622940; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otyepka M, 2007, BBA-GEN SUBJECTS, V1770, P376, DOI 10.1016/j.bbagen.2006.09.013; PEREIRA B, 1994, BIOCHEM BIOPH RES CO, V203, P59, DOI 10.1006/bbrc.1994.2148; SANDUJA SK, 1991, BLOOD, V78, P3178; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Shelnutt JA, 1998, CHEM SOC REV, V27, P31; SHIMIZU T, 1994, J BIOL CHEM, V269, P13296; TAI CL, 1980, PROSTAG LEUKOTR ESS, V4, P399, DOI 10.1016/0161-4630(80)90048-8; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P45, DOI 10.1107/S0907444902018048; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; ULLRICH V, 1981, BIOCHEM PHARMACOL, V30, P2033, DOI 10.1016/0006-2952(81)90218-5; ULLRICH V, 1994, ANGEW CHEM INT EDIT, V33, P1911, DOI 10.1002/anie.199419111; Yeh HC, 2005, BBA-MOL CELL BIOL L, V1738, P121, DOI 10.1016/j.bbalip.2005.11.007; Yeh HC, 2007, ARCH BIOCHEM BIOPHYS, V461, P159, DOI 10.1016/j.abb.2007.03.012; Zhao YH, 2007, BBA-GEN SUBJECTS, V1770, P402, DOI 10.1016/j.bbagen.2006.07.006; Zurek J, 2006, ORG BIOMOL CHEM, V4, P3931, DOI 10.1039/b611653a	38	41	45	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2917	2926		10.1074/jbc.M707470200	http://dx.doi.org/10.1074/jbc.M707470200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032380	hybrid, Green Accepted			2022-12-27	WOS:000252622300048
J	Chambers, JE; Jessop, CE; Bulleid, NJ				Chambers, Joseph E.; Jessop, Catherine E.; Bulleid, Neil J.			Formation of a major histocompatibility complex class I tapasin disulfide indicates a change in spatial organization of the peptide-loading complex during assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; DEPENDENT REDUCTASE ERP57; BOND FORMATION; OXIDOREDUCTASE ERP57; TRANSLATION SYSTEM; REDOX REGULATION; MAMMALIAN-CELLS; HEAVY-CHAIN; BETA(2)-MICROGLOBULIN; MOLECULES	The assembly and peptide loading of major histocompatibility complex Class I molecules within the endoplasmic reticulum are essential for antigen presentation at the cell surface and are facilitated by the peptide-loading complex. The formation of a mixed disulfide between the heavy chain of Class I and components of the loading complex (ERp57, protein disulfide isomerase, and tapasin) suggests that these molecules are involved in the redox regulation of components during assembly and peptide loading. We demonstrate here that a disulfide formed between heavy chain and tapasin can occur between cysteine residues located in the cytosolic regions of these proteins following translation of heavy chain in an in vitro translation system. The formation of this disulfide occurs after assembly into the loading complex and is coincident with the stabilization of the alpha 2 disulfide bond within the peptide binding grove. A ternary complex between heavy chain, ERp57, and tapasin was observed and shown to be stabilized by a disulfide between both tapasin-heavy chain and tapasin-ERp57. No disulfides were observed between ERp57 and heavy chain within the loading complex. The results provide a detailed evaluation of the various transient disulfides formed within the peptide-loading complex during biosynthesis. In addition, the absence of the disulfide between tapasin and heavy chain in TAP-deficient cells indicates that a change in the spatial organization of tapasin and heavy chain occurs following assembly into the loading complex.	[Chambers, Joseph E.; Jessop, Catherine E.; Bulleid, Neil J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Bulleid, NJ (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	neil.bulleid@manchester.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Bulleid, Neil/0000-0002-9839-5279	Biotechnology and Biological Sciences Research Council [BB/D00764X/1, C17806] Funding Source: Medline; BBSRC [BB/D00764X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Antoniou AN, 2002, EMBO J, V21, P2655, DOI 10.1093/emboj/21.11.2655; DEMARS R, 1985, P NATL ACAD SCI USA, V82, P8183, DOI 10.1073/pnas.82.23.8183; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, METHOD ENZYMOL, V348, P49, DOI 10.1016/S0076-6879(02)48625-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Farmery MR, 2000, J BIOL CHEM, V275, P14933, DOI 10.1074/jbc.275.20.14933; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Grandea AG, 1997, IMMUNOGENETICS, V46, P477, DOI 10.1007/s002510050308; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Hughes EA, 1998, CURR BIOL, V8, P709, DOI 10.1016/S0960-9822(98)70278-7; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Lewis JW, 1998, CURR BIOL, V8, P717, DOI 10.1016/S0960-9822(98)70280-5; Lindquist JA, 2001, FASEB J, V15, P1448, DOI 10.1096/fj.00-0720fje; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Peaper DR, 2005, EMBO J, V24, P3613, DOI 10.1038/sj.emboj.7600814; RIBAUDO RK, 1992, J IMMUNOL, V149, P2935; Santos SG, 2007, J BIOL CHEM, V282, P17587, DOI 10.1074/jbc.M702212200; SMITH JD, 1995, MOL IMMUNOL, V32, P531, DOI 10.1016/0161-5890(95)00013-5; Tector M, 1997, MOL IMMUNOL, V34, P401, DOI 10.1016/S0161-5890(97)00045-X; WANG H, 1994, J BIOL CHEM, V269, P22276; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679	28	19	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1862	1869		10.1074/jbc.M708196200	http://dx.doi.org/10.1074/jbc.M708196200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039656	hybrid			2022-12-27	WOS:000252501000012
J	Katsoulotos, GP; Qi, M; Qi, JC; Tanaka, K; Hughes, WE; Molloy, TJ; Adachi, R; Stevens, RL; Krilis, SA				Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Hughes, William E.; Molloy, Timothy J.; Adachi, Roberto; Stevens, Richard L.; Krilis, Steven A.			The diacylglycerol-dependent translocation of Ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE RELEASING PROTEIN-4; EXCHANGE FACTOR; SIGNAL-TRANSDUCTION; PROSTAGLANDIN D-2; GENE-EXPRESSION; PHORBOL ESTERS; BINDING MOTIFS; RAS ACTIVATION; W/WV MICE; RECEPTOR	Ras guanine nucleotide- releasing protein 4 (RasGRP4) is a mast cell (MC)-restricted guanine nucleotide exchange factor and diacylglycerol (DAG)/phorbol ester receptor. An RasGRP4-defective variant of the human MC line HMC-1 was used to create stable clones expressing green fluorescent protein-labeled RasGRP4 for monitoring the movement of this protein inside MCs after exposure to phorbol 12-myristate 13-acetate (PMA), and for evaluating the protein's ability to control gene expression. RasGRP4 resided primarily in the cytosol. After exposure to PMA, RasGRP4 quickly translocated to the inner leaflet of the cell's plasma membrane. 15-30 min later, this signaling protein translocated from the plasma membrane to other intracellular sites. The translocation of RasGRP4 from the cytosol to its varied membrane compartments was found to be highly dependent on Phe(548) in the protein's C1 DAG/PMA-binding domain. Extracellular signal-regulated kinases 1 and 2 were activated during this translocation process, and c-kit/CD117 was lost from the cell's surface. Transcript- profiling approaches revealed that RasGRP4 profoundly regulated the expression of hundreds of genes in HMC-1 cells. For example, the expression of the transcript that encodes the interleukin ( IL) 13 receptor IL-13R alpha 2 increased 61- to 860-fold in RasGRP4-expressing HMC1 cells. A marked increase in IL-13R alpha 2 protein levels also was found. The accumulated data suggest RasGRP4 translocates to varied intracellular compartments via its DAG/PMA-binding domain to regulate signaling pathways that control gene and protein expression in MCs, including the cell's ability to respond to IL-13.	[Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Krilis, Steven A.] Univ New S Wales, Dept Med, Kogarah, NSW 2217, Australia; [Katsoulotos, Gregory P.; Qi, Miao; Qi, Jian Cheng; Tanaka, Kumiko; Krilis, Steven A.] St George Hosp, Dept Immunol Allergy & Infect Dis, Kogarah, NSW 2217, Australia; [Hughes, William E.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Molloy, Timothy J.] St Vincents Hosp, Blood Dis & Canc Res Lab, Sydney, NSW 2010, Australia; [Adachi, Roberto] Univ Texas Houston, MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Stevens, Richard L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Stevens, Richard L.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of New South Wales Sydney; St George Hospital; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Krilis, SA (corresponding author), Univ New S Wales, Dept Med, 2 S St Ctr, Kogarah, NSW 2217, Australia.	S.Krilis@unsw.edu.au		Adachi, Roberto/0000-0002-0146-0768; Hughes, William/0000-0002-7149-3987	NHLBI NIH HHS [HL 36110] Funding Source: Medline; NIAID NIH HHS [AI 54950] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; BROWN KD, 1989, J IMMUNOL, V142, P679; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Carrasco S, 2004, MOL BIOL CELL, V15, P2932, DOI 10.1091/mbc.E03-11-0844; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Daines MO, 2006, J IMMUNOL, V176, P7495, DOI 10.4049/jimmunol.176.12.7495; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fushimi T, 1998, J ALLERGY CLIN IMMUN, V102, P134, DOI 10.1016/S0091-6749(98)70064-8; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GEISSLER EN, 1983, EXP HEMATOL, V11, P461; GORDON JR, 1990, BLOOD, V75, P1637; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Hsieh FH, 2001, J EXP MED, V193, P123, DOI 10.1084/jem.193.1.123; Irie K, 2004, BIOORGAN MED CHEM, V12, P4575, DOI 10.1016/j.bmc.2004.07.008; JAFFERY G, 1994, INT ARCH ALLERGY IMM, V105, P274, DOI 10.1159/000236769; KANAKURA Y, 1988, BLOOD, V72, P877; Kaur D, 2006, ALLERGY, V61, P1047, DOI 10.1111/j.1398-9995.2006.01139.x; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Kedra D, 1997, HUM GENET, V100, P611, DOI 10.1007/s004390050562; KITAMURA Y, 1978, BLOOD, V52, P447; Layer K, 2003, IMMUNITY, V19, P243, DOI 10.1016/S1074-7613(03)00209-7; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Li LX, 2003, J IMMUNOL, V171, P390, DOI 10.4049/jimmunol.171.1.390; Li LX, 2003, J BIOL CHEM, V278, P4725, DOI 10.1074/jbc.C200635200; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Lorentz A, 2005, J IMMUNOL, V174, P6751, DOI 10.4049/jimmunol.174.11.6751; Lorenzo PS, 2001, CANCER RES, V61, P943; MACCHIA L, 1995, BBA-LIPID LIPID MET, V1257, P58, DOI 10.1016/0005-2760(95)00048-H; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239, DOI 10.1074/jbc.270.7.3239; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Okamura SM, 2006, J BIOL CHEM, V281, P36132, DOI 10.1074/jbc.M605093200; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; PEREZ DI, 2004, MOL CELL BIOL, V24, P3485; RAZIN E, 1984, J IMMUNOL, V132, P1479; Rebhun JF, 2000, J BIOL CHEM, V275, P34901, DOI 10.1074/jbc.M005327200; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tang L, 2001, VET IMMUNOL IMMUNOP, V79, P181, DOI 10.1016/S0165-2427(01)00271-9; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VALENT P, 1989, BLOOD, V73, P1778; Yamashita S, 2000, J BIOL CHEM, V275, P25488, DOI 10.1074/jbc.M003414200; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916	59	12	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1610	1621		10.1074/jbc.M707042200	http://dx.doi.org/10.1074/jbc.M707042200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024961	hybrid			2022-12-27	WOS:000252282700047
J	Fushimi, K; Troeberg, L; Nakamura, H; Lim, NH; Nagase, H				Fushimi, Kazunari; Troeberg, Linda; Nakamura, Hiroyuki; Lim, Ngee Han; Nagase, Hideaki			Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SYNOVIAL-FLUID; CARTILAGE EXPLANTS; MATRIX-METALLOPROTEINASE; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; AGGRECANASE; CLEAVAGE; OSTEOARTHRITIS; DEGRADATION; BINDING	ADAMTS-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase2) are multidomain metalloproteinases belonging to the ADAMTS family. We have previously reported that human ADAMTS-5 has much higher aggrecanolytic activity than human ADAMTS-4. To investigate the different proteolytic activity of the two enzymes, we generated a series of chimeras by exchanging various non-catalytic domains of the two proteinases. We found that the catalytic domain of ADAMTS-5 has higher intrinsic catalytic ability than that of ADAMTS-4. The studies also demonstrated that the non-catalytic domains of ADAMTS-5 are more effective modifiers than those of ADAMTS-4, making both catalytic domains more active against aggrecan, an Escherichia coli-expressed interglobular domain of aggrecan and fibromodulin. Addition of the C-terminal thrombospondin type I motif of ADAMTS-5 to the C terminus of ADAMTS-4 increased the activity of ADAMTS-4 against aggrecan and fibromodulin severalfold. In contrast to previous reports (Kashiwagi, M., Enghild, J. J., Gendron, C., Hughes, C., Caterson, B., Itoh, Y., and Nagase, H. ( 2004) J. Biol. Chem. 279, 10109-10119 and Gao, G., Plaas, A., Thompson, V. P., Jin, S., Zuo, F., and Sandy, J. D. ( 2004) J. Biol. Chem. 279, 10042 10051), our detailed investigation of the role of the C-terminal spacer domain of ADAMTS-4 indicated that full-length ADAMTS-4 is similar to 20-times more active against aggrecan than its spacer domain deletion mutant, even at the Glu(373)-Ala(374) site of the interglobular domain. This discrepancy is most likely due to selective inhibition of full-length ADAMTS-4 by heparin, particularly for cleavage at the Glu(373)-Ala(374) bond. However, removal of the spacer domain from ADAMTS-4 greatly enhanced more general proteolytic activity against non-aggrecan substrates, e. g. E. coli-expressed interglobular domain, fibromodulin, and carboxymethylated transferrin.	[Fushimi, Kazunari; Troeberg, Linda; Nakamura, Hiroyuki; Lim, Ngee Han; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London W6 8LH, England	Imperial College London; University of Oxford	Nagase, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, 1 Aspenlea Rd, London W6 8LH, England.	h.nagase@imperial.ac.uk	nakamura, hiroyuki/A-2953-2013; Fushimi, Kazunari/AAN-8382-2021; Lim, Ngee Han/B-4226-2011	nakamura, hiroyuki/0000-0002-2524-3063; Lim, Ngee Han/0000-0002-8520-7857; /0000-0003-0939-4651; Fushimi, Kazunari/0000-0003-0884-1990	NIAMS NIH HHS [AR40994] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HASCALL VC, 1969, J BIOL CHEM, V244, P2384; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Melching LI, 2006, OSTEOARTHR CARTILAGE, V14, P1147, DOI 10.1016/j.joca.2006.05.014; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; WYCKOFF M, 1977, ANAL BIOCHEM, V78, P459, DOI 10.1016/0003-2697(77)90107-5; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	36	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6706	6716		10.1074/jbc.M708647200	http://dx.doi.org/10.1074/jbc.M708647200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18156631	hybrid			2022-12-27	WOS:000253779600012
J	Ozog, MA; Modha, G; Church, J; Reilly, R; Naus, CC				Ozog, Mark A.; Modha, Geetanjalee; Church, John; Reilly, Rayne; Naus, Christian C.			Co-administration of ciliary neurotrophic factor with its soluble receptor protects against neuronal death and enhances neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; LEUKEMIA INHIBITORY FACTOR; ENTORHINAL CORTEX LESION; ADULT-RAT BRAIN; PC12 CELLS; SYMPATHETIC NEURONS; MESSENGER-RNA; CNTF RECEPTOR; DIFFERENTIAL EXPRESSION; SULFATE PROTEOGLYCANS	Attempts to promote neuronal survival and repair with ciliary neurotrophic factor (CNTF) have met with limited success. The variability of results obtained with CNTF may, in part, reflect the fact that some of the biological actions of the cytokine are mediated by a complex formed between CNTF and its specific receptor, CNTFR alpha, which exists in both membrane-bound and soluble forms. In this study, we compared the actions of CNTF alone and CNTF complexed with soluble CNTFR alpha (hereafter termed "Complex") on neuronal survival and growth. Although CNTF alone produced limited effects, Complex protected against glutamate-mediated excitotoxicity via gap junction-dependent and -independent mechanisms. Further examination revealed that only Complex promoted neurite outgrowth. Differential gene expression analysis revealed that, compared with CNTF alone, Complex differentially regulates several neuroprotective and neurotrophic genes. Collectively, these findings indicate that CNTF exerts more robust effects on neuronal survival and growth when applied in combination with its soluble receptor.	[Ozog, Mark A.; Modha, Geetanjalee; Church, John; Reilly, Rayne; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Naus, CC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cnaus@interchange.ubc.ca						ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Avwenagha O, 2003, J NEUROCYTOL, V32, P1055, DOI 10.1023/B:NEUR.0000021902.65233.8d; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; Blanc EM, 1998, J NEUROCHEM, V70, P958; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cushing P, 2005, J NEUROSCI RES, V82, P788, DOI 10.1002/jnr.20689; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DELS, 2006, EUR J NEUROSCI, V23, P65; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DUGAN LL, 1995, J NEUROSCI, V15, P4545; Emerich DF, 2004, CELL TRANSPLANT, V13, P253, DOI 10.3727/000000004783983981; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Guo X, 1997, DEV BRAIN RES, V104, P101, DOI 10.1016/S0165-3806(97)00142-9; GUPTA SK, 1993, EUR J NEUROSCI, V5, P977, DOI 10.1111/j.1460-9568.1993.tb00949.x; Hartwig C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-53; HEYMANNS J, 1987, P NATL ACAD SCI USA, V84, P7758, DOI 10.1073/pnas.84.21.7758; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Holm NR, 2002, J NEUROCHEM, V82, P495, DOI 10.1046/j.1471-4159.2002.00963.x; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kelleher MO, 2006, ACTA NEUROCHIR, V148, P55, DOI 10.1007/s00701-005-0631-2; Kim BJ, 2004, INVEST OPHTH VIS SCI, V45, P3170, DOI 10.1167/iovs.03-0919; Kim IJ, 2004, J NEUROSCI, V24, P3304, DOI 10.1523/JNEUROSCI.3286-03.2004; LAWRANCE G, 1995, J NEUROCHEM, V64, P1483; Lee MY, 1997, J NEUROSCI, V17, P1137; Lee N, 2005, NEUROSCI LETT, V374, P161, DOI 10.1016/j.neulet.2004.10.048; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; MacLennan AJ, 1996, J NEUROSCI, V16, P621; Malgrange B, 1998, NEUROCHEM RES, V23, P1133, DOI 10.1023/A:1020724506337; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Matsui F, 2005, J NEUROSCI RES, V81, P837, DOI 10.1002/jnr.20603; McCallister WV, 2004, J RECONSTR MICROSURG, V20, P473, DOI 10.1055/s-2004-833499; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; NAGATA K, 1993, INT J DEV NEUROSCI, V11, P227, DOI 10.1016/0736-5748(93)90081-N; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Ng YP, 2003, J BIOL CHEM, V278, P38731, DOI 10.1074/jbc.M304623200; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; Ogata N, 1996, ACTA NEUROCHIR, V138, P580, DOI 10.1007/BF01411179; Ozog MA, 2002, CANCER RES, V62, P3544; Ozog MA, 2004, MOL BIOL CELL, V15, P4761, DOI 10.1091/mbc.E04-03-0271; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Park CK, 2000, BRAIN RES, V861, P345, DOI 10.1016/S0006-8993(00)02045-X; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; RUDGE JS, 1995, J NEUROSCI, V15, P6856; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; SAGGIO I, 1995, EMBO J, V14, P3045, DOI 10.1002/j.1460-2075.1995.tb07307.x; Shuto T, 2001, NEUROREPORT, V12, P1081, DOI 10.1097/00001756-200104170-00043; Simon R, 1995, NEUROREPORT, V7, P153, DOI 10.1097/00001756-199512000-00037; Smit M, 2003, BIOTECHNIQUES, V35, P254, DOI 10.2144/03352bm01; Sterneck E, 1996, J NEUROCHEM, V67, P1365; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Takeda K, 1998, J IMMUNOL, V161, P4652; Theis M, 2003, J NEUROSCI, V23, P766; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Treister NS, 2005, J DENT RES, V84, P160, DOI 10.1177/154405910508400210; Tu YH, 1998, J CEREBR BLOOD F MET, V18, P658, DOI 10.1097/00004647-199806000-00008; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Xia XG, 2002, MOL CELL NEUROSCI, V21, P379, DOI 10.1006/mcne.2002.1180; ZAHEER A, 1995, CELL MOL NEUROBIOL, V15, P221, DOI 10.1007/BF02073330; Zhang J, 2004, J RECONSTR MICROSURG, V20, P323, DOI 10.1055/s-2004-824891; ZHONG WX, 1994, BRAIN RES, V661, P56, DOI 10.1016/0006-8993(94)91180-0	84	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6546	6560		10.1074/jbc.M709065200	http://dx.doi.org/10.1074/jbc.M709065200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18086669	hybrid			2022-12-27	WOS:000253779500061
J	Itoh, H; Suzuta, T; Hoshino, T; Takaya, N				Itoh, Hideomi; Suzuta, Tetsuya; Hoshino, Takayuki; Takaya, Naoki			Novel dehydrogenase catalyzes oxidative hydrolysis of carbon-nitrogen double bonds for hydrazone degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; GLUTAMINE TRANSAMINASE; AGARICUS-BISPORUS; ACTIVE-SITE; METABOLISM; YEAST; PARTICIPATION	Hydrazines and their derivatives are versatile artificial and natural compounds that are metabolized by elusive biological systems. Here we identified microorganisms that assimilate hydrazones and isolated the yeast, Candida palmioleophila MK883. When cultured with adipic acid bis(ethylidene hydrazide) as the sole source of carbon, C. palmioleophila MK883 degraded hydrazones and accumulated adipic acid dihydrazide. Cytosolic NAD(+)-or NADP(+)-dependent hydrazone dehydrogenase (Hdh) activity was detectable under these conditions. The production of Hdh was inducible by adipic acid bis(ethylidene hydrazide) and the hydrazone, varelic acid ethylidene hydrazide, under the control of carbon catabolite repression. Purified Hdh oxidized and hydrated the C = N double bond of acetaldehyde hydrazones by reducing NAD(+) or NADP(+) to produce relevant hydrazides and acetate, the latter of which the yeast assimilated. The deduced amino acid sequence revealed that Hdh belongs to the aldehyde dehydrogenase (Aldh) superfamily. Kinetic and mutagenesis studies showed that Hdh formed a ternary complex with the substrates and that conserved Cys is essential for the activity. The mechanism of Hdh is similar to that of Aldh, except that it catalyzed oxidative hydrolysis of hydrazones that requires adding a water molecule to the reaction catalyzed by conventional Aldh. Surprisingly, both Hdh and Aldh from baker's yeast (Ald4p) catalyzed the Hdh reaction as well as aldehyde oxidation. Our findings are unique in that we discovered a biological mechanism for hydrazone utilization and a novel function of proteins in the Aldh family that act on C = N compounds.	[Itoh, Hideomi; Suzuta, Tetsuya; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	Itoh, Hideomi/M-3429-2018	Itoh, Hideomi/0000-0001-5114-9268				BARRATT RW, 1965, GENETICS, V52, P233; Boubekeur S, 2001, EUR J BIOCHEM, V268, P5057, DOI 10.1046/j.1432-1327.2001.02418.x; BRADBURY AF, 1987, EUR J BIOCHEM, V169, P579, DOI 10.1111/j.1432-1033.1987.tb13648.x; BRANDRISS MC, 1983, MOL CELL BIOL, V3, P1846, DOI 10.1128/MCB.3.10.1846; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; COOPER AJL, 1973, J BIOL CHEM, V248, P8489; COOPER AJL, 1972, BIOCHEMISTRY-US, V11, P661; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; GIGLIOTTI HJ, 1964, J BIOL CHEM, V239, P2274; HANKINSON O, 1974, J BIOL CHEM, V249, P2344; Haslett MR, 2004, BBA-GEN SUBJECTS, V1675, P81, DOI 10.1016/j.bbagen.2004.08.008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACOBSON MK, 1974, BIOCHIM BIOPHYS ACTA, V350, P277, DOI 10.1016/0005-2744(74)90502-6; Kennedy SH, 1997, J PSYCHIATR NEUROSCI, V22, P127; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; McCammon MT, 1996, GENETICS, V144, P57; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MICHELOT D, 1989, J TOXICOL CLIN EXPER, V9, P83; NAKASE T, 1988, J GEN APPL MICROBIOL, V34, P493, DOI 10.2323/jgam.34.493; Nguyen R, 2003, CHEM COMMUN, P942, DOI 10.1039/b211645f; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Ono Y, 1998, BIOL PHARM BULL, V21, P421; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; REYNOLDS DR, 1993, FUNGAL HOLOMORPH MIT, P225; ROTHGERY EF, 2004, J TOXICOL CLIN EXP, V9, P83; Sarich TC, 1999, J PHARMACOL EXP THER, V289, P695; Shimogawa H, 2006, TETRAHEDRON LETT, V47, P1409, DOI 10.1016/j.tetlet.2005.12.087; SMITH TA, 1969, PHYTOCHEMISTRY, V8, P2111, DOI 10.1016/S0031-9422(00)88168-6; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; STRECKER HJ, 1971, METHODS ENZYMOLOGY B, V17, P262; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; TOIDA I, 1963, J BIOCHEM-TOKYO, V53, P14, DOI 10.1093/oxfordjournals.jbchem.a127651; TOTH B, 1978, CANCER RES, V38, P177; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Wei BX, 2003, CHEM-BIOL INTERACT, V143, P85, DOI 10.1016/S0009-2797(02)00177-1	41	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5790	5800		10.1074/jbc.M709027200	http://dx.doi.org/10.1074/jbc.M709027200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096698	hybrid			2022-12-27	WOS:000253426700060
J	Piazzon, N; Rage, F; Schlotter, F; Moine, H; Branlant, C; Massenet, S				Piazzon, Nathalie; Rage, Florence; Schlotter, Florence; Moine, Herve; Branlant, Christiane; Massenet, Severine			In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile x mental retardation protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SPINAL MUSCULAR-ATROPHY; RNA-BINDING PROTEIN; DETERMINING GENE-PRODUCT; SMN COMPLEX; MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; FMR1 PROTEIN; RIBONUCLEOPROTEIN BIOGENESIS; CYTOPLASMIC LOCALIZATION; POLYRIBOSOMAL MRNPS	Spinal muscular atrophy (SMA) is caused by reduced levels of the survival of motor neuron (SMN) protein. Although the SMN complex is essential for assembly of spliceosomal U small nuclear RNPs, it is still not understood why reduced levels of the SMN protein specifically cause motor neuron degeneration. SMN was recently proposed to have specific functions in mRNA transport and translation regulation in neuronal processes. The defective protein in Fragile X mental retardation syndrome (FMRP) also plays a role in transport of mRNPs and in their translation. Therefore, we examined possible relationships of SMN with FMRP. We observed granules containing both transiently expressed red fluorescent protein(RFP)-tagged SMN and green fluorescent protein(GFP)-tagged FMRP in cell bodies and processes of rat primary neurons of hypothalamus in culture. By immunoprecipitation experiments, we detected an association of FMRP with the SMN complex in human neuroblastoma SH-SY5Y cells and in murine motor neuron MN-1 cells. Then, by in vitro experiments, we demonstrated that the SMN protein is essential for this association. We showed that the COOH-terminal region of FMRP, as well as the conserved YG box and the region encoded by exon 7 of SMN, are required for the interaction. Our findings suggest a link between the SMN complex and FMRP in neuronal cells.	[Piazzon, Nathalie; Schlotter, Florence; Branlant, Christiane; Massenet, Severine] CNRS, Fac Sci, Lab Maturat ARN & Enzymol Mol, UHP Nancy 1,UMR 7567, F-54506 Vandoeuvre Les Nancy, France; [Rage, Florence] Inst Genet Mol Montpellier, UMR 5535, F-34293 Montpellier, France; [Moine, Herve] CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Massenet, S (corresponding author), CNRS, Fac Sci, Lab Maturat ARN & Enzymol Mol, UHP Nancy 1,UMR 7567, BP 239, F-54506 Vandoeuvre Les Nancy, France.	severine.massenet@maem.uhp-nancy.fr	Rage, Florence/F-4828-2016; Moine, Herve/Q-2328-2016	Moine, Herve/0000-0002-6250-7902; Rage, Florence/0000-0003-1221-3903; Severine, Massenet/0000-0001-5187-8356; Branlant, Christiane/0000-0003-4728-5499				Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bechade C, 1999, EUR J NEUROSCI, V11, P293, DOI 10.1046/j.1460-9568.1999.00428.x; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dolzhanskaya N, 2003, BIOCHEM BIOPH RES CO, V305, P434, DOI 10.1016/S0006-291X(03)00766-6; Dolzhanskaya N, 2006, BIOCHEMISTRY-US, V45, P10385, DOI 10.1021/bi0525019; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lefebvre S, 2002, HUM MOL GENET, V11, P1017, DOI 10.1093/hmg/11.9.1017; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Rage F, 1999, ENDOCRINOLOGY, V140, P909, DOI 10.1210/en.140.2.909; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Schaeffer C, 2003, BIOL CELL, V95, P221, DOI 10.1016/S0248-4900(03)00037-6; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Siomi H, 2004, MENT RETARD DEV D R, V10, P68, DOI 10.1002/mrdd.20011; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Twiss JL, 2006, J NEUROTRAUM, V23, P295, DOI 10.1089/neu.2006.23.295; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	150	71	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5598	5610		10.1074/jbc.M707304200	http://dx.doi.org/10.1074/jbc.M707304200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093976	hybrid, Green Published			2022-12-27	WOS:000253426700040
J	Zhang, L; Liu, WZ; Hu, TC; Du, L; Luo, C; Chen, KX; Shen, X; Jiang, HL				Zhang, Liang; Liu, Weizhi; Hu, Tiancen; Du, Li; Luo, Cheng; Chen, Kaixian; Shen, Xu; Jiang, Hualiang			Structural basis for catalytic and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; ACP DEHYDRATASE; DISCOVERY; ISOMERASE; ALIGNMENT; TARGETS	beta-Hydroxyacyl-acyl carrier protein dehydratase (FabZ) is an important enzyme for the elongation cycles of both saturated and unsaturated fatty acids biosyntheses in the type II fatty acid biosynthesis system (FAS II) pathway. FabZ has been an essential target for the discovery of compounds effective against pathogenic microbes. In this work, to characterize the catalytic and inhibitory mechanisms of FabZ, the crystal structures of the FabZ of Helicobacter pylori (HpFabZ) and its complexes with two newly discovered inhibitors have been solved. Different from the structures of other bacterial FabZs, HpFabZ contains an extra short two-turn alpha-helix (alpha 4) between alpha 3 and beta 3, which plays an important role in shaping the substrate-binding tunnel. Residue Tyr-100 at the entrance of the tunnel adopts either an open or closed conformation in the crystal structure. The crystal structural characterization, the binding affinity determination, and the enzymatic activity assay of the HpFabZ mutant (Y100A) confirm the importance of Tyr-100 in catalytic activity and substrate binding. Residue Phe-83 at the exit tunnel was also refined in two alternative conformations, leading the tunnel to form an L-shape and U-shape. All these data thus contributed much to understanding the catalytic mechanism of HpFabZ. In addition, the co-crystal structures of HpFabZ with its inhibitors have suggested that the enzymatic activity of HpFabZ could be inhibited either by occupying the entrance of the tunnel or plugging the tunnel to prevent the substrate from accessing the active site. Our study has provided some insights into the catalytic and inhibitory mechanisms of FabZ, thus facilitating antibacterial agent development.	[Zhang, Liang; Liu, Weizhi; Hu, Tiancen; Du, Li; Luo, Cheng; Chen, Kaixian; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China; [Shen, Xu; Jiang, Hualiang] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; East China University of Science & Technology	Shen, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China.	xshen@mail.shcnc.ac.cn	Du, Li/L-2353-2015; Zhang, Liang/F-8064-2013	Zhang, Liang/0000-0002-7672-1168				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; DELANOUE WL, 2002, PUMOL MOL GRAPHICS S; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARWIN JL, 1980, J BIOL CHEM, V255, P1949; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Kostrewa D, 2005, PROTEIN SCI, V14, P1570, DOI 10.1110/ps.051373005; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Liu WZ, 2007, PROTEIN EXPRES PURIF, V52, P74, DOI 10.1016/j.pep.2006.09.003; Liu WZ, 2005, BIOCHEM BIOPH RES CO, V333, P1078, DOI 10.1016/j.bbrc.2005.05.197; Lu YJ, 2005, J BIOL CHEM, V280, P30342, DOI 10.1074/jbc.M504637200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Sharma SK, 2003, J BIOL CHEM, V278, P45661, DOI 10.1074/jbc.M304283200; Swarnamukhi PL, 2006, FEBS LETT, V580, P2653, DOI 10.1016/j.febslet.2006.04.014; Tasdemir D, 2006, J MED CHEM, V49, P3345, DOI 10.1021/jm0600545; Viola R, 2007, J APPL CRYSTALLOGR, V40, P539, DOI 10.1107/S0021889807012149; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200	27	55	72	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5370	5379		10.1074/jbc.M705566200	http://dx.doi.org/10.1074/jbc.M705566200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093984	hybrid			2022-12-27	WOS:000253426700017
J	Kizawa, K; Takahara, H; Troxler, H; Kleinert, P; Mochida, U; Heizmann, CW				Kizawa, Kenji; Takahara, Hidenari; Troxler, Heinz; Kleinert, Peter; Mochida, Urara; Heizmann, Claus W.			Specific citrullination causes assembly of a globular S100A3 homotetramer - A putative Ca2+ modulator matures human hair cuticle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; EPIDERMAL DIFFERENTIATION COMPLEX; PEPTIDYLARGININE DEIMINASE; CYSTEINE-RICH; CRYSTAL-STRUCTURE; HUMAN SKIN; FOLLICLE; TRICHOHYALIN; MOUSE; GENE	S100A3 is a unique member of the Ca2+- binding S100 protein family with the highest cysteine content and affinity for Zn2+. This protein is highly expressed in the differentiating cuticular cells within the hair follicle and organized into mature hair cuticles. Previous studies suggest a close association of S100A3 with epithelial differentiation, leading to hair shaft formation, but its molecular function is still unknown. By two-dimensional PAGE-Western blot analyses using a modified citrulline antibody, we discovered that more than half of the arginine residues of native S100A3 are progressively converted to citrullines by Ca2+-dependent peptidylarginine deiminases. Confocal immunofluorescent microscopy showed that the cytoplasmic S100A3 within the cuticular layer is mostly co-localized with the type III isoform of peptidylarginine deiminase (PAD3) but not with PAD1. Recombinant PAD1 and PAD2 are capable of converting all 4 arginines in recombinant S100A3, whereas PAD3 specifically converts only Arg-51 into citrulline. Gel filtration analyses showed that either enzymatic conversion of Arg-51 in S100A3 to citrulline or its mutational substitution with alanine (R51A) promotes a homotetramer assembly. Fluorescent titration of R51A suggested that its potential Ca2+ binding property increased during tetramerization. A prototype structural model of the globular Ca2+- bound S100A3 tetramer with citrulline residues is presented. High concentrations of S100A3 homotetramer might provide the millimolar level of Ca2+ required for hair cuticular barrier formation.	[Kizawa, Kenji] Kanebo Cosmet Inc, Basic Res Lab, Odawara 2500002, Japan; [Takahara, Hidenari; Mochida, Urara] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ibaraki 3000393, Japan; [Troxler, Heinz; Kleinert, Peter; Heizmann, Claus W.] Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland	Kanebo Cosmetics Inc.; Ibaraki University; University of Zurich	Kizawa, K (corresponding author), Kanebo Cosmet Inc, Basic Res Lab, 5-3-28 Kotobuki Cho, Odawara 2500002, Japan.	kizawa.kenji@kanebocos.co.jp		Takahara, Hidenari/0000-0003-2373-8588				Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; FOHR UG, 1995, J BIOL CHEM, V270, P21056, DOI 10.1074/jbc.270.36.21056; Fritz G, 1998, BBA-MOL CELL RES, V1448, P264, DOI 10.1016/S0167-4889(98)00138-4; Fritz G, 2002, J BIOL CHEM, V277, P33092, DOI 10.1074/jbc.M200574200; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kizawa K, 2005, J COSMET SCI, V56, P219; Kizawa K, 2005, BRIT J DERMATOL, V152, P314, DOI 10.1111/j.1365-2133.2004.06391.x; Kizawa K, 1998, J INVEST DERMATOL, V111, P879, DOI 10.1046/j.1523-1747.1998.00385.x; Kizawa K, 2002, BIOCHEM BIOPH RES CO, V299, P857, DOI 10.1016/S0006-291X(02)02744-4; Kizawa K, 1996, BBA-MOL CELL RES, V1312, P94, DOI 10.1016/0167-4889(96)00023-7; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mittl PRE, 2002, ACTA CRYSTALLOGR D, V58, P1255, DOI 10.1107/S0907444902008430; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Nachat R, 2005, J INVEST DERMATOL, V125, P34, DOI 10.1111/j.0022-202X.2005.23763.x; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Robinson NA, 1998, J BIOL CHEM, V273, P2721, DOI 10.1074/jbc.273.5.2721; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; TAKAHARA H, 1985, J BIOL CHEM, V260, P8378; Takizawa T, 1999, J HISTOCHEM CYTOCHEM, V47, P525, DOI 10.1177/002215549904700411; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200	42	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5004	5013		10.1074/jbc.M709357200	http://dx.doi.org/10.1074/jbc.M709357200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083705	hybrid, Green Accepted			2022-12-27	WOS:000253426500058
J	Tosha, T; Kagawa, N; Arase, M; Waterman, MR; Kitagawa, T				Tosha, Takehiko; Kagawa, Norio; Arase, Miharu; Waterman, Michael R.; Kitagawa, Teizo			Interaction between substrate and oxygen ligand responsible for effective O-O bond cleavage in bovine cytochrome P450 steroid 21-hydroxylase proved by Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CONGENITAL ADRENAL-HYPERPLASIA; FERROUS DIOXYGEN COMPLEX; FE-S BOND; RESONANCE RAMAN; ESCHERICHIA-COLI; PSEUDOMONAS-PUTIDA; OXYCYTOCHROME P450CAM; STRUCTURAL-CHANGES; BACILLUS-SUBTILIS	We investigated structural and functional properties of bovine cytochrome P450 steroid 21-hydroxylase (P450c21), which catalyzes hydroxylation at C-21 of progesterone and 17 alpha-hydroxyprogesterone. The uncoupled H2O2 formation was higher in the hydroxylation of progesterone (26% of NADPH consumed) than that of 17 alpha-hydroxyprogesterone (15% of NADPH consumed), indicating that 17 alpha-hydroxyprogesterone can better facilitate the O-O bond scission. In relation to this, it is noted that the O-O stretching mode (nu(O-O)) of the oxygen complex of P450c21 was sensitive to the substrate; the progesterone- or 17 alpha-hydroxyprogesterone-bound enzyme gave single (at 1137 cm(-1)) or split nu(O-O) bands (at 1124 and 1138 cm(-1)), respectively, demonstrating the presence of two forms for the latter. In contrast to nu(O-O), no corresponding difference was observed for the Fe-O-2 stretching mode between two different substrate-bound forms. The Fe-S(Cys) stretching mode in the ferric state was also identical (349 cm(-1)) for each substrate-bound form, suggesting that modulation through the axial thiolate by the substrate is unlikely. Therefore, it is deduced that the hydroxyl group at C-17 of 17 alpha-hydroxyprogesterone forms a hydrogen bond with the terminal oxygen atom of the FeOO complex in one form, yielding a lower nu(O-O) frequency with higher reactivity for O-O cleavage, whereas the other form in which the substrate does not provide a hydrogen bond to the oxygen ligand is essentially the same between the two kinds of substrates. In the hydrogen-bonded species, the substrate changes the geometry of the FeOO moiety, thereby performing the hydroxylation reaction more effectively in 17 alpha-hydroxyprogesterone than in progesterone.	[Tosha, Takehiko; Kitagawa, Teizo] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kagawa, Norio; Arase, Miharu; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Kitagawa, Teizo] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Vanderbilt University	Kitagawa, T (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan.	Riken-kitagawa@mosk.tytlabs.co.jp	Tosha, Takehiko/AAR-2404-2020	Tosha, Takehiko/0000-0002-8971-0759	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037942, R01GM037942] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00267] Funding Source: Medline; NIGMS NIH HHS [GM37942] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; Arase M, 2006, BIOCHEM BIOPH RES CO, V344, P400, DOI 10.1016/j.bbrc.2006.03.067; BANGCHAROENPAURPONG O, 1986, J BIOL CHEM, V261, P8089; BANGCHAROENPAURPONG O, 1986, BIOCHEMISTRY-US, V25, P2374, DOI 10.1021/bi00357a011; Bec N, 1998, J BIOL CHEM, V273, P13502, DOI 10.1074/jbc.273.22.13502; CHAMPION PM, 1978, J AM CHEM SOC, V100, P3743, DOI 10.1021/ja00480a015; CHAMPION PM, 1982, J AM CHEM SOC, V104, P5469, DOI 10.1021/ja00384a037; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chen ZC, 2003, BIOCHEMISTRY-US, V42, P2542, DOI 10.1021/bi027206s; Chen ZC, 2004, BIOCHEMISTRY-US, V43, P1798, DOI 10.1021/bi034920g; Couture M, 2000, J BIOL CHEM, V275, P3201, DOI 10.1074/jbc.275.5.3201; Das TK, 2001, P NATL ACAD SCI USA, V98, P479, DOI 10.1073/pnas.98.2.479; de Montellano O., 2005, CYTOCHROME P450 STRU; ESTABROOK RW, 1963, BIOCHEM Z, V338, P741; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HIGUCHI A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P240, DOI 10.1016/0005-2760(91)90064-O; HILDEBRAND DP, 1995, BIOCHEMISTRY-US, V34, P1997, DOI 10.1021/bi00006a021; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; HU SZ, 1991, J AM CHEM SOC, V113, P4815, DOI 10.1021/ja00013a016; Hu SZ, 1996, J AM CHEM SOC, V118, P12638, DOI 10.1021/ja962239e; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; Jameson GNL, 2002, BIOCHEMISTRY-US, V41, P13435, DOI 10.1021/bi026478s; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; KAGAWA N, 1990, J BIOL CHEM, V265, P11299; Kagawa N, 2003, STEROIDS, V68, P205, DOI 10.1016/S0039-128X(02)00168-X; KAGAWA N, 1991, J BIOL CHEM, V266, P11199; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; Kominami S, 2001, J BIOL CHEM, V276, P10753, DOI 10.1074/jbc.M006043200; Ledbetter AP, 1999, BIOCHEMISTRY-US, V38, P8014, DOI 10.1021/bi990619h; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Lu CY, 2007, J BIOL CHEM, V282, P13627, DOI 10.1074/jbc.M609397200; Macdonald IDG, 1999, J AM CHEM SOC, V121, P376, DOI 10.1021/ja9810383; Modi S, 1996, NAT STRUCT BIOL, V3, P414, DOI 10.1038/nsb0596-414; Nagano S, 2003, BIOCHEMISTRY-US, V42, P14507, DOI 10.1021/bi035410p; Nagano S, 2005, J BIOL CHEM, V280, P22102, DOI 10.1074/jbc.M501732200; Nagano S, 2005, J BIOL CHEM, V280, P31659, DOI 10.1074/jbc.M505261200; Neri F, 1999, BIOCHEMISTRY-US, V38, P7819, DOI 10.1021/bi982811+; Nickerson DP, 1997, FEBS LETT, V405, P153, DOI 10.1016/S0014-5793(97)00174-9; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; OZAKI Y, 1978, BIOCHEMISTRY-US, V17, P5826, DOI 10.1021/bi00619a033; Peterson ES, 1998, BIOCHEMISTRY-US, V37, P12301, DOI 10.1021/bi980752u; PETERSON JA, 1972, ARCH BIOCHEM BIOPHYS, V149, P197, DOI 10.1016/0003-9861(72)90315-3; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Schelvis JPM, 2002, BIOCHEMISTRY-US, V41, P5695, DOI 10.1021/bi0118456; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjodin T, 2001, BIOCHEMISTRY-US, V40, P6852, DOI 10.1021/bi002510b; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Smulevich G, 2005, ACCOUNTS CHEM RES, V38, P433, DOI 10.1021/ar020112q; Spiro TG, 1988, BIOL APPL RAMAN SPEC, V3, P1; Tosha T, 2006, BIOCHEMISTRY-US, V45, P5631, DOI 10.1021/bi060094a; Tosha T, 2004, J BIOL CHEM, V279, P42836, DOI 10.1074/jbc.M404216200; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Vogel KM, 1999, J AM CHEM SOC, V121, P9915, DOI 10.1021/ja990042r; Wei CC, 2003, J BIOL CHEM, V278, P46668, DOI 10.1074/jbc.M307682200; WELLS AV, 1992, BIOCHEMISTRY-US, V31, P4384, DOI 10.1021/bi00133a002; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Yoshioka S, 2002, J AM CHEM SOC, V124, P14571, DOI 10.1021/ja0265409; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	64	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3708	3717		10.1074/jbc.M707338200	http://dx.doi.org/10.1074/jbc.M707338200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18032381	hybrid			2022-12-27	WOS:000253083500004
J	Subbaramaiah, K; Hudis, C; Chang, SH; Hla, T; Dannenberg, AJ				Subbaramaiah, Kotha; Hudis, Clifford; Chang, Sung-Hee; Hla, Timothy; Dannenberg, Andrew J.			EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells - Evidence of a BRCA1 and p300 exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE STROMAL CELLS; TRANSCRIPTIONAL REGULATION; ESTROGEN BIOSYNTHESIS; GENE-EXPRESSION; ALTERNATIVE PROMOTERS; RESPONSIVE ELEMENT; GRANULOSA-CELLS; CYP19 GENE; TISSUE; ACTIVATION	Cytochrome P450 aromatase (aromatase), a product of the CYP19 gene, catalyzes the synthesis of estrogens from androgens. Because aromatase-dependent estrogen biosynthesis has been linked to hormone-dependent breast carcinogenesis, it is important to elucidate the mechanisms that regulate CYP19 gene expression. The main objective of this study was to identify the receptors (EP) for prostaglandin E-2 (PGE(2)) that mediate the induction of CYP19 transcription in human adipocytes and breast cancer cells. Treatment with PGE2 induced aromatase, an effect that was mimicked by either EP2 or EP4 agonists. Antagonists of EP2 or EP4 or small interference RNA-mediated down-regulation of these receptors suppressed PGE(2)-mediated induction of aromatase. PGE(2) via EP2 and EP4 stimulated the cAMP -> protein kinase A pathway resulting in enhanced interaction between P-CREB, p300, and the aromatase promoter I.3/II. Overexpressing a mutant form of p300 that lacks histone acetyltransferase activity suppressed PGE(2)-mediated induction of aromatase promoter activity. PGE(2) via EP2 and EP4 also caused a reduction in both the amounts of BRCA1 and the interaction between BRCA1 and the aromatase promoter I.3/II. Activation of the aromatase promoter by PGE(2) was suppressed by overexpressing wild-type BRCA1. Silencing of EP2 or EP4 also blocked PGE(2)-mediated induction of the progesterone receptor, a prototypic estrogen-response gene. In a mouse model, overexpressing COX-2 in the mammary gland, a known inducer of PGE(2) synthesis, led to increased aromatase mRNA and activity and reduced amounts of BRCA1; these effects were reversed by knocking out EP2. Taken together, these results suggest that PGE(2) via EP2 and EP4 activates the cAMP -> PKA -> CREB pathway leading to enhanced CYP19 transcription and increased aromatase activity. Reciprocal changes in the interaction between BRCA1, p300, and the aromatase promoter I.3/II contributed to the inductive effects of PGE(2).	[Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Hudis, Clifford] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chang, Sung-Hee; Hla, Timothy] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Ctr Vasc Biol, Farmington, CT 06030 USA	Cornell University; Memorial Sloan Kettering Cancer Center; University of Connecticut	Subbaramaiah, K (corresponding author), New York Presbyterian Hosp Cornell, 525 E 68th St,Rm F-203A, New York, NY 10065 USA.	ksubba@med.cornell.edu	Hudis, Clifford/AAW-9482-2021; Hla, Timothy/G-5873-2012	Hudis, Clifford/0000-0001-7144-8791; Hla, Timothy/0000-0001-8355-4065	NCI NIH HHS [P01CA77839] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Barnes PJ, 2006, J CLIN INVEST, V116, P1210, DOI 10.1172/JCI28535; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brodie AMH, 2001, J STEROID BIOCHEM, V79, P41, DOI 10.1016/S0960-0760(01)00131-5; Brueggemeier RW, 1999, CANCER LETT, V140, P27, DOI 10.1016/S0304-3835(99)00050-6; Bulun SE, 2005, PHARMACOL REV, V57, P359, DOI 10.1124/pr.57.3.6; Cai ZL, 2007, MOL CELL ENDOCRINOL, V263, P181, DOI 10.1016/j.mce.2006.09.012; Chang SH, 2005, CANCER RES, V65, P4496, DOI 10.1158/0008-5472.CAN-05-0129; Chen S, 2005, J STEROID BIOCHEM, V95, P17, DOI 10.1016/j.jsbmb.2005.04.002; Chen S, 2002, J STEROID BIOCHEM, V83, P93, DOI 10.1016/S0960-0760(02)00276-5; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; DuBois RN, 2004, JAMA-J AM MED ASSOC, V291, P2488, DOI 10.1001/jama.291.20.2488; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Ghosh S, 2007, AM J PHYSIOL-ENDOC M, V292, pE246, DOI 10.1152/ajpendo.00242.2006; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hayes F, 2000, CANCER RES, V60, P2411; Hu YF, 2005, ONCOGENE, V24, P8343, DOI 10.1038/sj.onc.1208985; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu ML, 2006, J CLIN ENDOCR METAB, V91, P4514, DOI 10.1210/jc.2006-1364; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; MAHENDROO MS, 1993, J BIOL CHEM, V268, P19463; Miki Y, 2007, CANCER RES, V67, P3945, DOI 10.1158/0008-5472.CAN-06-3105; Noble LS, 1997, J CLIN ENDOCR METAB, V82, P600, DOI 10.1210/jc.82.2.600; Prosperi JR, 2006, PROSTAG OTH LIPID M, V81, P55, DOI 10.1016/j.prostaglandins.2006.07.003; READ LD, 1988, MOL ENDOCRINOL, V2, P263, DOI 10.1210/mend-2-3-263; Richards JA, 2003, J CLIN ENDOCR METAB, V88, P2810, DOI 10.1210/jc.2002-021475; Rubin GL, 2000, CANCER RES, V60, P1604; SAVOURET JF, 1991, EMBO J, V10, P1875, DOI 10.1002/j.1460-2075.1991.tb07713.x; SILVA MC, 1989, CANCER RES, V49, P2588; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Strasser-Weippl K, 2003, J MAMMARY GLAND BIOL, V8, P5, DOI 10.1023/A:1025727103811; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Subbaramaiah K, 2006, CANCER RES, V66, P5504, DOI 10.1158/0008-5472.CAN-05-4076; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Terry MB, 2004, JAMA-J AM MED ASSOC, V291, P2433, DOI 10.1001/jama.291.20.2433; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wilson SJ, 2007, ARTERIOSCL THROM VAS, V27, P290, DOI 10.1161/01.ATV.0000252667.53790.4e; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhao Y, 1997, J STEROID BIOCHEM, V61, P203, DOI 10.1016/S0960-0760(97)80013-1; Zhao Y, 1996, ENDOCRINOLOGY, V137, P5739, DOI 10.1210/en.137.12.5739; Zhou DJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P179, DOI 10.1006/abbi.1999.1454	48	75	78	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3433	3444		10.1074/jbc.M705409200	http://dx.doi.org/10.1074/jbc.M705409200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18083712	hybrid			2022-12-27	WOS:000253083000049
J	Minamizaki, K; Mizoguchi, T; Goto, T; Tamiaki, H; Fujita, Y				Minamizaki, Kei; Mizoguchi, Tadashi; Goto, Takeaki; Tamiaki, Hitoshi; Fujita, Yuichi			Identification of two homologous genes, chlAI and chlA(II), that are differentially involved in isocyclic ring formation of chlorophyll a in the cyanobacterium Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOBACTER-CAPSULATUS; CHLAMYDOMONAS-REINHARDTII; PHOTOSYSTEM-I; BACTERIOCHLOROPHYLL BIOSYNTHESIS; PROTOCHLOROPHYLLIDE REDUCTASE; OXYGEN; ENZYME; PHOTOSYNTHESIS; CLUSTER; EVOLUTION	The isocyclic ring (E-ring) is a common structural feature of chlorophylls. The E-ring is formed by two structurally unrelated Mg-protoporphyrin IX monomethylester (MPE) cyclase systems, oxygen-dependent (AcsF), and oxygen-independent (BchE) systems, which involve incorporation of an oxygen atom from molecular oxygen and water into the C-131 position of MPE, respectively. Which system operates in cyanobacteria that can thrive in a variety of anaerobic environments remains an open question. The cyanobacterium Synechocystis sp.PCC 6803 has two acsF-like genes, sll1214 (chlA(I)) and sll1874 (chlA(II)), and three bchE-like genes, slr0905, sll1242, and slr0309. Five mutants lacking one of these genes were isolated. The Delta chlA(I) mutant failed to grow under aerobic conditions with anomalous accumulation of a pigment with fluorescence emission peak at 595 nm, which was identified 3,8-divinyl MPE by high-performance liquid chromatography-mass spectrometry analysis. The growth defect of Delta chlA(I) was restored by the cultivation under oxygen-limited (micro-oxic) conditions. MPE accumulation was also detected in Delta chlA(II) grown under microoxic conditions, but not in any of the bchE mutants. The phenotype was consistent with the expression pattern of two chlA genes: chlA(II) was induced under micro-oxic conditions in contrast to the constitutive expression of chlA(I). These findings suggested that ChlA(I) is the sole MPE cyclase system under aerobic conditions and that the induced ChlA(II) operates together with ChlA(I) under micro-oxic conditions. In addition, the accumulation of 3,8-divinyl MPE in the Delta chlA mutants suggested that the reduction of 8-vinyl group occurs after the formation of E-ring in Synechocystis sp. PCC 6803.	[Minamizaki, Kei; Goto, Takeaki; Fujita, Yuichi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Mizoguchi, Tadashi; Tamiaki, Hitoshi] Ritsumeikan Univ, Dept Biosci & Biotechnol, Kusatsu 5258577, Japan	Nagoya University; Ritsumeikan University	Fujita, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	fujita@agr.nagoya-u.ac.jp						AIBA H, 1981, J BIOL CHEM, V256, P1905; [Anonymous], 2002, HIST PHIL LIFE SCI; [Anonymous], 2002, PHOTOSYNTHETICA; Bollivar DW, 2006, PHOTOSYNTH RES, V90, P173, DOI 10.1007/s11120-006-9076-6; BOLLIVAR DW, 1995, PHOTOSYNTH RES, V43, P113, DOI 10.1007/BF00042968; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; BOLLIVAR DW, 2003, PORPHYRIN HDB, V13, P49; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1992, PLANT CELL PHYSIOL, V33, P81; Gough SP, 2000, P NATL ACAD SCI USA, V97, P6908, DOI 10.1073/pnas.97.12.6908; He QF, 1998, EUR J BIOCHEM, V253, P161, DOI 10.1046/j.1432-1327.1998.2530161.x; Howitt CA, 1996, BIOTECHNIQUES, V21, P32; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Knoll Andrew H., 2008, P1; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; NASRULHAQBOYCE A, 1987, BIOCHEM J, V243, P23, DOI 10.1042/bj2430023; Naylor GW, 1999, PHOTOSYNTH RES, V62, P121, DOI 10.1023/A:1006350405674; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; Ouchane S, 2007, J BIOL CHEM, V282, P7690, DOI 10.1074/jbc.M605985200; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; SAMBROOK J, 2000, MOL CLONING LAB MANU; Stal L.J., 2000, ECOLOGY CYANOBACTERI, P61; Stal LJ, 1997, FEMS MICROBIOL REV, V21, P179, DOI 10.1016/S0168-6445(97)00056-9; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; XU KP, 1994, J BACTERIOL, V176, P3196, DOI 10.1128/jb.176.11.3196-3203.1994; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zhang XH, 2005, FEBS J, V272, P1012, DOI 10.1111/j.1742-4658.2004.04535.x	45	68	69	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2684	2692		10.1074/jbc.M708954200	http://dx.doi.org/10.1074/jbc.M708954200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039649	hybrid			2022-12-27	WOS:000252622300025
J	Swiercz, JM; Worzfeld, T; Offermanns, S				Swiercz, Jakub M.; Worzfeld, Thomas; Offermanns, Stefan			ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CONTROLS INVASIVE GROWTH; AXON GUIDANCE; RECEPTOR PLEXIN-B1; SEMAPHORIN 3A; R-RAS; ACTIVATING PROTEIN; LIGAND-BINDING; ACTIVE RAC; PDZ-RHOGEF	Sema4D-induced activation of plexin-B1 has been reported to evoke different and sometimes opposing cellular responses. The mechanisms underlying the versatility of plexin-B1-mediated effects are not clear. Plexin-B1 can associate with the receptor tyrosine kinases ErbB-2 and Met. Here we show that Sema4D-induced activation and inactivation of RhoA require ErbB-2 and Met, respectively. In breast carcinoma cells, Sema4D can have pro- and anti-migratory effects depending on the presence of ErbB-2 and Met, and the exchange of the two receptor tyrosine kinases is sufficient to convert the cellular response to Sema4D from pro- to anti-migratory and vice versa. This work identifies a novel mechanism by which plexin-mediated signaling can be regulated and explains how Sema4D can exert different biological activities through the differential association of its receptor with ErbB-2 and Met.	[Swiercz, Jakub M.; Worzfeld, Thomas; Offermanns, Stefan] Univ Heidelberg, Inst Pharmacol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Offermanns, S (corresponding author), Univ Heidelberg, Inst Pharmacol, Neuenheimer Feld 366, D-69120 Heidelberg, Germany.	stefan.offermanns@pharma.uni-heidelberg.de	Offermanns, Stefan/L-3313-2017	Offermanns, Stefan/0000-0001-8676-6805				Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Bussolino F, 2006, ENDOTHELIUM-J ENDOTH, V13, P81, DOI 10.1080/10623320600698003; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Conrotto P, 2004, ONCOGENE, V23, P5131, DOI 10.1038/sj.onc.1207650; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Faltus T, 2004, NEOPLASIA, V6, P786, DOI 10.1593/neo.04313; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Hirotani M, 2002, BIOCHEM BIOPH RES CO, V297, P32, DOI 10.1016/S0006-291X(02)02122-8; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Maeda A, 2006, BIOCHEM BIOPH RES CO, V347, P1158, DOI 10.1016/j.bbrc.2006.07.040; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Negishi M, 2005, MOL NEUROBIOL, V32, P217, DOI 10.1385/MN:32:3:217; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Oinuma I, 2006, J CELL BIOL, V173, P601, DOI 10.1083/jcb.200508204; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Potiron V, 2007, ADV EXP MED BIOL, V600, P132; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; Schwamborn JC, 2004, J BIOL CHEM, V279, P30923, DOI 10.1074/jbc.C400082200; Swiercz JM, 2004, J CELL BIOL, V165, P869, DOI 10.1083/jcb.200312094; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Worzfeld T, 2004, EUR J NEUROSCI, V19, P2622, DOI 10.1111/j.0953-816X.2004.03401.x	48	103	122	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1893	1901		10.1074/jbc.M706822200	http://dx.doi.org/10.1074/jbc.M706822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025083	hybrid			2022-12-27	WOS:000252501000015
J	Wang, Y; De Arcangelis, V; Gao, X; Ramani, B; Jung, YS; Xiang, Y				Wang, Yongyu; De Arcangelis, Vania; Gao, Xiaoguang; Ramani, Biswarathan; Jung, Yi-Sook; Xiang, Yang			Norepinephrine-and epinephrine-induced distinct beta(2)-Adrenoceptor signaling is dictated by GRK2 phosphorylation in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; 7 TRANSMEMBRANE RECEPTORS; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; ADRENERGIC-RECEPTORS; ACTIVATION; DESENSITIZATION; KINASES; PATHWAY; STIMULATION	Agonist-dependent activation of G protein-coupled receptors induces diversified receptor cellular and signaling properties. Norepinephrine (NE) and epinephrine (Epi) are two endogenous ligands that activate adrenoceptor (AR) signals in a variety of physiological stress responses in animals. Here we use cardiomyocyte contraction rate response to analyze the endogenous beta(2)AR signaling induced by Epi or NE in cardiac tissue. The Epi-activated beta(2)AR induced a rapid contraction rate increase that peaked at 4 min after stimulation. In contrast, the NE-activated beta(2)AR induced a much slower contraction rate increase that peaked at 10 min after stimulation. Whereas both drugs activated beta(2)AR coupling to G(s) proteins, only Epi-activated receptors were capable of coupling to G(i) proteins. Subsequent studies showed that the Epi-activated beta(2)AR underwent a rapid phosphorylation by G protein-coupled receptor kinase 2 (GRK2) and subsequent dephosphorylation on serine residues 355 and 356, which was critical for sufficient receptor recycling and Gi coupling. In contrast, the NE-activated beta(2)ARs underwent slow GRK2 phosphorylation, receptor internalization and recycling, and failed to couple to Gi. Moreover, inhibiting beta(2)AR phosphorylation by beta ARK C terminus or dephosphorylation by okadaic acid prevented sufficient recycling and Gi coupling. Together, our data revealed that distinct temporal phosphorylation of beta(2)AR on serine 355 and 356 by GRK2 plays a critical role for dictating receptor cellular events and signaling properties induced by Epi or NE in cardiomyocytes. This study not only helps us understand the endogenous agonist-dependent beta(2)AR signaling in animal heart but also offers an example of how G protein-coupled receptor signaling may be finely regulated by GRK in physiological settings.	[Wang, Yongyu; De Arcangelis, Vania; Gao, Xiaoguang; Ramani, Biswarathan; Jung, Yi-Sook; Xiang, Yang] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61822 USA	University of Illinois System; University of Illinois Urbana-Champaign	Xiang, Y (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, 523 Burrill Hall 407 S,Goodwin Ave, Urbana, IL 61822 USA.	kevinyx@uiuc.edu	Wang, Yongyu/F-9039-2011	Wang, Yongyu/0000-0002-8804-3472; Wang, Yongyu/0000-0002-6088-8887	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082846] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL082846-03, R01 HL082846-01, R01 HL082846] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bissantz C, 2003, J RECEPT SIG TRANSD, V23, P123, DOI 10.1081/RRS-120025192; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; Choi DJ, 1997, J BIOL CHEM, V272, P17223, DOI 10.1074/jbc.272.27.17223; Currie GP, 2006, DRUG SAFETY, V29, P647, DOI 10.2165/00002018-200629080-00002; Devic E, 2001, MOL PHARMACOL, V60, P577; Eglen RM, 2005, P W PHARMACOL SOC, V48, P31; Flier J, 1996, NEW ENGL J MED, V334, P580, DOI 10.1056/NEJM199602293340907; Hata JA, 2004, J MOL CELL CARDIOL, V37, P11, DOI 10.1016/j.yjmcc.2004.03.014; Heubach JF, 2004, MOL PHARMACOL, V65, P1313, DOI 10.1124/mol.65.5.1313; Iaccarino G, 1999, Expert Opin Investig Drugs, V8, P545, DOI 10.1517/13543784.8.5.545; Johnson M, 1998, AM J RESP CRIT CARE, V158, pS146, DOI 10.1164/ajrccm.158.supplement_2.13tac110; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz RJ, 2000, CIRCULATION, V101, P1634; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mialet-Perez J, 2004, J BIOL CHEM, V279, P38603, DOI 10.1074/jbc.M403708200; Packer M, 1998, PROG CARDIOVASC DIS, V41, P39, DOI 10.1016/S0033-0620(98)80030-3; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PITCHER JA, 1995, P NATL ACAD SCI USA, V92, P8343, DOI 10.1073/pnas.92.18.8343; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Shcherbakova OG, 2007, J CELL BIOL, V176, P521, DOI 10.1083/jcb.200604167; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; von Zastrow M, 2004, NEUROPHARMACOLOGY, V47, P286, DOI 10.1016/j.neuropharm.2004.05.007; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	39	53	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1799	1807		10.1074/jbc.M705747200	http://dx.doi.org/10.1074/jbc.M705747200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18056263	hybrid			2022-12-27	WOS:000252501000005
J	Castellani, LW; Nguyen, CN; Charugundla, S; Weinstein, MM; Doan, CX; Blaner, WS; Wongsiriroj, N; Lusis, AJ				Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Blaner, William S.; Wongsiriroj, Nuttaporn; Lusis, Aldons J.			Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-II GENE; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; TRIGLYCERIDE-RICH LIPOPROTEINS; TRANSGENIC MICE; SKELETAL-MUSCLE; RISK-FACTORS; PEROXISOME PROLIFERATOR; COMBINED HYPERLIPIDEMIA; PLASMA TRIGLYCERIDES; LIPOGENIC ENZYMES	Apolipoprotein AII (apoAII) transgenic (apoAIItg) mice exhibit several traits associated with the insulin resistance (IR) syndrome, including IR, obesity, and a marked hypertriglyceridemia. Because treatment of the apoAIItg mice with rosiglitazone ameliorated the IR and hypertriglyceridemia, we hypothesized that the hypertriglyceridemia was due largely to overproduction of very low density lipoprotein ( VLDL) by the liver, a normal response to chronically elevated insulin and glucose. We now report in vivo and in vitro studies that indicate that hepatic fatty acid oxidation was reduced and lipogenesis increased, resulting in a 25% increase in triglyceride secretion in the apoAIItg mice. In addition, we observed that hydrolysis of triglycerides from both chylomicrons and VLDL was significantly reduced in the apoAIItg mice, further contributing to the hypertriglyceridemia. This is a direct, acute effect, because when mouse apoAII was injected into mice, plasma triglyceride concentrations were significantly increased within 4 h. VLDL from both control and apoAIItg mice contained significant amounts of apoAII, with similar to 4 times more apoAII on apoAIItg VLDL. ApoAII was shown to transfer spontaneously from high density lipoprotein (HDL) to VLDL in vitro, resulting in VLDL that was a poorer substrate for hydrolysis by lipoprotein lipase. These results indicate that one function of apoAII is to regulate the metabolism of triglyceride-rich lipoproteins, with HDL serving as a plasma reservoir of apoAII that is transferred to the triglyceride-rich lipoproteins in much the same way as VLDL and chylomicrons acquire most of their apoCs from HDL.	[Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Dept Cardiol, Los Angeles, CA 90095 USA; [Blaner, William S.; Wongsiriroj, Nuttaporn] Columbia Univ, Dept Med, New York, NY 10032 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Castellani, LW (corresponding author), Univ Calif Los Angeles, Dept Med, Div Cardiol, BH-307 CHS, Los Angeles, CA 90095 USA.	lcastellani@mednet.ucla.edu			NHLBI NIH HHS [HL28481] Funding Source: Medline; NIDDK NIH HHS [DK071673] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071673] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAUPOVIC P, 1991, J LIPID RES, V32, P9; Aleksandrovich OV, 2006, B EXP BIOL MED+, V141, P678, DOI 10.1007/s10517-006-0250-9; Allayee H, 2003, CIRC RES, V92, P1262, DOI 10.1161/01.RES.0000075600.87675.16; ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Baier L, 1998, DIABETES, V47, pA171; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BAZIN R, 1982, J LIPID RES, V23, P839; BLANER WS, 1994, J BIOL CHEM, V269, P16559; Boisfer E, 1999, J BIOL CHEM, V274, P11564, DOI 10.1074/jbc.274.17.11564; BORGHINI I, 1991, BIOCHIM BIOPHYS ACTA, V1083, P139, DOI 10.1016/0005-2760(91)90034-F; Brunmair B, 2001, DIABETES, V50, P2309, DOI 10.2337/diabetes.50.10.2309; Burger H, 1997, J ACQ IMMUN DEF SYND, V14, P321, DOI 10.1097/00042560-199704010-00003; Caiazza D, 2004, BIOCHEMISTRY-US, V43, P11898, DOI 10.1021/bi049776t; Castellani LW, 2004, J LIPID RES, V45, P2377, DOI 10.1194/jlr.M400345-JLR200; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; CASTELLANI LW, 1991, BIOCHIM BIOPHYS ACTA, V1086, P197, DOI 10.1016/0005-2760(91)90008-6; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Cerne D, 2000, RENAL FAILURE, V22, P799, DOI 10.1081/JDI-100101965; Cerne D, 2000, CLIN CHEM LAB MED, V38, P529, DOI 10.1515/CCLM.2000.078; COLBERG SR, 1995, J CLIN INVEST, V95, P1846, DOI 10.1172/JCI117864; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Delgado-Lista J, 2007, J NUTR, V137, P2024; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Dugue-Pujol S, 2006, J LIPID RES, V47, P2631, DOI 10.1194/jlr.M600112-JLR200; EISENBERG S, 1979, J BIOL CHEM, V254, P2603; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; Elbein SC, 1998, DIABETES, V47, pA15; Escola-Gil JC, 2000, J LIPID RES, V41, P1328; Escola-Gil JC, 1998, J LIPID RES, V39, P457; Escola-Gil JC, 2002, DIABETOLOGIA, V45, P600, DOI 10.1007/s00125-002-0778-9; Escola-Gil JC, 2001, J LIPID RES, V42, P241; FAGER G, 1980, ATHEROSCLEROSIS, V36, P67, DOI 10.1016/0021-9150(80)90199-9; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Hedrick CC, 2001, J LIPID RES, V42, P563; Hime NJ, 2006, J LIPID RES, V47, P115, DOI 10.1194/jlr.M500284-JLR200; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Julve J, 2000, BBA-MOL CELL BIOL L, V1488, P233, DOI 10.1016/S1388-1981(00)00127-X; Julve-Gil J, 1999, METABOLISM, V48, P415, DOI 10.1016/S0026-0495(99)90097-5; Kalopissis AD, 2003, CURR OPIN LIPIDOL, V14, P165, DOI 10.1097/00041433-200304000-00008; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Klos KL, 2001, ARTERIOSCL THROM VAS, V21, P971, DOI 10.1161/01.ATV.21.6.971; Lara-Castro C, 2005, OBES RES, V13, P507, DOI 10.1038/oby.2005.53; LEBOEUF RC, 1983, J BIOL CHEM, V258, P5063; LEBOEUF RC, 1990, J LIPID RES, V31, P91; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; MAGILL P, 1982, EUR J CLIN INVEST, V12, P113, DOI 10.1111/j.1365-2362.1982.tb00947.x; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; MAO SJT, 1981, FEBS LETT, V132, P289, DOI 10.1016/0014-5793(81)81181-7; MarzalCasacuberta A, 1996, J BIOL CHEM, V271, P6720, DOI 10.1074/jbc.271.12.6720; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; MILLS JL, 1992, J PEDIATR-US, V120, P863, DOI 10.1016/S0022-3476(05)81951-1; MUSLINER TA, 1988, J LIPID RES, V29, P349; OLUBADEWO J, 1983, J BIOL CHEM, V258, P938; Packard CJ, 2000, J LIPID RES, V41, P305; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; PILGER E, 1983, ARTERIOSCLEROSIS, V3, P57, DOI 10.1161/01.ATV.3.1.57; PUPPIONE DL, 1994, LIPIDS, V29, P595, DOI 10.1007/BF02536633; Redlich CA, 1996, AM J RESP CRIT CARE, V154, P1436, DOI 10.1164/ajrccm.154.5.8912761; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; ROSSENEU M, 1981, ACTA CARDIOL, P11; Rye KA, 2003, J BIOL CHEM, V278, P22530, DOI 10.1074/jbc.M213250200; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schernthaner GH, 2005, SCAND J CLIN LAB INV, V65, P30, DOI 10.1080/00365510500236119; SCHONFELD G, 1978, LIPIDS, V13, P951, DOI 10.1007/BF02533855; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SHILLABEER G, 1992, J LIPID RES, V33, P31; SOLERARGILAGA C, 1977, ARCH BIOCHEM BIOPHYS, V178, P135, DOI 10.1016/0003-9861(77)90177-1; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Tall AR, 1998, EUR HEART J, V19, pA31; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; TOZUKA M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P61, DOI 10.1016/0005-2760(92)90076-8; Turpeinen AK, 1999, DIABETES, V48, P1245, DOI 10.2337/diabetes.48.6.1245; van't Hooft FM, 2001, CIRCULATION, V104, P1223, DOI 10.1161/hc3601.095709; Vohl MC, 1997, ATHEROSCLEROSIS, V128, P183, DOI 10.1016/S0021-9150(96)05985-0; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; WARDEN CH, 1993, P NATL ACAD SCI USA, V90, P10886, DOI 10.1073/pnas.90.22.10886; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Zammit VA, 2002, ANN NY ACAD SCI, V967, P52; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	87	63	65	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11633	11644		10.1074/jbc.M708995200	http://dx.doi.org/10.1074/jbc.M708995200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18160395	Green Published, hybrid			2022-12-27	WOS:000255067400064
J	Mozzo, M; Dall'Osto, L; Hienerwadel, R; Bassi, R; Croce, R				Mozzo, Milena; Dall'Osto, Luca; Hienerwadel, Rainer; Bassi, Roberto; Croce, Roberta			Photoprotection in the antenna complexes of photosystem II - Role of individual xanthophylls in chlorophyll triplet quenching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; NONPHOTOCHEMICAL ENERGY-DISSIPATION; FEMTOSECOND TRANSIENT ABSORPTION; HIGHER-PLANTS; BINDING-SITE; SINGLET-OXYGEN; BETA-CAROTENE; LHCII; FLUORESCENCE; ARABIDOPSIS	In this work the photoprotective role of all xanthophylls in LHCII, Lhcb4, and Lhcb5 is investigated by laser-induced Triplet-minus-Singlet (TmS) spectroscopy. The comparison of native LHCII trimeric complexes with different carotenoid composition shows that the xanthophylls in sites V1 and N1 do not directly contribute to the chlorophyll triplet quenching. The largest part of the triplets is quenched by the lutein bound in site L1, which is located in close proximity to the chlorophylls responsible for the low energy state of the complex. The lutein in the L2 site is also active in triplet quenching, and it shows a longer triplet lifetime than the lutein in the L1 site. This lifetime difference depends on the occupancy of the N1 binding site, where neoxanthin acts as an oxygen barrier, limiting the access of O-2 to the inner domain of the Lhc complex, thereby strongly contributing to the photostability. The carotenoid triplet decay of monomeric Lhcb1, Lhcb4, and Lhcb5 is mono-exponential, with shorter lifetimes than observed for trimeric LHCII, suggesting that their inner domains are more accessible for O2. As for trimeric LHCII, only the xanthophylls in sites L1 and L2 are active in triplet quenching. Although the chlorophyll to carotenoid triplet transfer is efficient (95%) in all complexes, it is not perfect, leaving 5% of the chlorophyll triplets unquenched. This effect appears to be intrinsically related to the molecular organization of the Lhcb proteins.	[Mozzo, Milena; Croce, Roberta] Univ Groningen, Groningen Bimol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands; [Mozzo, Milena] Ist Biofis Consiglio Nazl Ric, I-38100 Trento, Italy; [Dall'Osto, Luca; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Hienerwadel, Rainer] Univ Aix Marseille 2, Fac Sci Luminy, LGBP Dept Biol, F-13288 Marseille, France	University of Groningen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Verona; UDICE-French Research Universities; Aix-Marseille Universite	Croce, R (corresponding author), Univ Groningen, Groningen Bimol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/HGU-9554-2022; Croce, Roberta/F-1174-2014; Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014; Dall'Osto, Luca/A-9384-2010	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Dall'Osto, Luca/0000-0001-9497-5156; bassi, roberto/0000-0002-4140-8446				ANDERSSON PO, 1991, PHOTOCHEM PHOTOBIOL, V54, P353, DOI 10.1111/j.1751-1097.1991.tb02027.x; Barzda V, 1998, BIOCHEMISTRY-US, V37, P546, DOI 10.1021/bi972123a; Barzda V, 2000, BIOCHEMISTRY-US, V39, P10468, DOI 10.1021/bi992826n; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BENSASSON RV, 1983, CONTRIBUTIONS CHEM B, V21, P836; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Carbonera D, 1992, APPL MAGN RESON, V3, P859, DOI 10.1007/BF03260117; CHAUVET JP, 1985, PHOTOCHEM PHOTOBIOL, V41, P83, DOI 10.1111/j.1751-1097.1985.tb03452.x; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; Croce R, 2001, BIOPHYS J, V80, P901, DOI 10.1016/S0006-3495(01)76069-9; Croce R, 2007, BIOCHEMISTRY-US, V46, P3846, DOI 10.1021/bi602531k; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Damjanovic A, 1999, PHYS REV E, V59, P3293, DOI 10.1103/PhysRevE.59.3293; Demmig-Adams B., 1989, PHOTOSYNTHESIS PLANT, V8; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; FARMILO A, 1973, PHOTOCHEM PHOTOBIOL, V18, P447, DOI 10.1111/j.1751-1097.1973.tb06448.x; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; FUJIMORI E, 1957, NATURE, V180, P1036, DOI 10.1038/1801036a0; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Gradinaru CC, 2000, J PHYS CHEM B, V104, P9330, DOI 10.1021/jp001752i; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Jhutti CS, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P491; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kleima FJ, 1999, BIOCHEMISTRY-US, V38, P6587, DOI 10.1021/bi982823v; KNOX JP, 1985, PLANTA, V164, P30, DOI 10.1007/BF00391022; KOYAMA Y, 1991, J PHOTOCH PHOTOBIO B, V9, P265; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; LAND EJ, 1971, PHOTOCHEM PHOTOBIOL, V13, P311, DOI 10.1111/j.1751-1097.1971.tb06119.x; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MATHIS P, 1967, CR HEBD ACAD SCI, V15, P1903; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; Naqvi KR, 1997, SPECTROCHIM ACTA A, V53, P2659, DOI 10.1016/S1386-1425(97)00160-1; NECHUSHTAI R, 1988, J PHYS CHEM-US, V92, P1165, DOI 10.1021/j100316a033; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Peterman EJG, 1995, BIOPHYS J, V69, P2670, DOI 10.1016/S0006-3495(95)80138-4; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Schodel R, 1998, BIOPHYS J, V75, P3143, DOI 10.1016/S0006-3495(98)77756-2; Schodel R, 1999, BIOPHYS J, V76, P2238, DOI 10.1016/S0006-3495(99)77380-7; Siefermann-Harms D, 1998, PHOTOSYNTH RES, V55, P83, DOI 10.1023/A:1005951307673; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Tardy F, 1996, J PHOTOCH PHOTOBIO B, V34, P87, DOI 10.1016/1011-1344(95)07272-1; VANDERVOS R, 1994, BBA-BIOENERGETICS, V1188, P243, DOI 10.1016/0005-2728(94)90042-6; Visser HM, 1996, CHEM PHYS, V210, P297, DOI 10.1016/0301-0104(96)00092-4; ZUCCHELLI G, 1988, J PHOTOCH PHOTOBIO B, V2, P483, DOI 10.1016/1011-1344(88)85077-2	66	155	155	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6184	6192		10.1074/jbc.M708961200	http://dx.doi.org/10.1074/jbc.M708961200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18079125	hybrid			2022-12-27	WOS:000253779500025
J	He, QY; Battistella, L; Morse, RH				He, Qiye; Battistella, Luisa; Morse, Randall H.			Mediator requirement downstream of chromatin remodeling during transcriptional activation of CHA1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; IN-VIVO TARGET; SACCHAROMYCES-CEREVISIAE; HISTONE H3; TERMINAL DOMAIN; INDEPENDENT RECRUITMENT; NUCLEOSOMAL DNA; REPEAT DOMAIN; PHO5 PROMOTER	Mediator complex is essential for transcription by RNA polymerase II in eukaryotes. Although chromatin remodeling is an integral part of transcriptional activation at many promoters, whether Mediator is required for this function has not been determined. Here we have used the yeast CHA1 gene to study the role of Mediator in chromatin remodeling and recruitment of the transcription machinery. We show by chromatin immunoprecipitation that Mediator subunits are recruited to the induced CHA1 promoter. Inactivation of Mediator at 37 degrees C in yeast harboring the srb4-138 (med17) ts mutation severely reduces CHA1 activation and prevents recruitment to the induced CHA1 promoter of Med18/Srb5, from the head module of Mediator, and Med14/Rgr1, which bridges the middle and tail modules. In contrast, recruitment of Med15/Gal11 from the tail module is unaffected in med17 ts yeast at 37 degrees C. Recruitment of TATA-binding protein (TBP) is severely compromised in the absence of functional Mediator, whereas Kin28 and polymerase II recruitment are reduced but to a lesser extent. Induced levels of histone H3K4me3 at the CHA1 promoter are not diminished by inactivation of Mediator, whereas recruitment of Paf1 and of Ser(2)- and Ser(5)- phosphorylated forms of Rbp1 are reduced but not eliminated. Loss of histone H3 from the induced CHA1 promoter is seen in wild type yeast but is greatly reduced by loss of intact Mediator. In contrast, Swi/Snf recruitment and nucleosome remodeling are unaffected by loss of Mediator function. Thus, Mediator is required for recruitment of the transcription machinery subsequent to chromatin remodeling during CHA1 induction.	[He, Qiye; Morse, Randall H.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Battistella, Luisa; Morse, Randall H.] New York State Dept Hlth, Wadsworth Ctr, Lab Dev Genet, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Morse, RH (corresponding author), Wadsworth Ctr, PO Box 22002, Albany, NY 12201 USA.	randall.morse@wadsworth.org		Morse, Randall/0000-0003-0000-8718				Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BORNAES C, 1993, MOL CELL BIOL, V13, P7604, DOI 10.1128/MCB.13.12.7604; BORNAES C, 1992, GENETICS, V131, P531; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hertel CB, 2005, MOL CELL BIOL, V25, P10755, DOI 10.1128/MCB.25.24.10755-10767.2005; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Holmberg S, 1996, GENETICS, V144, P467; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; KENT NA, 1993, NUCLEIC ACIDS RES, V21, P4653, DOI 10.1093/nar/21.19.4653; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2005, TRENDS BIOCHEM SCI, V30, P245, DOI 10.1016/j.tibs.2005.03.010; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; NONET ML, 1989, GENETICS, V123, P715; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Ryan MP, 1998, MOL CELL BIOL, V18, P1774, DOI 10.1128/MCB.18.4.1774; Ryan MP, 2000, MOL CELL BIOL, V20, P5847, DOI 10.1128/MCB.20.16.5847-5857.2000; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TSANG SS, 1993, BIOTECHNIQUES, V14, P380; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	90	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5276	5286		10.1074/jbc.M708266200	http://dx.doi.org/10.1074/jbc.M708266200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093974	hybrid			2022-12-27	WOS:000253426700007
J	Chen, C; Krausz, KW; Idle, JR; Gonzalez, FJ				Chen, Chi; Krausz, Kristopher W.; Idle, Jeffrey R.; Gonzalez, Frank J.			Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ALCOHOL-MEDIATED INCREASES; ACUTE LIVER-FAILURE; OXIDATIVE STRESS; RAT-LIVER; INDUCED HEPATOTOXICITY; CATECHOL METABOLITES; HEPATIC GLUTATHIONE; MOUSE HEPATOCYTES; COVALENT BINDING	CYP2E1 is recognized as the most important enzyme for initiation of acetaminophen ( APAP)-induced toxicity. In this study, the resistance of Cyp2e1-null mice to APAP treatment was confirmed by comparing serum aminotransferase activities and blood urea nitrogen levels in wild-type and Cyp2e1-null mice. However, unexpectedly, profiling of major known APAP metabolites in urine and serum revealed that the contribution of CYP2E1 to APAP metabolism decreased with increasing APAP doses administered. Measurement of hepatic glutathione and hydrogen peroxide levels exposed the importance of oxidative stress in determining the consequence of APAP overdose. Subsequent metabolomic analysis was capable of constructing a principal components analysis (PCA) model that delineated a relationship between urinary metabolomes and the responses to APAP treatment. Urinary ions high in wild-type mice treated with 400 mg/kg APAP were elucidated as 3-methoxy-APAP glucuronide (VII) and three novel APAP metabolites, including S-(5-acetylamino-2-hydroxyphenyl) mercaptopyruvic acid ( VI, formed by a Cys-APAP transamination reaction in kidney), 3,3'-biacetaminophen (VIII, an APAP dimer), and a benzothiazine compound (IX, originated from deacetylated APAP), through mass isotopomer analysis, accurate mass measurement, tandem mass spectrometry fragmentation, in vitro reactions, and chemical treatments. Dose-, time-, and genotype-dependent appearance of these minor APAP metabolites implied their association with the APAP-induced toxicity and potential biomarker application. Overall, the oxidative stress elicited by CYP2E1-mediated APAP metabolism might significantly contribute to APAP-induced toxicity. The combination of genetically modified animal models, mass isotopomer analysis, and metabolomics provides a powerful and efficient technical platform to characterize APAP-induced toxicity through identifying novel biomarkers and unraveling novel mechanisms.	[Chen, Chi; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, NIH, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Idle, Jeffrey R.] Charles Univ Prague, Inst Pharmacol, Fac Med 1, Prague 12800, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Charles University Prague	Gonzalez, FJ (corresponding author), NCI, NIH, Lab Metab, Ctr Canc Res, 37 Convert Dr, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Chen, Chi/B-4618-2008; Chen, Chi/AAF-5343-2020; Idle, Jeff/B-1152-2012	Chen, Chi/0000-0001-9703-604X; Idle, Jeff/0000-0002-6143-1520	Intramural NIH HHS [Z01 BC005562-19] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005562, ZIABC005562] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BALES JR, 1984, CLIN CHEM, V30, P1631; Boutis K, 2001, J TOXICOL-CLIN TOXIC, V39, P441, DOI 10.1081/CLT-100105413; Chen C, 2007, DRUG METAB REV, V39, P581, DOI 10.1080/03602530701497804; Chen C, 2007, CHEM RES TOXICOL, V20, P531, DOI 10.1021/tx600320w; Chen C, 2006, J PHARMACOL EXP THER, V318, P1330, DOI 10.1124/jpet.106.105213; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; CHRISTEN P, 1990, ANN NY ACAD SCI, V585, P331, DOI 10.1111/j.1749-6632.1990.tb28065.x; Coen M, 2004, J PHARMACEUT BIOMED, V35, P93, DOI 10.1016/j.jpba.2003.12.019; Coen M, 2003, CHEM RES TOXICOL, V16, P295, DOI 10.1021/tx0256127; Cohen S. D., 1998, TOXICOLOGY LIVER, P159; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; EKLIND KI, 1990, CARCINOGENESIS, V11, P2033, DOI 10.1093/carcin/11.11.2033; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; FORTE AJ, 1984, DRUG METAB DISPOS, V12, P484; Giri S, 2006, CHEM RES TOXICOL, V19, P818, DOI 10.1021/tx0600402; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Guo GL, 2004, TOXICOL SCI, V82, P374, DOI 10.1093/toxsci/kfh286; HART SGE, 1995, FUND APPL TOXICOL, V24, P260, DOI 10.1006/faat.1995.1029; HARVISON PJ, 1988, CHEM RES TOXICOL, V1, P47, DOI 10.1021/tx00001a009; Hinson JA, 2004, DRUG METAB REV, V36, P805, DOI 10.1081/DMR-200033494; HOLME JA, 1991, BIOCHEM PHARMACOL, V42, P1137, DOI 10.1016/0006-2952(91)90299-K; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Knight TR, 2002, J PHARMACOL EXP THER, V303, P468, DOI 10.1124/jpet.102.038968; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; MONKS TJ, 1990, MOL PHARMACOL, V38, P121; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Palumbo A, 2001, BIOCHEM J, V356, P105, DOI 10.1042/0264-6021:3560105; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; POTTER DW, 1987, J BIOL CHEM, V262, P974; POTTER DW, 1985, J BIOL CHEM, V260, P2174; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; Prota G, 2000, PIGM CELL RES, V13, P283, DOI 10.1034/j.1600-0749.2000.130412.x; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Shertzer HG, 2004, FREE RADICAL BIO MED, V36, P605, DOI 10.1016/j.freeradbiomed.2003.11.013; Sinclair J, 1998, BIOCHEM PHARMACOL, V55, P1557; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; SNAWDER JE, 1994, BIOCHEM BIOPH RES CO, V203, P532, DOI 10.1006/bbrc.1994.2215; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stern ST, 2005, TOXICOL APPL PHARM, V202, P151, DOI 10.1016/j.taap.2004.06.030; TOMISAWA H, 1988, XENOBIOTICA, V18, P1015, DOI 10.3109/00498258809042224; Wolf KK, 2007, DRUG METAB DISPOS, V35, P1223, DOI 10.1124/dmd.107.014738; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	53	104	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4543	4559		10.1074/jbc.M706299200	http://dx.doi.org/10.1074/jbc.M706299200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093979	hybrid, Green Accepted			2022-12-27	WOS:000253426500011
J	Iseli, TJ; Oakhill, JS; Bailey, MF; Wee, S; Walter, M; van Denderen, BJ; Castelli, LA; Katsis, F; Witters, LA; Stapleton, D; Macaulay, SL; Michell, BJ; Kemp, BE				Iseli, Tristan J.; Oakhill, Jonathan S.; Bailey, Michael F.; Wee, Sheena; Walter, Mark; van Denderen, Bryce J.; Castelli, Laura A.; Katsis, Frosa; Witters, Lee A.; Stapleton, David; Macaulay, S. Lance; Michell, Belinda J.; Kemp, Bruce E.			AMP-activated protein kinase subunit interactions - beta 1 :gamma 1 association requires beta 1 Thr-263 and Tyr-267	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNITS; POSTTRANSLATIONAL MODIFICATIONS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BATEMAN DOMAINS; BINDING; SEQUENCE; FORM	AMP-activated protein kinase (AMPK) plays multiple roles in the body's overall metabolic balance and response to exercise, nutritional stress, hormonal stimulation, and the glucose-lowering drugs metformin and rosiglitazone. AMPK consists of a catalytic alpha subunit and two non-catalytic subunits, beta and gamma, each with multiple isoforms that form active 1: 1: 1 heterotrimers. Here we show that recombinant human AMPK alpha 1 beta 1 gamma 1 expressed in insect cells is monomeric and displays specific activity and AMP responsiveness similar to rat liver AMPK. The previously determined crystal structure of the core of mammalian alpha beta gamma complex shows that beta binds alpha and gamma. Here we show that a beta 1(186-270)gamma 1 complex can form in the absence of detectable alpha subunit. Moreover, using alanine mutagenesis we show that beta 1 Thr-263 and Tyr-267 are required for beta gamma association but not alpha beta association.	[Iseli, Tristan J.; Oakhill, Jonathan S.; Wee, Sheena; Walter, Mark; van Denderen, Bryce J.; Katsis, Frosa; Michell, Belinda J.; Kemp, Bruce E.] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Bailey, Michael F.; Stapleton, David] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Witters, Lee A.] Dartmouth Med Sch, Dept Med, Endocrine Metab Div, Hanover, NH 03755 USA; [Witters, Lee A.] Dartmouth Med Sch, Dept Biochem, Endocrine Metab Div, Hanover, NH 03755 USA; [Castelli, Laura A.; Macaulay, S. Lance; Kemp, Bruce E.] CSIRO Mol Hlth Technologies, Parkville, Vic 3052, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; Dartmouth College; Dartmouth College; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Oakhill, JS (corresponding author), St Vincents Inst, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au; bmichell@svi.edu.au	castelli, laura/C-5400-2013; Iseli, Tristan/A-9537-2012; van Denderen, Bryce/AAW-5454-2021; Oakhill, Jonathan S/F-5724-2011; Macaulay, Stuart Lance/A-6086-2008; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019	Oakhill, Jonathan S/0000-0002-9475-1440; Macaulay, Stuart Lance/0000-0001-5069-9516; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082; Wee, Sheena/0000-0003-2536-3433	NIDDK NIH HHS [DK35712] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035712] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Taylor EB, 2006, AM J PHYSIOL-ENDOC M, V290, pE661, DOI 10.1152/ajpendo.00313.2005; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	36	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4799	4807		10.1074/jbc.M708298200	http://dx.doi.org/10.1074/jbc.M708298200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079111	hybrid			2022-12-27	WOS:000253426500037
J	Miyamoto, T; Oshiro, N; Yoshino, KI; Nakashima, A; Eguchi, S; Takahashi, M; Ono, Y; Kikkawa, U; Yonezawa, K				Miyamoto, Takafumi; Oshiro, Noriko; Yoshino, Ken-Ichi; Nakashima, Akio; Eguchi, Satoshi; Takahashi, Mikiko; Ono, Yoshitaka; Kikkawa, Ushio; Yonezawa, Kazuyoshi			AMP-activated protein kinase phosphorylates Golgi-specific brefeldin A resistance factor 1 at Thr(1337) to induce disassembly of Golgi apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RICH AKT SUBSTRATE; MAMMALIAN TARGET; CIS-GOLGI; SIGNALING PATHWAY; CELL STRUCTURE; GBF1; RAPAMYCIN; MTOR; IDENTIFICATION	Sufficiency and depletion of nutrients regulate the cellular activities through the protein phosphorylation reaction; however, many protein substrates remain to be clarified. GBF1 (Golgi-specific brefeldin A resistance factor 1), a guanine nucleotide exchange factor for the ADP-ribosylation factor family associated with the Golgi apparatus, was isolated as a phosphoprotein from the glucose-depleted cells by using the phospho-Akt-substrate antibody, which recognizes the substrate proteins of several protein kinases. The phosphorylation of GBF1 was induced by 2-deoxyglucose (2-DG), which blocks glucose utilization and increases the intracellular AMP concentration, and by AICAR, an AMP-activated protein kinase (AMPK) activator. This phosphorylation was observed in the cells expressing the constitutively active AMPK. The 2-DG-induced phosphorylation of GBF1 was suppressed by Compound C, an AMPK inhibitor, and by the overexpression of the kinase-negative AMPK. Analysis using the deletion and point mutants identified Thr(1337) as the 2-DG-induced phosphorylation site in GBF1, which is phosphorylated by AMPK in vitro. ATP depletion is known to provoke the Golgi apparatus disassembly. Immunofluorescent microscopic analysis with the Golgi markers indicated that GBF1 associates with the fragmented Golgi apparatus in the cells treated with 2-DG and AICAR. The expression of the kinase-negative AMPK and the GBF1 mutant replacing Thr(1337) by Ala prevented the 2-DG-induced Golgi disassembly. These results indicate that GBF1 is a novel AMPK substrate and that the AMPK-mediated phosphorylation of GBF1 at Thr1337 has a critical role, presumably by attenuating the function of GBF1, in the disassembly of the Golgi apparatus induced under stress conditions that lower the intracellular ATP concentration.	[Miyamoto, Takafumi; Oshiro, Noriko; Yoshino, Ken-Ichi; Nakashima, Akio; Eguchi, Satoshi; Takahashi, Mikiko; Ono, Yoshitaka; Kikkawa, Ushio; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University	Kikkawa, U (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ukikkawa@kobe-u.ac.jp	Miyamoto, Takafumi/T-6950-2019; Takahashi, Mikiko/AAH-2345-2019	Miyamoto, Takafumi/0000-0001-9363-2864				BANTA M, 1995, BIOCHEMISTRY-US, V34, P13359, DOI 10.1021/bi00041a012; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; CLUETT EB, 1993, J CELL BIOL, V120, P15, DOI 10.1083/jcb.120.1.15; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; del Valle M, 1999, J CELL SCI, V112, P4017; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; KEMP BE, 1991, METHOD ENZYMOL, V200, P121; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Koh H, 2007, BIOCHEM BIOPH RES CO, V362, P789, DOI 10.1016/j.bbrc.2007.08.016; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Mandell JW, 2003, AM J PATHOL, V163, P1687, DOI 10.1016/S0002-9440(10)63525-0; Marshall S., 2006, SCI STKE, V2006, pre7; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Sekulic A, 2000, CANCER RES, V60, P3504; Shin HW, 2005, METHOD ENZYMOL, V404, P206, DOI 10.1016/S0076-6879(05)04020-6; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wiche G, 1998, J CELL SCI, V111, P2477; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	42	35	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4430	4438		10.1074/jbc.M708296200	http://dx.doi.org/10.1074/jbc.M708296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063581	hybrid			2022-12-27	WOS:000253083500077
J	Neumeyer, T; Schiffler, B; Maier, E; Lang, AE; Aktories, K; Benz, R				Neumeyer, Tobias; Schiffler, Bettina; Maier, Elke; Lang, Alexander E.; Aktories, Klaus; Benz, Roland			Clostridium botulinum C2 toxin - Identification of the binding site for chloroquine and related compounds and influence of the binding site on properties of the C2II channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; PERFRINGENS IOTA-TOXIN; ANTHRAX PROTECTIVE ANTIGEN; CURRENT NOISE-ANALYSIS; ADP-RIBOSYLATES ACTIN; MATRIX PROTEIN PORIN; ENZYME COMPONENT C2I; BINARY TOXIN; PHENYLALANINE CLAMP; ESCHERICHIA-COLI	Clostridium botulinum C2 toxin belongs to the family of binary AB type toxins that are structurally organized into distinct enzyme (A, C2I) and binding (B, C2II) components. The proteolytically activated 60-kDa C2II binding component is essential for C2I transport into target cells. It oligomerizes into heptamers and forms channels in lipid bilayer membranes. The C2II channel is cation-selective and can be blocked by chloroquine and related compounds. Residues 303-330 of C2II contain a conserved pattern of alternating hydrophobic and hydrophilic residues, which has been implicated in the formation of two amphipathic beta-strands involved in membrane insertion and channel formation. In the present study, C2II mutants created by substitution of different negatively charged amino acids by alanine-scanning mutagenesis were analyzed in artificial lipid bilayer membranes. The results suggested that most of the C2II mutants formed SDS-resistant oligomers (heptamers) similar to wild type. The mutated negatively charged amino acids did not influence channel properties with the exception of Glu(399) and Asp(426), which are probably localized in the vestibule near the channel entrance. These mutants show a dramatic decrease in their affinity for binding of chloroquine and its analogues. Similarly, F428A, which represents the Phi-clamp in anthrax protective antigen, was mutated in C2II in several other amino acids. The C2II mutants F428A, F428D, F428Y, and F428W not only showed altered chloroquine binding but also had drastically changed single channel properties. The results suggest that amino acids Glu(399), Asp(426), and Phe(428) have a major impact on the function of C2II as a binding protein for C2I delivery into target cells.	[Neumeyer, Tobias; Schiffler, Bettina; Maier, Elke; Benz, Roland] Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxicol, D-79104 Freiburg, Germany	University of Wurzburg; University of Freiburg	Benz, R (corresponding author), Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, D-97074 Wurzburg, Germany.	roland.benz@mail.uni-wuerzburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Benz, Roland/0000-0002-9510-9265				AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P97; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2002, N-S ARCH PHARMACOL, V366, P501, DOI 10.1007/s00210-002-0626-y; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1987, J MEMBRANE BIOL, V100, P12; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Christensen KA, 2006, BIOCHEMISTRY-US, V45, P2380, DOI 10.1021/bi051830y; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Knapp O, 2002, J BIOL CHEM, V277, P6143, DOI 10.1074/jbc.M103939200; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Leuber M, 2006, BIOCHEMISTRY-US, V45, P283, DOI 10.1021/bi051351z; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; OHISHI I, 1987, INFECT IMMUN, V55, P1461, DOI 10.1128/IAI.55.6.1461-1465.1987; OHISHI I, 1980, INFECT IMMUN, V30, P668; OHISHI I, 1992, INFECT IMMUN, V60, P4648, DOI 10.1128/IAI.60.11.4648-4655.1992; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; SIMPSON LL, 1987, INFECT IMMUN, V55, P118, DOI 10.1128/IAI.55.1.118-122.1987; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	50	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3904	3914		10.1074/jbc.M709807200	http://dx.doi.org/10.1074/jbc.M709807200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077455	hybrid			2022-12-27	WOS:000253083500024
J	Phartiyal, P; Sale, H; Jones, EMC; Robertson, GA				Phartiyal, Pallavi; Sale, Harinath; Jones, Eugenia M. C.; Robertson, Gail A.			Endoplasmic reticulum retention and rescue by heteromeric assembly regulate human ERG 1a/1b surface channel composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; POTASSIUM CHANNEL; CARDIAC-ARRHYTHMIA; K+ CHANNEL; I-KR; MUTANT CHANNELS; HERG; TRAFFICKING; SIGNAL; MOUSE	Defects in the trafficking of subunits encoded by the human ether-a-go-go-related gene (hERG1) can lead to catastrophic arrhythmias and sudden cardiac death due to a reduction in I-Kr-mediated repolarization. Native I-Kr channels are composed of two alpha subunits, hERG 1a and 1b. In heterologous expression systems, hERG 1b subunits efficiently produce current only in heteromeric combination with hERG 1a. We used Western blot analysis and electrophysiological recordings in HEK-293 cells and Xenopus oocytes to monitor hERG 1b maturation in the secretory pathway and to determine the factors regulating surface expression of hERG 1b subunits. We found that 1b subunits expressed alone were largely retained in the endoplasmic reticulum (ER), thus accounting for the poor functional expression of homomeric 1b currents. Association with hERG 1a facilitated 1b ER export and surface expression. We show that hERG 1b subunits fail to mature because of an "RXR" ER retention signal specific to the 1b N terminus of the human sequence and not conserved in other species. Mutating the RXR facilitated maturation and functional expression of homomeric hERG 1b channels in a charge-dependent manner. Co-expression of the 1b RXR mutants with hERG 1a did not further enhance 1b maturation, suggesting that hERG 1a promotes 1b trafficking by overcoming the RXR-mediated retention. Thus, selective trafficking mechanisms regulate subunit composition of surface hERG channels.	[Phartiyal, Pallavi; Sale, Harinath; Jones, Eugenia M. C.; Robertson, Gail A.] Univ Wisconsin, Dept Physiol, Madison, WI 53711 USA; [Phartiyal, Pallavi] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Robertson, GA (corresponding author), Univ Wisconsin, Satillite Labs, 601 Sci Dr, Madison, WI 53711 USA.	robertson@physiology.wisc.edu		Robertson, Gail/0000-0003-4694-5790	NHLBI NIH HHS [R01HL081780] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081780] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Konstas AA, 2002, J BIOL CHEM, V277, P21346, DOI 10.1074/jbc.M202005200; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; Lees-Miller JP, 2003, MOL CELL BIOL, V23, P1856, DOI 10.1128/MCB.23.6.1856-1862.2003; LeesMiller JP, 1997, CIRC RES, V81, P719; London B, 1997, CIRC RES, V81, P870; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	23	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3702	3707		10.1074/jbc.M708999200	http://dx.doi.org/10.1074/jbc.M708999200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18048364	hybrid			2022-12-27	WOS:000253083500003
J	Wang, JH; Shiozawa, YS; Wang, JC; Wang, Y; Jung, YH; Pienta, KJ; Mehra, R; Loberg, R; Taichman, RS				Wang, Jianhua; Shiozawa, Yusuke; Wang, Jincheng; Wang, Yu; Jung, Younghun; Pienta, Kenneth J.; Mehra, Rohit; Loberg, Robert; Taichman, Russell S.			The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; COMPLETE NUCLEOTIDE-SEQUENCE; CELL-DERIVED FACTOR-1; BONE-MARROW; CXC-CHEMOKINE; STEM-CELLS; IN-VIVO; STEM/PROGENITOR CELLS; GENOMIC ORGANIZATION; ENDOTHELIAL-CELLS	Several reports have recently documented that CXCR7/RDC1 functions as a chemokine receptor for SDF-1/CXCL12, which regulates a spectrum of normal and pathological processes. In this study, the role of CXCR7/RDC1 in prostate cancer (PCa) was explored. Staining of high density tissue microarrays demonstrates that the levels of CXCR7/RDC1 expression increase as the tumors become more aggressive. In vitro and in vivo studies with PCa cell lines suggest that alterations in CXCR7/RDC1 expression are associated with enhanced adhesive and invasive activities in addition to a survival advantage. In addition, it was observed that CXCR7/RDC1 levels are regulated by CXCR4. Among the potential downstream targets of CXCR7/RDC1 are CD44 and cadherin-11, which are likely to contribute to the invasiveness of PCa cells. CXCR7/RDC1 also regulates the expression of the proangiogenic factors interleukin-8 or vascular endothelial growth factor, which are likely to participate in the regulation of tumor angiogenesis. Finally, we found that signaling by CXCR7/RDC1 activates AKT pathways. Together, these data demonstrate a role for CXCR7/RDC1 in PCa metastasis and progression and suggest potential targets for therapeutic intervention.	[Wang, Jianhua; Shiozawa, Yusuke; Wang, Jincheng; Wang, Yu; Jung, Younghun; Taichman, Russell S.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.; Loberg, Robert] Univ Michigan, Sch Med, Div Hematol Oncol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Mehra, Rohit] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Taichman, RS (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	rtaich@umich.edu	; Pienta, Kenneth/E-7679-2015	Taichman, Russell S./0000-0002-7890-0020; Pienta, Kenneth/0000-0002-4138-2186	NCI NIH HHS [5 P30 CA46592, P01 CA93900] Funding Source: Medline; NIDCR NIH HHS [DE13701] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592, P01CA093900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013701] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Addison CL, 2000, HUM GENE THER, V11, P247, DOI 10.1089/10430340050015996; Aiuti A, 1999, EUR J IMMUNOL, V29, P1823, DOI 10.1002/(SICI)1521-4141(199906)29:06<1823::AID-IMMU1823>3.0.CO;2-B; Ao MF, 2007, CANCER RES, V67, P4244, DOI 10.1158/0008-5472.CAN-06-3946; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Begley LA, 2007, J BIOL CHEM, V282, P26767, DOI 10.1074/jbc.M700440200; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Caruz A, 1998, FEBS LETT, V426, P271, DOI 10.1016/S0014-5793(98)00359-7; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Feil C, 1998, BIOCHEM BIOPH RES CO, V247, P38, DOI 10.1006/bbrc.1998.8499; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fureder W, 2006, AM J PATHOL, V168, P123, DOI 10.2353/ajpath.2006.050034; Gupta SK, 1999, J IMMUNOL, V163, P2368; Hajra KM, 2002, GENE CHROMOSOME CANC, V34, P255, DOI 10.1002/gcc.10083; Jubb AM, 2006, J CLIN ONCOL, V24, P217, DOI 10.1200/JCO.2005.01.5388; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Lataillade JJ, 2000, BLOOD, V95, P756, DOI 10.1182/blood.V95.3.756; Lazarini F, 2000, EUR J NEUROSCI, V12, P117, DOI 10.1046/j.1460-9568.2000.00894.x; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIBERT F, 1990, NUCLEIC ACIDS RES, V18, P1917, DOI 10.1093/nar/18.7.1917; LIBERT F, 1990, NUCLEIC ACIDS RES, V18, P1916, DOI 10.1093/nar/18.7.1916; Madden SL, 2004, AM J PATHOL, V165, P601, DOI 10.1016/S0002-9440(10)63324-X; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Ratajczak MZ, 2004, LEUKEMIA, V18, P29, DOI 10.1038/sj.leu.2403184; Ratajczak MZ, 2003, STEM CELLS, V21, P363, DOI 10.1634/stemcells.21-3-363; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Schier AF, 2003, CURR BIOL, V13, pR192, DOI 10.1016/S0960-9822(03)00122-2; Schrader AJ, 2002, BRIT J CANCER, V86, P1250, DOI 10.1038/sj.bjc.6600221; Shimizu N, 2000, J VIROL, V74, P619, DOI 10.1128/JVI.74.2.619-626.2000; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Sun YX, 2003, J CELL BIOCHEM, V89, P462, DOI 10.1002/jcb.10522; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2006, CANCER METAST REV, V25, P573, DOI 10.1007/s10555-006-9019-x; Wang JH, 2007, CANCER RES, V67, P149, DOI 10.1158/0008-5472.CAN-06-2971; Wegner SA, 1998, J BIOL CHEM, V273, P4754, DOI 10.1074/jbc.273.8.4754	49	385	446	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4283	4294		10.1074/jbc.M707465200	http://dx.doi.org/10.1074/jbc.M707465200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18057003	hybrid			2022-12-27	WOS:000253083500063
J	Kitagawa, N; Mazon, H; Heck, AJR; Wilkens, S				Kitagawa, Norton; Mazon, Hortense; Heck, Albert J. R.; Wilkens, Stephan			Stoichiometry of the peripheral stalk subunits E and G of yeast V-1-ATPase determined by mass spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; MEDIATED CROSS-LINKING; V-ATPASE; PROTEIN COMPLEXES; C VMA5P; LOCALIZATION; STATOR; FLIGHT; ACIDIFICATION; DOMAIN	The stoichiometry of yeast V-1-ATPase peripheral stalk subunits E and G was determined by two independent approaches using mass spectrometry (MS). First, the subunit ratio was inferred from measuring the molecular mass of the intact V-1-ATPase complex and each of the individual protein components, using native electrospray ionization-MS. The major observed intact complex had a mass of 593,600 Da, with minor components displaying masses of 553,550 and 428,300 Da, respectively. Second, defined amounts of V-1-ATPase purified from yeast grown on N-14-containing medium were titrated with defined amounts of N-15-labeled E and G subunits as internal standards. Following protease digestion of subunit bands, N-14- and N-15-containing peptide pairs were used for quantification of subunit stoichiometry using matrix-assisted laser desorption/ionization-time of flight MS. Results from both approaches are in excellent agreement and reveal that the subunit composition of yeast V-1-ATPase is A(3)B(3)DE(3)FG(3)H.	[Kitagawa, Norton; Wilkens, Stephan] SUNY Syracuse, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Kitagawa, Norton] Univ Calif Riverside, Cept Cell Mol & Dev Biol, Riverside, CA 92521 USA; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmacuet Sci, NL-3584 CA Utrecht, Netherlands; [Mazon, Hortense; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Biomol Mass Spectrometry, NL-3584 CA Utrecht, Netherlands	State University of New York (SUNY) System; University of California System; University of California Riverside; Utrecht University; Utrecht University	Wilkens, S (corresponding author), SUNY Syracuse, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	NCI NIH HHS [CA100246] Funding Source: Medline; NIGMS NIH HHS [GM58600] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Bronstrup M, 2004, EXPERT REV PROTEOMIC, V1, P503, DOI 10.1586/14789450.1.4.503; Chernushevich IV, 2004, ANAL CHEM, V76, P1754, DOI 10.1021/ac035406j; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Dunn SD, 2000, BBA-BIOENERGETICS, V1458, P356, DOI 10.1016/S0005-2728(00)00086-4; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Fethiere J, 2004, J BIOL CHEM, V279, P40670, DOI 10.1074/jbc.M407086200; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOUGH B, 2006, GNU SCI LIB REFERENC; Gras R, 1999, ELECTROPHORESIS, V20, P3535, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3535::AID-ELPS3535>3.3.CO;2-A; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Heck AJR, 2004, EXPERT REV PROTEOMIC, V1, P317, DOI 10.1586/14789450.1.3.317; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; HO MN, 1993, J BIOL CHEM, V268, P18286; Hochleitner EO, 2005, J BIOL CHEM, V280, P2536, DOI 10.1074/jbc.M409587200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kito K, 2007, J PROTEOME RES, V6, P792, DOI 10.1021/pr060447s; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Pan Sheng, 2007, Methods Mol Biol, V367, P209; Robinson CV, 2002, NAT STRUCT BIOL, V9, P505, DOI 10.1038/nsb0702-505; Rubinstein JL, 2003, EMBO J, V22, P6182, DOI 10.1093/emboj/cdg608; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sobott F, 2005, PHILOS T R SOC A, V363, P379, DOI 10.1098/rsta.2004.1498; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Synowsky SA, 2006, MOL CELL PROTEOMICS, V5, P1581, DOI 10.1074/mcp.M600043-MCP200; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Wilkens S, 2000, J MOL BIOL, V295, P387, DOI 10.1006/jmbi.1999.3381; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	48	79	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3329	3337		10.1074/jbc.M707924200	http://dx.doi.org/10.1074/jbc.M707924200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055462	hybrid			2022-12-27	WOS:000253083000037
J	Laird, DW				Laird, Dale W.			Closing the gap on autosomal dominant connexin-26 and connexin-43 mutants linked to human disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DENTO-DIGITAL DYSPLASIA; OCULODENTODIGITAL DYSPLASIA; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-GENETICS; MUTATIONS CAUSE; GJA1 MUTATIONS; MODEL; SKIN; DISORDERS; FAMILY	Cells within the vast majority of human tissues communicate directly through clustered arrays of intercellular channels called gap junctions. Gene ablation studies in mouse models have revealed that these intercellular channels are necessary for a variety of organ functions and that some of these genes are essential for survival. Molecular genetics has uncovered that germ line mutations in nearly half of the genes that encode the 21-member connexin family of gap junction proteins are linked to one or more human diseases. Frequently, these mutations are autosomal recessive, whereas in other cases, autosomal dominant mutations manifest as disease. Given the broad and overlapping distribution of connexins in a wide arrangement of tissues, it is hard to predict where connexin-linked diseases will clinically manifest. For instance, the most prevalent connexin in the human body is connexin-43 (Cx43), yet autosomal dominant mutations in the GJA1 gene, which encodes Cx43, exhibit modest developmental disorders resulting in a disease termed oculodentodigital dysplasia. Autosomal recessive mutations in the gene encoding Cx26 result in moderate to severe sensorineural hearing loss, whereas autosomal dominant mutations produce hearing loss and a wide range of skin diseases, including palmoplantar keratoderma. Here, we will focus on autosomal dominant mutations of the genes encoding Cx26 and Cx43 in relation to models that link genotypes to phenotypic outcomes with particular reference to how these approaches provide insight into human disease.	[Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Laird, Dale W/0000-0002-4568-3285; 				Ainsworth PJ, 1998, HUM GENET, V103, P242, DOI 10.1007/s004390050812; Bakirtzis G, 2003, HUM MOL GENET, V12, P1737, DOI 10.1093/hmg/ddg183; Bakirtzis G, 2003, CELL COMMUN ADHES, V10, P359, DOI 10.1080/714040453; Bugiani M, 2006, NEUROLOGY, V67, P273, DOI 10.1212/01.wnl.0000223832.66286.e4; Debeer P, 2005, EUR J MED GENET, V48, P377, DOI 10.1016/j.ejmg.2005.05.003; Flenniken AM, 2005, DEVELOPMENT, V132, P4375, DOI 10.1242/dev.02011; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Gong XQ, 2007, J BIOL CHEM, V282, P19190, DOI 10.1074/jbc.M609653200; Gong XQ, 2006, J BIOL CHEM, V281, P31801, DOI 10.1074/jbc.M605961200; Kalcheva N, 2007, P NATL ACAD SCI USA, V104, P20512, DOI 10.1073/pnas.0705472105; Kelly SC, 2006, EUR J DERMATOL, V16, P241; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Kleopa KA, 2006, NEUROMOL MED, V8, P107, DOI 10.1385/NMM:8:1:107; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Laird DW, 2005, BBA-BIOMEMBRANES, V1711, P172, DOI 10.1016/j.bbamem.2004.09.009; Langlois S, 2007, J BIOL CHEM, V282, P30171, DOI 10.1074/jbc.M703623200; Liu XZ, 2001, HUM MOL GENET, V10, P2945, DOI 10.1093/hmg/10.25.2945; Loddenkemper T, 2002, J NEUROL, V249, P584, DOI 10.1007/s004150200068; Maher AC, 2005, CELL COMMUN ADHES, V12, P219, DOI 10.1080/15419060500511818; Ni XQ, 2007, J MED GENET, V44, P532, DOI 10.1136/jmg.2006.047944; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Rabionet R, 2002, TRENDS MOL MED, V8, P205, DOI 10.1016/S1471-4914(02)02327-4; Ressot C, 1996, HUM GENET, V98, P172, DOI 10.1007/s004390050183; Ressot C, 2000, BRAIN RES REV, V32, P192, DOI 10.1016/S0165-0173(99)00081-8; Richard G, 2003, CLIN EXP DERMATOL, V28, P397, DOI 10.1046/j.1365-2230.2003.01312.x; Richard G, 2005, CLIN DERMATOL, V23, P23, DOI 10.1016/j.clindermatol.2004.09.010; Roscoe W, 2005, J BIOL CHEM, V280, P11458, DOI 10.1074/jbc.M409564200; Rouan F, 2001, J CELL SCI, V114, P2105; Scherer SS, 1999, NOVART FDN SYMP, V219, P175; Schnichels M, 2007, HUM MOL GENET, V16, P1216, DOI 10.1093/hmg/ddm068; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; STAUFFER KA, 1995, J BIOL CHEM, V270, P6768; Thomas T, 2004, J BIOL CHEM, V279, P19157, DOI 10.1074/jbc.M314117200; Thomas T, 2007, J MEMBRANE BIOL, V217, P93, DOI 10.1007/s00232-007-9036-x; van Steensel MAM, 2005, AM J MED GENET A, V132A, P171, DOI 10.1002/ajmg.a.30412; van Steensel MAM, 2004, AM J MED GENET C, V131C, P12, DOI 10.1002/ajmg.c.30030; Vreeburg M, 2007, AM J MED GENET A, V143A, P360, DOI 10.1002/ajmg.a.31558; Yang JJ, 2007, AUDIOL NEURO-OTOL, V12, P198, DOI 10.1159/000099024	42	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					2997	3001		10.1074/jbc.R700041200	http://dx.doi.org/10.1074/jbc.R700041200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18089569	hybrid			2022-12-27	WOS:000253083000001
J	Sasaki, N; Okishio, K; Ui-Tei, K; Saigo, K; Kinoshita-Toyoda, A; Toyoda, H; Nishimura, T; Suda, Y; Hayasaka, M; Hanaoka, K; Hitoshi, S; Ikenaka, K; Nishihara, S				Sasaki, Norihiko; Okishio, Kazuhiko; Ui-Tei, Kumiko; Saigo, Kaoru; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Nishimura, Tomoaki; Suda, Yasuo; Hayasaka, Michiko; Hanaoka, Kazunari; Hitoshi, Seiji; Ikenaka, Kazuhiro; Nishihara, Shoko			Heparan sulfate regulates self-renewal and pluripotency of embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR SUPPRESSORS EXT1; MOUSE EMBRYOS; TOUT-VELU; ES CELLS; DIFFERENTIATION; ACTIVATION; EXPRESSION; DROSOPHILA; NANOG; STAT3	Embryonic stem (ES) cell self-renewal and pluripotency are maintained by several signaling cascades and by expression of intrinsic factors, such as Oct3/4 and Nanog. The signaling cascades are activated by extrinsic factors, such as leukemia inhibitory factor, bone morphogenic protein, and Wnt. However, the mechanism that regulates extrinsic signaling in ES cells is unknown. Heparan sulfate (HS) chains are ubiquitously present as the cell surface proteoglycans and are known to play crucial roles in regulating several signaling pathways. Here we investigated whether HS chains on ES cells are involved in regulating signaling pathways that are important for the maintenance of ES cells. RNA interference-mediated knockdown of HS chain elongation inhibited mouse ES cell self-renewal and induced spontaneous differentiation of the cells into extraembryonic endoderm. Furthermore, autocrine/paracrine Wnt/beta-catenin signaling through HS chains was found to be required for the regulation of Nanog expression. We propose that HS chains are important for the extrinsic signaling required for mouse ES cell self-renewal and pluripotency.	[Sasaki, Norihiko; Okishio, Kazuhiko; Nishimura, Tomoaki; Suda, Yasuo; Nishihara, Shoko] Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, Tokyo 1928577, Japan; [Ui-Tei, Kumiko; Saigo, Kaoru] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; [Toyoda, Hidenao; Nishimura, Tomoaki] Chiba Univ, Grad Sch Pharmaceut Sci, DEpt Bioanal Chem, Chiba 2638522, Japan; [Nishimura, Tomoaki; Suda, Yasuo] Kagoshima Univ, DEpt Nanostruct & Adv Mat, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Nishimura, Tomoaki; Suda, Yasuo] Sudx Biotec Corp, Kobe, Hyogo 6500047, Japan; [Hayasaka, Michiko; Hanaoka, Kazunari] Kitasato Univ, Sch Sci, Mol Embryol Lab, Dept Biosci, Kanagawa 228, Japan; [Hitoshi, Seiji; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Aichi 4448585, Japan; [Sasaki, Norihiko; Kinoshita-Toyoda, Akiko; Toyoda, Hidenao; Suda, Yasuo; Nishihara, Shoko] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Soka University; University of Tokyo; Chiba University; Kagoshima University; Kitasato University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST)	Nishihara, S (corresponding author), Soka Univ, Cell Biol Lab, Dept Bioinformat, Fac Engn, 1-236 Tangi Cho, Tokyo 1928577, Japan.	shoko@t.soka.ac.jp		Nishihara, Shoko/0000-0002-1668-2603				Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; McCormick C, 1998, NAT GENET, V19, P158, DOI 10.1038/514; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Suda Y, 2006, BIOCONJUGATE CHEM, V17, P1125, DOI 10.1021/bc0600620; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	79	83	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3594	3606		10.1074/jbc.M705621200	http://dx.doi.org/10.1074/jbc.M705621200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18024963	hybrid			2022-12-27	WOS:000253083000065
J	Song, M; Basu, VP; Hanson, MN; Roques, BP; Bambara, RA				Song, Min; Basu, Vandana P.; Hanson, Mark N.; Roques, Bernard P.; Bambara, Robert A.			Proximity and branch migration mechanisms in HIV-1 minus strand strong stop DNA transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 NUCLEOCAPSID PROTEIN; VIRUS REVERSE-TRANSCRIPTASE; ACID-CHAPERONE ACTIVITY; ZINC-FINGER STRUCTURES; HUMAN-IMMUNODEFICIENCY; RNASE-H; IN-VITRO; GENOMIC RNA; CLEAVAGE SPECIFICITY; INVASION MECHANISM	Human immunodeficiency virus type 1 minus strand transfer was measured using a genomic donor-acceptor template system in vitro. Donor RNA D199, having the minimum region required for minus strong stop DNA synthesis, was previously shown to transfer with 35% efficiency to an acceptor RNA representing the 3 ' repeat region. Donor D520, having an additional 321-nucleotide segment extending into gag, transferred at 75% efficiency. In this study each transfer step was analyzed to account for the difference. Measurement of terminal transfer indicated that the 3 ' terminus of the cDNA generated using D520 is more accessible for transfer than that of D199. Nevertheless, acceptor competition experiments demonstrated that D520 has a greater preference for invasion-driven versus terminal transfer than D199. Competition mapping showed that the base of the transactivation response element is the primary invasion site for D520, important for efficient acceptor invasion. Acceptors complementary to the invasion and terminal transfer sites, but not the region between, allowed assessment of the significance of hybrid propagation by branch migration. These bipartite acceptors showed that with D520, invasion raises the local concentration of the acceptor for efficient terminal transfer by a proximity effect. However, with D199, invasion is relatively inefficient, and the cDNA 3 ' terminus is not very accessible. For most transfers that occurred, the acceptor accessed the cDNA 3 ' end by branch migration. Results suggest that both proximity and branch migration mechanisms contribute to transfers, with the proportion determined by donor-cDNA structure. D520 transfers better because it has greater accessibility for both invasion and terminus transfer.	[Song, Min; Basu, Vandana P.; Hanson, Mark N.; Bambara, Robert A.] Univ Rochester, Ctr Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Roques, Bernard P.] CNRS, Fac Pharm, INSERM, Dept Pharmacochim Mol & Struct,U266,UMR 8600, F-75270 Paris, France	University of Rochester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bambara, RA (corresponding author), Univ Rochester, Ctr Med, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	so, strawberry/F-6515-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM049573] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Brule F, 2000, NUCLEIC ACIDS RES, V28, P634, DOI 10.1093/nar/28.2.634; Chen Y, 2005, J BIOL CHEM, V280, P14443, DOI 10.1074/jbc.M412190200; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Chen Y, 2003, J BIOL CHEM, V278, P8006, DOI 10.1074/jbc.M210959200; Coffin J. M., 1990, VIROLOGY, P1437; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; DESTEFANO JJ, 1994, J MOL BIOL, V243, P558, DOI 10.1016/0022-2836(94)90030-2; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Driscoll MD, 2000, J VIROL, V74, P8785, DOI 10.1128/JVI.74.19.8785-8792.2000; Driscoll MD, 2001, J VIROL, V75, P672, DOI 10.1128/JVI.75.2.672-686.2001; Gao L, 2007, J BIOL CHEM, V282, P6222, DOI 10.1074/jbc.M610056200; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Guo JH, 2002, J VIROL, V76, P4370, DOI 10.1128/JVI.76.9.4370-4378.2002; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; Hanson MN, 2006, J MOL BIOL, V363, P878, DOI 10.1016/j.jmb.2006.08.068; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Heilman-Miller SL, 2004, J BIOL CHEM, V279, P44154, DOI 10.1074/jbc.M401646200; Hong MK, 2003, J MOL BIOL, V325, P1, DOI 10.1016/S0022-2836(02)01177-4; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KLAVER B, 1994, NUCLEIC ACIDS RES, V22, P137, DOI 10.1093/nar/22.2.137; Kulpa D, 1997, EMBO J, V16, P856, DOI 10.1093/emboj/16.4.856; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; LEE YMH, 1991, MOL CELL BIOL, V11, P1419, DOI 10.1128/MCB.11.3.1419; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; LOBEL LI, 1985, J VIROL, V53, P447, DOI 10.1128/JVI.53.2.447-455.1985; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Negroni M, 1999, J MOL BIOL, V286, P15, DOI 10.1006/jmbi.1998.2460; Ohi Y, 2000, J VIROL, V74, P8324, DOI 10.1128/JVI.74.18.8324-8334.2000; Ooms M, 2004, NUCLEIC ACIDS RES, V32, P819, DOI 10.1093/nar/gkh206; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Palaniappan C, 1996, J BIOL CHEM, V271, P2063, DOI 10.1074/jbc.271.47.29605; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Purohit V, 2005, J BIOL CHEM, V280, P40534, DOI 10.1074/jbc.M507839200; RAMSEY CA, 1993, J VIROL, V67, P4114, DOI 10.1128/JVI.67.7.4114-4121.1993; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song M, 2006, J BIOL CHEM, V281, P24227, DOI 10.1074/jbc.M603097200; Telesnitsky A., 1997, P121; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Topping R, 1998, J MOL BIOL, V281, P1, DOI 10.1006/jmbi.1998.1929; VARMUS H, 1989, MOBILE DNA, P53; VARMUS HE, 1978, J MOL BIOL, V120, P55, DOI 10.1016/0022-2836(78)90295-4; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200; Wu TY, 2007, NUCLEIC ACIDS RES, V35, P3974, DOI 10.1093/nar/gkm375; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Yin PD, 1997, J VIROL, V71, P2487, DOI 10.1128/JVI.71.3.2487-2494.1997; YOU JC, 1994, J BIOL CHEM, V269, P31491; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	65	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3141	3150		10.1074/jbc.M707343200	http://dx.doi.org/10.1074/jbc.M707343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073206	hybrid			2022-12-27	WOS:000253083000017
J	Chen, K; Tu, YZ; Zhang, YJ; Blair, HC; Zhang, L; Wu, CY				Chen, Ka; Tu, Yizeng; Zhang, Yongjun; Blair, Harry C.; Zhang, Lin; Wu, Chuanyue			PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; FOCAL ADHESION KINASE; MATRIX ADHESION; SIGNAL-TRANSDUCTION; SHAPE MODULATION; PROTEIN; PHOSPHORYLATION; PROMOTES; SRC; LOCALIZATION	Resistance to apoptosis is a hallmark of cancer cells. We report here that PINCH-1, a cytoplasmic component of cell-extracellular matrix adhesions, is required for protection of multiple types of cancer cells from apoptosis. Furthermore, using HT-1080 fibrosarcoma cells as a model system, we have investigated the signaling pathway through which PINCH-1 contributes to apoptosis resistance. Loss of PINCH-1 markedly increases the level of Bim and promotes Bim translocation to mitochondria, resulting in activation of the intrinsic apoptosis pathway. Depletion of Bim completely blocked apoptosis induced by the loss of PINCH-1.Thus, PINCH-1 contributes to apoptosis resistance through suppression of Bim. Mechanistically, PINCH-1 suppresses Bim not only transcriptionally but also post-transcriptionally. PINCH-1 promotes activating phosphorylation of Src family kinase and ERK1/2. Consistent with this, ERK1/2-mediated Ser69 phosphorylation of Bim, a key signal for turnover of Bim, is suppressed by the removal of PINCH-1. Our results demonstrate a strong dependence of multiple types of apoptosis-resistant cancer cells on PINCH-1 and provide new insights into the molecular mechanism by which cancer cells are protected from apoptosis.	[Chen, Ka; Tu, Yizeng; Zhang, Yongjun; Blair, Harry C.; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Zhang, Lin] Univ Pittsburgh, Dept Pharmacol, Sch Med, Pittsburgh, PA 15261 USA; [Zhang, Lin; Wu, Chuanyue] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu	Zhang, Lin/A-7389-2009	Zhang, Lin/0000-0003-0018-3903	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54639] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li FG, 1999, J CELL SCI, V112, P4589; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2007, CIRC RES, V100, P527, DOI 10.1161/01.RES.0000259041.37059.8c; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	60	62	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2508	2517		10.1074/jbc.M707307200	http://dx.doi.org/10.1074/jbc.M707307200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18063582	hybrid			2022-12-27	WOS:000252622300007
J	Fredenburgh, JC; Stafford, AR; Leslie, BA; Weitz, JI				Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.			Bivalent binding to gamma a/gamma ' fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; BOUND THROMBIN; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CATALYTIC SITE; PLASMA; INACTIVATION; AFFINITY; MODULATION; RESISTANCE	Thrombin exosite 1 binds the predominant gamma(A)/gamma(A)-fibrin form with low affinity. A subpopulation of fibrin molecules, gamma(A)/gamma '-fibrin, has an extended COOH terminus gamma '-chain that binds exosite 2 of thrombin. Bivalent binding to gamma A/gamma '-fibrin increases the affinity of thrombin 10-fold, as determined by surface plasmon resonance. Because of its higher affinity, thrombin dissociates 7-fold more slowly from gamma(A)/gamma '-fibrin clots than from gamma(A)/gamma '-fibrin clots. After 24 h of washing, however, both gamma(A)/gamma '- and gamma(A)/gamma(A)-fibrin clots generate fibrinopeptide A when incubated with fibrinogen, indicating the retention of active thrombin. Previous studies demonstrated that heparin heightens the affinity of thrombin for fibrin by simultaneously binding to fibrin and exosite 2 on thrombin to generate a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin and heparin cofactor II. In contrast, dermatan sulfate does not promote ternary complex formation because it does not bind to fibrin. Heparin-catalyzed rates of thrombin inhibition by antithrombin were 5-fold slower in gamma(A)/gamma-fibrin clots than they were in gamma(A)/gamma(A)-fibrin clots. This difference reflects bivalent binding of thrombin to gamma(A)/gamma '-fibrin because (a) it is abolished by addition of a gamma '-chain-directed antibody that blocks exosite 2-mediated binding of thrombin to the gamma '-chain and (b) the dermatan sulfate-catalyzed rate of thrombin inhibition by heparin cofactor II also is lower with gamma(A)/gamma '-fibrin than with gamma(A)/gamma '-fibrin clots. Thus, bivalent binding of thrombin to gamma(A)/gamma '-fibrin protects thrombin from inhibition, raising the possibility that gamma(A)/gamma '-fibrin serves as a reservoir of active thrombin that renders thrombi thrombogenic.	[Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.] Henderson Res Ctr, Hamilton, ON L8V 1C3, Canada; [Fredenburgh, James C.; Stafford, Alan R.; Leslie, Beverly A.; Weitz, Jeffrey I.] McMaster Univ, Hamilton, ON L8V 1C3, Canada	McMaster University	Weitz, JI (corresponding author), 711 Concess St, Hamilton, ON L8V 1C3, Canada.	jweitz@thrombosis.hhscr.org	Weitz, Jeffrey/AAD-1929-2019	Weitz, Jeffrey/0000-0002-1092-7550				Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Agnelli G, 2002, HAEMATOLOGICA, V87, P757; Becker DL, 1999, J BIOL CHEM, V274, P6226, DOI 10.1074/jbc.274.10.6226; Becker DL, 1997, ADV EXP MED BIOL, V425, P55; Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551; Celikel R, 2003, SCIENCE, V301, P218, DOI 10.1126/science.1084183; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; de Bosch NB, 2002, THROMB HAEMOSTASIS, V88, P253; De Candia E, 2001, J BIOL CHEM, V276, P4692, DOI 10.1074/jbc.M008160200; De Cristofaro R, 1998, CIRCULATION, V98, P1297, DOI 10.1161/01.CIR.98.13.1297; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; DIAMOND SL, 1993, BIOPHYS J, V65, P2622, DOI 10.1016/S0006-3495(93)81314-6; Dumas JJ, 2003, SCIENCE, V301, P222, DOI 10.1126/science.1083917; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Falls LA, 1997, J BIOL CHEM, V272, P14251, DOI 10.1074/jbc.272.22.14251; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493; Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088; Hogg PJ, 1997, THROMB HAEMOSTASIS, V77, P424; Kerlin B, 2004, BLOOD, V103, P1728, DOI 10.1182/blood-2003-08-2886; KEYT BA, 1992, ANAL BIOCHEM, V206, P73, DOI 10.1016/S0003-2697(05)80013-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; Liaw PCY, 2001, J BIOL CHEM, V276, P20959, DOI 10.1074/jbc.M010584200; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Lovely RS, 2002, THROMB HAEMOSTASIS, V88, P26; Luo J, 2001, J BIOCHEM-TOKYO, V130, P553, DOI 10.1093/oxfordjournals.jbchem.a003018; Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC; Mannila MN, 2007, J THROMB HAEMOST, V5, P766, DOI 10.1111/j.1538-7836.2007.02406.x; Meh DA, 2001, THROMB HAEMOSTASIS, V85, P470; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Monteiro RQ, 1999, BIOCHEM BIOPH RES CO, V262, P819, DOI 10.1006/bbrc.1999.1297; Mosesson MW, 2007, J THROMB HAEMOST, V5, P62, DOI 10.1111/j.1538-7836.2006.02270.x; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Mutch NJ, 2001, THROMB HAEMOSTASIS, V86, P1028; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; Pechik I, 2004, P NATL ACAD SCI USA, V101, P2718, DOI 10.1073/pnas.0303440101; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Pineda AO, 2007, BIOPHYS CHEM, V125, P556, DOI 10.1016/j.bpc.2006.08.005; Pospisil CH, 2003, J BIOL CHEM, V278, P21584, DOI 10.1074/jbc.M300545200; Siebenlist KR, 2005, BLOOD, V106, P2730, DOI 10.1182/blood-2005-01-0240; Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; Weitz JI, 2002, CIRCULATION, V105, P1004, DOI 10.1161/hc0802.104331; WOLFENSTEINTODEL C, 1981, BIOCHEMISTRY-US, V20, P6146, DOI 10.1021/bi00524a036; YE J, 1994, J BIOL CHEM, V269, P17965	46	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2470	2477		10.1074/jbc.M707710200	http://dx.doi.org/10.1074/jbc.M707710200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055456	hybrid			2022-12-27	WOS:000252622300003
J	Morris, DP; Lei, B; Wu, YX; Michelotti, GA; Schwinn, DA				Morris, Daniel P.; Lei, Beilei; Wu, Yue-Xuan; Michelotti, Gregory A.; Schwinn, Debra A.			The alpha(1a)-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; RESONANCE ENERGY-TRANSFER; LIPID RAFTS; SIGNALING PATHWAY; SMOOTH-MUSCLE; ACTIN CYTOSKELETON; COUPLED RECEPTORS; CARDIAC MYOCYTES; ADENYLYL-CYCLASE; MYOCARDIAL-CELLS	The alpha(1a)-adrenergic receptor (alpha(1a)AR) occupies intracellular and plasma membranes in both native and heterologous expression systems. Based on multiple independent lines of evidence, we demonstrate the alpha(1a)AR at the cell surface occupies membrane rafts but exits from rafts following stimulation. In non-detergent raft preparations, basal alpha(1a)AR is present in low density membrane rafts and colocalizes with its G protein effectors on density gradients. Raft disruption by cholesterol depletion with methyl-beta-cyclodextrin eliminates these light rafts. To confirm the presence of the alpha(1a)AR in plasma membrane rafts, fluorescence resonance energy transfer measurements were used to demonstrate colocalization of surface receptor and the raft marker, cholera toxin B. This colocalization was largely lost following alpha(1a)AR stimulation with phenylephrine. Similarly, receptor stimulation causes exit of the alpha(1a)AR from light rafts within 3-10 min in contrast to the G proteins, which largely remain in light rafts. Importantly, this delayed exit of the alpha(1a)AR suggests acute receptor signaling and desensitization occur entirely within rafts. Interestingly, both confocal analysis and measurement of surface alpha(1a)AR levels indicate modest receptor internalization during the 10 min following stimulation, suggesting most of the receptor has entered non-raft plasma membrane. Nevertheless, activation does increase the rate of receptor internalization as does disruption of rafts with methyl-beta-cyclodextrin, suggesting raft exit enables internalization. Confocal analysis of surface-labeled hemagglutinin-alpha(1a)AR reveals that basal and stimulated receptor occupies clathrin pits in fixed cells consistent with previous indirect evidence. The evidence presented here strongly suggests the alpha(1a)AR is a lipid raft protein under basal conditions and implies agonist-mediated signaling occurs from rafts.	[Morris, Daniel P.; Lei, Beilei; Wu, Yue-Xuan; Michelotti, Gregory A.] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Schwinn, Debra A.] Univ Washington, Dept Anesthesiol Pharmacol & Genome Sci, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle	Morris, DP (corresponding author), 595 LaSalle St,Ste 1027, Durham, NC 27710 USA.	morri082@mc.duke.edu		Michelotti, Gregory/0000-0002-7908-1979; Schwinn, Debra/0000-0002-9696-5231	NHLBI NIH HHS [R01 HL049103, R37 HL049103-13, R37 HL049103-12, R37 HL049103-14, HL 49103, R37 HL049103-11, R37 HL049103] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103, R01HL049103] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Christian AE, 1999, J LIPID RES, V40, P1475; Clarke CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2248, DOI 10.1152/ajpheart.01170.2006; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Dreja K, 2002, ARTERIOSCL THROM VAS, V22, P1267, DOI 10.1161/01.ATV.0000023438.32585.A1; Fernandez-Patron C, 2007, CAN J PHYSIOL PHARM, V85, P97, DOI 10.1139/Y06-097; FONSECA MI, 1995, J BIOL CHEM, V270, P8902, DOI 10.1074/jbc.270.15.8902; Fujita T, 2001, CARDIOVASC RES, V51, P709, DOI 10.1016/S0008-6363(01)00348-0; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Holowka D, 2000, J CELL SCI, V113, P1009; Huang Y, 2007, CIRCULATION, V115, P763, DOI 10.1161/CIRCULATIONAHA.106.664862; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lanzafame AA, 2006, AM J PHYSIOL-HEART C, V290, pH2059, DOI 10.1152/ajpheart.01210.2005; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mackenzie JF, 2000, J PHARMACOL EXP THER, V294, P434; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Morris JB, 2006, J MOL CELL CARDIOL, V41, P17, DOI 10.1016/j.yjmcc.2006.03.011; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliferenko S, 1999, J CELL BIOL, V146, P843, DOI 10.1083/jcb.146.4.843; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Price RR, 2002, J BIOL CHEM, V277, P9570, DOI 10.1074/jbc.M111762200; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Saeed AE, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-47; Salter-Cid L, 1999, P NATL ACAD SCI USA, V96, P5434, DOI 10.1073/pnas.96.10.5434; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SORKIN A, 1993, BIOESSAYS, V15, P375, DOI 10.1002/bies.950150603; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; VENEMA RC, 1993, J BIOL CHEM, V268, P2705; Vicentic A, 2002, J PHARMACOL EXP THER, V302, P58, DOI 10.1124/jpet.302.1.58; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Xiang Y, 2002, J BIOL CHEM, V277, P34280, DOI 10.1074/jbc.M201644200; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb	67	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2973	2985		10.1074/jbc.M705795200	http://dx.doi.org/10.1074/jbc.M705795200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048357	Green Accepted, hybrid			2022-12-27	WOS:000252622300053
J	Cheng, TS; Hsiao, YL; Lin, CC; Yu, CTR; Hsu, CM; Chang, MS; Lee, CI; Huang, CYF; Howng, SL; Hong, YR				Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Yu, Chang-Tze Ricky; Hsu, Ching-Mei; Chang, Mau-Sun; Lee, Chu-I; Huang, Chi-Ying F.; Howng, Shen-Long; Hong, Yi-Ren			Glycogen synthase kinase 3 beta interacts with and phosphorylates the spindle-associated protein astrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED-MAMMALIAN-CELLS; HUMAN NINEIN PROTEIN; MITOTIC-SPINDLE; ALZHEIMERS-DISEASE; CHROMOSOME SEGREGATION; 2-HYBRID SYSTEM; GENETIC SYSTEM; KINASE 3-BETA; BETA-CATENIN; TAU	Emerging evidence shows that glycogen synthase kinase 3 beta (GSK3 beta) is involved in mitotic division and that inhibiting of GSK3 beta kinase activity causes defects in spindle microtubule length and chromosome alignment. However, the purpose of GSK3 beta involvement in spindle microtubule assembly and accurate chromosome segregation remains obscure. Here, we report that GSK3 beta interacts with the spindle- associated protein Astrin both in vitro and in vivo. Additionally, Astrin acts as a substrate for GSK3 beta and is phosphorylated at Thr- 111, Thr- 937 ((S/ T) P motif) and Ser- 974/ Thr-978 ((S/ T) XXX(S/T)- p motif; p is a phosphorylatable residue). Inhibition of GSK3 beta impairs spindle and kinetochore accumulation of Astrin and spindle formation at mitosis, suggesting that Astrin association with the spindle microtubule and kinetochore may be dependent on phosphorylation by GSK3 beta. Conversely, depletion of Astrin by small interfering RNA has no detectable influence on the localization of GSK3 beta. Interestingly, in vitro assays demonstrated that Astrin enhances GSK3 beta- mediated phosphorylation of other substrates. Moreover, we showed that coexpression of Astrin and GSK3 beta differentially increases GSK3 beta- mediated Tau phosphorylation on an unprimed site. Collectively, these data indicate that GSK3 beta interacts with and phosphorylates the spindle- associated protein Astrin, resulting in targeting Astrin to the spindle microtubules and kinetochores. In turn, the GSK3 beta-Astrin complex may facilitate further physiological and pathological phosphorylation.	[Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Hsu, Ching-Mei; Hong, Yi-Ren] Kaohsiung Med Univ, Grad Inst Biochem, Kaohsiung 807, Taiwan; [Cheng, Tai-Shan; Hsiao, Yun-Ling; Lin, Ching-Chih; Hsu, Ching-Mei; Hong, Yi-Ren] Kaohsiung Med Univ, Grant Inst Med, Kaohsiung 807, Taiwan; [Lin, Ching-Chih] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 807, Taiwan; [Yu, Chang-Tze Ricky] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Nantou 545, Taiwan; [Chang, Mau-Sun] Mackay Mem Hosp, Dept Med Res, Taipei 104, Taiwan; [Lee, Chu-I] Fooyin Univ, Dept Med Technol, Kaohsiung 831, Taiwan; [Huang, Chi-Ying F.] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Howng, Shen-Long] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; National Chi Nan University; Mackay Memorial Hospital; Fooyin University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Hong, YR (corresponding author), Kaohsiung Med Univ, Grad Inst Biochem, 100 Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	m835016@cc.kmu.edu.tw	Huang, Chi-Ying/AFL-7729-2022; Huang, Chi-Ying/AAG-7672-2022; Hong, Yi-Ren/D-5514-2009; Howng, Shen-Long/D-5502-2009	Huang, Chi-Ying/0000-0003-4898-4937; Huang, Chi-Ying/0000-0003-4898-4937; CHANG, MAU-SUN/0000-0002-3703-2386; Hong, Yi-Ren/0000-0001-5470-6090				Abraha A, 2000, J CELL SCI, V113, P3737; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554; Chen CH, 2003, BIOCHEM BIOPH RES CO, V308, P975, DOI 10.1016/S0006-291X(03)01510-9; Cheng TS, 2007, EXP CELL RES, V313, P1710, DOI 10.1016/j.yexcr.2007.02.023; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Chou HY, 2006, BIOCHEMISTRY-US, V45, P11379, DOI 10.1021/bi061147r; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cohen P, 1999, PHILOS T R SOC B, V354, P485, DOI 10.1098/rstb.1999.0399; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 1999, J CELL SCI, V112, P3373; Gruber J, 2002, J CELL SCI, V115, P4053, DOI 10.1242/jcs.00088; Harborth J, 2001, J CELL SCI, V114, P4557; Hong YR, 2000, BBA-GENE STRUCT EXPR, V1492, P513, DOI 10.1016/S0167-4781(00)00127-5; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Liang MH, 2007, J BIOL CHEM, V282, P3904, DOI 10.1074/jbc.M605178200; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lin CC, 2006, CELL CYCLE, V5, P2517, DOI 10.4161/cc.5.21.3404; Lovestone S, 1996, NEUROSCIENCE, V73, P1145, DOI 10.1016/0306-4522(96)00126-1; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Mi KH, 2006, J BIOL CHEM, V281, P4787, DOI 10.1074/jbc.M508657200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; POPE WB, 1994, EXP NEUROL, V126, P185, DOI 10.1006/exnr.1994.1057; PREUSS U, 1995, MOL BIOL CELL, V6, P1397, DOI 10.1091/mbc.6.10.1397; Sanchez C, 2000, EUR J CELL BIOL, V79, P252, DOI 10.1078/S0171-9335(04)70028-X; SONG JS, 1995, J PROTEIN CHEM, V14, P95, DOI 10.1007/BF01888367; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Tighe A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-34; Vincent I, 1996, J CELL BIOL, V132, P413, DOI 10.1083/jcb.132.3.413; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; WANG QM, 1994, BIOCHEMISTRY-US, V33, P143, DOI 10.1021/bi00167a018; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhu L, 1997, Methods Mol Biol, V63, P173	55	27	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2454	2464		10.1074/jbc.M706794200	http://dx.doi.org/10.1074/jbc.M706794200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055457	hybrid, Green Submitted			2022-12-27	WOS:000252501000071
J	Maytum, R; Hatch, V; Konrad, M; Lehman, W; Geeves, MA				Maytum, Robin; Hatch, Victoria; Konrad, Manfred; Lehman, William; Geeves, Michael A.			Ultra short yeast tropomyosins show novel myosin regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE THIN-FILAMENTS; ACTIN-BINDING SITES; ALPHA-TROPOMYOSIN; SMOOTH-MUSCLE; STRIATED-MUSCLE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; COILED-COIL; F-ACTIN; COOPERATIVE REGULATION	Tropomyosin (Tm) is an alpha-helical coiled-coil actin-binding protein present in all eukaryotes from yeast to man. Its functional role has been best described in muscle regulation; however its much wider role in cytoskeletal actin regulation is still to be clarified. Isoforms vary in size from 284 or 248 amino acids in vertebrates, to 199 and 161 amino acids in yeast, spanning from 7 to 4 actin binding sites respectively. In Saccharomyces cerevisiae, the larger yTm1 protein is produced by an internal 38-amino acid duplication, corresponding to a single actin-binding site. We have produced an ultra-short Tm with only 125 amino acids by removing both of the 38 amino acid repeats from yTm1, with the addition of an Ala-Ser extension used to mimic the essential N-terminal acetylation. This short Tm, and an M1T mutant of it, bind to actin with a similar affinity to most Tms previously studied (K-50% similar to 0.5 mu M). However, an equilibrium fluorescence binding assay shows a much greater inhibition of myosin binding to actin than any previously studied Tm. Actin cosedimentation assays show this is caused by direct competition for binding to actin. The M1T mutant shows a reduced inhibition, probably due to weaker end-to-end interactions making it easier for myosin to displace Tm. All previously characterized Tms, although able to sterically block the myosin-binding site, are able to bind to actin along with myosin. By showing that Tm can compete directly with myosin for the same binding site these new Tms provide direct evidence for the steric blocking model.	[Maytum, Robin] Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Hatch, Victoria; Lehman, William] Max Planck Inst Biophys Chem, Inst Biophys Chem, D-73070 Gottingen, Germany; [Hatch, Victoria; Lehman, William] Boston Univ, Dept Physiol & Biophys, Boston, MA 02118 USA; [Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	University of London; Max Planck Society; Boston University; University of Kent	Maytum, R (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	r.maytum@qmul.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Maytum, Robin/0000-0003-0395-403X; Lehman, William/0000-0002-9430-9521	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036153, P01HL086655, R01HL036153, R55HL036153] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL86655, HL36153] Funding Source: Medline; Wellcome Trust [055881] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission)		AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Ansari S, 2003, J MUSCLE RES CELL M, V24, P513, DOI 10.1023/B:JURE.0000009812.74980.13; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Borovikov YS, 2001, INT J BIOCHEM CELL B, V33, P1151, DOI 10.1016/S1357-2725(01)00091-7; Cassell M, 1996, J BIOL CHEM, V271, P12867, DOI 10.1074/jbc.271.22.12867; Chen YD, 2001, BIOPHYS J, V80, P2338, DOI 10.1016/S0006-3495(01)76204-2; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; EATON BL, 1976, SCIENCE, V192, P1337, DOI 10.1126/science.131972; EGELMAN EH, 1986, ULTRAMICROSCOPY, V19, P367, DOI 10.1016/0304-3991(86)90096-3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 1995, BIOCHEMISTRY-US, V34, P16797, DOI 10.1021/bi00051a030; GREENFIELD NJ, 1993, PROTEIN SCI, V2, P1263, DOI 10.1002/pro.5560020809; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; Hammell RL, 1996, J BIOL CHEM, V271, P4236; Hammell RL, 1997, J BIOL CHEM, V272, P22409, DOI 10.1074/jbc.272.36.22409; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; Hitchcock-DeGregori SE, 2001, BIOCHEMISTRY-US, V40, P2104, DOI 10.1021/bi002421z; HitchcockDeGregori SE, 1996, J BIOL CHEM, V271, P3600; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; HITCHCOCKDEGREGORI SE, 1987, J BIOL CHEM, V262, P9730; Hodgkinson JL, 1997, BIOPHYS J, V72, P2398, DOI 10.1016/S0006-3495(97)78885-4; HOLMES KC, 1993, ADV EXP MED BIOL, V332, P15; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landis C, 1999, J BIOL CHEM, V274, P31279, DOI 10.1074/jbc.274.44.31279; Landis CA, 1997, J BIOL CHEM, V272, P14051, DOI 10.1074/jbc.272.22.14051; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lehman W, 2000, J MOL BIOL, V302, P593, DOI 10.1006/jmbi.2000.4080; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; LIU HP, 1989, P NATL ACAD SCI USA, V86, P90, DOI 10.1073/pnas.86.1.90; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; Maytum R, 2003, BIOPHYS J, V84, p319A; Maytum R, 2003, J BIOL CHEM, V278, P6696, DOI 10.1074/jbc.M210690200; Maytum R, 2001, BIOCHEMISTRY-US, V40, P7334, DOI 10.1021/bi010072i; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; MOODY C, 1990, J MUSCLE RES CELL M, V11, P176, DOI 10.1007/BF01766496; Moraczewska J, 2000, BIOCHEMISTRY-US, V39, P6891, DOI 10.1021/bi000242b; Moraczewska J, 1999, BIOCHEMISTRY-US, V38, P15885, DOI 10.1021/bi991816j; NOVY RE, 1993, BIOCHIM BIOPHYS ACTA, V1162, P255, DOI 10.1016/0167-4838(93)90289-4; Owen CH, 1996, J STRUCT BIOL, V116, P167, DOI 10.1006/jsbi.1996.0027; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PHILLIPS GN, 1979, NATURE, V278, P413, DOI 10.1038/278413a0; PHILLIPS GN, 1986, J MOL BIOL, V192, P111, DOI 10.1016/0022-2836(86)90468-7; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Resetar AM, 2002, BIOPHYS J, V83, P1039, DOI 10.1016/S0006-3495(02)75229-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Smith DA, 2003, BIOPHYS J, V84, P3155, DOI 10.1016/S0006-3495(03)70040-X; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Smith L, 1999, BIOPHYS J, V76, P400, DOI 10.1016/S0006-3495(99)77206-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; URBANCIKOVA M, 1994, J BIOL CHEM, V269, P24310; VIBERT P, 1993, J CELL BIOL, V123, P313, DOI 10.1083/jcb.123.2.313; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800; Vilfan A, 2001, BIOPHYS J, V81, P3146, DOI 10.1016/S0006-3495(01)75951-6; Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284; WEEDS AG, 1975, NATURE, V257, P54, DOI 10.1038/257054a0; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3	66	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1902	1910		10.1074/jbc.M708593200	http://dx.doi.org/10.1074/jbc.M708593200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006493	Green Published, hybrid			2022-12-27	WOS:000252501000016
J	Vagin, O; Tokhtaeva, E; Yakubov, I; Shevchenko, E; Sachs, G				Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George			Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia - Contribution of the Na,K-ATPase beta(1) subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEPTATE JUNCTION FUNCTION; PROTEIN-KINASE-C; ACETYLGLUCOSAMINYLTRANSFERASE-V; NA+/K+ ATPASE; CELL-ADHESION; CADHERIN; EXPRESSION; IDENTIFICATION; GLYCOSYLATION; SUPPRESSION	The majority of cell adhesion molecules are N-glycosylated, but the role of N-glycans in intercellular adhesion in epithelia remains ill-defined. Reducing N-glycan branching of cellular glycoproteins by swainsonine, the inhibitor of N-glycan processing, tightens and stabilizes cell-cell junctions as detected by a 3-fold decrease in the paracellular permeability and a 2-3-fold increase in the resistance of the adherens junction proteins to extraction by non-ionic detergent. In addition, exposure of cells to swainsonine inhibits motility of MDCK cells. Mutagenic removal of N-glycosylation sites from the Na,K-ATPase beta(1) subunit impairs cell-cell adhesion and decreases the effect of swainsonine on the paracellular permeability of the cell monolayer and also on detergent resistance of adherens junction proteins, indicating that the extent of N-glycan branching of this subunit is important for intercellular adhesion. The N-glycans of the Na,K-ATPase beta(1) subunit and E-cadherin are less complex in tight renal epithelia than in the leakier intestinal epithelium. The complexity of the N-glycans linked to these proteins gradually decreases upon the formation of a tight monolayer from dispersed MDCK cells. This correlates with a cell-cell adhesion-induced increase in expression of GnT-III (stops N-glycan branching) and a decrease in expression of GnTs IVC and V (promote N-glycan branching) as detected by real-time quantitative PCR. Consistent with these results, partial silencing of the gene encoding GnT-III increases branching of N-glycans linked to the Na,K-ATPase beta(1) subunit and other glycoproteins and results in a 2-fold increase in the paracellular permeability of MDCK cell monolayers. These results suggest epithelial cells can regulate tightness of cell junctions via remodeling of N-glycans, including those linked to the Na,K-ATPase beta(1)-subunit.	[Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George] Vet Adm Greater Los Angeles Hlth Care Syst, Los Angeles, CA 90073 USA; [Vagin, Olga; Tokhtaeva, Elmira; Yakubov, Iskandar; Shevchenko, Eugenia; Sachs, George] Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90073 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vagin, O (corresponding author), VAGLAHS W LA, 11301 Wilshire Blvd,Rm 324,Bldg 113, Los Angeles, CA 90073 USA.	olgav@ucla.edu	Yakubov, Iskandar/W-6936-2018	Yakubov, Iskandar/0000-0002-7367-428X	NIDDK NIH HHS [R56 DK058333, R01 DK046917-09S2, R01 DK077149-01A1, DK58333, R01 DK053642, DK077149, R01 DK058333-09, R01 DK058333, DK46917, R01 DK077149, R01 DK046917, R01 DK077149-02, R01 DK053642-10] Funding Source: Medline; PHS HHS [D53642] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058333, R01DK046917, R01DK077149, R01DK053642, R56DK058333] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Diamond J M, 1977, Physiologist, V20, P10; Dosaka-Akita H, 2004, CLIN CANCER RES, V10, P1773, DOI 10.1158/1078-0432.CCR-1047-3; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Genova JL, 2003, J CELL BIOL, V161, P979, DOI 10.1083/jcb.200212054; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Granovsky M, 2000, NAT MED, V6, P306; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Handerson T, 2003, CANCER RES, V63, P5363; Iijima J, 2006, J BIOL CHEM, V281, P13038, DOI 10.1074/jbc.M601961200; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Ishibashi Y, 2005, ONCOLOGY-BASEL, V69, P301, DOI 10.1159/000089680; Kapus A, 2006, BIOCHEM CELL BIOL, V84, P870, DOI 10.1139/O06-202; KINO T, 1985, J ANTIBIOT, V38, P936, DOI 10.7164/antibiotics.38.936; Kroepfl JF, 2001, J NEUROCHEM, V77, P1301, DOI 10.1046/j.1471-4159.2001.00343.x; Laughery MD, 2003, J BIOL CHEM, V278, P34794, DOI 10.1074/jbc.M302899200; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Murata K, 2000, CLIN CANCER RES, V6, P1772; Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; Rajasekaran AK, 1996, J CELL BIOL, V132, P451, DOI 10.1083/jcb.132.3.451; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rothen-Rutishauser B, 2002, J MEMBRANE BIOL, V188, P151, DOI 10.1007/s00232-001-0182-2; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Takahashi T, 2006, J UROLOGY, V175, P90, DOI 10.1016/S0022-5347(05)00044-3; TREUHEIT MJ, 1993, J BIOL CHEM, V268, P13914; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335	42	75	75	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2192	2202		10.1074/jbc.M704713200	http://dx.doi.org/10.1074/jbc.M704713200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025087	Green Accepted, hybrid			2022-12-27	WOS:000252501000047
J	Witting, SR; Brown, M; Saxena, R; Nabinger, S; Morral, N				Witting, Scott R.; Brown, Matthew; Saxena, Romil; Nabinger, Sarah; Morral, Nuria			Helper-dependent adenovirus-mediated short hairpin RNA expression in the liver activates the interferon response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-FACTOR-VIII; GENE-EXPRESSION; IN-VIVO; IMMUNE-RESPONSES; SINGLE INJECTION; STRANDED-RNA; VECTORS; MICE; INDUCTION; MICRORNAS	The use of RNA interference has proven to be an effective means to study the function of genes. Constitutive synthesis of small interfering RNA molecules can be accomplished with the use of viral vectors expressing short hairpin RNA (shRNA). Binding of shRNA to the target mRNA promotes transcript degradation. So far, little is known about the effects that shRNA induce in vivo. To determine the feasibility of using helper-dependent adenoviral vectors for expression of shRNA in liver, we have designed an shRNA construct to mouse fabp5 (fatty acid-binding protein 5). Intravenous administration of this vector resulted in similar to 75% silencing of fabp5. Increasing the dose of vector did not result in higher levels of silencing, indicating that there is a threshold for the level of knockdown that can be achieved. Synthesis of high levels of shRNA molecules did not alter the levels of cellular micro-RNA, such as miR-122 and let-7a, suggesting that the exportin-5 pathway was not affected. However, high level shRNA expression resulted in activation of the interferon response. Thus, an important consideration when using shRNA-based vectors in vivo is to closely monitor signs of interferon-stimulated gene expression, since a narrow window exists between gene silencing efficacy and nonspecific effects.	[Witting, Scott R.; Brown, Matthew; Nabinger, Sarah; Morral, Nuria] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Saxena, Romil] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Morral, Nuria] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Morral, N (corresponding author), Indiana Univ, Sch Med, Dept Med & Mol Genet, 975 W Walnut St, Indianapolis, IN 46202 USA.	nmorralc@iupui.edu	Morral, Nuria/AAC-7149-2020	Morral, Nuria/0000-0002-8932-2887	NIDDK NIH HHS [R01 DK078595, R21 DK069432, 1R21DK069432-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078595, R21DK069432] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; CARTER BJ, 2003, PHARM GENE DELIVERY, P183; Chen HH, 1997, P NATL ACAD SCI USA, V94, P1645, DOI 10.1073/pnas.94.5.1645; Chen LN, 1996, SOMAT CELL MOLEC GEN, V22, P477, DOI 10.1007/BF02369439; Connelly S, 1996, BLOOD, V87, P4671, DOI 10.1182/blood.V87.11.4671.bloodjournal87114671; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haecker SE, 1996, HUM GENE THER, V7, P1907, DOI 10.1089/hum.1996.7.15-1907; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Kishida T, 2004, J GENE MED, V6, P105, DOI 10.1002/jgm.456; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; KumarSingh R, 1996, HUM MOL GENET, V5, P913, DOI 10.1093/hmg/5.7.913; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Morral N, 1997, HUM GENE THER, V8, P1275, DOI 10.1089/hum.1997.8.10-1275; Morral N, 1998, HUM GENE THER, V9, P2709, DOI 10.1089/hum.1998.9.18-2709; Morral N, 2002, HUM GENE THER, V13, P1561, DOI 10.1089/10430340260201653; Morsy MA, 1998, P NATL ACAD SCI USA, V95, P7866, DOI 10.1073/pnas.95.14.7866; Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004; Narvaiza I, 2006, J VIROL, V80, P12236, DOI 10.1128/JVI.01205-06; Nguyen LH, 2001, BIOCHEMISTRY-US, V40, P7174, DOI 10.1021/bi010141t; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pham HT, 2006, BIOCHEM BIOPH RES CO, V348, P145, DOI 10.1016/j.bbrc.2006.07.061; Reddy PS, 2002, MOL THER, V5, P63, DOI 10.1006/mthe.2001.0510; SAKAMOTO N, IN PRESS J GASTROENT; Sandig V, 2000, P NATL ACAD SCI USA, V97, P1002, DOI 10.1073/pnas.97.3.1002; Schiedner G, 2002, J VIROL, V76, P1600, DOI 10.1128/JVI.76.4.1600-1609.2002; Schiedner G, 1998, NAT GENET, V18, P180, DOI 10.1038/ng0298-180; Schlee M, 2006, MOL THER, V14, P463, DOI 10.1016/j.ymthe.2006.06.001; Sledz CA, 2004, BIOCHEM SOC T, V32, P952, DOI 10.1042/BST0320952; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Toietta G, 2005, P NATL ACAD SCI USA, V102, P3930, DOI 10.1073/pnas.0500930102; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xu HY, 2006, BIOCHEM BIOPH RES CO, V349, P439, DOI 10.1016/j.bbrc.2006.08.071; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Youil R, 2001, J VIROL METHODS, V92, P91, DOI 10.1016/S0166-0934(00)00280-9	61	33	35	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2120	2128		10.1074/jbc.M704178200	http://dx.doi.org/10.1074/jbc.M704178200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025090	hybrid			2022-12-27	WOS:000252501000039
J	Modha, R; Campbell, LJ; Nietlispach, D; Buhecha, HR; Owen, D; Mott, HR				Modha, Rakhee; Campbell, Louise J.; Nietlispach, Daniel; Buhecha, Heeran R.; Owen, Darerca; Mott, Helen R.			The Rac1 polybasic region is required for interaction with its effector PRK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-RESONANCE EXPERIMENTS; PROTEIN-KINASE N; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; RHO EFFECTOR; MACROMOLECULAR STRUCTURE; PKN; DOMAIN; ACTIVATION	Protein kinase C-related kinase 1 (PRK1 or PKN) is involved in regulation of the intermediate filaments of the actin cytoskeleton, as well as having effects on processes as diverse as mitotic timing and apoptosis. It is activated by interacting with the Rho family small G proteins and arachidonic acid or by caspase cleavage. We have previously shown that the HR1b of PRK1 binds exclusively to Rac1, whereas the HR1a domain binds to both Rac1 and RhoA. Here, we have determined the solution structure of the HR1b-Rac complex. We show that HR1b binds to the C- terminal end of the effector loop and switch 2 of Rac1. Comparison with the HR1a-RhoA structure shows that this part of the Rac1- HR1b interaction is homologous to one of the contact sites that HR1a makes with RhoA. The Rac1 used in this study included the C-terminal polybasic region, which is frequently omitted from structural studies, as well as the core Gdomain. The Rac1 C-terminal region reverses in direction to interact with residues in switch 2, and the polybasic region itself interacts with residues in HR1b. The interactions with HR1b do not prevent the polybasic region being available to contact the negatively charged membrane phospholipids, which is considered to be its primary role. This is the first structural demonstration that the C terminus of a G protein forms a novel recognition element for effector binding.	[Modha, Rakhee; Campbell, Louise J.; Nietlispach, Daniel; Buhecha, Heeran R.; Owen, Darerca; Mott, Helen R.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Owen, D (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	do@bioc.cam.ac.uk; hrm28@bioc.cam.ac.uk	Mott, Helen/AAV-3873-2020	Mott, Helen/0000-0002-7890-7097; Nietlispach, Daniel/0000-0003-4364-9291	Biotechnology and Biological Sciences Research Council [BB/E013228/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Balendran A, 1999, CURR BIOL, V9, P393, DOI 10.1016/S0960-9822(99)80186-9; Blumenstein L, 2004, J BIOL CHEM, V279, P53419, DOI 10.1074/jbc.M409551200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cottone G, 2006, J CELL PHYSIOL, V207, P232, DOI 10.1002/jcp.20566; Dong LQ, 2000, P NATL ACAD SCI USA, V97, P5089, DOI 10.1073/pnas.090491897; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Feltham JL, 1997, BIOCHEMISTRY-US, V36, P8755, DOI 10.1021/bi970694x; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Flynn P, 2000, J BIOL CHEM, V275, P11064, DOI 10.1074/jbc.275.15.11064; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Gao QS, 2000, J BIOL CHEM, V275, P14824, DOI 10.1074/jbc.275.20.14824; Graham DL, 1999, BIOCHEMISTRY-US, V38, P985, DOI 10.1021/bi9821770; Hirshberg M, 1997, NAT STRUCT BIOL, V4, P147, DOI 10.1038/nsb0297-147; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kawamata T, 1998, J NEUROSCI, V18, P7402; Kitagawa M, 1996, BIOCHEM BIOPH RES CO, V220, P963, DOI 10.1006/bbrc.1996.0515; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Misaki K, 2001, P NATL ACAD SCI USA, V98, P125, DOI 10.1073/pnas.021541498; Morissette MR, 2000, AM J PHYSIOL-HEART C, V278, pH1769, DOI 10.1152/ajpheart.2000.278.6.H1769; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Nietlispach D, 2002, J AM CHEM SOC, V124, P11199, DOI 10.1021/ja025865m; Owen D, 2003, J BIOL CHEM, V278, P50578, DOI 10.1074/jbc.M304313200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Shibata H, 1999, MOL BRAIN RES, V74, P126, DOI 10.1016/S0169-328X(99)00273-9; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yoshinaga C, 1999, J BIOCHEM, V126, P475, DOI 10.1093/oxfordjournals.jbchem.a022476; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	49	39	41	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1492	1500		10.1074/jbc.M706760200	http://dx.doi.org/10.1074/jbc.M706760200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006505	hybrid			2022-12-27	WOS:000252282700033
J	Lloyd, AJ; Gilbey, AM; Blewett, AM; De Pascale, G; El Zoeiby, A; Levesque, RC; Catherwood, AC; Tomasz, A; Bugg, TDH; Roper, DI; Dowson, CG				Lloyd, Adrian J.; Gilbey, Andrea M.; Blewett, Anne M.; De Pascale, Gianfranco; El Zoeiby, Ahmed; Levesque, Roger C.; Catherwood, Anita C.; Tomasz, Alexander; Bugg, Timothy D. H.; Roper, David I.; Dowson, Christopher G.			Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-WALLS; TRANSFER-RIBONUCLEIC-ACIDS; ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE MURB; CONTINUOUS SPECTROPHOTOMETRIC ASSAY; HIGH-LEVEL PENICILLIN; INTERPEPTIDE BRIDGES; BIOSYNTHESIS; RESISTANCE; GLYCINE; BINDING	MurM is an aminoacyl ligase that adds L-serine or L-alanine as the first amino acid of a dipeptide branch to the stem peptide lysine of the pneumococcal peptidoglycan. MurM activity is essential for clinical pneumococcal penicillin resistance. Analysis of peptidoglycan from the highly penicillin-resistant Streptococcus pneumoniae strain 159 revealed that in vivo and in vitro, in the presence of the appropriate acyl-tRNA, MurM(159) alanylated the peptidoglycan epsilon-amino group of the stem peptide lysine in preference to its serylation. However, in contrast, identical analyses of the penicillin-susceptible strain Pn16 revealed that MurM(Pn16) activity supported serylation more than alanylation both in vivo and in vitro. Interestingly, both MurMPn16 acylation activities were far lower than the alanylation activity of MurM159. The resulting differing stem peptide structures of 159 and Pn16 were caused by the profoundly greater catalytic efficiency of MurM159 compared with MurMPn16 bought about by sequence variation between these enzymes and, to a lesser extent, differences in the in vivo tRNAAla: tRNASer ratio in 159 and Pn16. Kinetic analysis revealed that MurM159 acted during the lipid-linked stages of peptidoglycan synthesis, that the D-alanyl-D-alanine of the stem peptide and the lipid II N-acetylglucosaminyl group were not essential for substrate recognition, that epsilon-carboxylation of the lysine of the stem peptide was not tolerated, and that lipid II-alanine was a substrate, suggesting an evolutionary link to staphylococcal homologues of MurM such as FemA. Kinetic analysis also revealed that MurM recognized the acceptor stem and/or the T Psi C loop stem of the tRNAAla. It is anticipated that definition of the minimal structural features of MurM substrates will allow development of novel resistance inhibitors that will restore the efficacy of beta-lactams for treatment of pneumococcal infection.	[Lloyd, Adrian J.; Gilbey, Andrea M.; Blewett, Anne M.; Catherwood, Anita C.; Roper, David I.; Dowson, Christopher G.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [De Pascale, Gianfranco; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [El Zoeiby, Ahmed; Levesque, Roger C.] Univ Laval, Fac Med, Ctr Rech Fonct Struct & Ingn Prot, Ste Foy, PQ G1K 7P4, Canada; [Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	University of Warwick; University of Warwick; Laval University; Rockefeller University	Lloyd, AJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	adrian.lloyd@warwick.ac.uk	Levesque, Roger C./ABD-8407-2021; Dowson, Chris/N-6195-2014; Tomasz, Alexander/B-9939-2011; Roper, David I/A-2323-2011; Dowson, Christopher/ABG-5083-2021	Dowson, Chris/0000-0002-8294-8836; Roper, David I/0000-0003-0009-621X; Dowson, Christopher/0000-0002-8294-8836; Tomasz, Alexander/0000-0003-1520-1983; Levesque, Roger/0000-0001-8315-5937; Lloyd, Adrian/0000-0002-4638-4586	MRC [G0701400, G0500643, G0400848] Funding Source: UKRI; Medical Research Council [G0400848, G0500643, G0701400] Funding Source: Medline; Wellcome Trust [066443] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blewett AM, 2004, ACTA CRYSTALLOGR D, V60, P359, DOI 10.1107/S0907444903027720; Bouhss A, 2001, J BACTERIOL, V183, P5122, DOI 10.1128/JB.183.17.5122-5127.2001; BREUKINK E, 2003, J BIOL CHEM, V22, P2003; Bugg T.D.H., 1999, COMPREHENSIVE NATURA, P241; BUMSTED RM, 1968, J BIOL CHEM, V243, P779; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; DHALLA AM, 1995, BIOCHEMISTRY-US, V34, P5390, DOI 10.1021/bi00016a010; Dowson Christopher G., 1994, Trends in Microbiology, V2, P361, DOI 10.1016/0966-842X(94)90612-2; El Zoeiby A, 2001, FEMS MICROBIOL LETT, V201, P229, DOI 10.1016/S0378-1097(01)00268-3; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2001, J BIOL CHEM, V276, P39618, DOI 10.1074/jbc.M106425200; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; Ganchev DN, 2006, BIOCHEMISTRY-US, V45, P6195, DOI 10.1021/bi051913e; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hegde SS, 2003, J BIOL CHEM, V278, P22861, DOI 10.1074/jbc.M301565200; HENDERSON PJ, 1973, BIOCHEM J, V135, P101, DOI 10.1042/bj1350101; Hong HJ, 2005, J BIOL CHEM, V280, P13055, DOI 10.1074/jbc.M413801200; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jonsson M, 2003, MICROB DRUG RESIST, V9, P147, DOI 10.1089/107662903765826732; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; LINNETT PE, 1974, J BIOL CHEM, V249, P2497; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Maillard AP, 2005, J BACTERIOL, V187, P3833, DOI 10.1128/JB.187.11.3833-3838.2005; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MATSUHAS.M, 1967, J BIOL CHEM, V242, P3191; Nishida S, 2006, J BIOL CHEM, V281, P1714, DOI 10.1074/jbc.M509277200; PETIT JF, 1968, J BIOL CHEM, V243, P757; PLAPP R, 1970, J BIOL CHEM, V245, P3667; PLAPP R, 1970, J BIOL CHEM, V245, P3675; Reddy SG, 1999, J AM CHEM SOC, V121, P1175, DOI 10.1021/ja983850b; Ribas De Pouplana L, 2005, AMINOACYL TRNA SYNTH, P241; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4781; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4787; ROBERTS WSL, 1968, J BIOL CHEM, V243, P768; ROBERTS WSL, 1968, J BIOL CHEM, V243, P749; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; SEGEL IH, 1975, ENZYME KINETICS, P18; Severin A, 1996, J BACTERIOL, V178, P168, DOI 10.1128/jb.178.1.168-174.1996; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; STEWART TS, 1971, NATURE, V230, P36, DOI 10.1038/230036a0; Sylvester DR, 2001, BIOCHEM J, V355, P431, DOI 10.1042/0264-6021:3550431; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Villet R, 2007, NUCLEIC ACIDS RES, V35, P6870, DOI 10.1093/nar/gkm778; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014	61	68	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6402	6417		10.1074/jbc.M708105200	http://dx.doi.org/10.1074/jbc.M708105200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18077448	hybrid			2022-12-27	WOS:000253779500048
J	Porat, Z; Landau, G; Bercovich, Z; Krutauz, D; Glickman, M; Kahana, C				Porat, Ziv; Landau, Guy; Bercovich, Zippi; Krutauz, Dasha; Glickman, Michael; Kahana, Chaim			Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome - New insights on yeast antizyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; POLYAMINE METABOLISM; RETICULOCYTE LYSATE; INTRACELLULAR DEGRADATION; REGULATED DEGRADATION; REQUIRES INTERACTION; NEOPLASTIC GROWTH; IN-VIVO; CELLS; PROTEIN	Mammalian antizyme (mAz) is a central element of a feedback circuit regulating cellular polyamines by accelerating ornithine decarboxylase (ODC) degradation and inhibiting polyamine uptake. Although yeast antizyme (yAz) stimulates the degradation of yeast ODC(yODC), we show here that it has only a minor effect on polyamine uptake by yeast cells. A segment of yODC that parallels the Az binding segment of mammalian ODC (mODC) is required for its binding to yAz. Although demonstrating minimal homology to mAz, our results suggest that yAz stimulates yODC degradation via a similar mechanism of action. We demonstrate that interaction with yAz provokes degradation of yODC by yeast but not by mammalian proteasomes. This differential recognition may serve as a tool for investigating proteasome functions.	[Porat, Ziv; Landau, Guy; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Krutauz, Dasha; Glickman, Michael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, 1 Hertzel St, IL-76100 Rehovot, Israel.	chaim.kahana@weizmann.ac.il	Porat, Ziv/K-1672-2012	Porat, Ziv/0000-0003-3059-181X; Glickman, Michael/0000-0002-1222-8104				Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gupta R, 2001, P NATL ACAD SCI USA, V98, P10620, DOI 10.1073/pnas.181341298; HE Y, 1994, BIOCHEM BIOPH RES CO, V203, P608, DOI 10.1006/bbrc.1994.2226; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Leggett David S., 2005, V301, P57; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Madhubala R, 1998, Methods Mol Biol, V79, P131; MAMROUDKIDRON E, 1994, FEBS LETT, V337, P239, DOI 10.1016/0014-5793(94)80199-1; MAMROUDKIDRON E, 1994, FEBS LETT, V356, P162, DOI 10.1016/0014-5793(94)01260-1; MAMROUDKIDRON E, 1994, EUR J BIOCHEM, V226, P547, DOI 10.1111/j.1432-1033.1994.tb20079.x; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MIYAZAKI Y, 1993, EUR J BIOCHEM, V214, P837, DOI 10.1111/j.1432-1033.1993.tb17987.x; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; PEGG AE, 1988, CANCER RES, V48, P759; PILLAI R, 1993, P NATL ACAD SCI USA, V90, P11970, DOI 10.1073/pnas.90.24.11970; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; POULIN R, 1993, J BIOL CHEM, V268, P4690; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; ROSENBERGHASSON Y, 1991, EUR J BIOCHEM, V196, P647, DOI 10.1111/j.1432-1033.1991.tb15861.x; SCHWARTZ B, 1995, BIOCHEM J, V312, P83, DOI 10.1042/bj3120083; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; TOBIAS KE, 1995, CELL GROWTH DIFFER, V6, P1279; Toth C, 1999, J BIOL CHEM, V274, P25921, DOI 10.1074/jbc.274.36.25921; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wallace HM, 2003, BIOCHEM SOC T, V31, P393, DOI 10.1042/BST0310393; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	56	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4528	4534		10.1074/jbc.M708088200	http://dx.doi.org/10.1074/jbc.M708088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089576	hybrid			2022-12-27	WOS:000253426500009
J	Wang, Z; Ma, TH; Chi, XK; Pei, DQ				Wang, Zhe; Ma, Tianhua; Chi, Xiaoke; Pei, Duanqing			Aromatic residues in the C-terminal domain 2 are required for nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENCY SUSTAINING FACTOR; TRANSCRIPTION; SUBDOMAINS; NETWORK	Nanog was identified by its ability to sustain the LIF-independent self-renewal of mouse embryonic stem (ES) cells and has recently been shown to play a role in reprogramming adult fibroblasts into pluripotent stem cells. However, little is known about the structural basis of these remarkable activities of Nanog. We have previously identified an unusually strong transactivator named CD2 at its C terminus. Here we demonstrate that CD2 is required for Nanog to mediate ES cell self-renewal. Furthermore, deletion and point mutation analysis revealed that CD2 relies on at least seven aromatic amino acid residues to generate its potent transactivating activity. A mutant Nanog bearing alanine substitutions for these seven residues fails to confer LIF-independent self-renewal in mouse ES cells. Substitution of CD2 by the viral transactivator VP16 gave rise to Nanog-VP16, which is 10 times more active than wild-type Nanog in ES cells. Surprisingly, the expression of Nanog-VP16 in mouse ES cells induces differentiation and is thus unable to sustain LIF-independent self-renewal for mouse ES cells. Taken together, our results demonstrate that the CD2 domain of Nanog is a unique transactivator that utilizes aromatic residues to confer specific activity absolutely required for ES self-renewal.	[Wang, Zhe; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Peoples R China; [Wang, Zhe; Ma, Tianhua; Chi, Xiaoke] Tsinghua Univ, Sch Med,Inst Biomed, Lab Stem Cell Biol,Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012					Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	12	14	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4480	4489		10.1074/jbc.M706009200	http://dx.doi.org/10.1074/jbc.M706009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086680	hybrid			2022-12-27	WOS:000253426500004
J	Amrute-Nayak, M; Antognozzi, M; Scholz, T; Kojima, H; Brenner, B				Amrute-Nayak, Mamta; Antognozzi, Massimo; Scholz, Tim; Kojima, Hiroaki; Brenner, Bernhard			Inorganic phosphate binds to the empty nucleotide binding pocket of conventional myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICALLY SKINNED FIBERS; PROBES ACTOMYOSIN STATES; SKELETAL-MUSCLE FIBERS; FORCE GENERATION; ENERGY TRANSDUCTION; SINGLE-MOLECULE; ACTIN MOVEMENT; CONTRACTION; RELEASE; MECHANISM	In muscle inorganic phosphate strongly decreases force generation in the presence of millimolar MgATP, whereas phosphate slows shortening velocity only at micromolar MgATP concentrations. It is still controversial whether reduction in shortening velocity by phosphate results from phosphate binding to the nucleotide-free myosin head or from binding of phosphate to an actomyosin-ADP state as postulated for the inhibition of force generation by phosphate. Because most single-molecule studies are performed at micromolar concentrations of MgATP where phosphate effects on movement are rather prominent, clarification of the mechanisms of phosphate inhibition is essential for interpretation of data in which phosphate is used in single molecule studies to probe molecular events of force generation and movement. In in vitro assays we found that inhibition of filament gliding by inorganic phosphate was associated with increased fragmentation of actin filaments. In addition, phosphate did not extend dwell times of Cy3-EDA-ATP(2'(3')-O-[[2-[[6-[2-[3-(1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolio]-1-oxohexyl]amino] ethyl] carbamoyl] ATP) but reduced the number of Cy3-signals per field of view, approaching 50% at phosphate concentrations of 1-2mM. Apparently, inhibition of movement does not result from binding of phosphate to an actomyosin-ADP intermediate as proposed by Hooft and coworkers (Hooft, A. M., Maki, E. J., Cox, K. K., and Baker, J. E. (2007) Biochemistry 46, 3513-3520) but, rather, from forming a strong-binding actomyosin-phosphate intermediate.	[Amrute-Nayak, Mamta; Antognozzi, Massimo; Scholz, Tim; Brenner, Bernhard] Hannover Med Sch, Dept Mol & Cell Physiol, D-30625 Hannover, Germany; [Kojima, Hiroaki] Kobe Adv ICT Res Ctr, Natl Inst Informat & Commun Technol, Kobe, Hyogo 6512492, Japan	Hannover Medical School; National Institute of Information & Communications Technology (NICT) - Japan	Brenner, B (corresponding author), Hannover Med Sch, Dept Mol & Cell Physiol, D-30625 Hannover, Germany.	brenner.bernhard@mh-hannover.de	Amrute-Nayak, Mamta/P-7447-2019; Scholz, Tim/A-7798-2013	Scholz, Tim/0000-0002-2127-9843; Antognozzi, Massimo/0000-0001-5396-0564				ALTRINGHAM JD, 1985, J PHYSIOL-LONDON, V368, P491, DOI 10.1113/jphysiol.1985.sp015871; AMRUTE M, 2006, BIOPHYS J S, V90, P434; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; BRENNER B, 1994, J MUSCLE RES CELL M, V15, P201; BRENNER B, 1993, P NATL ACAD SCI USA, V90, P5252, DOI 10.1073/pnas.90.11.5252; BRENNER B, 1986, BIOPHYS J, V50, P1101, DOI 10.1016/S0006-3495(86)83554-8; BRENNER B, 1995, BIOPHYS J, V68, pS106; Brenner B., 1990, MUSCLE MECH BIOLOGIC, P77; CHASE PB, 1994, J MUSCLE RES CELL M, V15, P119, DOI 10.1007/BF00130423; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; Conibear PB, 1996, BIOCHEMISTRY-US, V35, P2299, DOI 10.1021/bi951824+; COOKE R, 1988, J PHYSIOL-LONDON, V395, P77, DOI 10.1113/jphysiol.1988.sp016909; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kintses B, 2006, BIOPHYS J, V91, P4605, DOI 10.1529/biophysj.106.092833; Kraft T, 2005, P NATL ACAD SCI USA, V102, P13861, DOI 10.1073/pnas.0504026102; KRAFT T, 1995, BIOPHYS J, V69, P1246, DOI 10.1016/S0006-3495(95)80018-4; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARUTA S, 1993, J BIOL CHEM, V268, P7093; MCKILLOP DFA, 1990, BIOCHEM SOC T, V18, P585, DOI 10.1042/bst0180585; MILLAR NC, 1990, J BIOL CHEM, V265, P20234; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Oiwa K, 2000, BIOPHYS J, V78, P3048, DOI 10.1016/S0006-3495(00)76843-3; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PATE E, 1989, PFLUG ARCH EUR J PHY, V414, P73, DOI 10.1007/BF00585629; Pate E, 1998, BIOPHYS J, V74, P369, DOI 10.1016/S0006-3495(98)77794-X; PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809; RUEGG JC, 1971, PFLUG ARCH EUR J PHY, V325, P359, DOI 10.1007/BF00592176; Takagi Y, 2004, PHILOS T R SOC B, V359, P1913, DOI 10.1098/rstb.2004.1561; Takagi Y, 2004, BIOPHYS J, V86, p54A; TESI C, 1988, FEBS LETT, V236, P256, DOI 10.1016/0014-5793(88)80326-0; Tesi C, 2002, J PHYSIOL-LONDON, V541, P187, DOI 10.1113/jphysiol.2001.013418; Thedinga E, 1999, J MUSCLE RES CELL M, V20, P785, DOI 10.1023/A:1005658825375; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; TOYOSHIMA YY, 1989, NATURE, V341, P154, DOI 10.1038/341154a0; WARSHAW DM, 1991, J BIOL CHEM, V266, P24339; YU LC, 1989, BIOPHYS J, V55, P441, DOI 10.1016/S0006-3495(89)82838-3	46	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3773	3781		10.1074/jbc.M706779200	http://dx.doi.org/10.1074/jbc.M706779200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079122	hybrid, Green Published			2022-12-27	WOS:000253083500011
J	Detro-Dassen, S; Schanzler, M; Lauks, H; Martin, I; zu Berstenhorst, SM; Nothmann, D; Torres-Salazar, D; Hidalgo, P; Schmalzing, G; Fahlke, C				Detro-Dassen, Silvia; Schaenzler, Michael; Lauks, Heike; Martin, Ina; zu Berstenhorst, Sonja Meyer; Nothmann, Doreen; Torres-Salazar, Delany; Hidalgo, Patricia; Schmalzing, Guenther; Fahlke, Christoph			Conserved dimeric subunit stoichiometry of SLC26 multifunctional anion exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN; OLIGOMERIC STRUCTURE; CHLORIDE CHANNEL; PRESTIN; MEMBRANE; GENE; EXPRESSION; TOPOLOGY; STATE; TRANSPORTERS	The SLC26 gene family encodes multifunctional transport proteins in numerous tissues and organs. Some paralogs function as anion exchangers, others as anion channels, and one, prestin (SLC26A5), represents a membrane-bound motor protein in outer hair cells of the inner ear. At present, little is known about the molecular basis of this functional diversity. We studied the subunit stoichiometry of one bacterial, one teleost, and two mammalian SLC26 isoforms expressed in Xenopus laevis oocytes or in mammalian cells using blue native PAGE and chemical cross-linking. All tested SLC26s are assembled as dimers composed of two identical subunits. Co-expression of two mutant prestins with distinct voltage-dependent capacitances results in motor proteins with novel electrical properties, indicating that the two subunits do not function independently. Our results indicate that an evolutionarily conserved dimeric quaternary structure represents the native and functional state of SLC26 transporters.	[Detro-Dassen, Silvia; Lauks, Heike; Schmalzing, Guenther] Univ Aachen, Rhein Westfal TH Aachen, Abt Mol Pharmakol, D-52074 Aachen, Germany; [Schaenzler, Michael; Martin, Ina; zu Berstenhorst, Sonja Meyer; Nothmann, Doreen; Torres-Salazar, Delany; Hidalgo, Patricia; Fahlke, Christoph] Med Hochschule Hannover, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Zentrum System Neurowissensch Hannover, D-30625 Hannover, Germany	RWTH Aachen University; Hannover Medical School	Schmalzing, G (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Abt Mol Pharmakol, Wendlingweg 2, D-52074 Aachen, Germany.	gschmalzing@ukaachen.de; fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013; Hidalgo, Patricia/I-7506-2013	Fahlke, Christoph/0000-0001-8602-9952; Hidalgo, Patricia/0000-0002-4162-6590; Torres-Salazar, Delany/0000-0002-6789-9810				Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Everett LA, 1999, HUM MOL GENET, V8, P1883, DOI 10.1093/hmg/8.10.1883; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Failer BU, 2003, EUR J BIOCHEM, V270, P1802, DOI 10.1046/j.1432-1033.2003.03542.x; Fernandez E, 2006, J BIOL CHEM, V281, P26552, DOI 10.1074/jbc.M604049200; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Toth T, 2007, INT J MOL MED, V20, P545; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	55	72	72	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4177	4188		10.1074/jbc.M704924200	http://dx.doi.org/10.1074/jbc.M704924200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073211	hybrid			2022-12-27	WOS:000253083500053
J	Odell, AF; Van Helden, DF; Scott, JL				Odell, Adam F.; Van Helden, Dirk F.; Scott, Judith L.			The spectrin cytoskeleton influences the surface expression and activation of human transient receptor potential channel 4 channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; STORE-OPERATED CHANNELS; ALPHA-II-SPECTRIN; TRPC CHANNELS; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TERMINAL DOMAIN; BRAIN SPECTRIN; TYROSINE PHOSPHORYLATION; ENDOPLASMIC-RETICULUM	Despite over a decade of research, only recently have the mechanisms governing transient receptor potential channel (TRPC) channel function begun to emerge, with an essential role for accessory proteins in this process. We previously identified a tyrosine phosphorylation event as critical in the plasma membrane translocation and activation of hTRPC4 channels following epidermal growth factor (EGF) receptor activation. To further characterize the signaling events underlying this process, a yeast-two hybrid screen was performed on the C terminus of hTRPC4. The intracellular C-terminal region from proline 686 to leucine 977 was used to screen a human brain cDNA library. Two members of the spectrin family, alpha II- and beta V-spectrin, were identified as binding partners. The interaction of hTRPC4 with alpha II-spectrin and beta V-spectrin was confirmed by glutathione S-transferase pulldown and co-immunoprecipitation experiments. Deletion analysis identified amino acids 730 758 of hTRPC4 as critical for the interaction with this region located within a coiled-coil domain, juxtaposing the Ca2+/calmodulin and IP3R-binding region (CIRB domain). This region is deleted in the proposed delta hTRPC4 splice variant form, which failed to undergo both EGF-induced membrane insertion and activation, providing a genetic mechanism for regulating channel activity. We also demonstrate that the exocytotic insertion and activation of hTRPC4 following EGF application is accompanied by dissociation from alpha II-spectrin. Furthermore, depletion of alpha II-spectrin by small interference RNA reduces the basal surface expression of alpha hTRPC4 and prevents the enhanced membrane insertion in response to EGF application. Importantly, depletion of alpha II-spectrin did not affect the expression of the delta variant. Taken together, these results demonstrate that a direct interaction between hTRPC4 and the spectrin cytoskeleton is involved in the regulation of hTRPC4 surface expression and activation.	[Odell, Adam F.; Van Helden, Dirk F.; Scott, Judith L.] Univ Newcastle, Fac Hlth, Sch Biomed Sci, Newcastle, NSW 2308, Australia	University of Newcastle	Odell, AF (corresponding author), Univ Leeds, Leeds, W Yorkshire, England.	a.f.odell@leeds.ac.uk	Odell, Adam/J-1386-2012					ABDI KM, 2007, IN PRESS MOL BIOL CE; Ambudkar IS, 2006, TRENDS PHARMACOL SCI, V27, P25, DOI 10.1016/j.tips.2005.11.008; Bennett V, 1990, CURR OPIN CELL BIOL, V2, P51, DOI 10.1016/S0955-0674(05)80030-4; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bloch RJ, 1997, SOC GEN PHY, V52, P177; Bollimuntha S, 2005, VISUAL NEUROSCI, V22, P163, DOI 10.1017/S0952523805222058; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Cioffi DL, 2003, CELL CALCIUM, V33, P323, DOI 10.1016/S0143-4160(03)00046-0; Cukovic D, 2001, FEBS LETT, V498, P87, DOI 10.1016/S0014-5793(01)02505-4; Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Goel M, 2005, PFLUG ARCH EUR J PHY, V451, P87, DOI 10.1007/s00424-005-1454-y; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hryniewicz-Jankowska A, 2002, FOLIA HISTOCHEM CYTO, V40, P239; Iga M, 1997, BIOCHEM BIOPH RES CO, V231, P852, DOI 10.1006/bbrc.1997.6202; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Kiselyov K., 2007, V179, P559; Kiselyov K, 2005, PFLUG ARCH EUR J PHY, V451, P116, DOI 10.1007/s00424-005-1442-2; Kiselyov K, 1999, MOL CELL, V4, P423, DOI 10.1016/S1097-2765(00)80344-5; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Kontrogianni-Konstantopoulos A, 2001, J BIOL CHEM, V276, P20679, DOI 10.1074/jbc.M010581200; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Mery L, 2002, J CELL SCI, V115, P3497; Mery L, 2001, FEBS LETT, V487, P377, DOI 10.1016/S0014-5793(00)02362-0; Morales S, 2005, CELL SIGNAL, V17, P635, DOI 10.1016/j.cellsig.2004.10.002; Nakano M, 2001, BIOCHEM BIOPH RES CO, V288, P468, DOI 10.1006/bbrc.2001.5795; Nicolas G, 2002, MOL CELL BIOL, V22, P3527, DOI 10.1128/MCB.22.10.3527-3536.2002; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Ordaz B, 2005, J BIOL CHEM, V280, P30788, DOI 10.1074/jbc.M504745200; PERRIN D, 1985, NATURE, V315, P589, DOI 10.1038/315589a0; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; SIKORSKI AF, 1991, J CELL BIOL, V114, P313, DOI 10.1083/jcb.114.2.313; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Thomas G, 1998, BIOESSAYS, V20, P600, DOI 10.1002/(SICI)1521-1878(199807)20:7<600::AID-BIES13>3.0.CO;2-3; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Voas MG, 2007, CURR BIOL, V17, P562, DOI 10.1016/j.cub.2007.01.071; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Wu XY, 2002, J BIOL CHEM, V277, P13597, DOI 10.1074/jbc.M110881200; Yang H, 2005, J BIOL CHEM, V280, P32230, DOI 10.1074/jbc.M504553200; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zhu Michael X, 2004, Novartis Found Symp, V258, P44; Zuckerman JB, 1999, J BIOL CHEM, V274, P23286, DOI 10.1074/jbc.274.33.23286	53	33	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4395	4407		10.1074/jbc.M709729200	http://dx.doi.org/10.1074/jbc.M709729200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18048348	Green Published, hybrid			2022-12-27	WOS:000253083500074
J	Okoshi, R; Ozaki, T; Yamamoto, H; Ando, K; Koida, N; Ono, S; Koda, T; Kamijo, T; Nakagawara, A; Kizaki, H				Okoshi, Rintaro; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Koida, Nami; Ono, Sayaka; Koda, Tadayuki; Kamijo, Takehiko; Nakagawara, Akira; Kizaki, Harutoshi			Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-METABOLISM; P53; PHOSPHORYLATION; EXPRESSION; PATHWAY; CASCADE; DEGRADATION; HOMEOSTASIS; UPSTREAM; DYNAMICS	Tumor suppressor p53-dependent stress response pathways play an important role in cell fate determination. In this study, we have found that glucose depletion promotes the phosphorylation of AMP-activated protein kinase catalytic subunit alpha (AMPK alpha) in association with a significant up-regulation of p53, thereby inducing p53-dependent apoptosis in vivo and in vitro. Thymocytes prepared from glucose-depleted wild-type mice but not from p53-deficient mice underwent apoptosis, which was accompanied by a remarkable phosphorylation of AMPK alpha and a significant induction of p53 as well as pro-apoptotic Bax. Similar results were also obtained in human osteosarcoma-derived U2OS cells bearing wild-type p53 following glucose starvation. Of note, glucose deprivation led to a significant accumulation of p53 phosphorylated at Ser-46, but not at Ser-15 and Ser-20, and a transcriptional induction of p53 as well as proapoptotic p53 AIP1. Small interference RNA-mediated knockdown of p53 caused an inhibition of apoptosis following glucose depletion. Additionally, apoptosis triggered by glucose deprivation was markedly impaired by small interference RNA-mediated depletion of AMPK alpha. Under our experimental conditions, down-regulation of AMPK alpha caused an attenuation of p53 accumulation and its phosphorylation at Ser-46. In support of these observations, enforced expression of AMPK alpha led to apoptosis and resulted in an induction of p53 at protein and mRNA levels. Furthermore, p53 promoter region responded to AMPK alpha and glucose deprivation as judged by luciferase reporter assay. Taken together, our present findings suggest that AMPK-dependent transcriptional induction and phosphorylation of p53 at Ser-46 play a crucial role in the induction of apoptosis under carbon source depletion.	[Okoshi, Rintaro; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Koida, Nami; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan; [Okoshi, Rintaro; Kizaki, Harutoshi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Chiba 2618502, Japan; [Ono, Sayaka; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Ctr Funct Gen, Chiba 2608717, Japan	Chiba Cancer Center; Tokyo Dental College; Hisamitsu Pharmaceutical Co Ltd	Nakagawara, A (corresponding author), Chiba Canc Ctr Res Inst, Div Biochem, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; kizaki@tdc.ac.jp						BEG ZH, 1973, BIOCHEM BIOPH RES CO, V54, P1362, DOI 10.1016/0006-291X(73)91137-6; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Chao C, 2003, J BIOL CHEM, V278, P41028, DOI 10.1074/jbc.M306938200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dauth I, 2007, CANCER RES, V67, P2274, DOI 10.1158/0008-5472.CAN-06-2884; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Garcia SN, 1999, CELL, V97, P825, DOI 10.1016/S0092-8674(00)80794-1; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Karni-Schmidt O, 2007, ONCOGENE, V26, P3878, DOI 10.1038/sj.onc.1210162; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Matsuda K, 2002, CANCER RES, V62, P2883; Mekhail K, 2005, J CELL BIOL, V170, P733, DOI 10.1083/jcb.200506030; Noda A, 2000, ONCOGENE, V19, P21, DOI 10.1038/sj.onc.1203230; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Prives C, 1999, J PATHOL, V187, P112; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Raman V, 2000, J BIOL CHEM, V275, P26551, DOI 10.1074/jbc.C000324200; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stefanelli C, 1998, BIOCHEM BIOPH RES CO, V243, P821, DOI 10.1006/bbrc.1998.8154; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511; Wesierska-Gadek J, 2002, INT J CANCER, V101, P128, DOI 10.1002/ijc.10580; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; YOSHIDA K, 2006, J BIOL CHEM, V281, P5834	41	231	241	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3979	3987		10.1074/jbc.M705232200	http://dx.doi.org/10.1074/jbc.M705232200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056705	hybrid			2022-12-27	WOS:000253083500032
J	Wu, LNY; Genge, BR; Wuthier, RE				Wu, Licia N. Y.; Genge, Brian R.; Wuthier, Roy E.			Analysis and molecular modeling of the formation, structure, and activity of the phosphatidylserine-calcium-phosphate complex associated with biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CARTILAGE; MATRIX VESICLES INVITRO; MINERAL FORMATION; IN-VITRO; EPIPHYSEAL CARTILAGE; NUCLEATIONAL CORE; BINDING-PROTEINS; LIGHT-SCATTERING; DYNAMICS; ION	The nucleational core of matrix vesicles contains a complex (CPLX) of phosphatidylserine (PS), Ca2+, and inorganic phosphate (Pi) that is important to both normal and pathological calcification. Factors required for PS-CPLX formation and nucleational activity were studied using in vitro model systems and molecular dynamic simulations. Ca2+ levels required for and rates of PS-CPLX formation were monitored by light scattering at 340 nm, assessing changes in amount and particle size. Fourier transform infrared spectroscopy was used to explore changes in chemical structure and composition. Washing with pH 5 buffer was used to examine the role of amorphous calcium phosphate in CPLX nucleational activity, which was assessed by incubation in synthetic cartilage lymph with varied pH values. Addition of 4 Ca2+/PS was minimally required to form viable complexes. During the critical first 10-min reaction period, rapid reduction in particle size signaled changes in PS-CPLX structure. Fourier transform infrared spectroscopy revealed increasing mineral phosphate that became progressively deprotonated to PO43+. This Ca2+-mediated effect was mimicked in part by increasing the Ca2+/PS reaction ratio. Molecular dynamic simulations provided key insight into initial interactions between Ca2+ and Pi and the carboxyl, amino, and phosphodiester groups of PS. Deduced interatomic distances agreed closely with previous radial distribution function x-ray-absorption fine structure measurements, except for an elongated Ca2+-N distance, suggesting additional changes in atomic structure during the critical 10-min ripening period. These findings clarify the process of PS-CPLX formation, reveal details of its structure, and provide insight into its role as a nucleator of crystalline calcium phosphate mineral formation.	[Wuthier, Roy E.] Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wu, LNY (corresponding author), Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, 631 Sumter St, Columbia, SC 29208 USA.	wuthier@mail.chem.sc.edu			NIAMS NIH HHS [AR18983, AR42359] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042359, R01AR018983] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAMSON MB, 1964, J BIOL CHEM, V239, P70; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; ANDERSON HC, 1988, RHEUM DIS CLIN N AM, V14, P303; ANGHILERI LJ, 1972, EXPERIENTIA, V28, P1086, DOI 10.1007/BF01918690; BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; BLUMENTHAL NC, 1977, CALC TISS RES, V23, P245, DOI 10.1007/BF02012793; BOSKEY AL, 1978, P SOC EXP BIOL MED, V157, P590; BOSKEY AL, 1976, CALC TISS RES, V19, P273; BOSKEY AL, 1988, AM J PATHOL, V133, P22; BOSKEY AL, 1982, CALCIF TISSUE INT S2, V34, P1; BOYAN BD, 1984, CALCIFIED TISSUE INT, V36, P214, DOI 10.1007/BF02405320; BOYANSALYERS BD, 1980, CALCIFIED TISSUE INT, V30, P167, DOI 10.1007/BF02408622; BRECEVIC L, 1972, CALC TISS RES, V10, P82, DOI 10.1007/BF02012538; BRIGHTON CT, 1976, FED PROC, V35, P143; COTMORE JM, 1971, SCIENCE, V172, P1339, DOI 10.1126/science.172.3990.1339; EANES ED, 1970, CALC TISS RES, V5, P133, DOI 10.1007/BF02017543; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Floris FM, 2002, J CHEM PHYS, V116, P5460, DOI 10.1063/1.1453957; Frisch M.J., 2016, GAUSSIAN16 REV B01; GENGE B, 1992, BONE MINER, V17, P202, DOI 10.1016/0169-6009(92)90737-X; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; GENGE BR, 1990, J BIOL CHEM, V265, P4703; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Genge BR, 2007, ANAL BIOCHEM, V367, P159, DOI 10.1016/j.ab.2007.04.029; HOLWERDA DL, 1981, BIOCHEMISTRY-US, V20, P418, DOI 10.1021/bi00505a030; HOWELL DS, 1968, J CLIN INVEST, V47, P1121, DOI 10.1172/JCI105801; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; IANNOTTI JP, 1989, J ORTHOPAED RES, V7, P511, DOI 10.1002/jor.1100070408; IANNOTTI JP, 1985, J BONE JOINT SURG AM, V67A, P113, DOI 10.2106/00004623-198567010-00014; IANNOTTI JP, 1994, CLIN ORTHOP RELAT R, P222; IRVING JT, 1961, ARCH ORAL BIOL, V5, P323, DOI 10.1016/0003-9969(61)90067-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; LATIMER P, 1982, ANNU REV BIOPHYS BIO, V11, P129, DOI 10.1146/annurev.bb.11.060182.001021; LATIMER P, 1977, ARCH BIOCHEM BIOPHYS, V180, P151; LYSTER RLJ, 1984, BIOCHIM BIOPHYS ACTA, V801, P315, DOI 10.1016/0304-4165(84)90082-5; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAJESKA RJ, 1979, CALCIFIED TISSUE INT, V27, P41, DOI 10.1007/BF02441159; Marchand S, 1998, PROTEINS, V33, P265, DOI 10.1002/(SICI)1097-0134(19981101)33:2<265::AID-PROT10>3.3.CO;2-G; MCGANN TCA, 1983, CALCIFIED TISSUE INT, V35, P821, DOI 10.1007/BF02405131; NASH HA, 1964, P NATL ACAD SCI USA, V51, P476, DOI 10.1073/pnas.51.3.476; Pandit SA, 2002, BIOPHYS J, V82, P1818, DOI 10.1016/S0006-3495(02)75532-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; POSNER AS, 1975, J DENT RES, V54, pB88, DOI 10.1177/00220345750540023301; POSNER AS, 1977, CALCIF TISSUE RES, V22, pS208; Pye CC, 2004, CAN J ANAL SCI SPECT, V49, P175; SAUER GR, 1988, J BIOL CHEM, V263, P13718; Taylor MG, 1998, CELL MOL LIFE SCI, V54, P196, DOI 10.1007/s000180050143; TERMINE JD, 1970, ARCH BIOCHEM BIOPHYS, V140, P318, DOI 10.1016/0003-9861(70)90072-X; TERMINE JD, 1967, P SOC EXP BIOL MED, V125, P4; TSUI FC, 1986, BIOPHYS J, V49, P459, DOI 10.1016/S0006-3495(86)83655-4; VALHMU WB, 1990, BONE MINER, V8, P195, DOI 10.1016/0169-6009(90)90105-O; Wu LNY, 1997, CLIN ORTHOP RELAT R, P310; Wu LNY, 2003, J INORG BIOCHEM, V94, P221, DOI 10.1016/S0162-0134(03)00003-5; WU LNY, 1993, J BIOL CHEM, V268, P25084; Wu LNY, 1996, CONNECT TISSUE RES, V35, P309, DOI 10.3109/03008209609029205; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; WUTHIER RE, 1977, CALC TISS RES, V23, P125, DOI 10.1007/BF02012777; WUTHIER RE, 1975, CALC TISS RES, V19, P197, DOI 10.1007/BF02564004; WUTHIER RE, 1968, J LIPID RES, V9, P68; WUTHIER RE, 1977, CALC TISS RES, V24, P163, DOI 10.1007/BF02223311; Zahn D, 2004, Z ANORG ALLG CHEM, V630, P1507, DOI 10.1002/zaac.200400151	66	32	33	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3827	3838		10.1074/jbc.M707653200	http://dx.doi.org/10.1074/jbc.M707653200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077457	hybrid			2022-12-27	WOS:000253083500017
J	Kimball, SR; Do, AND; Kutzler, L; Cavener, DR; Jefferson, LS				Kimball, Scot R.; Do, A. N. Dang; Kutzler, Lydia; Cavener, Douglas R.; Jefferson, Leonard S.			Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; STRESS-RESPONSE GENE; P70 S6 KINASE; MAMMALIAN TARGET; SKELETAL-MUSCLE; AMINO-ACID; TRANSLATION INITIATION; CARDIAC-HYPERTROPHY; RAPAMYCIN MTOR; PHAS-I	mTORC1 is a complex of proteins that includes the mammalian target of rapamycin (mTOR) and several regulatory proteins. It is activated by a variety of hormones (e. g. insulin) and nutrients (e. g. amino acids) that act to stimulate cell growth and proliferation and repressed by hormones (e. g. glucocorticoids) that act to reduce cell growth. Curiously, mTORC1 signaling is reported to be rapidly (e. g. within 1-2 h) activated by inhibitors of protein synthesis that act on either mRNA translation elongation or gene transcription. However, the basis for the mTORC1 activation has not been satisfactorily delineated. In the present study, mTORC1 signaling was found to be activated in response to inhibition of either the initiation or elongation phases of mRNA translation. Changes in mTORC1 signaling were inversely proportional to alterations in the expression of the mTORC1 repressor, REDD1, but not the expression of TRB3 or TSC2. Moreover the cycloheximide-induced increase in mTORC1 signaling was significantly attenuated in cells lacking REDD1, showing that REDD1 plays an integral role in the response. Finally, the half-life of REDD1 was estimated to be 5 min or less. Overall, the results are consistent with a model in which inhibition of protein synthesis leads to a loss of REDD1 protein because of its rapid degradation, and in part reduced REDD1 expression subsequently leads to de-repression of mTORC1 activity.	[Kimball, Scot R.; Do, A. N. Dang; Kutzler, Lydia; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H 166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu	Cavener, Douglas R/E-3524-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cuaz-Perolin C, 2004, ARTERIOSCL THROM VAS, V24, P1830, DOI 10.1161/01.ATV.0000142366.69080.c3; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Earnshaw WC, 2006, CURR OPIN CELL BIOL, V18, P587, DOI 10.1016/j.ceb.2006.10.010; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; Galbaugh T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-34; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goggin MM, 2004, HEPATOLOGY, V40, P537, DOI 10.1002/hep.20338; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jones S, 2007, NAT REV MICROBIOL, V5, P331, DOI 10.1038/nrmicro1666; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kimball SR, 2003, AM J PHYSIOL-ENDOC M, V285, pE637, DOI 10.1152/ajpendo.00340.2002; Kimball SR, 2002, AM J PHYSIOL-ENDOC M, V282, pE585, DOI 10.1152/ajpendo.00269.2001; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lang CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE336, DOI 10.1152/ajpendo.00366.2001; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Lin L, 2005, BIOCHEMISTRY-US, V44, P3909, DOI 10.1021/bi047574r; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; MACLEAN DA, 1991, J APPL PHYSIOL, V70, P2095, DOI 10.1152/jappl.1991.70.5.2095; MARVIN OB, 2004, CARDIOVASC DRUG THER, V18, P257; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Palmer LK, 2006, AM J PHYSIOL-ENDOC M, V290, pE1267, DOI 10.1152/ajpendo.00463.2005; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Safer B, 1979, Methods Enzymol, V60, P61; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE1185, DOI 10.1152/ajpendo.2000.279.5.E1185; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	63	81	85	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3465	3475		10.1074/jbc.M706643200	http://dx.doi.org/10.1074/jbc.M706643200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070882	hybrid, Green Accepted			2022-12-27	WOS:000253083000052
J	Rossi, F; Garavaglia, S; Montalbano, V; Walsh, MA; Rizzi, M				Rossi, Franca; Garavaglia, Silvia; Montalbano, Valeria; Walsh, Martin A.; Rizzi, Menico			Crystal structure of human kynurenine aminotransferase II, a drug target for the treatment of schizophrenia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARTATE-AMINOTRANSFERASE; ACID LEVELS; BRAIN; RAT; TRANSMISSION; METABOLISM; EXPRESSION; EVOLUTION; MOLSCRIPT; REVEALS	Kynurenic acid is an endogenous neuroactive compound whose unbalancing is involved in the pathogenesis and progression of several neurological diseases. Kynurenic acid synthesis in the human brain is sustained by the catalytic activity of two kynurenine aminotransferases, hKAT I and hKAT II. A wealth of pharmacological data highlight hKAT II as a sensible target for the treatment of neuropathological conditions characterized by a kynurenic acid excess, such as schizophrenia and cognitive impairment. We have solved the structure of human KAT II by means of the single-wavelength anomalous dispersion method at 2.3-angstrom resolution. Although closely resembling the classical aminotransferase fold, the hKAT II architecture displays unique features. Structural comparison with a prototypical aspartate aminotransferase reveals a novel antiparallel strand-loop-strand motif that forms an unprecedented intersubunit beta-sheet in the functional hKAT II dimer. Moreover, the N-terminal regions of hKAT II and aspartate aminotransferase appear to have converged to highly similar although 2-fold symmetry-related conformations, which fulfill the same functional role. A detailed structural comparison of hKAT I and hKAT II reveals a larger and more aliphatic character to the active site of hKAT II due to the absence of the aromatic cage involved in ligand binding in hKAT I. The observed structural differences could be exploited for the rational design of highly selective hKAT II inhibitors.	[Rossi, Franca; Garavaglia, Silvia; Montalbano, Valeria; Rizzi, Menico] Univ Piemonte Orientale, DiSCAFF INFM, I-28100 Novara, Italy; [Walsh, Martin A.] European Synchrotron Radiat Facil, Med Res Council France, F-38043 Grenoble, France	University of Eastern Piedmont Amedeo Avogadro; European Synchrotron Radiation Facility (ESRF)	Rizzi, M (corresponding author), Univ Piemonte Orientale, DiSCAFF, Via Bovio 6, I-28100 Novara, Italy.	rizzi@pharm.unipmn.it	garavaglia, silvia/C-5588-2013; garavaglia, silvia/AIA-1816-2022; Walsh, Martin A/I-1566-2013	Walsh, Martin A/0000-0001-5683-1151; garavaglia, silvia/0000-0001-8494-1729	Medical Research Council [G0500367] Funding Source: Medline; MRC [G0500367] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baran H, 1996, LIFE SCI, V58, P1891, DOI 10.1016/0024-3205(96)00173-7; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Chess AC, 2006, BEHAV BRAIN RES, V170, P326, DOI 10.1016/j.bbr.2006.03.006; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Christen P, 2001, CHEM REC, V1, P436, DOI 10.1002/tcr.10005; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; DeLano W.L, PYMOL MOL GRAPHICS S; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FU D, 1992, J COMP NEUROL, V321, P477, DOI 10.1002/cne.903210313; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guidetti P, 2007, GLIA, V55, P78, DOI 10.1002/glia.20432; Han Q, 2005, FEBS J, V272, P2198, DOI 10.1111/j.1742-4658.2005.04643.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Jensen RA, 1996, J BACTERIOL, V178, P2161, DOI 10.1128/jb.178.8.2161-2171.1996; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krupka HI, 2000, EMBO J, V19, P3168, DOI 10.1093/emboj/19.13.3168; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X; Mosca M, 1996, ADV EXP MED BIOL, V398, P449; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai T, 1999, BIOCHEMISTRY-US, V38, P2413, DOI 10.1021/bi9819881; OKUNO E, 1991, BRAIN RES, V542, P307, DOI 10.1016/0006-8993(91)91583-M; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Poeggeler B, 2007, NEUROSCIENCE, V148, P188, DOI 10.1016/j.neuroscience.2007.05.033; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Stone TW, 2001, TOXICON, V39, P61, DOI 10.1016/S0041-0101(00)00156-2; Wu HQ, 2007, J NEURAL TRANSM, V114, P33, DOI 10.1007/s00702-006-0562-y; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034; Yu P, 2004, MOL CELL BIOL, V24, P6919, DOI 10.1128/MCB.24.16.6919-6930.2004	55	47	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3559	3566		10.1074/jbc.M707925200	http://dx.doi.org/10.1074/jbc.M707925200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056996	hybrid			2022-12-27	WOS:000253083000061
J	Bellon, SF; Kaplan-Lefko, P; Yang, YJ; Zhang, YH; Moriguchi, J; Rex, K; Johnson, CW; Rose, PE; Long, AM; O'Connor, AB; Gu, Y; Coxon, A; Kim, TS; Tasker, A; Burgess, TL; Dussault, I				Bellon, Steven F.; Kaplan-Lefko, Paula; Yang, Yajing; Zhang, Yihong; Moriguchi, Jodi; Rex, Karen; Johnson, Carol W.; Rose, Paul E.; Long, Alexander M.; O'Connor, Anne B.; Gu, Yan; Coxon, Angela; Kim, Tae-Seong; Tasker, Andrew; Burgess, Teresa L.; Dussault, Isabelle			C-met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; GASTROINTESTINAL STROMAL TUMORS; RECEPTOR TYROSINE KINASE; SMALL-MOLECULE INHIBITOR; MONOCLONAL-ANTIBODIES; IMATINIB RESISTANCE; GLIOBLASTOMA GROWTH; ANTITUMOR-ACTIVITY; HGF/SF RECEPTOR; MOUSE MODEL	c-Met is a receptor tyrosine kinase often deregulated in human cancers, thus making it an attractive drug target. One mechanism by which c-Met deregulation leads to cancer is through gain-of-function mutations. Therefore, small molecules capable of targeting these mutations could offer therapeutic benefits for affected patients. SU11274 was recently described and reported to inhibit the activity of the wild-type and some mutant forms of c-Met, whereas other mutants are resistant to inhibition. We identified a novel series of c-Met small molecule inhibitors that are active against multiple mutants previously identified in hereditary papillary renal cell carcinoma patients. AM7 is active against wild-type c-Met as well as several mutants, inhibits c-Met-mediated signaling in MKN-45 and U-87 MG cells, and inhibits tumor growth in these two models grown as xenografts. The crystal structures of AM7 and SU11274 bound to unphosphorylated c- Met have been determined. The AM7 structure reveals a novel binding mode compared with other published c-Met inhibitors and SU11274. The molecule binds the kinase linker and then extends into a new hydrophobic binding site. This binding site is created by a significant movement of the C-helix and so represents an inactive conformation of the c-Met kinase. Thus, our results demonstrate that it is possible to identify and design inhibitors that will likely be active against mutants found in different cancers.	[Kaplan-Lefko, Paula; Yang, Yajing; Zhang, Yihong; Moriguchi, Jodi; Rex, Karen; Coxon, Angela; Burgess, Teresa L.; Dussault, Isabelle] Amgen Inc, Dept Oncol Res, Newbury Pk, CA 91320 USA; [Rose, Paul E.; Long, Alexander M.; O'Connor, Anne B.; Gu, Yan] Amgen Inc, Dept Mol Struct, Newbury Pk, CA 91320 USA; [Johnson, Carol W.] Amgen Inc, Dept Pathol, Newbury Pk, CA 91320 USA; [Kim, Tae-Seong; Tasker, Andrew] Amgen Inc, Dept Med Chem, Newbury Pk, CA 91320 USA	Amgen; Amgen; Amgen; Amgen	Dussault, I (corresponding author), Amgen Inc, Dept Oncol Res, 1 Amgen Ctr Dr, Newbury Pk, CA 91320 USA.	idussaul@amgen.com						Abounader R, 1999, J NATL CANCER I, V91, P1548, DOI 10.1093/jnci/91.18.1548; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Brockmann MA, 2003, CLIN CANCER RES, V9, P4578; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Christensen JG, 2003, CANCER RES, V63, P7345; Corso S, 2005, TRENDS MOL MED, V11, P284, DOI 10.1016/j.molmed.2005.04.005; Date K, 1997, FEBS LETT, V420, P1, DOI 10.1016/S0014-5793(97)01475-0; Debiec-Rychter M, 2005, GASTROENTEROLOGY, V128, P270, DOI 10.1053/j.gastro.2004.11.020; Debiec-Rychter M, 2004, EUR J CANCER, V40, P689, DOI 10.1016/j.ejca.2003.11.025; Dharmawardana PG, 2004, CURR MOL MED, V4, P855, DOI 10.2174/1566524043359674; Giordano S, 2000, FASEB J, V14, P399, DOI 10.1096/fasebj.14.2.399; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Hodous BL, 2007, J MED CHEM, V50, P611, DOI 10.1021/jm061107l; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Kim SJ, 2003, CLIN CANCER RES, V9, P5161; KOMADA M, 1994, J BIOL CHEM, V269, P16131; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; Michieli P, 2004, CANCER CELL, V6, P61, DOI 10.1016/j.ccr.2004.05.032; Nagar B, 2002, CANCER RES, V62, P4236; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Olivero M, 1999, INT J CANCER, V82, P640, DOI 10.1002/(SICI)1097-0215(19990827)82:5<640::AID-IJC4>3.0.CO;2-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polverino A, 2006, CANCER RES, V66, P8715, DOI 10.1158/0008-5472.CAN-05-4665; REGECAMBRIN G, 1992, CANCER GENET CYTOGEN, V64, P170, DOI 10.1016/0165-4608(92)90350-H; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; Sattler M, 2003, CANCER RES, V63, P5462; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schmidt L, 1999, ONCOGENE, V18, P2343, DOI 10.1038/sj.onc.1202547; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Tamborini E, 2006, ONCOGENE, V25, P6140, DOI 10.1038/sj.onc.1209639; Tamborini E, 2004, CLIN CANCER RES, V10, P938, DOI 10.1158/1078-0432.CCR-03-0059; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; Tomioka D, 2001, CANCER RES, V61, P7518; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Wang XY, 2003, MOL CANCER THER, V2, P1085; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; ZHU H, 1994, J BIOL CHEM, V269, P29943; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	51	114	126	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2675	2683		10.1074/jbc.M705774200	http://dx.doi.org/10.1074/jbc.M705774200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18055465	hybrid			2022-12-27	WOS:000252622300024
J	Qiu, C; Lienhard, S; Hynes, NE; Badache, A; Leahy, DJ				Qiu, Chen; Lienhard, Susanne; Hynes, Nancy E.; Badache, Ali; Leahy, Daniel J.			Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERBB SIGNALING NETWORK; PROTOCATECHUATE 4,5-DIOXYGENASE; ACTIVATION; RECEPTORS; PROTEINS; SYSTEM; KINASE; CANCER; SHC	Memo (mediator of ErbB2-driven cell motility) is a 297-aminoacid protein recently shown to co-precipitate with the C terminus of ErbB2 and be required for ErbB2-driven cell motility. Memo is not homologous to any known signaling proteins, and how it mediates ErbB2 signals is not known. To provide a molecular basis for understanding Memo function, we have determined and report here the 2.1 angstrom crystal structure of human Memo and show it be homologous to class III nonheme iron-dependent dioxygenases, a structural class that now includes a zinc-binding protein of unknown function. No metal binding or enzymatic activity can be detected for Memo, but Memo does bind directly to a specific ErbB2-derived phosphopeptide encompassing Tyr-1227 using its vestigial enzymatic active site. Memo thus represents a new class of phosphotyrosine-binding protein.	[Qiu, Chen; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Lienhard, Susanne; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Leahy, Daniel J.] INSERM, U599, Ctr Rech Cancrol Marseille, F-13009 Marseille, France; [Badache, Ali] Univ Aix Marseille 2, F-13007 Marseille, France; [Badache, Ali] Inst J Paoli I Calmettes, F-13009 Marseille, France	Johns Hopkins University; Friedrich Miescher Institute for Biomedical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu	Badache, Ali/Q-6098-2017	Badache, Ali/0000-0001-7710-2505	NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 90466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Bertini I, 1984, Adv Inorg Biochem, V6, P71; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lippard S. J., 1994, PRINCIPLES BIOINORGA; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NODA Y, 1990, J BACTERIOL, V172, P2704, DOI 10.1128/jb.172.5.2704-2709.1990; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; RICCI A, 1995, ONCOGENE, V11, P1519; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SEGATTO O, 1993, ONCOGENE, V8, P2105; Sugimoto K, 1999, STRUCTURE, V7, P953, DOI 10.1016/S0969-2126(99)80122-1; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou MM, 1995, J BIOL CHEM, V270, P31119, DOI 10.1074/jbc.270.52.31119	27	22	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2734	2740		10.1074/jbc.M703523200	http://dx.doi.org/10.1074/jbc.M703523200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045866	hybrid			2022-12-27	WOS:000252622300031
J	Jia, SJ; Ren, Z; Li, X; Zheng, Y; Meng, AM				Jia, Shunji; Ren, Zhen; Li, Xiang; Zheng, Ying; Meng, Anming			smad2 and smad3 are required for mesendoderm induction by transforming growth factor-beta/Nodal signals in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-EYED-PINHEAD; NODAL-RELATED SIGNALS; TGF-BETA; VERTEBRATE DEVELOPMENT; TARGETED DISRUPTION; MESODERM INDUCTION; GENE-EXPRESSION; AXIS FORMATION; MOUSE EMBRYO; IDENTIFICATION	The transforming growth factor-beta ligands Nodal, activin, and Vg1 play important roles in mesendoderm induction and patterning during vertebrate embryogenesis. These ligands are believed to transduce the signal through the receptor-activated transcription factors Smad2 and Smad3. However, the roles of smad2/ 3 genes in development of zebrafish embryos are largely unknown because the presence of multiple smad2/ 3 genes and their maternal expression have hampered the investigation of their developmental roles. We generated potent and specific dominant- negative forms of zebrafish Smad2, Smad3a, and Smad3b by mutating multiple amino acids. Overexpression of these mutants abolished mesendoderm induction by ectopic Nodal signaling in zebrafish embryos. Expression of dominantnegative smad2/3 abrogated Smad2/3 activities in wild- type embryos and caused various mesendodermal defects similar to those in Nodal- deficient embryos. Smad2/3-deficient cells transplanted into the blastodermal margin of wild- type hosts preferentially differentiated into ectodermal tissues rather than mesendodermal tissues, supporting the idea that response of cells to mesendoderm inducers requires Smad2/3 activities. Interference with Smad2/3 activities in Zoep, Moep, and MZoep mutant embryos resulted in more severe mesendodermal defects. Thus, our data reveal that Nodal signaling and mesendoderm induction depend on Smad2/3 and suggest that transforming growth factor-beta signals other than Nodal also contribute to Smad2/3 signaling and embryonic patterning.	[Jia, Shunji; Ren, Zhen; Li, Xiang; Zheng, Ying; Meng, Anming] Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Meng, Anming/A-4785-2012	Ren, Zhen/0000-0002-2547-8313; Meng, Anming/0000-0001-7228-3431				Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Datto MB, 1999, MOL CELL BIOL, V19, P2495; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Driever W, 1996, DEVELOPMENT, V123, P37; Dunn NR, 2004, DEVELOPMENT, V131, P1717, DOI 10.1242/dev.01072; Feldman B, 2000, CURR BIOL, V10, P531, DOI 10.1016/S0960-9822(00)00469-3; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Haffter P, 1996, DEVELOPMENT, V123, P1; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; HUANG HC, 1995, EMBO J, V14, P5965, DOI 10.1002/j.1460-2075.1995.tb00285.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kumar A, 2001, J BIOL CHEM, V276, P656, DOI 10.1074/jbc.M004649200; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Pogoda HM, 2002, DEV DYNAM, V224, P334, DOI 10.1002/dvdy.10113; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Renucci A, 1996, DEVELOPMENT, V122, P3735; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1997, DEVELOPMENT, V124, P327; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Sun BI, 1999, DEVELOPMENT, V126, P1467; Sun ZH, 2006, BIOCHEM BIOPH RES CO, V345, P694, DOI 10.1016/j.bbrc.2006.04.148; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Tremblay KD, 2000, DEVELOPMENT, V127, P3079; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Xiong B, 2006, DEV CELL, V11, P225, DOI 10.1016/j.devcel.2006.06.012; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhao J, 2003, EMBO J, V22, P6078, DOI 10.1093/emboj/cdg593; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	49	48	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2418	2426		10.1074/jbc.M707578200	http://dx.doi.org/10.1074/jbc.M707578200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025082	hybrid			2022-12-27	WOS:000252501000068
J	Bonente, G; Howes, BD; Caffarri, S; Smulevich, G; Bassi, R				Bonente, Giulia; Howes, Barry D.; Caffarri, Stefano; Smulevich, Giulietta; Bassi, Roberto			Interactions between the photosystem II subunit PsbS and xanthophylls studied in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; NONPHOTOCHEMICAL ENERGY-DISSIPATION; RESOLVED FLUORESCENCE ANALYSIS; PIGMENT-PIGMENT INTERACTIONS; CAROTENOID-BINDING-SITES; HIGHER-PLANT ANTENNA; CHLOROPHYLL FLUORESCENCE; CHLOROPLAST MEMBRANES; ARABIDOPSIS-THALIANA; MOLECULAR MECHANISM	The photosystem II subunit PsbS is essential for excess energy dissipation (qE); however, both lutein and zeaxanthin are needed for its full activation. Based on previous work, two models can be proposed in which PsbS is either 1) the gene product where the quenching activity is located or 2) a proton-sensing trigger that activates the quencher molecules. The first hypothesis requires xanthophyll binding to two PsbS-binding sites, each activated by the protonation of a dicyclohexylcarbodiimide-binding lumen-exposed glutamic acid residue. To assess the existence and properties of these xanthophyll-binding sites, PsbS point mutants on each of the two Glu residues PsbS E122Q and PsbS E226Q were crossed with the npq1/npq4 and lut2/ npq4 mutants lacking zeaxanthin and lutein, respectively. Double mutants E122Q/npq1 and E226Q/npq1 had no qE, whereas E122Q/lut2 and E226Q/lut2 showed a strong qE reduction with respect to both lut2 and single glutamate mutants. These findings exclude a specific interaction between lutein or zeaxanthin and a dicyclohexylcarbodiimide-binding site and suggest that the dependence of nonphotochemical quenching on xanthophyll composition is not due to pigment binding to PsbS. To verify, in vitro, the capacity of xanthophylls to bind PsbS, we have produced recombinant PsbS refolded with purified pigments and shown that Raman signals, previously attributed to PsbS-zeaxanthin interactions, are in fact due to xanthophyll aggregation. We conclude that the xanthophyll dependence of qE is not due to PsbS but to other pigment-binding proteins, probably of the Lhcb type.	[Bonente, Giulia; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Bonente, Giulia; Caffarri, Stefano; Bassi, Roberto] Univ Aix Marseille 2, Fac Sci Luminy, Lab Genet & Biophys Plantes, Marseille 9, France; [Howes, Barry D.; Smulevich, Giulietta] Univ Florence, Dipartimento Chim, I-50019 Florence, Italy	University of Verona; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Florence	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Strada Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	smulevich, giulietta/A-6510-2008; Caffarri, Stefano/AAX-8913-2021	Caffarri, Stefano/0000-0002-4729-7679; bassi, roberto/0000-0002-4140-8446; Smulevich, Giulietta/0000-0003-3021-8919				Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; BASSI R, 1987, J BIOL CHEM, V262, P13333; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; Billsten HH, 2005, J PHYS CHEM A, V109, P1521, DOI 10.1021/jp044847j; BRIANTAIS JM, 1966, CR ACAD SCI D NAT, V263, P1899; Briantais JM, 1996, PHOTOSYNTH RES, V48, P189, DOI 10.1007/BF00041008; CAMMARATA KV, 1992, PHOTOSYNTH RES, V33, P235, DOI 10.1007/BF00030034; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; CROFTS AR, 1994, FEBS LETT, V352, P265, DOI 10.1016/0014-5793(94)00976-7; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; DALLOSTO L, 2007, J BIOL CHEM; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; FUNK C, 1995, J BIOL CHEM, V270, P30141; FUNK C, 1995, BIOCHEMISTRY-US, V34, P11133, DOI 10.1021/bi00035a019; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Grabowski B, 2001, P NATL ACAD SCI USA, V98, P2911, DOI 10.1073/pnas.031587198; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MEYER M, 1993, Z NATURFORSCH C, V48, P461; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; PAULSEN H, 1992, EUR J BIOCHEM, V205, P71, DOI 10.1111/j.1432-1033.1992.tb16752.x; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; PREISS S, 1995, PLANT PHYSIOL, V107, P709, DOI 10.1104/pp.107.3.709; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schulz H, 2005, BIOPOLYMERS, V77, P212, DOI 10.1002/bip.20215	70	106	108	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8434	8445		10.1074/jbc.M708291200	http://dx.doi.org/10.1074/jbc.M708291200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18070876	Green Published, hybrid			2022-12-27	WOS:000254288000041
J	Hadfield, KD; Rock, CF; Inkson, CA; Dallas, SL; Sudre, L; Wallis, GA; Boot-Handford, RP; Canfield, AE				Hadfield, Kristen D.; Rock, Claire Farrington; Inkson, Colette A.; Dallas, Sarah L.; Sudre, Laure; Wallis, Gillian A.; Boot-Handford, Raymond P.; Canfield, Ann E.			HtrA1 inhibits mineral deposition by osteoblasts - Requirement for the protease and PDZ domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-GLA-PROTEIN; BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR-BETA; SERINE-PROTEASE; EXTRACELLULAR-MATRIX; TGF-BETA; INTEGRIN RECEPTORS; IN-VITRO; DIFFERENTIATION; CALCIFICATION	HtrA1 is a secreted multidomain protein with serine protease activity. In light of increasing evidence implicating this protein in the regulation of skeletal development and pathology, we investigated the role of HtrA1 in osteoblast mineralization and identified domains essential for this activity. We demonstrate increased HtrA1 expression in differentiating 2T3 osteoblasts prior to the appearance of mineralization. HtrA1 is subsequently down-regulated in fully mineralized cultures. The functional role of HtrA1 in matrix calcification was investigated using three complementary approaches. First, we transfected a full-length HtrA1 expression plasmid into 2T3 cells and showed that overexpression of HtrA1 delayed mineralization, reduced expression of Cbfa1 and collagen type I mRNA, and prevented BMP-2-induced mineralization. Second, knocking down HtrA1 expression using short interfering RNA induced mineral deposition by 2T3 cells. Third, by expressing a series of recombinant HtrA1 proteins, we demonstrated that the protease domain and the PDZ domain are essential for the inhibitory effect of HtrA1 on osteoblast mineralization. Finally, we tested whether HtrA1 cleaves specific matrix proteins that are known to regulate osteoblast differentiation, mineralization, and/or BMP-2 activity. Full-length recombinant HtrA1 cleaved recombinant decorin, fibronectin, and matrix Gla protein. Both the protease domain and the PDZ domain were necessary for the cleavage of matrix Gla protein, whereas the PDZ domain was not required for the cleavage of decorin or fibronectin. Type I collagen was not cleaved by recombinant HtrA1. These results suggest that HtrA1 may regulate matrix calcification via the inhibition of BMP-2 signaling, modulating osteoblast gene expression, and/or via the degradation of specific matrix proteins.	[Hadfield, Kristen D.; Rock, Claire Farrington; Inkson, Colette A.; Sudre, Laure; Wallis, Gillian A.; Boot-Handford, Raymond P.; Canfield, Ann E.] Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Genet, Sch Clin & Lab Sci, Cardiovasc Res Grp, Manchester M13 9PT, Lancs, England; [Dallas, Sarah L.] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Manchester; University of Manchester; University of Missouri System; University of Missouri Kansas City	Canfield, AE (corresponding author), Univ Manchester, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	ann.canfield@manchester.ac.uk		Boot-Handford, Raymond/0000-0002-6167-8419; Inkson, Colette/0000-0003-1215-312X; Canfield, Ann/0000-0002-8983-5674	Arthritis Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; BOSKEY AL, 1984, ORTHOP CLIN N AM, V15, P597; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Canfield AE, 2000, FEBS LETT, V487, P267, DOI 10.1016/S0014-5793(00)02363-2; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; DOHERTY M, 1998, BIOCHEM SOC T, V26, pS410; Fischer JW, 2004, ARTERIOSCL THROM VAS, V24, P2391, DOI 10.1161/01.ATV.0000147029.63303.28; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Harris SE, 2003, FRONT BIOSCI, V8, pS1249, DOI 10.2741/1170; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Hoshi K, 1999, J BONE MINER RES, V14, P273, DOI 10.1359/jbmr.1999.14.2.273; Hoshi K, 2001, J BONE MINER RES, V16, P289, DOI 10.1359/jbmr.2001.16.2.289; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Landis W J, 1999, Gravit Space Biol Bull, V12, P15; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mochida Y, 2003, BIOCHEM BIOPH RES CO, V305, P6, DOI 10.1016/S0006-291X(03)00693-4; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishimoto SK, 2005, MATRIX BIOL, V24, P353, DOI 10.1016/j.matbio.2005.05.004; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Pereira M, 2002, J CELL SCI, V115, P609; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; PRICE PA, 1985, J BIOL CHEM, V260, P4971; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Waddington R. J., 2003, European Cells & Materials, V6, P12; Wajih N, 2004, J BIOL CHEM, V279, P43052, DOI 10.1074/jbc.M407180200; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	65	57	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5928	5938		10.1074/jbc.M709299200	http://dx.doi.org/10.1074/jbc.M709299200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156628	hybrid			2022-12-27	WOS:000253426700071
J	Jefferies, KC; Forgac, M				Jefferies, Kevin C.; Forgac, Michael			Subunit h of the vacuolar (H+) ATPase inhibits ATP hydrolysis by the free V-1 domain by interaction with the rotary subunit F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; PROTON-TRANSLOCATING ATPASE; MEDIATED CROSS-LINKING; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; COMPLEX; VMA13P; V-1; ACIDIFICATION; LOCALIZATION	The vacuolar (H+) ATPases (V-ATPases) are large, multimeric proton pumps that, like the related family of F1F0 ATP synthases, employ a rotary mechanism. ATP hydrolysis by the peripheral V-1 domain drives rotation of a rotary complex (the rotor) relative to the stationary part of the enzyme (the stator), leading to proton translocation through the integral V-0 domain. One mechanism of regulating V-ATPase activity in vivo involves reversible dissociation of the V-1 and V-0 domains. Unlike the corresponding domains in F1F0, the dissociated V-1 domain does not hydrolyze ATP, and the free V0 domain does not passively conduct protons. These properties are important to avoid generation of an uncoupled ATPase activity or an unregulated proton conductance upon dissociation of the complex in vivo. Previous results (Parra, K. J., Keenan, K. L., and Kane, P. M. (2000) J. Biol. Chem. 275, 21761-21767) showed that subunit H(part of the stator) inhibits ATP hydrolysis by free V-1. To test the hypothesis that subunit H accomplishes this by bridging rotor and stator in free V-1, cysteine-mediated cross-linking studies were performed. Unique cysteine residues were introduced over the surface of subunit H from yeast by site-directed mutagenesis and used as the site of attachment of the photo-activated cross-linking reagent maleimido benzophenone. After UV-activated cross-linking, cross-linked products were identified by Western blot using subunit-specific antibodies. The results indicate that the subunit H mutant S381C shows cross-linking between subunit H and subunit F (a rotor subunit) in the free V-1 domain but not in the intact V1V0 complex. These results indicate that subunits H and F are proximal in free V-1, supporting the hypothesis that subunit H inhibits free V-1 by bridging the rotary and stator domains.	[Jefferies, Kevin C.; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NIDDK NIH HHS [DK34928, P30 DK034928] Funding Source: Medline; NIGMS NIH HHS [R37 GM034478-22, R37 GM034478, R01 GM034478, R37 GM034478-21, R37 GM034478-20, GM 34478, R37 GM034478-23] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SENNOUNE SR, 2004, AM J PHYSIOL-CELL PH, V286, P1443; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200	42	65	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4512	4519		10.1074/jbc.M707144200	http://dx.doi.org/10.1074/jbc.M707144200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156183	Green Accepted, hybrid			2022-12-27	WOS:000253426500007
J	Kang, S; Dong, S; Guo, A; Ruan, H; Lonial, S; Khoury, HJ; Gu, TL; Chen, J				Kang, Sumin; Dong, Shaozhong; Guo, Ailan; Ruan, Hong; Lonial, Sagar; Khoury, Hanna Jean; Gu, Ting-Lei; Chen, Jing			Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and Src-dependent tyrosine phosphorylation of RSK2 at Tyr-529	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; DOCKING SITE; SIGNAL-TRANSDUCTION; HISTONE H3; MAP	The Ser/Thr kinase ribosomal S6 kinase 2 (RSK2) has been demonstrated to phosphorylate transcription factor CREB ( cyclic AMP-responsive-binding protein) and histone H3 in response to mitogenic stimulation by epidermal growth factor (EGF). EGF activates the MEK/ERK pathway to activate RSK2. We recently reported that receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) directly tyrosine phosphorylates RSK2 at Tyr-529, which consequently regulates RSK2 activation by facilitating inactive ERK binding to RSK2 that is required for ERK-dependent phosphorylation and activation of RSK2 (Kang, S., Dong, S., Gu, T. L., Guo, A., Cohen, M. S., Lonial, S., Khoury, H. J., Fabbro, D., Gilliland, D. G., Bergsagel, P. L., Taunton, J., Polakiewicz, R. D., and Chen, J. ( 2007) Cancer Cell 12, 201-214). Here we report that upon treatment of EGF, RSK2 was tyrosine-phosphorylated at Tyr-529 and activated in 293T and COS7 cells that do not express FGFR3. In contrast to FGFR3, the receptor tyrosine kinase EGF receptor did not directly phosphorylate RSK2 at Tyr-529 in an in vitro kinase assay using recombinant RSK2 and active EGF receptor or FGFR3. By mass spectroscopy-based studies, we identified Src tyrosine kinase family members Src and Fyn as upstream kinases of RSK2 Tyr-529. Treatment of Src inhibitor PP2 effectively attenuated EGF-dependent activation and Tyr-529 phosphorylation of RSK2, suggesting that Src family members are the kinases that phosphorylate RSK2 at Tyr-529 in response to EGF. Src and Fyn were able to directly phosphorylate RSK2 at Tyr-529 in the in vitro kinase assay. In vitro reconstitution of Tyr-529 phosphorylation by Src in glutathione S-transferase- tagged RSK2 enhanced inactive ERK binding to RSK2 wild type, but not the Y529F mutant. Together, our findings suggest that Src-dependent phosphorylation at Tyr-529 facilitates inactive ERK binding to RSK2, which might be a general requirement for RSK2 activation by EGF through the MEK/ERK pathway.	[Kang, Sumin; Dong, Shaozhong; Lonial, Sagar; Khoury, Hanna Jean; Chen, Jing] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Guo, Ailan; Ruan, Hong; Gu, Ting-Lei] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Emory University	Chen, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	jchen@emory.edu			NCI NIH HHS [R01 CA120272-02, CA120272, R01 CA120272] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120272] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Strelkov IS, 2002, CANCER RES, V62, P75; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	15	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4652	4657		10.1074/jbc.M709673200	http://dx.doi.org/10.1074/jbc.M709673200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156174	hybrid, Green Accepted			2022-12-27	WOS:000253426500022
J	Makareeva, E; Mertz, EL; Kuznetsova, NV; Sutter, MB; DeRidder, AM; Cabral, WA; Barnes, AM; McBride, DJ; Marini, JC; Leikin, S				Makareeva, Elena; Mertz, Edward L.; Kuznetsova, Natalia V.; Sutter, Mary B.; DeRidder, Angela M.; Cabral, Wayne A.; Barnes, Aileen M.; McBride, Daniel J.; Marini, Joan C.; Leikin, Sergey			Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; THERMAL-STABILITY; ELECTRON-MICROGRAPHS; MOLECULAR PACKING; ALPHA-1(I) CHAIN; ALPHA-2(I) CHAIN; DANLOS-SYNDROME; MODEL PEPTIDES; BINDING SITES; MURINE MODEL	We investigated regions of different helical stability within human type I collagen and discussed their role in intermolecular interactions and osteogenesis imperfecta (OI). By differential scanning calorimetry and circular dichroism, we measured and mapped changes in the collagen melting temperature (Delta T-m) for 41 different Gly substitutions from 47 OI patients. In contrast to peptides, we found no correlations of Delta T-m with the identity of the substituting residue. Instead, we observed regular variations in Delta T-m with the substitution location in different triple helix regions. To relate the Delta T-m map to peptide-based stability predictions, we extracted the activation energy of local helix unfolding (Delta G(double dagger)) from the reported peptide data. We constructed the Delta G(double dagger) map and tested it by measuring the H-D exchange rate for glycine NH residues involved in interchain hydrogen bonds. Based on the Delta T-m and Delta G(double dagger) maps, we delineated regional variations in the collagen triple helix stability. Two large, flexible regions deduced from the Delta T-m map aligned with the regions important for collagen fibril assembly and ligand binding. One of these regions also aligned with a lethal region for Gly substitutions in the alpha 1(I) chain.	[Makareeva, Elena; Mertz, Edward L.; Kuznetsova, Natalia V.; Sutter, Mary B.; DeRidder, Angela M.; Leikin, Sergey] NICHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [McBride, Daniel J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore	Leikin, S (corresponding author), NICHD, Sect Phys Biochem, NIH, Bldg 9,Rm 1E-127, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Leikin, Sergey/A-5518-2008; Makareeva, Elena/F-5183-2011	Leikin, Sergey/0000-0001-7095-0739; Makareeva, Elena/0000-0002-5815-0760; Barnes, Aileen/0000-0001-8021-4997	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008810, ZIAHD000256, ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408, Z01HD008810, Z01HD000256] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREEVA N S, 1970, Biofizika, V15, P198; Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BRADBURY EM, 1958, DISCUSS FARADAY SOC, P173; BURJANADZE TV, 1992, BIOPOLYMERS, V32, P951, DOI 10.1002/bip.360320806; Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Chu M., 2002, CONNECTIVE TISSUE IT, P223, DOI [10.1002/0471221929.ch2(ii), DOI 10.1002/0471221929.CH2(II)]; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; ESIPOVA N G, 1958, Biofizika, V3, P529; FERTALA A, 1993, BIOCHEM J, V289, P195, DOI 10.1042/bj2890195; Forlino A, 1999, J BIOL CHEM, V274, P37923, DOI 10.1074/jbc.274.53.37923; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Fraser ROB, 1973, CONFORMATION FIBROUS, P344; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; HULMES DJS, 1977, J MOL BIOL, V110, P643, DOI 10.1016/S0022-2836(77)80082-X; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; KADLER KE, 1988, J BIOL CHEM, V263, P10517; Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Kuznetsova NV, 2004, MATRIX BIOL, V23, P101, DOI 10.1016/j.matbio.2004.03.002; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARINI JC, 2007, NELSON TXB PEDIAT, P2887; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mertz EL, 2004, BIOCHEMISTRY-US, V43, P14901, DOI 10.1021/bi048788b; Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1; PRIVALOV PL, 1979, J MOL BIOL, V127, P203, DOI 10.1016/0022-2836(79)90240-7; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Radmer RJ, 2004, BIOCHEMISTRY-US, V43, P5314, DOI 10.1021/bi035676w; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; TIKTOPULO E I, 1979, Molekulyarnaya Biologiya (Moscow), V13, P619; Wess TJ, 1998, J STRUCT BIOL, V122, P92, DOI 10.1006/jsbi.1998.3991; WESTERHAUSEN A, 1990, J BIOL CHEM, V265, P13995; YEE RY, 1974, J MOL BIOL, V83, P1, DOI 10.1016/0022-2836(74)90420-3; Zafarullah K, 1997, MATRIX BIOL, V16, P245, DOI 10.1016/S0945-053X(97)90013-5	58	72	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4787	4798		10.1074/jbc.M705773200	http://dx.doi.org/10.1074/jbc.M705773200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073209	hybrid			2022-12-27	WOS:000253426500036
J	Prosser, BL; Wright, NT; Ndez-Ochoa, EOH; Varney, KM; Liu, Y; Olojo, RO; Zimmer, DB; Weber, DJ; Schneider, MF				Prosser, Benjamin L.; Wright, Nathan T.; Ndez-Ochoa, Erick O. Herna; Varney, Kristen M.; Liu, Yewei; Olojo, Rotimi O.; Zimmer, Danna B.; Weber, David J.; Schneider, Martin F.			S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING PROTEIN S100A1; CA2+ RELEASE CHANNEL; 3-DIMENSIONAL SOLUTION STRUCTURE; CALCIUM-BINDING; REGULATORY DOMAIN; HEART-FAILURE; C-TERMINUS; TARGET; ALPHA; C-13	S100A1, a 21-kDa dimeric Ca2+-binding protein, is an enhancer of cardiac Ca2+ release and contractility and a potential therapeutic agent for the treatment of cardiomyopathy. The role of S100A1 in skeletal muscle has been less well defined. Additionally, the precise molecular mechanism underlying S100A1 modulation of sarcoplasmic reticulum Ca2+ release in striated muscle has not been fully elucidated. Here, utilizing a genetic approach to knock out S100A1, we demonstrate a direct physiological role of S100A1 in excitation-contraction coupling in skeletal muscle. We show that the absence of S100A1 leads to decreased global myoplasmic Ca2+ transients following electrical excitation. Using high speed confocal microscopy, we demonstrate with high temporal resolution depressed activation of sarcoplasmic reticulum Ca2+ release in S100A1(-/-) muscle fibers. Through competition assays with sarcoplasmic reticulum vesicles and through tryptophan fluorescence experiments, we also identify a novel S100A1-binding site on the cytoplasmic face of the intact ryanodine receptor that is conserved throughout striated muscle and corresponds to a previously identified calmodulin-binding site. Using a 12-mer peptide of this putative binding domain, we demonstrate low micromolar binding affinity to S100A1. NMR spectroscopy reveals this peptide binds within the Ca2+ -dependent hydrophobic pocket of S100A1. Taken together, these data suggest that S100A1 plays a significant role in skeletal muscle excitation-contraction coupling, primarily through specific interactions with a conserved binding domain of the ryanodine receptor. This warrants further investigation into the use of S100A1 as a therapeutic target for the treatment of both cardiac and skeletal myopathies.	[Prosser, Benjamin L.; Wright, Nathan T.; Ndez-Ochoa, Erick O. Herna; Varney, Kristen M.; Liu, Yewei; Olojo, Rotimi O.; Weber, David J.; Schneider, Martin F.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zimmer, Danna B.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station	Weber, DJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dweber@umaryland.edu; mschneid@umaryland.edu	Weber, David J/B-5349-2011; Tuluc, Petronel/C-2527-2011	Weber, David J/0000-0002-8824-1110; Wright, Nathan/0000-0003-0177-6129; Prosser, Benjamin/0000-0003-3696-9131	NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010441, S10RR015741, S10RR016812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592, R01AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER; NCI NIH HHS [CA107331, R01 CA107331] Funding Source: Medline; NCRR NIH HHS [S10 RR10441, S10 RR16812] Funding Source: Medline; NIAMS NIH HHS [R01 AR055099, T32 AR007592] Funding Source: Medline; NIGMS NIH HHS [R01 GM058888, GM58888] Funding Source: Medline; PHS HHS [S10 R15741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baldisseri DM, 1999, J BIOMOL NMR, V14, P91, DOI 10.1023/A:1008301518346; Carlomagno T, 1997, J MAGN RESON, V126, P110, DOI 10.1006/jmre.1997.1157; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFranco M, 2005, J MEMBRANE BIOL, V208, P141, DOI 10.1007/s00232-005-0825-9; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002; EDISON AS, 1994, METHOD ENZYMOL, V239, P3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HAIMOTO H, 1987, J NEUROCHEM, V48, P917, DOI 10.1111/j.1471-4159.1987.tb05604.x; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kettlewell S, 2005, J MOL CELL CARDIOL, V39, P900, DOI 10.1016/j.yjmcc.2005.06.018; Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; LIVE DH, 1984, J AM CHEM SOC, V106, P1939, DOI 10.1021/ja00319a006; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Maco B, 2001, PHYSIOL RES, V50, P567; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MATISE M, 2000, GENE TARGETING PRACT; MENEGAZZI P, 1994, BIOCHEMISTRY-US, V33, P9078, DOI 10.1021/bi00197a008; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; MUHANDIRAM DR, 1993, J BIOMOL NMR, V3, P463; O'Connell KMS, 2002, J GEN PHYSIOL, V120, P337, DOI 10.1085/jgp.20028617; Pleger ST, 2006, EUR J MED RES, V11, P418; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Pleger ST, 2007, CARDIOVASC RES, V75, P1, DOI 10.1016/j.cardiores.2007.05.009; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2005, J BIOL CHEM, V280, P11713, DOI 10.1074/jbc.M408189200; Rodney GG, 2003, BIOPHYS J, V85, P921, DOI 10.1016/S0006-3495(03)74531-7; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Rustandi RR, 1999, PROTEIN SCI, V8, P1743, DOI 10.1110/ps.8.9.1743; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; SPERA S, 1991, Journal of Biomolecular NMR, V1, P155, DOI 10.1007/BF01877227; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Weber DJ, 2000, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, P521; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZIMMER DB, 1991, CELL MOTIL CYTOSKEL, V20, P325, DOI 10.1002/cm.970200408	65	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5046	5057		10.1074/jbc.M709231200	http://dx.doi.org/10.1074/jbc.M709231200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089560	hybrid, Green Accepted			2022-12-27	WOS:000253426500062
J	Severi, E; Muller, A; Potts, JR; Leech, A; Williamson, D; Wilson, KS; Thomas, GH				Severi, Emmanuele; Mueller, Axel; Potts, Jennifer R.; Leech, Andrew; Williamson, David; Wilson, Keith S.; Thomas, Gavin H.			Sialic acid mutarotation is catalyzed by the Escherichia coli beta-propeller protein YjhT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KELCH-REPEAT SUPERFAMILY; HAEMOPHILUS-INFLUENZAE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; SERUM RESISTANCE; VIRULENCE FACTOR; NEURAMINIC ACID; LIPOPOLYSACCHARIDE; TRANSPORTER; K-12	The acquisition of host-derived sialic acid is an important virulence factor for some bacterial pathogens, but in vivo this sugar acid is sequestered in sialoconjugates as the alpha-anomer. In solution, however, sialic acid is present mainly as the beta-anomer, formed by a slow spontaneous mutarotation. We studied the Escherichia coli protein YjhT as a member of a family of uncharacterized proteins present in many sialic acid-utilizing pathogens. This protein is able to accelerate the equilibration of the alpha- and beta-anomers of the sialic acid N-acetylneuraminic acid, thus describing a novel sialic acid mutarotase activity. The structure of this periplasmic protein, solved to 1.5 A resolution, reveals a dimeric 6-bladed unclosed beta-propeller, the first of a bacterial Kelch domain protein. Mutagenesis of conserved residues in YjhT demonstrated an important role for Glu-209 and Arg-215 in mutarotase activity. We also present data suggesting that the ability to utilize alpha-N-acetylneuraminic acid released from complex sialoconjugates in vivo provides a physiological advantage to bacteria containing YjhT.	[Severi, Emmanuele; Mueller, Axel; Potts, Jennifer R.; Thomas, Gavin H.] Univ York, Dept Biol Area 10, York YO10 5YW, N Yorkshire, England; [Mueller, Axel; Potts, Jennifer R.; Williamson, David; Wilson, Keith S.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Leech, Andrew] Univ York, Dept Biol Area 15, Technol Facil, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Thomas, GH (corresponding author), Univ York, Dept Biol Area 10, York YO10 5YW, N Yorkshire, England.	ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council [BB/C509807/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; BOUFFARD GG, 1994, J MOL BIOL, V244, P269, DOI 10.1006/jmbi.1994.1728; BROWN EB, 1975, BIOCHIM BIOPHYS ACTA, V399, P124, DOI 10.1016/0304-4165(75)90218-4; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Cox AD, 2002, EUR J BIOCHEM, V269, P4009, DOI 10.1046/j.1432-1033.2002.03090.x; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEBOLIN H, 1981, TETRAHEDRON LETT, V22, P1383, DOI 10.1016/S0040-4039(01)90327-2; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Graille M, 2006, J BIOL CHEM, V281, P30175, DOI 10.1074/jbc.M604443200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; JAQUES LW, 1977, J BIOL CHEM, V252, P4533; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Langen H, 2000, ELECTROPHORESIS, V21, P411, DOI 10.1002/(SICI)1522-2683(20000101)21:2<411::AID-ELPS411>3.3.CO;2-W; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Oh H, 1999, J BIOL CHEM, V274, P14006, DOI 10.1074/jbc.274.20.14006; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Ryu KS, 2005, J MOL BIOL, V349, P153, DOI 10.1016/j.jmb.2005.03.047; Ryu KS, 2004, J BIOL CHEM, V279, P25544, DOI 10.1074/jbc.M402016200; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Sohanpal BK, 2004, P NATL ACAD SCI USA, V101, P16322, DOI 10.1073/pnas.0405821101; Thoden JB, 2003, PROTEIN SCI, V12, P1051, DOI 10.1110/ps.0243203; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Vimr E, 2000, MOL MICROBIOL, V36, P1113, DOI 10.1046/j.1365-2958.2000.01925.x; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	61	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4841	4849		10.1074/jbc.M707822200	http://dx.doi.org/10.1074/jbc.M707822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063573	Green Accepted, hybrid			2022-12-27	WOS:000253426500042
J	Collom, SL; Laddusaw, RM; Burch, AM; Kuzmic, P; Perry, MD; Miller, GP				Collom, Samuel L.; Laddusaw, Ryan M.; Burch, Amber M.; Kuzmic, Petr; Perry, Martin D., Jr.; Miller, Grover P.			CYP2E1 substrate inhibition - Mechanistic interpretation through an effector site for monocyclic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-P450 2E1; ACTIVE-SITE; P450 2E1; EXPRESSION; PURIFICATION; METABOLISM; OXIDATION; DYNAMICS; NITROPHENOL; HYDROXYLASE	In this study we offer a mechanistic interpretation of the previously known but unexplained substrate inhibition observed for CYP2E1. At low substrate concentrations, p-nitrophenol (pNP) was rapidly turned over (47 min(-1)) with relatively low K-m (24 mu M); nevertheless, at concentrations of > 100 mu M, the rate of pNP oxidation gradually decreased as a second molecule bound to CYP2E1 through an effector site (K-ss = 260 mu M), which inhibited activity at the catalytic site. 4-Methylpyrazole (4MP) was a potent inhibitor for both sites through a mixed inhibition mechanism. The K-i for the catalytic site was 2.0 mu M. Although we were unable to discriminate whether an EIS or ESI complex formed, the respective inhibition constants were far lower than K-ss. Bicyclic indazole (IND) inhibited catalysis through a single CYP2E1 site (K-i = 0.12 mu M). Similarly, 4MP and IND yielded type II binding spectra that reflected the association of either two 4MP or one IND molecule(s) to CYP2E1, respectively. Based on computational docking studies with a homology model for CYP2E1, the two sites for monocyclic molecules, pNP and 4MP, exist within a narrow channel connecting the active site to the surface of the enzyme. Because of the presence of the heme iron, one site supports catalysis, whereas the other more distal effector site binds molecules that can influence the binding orientation and egress of molecules for the catalytic site. Although IND did not bind these sites simultaneously, the presence of IND at the catalytic site blocked binding at the effector site.	[Collom, Samuel L.; Burch, Amber M.; Miller, Grover P.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Laddusaw, Ryan M.; Perry, Martin D., Jr.] Ouachita Baptist Univ, Dept Chem, Arkadelphia, AR 71998 USA; [Kuzmic, Petr] BioKin Ltd, Pullman, WA 99163 USA	University of Arkansas System; University of Arkansas Medical Sciences	Miller, GP (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, 4301 W Markham St,Slot 516, Little Rock, AR 72205 USA.	millergroverp@uams.edu	Miller, Grover P/AAY-7582-2020; Collom, Samuel/L-9287-2013	Miller, Grover P/0000-0002-4743-8187; Kuzmic, Petr/0000-0001-5250-8381	NCRR NIH HHS [P20 RR015569-060011, P20 RR015569] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Banerjee S, 2002, BIOTECHNOL BIOENG, V77, P462, DOI 10.1002/bit.10151; BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125; Burnham KP., 2002, MODEL SELECTION MULT, V2, P70; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Cheng DM, 2004, PROTEIN EXPRES PURIF, V33, P66, DOI 10.1016/j.pep.2003.08.009; Collom SL, 2007, ARCH BIOCHEM BIOPHYS, V459, P59, DOI 10.1016/j.abb.2006.10.028; COON MJ, 1983, PHARMACOL BIOCHEM BE, V18, P177, DOI 10.1016/0091-3057(83)90168-5; Doty SL, 2000, P NATL ACAD SCI USA, V97, P6287, DOI 10.1073/pnas.97.12.6287; Easterbrook J, 2001, DRUG METAB DISPOS, V29, P141; FUKUDA T, 1993, J BIOCHEM-TOKYO, V113, P7, DOI 10.1093/oxfordjournals.jbchem.a124006; GUENGERICH FP, 1994, TOXICOL LETT, V70, P133; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HARGREAVES MB, 1994, DRUG METAB DISPOS, V22, P806; Harrelson JP, 2007, BIOCHEM BIOPH RES CO, V352, P843, DOI 10.1016/j.bbrc.2006.11.071; Houston JB, 2005, ARCH BIOCHEM BIOPHYS, V433, P351, DOI 10.1016/j.abb.2004.09.010; Jain AN, 1996, J COMPUT AID MOL DES, V10, P427, DOI 10.1007/BF00124474; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jamakhandi AP, 2005, ARCH BIOCHEM BIOPHYS, V439, P165, DOI 10.1016/j.abb.2005.04.022; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; Jefcoate C R, 1978, Methods Enzymol, V52, P258; KOOP DR, 1986, MOL PHARMACOL, V29, P399; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; LARSON JR, 1991, P NATL ACAD SCI USA, V88, P9141, DOI 10.1073/pnas.88.20.9141; Lewis D. F. V., 2002, Xenobiotica, V32, P305, DOI 10.1080/00498250110112015; Lewis DFV, 2003, J BIOCHEM MOL TOXIC, V17, P47, DOI 10.1002/jbt.10055; Miller GP, 2001, BIOCHEMISTRY-US, V40, P7262, DOI 10.1021/bi010402z; Park JY, 2003, J MED CHEM, V46, P1645, DOI 10.1021/jm020538a; Robertson Graham, 2001, American Journal of Physiology, V281, pG1135; Ronis MJJ, 1996, CYTOCHROMES P450 MET, P211; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Smith SV, 2006, BIOCHEMISTRY-US, V45, P15617, DOI 10.1021/bi061873u; Spatzenegger M, 2003, J PHARMACOL EXP THER, V304, P477, DOI 10.1124/jpet.102.043323; Tan YZ, 1997, XENOBIOTICA, V27, P287, DOI 10.1080/004982597240613; TASSANEEYAKUL W, 1993, BIOCHEM PHARMACOL, V46, P1975, DOI 10.1016/0006-2952(93)90639-E; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; YAMAZAKI H, 1995, DRUG METAB DISPOS, V23, P438	39	56	57	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3487	3496		10.1074/jbc.M707630200	http://dx.doi.org/10.1074/jbc.M707630200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056994	hybrid, Green Accepted			2022-12-27	WOS:000253083000054
J	Ozturk, N; Song, SH; Selby, CP; Sancar, A				Ozturk, Nuri; Song, Sang-Hun; Selby, Christopher P.; Sancar, Aziz			Animal type 1 cryptochromes - Analysis of the redox state of the flavin cofactor by site-directed mutagenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE-LIGHT PHOTORECEPTOR; DNA PHOTOLYASE; CIRCADIAN CLOCK; ACTION SPECTRUM; DROSOPHILA; ARABIDOPSIS; REPAIR; ROLES; GENE	It has recently been realized that animal cryptochromes (CRYs) fall into two broad groups. Type 1 CRYs, the prototype of which is the Drosophila CRY, that is known to be a circadian photoreceptor. Type 2 CRYs, the prototypes of which are human CRY 1 and CRY 2, are known to function as core clock proteins. The mechanism of photosignaling by the Type 1 CRYs is not well understood. We recently reported that the flavin cofactor of the Type 1 CRY of the monarch butterfly may be in the form of flavin anion radical, FAD., in vivo. Here we describe the purification and characterization of wild-type and mutant forms of Type 1 CRYs from fruit fly, butterfly, mosquito, and silk moth. Cryptochromes from all four sources contain FAD(ox) when purified, and the flavin is readily reduced to FAD by light. Interestingly, mutations that block photoreduction in vitro do not affect the photoreceptor activities of these CRYs, but mutations that reduce the stability of FAD. in vitro abolish the photoreceptor function of Type 1 CRYs in vivo. Collectively, our data provide strong evidence for functional similarities of Type 1 CRYs across insect species and further support the proposal that FAD represents the ground state and not the excited state of the flavin cofactor in Type 1 CRYs.	[Sancar, Aziz] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Ozturk, Nuri; Song, Sang-Hun; Selby, Christopher P.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Bldg CB 72600, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Ozturk, Nuri/F-4140-2011	Ozturk, Nuri/0000-0001-5206-4127; Song, Sang-Hun/0000-0002-9609-3269	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031082, R01GM031082] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31082] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Froy O, 2002, CURR BIOL, V12, P147, DOI 10.1016/S0960-9822(01)00656-X; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Kao YT, 2007, CELL BIOCHEM BIOPHYS, V48, P32, DOI 10.1007/s12013-007-0034-5; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lin CT, 2003, ANNU REV PLANT BIOL, V54, P469, DOI 10.1146/annurev.arplant.54.110901.160901; Losi A, 2007, PHOTOCHEM PHOTOBIOL, V83, P1283, DOI 10.1111/j.1751-1097.2007.00196.x; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozgur S, 2006, BIOCHEMISTRY-US, V45, P13369, DOI 10.1021/bi061556n; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; PAYNE G, 1990, BIOCHEMISTRY-US, V29, P7715, DOI 10.1021/bi00485a021; RUPERT CS, 1962, J GEN PHYSIOL, V45, P725, DOI 10.1085/jgp.45.4.725; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Selby CP, 1999, PHOTOCHEM PHOTOBIOL, V69, P105, DOI 10.1562/0031-8655(1999)069<0105:ATMOTP>2.3.CO;2; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; ZHAO X, 2007, J BIOL CHEM, V272, P32580; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	33	101	103	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3256	3263		10.1074/jbc.M708612200	http://dx.doi.org/10.1074/jbc.M708612200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056988	hybrid			2022-12-27	WOS:000253083000029
J	Charles, RP; Guitard, M; Leyvraz, C; Breiden, B; Haftek, M; Haftek-Terreau, Z; Stehle, JC; Sandhoff, K; Hummler, E				Charles, Roch-Philippe; Guitard, Marjorie; Leyvraz, Celine; Breiden, Bernadette; Haftek, Marek; Haftek-Terreau, Zofia; Stehle, Jean-Christophe; Sandhoff, Konrad; Hummler, Edith			Postnatal requirement of the epithelial sodium channel for maintenance of epidermal barrier function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRATUM-CORNEUM CERAMIDES; TIGHT JUNCTION PROTEINS; LUNG LIQUID CLEARANCE; PERMEABILITY BARRIER; BETA-GLUCOCEREBROSIDASE; NEONATAL DEATH; DEFICIENT MICE; OMEGA-HYDROXYCERAMIDES; TARGETED DISRUPTION; PHOSPHOLIPASE A(2)	In skin, the physiological consequence of an epithelial sodium channel (ENaC) deficiency is not obvious directly at birth. Nevertheless, within hours after birth, mice deficient for the alpha-subunit of the highly amiloride-sensitive epithelial sodium channel (alpha ENaC/Scnn1a) suffer from a significant increased dehydration. This is characterized by a loss of body weight (by 6% in 6 h) and an increased transepidermal water loss, which is accompanied by a higher skin surface pH in 1-day-old pups. Although early and late differentiation markers, as well as tight junction protein distribution and function, seem unaffected, deficiency of alpha ENaC severely disturbs the stratum corneum lipid composition with decreased ceramide and cholesterol levels, and increased pro-barrier lipids, whereas covalently bound lipids are drastically reduced. Ultrastructural analysis revealed morphological changes in the formation of intercellular lamellar lipids and the lamellar body secretion. Extracellular formation of the lamellar lipids proved to be abnormal in the knockouts. In conclusion, ENaC deficiency results in progressive dehydration and, consequently, weight loss due to severe impairment of lipid formation and secretion. Our data demonstrate that ENaC expression is required for the postnatal maintenance of the epidermal barrier function but not for its generation.	[Charles, Roch-Philippe; Guitard, Marjorie; Leyvraz, Celine; Hummler, Edith] Univ Lausanne, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Stehle, Jean-Christophe] Univ Lausanne, Dept Pathol, CH-1005 Lausanne, Switzerland; [Breiden, Bernadette; Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, Membrane Biol & Lipid Biochem Unit, D-53121 Bonn, Germany; [Haftek, Marek; Haftek-Terreau, Zofia] Ecole Normale Super Lyon, IFR128, Lab Joliot Curie, F-69000 Lyon, France	University of Lausanne; University of Lausanne; University of Bonn; Ecole Normale Superieure de Lyon (ENS de LYON)	Hummler, E (corresponding author), Univ Lausanne, Dept Pharmacol & Toxicol, Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Edith.Hummler@unil.ch	Breiden, Bernadette/S-3005-2019; HAFTEK-TERREAU, Zofia/F-5127-2018; Breiden, Bernadette/F-2422-2014	Breiden, Bernadette/0000-0002-4838-4109; HAFTEK-TERREAU, Zofia/0000-0002-4028-3362; Breiden, Bernadette/0000-0002-4838-4109; Charles, Roch-Philippe/0000-0002-5243-3866				ASZTERBAUM M, 1992, PEDIATR RES, V31, P308, DOI 10.1203/00006450-199204000-00002; ASZTERBAUM M, 1993, J CLIN INVEST, V91, P2703, DOI 10.1172/JCI116509; Barker PM, 1998, J CLIN INVEST, V102, P1634, DOI 10.1172/JCI3971; Behne MJ, 2003, J INVEST DERMATOL, V120, P998, DOI 10.1046/j.1523-1747.2003.12262.x; Behne MJ, 2002, J BIOL CHEM, V277, P47399, DOI 10.1074/jbc.M204759200; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; Brandner JM, 2006, SKIN PHARMACOL PHYS, V19, P71, DOI 10.1159/000091973; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brouard M, 1999, J CELL SCI, V112, P3343; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Chifflet S, 2005, AM J PHYSIOL-CELL PH, V288, pC1420, DOI 10.1152/ajpcell.00259.2004; Choi MJ, 2005, AM J CLIN DERMATOL, V6, P215, DOI 10.2165/00128071-200506040-00002; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Doering T, 1999, FEBS LETT, V447, P167, DOI 10.1016/S0014-5793(99)00274-4; Doering T, 2002, J LIPID RES, V43, P1727, DOI 10.1194/jlr.M200208-JLR200; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Fluhr JW, 2004, J INVEST DERMATOL, V122, P320, DOI 10.1046/j.0022-202X.2003.00204.x; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Guitard M, 2004, NEWS PHYSIOL SCI, V19, P75, DOI 10.1152/nips.01503.2003; Haftek M, 1998, MICROSC RES TECHNIQ, V43, P242, DOI 10.1002/(SICI)1097-0029(19981101)43:3<242::AID-JEMT6>3.0.CO;2-G; Hamanaka S, 2002, J INVEST DERMATOL, V119, P416, DOI 10.1046/j.1523-1747.2002.01836.x; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; HOLLERAN WM, 1992, J LIPID RES, V33, P1201; HOLLERAN WM, 1994, J LIPID RES, V35, P905; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hummler E, 2005, J AM SOC NEPHROL, V16, P3160, DOI 10.1681/ASN.2005040450; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hummler E, 1996, KIDNEY BLOOD PRESS R, V19, P160, DOI 10.1159/000174065; Hummler E, 1997, P NATL ACAD SCI USA, V94, P11710, DOI 10.1073/pnas.94.21.11710; Indra AK, 2005, DEVELOPMENT, V132, P4533, DOI 10.1242/dev.02019; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Krien PM, 2000, J INVEST DERMATOL, V115, P414, DOI 10.1046/j.1523-1747.2000.00083.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Li WM, 2007, INT J BIOL SCI, V3, P120; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Macheleidt O, 2002, J INVEST DERMATOL, V119, P166, DOI 10.1046/j.1523-1747.2002.01833.x; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mauro T, 2002, J INVEST DERMATOL, V118, P589, DOI 10.1046/j.1523-1747.2002.01721.x; MAURO T, 1995, J INVEST DERMATOL, V105, P203, DOI 10.1111/1523-1747.ep12317130; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; NAVARRO JM, 1995, J BIOL CHEM, V270, P21362, DOI 10.1074/jbc.270.36.21362; Nemes Z, 1999, P NATL ACAD SCI USA, V96, P8402, DOI 10.1073/pnas.96.15.8402; Oda Y, 1999, J INVEST DERMATOL, V113, P796, DOI 10.1046/j.1523-1747.1999.00742.x; Park BD, 2003, J INVEST DERMATOL, V121, P794, DOI 10.1046/j.1523-1747.2003.12470.x; PRadervand S, 1999, P NATL ACAD SCI USA, V96, P1732, DOI 10.1073/pnas.96.4.1732; PUOTI A, 1995, AM J PHYSIOL-CELL PH, V269, pC188, DOI 10.1152/ajpcell.1995.269.1.C188; Reichelt J, 2004, EUR J CELL BIOL, V83, P747, DOI 10.1078/0171-9335-00429; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Schadow A, 2001, J INVEST DERMATOL, V116, P31, DOI 10.1046/j.1523-1747.2001.00179.x; Schluter H, 2007, EUR J CELL BIOL, V86, P645, DOI 10.1016/j.ejcb.2007.01.001; Segre JA, 2006, J CLIN INVEST, V116, P1150, DOI 10.1172/JCI28521; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Uchida Y, 2000, J LIPID RES, V41, P2071; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Yosipovitch G, 2000, PEDIATRICS, V106, P105, DOI 10.1542/peds.106.1.105; Zettersten E, 1998, J INVEST DERMATOL, V111, P784, DOI 10.1046/j.1523-1747.1998.00386.x	63	30	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2622	2630		10.1074/jbc.M708829200	http://dx.doi.org/10.1074/jbc.M708829200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18039670	hybrid			2022-12-27	WOS:000252622300019
J	Goraczniak, R; Gunderson, SI				Goraczniak, Rafal; Gunderson, Samuel I.			The regulatory element in the 3 '-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-31; LATE MESSENGER-RNA; U1 SNRNP; POLY(A) POLYMERASE; EPITHELIAL-CELLS; CERVICAL-CANCER; TERMINAL EXONS; DIFFERENTIATION; SEQUENCES; COMPLEX	The 3 '-untranslated regions (UTRs) of human papillomavirus 16 (HPV16) and bovine papillomavirus 1 (BPV1) contain a negative regulatory element (NRE) that inhibits viral late gene expression. The BPV1 NRE consists of a single 9-nucleotide (nt) U1 small nuclear ribonucleoprotein (snRNP) base pairing site (herein called a U1 binding site) that via U1 snRNP binding leads to inhibition of the late poly(A) site. The 79-nt HPV16 NRE is far more complicated, consisting of 4 overlapping very weak U1 binding sites followed by a poorly understood GU-rich element (GRE). We undertook a molecular dissection of the HPV16 GRE and identify via UV cross-linking, RNA affinity chromatography, and mass spectrometry that is bound by the CUG-binding protein 1 (CUGBP1). Reporter assays coupled with knocking down CUGBP1 levels by small interfering RNA and Dox-regulated shRNA, demonstrate CUGBP1 is inhibitory in vivo. CUGBP1 is the first GRE-binding protein to have RNA interfering knockdown evidence in support of its role in vivo. Several fine-scale GRE mutations that inactivate GRE activity in vivo and GRE binding to CUGBP1 in vitro are identified. The CUGBP1 . GRE complex has no activity on its own but specifically synergizes with weak U1 binding sites to inhibit expression in vivo. No synergy is seen if the U1 binding sites are made weaker by a 1-nt down-mutation or made stronger by a 1-nt up-mutation, underscoring that the GRE operates only on weak sites. Interestingly, inhibition occurs at multiple levels, in particular at the level of poly(A) site activity, nuclear-cytoplasmic export, and translation of the mRNA. Implications for understanding the HPV16 life cycle are discussed.	[Goraczniak, Rafal; Gunderson, Samuel I.] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Gunderson, SI (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	gunderson@biology.rutgers.edu			NATIONAL CANCER INSTITUTE [R21CA119934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057286] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA119934] Funding Source: Medline; NIGMS NIH HHS [R01 GM057286] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER CC, 1990, PAPILLOMAVIRUSES HUM, P91; BARKSDALE SK, 1993, J VIROL, V67, P5605, DOI 10.1128/JVI.67.9.5605-5616.1993; Beckley SA, 2001, MOL CELL BIOL, V21, P2815, DOI 10.1128/MCB.21.8.2815-2825.2001; Bodily JM, 2005, J VIROL, V79, P3309, DOI 10.1128/JVI.79.6.3309-3321.2005; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CHAN SY, 1995, J VIROL, V69, P3074, DOI 10.1128/JVI.69.5.3074-3083.1995; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Cumming SA, 2003, J VIROL, V77, P5167, DOI 10.1128/JVI.77.9.5167-5177.2003; Cumming SA, 2002, J VIROL, V76, P5993, DOI 10.1128/JVI.76.12.5993-6003.2002; DietrichGoetz W, 1997, P NATL ACAD SCI USA, V94, P163, DOI 10.1073/pnas.94.1.163; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; FURTH PA, 1994, MOL CELL BIOL, V14, P5278, DOI 10.1128/MCB.14.8.5278; FURTH PA, 1991, J VIROL, V65, P5806, DOI 10.1128/JVI.65.11.5806-5812.1991; Grassmann K, 1996, VIROLOGY, V223, P185, DOI 10.1006/viro.1996.0467; GUAN F, 2007, IN PRESS RNA; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761; Howley M. P., 1996, FIELDS VIROLOGY, P2045; KAO PN, 1994, J BIOL CHEM, V269, P20691; KENNEDY IM, 1990, J VIROL, V64, P1825, DOI 10.1128/JVI.64.4.1825-1829.1990; Koffa MD, 2000, P NATL ACAD SCI USA, V97, P4677, DOI 10.1073/pnas.070049097; Longworth MS, 2004, J VIROL, V78, P3533, DOI 10.1128/JVI.78.7.3533-3541.2004; Marquis J, 2006, BIOCHEM J, V400, P291, DOI 10.1042/BJ20060490; McPhillips MG, 2004, J VIROL, V78, P10598, DOI 10.1128/JVI.78.19.10598-10605.2004; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Sokolowski M, 1998, J VIROL, V72, P1504, DOI 10.1128/JVI.72.2.1504-1515.1998; STOLER MH, 1989, VIROLOGY, V172, P331, DOI 10.1016/0042-6822(89)90135-9; STUMP WT, 1995, RNA, V1, P55; Takahashi N, 2000, BIOCHEM BIOPH RES CO, V277, P518, DOI 10.1006/bbrc.2000.3694; TAN W, 1995, J VIROL, V69, P5607, DOI 10.1128/JVI.69.9.5607-5620.1995; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55; ZURHAUSEN H, 1987, PAPOVAVIRIDAE PAPILL, P245	41	28	29	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2286	2296		10.1074/jbc.M708789200	http://dx.doi.org/10.1074/jbc.M708789200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042543	hybrid			2022-12-27	WOS:000252501000056
J	Kuo, YC; Huang, KY; Yang, CH; Yang, YS; Lee, WY; Chiang, CW				Kuo, Yi-Chun; Huang, Kai-Yun; Yang, Chung-Hsiang; Yang, Yu-San; Lee, Wen-Yu; Chiang, Chi-Wu			Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55 alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; AKT/PROTEIN-KINASE-B; SMALL TUMOR-ANTIGEN; POSITIVE REGULATION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; GENE IEX-1; S6 KINASE; 2A PP2A; ACTIVATION	Akt is a protein serine/threonine kinase that is involved in the regulation of diverse cellular processes. Phosphorylation of Akt at regulatory residues Thr-308 and Ser-473 leads to its full activation. The protein phosphatase 2A ( PP2A) has long been known to negatively regulate Akt activity. The PP2A holoenzyme consists of the structural subunit ( A), catalytic subunit ( C), and a variable regulatory subunit ( B). Here we report the identification of the specific B regulatory subunit that targets the PP2A holoenzyme to Akt. We found endogenous association of PP2A AB55C holoenzymes with Akt by co-immunoprecipitation analyses in pro-lymphoid FL5.12 cells. Akt was shown to associate with ectopically expressed B55 alpha subunit in NIH3T3 cells. The direct interaction between B55 alpha subunit and Akt was confirmed using in vitro pulldown analyses. Intriguingly, we found that overexpression of B55 alpha subunit significantly impaired phosphorylation at Thr-308, but to a lesser extent at Ser-473 of Akt in both FL5.12 and NIH3T3 cells. Concomitantly, phosphorylation of a subset of Akt substrates, including FoxO3a, was substantially decreased by B55 alpha overexpression in these cells. Silencing of B55 alpha expression markedly increased phosphorylation at Thr-308 but not at Ser-473 in both FL5.12 cells and NIH3T3 cells. Consistently, PP2A AB55 alpha C holoenzymes preferentially dephosphorylated phospho-Thr-308 rather than phospho-Ser-473 in in vitro dephosphorylation assays. Furthermore, B55 alpha overexpression retarded proliferation of NIH3T3 cells, and knockdown of B55 alpha expression increased survival of FL5.12 cells upon interleukin-3 deprivation. Together, our data demonstrate that B55 alpha-dependent targeting of the PP2A holoenzyme to Akt selectively regulates Akt phosphorylation at Thr-308 to regulate cell proliferation and survival.	[Kuo, Yi-Chun; Huang, Kai-Yun; Yang, Chung-Hsiang; Yang, Yu-San; Lee, Wen-Yu; Chiang, Chi-Wu] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 701, Taiwan; [Chiang, Chi-Wu] Natl Cheng Kung Univ, Ctr Regulat & Signal Transduct Res, Tainan 701, Taiwan	National Cheng Kung University; National Cheng Kung University	Chiang, CW (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, 1 Univ Rd, Tainan 701, Taiwan.	chiangcw@mail.ncku.edu.tw						Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Borgatti P, 2003, J CELL PHYSIOL, V196, P79, DOI 10.1002/jcp.10279; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen D, 1999, MOL CELL BIOL, V19, P4684; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chiang CW, 2001, BLOOD, V97, P1289, DOI 10.1182/blood.V97.5.1289; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Coffer PJ, 1998, BIOCHEM J, V335, P1; Csortos C, 1996, J BIOL CHEM, V271, P2578, DOI 10.1074/jbc.271.5.2578; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fu DX, 2003, J BIOL CHEM, V278, P1487, DOI 10.1074/jbc.M210631200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; HEALY AM, 1991, MOL CELL BIOL, V11, P5767, DOI 10.1128/MCB.11.11.5767; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Heriche JK, 1997, SCIENCE, V276, P952, DOI 10.1126/science.276.5314.952; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ivaska J, 2002, MOL CELL BIOL, V22, P1352, DOI 10.1128/MCB.22.5.1352-1359.2002; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kray AE, 2005, J BIOL CHEM, V280, P35974, DOI 10.1074/jbc.M506093200; Lam EWF, 2006, BIOCHEM SOC T, V34, P722, DOI 10.1042/BST0340722; Lee T, 2003, J CELL PHYSIOL, V194, P349, DOI 10.1002/jcp.10211; Letourneux C, 2006, EMBO J, V25, P727, DOI 10.1038/sj.emboj.7600980; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MAYER RE, 1991, BIOCHEMISTRY-US, V30, P3589, DOI 10.1021/bi00229a001; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Resjo S, 2002, CELL SIGNAL, V14, P231, DOI 10.1016/S0898-6568(01)00238-8; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Scheid MP, 2002, MOL CELL BIOL, V22, P6247, DOI 10.1128/MCB.22.17.6247-6260.2002; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Strack S, 2002, J BIOL CHEM, V277, P41525, DOI 10.1074/jbc.M203767200; Tanabe O, 1996, FEBS LETT, V379, P107, DOI 10.1016/0014-5793(95)01500-0; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Van Kanegan MJ, 2005, J BIOL CHEM, V280, P36029, DOI 10.1074/jbc.M506986200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Westphal RS, 1999, J BIOL CHEM, V274, P687, DOI 10.1074/jbc.274.2.687; Westphal RS, 1998, SCIENCE, V280, P1258, DOI 10.1126/science.280.5367.1258; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yamada T, 2001, J BIOL CHEM, V276, P5339, DOI 10.1074/jbc.M005685200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yellaturu CR, 2002, J BIOL CHEM, V277, P40148, DOI 10.1074/jbc.M206376200; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345; ZOLNIEROWICZ S, 1994, BIOCHEMISTRY-US, V33, P11858, DOI 10.1021/bi00205a023; Zolnierowicz S, 2000, BIOCHEM PHARMACOL, V60, P1225, DOI 10.1016/S0006-2952(00)00424-X	72	277	283	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1882	1892		10.1074/jbc.M709585200	http://dx.doi.org/10.1074/jbc.M709585200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18042541	hybrid			2022-12-27	WOS:000252501000014
J	Liu, C; Mao, K; Zhang, M; Sun, ZG; Hong, WZ; Li, CY; Peng, B; Chang, ZY				Liu, Chong; Mao, Kai; Zhang, Meng; Sun, Zhaogang; Hong, Weizhe; Li, Chuanyou; Peng, Bo; Chang, Zengyi			The SH3-like domain switches its interaction partners to modulate the repression activity of mycobacterial iron-dependent transcription regulator in response to metal ion fluctuations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN REPRESSOR; OXIDATIVE-STRESS-RESPONSE; HOMOLOGY 3-LIKE DOMAIN; DNA-SEQUENCE ANALYSIS; CORYNEBACTERIUM-DIPHTHERIAE; CRYSTAL-STRUCTURE; CROSS-LINKING; DTXR HOMOLOG; TUBERCULOSIS HSP16.3; MOLECULAR-CLONING	Iron-dependent regulator (IdeR), a metal ion-activated pleiotropic transcription factor, plays a critical role in maintaining the intracellular iron homeostasis in Mycobacteria, which is important for the normal growth of the cells. This study was initially performed in an attempt to elucidate all potential interactions between the various domains of IdeR that occur in living mycobacterial cells. This led to a hitherto unidentified self-association for the SH3-like domain of IdeR. Further studies demonstrate that the SH3-like domain interacts with different partners in the dimeric forms of IdeR depending on the levels of metal ions in the environment: it undergoes inter-subunit self-association in the metal-free DNA-non-binding form, but interacts with the N-terminal domain in the metal-bound DNA-binding form in an intra-subunit manner to finely modulate the transcription repression activity of IdeR. Our more detailed mapping studies reveal that the SH3-like domain uses an overlapping surface to participate in these two interactions, which therefore occur in a mutually exclusive fashion. This novel mechanism would allow an effective and cooperative interconversion between the two functional forms of IdeR. Our data also demonstrate that a disturbance of the interactions involving the SH3-like domain impairs the transcription repression activity of IdeR and delays the growth of mycobacterial cells.	[Mao, Kai; Zhang, Meng; Chang, Zengyi] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Liu, Chong; Hong, Weizhe] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Zhaogang; Li, Chuanyou] Beijing TB & Thorat Tumor Res Inst, Dept Bacteriol & Immunol, Beijing 101149, Peoples R China; [Peng, Bo] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei Province, Peoples R China; [Chang, Zengyi] Peking Univ, Ctr Prot Sci, Beijing 100871, Peoples R China; [Chang, Zengyi] Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Beijing 100871, Peoples R China	Peking University; Tsinghua University; Huazhong University of Science & Technology; Peking University; Peking University	Chang, ZY (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	changzy@pku.edu.cn	Hong, Weizhe/AAD-7172-2020; Hong, Weizhe/E-3164-2010; Liu, Chong/J-4826-2014; Peng, Bo/A-7125-2017; Peng, Bo/AAU-3941-2021; Liu, Chong/G-3514-2011; Peng, Bo/W-5129-2019	Hong, Weizhe/0000-0003-1523-8575; Hong, Weizhe/0000-0003-1523-8575; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939; Peng, Bo/0000-0003-4183-5939				Abulimiti A, 2003, J MOL BIOL, V326, P1013, DOI 10.1016/S0022-2836(03)00018-4; Ainsa JA, 1996, GENE, V176, P23, DOI 10.1016/0378-1119(96)00202-8; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V2; Boland CA, 2000, FEMS MICROBIOL LETT, V191, P1, DOI 10.1111/j.1574-6968.2000.tb09310.x; Bonner JJ, 2000, J MOL BIOL, V302, P581, DOI 10.1006/jmbi.2000.4096; BOYD J, 1990, P NATL ACAD SCI USA, V87, P5968, DOI 10.1073/pnas.87.15.5968; Chen CSY, 2000, BIOCHEMISTRY-US, V39, P10397, DOI 10.1021/bi0009284; Chou CJ, 2004, J BIOL CHEM, V279, P53554, DOI 10.1074/jbc.M407385200; COHEN GB, 1995, CELL, V80, P237, DOI 10.1016/0092-8674(95)90406-9; Comeau SR, 2005, J STRUCT BIOL, V150, P233, DOI 10.1016/j.jsb.2005.03.006; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Dussurget O, 1999, J BACTERIOL, V181, P3402, DOI 10.1128/JB.181.11.3402-3408.1999; Dussurget O, 1996, MOL MICROBIOL, V22, P535, DOI 10.1046/j.1365-2958.1996.1461511.x; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Feese MD, 2001, J BIOL CHEM, V276, P5959, DOI 10.1074/jbc.M007531200; Feng YJ, 2006, PROTEIN SCI, V15, P1441, DOI 10.1110/ps.062175806; FISS EH, 1994, MOL MICROBIOL, V14, P557, DOI 10.1111/j.1365-2958.1994.tb02189.x; Fu XM, 2004, BIOCHEMISTRY-MOSCOW+, V69, P552, DOI 10.1023/B:BIRY.0000029854.86015.61; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Gu LX, 2002, J MOL BIOL, V319, P517, DOI 10.1016/S0022-2836(02)00311-X; GUNTERSEEBOTH K, 1995, GENE, V166, P117, DOI 10.1016/0378-1119(95)00628-7; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Kristensen O, 2006, EMBO J, V25, P785, DOI 10.1038/sj.emboj.7600982; LEE GF, 1995, P NATL ACAD SCI USA, V92, P5416, DOI 10.1073/pnas.92.12.5416; Love JF, 2004, P NATL ACAD SCI USA, V101, P2506, DOI 10.1073/pnas.0303794101; Love JF, 2003, J BACTERIOL, V185, P2251, DOI 10.1128/JB.185.7.2251-2258.2003; Love JF, 2002, J MICROBIOL METH, V51, P63, DOI 10.1016/S0167-7012(02)00058-1; Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; OGUIZA JA, 1995, J BACTERIOL, V177, P465, DOI 10.1128/jb.177.2.465-467.1995; Oram DM, 2005, FEMS MICROBIOL LETT, V243, P1, DOI 10.1016/j.femsle.2004.11.031; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Pohl E, 1999, J MOL BIOL, V285, P1145, DOI 10.1006/jmbi.1998.2339; Pohl E, 1999, J MOL BIOL, V292, P653, DOI 10.1006/jmbi.1999.3073; RABENSTEIN MD, 1995, P NATL ACAD SCI USA, V92, P8239, DOI 10.1073/pnas.92.18.8239; Rodriguez GM, 2003, MOL MICROBIOL, V47, P1485, DOI 10.1046/j.1365-2958.2003.03384.x; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHMITT MP, 1995, INFECT IMMUN, V63, P4284, DOI 10.1128/IAI.63.11.4284-4289.1995; Semavina M, 2006, BIOCHEMISTRY-US, V45, P12480, DOI 10.1021/bi060797s; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Spatafora G, 2001, MICROBIOL-SGM, V147, P1599, DOI 10.1099/00221287-147-6-1599; Spiering MM, 2003, P NATL ACAD SCI USA, V100, P3808, DOI 10.1073/pnas.0737977100; TAO X, 1995, P NATL ACAD SCI USA, V92, P6803, DOI 10.1073/pnas.92.15.6803; TAO X, 1993, P NATL ACAD SCI USA, V90, P8524, DOI 10.1073/pnas.90.18.8524; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Twigg PD, 2001, P NATL ACAD SCI USA, V98, P11259, DOI 10.1073/pnas.191354798; Wang G, 1999, P NATL ACAD SCI USA, V96, P6119, DOI 10.1073/pnas.96.11.6119; White A, 1998, NATURE, V394, P502, DOI 10.1038/28893; Wisedchaisri G, 2004, J MOL BIOL, V342, P1155, DOI 10.1016/j.jmb.2004.07.083; Wisedchaisri G, 2007, BIOCHEMISTRY-US, V46, P436, DOI 10.1021/bi0609826; Wu JH, 1996, P NATL ACAD SCI USA, V93, P10123, DOI 10.1073/pnas.93.19.10123; Wylie GP, 2005, BIOCHEMISTRY-US, V44, P40, DOI 10.1021/bi048035p	58	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2439	2453		10.1074/jbc.M706580200	http://dx.doi.org/10.1074/jbc.M706580200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18055464	hybrid			2022-12-27	WOS:000252501000070
J	Khan, MA; Miyoshi, H; Gallie, DR; Goss, DJ				Khan, Mateen A.; Miyoshi, Hiroshi; Gallie, Daniel R.; Goss, Dixie J.			Potyvirus genome-linked protein, VPg, directly affects wheat germ in vitro translation - Interactions with translation initiation factors eif4f and eifiso4f	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO ETCH VIRUS; CAP-INDEPENDENT TRANSLATION; TURNIP-MOSAIC-VIRUS; LONG-DISTANCE MOVEMENT; MESSENGER-RNA; ISOZYME FORM; ELONGATION-FACTORS; ESCHERICHIA-COLI; POTATO-VIRUS; 5' LEADER	Potyvirus genome linked protein, VPg, interacts with translation initiation factors eIF4E and eIFiso4E, but its role in protein synthesis has not been elucidated. We show that addition of VPg to wheat germ extract leads to enhancement of uncapped viral mRNA translation and inhibition of capped viral mRNA translation. This provides a significant competitive advantage to the uncapped viral mRNA. To understand the molecular basis of these effects, we have characterized the interaction of VPg with eIF4F, eIFiso4F, and a structured RNA derived from tobacco etch virus (TEV RNA). When VPg formed a complex with eIF4F, the affinity for TEV RNA increased more than 4-fold compared with eIF4F alone (19.4 and 79.0 nM, respectively). The binding affinity of eIF4F to TEV RNA correlates with translation efficiency. VPg enhanced eIFiso4F binding to TEV RNA 1.6-fold ( 178 nM compared with 108 nM). Kinetic studies of eIF4F and eIFiso4F with VPg show similar to 2.6-fold faster association for eIFiso4F center dot VPg as compared with eIF4F center dot VPg. The dissociation rate was similar to 2.9-fold slower for eIFiso4F than eIF4F with VPg. These data demonstrate that eIFiso4F can kinetically compete with eIF4F for VPg binding. The quantitative data presented here suggest a model where eIF4F center dot VPg interaction enhances cap-independent translation by increasing the affinity of eIF4F for TEV RNA. This is the first evidence of direct participation of VPg in translation initiation.	[Khan, Mateen A.; Goss, Dixie J.] CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA; [Khan, Mateen A.; Goss, Dixie J.] CUNY, Grad Ctr, New York, NY 10065 USA; [Miyoshi, Hiroshi] St Marianna Univ, Sch Med, Dept Microbiol, Kawasaki, Kanagawa 2168511, Japan; [Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Saint Marianna University; University of California System; University of California Riverside	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Khan, Mateen A./0000-0002-2300-4595; Miyoshi, Hiroshi/0000-0002-0489-9848	NCRR NIH HHS [RR 03037] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P5462; ALLEN ML, 1992, J BIOL CHEM, V267, P23232; ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; BROWNING KS, 1990, J BIOL CHEM, V265, P17967; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; CARRINGTON JC, 1993, J VIROL, V67, P6995, DOI 10.1128/JVI.67.12.6995-7000.1993; Cotton S, 2006, VIROLOGY, V351, P92, DOI 10.1016/j.virol.2006.03.019; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Firpo MA, 1996, J BIOL CHEM, V271, P4693; GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; HARRIS KS, 1994, J BIOL CHEM, V269, P27004; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Keller KE, 1998, MOL PLANT MICROBE IN, V11, P124, DOI 10.1094/MPMI.1998.11.2.124; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LAX S, 1985, P NATL ACAD SCI USA, V82, P330, DOI 10.1073/pnas.82.2.330; LAX SR, 1986, METHOD ENZYMOL, V118, P109; LAX SR, 1986, J BIOL CHEM, V261, P5632; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; METZ AM, 1992, NUCLEIC ACIDS RES, V20, P4096, DOI 10.1093/nar/20.15.4096; Miyoshi H, 2006, BIOCHIMIE, V88, P329, DOI 10.1016/j.biochi.2005.09.002; Murphy JF, 1996, VIROLOGY, V220, P535, DOI 10.1006/viro.1996.0344; Nicolas O, 1997, VIROLOGY, V237, P452, DOI 10.1006/viro.1997.8780; Niepel M, 1999, J VIROL, V73, P9080, DOI 10.1128/JVI.73.11.9080-9088.1999; OLSEN K, 1993, BIOCHEMISTRY-US, V32, P9686, DOI 10.1021/bi00088a021; Oruetxebarria I, 2001, VIRUS RES, V73, P103, DOI 10.1016/S0168-1702(00)00216-1; Rajamaki ML, 1999, MOL PLANT MICROBE IN, V12, P1074, DOI 10.1094/MPMI.1999.12.12.1074; Rajamaki ML, 2002, MOL PLANT MICROBE IN, V15, P138, DOI 10.1094/MPMI.2002.15.2.138; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; RIECHMANN JL, 1992, J GEN VIROL, V73, P1, DOI 10.1099/0022-1317-73-1-1; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Roudet-Tavert G, 2007, J GEN VIROL, V88, P1029, DOI 10.1099/vir.0.82501-0; Schaad MC, 1997, J VIROL, V71, P8624, DOI 10.1128/JVI.71.11.8624-8631.1997; Schaad MC, 1996, J VIROL, V70, P2556, DOI 10.1128/JVI.70.4.2556-2561.1996; Suehiro N, 2004, J GEN VIROL, V85, P2087, DOI 10.1099/vir.0.79825-0; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	48	77	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1340	1349		10.1074/jbc.M703356200	http://dx.doi.org/10.1074/jbc.M703356200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18045881	hybrid			2022-12-27	WOS:000252282700017
J	Wu, GS; Aoyama, C; Young, SG; Vance, DE				Wu, Gengshu; Aoyama, Chieko; Young, Stephen G.; Vance, Dennis E.			Early embryonic lethality caused by disruption of the gene for choline kinase alpha, the first enzyme in phosphatidylcholine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; LOW-DENSITY LIPOPROTEINS; TARGETED DELETION; FREE-CHOLESTEROL; LIVER; MICE; CTP; METABOLISM; PLASMA	Choline kinase alpha (CK-alpha) is one of two mammalian enzymes that catalyze the phosphorylation of choline to phosphocholine in the biosynthesis of the major membrane phospholipid, phosphatidylcholine. We created mice lacking CK-alpha with an embryonic stem cell line containing an insertional mutation in the gene for CK-alpha (Chka). Embryos homozygous for the mutant Chka allele were recovered at the blastocyst stage, but not at embryonic day 7.5, indicating that CK-alpha is crucial for the early development of mouse embryos. Heterozygous mutant mice (Chka(+/-)) appeared entirely normal in their embryonic development and gross anatomy, and they were fertile. Although choline kinase activity was decreased by similar to 30%, the amount of phosphatidylcholine in cells and the levels of other enzymes involved in phosphatidylcholine biosynthesis were unaffected. Phosphatidylcholine biosynthesis measured by choline incorporation into hepatocytes was also not compromised in Chka(+/-) mice. Enhanced levels of choline and attenuated levels of phosphocholine were observed in both the livers and testes of Chka(+/-) mice. Triacylglycerol and cholesterol ester were elevated similar to 2-fold in the livers, whereas neutral lipid profiles in plasma were similar in Chka(+/-) and wild-type (Chka(+/+)) mice. Thus, Chka is an essential gene for early embryonic development, but adult mice do not require full expression of the gene for normal levels of phosphatidylcholine.	[Wu, Gengshu; Aoyama, Chieko; Vance, Dennis E.] Univ Alberta, Canadian Inst Hlth Res Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	University of Alberta; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Vance, DE (corresponding author), HMRC 320, Edmonton, AB T6G 2S2, Canada.	dennis.vance@ualberta.ca		Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [P01 HL090553-03, U01 HL066621, R01 HL087228-04, R01 HL087228-03, R01 HL087228, P01 HL090553, U01 HL 66621, P01 HL090553-04] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066621, P01HL090553, R01HL087228] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Bhakoo KK, 1996, CANCER RES, V56, P4630; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Chung TW, 1997, J BIOL CHEM, V272, P3064, DOI 10.1074/jbc.272.5.3064; CUADRADO A, 1993, ONCOGENE, V8, P2959; de Molina AR, 2002, ONCOGENE, V21, P4317, DOI 10.1038/sj.onc.1205556; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Fisher MC, 2002, FASEB J, V16, P619, DOI 10.1096/fj.01-0564fje; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Henneberry AL, 2000, J BIOL CHEM, V275, P29808, DOI 10.1074/jbc.M005786200; ISHIDATE K, 1983, BIOCHEM BIOPH RES CO, V111, P683, DOI 10.1016/0006-291X(83)90360-1; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; LOHNINGER A, 1990, ANAL BIOCHEM, V186, P243, DOI 10.1016/0003-2697(90)90074-J; MACARA IG, 1989, MOL CELL BIOL, V9, P325, DOI 10.1128/MCB.9.1.325; MCCLUER RH, 1986, ADV CHROMATOGR, V25, P309; Michel V, 2006, EXP BIOL MED, V231, P490; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Noga AA, 2003, J LIPID RES, V44, P1998, DOI 10.1194/jlr.M300226-JLR200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; TEEGARDEN D, 1990, J BIOL CHEM, V265, P6042; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074/jbc.M605861200; Titarenko E, 1997, PLANT PHYSIOL, V115, P817, DOI 10.1104/pp.115.2.817; Vance D.E., 2002, BIOCH LIPIDS LIPOPRO, P205; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1997, P NATL ACAD SCI USA, V94, P12880, DOI 10.1073/pnas.94.24.12880; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; ZEISEL SH, 1981, BIOCHEM J, V198, P565, DOI 10.1042/bj1980565; ZEISEL SH, 1980, LIFE SCI, V26, P1827, DOI 10.1016/0024-3205(80)90585-8; Zeisel SH, 2000, NUTRITION, V16, P669, DOI 10.1016/S0899-9007(00)00349-X; Zeisel SH, 2005, AM J CLIN NUTR, V82, P719, DOI 10.1093/ajcn/82.4.719; Zeisel SH, 2000, J AM COLL NUTR, V19, p528S, DOI 10.1080/07315724.2000.10718976; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	45	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1456	1462		10.1074/jbc.M708766200	http://dx.doi.org/10.1074/jbc.M708766200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18029352	Green Accepted, hybrid			2022-12-27	WOS:000252282700029
J	Yao, HB; Ye, J				Yao, Hongbing; Ye, Jin			Long chain Acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-RNA REPLICATION; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMA HIGH-DENSITY; APOLIPOPROTEIN-B; SECRETION; HEPATOCYTES; TRIACYLGLYCEROL; BIOSYNTHESIS; LIVER; MICE	Hepatocytes play a crucial role in regulating lipid metabolism by exporting cholesterol and triglyceride into plasma through secretion of very low density lipoproteins (VLDL). VLDL production is also required for release of hepatitis C virus (HCV) from infected hepatocytes. Here, we show that long chain acyl-CoA synthetase 3 (ACSL3) plays a crucial role in secretion of VLDL and HCV from hepatocytes. In cultured human hepatoma Huh7 cells, ACSL3 is specifically required for incorporation of fatty acids into phosphatidylcholine. In cells receiving small interfering RNA targeting ACSL3, secretion of apolipoprotein B, the major protein component of VLDL, was inhibited and the lipoprotein was rapidly degraded. This inhibition in secretion was completely eliminated when these cells were treated with phosphatidylcholine. Treatment of cells with small interfering RNA targeting ACSL3 also inhibited secretion of HCV from Huh7-derived cells. These results identify ACSL3 as a new enzymatic target to limit VLDL secretion and HCV infection.	[Yao, Hongbing; Ye, Jin] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	jin.ye@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Avramoglu RK, 2004, REV ENDOCR METAB DIS, V5, P293, DOI 10.1023/B:REMD.0000045100.66675.92; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cai ZH, 2005, J VIROL, V79, P13963, DOI 10.1128/JVI.79.22.13963-13973.2005; Coleman RA, 2002, J NUTR, V132, P2123, DOI 10.1093/jn/132.8.2123; Coleman RA, 2000, ANNU REV NUTR, V20, P77, DOI 10.1146/annurev.nutr.20.1.77; DIXON JL, 1991, J BIOL CHEM, V266, P5080; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; EPAND RM, 1992, BIOCHEMISTRY-US, V31, P1550, DOI 10.1021/bi00120a036; ESKO JD, 1982, P NATL ACAD SCI-BIOL, V79, P1698, DOI 10.1073/pnas.79.6.1698; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Fujimoto Y, 2007, J LIPID RES, V48, P1280, DOI 10.1194/jlr.M700050-JLR200; Fujino T, 1996, J BIOL CHEM, V271, P16748, DOI 10.1074/jbc.271.28.16748; Gibbons GF, 2004, BIOCHEM SOC T, V32, P59, DOI 10.1042/BST0320059; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Li LO, 2006, J BIOL CHEM, V281, P37246, DOI 10.1074/jbc.M604427200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; TOMODA H, 1991, J BIOL CHEM, V266, P4214; VERKADE HJ, 1993, J BIOL CHEM, V268, P24990; YAO ZM, 1989, J BIOL CHEM, V264, P11373	32	80	87	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					849	854		10.1074/jbc.M706160200	http://dx.doi.org/10.1074/jbc.M706160200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003621	hybrid			2022-12-27	WOS:000252128100025
J	Dallagiovanna, B; Correa, A; Probst, CM; Holetz, F; Smircich, P; de Aguiar, AM; Mansur, F; da Silva, CV; Mortara, RA; Garat, B; Buck, GA; Goldenberg, S; Krieger, MA				Dallagiovanna, Bruno; Correa, Alejandro; Probst, Christian M.; Holetz, Fabiola; Smircich, Pablo; de Aguiar, Alessandra Melo; Mansur, Fernanda; da Silva, Claudio Vieira; Mortara, Renato A.; Garat, Beatriz; Buck, Gregory A.; Goldenberg, Samuel; Krieger, Marco A.			Functional genomic characterization of mRNAs associated with TcPUF6, a pumilio-like protein from Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEINS; FAMILY; NANOS; DIFFERENTIATION; RECOGNITION; RECRUITMENT; LEISHMANIA; EXPRESSION; DROSOPHILA; COMPLEXES	Trypanosoma cruzi is the protozoan parasite that causes Chagas disease or American trypanosomiasis. Kinetoplastid parasites could be considered as model organisms for studying factors involved in posttranscriptional regulation because they control gene expression almost exclusively at this level. The PUF(Pumilio/FBF1) protein family regulates mRNA stability and translation in eukaryotes, and several members have been identified in trypano-somatids. We used a ribonomic approach to identify the putative target mRNAs associated with TcPUF6, a member of the T. cruzi PUF family. TcPUF6 is expressed in discrete sites in the cytoplasm at various stages of the parasite life cycle and is not associated with the translation machinery. The overexpression of a tandem affinity purification-tagged TcPUF6 protein allowed the identification of associated mRNAs by affinity purification assays and microarray hybridization yielding nine putative target mRNAs. Whole expression analysis of transfected parasites showed that the mRNAs associated with TcPUF6 were down-regulated in populations overexpressing TcPUF6. The association of TcPUF6 with the TcDhh1 helicase in vivo and the cellular co-localization of these proteins in epimastigote forms suggest that TcPUF6 promotes degradation of its associated mRNAs through interaction with RNA degradation complexes. Analysis of the mRNA levels of the putative TcPUF6-regulated genes during the parasite life cycle showed that their transcripts were up-regulated in metacyclic trypomastigotes. In these infective forms no co-localization between TcPUF6 and TcDhh1 was observed. Our results suggest that TcPUF6 regulates the half-lives of its associated transcripts via differential association with mRNA degradation complexes throughout its life cycle.	[Dallagiovanna, Bruno; Correa, Alejandro; Probst, Christian M.; Holetz, Fabiola; de Aguiar, Alessandra Melo; Mansur, Fernanda; Goldenberg, Samuel; Krieger, Marco A.] Inst Biol Mol Parana, BR-81350010 Curitiba, Parana, Brazil; [Dallagiovanna, Bruno; Probst, Christian M.; de Aguiar, Alessandra Melo; Goldenberg, Samuel; Krieger, Marco A.] Fundacao Oswaldo Cruz, BR-21040900 Rio De Janeiro, Brazil; [Smircich, Pablo; Garat, Beatriz] Fac Ciencias, Lab Interacc Mol, Montevideo 11400, Uruguay; [da Silva, Claudio Vieira; Mortara, Renato A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23284 USA	Fundacao Oswaldo Cruz; Universidad de la Republica, Uruguay; Universidade Federal de Sao Paulo (UNIFESP); Virginia Commonwealth University	Krieger, MA (corresponding author), Rua Professor Algacyr Munhoz Mader 3775, BR-81350010 Curitiba, Parana, Brazil.	mkrieger@tecpar.br	Aguiar, Alessandra/B-4899-2010; P, CM/B-1358-2013; Probst, Christian/B-8678-2009; Holetz, Fabíola Barbieri/AAA-4831-2019; Goldenberg, Samuel/ABD-8908-2022; GOLDENBERG, SAMUEL/B-4116-2009; Krieger, Marco/AAE-8611-2020; Mortara, Renato A./C-1864-2012; da Silva, Claudio Vieira/AAK-1485-2021; Mansur, Fernanda C B/N-9283-2018; Dallagiovanna, Bruno/AAA-3603-2019; Publica, Inct Saude/J-9544-2013	Aguiar, Alessandra/0000-0002-6167-8478; Probst, Christian/0000-0001-9993-6375; GOLDENBERG, SAMUEL/0000-0002-4892-163X; Mortara, Renato A./0000-0002-2311-8349; da Silva, Claudio Vieira/0000-0002-5052-3139; Dallagiovanna, Bruno/0000-0001-6992-7048; Krieger, Marco Aurelio/0000-0003-0030-3952; Garat, Beatriz/0000-0003-2679-8244; Smircich, Pablo/0000-0002-3856-3920	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050196] Funding Source: NIH RePORTER; NIAID NIH HHS [5 R01 AI 050196-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Caro F, 2006, EXP PARASITOL, V113, P112, DOI 10.1016/j.exppara.2005.12.015; Cassola A, 2007, MOL MICROBIOL, V65, P655, DOI 10.1111/j.1365-2958.2007.05833.x; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Contreras VT, 2002, MEM I OSWALDO CRUZ, V97, P1213, DOI 10.1590/S0074-02762002000800025; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Dallagiovanna B, 2005, EXP PARASITOL, V109, P260, DOI 10.1016/j.exppara.2005.01.003; DESOUZA W, 2002, KINETOPLASTID BIOL D, V31, P1; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; HOEK M, 2001, MOL BIOCHEM PARASIT, V57, P706; Holetz FB, 2007, BIOCHEM BIOPH RES CO, V356, P1062, DOI 10.1016/j.bbrc.2007.03.104; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2001, P NATL ACAD SCI USA, V98, P7018, DOI 10.1073/pnas.111145598; KELLY JM, 1992, NUCLEIC ACIDS RES, V20, P3963, DOI 10.1093/nar/20.15.3963; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mishra KK, 2003, EUKARYOT CELL, V2, P1009, DOI 10.1128/EC.2.5.1009-1017.2003; Nardelli SC, 2007, EUKARYOT CELL, V6, P337, DOI 10.1128/EC.00279-06; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Teixeira SMR, 1998, BRAZ J MED BIOL RES, V31, P1503, DOI 10.1590/S0100-879X1998001200001; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; WHARTON RP, 2006, SCI STKE, pPE37, DOI DOI 10.1126/STKE.3542006PE37; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wreden C, 1997, DEVELOPMENT, V124, P3015	35	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8266	8273		10.1074/jbc.M703097200	http://dx.doi.org/10.1074/jbc.M703097200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18056709	Green Published, hybrid			2022-12-27	WOS:000254288000024
J	Zang, Y; Yu, LF; Pang, T; Fang, LP; Feng, X; Wen, TQ; Nan, FJ; Feng, LY; Li, J				Zang, Yi; Yu, Li-Fang; Pang, Tao; Fang, Lei-Ping; Feng, Xu; Wen, Tie-Qiao; Nan, Fa-Jun; Feng, Lin-Yin; Li, Jia			AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; IN-VIVO; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; ASTROCYTE DIFFERENTIATION; NEURONAL SURVIVAL; MOUSE-BRAIN; FATTY-ACID; PROGENITOR; ASTROGLIOGENESIS	Neural stem cell differentiation and the determination of lineage decision between neuronal and glial fates have important implications in the study of developmental, pathological, and regenerative processes. Although small molecule chemicals with the ability to control neural stem cell fate are considered extremely useful tools in this field, few were reported. AICAR is an adenosine analog and extensively used to activate AMP-activated protein kinase (AMPK), a metabolic "fuel gauge" of the biological system. In the present study, we found an unrecognized astrogliogenic activity of AICAR on not only immortalized neural stem cell line C17.2 (C17.2-NSC), but also primary neural stem cells (NSCs) derived from post-natal (P0) rat hippocampus (P0-NSC) and embryonic day 14 (E14) rat embryonic cortex (E14-NSC). However, another AMPK activator, Metformin, did not alter either the C17.2-NSC or E14-NSC undifferentiated state although both Metformin and AICAR can activate the AMPK pathway in NSC. Furthermore, overexpression of dominant-negative mutants of AMPK in C17.2-NSC was unable to block the gliogenic effects of AICAR. We also found AICAR could activate the Janus kinase (JAK) STAT3 pathway in both C17.2-NSC and E14-NSC but Metformin fails. JAK inhibitor I abolished the gliogenic effects of AICAR. Taken together, these results suggest that the astroglial differentiation effect of AICAR on neural stem cells was acting independently of AMPK and that the JAK-STAT3 pathway is essential for the gliogenic effect of AICAR.	[Zang, Yi; Yu, Li-Fang; Pang, Tao; Feng, Xu; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Fang, Lei-Ping; Feng, Lin-Yin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Neurol Pharmacol Dept, Shanghai 201203, Peoples R China; [Wen, Tie-Qiao] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Li, J (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	TUjli@mail.shcnc.ac.cnUT	Li, Jia/F-9116-2011; li, jia/GVT-7587-2022					Aberg MAI, 2001, MOL CELL NEUROSCI, V17, P426, DOI 10.1006/mcne.2000.0947; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Christopher M, 2006, AM J PHYSIOL-ENDOC M, V291, pE1131, DOI 10.1152/ajpendo.00518.2005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Favero CB, 2007, BRAIN RES, V1168, P1, DOI 10.1016/j.brainres.2007.06.087; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pencek RR, 2005, DIABETES, V54, P355, DOI 10.2337/diabetes.54.2.355; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Taylor RM, 1997, TRANSPL P, V29, P845, DOI 10.1016/S0041-1345(96)00163-7; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zimmermann H, 2006, PFLUG ARCH EUR J PHY, V452, P573, DOI 10.1007/s00424-006-0067-4	52	54	57	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6201	6208		10.1074/jbc.M708619200	http://dx.doi.org/10.1074/jbc.M708619200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18077446	hybrid			2022-12-27	WOS:000253779500027
J	Robling, AG; Niziolek, PJ; Baldridge, LA; Condon, KW; Allen, MR; Alam, I; Mantila, SM; Gluhak-Heinrich, J; Bellido, TM; Harris, SE; Turner, CH				Robling, Alexander G.; Niziolek, Paul J.; Baldridge, Lee A.; Condon, Keith W.; Allen, Matthew R.; Alam, Imranul; Mantila, Sara M.; Gluhak-Heinrich, Jelica; Bellido, Teresita M.; Harris, Stephen E.; Turner, Charles H.			Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAN-BUCHEM-DISEASE; AFFECTED INDIVIDUALS; PARATHYROID-HORMONE; OSTEOBLASTIC CELLS; ANABOLIC RESPONSE; MINERAL DENSITY; GENE-EXPRESSION; WNT CORECEPTOR; MESSENGER-RNA; FLUID SHEAR	Sclerostin, the protein product of the Sost gene, is a potent inhibitor of bone formation. Among bone cells, sclerostin is found nearly exclusively in the osteocytes, the cell type that historically has been implicated in sensing and initiating mechanical signaling. The recent discovery of the antagonistic effects of sclerostin on Lrp5 receptor signaling, a crucial mediator of skeletal mechanotransduction, provides a potential mechanism for the osteocytes to control mechanotransduction, by adjusting their sclerostin (Wnt inhibitory) signal output to modulate Wnt signaling in the effector cell population. We investigated the mechanoregulation of Sost and sclerostin under enhanced (ulnar loading) and reduced (hindlimb unloading) loading conditions. Sost transcripts and sclerostin protein levels were dramatically reduced by ulnar loading. Portions of the ulnar cortex receiving a greater strain stimulus were associated with a greater reduction in Sost staining intensity and sclerostin-positive osteocytes (revealed via in situ hybridization and immunohistochemistry, respectively) than were lower strain portions of the tissue. Hindlimb unloading yielded a significant increase in Sost expression in the tibia. Modulation of sclerostin levels appears to be a finely tuned mechanism by which osteocytes coordinate regional and local osteogenesis in response to increased mechanical stimulation, perhaps via releasing the local inhibition of Wnt/Lrp5 signaling.	[Robling, Alexander G.; Condon, Keith W.; Allen, Matthew R.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Robling, Alexander G.; Niziolek, Paul J.; Alam, Imranul; Mantila, Sara M.; Turner, Charles H.] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Baldridge, Lee A.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Periodont, San Antonio, TX 78229 USA; [Bellido, Teresita M.] Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA; [Turner, Charles H.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Gluhak-Heinrich, Jelica] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, San Antonio, TX 78229 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio	Robling, AG (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	arobling@iupui.edu	Allen, Matthew/A-8799-2015	Allen, Matthew/0000-0002-1174-9004	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237, P01AR046798, R01AR046530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR53237, AR46798, AR046530] Funding Source: Medline; NIDDK NIH HHS [DK076007] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Barou O, 1998, AM J PHYSIOL-ENDOC M, V274, pE108, DOI 10.1152/ajpendo.1998.274.1.E108; BEIGHTON P, 1976, ANN INTERN MED, V84, P393, DOI 10.7326/0003-4819-84-4-393; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bex F, 2003, J BONE MINER RES, V18, pS60; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; BROMMAGE R, 2006, 36 INT SUN VALL WORK, P8; Cheline AJ, 2002, BONE, V31, P570, DOI 10.1016/S8756-3282(02)00865-7; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; Cullen DM, 2004, J BONE MINER RES, V19, pS396; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gardner JC, 2005, J CLIN ENDOCR METAB, V90, P6392, DOI 10.1210/jc.2005-1235; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hofmeyr Louis M, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P393, DOI 10.1097/01.moo.0000134441.84110.9e; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Lane N, 2006, BULL HOSP JT DIS, V64, P67; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; MACHWATE M, 1993, AM J PHYSIOL, V264, pE790, DOI 10.1152/ajpendo.1993.264.5.E790; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sun N, 2003, J BONE MINER RES, V18, pS7; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Turner CH, 2005, J BONE MINER METAB, V23, P16, DOI 10.1007/BF03026318; Turner CH, 2003, EXERC SPORT SCI REV, V31, P45, DOI 10.1097/00003677-200301000-00009; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; ZHANG RW, 1995, J BONE MINER RES, V10, P415	55	922	960	2	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5866	5875		10.1074/jbc.M705092200	http://dx.doi.org/10.1074/jbc.M705092200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089564	hybrid			2022-12-27	WOS:000253426700065
J	Scheschonka, A; Findlow, S; Schemm, R; El Far, O; Caldwell, JH; Crump, MP; Holden-Dye, K; O'Connor, V; Betz, H; Werner, JM				Scheschonka, Astrid; Findlow, Stuart; Schemm, Rudolf; El Far, Oussama; Caldwell, John H.; Crump, Matthew P.; Holden-Dye, Kate; O'Connor, Vincent; Betz, Heinrich; Werner, Joern M.			Structural determinants of calmodulin binding to the intracellular c-terminal domain of the metabotropic glutamate receptor 7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; PROTEIN-KINASE-C; TARGET RECOGNITION; PKC PHOSPHORYLATION; BACKBONE DYNAMICS; CALCIUM; COMPLEX; INACTIVATION; SPECTROSCOPY; MODULATION	Calmodulin (CaM) binds in a Ca2+-dependent manner to the intracellular C-terminal domains of most group III metabotropic glutamate receptors (mGluRs). Here we combined mutational and biophysical approaches to define the structural basis of CaM binding to mGluR 7A. Ca2+/CaM was found to interact with mGluR 7A primarily via its C-lobe at a 1:1 CaM:C-tail stoichiometry. Pulldown experiments with mutant CaM and mGluR 7A C-tail constructs and high resolution NMR with peptides corresponding to the CaM binding region of mGluR 7A allowed us to define hydrophobic and ionic interactions required for Ca2+/CaM binding and identified a 1-8-14 CaM-binding motif. The Ca2+/CaM center dot mGluR 7A peptide complex displays a classical wraparound structure that closely resembles that formed by Ca2+/CaM upon binding to smooth muscle myosin light chain kinase. Our data provide insight into how Ca2+/CaM regulates group III mGluR signaling via competition with intracellular proteins for receptor-binding sites.	[Scheschonka, Astrid; Schemm, Rudolf; El Far, Oussama; Caldwell, John H.; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Findlow, Stuart; Crump, Matthew P.; Holden-Dye, Kate; O'Connor, Vincent; Werner, Joern M.] Univ South, Sch Biol Sci, Southampton S016 7PX, Hants, England	Max Planck Society	Betz, H (corresponding author), MPI Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpihfrankfurt.mpg.de; jmwe@soton.ac.uk	Werner, Joern/E-1148-2013; EL FAR, Oussama/P-9915-2019; Far, Oussama El/D-4225-2017	EL FAR, Oussama/0000-0002-7473-8345; Far, Oussama El/0000-0002-7473-8345; O'Connor, Vincent/0000-0003-3185-5709; Werner, Jorn/0000-0002-4712-1833; Crump, Matthew/0000-0002-7868-5818	MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; Cook AG, 2005, FEBS J, V272, P1511, DOI 10.1111/j.1742-4658.2005.04591.x; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; Dev KK, 2000, J NEUROSCI, V20, P7252; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Macek TA, 1998, J NEUROSCI, V18, P6138; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Perroy J, 2000, J NEUROSCI, V20, P7896; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rooney Luke M, 2004, Methods Mol Biol, V278, P123; SAIMI Y, 1994, FEBS LETT, V350, P155, DOI 10.1016/0014-5793(94)00782-9; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sorensen SD, 2002, MOL PHARMACOL, V61, P1303, DOI 10.1124/mol.61.6.1303; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	57	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5577	5588		10.1074/jbc.M709505200	http://dx.doi.org/10.1074/jbc.M709505200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089570	hybrid			2022-12-27	WOS:000253426700038
J	Snyder, M; Huang, XY; Zhang, JJL				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Identification of novel direct Stat3 target genes for control of growth and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MAMMARY EPITHELIAL-CELLS; FACTOR-KAPPA-B; TRANSCRIPTIONAL ACTIVATION; SIGNAL TRANSDUCERS; MYOGENIC DIFFERENTIATION; DNA-BINDING; PROTEINS; PATHWAY; ROLES	Signal transducer and activator of transcription 3 (Stat3) is a key regulator of gene expression in response to signaling of the glycoprotein 130 (gp130) family cytokines, including interleukin 6, oncostatin M, and leukemia inhibitory factor. Many efforts have been made to identify Stat3 target genes and to understand the mechanism of how Stat3 regulates gene expression. Using the microarray technique, hundreds of genes have been documented to be potential Stat3 target genes in different cell types. However, only a small fraction of these genes have been proven to be true direct Stat3 target genes. Here we report the identification of novel direct Stat3 target genes using a genome-wide screening procedure based on the chromatin immunoprecipitation method. These novel Stat3 target genes are involved in a diverse array of biological processes such as oncogenesis, cell growth, and differentiation. We show that Stat3 can act as both a repressor and activator on its direct target genes. We further show that most of the novel Stat3 direct target genes are dependent on Stat3 for their transcriptional regulation. In addition, using a physiological cell system, we demonstrate that Stat3 is required for the transcriptional regulation of two of the newly identified direct Stat3 target genes important for muscle differentiation.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University	Zhang, JJL (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	jjz2002@med.cornell.edu			NIA NIH HHS [AG023202] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023202] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Austin L, 2000, MUSCLE NERVE, V23, P1700, DOI 10.1002/1097-4598(200011)23:11<1700::AID-MUS5>3.0.CO;2-W; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu WF, 2005, J IMMUNOL, V175, P7419, DOI 10.4049/jimmunol.175.11.7419; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	44	84	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3791	3798		10.1074/jbc.M706976200	http://dx.doi.org/10.1074/jbc.M706976200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065416	hybrid			2022-12-27	WOS:000253083500013
J	Curaba, JL; Chen, XM				Curaba, Julien; Chen, Xuemei			Biochemical activities of Arabidopsis RNA-dependent RNA polymerase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-ACTING SIRNAS; DE-NOVO INITIATION; VIRAL-RNA; TOBACCO-LEAVES; TOMATO LEAVES; C-ELEGANS; POLYMERASE; GENE; REQUIRES; PROTEIN	In Arabidopsis, genetic evidence demonstrates that RNA-dependent RNA polymerase 6 (RDR6) plays a fundamental role in at least four RNA silencing pathways whose functions range from defense against transgenes or viruses to endogene regulation in development and in stress responses. Despite its critical role in RNA silencing, the biochemical activities of RDR6 have yet to be characterized. In this study, we transiently expressed Arabidopsis RDR6 in Nicotiana benthamiana and investigated the biochemical activities of immunopurified RDR6 in vitro. We showed that RDR6 possesses terminal nucleotidyltransferase activity as well as primer-independent RNA polymerase activity on single-stranded RNAs. We found that RDR6 cannot distinguish RNAs with or without a cap or poly( A) tail. We also demonstrated that RDR6 has strong polymerase activity on single-stranded DNA. All these activities require the conserved catalytic Asp(867) residue. Our findings have important implications on the processes involving RDR6 in vivo and provide new biochemical insights into the mechanisms of RNA silencing in Arabidopsis.	[Curaba, Julien; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu		Chen, Xuemei/0000-0002-5209-1157	NIGMS NIH HHS [R01 GM061146, R01 GM061146-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ASTIERMA.S, 1971, BIOCHIM BIOPHYS ACTA, V232, P484, DOI 10.1016/0005-2787(71)90602-2; ASTIERMANIFACIER S, 1978, CR ACAD SCI D NAT, V287, P1043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DUDA CT, 1979, VIROLOGY, V92, P180, DOI 10.1016/0042-6822(79)90223-X; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; HONDA A, 1986, J BIOL CHEM, V261, P5987; IKEGAMI M, 1979, J BIOL CHEM, V254, P149; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	48	83	92	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3059	3066		10.1074/jbc.M708983200	http://dx.doi.org/10.1074/jbc.M708983200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063577	Green Accepted, hybrid			2022-12-27	WOS:000253083000009
J	Abrahams, A; Mowla, S; Parker, MI; Goding, CR; Prince, S				Abrahams, Amaal; Mowla, Shaheen; Parker, M. Iqbal; Goding, Colin R.; Prince, Sharon			UV-mediated regulation of the anti-senescence factor Tbx2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-BOX GENES; NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTION FACTOR; DNA-BINDING; P38 KINASE; EXPRESSION; SENESCENCE; ACTIVATION; STRESS; SIGNAL	Several lines of evidence have implicated members of the developmentally important T-box gene family in cell cycle regulation and in cancer. Importantly, the highly related T-box factors Tbx2 and Tbx3 can suppress senescence through repressing the cyclin-dependent kinase inhibitors p19(ARF) and p21(WAF1/CIP1/SDII). Furthermore, Tbx2 is up-regulated in several cancers, including melanomas where it was shown to function as an anti-senescence factor, suggesting that this may be one of the mechanisms by which T-box proteins contribute to the oncogenic process. However, very little is known about whether Tbx2 is regulated by p21-mediated stress-induced senescence signaling pathways. In this study, using the MCF-7 breast cancer cell line known to overexpress Tbx2, we show that in response to stress induced by ultraviolet irradiation the Tbx2 protein is specifically phosphorylated by the p38 mitogen-activated protein kinase. Using site-directed mutagenesis and in vitro kinase assays, we have identified serine residues 336, 623, and 675 in the Tbx2 protein as the p38 target sites and show that these sites are phosphorylated in vivo. Importantly, we show by Western blotting, immunofluorescence, and reporter assays that this phosphorylation leads to increased Tbx2 protein levels, predominant nuclear localization of the protein, and an increase in the ability of Tbx2 to repress the p21(WAF1/CIP1/SDII) promoter. These results show for the first time that the ability of Tbx2 to repress the p21 gene is enhanced in response to a stress-induced senescence pathway, which leads to a better understanding of the regulation of the anti-senescence function of Tbx2.	[Mowla, Shaheen; Prince, Sharon] Univ Cape Town, Fac Hlth Sci, Div Cell Biol, ZA-7925 Cape Town, South Africa; [Abrahams, Amaal; Parker, M. Iqbal] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Goding, Colin R.] Marie Curie Res Inst, Signal & Dev Lab, Surrey RH8 OTL, England	University of Cape Town; University of Cape Town	Prince, S (corresponding author), Univ Cape Town, Fac Hlth Sci, Div Cell Biol, ZA-7925 Cape Town, South Africa.	sharon.prince@uct.ac.za	Prince, Sharon/AFU-4911-2022; Mowla, Shaheen/AAR-8297-2021	Prince, Sharon/0000-0002-6975-5255; Mowla, Shaheen/0000-0001-6802-0495; Goding, Colin/0000-0002-1614-3909	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGULNIK SI, 1995, GENOMICS, V25, P214, DOI 10.1016/0888-7543(95)80128-9; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bilican B, 2006, EXP CELL RES, V312, P2358, DOI 10.1016/j.yexcr.2006.03.033; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Brummelkamp TR, 2002, J BIOL CHEM, V277, P6567, DOI 10.1074/jbc.M110492200; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Carlson H, 2002, ONCOGENE, V21, P3827, DOI 10.1038/sj.onc.1205476; Carlson H, 2001, HUM MOL GENET, V10, P2403, DOI 10.1093/hmg/10.21.2403; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Cooper MP, 1999, MOL BIOL CELL, V10, P2119, DOI 10.1091/mbc.10.7.2119; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Haq R, 2002, CANCER RES, V62, P5076; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Ito A, 2005, CANCER LETT, V219, P105, DOI 10.1016/j.canlet.2004.07.051; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Keller D, 1999, BIOCHEM BIOPH RES CO, V261, P464, DOI 10.1006/bbrc.1999.1023; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lingbeek ME, 2002, J BIOL CHEM, V277, P26120, DOI 10.1074/jbc.M200403200; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; McDonald E, 1996, CANCER RES, V56, P2250; McKay BC, 1998, ONCOGENE, V17, P545, DOI 10.1038/sj.onc.1201963; Miyahara K, 2004, J NEUROBIOL, V58, P392, DOI 10.1002/neu.10299; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; PAN ZQ, 1995, J BIOL CHEM, V270, P22008, DOI 10.1074/jbc.270.37.22008; Papaioannou VE, 2001, INT REV CYTOL, V207, P1; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Renard CA, 2007, CANCER RES, V67, P901, DOI 10.1158/0008-5472.CAN-06-2344; Roninson IB, 2003, CANCER RES, V63, P2705; Sheikh MS, 1997, ONCOGENE, V14, P1875, DOI 10.1038/sj.onc.1201004; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sinclair CS, 2002, CANCER RES, V62, P3587; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wang JA, 1999, INT J RADIAT BIOL, V75, P301, DOI 10.1080/095530099140483; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	49	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2223	2230		10.1074/jbc.M705651200	http://dx.doi.org/10.1074/jbc.M705651200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025091	hybrid, Green Published			2022-12-27	WOS:000252501000050
J	Lee, MH; El-Shewy, HM; Luttrell, DK; Luttrell, LM				Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.			Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; NUCLEAR EXPORT SIGNAL; REGULATED KINASES; ERK1/2 ACTIVATION; EGF RECEPTOR; BETA-ARRESTIN-2; ENDOCYTOSIS; PATHWAYS; MAPK; PHOSPHORYLATION	Heptahelical G protein-coupled receptors employ several mechanisms to activate the ERK1/2 cascade and control gene transcription. Previous work with the angiotensin AT1a receptor has shown that G(q/11) activation leads to a rapid and transient rise in ERK1/2 activity, whereas beta-arrestin binding supports sustained ERK1/2 activation by scaffolding a Raf center dot MEK center dot ERK complex associated with the internalized receptor. In this study, we compared the role of the two beta-arrestin isoforms in AT1a receptor desensitization, ERK1/2 activation and transcription using selective RNA interference. In HEK293 cells, both the native AT1a receptor and a G protein-coupling deficient DRY/AAY mutant recruited beta-arrestin1 and beta-arrestin2 upon angiotensin binding and internalized with the receptor. In contrast, only beta-arrestin2 supported protein kinase C-independent ERK1/2 activation by both the AT1a and DRY/AAY receptors. Using focused gene expression filter arrays to screen for endogenous transcriptional responses, we found that silencing beta-arrestin1 or beta-arrestin2 individually did not alter the response pattern but that silencing both caused a marked increase in the number of transcripts that were significantly up-regulated in response to AT1a receptor activation. The DRY/AAY receptor failed to elicit any detectable transcriptional response despite its ability to stimulate beta-arrestin2- dependent ERK1/2 activation. These results indicate that the transcriptional response to AT1a receptor activation primarily reflects heterotrimeric G protein activation. Although beta-arrestin1 and beta-arrestin2 are functionally specialized with respect to supporting G protein-independent ERK1/2 activation, their common effect is to dampen the transcriptional response by promoting receptor desensitization.	[Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Med Univ S Carolina, Dept Mol Biol, Charleston, SC 29425 USA; [Lee, Mi-Hye; El-Shewy, Hesham M.; Luttrell, Deirdre K.; Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949	NIDDK NIH HHS [DK55524] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055524, R56DK055524] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Ali MS, 1997, J BIOL CHEM, V272, P23382, DOI 10.1074/jbc.272.37.23382; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Elorza A, 2000, MOL PHARMACOL, V57, P778, DOI 10.1124/mol.57.4.778; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Ge L, 2003, J BIOL CHEM, V278, P34418, DOI 10.1074/jbc.M300573200; Gesty-Palmer D, 2005, J BIOL CHEM, V280, P32157, DOI 10.1074/jbc.M507460200; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Heeneman S, 2000, J BIOL CHEM, V275, P15926, DOI 10.1074/jbc.M909616199; Jafri F, 2006, J BIOL CHEM, V281, P19346, DOI 10.1074/jbc.M512643200; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lin FT, 1999, J BIOL CHEM, V274, P15971, DOI 10.1074/jbc.274.23.15971; LINSEMAN DA, 1995, J BIOL CHEM, V270, P12563, DOI 10.1074/jbc.270.21.12563; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Marrero MB, 1998, AM J PHYSIOL-CELL PH, V275, pC1216, DOI 10.1152/ajpcell.1998.275.5.C1216; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Miller WE, 2001, J BIOL CHEM, V276, P27770, DOI 10.1074/jbc.M102264200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Stoffel RH, 1997, J MEMBRANE BIOL, V157, P1, DOI 10.1007/s002329900210; Terrillon S, 2004, EMBO J, V23, P3950, DOI 10.1038/sj.emboj.7600387; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	49	52	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2088	2097		10.1074/jbc.M706892200	http://dx.doi.org/10.1074/jbc.M706892200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006496	hybrid			2022-12-27	WOS:000252501000036
J	Maya-Monteiro, CM; Almeida, PE; D'Avila, H; Martins, AS; Rezende, AP; Castro-Faria-Neto, H; Bozza, PT				Maya-Monteiro, Clarissa M.; Almeida, Patricia E.; D'Avila, Heloisa; Martins, Aline S.; Rezende, Ana Paula; Castro-Faria-Neto, Hugo; Bozza, Patricia T.			Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROPLET-ASSOCIATED PROTEINS; DIFFERENTIATION-RELATED PROTEIN; FATTY-ACID OXIDATION; P70 S6 KINASE; ADIPOCYTE DIFFERENTIATION; SKELETAL-MUSCLE; GENE-EXPRESSION; MTOR; CELL; INSULIN	Leptin is an adipocyte-derived hormone/cytokine that links nutritional status with neuroendocrine and immune functions. Lipid bodies (lipid droplets) are emerging as dynamic organelles with roles in lipid metabolism and inflammation. Here we investigated the roles of leptin in signaling pathways involved in cytoplasmic lipid body biogenesis and leukotriene B-4 synthesis in macrophages. Our results demonstrated that leptin directly activated macrophages and induced the formation of adipose differentiation-related protein-enriched lipid bodies. Newly formed lipid bodies were sites of 5-lipoxygenase localization and correlated with an enhanced capacity of leukotriene B-4 production. We demonstrated that leptin-induced macrophage activation was dependent on phosphatidylinositol 3-kinase (PI3K) activity, since the lipid body formation was inhibited by LY294002 and was absent in the PI3K knock-out mice. Leptin induces phosphorylation of p70(S6K) and 4EBP1 key downstream signaling intermediates of the mammalian target of rapamycin (mTOR) pathway in a rapamycin-sensitive mechanism. The mTOR inhibitor, rapamycin, inhibited leptin-induced lipid body formation, both in vivo and in vitro. In addition, rapamycin inhibited leptin-induced adipose differentiation-related protein accumulation in macrophages and lipid body-dependent leukotriene synthesis, demonstrating a key role for mTOR in lipid body biogenesis and function. Our results establish PI3K/mTOR as an important signaling pathway for leptin-induced cytoplasmic lipid body biogenesis and adipose differentiation-related protein accumulation. Furthermore, we demonstrate a previously unrecognized link between intracellular (mTOR) and systemic (leptin) nutrient sensors in macrophage lipid metabolism. Leptin-induced increased formation of cytoplasmic lipid bodies and enhanced inflammatory mediator production in macrophages may have implications for obesity-related cardiovascular diseases.	[Maya-Monteiro, Clarissa M.; Almeida, Patricia E.; D'Avila, Heloisa; Martins, Aline S.; Rezende, Ana Paula; Castro-Faria-Neto, Hugo; Bozza, Patricia T.] Fundacao Oswaldo Cruz, Lab Imunofarmcol, Inst Oswaldo Cruz, BR-21045900 Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz	Maya-Monteiro, CM (corresponding author), Fundacao Oswaldo Cruz, Lab Imunofarmcol, Inst Oswaldo Cruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.	clarissa@ioc.fiocruz.br; pbozza@ioc.fiocruz.br	maya-monteiro, clarissa/A-9091-2010; Bozza, Patricia T./AAE-2933-2021; Bozza, Patricia T./AAM-4537-2021	Bozza, Patricia T./0000-0001-8349-9529; Almeida, Patricia Elaine de/0000-0002-9081-8601				Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003; Bendinelli P, 2005, BIOCHEM BIOPH RES CO, V332, P719, DOI 10.1016/j.bbrc.2005.05.009; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Bozza PT, 2007, PHARMACOL THERAPEUT, V113, P30, DOI 10.1016/j.pharmthera.2006.06.006; Bozza PT, 1997, J EXP MED, V186, P909, DOI 10.1084/jem.186.6.909; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; Davies JD, 2005, J BIOL CHEM, V280, P3911, DOI 10.1074/jbc.M410075200; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; DVORAK AM, 1993, INT ARCH ALLERGY IMM, V101, P136, DOI 10.1159/000236511; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kjerrulf M, 2006, INFLAMM RES, V55, P300, DOI 10.1007/s00011-006-0087-8; Kraiss LW, 2000, AM J PHYSIOL-HEART C, V278, pH1537, DOI 10.1152/ajpheart.2000.278.5.H1537; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Laakso M, 1999, DIABETES, V48, P937, DOI 10.2337/diabetes.48.5.937; Lam QLK, 2007, CELL MOL IMMUNOL, V4, P1; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lekmine F, 2004, EXP CELL RES, V295, P173, DOI 10.1016/j.yexcr.2003.12.021; Lekmine F, 2003, J BIOL CHEM, V278, P27772, DOI 10.1074/jbc.M301364200; Leyva F, 1998, EUR HEART J, V19, P1547, DOI 10.1053/euhj.1998.1045; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Li L, 2005, DIABETES, V54, P2227, DOI 10.2337/diabetes.54.7.2227; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Mahoney TS, 2001, P NATL ACAD SCI USA, V98, P10284, DOI 10.1073/pnas.181201398; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin-Romero C, 2001, CELL IMMUNOL, V212, P83, DOI 10.1006/cimm.2001.1851; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mishra R, 2004, AM J PHYSIOL-RENAL, V286, pF913, DOI 10.1152/ajprenal.00323.2003; Motomura W, 2006, BIOCHEM BIOPH RES CO, V340, P1111, DOI 10.1016/j.bbrc.2005.12.121; Nakata M, 1999, DIABETES, V48, P426, DOI 10.2337/diabetes.48.2.426; O'Rourke L, 2002, J BIOL CHEM, V277, P42557, DOI 10.1074/jbc.M202151200; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Reiter AK, 2005, AM J PHYSIOL-ENDOC M, V288, pE980, DOI 10.1152/ajpendo.00333.2004; Ren J, 2004, J ENDOCRINOL, V181, P1, DOI 10.1677/joe.0.1810001; Robenek H, 2005, J BIOL CHEM, V280, P26330, DOI 10.1074/jbc.M413312200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wang SM, 2003, HISTOCHEM CELL BIOL, V120, P285, DOI 10.1007/s00418-003-0575-7; Wang ZW, 2005, DIABETES, V54, P2328, DOI 10.2337/diabetes.54.8.2328; Weyrich AS, 2007, BLOOD, V109, P1975, DOI 10.1182/blood-2006-08-042192; Winters B, 2000, J APPL PHYSIOL, V89, P2382, DOI 10.1152/jappl.2000.89.6.2382; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yamagishi SI, 2001, J BIOL CHEM, V276, P25096, DOI 10.1074/jbc.M007383200; YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086; Yu WG, 1998, AM J PATHOL, V152, P759; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhao AZ, 2000, J BIOL CHEM, V275, P11348, DOI 10.1074/jbc.275.15.11348	71	97	102	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2203	2210		10.1074/jbc.M706706200	http://dx.doi.org/10.1074/jbc.M706706200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039669	hybrid, Green Published			2022-12-27	WOS:000252501000048
J	Miller, E; Fiete, D; Blake, NMJ; Beranek, M; Oates, EL; Mi, Y; Roseman, DS; Baenziger, JU				Miller, Erin; Fiete, Dorothy; Blake, Nicquet M. J.; Beranek, Mary; Oates, Edward L.; Mi, Yiling; Roseman, Daniel S.; Baenziger, Jacques U.			A necessary and sufficient determinant for protein-selective glycosylation in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE-TRANSFERASE; RENILLA-RENIFORMIS LUCIFERASE; HUMAN CHORIONIC-GONADOTROPIN; CELL-ADHESION MOLECULE; CIRCULATORY HALF-LIFE; BOVINE LUTROPIN; AMINO-ACIDS; MANNOSE PHOSPHORYLATION; GALNAC-TRANSFERASE	A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI(CA6) bearN-linked oligosaccharides that are modified with beta 1,4-linked N-acetylgalactosamine ( GalNAc). The selective addition of GalNAc to these glycoproteins requires that the beta 1,4-N-acetylgalactosaminyl-transferase (beta GT) recognize both the oligosaccharide acceptor and a peptide recognition determinant on the substrate glycoprotein. We report here that two recently cloned beta GTs, beta GT3 and beta GT4, that are able to transfer GalNAc to GlcNAc in beta 1,4-linkage display the necessary glycoprotein specificity in vivo. Both beta GTs transfer GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to those on transferrin ( Trf). A single peptide recognition determinant encoded in the carboxyl-terminal 19-amino acid sequence of bovine CA6 mediates transfer of GalNAc to each of its two N-linked oligosaccharides. The addition of this 19-amino acid sequence to the carboxyl terminus of Trf confers full acceptor activity onto Trf for both beta GT3 and beta GT4 in vivo. The complete 19-amino acid sequence is required for optimal GalNAc addition in vivo, indicating that the peptide sequence is both necessary and sufficient for recognition by beta GT3 and beta GT4.	[Miller, Erin; Fiete, Dorothy; Blake, Nicquet M. J.; Beranek, Mary; Oates, Edward L.; Mi, Yiling; Roseman, Daniel S.; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 4940 Parkview Pl St, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041738] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058474] Funding Source: Medline; NIDDK NIH HHS [R01-DK41738, R01 DK041738] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; BARNES WM, 2003, PCR PRIMER LAB MANUA; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CHOU PY, 1989, PREDICTION PROTEIN S, P549; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cuozzo JW, 1998, J BIOL CHEM, V273, P21067, DOI 10.1074/jbc.273.33.21067; DELL A, 1995, J BIOL CHEM, V270, P24116, DOI 10.1074/jbc.270.41.24116; DHARMESH SM, 1993, J BIOL CHEM, V268, P17096; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1985, J BIOL CHEM, V260, P5623; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hooper LV, 1996, FASEB J, V10, P1137, DOI 10.1096/fasebj.10.10.8751716; HOOPER LV, 1995, J BIOL CHEM, V270, P5985, DOI 10.1074/jbc.270.11.5985; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; KORNFELD S, 1990, BIOCHEM SOC T, V18, P367, DOI 10.1042/bst0180367; LAPTHORN AJ, 1994, NATURE, V369, P455, DOI 10.1038/369455a0; Liu JX, 1997, GENE, V203, P141, DOI 10.1016/S0378-1119(97)00505-2; Liu JX, 1999, GENE, V237, P153, DOI 10.1016/S0378-1119(99)00314-5; Lorenz WW, 1996, J BIOLUM CHEMILUM, V11, P31, DOI 10.1002/(SICI)1099-1271(199601)11:1<31::AID-BIO398>3.0.CO;2-M; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Manzella SM, 1996, J BIOL CHEM, V271, P12117, DOI 10.1074/jbc.271.21.12117; Manzella SM, 1997, J BIOL CHEM, V272, P4775, DOI 10.1074/jbc.272.8.4775; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; Nishikawa A, 1999, J BIOL CHEM, V274, P19309, DOI 10.1074/jbc.274.27.19309; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; SKELTON TP, 1992, J BIOL CHEM, V267, P12998; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1992, J BIOL CHEM, V267, P19140; SMITH PL, 1990, J BIOL CHEM, V265, P874; SMITH PL, 1992, P NATL ACAD SCI USA, V89, P329, DOI 10.1073/pnas.89.1.329; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; WOODWORTH A, 2001, GLYCOBIOLOGY, V11; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X	51	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1985	1991		10.1074/jbc.M708160200	http://dx.doi.org/10.1074/jbc.M708160200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048353	hybrid			2022-12-27	WOS:000252501000025
J	Carra, S; Seguin, SJ; Lambert, H; Landry, J				Carra, Serena; Seguin, Samuel J.; Lambert, Herman; Landry, Jacques			HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ALPHA-B-CRYSTALLIN; MOLECULAR CHAPERONES; MUTANT HUNTINGTIN; UBIQUITIN LIGASE; AUTOPHAGY; POLYGLUTAMINE; DEGRADATION; SUPPRESSION; TOXICITY	Mutations in HspB8, a member of the B group of heat shock proteins (Hsp), have been associated with human neuromuscular disorders. However, the exact function of HspB8 is not yet clear. We previously demonstrated that overexpression of HspB8 in cultured cells prevents the accumulation of aggregation-prone proteins such as the polyglutamine protein Htt43Q. Here we report that HspB8 forms a stable complex with Bag3 in cells and that the formation of this complex is essential for the activity of HspB8. Bag3 overexpression resulted in the accelerated degradation of Htt43Q, whereas Bag3 knockdown prevented HspB8-induced Htt43Q degradation. Additionally, depleting Bag3 caused a reduction in the endogenous levels of LC3-II, a key molecule involved in macroautophagy, whereas overexpressing Bag3 or HspB8 stimulated the formation LC3-II. These results suggested that the HspB8-Bag3 complex might stimulate the degradation of Htt43Q by macroautophagy. This was confirmed by the observation that treatments with macroautophagy inhibitors significantly decreased HspB8- and Bag3-induced degradation of Htt43Q. We conclude that the HspB8 activity is intrinsically dependent on Bag3, a protein that may facilitate the disposal of doomed proteins by stimulating macroautophagy.	[Landry, Jacques] Univ Laval, Ctr Rech Cancerol, Lhotel Dieu Quebec, Quebec City, PQ G1R 2J6, Canada; Univ Laval, Dept Med, Quebec City, PQ G1R 2J6, Canada	Laval University; Laval University	Landry, J (corresponding author), Univ Laval, Ctr Rech Cancerol, Lhotel Dieu Quebec, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	jacques.landry@med.ulaval.ca	Carra, Serena/O-2835-2015	Carra, Serena/0000-0003-0939-0140				Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Benndorf R, 2004, NAT GENET, V36, P547, DOI 10.1038/ng0604-547; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bonini NM, 2002, P NATL ACAD SCI USA, V99, P16407, DOI 10.1073/pnas.152330499; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Esser C, 2004, BBA-MOL CELL RES, V1695, P171, DOI 10.1016/j.bbamcr.2004.09.020; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Irobi J, 2004, NAT GENET, V36, P597, DOI 10.1038/ng1328; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lambert H, 1999, J BIOL CHEM, V274, P9378, DOI 10.1074/jbc.274.14.9378; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Wyttenbach A, 2000, P NATL ACAD SCI USA, V97, P2898, DOI 10.1073/pnas.97.6.2898; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zobel ATC, 2005, CELL STRESS CHAPERON, V10, P157, DOI 10.1379/CSC-102.1; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	50	258	262	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1437	1444		10.1074/jbc.M706304200	http://dx.doi.org/10.1074/jbc.M706304200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006506	hybrid			2022-12-27	WOS:000252282700027
J	Fisher, LA; Bessho, M; Bessho, T				Fisher, Laura A.; Bessho, Mika; Bessho, Tadayoshi			Processing of a psoralen DNA interstrand cross-link by XPF-ERCC1 complex in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; HOMOLOGOUS RECOMBINATIONAL REPAIR; DOUBLE-STRAND BREAKS; ENDONUCLEASE ERCC1-XPF; MOLECULAR-MECHANISMS; CELLULAR-RESPONSES; MAMMALIAN-CELLS; FANCONI-ANEMIA; REPLICATION; NUCLEASE	The processing of stalled forks caused by DNA interstrand cross-links (ICLs) has been proposed to be an important step in initiating mammalian ICL repair. To investigate a role of the XPF-ERCC1 complex in this process, we designed a model substrate DNA with a single psoralen ICL at a three-way junction (Y-shaped DNA), which mimics a stalled fork structure. We found that the XPF-ERCC1 complex makes an incision 5' to a psoralen lesion on Y-shaped DNA in a damage-dependent manner. Furthermore, the XPF-ERCC1 complex generates an ICL-specific incision on the 3'-side of an ICL. The ICL-specific 3'-incision, along with the 5'-incision, on the cross-linked Y-shaped DNA resulted in the separation of the two cross-linked strands (the unhooking of the ICL) and the induction of a double strand break near the cross-linked site. These results implicate the XPF-ERCC1 complex in initiating ICL repair by unhooking the ICL, which simultaneously induces a double strand break at a stalled fork.	[Fisher, Laura A.; Bessho, Mika; Bessho, Tadayoshi] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Bessho, T (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 986805 Nebraska Med Ctr, Omaha, NE 68198 USA.	tbessho@unmc.edu			NATIONAL CANCER INSTITUTE [R01CA095291, T32CA009476] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 95291, T32 CA 09476] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adair GR, 2000, EMBO J, V19, P5552, DOI 10.1093/emboj/19.20.5552; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Bessho T, 1997, MOL CELL BIOL, V17, P6822, DOI 10.1128/MCB.17.12.6822; Chen XB, 2001, MOL CELL, V8, P1117, DOI 10.1016/S1097-2765(01)00375-6; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Cipak L, 2006, NAT STRUCT MOL BIOL, V13, P729, DOI 10.1038/nsmb1120; de Laat WL, 1998, J BIOL CHEM, V273, P7835, DOI 10.1074/jbc.273.14.7835; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Guzder SN, 2004, GENE DEV, V18, P2283, DOI 10.1101/gad.1232804; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Kuraoka I, 2000, J BIOL CHEM, V275, P26632, DOI 10.1074/jbc.C000337200; McPherson JP, 2004, SCIENCE, V304, P1822, DOI 10.1126/science.1094557; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedernhofer LJ, 2001, EMBO J, V20, P6540, DOI 10.1093/emboj/20.22.6540; Noll DM, 2006, CHEM REV, V106, P277, DOI 10.1021/cr040478b; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Thompson LH, 1996, MUTAT RES-DNA REPAIR, V363, P77, DOI 10.1016/0921-8777(96)00008-0; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	30	54	57	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1275	1281		10.1074/jbc.M708072200	http://dx.doi.org/10.1074/jbc.M708072200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18006494	hybrid			2022-12-27	WOS:000252282700010
J	Oltmann-Norden, I; Galuska, SP; Hildebrandt, H; Geyer, R; Gerardy-Schahn, R; Geyer, H; Muhlenhoff, M				Oltmann-Norden, Imke; Galuska, Sebastian P.; Hildebrandt, Herbert; Geyer, Rudolf; Gerardy-Schahn, Rita; Geyer, Hildegard; Muehlenhoff, Martina			Impact of the polysialyltransferases ST8Siall and ST8SiaIV on polysialic acid synthesis during postnatal mouse brain development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULE; MICE DEFICIENT; EMBRYONIC FORM; MESSENGER-RNA; DENTATE GYRUS; PSA-NCAM; IN-VIVO; II STX; EXPRESSION; ADULT	Polysialic acid (polySia), a post-translational modification of the neural cell adhesion molecule (NCAM), is the key regulator of NCAM-mediated functions and crucial for normal brain development, postnatal growth, and survival. Two polysialyl-transferases, ST8SiaII and ST8SiaIV, mediate polySia biosynthesis. To dissect the impact of each enzyme during postnatal brain development, we monitored the developmental changes in NCAM polysialylation in wild-type, ST8SiaII-, and ST8SiaIV-deficient mice using whole brain lysates obtained at 10 time points from postnatal days 1 to 21 and from adult mice. In wildtype and ST8SiaIV- null brain, polySia biosynthesis kept pace with the rapid increase in brain weight until day 9, and nearly all NCAM was polysialylated. Thereafter, polySia dropped by similar to 70% within 1 week, accompanied by the first occurrence of polySia-free NCAM-140 and NCAM-180. In ST8SiaII-null brain, polySia declined immediately after birth, leading to 60% less polySia at day 9 combined with the untimely appearance of polySia-free NCAM. Polysialyltransferase deficiency did not alter NCAM expression level or isoform pattern. In all three genotypes, NCAM-140 and NCAM- 180 were expressed at constant levels from days 1 to 21 and provided the major polySia acceptors. By contrast, NCAM- 120 first appeared at day 5, followed by a strong up- regulation inverse to the decrease in polySia. Together, we provide a comprehensive quantitative analysis of the developmental changes in polySia level, NCAM polysialylation status, and polysialyltransferase transcript levels and show that the predominant role of ST8SiaII during postnatal brain development is restricted to the first 15 days.	[Oltmann-Norden, Imke; Hildebrandt, Herbert; Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Galuska, Sebastian P.; Geyer, Rudolf; Geyer, Hildegard] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen	Muhlenhoff, M (corresponding author), Hannover Med Sch, Abt Zellulare Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	muehlenhoff.martina@mh-hannover.de	Hildebrandt, Herbert/A-7873-2010	Hildebrandt, Herbert/0000-0002-1044-0881				Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 2007, MOL CELL BIOL, V27, P6659, DOI 10.1128/MCB.00205-07; Arai M, 2006, BIOL PSYCHIAT, V59, P652, DOI 10.1016/j.biopsych.2005.08.016; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Becker CG, 1996, J NEUROSCI RES, V45, P143, DOI 10.1002/(SICI)1097-4547(19960715)45:2<143::AID-JNR6>3.0.CO;2-A; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; BENJAMINS JA, 1972, BASIC NEUROCHEMISTRY, P269; BHAT S, 1988, J NEUROCHEM, V50, P1830, DOI 10.1111/j.1471-4159.1988.tb02485.x; BHAT S, 1986, J NEUROSCI, V6, P3348; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; Durbec P, 2001, MOL NEUROBIOL, V24, P53; Eckhardt M, 2000, J NEUROSCI, V20, P5234, DOI 10.1523/JNEUROSCI.20-14-05234.2000; EDELMAN GM, 1982, P NATL ACAD SCI-BIOL, V79, P7036, DOI 10.1073/pnas.79.22.7036; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Gascon E, 2007, BRAIN RES REV, V56, P101, DOI 10.1016/j.brainresrev.2007.05.014; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; Hildebrandt H, 2007, J NEUROCHEM, V103, P56, DOI 10.1111/j.1471-4159.2007.04716.x; HIRN M, 1983, BRAIN RES, V265, P87, DOI 10.1016/0006-8993(83)91337-9; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Jakovcevski I, 2007, NEUROSCIENCE, V149, P328, DOI 10.1016/j.neuroscience.2007.07.044; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; Kurosawa N, 1997, J NEUROCHEM, V69, P494; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; MARGOLIS RK, 1983, BIOCHEM BIOPH RES CO, V116, P889, DOI 10.1016/S0006-291X(83)80225-3; Markram K, 2007, NEUROSCIENCE, V144, P788, DOI 10.1016/j.neuroscience.2006.10.024; Maziade M, 2005, MOL PSYCHIATR, V10, P486, DOI 10.1038/sj.mp.4001594; Mody M, 2001, P NATL ACAD SCI USA, V98, P8862, DOI 10.1073/pnas.141244998; Muhlenhoff M, 1996, CURR BIOL, V6, P1188, DOI 10.1016/S0960-9822(02)70687-8; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; OUMESMAR BN, 1995, EUR J NEUROSCI, V7, P480, DOI 10.1111/j.1460-9568.1995.tb00344.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Sato C, 1999, ANAL BIOCHEM, V266, P102, DOI 10.1006/abio.1998.2921; SEKI T, 1993, NEUROSCI RES, V17, P265, DOI 10.1016/0168-0102(93)90111-3; SEKI T, 1991, NEUROSCI RES, V12, P503, DOI 10.1016/S0168-0102(09)80003-5; Shen HM, 1997, J NEUROSCI, V17, P5221; Stoenica L, 2006, EUR J NEUROSCI, V23, P2255, DOI 10.1111/j.1460-9568.2006.04771.x; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Tao R, 2007, SCHIZOPHR RES, V90, P108, DOI 10.1016/j.schres.2006.09.029; Theodosis DT, 1999, J NEUROSCI, V19, P10228; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; TROTTER J, 1989, J NEUROSCI RES, V22, P369, DOI 10.1002/jnr.490220402; UZMAN LL, 1958, J NEUROCHEM, V3, P170, DOI 10.1111/j.1471-4159.1958.tb12624.x; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Wood GK, 1997, MOL BRAIN RES, V51, P69, DOI 10.1016/S0169-328X(97)00209-X; Yamamoto N, 2000, J NEUROSCI, V20, P9145; YANG PF, 1994, J BIOL CHEM, V269, P23039	64	82	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1463	1471		10.1074/jbc.M708463200	http://dx.doi.org/10.1074/jbc.M708463200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18045870	hybrid			2022-12-27	WOS:000252282700030
J	Le Saux, CJ; Teeters, K; Miyasato, SK; Hoffmann, PR; Bollt, O; Douet, V; Shohet, RV; Broide, DH; Tam, EK				Le Saux, Claude Jourdan; Teeters, Kelsa; Miyasato, Shelley K.; Hoffmann, Peter R.; Bollt, Oana; Douet, Vanessa; Shohet, Ralph V.; Broide, David H.; Tam, Elizabeth K.			Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; HUMAN LUNG FIBROBLASTS; NITRIC-OXIDE SYNTHASE; TGF-BETA; GENE-TRANSCRIPTION; SKIN FIBROBLASTS; MESSENGER-RNA; II RECEPTOR; MOUSE MODEL	Asthma can progress to subepithelial airway fibrosis, mediated in large part by transforming growth factor-beta(TGF-beta). The scaffolding protein caveolin-1 (cav1) can inhibit the activity of TGF-beta, perhaps by forming membrane invaginations that enfold TGF-beta receptors. The study goals were 1) to evaluate how allergen challenge affects lung expression of cav1 and the density of caveolae in vivo 2) to determine whether reduced cav1 expression is mediated by interleukin (IL)-4 and 3) to measure the effects of decreased expression of cav1 on TGF-beta signaling. C57BL/6J, IL-4-deficient mice, and cav1-deficient mice, sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) at days 0 and 12, received intranasal phosphate-buffered saline or OVA challenges at days 24, 26, and 28. Additionally, another group of C57BL/6J mice received IL-4 by intratracheal instillation for 7 days. We confirmed that the OVA-allergen challenge increased eosinophilia and T-helper type 2-related cytokine levels (IL-4, IL-5, and IL-13) in bronchoalveolar lavage. Allergen challenge reduced lung cav1 mRNA abundance by 40%, cav1 protein by 30%, and the number of lung fibroblast caveolae by 50%. Administration of IL-4 in vivo also substantially decreased cav1 expression. In contrast, the allergen challenge did not decrease cav1 expression in IL-4-deficient mice. The reduced expression of cav1 was associated with activation of TGF-beta signaling that was further enhanced in OVA-sensitized and challenged cav1-deficient mice. This study demonstrates a previously unknown modulation of TGF-beta signaling by IL-4, via cav1, suggesting novel therapeutic targets for controlling the effects of TGF-beta and thereby ameliorating pathological airway remodeling.	[Le Saux, Claude Jourdan; Teeters, Kelsa; Miyasato, Shelley K.; Hoffmann, Peter R.] Univ Hawaii, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Bollt, Oana; Shohet, Ralph V.; Tam, Elizabeth K.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96813 USA; [Broide, David H.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA	University of Hawaii System; University of Hawaii System; University of California System; University of California San Diego	Le Saux, CJ (corresponding author), 651 Ilalo St BSB 222, Honolulu, HI 96813 USA.	claude@pbrc.hawaii.edu	Le Saux, Claude/AGF-7659-2022	Le Saux, Claude/0000-0002-6041-2870; Broide, David/0000-0001-8405-9090	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453, G12RR003061, P20RR016467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UH1HL073449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R01AI072115, R37AI038425] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR016467, G12RR0003061, RR16453] Funding Source: Medline; NHLBI NIH HHS [HL073449] Funding Source: Medline; NIAID NIH HHS [R01 AI072115-03, U19 AI070535, R37 AI038425-14, R37 AI038425, U19 AI070535-040001, U19 AI070535-04, R01 AI072115, U19 AI070535-049001] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Bergeron C, 2003, CHEST, V123, p424S, DOI 10.1378/chest.123.3_suppl.424S; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Engelman JA, 1999, J BIOL CHEM, V274, P32333, DOI 10.1074/jbc.274.45.32333; Fielding CJ, 1999, BIOCHEMISTRY-US, V38, P2506, DOI 10.1021/bi981012o; Finkelman FD, 2005, J IMMUNOL, V174, P4630, DOI 10.4049/jimmunol.174.8.4630; FRANZEN P, 1993, CELL, V75, P681, DOI 10.1016/0092-8674(93)90489-D; Fujitsu Y, 2003, EXP EYE RES, V76, P107, DOI 10.1016/S0014-4835(02)00248-8; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Ikeda RK, 2003, AM J RESP CELL MOL, V28, P655, DOI 10.1165/rcmb.4853; Jakubzick C, 2004, AM J PATHOL, V164, P1989, DOI 10.1016/S0002-9440(10)63759-5; Jasmin JF, 2004, CARDIOVASC RES, V63, P747, DOI 10.1016/j.cardiores.2004.05.018; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kumar RK, 2002, CLIN EXP ALLERGY, V32, P1104, DOI 10.1046/j.1365-2222.2002.01420.x; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Leigh R, 2004, AM J RESP CRIT CARE, V169, P860, DOI 10.1164/rccm.200305-706OC; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; Llaverias G, 2004, J LIPID RES, V45, P2015, DOI 10.1194/jlr.M400049-JLR200; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Makhluf HA, 1996, J INVEST DERMATOL, V107, P856, DOI 10.1111/1523-1747.ep12331160; McMillan SJ, 2005, J IMMUNOL, V174, P5774, DOI 10.4049/jimmunol.174.9.5774; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Nakao A, 2002, J ALLERGY CLIN IMMUN, V110, P873, DOI 10.1067/mai.2002.129236; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ong PY, 1999, MED HYPOTHESES, V53, P19, DOI 10.1054/mehy.1997.0700; Perkins C, 2006, J ALLERGY CLIN IMMUN, V118, P410, DOI 10.1016/j.jaci.2006.06.004; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2001, EXP CELL RES, V271, P36, DOI 10.1006/excr.2001.5372; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; Sagara H, 2002, J ALLERGY CLIN IMMUN, V110, P249, DOI 10.1067/mai.2002.126078; Shaul PW, 1996, J BIOL CHEM, V271, P6518, DOI 10.1074/jbc.271.11.6518; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1997, CELL MOL BIOL, V43, P293; Valles PG, 2007, PEDIATR NEPHROL, V22, P237, DOI 10.1007/s00467-006-0290-4; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Zhang XL, 2005, J BIOL CHEM, V280, P12239, DOI 10.1074/jbc.M413284200; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0	50	50	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5760	5768		10.1074/jbc.M701572200	http://dx.doi.org/10.1074/jbc.M701572200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056268	hybrid			2022-12-27	WOS:000253426700057
J	Kimple, ME; Joseph, JW; Bailey, CL; Fueger, PT; Hendry, IA; Newgard, CB; Casey, PJ				Kimple, Michelle E.; Joseph, Jamie W.; Bailey, Candice L.; Fueger, Patrick T.; Hendry, Ian A.; Newgard, Christopher B.; Casey, Patrick J.			G alpha(z) negatively regulates insulin secretion and glucose clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNIT; BETA-CELLS; IN-VIVO; BIOCHEMICAL-PROPERTIES; PANCREATIC-ISLETS; CYCLIC-AMP; G(Z); ACTIVATION; MECHANISMS; EXPRESSION	Relatively little is known about the in vivo functions of the alpha subunit of the heterotrimeric G protein G(z) (G alpha(z)). Clues to one potential function recently emerged with the finding that activation of G alpha(z) inhibits glucose-stimulated insulin secretion in an insulinoma cell line (Kimple, M. E., Nixon, A. B., Kelly, P., Bailey, C. L., Young, K. H., Fields, T. A., and Casey, P. J. ( 2005) J. Biol. Chem. 280, 31708-31713). To extend this study in vivo, a G alpha(z) knock-out mouse model was utilized to determine whether G alpha(z) function plays a role in the inhibition of insulin secretion. No differences were discovered in the gross morphology of the pancreatic islets or in the islet DNA, protein, or insulin content between G alpha(z)-null and wild-type mice. There was also no difference between the insulin sensitivity of G alpha(z)-null mice and wildtype controls, as measured by insulin tolerance tests. G alpha(z)-null mice did, however, display increased plasma insulin concentrations and a corresponding increase in glucose clearance following intraperitoneal and oral glucose challenge as compared with wild-type controls. The increased plasma insulin observed in G alpha(z)-null mice is most likely a direct result of enhanced insulin secretion, since pancreatic islets isolated from G alpha(z)-null mice exhibited significantly higher glucose-stimulated insulin secretion than those of wild-type mice. Finally, the increased insulin secretion observed in G alpha(z)-null islets appears to be due to the relief of a tonic inhibition of adenylyl cyclase, as cAMP production was significantly increased in G alpha(z)-null islets in the absence of exogenous stimulation. These findings indicate that G alpha(z) may be a potential new target for therapeutics aimed at ameliorating beta-cell dysfunction in Type 2 diabetes.	[Kimple, Michelle E.; Bailey, Candice L.; Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Biochem & Biophys, Durham, NC 27710 USA; [Joseph, Jamie W.; Fueger, Patrick T.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Hendry, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Duke University; Duke University; Duke University; Australian National University; John Curtin School of Medical Research	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	casey006@mc.duke.edu		Casey, Patrick/0000-0002-7366-9309	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080845, F32DK067799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055717, R55GM055717] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42583, F32 DK067799, DK67799, K01 DK080845] Funding Source: Medline; NIGMS NIH HHS [GM55717] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Chen JF, 1997, J MOL MED, V75, P283, DOI 10.1007/s001090050113; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Furman B, 2006, CURR OPIN INVEST DR, V7, P898; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Ho MKC, 2001, ONCOGENE, V20, P1615, DOI 10.1038/sj.onc.1204190; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KATADA T, 1979, J BIOL CHEM, V254, P469; Kelleher KL, 2001, THROMB HAEMOSTASIS, V85, P529; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; KONRAD RJ, 1995, J BIOL CHEM, V270, P12869, DOI 10.1074/jbc.270.21.12869; Kowluru A, 1996, BIOCHEM J, V313, P97, DOI 10.1042/bj3130097; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; MALAISSE WJ, 1984, EXPERIENTIA, V40, P1068, DOI 10.1007/BF01971453; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Oleskevich S, 2005, NEUROREPORT, V16, P921, DOI 10.1097/00001756-200506210-00009; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Song XS, 2001, J BIOL CHEM, V276, P34651, DOI 10.1074/jbc.M105894200; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Triplitt CL, 2007, AM J MANAG CARE, V13, pS47; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; van den Buuse M, 2005, PSYCHOPHARMACOLOGY, V183, P358, DOI 10.1007/s00213-005-0181-6; Weinhaus AJ, 1998, DIABETES, V47, P1426, DOI 10.2337/diabetes.47.9.1426; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	39	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4560	4567		10.1074/jbc.M706481200	http://dx.doi.org/10.1074/jbc.M706481200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096703	hybrid			2022-12-27	WOS:000253426500012
J	Lafont, JE; Talma, S; Hopfgarten, C; Murphy, CL				Lafont, Jerome E.; Talma, Sonia; Hopfgarten, Christine; Murphy, Christopher L.			Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; OXYGEN-TENSION; CAMPOMELIC DYSPLASIA; COLLAGEN GENE; CELL-SHAPE; ACTIVIN-A; CARTILAGE; SOX9; EXPRESSION	The chondrocyte is solely responsible for synthesis and maintenance of the resilient articular cartilage matrix that gives this load-bearing tissue its mechanical integrity. When the differentiated cell phenotype is lost, the matrix becomes compromised and cartilage function begins to fail. We have recently shown that hypoxia promotes the differentiated phenotype through hypoxia-inducible factor 2 alpha (HIF-2 alpha)-mediated SOX9 induction of the main matrix genes. However, to date, only a few genes have been shown to be SOX9 targets, while little is known about SOX9-independent regulators. We therefore performed a detailed microarray study to address these issues. Analysis involved 35 arrays on chondrocytes obtained from seven healthy, non-elderly human cartilage samples. Genes were selected that were down-regulated with serial passage in culture ( as this causes loss of the differentiated phenotype) and subsequently up-regulated in hypoxia. The importance of key findings was further probed using the technique of RNA interference on these human articular chondrocytes. Our results show that hypoxia has a broader beneficial effect on the chondrocyte phenotype than has been previously described. Of especial note, we report new hypoxia-inducible and SOX9-regulated genes, Gdf10 and Chm-I. In addition, Mig6 and InhbA were induced by hypoxia, predominantly via HIF-2 alpha, but were not regulated by SOX9. Therefore, hypoxia, and more specifically HIF-2 alpha, promotes both SOX9-dependent and -independent factors important for cartilage homeostasis. HIF-2 alpha may therefore represent a new and promising therapeutic target for cartilage repair.	[Lafont, Jerome E.; Talma, Sonia; Hopfgarten, Christine; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk	Lafont, Jerome E/AAY-2277-2020	Lafont, Jerome E/0000-0001-8313-9873	Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council [bbsb0126x, BBS/B/0126X] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; Chang DM, 2007, RHEUMATOL INT, V27, P1049, DOI 10.1007/s00296-007-0350-5; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Etherington P J, 2002, Clin Exp Rheumatol, V20, P799; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Francioli SE, 2007, TISSUE ENG, V13, P1227, DOI 10.1089/ten.2006.0342; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 2001, OSTEOARTHR CARTILAGE, V9, pS91, DOI 10.1053/joca.2001.0450; Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	34	114	123	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4778	4786		10.1074/jbc.M707729200	http://dx.doi.org/10.1074/jbc.M707729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077449	hybrid			2022-12-27	WOS:000253426500035
J	Oliver, DC; Paetzel, M				Oliver, David C.; Paetzel, Mark			Crystal structure of the major periplasmic domain of the bacterial membrane protein assembly facilitator YidC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; X-RAY-STRUCTURE; NASCENT FTSQ; INSERTION; TRANSLOCATION; PROGRAM; REGIONS; SECD; ALIGNMENT; SOFTWARE	The essential bacterial membrane protein YidC facilitates insertion and assembly of proteins destined for integration into the inner membrane. It has homologues in both mitochondria and chloroplasts. Here we report the crystal structure of the Escherichia coli YidC major periplasmic domain ( YidC(EC)P1) at 2.5 angstrom resolution. This domain is present in YidC from Gram-negative bacteria and is more than half the size of the full-length protein. The structure reveals that YidC(EC)P1 is made up of a large twisted beta-sandwich protein fold with a C-terminal alpha-helix that packs against one face of the beta-sandwich. Our structure and sequence analysis reveals that the C-terminal alpha-helix and the beta-sheet that it lays against are the most conserved regions of the domain. The region corresponding to the C-terminal alpha-helix was previously shown to be important for the protein insertase function of YidC and is conserved in other YidC-like proteins. The structure reveals that a region of YidC that was previously shown to be involved in binding to SecF maps to one edge of the beta-sandwich. Electrostatic analysis of the molecular surface for this region of YidC reveals a predominantly charged surface and suggests that the SecF-YidC interaction may be electrostatic in nature. Interestingly, YidC(EC)P1 has significant structural similarity to galactose mutarotase from Lactococcus lactis, suggesting that this domain may have another function besides its role in membrane protein assembly.	[Oliver, David C.; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, S Sci Bldg,8888 Univ Dr,Burna, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Froderberg L, 2004, J BIOL CHEM, V279, P31026, DOI 10.1074/jbc.M403229200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanoulle X, 2004, J MOL BIOL, V342, P195, DOI 10.1016/j.jmb.2004.07.004; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1990, PROTEINS, V8, P203, DOI 10.1002/prot.340080303; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z	59	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5208	5216		10.1074/jbc.M708936200	http://dx.doi.org/10.1074/jbc.M708936200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093969	Green Published, hybrid			2022-12-27	WOS:000253426500078
J	Primo, ME; Klinke, S; Sica, MP; Goldbaum, FA; Jakoncic, J; Poskus, E; Ermacora, MR				Primo, Maria E.; Klinke, Sebastian; Sica, Mauricio P.; Goldbaum, Fernando A.; Jakoncic, Jean; Poskus, Edgardo; Ermacora, Mario R.			Structure of the mature ectodomain of the human receptor-type protein-tyrosine phosphatase IA-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEA MODULE; MACROMOLECULAR STRUCTURES; CLEAVAGE; DOMAIN; TRANSMEMBRANE; IA-2-BETA; ALPHA; INHIBITION; REFINEMENT; EXPRESSION	IA-2 (insulinoma-associated protein 2) is a protein-tyrosine phosphatase receptor located in secretory granules of neuroendocrine cells. Initially, it attracted attention due to its involvement in the autoimmune response associated to diabetes. Later it was found that upon exocytosis, the cytoplasmic domain of IA-2 is cleaved and relocated to the nucleus, where it enhances the transcription of the insulin gene. A concerted functioning of the whole receptor is to be expected. However, very little is known about the structure and function of the transmembrane and extracellular domains of IA-2. To address this issue, we solved the x-ray structure of the mature ectodomain of IA-2 (meIA-2) to 1.30 A resolution. The fold of meIA-2 is related to the SEA ( sea urchin sperm protein, enterokinase, agrin)) domains of mucins, suggesting its participation in adhesive contacts to the extracellular matrix and providing clues on how this kind of molecule may associate and form homo- and heterodimers. Moreover, we discovered that meIA-2 is self-proteolyzed in vitro by reactive oxygen species, suggesting the possibility of a new shedding mechanism that might be significant in normal function or pathological processes. Knowledge of meIA-2 structure should facilitate the search of its possible ligands and molecular interactions.	[Primo, Maria E.; Klinke, Sebastian; Sica, Mauricio P.; Goldbaum, Fernando A.; Poskus, Edgardo; Ermacora, Mario R.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Primo, Maria E.; Poskus, Edgardo] Idehu Conicet UBA, Junin 954, Buenos Aires, DF, Argentina; [Primo, Maria E.; Poskus, Edgardo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol, Buenos Aires, DF, Argentina; [Klinke, Sebastian; Goldbaum, Fernando A.] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, RA-1033 Buenos Aires, DF, Argentina; [Sica, Mauricio P.; Ermacora, Mario R.] Univ Nacl Quilmes, Dept Ciencia Tecnol, Buenos Aires, DF, Argentina; [Jakoncic, Jean] Brookhaven Natl Lab, Upton, NY 11973 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; United States Department of Energy (DOE); Brookhaven National Laboratory	Ermacora, MR (corresponding author), Consejo Nacl Invest Cient & Tecn, Rivadavia 1917 C1033AAJ,Ciudad Autonoma, RA-1033 Buenos Aires, DF, Argentina.	ermacora@unq.edu.ar	Klinke, Sebastián/N-6174-2018	Klinke, Sebastián/0000-0002-8777-0870; Primo, Maria Evangelina/0000-0002-6873-8867; Ermacora, Mario/0000-0002-1754-4202; Goldbaum, Fernando/0000-0001-6235-3002				Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; BRADYKALNAY SM, 1995, CURR OPIN CELL BIOL, V7, P650, DOI 10.1016/0955-0674(95)80106-5; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engelmann K, 2005, GLYCOBIOLOGY, V15, P1111, DOI 10.1093/glycob/cwi099; ERMACORA MR, 1992, P NATL ACAD SCI USA, V89, P6383, DOI 10.1073/pnas.89.14.6383; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Feenstra KA, 1999, J COMPUT CHEM, V20, P786, DOI 10.1002/(SICI)1096-987X(199906)20:8<786::AID-JCC5>3.0.CO;2-B; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Gross S, 2002, J BIOL CHEM, V277, P48139, DOI 10.1074/jbc.M208228200; Hermel JM, 1999, EUR J NEUROSCI, V11, P2609, DOI 10.1046/j.1460-9568.1999.00677.x; Holm L, 1998, PROTEINS, V33, P88, DOI 10.1002/(SICI)1097-0134(19981001)33:1<88::AID-PROT8>3.0.CO;2-H; Hubbard TJP, 1997, NUCLEIC ACIDS RES, V25, P236, DOI 10.1093/nar/25.1.236; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubosaki A, 2006, ENDOCRINOLOGY, V147, P811, DOI 10.1210/en.2005-0638; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; LAN NS, 1996, P NATL ACAD SCI USA, V93, P6367; LASKOWSKI M, 1955, METHOD ENZYMOL, V2, P26, DOI 10.1016/S0076-6879(55)02167-8; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Maeda T, 2004, J BIOL CHEM, V279, P13174, DOI 10.1074/jbc.M309417200; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmai-Pallag T, 2005, FEBS J, V272, P2901, DOI 10.1111/j.1742-4658.2005.04711.x; Primo ME, 2006, BBA-PROTEINS PROTEOM, V1764, P174, DOI 10.1016/j.bbapap.2005.11.014; SANTOS J, 2007, BIOPHYS J, V11, P11; Sereikaite J, 2006, PROTEIN J, V25, P369, DOI 10.1007/s10930-006-9014-7; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trajkovski M, 2004, J CELL BIOL, V167, P1063, DOI 10.1083/jcb.200408172; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; van der Wijk T, 2003, J BIOL CHEM, V278, P13968, DOI 10.1074/jbc.M300632200; Wreschner DH, 2002, PROTEIN SCI, V11, P698, DOI 10.1110/ps.16502	48	18	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4674	4681		10.1074/jbc.M708144200	http://dx.doi.org/10.1074/jbc.M708144200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18048354	hybrid			2022-12-27	WOS:000253426500025
J	Shen, Y; Hirsch, DS; Sasiela, CA; Wu, WJ				Shen, Yi; Hirsch, Dianne S.; Sasiela, Christy A.; Wu, Wen Jin			Cdc42 regulates E-cadherin ubiquitination and degradation through an epidermal growth factor receptor to Src-mediated pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; EPITHELIAL-MESENCHYMAL TRANSITIONS; BREAST-CANCER CELLS; RHO-GTPASES; DOWN-REGULATION; BETA-CATENIN; C-CBL; RAC1; ENDOCYTOSIS; ACTIVATION	E-cadherins play an essential role in maintaining epithelial polarity by forming Ca2+-dependent adherens junctions between epithelial cells. Here, we report that Ca2+ depletion induces E-cadherin ubiquitination and lysosomal degradation and that Cdc42 plays an important role in regulating this process. We demonstrate that Ca2+ depletion induces activation of Cdc42. This in turn up-regulates epidermal growth factor receptor (EGFR) signaling to mediate Src activation, leading to E-cadherin ubiquitination and lysosomal degradation. Silencing Cdc42 blocks activation of EGFR and Src induced by Ca2+ depletion, resulting in a reduction in E-cadherin degradation. The role of Cdc42 in regulating E-cadherin ubiquitination and degradation is underscored by the fact that constitutively active Cdc42(F28L) increases the activity of EGFR and Src and significantly enhances E-cadherin ubiquitination and lysosomal degradation. Furthermore, we found that GTP-dependent binding of Cdc42 to E-cadherin is critical for Cdc42 to induce the dissolution of adherens junctions. Our data support a model that activation of Cdc42 contributes to mesenchyme-like phenotype by targeting of E-cadherin for lysosomal degradation.	[Shen, Yi; Hirsch, Dianne S.; Sasiela, Christy A.; Wu, Wen Jin] US FDA, CDER, OPS, OBP,Div Monoclonal Antibodies, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Wu, WJ (corresponding author), US FDA, CDER, OPS, OBP,Div Monoclonal Antibodies, Bethesda, MD 20892 USA.	wen.wu@fda.hhs.gov						Akhtar N, 2000, CELL ADHES COMMUN, V7, P465, DOI 10.3109/15419060009040304; Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Al Moustafa AE, 2002, LUNG CANCER, V37, P49, DOI 10.1016/S0169-5002(02)00025-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Birchmeier W, 2005, EMBO REP, V6, P413, DOI 10.1038/sj.embor.7400408; Braga V, 2000, NAT CELL BIOL, V2, pE182, DOI 10.1038/35036433; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cary LA, 1996, J CELL SCI, V109, P1787; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Czekay RP, 1997, MOL BIOL CELL, V8, P517, DOI 10.1091/mbc.8.3.517; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Fukuyama T, 2005, J BIOL CHEM, V280, P815, DOI 10.1074/jbc.M411099200; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GRAEVE L, 1989, J CELL BIOL, V109, P2809, DOI 10.1083/jcb.109.6.2809; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hazan RB, 1998, J BIOL CHEM, V273, P9078, DOI 10.1074/jbc.273.15.9078; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Hirsch DS, 2001, J BIOL CHEM, V276, P875, DOI 10.1074/jbc.M007039200; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mbalaviele G, 1996, CANCER RES, V56, P4063; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SOUZASCHOREY C, 2005, TRENDS CELL BIOL, V15, P19; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Golen KL, 2000, CANCER RES, V60, P5832; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Wu WJ, 1998, J BIOL CHEM, V273, P16655, DOI 10.1074/jbc.273.27.16655; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119	53	99	101	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5127	5137		10.1074/jbc.M703300200	http://dx.doi.org/10.1074/jbc.M703300200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18057010	hybrid			2022-12-27	WOS:000253426500070
J	Zhang, WX; Yang, NL; Shi, XM				Zhang, Weixi; Yang, Nianlan; Shi, Xing-Ming			Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; INHIBITION; ADIPOGENESIS; PROTEIN; GENE; LINE; CORTICOSTEROIDS; DEXAMETHASONE; OSTEOPOROSIS; OSF2/CBFA1	Mesenchymal stem cells (MSCs) can differentiate into multiple cell lineages, including osteoblasts and adipocytes. We reported previously that glucocorticoid-induced leucine zipper (GILZ) inhibits peroxisome proliferator-activated receptor gamma-2 (Ppar gamma 2) expression and blocks adipocyte differentiation. Here we show that overexpression of GILZ in mouse MSCs, but not MC3T3-E1 osteoblasts, increases alkaline phosphatase activity and enhances mineralized bone nodule formation, whereas knockdown of Gilz reduces MSC osteogenic differentiation capacity. Consistent with these observations, real-time reverse transcription-PCR analysis showed that both basal and differentiation-induced transcripts of the lineage commitment gene Runx2/Cbfa1, as well as osteoblast differentiation marker genes including alkaline phosphatase, type I collagen, and osteocalcin, were all increased in GILZ-expressing cells. In contrast, the mRNA levels of adipogenic Ppar gamma 2 and C/ebp alpha were significantly reduced in GILZ-expressing cells under both osteogenic and adipogenic conditions. Together, our results demonstrate that GILZ functions as a modulator of MSCs and that overexpression of GILZ shifts the balance between osteogenic and adipogenic differentiation of MSCs toward the osteogenic pathway. These data suggest that GILZ may have therapeutic value for stem cell-based therapies of metabolic bone diseases, such as fracture repair.	[Shi, Xing-Ming] Med Coll Georgia, Inst Mol Med & Genet, Dept Pathol, Augusta, GA 30912 USA; [Zhang, Weixi; Yang, Nianlan; Shi, Xing-Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Mol Med & Genet, Guangzhou, Peoples R China; [Zhang, Weixi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Peoples R China; [Yang, Nianlan] Wuhan Univ, Renmin Hosp, Dept Hematol, Wuhan 430072, Peoples R China	University System of Georgia; Augusta University; Sun Yat Sen University; Sun Yat Sen University; Wuhan University	Shi, XM (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Dept Pathol, 1120 15th St,CB-2803, Augusta, GA 30912 USA.	xshi@mcg.edu						Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Bazzy-Asaad A, 2001, CURR OPIN PEDIATR, V13, P523, DOI 10.1097/00008480-200112000-00005; BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Clowes JA, 2001, CURR OPIN RHEUMATOL, V13, P326, DOI 10.1097/00002281-200107000-00015; Conn DL, 2001, ARTHRIT RHEUM-ARTHR, V45, P462, DOI 10.1002/1529-0131(200110)45:5<462::AID-ART366>3.0.CO;2-V; Corren J, 2001, ANN ALLERG ASTHMA IM, V87, P405, DOI 10.1016/S1081-1206(10)62922-5; CRUESS RL, 1975, CLIN ORTHOP RELAT R, V113, P178; Cui Q, 1997, J BONE JOINT SURG AM, V79A, P1054, DOI 10.2106/00004623-199707000-00012; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; HARRIS ED, 1983, HOSP PRACT, V18, P137; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; Kirwan JR, 2000, Z RHEUMATOL, V59, P85; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LOCASCIO V, 1990, BONE MINER, V8, P39, DOI 10.1016/0169-6009(91)90139-Q; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park SJ, 2001, J HEART LUNG TRANSPL, V20, P304, DOI 10.1016/S1053-2498(00)00316-8; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Tynan SH, 2004, J STEROID BIOCHEM, V91, P225, DOI 10.1016/j.jsbmb.2004.05.002; Walsh LJ, 2001, THORAX, V56, P279, DOI 10.1136/thorax.56.4.279; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; YANG N, 2007, IN PRESS J CELL BIOC	47	118	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4723	4729		10.1074/jbc.M704147200	http://dx.doi.org/10.1074/jbc.M704147200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18084007	hybrid			2022-12-27	WOS:000253426500030
J	Smith, AE; Kim, SH; Liu, F; Jia, WY; Vinogradov, E; Gyles, CL; Bishop, RE				Smith, Abigail E.; Kim, Sang-Hyun; Liu, Feng; Jia, Wenyi; Vinogradov, Evgeny; Gyles, Carlton L.; Bishop, Russell E.			PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157 : H7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; LIPID-A; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; MOLECULAR-BASIS; UDP-GLUCOSE; POLYACRYLAMIDE GELS; SHIGELLA-FLEXNERI; HYDROCARBON RULER; ENZYME PAGP	The Escherichia coli outer membrane phospholipid: lipid A palmitoyltransferase PagP is normally a latent enzyme, but it can be directly activated in outer membranes by lipid redistribution associated with a breach in the permeability barrier. We now demonstrate that a lipid A myristate deficiency in an E. coli O157:H7 msbB mutant constitutively activates PagP in outer membranes. The lipid A myristate deficiency is associated with hydrophobic antibiotic sensitivity and, unexpectedly, with serum sensitivity, which resulted from O-antigen polysaccharide absence due to a cytoplasmically determined truncation at the first outer core glucose unit of the R3 core oligosaccharide. Mutational inactivation of pagP in the myristate-deficient lipid A background aggravated the hydrophobic antibiotic sensitivity as a result of losing a partially compensatory increase in lipid A palmitoylation while simultaneously restoring serum resistance and O-antigen attachment to intact lipopolysaccharide. Complementation with either wild-type pagP or catalytically inactive pagPSer77Ala alleles restored the R3 core truncation. However, the intact lipopolysaccharide was preserved after complementation with an internal deletion pagP Delta 5-14 allele, which mostly eliminates a periplasmic amphipathic alpha-helical domain but fully supports cell surface lipid A palmitoylation. Our findings indicate that activation of PagP not only triggers lipid A palmitoylation in the outer membrane but also separately truncates the R3 core oligosaccharide in the cytoplasm. We discuss the implication that PagP might function as an apical sensory transducer, which can be activated by a breach in the outer membrane permeability barrier.	[Smith, Abigail E.; Liu, Feng; Bishop, Russell E.] McMaster Univ, Dept Biol & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Kim, Sang-Hyun; Jia, Wenyi; Bishop, Russell E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kim, Sang-Hyun; Jia, Wenyi; Bishop, Russell E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Gyles, Carlton L.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	McMaster University; University of Toronto; University of Toronto; National Research Council Canada; University of Guelph	Smith, AE (corresponding author), McMaster Univ, Dept Biol & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.			Vinogradov, Evgeny/0000-0002-5364-1376	CIHR [84329-1] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; BISHOP RE, 2007, BIOCH BIOPHYS ACTA; BOHRINGER J, 1995, J BACTERIOL, V177, P413; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Clementz T, 1997, J BIOL CHEM, V272, P10353; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Edwards-Jones B, 2004, MICROBIOL-SGM, V150, P1079, DOI 10.1099/mic.0.26840-0; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HELMUTH R, 1985, INFECT IMMUN, V48, P175, DOI 10.1128/IAI.48.1.175-182.1985; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072; Hwang PM, 2004, P NATL ACAD SCI USA, V101, P9618, DOI 10.1073/pnas.0402324101; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Joiner K A, 1985, Curr Top Microbiol Immunol, V121, P99; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k; Kim SH, 2006, MICROBIOL-SGM, V152, P657, DOI 10.1099/mic.0.28692-0; Kim SH, 2004, INFECT IMMUN, V72, P1174, DOI 10.1128/IAI.72.2.1174-1180.2004; LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x; Marolda CL, 1996, MOL MICROBIOL, V22, P827, DOI 10.1046/j.1365-2958.1996.01531.x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Murray SR, 2001, J BACTERIOL, V183, P5554, DOI 10.1128/JB.183.19.5554-5561.2001; *NAT COMM CLIN LAB, 2002, PERF STAND ANT DISK, V22, pM31; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1979, Adv Microb Physiol, V20, P163; Pilione MR, 2004, INFECT IMMUN, V72, P2837, DOI 10.1128/IAI.72.5.2837-2842.2004; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHINDLER M, 1979, BIOCHEMISTRY-US, V18, P4425, DOI 10.1021/bi00587a024; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yoon JW, 2005, INFECT IMMUN, V73, P2367, DOI 10.1128/IAI.73.4.2367-2378.2005; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	61	25	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4332	4343		10.1074/jbc.M708163200	http://dx.doi.org/10.1074/jbc.M708163200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070877	Green Accepted, hybrid			2022-12-27	WOS:000253083500068
J	Wang, ZQ; Zhang, L; Qiao, AM; Watson, K; Zhang, JW; Fan, GH				Wang, Ziqing; Zhang, Li; Qiao, Aimin; Watson, Kurt; Zhang, Jingwu; Fan, Guo-Huang			Activation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; ANTIGEN PRESENTATION; INTERFERON-GAMMA; FINGER PROTEINS; GLIOMA-CELLS; LIGASE; INTERNALIZATION; EXPRESSION; MOLECULES	Many cancer cells display down-regulated major histocompatibility complex (MHC) class I antigen (MHC-I), which seems to enable them to evade immune surveillance, whereas the underlying mechanisms remain incompletely understood. Here, we demonstrate that ligand (CXCL12) stimulation of CXCR4, a major chemokine receptor expressed in many malignant cancer cells, induced MHC-I heavy chain down-regulation from the cell surface of the human epithelioid carcinoma HeLa cells, the human U251 and U87 glioblastoma cells, the human MDA-MD 231 breast cancer cells, and the human SK-N-BE (2) neuroblastoma cells. Activation of CXCR4 also induced MHC-I down-regulation in human peripheral blood mononuclear cells. The internalized MHC-I heavy chain molecules were partially co-localized with Rab7, a later endosomal marker. Activation of CXCR4 induced ubiquitination of MHC-I heavy chain, and mutation of the C-terminal two lysine residues (Lys-332, Lys337) on one of the MHC-I alleles, HLA.B7, blocked CXCR4-evoked ubiquitination and down-regulation of HLA.B7. Moreover, purified GST-conjugated CXCR4 C terminus directly associated with the purified His-tagged beta 2-microglobulin (beta 2M), and MHC-I heavy chain was co-immunoprecipitated with CXCR4 in a beta 2M-dependent manner. This interaction appears to be critical for CXCR4-evoked down-regulation of MHC-I heavy chain as evidenced by the data that MHC-I heavy chain down-regulation was inhibited by either truncation of the CXCR4 C terminus or knockdown of beta 2M. All together, these findings shed new light on the role of CXCR4 in tumor evasion of immune surveillance via inducing MHC-I down-regulation from the cell surface.	[Qiao, Aimin; Watson, Kurt; Fan, Guo-Huang] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Wang, Ziqing; Zhang, Jingwu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Wang, Ziqing; Zhang, Jingwu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Qiao, Aimin; Watson, Kurt; Fan, Guo-Huang] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Zhang, Li] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Meharry Medical College; Vanderbilt University	Fan, GH (corresponding author), Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA.	gfan@mmc.edu			NINDS NIH HHS [U54NS41071] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chang CC, 2006, SEMIN CANCER BIOL, V16, P383, DOI 10.1016/j.semcancer.2006.07.001; Chang Chien-Chung, 2003, Keio Journal of Medicine, V52, P220; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Haque M, 2001, J GEN VIROL, V82, P1175, DOI 10.1099/0022-1317-82-5-1175; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kucia M, 2004, J MOL HISTOL, V35, P233; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; Muller H, 2001, EUR J SURG ONCOL, V27, P652, DOI 10.1053/ejso.2001.1193; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Peng SB, 2005, MOL CANCER RES, V3, P227; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; TATAKE RJ, 1992, TRANSPLANTATION, V54, P395, DOI 10.1097/00007890-199209000-00002; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Zagzag D, 2005, LAB INVEST, V85, P328, DOI 10.1038/labinvest.3700233; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	39	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3951	3959		10.1074/jbc.M706848200	http://dx.doi.org/10.1074/jbc.M706848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18083706	hybrid			2022-12-27	WOS:000253083500029
J	Yamano, K; Yatsukawa, YI; Esaki, M; Hobbs, AEA; Jensen, RE; Endo, T				Yamano, Koji; Yatsukawa, Yoh-Ichi; Esaki, Masatoshi; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Endo, Toshiya			Tom20 and Tom22 share the common signal recognition pathway in mitochondrial protein import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; YEAST MITOCHONDRIA; FUNCTIONAL COOPERATION; PRECURSOR BINDING; INSERTION PATHWAY; RECEPTOR COMPLEX; TRANSLOCATION; PRESEQUENCE; DOMAIN; PREPROTEIN	Precise targeting of mitochondrial precursor proteins to mitochondria requires receptor functions of Tom20, Tom22, and Tom70 on the mitochondrial surface. Tom20 is a major import receptor that recognizes preferentially mitochondrial presequences, and Tom70 is a specialized receptor that recognizes presequence-less inner membrane proteins. The cytosolic domain of Tom22 appears to function as a receptor in cooperation with Tom20, but how its substrate specificity differs from that of Tom20 remains unclear. To reveal possible differences in substrate specificities between Tom20 and Tom22, if any, we deleted the receptor domain of Tom20 or Tom22 in mitochondria in vitro by introducing cleavage sites for a tobacco etch virus protease between the receptor domains and transmembrane segments of Tom20 and Tom22. Then mitochondria without the receptor domain of Tom20 or Tom22 were analyzed for their abilities to import various mitochondrial precursor proteins targeted to different mitochondrial subcompartments in vitro. The effects of deletion of the receptor domains on the import of different mitochondrial proteins for different import pathways were quite similar between Tom20 and Tom22. Therefore Tom20 and Tom22 are apparently involved in the same step or sequential steps along the same pathway of targeting signal recognition in import.	[Yamano, Koji; Yatsukawa, Yoh-Ichi; Esaki, Masatoshi; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hobbs, Alyson E. Aiken; Jensen, Robert E.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Endo, Toshiya] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Johns Hopkins University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022					Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Esaki M, 2004, J BIOL CHEM, V279, P45701, DOI 10.1074/jbc.M404591200; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Hulett JM, 2007, MOL BIOL EVOL, V24, P1909, DOI 10.1093/molbev/msm126; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; LITHGOW T, 1995, J BIOL CHEM, V270, P14267, DOI 10.1074/jbc.270.24.14267; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; MAYER A, 1995, EMBO J, V14, P4204, DOI 10.1002/j.1460-2075.1995.tb00094.x; MOCZKO M, 1993, FEBS LETT, V326, P251, DOI 10.1016/0014-5793(93)81801-6; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Nakai M, 1995, J BIOL CHEM, V270, P30571, DOI 10.1074/jbc.270.51.30571; NAKAI M, 1995, FEBS LETT, V357, P202; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Obita T, 2003, J MOL BIOL, V328, P495, DOI 10.1016/S0022-2836(03)00288-2; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; PFALLER R, 1989, J BIOL CHEM, V264, P34; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2003, J MOL BIOL, V327, P465, DOI 10.1016/S0022-2836(03)00118-9; Yamano K, 2005, J BIOL CHEM, V280, P10011, DOI 10.1074/jbc.M413264200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	47	102	102	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3799	3807		10.1074/jbc.M708339200	http://dx.doi.org/10.1074/jbc.M708339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063580	hybrid			2022-12-27	WOS:000253083500014
J	Han, Q; Robinson, H; Li, JY				Han, Qian; Robinson, Howard; Li, Jianyong			Crystal structure of human kynurenine aminotransferase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE AMINOTRANSFERASE; 5-PHOSPHATE-TYPE ASPARTATE AMINOTRANSFERASES; ESCHERICHIA-COLI; 3-NITROPROPIONIC ACID; SYNAPTIC-TRANSMISSION; HUNTINGTONS-DISEASE; EXPRESSION; RECEPTOR; PROTEIN; REFINEMENT	Human kynurenine aminotransferase II (hKAT-II) efficiently catalyzes the transamination of knunrenine to kynurenic acid (KYNA). KYNA is the only known endogenous antagonist of N-methyl-D-aspartate (NMDA) receptors and is also an antagonist of 7-nicotinic acetylcholine receptors. Abnormal concentrations of brain KYNA have been implicated in the pathogenesis and development of several neurological and psychiatric diseases in humans. Consequently, enzymes involved in the production of brain KYNA have been considered potential regulatory targets. In this article, we report a 2.16 angstrom crystal structure of hKAT-II and a 1.95 angstrom structure of its complex with kynurenine. The protein architecture of hKAT-II reveals that it belongs to the fold-type I pyridoxal 5-phosphate (PLP)-dependent enzymes. In comparison with all subclasses of fold-type I-PLP-dependent enzymes, we propose that hKAT-II represents a novel subclass in the fold-type I enzymes because of the unique folding of its first 65 N-terminal residues. This study provides a molecular basis for future effort in maintaining physiological concentrations of KYNA through molecular and biochemical regulation of hKAT-II.	[Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Han, Qian; Li, Jianyong] Virginia Tech Univ, Dept Biochem, Blacksburg, VA 24061 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Virginia Polytechnic Institute & State University	Li, JY (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/AAS-2134-2020; Han, Qian/J-8696-2014	Han, Qian/0000-0001-6245-5252	NIAID NIH HHS [R01 AI44399] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044399] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alkondon M, 2004, J NEUROSCI, V24, P4635, DOI 10.1523/JNEUROSCI.5631-03.2004; BEAL MF, 1990, J NEUROCHEM, V55, P1327, DOI 10.1111/j.1471-4159.1990.tb03143.x; BIRCH PJ, 1988, EUR J PHARMACOL, V154, P85, DOI 10.1016/0014-2999(88)90367-6; BUCHLI R, 1995, J BIOL CHEM, V270, P29330, DOI 10.1074/jbc.270.49.29330; Chon H, 2005, PROTEINS, V61, P685, DOI 10.1002/prot.20614; Csillik A, 2002, EXP NEUROL, V177, P233, DOI 10.1006/exnr.2002.7973; DeLano W.L, PYMOL MOL GRAPHICS S; Erhardt S, 2001, NEUROSCI LETT, V313, P96, DOI 10.1016/S0304-3940(01)02242-X; Erhardt S, 2007, PHYSIOL BEHAV, V92, P203, DOI 10.1016/j.physbeh.2007.05.025; Goh DLM, 2002, MOL GENET METAB, V76, P172, DOI 10.1016/S1096-7192(02)00037-9; Goto M, 2004, J BIOL CHEM, V279, P16518, DOI 10.1074/jbc.M311575200; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 1997, J NEUROSCI RES, V50, P457; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Han Q, 2004, EUR J BIOCHEM, V271, P4804, DOI 10.1111/j.1432-1033.2004.04446.x; Han Q, 2002, J BIOL CHEM, V277, P15781, DOI 10.1074/jbc.M201202200; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; JAGER J, 1994, J MOL BIOL, V239, P285, DOI 10.1006/jmbi.1994.1368; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEESON PD, 1994, J MED CHEM, V37, P4053, DOI 10.1021/jm00050a001; Luchowski P, 2002, NEUROSCI LETT, V330, P49, DOI 10.1016/S0304-3940(02)00735-8; MALASHKEVICH VN, 1995, J MOL BIOL, V247, P111, DOI 10.1006/jmbi.1994.0126; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MCPHALEN CA, 1992, J MOL BIOL, V225, P495, DOI 10.1016/0022-2836(92)90935-D; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; MIYAHARA I, 1994, J BIOCHEM, V116, P1001, DOI 10.1093/oxfordjournals.jbchem.a124620; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGURA A, 1988, EXP BRAIN RES, V73, P447, DOI 10.1007/BF00406601; OKAMOTO A, 1994, J BIOCHEM, V116, P95, DOI 10.1093/oxfordjournals.jbchem.a124509; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMADA M, 1998, FRONT BIOSCI, V3, P701; PELLICCIARI R, 1994, J MED CHEM, V37, P647, DOI 10.1021/jm00031a015; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rhee S, 1997, J BIOL CHEM, V272, P17293, DOI 10.1074/jbc.272.28.17293; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schwarcz R, 2001, BIOL PSYCHIAT, V50, P521, DOI 10.1016/S0006-3223(01)01078-2; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; SPECIALE C, 1990, NEUROSCI LETT, V116, P198, DOI 10.1016/0304-3940(90)90410-B; Stone TW, 2007, EUR J NEUROSCI, V25, P2656, DOI 10.1111/j.1460-9568.2007.05540.x; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; STONE TW, 1984, NEUROSCI LETT, V52, P335, DOI 10.1016/0304-3940(84)90184-8; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SWARTZ KJ, 1990, J NEUROSCI, V10, P2965; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; TOBES MC, 1977, J BIOL CHEM, V252, P4591; TURSKI WA, 1989, J NEUROCHEM, V52, P1629, DOI 10.1111/j.1471-4159.1989.tb09218.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yu P, 2006, GENE, V365, P111, DOI 10.1016/J.gene.2005.09.034; Yu P, 1999, MAMM GENOME, V10, P845, DOI 10.1007/s003359901102; Yu P, 2004, MOL CELL BIOL, V24, P6919, DOI 10.1128/MCB.24.16.6919-6930.2004	66	42	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3567	3573		10.1074/jbc.M708358200	http://dx.doi.org/10.1074/jbc.M708358200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18056995	hybrid			2022-12-27	WOS:000253083000062
J	Meng, J; Parroche, P; Golenbock, DT; McKnight, CJ				Meng, Jianmin; Parroche, Peggy; Golenbock, Douglas T.; McKnight, C. James			The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LPS BINDING-PROTEIN; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; LIPOPOLYSACCHARIDE LPS; SIGNAL-TRANSDUCTION; SECRETORY PATHWAY; RECEPTOR 4; ENDOTOXIN; IDENTIFICATION; CELLS	Innate immunity is the first line defense against invading pathogens. During Gram-negative bacterial infection, the Toll-like receptor 4 and MD-2 complex recognize lipopolysaccharide present in the bacterial cell wall. This recognition can be enhanced 100-1000-fold by CD14. However, the beneficial role provided by CD14 becomes detrimental in the context of sepsis and septic shock. An understanding of how CD14 functions will therefore benefit treatments targeted at both immune suppression and immune enhancement. In the present study, we use site-directed mutagenesis to address the role of disulfide bonds and N-linked glycosylation on CD14. A differential impact is observed for the five disulfide bonds on CD14 folding, with the first two (Cys(6)-Cys(17) and Cys(15)-Cys(32)) being indispensable, the third and fourth (Cys(168)-Cys(198) and Cys(222)-Cys(253)) being important, and the last (Cys(287)-Cys(333)) being dispensable. A functional role is observed for the first disulfide bond because the C6A substitution severely reduces the ability of CD14 to confer lipopolysaccharide responsiveness to U373 cells. Two of the four predicted glycosylation sites, asparagines 132 and 263, are actually involved in N-linked glycosylation, resulting in heterogeneity in CD14 molecular weight. Furthermore, glycosylation at Asn(132) plays a role in CD14 trafficking and upstream and/or downstream ligand interactions. When mapped onto the crystal structure of mouse CD14, the first two disulfide bonds and Asn132 are in close proximity to the initial beta strands of the leucine rich repeat domain. Thus, disulfide bonds and N-linked glycosylation in the initial beta sheets of the inner concave surface of CD14 are crucial for structure and function.	[Meng, Jianmin; McKnight, C. James] Boston Univ, Sch Med, Dept Phys & Biophys, Boston, MA 02118 USA; [Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 02118 USA	Boston University; University of Massachusetts System; University of Massachusetts Worcester	McKnight, CJ (corresponding author), 700 Albany St, W407, Worcester, MA 01605 USA.	cjmck@bu.edu		McKnight, Christopher/0000-0002-3237-0896	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54060] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Ausubel FM, 1988, MOL REPROD DEV; BALL ED, 1982, P NATL ACAD SCI-BIOL, V79, P5374, DOI 10.1073/pnas.79.17.5374; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Cacan R, 2000, GLYCOBIOLOGY, V10, P645, DOI 10.1093/glycob/10.7.645; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; GOLENBOCK DT, 1993, J BIOL CHEM, V268, P22055; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HAZIOT A, 1988, J IMMUNOL, V141, P547; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2001, PHILOS T ROY SOC B, V356, P147, DOI 10.1098/rstb.2000.0759; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Jiang QQ, 2000, J IMMUNOL, V165, P3541, DOI 10.4049/jimmunol.165.7.3541; JUAN TSC, 1995, J BIOL CHEM, V270, P17237, DOI 10.1074/jbc.270.29.17237; JUAN TSC, 1995, J BIOL CHEM, V270, P5219, DOI 10.1074/jbc.270.10.5219; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JD, 1992, J EXP MED, V175, P1697, DOI 10.1084/jem.175.6.1697; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; MCGINLEY MD, 1995, J BIOL CHEM, V270, P5213, DOI 10.1074/jbc.270.10.5213; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Moore KJ, 2000, J IMMUNOL, V165, P4272, DOI 10.4049/jimmunol.165.8.4272; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sambrook J., 1989, MOL CLONING LAB COUR; Schimke J, 1998, P NATL ACAD SCI USA, V95, P13875, DOI 10.1073/pnas.95.23.13875; SETOGUCHI M, 1989, MOL CELL BIOL, V9, P4515, DOI 10.1128/MCB.9.10.4515; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spiro RG, 2000, J BIOL CHEM, V275, P35657, DOI 10.1074/jbc.R000022200; Stelter F, 1997, EUR J BIOCHEM, V243, P100, DOI 10.1111/j.1432-1033.1997.00100.x; Sugiyama T, 2001, J IMMUNOL, V166, P826, DOI 10.4049/jimmunol.166.2.826; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Warren Charles E., 1993, Current Opinion in Biotechnology, V4, P596, DOI 10.1016/0958-1669(93)90083-9; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160	47	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3376	3384		10.1074/jbc.M707640200	http://dx.doi.org/10.1074/jbc.M707640200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18057002	hybrid			2022-12-27	WOS:000253083000042
J	Kamiya, Y; Kamiya, D; Yamamoto, K; Nyfeler, B; Hauri, HP; Kato, K				Kamiya, Yukiko; Kamiya, Daiki; Yamamoto, Kazuo; Nyfeler, Beat; Hauri, Hans-Peter; Kato, Koichi			Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTAL AFFINITY-CHROMATOGRAPHY; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; TRANSPORT RECEPTOR; BINDING-PROPERTIES; PROTEIN; GLYCOPROTEINS; GLYCANS; GLUCOSYLATION; COMPARTMENT	ERGIC-53, VIPL, and VIP36 are related type 1 membrane proteins of the mammalian early secretory pathway. They are classified as L-type lectins because of their luminal carbohydrate recognition domain, which exhibits homology to leguminous lectins. These L-type lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a Ca2+ -dependent manner, suggesting a role in glycoprotein sorting and trafficking. To understand the function of these lectins, knowledge of their carbohydrate specificity is crucial but only available for VIP36 (Kamiya, Y., Yamaguchi, Y., Takahashi, N., Arata, Y., Kasai, K. I., Ihara, Y., Matsuo, I., Ito, Y., Yamamoto, K., and Kato, K. ( 2005) J. Biol. Chem. 280, 37178-37182). Here we provide a comprehensive and quantitative analysis of sugar recognition of the carbohydrate recognition domains of ERGIC-53 and VIPL in comparison with VIP36 using a pyridylaminated sugar library in conjunction with frontal affinity chromatography. Frontal affinity chromatography revealed selective interaction of VIPL and VIP36 with the deglucosylated trimannose in the D1 branch of high-mannose-type oligosaccharides but with different pH dependence. ERGIC-53 bound high-mannose-type oligosaccharides with low affinity and broad specificity, not discriminating between monoglucosylated and deglucosylated high-mannose-type oligosaccharides. Based on the sugar-binding properties in conjunction with known features of these proteins, we propose a model for the action of the three lectins in glycoprotein guidance and trafficking. Moreover, structure-based mutagenesis revealed that the sugar-binding properties of these L-type lectins can be switched by single amino acid substitutions.	[Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Yamamoto, Kazuo; Kato, Koichi] CREST, Japan Sci & Technol Corp, Kawaguchi, Saitama 3321102, Japan; [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2278562, Japan; [Nyfeler, Beat; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Kato, Koichi] Nat Inst Nat Sci, Inst Mol Sci, Aichi 4448787, Japan; [Kato, Koichi] Ocahanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan; [Kato, Koichi] GLYENCE Co Ltd, Nagoya, Aichi 4740858, Japan	Nagoya City University; Japan Science & Technology Agency (JST); University of Tokyo; University of Basel; National Institutes of Natural Sciences (NINS) - Japan	Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	kkato@phar.nagoya-cu.ac.jp		Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886				Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200; Fullekrug J, 1999, J CELL SCI, V112, P2813; Hauri HP, 2000, J CELL SCI, V113, P587; Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2006, TRENDS GLYCOSCI GLYC, V18, P231, DOI 10.4052/tigg.18.231; KASAI K, 1986, J CHROMATOGR, V376, P33, DOI 10.1016/S0378-4347(00)80822-1; Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7; Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Yamaguchi D, 2007, GLYCOBIOLOGY, V17, P1061, DOI 10.1093/glycob/cwm074; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	29	105	106	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1857	1861		10.1074/jbc.M709384200	http://dx.doi.org/10.1074/jbc.M709384200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18025080	hybrid			2022-12-27	WOS:000252501000011
J	Klumpp, K; Kalayanov, G; Ma, H; Le Pogam, S; Leveque, V; Jiang, WR; Inocencio, N; De Witte, A; Rajyaguru, S; Tai, E; Chanda, S; Irwin, MR; Sund, C; Winqist, A; Maltseva, T; Eriksson, S; Usova, E; Smith, M; Alker, A; Najera, I; Cammack, N; Martin, JA; Johansson, NG; Smith, DB				Klumpp, Klaus; Kalayanov, Genadiy; Ma, Han; Le Pogam, Sophie; Leveque, Vincent; Jiang, Wen-Rong; Inocencio, Nicole; De Witte, Anniek; Rajyaguru, Sonal; Tai, Ezra; Chanda, Sushmita; Irwin, Michael R.; Sund, Christian; Winqist, Anna; Maltseva, Tatiana; Eriksson, Staffan; Usova, Elena; Smith, Mark; Alker, Andre; Najera, Isabel; Cammack, Nick; Martin, Joseph A.; Johansson, Nils Gunnar; Smith, David B.			2 '-deoxy-4 '-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2 '-alpha-hydroxyl groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; THYMIDINE KINASE; PLUS RIBAVIRIN; SPECIFICITY; EXPRESSION; REPLICON; DESIGN; RIBOSE; DNA	RNA polymerases effectively discriminate against deoxyribo-nucleotides and specifically recognize ribonucleotide substrates most likely through direct hydrogen bonding interaction with the 2 '-alpha-hydroxy moieties of ribonucleosides. Therefore, ribonucleoside analogs as inhibitors of viral RNA polymerases have mostly been designed to retain hydrogen bonding potential at this site for optimal inhibitory potency. Here, two novel nucleoside triphosphate analogs are described, which are efficiently incorporated into nascent RNA by the RNA-dependent RNA polymerase NS5B of hepatitis C virus (HCV), causing chain termination, despite the lack of alpha-hydroxy moieties. 2 '-Deoxy-2 '-beta-fluoro-4 '-azidocytidine (RO-0622) and 2 '-deoxy-2 '-beta-hydroxy-4 '-azidocytidine (RO-9187) were excellent substrates for deoxycytidine kinase and were phosphorylated with efficiencies up to 3-fold higher than deoxycytidine. As compared with previous reports on ribonucleosides, higher levels of triphosphate were formed from RO-9187 in primary human hepatocytes, and both compounds were potent inhibitors of HCV virus replication in the replicon system (IC50 = 171 +/- 12 nM and 24 +/- 3 nM for RO-9187 and RO-0622, respectively; CC50 > 1 mM for both). Both compounds inhibited RNA synthesis by HCV polymerases from either HCV genotypes 1a and 1b or containing S96T or S282T point mutations with similar potencies, suggesting no cross-resistance with either R1479 (4 '-azidocytidine) or 2 '-C-methyl nucleosides. Pharmacokinetic studies with RO-9187 in rats and dogs showed that plasma concentrations exceeding HCV replicon IC50 values 8-150-fold could be achieved by low dose (10 mg/kg) oral administration. Therefore, 2 '-alpha-deoxy-4 '-azido nucleosides are a new class of antiviral nucleosides with promising preclinical properties as potential medicines for the treatment of HCV infection.	[Klumpp, Klaus; Ma, Han; Le Pogam, Sophie; Leveque, Vincent; Jiang, Wen-Rong; Inocencio, Nicole; De Witte, Anniek; Rajyaguru, Sonal; Tai, Ezra; Chanda, Sushmita; Irwin, Michael R.; Smith, Mark; Najera, Isabel; Cammack, Nick; Martin, Joseph A.; Smith, David B.] Roche Palo Alto LLC, Palo Alto, CA 94304 USA; [Eriksson, Staffan; Usova, Elena] Swedish Univ Agr Sci, Ctr Biomed, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Kalayanov, Genadiy; Sund, Christian; Winqist, Anna; Maltseva, Tatiana; Johansson, Nils Gunnar] Medivir AB, SE-14144 Huddinge, Sweden; [Alker, Andre] Hoffmann La Roche Ag, CH-4070 Basel, Switzerland	Roche Holding; Swedish University of Agricultural Sciences; Medivir; Roche Holding	Klumpp, K (corresponding author), Roche Palo Alto LLC, 3431 Hillview Ave, Palo Alto, CA 94304 USA.	Klaus.klumpp@roche.com	Irwin, Michael R./H-4870-2013	Irwin, Michael R./0000-0002-1502-8431; Agback, Tatiana/0000-0003-1325-6024				Berger I, 1998, NUCLEIC ACIDS RES, V26, P2473, DOI 10.1093/nar/26.10.2473; BLANDIN M, 1974, BIOCHIM BIOPHYS ACTA, V361, P249, DOI 10.1016/0005-2787(74)90368-2; Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002; Brieba LG, 2000, BIOCHEMISTRY-US, V39, P919, DOI 10.1021/bi992324+; CANONICO PG, 1984, TOXICOL APPL PHARM, V74, P155, DOI 10.1016/0041-008X(84)90138-8; Clark JL, 2005, J MED CHEM, V48, P5504, DOI 10.1021/jm0502788; Dore GJ, 2007, AIDS, V21, P1555, DOI 10.1097/QAD.0b013e328216f2c7; DUARTE MIS, 1989, J SUBMICR CYTOL PATH, V21, P275; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8312, DOI 10.1021/bi00083a035; HILLYARD IW, 1980, RIBAVIRIN BROAD SPEC, P59; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Klumpp K, 2006, J BIOL CHEM, V281, P3793, DOI 10.1074/jbc.M510195200; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Le Pogam S, 2006, VIROLOGY, V351, P349, DOI 10.1016/j.virol.2006.03.045; LIAW YC, 1992, NUCLEIC ACIDS RES, V20, P459, DOI 10.1093/nar/20.3.459; Ma H, 2007, J BIOL CHEM, V282, P29812, DOI 10.1074/jbc.M705274200; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004; PARDI A, 1981, BIOCHEMISTRY-US, V20, P3986, DOI 10.1021/bi00517a007; Perrone P, 2007, J MED CHEM, V50, P5463, DOI 10.1021/jm070362i; Perrone P, 2007, J MED CHEM, V50, P1840, DOI 10.1021/jm0613370; Pietschmann T, 2001, J VIROL, V75, P1252, DOI 10.1128/JVI.75.3.1252-1264.2001; Roberts S, 2006, HEPATOLOGY, V44, p692A; Sabini E, 2003, NAT STRUCT BIOL, V10, P513, DOI 10.1038/nsb942; SANTOS RA, 1984, BIOCHEMISTRY-US, V28, P9372; Sheldon J, 2007, EXPERT OPIN INV DRUG, V16, P1171, DOI 10.1517/13543784.16.8.1171; Shim J, 2003, ANTIVIR RES, V58, P243, DOI 10.1016/S0166-3542(03)00007-X; Smith DB, 2007, BIOORG MED CHEM LETT, V17, P2570, DOI 10.1016/j.bmcl.2007.02.004; Sorbera LA, 2006, DRUG FUTURE, V31, P320, DOI 10.1358/dof.2006.031.04.977853; SOUSA R, 1995, EMBO J, V14, P4609, DOI 10.1002/j.1460-2075.1995.tb00140.x; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; Stuyver LJ, 2004, ANTIMICROB AGENTS CH, V48, P651, DOI 10.1128/AAC.48.2.651-654.2004; TISDALE M, 1995, ANTIMICROB AGENTS CH, V39, P2454, DOI 10.1128/AAC.39.11.2454; TISDALE M, 1993, ANTIVIR CHEM CHEMOTH, V4, P281, DOI 10.1177/095632029300400504; Tomassini JE, 2005, ANTIMICROB AGENTS CH, V49, P2050, DOI 10.1128/AAC.49.5.2050-2058.2005; UESUGI S, 1981, BIOCHEMISTRY-US, V20, P3056, DOI 10.1021/bi00514a011; Usova EV, 1997, EUR J BIOCHEM, V248, P762, DOI 10.1111/j.1432-1033.1997.t01-2-00762.x; Van Rompay AR, 2001, MOL PHARMACOL, V59, P1181, DOI 10.1124/mol.59.5.1181; Wang JH, 2000, BIOCHEM PHARMACOL, V59, P1583, DOI 10.1016/S0006-2952(00)00285-9; Wang LY, 2000, BIOCHEM J, V351, P469, DOI 10.1042/0264-6021:3510469; Wang QM, 2004, PROTEIN EXPRES PURIF, V35, P304, DOI 10.1016/j.pep.2004.01.017	44	75	91	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2167	2175		10.1074/jbc.M708929200	http://dx.doi.org/10.1074/jbc.M708929200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18003608	hybrid			2022-12-27	WOS:000252501000044
J	Narang, SS; Malone, CL; Deschenes, RJ; Fassler, JS				Narang, Sandhya S.; Malone, Cheryl L.; Deschenes, Robert J.; Fassler, Jan S.			Modulation of yeast Sln1 kinase activity by the Ccw12 cell wall protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MUTANTS; GENOME-WIDE ANALYSIS; INTEGRITY PATHWAY; TURGOR PRESSURE; GENE-EXPRESSION; SUN FAMILY; GLYCEROL; SKN7P; REGULATORS; OSMOSENSOR	The yeast Sln1p sensor kinase is best known as an osmosensor involved in the regulation of the hyperosmolarity glycerol mitogen-activated protein kinase cascade. Down-regulation of Sln1 kinase activity occurs under hypertonic conditions and leads to phosphorylation of the Hog1p mitogen-activated protein kinase and increased osmotic stress-response gene expression. Conditions leading to kinase up-regulation include osmotic imbalance caused by glycerol retention in the glycerol channel mutant, fps1 (Tao, W., Deschenes, R. J., and Fassler, J. S. (1999) J. Biol. Chem. 274, 360-367). The hypothesis that Sln1p kinase activity is responsive to turgor was first suggested by the increased Sln1p kinase activity in mutants lacking Fps1p in which glycerol accumulation leads to water uptake. Also consistent with the turgor hypothesis is the observation that reduced turgor caused by treatment of cells with nystatin, a drug that increases membrane permeability and causes cell shrinkage, reduced Sln1p kinase activity (Tao, W., Deschenes, R. J., and Fassler, J. S. (1999) J. Biol. Chem. 274, 360-367; Reiser, V., Raitt, D. C., and Saito, H. (2003) J. Cell Biol. 161, 1035-1040). The turgor hypothesis is revisited here in the context of the identification and characterization of the cell wall gene, CCW12, as a determinant of Sln1p activity. Results of this analysis suggest that the activity of the plasma membrane localized Sln1p is affected by the presence or absence of specific outer cell wall proteins and that this effect is independent of turgor.	[Narang, Sandhya S.; Malone, Cheryl L.; Fassler, Jan S.] Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; [Deschenes, Robert J.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	University of Iowa; Medical College of Wisconsin	Fassler, JS (corresponding author), Univ Iowa, Dept Biol Sci, 202 BBE, Iowa City, IA 52242 USA.	jan-fassler@uiowa.edu	Deschenes, Robert J/E-4926-2010	Deschenes, Robert J/0000-0001-8325-4257	NIGMS NIH HHS [R01 GM056719-08, GM56719, R01 GM056719] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056719] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Alberts AS, 1998, J BIOL CHEM, V273, P8616, DOI 10.1074/jbc.273.15.8616; Ausubel FM, 1988, MOL REPROD DEV; BROWN JL, 1993, J BACTERIOL, V175, P6908, DOI 10.1128/jb.175.21.6908-6915.1993; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; Fassler JS, 1997, J BIOL CHEM, V272, P13365, DOI 10.1074/jbc.272.20.13365; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hagen I, 2004, MOL MICROBIOL, V52, P1413, DOI 10.1111/j.1365-2958.2004.04064.x; HARDWICK KG, 1992, EMBO J, V11, P4187, DOI 10.1002/j.1460-2075.1992.tb05512.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KITAMURA K, 1981, AGR BIOL CHEM TOKYO, V45, P1761, DOI 10.1080/00021369.1981.10864786; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; LUYTEN K, 1995, EMBO J, V14, P1360, DOI 10.1002/j.1460-2075.1995.tb07122.x; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Miller JH, 1972, EXPT MOL GENETICS, P354; Mouassite M, 2000, YEAST, V16, P905, DOI 10.1002/1097-0061(200007)16:10<905::AID-YEA584>3.0.CO;2-1; Mrsa V, 1999, J BACTERIOL, V181, P3076, DOI 10.1128/JB.181.10.3076-3086.1999; O'Rourke SM, 2002, MOL CELL BIOL, V22, P4739, DOI 10.1128/MCB.22.13.4739-4749.2002; Ostrander DB, 1999, J BACTERIOL, V181, P2527, DOI 10.1128/JB.181.8.2527-2534.1999; OTA IM, 1992, P NATL ACAD SCI USA, V89, P2355, DOI 10.1073/pnas.89.6.2355; PELISSIER P, 1995, CURR GENET, V27, P409, DOI 10.1007/BF00311209; Ragni E, 2007, YEAST, V24, P309, DOI 10.1002/yea.1465; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reiser V, 2000, NAT CELL BIOL, V2, P620, DOI 10.1038/35023568; Shimoi H, 1998, J BACTERIOL, V180, P3381, DOI 10.1128/JB.180.13.3381-3387.1998; SIKORSKI RS, 1989, GENETICS, V122, P19; Sutherland FCW, 1997, J BACTERIOL, V179, P7790, DOI 10.1128/jb.179.24.7790-7795.1997; Tamas MJ, 1999, MOL MICROBIOL, V31, P1087, DOI 10.1046/j.1365-2958.1999.01248.x; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tao W, 1999, J BIOL CHEM, V274, P360, DOI 10.1074/jbc.274.1.360; Velours G, 2002, FEMS MICROBIOL LETT, V207, P165, DOI 10.1111/j.1574-6968.2002.tb11046.x; Yenush L, 2002, EMBO J, V21, P920, DOI 10.1093/emboj/21.5.920	46	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1962	1973		10.1074/jbc.M706877200	http://dx.doi.org/10.1074/jbc.M706877200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048366	hybrid, Green Accepted			2022-12-27	WOS:000252501000023
J	Poirier, S; Mayer, G; Benjannet, S; Bergeron, E; Marcinkiewicz, J; Nassoury, N; Mayer, H; Nimpf, J; Prat, A; Seidah, NG				Poirier, Steve; Mayer, Gaetan; Benjannet, Suzanne; Bergeron, Eric; Marcinkiewicz, Jadwiga; Nassoury, Nasha; Mayer, Harald; Nimpf, Johannes; Prat, Annik; Seidah, Nabil G.			The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL-DOMINANT HYPERCHOLESTEROLEMIA; SECRETED PCSK9; GROWTH-FACTOR; MICE LACKING; MUTATIONS; GENE; CHOLESTEROL; MUTANTS; PATHWAY; OVEREXPRESSION	The proprotein convertase PCSK9 gene is the third locus implicated in familial hypercholesterolemia, emphasizing its role in cardiovascular diseases. Loss of function mutations and gene disruption of PCSK9 resulted in a higher clearance of plasma low density lipoprotein cholesterol, likely due to a reduced degradation of the liver low density lipoprotein receptor (LDLR). In this study, we show that two of the closest family members to LDLR are also PCSK9 targets. These include the very low density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2) implicated in neuronal development and lipid metabolism. Our results show that wild type PCSK9 and more so its natural gain of function mutant D374Y can efficiently degrade the LDLR, VLDLR, and ApoER2 either following cellular co-expression or re-internalization of secreted human PCSK9. Such PCSK9-induced degradation does not require its catalytic activity. Membrane-bound PCSK9 chimeras enhanced the intracellular targeting of PCSK9 to late endosomes/lysosomes and resulted in a much more efficient degradation of the three receptors. We also demonstrate that the activity of PCSK9 and its binding affinity on VLDLR and ApoER2 does not depend on the presence of LDLR. Finally, in situ hybridization show close localization of PCSK9 mRNA expression to that of VLDLR in mouse postnatal day 1 cerebellum. Thus, this study demonstrates a more general effect of PCSK9 on the degradation of the LDLR family that emphasizes its major role in cholesterol and lipid homeostasis as well as brain development.	[Poirier, Steve; Mayer, Gaetan; Benjannet, Suzanne; Bergeron, Eric; Marcinkiewicz, Jadwiga; Nassoury, Nasha; Prat, Annik; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Mayer, Harald; Nimpf, Johannes] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Seidah, NG (corresponding author), 110 Pine Ave, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Bergeron, Eric/N-9566-2019; Seidah, Nabil/I-3596-2013; Prat, Annik/S-6757-2018	Bergeron, Eric/0000-0003-3398-8628; Seidah, Nabil/0000-0001-6503-9342; Prat, Annik/0000-0002-8007-5277; Nimpf, Johannes/0000-0002-9273-3492				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 1997, J BIOL CHEM, V272, P26210, DOI 10.1074/jbc.272.42.26210; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BOURBON M, 2007, ATHEROSCLEROSIS; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Conesa M, 2003, BIOCHEM J, V370, P703, DOI 10.1042/BJ20021301; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2007, TRENDS BIOCHEM SCI, V32, P71, DOI 10.1016/j.tibs.2006.12.008; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; KRIEGER M, 1983, CELL, V33, P413, DOI 10.1016/0092-8674(83)90423-3; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Poirier S, 2006, J NEUROCHEM, V98, P838, DOI 10.1111/j.1471-4159.2006.03928.x; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Reiner O, 2002, MOL PSYCHIATR, V7, P12, DOI 10.1038/sj/mp/4000975; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Stolt PC, 2006, CELL SIGNAL, V18, P1560, DOI 10.1016/j.cellsig.2006.03.008; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao SF, 2007, DEV DYNAM, V236, P2708, DOI 10.1002/dvdy.21283; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	43	324	371	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2363	2372		10.1074/jbc.M708098200	http://dx.doi.org/10.1074/jbc.M708098200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039658	hybrid			2022-12-27	WOS:000252501000063
J	Tucker, NP; D'Autreaux, B; Yousafzai, FK; Fairhurst, SA; Spiro, S; Dixon, R				Tucker, Nicholas P.; D'Autreaux, Benoit; Yousafzai, Faridoon K.; Fairhurst, Shirley A.; Spiro, Stephen; Dixon, Ray			Analysis of the nitric oxide-sensing non-heme iron center in the NorR regulatory protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RALSTONIA-EUTROPHA H16; ELECTRON-PARAMAGNETIC-RESONANCE; FURIOSUS SUPEROXIDE REDUCTASE; SOLUBLE GUANYLATE-CYCLASE; ESCHERICHIA-COLI; TRANSCRIPTION FACTOR; ACTIVE-SITE; CRYSTAL-STRUCTURE; GENE-EXPRESSION; MOLECULAR-BASIS	The NorR regulatory protein senses nitric oxide ( NO) to activate genes required for NO detoxification under anaerobic and microaerobic conditions in Escherichia coli. NorR belongs to the sigma(54)-dependent family of transcriptional activators and contains an N-terminal regulatory GAF (c (G) under bar MP phosphodiesterase, adenylate cyclase, (F) under bar hlA) domain that controls the ATPase activity of the central AAA+ domain to regulate productive interactions with sigma(54). Binding of NO to a non-heme iron center in the GAF domain results in the formation of a mononitrosyl-iron complex and releases intramolecular repression of the AAA+ domain to enable activation of transcription. In this study, we have further characterized NorR spectroscopically and substituted conserved residues in the GAF domain. This analysis, in combination with structural modeling of the GAF domain, has identified five candidate ligands to the non-heme iron and suggests a model in which the metal ion is coordinated in a pseudo-octahedral environment by three aspartate residues, an arginine, and a cysteine.	[Tucker, Nicholas P.; D'Autreaux, Benoit; Yousafzai, Faridoon K.; Fairhurst, Shirley A.; Dixon, Ray] John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Spiro, Stephen] John Innes Ctr Plant Sci Res, Dept Mol & Cell Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dixon, R (corresponding author), John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	ray.dixon@bbsrc.ac.uk	Spiro, Stephen/B-1838-2009; D'Autreaux, Benoit/M-8520-2018	Spiro, Stephen/0000-0001-5975-9984; Tucker, Nicholas/0000-0002-6331-3704; D'Autreaux, Benoit/0000-0002-1276-3019	BBSRC [BB/D009588/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009588/1, BBS/E/J/00000016] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AASA R, 1975, J MAGN RESON, V19, P308, DOI 10.1016/0022-2364(75)90045-1; Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; ARCIERO DM, 1985, J BIOL CHEM, V260, P4035; BANCI L, 1982, STRUCT BOND, V52, P37, DOI 10.1007/BFb0111296; Bennett B, 1997, BIOCHEMISTRY-US, V36, P9837, DOI 10.1021/bi970735p; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; Breece RM, 2005, J BIOL CHEM, V280, P11074, DOI 10.1074/jbc.M412582200; Busch A, 2005, BIOCHEM SOC T, V33, P193, DOI 10.1042/BST0330193; Chauvin AS, 2003, INORG CHEM, V42, P1895, DOI 10.1021/ic020401a; Clay MD, 2003, J BIOL INORG CHEM, V8, P671, DOI 10.1007/s00775-003-0465-4; Clay MD, 2003, P NATL ACAD SCI USA, V100, P3796, DOI 10.1073/pnas.0636858100; Clay MD, 2002, J AM CHEM SOC, V124, P788, DOI 10.1021/ja016889g; Cramm R, 2006, BIOCHEM SOC T, V34, P182, DOI 10.1042/BST0340182; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; D'Autreaux B, 2002, P NATL ACAD SCI USA, V99, P16619, DOI 10.1073/pnas.252591299; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; DAVIS JC, 1981, BIOCHEMISTRY-US, V20, P4062, DOI 10.1021/bi00517a018; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; ENEMARK JH, 1974, COORDIN CHEM REV, V13, P339, DOI 10.1016/S0010-8545(00)80259-3; Fairlie DP, 1997, INORG CHEM, V36, P1020, DOI 10.1021/ic961138e; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; FUJISAWA H, 1968, J BIOL CHEM, V243, P2673; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Griep MA, 1997, BIOCHEMISTRY-US, V36, P544, DOI 10.1021/bi9612778; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Ho YSJ, 2000, EMBO J, V19, P5288, DOI 10.1093/emboj/19.20.5288; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Klink A, 2007, J BACTERIOL, V189, P2743, DOI 10.1128/JB.01865-06; Lee YY, 2006, MICROBIOL-SGM, V152, P1461, DOI 10.1099/mic.0.28796-0; LIN J, 1992, MAR CHEM, V38, P283, DOI 10.1016/0304-4203(92)90038-C; MARTINELLI RA, 1989, BIOCHEMISTRY-US, V28, P2251, DOI 10.1021/bi00431a042; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Outten CE, 2001, BIOCHEMISTRY-US, V40, P10417, DOI 10.1021/bi0155448; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; Ray P, 2002, NUCLEIC ACIDS RES, V30, P3972, DOI 10.1093/nar/gkf528; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003; THOMPSEN JC, 1984, ANAL CHEM, V56, P755, DOI 10.1021/ac00268a037; Tucker NP, 2004, J BACTERIOL, V186, P6656, DOI 10.1128/JB.186.19.6656-6660.2004; VASAK M, 1981, BIOCHEMISTRY-US, V20, P6659, DOI 10.1021/bi00526a021; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; WERTH MT, 1995, INORG CHEM, V34, P218, DOI 10.1021/ic00105a037; Yikilmaz E, 2002, J AM CHEM SOC, V124, P3482, DOI 10.1021/ja011220v; Zhang X, 2002, MOL MICROBIOL, V45, P895, DOI 10.1046/j.1365-2958.2002.03065.x; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	60	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					908	918		10.1074/jbc.M705850200	http://dx.doi.org/10.1074/jbc.M705850200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003617	hybrid			2022-12-27	WOS:000252128100031
J	Okano, T; Shimomura, Y; Yamane, M; Suhara, Y; Kamao, M; Sugiura, M; Nakagawa, K				Okano, Toshio; Shimomura, Yuka; Yamane, Makiko; Suhara, Yoshitomo; Kamao, Maya; Sugiura, Makiko; Nakagawa, Kimie			Conversion of phylloquinone (vitamin K-1) into menaquinone-4 (vitamin K-2) in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT CARBOXYLASE; BLOOD-COAGULATION; DIETARY PHYLLOQUINONE; TISSUE MENAQUINONE-4; GAMMA-CARBOXYLATION; PRIMARY CULTURES; METABOLISM; RATS; PROTEINS; ACCUMULATION	There are two forms of naturally occurring vitamin K, phylloquinone and the menaquinones. Phylloquinone (vitamin K-1) is a major type (>90%) of dietary vitamin K, but its concentrations in animal tissues are remarkably low compared with those of the menaquinones, especially menaquinone-4 (vitamin K-2), the major form (>90%) of vitamin K in tissues. Despite this great difference, the origin of tissue menaquinone-4 has yet to be exclusively defined. It is postulated that phylloquinone is converted into menaquinone-4 and accumulates in extrahepatic tissues. To clarify this, phylloquinone with a deuterium-labeled 2-methyl- 1,4-naphthoquinone ring was given orally to mice, and cerebra were collected for D NMR and liquid chromatography-tandem mass spectrometry analyses. We identified the labeled menaquinone-4 that was converted from the given phylloquinone, and this conversion occurred following an oral or enteral administration, but not parenteral or intracerebroventricular administration. By the oral route, the phylloquinone with the deuterium-labeled side chain in addition to the labeled 2-methyl- 1,4-naphthoquinone was clearly converted into a labeled menaquinone-4 with a non-deuterium-labeled side chain, implying that phylloquinone was converted into menaquinone-4 via integral side-chain removal. The conversion also occurred in cerebral slice cultures and primary cultures. Deuterium-labeled menadione was consistently converted into the labeled menaquinone-4 with all of the administration routes and the culture conditions tested. Our results suggest that cerebral menaquinone-4 originates from phylloquinone intake and that there are two routes of accumulation, one is the release of menadione from phylloquinone in the intestine followed by the prenylation of menadione into menaquinone-4 in tissues, and another is cleavage and prenylation within the cerebrum.	[Okano, Toshio; Shimomura, Yuka; Yamane, Makiko; Suhara, Yoshitomo; Kamao, Maya; Nakagawa, Kimie] Kobe Pharmaceut Univ, Dept Hygn Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Sugiura, Makiko] Kobe Pharmaceut Univ, Analyt Ctr, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hygn Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp		Suhara, Yoshitomo/0000-0002-4770-2910				Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; BILLETER M, 1960, BIOCHEM Z, V333, P430; Bristol JA, 1996, BLOOD, V88, P2585, DOI 10.1182/blood.V88.7.2585.bloodjournal8872585; CARLISLE TL, 1980, BIOCHEMISTRY-US, V19, P1161, DOI 10.1021/bi00547a019; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; FABRE M, 1985, DEV NEUROSCI-BASEL, V7, P323, DOI 10.1159/000112300; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1992, NEW ENGL J MED, V326, P800; Huber AM, 1999, J NUTR, V129, P1039, DOI 10.1093/jn/129.5.1039; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; JOLLY DW, 1977, AM J PHYSIOL, V232, pH12, DOI 10.1152/ajpheart.1977.232.1.H12; LOSITO R, 1967, BIOCHEMISTRY-US, V6, P62, DOI 10.1021/bi00853a012; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; MARY E, 1981, J CELL BIOL, V90, P622; METTA VC, 1960, J NUTR, V72, P455, DOI 10.1093/jn/72.4.455; PRICE PA, 1988, ANNU REV NUTR, V8, P565, DOI 10.1146/annurev.nu.08.070188.003025; RODEN JE, 1998, BIOCHIM BIOPHYS ACTA, V1379, P69; SEEGERS WH, 1965, THROMB DIATH HAEMOST, V14, P213; Servitja JM, 2000, J NEUROCHEM, V75, P788, DOI 10.1046/j.1471-4159.2000.0750788.x; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shearer M J, 1974, Vitam Horm, V32, P513; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Suhara Y, 2005, ANAL CHEM, V77, P757, DOI 10.1021/ac0489667; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; SUTTIE JW, 1995, ANNU REV NUTR, V15, P399, DOI 10.1146/annurev.nu.15.070195.002151; SUTTIE JW, 1980, CRC CR REV BIOCH MOL, V8, P191, DOI 10.3109/10409238009105469; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; Tsaioun KI, 1999, NUTR REV, V57, P231, DOI 10.1111/j.1753-4887.1999.tb06950.x; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; WILL BH, 1992, J NUTR, V122, P2354, DOI 10.1093/jn/122.12.2354	34	176	190	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11270	11279		10.1074/jbc.M702971200	http://dx.doi.org/10.1074/jbc.M702971200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18083713	hybrid			2022-12-27	WOS:000255067400023
J	Bhattacharyya, S; Marinic, TE; Krukovets, I; Hoppe, G; Stenina, OI				Bhattacharyya, Sanghamitra; Marinic, Tina E.; Krukovets, Irene; Hoppe, George; Stenina, Olga I.			Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MESANGIAL CELLS; IN-VITRO; ANGIOGENESIS; PROLIFERATION; EXPRESSION; GENES	Hyperglycemia is an independent risk factor for development of vascular diabetic complications. Vascular dysfunction in diabetics manifests in a tissue-specific manner; macrovasculature is affected by atherosclerotic lesions, and microvascular complications are described as "aberrant angiogenesis": in the same patient angiogenesis is increased in some tissues ( e. g. retinal neovascularization) and decreased in others ( e. g. in skin). Molecular cell- and tissue-specific mechanisms regulating the response of vasculature to hyperglycemia remain unclear. Thrombospondin-1 (TSP-1), a potent antiangiogenic and proatherogenic protein, has been implicated in the development of several vascular diabetic complications ( atherosclerosis, nephropathy, and cardiomyopathy). This study examines cell type-specific regulation of production of thrombospondin-1 by high glucose. We previously reported the increased expression of TSP-1 in the large arteries of diabetic animals. mRNA and protein levels were up- regulated in response to high glucose. Unlike in macrovascular cells, TSP-1 protein levels are dramatically decreased in response to high glucose in microvascular endothelial cells and retinal pigment epithelial cells (RPE). This down-regulation is post-transcriptional; mRNA levels are increased. In situ mRNA hybridization and immunohistochemistry revealed that the level of mRNA is up- regulated in RPE of diabetic rats, whereas the protein level is decreased. This cell type-specific post-transcriptional suppression of TSP-1 production in response to high glucose in microvascular endothelial cells and RPE is controlled by untranslated regions of TSP-1 mRNA that regulate coupling of TSP-1 mRNA to polysomes and its translation. The cell specific regulation of TSP-1 suggests a potential mechanism for the aberrant angiogenesis in diabetics and TSP-1 involvement in development of various vascular diabetic complications.	[Bhattacharyya, Sanghamitra; Marinic, Tina E.; Krukovets, Irene; Stenina, Olga I.] Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Cleveland, OH 44026 USA; [Hoppe, George] Cole Eye Inst, Cleveland Clin, Cleveland, OH 44026 USA	Cleveland Clinic Foundation	Stenina, OI (corresponding author), NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	stenino@ccf.org		, Olga/0000-0002-1256-0545	NATIONAL EYE INSTITUTE [P30EY001931] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062128, R01DK067532] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY01931] Funding Source: Medline; NHLBI NIH HHS [P50 HL077107] Funding Source: Medline; NIDDK NIH HHS [R01 DK067532, K01 DK62128] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; BAYRAKTAR M, 1994, J INT MED RES, V22, P90, DOI 10.1177/030006059402200204; Belmadani S, 2007, AM J PATHOL; CANFIELD AE, 1995, J CELL SCI, V108, P797; Carpizo D, 2000, CANCER METAST REV, V19, P159, DOI 10.1023/A:1026570331022; Carron JA, 2000, INT J BIOCHEM CELL B, V32, P1137, DOI 10.1016/S1357-2725(00)00065-0; DIPIETRO LA, 1994, J VASC RES, V31, P178, DOI 10.1159/000319585; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Hawighorst T, 2002, ONCOGENE, V21, P7945, DOI 10.1038/sj.onc.1205956; HISCOTT P, 1992, EYE, V6, P566, DOI 10.1038/eye.1992.123; Hugo CPM, 1999, KIDNEY INT, V55, P2236, DOI 10.1046/j.1523-1755.1999.00459.x; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Nathan DM, 2003, NEW ENGL J MED, V348, P761; NATHAN DM, 1950, NEW ENGL J MED, V353, P2643; Peyvandi F, 2003, BLOOD, V102, p314A; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X; Roth JJ, 1998, J SURG RES, V74, P11, DOI 10.1006/jsre.1997.5209; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; SHEIBANI N, 1995, P NATL ACAD SCI USA, V92, P6788, DOI 10.1073/pnas.92.15.6788; Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Tada H, 1995, TOHOKU J EXP MED, V177, P293, DOI 10.1620/tjem.177.293; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703, DOI 10.1681/ASN.V124703; Zhao XM, 2001, CIRCULATION, V103, P525, DOI 10.1161/01.CIR.103.4.525	36	40	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5699	5707		10.1074/jbc.M706435200	http://dx.doi.org/10.1074/jbc.M706435200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096704	hybrid			2022-12-27	WOS:000253426700051
J	Job, V; Carapito, R; Vernet, T; Dessen, A; Zapun, A				Job, Viviana; Carapito, Raphael; Vernet, Thierry; Dessen, Andrea; Zapun, Andre			Common alterations in PBP1a from resistant streptococcus pneumoniae decrease its reactivity toward beta-lactams - Structural insights	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; CLINICAL ISOLATE; GENES; ANTIBIOTICS; PBP2X; 2X; 1A; SUSCEPTIBILITY; IDENTIFICATION	The development of high level beta-lactam resistance in the pneumococcus requires the expression of an altered form of PBP1a, in addition to modified forms of PBP2b and PBP2x, which are necessary for the appearance of low levels of resistance. Here, we present the crystal structure of a soluble form of PBP1a from the highly resistant Streptococcus pneumoniae strain 5204 (minimal inhibitory concentration of cefotaxime is 12 mg center dot liter(-1)). Mutations T371A, which is adjacent to the catalytic nucleophile Ser(370), and TSQF(574-577) NTGY, which lie in a loop bordering the active site cleft, were investigated by site-directed mutagenesis. The consequences of these substitutions on reaction kinetics with beta-lactams were probed in vitro, and their effect on resistance was measured in vivo. The results are interpreted in the framework of the crystal structure, which displays a narrower, discontinuous active site cavity, compared with that of PBP1a from the beta-lactam susceptible strain R6, as well as a reorientation of the catalytic Ser(370).	[Carapito, Raphael; Vernet, Thierry; Zapun, Andre] Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Ingn Macromol, F-38025 Grenoble, France; [Job, Viviana; Dessen, Andrea] Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Prot Membranaires, F-38025 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Zapun, A (corresponding author), Univ Grenoble 1, CNRS,UMR 5075, Inst Biol Struct Jean Pierre Ebel, Lab Ingn Macromol, 41 Rue Jules Horwitz, F-38025 Grenoble, France.	andre.zapun@ibs.fr	Carapito, Raphael/ABG-5061-2020; Carapito, Raphael/O-5317-2016; Vernet, Thierry/G-1118-2012	Carapito, Raphael/0000-0002-7036-442X; Carapito, Raphael/0000-0002-7036-442X; Zapun, Andre/0000-0001-8953-4399; Dessen, Andrea/0000-0001-6487-4020; Job, Viviana/0000-0001-8421-5292				[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carapito R, 2006, J BIOL CHEM, V281, P1771, DOI 10.1074/jbc.M511506200; Carapito R, 2006, ANAL BIOCHEM, V355, P110, DOI 10.1016/j.ab.2006.04.047; Chesnel L, 2003, J BIOL CHEM, V278, P44448, DOI 10.1074/jbc.M305948200; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; Contreras-Martel C, 2006, J MOL BIOL, V355, P684, DOI 10.1016/j.jmb.2005.10.030; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Di Guilmi AM, 1998, J BACTERIOL, V180, P5652, DOI 10.1128/JB.180.21.5652-5659.1998; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1993, MOL MICROBIOL, V9, P635, DOI 10.1111/j.1365-2958.1993.tb01723.x; du Plessis M, 1999, J CLIN MICROBIOL, V37, P628, DOI 10.1128/JCM.37.3.628-632.1999; du Plessis M, 2002, ANTIMICROB AGENTS CH, V46, P2349, DOI 10.1128/AAC.46.8.2349-2357.2002; Graves-Woodward K, 1998, BIOCHEM J, V332, P755, DOI 10.1042/bj3320755; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LAIBLE G, 1991, MOL MICROBIOL, V5, P1993, DOI 10.1111/j.1365-2958.1991.tb00821.x; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu WP, 2001, J BIOL CHEM, V276, P31494, DOI 10.1074/jbc.M102499200; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MARTIN C, 1992, EMBO J, V11, P3831, DOI 10.1002/j.1460-2075.1992.tb05475.x; MAUGEIN J, 2006, B EPIDEMIOLOGIQUE HE, V1, P6; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Mouz N, 1999, J BIOL CHEM, V274, P19175, DOI 10.1074/jbc.274.27.19175; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Reichmann P, 1996, MICROB DRUG RESIST, V2, P177, DOI 10.1089/mdr.1996.2.177; SIBOLD C, 1994, MOL MICROBIOL, V12, P1013, DOI 10.1111/j.1365-2958.1994.tb01089.x; Smith AM, 1998, ANTIMICROB AGENTS CH, V42, P1329, DOI 10.1128/AAC.42.6.1329; Smith AM, 2003, ANTIMICROB AGENTS CH, V47, P387, DOI 10.1128/AAC.47.1.387-389.2003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133	38	37	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4886	4894		10.1074/jbc.M706181200	http://dx.doi.org/10.1074/jbc.M706181200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18055459	Green Published, hybrid			2022-12-27	WOS:000253426500046
J	VanDemark, AP; Xin, H; McCullough, L; Rawlins, R; Bentley, S; Heroux, A; Stillman, DJ; Hill, CP; Formosa, T				VanDemark, Andrew P.; Xin, Hua; McCullough, Laura; Rawlins, Robert; Bentley, Shayla; Heroux, Annie; Stillman, David J.; Hill, Christopher P.; Formosa, Tim			Structural and functional analysis of the Spt16p N-terminal domain reveals overlapping roles of yFACT subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; METHIONINE AMINOPEPTIDASE; CREATINE AMIDINOHYDROLASE; CRYSTAL-STRUCTURE; YEAST FACT; TRANSCRIPTION; COMPLEXES; BINDING	yFACT (heterodimers of Saccharomyces cerevisiae Spt16-Pob3 combined with Nhp6) binds to and alters the properties of nucleosomes. The essential function of yFACT is not disrupted by deletion of the N-terminal domain (NTD) of Spt16 or by mutation of the middle domain of Pob3, but either alteration makes yeast cells sensitive to DNA replication stress. We have determined the structure of the Spt16 NTD and find evidence for a conserved potential peptide-binding site. Pob3-M also contains a putative binding site, and we show that these two sites perform an overlapping essential function. We find that yFACT can bind the N-terminal tails of some histones and that this interaction is important for yFACT-nucleosome binding. However, neither the Spt16 NTD nor a key residue in the putative Pob3-M-binding site was required for interactions with histone N termini or for yFACT-mediated nucleosome reorganization in vitro. Instead, both potential binding sites interact functionally with the C-terminal docking domain of the histone H2A. yFACT therefore appears to make multiple contacts with different sites within nucleosomes, and these interactions are partially redundant with one another. The docking domain of H2A is identified as an important participant in maintaining stability during yFACT-mediated nucleosome reorganization, suggesting new models for the mechanism of this activity.	[VanDemark, Andrew P.; Xin, Hua; McCullough, Laura; Rawlins, Robert; Hill, Christopher P.; Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Bentley, Shayla; Stillman, David J.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory; Utah System of Higher Education; University of Utah	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu; tim@biochem.utah.edu		Formosa, Tim/0000-0002-8477-2483; Stillman, David/0000-0002-5268-2416; VanDemark, Andrew/0000-0003-3424-4831	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076242] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076242] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, CURR BIOL, V8, pR111, DOI 10.1016/S0960-9822(98)70982-0; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Burke D., 2000, METHODS YEAST GENETI; COLL M, 1990, J MOL BIOL, V214, P597, DOI 10.1016/0022-2836(90)90201-V; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hertel L, 1999, EXP CELL RES, V250, P313, DOI 10.1006/excr.1999.4495; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2002, ACTA CRYSTALLOGR D, V58, P1322, DOI 10.1107/S0907444902010156; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Singer RA, 2004, BIOCHEM CELL BIOL, V82, P419, DOI 10.1139/O04-050; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; VanDemark AP, 2007, MOL CELL, V27, P171, DOI 10.1016/j.molcel.2007.06.007; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	49	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5058	5068		10.1074/jbc.M708682200	http://dx.doi.org/10.1074/jbc.M708682200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089575	hybrid			2022-12-27	WOS:000253426500063
J	Langelier, MF; Servent, KM; Rogers, EE; Pascal, JM				Langelier, Marie-France; Servent, Kristin M.; Rogers, Elizabeth E.; Pascal, John M.			A third zinc-binding domain of human poly(ADP-ribose) polymerase-1 coordinates DNA-dependent enzyme activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLTRANSFERASE; CATALYTIC-ACTIVITY; PROTEIN; PARP-1; SIGNAL; ASSOCIATION; CLEAVAGE; FINGERS; DAMAGE; XRCC1	Poly(ADP-ribose) polymerase-1 (PARP-1) is a chromatin-associated enzyme with multiple cellular functions, including DNA repair, transcriptional regulation, and cell signaling. PARP-1 has a modular architecture with six independent domains comprising the 113-kDa polypeptide. Two zinc finger domains at the N terminus of PARP-1 bind to DNA and thereby activate the catalytic domain situated at the C terminus of the enzyme. The tight coupling of DNA binding and catalytic activities is critical to the cellular regulation of PARP-1 function; however, the mechanism for coordinating these activities remains an unsolved problem. Here, we demonstrate using spectroscopic and crystallographic analysis that human PARP-1 has a third zinc-binding domain. Biochemical mutagenesis and deletion analysis indicate that this region mediates interdomain contacts important for DNA-dependent enzyme activation. The crystal structure of the third zinc-binding domain reveals a zinc ribbon fold and suggests conserved residues that could form interdomain contacts. The new zinc-binding domain self-associates in the crystal lattice to form a homodimer with a head-to-tail arrangement. The structure of the homodimer provides a scaffold for assembling the activated state of PARP-1 and suggests a mechanism for coupling the DNA binding and catalytic functions of PARP-1.	[Langelier, Marie-France; Servent, Kristin M.; Rogers, Elizabeth E.; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), 233 South 10th St,BLSB 804, Philadelphia, PA 19107 USA.	John.Pascal@mail.jci.tju.edu						ALVAREZGONZALEZ R, 1987, BIOCHEMISTRY-US, V26, P3218, DOI 10.1021/bi00385a042; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BAUER PI, 1990, BIOCHEM J, V270, P17, DOI 10.1042/bj2700017; Bertini I, 1984, Adv Inorg Biochem, V6, P71; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; BUKI KG, 1995, J BIOL CHEM, V270, P3370, DOI 10.1074/jbc.270.7.3370; BUKI KG, 1988, BIOCHEMISTRY-US, V27, P5990, DOI 10.1021/bi00416a024; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Amours D, 2001, J CELL SCI, V114, P3771; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; GRATZER WB, 1969, NATURE, V222, P426, DOI 10.1038/222426a0; Haince JF, 2005, TRENDS MOL MED, V11, P456, DOI 10.1016/j.molmed.2005.08.003; Huang K, 2004, BIOCHEMISTRY-US, V43, P217, DOI 10.1021/bi0301800; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; KAMESHITA I, 1986, J BIOL CHEM, V261, P3863; Kanai M, 2007, NAT CELL BIOL, V9, P1175, DOI 10.1038/ncb1638; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; KAWAICHI M, 1981, J BIOL CHEM, V256, P9483; Kim JW, 2000, J BIOL CHEM, V275, P8121, DOI 10.1074/jbc.275.11.8121; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Matthews JM, 2000, EUR J BIOCHEM, V267, P1030, DOI 10.1046/j.1432-1327.2000.01095.x; MAY SW, 1978, BIOCHEMISTRY-US, V17, P3333, DOI 10.1021/bi00609a025; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Rolli V., 2000, DNA DAMAGE STRESS SI, P35; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; SASTRY SS, 1989, BIOCHEMISTRY-US, V28, P5670, DOI 10.1021/bi00439a050; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THIBODEAU J, 1993, BIOCHIM BIOPHYS ACTA, V1163, P49, DOI 10.1016/0167-4838(93)90277-X; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; ZAHRADKA P, 1984, EUR J BIOCHEM, V142, P503, DOI 10.1111/j.1432-1033.1984.tb08314.x; RIKEN STRUCTURAL GEN	52	146	157	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4105	4114		10.1074/jbc.M708558200	http://dx.doi.org/10.1074/jbc.M708558200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18055453	hybrid			2022-12-27	WOS:000253083500046
J	Barthelemy, PA; Raab, H; Appleton, BA; Bond, CJ; Wu, P; Wiesmann, C; Sidhu, SS				Barthelemy, Pierre A.; Raab, Helga; Appleton, Brent A.; Bond, Christopher J.; Wu, Ping; Wiesmann, Christian; Sidhu, Sachdev S.			Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human V-H domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY HUMAN-ANTIBODIES; STAPHYLOCOCCAL PROTEIN-A; LLAMA VHH DOMAIN; SINGLE-DOMAIN; CRYSTAL-STRUCTURE; ANTIGEN-BINDING; ANTI-P185HER2 ANTIBODY; ESCHERICHIA-COLI; VARIABLE DOMAIN; PHAGE DISPLAY	We report a comprehensive analysis of sequence features that allow for the production of autonomous human heavy chain variable (V-H) domains that are stable and soluble in the absence of a light chain partner. Using combinatorial phage- displayed libraries and conventional biophysical methods, we analyzed the entire former light chain interface and the third complementarity determining region (CDR3). Unlike the monomeric variable domains of camelid heavy chain antibodies (VHH domains), in which autonomous behavior depends on interactions between the hydrophobic former light chain interface and CDR3, we find that the stability of many in vitro evolved V-H domains is essentially independent of the CDR3 sequence and instead derives from mutations that increase the hydrophilicity of the former light chain interface by replacing exposed hydrophobic residues with structurally compatible hydrophilic substitutions. The engineered domains can be expressed recombinantly at high yield, are predominantly monomeric at high concentrations, unfold reversibly, and are even more thermostable than typical camelid VHH domains. Many of the stabilizing mutations are rare in natural V-H and VHH domains and thus could not be predicted by studying natural sequences and structures. The results demonstrate that autonomous V-H domains with structural properties beyond the scope of natural frameworks can be derived by using non- natural mutations, which differ from those found in camelid VHH domains. These findings should enable the development of libraries of synthetic V-H domains with CDR3 diversities unconstrained by structural demands.	[Barthelemy, Pierre A.; Appleton, Brent A.; Bond, Christopher J.; Wu, Ping; Wiesmann, Christian; Sidhu, Sachdev S.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Raab, Helga] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Sidhu, SS (corresponding author), Genentech Inc, Dept Prot Engn, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA.	sidhu@gene.com		Wiesmann, Christian/0000-0002-4092-9880; Appleton, Brent/0000-0003-1136-5649				BARBAS CF, 1993, GENE, V137, P57, DOI 10.1016/0378-1119(93)90251-W; Bond CJ, 2005, J MOL BIOL, V348, P699, DOI 10.1016/j.jmb.2005.02.063; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CARTER P, 1992, BIO-TECHNOL, V10, P163, DOI 10.1038/nbt0292-163; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Cortez-Retamozo V, 2002, INT J CANCER, V98, P456, DOI 10.1002/ijc.10212; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DAVIES J, 1995, BIO-TECHNOL, V13, P475, DOI 10.1038/nbt0595-475; de Wildt RMT, 2000, NAT BIOTECHNOL, V18, P989, DOI 10.1038/79494; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Graille M, 2000, P NATL ACAD SCI USA, V97, P5399, DOI 10.1073/pnas.97.10.5399; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2000, MOL IMMUNOL, V37, P579, DOI 10.1016/S0161-5890(00)00081-X; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; KABAT EA, 1987, SEQUENCES PROTEINS I, P1; KELLEY RF, 1992, BIOCHEMISTRY-US, V31, P5434, DOI 10.1021/bi00139a003; KELLEY RF, 1993, BIOCHEMISTRY-US, V32, P6828, DOI 10.1021/bi00078a005; KIRKHAM PM, 1992, EMBO J, V11, P603, DOI 10.1002/j.1460-2075.1992.tb05092.x; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; KORTT AA, 1995, J PROTEIN CHEM, V14, P167, DOI 10.1007/BF01980329; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Martin F, 1997, PROTEIN ENG, V10, P607, DOI 10.1093/protein/10.5.607; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Meininger DP, 2000, BIOCHEMISTRY-US, V39, P26, DOI 10.1021/bi9920174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Potter K N, 1997, Int Rev Immunol, V14, P291, DOI 10.3109/08830189709116521; Potter KN, 1996, J IMMUNOL, V157, P2982; Reiter Y, 1999, J MOL BIOL, V290, P685, DOI 10.1006/jmbi.1999.2923; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; RIECHMANN L, 1995, J BIOMOL NMR, V6, P141, DOI 10.1007/BF00211778; Riechmann L, 1999, J IMMUNOL METHODS, V231, P25, DOI 10.1016/S0022-1759(99)00138-6; Rosebrough S F, 1996, Q J Nucl Med, V40, P234; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Sidhu SS, 2000, J MOL BIOL, V296, P487, DOI 10.1006/jmbi.1999.3465; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; Spinelli S, 2004, FEBS LETT, V564, P35, DOI 10.1016/S0014-5793(04)00304-7; Spinelli S, 2001, J MOL BIOL, V311, P123, DOI 10.1006/jmbi.2001.4856; Starovasnik MA, 1999, PROTEIN SCI, V8, P1423, DOI 10.1110/ps.8.7.1423; Stijlemans B, 2004, J BIOL CHEM, V279, P1256, DOI 10.1074/jbc.M307341200; Sundaresan G, 2003, J NUCL MED, V44, P1962; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; Tokunaga Eriko, 2006, Int J Clin Oncol, V11, P199, DOI 10.1007/s10147-006-0575-4; Voordijk S, 2000, J MOL BIOL, V300, P963, DOI 10.1006/jmbi.2000.3890; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zuckier LS, 1997, SEMIN NUCL MED, V27, P10, DOI 10.1016/S0001-2998(97)80033-5	74	131	176	6	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3639	3654		10.1074/jbc.M708536200	http://dx.doi.org/10.1074/jbc.M708536200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18045863	hybrid			2022-12-27	WOS:000253083000069
J	Alter-Koltunoff, M; Goren, S; Nousbeck, J; Feng, CG; Sher, A; Ozato, K; Azriel, A; Levi, BZ				Alter-Koltunoff, Michal; Goren, Sigal; Nousbeck, Janna; Feng, Carl G.; Sher, Alan; Ozato, Keiko; Azriel, Aviva; Levi, Ben-Zion			Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-BINDING-PROTEIN; INFECTIOUS-DISEASE SUSCEPTIBILITY; INTRACELLULAR IRON TRANSPORT; MYELOID PROGENITOR CELLS; NATURAL-RESISTANCE; GENE-EXPRESSION; INTERLEUKIN-12 EXPRESSION; TRANSCRIPTION FACTOR; LEISHMANIA-DONOVANI; DENDRITIC CELLS	Macrophages are a central arm of innate immune defense against intracellular pathogens. They internalize microbes into phagosomes where the invaders are being killed by oxygen and nitrogen reactive species. Despite this battery of antimicrobial molecules, some are able to thrive within the phagosome thus termed intraphagosomal pathogens among which are Salmonella, Leishmania, and Mycobacteria. In mice, a single dominant gene termed Nramp1/Slc11a1 controls innate resistance to such pathogens. This gene is expressed exclusively in myeloid cells. Previously, we have shown that the restricted expression of Nramp1 is regulated by a myeloid cell-specific transcription factor termed IRF-8/ICSBP. It is demonstrated here that the induction of Nramp1 expression in activated macrophages is accompanied by a promoter shift from a repression state elicited by c-Myc to an activation state elicited by the induction of IRF-8 in activated macrophages. This transition from repression to activation is facilitated by a competitive protein-protein interaction with the transcription factor Miz-1. To show that IRF-8 is directly involved in the elimination of intraphagosomal pathogens through the regulation of Nramp1 gene expression, we bred wild type as well as IRF-8 and Nramp1 null mouse strains and examined macrophages derived from bone marrow and peritoneum. Our results clearly show that the absence of IRF-8 and Nramp1 leads to the same phenotype; defective killing of intraphagosomal Salmonella enterica serovar typhimurium and Mycobacterium bovis. Thus, interplay between repression and activation state of the Nramp1 promoter mediated by IRF-8 provides the molecular basis by which macrophages resist intraphagosomal pathogens at early stage after infection.	[Alter-Koltunoff, Michal; Goren, Sigal; Nousbeck, Janna; Azriel, Aviva; Levi, Ben-Zion] Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel; [Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Bethesda, MD 20892 USA; [Feng, Carl G.; Sher, Alan] NIAID, Immunol Sect, Natl Inst Hlth, Bethesda, MD 20892 USA	Technion Israel Institute of Technology; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Levi, BZ (corresponding author), Technion Israel Inst Technol, Dept Food Engn & Biotechnol, IL-32000 Haifa, Israel.	blevi@technion.ac.il		feng, carl/0000-0003-4301-4640	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001044, ZIAAI001044] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alter-Koltunoff M, 2003, J BIOL CHEM, V278, P44025, DOI 10.1074/jbc.M307954200; Atkinson PGP, 1999, IMMUNOLOGY, V96, P656; Barton CH, 1999, J LEUKOCYTE BIOL, V66, P757, DOI 10.1002/jlb.66.5.757; Bayele HK, 2007, BLOOD, V110, P3039, DOI 10.1182/blood-2006-12-063289; Blackwell JM, 2003, IMMUNOL LETT, V85, P197, DOI 10.1016/S0165-2478(02)00231-6; Blackwell JM, 2001, TRENDS MOL MED, V7, P521, DOI 10.1016/S1471-4914(01)02169-4; Bowen H, 2002, J BIOL CHEM, V277, P34997, DOI 10.1074/jbc.M204232200; Cuellar-Mata P, 2002, J BIOL CHEM, V277, P2258, DOI 10.1074/jbc.M105508200; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; Eklund EA, 1999, J IMMUNOL, V163, P6095; Fortier A, 2005, J LEUKOCYTE BIOL, V77, P868, DOI 10.1189/jlb.1004616; Giese NA, 1997, J EXP MED, V186, P1535, DOI 10.1084/jem.186.9.1535; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Govoni G, 1996, INFECT IMMUN, V64, P2923, DOI 10.1128/IAI.64.8.2923-2929.1996; Gruenheid S, 1997, J EXP MED, V185, P717, DOI 10.1084/jem.185.4.717; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kim YM, 2000, J IMMUNOL, V165, P3198, DOI 10.4049/jimmunol.165.6.3198; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Marecki S, 2001, J IMMUNOL, V166, P6829, DOI 10.4049/jimmunol.166.11.6829; Monack DM, 1996, P NATL ACAD SCI USA, V93, P9833, DOI 10.1073/pnas.93.18.9833; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; Ozato K, 2002, BIOTECHNIQUES, V33, pS66; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; SchartonKersten T, 1997, J EXP MED, V186, P1523, DOI 10.1084/jem.186.9.1523; Schneider A, 1997, CURR TOP MICROBIOL, V224, P137; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Searle S, 1999, J MED GENET, V36, P295; Searle S, 1998, J CELL SCI, V111, P2855; Stober CB, 2007, INFECT IMMUN, V75, P5059, DOI 10.1128/IAI.00153-07; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2003, BLOOD, V102, P4547, DOI 10.1182/blood-2003-01-0291; Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; Via LE, 1998, J CELL SCI, V111, P897; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Wang IM, 2000, J IMMUNOL, V165, P271, DOI 10.4049/jimmunol.165.1.271; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; White JK, 2005, J LEUKOCYTE BIOL, V77, P311, DOI 10.1189/jlb.0904546; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013	51	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2724	2733		10.1074/jbc.M707704200	http://dx.doi.org/10.1074/jbc.M707704200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18045875	hybrid			2022-12-27	WOS:000252622300030
J	Gauguin, L; Klaproth, B; Sajid, W; Andersen, AS; McNeil, KA; Forbes, BE; De Meyts, P				Gauguin, Lisbeth; Klaproth, Birgit; Sajid, Waseem; Andersen, Asser S.; McNeil, Kerrie A.; Forbes, Briony E.; De Meyts, Pierre			Structural basis for the lower affinity of the insulin-like growth factors for the insulin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; FACTOR-I; IGF-II; FUNCTIONAL-CHARACTERISTICS; NEGATIVE COOPERATIVITY; 6-PHOSPHATE RECEPTOR; CRYSTAL-STRUCTURE; FUSION PROTEINS; LIGAND-BINDING; FACTOR (IGF)-I	Insulin and the insulin-like growth factors (IGFs) bind with high affinity to their cognate receptor and with lower affinity to the noncognate receptor. The major structural difference between insulin and the IGFs is that the IGFs are single chain polypeptides containing A-, B-, C-, and D- domains, whereas the insulin molecule contains separate A- and B- chains. The C- domain of IGF-I is critical for high affinity binding to the insulin-like growth factor I receptor, and lack of a C- domain largely explains the low affinity of insulin for the insulin-like growth factor I receptor. It is less clear why the IGFs have lower affinity for the insulin receptor. In this study, 24 insulin analogues and four IGF analogues were expressed and analyzed to explore the role of amino acid differences in the A- and B- domains between insulin and the IGFs in binding affinity for the insulin receptor. Using the information obtained from single substituted analogues, four multiple substituted analogues were produced. A "quadruple insulin" analogue ([Phe(A8), Ser(A10), Thr(B5), Gln(B16)] Ins) showed affinity as IGF-I for the insulin receptor, and a "sextuple insulin" analogue ([Phe(A8), Ser(A10), Thr(A18), Thr(B5), Thr(B14), Gln(B16)] Ins) showed an affinity close to that of IGF-II for the insulin receptor, whereas a "quadruple IGF-I" analogue ([His(4), Tyr(15), Thr(49), Ile(51)] IGF-I) and a "sextuple IGF-II" analogue ([His(7), Ala(16), Tyr(18), Thr(48), Ile(50), Asn58] IGF-II) showed affinities similar to that of insulin for the insulin receptor. The mitogenic potency of these analogues correlated well with the binding properties. Thus, a small number of A- and B- domain substitutions that map to the IGF surface equivalent to the classical binding surface of insulin weaken two hotspots that bind to the insulin receptor site 1.	[Gauguin, Lisbeth; Klaproth, Birgit; Sajid, Waseem; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Andersen, Asser S.] Novo Nordisk AS, Prot Express, DK-2760 Malov, Denmark; [McNeil, Kerrie A.; Forbes, Briony E.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Novo Nordisk; Hagedorn Research Institute; Novo Nordisk; University of Adelaide	Gauguin, L (corresponding author), Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark.	LGau@hagedorn.dk	Forbes, Briony/R-1838-2019	De Meyts, Pierre/0000-0001-6214-0824; Forbes, Briony/0000-0003-4360-9927				Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAYNE ML, 1989, J BIOL CHEM, V264, P11004; BAYNE ML, 1990, J BIOL CHEM, V265, P15648; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; Benyoucef S, 2007, BIOCHEM J, V403, P603, DOI 10.1042/BJ20061709; Blundell T L, 1971, Recent Prog Horm Res, V27, P1; CASCIERI MA, 1988, BIOCHEMISTRY-US, V27, P3229, DOI 10.1021/bi00409a016; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Delaine C, 2007, J BIOL CHEM, V282, P18886, DOI 10.1074/jbc.M700531200; DEMEYTS P, 1978, NATURE, V273, P504; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Denley A, 2005, MOL ENDOCRINOL, V19, P711, DOI 10.1210/me.2004-0409; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Efstratiadis A, 1998, INT J DEV BIOL, V42, P955; FRANCIS GL, 1993, BIOCHEM J, V293, P713, DOI 10.1042/bj2930713; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; HU SQ, 1993, J PROTEIN CHEM, V12, P741, DOI 10.1007/BF01024932; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; Jansson M, 1998, J BIOL CHEM, V273, P24701, DOI 10.1074/jbc.273.38.24701; Jensen A. M., 2000, THESIS U COPENHAGEN; KING R, 1992, J MOL ENDOCRINOL, V8, P29, DOI 10.1677/jme.0.0080029; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 2001, Biotechnol Genet Eng Rev, V18, P89; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Lawrence MC, 2007, CURR OPIN STRUC BIOL, V17, P699, DOI 10.1016/j.sbi.2007.07.007; Lien S, 2001, BIOTECHNOL BIOENG, V74, P335, DOI 10.1002/bit.1124; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MILNER SJ, 1995, BIOCHEM J, V308, P865, DOI 10.1042/bj3080865; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; PALSGAARD J, 2003, RECEPTOR BINDING PRO; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RYLE AP, 1955, BIOCHEM J, V60, P541, DOI 10.1042/bj0600541; SAKANO KI, 1991, J BIOL CHEM, V266, P20626; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1985, J PROTEIN CHEM, V4, P185, DOI 10.1007/BF01025264; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Shooter GK, 1996, J MOL ENDOCRINOL, V17, P237, DOI 10.1677/jme.0.0170237; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; TSUNASAWA S, 1989, J BIOL CHEM, V264, P3832; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	56	48	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2604	2613		10.1074/jbc.M709220200	http://dx.doi.org/10.1074/jbc.M709220200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048361	hybrid			2022-12-27	WOS:000252622300017
J	Kleinschmidt, AM; Nassiri, M; Stitt, MS; Wasserloos, K; Watkins, SC; Pitt, BR; Jahroudi, N				Kleinschmidt, Ann M.; Nassiri, Marjan; Stitt, Molly S.; Wasserloos, Karla; Watkins, Simon C.; Pitt, Bruce R.; Jahroudi, Nadia			Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO EXPRESSION; PHENOTYPIC HETEROGENEITY; NUCLEAR ACTIN; TRANSCRIPTION; IDENTIFICATION; REPRESSOR; ELEMENTS; LOCUS; CD34	In vivo analyses of the VWF promoter previously demonstrated that a fragment spanning sequences -487 to +247 targets promoter activation to brain vascular endothelial cells, whereas a longer fragment including 2182 bp of the 5'- flanking sequences, the first exon, and the first intron activated expression in endothelial cells of the heart and muscles as well as the brain of transgenic mice. These results suggested that additional VWF gene sequences were required for expression in other vascular endothelial cells in vivo. We have now identified a region within intron 51 of theVWFgene that is DNase I-hypersensitive (HSS) specifically in nonendothelial cells and interacts with endothelial and nonendothelial specific complexes that contain YY1. We demonstrate that beta-actin is associated with YY1 specifically in the nucleus of nonendothelial cells and is a component of the nuclear protein complexes that interact with the DNase I-hypersensitive region. In vitro transfection analyses demonstrated that HSS sequences containing this YY1-binding site do not significantly affect VWF promoter activity. However, in vivo analyses demonstrated that addition of these sequences to the VWF promoter ( - 487 to + 247) results in promoter activation in lung and brain vascular endothelial cells. These results demonstrate that the HSS sequences in intron 51 of the VWF gene contain cis-acting elements that are necessary for the VWF gene transcription in a subset of lung endothelial cells in vivo.	[Nassiri, Marjan; Jahroudi, Nadia] Univ Alberta, Dept Med Nephrol, Edmonton, AB T6G 2S2, Canada; [Kleinschmidt, Ann M.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA; [Stitt, Molly S.; Wasserloos, Karla; Pitt, Bruce R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA	University of Alberta; Allegheny College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jahroudi, N (corresponding author), Univ Alberta, Dept Med Nephrol, 261C-HMRC, Edmonton, AB T6G 2S2, Canada.	nadia.jahroudi@ualberta.ca	Watkins, Simon/ABG-2590-2021; Stitt, Mark/GVT-1242-2022	Watkins, Simon/0000-0003-4092-1552; Stitt, Mark/0000-0002-4900-1763	NHLBI NIH HHS [HL 67729] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067729] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; AIRD WC, 1995, P NATL ACAD SCI USA, V92, P4567, DOI 10.1073/pnas.92.10.4567; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Duta F, 2006, HISTOCHEM CELL BIOL, V126, P495, DOI 10.1007/s00418-006-0188-z; Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193; Guillot PV, 2000, PHYSIOL GENOMICS, V2, P77, DOI 10.1152/physiolgenomics.2000.2.2.77; Hough C, 2005, BLOOD, V105, P1531, DOI 10.1182/blood-2002-10-3093; HOYT DG, 1995, AM J PHYSIOL-LUNG C, V269, pL171, DOI 10.1152/ajplung.1995.269.2.L171; Jahroudi N, 1996, J BIOL CHEM, V271, P21413, DOI 10.1074/jbc.271.35.21413; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Jahroudi N, 2003, J ALZHEIMERS DIS, V5, P149, DOI 10.3233/JAD-2003-5209; Kajiyama Y, 2006, J BIOL CHEM, V281, P30122, DOI 10.1074/jbc.M603491200; Kappel A, 1999, BLOOD, V93, P4284, DOI 10.1182/blood.V93.12.4284.412k25_4284_4292; Kawanami O, 2000, PATHOL INT, V50, P136, DOI 10.1046/j.1440-1827.2000.01006.x; Kawanami Oichi, 2000, Journal of Nippon Medical School, V67, P118, DOI 10.1272/jnms.67.118; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; MANCUSO DJ, 1989, J BIOL CHEM, V264, P19514; MAUTNER J, 1995, NUCLEIC ACIDS RES, V23, P72, DOI 10.1093/nar/23.1.72; Muller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4; Peng Y, 2007, ONCOGENE, V26, P7576, DOI 10.1038/sj.onc.1210565; Peng YW, 2002, BLOOD, V99, P2408, DOI 10.1182/blood.V99.7.2408; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Prandini MH, 2005, ONCOGENE, V24, P2992, DOI 10.1038/sj.onc.1208483; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Radomska HS, 1998, GENE, V222, P305, DOI 10.1016/S0378-1119(98)00491-0; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Roque MC, 1996, MOL CELL BIOL, V16, P3138; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHLAEGER TM, 1995, DEVELOPMENT, V121, P1089; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Schwachtgen JL, 1997, ONCOGENE, V15, P3091, DOI 10.1038/sj.onc.1201502; Schwachtgen JL, 1998, BLOOD, V92, P1247, DOI 10.1182/blood.V92.4.1247.416k08_1247_1258; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHRIVASTAVA A, 1994, NUCLEIC ACIDS RES, V22, P5151, DOI 10.1093/nar/22.24.5151; Teichert AM, 2000, AM J PHYSIOL-HEART C, V278, pH1352, DOI 10.1152/ajpheart.2000.278.4.H1352; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Wang XY, 2004, BLOOD, V104, P1725, DOI 10.1182/blood-2004-01-0082; Wu JI, 2007, SCIENCE, V316, P1710, DOI 10.1126/science.1145014; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	42	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2741	2750		10.1074/jbc.M705466200	http://dx.doi.org/10.1074/jbc.M705466200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18048367	hybrid			2022-12-27	WOS:000252622300032
J	Alejandro, EU; Johnson, JD				Alejandro, Emilyn U.; Johnson, James D.			Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; GLUCAGON-LIKE PEPTIDE-1; REGULATED KINASE; INSULIN-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; SIGNAL-TRANSDUCTION; BCL-2 EXPRESSION; RESPONSE ELEMENT; CA2+ INFLUX; ISLET MASS	The serine threonine kinase Raf-1 plays a protective role in many cell types, but its function in pancreatic beta-cells has not been elucidated. In the present study, we examined whether primary beta-cells possess Raf-1 and tested the hypothesis that Raf-1 is critical for beta-cell survival. Using reverse transcriptase-PCR, Western blot, and immunofluorescence, we identified Raf-1 in human islets, mouse islets, and in the MIN6 beta-cell line. Blocking Raf-1 activity using a specific Raf-1 inhibitor or dominant-negative Raf-1 mutants led to a time-and dose-dependent increase in cell death, assessed by real-time imaging of propidium iodide incorporation, TUNEL, PCR-enhanced DNA laddering, and Caspase-3 cleavage. Although the rapid increase in apoptotic cell death was associated with decreased Erk phosphorylation, studies with two Mek inhibitors suggested that the classical Erk-dependent pathway could explain only part of the cell death observed after inhibition of Raf-1. An alternative Erk-independent pathway downstream of Raf-1 kinase involving the pro-apoptotic protein Bad has recently been characterized in other tissues. Inhibiting Raf-1 in beta-cells led to a striking loss of Bad phosphorylation at serine 112 and an increase in the protein levels of both Bad and Bax. Together, our data strongly suggest that Raf-1 signaling plays an important role regulating beta-cell survival, via both Erk-dependent and Bad-dependent mechanisms. Conversely, acutely inhibiting phosphatidylinositol 3-kinase Akt had more modest effects on beta-cell death. These studies identify Raf-1 as a critical anti-apoptotic kinase in pancreatic beta-cells and contribute to our understanding of survival signaling in this cell type.	[Alejandro, Emilyn U.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Alejandro, Emilyn U.; Johnson, James D.] Univ British Columbia, Dept Surg, Lab Mol Signaling Diabet, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Alejandro, Emilyn/0000-0002-7941-8439; Johnson, James/0000-0002-7523-9433	NIDDK NIH HHS [F31 DK079346-01, F31DK079346, F31 DK079346] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK079346] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; Augstein P, 1998, MOL MED, V4, P495, DOI 10.1007/BF03401754; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; BLACKSHEAR PJ, 1990, J BIOL CHEM, V265, P12131; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Costes S, 2006, DIABETES, V55, P2220, DOI 10.2337/db05-1618; Dalle S, 2004, J BIOL CHEM, V279, P20345, DOI 10.1074/jbc.M312483200; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Edwards LA, 2006, MOL CANCER THER, V5, P645, DOI 10.1158/1535-7163.MCT-05-0099; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hindley A, 2002, J CELL SCI, V115, P1575; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; Hugl SR, 1998, J BIOL CHEM, V273, P17771, DOI 10.1074/jbc.273.28.17771; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Jun T., 1999, SCI STKE, V1999, pPE1; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Longuet C, 2005, ENDOCRINOLOGY, V146, P643, DOI 10.1210/en.2004-0841; Maedler K, 2004, DIABETES, V53, P1706, DOI 10.2337/diabetes.53.7.1706; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto K, 1999, J BIOL CHEM, V274, P2053, DOI 10.1074/jbc.274.4.2053; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pavlovic D, 2000, EUR CYTOKINE NETW, V11, P267; Peruzzi F, 2001, J BIOL CHEM, V276, P25990, DOI 10.1074/jbc.M103188200; Ramachandran S, 2006, AM J TRANSPLANT, V6, P1696, DOI 10.1111/j.1600-6143.2006.01368.x; Salvalaggio PRO, 2002, TRANSPLANTATION, V74, P877, DOI 10.1097/00007890-200209270-00023; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Trumper J, 2005, DIABETOLOGIA, V48, P1534, DOI 10.1007/s00125-005-1820-5; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Wang S, 1998, MOL CELL BIOL, V18, P7487, DOI 10.1128/MCB.18.12.7487; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zhang LZ, 2004, SURGERY, V136, P708, DOI 10.1016/j.surg.2003.12.013; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zimmermann S, 1997, ONCOGENE, V15, P1503, DOI 10.1038/sj.onc.1201322	65	43	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2407	2417		10.1074/jbc.M703612200	http://dx.doi.org/10.1074/jbc.M703612200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18006502	Green Accepted, hybrid			2022-12-27	WOS:000252501000067
J	Iijima, R; Kunieda, T; Yamaguchi, S; Kamigaki, H; Fujii-Taira, I; Sekimizu, K; Kubo, T; Natori, S; Homma, KJ				Iijima, Ryoko; Kunieda, Takekazu; Yamaguchi, Shinji; Kamigaki, Hiroko; Fujii-Taira, Ikuko; Sekimizu, Kazuhisa; Kubo, Takeo; Natori, Shunji; Homma, Koichi J.			The extracellular adenosine deaminase growth factor, ADGF/CECR1, plays a role in Xenopus embryogenesis via the adenosine/P1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAT-EYE SYNDROME; EMBRYONIC-CELL LINE; CENTRAL-NERVOUS-SYSTEM; SARCOPHAGA-PEREGRINA; GASTRULA EMBRYOS; GENE FAMILY; FLESH FLY; EXPRESSION; DROSOPHILA; PURIFICATION	Adenosine deaminase- related growth factors (ADGF), also known as CECR1 in vertebrates, are a novel family of growth factors with sequence similarity to classical cellular adenosine deaminase. Although genes for ADGF/ CECR1 have been identified in both invertebrates as well as vertebrates, their in vivo functions in vertebrates remain unknown. We isolated cDNA clones for two cerc 1s from Xenopus laevis. Both recombinant Xenopus CECR1s exhibited adenosine deaminase and growth factor activity, and the adenosine deaminase activity was found to be indispensable for growth factor activity. The Xenopus cerc 1s are expressed in the somites, pronephros, eyes, cement gland, neural tube, and neural floor plate of the embryos. Knock- down of these two genes using morpholino oligonucleotides caused a reduction in the body size and abnormalities of the body axis in the Xenopus embryos, accompanied by selective changes in the expression of developmental marker genes. Injection of adenosine, agonists for adenosine/P1 receptors, or adenosine deaminase inhibitor into late gastrula archenteron embryos resulted in developmental defects similar to those caused by morpholino oligonucleotide injection. These results show, for the first time, the involvement of CECR1s via the adenosine/P1 receptors in vertebrate embryogenesis via regulation of extracellular adenosine concentrations.	[Yamaguchi, Shinji; Kamigaki, Hiroko; Homma, Koichi J.] Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 2290195, Japan; [Iijima, Ryoko; Yamaguchi, Shinji; Fujii-Taira, Ikuko; Sekimizu, Kazuhisa; Homma, Koichi J.] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iijima, Ryoko; Kunieda, Takekazu; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Iijima, Ryoko; Fujii-Taira, Ikuko; Natori, Shunji] RIKEN, Natori Special Lab, Wako, Saitama 3510198, Japan	Teikyo University; University of Tokyo; University of Tokyo; RIKEN	Homma, KJ (corresponding author), Teikyo Univ, Fac Pharmaceut Sci, Kanagawa 2290195, Japan.	homma-kj@umin.ac.jp	KUBO, TAKEO/G-4951-2014; Kunieda, Takekazu/G-4946-2014	Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335				AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akalal DBG, 2003, MOL BRAIN RES, V117, P228, DOI 10.1016/S0169-328X(03)00287-0; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Carroll TJ, 1996, DEV DYNAM, V206, P131, DOI 10.1002/(SICI)1097-0177(199606)206:2<131::AID-AJA2>3.3.CO;2-I; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; Chanoine C, 2003, DEV DYNAM, V226, P12, DOI 10.1002/dvdy.10206; Charlab R, 2001, GENE, V267, P13, DOI 10.1016/S0378-1119(01)00393-6; Chen Y, 2003, BIOCHEM BIOPH RES CO, V310, P121, DOI 10.1016/j.bbrc.2003.08.127; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Dolezal T, 2003, GENETICS, V165, P653; Dosch R, 1997, DEVELOPMENT, V124, P2325; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; FREEDOM RM, 1973, AM J DIS CHILD, V126, P16, DOI 10.1001/archpedi.1973.02110190012003; Ghanbari H, 2001, MECH DEVELOP, V101, P271, DOI 10.1016/S0925-4773(00)00572-4; Hatada S, 1997, GENE, V203, P183, DOI 10.1016/S0378-1119(97)00512-X; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Homma KJ, 2001, J BIOL CHEM, V276, P43761, DOI 10.1074/jbc.M105088200; Iwaki-Egawa S, 2001, J RHEUMATOL, V28, P485; Jackson EK, 2004, ANNU REV PHYSIOL, V66, P571, DOI 10.1146/annurev.physiol.66.032102.111604; Klein SL, 2002, DEV DYNAM, V225, P384, DOI 10.1002/dvdy.10174; KOMANO H, 1987, BIOCHEM J, V248, P217, DOI 10.1042/bj2480217; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Maier SA, 2005, J MOL EVOL, V61, P776, DOI 10.1007/s00239-005-0046-y; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Matsushita T, 2000, J BIOL CHEM, V275, P36934, DOI 10.1074/jbc.M003455200; Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161; MITSUHAS.J, 1964, CONTRIB BOYCE THOMPS, V22, P435; Mizuno N, 1999, DIFFERENTIATION, V64, P143, DOI 10.1046/j.1432-0436.1999.6430143.x; MOHUN TJ, 1984, NATURE, V311, P716, DOI 10.1038/311716a0; Montesinos MC, 2004, AM J PATHOL, V164, P1887, DOI 10.1016/S0002-9440(10)63749-2; NEILSEN H, 1997, PROTEIN ENG, V10, P1; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; PAGE B, 1993, INT J ONCOL, V3, P473; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pera EM, 2003, GENE EXPR PATTERNS, V3, P147, DOI 10.1016/S1567-133X(03)00011-5; Pommereit D, 2001, MECH DEVELOP, V102, P255, DOI 10.1016/S0925-4773(01)00305-7; RATECH H, 1981, ENZYME, V26, P74, DOI 10.1159/000459153; Riazi AM, 2005, TRANSGENIC RES, V14, P333, DOI 10.1007/s11248-005-1174-2; Riazi MA, 2000, GENOMICS, V64, P277, DOI 10.1006/geno.1999.6099; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato A, 2000, MECH DEVELOP, V92, P273, DOI 10.1016/S0925-4773(99)00331-7; SCHINZEL A, 1981, HUM GENET, V57, P148; Shiokawa K, 1997, Methods Mol Biol, V62, P247; SIMON LN, 1970, BIOCHEMISTRY-US, V9, P573, DOI 10.1021/bi00805a018; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Skoglund P, 2007, DEV BIOL, V301, P404, DOI 10.1016/j.ydbio.2006.09.005; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Tanaka Y, 2006, BIOCHEM BIOPH RES CO, V350, P334, DOI 10.1016/j.bbrc.2006.09.047; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WIGINTON DA, 1981, BIOCHEM J, V195, P389, DOI 10.1042/bj1950389; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; Zhou XL, 2004, DEV BIOL, V271, P322, DOI 10.1016/j.ydbio.2004.03.036; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	60	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2255	2264		10.1074/jbc.M709279200	http://dx.doi.org/10.1074/jbc.M709279200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032387	hybrid			2022-12-27	WOS:000252501000053
J	Fedor, MJ				Fedor, Martha J.			Alternative splicing minireview series: Combinatorial control facilitates splicing regulation of gene expression and enhances genome diversity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review									[Fedor, Martha J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Fedor, Martha J.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Fedor, MJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB35, La Jolla, CA 92037 USA.	mfedor@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062277, R01GM046422] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 046422, R01 GM 062277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164	6	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1209	1210		10.1074/jbc.R700046200	http://dx.doi.org/10.1074/jbc.R700046200			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024424	hybrid			2022-12-27	WOS:000252282700001
J	Mowbray, AL; Kang, DH; Rhee, SG; Kang, SW; Jo, H				Mowbray, Amy L.; Kang, Dong-Hoon; Rhee, Sue Goo; Kang, Sang Won; Jo, Hanjoong			Laminar shear stress up-regulates peroxiredoxins (PRX) in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; CAROTID BIFURCATION; SIGNAL-TRANSDUCTION; MONOCYTE ADHESION; WALL SHEAR; EXPRESSION; PROTEIN; FLOW; ATHEROSCLEROSIS; MECHANISMS	Shear stress plays a significant role in endothelial cell biology and atherosclerosis development. Previous work by our group has shown that fluid flow stimulates important functional changes in cells through protein expression regulation. Peroxiredoxins (PRX) are a family of antioxidant enzymes but have yet to be investigated in response to shear stress. Studies have shown that oscillatory shear stress (OS) increases reactive oxygen species (ROS) levels in endothelial cells, whereas laminar shear stress (LS) blocks this response. We hypothesized that PRX are responsible for the anti-oxidative effect of LS. To test this hypothesis, bovine aortic endothelial cells (BAEC) were subjected to LS (15 dyn/cm(2)), OS (+/- 5 dyn/cm(2), 1 Hz), or static conditions for 24 h. Using Western blot and immunofluorescence staining, all six isoforms of PRX were identified in BAEC. When compared with OS and static, exposure to chronic LS up-regulated PRX 1 levels intracellularly. LS also increased expression of PRX 5 relative to static controls, but not OS. PRX exhibited broad subcellular localization, with distribution in the cytoplasm, Golgi, mitochondria, and intermediate filaments. In addition, PRX 1 knock down, using specific small interference RNA, attenuated LS-dependent reactive oxygen species reduction in BAEC. However, PRX 5 depletion did not. Together, these results suggest that PRX 1 is a novel mechanosensitive antioxidant, playing an important role in shear-dependent regulation of endothelial biology and atherosclerosis.	[Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea; [Mowbray, Amy L.; Jo, Hanjoong] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [Jo, Hanjoong] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA	Ewha Womans University; University System of Georgia; Georgia Institute of Technology; Emory University	Kang, SW (corresponding author), Ewha Womans Univ, Dept Life Sci, 11-1 Daehyun Dong, Seoul 120750, South Korea.	kangsw@ewha.ac.kr; hanjoong.jo@bme.gatech.edu	Jo, Hanjoong/L-6216-2019	Jo, Hanjoong/0000-0003-1833-372X	NHLBI NIH HHS [HL 71014, HL 75209, HL 70531] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075209, R01HL071014, R01HL070531] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; CARO CG, 1969, NATURE, V223, P1159, DOI 10.1038/2231159a0; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Chen XL, 2003, J BIOL CHEM, V278, P703, DOI 10.1074/jbc.M203161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davies PF, 2001, ANN NY ACAD SCI, V947, P7; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Finkel T, 1999, J LEUKOCYTE BIOL, V65, P337, DOI 10.1002/jlb.65.3.337; Go YM, 2001, J APPL PHYSIOL, V91, P1574, DOI 10.1152/jappl.2001.91.4.1574; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Hajra L, 2000, P NATL ACAD SCI USA, V97, P9052, DOI 10.1073/pnas.97.16.9052; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Hwang J, 2003, J BIOL CHEM, V278, P47291, DOI 10.1074/jbc.M305150200; Hwang J, 2003, CIRC RES, V93, P1225, DOI 10.1161/01.RES.0000104087.29395.66; Immenschuh S, 2005, ANTIOXID REDOX SIGN, V7, P768, DOI 10.1089/ars.2005.7.768; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kinnula VL, 2002, THORAX, V57, P157, DOI 10.1136/thorax.57.2.157; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; McNally JS, 2003, AM J PHYSIOL-HEART C, V285, pH2290, DOI 10.1152/ajpheart.00515.2003; Mueller CFH, 2005, CIRC RES, V97, P637, DOI 10.1161/01.RES.0000183734.21112.b7; Nerem RM, 1998, AM J MED SCI, V316, P169, DOI 10.1097/00000441-199809000-00004; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; SUZUKI Y, 1992, BIOCHEM BIOPH RES CO, V184, P1339, DOI 10.1016/S0006-291X(05)80029-4; Sykes MC, 2007, CIRC RES, V100, P152, DOI 10.1161/01.RES.0000258171.08020.72; Takeshita S, 2000, BIOCHEM BIOPH RES CO, V273, P66, DOI 10.1006/bbrc.2000.2898; Terman A, 2007, J PATHOL, V211, P134, DOI 10.1002/path.2094; Topper JN, 1996, P NATL ACAD SCI USA, V93, P10417, DOI 10.1073/pnas.93.19.10417; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Walford GA, 2004, J BIOL CHEM, V279, P4425, DOI 10.1074/jbc.M310582200; WEBER C, 1994, ARTERIOSCLER THROMB, V14, P1665, DOI 10.1161/01.ATV.14.10.1665; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502	43	71	72	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1622	1627		10.1074/jbc.M707985200	http://dx.doi.org/10.1074/jbc.M707985200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024958	hybrid			2022-12-27	WOS:000252282700048
J	Tang, DM; Mar, K; Warren, G; Wang, YZ				Tang, Danming; Mar, Kari; Warren, Graham; Wang, Yanzhuang			Molecular mechanism of mitotic Golgi disassembly and reassembly revealed by a defined reconstitution assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; PROTEIN PHOSPHATASE 2A; ADP-RIBOSYLATION FACTOR; MEMBRANE-FUSION; COATED VESICLES; STACKING FACTOR; SNARE COMPLEX; CDC2 KINASE; IN-VITRO; APPARATUS	In mammalian cells, flat Golgi cisternae closely arrange together to form stacks. During mitosis, the stacked structure undergoes a continuous fragmentation process. The generated mitotic Golgi fragments are distributed into the daughter cells, where they are reassembled into new Golgi stacks. In this study, an in vitro assay has been developed using purified proteins and Golgi membranes to reconstitute the Golgi disassembly and reassembly processes. This technique provides a useful tool to delineate the mechanisms underlying the morphological change. There are two processes during Golgi disassembly: unstacking and vesiculation. Unstacking is mediated by two mitotic kinases, cdc2 and plk, which phosphorylate the Golgi stacking protein GRASP65 and thus disrupt the oligomer of this protein. Vesiculation is mediated by the COPI budding machinery ARF1 and the coatomer complex. When treated with a combination of purified kinases, ARF1 and coatomer, the Golgi membranes were completely fragmented into vesicles. After mitosis, there are also two processes in Golgi reassembly: formation of single cisternae by membrane fusion, and restacking. Cisternal membrane fusion requires two AAA ATPases, p97 and NSF (N-ethylmaleimide-sensitive fusion protein), each of which functions together with specific adaptor proteins. Restacking of the newly formed Golgi cisternae requires dephosphorylation of Golgi stacking proteins by the protein phosphatase PP2A. This systematic study revealed the minimal machinery that controls the mitotic Golgi disassembly and reassembly processes.	[Tang, Danming; Mar, Kari; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Warren, Graham] Max F Perutz Labs, A-1030 Vienna, Austria	University of Michigan System; University of Michigan; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Tang, DM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	yzwang@umich.edu	Wang, Yanzhuang/AAE-5299-2019	Wang, Yanzhuang/0000-0002-1864-7094	NIGMS NIH HHS [R01 GM087364, R01 GM087364-02, R01 GM087364-01, R01 GM087364-03, R01 GM087364-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Cosson P, 2005, P NATL ACAD SCI USA, V102, P14647, DOI 10.1073/pnas.0507394102; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Levine TP, 1995, COLD SPRING HARB SYM, V60, P549, DOI 10.1101/SQB.1995.060.01.058; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lucocq J M, 1988, Prog Clin Biol Res, V270, P431; LUCOCQ JM, 1987, J CELL BIOL, V104, P865, DOI 10.1083/jcb.104.4.865; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MISTELI T, 1995, J CELL SCI, V108, P2715; MISTELI T, 1994, J CELL BIOL, V125, P269, DOI 10.1083/jcb.125.2.269; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Nickel W, 1998, J CELL SCI, V111, P3081; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; ROBBINS E, 1964, J HISTOCHEM CYTOCHEM, V12, P704, DOI 10.1177/12.9.704; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; SERAFINI T, 1992, METHOD ENZYMOL, V219, P286; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Taguchi T, 2003, TRAFFIC, V4, P344, DOI 10.1034/j.1600-0854.2003.00091.x; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; WANG Y, 2006, CELL BIOL LAB HDB; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Xiang Y, 2007, J BIOL CHEM, V282, P21829, DOI 10.1074/jbc.M611716200; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004	58	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6085	6094		10.1074/jbc.M707715200	http://dx.doi.org/10.1074/jbc.M707715200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156178	Green Accepted, hybrid			2022-12-27	WOS:000253779500014
J	Brocardo, M; Lei, Y; Tighe, A; Taylor, SS; Mok, MTS; Henderson, BR				Brocardo, Mariana; Lei, Ying; Tighe, Anthony; Taylor, Stephen S.; Mok, Myth T. S.; Henderson, Beric R.			Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; APOPTOSIS; DOMAIN; INSTABILITY; CLEAVAGE; BINDING; SIGNAL; ACTIN; CELLS	The adenomatous polyposis coli (APC) protein tumor suppressor is mutated in the majority of colon cancers. Most APC gene mutations cause deletion of the C terminus and disrupt APC regulation of beta-catenin turnover, microtubule dynamics, and chromosome segregation. Truncated APC mutant peptides may also gain unique properties, not exhibited by wild-type APC, which contribute to tumor cell survival and proliferation. Here we report a differential subcellular localization pattern for wild-type and mutant APC. A pool of APC truncation mutants was detected at mitochondria by cellular fractionation and confocal microscopy. In contrast, wild-type APC located poorly at mitochondria. Similar results were observed for endogenous and stably induced forms of APC, with the shortest N-terminal mutant peptides (N750, N853, N1309, N1337) displaying the strongest mitochondrial staining. The knock down of mutant APC(N1337) in SW480 tumor cells caused an increase in apoptosis and mitochondrial membrane permeability, and this correlated with reduced Bcl-2 protein levels in mitochondrial fractions. Interestingly, the silencing of APC did not alter expression of beta-catenin or the apoptotic regulatory factors Bax, Bcl-xL, or survivin. APC formed a complex with Bcl-2 in mitochondrial fractions, and this may contribute to the APC-dependent regulation of Bcl-2. We propose that a subset of cancer mutations induce APC mitochondrial localization and that APC regulation of Bcl-2 at mitochondria may contribute to tumor cell survival.	[Brocardo, Mariana; Lei, Ying; Mok, Myth T. S.; Henderson, Beric R.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Tighe, Anthony; Taylor, Stephen S.; Henderson, Beric R.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Sydney; Westmead Institute for Medical Research; University of Manchester	Henderson, BR (corresponding author), Westmead Millennium Inst, Darcy Rd PO Box 412, Westmead, NSW 2145, Australia.	beric_henderson@wmi.usyd.edu.au	Taylor, Stephen/GZL-6499-2022; Mok, Myth/M-2958-2013	Mok, Myth/0000-0003-3156-4944; Brocardo, Mariana/0000-0002-3962-7308; Taylor, Stephen/0000-0003-4621-9326				Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Boman BM, 2004, AM J PATHOL, V165, P1489, DOI 10.1016/S0002-9440(10)63407-4; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Browne SJ, 1998, CELL DEATH DIFFER, V5, P206, DOI 10.1038/sj.cdd.4400331; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chartrain I, 2007, CELL BIOL INT, V31, P196, DOI 10.1016/j.cellbi.2006.10.005; Chen TA, 2003, CANCER RES, V63, P4368; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Li ZY, 2005, CANCER RES, V65, P5195, DOI 10.1158/0008-5472.CAN-04-4609; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Polakis P, 2000, GENE DEV, V14, P1837; Qian J, 2007, ONCOGENE, V26, P4872, DOI 10.1038/sj.onc.1210265; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Sinicrope FA, 2005, MOL CANCER THER, V4, P1475, DOI 10.1158/1535-7163.MCT-05-0137; Steigerwald K, 2005, MOL CANCER RES, V3, P78, DOI 10.1158/1541-7786.MCR-03-0189; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Venesio T, 2003, MODERN PATHOL, V16, P57, DOI 10.1097/01.MP.0000042421.83775.0E; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Webb SJ, 1999, FASEB J, V13, P339, DOI 10.1096/fasebj.13.2.339; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	38	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5950	5959		10.1074/jbc.M708775200	http://dx.doi.org/10.1074/jbc.M708775200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160396	hybrid			2022-12-27	WOS:000253426700073
J	Xi, JH; Bai, F; Gross, J; Townsend, RR; Menko, AS; Andley, UP				Xi, Jing-hua; Bai, Fang; Gross, Julia; Townsend, R. Reid; Menko, A. Sue; Andley, Usha P.			Mechanism of small heat shock protein function in vivo - A knock-in mouse model demonstrates that the R49C mutation in alpha A-crystallin enhances protein insolubility and cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LENS EPITHELIAL-CELLS; AUTOSOMAL-DOMINANT CATARACT; RESONANCE ENERGY-TRANSFER; CHAPERONE-LIKE ACTIVITY; B-CRYSTALLIN; MOLECULAR CHAPERONE; HEREDITARY CATARACT; SIGNALING PATHWAYS; MISSENSE MUTATION; INDUCED APOPTOSIS	alpha A-crystallin (Cryaa/HSPB4) is a small heat shock protein and molecular chaperone that prevents nonspecific aggregation of denaturing proteins. Several point mutations in the alpha A-crystallin gene cause congenital human cataracts by unknown mechanisms. We took a novel approach to investigate the molecular mechanism of cataract formation in vivo by creating gene knock-in mice expressing the arginine 49 to cysteine mutation (R49C) in alpha A-crystallin (alpha A-R49C). This mutation has been linked with autosomal dominant hereditary cataracts in a four-generation Caucasian family. Homologous recombination in embryonic stem cells was performed using a plasmid containing the C to T transition in exon 1 of the cryaa gene. alpha A-R49C heterozygosity led to early cataracts characterized by nuclear opacities. Unexpectedly, alpha A-R49C homozygosity led to small eye phenotype and severe cataracts at birth. Wild type littermates did not show these abnormalities. Lens fiber cells of alpha A-R49C homozygous mice displayed an increase in cell death by apoptosis mediated by a 5-fold decrease in phosphorylated Bad, an anti-apoptotic protein, but an increase in Bcl-2 expression. However, proliferation measured by in vivo bromodeoxyuridine labeling did not decline. The alpha A-R49C heterozygous and homozygous knock-in lenses demonstrated an increase in insoluble alpha A-crystallin and alpha B-crystallin and a surprising increase in expression of cytoplasmic gamma-crystallin, whereas no changes in beta-crystallin were observed. Co-immunoprecipitation analysis showed increased interaction between alpha A-crystallin and lens substrate proteins in the heterozygous knock-in lenses. To our knowledge this is the first knock-in mouse model for a crystallin mutation causing hereditary human cataract and establishes that alpha A-R49C promotes protein insolubility and cell death in vivo.	[Xi, Jing-hua; Bai, Fang; Andley, Usha P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Gross, Julia; Townsend, R. Reid] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Townsend, R. Reid] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Menko, A. Sue] Thomas Jefferson Univ, Dept Anat Pathol, Dept Cell Biol & Anat, Philadelphia, PA 19107 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Jefferson University	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	andley@vision.wustl.edu		Andley, Usha/0000-0001-7049-7591; Menko, A. Sue/0000-0002-7514-4696	NEI NIH HHS [EY02687, R01EY05681] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005681, P30EY002687] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alizadeh A, 2002, INVEST OPHTH VIS SCI, V43, P3722; ANDLEY UP, 1986, PHOTOCHEM PHOTOBIOL, V44, P67, DOI 10.1111/j.1751-1097.1986.tb03565.x; Andley UP, 1996, J BIOL CHEM, V271, P31973, DOI 10.1074/jbc.271.50.31973; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2004, PHOTOCHEM PHOTOBIOL, V80, P61, DOI 10.1562/2004-02-03-RA-075.1; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2001, FASEB J, V15, P221, DOI 10.1096/fj.00-0296com; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Beebe DC, 2000, DEV BIOL, V220, P424, DOI 10.1006/dbio.2000.9638; Beebe DC, 2001, INVEST OPHTH VIS SCI, V42, P727; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bhat SP, 2004, EXP EYE RES, V79, P809, DOI 10.1016/j.exer.2004.08.020; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bloss TA, 2003, NATURE, V424, P1066, DOI 10.1038/nature01920; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cobb BA, 2002, BIOCHEMISTRY-US, V41, P483, DOI 10.1021/bi0112457; Cobb BA, 2000, BIOCHEMISTRY-US, V39, P15791, DOI 10.1021/bi001453j; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Ferreira-Cornwell MC, 2000, EXP CELL RES, V256, P237, DOI 10.1006/excr.2000.4819; FITZGERALD PG, 1987, INVEST OPHTH VIS SCI, V28, P795; Fu L, 2003, INVEST OPHTH VIS SCI, V44, P1155, DOI 10.1167/iovs.02-0950; Gaestel M, 2002, Prog Mol Subcell Biol, V28, P151; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; King JB, 2006, ANAL CHEM, V78, P2171, DOI 10.1021/ac051520l; Koteiche HA, 2006, J BIOL CHEM, V281, P14273, DOI 10.1074/jbc.M512938200; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Leong L, 2000, INVEST OPHTH VIS SCI, V41, P3503; Liang JJ, 2006, PROTEIN SCI, V15, P1619, DOI 10.1110/ps.062216006; LIANG JN, 1982, BIOCHEMISTRY-US, V21, P1847, DOI 10.1021/bi00537a022; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Liu BF, 2007, MOL VIS, V13, P854; Liu HQ, 2005, J BIOL CHEM, V280, P25071, DOI 10.1074/jbc.M502490200; Liu YZ, 2006, INVEST OPHTH VIS SCI, V47, P1069, DOI 10.1167/iovs.05-1004; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; Menko AS, 2002, EXP EYE RES, V75, P485, DOI 10.1006/exer.2002.2057; Menko AS, 2002, DEV DYNAM, V224, P321, DOI 10.1002/dvdy.10111; MENKO AS, INVESTIG OPHTHALMOL, V46; Menko KS, 2001, DEV DYNAM, V220, P337, DOI 10.1002/dvdy.1114; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; NAGY A, 1990, DEVELOPMENT, V110, P815; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; Pras E, 2000, INVEST OPHTH VIS SCI, V41, P3511; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Skvorak K, 2006, GENESIS, V44, P345, DOI 10.1002/dvg.20222; Sreelakshmi Y, 2006, MOL VIS, V12, P581; Sun TX, 1997, J BIOL CHEM, V272, P6220, DOI 10.1074/jbc.272.10.6220; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Vanita V, 2006, MOL VIS, V12, P518; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Walker JL, 2002, DEV BIOL, V251, P195, DOI 10.1006/dbio.2002.0823; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wang YQ, 1999, EXP CELL RES, V249, P123, DOI 10.1006/excr.1999.4450; White TW, 2002, SCIENCE, V295, P319, DOI 10.1126/science.1067582; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2003, MOL VIS, V9, P410; Xi JH, 2006, FASEB J, V20, P846, DOI 10.1096/fj.05-5532com; Xia CH, 2006, INVEST OPHTH VIS SCI, V47, P3004, DOI 10.1167/iovs.06-0178; Zhou J, 2004, INVEST OPHTH VIS SCI, V45, P2314, DOI 10.1167/iovs.03-1210	74	47	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5801	5814		10.1074/jbc.M708704200	http://dx.doi.org/10.1074/jbc.M708704200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18056999	hybrid			2022-12-27	WOS:000253426700061
J	Mora, L; Klepsch, M; Buckingham, RH; Heurgue-Hamard, V; Kervestin, S; de Zamaroczy, M				Mora, Liliana; Klepsch, Mirjam; Buckingham, Richard H.; Heurgue-Hamard, Valerie; Kervestin, Stephanie; de Zamaroczy, Miklos			Dual roles of the central domain of colicin D tRNase in TonB-mediated import and in immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE RECEPTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IN-VIVO; NUCLEOTIDE-SEQUENCE; DEPENDENT COLICINS; PROTEIN; FHUA; TRANSPORT; CLEAVAGE	Colicin D import into Escherichia coli requires an interaction via its TonB box with the energy transducer TonB. Colicin D cytotoxicity is inhibited by specific tonB mutations, but it is restored by suppressor mutations in the TonB box. Here we report that there is a second site of interaction between TonB and colicin D, which is dependent upon a 45-amino acid region, within the uncharacterized central domain of colicin D. In addition, the 8th amino acids of colicin D (a glycine) and colicin B (a valine), adjacent to their TonB boxes, are also required for TonB recognition, suggesting that high affinity complex formation involves multiple interactions between these colicins and TonB. The central domain also contributes to the formation of the immunity complex, as well as being essential for uptake and thus killing. Colicin D is normally secreted in association with the immunity protein, and this complex involves the following two interactions: a major interaction with the C-terminal tRNase domain and a second interaction involving the central domain of colicin D and, most probably, the alpha 4 helix of ImmD, which is on the opposite side of ImmD compared with the major interface. In contrast, formation of the immunity complex with the processed cytotoxic domain, the form expected to be found in the cytoplasm after colicin D uptake, requires only the major interaction. Klebicin D has, like colicin D, a ribonuclease activity toward tRNAArg and a central domain, which can form a complex with ImmD but which does not function in TonB-mediated transport.	[Mora, Liliana; Klepsch, Mirjam; Buckingham, Richard H.; Heurgue-Hamard, Valerie; Kervestin, Stephanie; de Zamaroczy, Miklos] CNRS, IBPC, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), CNRS, IBPC, UPR 9073, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	zamaroczy@ibpc.fr		HEURGUE-HAMARD, VALERIE/0000-0003-1576-7231; Buckingham, Richard/0000-0002-8567-4500				BELL PE, 1990, J BACTERIOL, V172, P3826, DOI 10.1128/jb.172.7.3826-3829.1990; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Braun V, 2003, FRONT BIOSCI-LANDMRK, V8, pS1409, DOI 10.2741/1232; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2003, P NATL ACAD SCI USA, V100, P10688, DOI 10.1073/pnas.1932538100; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Carter DM, 2006, J MOL BIOL, V357, P236, DOI 10.1016/j.jmb.2005.12.039; Chavan M, 2005, J MOL EVOL, V60, P546, DOI 10.1007/s00239-004-0263-9; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; DEGRAAF FK, 1977, EUR J BIOCHEM, V73, P107; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FRENETTE M, 1991, J MOL BIOL, V217, P421, DOI 10.1016/0022-2836(91)90746-S; Ghosh J, 2004, MOL MICROBIOL, V51, P203, DOI 10.1046/j.1365-2958.2003.03816.x; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; Kageyama M, 1996, J BACTERIOL, V178, P103, DOI 10.1128/jb.178.1.103-110.1996; Larsen RA, 1997, J BACTERIOL, V179, P3213, DOI 10.1128/jb.179.10.3213-3221.1997; Lazdunski CJ, 1998, J BACTERIOL, V180, P4993, DOI 10.1128/JB.180.19.4993-5002.1998; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moeck GS, 2001, J BACTERIOL, V183, P2755, DOI 10.1128/JB.183.9.2755-2764.2001; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Ogierman M, 2003, J BACTERIOL, V185, P1870, DOI 10.1128/JB.185.6.1870-1885.2003; OUDEGA B, 1977, EUR J BIOCHEM, V78, P445, DOI 10.1111/j.1432-1033.1977.tb11757.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; PUGSLEY AP, 1977, BIOCHEM BIOPH RES CO, V74, P903, DOI 10.1016/0006-291X(77)91604-7; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Sauter A, 2003, J BACTERIOL, V185, P5747, DOI 10.1128/JB.185.19.5747-5754.2003; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SKARE JT, 1993, J BIOL CHEM, V268, P16302; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	49	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4993	5003		10.1074/jbc.M706846200	http://dx.doi.org/10.1074/jbc.M706846200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083710	hybrid			2022-12-27	WOS:000253426500057
J	van Holde, KE				van Holde, Kensal E.			Learning how to be a scientist (Reprinted from JBC, December, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Reprint							CHROMATIN; NUCLEOHISTONE; EQUILIBRIUM; PARTICLES; FRAGMENTS; MODEL; DNA		Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	van Holde, KE (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	mrathja@asbmb.org						BRAM S, 1971, J MOL BIOL, V55, P325; CLARK RJ, 1971, NATURE-NEW BIOL, V229, P101, DOI 10.1038/newbio229101a0; DING DW, 1972, BIOPOLYMERS, V11, P2109, DOI 10.1002/bip.1972.360111011; LOHR D, 1975, SCIENCE, V188, P165, DOI 10.1126/science.1090006; PARDON JF, 1975, NUCLEIC ACIDS RES, V2, P2163, DOI 10.1093/nar/2.11.2163; PARDON JF, 1972, J MOL BIOL, V68, P115; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; RILL R, 1973, J BIOL CHEM, V248, P1080; SAHASRABUDDHE CG, 1974, J BIOL CHEM, V249, P152; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; van Holde K, 2006, J BIOL CHEM, V281, P12197, DOI 10.1074/jbc.R500025200; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; 2007, J BIOL CHEM     1219	14	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4461	4463		10.1074/jbc.X700002200	http://dx.doi.org/10.1074/jbc.X700002200			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093967	hybrid			2022-12-27	WOS:000253426500001
J	Chandrasekar, B; Patel, DN; Mummidi, S; Kim, JW; Clark, RA; Valente, AJ				Chandrasekar, Bysani; Patel, Devang N.; Mummidi, Srinivas; Kim, Jae-Woo; Clark, Robert A.; Valente, Anthony J.			Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; CCAAT/ENHANCER BINDING-PROTEIN; VASCULAR INFLAMMATORY MARKERS; ADIPOSE-SPECIFIC PROTEIN; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; WEIGHT-LOSS; INSULIN-RESISTANCE; GENE-EXPRESSION	An inverse correlation between the pro-inflammatory cytokine interleukin-18 and the anti-atherogenic adipokine adiponectin has been reported in the chronic pathological conditions obesity, insulin resistance, coronary artery disease, and metabolic syndrome. We investigated whether this relationship is coincidental or has a causal basis. Here we show that interleukin-18 (IL-18) suppresses adiponectin transcription, mRNA expression, and secretion by 3T3-L1 adipocytes. IL-18 suppresses adiponectin promoter-reporter activity, an effect reversed by deletion or mutation of the NFATc4 core DNA-binding site. IL-18 induces NFATc4 phosphorylation (Ser(676)), nuclear translocation, and in vivo DNA binding. IL-18 induces ERK1/2 phosphorylation and enzyme activity, and pretreatment with the MEK inhibitor U0126, ERK1/2 inhibitor PD98059, or small interference RNA targeted to ERK1/2 attenuates ERK1/2 activation and NFATc4 phosphorylation. Finally, inhibition of ERK1/2 or NFATc4 knockdown reverses IL-18-mediated adiponectin suppression. In contrast to its inhibitory effects on adiponectin expression, IL-18 potently stimulates PAI-1 secretion. These data demonstrate for the first time that IL-18 selectively suppresses adiponectin expression via ERK1/2-dependent NFATc4 activation and suggest that the inverse relationship observed between IL-18 and adiponectin in various chronic pathological conditions is causally related. Thus, targeting IL-18 expression may enhance adiponectin expression and mitigate disease progression.	[Chandrasekar, Bysani; Patel, Devang N.; Mummidi, Srinivas; Clark, Robert A.; Valente, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chandrasekar, Bysani; Mummidi, Srinivas; Clark, Robert A.] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Kim, Jae-Woo] Yonsei Univ, Coll Med, Med Res Ctr Chron Metab Dis, Dept Biochem & Mol Biol, Seoul 120752, South Korea	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Yonsei University; Yonsei University Health System	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Clark, Robert/Q-6764-2019; Mummidi, Srinivas/H-3335-2017; Mummidi, Srinivas/C-1004-2008	Clark, Robert/0000-0002-4892-3619; Mummidi, Srinivas/0000-0002-4068-6380; Mummidi, Srinivas/0000-0002-4068-6380; Kim, Jae-woo/0000-0001-5456-9495				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chandrasekar B, 2005, J BIOL CHEM, V280, P26263, DOI 10.1074/jbc.M502586200; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fischer CP, 2005, CLIN IMMUNOL, V117, P152, DOI 10.1016/j.clim.2005.07.008; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Giugliano G, 2004, BRIT J PLAST SURG, V57, P190, DOI 10.1016/j.bjps.2003.12.010; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoo RLC, 2007, ARTERIOSCL THROM VAS, V27, P2777, DOI 10.1161/ATVBAHA.107.152462; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kita A, 2005, BIOCHEM BIOPH RES CO, V331, P484, DOI 10.1016/j.bbrc.2005.03.205; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Magkos F, 2007, CURR OPIN CLIN NUTR, V10, P571, DOI 10.1097/MCO.0b013e3282bf6ea8; Morel JCM, 2002, J BIOL CHEM, V277, P34679, DOI 10.1074/jbc.M206337200; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schernthaner GH, 2006, OBES SURG, V16, P709, DOI 10.1381/096089206777346763; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Straczkowski M, 2007, INT J OBESITY, V31, P221, DOI 10.1038/sj.ijo.0803421; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Thompson SR, 2007, METABOLISM, V56, P662, DOI 10.1016/j.metabol.2006.12.015; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Vilarrasa N, 2007, CLIN ENDOCRINOL, V67, P679, DOI 10.1111/j.1365-2265.2007.02945.x; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yang JY, 2006, OBESITY, V14, P1691, DOI 10.1038/oby.2006.194; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	56	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4200	4209		10.1074/jbc.M708142200	http://dx.doi.org/10.1074/jbc.M708142200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086672	hybrid			2022-12-27	WOS:000253083500055
J	Song, CY; Wen, WY; Rayala, SK; Chen, MZ; Ma, JP; Zhang, MJ; Kumar, R				Song, Chunying; Wen, Wenyu; Rayala, Suresh K.; Chen, Mingzhi; Ma, Jianpeng; Zhang, Mingjie; Kumar, Rakesh			Serine 88 phosphorylation of the 8-kDa dynein light chain 1 is a molecular switch for its dimerization status and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN LC8; NITRIC-OXIDE SYNTHASE; CYTOPLASMIC DYNEIN; MYOSIN-V; PROTEIN; DROSOPHILA; DOMAIN; DIMER; MECHANISM; INTERACTS	Dynein light chain 1 (DLC1, also known as DYNLL1, LC8, and PIN), a ubiquitously expressed and highly conserved protein, participates in a variety of essential intracellular events. Transition of DLC1 between dimer and monomer forms might play a crucial role in its function. However, the molecular mechanism(s) that control the transition remain unknown. DLC1 phosphorylation on Ser(88) by p21-activated kinase 1 (Pak1), a signaling nodule, promotes mammalian cell survival by regulating its interaction with Bim and the stability of Bim. Here we discovered that phosphorylation of Ser(88), which juxtapose each other at the interface of the DLC dimer, disrupts DLC1 dimer formation and consequently impairs its interaction with Bim. Overexpression of a Ser(88) phosphorylation-inactive DLC1 mutant in mammary epithelium cells and in a transgenic animal model caused apoptosis and accelerated mammary gland involution, respectively, with increased Bim levels. Structural and biophysical studies suggested that phosphorylation-mimicking mutation leads to dissociation of the DLC1 dimer to a pure folded monomer. The phosphorylation-induced DLC1 monomer is incapable of binding to its substrate Bim. These findings reveal a previously unrecognized regulatory mechanism of DLC1 in which the Ser(88) phosphorylation acts as a molecular switch for the transition of DLC1 from dimer to monomer, thereby modulating its interaction with substrates and consequently regulating the functions of DLC1.	[Wen, Wenyu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Kowloon, Hong Kong, Peoples R China; [Song, Chunying; Rayala, Suresh K.; Kumar, Rakesh] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Mingzhi; Ma, Jianpeng; Kumar, Rakesh] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Hong Kong University of Science & Technology; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk; rkumar@mdanderson.org	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Zhang, Mingjie/0000-0001-9404-0190; Rayala, Suresh/0000-0003-4394-4450	NCI NIH HHS [CA80066, CA90970] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080066, R01CA090970] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Chang YWE, 2000, MOL CELL BIOL, V20, P8571, DOI 10.1128/MCB.20.22.8571-8579.2000; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Dick T, 1996, MOL CELL BIOL, V16, P1966; Epstein E, 2000, J CLIN INVEST, V105, P505, DOI 10.1172/JCI8557; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOLLANDER P, 2006, CANCER RES, V66, P5941; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Mohan PMK, 2007, BIOCHEM BIOPH RES CO, V355, P950, DOI 10.1016/j.bbrc.2007.02.072; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Phillis R, 1996, DEVELOPMENT, V122, P2955; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Seol MB, 2005, MOL CELLS, V20, P97; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200	40	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4004	4013		10.1074/jbc.M704512200	http://dx.doi.org/10.1074/jbc.M704512200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18084006	hybrid			2022-12-27	WOS:000253083500035
J	Ulsamer, A; Ortuno, MJ; Ruiz, S; Susperregui, ARG; Osses, N; Rosa, JL; Ventura, F				Ulsamer, Arnau; Ortuno, M. Jose; Ruiz, Silvia; Susperregui, Antonio R. G.; Osses, Nelson; Rosa, Jose Luis; Ventura, Francesc			BMP-2 induces osterix expression through up-regulation of Dlx5 and its phosphorylation by p38	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR OSTERIX; BONE MORPHOGENETIC PROTEINS; PRX1 HOMEOBOX GENE; OSTEOBLAST DIFFERENTIATION; OSTEOCALCIN GENE; SIGNALING PATHWAYS; MESENCHYMAL CELLS; RUNX2; BINDING	Osterix, a zinc-finger transcription factor, is specifically expressed in osteoblasts and osteocytes of all developing bones. Because no bone formation occurs in Osterix null mice, Osterix is thought to be an essential regulator of osteoblast differentiation. We report that bone morphogenetic protein-2 (BMP-2) induces an increase in Osterix expression, which is mediated through a homeodomain sequence located in the proximal region of the Osterix promoter. Our results demonstrate that induction of Dlx5 by BMP-2 mediates Osterix transcriptional activation. First, BMP-2 induction of Dlx5 precedes the induction of Osterix. Second, Dlx5 binds to the BMP-responsive homeodomain sequences both in vitro and in vivo. Third, Dlx5 overexpression and knock-down assays demonstrate its role in activating Osterix expression in response to BMP-2. Furthermore, we show that Dlx5 is a novel substrate for p38 MAPK in vitro and in vivo and that Ser-34 and Ser-217 are the sites phosphorylated by p38. Phosphorylation at Ser-34/217 increases the transactivation potential of Dlx5. Thus, we propose that BMP activates expression of Osterix through the induction of Dlx5 and its further transcriptional activation by p38-mediated phosphorylation.	[Ulsamer, Arnau; Ortuno, M. Jose; Ruiz, Silvia; Susperregui, Antonio R. G.; Rosa, Jose Luis; Ventura, Francesc] Univ Barcelona, LHosp Llobregat, IDIBELL, Dept Ciencias Fisiol 2, E-08907 Barcelona, Spain; [Osses, Nelson] Pontificia Univ Catolica Valparaiso, Fac Ciencias Basicas & Matemat, Inst Quim, Valparaiso 4059, Chile	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Pontificia Universidad Catolica de Valparaiso	Ventura, F (corresponding author), Univ Barcelona, LHosp Llobregat, IDIBELL, Dept Ciencias Fisiol 2, C-Feixa Llarga S-N, E-08907 Barcelona, Spain.	fventura@ub.edu	Ventura, Francesc/ABG-2285-2020; Osses, Nelson/V-9065-2019; Ventura, Francesc/K-9700-2014; Rosa, Jose Luis/K-6685-2014; Ulsamer, A/H-7994-2014	Ventura, Francesc/0000-0001-9673-9405; Osses, Nelson/0000-0003-0974-1051; Ventura, Francesc/0000-0001-9673-9405; Rosa, Jose Luis/0000-0002-6161-5688; Ulsamer, A/0000-0001-7808-1005; Ortuno Romero, Maria Jose/0000-0002-0200-9952				Acampora D, 1999, DEVELOPMENT, V126, P3795; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Celil AB, 2005, J CELL BIOCHEM, V95, P518, DOI 10.1002/jcb.20429; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Depew MJ, 1999, DEVELOPMENT, V126, P3831; Depew MJ, 2005, J ANAT, V207, P501, DOI 10.1111/j.1469-7580.2005.00487.x; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan DW, 2007, J CELL PHYSIOL, V211, P577, DOI 10.1002/jcp.21016; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Harris SE, 2003, FRONT BIOSCI, V8, pS1249, DOI 10.2741/1170; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Kim YJ, 2006, GENE, V366, P145, DOI 10.1016/j.gene.2005.08.021; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Kusanagi K, 2000, MOL BIOL CELL, V11, P555, DOI 10.1091/mbc.11.2.555; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee JY, 2006, MOL CELLS, V22, P182; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Milona M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-43; Mitchell JM, 2006, J DENT RES, V85, P888, DOI 10.1177/154405910608501003; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Norris RA, 2001, J BIOL CHEM, V276, P26829, DOI 10.1074/jbc.M100239200; Noth U, 2003, EXP CELL RES, V291, P201, DOI 10.1016/S0014-4827(03)00386-0; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Villagra A, 2006, J BIOL CHEM, V281, P22695, DOI 10.1074/jbc.M511640200; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Young DW, 2005, J CELL BIOCHEM, V94, P720, DOI 10.1002/jcb.20332	54	176	195	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3816	3826		10.1074/jbc.M704724200	http://dx.doi.org/10.1074/jbc.M704724200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18056716	Green Published, hybrid			2022-12-27	WOS:000253083500016
J	Umeda, D; Yano, S; Yamada, K; Tachibana, H				Umeda, Daisuke; Yano, Satomi; Yamada, Koji; Tachibana, Hirofumi			Green tea Polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; ELONGATION-FACTOR 1A; GENETIC SUPPRESSOR ELEMENTS; HUMAN T-LYMPHOCYTES; MYOSIN PHOSPHATASE; BINDING PROTEIN; ACTIN-FILAMENTS; NONMUSCLE CELLS; LIGHT-CHAIN; EXPRESSION	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to be a potent chemopreventive agent. Recently, 67-kDa laminin receptor (67LR) has been identified as a cell surface receptor for EGCG that mediates the anticancer activity of EGCG. Indeed, expression of 67LR confers EGCG responsiveness to tumor cells; however, the molecular basis for the anticancer activity of EGCG in vivo is not entirely understood. Here we show that (i) using a direct genetic screen, eukaryotic translation elongation factor 1A (eEF1A) is identified as a component responsible for the anticancer activity of EGCG; (ii) through both eEF1A and 67LR, EGCG induces the dephosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) at Thr-696 and activates myosin phosphatase; and (iii) silencing of 67LR, eEF1A, or MYPT1 in tumor cells results in abrogation of EGCG-induced tumor growth inhibition in vivo. Additionally, we found that eEF1A is up-regulated by EGCG through 67LR. Overall, these findings implicate both eEF1A and MYPT1 in EGCG signaling for cancer prevention through 67LR.	[Umeda, Daisuke; Yano, Satomi; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Lab Food Chem, Fukuoka 8128581, Japan; [Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Dept Funct Metab Design, Lab Funct Food Design, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Tachibana, H (corresponding author), Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Umeda, Daisuke/0000-0001-6301-9938				Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canfield SM, 1999, J IMMUNOL, V163, P3430; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; DEVER TE, 1989, J BIOL CHEM, V264, P20518; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edmonds BT, 1996, J CELL SCI, V109, P2705; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Gloe T, 1999, J BIOL CHEM, V274, P15996, DOI 10.1074/jbc.274.23.15996; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hong J, 2002, CANCER RES, V62, P7241; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim K, 2005, BIOCHEM BIOPH RES CO, V338, P1327, DOI 10.1016/j.bbrc.2005.10.089; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Maciver SK, 1996, BIOESSAYS, V18, P179, DOI 10.1002/bies.950180304; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; RONINSON IB, 1995, CANCER RES, V55, P4023; Satoh K, 1999, BRIT J CANCER, V80, P1115, DOI 10.1038/sj.bjc.6690474; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; VANDEBROEK I, 2001, BRIT J CANCER, V96, P1387; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.230S, 10.1093/ajcn/81.1.243S]; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yang CS, 1997, NATURE, V389, P134, DOI 10.1038/38154; Yang CS, 2000, J NUTR, V130, p472S, DOI 10.1093/jn/130.2.472S; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	54	169	179	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3050	3058		10.1074/jbc.M707892200	http://dx.doi.org/10.1074/jbc.M707892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18079119	hybrid			2022-12-27	WOS:000253083000008
J	Wonderlich, ER; Williams, M; Collins, KL				Wonderlich, Elizabeth R.; Williams, Maya; Collins, Kathleen L.			The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu 1 subunit is necessary for nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; HIV-1 NEF; DOWN-REGULATION; MHC-I; CLATHRIN ADAPTER; SORTING SIGNALS; TRAFFICKING; PROTEIN; CELLS; DISTINCT	To evade the anti-human immunodeficiency virus (HIV) immune response, the HIV Nef protein disrupts major histocompatibility complex class I (MHC-I) trafficking by recruiting the clathrin adaptor protein 1 (AP-1) to the MHC-I cytoplasmic tail. Under normal conditions AP-1 binds dileucine and tyrosine signals (YXX phi motifs) via physically separate binding sites. In the case of the Nef- MHC-I complex, a tyrosine in the human leukocyte antigen (HLA)-A2 cytoplasmic tail ((320)YSQA) and a methionine in Nef (Met(20)) are absolutely required for AP-1 binding. Also present in Nef is a dileucine motif, which does not normally affect MHC-I trafficking and is not needed to recruit AP-1 to the Nef- MHC-I-complex. However, evidence is presented here that this dileucine motif can be activated by fusing Nef to the HLA-A2 tail in cis. Thus, the inability of this motif to function in trans likely results from a structural change that occurs when Nef binds to the MHC-I cytoplasmic tail. The physiologically relevant tyrosine-dependent recruitment of AP-1 to MHC-I, which occurs whether Nef is present in cis or trans, was stabilized by the acidic and polyproline domains within Nef. Additionally, amino acids Ala(324) and Asp(327) in the cytoplasmic tails of HLA-A and (but not HLA-C and HLA-E) molecules also stabilized AP-1 binding. Finally, mutation of the tyrosine binding pocket in the mu subunit of AP-1 created a dominant negative inhibitor of Nef- induced down-modulation of HLA-A2 that disrupted binding of wild type AP-1 to the Nef- MHC-I complex. Thus, these data provide evidence that Nef binding to the MHC-I cytoplasmic tail stabilizes the interaction of a tyrosine in the MHC-I cytoplasmic tail with the natural tyrosine binding pocket in AP-1.	[Collins, Kathleen L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wonderlich, Elizabeth R.; Williams, Maya; Collins, Kathleen L.] Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Collins, Kathleen L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, KL (corresponding author), Univ Michigan, Dept Internal Med, 3510 MSRB 1 Box 0652,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	klcollin@umich.edu			NIAID NIH HHS [R01AI46998] Funding Source: Medline; NIGMS NIH HHS [T32 GM007315] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Chang AH, 1998, FEBS LETT, V441, P307, DOI 10.1016/S0014-5793(98)01569-5; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; KERKAU T, 1989, AIDS RES HUM RETROV, V5, P613, DOI 10.1089/aid.1989.5.613; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Williams M, 2002, J VIROL, V76, P12173, DOI 10.1128/JVI.76.23.12173-12184.2002	36	60	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3011	3022		10.1074/jbc.M707760200	http://dx.doi.org/10.1074/jbc.M707760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073204	hybrid			2022-12-27	WOS:000253083000004
J	Zhao, X; Nicholls, JM; Chen, YG				Zhao, Xingang; Nicholls, John M.; Chen, Ye-Guang			Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATOR INHIBITOR-1 GENE; TGF-BETA; SARS CORONAVIRUS; TRANSCRIPTIONAL ACTIVATION; PULMONARY-FIBROSIS; TUMOR SUPPRESSION; MAMMALIAN-CELLS; EXPRESSION; BINDING; VIRUS	Severe acute respiratory syndrome (SARS) is an acute infectious disease with significant mortality. Atypical clinical feature associated with SARS is pulmonary fibrosis and the associated lung failure. However, the underlying mechanism remains elusive. In this study, we demonstrate that SARS-associated coronavirus (SARS-CoV) nucleocapsid (N) protein potentiates transforming growth factor-beta (TGF-beta)-induced expression of plasminogen activator inhibitor-1 but attenuates Smad3/Smad4-mediated apoptosis of human peripheral lung epithelial HPL1 cells. The promoting effect of N protein on the transcriptional responses of TGF-beta is Smad3-specific. N protein associates with Smad3 and promotes Smad3-p300 complex formation while it interferes with the complex formation between Smad3 and Smad4. These findings provide evidence of a novel mechanism whereby N protein modulates TGF-beta signaling to block apoptosis of SARS-CoV-infected host cells and meanwhile promote tissue fibrosis. Our results reveal a novel mode of Smad3 action in a Smad4-independent manner and may lead to successful strategies for SARS treatment by targeting the TGF-beta signaling molecules.	[Zhao, Xingang; Chen, Ye-Guang] Tsinghua Univ, Dept Biol Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China	Tsinghua University; University of Hong Kong	Chen, YG (corresponding author), Tsinghua Univ, Dept Biol Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Nicholls, John Malcolm/C-4375-2009	Nicholls, John Malcolm/0000-0001-7217-7444				BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Che XY, 2004, EMERG INFECT DIS, V10, P1947, DOI 10.3201/eid1011.040516; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ding YQ, 2003, J PATHOL, V200, P282, DOI 10.1002/path.1440; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; He L, 2006, J PATHOL, V210, P288, DOI 10.1002/path.2067; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; KEETON MR, 1991, J BIOL CHEM, V266, P23048; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Law PTW, 2005, J GEN VIROL, V86, P1921, DOI 10.1099/vir.0.80813-0; Lee DK, 2001, GENE DEV, V15, P455, DOI 10.1101/gad.856201; Lee DK, 2002, J BIOL CHEM, V277, P33766, DOI 10.1074/jbc.M200150200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masuda A, 1997, CANCER RES, V57, P4898; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nishihara A, 1999, J BIOL CHEM, V274, P28716, DOI 10.1074/jbc.274.40.28716; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Prokova V, 2002, J BIOL CHEM, V277, P9342, DOI 10.1074/jbc.M109099200; Roberts AB, 2006, CYTOKINE GROWTH F R, V17, P19, DOI 10.1016/j.cytogfr.2005.09.008; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Rowland RRR, 2005, J VIROL, V79, P11507, DOI 10.1128/JVI.79.17.11507-11512.2005; Schwarte-Waldhoff I, 1999, ONCOGENE, V18, P3152, DOI 10.1038/sj.onc.1202641; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sirard C, 2000, J BIOL CHEM, V275, P2063, DOI 10.1074/jbc.275.3.2063; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Surjit M, 2006, J BIOL CHEM, V281, P10669, DOI 10.1074/jbc.M509233200; Surjit M, 2004, BIOCHEM J, V383, P13, DOI 10.1042/BJ20040984; Tan YJ, 2004, J VIROL, V78, P14043, DOI 10.1128/JVI.78.24.14043-14047.2004; Tan YW, 2006, NUCLEIC ACIDS RES, V34, P4816, DOI 10.1093/nar/gkl650; Timani KA, 2005, VIRUS RES, V114, P23, DOI 10.1016/j.virusres.2005.05.007; Wang Z, 2004, J VIROL, V78, P7523, DOI 10.1128/JVI.78.14.7523-7527.2004; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Yanagisawa K, 1998, ONCOGENE, V17, P1743, DOI 10.1038/sj.onc.1202052; Yuan XL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-66; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	55	122	127	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3272	3280		10.1074/jbc.M708033200	http://dx.doi.org/10.1074/jbc.M708033200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18055455	Green Published, hybrid			2022-12-27	WOS:000253083000031
J	Christianson, JL; Nicoloro, S; Straubhaar, J; Czech, MP				Christianson, Jennifer L.; Nicoloro, Sarah; Straubhaar, Juerg; Czech, Michael P.			Stearoyl-CoA desaturase 2 is required for peroxisome proliferator-activated receptor gamma expression and adipogenesis in cultured 3T3-L1 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; PROTEIN-KINASE; TRANSLATION INITIATION; MAMMALIAN TARGET; GENE-EXPRESSION; C/EBP-ALPHA; ACID; INSULIN; MICE	Based on recent evidence that fatty acid synthase and endogenously produced fatty acid derivatives are required for adipogenesis in 3T3-L1 adipocytes, we conducted a small interfering RNA-based screen to identify other fatty acid-metabolizing enzymes that may mediate this effect. Of 24 enzymes screened, stearoyl-CoA desaturase 2 (SCD2) was found to be uniquely and absolutely required for adipogenesis. Remarkably, SCD2 also controls the maintenance of adipocyte-specific gene expression in fully differentiated 3T3-L1 adipocytes, including the expression of SCD1. Despite the high sequence similarity between SCD2 and SCD1, silencing of SCD1 did not down-regulate 3T3-L1 cell differentiation or gene expression. SCD2 mRNA expression was also uniquely elevated 44-fold in adipose tissue upon feeding mice a high fat diet, whereas SCD1 showed little response. The inhibition of adipogenesis caused by SCD2 depletion was associated with a decrease in peroxisome proliferator-activated receptor gamma ( PPAR gamma) mRNA and protein, whereas in mature adipocytes loss of SCD2 diminished PPAR gamma protein levels, with little change in mRNA levels. In the latter case, SCD2 depletion did not change the degradation rate of PPAR gamma protein but decreased the metabolic labeling of PPAR gamma protein using [S-35] methionine/cysteine, indicating protein translation was decreased. This requirement of SCD2 for optimal protein synthesis in fully differentiated adipocytes was verified by polysome profile analysis, where a shift in the mRNA to monosomes was apparent in response to SCD2 silencing. These results reveal that SCD2 is required for the induction and maintenance of PPAR gamma protein levels and adipogenesis in 3T3-L1 cells.	[Christianson, Jennifer L.; Nicoloro, Sarah; Straubhaar, Juerg; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu		Nicoloro, Sarah/0000-0002-8638-4556	NIDDK NIH HHS [DK 60837, DK 32520, DK 30898] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030898, R01DK060837, P30DK032520, R01DK030898] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aktas H, 2004, J NUTR, V134, p2487S, DOI 10.1093/jn/134.9.2487S; Aslan H, 2006, OBES SURG, V16, P1526, DOI 10.1381/096089206778869942; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Bull AW, 2003, CARCINOGENESIS, V24, P1717, DOI 10.1093/carcin/bgg131; Camp HS, 2001, ENDOCRINOLOGY, V142, P3207, DOI 10.1210/en.142.7.3207; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gomez FE, 2003, BIOCHEM BIOPH RES CO, V300, P316; Gustafson B, 2003, BIOCHEM BIOPH RES CO, V308, P933, DOI 10.1016/S0006-291X(03)01518-3; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kersten S, 2002, EUR J PHARMACOL, V440, P223, DOI 10.1016/S0014-2999(02)01431-0; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Levert KL, 2002, J BIOL CHEM, V277, P16347, DOI 10.1074/jbc.C200113200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man WC, 2006, J BIOL CHEM, V281, P1251, DOI 10.1074/jbc.M508733200; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Meric F, 2002, MOL CANCER THER, V1, P971; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Miyazaki M, 2001, J NUTR, V131, P2260, DOI 10.1093/jn/131.9.2260; Neeli I, 2003, BIOCHEM BIOPH RES CO, V309, P755, DOI 10.1016/j.bbrc.2003.08.066; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; ROTMAN EI, 1992, BIOCHEM J, V282, P487, DOI 10.1042/bj2820487; Schmid B, 2005, BIOCHEM BIOPH RES CO, V328, P1073, DOI 10.1016/j.bbrc.2005.01.067; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Stewart WC, 2004, BIOCHEM BIOPH RES CO, V324, P355, DOI 10.1016/j.bbrc.2004.09.053; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V319, P235, DOI 10.1016/j.bbrc.2004.04.176; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Zhang SB, 2005, BIOCHEM J, V388, P135, DOI 10.1042/BJ20041554	50	56	56	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2906	2916		10.1074/jbc.M705656200	http://dx.doi.org/10.1074/jbc.M705656200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18032385	hybrid			2022-12-27	WOS:000252622300047
J	Chien, YH; Jiang, N; Li, F; Zhang, F; Zhu, C; Leckband, D				Chien, Yuan-Hung; Jiang, Ning; Li, Fang; Zhang, Fang; Zhu, Cheng; Leckband, Deborah			Two stage cadherin kinetics require multiple extracellular domains but not the cytoplasmic region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; LIGAND BINDING-KINETICS; C-CADHERIN; CONFORMATIONAL-CHANGES; LATERAL DIMERIZATION; FUNCTIONAL-ANALYSIS; CONCURRENT BINDING; STRUCTURAL BASIS; CALCIUM-BINDING; I-DOMAIN	Micropipette manipulation measurements quantified the pre-steady state binding kinetics between cell pairs mediated by Xenopus cleavage stage cadherin. The time-dependence of the intercellular binding probability exhibits a fast forming, low probability binding state, which transitions to a slower forming, high probability state. The biphasic kinetics are independent of the cytoplasmic region, but the transition to the high probability state requires the third extracellular domain EC3. Deleting either EC3 or EC3-5, or substituting Trp(2) for Ala reduces the binding curves to a simple, monophasic rise in binding probability to a limiting plateau, as predicted for a single site binding mechanism. The two stage cadherin binding process reported here directly parallels previous biophysical studies, and confirms that the cadherin ectodomain governs the initial intercellular adhesion dynamics.	[Chien, Yuan-Hung] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Jiang, Ning; Zhang, Fang; Zhu, Cheng] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Li, Fang] Univ Illinois, Urbana, IL 61801 USA; [Leckband, Deborah] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University System of Georgia; Georgia Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhu, C (corresponding author), 315 Ferst Dr, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu; Leckband@uiuc.edu	Jiang, Ning/M-5448-2017; Zhu, Cheng/A-5724-2011	Jiang, Ning/0000-0003-1103-5922; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902, R21AI044902, R01AI038282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051338] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR006009] Funding Source: Medline; NIAID NIH HHS [R01 AI044902, R01 AI038282, R01 AI44902, R21 AI044902, R01 AI38282] Funding Source: Medline; NIGMS NIH HHS [R01 GM51338, R01 GM051338] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahrens T, 2002, J BIOL CHEM, V277, P19455, DOI 10.1074/jbc.M200606200; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Braga VMM, 2005, CURR OPIN CELL BIOL, V17, P466, DOI 10.1016/j.ceb.2005.08.012; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chesla SE, 2000, J BIOL CHEM, V275, P10235, DOI 10.1074/jbc.275.14.10235; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Dumaswala UJ, 1996, BLOOD, V88, P697, DOI 10.1182/blood.V88.2.697.bloodjournal882697; EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2; GOLD ER, 1967, J IMMUNOL, V99, P859; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kaibuchi K, 1999, CURR OPIN CELL BIOL, V11, P591, DOI 10.1016/S0955-0674(99)00014-9; KAPLANSKI G, 1993, BIOPHYS J, V64, P1922, DOI 10.1016/S0006-3495(93)81563-7; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; KOFLER R, 1977, J IMMUNOL METHODS, V16, P201, DOI 10.1016/0022-1759(77)90198-3; Long M, 2001, ANN BIOMED ENG, V29, P935, DOI 10.1114/1.1415529; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6; Ozawa M, 2002, J BIOL CHEM, V277, P19600, DOI 10.1074/jbc.M202029200; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pierres A, 1996, J IMMUNOL METHODS, V196, P105, DOI 10.1016/0022-1759(96)00103-2; PIERRES A, 1995, J BIOL CHEM, V270, P26586, DOI 10.1074/jbc.270.44.26586; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 2001, BIOPHYS J, V80, P1758, DOI 10.1016/S0006-3495(01)76146-2; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Tomschy A, 1996, EMBO J, V15, P3507, DOI 10.1002/j.1460-2075.1996.tb00719.x; Tsuiji H, 2007, J BIOL CHEM, V282, P12871, DOI 10.1074/jbc.M611725200; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WEIDNER KM, 1990, J CELL BIOL, V111, P2097, DOI 10.1083/jcb.111.5.2097; Williams TE, 2000, BIOPHYS J, V79, P1867, DOI 10.1016/S0006-3495(00)76436-8; Williams TE, 2000, BIOPHYS J, V79, P1858, DOI 10.1016/S0006-3495(00)76435-6; Williams TE, 2001, J BIOL CHEM, V276, P13283, DOI 10.1074/jbc.M010427200; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhong Y, 1999, J CELL BIOL, V144, P351, DOI 10.1083/jcb.144.2.351; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7; Zhu C, 2000, BIOPHYS J, V79, P1850, DOI 10.1016/S0006-3495(00)76434-4	59	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1848	1856		10.1074/jbc.M708044200	http://dx.doi.org/10.1074/jbc.M708044200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	17999960	Green Accepted, hybrid			2022-12-27	WOS:000252501000010
J	Hamamoto, S; Marui, J; Matsuoka, K; Higashi, K; Igarashi, K; Nakagawa, T; Kuroda, T; Mori, Y; Murata, Y; Nakanishi, Y; Maeshima, M; Yabe, I; Uozumi, N				Hamamoto, Shin; Marui, Junichiro; Matsuoka, Ken; Higashi, Kyohei; Igarashi, Kazuei; Nakagawa, Tsuyoshi; Kuroda, Teruo; Mori, Yasuo; Murata, Yoshiyuki; Nakanishi, Yoichi; Maeshima, Masayoshi; Yabe, Isamu; Uozumi, Nobuyuki			Characterization of a tobacco TPK-type K+ channel as a novel tonoplast K+ channel using yeast tonoplasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; ION CHANNELS; SACCHAROMYCES-CEREVISIAE; VACUOLAR MEMBRANE; PATCH-CLAMP; ARGININE DECARBOXYLASE; ESCHERICHIA-COLI; CYTOPLASMIC PORE; PLASMA-MEMBRANE; GUARD-CELLS	The tonoplast K+ membrane transport system plays a crucial role in maintaining K+ homeostasis in plant cells. Here, we isolated cDNAs encoding a two-pore K+ channel (NtTPK1) from Nicotiana tabacum cv. SR1 and cultured BY-2 tobacco cells. Two of the four variants of NtTPK1 contained VHG and GHG instead of the GYG signature sequence in the second pore region. All four products were functional when expressed in the Escherichia coli cell membrane, and NtTPK1 was targeted to the tonoplast in tobacco cells. Two of the three promoter sequences isolated from N. tabacum cv. SR1 were active, and expression from these was increased similar to 2-fold by salt stress or high osmotic shock. To determine the properties of NtTPK1, we enlarged mutant yeast cells with inactivated endogenous tonoplast channels and prepared tonoplasts suitable for patch clamp recording allowing the NtTPK1-related channel conductance to be distinguished from the small endogenous currents. NtTPK1 exhibited strong selectivity for K+ over Na+. NtTPK1 activity was sensitive to spermidine and spermine, which were shown to be present in tobacco cells. NtTPK1 was active in the absence of Ca2+, but a cytosolic concentration of 45 mu M Ca2+ resulted in a 2-fold increase in the amplitude of the K+ current. Acidification of the cytosol topH5.5 also markedly increased NtTPK1-mediated K+ currents. These results show that NtTPK1 is a novel tonoplast K+ channel belonging to a different group from the previously characterized vacuolar channels SV, FV, and VK.	[Hamamoto, Shin; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Marui, Junichiro] Tohoku Univ, New Ind Creat Hatchery Ctr, Sendai, Miyagi 9808579, Japan; [Matsuoka, Ken] Kyushu Univ, Lab Plant Nutr, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Higashi, Kyohei; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Nakagawa, Tsuyoshi] Shimane Univ, Dept Mol & Funct Genom, Ctr Integrated Res Sci, Matsue, Shimane 6908504, Japan; [Kuroda, Teruo] Okayama Univ, Sch Med Dent & Pharmaceut Sci, Dept Genome Appl Microbiol, Grad Sch Med, Okayama 7008530, Japan; [Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Div Synth Chem & Biol Chem, Kyoto 6158510, Japan; [Murata, Yoshiyuki] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Nakanishi, Yoichi; Maeshima, Masayoshi] Nagoya Univ, Grad Sch Bioagr Sci, Lab Cell Dynam, Nagoya, Aichi 4648601, Japan; [Yabe, Isamu] Univ Tokyo, Bunkyo Ku, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Tohoku University; Tohoku University; Kyushu University; Chiba University; Shimane University; Okayama University; Kyoto University; Okayama University; Nagoya University; University of Tokyo	Uozumi, N (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Matsuoka, Ken/E-3215-2010; Maeshima, Masayoshi/D-3073-2013; Uozumi, Nobuyuki/AAG-3252-2019; KURODA, Teruo/B-2028-2011	Maeshima, Masayoshi/0000-0002-1611-5481; Higashi, Kyohei/0000-0002-2622-4825; Uozumi, Nobuyuki/0000-0003-4268-1126; Matsuoka, Ken/0000-0001-7229-7294				Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Becker D, 2004, P NATL ACAD SCI USA, V101, P15621, DOI 10.1073/pnas.0401502101; BERTL A, 1990, P NATL ACAD SCI USA, V87, P7824, DOI 10.1073/pnas.87.20.7824; Bihler H, 2005, PLANT PHYSIOL, V139, P417, DOI 10.1104/pp.105.065599; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Czempinski K, 1997, EMBO J, V16, P2565, DOI 10.1093/emboj/16.10.2565; Czempinski K, 2002, PLANT J, V29, P809, DOI 10.1046/j.1365-313X.2002.01260.x; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; FLORES HE, 1982, SCIENCE, V217, P1259, DOI 10.1126/science.217.4566.1259; FRIEDMAN R, 1986, PLANT PHYSIOL, V82, P1154, DOI 10.1104/pp.82.4.1154; FRITZE K, 1995, PLANT J, V7, P261, DOI 10.1046/j.1365-313X.1995.7020261.x; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Gambale F, 2006, J MEMBRANE BIOL, V210, P1, DOI [10.1007/s00232-006-0856-x, 10.1007/S00232-006-0856-X]; GELLI A, 1993, PLANT PHYSIOL, V102, P1139, DOI 10.1104/pp.102.4.1139; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; GOODALL GJ, 1990, METHOD ENZYMOL, V181, P148; GUELMAN R, 2002, BONE, V30, P23; Hagiwara Y, 2003, EMBO J, V22, P344, DOI 10.1093/emboj/cdg033; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; IGARASHI K, 1986, J BACTERIOL, V166, P128, DOI 10.1128/jb.166.1.128-134.1986; JEFFERSON RA, 1987, EMBO J, V6, P3901; Johannes E, 2001, PLANT PHYSIOL, V127, P119, DOI 10.1104/pp.127.1.119; Kaplan B, 2007, FEBS LETT, V581, P2237, DOI 10.1016/j.febslet.2007.02.017; Kim Y, 1999, AM J PHYSIOL-HEART C, V277, pH1669, DOI 10.1152/ajpheart.1999.277.5.H1669; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kumar A, 1996, PLANT J, V9, P147, DOI 10.1046/j.1365-313X.1996.09020147.x; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; Kuroda T, 2004, J MEMBRANE BIOL, V198, P177, DOI 10.1007/s00232-004-0671-1; Kuroda T, 1998, J BIOL CHEM, V273, P16897, DOI 10.1074/jbc.273.27.16897; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Latz A, 2007, PLANT J, V52, P449, DOI 10.1111/j.1365-313X.2007.03255.x; Lebaudy A, 2007, FEBS LETT, V581, P2357, DOI 10.1016/j.febslet.2007.03.058; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; LIOUBOV T, 1997, PLANT J, V11, P1059; Liu K, 2000, PLANT PHYSIOL, V124, P1315, DOI 10.1104/pp.124.3.1315; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lurin C, 2000, BIOCHEM J, V348, P291, DOI 10.1042/0264-6021:3480291; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MAESHIMA M, 1994, PLANT PHYSIOL, V106, P61, DOI 10.1104/pp.106.1.61; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Masgrau C, 1997, PLANT J, V11, P465, DOI 10.1046/j.1365-313X.1997.11030465.x; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MATSUOKA K, 1991, P NATL ACAD SCI USA, V88, P834, DOI 10.1073/pnas.88.3.834; MCGARVEY P, 1991, BIOTECHNIQUES, V11, P428; MERSEREAU M, 1990, GENE, V90, P149, DOI 10.1016/0378-1119(90)90452-W; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nakanishi Y, 2003, J BIOCHEM, V134, P615, DOI 10.1093/jb/mvg184; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Pandey S, 2007, FEBS LETT, V581, P2325, DOI 10.1016/j.febslet.2007.04.008; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; SLOCUM RD, 1984, ARCH BIOCHEM BIOPHYS, V235, P283, DOI 10.1016/0003-9861(84)90201-7; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Suga S, 2001, PLANTA, V212, P294, DOI 10.1007/s004250000396; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TANAKA K, 1990, MOL CELL BIOL, V10, P4303, DOI 10.1128/MCB.10.8.4303; Tena G, 1998, PLANT J, V16, P173, DOI 10.1046/j.1365-313x.1998.00283.x; THIEL G, 1993, P NATL ACAD SCI USA, V90, P11493, DOI 10.1073/pnas.90.24.11493; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; UOZUMI N, 2007, AM J PHYSIOL-CELL PH, V104, P34; Voelker C, 2006, PLANT J, V48, P296, DOI 10.1111/j.1365-313X.2006.02868.x; Walker DJ, 1996, P NATL ACAD SCI USA, V93, P10510, DOI 10.1073/pnas.93.19.10510; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; WARD JM, 1994, PLANT CELL, V6, P669; Watson MB, 1998, PLANT J, V13, P231, DOI 10.1046/j.1365-313X.1998.00027.x; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903; YOSHIHISA T, 1988, J BIOL CHEM, V263, P5158; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; ZHOU XL, 1995, FEBS LETT, V373, P170, DOI 10.1016/0014-5793(95)01035-D	84	59	69	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1911	1920		10.1074/jbc.M708213200	http://dx.doi.org/10.1074/jbc.M708213200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18029350	hybrid			2022-12-27	WOS:000252501000017
J	Lito, P; Mets, BD; Kleff, S; O'Reilly, S; Maher, VM; McCormick, JJ				Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin			Evidence that Sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; CELL STRAIN MSU-1.1; MALIGNANT-TRANSFORMATION; DOWN-REGULATION; GENE-EXPRESSION; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; INHIBITOR; PATHWAY	Sprouty 2 (Spry2) acts as an inhibitor of receptor tyrosine kinase signaling in various cellular contexts. Interestingly, Spry2 also prevents the c-Cbl-induced degradation of epidermal growth factor receptor ( EGFR). We compared human fibroblasts malignantly transformed by overexpression of H-Ras(V12) oncogene to their nontransformed parental cells and found that the malignant cells express a high level of Spry2. These cells also exhibited an increase in the level of EGFR compared with their precursor cells. We found that intact EGFR was required if H-Ras-transformed cells were to grow in the absence of exogenous growth factors or form large colonies in agarose. When we decreased expression of Spry2, using a Spry2-specific shRNA, the H-Ras(V12)-transformed fibroblasts could no longer form large colonies in agarose, grow in reduced levels of serum, or form tumors in athymic mice. The level of active H-Ras in these cells remained unaltered. A similar, but less pronounced, effect in tumor formation was observed when Spry2 was down-regulated in human patient-derived fibrosarcoma cell lines. In H-Ras-transformed cells Spry2 sustained the level and the downstream signaling activity of EGFR. In the parental, non-HRas-transformed fibroblasts, expression of Spry2 resulted in the inhibition of H-Ras and ERK activation, suggesting that the positive effect of Spry2 in tumor formation is specific to H-Ras transformation. Co-immunoprecipitation studies with H-Ras-transformed cells revealed that Spry2 and H-Ras interact and that H-Ras interacts with Spry2-binding partners, c-Cbl and CIN85, in a Spry2-dependent manner. These data show that Spry2 plays a critical role in the ability of H-Ras-transformed cells to form tumors in athymic mice.	[Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin] Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lito, Piro; Mets, Bryan D.; Kleff, Susanne; O'Reilly, Sandra; Maher, Veronica M.; McCormick, J. Justin] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	McCormick, JJ (corresponding author), Michigan State Univ, Carcinogenesis Lab, Dept Microbiol & Mol Genet, Food Safety & Toxicol Bldg, E Lansing, MI 48824 USA.				NATIONAL CANCER INSTITUTE [R01CA098305] Funding Source: NIH RePORTER; NCI NIH HHS [CA098305] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Boley SE, 2000, CANCER RES, V60, P4105; Casanova ML, 2002, CANCER RES, V62, P3402; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Choi H, 2006, J IMMUNOL, V176, P6034, DOI 10.4049/jimmunol.176.10.6034; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Fritzsche S, 2006, ENDOCR-RELAT CANCER, V13, P839, DOI 10.1677/erc.1.01190; FRY DG, 1990, ONCOGENE, V5, P1415; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hamilton M, 1998, J BIOL CHEM, V273, P28155, DOI 10.1074/jbc.273.43.28155; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Lee M, 2006, BIOCHEM BIOPH RES CO, V350, P450, DOI 10.1016/j.bbrc.2006.09.067; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lou Z, 2005, CANCER RES, V65, P1007; Martinez-Lacaci I, 2000, INT J CANCER, V88, P44, DOI 10.1002/1097-0215(20001001)88:1<44::AID-IJC7>3.0.CO;2-8; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; MCCORMICK JJ, 1994, RISK ANAL, V14, P257, DOI 10.1111/j.1539-6924.1994.tb00240.x; Minowada G, 1999, DEVELOPMENT, V126, P4465; MORGAN TL, 1991, EXP CELL RES, V197, P125, DOI 10.1016/0014-4827(91)90489-H; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; O'Reilly S, 1998, RADIAT RES, V150, P577, DOI 10.2307/3579875; Qing J, 1999, ONCOGENE, V18, P335, DOI 10.1038/sj.onc.1202290; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; WILSON DM, 1990, CANCER RES, V50, P5587; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200	47	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2002	2009		10.1074/jbc.M709046200	http://dx.doi.org/10.1074/jbc.M709046200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18048363	hybrid			2022-12-27	WOS:000252501000027
J	Zhang, Y; Zhou, Y; Schweizer, U; Savaskan, NE; Hua, D; Kipnis, J; Hatfield, DL; Gladyshev, VN				Zhang, Yan; Zhou, You; Schweizer, Ulrich; Savaskan, Nicolai E.; Hua, Deame; Kipnis, Jonathan; Hatfield, Dolph L.; Gladyshev, Vadim N.			Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-PEROXIDASE; TYPE-2 DEIODINASE; TARGET TISSUES; GLIAL-CELLS; RICH DOMAIN; RAT-BRAIN; THIOREDOXIN; MECHANISM; PATTERNS; MICE	Although dietary selenium (Se) deficiency results in phenotypes associated with selenoprotein depletion in various organs, the brain is protected from Se loss. To address the basis for the critical role of Se in brain function, we carried out comparative gene expression analyses for the complete selenoproteome and associated biosynthetic factors. Using the Allen Brain Atlas, we evaluated 159 regions of adult mouse brain and provided experimental analyses of selected selenoproteins. All 24 selenoprotein mRNAs were expressed in the mouse brain. Most strikingly, neurons in olfactory bulb, hippocampus, cerebral cortex, and cerebellar cortex were exceptionally rich in selenoprotein gene expression, in particular in GPx4, SelK, SelM, SelW, and Sep15. Over half of the selenoprotein genes were also expressed in the choroid plexus. A unique expression pattern was observed for one of the highly expressed selenoprotein genes, SelP, which we suggest to provide neurons with Se. Cluster analysis of the expression data linked certain selenoproteins and selenocysteine machinery genes and suggested functional linkages among selenoproteins, such as that between SelM and Sep15. Overall, this study suggests that the main functions of selenium in mammals are confined to certain neurons in the brain.	[Zhang, Yan; Hua, Deame; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Zhou, You] Univ Nebraska, Ctr Biotechnol, Lincoln, NE 68588 USA; [Schweizer, Ulrich] Charite, Neurosci Res Ctr, D-10117 Berlin, Germany; [Savaskan, Nicolai E.] ETH & Univ Zurich, Brain Res Inst, Dept Neuromorphol, CH-8057 Zurich, Switzerland; [Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA; [Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gladyshev, VN (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA.	vgladyshev1@unl.edu	Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013; Savaskan, Nicolai/D-2923-2018	Schweizer, Ulrich/0000-0003-1380-4780; Savaskan, Nicolai/0000-0003-1348-094X; Gladyshev, Vadim/0000-0002-0372-7016	NATIONAL CANCER INSTITUTE [Z01BC010767, ZIABC010767, Z01BC005317, ZIABC005317] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Baek IJ, 2005, ANAT EMBRYOL, V209, P315, DOI 10.1007/s00429-004-0447-5; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BEHNE D, 1984, J NUTR, V114, P1289, DOI 10.1093/jn/114.7.1289; Brown K M, 2001, Public Health Nutr, V4, P593; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; BURK RF, 1972, J NUTR, V102, P1049, DOI 10.1093/jn/102.8.1049; Ciorba MA, 1999, FEBS LETT, V442, P48, DOI 10.1016/S0014-5793(98)01616-0; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Fekete C, 2007, ENDOCRINOLOGY, V148, P4865, DOI 10.1210/en.2007-0448; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; Drasch G, 2000, BIOL TRACE ELEM RES, V77, P219, DOI 10.1385/BTER:77:3:219; Dreher I, 1997, J TRACE ELEM MED BIO, V11, P83, DOI 10.1016/S0946-672X(97)80031-4; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dubois GM, 2006, ENDOCRINOLOGY, V147, P4941, DOI 10.1210/en.2006-0609; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ejima A, 1996, BIOL TRACE ELEM RES, V54, P9, DOI 10.1007/BF02785316; Fekete C, 2007, FRONT NEUROENDOCRIN, V28, P97, DOI 10.1016/j.yfrne.2007.04.002; Ferguson AD, 2006, J BIOL CHEM, V281, P3536, DOI 10.1074/jbc.M511386200; Galton VA, 2005, THYROID, V15, P823, DOI 10.1089/thy.2005.15.823; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Geoghegan M, 2006, CURR OPIN CRIT CARE, V12, P136, DOI 10.1097/01.ccx.0000216581.80051.d6; GuadanoFerraz A, 1997, P NATL ACAD SCI USA, V94, P10391, DOI 10.1073/pnas.94.19.10391; Hadaszadeh BM, 2006, PHYSIOLOGY, V21, P307, DOI 10.1152/physiol.00021.2006; Hatfield D.L., 2002, SELENIUM ITS MOL BIO, V36, P235, DOI 10.1080/10715760290006394; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; HOCK A, 1975, BRAIN, V98, P49, DOI 10.1093/brain/98.1.49; Hoffmann PR, 2007, NUCLEIC ACIDS RES, V35, P3963, DOI 10.1093/nar/gkm355; Jurado J, 2003, J BIOL CHEM, V278, P45546, DOI 10.1074/jbc.M307866200; Kohrle J, 2000, CELL MOL LIFE SCI, V57, P1853, DOI 10.1007/PL00000667; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Labunskyy VM, 2005, J BIOL CHEM, V280, P37839, DOI 10.1074/jbc.M508685200; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-19; MCFARLAND LZ, 1970, POULTRY SCI, V49, P216, DOI 10.3382/ps.0490216; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Nakayama A, 2007, J NUTR, V137, P690, DOI 10.1093/jn/137.3.690; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; OSTER O, 1988, BIOL TRACE ELEM RES, V15, P23, DOI 10.1007/BF02990125; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Petit N, 2003, HUM MOL GENET, V12, P1045, DOI 10.1093/hmg/ddg115; Rayman MP, 2005, P NUTR SOC, V64, P527, DOI 10.1079/PNS2005467; RENKO K, 2008, IN PERSS BIOCH J; SAIJOH K, 1995, MOL BRAIN RES, V30, P301, DOI 10.1016/0169-328X(94)00007-2; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Savaskan NE, 2002, FASEB J, V16, P112, DOI 10.1096/fj.02-0067fje; Savaskan NE, 2007, FREE RADICAL BIO MED, V43, P191, DOI 10.1016/j.freeradbiomed.2007.03.033; Scharpf M, 2007, J NEURAL TRANSM, V114, P877, DOI 10.1007/s00702-006-0617-0; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, IUBMB LIFE, V57, P737, DOI 10.1080/15216540500364255; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Squires Jeffrey, 2006, Hawaii Med J, V65, P239; Steinert P, 1998, BIOL CHEM, V379, P683, DOI 10.1515/bchm.1998.379.6.683; Sun Y, 2001, J NUTR BIOCHEM, V12, P88, DOI 10.1016/S0955-2863(00)00130-3; TAKIZAWA S, 1994, J NEUROL SCI, V122, P66, DOI 10.1016/0022-510X(94)90053-1; TRAPP GA, 1975, J NEUROCHEM, V24, P593, DOI 10.1111/j.1471-4159.1975.tb07682.x; Trepanier G, 1996, NEUROSCIENCE, V75, P231, DOI 10.1016/0306-4522(96)00222-9; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Zachara BA, 2001, ARCH ENVIRON HEALTH, V56, P461, DOI 10.1080/00039890109604483	63	118	121	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2427	2438		10.1074/jbc.M707951200	http://dx.doi.org/10.1074/jbc.M707951200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18032379	Green Submitted, hybrid			2022-12-27	WOS:000252501000069
J	Zhou, H; Mak, W; Zheng, Y; Dunstan, CR; Seibel, MJ				Zhou, Hong; Mak, Wendy; Zheng, Yu; Dunstan, Colin R.; Seibel, Markus J.			Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BONE MORPHOGENETIC PROTEIN; INDIAN HEDGEHOG; IN-VITRO; CHONDROCYTE DIFFERENTIATION; BETA-CATENIN; EXPRESSION; GENE; LRP5; GLUCOCORTICOIDS	Lineage commitment of mesenchymal progenitor cells is still poorly understood. Here we demonstrate that Wnt signaling by osteoblasts is essential for mesenchymal progenitor cells to differentiate away from a default adipogenic into an osteoblastic lineage. Dominant adipogenesis and reduced osteoblastogenesis were observed in calvarial cell cultures from transgenic mice characterized by osteoblast-targeted disruption of glucocorticoid signaling. This phenotypic shift in mesenchymal progenitor cell commitment was associated with reciprocal regulation of early adipogenic and osteoblastogenic transcription factors and with a reduction in Wnt7b and Wnt10b mRNA and beta-catenin protein levels in transgenic versus non-transgenic cultures. Transwell co-culture of transgenic mesenchymal progenitor cells with wild type osteoblasts restored commitment to the osteoblast lineage. This effect was blocked by adding sFRP1, a Wnt inhibitor, to the co-culture. Treatment of transgenic cultures with Wnt3a resulted in stimulation of osteoblastogenesis and suppression of adipogenesis. Our findings suggest a novel cellular mechanism in bone cell biology in which osteoblasts exert direct control over the lineage commitment of their mesenchymal progenitor through Wnt signaling. This glucocorticoid-dependent forward control function indicates a central role for osteoblasts in the regulation of early osteoblastogenesis.			Zhou, H (corresponding author), Univ Sydney, ANZAC Res Inst, Bone Res Program, Hosp Rd, Concord, NSW 2139, Australia.	hzhou@med.usyd.edu.au	Ekanayake, Kanchana/P-8817-2016; Dunstan, Colin/G-6214-2013; Research Institute, ANZAC/CAE-9030-2022; Zheng, Yu/B-4381-2012	Dunstan, Colin/0000-0001-7586-4071; Seibel, Markus J/0000-0002-2701-378X; Zheng, Yu/0000-0002-6324-8148; Zhou, Hong/0000-0001-5899-9660				Atanasov AG, 2003, BIOCHEM BIOPH RES CO, V308, P257, DOI 10.1016/S0006-291X(03)01359-7; Bellows CG, 2001, J BONE MINER RES, V16, P1983, DOI 10.1359/jbmr.2001.16.11.1983; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Cochrane RL, 2007, GENESIS, V45, P17, DOI 10.1002/dvg.20259; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dovio A, 2004, J CLIN ENDOCR METAB, V89, P4923, DOI 10.1210/jc.2004-0164; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ferrari P, 1996, AM J PHYSIOL-ENDOC M, V270, pE900, DOI 10.1152/ajpendo.1996.270.5.E900; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic Z, 2002, BONE, V31, P654, DOI 10.1016/S8756-3282(02)00912-2; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kulkarni NH, 2006, J BONE MINER RES, V21, P910, DOI 10.1359/JBMR.060316; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Li XF, 2005, NAT GENET, V37, P945, DOI 10.1038/ng1614; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; MARTIN RB, 1990, CALCIFIED TISSUE INT, V46, P189, DOI 10.1007/BF02555043; Moon RT, 1997, TRENDS GENET, V13, P157, DOI 10.1016/S0168-9525(97)01093-7; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Shane E, 1997, J CLIN ENDOCR METAB, V82, P1497, DOI 10.1210/jc.82.5.1497; Sher LB, 2006, CALCIFIED TISSUE INT, V79, P118, DOI 10.1007/s00223-005-0297-z; Sher LB, 2004, ENDOCRINOLOGY, V145, P922, DOI 10.1210/en.2003-0655; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Stewart PM, 1999, VITAM HORM, V57, P249; Suda N, 1996, J CELL PHYSIOL, V166, P94, DOI 10.1002/(SICI)1097-4652(199601)166:1<94::AID-JCP11>3.0.CO;2-P; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Woitge HW, 2001, ENDOCRINOLOGY, V142, P1341, DOI 10.1210/en.142.3.1341; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	55	109	126	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					1936	1945		10.1074/jbc.M702687200	http://dx.doi.org/10.1074/jbc.M702687200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18045882	hybrid			2022-12-27	WOS:000252501000020
J	Banci, L; Bertini, I; Ciofi-Baffoni, S; Janicka, A; Martinelli, M; Kozlowski, H; Palumaa, P				Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele; Kozlowski, Henryk; Palumaa, Peep			A structural-dynamical characterization of human Cox17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL INTERMEMBRANE SPACE; NMR STRUCTURE DETERMINATION; COPPER CHAPERONE COX17; CHEMICAL-SHIFT; PROTEIN NMR; SACCHAROMYCES-CEREVISIAE; ATX1 METALLOCHAPERONE; CU(I)-LOADED STATES; HUMAN SCO1	Human Cox17 is a key mitochondrial copper chaperone responsible for supplying copper ions, through the assistance of Sco1, Sco2, and Cox11, to cytochrome c oxidase, the terminal enzyme of the mitochondrial energy transducing respiratory chain. A structural and dynamical characterization of human Cox17 in its various functional metallated and redox states is presented here. The NMR solution structure of the partially oxidized Cox17 ( Cox17(2S-S)) consists of a coiled coil-helix-coiled coil-helix domain stabilized by two disulfide bonds involving Cys(25)-Cys(54) and Cys(35)-Cys(44), preceded by a flexible and completely unstructured N-terminal tail. In human Cu(I) Cox172S-S the copper(I) ion is coordinated by the sulfurs of Cys(22) and Cys(23), and this is the first example of a Cys-Cys binding motif in copper proteins. Copper(I) binding as well as the formation of a third disulfide involving Cys(22) and Cys(23) cause structural and dynamical changes only restricted to the metal-binding region. Redox properties of the disulfides of human Cox17, here investigated, strongly support the current hypothesis that the unstructured fully reduced Cox17 protein is present in the cytoplasm and enters the intermembrane space (IMS) where is then oxidized by Mia40 to Cox17(2S-S), thus becoming partially structured and trapped into the IMS. Cox17(2S-S) is the functional species in the IMS, it can bind only one copper(I) ion and is then ready to enter the pathway of copper delivery to cytochrome c oxidase. The copper(I) form of Cox172(S-S) has features specific for copper chaperones.	[Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele] Univ Florence, CERM, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Janicka, Anna; Kozlowski, Henryk] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland; [Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	University of Florence; University of Florence; University of Wroclaw; Tallinn University of Technology	Bertini, I (corresponding author), Univ Florence, CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Palumaa, Peep/B-4668-2019; Palumaa, Peep/AAF-7617-2020; Ciofi-Baffoni, Simone/AAH-9778-2021	Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; BANCI, LUCIA/0000-0003-0562-5774; Janicka-Klos, Anna/0000-0001-9713-4424; Kozlowski, Henryk/0000-0001-5769-8583; Ciofi Baffoni, Simone/0000-0002-2376-3321; martinelli, manuele/0000-0002-9371-076X				Abajian C, 2004, J BIOL CHEM, V279, P53584, DOI 10.1074/jbc.M408099200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2004, J BIOL CHEM, V279, P27502, DOI 10.1074/jbc.M402005200; Banci L, 2003, BIOCHEMISTRY-US, V42, P2467, DOI 10.1021/bi0205810; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beinert H, 1995, CHEM BIOL, V2, P781, DOI 10.1016/1074-5521(95)90082-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; CASE DA, 2004, AMBER 8 VERSION 8 U; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chen ZW, 1997, EUR J BIOCHEM, V249, P518, DOI 10.1111/j.1432-1033.1997.t01-2-00518.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PELTON JG, 1993, PROTEIN SCI, V2, P543; Poger D, 2005, FEBS LETT, V579, P5287, DOI 10.1016/j.febslet.2005.08.052; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Punter FA, 2003, J BIOL CHEM, V278, P30875, DOI 10.1074/jbc.M302358200; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Srinivasan C, 1998, BIOCHEMISTRY-US, V37, P7572, DOI 10.1021/bi980418y; Takenouchi T, 1999, BBA-GEN SUBJECTS, V1472, P498, DOI 10.1016/S0304-4165(99)00158-0; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; Voronova A, 2007, PROTEIN EXPRES PURIF, V53, P138, DOI 10.1016/j.pep.2006.11.014; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; WISHART DS, 1994, J BIOMOL NMR, V4, P171	55	80	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7912	7920		10.1074/jbc.M708016200	http://dx.doi.org/10.1074/jbc.M708016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18093982	hybrid			2022-12-27	WOS:000253997900067
J	Zhdanov, AV; Ward, MW; Prehn, JHM; Papkovsky, DB				Zhdanov, Alexander V.; Ward, Manus W.; Prehn, Jochen H. M.; Papkovsky, Dmitri B.			Dynamics of intracellular oxygen in PC12 cells upon stimulation of neurotransmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE EXCITOTOXICITY; POTASSIUM CHANNELS; PROTEIN-KINASE; TETANUS TOXIN; MITOCHONDRIAL; CALCIUM; CA2+; RELEASE; ACTIVATION; SECRETION	Neurotransmission, synaptic plasticity, and maintenance of membrane excitability require high mitochondrial activity in neurosecretory cells. Using a fluorescence-based intracellular O-2 sensing technique, we investigated the respiration of differentiated PC12 cells upon depolarization with 100 mM K+. Single cell confocal analysis identified a significant depolarization of the plasma membrane potential and a relatively minor depolarization of the mitochondrial membrane potential following K+ exposure. We observed a two-phase respiratory response: a first intense spike lasting similar to 10 min, during which average intracellular O-2 was reduced from 85 - 90% of air saturation to 55 - 65%, followed by a second wave of smaller amplitude and longer duration. The fast rise in O-2 consumption coincided with a transient increase in cellular ATP by similar to 60%, which was provided largely by oxidative phosphorylation and by glycolysis. The increase of respiration was orchestrated mainly by Ca2+ release from the endoplasmic reticulum, whereas the influx of extracellular Ca2+ contributed similar to 20%. Depletion of Ca2+ stores by ryanodine, thapsigargin, and 4-chloro- m-cresol reduced the amplitude of respiratory spike by 45, 63, and 71%, respectively, whereas chelation of intracellular Ca2+ abolished the response. Uncoupling of the mitochondria with the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone amplified the responses to K+; elevated respiration induced a profound deoxygenation without increasing the cellular ATP levels reduced by carbonyl cyanide p-trifluoromethoxyphenylhydrazone. Cleavage of synaptobrevin 2 by tetanus toxin, known to reduce neurotransmission, did not affect the respiratory response to K+, whereas the general excitability of (d)PC12 cells increased.	[Zhdanov, Alexander V.; Papkovsky, Dmitri B.] Univ Coll Cork, Dept Biochem, Cork, Ireland; [Ward, Manus W.; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med, Dublin 2, Ireland; [Papkovsky, Dmitri B.] Univ Coll Cork, Bioinnovat Ctr, Luxcel Biosci, Cork, Ireland	University College Cork; Royal College of Surgeons - Ireland; University College Cork	Papkovsky, DB (corresponding author), Univ Coll Cork, Dept Biochem, Cavanagh Pharm Bldg, Cork, Ireland.	d.papkovsky@ucc.ie	Prehn, Jochen HM/A-3928-2010	Prehn, Jochen HM/0000-0003-3479-7794; Ward, Manus/0000-0002-7085-9668; Zhdanov, Alexander/0000-0001-5787-2035; Papkovsky, Dmitri/0000-0003-1556-1145				Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amino S, 2002, J BIOCHEM, V131, P887, DOI 10.1093/oxfordjournals.jbchem.a003179; Anthony AC, 2005, J BIOL CHEM, V280, P37278, DOI 10.1074/jbc.M504137200; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Billups B, 2002, J NEUROSCI, V22, P5840; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BRITTON P, 1995, BRAIN RES, V673, P331, DOI 10.1016/0006-8993(94)01458-T; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Buerk DG, 2004, METHOD ENZYMOL, V381, P665; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hogan MC, 1999, J APPL PHYSIOL, V86, P720, DOI 10.1152/jappl.1999.86.2.720; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Ladewig T, 2003, J PHYSIOL-LONDON, V547, P775, DOI 10.1113/jphysiol.2002.033605; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu HY, 1996, J NEUROSCI, V16, P7557; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MARTIN PT, 1991, J BIOL CHEM, V266, P7388; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NISHI R, 1981, DEV BIOL, V87, P301, DOI 10.1016/0012-1606(81)90153-6; O'Riordan TC, 2007, ANAL CHEM, V79, P9414, DOI 10.1021/ac701770b; O'Riordan TC, 2007, AM J PHYSIOL-REG I, V292, pR1613, DOI 10.1152/ajpregu.00707.2006; Onn SP, 2003, J PHARMACOL EXP THER, V306, P870, DOI 10.1124/jpet.103.050062; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; REYNOLDS EE, 1982, BIOCHEMISTRY-US, V21, P4795, DOI 10.1021/bi00262a042; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; SANDBERG K, 1989, J BIOL CHEM, V264, P5679; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Silver I, 1998, ADV EXP MED BIOL, V454, P7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; VALEUR B, 2002, MOL FLUORESCENCE PRI, P351; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Ward MW, 2000, J NEUROSCI, V20, P7208; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Westerink RHS, 2000, BIOCHEM BIOPH RES CO, V270, P625, DOI 10.1006/bbrc.2000.2470; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zhu WH, 1996, AM J PHYSIOL-CELL PH, V271, pC658, DOI 10.1152/ajpcell.1996.271.2.C658; ZORZATO F, 1993, MOL PHARMACOL, V44, P1192	59	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5650	5661		10.1074/jbc.M706439200	http://dx.doi.org/10.1074/jbc.M706439200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086678	hybrid			2022-12-27	WOS:000253426700045
J	Birts, CN; Barton, CH; Wilton, DC				Birts, Charles N.; Barton, C. Howard; Wilton, David C.			A catalytically independent physiological function for human acute phase protein group IIA phospholipase A(2) - Cellular uptake facilitates cell debris removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH PEPTIDES; PENETRATING PEPTIDES; HEPARAN-SULFATE; ANTIBACTERIAL PROPERTIES; INTERFACIAL BINDING; LIPOPROTEIN-LIPASE; HUMAN NEUTROPHILS; ESCHERICHIA-COLI; ARACHIDONIC-ACID; PLASMA-MEMBRANE	Human group IIA phospholipase A(2) (IIA PLA(2)) is an acute phase protein first identified at high concentrations in synovial fluid from patients with rheumatoid arthritis. Its physiological role has since been debated; the enzyme has a very high affinity for anionic phospholipid interfaces but expresses almost zero activity with zwitter-ionic phospholipid substrates, because of a lack of interfacial binding. We have prepared the cysteine-containing mutant (S74C) to allow the covalent attachment of fluorescent reporter groups. We show that fluorescently labeled IIA was taken up by phorbol 12-myristate 13-acetate-activated THP-1 cells in an energy-dependent process involving cell surface heparan sulfate proteoglycans. Uptake concurrently involved significant cell swelling, characteristic of macropinocytosis and the fluorescent enzyme localized to the nucleus. The endocytic process did not necessitate enzyme catalysis, ruling out membrane phospholipid hydrolysis as an essential requirement. The enzyme produced supramolecular aggregates with anionic phospholipid vesicles as a result of bridging between particles, a property that is unique to this globally cationic IIA PLA2. Uptake of such aggregates labeled with fluorescent anionic phospholipid was dramatically enhanced by the IIA protein, and uptake involved binding to heparan sulfate proteoglycans on activated THP-1 cells. A physiological role for this protein is proposed that involves the removal of anionic extracellular cell debris, including anionic microparticles generated as a result of trauma, infection, and the inflammatory response, and under such conditions serum levels of IIA PLA2 can increase similar to 1000-fold. A similar pathway may be significant in the uptake into cells of anionic vector DNA involving cationic lipid transfection protocols.	[Birts, Charles N.; Barton, C. Howard; Wilton, David C.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Southampton	Wilton, DC (corresponding author), Univ Southampton, Sch Biol Sci, Basett Crescent E, Southampton SO16 7PX, Hants, England.	dcw@soton.ac.uk	Birts, Charles N/N-9845-2013	Birts, Charles/0000-0002-0368-8766	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abe A, 2004, J LIPID RES, V45, P667, DOI 10.1194/jlr.M300342-JLR200; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Beck S, 2003, J BIOL CHEM, V278, P29799, DOI 10.1074/jbc.M211763200; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1488, P71, DOI 10.1016/S1388-1981(00)00111-6; Canaan S, 2002, J BIOL CHEM, V277, P30984, DOI 10.1074/jbc.M203649200; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Enomoto A, 2000, BIOCHEM BIOPH RES CO, V276, P667, DOI 10.1006/bbrc.2000.3468; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Femling JK, 2005, J IMMUNOL, V175, P4653, DOI 10.4049/jimmunol.175.7.4653; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Groeneveld ABJ, 2003, CLIN IMMUNOL, V106, P106, DOI 10.1016/S1521-6616(02)00025-6; Hack CE, 1997, IMMUNOL TODAY, V18, P111, DOI 10.1016/S0167-5699(97)01002-5; JAIN MK, 1987, BIOCHIM BIOPHYS ACTA, V905, P1, DOI 10.1016/0005-2736(87)90002-2; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; Makoveichuk E, 2004, BBA-MOL CELL BIOL L, V1686, P37, DOI 10.1016/j.bbalip.2004.08.015; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Othman R, 1996, BBA-LIPID LIPID MET, V1303, P92, DOI 10.1016/0005-2760(96)00083-5; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; PRUZANSKI W, 1985, J RHEUMATOL, V12, P211; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Salanova B, 2007, J BIOL CHEM, V282, P27960, DOI 10.1074/jbc.M704039200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCOTT DL, 1994, BIOPHYS J, V67, P493, DOI 10.1016/S0006-3495(94)80546-6; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wilton DC, 2005, EUR J LIPID SCI TECH, V107, P193, DOI 10.1002/ejlt.200401089; WILTON DC, 1990, BIOCHEM J, V266, P435, DOI 10.1042/bj2660435; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675	66	25	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5034	5045		10.1074/jbc.M708844200	http://dx.doi.org/10.1074/jbc.M708844200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089561	hybrid			2022-12-27	WOS:000253426500061
J	Hilger, D; Bohm, M; Hackmann, A; Jung, H				Hilger, Daniel; Bohm, Maret; Hackmann, Alexandra; Jung, Heinrich			Role of Ser-340 and Thr-341 in transmembrane domain IX of the Na+/Proline transporter PutP of Escherichia coli in ligand binding and transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR-BINDING; NA+/GLUCOSE COTRANSPORTER; SYMPORTER FAMILY; PROLINE UPTAKE; PROTEIN; PERMEASE; NA+; MEMBRANE; TOPOLOGY; RECONSTITUTION	The Na+/solute symporter family comprises more than 400 members of pro- and eukaryotic origin. Using the Na+/proline transporter PutP of Escherichia coli as a model, the role of two conserved residues, Ser-340 and Thr-341, is investigated to obtain insights into the mechanism of transport catalyzed by members of this family. Substitution of these amino acids alters the transport kinetics of cells and proteoliposomes containing the PutP variants significantly. In particular, the apparent affinities for Na+ and Li+ are reduced by 2 orders of magnitude or more. Also proline binding is affected, albeit to a lesser extent than ion binding. Thereby, the presence of a hydroxyl group at position 341 is essential for high affinity ligand binding. Furthermore, Cys placed at position 340 or 341 reacts with sulfhydryl reagents of different polarity, indicating accessibility from the water phase. In addition, Cys cross-linking suggests proximity of the residues to other amino acids previously shown to be crucial for ligand binding. For these reasons it is suggested that Ser-340 and Thr-341 are located in a ligand translocation pathway. Furthermore, it is proposed that the side chain of Thr-341 directly participates in Na+ binding.	[Hilger, Daniel; Jung, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 1, D-80638 Munich, Germany; [Hilger, Daniel] Munich Ctr Integrated Prot Sci CiPSM, D-80638 Munich, Germany; [Bohm, Maret; Hackmann, Alexandra; Jung, Heinrich] Univ Osnabruck, Dept Microbiol, D-49069 Osnabruck, Germany	University of Munich; University of Munich; University Osnabruck	Jung, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 1, Maria Ward Str 1A, D-80638 Munich, Germany.	hjung@lmu.de	Hilger, Daniel/C-7297-2019; Jung, Heinrich/K-3790-2014	Hilger, Daniel/0000-0001-5179-1357; Jung, Heinrich/0000-0002-5450-3063				Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CC, 1985, J MEMBRANE BIOL, V84, P157, DOI 10.1007/BF01872213; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; DILA DK, 1986, J BACTERIOL, V168, P590, DOI 10.1128/jb.168.2.590-594.1986; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Jeschke G, 2004, BIOPHYS J, V86, P2551, DOI 10.1016/S0006-3495(04)74310-6; Jung H, 2006, J MEMBRANE BIOL, V213, P119, DOI 10.1007/s00232-006-0880-x; Jung H, 1998, BBA-BIOENERGETICS, V1365, P60, DOI 10.1016/S0005-2728(98)00044-9; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kumar A, 2007, BIOCHEMISTRY-US, V46, P2758, DOI 10.1021/bi061696x; Meinild AK, 2001, BIOCHEMISTRY-US, V40, P11897, DOI 10.1021/bi011026l; MILLER JH, 1992, SHORT COURSE BACTERI, P439; Padan E, 2000, BACTERIAL STRESS RESPONSES, P117; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schwan WR, 2006, INFECT IMMUN, V74, P399, DOI 10.1128/IAI.74.1.399-409.2006; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Wegener C, 2000, BIOCHEMISTRY-US, V39, P4831, DOI 10.1021/bi992442x; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAMATO I, 1990, J MEMBRANE BIOL, V114, P143, DOI 10.1007/BF01869095; Yamato I., 1993, ALKALI CATION TRANSP, P53; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou A, 2004, J MOL BIOL, V343, P931, DOI 10.1016/j.jmb.2004.09.002	42	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4921	4929		10.1074/jbc.M706741200	http://dx.doi.org/10.1074/jbc.M706741200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156179	hybrid			2022-12-27	WOS:000253426500050
J	Picard, N; Eladari, D; El Moghrabi, S; Planes, C; Bourgeois, S; Houillier, P; Wang, Q; Burnier, M; Deschenes, G; Knepper, MA; Meneton, P; Chambrey, R				Picard, Nicolas; Eladari, Dominique; El Moghrabi, Soumaya; Planes, Carole; Bourgeois, Soline; Houillier, Pascal; Wang, Qing; Burnier, Michel; Deschenes, Georges; Knepper, Mark A.; Meneton, Pierre; Chambrey, Regine			Defective ENaC processing and function in tissue kallikrein-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; CORTICAL COLLECTING DUCT; URINARY KALLIKREIN; SERINE PROTEASES; RENIN-ACTIVITY; ACTIVATION; EXCRETION; RAT; PROSTASIN; LACKING	An inverse relationship exists between urinary tissue kallikrein (TK) excretion and blood pressure in humans and rodents. In the kidney TK is synthesized in large amounts in the connecting tubule and is mainly released into the urinary fluid where its function remains unknown. In the present study mice with no functional gene coding for TK (TK-/-) were used to test whether the enzyme regulates apically expressed sodium transporters. Semiquantitative immunoblotting of the renal cortex revealed an absence of the 70-kDa form of gamma-ENaC in TK-/- mice. Urinary Na+ excretion after amiloride injection was blunted in TK-/- mice, consistent with reduced renal ENaC activity. Amiloride-sensitive transepithelial potential difference in the colon, where TK is also expressed, was decreased in TK-/- mice, whereas amiloride-ensitive alveolar fluid clearance in the lung, where TK is not expressed, was unchanged. In mice lacking the B2 receptor for kinins, the abundance of the 70-kDa form of gamma-ENaC was increased, indicating that its absence in TK-/- mice is not kinin-mediated. Incubation of membrane proteins from renal cortex of TK-/- mice with TK resulted in the appearance of the 70-kDa band of the gamma-ENaC, indicating that TK was able to promote gamma-ENaC cleavage in vitro. Finally, in mouse cortical collecting ducts isolated and microperfused in vitro, the addition of TK in the luminal fluid increased significantly intracellular Na+ concentration, consistent with an activation of the luminal entry of the cation. The results demonstrate that TK, like several other proteases, can activate ENaC in the kidney and the colon.	[Picard, Nicolas; Eladari, Dominique; El Moghrabi, Soumaya; Bourgeois, Soline; Houillier, Pascal; Meneton, Pierre; Chambrey, Regine] Univ Paris 05, INSERM, U872,Fac Med Rene Descartes, Ctr Rech Cordeliers, F-75006 Paris, France; [Planes, Carole] Univ Paris 07, INSERM, U773 CRB3, UFR Med, F-75018 Paris, France; [Eladari, Dominique] Hop Necker Enfants Malad, Dept Physiol, F-75015 Paris, France; [Wang, Qing; Burnier, Michel] CHU Vaudois, Dept Nephrol, CH-1011 Lausanne, Switzerland; [Deschenes, Georges] UPMC, CNRS, UMR 7134, F-75006 Paris, France; [Knepper, Mark A.] NHLBI, Natl Inst Hlth, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Eladari, D (corresponding author), Univ Paris 05, INSERM, U872,Fac Med Rene Descartes, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.	eladari@ccr.jussieu.fr	Knepper, Mark/AAF-8412-2020; Picard, Nicolas/B-6677-2012; Meneton, Pierre/T-1216-2019; Houillier, Pascal/AAD-4903-2019	Picard, Nicolas/0000-0002-1695-3389; Houillier, Pascal/0000-0003-4953-6917; deschenes, georges/0000-0002-5158-2915; planes, carole/0000-0003-2286-366X; Eladari, Dominique/0000-0003-1067-0844	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285, Z01HL001285] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Alfie ME, 1997, HYPERTENSION, V29, P483, DOI 10.1161/01.HYP.29.1.483; BERRY TD, 1989, HYPERTENSION, V13, P3, DOI 10.1161/01.HYP.13.1.3; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Delpire E, 1996, NEPHROL DIAL TRANSPL, V11, P1967, DOI 10.1093/oxfordjournals.ndt.a027081; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kim GH, 1999, J AM SOC NEPHROL, V10, P935; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; LECHI A, 1978, CLIN SCI MOL MED, V55, P51, DOI 10.1042/cs0550051; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Loffing J, 2003, AM J PHYSIOL-RENAL, V284, pF628, DOI 10.1152/ajprenal.00217.2002; Lourdel S, 2005, J AM SOC NEPHROL, V16, P3642, DOI 10.1681/ASN.2005040363; MARGOLIUS HS, 1971, LANCET, V2, P1063; MARGOLIUS HS, 1972, CIRC RES, V30, P358, DOI 10.1161/01.RES.30.3.358; Masilamani S, 2002, AM J PHYSIOL-RENAL, V283, pF648, DOI 10.1152/ajprenal.00016.2002; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MENARD J, 1972, ENDOCRINOLOGY, V90, P422, DOI 10.1210/endo-90-2-422; Meneton P, 2001, P NATL ACAD SCI USA, V98, P2634, DOI 10.1073/pnas.051619598; Morris RG, 2006, AM J PHYSIOL-RENAL, V290, pF1416, DOI 10.1152/ajprenal.00421.2005; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; NISHIMURA K, 1980, P NATL ACAD SCI-BIOL, V77, P4975, DOI 10.1073/pnas.77.8.4975; OBIKA LFO, 1986, CLIN SCI, V71, P497, DOI 10.1042/cs0710497; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; PROUD D, 1983, AM J PHYSIOL, V244, pF510, DOI 10.1152/ajprenal.1983.244.5.F510; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; SEINO M, 1975, TOHOKU J EXP MED, V116, P359, DOI 10.1620/tjem.116.359; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	48	87	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4602	4611		10.1074/jbc.M705664200	http://dx.doi.org/10.1074/jbc.M705664200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086683	Green Accepted, hybrid			2022-12-27	WOS:000253426500017
J	Benton, CR; Nickerson, JG; Lally, J; Han, XX; Holloway, GP; Glatz, JFC; Luiken, JJFP; Graham, TE; Heikkila, JJ; Bonen, A				Benton, Carley R.; Nickerson, James G.; Lally, James; Han, Xiao-Xia; Holloway, Graham P.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Graham, Terry E.; Heikkila, John J.; Bonen, Arend			Modest PGC-1 alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID TRANSLOCASE; OBESE ZUCKER RATS; CARNITINE PALMITOYLTRANSFERASE-I; RECEPTOR-GAMMA COACTIVATOR-1; ACTIVATED PROTEIN-KINASE; GENE-TRANSFER; CONTRACTILE ACTIVITY; BINDING PROTEIN	PGC-1 alpha overexpression in skeletal muscle, in vivo, has yielded disappointing and unexpected effects, including disrupted cellular integrity and insulin resistance. These unanticipated results may stem from an excessive PGC-1 alpha overexpression in transgenic animals. Therefore, we examined the effects of a modest PGC-1 alpha overexpression in a single rat muscle, in vivo, on fuel-handling proteins and insulin sensitivity. We also examined whether modest PGC-1 alpha overexpression selectively targeted subsarcolemmal (SS) mitochondrial proteins and fatty acid oxidation, because SS mitochondria are metabolically more plastic than intermyofibrillar (IMF) mitochondria. Among metabolically heterogeneous rat hindlimb muscles, PGC-1 alpha was highly correlated with their oxidative fiber content and with substrate transport proteins (GLUT4, FABPpm, and FAT/ CD36) and mitochondrial proteins (COXIV and mTFA) but not with insulin-signaling proteins (phosphatidylinositol 3-kinase, IRS-1, and Akt2), nor with 5'-AMP-activated protein kinase, alpha 2 subunit, and HSL. Transfection of PGC-1 alpha into the red (RTA) and white tibialis anterior (WTA) compartments of the tibialis anterior muscle increased PGC-1 alpha protein by 23-25%. This also induced the up-regulation of transport proteins (FAT/ CD36, 35-195%; GLUT4, 20-32%) and 5'-AMP-activated protein kinase, alpha 2 subunit (37-48%), but not other proteins (FABPpm, IRS-1, phosphatidylinositol 3-kinase, Akt2, and HSL). SS and IMF mitochondrial proteins were also up-regulated, including COXIV (15-75%), FAT/ CD36 (17-30%), and mTFA (15-85%). PGC-1 alpha overexpression also increased palmitate oxidation in SS (RTA, + 116%; WTA, + 40%) but not in IMF mitochondria, and increased insulin-stimulated phosphorylation of AKT2 (28 - 43%) and rates of glucose transport (RTA, + 20%; WTA, + 38%). Thus, in skeletal muscle in vivo, a modest PGC-1 alpha overexpression up-regulated selected plasmalemmal and mitochondrial fuel-handling proteins, increased SS (not IMF) mitochondrial fatty acid oxidation, and improved insulin sensitivity.	[Benton, Carley R.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Heikkila, John J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Benton, Carley R.; Nickerson, James G.; Lally, James; Han, Xiao-Xia; Holloway, Graham P.; Graham, Terry E.; Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Waterloo; University of Waterloo; Maastricht University; University of Guelph	Benton, CR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.							Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Benton CR, 2004, BIOCHEM BIOPH RES CO, V323, P249, DOI 10.1016/j.bbrc.2004.08.084; BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bradbury MW, 2000, BIOCHEM J, V345, P423, DOI 10.1042/0264-6021:3450423; BROZINICK JT, 1993, AM J PHYSIOL, V265, pE419, DOI 10.1152/ajpendo.1993.265.3.E419; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; CHOI CS, 2007, KEYSTONE S DIABETES, P157; Christ CY, 2002, J APPL PHYSIOL, V92, P736, DOI 10.1152/japplphysiol.00784.2001; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Coort SLM, 2005, J LIPID RES, V46, P1295, DOI 10.1194/jlr.M400426-JLR200; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; HAN XX, 1995, AM J PHYSIOL-REG I, V269, pR544, DOI 10.1152/ajpregu.1995.269.3.R544; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770; Koonen DPY, 2004, AM J PHYSIOL-ENDOC M, V286, pE1042, DOI 10.1152/ajpendo.00531.2003; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Langfort J, 1999, BIOCHEM J, V340, P459, DOI 10.1042/0264-6021:3400459; Lee MJ, 2002, EXP MOL MED, V34, P265, DOI 10.1038/emm.2002.37; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lemieux K, 2000, DIABETES, V49, P183, DOI 10.2337/diabetes.49.2.183; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Matsuno K, 1996, BRIT J HAEMATOL, V92, P960, DOI 10.1046/j.1365-2141.1996.422962.x; MATTHAI AS, 2006, ACSM INTEGRATIVE PHY, P20; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; MEGENEY LA, 1992, AM J PHYSIOL, V262, pE20, DOI 10.1152/ajpendo.1992.262.1.E20; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen OH, 2006, AM J PHYSIOL-ENDOC M, V291, pE807, DOI 10.1152/ajpendo.00591.2005; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; RUDERMAN NB, 1971, BIOCHEM J, V124, P639, DOI 10.1042/bj1240639; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690, DOI 10.1152/ajpregu.1999.277.6.R1690; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; STUMP DD, 1993, AM J PHYSIOL, V265, P894; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095	75	164	175	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4228	4240		10.1074/jbc.M704332200	http://dx.doi.org/10.1074/jbc.M704332200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079123	hybrid			2022-12-27	WOS:000253083500058
J	Wu, JH; Bohanan, CS; Neumann, JC; Lingrel, JB				Wu, Jinghai; Bohanan, Cynthia S.; Neumann, Jon C.; Lingrel, Jerry B.			KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; IN-VIVO; CARDIOVASCULAR DEVELOPMENT; PROINFLAMMATORY ACTIVATION; SPHINGOSINE 1-PHOSPHATE; TUMOR ANGIOGENESIS; KINASE INHIBITOR; TYROSINE KINASE; GENE-EXPRESSION; C-SRC	Vasculogenesis, angiogenesis, and maturation are three major phases of the development of blood vessels. Although many receptors required for blood vessel formation have been defined, the intracellular signal transduction pathways involved in vascular maturation remain unclear. KLF2(-/-) embryos fail to develop beyond 13.5 days because of a lack of blood vessel stabilization. The molecular mechanism of KLF2 function in embryonic vascular vessels is still largely unknown. Here we show a normal development pattern of endothelial cells in KLF2(-/-) embryos but a defect of smooth muscle cells at the dorsal side of the aorta. This phenotype results from arrested vascular maturation characterized by the failure of mural cells to migrate around endothelial cells. This migration defect is also observed when platelet-derived growth factor-B (PDGF) controlled migration is studied in murine embryonic fibroblast (MEF) cells from KLF2(-/-) animals. In addition, KLF2(-/-) MEFs exhibit a significant growth defect, indicating that KLF2 is required to maintain the viability of MEF cells. The PDGF signal is mediated through the Src signaling pathway, and a downstream target of KLF2 is sphingosine 1-phosphate receptor 1. These studies demonstrate that KLF2 is required for smooth muscle cell migration and elucidate a novel mechanism involving communication between PDGF and KLF2 in vascular maturation.	[Wu, Jinghai; Bohanan, Cynthia S.; Neumann, Jon C.; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Lingrel, JB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	jerry.lingrel@uc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057281] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL57281] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Groenendijk BCW, 2004, DEV DYNAM, V230, P57, DOI 10.1002/dvdy.20029; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maupas-Schwalm F, 2004, FASEB J, V18, P1398, DOI 10.1096/fj.03-1123fje; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Saksena S, 2005, J BIOL CHEM, V280, P11859, DOI 10.1074/jbc.M411553200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; St Croix B, 2000, SCIENCE, V289, P1197; Takahashi Y, 1996, ANAT EMBRYOL, V194, P515; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yang X, 1999, DEVELOPMENT, V126, P1571; Zhu YJ, 2003, J BIOL CHEM, V278, P36257, DOI 10.1074/jbc.M303171200	56	71	73	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3942	3950		10.1074/jbc.M707882200	http://dx.doi.org/10.1074/jbc.M707882200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063572	hybrid			2022-12-27	WOS:000253083500028
J	Zdebik, AA; Zifarelli, G; Bergsdorf, EY; Soliani, P; Scheel, O; Jentsch, TJ; Pusch, M				Zdebik, Anselm A.; Zifarelli, Giovanni; Bergsdorf, Eun-Yeong; Soliani, Paolo; Scheel, Olaf; Jentsch, Thomas J.; Pusch, Michael			Determinants of anion-proton coupling in mammalian endosomal CLC proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							/H+ EXCHANGE TRANSPORTER; CHLORIDE CHANNEL; MOLECULAR-BASIS; ION-TRANSPORT; DISEASE; SELECTIVITY; EXPRESSION; CLONING; SIGNAL; PORES	Many proteins of the CLC gene family are Cl- channels, whereas others, like the bacterial ecClC-1 or mammalian ClC-4 and -5, mediate Cl-/H- exchange. Mutating a "gating glutamate" (Glu-224 in ClC-4 and Glu-211 in ClC-5) converted these exchangers into anion conductances, as did the neutralization of another, intracellular "proton glutamate" in ecClC-1. We show here that neutralizing the proton glutamate of ClC-4 (Glu-281) and ClC-5 (Glu-268), but not replacing it with aspartate, histidine, or tyrosine, rather abolished Cl- and H+ transport. Surface expression was unchanged by these mutations. Uncoupled Cl- transport could be restored in the ClC-4(E281A) and ClC-5(E268A) proton glutamate mutations by additionally neutralizing the gating glutamates, suggesting that wild type proteins transport anions only when protons are supplied through a cytoplasmic H (+) donor. Each monomeric unit of the dimeric protein was found to be able to carry out Cl-/H- exchange independently from the transport activity of the neighboring subunit. NO3- or SCN- transport was partially uncoupled from H+ countertransport but still depended on the proton glutamate. Inserting proton glutamates into CLC channels altered their gating but failed to convert them into Cl-/H+ exchangers. Noise analysis indicated that ClC-5 switches between silent and transporting states with an apparent unitary conductance of 0.5 picosiemens. Our results are consistent with the idea that Cl-/H+ exchange of the endosomal ClC-4 and -5 proteins relies on proton delivery from an intracellular titratable residue at position 268 (numbering of ClC-5) and that the strong rectification of currents arises from the voltage-dependent proton transfer from Glu-268 to Glu-211.	[Zdebik, Anselm A.; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zdebik, Anselm A.; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.] Max Delbruck Centrum Mol Med MDC, D-13125 Berlin, Germany; [Zdebik, Anselm A.; Scheel, Olaf; Jentsch, Thomas J.] Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Zifarelli, Giovanni; Soliani, Paolo; Pusch, Michael] CNR, Ist Biofis, I-16149 Genoa, Italy	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Jentsch, TJ (corresponding author), Robert Rossle Str 10, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Horstmann, Britta/C-2154-2008	Pusch, Michael/0000-0002-8644-8847; Jentsch, Thomas/0000-0002-3509-2553	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KOLB HA, 1980, BIOPHYS CHEM, V12, P21, DOI 10.1016/0301-4622(80)80036-6; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Niemeyer MI, 2003, J PHYSIOL-LONDON, V553, P873, DOI 10.1113/jphysiol.2003.055988; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZITARELLI G, 2007, REV PHYSL BIOCH PHAR, V158, P23	33	107	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4219	4227		10.1074/jbc.M708368200	http://dx.doi.org/10.1074/jbc.M708368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063579	hybrid			2022-12-27	WOS:000253083500057
J	Dong, WJ; Xing, J; Ouyang, YX; An, JL; Cheung, HC				Dong, Wen-Ji; Xing, Jun; Ouyang, Yexin; An, Jianli; Cheung, Herbert C.			Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTENSION; I PHOSPHORYLATION; REGULATORY DOMAIN; CONFORMATIONAL EXCHANGE; SKELETAL-MUSCLE; CALCIUM; MUTATIONS; BINDING; PROTEIN; CA2+	The key events in regulating cardiac muscle contraction involve Ca2+ binding to and release from cTnC (troponin C) and structural changes in cTnC and other thin filament proteins triggered by Ca2+ movement. Single mutations L29Q and G159D in human cTnC have been reported to associate with familial hypertrophic and dilated cardiomyopathy, respectively. We have examined the effects of these individual mutations on structural transitions in the regulatory N-domain of cTnC triggered by Ca2+ binding and dissociation. This study was carried out with a double mutant or triple mutants of cTnC, reconstituted into troponin with tryptophanless cTnI and cTnT. The double mutant, cTnC(L12W/N51C) labeled with 1,5-IAEDANS at Cys-51, served as a control to monitor Ca2+-induced opening and closing of the N-domain by Forster resonance energy transfer (FRET). The triple mutants contained both L12W and N51C labeled with 1,5-IAEDANS, and either L29Q or G159D. Both mutations had minimal effects on the equilibrium distance between Trp-12 and Cys-51-AEDANS in the absence or presence of bound Ca2+. L29Q had no effect on the closing rate of the N-domain triggered by release of Ca2+, but reduced the Ca2+-induced opening rate. G159D reduced both the closing and opening rates. Previous results showed that the closing rate of cTnC N-domain triggered by Ca2+ dissociation was substantially enhanced by PKA phosphorylation of cTnI. This rate enhancement was abolished by L29Q or G159D. These mutations alter the kinetics of structural transitions in the regulatory N-domain of cTnC that are involved in either activation (L29Q) or deactivation (G159D). Both mutations appear to be antagonistic toward phosphorylation signaling between cTnI and cTnC.	[Dong, Wen-Ji] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Dong, Wen-Ji; Ouyang, Yexin] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Xing, Jun; An, Jianli; Cheung, Herbert C.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Washington State University; Washington State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011		NHLBI NIH HHS [HL52508, HL80186, R01 HL080186] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL052508] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Abbott MB, 2000, FEBS LETT, V469, P168, DOI 10.1016/S0014-5793(00)01271-0; Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Dong WJ, 2000, PROTEINS, V41, P438, DOI 10.1002/1097-0134(20001201)41:4<438::AID-PROT20>3.0.CO;2-E; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1997, J BIOL CHEM, V272, P19229, DOI 10.1074/jbc.272.31.19229; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; Gong Z, 1998, BIOPHYS J, V74, pA51; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Johns EC, 1997, PFLUG ARCH EUR J PHY, V433, P842, DOI 10.1007/s004240050353; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LIAO RL, 1994, BIOCHEMISTRY-US, V33, P12729, DOI 10.1021/bi00208a026; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; ROSENFELD SS, 1985, J BIOL CHEM, V260, P242; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Schmidtmann A, 2002, FEBS LETT, V513, P289, DOI 10.1016/S0014-5793(02)02340-2; She MD, 1998, J MOL BIOL, V281, P445, DOI 10.1006/jmbi.1998.1933; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Solaro RJ, 2002, J NUCL CARDIOL, V9, P523, DOI 10.1067/mnc.2002.127626; SOLARO RJ, 2002, HDB PHYSL, V1; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Ward DG, 2004, BIOCHEMISTRY-US, V43, P5772, DOI 10.1021/bi036310m; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	51	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3424	3432		10.1074/jbc.M703822200	http://dx.doi.org/10.1074/jbc.M703822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063575	hybrid			2022-12-27	WOS:000253083000048
J	Dammeyer, P; Damdimopoulos, AE; Nordman, T; Jimenez, A; Miranda-Vizuete, A; Arner, ESJ				Dammeyer, Pascal; Damdimopoulos, Anastasios E.; Nordman, Tomas; Jimenez, Alberto; Miranda-Vizuete, Antonio; Arner, Elias S. J.			Induction of cell membrane protrusions by the N-terminal glutaredoxin domain of a rare splice variant of human thioredoxin reductase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN REDUCTASE; EARLY EMBRYONIC LETHALITY; REDOX REGULATION; GLUTATHIONE-REDUCTASE; ACTIVE-SITE; SYSTEM; MECHANISM; TUBULIN; TESTIS; RAT	The human thioredoxin system has a wide range of functions in cells including regulation of cell proliferation and differentiation, immune system modulation, antioxidant defense, redox control of transcription factor activity, and promotion of cancer development. A key component of this enzymatic system is the selenoprotein thioredoxin reductase 1(TrxR1), encoded by the TXNRD1 gene. Transcription of TXNRD1 involves alternative splicing, leading to a number of transcripts also encoding isoforms of TrxR1 that differ from each other at their N-terminal domains. Here we have studied the TXNRD1_v3 isoform containing an atypical N-terminal glutaredoxin (Grx) domain. Expression of the transcript of this isoform was found predominantly in testis but was also detected in ovary, spleen, heart, liver, kidney, and pancreas. By immunohistochemical analysis in human testis with antibodies specific for the Grx domain of TXNRD1_v3, the protein was found to be predominantly expressed in the Leydig cells. Expression of the TXNRD1_v3 transcript was also found in several cancer cell lines (HCC1937, H23, A549, U1810, or H157), and in HeLa cells, it was induced by estradiol or testosterone treatments. Surprisingly, green fluorescent protein fusions with the complete TXNRD1_v3 protein or with only its Grx domain localized to distinct cellular sites in proximity to actin, and furthermore, had a potent capacity to rapidly induce cell membrane protrusions. Analyses of these structures suggested that the Grx domain of TXNRD1_ v3 localizes first in the emerging protrusion and is then followed into the protrusions by actin and subsequently by tubulin. The results presented thus reveal that TXNRD1_ v3 has a unique and distinct expression pattern in human cells and suggest that the protein can guide actin polymerization in relation to cell membrane restructuring.	[Dammeyer, Pascal; Nordman, Tomas; Arner, Elias S. J.] Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden; [Damdimopoulos, Anastasios E.; Jimenez, Alberto; Miranda-Vizuete, Antonio] Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Karolinska Institutet; Karolinska Institutet	Arner, ESJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Med Nobel Inst Biochem, SE-17177 Stockholm, Sweden.	Elias.Arner@ki.se	Miranda-Vizuete, Antonio/D-6927-2012; Jiménez, Alberto/A-6234-2009; Arnér, Elias S.J./J-5832-2012; Arnér, Elias/K-6737-2019; IBIS, REDOX/J-7473-2017	Miranda-Vizuete, Antonio/0000-0002-6856-5396; Jiménez, Alberto/0000-0003-3685-6479; Arnér, Elias S.J./0000-0002-4807-6114; Arnér, Elias/0000-0002-4807-6114; Damdimopoulos, Anastasios/0000-0003-4425-1189				Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Damdimopoulos AE, 2004, J BIOL CHEM, V279, P38721, DOI 10.1074/jbc.M402753200; GAYTAN F, 1994, J REPROD FERTIL, V102, P393, DOI 10.1530/jrf.0.1020393; Gromer S, 2004, MED RES REV, V24, P40, DOI 10.1002/med.10051; Gromer S, 2002, METHOD ENZYMOL, V347, P382; Jimenez A, 2004, J BIOL CHEM, V279, P34971, DOI 10.1074/jbc.M404192200; KHAN IA, 1991, BIOCHIM BIOPHYS ACTA, V1076, P289, DOI 10.1016/0167-4838(91)90280-D; Landino LM, 2004, BIOCHEM BIOPH RES CO, V314, P555, DOI 10.1016/j.bbrc.2003.12.126; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Lee SR, 1999, J BIOL CHEM, V274, P4722, DOI 10.1074/jbc.274.8.4722; Lee SR, 2000, P NATL ACAD SCI USA, V97, P2521, DOI 10.1073/pnas.050579797; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; LUDUENA RF, 1991, PHARMACOL THERAPEUT, V49, P133, DOI 10.1016/0163-7258(91)90027-J; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Miranda-Vizuete A, 1999, EUR J BIOCHEM, V261, P405, DOI 10.1046/j.1432-1327.1999.00286.x; Miranda-Vizuete A, 2004, ANTIOXID REDOX SIGN, V6, P25, DOI 10.1089/152308604771978327; Miranda-Vizuete A, 2001, J BIOL CHEM, V276, P31567, DOI 10.1074/jbc.M101760200; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nonn L, 2003, MOL CELL BIOL, V23, P916, DOI 10.1128/MCB.23.3.916-922.2003; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Osborne S A, 2001, BMC Genomics, V2, P10, DOI 10.1186/1471-2164-2-10; PFEIFFER DC, 1991, ANAT REC, V230, P473, DOI 10.1002/ar.1092300406; Rigobello MP, 1998, FREE RADICAL BIO MED, V24, P370, DOI 10.1016/S0891-5849(97)00216-5; Rundlof AK, 2000, BIOCHEM J, V347, P661, DOI 10.1042/0264-6021:3470661; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Rundlof AK, 2001, J BIOL CHEM, V276, P30542, DOI 10.1074/jbc.M101452200; Rundlof AK, 2007, DIFFERENTIATION, V75, P123, DOI 10.1111/j.1432-0436.2006.00121.x; Sadek CM, 2003, J BIOL CHEM, V278, P13133, DOI 10.1074/jbc.M300369200; Sadek CM, 2001, GENES CELLS, V6, P1077, DOI 10.1046/j.1365-2443.2001.00484.x; Sandalova T, 2001, P NATL ACAD SCI USA, V98, P9533, DOI 10.1073/pnas.171178698; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Sun QA, 2005, BIOCHEMISTRY-US, V44, P14528, DOI 10.1021/bi051321w; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Sun QA, 2001, J BIOL CHEM, V276, P3106, DOI 10.1074/jbc.M004750200; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wang J, 2003, P NATL ACAD SCI USA, V100, P5103, DOI 10.1073/pnas.0931345100; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zhon LW, 1998, J BIOL CHEM, V273, P8581, DOI 10.1074/jbc.273.15.8581; Zhong LW, 2000, P NATL ACAD SCI USA, V97, P5854, DOI 10.1073/pnas.100114897; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	44	37	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2814	2821		10.1074/jbc.M708939200	http://dx.doi.org/10.1074/jbc.M708939200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18042542	Green Submitted, hybrid			2022-12-27	WOS:000252622300039
J	Xi, QR; He, W; Zhang, XHF; Le, HV; Massague, J				Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan			Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-LINES; PLASMINOGEN-ACTIVATOR INHIBITOR; BREAST-CANCER; LUNG-CANCER; C-MYC; NUCLEOSOME DISRUPTION; MEDIATED REPRESSION; SNON ONCOPROTEIN; BINDING-PROTEINS; GENE-REGULATION	The transcription factors Smad2 and Smad3 mediate a large set of gene responses induced by the cytokine transforming growth factor beta(TGF beta), but the extent to which their function depends on chromatin remodeling remains to be defined. We observed interactions between these two Smads and BRG1, BAF250b, BAF170, and BAF155, which are core components of the SWI/SNF chromatin-remodeling complex. Smad2 and Smad3 have similar affinity for these components in vitro, and their interactions are primarily mediated by BRG1. In vivo, however, BRG1 predominantly interacts with Smad3, and this interaction is enhanced by TGF beta stimulation. Our results suggest that BRG1 is incorporated into transcriptional complexes that are formed by activated Smads in the nucleus, on target promoters. Using BRG1-deficient cell systems, we defined the BRG1 dependence of the TGF beta transcriptional program genome-wide. Most TGF beta gene responses in human epithelial cells are dependent on BRG1 function. Remarkably, BRG1 is not required for the TGF beta-mediated induction of SMAD7 and SNON, which encode key mediators of negative feedback in this pathway. Our results provide a genome-wide scope of the participation of BRG1 in TGF beta action and suggest a widespread yet differential involvement of BRG1 SWI/SNF remodeler in the transcriptional response of many genes to this cytokine.	[Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Xi, Qiaoran; He, Wei; Zhang, Xiang H. -F.; Le, Hong-Van; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, Box 116,1275 York Ave, New York, NY 10021 USA.	j-massague@ski.mskcc.org	Zhang, Xiang/B-1522-2008	Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670	NCI NIH HHS [R37 CA034610-26, P30 CA008748, R01 CA034610, R37 CA034610, CA34610] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, R37CA034610, R01CA034610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chen CR, 2001, P NATL ACAD SCI USA, V98, P992, DOI 10.1073/pnas.98.3.992; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hougaard S, 1999, BRIT J CANCER, V79, P1005, DOI 10.1038/sj.bjc.6690161; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Moussad EEDA, 2000, MOL GENET METAB, V71, P276, DOI 10.1006/mgme.2000.3059; Mudhasani R, 2005, MOL IMMUNOL, V42, P673, DOI 10.1016/j.molimm.2004.09.021; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Osada H, 2001, CANCER RES, V61, P8331; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; Reisman DN, 2003, CANCER RES, V63, P560; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simone C, 2006, J CELL PHYSIOL, V207, P309, DOI 10.1002/jcp.20514; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhu QW, 2005, MOL CELL BIOL, V25, P10731, DOI 10.1128/MCB.25.24.10731-10744.2005	71	81	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2008	283	2					1146	1155		10.1074/jbc.M707479200	http://dx.doi.org/10.1074/jbc.M707479200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	248CE	18003620	hybrid, Green Accepted			2022-12-27	WOS:000252128100055
J	Jiang, L; Fan, JM; Bai, L; Wang, Y; Chen, Y; Yang, L; Chen, LY; Xu, T				Jiang, Li; Fan, Junmei; Bai, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao			Direct quantification of fusion rate reveals a distal role for AS160 in insulin-stimulated fusion of GLUT4 storage vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; REGULATED MEMBRANE AMINOPEPTIDASE; EVANESCENT-WAVE MICROSCOPY; SKELETAL-MUSCLE; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; FLUORESCENT PROTEIN; CELL-SURFACE; TRAFFICKING; TRANSLOCATION	Insulin-stimulated GLUT4 translocation to the plasma membrane constitutes a key process for blood glucose control. However, convenient and robust assays to monitor this dynamic process in real time are lacking, which hinders current progress toward elucidation of the underlying molecular events as well as screens for drugs targeting this particular pathway. Here, we have developed a novel dual colored probe to monitor the translocation process of GLUT4 based on dual color fluorescence measurement. We demonstrate that this probe is more than an order of magnitude more sensitive than the current technology for detecting fusion events from single GLUT4 storage vesicles (GSVs). A small fraction of fusion events were found to be of the "kiss-and-run" type. For the first time, we show that insulin stimulation evokes a similar to 40-fold increase in the fusion of GSVs in 3T3-L1 adipocytes, compared with basal conditions. The probe can also be used to monitor the prefusion behavior of GSVs. By quantifying both the docking and fusion rates simultaneously, we demonstrate a proportional inhibition in both docking and fusion of GSVs by a dominant negative mutant of AS160, indicating a role for AS160 in the docking of GSVs but not in the regulation of GSV fusion after docking.	[Fan, Junmei; Bai, Li; Xu, Tao] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Jiang, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao] Chinese Acad Sci, Inst Biophys, Joint Lab, Beijing 100101, Peoples R China; [Jiang, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao] Huazhong Univ Sci & Technol, Natl Lab Biomacromol, Chinese Acad Sci, Beijing 100101, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Huazhong University of Science & Technology	Xu, T (corresponding author), Chinese Acad Sci, Inst Biophys, Joint Lab, Beijing 100101, Peoples R China.	xutao@ibp.ac.cn	Xu, Tao/G-5474-2010; Bai, Li/N-8311-2013; fan, junmei/D-6147-2011; Chen, Liangyi/F-1352-2010; Chen, Yu/G-8724-2013	Chen, Liangyi/0000-0003-1270-7321; 				Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; COLE KS, 1968, J GEN PHYSIOL, V51, pS1; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KANDROR K, 1994, J BIOL CHEM, V269, P138; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lampson MA, 2000, J CELL SCI, V113, P4065; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Li CH, 2004, CELL RES, V14, P480, DOI 10.1038/sj.cr.7290251; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Martin S, 1997, J CELL SCI, V110, P2281; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Yang XF, 2005, BIOCHEM BIOPH RES CO, V330, P914, DOI 10.1016/j.bbrc.2005.03.054; Yang XF, 2006, J BIOL CHEM, V281, P15457, DOI 10.1074/jbc.M513246200; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	34	64	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8508	8516		10.1074/jbc.M708688200	http://dx.doi.org/10.1074/jbc.M708688200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18063571	Green Published, hybrid			2022-12-27	WOS:000254288000049
J	Ghosh, JC; Dohi, T; Kang, BH; Altieri, DC				Ghosh, Jagadish C.; Dohi, Takehiko; Kang, Byoung Heon; Altieri, Dario C.			Hsp60 regulation of tumor cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; HSP70 FAMILY-MEMBER; MOLECULAR CHAPERONES; CYTOPLASMIC SEQUESTRATION; CANCER-CELLS; SURVIVIN; P53; EXPRESSION; HSP90; HSP10	Molecular chaperones may promote cell survival, but how this process is regulated, especially in cancer, is not well understood. Using high throughput proteomics screening, we identified the cell cycle regulator and apoptosis inhibitor survivin as a novel protein associated with the molecular chaperone Hsp60. Acute ablation of Hsp60 by small interfering RNA destabilizes the mitochondrial pool of survivin, induces mitochondrial dysfunction, and activates caspase-dependent apoptosis. This response involves disruption of an Hsp60-p53 complex, which results in p53 stabilization, increased expression of pro-apoptotic Bax, and Bax-dependent apoptosis. In vivo, Hsp60 is abundantly expressed in primary human tumors, as compared with matched normal tissues, and small interfering RNA ablation of Hsp60 in normal cells is well tolerated and does not cause apoptosis. Therefore, Hsp60 orchestrates a broad cell survival program centered on stabilization of mitochondrial survivin and restraining of p53 function, and this process is selectively exploited in cancer. Hsp60 inhibitors may function as attractive anticancer agents by differentially inducing apoptosis in tumor cells.	[Ghosh, Jagadish C.; Dohi, Takehiko; Kang, Byoung Heon; Altieri, Dario C.] Univ Massachusetts, Sch Med, Ctr Canc, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	dario.altieri@umassmed.edu	Kang, Byoung Heon/E-6165-2010	Kang, Byoung Heon/0000-0001-5902-0549	NATIONAL CANCER INSTITUTE [R01CA078810, R01CA090917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090917, CA78810, CA90917] Funding Source: Medline; NHLBI NIH HHS [R37 HL054131, HL54131] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Ghosh JC, 2006, CANCER RES, V66, P11576, DOI 10.1158/0008-5472.CAN-06-3095; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Thomas X, 2005, LEUKEMIA RES, V29, P1049, DOI 10.1016/j.leukres.2005.02.010; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	45	217	227	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5188	5194		10.1074/jbc.M705904200	http://dx.doi.org/10.1074/jbc.M705904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086682	Green Published, hybrid			2022-12-27	WOS:000253426500076
J	Liang, FP; Lin, CH; Kuo, CD; Chao, HP; Fu, SL				Liang, Fong-Pin; Lin, Chao-Hsiung; Kuo, Cheng-Deng; Chao, Hsueh-Ping; Fu, Shu-Ling			Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; C-SRC; PANICULATA EXTRACT; KINASE INHIBITOR; EPITHELIAL-CELLS; TYROSINE KINASE; MAP KINASE; E-CADHERIN; ACTIVATION; EXPRESSION	Elevated expression and aberrant activation of the src oncogene are strongly associated with cancer initiation and progression, thereby making Src a promising molecular target for anti-cancer therapy. Through drug screening using a temperature-inducible v-Src-transformed epithelial cell line, we found that andrographolide could suppress v-Src-induced transformation and down-regulate v-Src protein expression. In addition, actin cable dissolution and E-cadherin down-regulation, features of transformed phenotype, are perturbed by andrographolide. Moreover, andrographolide promoted v-Src degradation via a ubiquitin-dependent manner. Although andrographolide treatment altered the tyrosine phosphorylation pattern in v-Src-expressing cells, it did not directly affect the kinase activity of v-Src. Both the Erk and phosphatidylinositol 3-kinase signaling pathways were strongly inhibited in andrographolide-treated v-Src cells. However, only MKK inhibitors (PD98059 and U0126) were able to cause a non-transformed morphology similar to that of andrographolide-treated v-Src cells. Moreover, overexpression of constitutively active MKK1 in v-Src cells blocked andrographolide-mediated morphological inhibition. Interestingly, andrographolide treatment could also reduce the protein level of the c-Src truncation mutant (Src531), an Src mutant originally identified from human colon cancer cells. In summary, we demonstrated that andrographolide antagonized v-Src action through promotion of v-Src protein degradation. Furthermore, attenuation of the Erk1/2 signaling pathway is essential for andrographolide-mediated inhibition of v-Src transformation. Our results demonstrate that andrographolide can act as a v-Src inhibitor and reveal a novel action mechanism of andrographolide.	[Liang, Fong-Pin; Chao, Hsueh-Ping; Fu, Shu-Ling] Natl Yang Ming Univ, Inst Tradit Med, Taipei 11221, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Fac Life Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Fu, Shu-Ling] Taipei City Hosp, Dept Res & Educ, Taipei 10341, Taiwan; [Kuo, Cheng-Deng] Vet Gen Hosp, Dept Res & Educ, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Fu, SL (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, 155 Sec 2,Li Nong St, Taipei 11221, Taiwan.	slfu@ym.edu.tw	Kuo, Cheng-Deng/AAP-7010-2021	Kuo, Cheng-Deng/0000-0002-3989-1950; Chao, Hsueh-Ping/0000-0001-9404-4300				An WG, 2000, CELL GROWTH DIFFER, V11, P355; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Brunton VG, 1998, CANCER CHEMOTH PHARM, V41, P417, DOI 10.1007/s002800050760; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Chen JH, 2004, BIOCHEM PHARMACOL, V67, P1337, DOI 10.1016/j.bcp.2003.12.015; Chiou WF, 2000, BRIT J PHARMACOL, V129, P1553, DOI 10.1038/sj.bjp.0703191; Dehm S, 2001, FEBS LETT, V487, P367, DOI 10.1016/S0014-5793(00)02354-1; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang BH, 1997, CANCER RES, V57, P5328; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; KWON HJ, 1992, BIOSCI BIOTECH BIOCH, V56, P538; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Nguyen KT, 2000, ONCOGENE, V19, P5385, DOI 10.1038/sj.onc.1203911; Oldham SM, 1998, ONCOGENE, V16, P2565, DOI 10.1038/sj.onc.1201784; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Riley D, 2001, ONCOGENE, V20, P5941, DOI 10.1038/sj.onc.1204826; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Sharma SV, 2001, ONCOGENE, V20, P2068, DOI 10.1038/sj.onc.1204296; Sheeja K, 2007, IMMUNOPHARM IMMUNOT, V29, P81, DOI 10.1080/08923970701282726; Sheeja K, 2007, INT IMMUNOPHARMACOL, V7, P211, DOI 10.1016/j.intimp.2006.10.002; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; STOKER AW, 1986, J VIROL, V58, P876, DOI 10.1128/JVI.58.3.876-883.1986; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zhou J, 2006, BIOCHEM PHARMACOL, V72, P132, DOI 10.1016/j.bcp.2006.04.019	49	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5023	5033		10.1074/jbc.M705877200	http://dx.doi.org/10.1074/jbc.M705877200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086662	hybrid			2022-12-27	WOS:000253426500060
J	Ross, JA; Nagy, ZS; Kirken, RA				Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.			The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR ACTIVITY; SIGNAL-TRANSDUCTION; PROHIBITIN FAMILY; ANTIGEN RECEPTOR; TYROSINE KINASE; TRANSCRIPTIONAL ACTIVITY; ACTIVITY REA; EXPRESSION; PROTEIN; ACTIVATION	Many immune pathologies are the result of aberrant regulation of T lymphocytes. A functional proteomics approach utilizing two-dimensional gel electrophoresis coupled with mass spectrometry was employed to identify differentially expressed proteins in response to T cell activation. Two members of the prohibitin family of proteins, Phb1 and Phb2, were determined to be up-regulated 4-5- fold upon activation of primary human T cells. Furthermore, their expression was dependent upon CD3 and CD28 signaling pathways that synergistically led to the up-regulation (13-15-fold) of Phb1 and Phb2 mRNA levels as early as 48 h after activation. Additionally, orthophosphate labeling coupled with phosphoamino acid analysis identified Phb1 to be serine and Phb2 serine and tyrosine phosphorylated. Tyrosine phosphorylation of Phb2 was mapped to Tyr(248) using mass spectrometry and confirmed by mutagenesis and phosphospecific antibodies. In contrast to previous reports of Phb1 and Phb2 being nuclear localized, subcellular fractionation, immunofluorescent, and electron microscopy revealed both proteins to localize to the mitochondrial inner membrane of human T cells. Accordingly, small interfering RNA-mediated knockdown of Phbs in Kit225 cells resulted in disruption of mitochondrial membrane potential. Additionally, Phb1 and Phb2 protein levels were up-regulated 2.5-fold during cytokine deprivation-mediated apoptosis of Kit225 cells, suggesting this complex plays a protective role in human T cells. Taken together, Phb1 and Phb2 are novel phosphoproteins up-regulated during T cell activation that function to maintain mitochondrial integrity and thus represent previously unrecognized therapeutic targets for regulating T cell activation, differentiation, viability, and function.	[Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79902 USA	University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79902 USA.	rkirken@utep.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053566] Funding Source: NIH RePORTER; NCRR NIH HHS [5G12RR008124] Funding Source: Medline; NIAID NIH HHS [AI053566] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aringer M, 2003, J IMMUNOL, V170, P6057, DOI 10.4049/jimmunol.170.12.6057; ARTALSANZ M, 2003, J BIOL CHEM, V279, P32091; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; DANG NH, 1991, J IMMUNOL, V147, P2825; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Dixit VD, 2003, ENDOCRINOLOGY, V144, P1496, DOI 10.1210/en.2002-220955; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; HE B, 2007, MOL ENDOCRINOL, DOI DOI 10.1210/ME.2007.0400; HORI T, 1987, BLOOD, V70, P1069; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Katial RK, 1998, CLIN DIAGN LAB IMMUN, V5, P78, DOI 10.1128/CDLI.5.1.78-81.1998; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Manjeshwar S, 2003, CANCER RES, V63, P5251; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; MIYOSHI I, 1981, GANN, V72, P978; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROSKAMS AJI, 1993, J CELL PHYSIOL, V157, P289, DOI 10.1002/jcp.1041570211; Schamberger CJ, 2004, FEBS LETT, V573, P19, DOI 10.1016/j.febslet.2004.07.053; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stepkowski SM, 2005, J IMMUNOL, V175, P4236, DOI 10.4049/jimmunol.175.7.4236; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Takata H, 2007, CURR BIOL, V17, P1356, DOI 10.1016/j.cub.2007.07.009; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2007, J BIOL CHEM, V282, P12804, DOI 10.1074/jbc.M609031200; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Thompson WE, 1997, J REPROD FERTIL, V109, P337, DOI 10.1530/jrf.0.1090337; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; WANGE RL, 1993, J BIOL CHEM, V268, P19797; Winter A, 2007, PROTEINS, V68, P353, DOI 10.1002/prot.21355; Woodlock TJ, 2001, BLOOD CELL MOL DIS, V27, P27, DOI 10.1006/bcmd.2000.0348; Zhang J, 1998, J IMMUNOL, V160, P1148; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	68	76	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4699	4713		10.1074/jbc.M708232200	http://dx.doi.org/10.1074/jbc.M708232200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086671	hybrid			2022-12-27	WOS:000253426500028
J	Serrano-Gomez, D; Sierra-Filardi, E; Martinez-Nunez, RT; Caparros, E; Delgado, R; Munoz-Fernandez, MA; Abad, MA; Jimenez-Barbero, J; Leal, M; Corbi, AL				Serrano-Gomez, Diego; Sierra-Filardi, Elena; Martinez-Nunez, Rocio T.; Caparros, Esther; Delgado, Rafael; Munoz-Fernandez, Mari Angeles; Abad, Maria Antonia; Jimenez-Barbero, Jesus; Leal, Manuel; Corbi, Angel L.			Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; DC-SIGN CD209; MOLECULE-3 (ICAM-3)-GRABBING NONINTEGRIN; SELECTIVE RECOGNITION; REGION POLYMORPHISMS; TRANS-INFECTION; LIGAND-BINDING; VIRUS; EXPRESSION; ANTIGEN	The myeloid C-type lectin dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN, CD209) recognizes oligosaccharide ligands on clinically relevant pathogens (HIV, Mycobacterium, and Aspergillus). Alternative splicing and genomic polymorphism generate DC-SIGN mRNA variants, which have been detected at sites of pathogen entrance and transmission. We present evidence that DC-SIGN neck variants are expressed on dendritic and myeloid cells at the RNA and protein levels. Structural analysis revealed that multimerization of DC-SIGN within a cellular context depends on the lectin domain and the number and arrangement of the repeats within the neck region, whose glycosylation negatively affects oligomer formation. Naturally occurring DC-SIGN neck variants differ in multimerization competence in the cell membrane, exhibit altered sugar binding ability, and retain pathogen-interacting capacity, implying that pathogen-induced cluster formation predominates over the basal multimerization capability. Analysis of DC-SIGN neck polymorphisms indicated that the number of allelic variants is higher than previously thought and that multimerization of the prototypic molecule is modulated in the presence of allelic variants with a different neck structure. Our results demonstrate that the presence of allelic variants or a high level of expression of neck domain splicing isoforms might influence the presence and stability of DC-SIGN multimers on the cell surface, thus providing a molecular explanation for the correlation between DC-SIGN polymorphisms and altered susceptibility to HIV-1 and other pathogens.	[Serrano-Gomez, Diego; Sierra-Filardi, Elena; Martinez-Nunez, Rocio T.; Caparros, Esther; Jimenez-Barbero, Jesus; Corbi, Angel L.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Delgado, Rafael] Hosp 12 Octubre, Mol Microbiol Lab, E-28041 Madrid, Spain; [Munoz-Fernandez, Mari Angeles] Hosp Gen Gregorio Maranon, Serv Immunol, E-28007 Madrid, Spain; [Abad, Maria Antonia; Leal, Manuel] Hosp Univ Virgen Rocio, Serv Enfermedades Infec, E-41013 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Virgen del Rocio University Hospital	Corbi, AL (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, E-28040 Madrid, Spain.	acorbi@cib.csic.es	Delgado, Rafael/C-4910-2016; Serrano-Gómez, Diego/W-2857-2018; Sierra-Filardi, Elena/H-9775-2015; Caparrós, Esther/AHD-3233-2022; Corbí, Angel L./ABC-8146-2020; DELGADO, RAFAEL/A-2938-2012; JIMENEZ-BARBERO, JESUS/D-4431-2014; Leal, Manuel/C-8458-2015	Delgado, Rafael/0000-0002-6912-4736; Serrano-Gómez, Diego/0000-0003-4965-8869; Sierra-Filardi, Elena/0000-0003-4439-2037; Caparrós, Esther/0000-0002-9681-0408; Corbí, Angel L./0000-0003-1980-5733; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Munoz-Fernandez/0000-0002-0813-4500				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barreiro LB, 2006, HUM IMMUNOL, V67, P102, DOI 10.1016/j.humimm.2006.02.028; Barreiro LB, 2006, J INFECT DIS, V194, P1184, DOI 10.1086/507845; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Bleijs DA, 2001, TRENDS IMMUNOL, V22, P457, DOI 10.1016/S1471-4906(01)01974-3; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Colmenares M, 2004, J IMMUNOL, V172, P1186, DOI 10.4049/jimmunol.172.2.1186; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; de la Rosa G, 2005, J LEUKOCYTE BIOL, V77, P699, DOI 10.1189/jlb.0904529; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Falkowska E, 2006, J GEN VIROL, V87, P2571, DOI 10.1099/vir.0.82034-0; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2001, PLACENTA, V22, pS19, DOI 10.1053/plac.2001.0674; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mari S, 2005, ANGEW CHEM INT EDIT, V44, P296, DOI 10.1002/anie.200461574; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nattermann J, 2006, J VIRAL HEPATITIS, V13, P42, DOI 10.1111/j.1365-2893.2005.00652.x; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Serrano-Gomez D, 2007, ANTIMICROB AGENTS CH, V51, P2313, DOI 10.1128/AAC.01289-06; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026; Su SV, 2004, J BIOL CHEM, V279, P19122, DOI 10.1074/jbc.M400184200; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	60	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3889	3903		10.1074/jbc.M706004200	http://dx.doi.org/10.1074/jbc.M706004200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073208	hybrid, Green Published			2022-12-27	WOS:000253083500023
J	Tartari, CJ; Gunby, RH; Coluccia, AML; Sottocornola, R; Cimbro, B; Scapozza, L; Donella-Deana, A; Pinna, LA; Gambacorti-Passerini, C				Tartari, Carmen J.; Gunby, Rosalind H.; Coluccia, Addolorata M. L.; Sottocornola, Roberta; Cimbro, Barbara; Scapozza, Leonardo; Donella-Deana, Arianna; Pinna, Lorenzo A.; Gambacorti-Passerini, Carlo			Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; SIGNAL TRANSDUCER; MAMMALIAN TARGET; ALK EXPRESSION; FUSION PROTEIN; STAT3; NUCLEOPHOSMIN; ACTIVATION; PHOSPHORYLATION; CONTRIBUTES	NPM/ALK is an oncogenic fusion protein expressed in similar to 50% of anaplastic large cell lymphoma cases. It derives from the t(2; 5)(p23; q35) chromosomal translocation that fuses the catalytic domain of the tyrosine kinase, anaplastic lymphoma kinase (ALK), with the dimerization domain of the ubiquitously expressed nucleophosmin (NPM) protein. Dimerization of the ALK kinase domain leads to its autophosphorylation and constitutive activation. Activated NPM/ALK stimulates downstream survival and proliferation signaling pathways leading to malignant transformation. Herein, we investigated the molecular mechanisms of autoactivation of the catalytic domain of ALK. Because kinases are typically regulated by autophosphorylation of their activation loops, we systematically mutated (Tyr --> Phe) three potential autophosphorylation sites contained in the "YXXXYY" motif of the ALK activation loop, and determined the effect of these mutations on the catalytic activity and biological function of NPM/ALK. We observed that mutation of both the second and third tyrosine residues (YFF mutant) did not affect the kinase activity or transforming ability of NPM/ALK. In contrast, mutation of the first and second (FFY), first and third (FYF), or all three (FFF) tyrosine residues impaired both kinase activity and transforming ability of NPM/ALK. Furthermore, a DFF mutant, in which the aspartic residue introduces a negative charge similar to a phosphorylated tyrosine, possessed catalytic activity similar to the YFF mutant. Together, our findings indicate that phosphorylation of the first tyrosine of the YXXXYY motif is necessary for the autoactivation of the ALK kinase domain and the transforming activity of NPM/ALK.	[Tartari, Carmen J.; Gunby, Rosalind H.; Coluccia, Addolorata M. L.; Sottocornola, Roberta; Cimbro, Barbara; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin & Prevent Med, I-20052 Monza, Italy; [Tartari, Carmen J.] Natl Canc Inst Fdn, Dept Expt Oncol, I-20133 Milan, Italy; [Scapozza, Leonardo] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland; [Scapozza, Leonardo] Univ Lausanne, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland; [Donella-Deana, Arianna; Pinna, Lorenzo A.] Univ Padua, Venetian Inst Mol Med, Dept Biol Chem, I-35122 Padua, Italy; [Gambacorti-Passerini, Carlo] McGill Univ, Dept Internal Med, Montreal, PQ H3A 2T5, Canada	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Geneva; University of Lausanne; University of Padua; Veneto Institute Molecular Medicine; McGill University	Tartari, CJ (corresponding author), Univ Milano Bicocca, Dept Clin & Prevent Med, Via Cadore 48, I-20052 Monza, Italy.	carmen.tartari@unimib.it	Tartari, Carmen Julia/AAA-8104-2019	Tartari, Carmen Julia/0000-0002-4576-2928; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Scapozza, Leonardo/0000-0003-1079-648X; Pinna, Lorenzo A./0000-0002-8856-4956	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Amin HM, 2006, LAB INVEST, V86, P417, DOI 10.1038/labinvest.3700393; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Coluccia AML, 2005, EXPERT OPIN THER TAR, V9, P515, DOI 10.1517/14728222.9.3.515; Coluccia AML, 2004, BLOOD, V103, P2787, DOI 10.1182/blood-2003-09-3144; Cook JR, 2001, AM J SURG PATHOL, V25, P1364, DOI 10.1097/00000478-200111000-00003; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Gunby RH, 2003, HAEMATOLOGICA, V88, P408; Gunby RH, 2007, ANTI-CANCER AGENT ME, V7, P594, DOI 10.2174/187152007784111340; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Kasprzycka M, 2006, P NATL ACAD SCI USA, V103, P9964, DOI 10.1073/pnas.0603507103; Khoury JD, 2003, CLIN CANCER RES, V9, P3692; Lai R, 2005, HUM PATHOL, V36, P939, DOI 10.1016/j.humpath.2005.07.011; Lai R, 2004, AM J PATHOL, V164, P2251, DOI 10.1016/S0002-9440(10)63781-9; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nieborowska-Skorska M, 2001, CANCER RES, V61, P6517; Pulford K, 2004, CELL MOL LIFE SCI, V61, P2939, DOI 10.1007/s00018-004-4275-9; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rudzki Zbigniew, 2005, Polish Journal of Pathology, V56, P37; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Slupianek A, 2001, CANCER RES, V61, P2194; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; ZHANG B, 1991, J BIOL CHEM, V266, P990; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466	38	46	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3743	3750		10.1074/jbc.M706067200	http://dx.doi.org/10.1074/jbc.M706067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070884	hybrid			2022-12-27	WOS:000253083500007
J	Alvarez, VE; Kosec, G; Anna, CS; Turk, V; Cazzulo, JJ; Turk, B				Alvarez, Vanina E.; Kosec, Gregor; Anna, Celso Sant; Turk, Vito; Cazzulo, Juan J.; Turk, Boris			Autophagy is involved in nutritional stress response and differentiation in Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; MAMMALIAN AUTOPHAGY; MOLECULAR MACHINERY; TARGETING PATHWAY; PROTEINS; CYSTEINE; YEAST; CYTOPLASM; VACUOLE; INHIBITORS	Autophagy is the major mechanism used by eukaryotic cells to degrade and recycle proteins and organelles. Bioinformatics analysis of the genome of the protozoan parasite Trypanosoma cruzi revealed the presence of all components of the Atg8 conjugation system, whereas Atg12, Atg5, and Atg10 as the major components of the Atg12 pathway could not be identified. The two TcATG4 (autophagin) homologs present in the genome were found to correctly process the two ATG8 homologs after the conserved Gly residue. Functional studies revealed that both ATG4 homologues but only one T. cruzi ATG8 homolog (TcATG8.1) complemented yeast deletion strains. During starvation of the parasite, TcAtg8.1, but not TcAtg8.2, was found by immunofluorescence to be located in autophagosome-like vesicles. This confirms its function as an Atg8/LC3 homolog and its potential to be used as an autophagosomal marker. Most importantly, autophagy is involved in differentiation between developmental stages of T. cruzi, a process that is essential for parasite maintenance and survival. These findings suggest that the autophagy pathway could represent a target for a novel chemotherapeutic strategy against Chagas disease.	[Kosec, Gregor; Turk, Vito; Turk, Boris] Univ Ljubljana, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia; [Alvarez, Vanina E.; Cazzulo, Juan J.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, IIB INTECH, Buenos Aires, DF, Argentina; [Anna, Celso Sant] Univ Fed Rio de Janeiro, Lab Ultrastrutura Celular Hertha Meyer, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, RJ, Brazil; [Kosec, Gregor; Turk, Vito; Turk, Boris] Univ Ljubljana, Jozef Stefan Inst, Dept Biol Mol Biol & Struct Biol, SL-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade Federal do Rio de Janeiro; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Turk, B (corresponding author), Univ Ljubljana, Jozef Stefan Inst, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si		Alvarez, Vanina/0000-0002-9890-6980; Turk, Boris/0000-0002-9007-5764				Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; AMEISEN JC, 1995, CELL DEATH DIFFER, V2, P285; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Braga MV, 2006, FEMS MICROBIOL LETT, V256, P209, DOI 10.1111/j.1574-6968.2006.00125.x; Cazzulo Juan Jose, 2002, Current Topics in Medicinal Chemistry, V2, P1261, DOI 10.2174/1568026023392995; Chiari E., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P23; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; DECAZZULO BMF, 1994, FEMS MICROBIOL LETT, V124, P81; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ESTEVES MG, 1989, FEMS MICROBIOL LETT, V59, P31; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; HARTH G, 1993, MOL BIOCHEM PARASIT, V58, P17, DOI 10.1016/0166-6851(93)90086-D; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketelaar T, 2004, FEBS LETT, V567, P302, DOI 10.1016/j.febslet.2004.04.088; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kollien AH, 2000, PARASITOL TODAY, V16, P381, DOI 10.1016/S0169-4758(00)01724-5; Kosec G, 2006, MOL BIOCHEM PARASIT, V145, P18, DOI 10.1016/j.molbiopara.2005.09.001; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; MartinezCalvillo S, 1997, GENE, V199, P71, DOI 10.1016/S0378-1119(97)00348-X; Melo RL, 2001, ANAL BIOCHEM, V293, P71, DOI 10.1006/abio.2001.5115; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Parussini F, 2003, MOL BIOCHEM PARASIT, V131, P11, DOI 10.1016/S0166-6851(03)00175-0; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; Rigden DJ, 2005, BIOCHEM SOC T, V33, P972, DOI 10.1042/BST20050972; SAMBROOK J, 1989, MOL CLONING, V2, P9; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Selzer PM, 1999, P NATL ACAD SCI USA, V96, P11015, DOI 10.1073/pnas.96.20.11015; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; SYLVESTER D, 1976, COMP BIOCHEM PHYS B, V55, P443, DOI 10.1016/0305-0491(76)90318-7; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zingales B, 1997, MEM I OSWALDO CRUZ, V92, P811, DOI 10.1590/S0074-02761997000600016	56	116	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3454	3464		10.1074/jbc.M708474200	http://dx.doi.org/10.1074/jbc.M708474200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18039653	hybrid			2022-12-27	WOS:000253083000051
J	Robertson, PD; Warren, EM; Zhang, H; Friedman, DB; Lary, JW; Cole, JL; Tutter, AV; Walter, JC; Fanning, E; Eichman, BF				Robertson, Patrick D.; Warren, Eric M.; Zhang, Haijiang; Friedman, David B.; Lary, Jeffrey W.; Cole, James L.; Tutter, Antonin V.; Walter, Johannes C.; Fanning, Ellen; Eichman, Brandt F.			Domain architecture and biochemical characterization of vertebrate Mcm10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; CYCLIN-DEPENDENT KINASES; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DNA; FISSION YEAST; SEDIMENTATION-VELOCITY; CHROMATIN ASSOCIATION	Mcm10 plays a key role in initiation and elongation of eukaryotic chromosomal DNA replication. As a first step to better understand the structure and function of vertebrate Mcm10, we have determined the structural architecture of Xenopus laevis Mcm10 (xMcm10) and characterized each domain biochemically. Limited proteolytic digestion of the full-length protein revealed N-terminal-, internal (ID)-, and C-terminal (CTD)-structured domains. Analytical ultracentrifugation revealed that xMcm10 self-associates and that the N-terminal domain forms homodimeric assemblies. DNA binding activity of xMcm10 was mapped to the ID and CTD, each of which binds to single- and double-stranded DNA with low micromolar affinity. The structural integrity of xMcm10-ID and CTD is dependent on the presence of bound zinc, which was experimentally verified by atomic absorption spectroscopy and proteolysis protection assays. The ID and CTD also bind independently to the N-terminal 323 residues of the p180 subunit of DNA polymerase alpha-primase. We propose that the modularity of the protein architecture, with discrete domains for dimerization and for binding to DNA and DNA polymerase alpha-primase, provides an effective means for coordinating the biochemical activities of Mcm10 within the replisome.	[Robertson, Patrick D.; Warren, Eric M.; Zhang, Haijiang; Fanning, Ellen; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Friedman, David B.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Storrs, CT 06269 USA; [Tutter, Antonin V.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; University of Connecticut; Harvard University; Harvard Medical School	Eichman, BF (corresponding author), Vanderbilt Univ, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu	Cole, James/G-2586-2011	Walter, Johannes/0000-0002-4186-7570	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, T32GM008320, R01GM052948] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES000267] Funding Source: Medline; NIGMS NIH HHS [GM52948, GM080570, R01 GM080570, R01 GM080570-01, R01 GM052948, T32 GM008320, R01 GM080570-02, T32 GM08320] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kwon K, 2003, J BIOL CHEM, V278, P19442, DOI 10.1074/jbc.M300934200; LAUE TM, 1992, SEDNTERP; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Leon O, 2000, BIOL RES, V33, P21; MAINE GT, 1984, GENETICS, V106, P365; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	66	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3338	3348		10.1074/jbc.M706267200	http://dx.doi.org/10.1074/jbc.M706267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065420	Green Accepted, Green Submitted, hybrid			2022-12-27	WOS:000253083000038
J	Xie, MY; Mosig, A; Qi, X; Li, Y; Stadler, PF; Chen, JJL				Xie, Mingyi; Mosig, Axel; Qi, Xiaodong; Li, Yang; Stadler, Peter F.; Chen, Julian J. -L.			Structure and function of the smallest vertebrate telomerase RNA from teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BODY-SPECIFIC LOCALIZATION; GENOME DUPLICATION; DOMAIN; IDENTIFICATION; PSEUDOKNOT; REVEALS	Telomerase extends chromosome ends by copying a short template sequence within its intrinsic RNA component. Telomerase RNA (TR) from different groups of species varies dramatically in sequence and size. We report here the bioinformatic identification, secondary structure comparison, and functional analysis of the smallest known vertebrate TRs from five teleost fishes. The teleost TRs (312-348 nucleotides) are significantly smaller than the cartilaginous fish TRs (478-559 nucleotides) and tetrapod TRs. This remarkable length reduction of teleost fish TRs correlates positively with the genome size, reflecting an unusual structural plasticity of TR during evolution. The teleost TR consists of a compact three-domain structure, lacking most of the sequences in regions that are variable in other vertebrate TR structures. The medaka and fugu TRs, when assembled with their telomerase reverse transcriptase (TERT) protein counterparts, reconstituted active and processive telomerase enzymes. Titration analysis of individual RNA domains suggests that the efficient assembly of the telomerase complex is influenced more by the telomerase reverse transcriptase (TERT) binding of the CR4-CR5 domain than the pseudoknot domain of TR. The remarkably small teleost fish TR further expands our understanding about the evolutionary divergence of vertebrate TR.	[Xie, Mingyi; Qi, Xiaodong; Li, Yang; Chen, Julian J. -L.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Xie, Mingyi; Qi, Xiaodong; Li, Yang; Chen, Julian J. -L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04107 Leipzig, Germany; [Mosig, Axel] Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Dept Combinator & Geometry, Shanghai 200031, Peoples R China; [Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Dept Theoret Chem, A-1090 Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Leipzig University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Leipzig University; University of Vienna; The Santa Fe Institute	Chen, JJL (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	JLChen@asu.edu	Chen, Julian J.-L./D-6488-2014; Stadler, Peter F. F/L-7857-2015	Chen, Julian J.-L./0000-0002-7253-2722; Stadler, Peter F. F/0000-0002-5016-5191; Mosig, Axel/0000-0001-7266-8323				Backofen R, 2007, J EXP ZOOL PART B, V308B, P1, DOI 10.1002/jezb.21130; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chen JL, 2004, TRENDS BIOCHEM SCI, V29, P183, DOI 10.1016/j.tibs.2004.02.003; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Chen JL, 2003, EMBO J, V22, P304, DOI 10.1093/emboj/cdg024; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Comolli LR, 2002, P NATL ACAD SCI USA, V99, P16998, DOI 10.1073/pnas.262663599; Eddy SR, 2006, COLD SPRING HARB SYM, V71, P117, DOI 10.1101/sqb.2006.71.003; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Ly H, 2005, BLOOD, V105, P2332, DOI 10.1182/blood-2004-09-3659; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Mitchell JR, 2000, MOL CELL, V6, P361, DOI 10.1016/S1097-2765(00)00036-8; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mosig A, 2007, LECT N BIOINFORMAT, V4645, P335; Mosig Axel, 2006, Genomics Proteomics & Bioinformatics, V4, P56, DOI 10.1016/S1672-0229(06)60017-X; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Richard P, 2003, EMBO J, V22, P4283, DOI 10.1093/emboj/cdg394; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; Tesmer VM, 1999, MOL CELL BIOL, V19, P6207; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Venkatesh B, 2006, SCIENCE, V314, P1892, DOI 10.1126/science.1130708; Vitali P, 2003, NUCLEIC ACIDS RES, V31, P6543, DOI 10.1093/nar/gkg849; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Yap WH, 2005, GENE, V353, P207, DOI 10.1016/j.gene.2005.04.038	37	63	69	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2008	283	4					2049	2059		10.1074/jbc.M708032200	http://dx.doi.org/10.1074/jbc.M708032200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	253EH	18039659	hybrid, Green Published			2022-12-27	WOS:000252501000032
J	Burgess, SC; Iizuka, K; Jeoung, NH; Harris, RA; Kashiwaya, Y; Veech, RL; Kitazume, T; Uyeda, K				Burgess, Shawn C.; Iizuka, Katsumi; Jeoung, Nam Ho; Harris, Robert A.; Kashiwaya, Yoshihiro; Veech, Richard L.; Kitazume, Tatsuya; Uyeda, Kosaku			Carbohydrate-response element-binding protein deletion alters substrate utilization producing an energy-deficient liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; TRICARBOXYLIC-ACID CYCLE; TRANSCRIPTION FACTOR; RAT-LIVER; GLUCOSE; MECHANISM; KINASE; PHOSPHORYLATION; PHOSPHATASE; LIPOGENESIS	Livers from mice lacking the carbohydrate-responsive element-binding protein (ChREBP) were compared with wild type (WT) mice to determine the effect of this transcription factor on hepatic energy metabolism. The pyruvate dehydrogenase complex was considerably more active in ChREBP(-/-) mice because of diminished pyruvate dehydrogenase kinase activity. Greater pyruvate dehydrogenase complex activity caused a stimulation of lactate and pyruvate oxidation, and it significantly impaired fatty acid oxidation in perfused livers from ChREBP(-/-) mice. This shift in mitochondrial substrate utilization led to a 3-fold reduction of the free cytosolic [NAD(+)]/[NADH] ratio, a 1.7-fold increase in the free mitochondrial [NAD(+)]/[NADH] ratio, and a 2-fold decrease in the free cytosolic [ATP]/[ADP][P-i] ratio in the ChREBP(-/-) liver compared with control. Hepatic pyruvate carboxylase flux was impaired with ChREBP deletion secondary to decreased fatty acid oxidation, increased pyruvate oxidation, and limited pyruvate availability because of reduced activity of liver pyruvate kinase and malic enzyme, which replenish pyruvate via glycolysis and pyruvate cycling. Overall, the shift from fat utilization to pyruvate and lactate utilization resulted in a decrease in the energy of ATP hydrolysis and a hypo-energetic state in the livers of ChREBP(-/-) mice.	[Iizuka, Katsumi; Kitazume, Tatsuya; Uyeda, Kosaku] Univ Texas SW Med Sch, Dept Biochem, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Burgess, Shawn C.] Univ Texas SW Med Sch, Dept Pharmacol, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dept Vet Affairs Med Ctr, Dallas, TX 75390 USA; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Kashiwaya, Yoshihiro; Veech, Richard L.] NIAAA, Lab Met Control, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Uyeda, K (corresponding author), Univ Texas SW Med Sch & Vet Affairs, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kuyeda6400@aol.com	Iizuka, Katsumi/AAB-9135-2019	Iizuka, Katsumi/0000-0002-9837-6238; Jeoung, Nam Ho/0000-0002-7584-3761	NCRR NIH HHS [RR 02584] Funding Source: Medline; NIDDK NIH HHS [DK 063948-04, DK 076169, DK 47844] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, R01DK047844, R01DK063948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000111, Z01AA000111] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ASHCROFT SJ, 1968, BIOCHEM J, V107, P599, DOI 10.1042/bj1070599; Bergmeyer H.U., 1985, METHODS ENZYMATIC AN; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; ENGEL PC, 1969, BIOCHEM J, V115, P621, DOI 10.1042/bj1150621; GUYNN RW, 1973, J BIOL CHEM, V248, P6966; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Jeoung NH, 2006, ANAL BIOCHEM, V356, P44, DOI 10.1016/j.ab.2006.06.017; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; KRAHENBUHL S, 1991, J BIOL CHEM, V266, P20998; KREBS HA, 1969, PYRIDINE NUCLEOTIDE, P329; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; KWACK H, 1992, CURR TOP CELL REGUL, V33, P185; Lamprecht W, 1974, METHOD ENZYMAT AN, P2101; Liu YQ, 1996, J BIOL CHEM, V271, P8824, DOI 10.1074/jbc.271.15.8824; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Mochel F, 2005, MOL GENET METAB, V84, P305, DOI 10.1016/j.ymgme.2004.09.007; NISHIMURA M, 1995, J BIOL CHEM, V270, P26341, DOI 10.1074/jbc.270.44.26341; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; SPRY M, 1971, THESIS OXFORD U OXFO; Veech RL, 2002, IUBMB LIFE, V54, P241, DOI 10.1080/15216540215678; VEECH RL, 1994, ALCOHOL CLIN EXP RES, V18, P1040, DOI 10.1111/j.1530-0277.1994.tb00081.x; VEECH RL, 1979, J BIOL CHEM, V254, P6538; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Wu PF, 1999, DIABETES, V48, P1593, DOI 10.2337/diabetes.48.8.1593; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298	34	43	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1670	1678		10.1074/jbc.M706540200	http://dx.doi.org/10.1074/jbc.M706540200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18042547	hybrid			2022-12-27	WOS:000252282700054
J	Huang, D; Cai, DT; Chua, RYR; Kemeny, DM; Wong, SH				Huang, Dachuan; Cai, Deyu Tarika; Chua, Rong Yuan Ray; Kemeny, David Michael; Wong, Siew Heng			Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; NITRIC-OXIDE SYNTHASE; INVARIANT CHAIN; ANTIGEN PRESENTATION; ASPARAGINE ENDOPEPTIDASE; CYSTEINE PROTEASES; S-NITROSATION; IN-VIVO; HLA-DM; EXPRESSION	Dendritic cells (DC) are professional antigen-presenting cells that possess specific and efficient mechanisms to initiate immune responses. Upon encounter with pathogens, immature DC will go through a maturation process that converts them to highly immunogenic mature DC. Despite the fact that nitric oxide (NO) was produced in large amounts in maturing DC, it is still unclear whether NO is the key molecule that initiates and enhances DC maturation and T cell proliferation, respectively. Here, we report that NO donor and overexpression of either nitric-oxide synthase 2 (NOS2) or nitric-oxide synthase 3 (NOS3) alone can induce surface expression of major histocompatibility complex class II (MHC II) and both the essential co-stimulatory molecules CD80 and CD86 in immature DC. Consistently, NO donor-treated immature DC were capable of enhancing T cell proliferation in vitro in the absence of lipolysaccharide. Interestingly, NOS2 interacts with CD74 (the MHC II-associated invariant chain), and the degradation of CD74 by caspases in immature DC was inhibited upon treatment with NO donor. Because the trafficking of MHC II is CD74-dependent, the increase in cell surface localization of MHC II in maturing DC is in part due to the increase in CD74 protein expression in the presence of NOS2 and NO.	[Huang, Dachuan; Cai, Deyu Tarika; Chua, Rong Yuan Ray; Wong, Siew Heng] Natl Univ Singapore, Lab Membrane Trafficking & Immunoregulat, Dept Microbiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Kemeny, David Michael; Wong, Siew Heng] Natl Univ Singapore, Immunol Programme, Singapore 117597, Singapore	National University of Singapore; National University of Singapore	Wong, SH (corresponding author), 03-14 Block MD4A,5 Sci Dr 2, Singapore, Singapore.	micwsh@nus.edu.sg		HUANG, DACHUAN/0000-0002-7518-4081				Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bonham CA, 1996, TRANSPLANTATION, V62, P1871, DOI 10.1097/00007890-199612270-00033; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Connelly L, 2005, J BIOL CHEM, V280, P10040, DOI 10.1074/jbc.M411991200; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Engering AJ, 1998, INT IMMUNOL, V10, P1713, DOI 10.1093/intimm/10.11.1713; Gomez J, 2004, TISSUE ANTIGENS, V63, P149, DOI 10.1111/j.1399-0039.2004.00159.x; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Houde C, 2003, J BIOL CHEM, V278, P16929, DOI 10.1074/jbc.M301842200; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Kamada S, 1997, CELL DEATH DIFFER, V4, P473, DOI 10.1038/sj.cdd.4400268; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maehr R, 2005, J IMMUNOL, V174, P7066, DOI 10.4049/jimmunol.174.11.7066; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Manoury B, 2003, IMMUNITY, V18, P489, DOI 10.1016/S1074-7613(03)00085-2; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Mohr S, 1997, BIOCHEM BIOPH RES CO, V238, P387, DOI 10.1006/bbrc.1997.7304; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pritchard KA, 2001, J BIOL CHEM, V276, P17621, DOI 10.1074/jbc.C100084200; Rossig L, 1999, J BIOL CHEM, V274, P6823, DOI 10.1074/jbc.274.11.6823; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Serwe M, 1997, INT IMMUNOL, V9, P983, DOI 10.1093/intimm/9.7.983; Starlets D, 2006, BLOOD, V107, P4807, DOI 10.1182/blood-2005-11-4334; Tannenbaum SR, 2006, ACS CHEM BIOL, V1, P615, DOI 10.1021/cb600439h; Vo PA, 2005, J BIOL CHEM, V280, P7236, DOI 10.1074/jbc.M411317200; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102	31	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1713	1722		10.1074/jbc.M705998200	http://dx.doi.org/10.1074/jbc.M705998200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18003616	hybrid			2022-12-27	WOS:000252282700058
J	Yang, KJ; Shin, S; Piao, L; Shin, E; Li, YW; Park, KA; Byun, HS; Won, MH; Hong, JH; Kweon, GR; Hur, GM; Seok, JH; Chun, T; Brazil, DP; Hemmings, BA; Park, J				Yang, Keum-Jin; Shin, Sanghee; Piao, Longzhen; Shin, Eulsoon; Li, Yuwen; Park, Kyeong Ah; Byun, Hee Sun; Won, Minho; Hong, Janghee; Kweon, Gi Ryang; Hur, Gang Min; Seok, Jeong Ho; Chun, Taehoon; Brazil, Derek P.; Hemmings, Brian A.; Park, Jongsun			Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK; DOCKING SITE; INSULIN-RECEPTOR; AGC KINASES; SH3 DOMAIN; C-ZETA; ACTIVATION; COMPLEX; HSP90	3-Phosphoinositide-dependent protein kinase-1 (PDK1) appears to play a central regulatory role in many cell signalings between phosphoinositide-3 kinase and various intracellular serine/threonine kinases. In resting cells, PDK1 is known to be constitutively active and is further activated by tyrosine phosphorylation (Tyr(9) and Tyr(373/376)) following the treatment of the cell with insulin or pervanadate. However, little is known about the mechanisms for this additional activation of PDK1. Here, we report that the SH2 domain of Src, Crk, and GAP recognized tyrosine-phosphorylated PDK1 in vitro. Destabilization of PDK1 induced by geldanamycin (a Hsp90 inhibitor) was partially blocked in HEK 293 cells expressing PDK1- Y9F. Co-expression of Hsp90 enhanced PDK1-Src complex formation and led to further increased PDK1 activity toward PKB and SGK. Immunohistochemical analysis with anti- phospho-Tyr9 antibodies showed that the level of Tyr9 phosphorylation was markedly increased in tumor samples compared with normal. Taken together, these data suggest that phosphorylation of PDK1 on Tyr9, distinct from Tyr373/376, is important for PDK1/Src complex formation, leading to PDK1 activation. Furthermore, Tyr9 phosphorylation is critical for the stabilization of both PDK1 and the PDK1/Src complex via Hsp90-mediated protection of PDK1 degradation.	[Yang, Keum-Jin; Shin, Sanghee; Piao, Longzhen; Shin, Eulsoon; Li, Yuwen; Park, Kyeong Ah; Byun, Hee Sun; Won, Minho; Hong, Janghee; Hur, Gang Min; Seok, Jeong Ho; Park, Jongsun] Chungnam Natl Univ, Coll Med, Dept Pharmacol, Daejeon Reg Canc Ctr,Canc Res Inst,Res Inst Med S, Taejon 301131, South Korea; [Kweon, Gi Ryang] Chungnam Natl Univ, Coll Med, Dept Biochem, Taejon 301131, South Korea; [Chun, Taehoon] Korea Univ, Sch Life Sci & Biotechnol, Div Biotechnol, Seoul 136701, South Korea; [Brazil, Derek P.] Univ Coll Dublin, Univ Coll Dublin Conway Inst, Univ Coll Dublin Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Chungnam National University; Chungnam National University; Korea University; University College Dublin; Friedrich Miescher Institute for Biomedical Research	Park, J (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol, Daejeon Reg Canc Ctr,Canc Res Inst,Res Inst Med S, 6 Munhwa Dong, Taejon 301131, South Korea.	insulin@cnu.ac.kr	Park, Jongsun/E-7465-2010; Hur, Gang-min/ABF-9263-2021; li, yuwen/HGU-6435-2022; Chun, Taehoon/F-2052-2013	Park, Jongsun/0000-0002-4690-1854; Hur, Gang-min/0000-0003-4870-6574; Li, Yuwen/0000-0002-6218-148X; Brazil, Derek/0000-0003-1375-1076; Hong, Jang-Hee/0000-0002-0623-5455; Won, Minho/0000-0002-5873-5216				Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; AMMIRANTE M, 2007, IN PRESS ONCOGENE; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Andjelkovic M, 1999, MOL CELL BIOL, V19, P5061; Azar ZM, 2006, CAN J PHYSIOL PHARM, V84, P777, DOI 10.1139/Y06-024; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Biondi RM, 2000, EMBO J, V19, P979, DOI 10.1093/emboj/19.5.979; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; CIOCCA DR, 1992, CANCER RES, V52, P3648; Collins BJ, 2003, EMBO J, V22, P4202, DOI 10.1093/emboj/cdg407; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Donaldson LW, 2002, P NATL ACAD SCI USA, V99, P14053, DOI 10.1073/pnas.212518799; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; ELIAS JM, 1989, AM J CLIN PATHOL, V92, P836; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Fiory F, 2005, MOL CELL BIOL, V25, P10803, DOI 10.1128/MCB.25.24.10803-10814.2005; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Fujita N, 2003, CANCER CHEMOTH PHARM, V52, pS24, DOI 10.1007/s00280-003-0591-2; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x; Hinton HJ, 2004, NAT IMMUNOL, V5, P539, DOI 10.1038/ni1062; Kikani CK, 2005, J CELL BIOCHEM, V96, P1157, DOI 10.1002/jcb.20651; Kim DW, 2003, MOL ENDOCRINOL, V17, P1382, DOI 10.1210/me.2002-0402; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Komander D, 2003, BIOCHEM J, V375, P255, DOI 10.1042/BJ20031119; Latour S, 2003, NAT CELL BIOL, V5, P149, DOI 10.1038/ncb919; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Meares GP, 2004, FEBS LETT, V574, P181, DOI 10.1016/j.febslet.2004.08.026; Mehdi MZ, 2005, ANTIOXID REDOX SIGN, V7, P1014, DOI 10.1089/ars.2005.7.1014; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 1999, DRUG RESIST UPDATE, V2, P165, DOI 10.1054/drup.1999.0082; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Park KA, 2007, CARCINOGENESIS, V28, P71, DOI 10.1093/carcin/bgl094; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Roche S, 1996, EMBO J, V15, P4940, DOI 10.1002/j.1460-2075.1996.tb00874.x; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sato S, 2002, J BIOL CHEM, V277, P39360, DOI 10.1074/jbc.M205141200; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Taniyama Y, 2003, MOL CELL BIOL, V23, P8019, DOI 10.1128/MCB.23.22.8019-8029.2003; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U; Yun BG, 2005, CELL SIGNAL, V17, P1477, DOI 10.1016/j.cellsig.2005.03.006; Zeng ZH, 2006, CANCER RES, V66, P3737, DOI 10.1158/0008-5472.CAN-05-1278	67	57	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2008	283	3					1480	1491		10.1074/jbc.M706361200	http://dx.doi.org/10.1074/jbc.M706361200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	250EL	18024423	hybrid			2022-12-27	WOS:000252282700032
J	Schug, ZT; da Fonseca, PCA; Bhanumathy, CD; Wagner, L; Zhang, XC; Bailey, B; Morris, EP; Yule, DI; Joseph, SK				Schug, Zachary T.; da Fonseca, Paula C. A.; Bhanumathy, Cunnigaiper D.; Wagner, Larry, II; Zhang, Xianchao; Bailey, Bradley; Morris, Edward P.; Yule, David I.; Joseph, Suresh K.			Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; INWARD RECTIFIER CHANNEL; CENTRAL CORE DISEASE; LIGAND-BINDING SITE; POTASSIUM-CHANNEL; K+ CHANNEL; CA2+ RELEASE; ION PERMEATION; TRISPHOSPHATE RECEPTORS; FUNCTIONAL-PROPERTIES	Specific residues in the putative pore helix, selectivity filter, and S6 transmembrane helix of the inositol 1,4,5-trisphosphate receptor were mutated in order to examine their effects on channel function. Mutation of 5 of 8 highly conserved residues in the pore helix/selectivity filter region inactivated the channel (C2533A, G2541A, G2545A, G2546A, and G2547A). Of the remaining three mutants, C2527A and R2543A were partially active and G2549A behaved like wild type receptor. Mutation of a putative glycine hinge residue in the S6 helix (G2586A) or a putative gating residue at the cytosolic end of S6 helix (F2592A) had minimal effects on function, although channel function was inactivated by G2586P and F2592D mutations. The mutagenesis data are interpreted in the context of a structural homology model of the inositol 1,4,5-trisphosphate receptor.	[Schug, Zachary T.; Bhanumathy, Cunnigaiper D.; Zhang, Xianchao; Bailey, Bradley; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [Wagner, Larry, II] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Rochester	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, 1020 Locust St JAH 230A, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		Schug, Zachary/0000-0003-4197-8227; da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	British Heart Foundation [PG/07/076/23480] Funding Source: Medline; Cancer Research UK Funding Source: Medline; NIAAA NIH HHS [T32 AA 07463] Funding Source: Medline; NIDCR NIH HHS [DE 14765] Funding Source: Medline; NIDDK NIH HHS [DK 54568, DK 34804] Funding Source: Medline; Wellcome Trust Funding Source: Medline	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Bhanumathy CD, 2006, J BIOL CHEM, V281, P3722, DOI 10.1074/jbc.M509966200; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Boehning D, 2001, BIOPHYS J, V81, P117, DOI 10.1016/S0006-3495(01)75685-8; Boehning D, 2001, J BIOL CHEM, V276, P13509, DOI 10.1074/jbc.C100094200; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chivers PT, 1996, EMBO J, V15, P2659, DOI 10.1002/j.1460-2075.1996.tb00626.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Dart C, 1998, J PHYSIOL-LONDON, V511, P25, DOI 10.1111/j.1469-7793.1998.025bi.x; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Dellis O, 2006, SCIENCE, V313, P229, DOI 10.1126/science.1125203; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Iqbalsyah TM, 2006, PROTEIN SCI, V15, P1945, DOI 10.1110/ps.062271506; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Khan MT, 2007, J BIOL CHEM, V282, P32983, DOI 10.1074/jbc.M705183200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramos-Franco J, 1999, J GEN PHYSIOL, V114, P243, DOI 10.1085/jgp.114.2.243; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenhouse-Dantsker A, 2006, BIOPHYS J, V91, P2860, DOI 10.1529/biophysj.105.080242; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Srikanth S, 2004, BIOPHYS J, V86, P3634, DOI 10.1529/biophysj.104.040121; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Tikhonov DB, 2004, BIOPHYS J, V87, P1526, DOI 10.1529/biophysj.103.037770; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wagner LE, 2006, J BIOL CHEM, V281, P17410, DOI 10.1074/jbc.M601340200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3	57	111	111	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2939	2948		10.1074/jbc.M706645200	http://dx.doi.org/10.1074/jbc.M706645200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18534977	hybrid			2022-12-27	WOS:000252622300050
